data_3zgp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3zgp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.443 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.7 m-20 . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 109.456 -0.572 . . . . 0.42999999999999999 109.456 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 70.6 m -158.08 134.3 9.4 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.467 -1.242 . . . . 1.0 108.715 169.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.623 ' CD2' HD11 ' A' ' 464' ' ' LEU . 37.1 p90 174.61 158.39 0.17 Allowed 'General case' 0 C--O 1.212 -0.876 0 O-C-N 123.316 0.385 . . . . 0.88 111.545 -175.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.705 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -78.23 149.32 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 164.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.525 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.2 tt0 -149.34 139.57 22.24 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.459 -0.791 . . . . 2.0099999999999998 109.902 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.706 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -132.52 161.53 41.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.039 0.447 . . . . 1.04 111.412 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.504 ' N ' HG13 ' A' ' 347' ' ' VAL . 32.5 t0 -140.23 106.35 5.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.385 -1.339 . . . . 0.23999999999999999 107.385 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.642 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -83.02 -34.88 26.18 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 124.071 1.891 . . . . 1.02 110.139 -170.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.422 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.0 OUTLIER -55.63 -41.77 74.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 111.144 -2.753 . . . . 0.59999999999999998 107.757 176.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 19.1 m-80 -105.52 7.66 33.06 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 110.912 -2.858 . . . . 0.20999999999999999 111.666 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.851 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 82.9 mm-40 28.8 63.86 0.12 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 112.825 -1.989 . . . . 2.54 114.294 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.615 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 27.2 t60 -141.87 137.71 31.58 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.665 -1.152 . . . . 0.12 110.125 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.609 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.4 OUTLIER -113.55 157.89 21.48 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.218 0.532 . . . . 1.0 110.385 -178.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.556 ' CD1' HG12 ' A' ' 362' ' ' VAL . 30.5 m-90 -143.3 153.88 43.22 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.274 -0.876 . . . . 0.11 111.137 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.697 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.0 t80 -109.35 153.07 24.46 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.46 -1.681 . . . . 1.1000000000000001 106.46 151.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.9 m-85 -127.43 119.37 25.99 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.946 -1.024 . . . . 0.60999999999999999 110.384 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.8 tppt? -121.1 135.65 55.14 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.408 -1.701 . . . . 0.93999999999999995 106.408 168.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.479 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 72.11 15.77 5.42 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.071 0.767 . . . . 0.42999999999999999 113.071 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.443 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.65 7.09 88.29 Favored Glycine 0 CA--C 1.485 -1.826 0 CA-C-N 115.693 -0.685 . . . . 0.17999999999999999 112.731 -173.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.479 ' HG2' ' HB3' ' A' ' 359' ' ' ASP . 18.1 ptmt -127.93 178.13 6.39 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 104.505 -2.406 . . . . 1.0900000000000001 104.505 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 16.7 m -104.51 157.83 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 N-CA-C 116.475 2.028 . . . . 1.02 116.475 -174.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.584 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -107.86 -27.97 9.91 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-N 110.477 -3.056 . . . . 1.01 106.286 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.12 144.31 48.49 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 111.471 -2.604 . . . . 1.02 111.625 -175.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.615 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 3.4 tt0 -140.34 117.47 11.22 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 104.426 -2.435 . . . . 0.47999999999999998 104.426 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.679 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.6 OUTLIER -149.55 160.39 43.52 Favored 'General case' 0 N--CA 1.393 -3.297 0 C-N-CA 117.871 -1.532 . . . . 1.02 110.636 -179.332 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.75 138.9 38.12 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 108.334 -0.987 . . . . 1.8 108.334 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.695 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.0 pp -136.47 -174.21 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-O 122.11 0.957 . . . . 1.01 112.25 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.851 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.7 OUTLIER -150.12 118.82 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 113.02 -1.9 . . . . 1.04 108.793 172.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.521 ' HG ' HG13 ' A' ' 443' ' ' ILE . 0.2 OUTLIER -78.63 -168.08 1.28 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.555 -1.657 . . . . 1.6000000000000001 110.349 -178.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.43 168.07 43.75 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 118.485 -1.816 . . . . 0.14000000000000001 112.311 -174.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -73.61 158.74 85.92 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.626 0.727 . . . . 1.47 111.9 -166.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.639 ' HG3' ' CZ3' ' A' ' 434' ' ' TRP . 88.1 Cg_exo -57.43 -28.99 82.92 Favored 'Trans proline' 0 CA--C 1.495 -1.426 0 C-N-CA 125.182 3.922 . . . . 0.28000000000000003 113.435 -173.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.441 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.9 p -71.57 -33.71 69.31 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.405 -1.725 . . . . 1.0800000000000001 109.618 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.573 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.6 t -141.36 70.57 26.97 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 123.737 1.732 . . . . 1.1000000000000001 109.584 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 375' ' ' THR . 79.0 Cg_exo -59.46 157.55 30.97 Favored 'Trans proline' 0 C--N 1.314 -1.256 1 C-N-CA 126.494 4.796 . . . . 0.38 114.481 -172.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.497 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -87.35 146.16 39.24 Favored Pre-proline 0 N--CA 1.425 -1.723 0 N-CA-C 108.44 -0.948 . . . . 1.1299999999999999 108.44 174.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.4 Cg_exo -76.08 -44.15 0.28 Allowed 'Trans proline' 0 CA--C 1.511 -0.657 0 C-N-CA 124.8 3.667 . . . . 0.20999999999999999 112.136 -167.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.663 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 57.67 137.88 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 123.249 1.499 . . . . 1.0600000000000001 113.608 -172.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 150.47 -111.02 0.49 Allowed Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 112.592 -2.095 . . . . 0.20000000000000001 110.319 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.435 ' O ' HG11 ' A' ' 381' ' ' VAL . 5.7 p -130.17 113.51 26.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 122.496 1.141 . . . . 1.5 111.078 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.598 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 1.8 m-85 -114.68 -171.21 1.89 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.929 -1.508 . . . . 0.28000000000000003 106.929 173.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.51 ' CD1' ' HA ' ' A' ' 462' ' ' PRO . 1.4 t80 -150.03 124.58 9.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.856 1.207 . . . . 0.96999999999999997 112.838 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 386' ' ' ASN . 2.3 p -89.45 91.95 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-O 123.047 1.403 . . . . 1.02 109.13 169.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -93.8 11.24 29.96 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 113.298 -1.773 . . . . 3.1299999999999999 107.851 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.733 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.0 t30 -169.19 126.18 0.94 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 113.793 -1.548 . . . . 0.42999999999999999 110.086 172.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.642 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.89 143.68 31.47 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.828 -1.078 . . . . 1.73 109.121 171.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.725 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 26.7 mm-40 -126.11 157.61 37.61 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.599 1.333 . . . . 0.70999999999999996 114.599 -167.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.696 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 45.2 mt-10 -135.63 127.16 28.77 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 113.155 -1.839 . . . . 0.38 108.902 172.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.14 49.62 18.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 123.159 1.457 . . . . 0.40999999999999998 109.335 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.451 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -81.88 168.5 17.87 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 112.579 -2.1 . . . . 1.02 109.454 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.0 m -132.27 119.59 21.0 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.904 0.859 . . . . 1.04 111.745 170.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.6 mp -80.2 88.84 5.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.802 -1.545 . . . . 1.27 112.167 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.581 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.5 mttt . . . . . 0 C--N 1.284 -2.271 0 CA-C-N 113.657 -1.61 . . . . 0.96999999999999997 113.502 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.581 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.778 0 CA-C-O 120.977 0.418 . . . . 0.53000000000000003 109.91 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.2 97.35 5.23 Favored Pre-proline 0 N--CA 1.434 -1.254 0 N-CA-C 108.233 -1.025 . . . . 0.45000000000000001 108.233 171.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.2 Cg_exo -69.31 110.59 2.5 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 122.012 1.808 . . . . 0.22 110.047 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.587 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -110.02 158.03 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 CA-C-N 113.132 -1.849 . . . . 1.04 107.582 -168.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.696 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.0 m-80 -89.27 -21.8 23.02 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.031 -0.729 . . . . 0.65000000000000002 109.031 -174.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.635 ' HD1' ' CD2' ' A' ' 409' ' ' TYR . 94.1 m-85 -158.86 127.54 5.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.924 -1.035 . . . . 0.92000000000000004 108.229 -170.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.612 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 21.9 t-105 -144.93 136.26 25.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.692 0.758 . . . . 0.10000000000000001 111.397 -166.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.642 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.8 mmt -119.68 93.65 47.72 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.157 -1.053 . . . . 1.01 108.157 173.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.733 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.2 Cg_endo . . . . . 0 N--CA 1.459 -0.552 0 C-N-CA 122.171 1.914 . . . . 0.5 111.351 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 419' ' ' GLY . 40.6 t . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.425 0.631 . . . . 1.45 111.69 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.612 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -176.4 123.47 0.91 Allowed Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.049 -1.221 . . . . 0.20000000000000001 110.049 170.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.69 HG23 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.63 141.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.382 -0.599 . . . . 1.0900000000000001 109.382 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.586 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.6 p80 -159.82 160.1 33.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.295 -0.412 . . . . 0.10000000000000001 111.525 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.587 ' O ' HG21 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -82.59 145.92 29.44 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.02 -1.104 . . . . 1.0700000000000001 108.02 172.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 445' ' ' THR . 37.9 t -134.78 97.68 3.83 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.65 0.738 . . . . 0.5 110.191 -172.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.436 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 24.1 t70 . . . . . 0 C--N 1.314 -0.954 0 CA-C-N 114.604 -1.18 . . . . 0.41999999999999998 109.665 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.519 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.1 pm0 . . . . . 0 N--CA 1.434 -1.248 0 CA-C-O 122.199 0.999 . . . . 2.1600000000000001 113.283 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.63 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -160.57 128.6 4.55 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 106.384 -1.71 . . . . 0.91000000000000003 106.384 167.501 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.73 -156.71 28.32 Favored Glycine 0 C--N 1.285 -2.286 0 C-N-CA 119.975 -1.107 . . . . 0.20000000000000001 110.682 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.463 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.27 165.35 0.01 OUTLIER Glycine 0 CA--C 1.489 -1.549 0 C-N-CA 120.243 -0.98 . . . . 0.25 111.667 166.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.495 ' HB3' ' HD2' ' A' ' 435' ' ' LYS . 7.5 m-20 -53.48 102.98 0.06 Allowed 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.268 -1.466 . . . . 1.8500000000000001 113.499 -156.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.588 ' CD2' ' HD2' ' A' ' 437' ' ' ARG . 30.0 mt -94.66 -33.99 12.75 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 112.892 -1.958 . . . . 1.8200000000000001 109.452 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.66 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.1 p-90 -52.32 -27.32 14.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.841 -1.072 . . . . 0.17999999999999999 112.501 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.66 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.87 -33.17 16.56 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.276 0.56 . . . . 1.05 112.275 -178.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.412 ' H ' HG21 ' A' ' 436' ' ' THR . 1.5 p -90.62 -38.36 13.18 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.215 -0.902 . . . . 1.0600000000000001 110.765 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.588 ' HD2' ' CD2' ' A' ' 433' ' ' LEU . 1.5 mtp85 -98.49 -17.94 18.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.6 -1.182 . . . . 2.3700000000000001 109.992 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.36 48.05 55.02 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.833 -1.076 . . . . 0.23999999999999999 115.043 163.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.1 p -83.93 110.65 18.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.674 1.237 . . . . 1.7 111.615 -172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 35.13 -121.44 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.444 -1.253 . . . . 0.56999999999999995 113.418 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.448 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -131.75 -19.35 1.17 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.842 -0.617 . . . . 0.28999999999999998 113.703 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 29.4 p -99.95 -167.66 1.49 Allowed 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 117.923 0.862 . . . . 0.40000000000000002 112.61 -174.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.521 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.0 mp -99.03 126.26 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 114.698 -1.137 . . . . 1.04 110.928 -173.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.73 99.92 11.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.69 -0.686 . . . . 0.62 110.064 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.695 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.2 m -97.35 143.09 25.56 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-N 115.235 -0.893 . . . . 1.02 112.379 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.679 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 87.6 Cg_exo -49.59 144.59 18.93 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 124.023 3.149 . . . . 0.23999999999999999 113.36 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.63 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.1 Cg_exo -65.92 -27.26 50.99 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.734 2.289 . . . . 0.31 111.991 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 14.5 m -75.68 -24.12 56.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.453 -0.794 . . . . 1.48 112.18 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.709 ' O ' HD23 ' A' ' 364' ' ' LEU . 29.0 m -100.36 -49.31 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 113.171 0.804 . . . . 1.03 113.171 -168.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.933 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.93 -2.08 4.82 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.888 -0.725 . . . . 1.02 110.191 -178.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.57 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.2 pttp -81.45 -38.51 26.31 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 122.554 1.168 . . . . 1.5900000000000001 108.197 173.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.58 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.4 mm-40 -62.53 -46.5 88.12 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-N 112.418 -2.174 . . . . 0.25 106.463 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.933 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.8 tp -46.34 -66.89 0.34 Allowed 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 109.807 -3.361 . . . . 1.02 112.579 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.506 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 17.4 t80 -45.4 -24.28 0.29 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 124.038 0.836 . . . . 0.17000000000000001 109.617 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.27 -27.36 25.68 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.76 -1.109 . . . . 0.13 111.685 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.578 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -100.83 -44.57 5.73 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 113.304 0.853 . . . . 1.02 113.304 177.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.705 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -74.01 149.92 7.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 122.528 1.156 . . . . 1.01 111.464 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.537 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.24 156.12 34.44 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-N 112.929 -1.941 . . . . 0.47999999999999998 108.121 -177.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.542 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.5 mppt? -56.36 103.03 0.09 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 109.248 -0.649 . . . . 1.7 109.248 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.61 -6.89 6.59 Favored Glycine 0 C--N 1.308 -0.981 0 CA-C-N 114.148 -1.387 . . . . 0.22 111.863 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.575 HG21 ' HA ' ' A' ' 344' ' ' TYR . 7.7 m -69.63 147.81 96.64 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 109.425 -0.583 . . . . 0.94999999999999996 109.425 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 2.5 Cg_endo -90.26 151.62 4.58 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 122.683 2.255 . . . . 0.23000000000000001 110.005 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.582 ' CG1' ' HB2' ' A' ' 382' ' ' PHE . 1.6 t -121.57 133.54 67.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 114.686 -1.143 . . . . 1.27 109.088 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.676 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.3 mp -133.04 148.5 52.21 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 119.494 -0.882 . . . . 1.05 109.684 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.706 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.11 141.57 33.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.132 -2.174 . . . . 1.01 105.132 166.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.527 ' N ' HD23 ' A' ' 349' ' ' LEU . 12.8 p90 . . . . . 0 C--O 1.246 0.915 0 O-C-N 123.568 0.543 . . . . 1.0900000000000001 111.476 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.567 0.699 . . . . 0.42999999999999999 109.318 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 99.5 m -158.95 135.24 9.14 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.288 -1.324 . . . . 1.0 108.78 168.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.64 ' CD2' HD11 ' A' ' 464' ' ' LEU . 40.6 p90 174.64 158.09 0.16 Allowed 'General case' 0 C--O 1.211 -0.964 0 O-C-N 123.326 0.391 . . . . 0.88 111.348 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.681 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.74 151.79 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 164.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.548 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.2 tt0 -149.64 142.69 24.92 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.591 -0.731 . . . . 2.0099999999999998 109.568 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.69 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.67 161.69 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 121.019 0.438 . . . . 1.04 111.019 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.505 ' N ' HG13 ' A' ' 347' ' ' VAL . 31.7 t0 -140.03 105.72 5.13 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.158 -1.423 . . . . 0.23999999999999999 107.158 173.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.618 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -81.24 -35.09 31.64 Favored 'General case' 0 CA--C 1.481 -1.678 0 CA-C-O 122.838 1.304 . . . . 1.02 110.212 -168.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -55.27 -44.89 76.03 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 110.706 -2.952 . . . . 0.59999999999999998 108.063 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -100.44 5.51 44.26 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 110.932 -2.849 . . . . 0.20999999999999999 110.904 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.554 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.6 OUTLIER 34.79 61.15 0.6 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 112.794 -2.003 . . . . 2.54 112.981 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.593 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 21.4 t60 -141.58 134.96 29.57 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.714 -0.675 . . . . 0.12 109.863 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.604 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.37 156.55 23.23 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.238 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.547 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.6 m-90 -142.06 155.33 45.38 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.551 -0.75 . . . . 0.11 111.195 -175.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.692 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.9 t80 -110.42 153.17 25.37 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 106.582 -1.636 . . . . 1.1000000000000001 106.582 151.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.3 m-85 -128.51 115.97 18.96 Favored 'General case' 0 C--N 1.269 -2.893 0 CA-C-N 114.855 -1.066 . . . . 0.60999999999999999 110.289 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.6 tppt? -116.33 140.02 49.78 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.777 -1.934 . . . . 0.93999999999999995 105.777 168.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.46 19.4 10.02 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.358 0.873 . . . . 0.42999999999999999 113.358 171.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 75.17 7.88 82.62 Favored Glycine 0 CA--C 1.489 -1.537 0 CA-C-N 115.573 -0.739 . . . . 0.17999999999999999 113.417 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.0 ptmt -128.0 178.26 6.32 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 104.682 -2.34 . . . . 1.0900000000000001 104.682 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 15.6 m -105.0 157.52 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 N-CA-C 116.205 1.928 . . . . 1.02 116.205 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.575 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.03 -26.52 10.14 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 110.461 -3.063 . . . . 1.01 106.358 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.75 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -135.04 143.7 46.86 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 111.511 -2.586 . . . . 1.02 111.726 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.593 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 2.6 tt0 -142.01 117.77 10.45 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.673 -2.343 . . . . 0.47999999999999998 104.673 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.604 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.81 164.49 35.19 Favored 'General case' 0 N--CA 1.398 -3.053 0 C-N-CA 118.129 -1.428 . . . . 1.02 111.548 -178.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.66 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 10.3 p-10 -103.3 133.12 48.91 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.366 -1.288 . . . . 1.8 109.633 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.665 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -134.07 -173.63 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 122.345 1.069 . . . . 1.01 112.307 -171.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.48 121.81 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 112.904 -1.953 . . . . 1.04 108.491 172.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.563 ' HG ' ' HB3' ' A' ' 349' ' ' LEU . 56.9 p -77.69 -168.83 1.3 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 112.678 -2.055 . . . . 1.6000000000000001 111.418 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.48 167.24 42.65 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 118.536 -1.792 . . . . 0.14000000000000001 111.771 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 6.7 ptmt -74.48 155.76 87.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.413 0.625 . . . . 1.47 111.633 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.646 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 78.8 Cg_exo -54.71 -30.07 64.82 Favored 'Trans proline' 0 CA--C 1.498 -1.318 1 C-N-CA 125.386 4.057 . . . . 0.28000000000000003 113.345 -173.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.449 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 20.0 p -70.79 -34.51 71.85 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.568 -1.651 . . . . 1.0800000000000001 109.706 -176.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.573 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.9 t -141.94 69.98 23.92 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 123.78 1.753 . . . . 1.1000000000000001 109.439 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.4 Cg_exo -58.49 166.07 6.75 Favored 'Trans proline' 0 C--N 1.316 -1.157 1 C-N-CA 126.918 5.079 . . . . 0.38 115.81 -170.252 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 0.5 OUTLIER -93.75 140.77 23.14 Favored Pre-proline 0 N--CA 1.419 -1.985 0 CA-C-N 114.458 -1.246 . . . . 1.1299999999999999 108.331 170.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.4 Cg_exo -76.33 -45.96 0.19 Allowed 'Trans proline' 0 CA--C 1.514 -0.48 0 C-N-CA 124.547 3.498 . . . . 0.20999999999999999 112.081 -170.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.653 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 62.48 138.59 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.313 1.53 . . . . 1.0600000000000001 113.597 -172.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 151.59 -111.66 0.51 Allowed Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 112.281 -2.236 . . . . 0.20000000000000001 109.471 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.444 ' O ' HG11 ' A' ' 381' ' ' VAL . 5.9 p -130.92 119.38 44.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.743 0.782 . . . . 1.5 110.461 176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.599 ' HD2' ' CD1' ' A' ' 382' ' ' PHE . 2.8 m-85 -118.23 -173.86 2.54 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.168 -1.419 . . . . 0.28000000000000003 107.168 172.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -141.05 123.43 15.82 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 120.623 -1.298 . . . . 0.96999999999999997 112.959 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.48 91.98 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-O 123.105 1.431 . . . . 1.02 109.403 169.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -93.7 11.95 27.24 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.274 -1.785 . . . . 3.1299999999999999 108.199 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.759 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.7 t30 -168.64 126.41 1.06 Allowed 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 113.995 -1.457 . . . . 0.42999999999999999 110.162 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.642 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.34 141.87 33.57 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.747 -1.115 . . . . 1.73 108.94 169.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.752 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 13.9 mm-40 -126.1 157.69 37.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 114.443 1.275 . . . . 0.70999999999999996 114.443 -167.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 47.3 mt-10 -137.73 127.2 24.93 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.013 -1.903 . . . . 0.38 108.613 173.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.6 t70 56.48 47.77 18.1 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.227 1.489 . . . . 0.40999999999999998 109.026 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -83.7 169.28 15.44 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 112.367 -2.197 . . . . 1.02 109.393 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 20.7 m -132.6 121.14 22.76 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.863 0.839 . . . . 1.04 111.693 169.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.512 HD22 ' CG ' ' A' ' 421' ' ' HIS . 3.8 mp -80.35 89.17 5.54 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.829 -1.532 . . . . 1.27 112.601 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.592 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.1 mttt . . . . . 0 C--N 1.284 -2.269 0 CA-C-N 113.687 -1.597 . . . . 0.96999999999999997 113.117 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.592 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.444 -0.732 0 CA-C-O 121.13 0.491 . . . . 0.53000000000000003 110.161 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.14 97.23 4.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.177 -1.045 . . . . 0.45000000000000001 108.177 169.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.2 Cg_exo -69.02 109.55 2.19 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.851 1.701 . . . . 0.22 110.26 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.526 ' CG1' ' HB2' ' A' ' 410' ' ' TRP . 0.4 OUTLIER -108.97 157.48 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-N 113.194 -1.821 . . . . 1.04 107.697 -167.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.724 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.9 m-80 -89.7 -20.61 23.4 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.016 -0.735 . . . . 0.65000000000000002 109.016 -174.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 87.8 m-85 -158.45 126.43 5.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.968 -1.015 . . . . 0.92000000000000004 108.508 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.617 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.3 t-105 -144.52 134.89 24.43 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.781 0.8 . . . . 0.10000000000000001 111.295 -167.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.642 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -116.71 92.63 38.57 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 107.609 -1.256 . . . . 1.01 107.609 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.759 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.3 Cg_endo . . . . . 0 C--N 1.348 0.539 0 C-N-CA 122.434 2.09 . . . . 0.5 111.68 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 419' ' ' GLY . 43.1 t . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 121.123 0.487 . . . . 1.45 111.641 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.589 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -175.06 121.52 0.83 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.17 -1.172 . . . . 0.20000000000000001 110.17 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.678 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.7 141.78 14.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.928 -0.397 . . . . 1.0900000000000001 109.928 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.593 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.5 p80 -159.89 161.59 34.4 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.097 -0.501 . . . . 0.10000000000000001 111.338 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.627 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -82.24 147.68 28.81 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.988 -1.115 . . . . 1.0700000000000001 107.988 171.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 445' ' ' THR . 29.4 t -132.83 96.91 3.9 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.813 0.815 . . . . 0.5 109.843 -173.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 N--CA 1.443 -0.787 0 CA-C-N 114.15 -1.386 . . . . 0.41999999999999998 109.353 -177.784 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.607 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.0 pm0 . . . . . 0 N--CA 1.435 -1.196 0 CA-C-O 122.248 1.023 . . . . 2.1600000000000001 113.464 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.701 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.67 129.22 3.51 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 112.722 -2.035 . . . . 0.91000000000000003 105.672 173.033 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.59 -158.07 30.55 Favored Glycine 0 C--N 1.284 -2.361 0 N-CA-C 110.538 -1.025 . . . . 0.20000000000000001 110.538 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.434 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -45.3 174.58 0.01 OUTLIER Glycine 0 CA--C 1.498 -0.979 0 C-N-CA 120.217 -0.992 . . . . 0.25 111.66 167.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.525 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -52.01 101.89 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 123.386 1.565 . . . . 1.8500000000000001 113.76 -154.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.649 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.27 -37.92 10.32 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 112.575 -2.102 . . . . 1.8200000000000001 109.798 170.04 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.671 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.4 p-90 -53.94 -27.28 30.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.442 -0.799 . . . . 0.17999999999999999 112.39 -170.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.671 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.39 -34.07 16.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.593 0.59 . . . . 1.05 112.593 -177.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.4 p -92.75 -42.42 9.58 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.045 -0.979 . . . . 1.0600000000000001 110.812 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.649 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.5 mtp180 -93.89 -18.36 22.05 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.971 -1.013 . . . . 2.3700000000000001 110.062 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.56 50.52 48.1 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 115.811 1.084 . . . . 0.23999999999999999 115.811 161.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 17.5 m -82.56 111.37 18.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 119.145 1.473 . . . . 1.7 111.237 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 34.18 -120.65 0.09 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.827 -1.079 . . . . 0.56999999999999995 113.412 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -130.99 -18.76 1.32 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.986 -0.626 . . . . 0.28999999999999998 113.741 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 29.5 p -103.62 -165.63 1.18 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.816 0.673 . . . . 0.40000000000000002 112.816 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.442 HD11 HG12 ' A' ' 465' ' ' VAL . 2.2 mp -95.86 132.79 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.121 -0.945 . . . . 1.04 110.825 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.82 98.06 7.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.936 -0.575 . . . . 0.62 110.26 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.665 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.5 m -93.88 140.17 22.9 Favored Pre-proline 0 N--CA 1.439 -0.997 0 CA-C-N 115.392 -0.822 . . . . 1.02 113.206 -176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.698 ' O ' HG23 ' A' ' 449' ' ' VAL . 74.1 Cg_exo -51.97 135.75 51.51 Favored 'Trans proline' 0 CA--C 1.496 -1.392 0 C-N-CA 124.629 3.553 . . . . 0.23999999999999999 115.532 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.701 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 50.0 Cg_exo -56.76 -38.82 94.88 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.279 1.319 . . . . 0.31 111.618 -167.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.582 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 21.0 m -62.46 -25.61 68.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.225 0.824 . . . . 1.48 113.225 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.75 ' O ' HD23 ' A' ' 364' ' ' LEU . 22.6 m -98.42 -47.76 12.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 O-C-N 121.33 -0.856 . . . . 1.03 112.997 -169.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.942 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.49 -1.98 5.76 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.613 -0.835 . . . . 1.02 110.344 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 448' ' ' SER . 14.2 pttp -80.78 -38.59 28.28 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 122.67 1.224 . . . . 1.5900000000000001 108.294 173.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.577 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.8 mm-40 -61.6 -46.58 89.24 Favored 'General case' 0 CA--C 1.47 -2.104 0 CA-C-N 112.305 -2.225 . . . . 0.25 106.36 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.942 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -47.23 -66.59 0.38 Allowed 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 109.766 -3.379 . . . . 1.02 112.688 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.499 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 19.0 t80 -45.71 -23.86 0.3 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 123.935 0.772 . . . . 0.17000000000000001 109.581 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.46 -26.64 27.22 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 114.789 -1.096 . . . . 0.13 111.772 -175.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.596 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -101.96 -44.64 5.43 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 113.462 0.912 . . . . 1.02 113.462 177.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.681 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.98 148.03 9.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.495 1.141 . . . . 1.01 111.402 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.5 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -118.04 156.72 28.11 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 113.005 -1.907 . . . . 0.47999999999999998 108.772 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.598 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 43.1 mtmt -57.28 102.99 0.1 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.659 0.742 . . . . 1.7 109.686 170.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.96 -10.78 6.26 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 113.837 -1.529 . . . . 0.22 111.369 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.588 HG21 ' HA ' ' A' ' 344' ' ' TYR . 17.0 m -66.72 149.34 98.34 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 108.842 -0.799 . . . . 0.94999999999999996 108.842 171.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 4.7 Cg_endo -93.67 159.07 2.35 Favored 'Trans proline' 0 N--CA 1.426 -2.499 0 C-N-CA 122.411 2.074 . . . . 0.23000000000000001 109.866 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.708 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -124.46 148.83 28.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.504 -1.295 . . . . 1.27 107.504 172.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.683 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.7 mp -134.01 150.2 51.23 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.463 -0.94 . . . . 1.05 108.463 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.69 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.8 OUTLIER -138.72 141.99 35.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 105.113 -2.18 . . . . 1.01 105.113 165.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.561 ' N ' HD23 ' A' ' 349' ' ' LEU . 12.1 p90 . . . . . 0 C--O 1.245 0.822 0 O-C-N 123.688 0.617 . . . . 1.0900000000000001 111.064 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.406 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 4.9 m-20 . . . . . 0 N--CA 1.443 -0.812 0 N-CA-C 109.278 -0.638 . . . . 0.42999999999999999 109.278 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 88.0 m -158.43 134.72 9.33 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.512 -1.222 . . . . 1.0 109.104 169.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.653 ' CD2' HD11 ' A' ' 464' ' ' LEU . 37.8 p90 174.15 158.82 0.15 Allowed 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 123.42 0.45 . . . . 0.88 111.112 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.69 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.62 151.85 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 164.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.58 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.21 140.91 23.53 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.583 -0.735 . . . . 2.0099999999999998 109.543 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.7 HG21 ' O ' ' A' ' 464' ' ' LEU . 2.7 t -134.7 162.03 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.095 0.474 . . . . 1.04 111.287 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.532 ' HA ' ' C ' ' A' ' 466' ' ' PHE . 27.8 t0 -140.26 106.8 5.32 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.205 -1.406 . . . . 0.23999999999999999 107.205 174.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.676 ' O ' ' HG3' ' A' ' 352' ' ' GLN . 0.3 OUTLIER -83.57 -33.77 25.33 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 123.378 1.561 . . . . 1.02 110.21 -169.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.17 -44.88 83.93 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 110.625 -2.989 . . . . 0.59999999999999998 107.908 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -102.4 4.84 39.29 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 111.155 -2.748 . . . . 0.20999999999999999 111.227 -175.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.676 ' HG3' ' O ' ' A' ' 349' ' ' LEU . 29.6 mt-30 32.69 63.54 0.3 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 112.857 -1.974 . . . . 2.54 113.748 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.583 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.3 t60 -142.05 135.31 29.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.914 -1.039 . . . . 0.12 109.332 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.608 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.16 156.4 23.28 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.067 -178.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.546 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.7 m-90 -142.01 155.13 45.42 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.184 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.682 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.3 t80 -110.26 153.31 25.02 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 106.61 -1.626 . . . . 1.1000000000000001 106.61 151.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 11.7 m-85 -127.65 118.77 24.48 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 114.936 -1.029 . . . . 0.60999999999999999 110.416 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.2 tppt? -120.0 136.83 54.41 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.96 -1.867 . . . . 0.93999999999999995 105.96 168.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.55 17.8 7.86 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.481 0.919 . . . . 0.42999999999999999 113.481 174.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.406 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.67 8.34 87.2 Favored Glycine 0 CA--C 1.485 -1.793 0 C-N-CA 120.825 -0.702 . . . . 0.17999999999999999 112.918 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.4 ptmt -129.08 177.7 6.94 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 104.564 -2.384 . . . . 1.0900000000000001 104.564 178.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.1 m -104.12 157.69 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 N-CA-C 116.344 1.979 . . . . 1.02 116.344 -175.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.587 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -108.8 -27.67 9.63 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 110.513 -3.04 . . . . 1.01 106.493 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.735 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.82 144.58 49.07 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 111.495 -2.593 . . . . 1.02 111.535 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.583 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 3.5 tt0 -140.43 118.22 11.71 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 104.53 -2.396 . . . . 0.47999999999999998 104.53 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.614 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -150.05 163.41 38.23 Favored 'General case' 0 N--CA 1.397 -3.089 0 C-N-CA 117.626 -1.63 . . . . 1.02 111.869 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.699 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 11.9 p-10 -101.96 134.14 45.65 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 114.027 -1.442 . . . . 1.8 109.545 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.682 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.11 -173.59 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 CA-C-O 122.26 1.029 . . . . 1.01 112.457 -172.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.47 118.63 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.075 -1.875 . . . . 1.04 107.722 173.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.53 ' HG ' HG13 ' A' ' 443' ' ' ILE . 0.2 OUTLIER -79.42 -167.98 1.38 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.127 -1.397 . . . . 1.6000000000000001 110.773 -177.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.45 164.45 39.88 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 118.639 -1.743 . . . . 0.14000000000000001 112.407 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 11.0 ptmt -70.97 158.05 89.0 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.639 0.733 . . . . 1.47 111.698 -167.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.627 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.4 Cg_exo -57.83 -29.48 86.23 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 125.184 3.923 . . . . 0.28000000000000003 113.348 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.454 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 17.8 p -71.76 -32.76 68.03 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.608 -1.633 . . . . 1.0800000000000001 109.725 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.562 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.5 t -141.07 70.47 28.43 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-O 123.807 1.765 . . . . 1.1000000000000001 109.31 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.0 Cg_exo -58.94 162.79 12.64 Favored 'Trans proline' 0 C--N 1.312 -1.358 1 C-N-CA 126.486 4.791 . . . . 0.38 115.165 -171.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.525 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -96.06 141.99 23.93 Favored Pre-proline 0 N--CA 1.419 -1.979 0 CA-C-N 114.729 -1.123 . . . . 1.1299999999999999 108.503 171.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.6 Cg_exo -76.31 -44.56 0.24 Allowed 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 124.719 3.612 . . . . 0.20999999999999999 111.95 -167.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.654 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 61.49 138.05 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 123.328 1.537 . . . . 1.0600000000000001 113.467 -172.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 153.0 -114.43 0.62 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 112.201 -2.272 . . . . 0.20000000000000001 109.362 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.433 ' O ' HG11 ' A' ' 381' ' ' VAL . 7.3 p -130.73 117.21 37.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.892 0.854 . . . . 1.5 110.661 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.611 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.9 m-85 -115.58 -174.04 2.45 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.147 -1.427 . . . . 0.28000000000000003 107.147 173.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.46 123.49 17.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 119.987 1.267 . . . . 0.96999999999999997 113.41 -171.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.06 92.23 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 123.06 1.41 . . . . 1.02 109.337 168.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -94.22 11.96 28.39 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.428 -1.714 . . . . 3.1299999999999999 108.18 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.755 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 9.0 t30 -169.37 126.65 0.93 Allowed 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 113.972 -1.467 . . . . 0.42999999999999999 110.174 172.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.611 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.16 145.99 26.61 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.064 -0.971 . . . . 1.73 109.098 168.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.737 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 19.5 mm-40 -126.29 159.2 33.76 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 114.509 1.3 . . . . 0.70999999999999996 114.509 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.752 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 40.1 mt-10 -138.37 127.52 24.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.211 -1.813 . . . . 0.38 108.674 173.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.81 45.52 21.48 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 123.338 1.542 . . . . 0.40999999999999998 108.729 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -80.77 166.6 20.84 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 112.513 -2.13 . . . . 1.02 109.177 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 16.9 m -132.08 120.65 22.64 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.091 0.948 . . . . 1.04 111.551 170.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -81.13 88.6 5.99 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.871 -1.513 . . . . 1.27 112.048 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.582 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.3 mttt . . . . . 0 C--N 1.284 -2.245 0 CA-C-N 113.585 -1.643 . . . . 0.96999999999999997 113.129 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.582 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.61 0 CA-C-O 121.12 0.486 . . . . 0.53000000000000003 110.151 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.81 97.33 4.96 Favored Pre-proline 0 N--CA 1.436 -1.153 0 N-CA-C 108.275 -1.009 . . . . 0.45000000000000001 108.275 170.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 18.1 Cg_exo -69.04 111.1 2.57 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.065 1.843 . . . . 0.22 110.023 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -110.99 153.45 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 CA-C-N 112.958 -1.928 . . . . 1.04 107.626 -167.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 21.5 m-80 -86.14 -20.44 28.64 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.902 -0.777 . . . . 0.65000000000000002 108.902 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.642 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 96.4 m-85 -159.0 127.31 5.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.12 -0.945 . . . . 0.92000000000000004 108.643 -170.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.613 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 23.3 t-105 -145.12 134.35 22.86 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.641 0.734 . . . . 0.10000000000000001 111.185 -167.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.611 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.5 mmt -116.44 93.69 40.72 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.908 -1.145 . . . . 1.01 107.908 173.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.755 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 39.0 Cg_endo . . . . . 0 N--CA 1.46 -0.464 0 C-N-CA 122.311 2.007 . . . . 0.5 112.239 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 419' ' ' GLY . 36.5 t . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 121.321 0.582 . . . . 1.45 111.943 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.602 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -178.84 121.4 0.75 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 109.931 -1.268 . . . . 0.20000000000000001 109.931 171.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.672 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.66 143.09 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 110.034 -0.358 . . . . 1.0900000000000001 110.034 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.592 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.4 p80 -160.58 162.11 32.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.245 -0.434 . . . . 0.10000000000000001 111.409 -174.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.591 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.45 145.86 27.93 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.947 -1.131 . . . . 1.0700000000000001 107.947 172.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.2 t -134.17 98.63 4.17 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.745 0.783 . . . . 0.5 110.5 -171.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 C--N 1.314 -0.952 0 CA-C-N 114.117 -1.401 . . . . 0.41999999999999998 109.418 -177.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.475 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.428 -1.531 0 CA-C-O 122.205 1.002 . . . . 2.1600000000000001 111.779 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.699 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.9 OUTLIER -159.58 124.84 4.11 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 105.129 -2.175 . . . . 0.91000000000000003 105.129 173.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.09 -157.75 30.16 Favored Glycine 0 C--N 1.284 -2.333 0 C-N-CA 119.46 -1.352 . . . . 0.20000000000000001 111.354 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -46.26 173.48 0.02 OUTLIER Glycine 0 CA--C 1.501 -0.805 0 C-N-CA 120.609 -0.805 . . . . 0.25 111.694 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.582 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.3 p-10 -52.57 100.8 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 123.743 1.735 . . . . 1.8500000000000001 114.035 -150.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.649 ' HG ' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.55 -43.58 7.53 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 111.805 -2.452 . . . . 1.8200000000000001 109.721 170.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.708 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.5 p-90 -52.12 -27.31 13.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.718 -0.674 . . . . 0.17999999999999999 112.504 -171.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.708 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.89 -32.56 15.98 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.397 0.618 . . . . 1.05 112.452 -177.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.417 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.8 p -94.15 -43.24 8.57 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.951 -1.022 . . . . 1.0600000000000001 111.069 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.649 ' CD ' ' HG ' ' A' ' 433' ' ' LEU . 0.2 OUTLIER -87.59 -20.18 26.77 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.768 -1.106 . . . . 2.3700000000000001 109.153 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.59 47.7 63.02 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 113.631 -1.622 . . . . 0.23999999999999999 115.138 164.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.5 p -82.88 110.23 17.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 118.962 1.381 . . . . 1.7 111.675 -171.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 33.54 -117.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.291 -1.322 . . . . 0.56999999999999995 113.47 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -135.57 -16.32 0.91 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.906 -0.664 . . . . 0.28999999999999998 113.79 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 29.1 p -103.57 -166.56 1.27 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.834 0.817 . . . . 0.40000000000000002 112.621 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.53 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.0 mp -96.16 129.41 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.107 -0.952 . . . . 1.04 110.736 -175.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.59 93.41 5.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.976 -0.556 . . . . 0.62 110.332 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.682 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.2 m -89.14 141.98 29.7 Favored Pre-proline 0 N--CA 1.438 -1.038 0 CA-C-N 115.234 -0.894 . . . . 1.02 112.549 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.614 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 87.1 Cg_exo -49.61 144.77 18.58 Favored 'Trans proline' 0 CA--C 1.506 -0.89 0 C-N-CA 124.158 3.239 . . . . 0.23999999999999999 113.549 175.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.613 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.7 Cg_exo -65.12 -27.02 57.19 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.855 2.37 . . . . 0.31 112.234 -175.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.505 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 11.9 m -76.31 -23.9 54.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.863 -0.608 . . . . 1.48 112.237 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.735 ' O ' HD23 ' A' ' 364' ' ' LEU . 30.8 m -100.59 -48.7 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 113.009 0.744 . . . . 1.03 113.009 -169.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.92 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.87 -2.1 4.78 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.847 -0.741 . . . . 1.02 110.353 -178.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.505 ' HE3' ' O ' ' A' ' 448' ' ' SER . 15.8 pttp -80.81 -39.43 26.7 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.085 -1.08 . . . . 1.5900000000000001 108.085 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.58 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.4 mm-40 -61.45 -45.9 92.32 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 112.578 -2.101 . . . . 0.25 106.46 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.92 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.5 tp -47.69 -67.12 0.3 Allowed 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 109.701 -3.409 . . . . 1.02 112.719 172.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.552 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 14.4 t80 -45.93 -23.28 0.27 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.794 0.807 . . . . 0.17000000000000001 109.562 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.15 -26.01 27.29 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.72 -1.127 . . . . 0.13 111.842 -176.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.578 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -102.71 -43.91 5.45 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 113.504 0.927 . . . . 1.02 113.504 177.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.69 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.47 150.38 7.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 122.523 1.154 . . . . 1.01 111.196 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.54 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -120.84 156.77 31.23 Favored 'General case' 0 N--CA 1.414 -2.255 0 CA-C-N 112.978 -1.919 . . . . 0.47999999999999998 108.418 -177.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.563 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 4.2 mppt? -59.34 101.86 0.12 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.888 -0.782 . . . . 1.7 108.888 171.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.3 -11.74 5.81 Favored Glycine 0 C--N 1.306 -1.132 0 CA-C-N 113.955 -1.475 . . . . 0.22 111.482 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.579 HG21 ' HA ' ' A' ' 344' ' ' TYR . 15.6 m -66.65 149.33 98.29 Favored Pre-proline 0 N--CA 1.44 -0.964 0 N-CA-C 108.651 -0.87 . . . . 0.94999999999999996 108.651 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.6 Cg_endo -93.72 160.63 2.31 Favored 'Trans proline' 0 N--CA 1.422 -2.707 0 C-N-CA 122.196 1.931 . . . . 0.23000000000000001 109.929 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.729 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -123.99 150.07 28.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.281 -1.377 . . . . 1.27 107.281 171.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.7 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.6 mp -134.08 149.06 51.11 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 108.179 -1.045 . . . . 1.05 108.179 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.677 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -137.74 142.25 36.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 105.266 -2.124 . . . . 1.01 105.266 165.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 8.3 p90 . . . . . 0 C--O 1.244 0.79 0 O-C-N 123.83 0.706 . . . . 1.0900000000000001 110.787 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.478 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 13.3 m-20 . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 109.341 -0.614 . . . . 0.42999999999999999 109.341 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 97.2 m -159.78 135.61 8.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.8 -1.091 . . . . 1.0 109.857 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.613 ' CD2' HD11 ' A' ' 464' ' ' LEU . 37.5 p90 173.02 159.7 0.12 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.192 0.308 . . . . 0.88 110.812 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.68 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.97 151.54 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 164.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.579 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 35.1 tt0 -149.72 141.05 23.22 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.486 -0.779 . . . . 2.0099999999999998 109.626 -176.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 464' ' ' LEU . 2.8 t -134.44 161.87 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 122.126 -0.359 . . . . 1.04 111.104 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.524 ' HA ' ' C ' ' A' ' 466' ' ' PHE . 20.7 t0 -140.26 107.21 5.42 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.663 -1.236 . . . . 0.23999999999999999 107.663 173.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.66 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -83.55 -33.35 25.46 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-O 122.77 1.271 . . . . 1.02 110.273 -168.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 466' ' ' PHE . 1.0 OUTLIER -59.72 -43.4 94.16 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 110.87 -2.877 . . . . 0.59999999999999998 108.261 177.03 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -102.83 8.12 39.35 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 111.153 -2.749 . . . . 0.20999999999999999 110.749 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.555 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 15.3 mp0 32.93 61.27 0.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 112.906 -1.952 . . . . 2.54 113.56 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.608 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 24.8 t60 -142.94 137.13 29.2 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.868 -0.605 . . . . 0.12 109.86 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.6 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.4 OUTLIER -114.48 156.53 24.39 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.249 -179.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.541 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.8 m-90 -142.21 154.18 44.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.482 -0.781 . . . . 0.11 111.191 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.696 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.5 t80 -110.15 153.11 25.18 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.491 -1.67 . . . . 1.1000000000000001 106.491 151.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.9 m-85 -127.61 117.12 21.41 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.883 -1.053 . . . . 0.60999999999999999 109.948 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.7 tppt? -118.13 140.05 50.35 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 105.854 -1.906 . . . . 0.93999999999999995 105.854 168.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.65 17.21 10.57 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.597 0.962 . . . . 0.42999999999999999 113.597 171.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.478 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.97 8.06 87.41 Favored Glycine 0 CA--C 1.483 -1.954 0 CA-C-O 122.064 0.813 . . . . 0.17999999999999999 112.961 -175.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 16.1 ptmt -126.83 177.26 6.7 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 104.484 -2.413 . . . . 1.0900000000000001 104.484 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 17.0 m -104.29 157.11 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.841 0 C-N-CA 116.982 -1.887 . . . . 1.02 115.626 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.565 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -106.61 -28.23 10.37 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-N 110.544 -3.025 . . . . 1.01 106.125 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.748 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -133.17 143.48 49.24 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 111.413 -2.63 . . . . 1.02 111.896 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.608 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -139.98 117.55 11.51 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 104.361 -2.459 . . . . 0.47999999999999998 104.361 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.662 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.6 OUTLIER -149.94 161.02 43.12 Favored 'General case' 0 N--CA 1.397 -3.11 0 C-N-CA 117.795 -1.562 . . . . 1.02 110.691 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.17 141.61 32.77 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.448 -0.945 . . . . 1.8 108.448 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.671 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -138.66 -172.82 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 CA-C-O 122.54 1.162 . . . . 1.01 111.947 -173.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.86 120.13 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 112.725 -2.034 . . . . 1.04 108.197 173.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.542 ' HG ' HG13 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -80.13 -168.06 1.52 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.977 -1.465 . . . . 1.6000000000000001 110.36 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.418 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.19 168.32 44.54 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 118.528 -1.796 . . . . 0.14000000000000001 112.26 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 5.3 ptmt -73.8 158.11 86.48 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.56 0.695 . . . . 1.47 112.037 -165.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.64 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 82.3 Cg_exo -57.68 -30.66 89.68 Favored 'Trans proline' 0 CA--C 1.493 -1.555 0 C-N-CA 125.273 3.982 . . . . 0.28000000000000003 113.347 -172.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.402 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 22.7 p -68.61 -33.81 74.69 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.346 -1.752 . . . . 1.0800000000000001 109.325 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.564 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.5 t -142.88 70.28 19.15 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 123.585 1.659 . . . . 1.1000000000000001 110.37 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 375' ' ' THR . 83.4 Cg_exo -58.99 157.43 29.2 Favored 'Trans proline' 0 C--N 1.314 -1.273 1 C-N-CA 126.601 4.868 . . . . 0.38 115.145 -171.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.517 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -86.37 147.87 45.57 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 115.192 -0.913 . . . . 1.1299999999999999 108.702 173.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -78.08 -44.64 0.16 Allowed 'Trans proline' 0 CA--C 1.512 -0.592 0 C-N-CA 124.853 3.702 . . . . 0.20999999999999999 112.417 -167.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.658 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.49 138.52 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 123.345 1.545 . . . . 1.0600000000000001 113.639 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.69 -115.13 0.68 Allowed Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 112.27 -2.241 . . . . 0.20000000000000001 109.318 -177.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.436 ' O ' HG11 ' A' ' 381' ' ' VAL . 4.6 p -128.35 121.18 54.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.846 0.832 . . . . 1.5 110.266 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.606 ' HD2' ' CD1' ' A' ' 382' ' ' PHE . 2.9 m-85 -118.32 -174.38 2.65 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.87 -1.529 . . . . 0.28000000000000003 106.87 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -139.67 123.02 17.09 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 120.801 -1.187 . . . . 0.96999999999999997 112.937 -171.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.41 92.7 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 123.056 1.407 . . . . 1.02 109.544 170.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -92.94 10.82 29.64 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 113.317 -1.765 . . . . 3.1299999999999999 108.334 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.749 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.1 t30 -169.21 126.91 0.96 Allowed 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 114.149 -1.387 . . . . 0.42999999999999999 110.393 172.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.646 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.11 142.7 30.26 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.825 -1.079 . . . . 1.73 108.944 168.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 23.7 mm-40 -123.9 162.44 23.33 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 114.835 1.42 . . . . 0.70999999999999996 114.835 -169.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 43.7 mt-10 -129.86 144.98 51.58 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 112.927 -1.942 . . . . 0.38 105.953 170.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.9 t70 39.51 47.66 1.65 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 122.766 1.269 . . . . 0.40999999999999998 109.834 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.485 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -82.8 168.15 17.42 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 111.937 -2.392 . . . . 1.02 108.977 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 10.2 m -132.04 119.5 21.11 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.948 0.88 . . . . 1.04 111.24 170.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.9 mp -77.27 87.12 3.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.852 -1.522 . . . . 1.27 111.787 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.572 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.3 mttt . . . . . 0 C--N 1.286 -2.18 0 CA-C-N 113.266 -1.788 . . . . 0.96999999999999997 113.406 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.572 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 1.3 mp0 . . . . . 0 N--CA 1.443 -0.788 0 CA-C-O 121.056 0.455 . . . . 0.53000000000000003 110.779 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.79 97.55 4.94 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 107.98 -1.119 . . . . 0.45000000000000001 107.98 170.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 22.7 Cg_exo -68.58 110.24 2.26 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.076 1.851 . . . . 0.22 110.631 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.63 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -110.55 158.4 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 CA-C-N 113.036 -1.893 . . . . 1.04 107.912 -168.305 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.637 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.8 OUTLIER -92.04 -19.43 22.37 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.934 -0.765 . . . . 0.65000000000000002 108.934 -174.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 0.637 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.9 m-85 -160.46 127.88 4.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.025 -1.102 . . . . 0.92000000000000004 108.025 -171.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.0 t-105 -144.93 131.51 19.87 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.746 0.784 . . . . 0.10000000000000001 111.561 -166.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.646 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.4 mmt -112.91 92.32 20.57 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 107.866 -1.161 . . . . 1.01 107.866 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.749 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.7 Cg_endo . . . . . 0 N--CA 1.458 -0.572 0 C-N-CA 122.265 1.976 . . . . 0.5 111.626 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.58 HG13 ' N ' ' A' ' 419' ' ' GLY . 36.6 t . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.33 0.585 . . . . 1.45 112.115 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.58 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -174.87 121.11 0.81 Allowed Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 110.084 -1.206 . . . . 0.20000000000000001 110.084 169.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.629 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.2 mp -82.09 142.22 13.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 110.107 -0.331 . . . . 1.0900000000000001 110.107 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.589 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.0 p80 -159.5 161.73 35.42 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.094 -0.503 . . . . 0.10000000000000001 111.37 -174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.63 ' O ' HG21 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -86.5 148.11 25.67 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.962 -1.125 . . . . 1.0700000000000001 107.962 172.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.6 t -133.14 96.57 3.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.907 0.86 . . . . 0.5 110.136 -171.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 C--N 1.314 -0.941 0 CA-C-N 114.103 -1.408 . . . . 0.41999999999999998 109.281 -176.14 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.548 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.9 pm0 . . . . . 0 N--CA 1.438 -1.033 0 CA-C-O 122.312 1.053 . . . . 2.1600000000000001 113.375 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.927 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.81 128.54 3.3 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 112.587 -2.097 . . . . 0.91000000000000003 105.769 171.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.35 -157.8 30.18 Favored Glycine 0 C--N 1.281 -2.502 0 C-N-CA 119.892 -1.147 . . . . 0.20000000000000001 110.404 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.432 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.88 173.89 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.064 -1.065 . . . . 0.25 111.574 167.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.506 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.4 p-10 -51.47 102.35 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 123.448 1.594 . . . . 1.8500000000000001 113.893 -152.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.647 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.56 -37.5 10.35 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-N 112.6 -2.091 . . . . 1.8200000000000001 109.782 168.187 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.713 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.2 p-90 -53.9 -27.0 27.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.457 -0.792 . . . . 0.17999999999999999 112.274 -170.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.713 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.46 -35.38 15.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.587 0.588 . . . . 1.05 112.587 -178.072 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.9 p -90.1 -42.56 11.02 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.07 -0.968 . . . . 1.0600000000000001 110.943 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.647 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.1 mtp180 -92.94 -18.51 22.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.651 -1.159 . . . . 2.3700000000000001 109.524 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.24 49.17 45.16 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 115.642 1.017 . . . . 0.23999999999999999 115.642 160.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 28.3 m -83.75 111.49 19.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 119.162 1.481 . . . . 1.7 111.598 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 35.99 -115.69 0.1 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.594 0.961 . . . . 0.56999999999999995 113.594 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.418 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -137.35 -20.31 0.56 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.423 -0.808 . . . . 0.28999999999999998 113.64 -174.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 27.1 p -97.66 -167.26 1.5 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.003 0.901 . . . . 0.40000000000000002 112.624 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.542 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.0 mp -99.39 130.14 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 114.864 -1.062 . . . . 1.04 110.535 -175.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.88 94.32 5.75 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.763 -0.653 . . . . 0.62 110.198 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.671 ' HA ' HG23 ' A' ' 368' ' ' ILE . 4.3 m -90.41 144.41 30.78 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.017 -0.992 . . . . 1.02 112.555 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.662 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 73.0 Cg_exo -52.13 145.4 34.37 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 124.114 3.209 . . . . 0.23999999999999999 113.365 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.927 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 36.8 Cg_exo -66.3 -30.6 45.07 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.956 2.437 . . . . 0.31 112.392 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.533 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 13.8 m -72.13 -23.6 61.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.75 -0.659 . . . . 1.48 111.725 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.748 ' O ' HD23 ' A' ' 364' ' ' LEU . 26.4 m -100.51 -49.38 11.17 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 N-CA-C 112.858 0.688 . . . . 1.03 112.858 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.92 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.24 -2.1 5.41 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.707 -0.797 . . . . 1.02 110.29 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.533 ' HE3' ' O ' ' A' ' 448' ' ' SER . 16.4 pttp -81.03 -38.08 28.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.505 1.145 . . . . 1.5900000000000001 108.137 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.574 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.9 mm-40 -62.83 -46.23 88.9 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 112.36 -2.2 . . . . 0.25 106.513 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.92 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.5 tp -47.78 -66.56 0.38 Allowed 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 109.843 -3.344 . . . . 1.02 112.511 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.509 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 22.6 t80 -45.96 -23.27 0.28 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 123.903 0.752 . . . . 0.17000000000000001 109.597 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.92 -25.04 28.18 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.849 -1.068 . . . . 0.13 111.878 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.604 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -103.73 -44.2 5.14 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 113.425 0.898 . . . . 1.02 113.425 176.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.49 150.74 7.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-O 122.44 1.114 . . . . 1.01 111.125 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.538 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.09 155.74 35.05 Favored 'General case' 0 N--CA 1.412 -2.332 0 CA-C-N 112.849 -1.978 . . . . 0.47999999999999998 108.602 -177.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.616 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 43.8 mtmt -55.96 102.14 0.07 Allowed 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.669 0.747 . . . . 1.7 109.696 170.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.18 -8.93 6.67 Favored Glycine 0 C--N 1.304 -1.23 0 CA-C-N 113.762 -1.563 . . . . 0.22 111.716 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 344' ' ' TYR . 9.0 m -68.37 149.46 98.04 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 108.833 -0.803 . . . . 0.94999999999999996 108.833 172.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.4 Cg_endo -93.82 156.69 2.3 Favored 'Trans proline' 0 N--CA 1.424 -2.579 0 C-N-CA 122.3 2.0 . . . . 0.23000000000000001 109.906 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.711 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -121.9 149.03 25.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.554 -1.276 . . . . 1.27 107.554 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.697 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.6 mp -134.08 149.02 51.1 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.548 -0.908 . . . . 1.05 108.548 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.695 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -137.35 141.4 39.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 105.589 -2.004 . . . . 1.01 105.589 165.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.579 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 7.6 p90 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.469 -1.253 . . . . 1.0900000000000001 110.926 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.463 ' HB3' ' N ' ' A' ' 360' ' ' GLY . 33.7 m-20 . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 121.598 0.713 . . . . 0.42999999999999999 111.83 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 1.137 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 96.8 m -159.28 134.37 8.22 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.021 163.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.677 ' CD2' HD11 ' A' ' 464' ' ' LEU . 39.5 p90 174.63 157.84 0.16 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 120.856 0.36 . . . . 0.88 111.759 -175.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.682 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.2 OUTLIER -77.86 152.59 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 164.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.528 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.1 tt0 -150.52 142.96 24.38 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.741 -0.663 . . . . 2.0099999999999998 109.415 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.693 HG21 ' O ' ' A' ' 464' ' ' LEU . 2.6 t -134.62 162.37 38.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.124 0.488 . . . . 1.04 111.382 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.533 ' HA ' ' C ' ' A' ' 466' ' ' PHE . 29.3 t0 -140.05 106.32 5.26 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.356 -1.35 . . . . 0.23999999999999999 107.356 173.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.668 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -83.11 -34.9 26.0 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 123.365 1.555 . . . . 1.02 110.075 -169.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.42 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 0.4 OUTLIER -54.91 -44.98 74.67 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 110.705 -2.952 . . . . 0.59999999999999998 107.692 176.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 23.5 m-80 -103.36 6.77 38.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 111.219 -2.718 . . . . 0.20999999999999999 111.563 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.736 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 15.6 mm-40 32.82 62.35 0.35 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 112.791 -2.004 . . . . 2.54 113.615 -175.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.621 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.0 t60 -141.47 135.15 29.98 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.213 -0.903 . . . . 0.12 109.475 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.59 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.4 OUTLIER -112.71 157.26 21.51 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.375 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.523 ' CD1' HG12 ' A' ' 362' ' ' VAL . 30.3 m-90 -142.27 155.27 45.21 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.713 -0.676 . . . . 0.11 111.416 -175.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.137 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 88.2 t80 -111.2 153.34 25.96 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 106.811 -1.551 . . . . 1.1000000000000001 106.811 151.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 17.1 m-85 -127.42 119.18 25.56 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.947 -1.024 . . . . 0.60999999999999999 110.048 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.458 ' HB2' ' HE2' ' A' ' 356' ' ' TYR . 10.4 tppt? -123.14 112.89 18.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.097 -0.956 . . . . 0.93999999999999995 108.547 173.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 358' ' ' LYS . 0.2 OUTLIER 75.97 41.26 0.24 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 123.914 0.759 . . . . 0.42999999999999999 112.683 -177.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.463 ' N ' ' HB3' ' A' ' 342' ' ' ASP . . . 59.24 16.79 35.79 Favored Glycine 0 CA--C 1.496 -1.14 0 CA-C-O 122.372 0.984 . . . . 0.17999999999999999 113.232 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 358' ' ' LYS . 14.9 ptmt -140.32 167.66 21.61 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 104.534 -2.395 . . . . 1.0900000000000001 104.534 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.1 m -98.89 157.56 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.735 0 N-CA-C 116.057 1.873 . . . . 1.02 116.057 -171.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.639 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.99 -27.51 9.18 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 110.357 -3.11 . . . . 1.01 106.21 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.4 143.99 47.92 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 111.563 -2.562 . . . . 1.02 111.846 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.621 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 2.9 tt0 -141.37 118.61 11.38 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 104.359 -2.46 . . . . 0.47999999999999998 104.359 175.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.592 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -150.29 165.55 32.67 Favored 'General case' 0 N--CA 1.403 -2.781 0 C-N-CA 118.07 -1.452 . . . . 1.02 112.157 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.711 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 12.4 p-10 -102.05 135.44 43.62 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.174 -1.376 . . . . 1.8 109.63 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.675 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.3 pp -138.24 -173.06 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.252 0 CA-C-O 122.212 1.006 . . . . 1.01 112.754 -170.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.736 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -152.86 120.97 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 112.895 -1.957 . . . . 1.04 109.468 171.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.566 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.6 OUTLIER -77.95 -168.92 1.38 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.874 -1.512 . . . . 1.6000000000000001 110.678 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -86.32 173.3 46.05 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.063 -1.541 . . . . 0.14000000000000001 112.272 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -78.54 158.38 76.19 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.614 0.721 . . . . 1.47 111.921 -166.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.603 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 92.8 Cg_exo -56.64 -28.95 77.54 Favored 'Trans proline' 0 CA--C 1.498 -1.311 0 C-N-CA 125.273 3.982 . . . . 0.28000000000000003 113.234 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.46 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 16.9 p -69.52 -33.99 73.62 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.33 -1.759 . . . . 1.0800000000000001 109.855 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.7 t -140.73 70.35 30.6 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 123.841 1.781 . . . . 1.1000000000000001 108.801 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 375' ' ' THR . 85.4 Cg_exo -57.31 154.33 35.46 Favored 'Trans proline' 0 C--N 1.31 -1.465 1 C-N-CA 126.522 4.814 . . . . 0.38 115.447 -169.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.566 HG22 ' OG ' ' A' ' 370' ' ' SER . 2.2 m -80.6 130.74 63.43 Favored Pre-proline 0 N--CA 1.404 -2.76 0 CA-C-N 114.116 -1.402 . . . . 1.1299999999999999 108.611 172.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.1 Cg_exo -72.0 -43.86 1.07 Allowed 'Trans proline' 0 CA--C 1.511 -0.664 0 C-N-CA 123.599 2.866 . . . . 0.20999999999999999 111.772 -170.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.674 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.19 137.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 123.412 1.577 . . . . 1.0600000000000001 113.542 -173.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 154.3 -121.78 1.17 Allowed Glycine 0 N--CA 1.429 -1.8 0 CA-C-N 112.218 -2.264 . . . . 0.20000000000000001 109.401 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 72.5 t -125.23 110.65 25.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.345 0.593 . . . . 1.5 110.632 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.609 ' HE1' ' CE2' ' A' ' 382' ' ' PHE . 5.1 m-85 -110.32 -173.87 2.35 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.405 -1.331 . . . . 0.28000000000000003 107.405 174.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -141.27 121.92 14.26 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 120.844 -1.16 . . . . 0.96999999999999997 112.827 -172.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.6 p -82.81 92.71 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 CA-C-O 122.827 1.299 . . . . 1.02 108.839 170.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 49.6 p-90 -83.95 0.35 48.26 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 113.201 -1.818 . . . . 3.1299999999999999 107.806 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.789 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 5.9 t30 -170.33 128.18 0.84 Allowed 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 114.744 -1.116 . . . . 0.42999999999999999 110.662 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.627 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -95.96 141.95 28.77 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.388 -0.823 . . . . 1.73 109.086 169.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.708 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 9.9 mm-40 -126.75 159.95 32.27 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 114.786 1.402 . . . . 0.70999999999999996 114.786 -167.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 52.2 mt-10 -137.34 128.14 27.19 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.071 -1.877 . . . . 0.38 108.867 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.4 t70 53.91 45.22 28.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 123.386 1.565 . . . . 0.40999999999999998 108.884 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -80.03 167.64 20.18 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 112.104 -2.317 . . . . 1.02 109.477 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 16.9 m -132.46 119.06 20.11 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.051 0.929 . . . . 1.04 111.903 171.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -78.41 88.66 4.4 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.693 -1.594 . . . . 1.27 112.119 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.587 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.7 mttt . . . . . 0 C--N 1.285 -2.222 0 CA-C-N 113.666 -1.606 . . . . 0.96999999999999997 113.811 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.587 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 121.04 0.448 . . . . 0.53000000000000003 110.152 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.516 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.08 97.23 5.3 Favored Pre-proline 0 N--CA 1.437 -1.114 0 N-CA-C 108.38 -0.97 . . . . 0.45000000000000001 108.38 172.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.9 Cg_exo -68.62 111.44 2.57 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 122.102 1.868 . . . . 0.22 110.268 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -111.72 155.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 CA-C-N 112.861 -1.972 . . . . 1.04 107.746 -168.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.646 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.1 m-80 -86.86 -20.47 27.42 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.316 -0.624 . . . . 0.65000000000000002 109.316 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 97.7 m-85 -160.24 127.51 4.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.866 -1.061 . . . . 0.92000000000000004 108.189 -171.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 17.3 t-105 -142.95 131.27 22.11 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.591 0.71 . . . . 0.10000000000000001 111.07 -167.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.627 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 13.3 mmt -116.34 86.67 18.21 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.279 -1.008 . . . . 1.01 108.279 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.789 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 15.0 Cg_endo . . . . . 0 N--CA 1.437 -1.799 0 C-N-CA 120.945 1.096 . . . . 0.5 109.372 174.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 419' ' ' GLY . 22.1 t . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 112.628 0.603 . . . . 1.45 112.628 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.593 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -178.26 119.24 0.65 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.61 -0.996 . . . . 0.20000000000000001 110.61 170.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.607 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.5 mt -81.13 144.15 11.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 120.836 0.35 . . . . 1.0900000000000001 111.06 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.594 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.9 p80 -159.41 161.54 35.6 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.028 -0.533 . . . . 0.10000000000000001 111.218 -174.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.2 149.51 25.46 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.826 -1.176 . . . . 1.0700000000000001 107.826 171.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 445' ' ' THR . 34.3 t -133.31 96.5 3.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.553 0.692 . . . . 0.5 110.034 -171.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 114.736 -1.12 . . . . 0.41999999999999998 109.387 -175.568 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.527 ' HG3' HD23 ' A' ' 433' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 122.563 1.173 . . . . 2.1600000000000001 113.481 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.752 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -157.35 132.04 8.64 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.101 -2.318 . . . . 0.91000000000000003 105.307 167.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.04 -159.57 32.84 Favored Glycine 0 C--N 1.283 -2.363 0 C-N-CA 120.095 -1.05 . . . . 0.20000000000000001 110.511 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.449 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -47.06 175.32 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 120.24 -0.981 . . . . 0.25 111.621 168.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.504 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.4 p-10 -50.53 101.03 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.625 1.678 . . . . 1.8500000000000001 113.764 -154.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.632 ' CD2' ' HD2' ' A' ' 437' ' ' ARG . 34.7 mt -97.68 -37.89 9.73 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.007 -2.36 . . . . 1.8200000000000001 107.858 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.69 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 64.8 p-90 -48.39 -34.39 10.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.182 0.438 . . . . 0.17999999999999999 112.182 -172.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.69 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -83.96 -36.9 22.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.934 -0.576 . . . . 1.05 112.144 -175.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.451 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.8 p -88.09 -41.89 12.75 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.247 -0.888 . . . . 1.0600000000000001 110.534 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.632 ' HD2' ' CD2' ' A' ' 433' ' ' LEU . 0.0 OUTLIER -93.8 -19.19 21.26 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.629 -1.169 . . . . 2.3700000000000001 110.067 -177.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.652 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.5 48.11 55.8 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.744 -1.116 . . . . 0.23999999999999999 114.875 163.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 35.2 m -85.2 111.73 20.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 118.71 1.255 . . . . 1.7 111.794 -173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 36.35 -121.59 0.16 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.717 -1.129 . . . . 0.56999999999999995 113.969 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -134.6 -12.87 1.32 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.106 -0.569 . . . . 0.28999999999999998 113.967 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 28.4 p -104.27 -166.59 1.26 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.987 0.894 . . . . 0.40000000000000002 112.839 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.555 HG13 ' HG ' ' A' ' 370' ' ' SER . 1.9 mp -97.49 131.4 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.023 -0.989 . . . . 1.04 110.665 -175.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.71 93.59 5.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.714 -0.676 . . . . 0.62 110.248 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.675 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.2 m -89.01 143.98 32.09 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 114.962 -1.017 . . . . 1.02 112.578 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.592 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 77.1 Cg_exo -52.17 145.58 34.03 Favored 'Trans proline' 0 CA--C 1.506 -0.896 0 C-N-CA 124.055 3.17 . . . . 0.23999999999999999 113.246 174.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.752 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 31.3 Cg_exo -65.39 -26.97 55.18 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.995 2.464 . . . . 0.31 112.552 -176.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.494 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 52.1 p -75.7 -25.08 56.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.9 0.857 . . . . 1.48 112.054 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.738 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.9 m -99.57 -50.49 10.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.556 -0.747 . . . . 1.03 112.806 -171.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.931 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.43 -2.1 4.23 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.796 -0.762 . . . . 1.02 110.37 -177.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.496 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.7 pttp -81.3 -39.04 25.81 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.417 1.104 . . . . 1.5900000000000001 108.05 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.58 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.0 mm-40 -61.63 -46.28 90.47 Favored 'General case' 0 CA--C 1.472 -2.036 0 CA-C-N 112.488 -2.142 . . . . 0.25 106.579 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.931 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.2 tp -47.05 -66.39 0.41 Allowed 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 109.713 -3.403 . . . . 1.02 112.647 172.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.52 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 21.6 t80 -45.9 -23.69 0.31 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 123.9 0.75 . . . . 0.17000000000000001 109.547 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.31 -25.65 27.93 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 114.791 -1.095 . . . . 0.13 111.97 -176.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.634 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -103.61 -44.9 4.98 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 113.566 0.95 . . . . 1.02 113.566 177.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.682 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -71.45 145.96 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.587 1.184 . . . . 1.01 111.026 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.487 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -114.55 156.07 25.3 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 112.894 -1.957 . . . . 0.47999999999999998 108.679 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.608 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 39.5 mtmt -59.31 103.27 0.17 Allowed 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.778 0.799 . . . . 1.7 109.225 169.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 127.82 -10.18 6.72 Favored Glycine 0 C--N 1.302 -1.33 0 CA-C-N 113.592 -1.64 . . . . 0.22 111.403 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 344' ' ' TYR . 6.1 m -67.81 149.75 98.1 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 108.067 -1.086 . . . . 0.94999999999999996 108.067 169.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.512 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 8.4 Cg_endo -94.75 167.3 1.71 Allowed 'Trans proline' 0 N--CA 1.416 -3.08 0 C-N-CA 121.943 1.762 . . . . 0.23000000000000001 109.589 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.73 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -128.37 153.86 38.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.109 -1.071 . . . . 1.27 108.109 171.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.693 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.7 mp -134.26 151.14 51.12 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 108.621 -0.881 . . . . 1.05 108.621 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.6 OUTLIER -140.01 139.55 36.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 105.135 -2.172 . . . . 1.01 105.135 165.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.533 ' C ' ' HA ' ' A' ' 348' ' ' ASP . 13.4 p90 . . . . . 0 C--O 1.243 0.72 0 O-C-N 123.744 0.652 . . . . 1.0900000000000001 111.219 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.425 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 3.2 m-20 . . . . . 0 N--CA 1.443 -0.811 0 N-CA-C 109.34 -0.615 . . . . 0.42999999999999999 109.34 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 97.6 m -158.55 136.21 10.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.589 -1.187 . . . . 1.0 109.113 169.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.692 ' CD2' HD11 ' A' ' 464' ' ' LEU . 31.9 p90 174.85 157.32 0.16 Allowed 'General case' 0 CA--C 1.5 -0.969 0 O-C-N 123.511 0.507 . . . . 0.88 111.129 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.68 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.6 OUTLIER -76.71 151.64 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 108.495 -0.928 . . . . 1.0 108.495 164.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.822 ' CD ' ' HE1' ' A' ' 466' ' ' PHE . 6.9 tp10 -149.57 146.3 27.26 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.504 -0.771 . . . . 2.0099999999999998 109.902 -173.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.711 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -143.04 160.33 17.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.382 0.611 . . . . 1.04 111.667 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.538 ' N ' HG13 ' A' ' 347' ' ' VAL . 27.1 t0 -141.07 106.47 5.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.378 -1.341 . . . . 0.23999999999999999 107.378 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.652 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.41 -34.61 28.22 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 122.717 1.246 . . . . 1.02 110.42 -167.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.431 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 1.5 mt-10 -57.43 -44.12 84.44 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 110.88 -2.873 . . . . 0.59999999999999998 108.013 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -100.67 5.26 43.73 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 111.045 -2.798 . . . . 0.20999999999999999 111.037 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.587 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.5 mp0 34.96 61.54 0.6 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 112.766 -2.016 . . . . 2.54 113.367 -175.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.59 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.5 t60 -142.61 135.46 28.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.785 -0.643 . . . . 0.12 109.664 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.598 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.73 158.27 20.28 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.86 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.587 ' CD1' HG12 ' A' ' 362' ' ' VAL . 32.5 m-90 -143.23 158.55 43.52 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.358 0.663 . . . . 0.11 110.695 -176.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.68 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.4 t80 -111.86 153.36 26.77 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.176 -1.787 . . . . 1.1000000000000001 106.176 150.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 7.9 m-85 -127.74 116.31 20.03 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.13 -0.941 . . . . 0.60999999999999999 110.15 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.3 tppt? -117.97 138.91 51.85 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.215 -1.772 . . . . 0.93999999999999995 106.215 168.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.43 17.14 9.18 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.268 0.84 . . . . 0.42999999999999999 113.268 172.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.38 7.66 87.82 Favored Glycine 0 CA--C 1.488 -1.647 0 C-N-CA 120.801 -0.714 . . . . 0.17999999999999999 112.937 -174.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.3 ptmt -128.68 178.4 6.36 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 104.486 -2.412 . . . . 1.0900000000000001 104.486 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.587 HG12 ' CD1' ' A' ' 355' ' ' TRP . 16.0 m -105.01 158.2 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 116.339 1.977 . . . . 1.02 116.339 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.575 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.36 -26.93 9.76 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 110.625 -2.989 . . . . 1.01 106.456 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.714 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.37 144.53 48.29 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 111.477 -2.601 . . . . 1.02 111.432 -176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.59 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.1 tt0 -141.19 117.77 10.91 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 104.374 -2.454 . . . . 0.47999999999999998 104.374 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.598 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.66 163.5 37.74 Favored 'General case' 0 N--CA 1.399 -2.98 0 C-N-CA 117.896 -1.521 . . . . 1.02 111.306 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.445 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 22.2 p-10 -103.4 136.46 43.11 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 114.907 -1.042 . . . . 1.8 109.484 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.702 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -136.13 -174.04 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 CA-C-O 122.484 1.135 . . . . 1.01 112.559 -170.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.7 OUTLIER -150.54 119.68 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 112.731 -2.031 . . . . 1.04 107.798 173.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.544 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.74 -168.49 1.6 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.269 -1.332 . . . . 1.6000000000000001 110.132 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -83.87 165.39 41.87 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 118.419 -1.848 . . . . 0.14000000000000001 112.636 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.5 ptmt -67.06 155.76 89.53 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.719 -0.74 . . . . 1.47 112.22 -167.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.626 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 95.1 Cg_exo -55.95 -30.74 79.08 Favored 'Trans proline' 0 CA--C 1.495 -1.458 1 C-N-CA 125.332 4.021 . . . . 0.28000000000000003 113.932 -173.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 23.3 p -68.65 -30.67 69.42 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.882 -1.508 . . . . 1.0800000000000001 109.546 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.53 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -141.97 70.82 23.88 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 123.266 1.508 . . . . 1.1000000000000001 110.032 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 375' ' ' THR . 72.8 Cg_exo -58.62 148.24 83.0 Favored 'Trans proline' 0 C--N 1.307 -1.614 1 C-N-CA 126.028 4.485 . . . . 0.38 113.603 -172.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.544 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -77.93 144.54 68.31 Favored Pre-proline 0 N--CA 1.423 -1.812 0 N-CA-C 108.546 -0.909 . . . . 1.1299999999999999 108.546 175.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.2 Cg_exo -75.4 -45.07 0.27 Allowed 'Trans proline' 0 CA--C 1.51 -0.722 0 C-N-CA 124.352 3.368 . . . . 0.20999999999999999 111.705 -167.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.662 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 60.21 139.24 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 123.051 1.405 . . . . 1.0600000000000001 113.148 -172.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.8 -117.66 0.84 Allowed Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 112.558 -2.11 . . . . 0.20000000000000001 109.317 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.41 ' O ' HG11 ' A' ' 381' ' ' VAL . 9.4 p -130.38 114.44 28.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.993 0.901 . . . . 1.5 110.616 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.61 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.4 m-85 -113.16 -174.06 2.38 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.246 -1.39 . . . . 0.28000000000000003 107.246 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -140.44 123.75 16.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.369 1.44 . . . . 0.96999999999999997 113.513 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -89.93 92.57 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 CA-C-O 123.009 1.385 . . . . 1.02 109.543 169.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -93.12 11.1 28.92 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.416 -1.72 . . . . 3.1299999999999999 108.176 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.727 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.0 t30 -169.21 126.64 0.95 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 113.927 -1.488 . . . . 0.42999999999999999 110.366 172.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.68 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -98.46 140.92 31.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.853 -1.067 . . . . 1.73 109.117 169.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.755 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 18.6 mm-40 -124.05 157.18 35.1 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.547 1.314 . . . . 0.70999999999999996 114.547 -168.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.725 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 44.1 mt-10 -137.13 127.89 27.19 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 112.825 -1.988 . . . . 0.38 108.397 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 32.1 t70 55.22 48.48 19.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 123.346 1.546 . . . . 0.40999999999999998 108.92 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -83.04 167.97 17.38 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 112.629 -2.078 . . . . 1.02 109.153 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 25.9 m -132.68 119.34 20.26 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.071 0.939 . . . . 1.04 111.733 170.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 4.2 mp -80.86 91.38 5.97 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.748 -1.569 . . . . 1.27 112.249 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.566 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.0 mttt . . . . . 0 C--N 1.283 -2.32 0 CA-C-N 113.971 -1.468 . . . . 0.96999999999999997 113.077 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.566 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.812 0 N-CA-C 109.801 -0.444 . . . . 0.53000000000000003 109.801 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.36 97.25 5.17 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.277 -1.009 . . . . 0.45000000000000001 108.277 172.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 16.4 Cg_exo -69.9 109.9 2.45 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 121.797 1.665 . . . . 0.22 109.952 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -108.97 155.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-N 112.667 -2.06 . . . . 1.04 107.766 -167.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.725 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.0 m-80 -86.85 -20.99 26.68 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.179 -0.674 . . . . 0.65000000000000002 109.179 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 0.755 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 95.0 m-85 -158.7 127.0 5.24 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.353 1.033 . . . . 0.92000000000000004 108.79 -171.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 24.1 t-105 -145.11 137.09 25.7 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.756 0.789 . . . . 0.10000000000000001 110.953 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.68 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.6 mmt -119.87 93.72 47.94 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 107.651 -1.24 . . . . 1.01 107.651 173.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.727 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 40.0 Cg_endo . . . . . 0 C--N 1.35 0.624 0 C-N-CA 122.356 2.037 . . . . 0.5 112.414 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 419' ' ' GLY . 29.1 t . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.431 0.634 . . . . 1.45 112.012 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.597 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -178.03 122.43 0.82 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.606 -1.398 . . . . 0.20000000000000001 109.606 170.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.647 HG21 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.72 142.52 13.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.799 -0.445 . . . . 1.0900000000000001 109.799 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.594 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.4 p80 -159.83 162.48 34.73 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.196 -0.456 . . . . 0.10000000000000001 111.659 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.634 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.88 143.8 28.03 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.845 -1.169 . . . . 1.0700000000000001 107.845 171.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 445' ' ' THR . 28.5 t -133.83 99.03 4.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.874 0.845 . . . . 0.5 110.701 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 N--CA 1.44 -0.937 0 CA-C-N 114.132 -1.395 . . . . 0.41999999999999998 109.537 -176.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.549 ' HG3' HD23 ' A' ' 433' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.426 -1.673 0 CA-C-O 122.115 0.959 . . . . 2.1600000000000001 111.543 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.968 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -154.32 132.58 11.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.201 -2.148 . . . . 0.91000000000000003 105.201 169.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.61 -158.34 30.96 Favored Glycine 0 C--N 1.285 -2.294 0 N-CA-C 110.438 -1.065 . . . . 0.20000000000000001 110.438 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -47.08 174.14 0.02 OUTLIER Glycine 0 CA--C 1.495 -1.192 0 C-N-CA 120.096 -1.05 . . . . 0.25 111.499 168.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.559 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 7.0 p-10 -52.59 101.29 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 123.422 1.582 . . . . 1.8500000000000001 113.883 -154.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.598 ' CD2' ' HD2' ' A' ' 437' ' ' ARG . 41.6 mt -97.47 -34.65 10.93 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 112.203 -2.271 . . . . 1.8200000000000001 109.383 171.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.697 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.2 p-90 -53.74 -26.36 22.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.017 -0.992 . . . . 0.17999999999999999 112.004 -173.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.697 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.11 -36.33 14.06 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.618 -0.719 . . . . 1.05 112.308 -178.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.442 ' H ' HG21 ' A' ' 436' ' ' THR . 2.2 p -88.15 -41.02 13.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.143 -0.935 . . . . 1.0600000000000001 110.381 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.598 ' HD2' ' CD2' ' A' ' 433' ' ' LEU . 2.1 mtp85 -93.06 -20.69 20.29 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.431 -1.258 . . . . 2.3700000000000001 109.704 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.91 45.8 49.86 Favored Glycine 0 N--CA 1.443 -0.834 0 O-C-N 124.284 0.99 . . . . 0.23999999999999999 114.072 166.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 20.8 m -84.69 110.13 18.53 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.654 -1.218 . . . . 1.7 111.367 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.446 ' HB3' ' H ' ' A' ' 441' ' ' GLY . 29.1 m-70 46.11 -145.0 0.21 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.607 -1.179 . . . . 0.56999999999999995 113.629 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 440' ' ' HIS . . . -110.65 -23.41 5.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.506 -0.854 . . . . 0.28999999999999998 113.566 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.44 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 31.2 p -101.57 -165.43 1.19 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 113.645 0.98 . . . . 0.40000000000000002 113.645 -170.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.536 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.0 mp -90.23 133.35 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.569 -0.741 . . . . 1.04 110.61 -176.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.11 90.9 3.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.366 0.603 . . . . 0.62 110.286 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.702 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.3 m -85.82 142.33 36.66 Favored Pre-proline 0 N--CA 1.436 -1.126 0 CA-C-N 115.105 -0.952 . . . . 1.02 112.512 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.595 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 82.0 Cg_exo -49.58 145.56 16.7 Favored 'Trans proline' 0 CA--C 1.509 -0.767 0 C-N-CA 123.891 3.06 . . . . 0.23999999999999999 113.572 175.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.968 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 28.4 Cg_exo -66.7 -21.05 52.21 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.827 2.352 . . . . 0.31 112.034 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.552 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 33.4 p -83.35 -24.07 32.23 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.233 -0.894 . . . . 1.48 112.291 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.714 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.8 m -99.64 -47.98 11.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 112.954 0.724 . . . . 1.03 112.954 -171.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.946 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.36 -1.77 3.8 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.789 -0.764 . . . . 1.02 110.462 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.552 ' HE3' ' O ' ' A' ' 448' ' ' SER . 17.2 pttp -81.5 -38.27 26.56 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.698 1.237 . . . . 1.5900000000000001 108.33 173.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.597 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.7 mm-40 -62.57 -46.28 89.05 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-N 112.299 -2.228 . . . . 0.25 106.328 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.946 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -47.28 -66.61 0.38 Allowed 'General case' 0 N--CA 1.406 -2.633 0 CA-C-N 109.832 -3.349 . . . . 1.02 112.956 172.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.488 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.3 t80 -46.26 -22.59 0.25 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.866 0.841 . . . . 0.17000000000000001 109.396 176.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.83 -25.32 30.0 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.674 -1.148 . . . . 0.13 112.008 -176.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.615 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -103.5 -43.7 5.32 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 113.705 1.002 . . . . 1.02 113.705 176.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.87 149.8 7.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.432 1.11 . . . . 1.01 111.278 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.503 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -121.68 156.4 33.13 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 112.99 -1.914 . . . . 0.47999999999999998 108.64 -177.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.515 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 2.5 mppt? -58.66 103.2 0.14 Allowed 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.775 -0.824 . . . . 1.7 108.775 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.75 -9.08 6.11 Favored Glycine 0 C--N 1.307 -1.069 0 CA-C-N 113.935 -1.484 . . . . 0.22 111.616 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.592 HG21 ' HA ' ' A' ' 344' ' ' TYR . 19.0 m -69.31 150.05 97.26 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.972 -0.751 . . . . 0.94999999999999996 108.972 171.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.7 Cg_endo -93.84 163.06 2.22 Favored 'Trans proline' 0 N--CA 1.423 -2.664 0 C-N-CA 122.34 2.026 . . . . 0.23000000000000001 109.919 176.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.742 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.7 m -126.64 149.23 31.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 107.502 -1.296 . . . . 1.27 107.502 171.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 344' ' ' TYR . 3.5 mp -134.86 150.3 50.45 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 108.426 -0.953 . . . . 1.05 108.426 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.711 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.94 143.12 28.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 105.72 -1.956 . . . . 1.01 105.72 166.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.822 ' HE1' ' CD ' ' A' ' 346' ' ' GLU . 9.3 p90 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 123.185 0.594 . . . . 1.0900000000000001 110.316 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.47 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 6.2 m-20 . . . . . 0 N--CA 1.445 -0.704 0 CA-C-O 121.046 0.45 . . . . 0.42999999999999999 110.264 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 1.11 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 46.9 m -158.01 135.48 10.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.77 -1.104 . . . . 1.0 108.681 167.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.672 ' CD2' HD11 ' A' ' 464' ' ' LEU . 39.7 p90 174.22 159.18 0.16 Allowed 'General case' 0 C--O 1.214 -0.795 0 O-C-N 123.337 0.398 . . . . 0.88 110.851 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.679 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.99 152.13 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.313 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 164.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.534 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.72 143.14 25.26 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.628 -0.715 . . . . 2.0099999999999998 109.452 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.699 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.9 t -135.15 162.43 38.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 120.733 -0.387 . . . . 1.04 111.213 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.532 ' N ' HG13 ' A' ' 347' ' ' VAL . 36.7 t0 -140.23 106.81 5.33 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.468 -1.308 . . . . 0.23999999999999999 107.468 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.667 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.48 -34.9 27.86 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-O 122.752 1.263 . . . . 1.02 110.436 -167.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.412 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 0.8 OUTLIER -58.02 -44.98 87.6 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 110.797 -2.91 . . . . 0.59999999999999998 108.308 176.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 24.9 m-80 -100.61 5.94 44.01 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 111.012 -2.813 . . . . 0.20999999999999999 111.057 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.7 mp0 35.09 61.32 0.63 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 112.725 -2.034 . . . . 2.54 113.16 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.596 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 21.5 t60 -142.2 134.6 27.91 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.646 -0.706 . . . . 0.12 109.742 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.586 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.71 157.85 20.78 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.822 -0.627 . . . . 1.0 110.106 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.55 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.1 m-90 -142.62 156.02 45.02 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.499 0.72 . . . . 0.11 111.258 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.11 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 89.0 t80 -110.81 153.82 24.84 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 106.424 -1.695 . . . . 1.1000000000000001 106.424 151.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.6 m-85 -127.86 119.09 24.9 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 114.892 -1.049 . . . . 0.60999999999999999 110.351 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.2 tppt? -120.56 132.41 55.15 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.277 -1.749 . . . . 0.93999999999999995 106.277 167.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.438 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 75.1 16.53 2.8 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 113.136 0.791 . . . . 0.42999999999999999 113.136 174.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.47 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.13 5.73 88.99 Favored Glycine 0 CA--C 1.485 -1.828 0 CA-C-O 121.814 0.675 . . . . 0.17999999999999999 112.887 -173.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 19.9 ptmt -128.92 177.23 7.25 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.502 -2.407 . . . . 1.0900000000000001 104.502 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.0 m -103.56 158.22 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 116.713 2.116 . . . . 1.02 116.713 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.638 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.15 -28.65 8.93 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 110.39 -3.096 . . . . 1.01 106.207 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -133.87 145.91 50.1 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 111.589 -2.551 . . . . 1.02 111.669 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.596 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 3.3 tt0 -143.72 118.47 9.87 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 104.499 -2.408 . . . . 0.47999999999999998 104.499 175.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.605 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -149.81 165.39 32.65 Favored 'General case' 0 N--CA 1.401 -2.915 0 C-N-CA 118.132 -1.427 . . . . 1.02 111.631 -179.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.653 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 15.5 p-10 -103.81 133.33 48.98 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.669 -1.15 . . . . 1.8 110.087 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.673 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -133.77 -173.75 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-O 122.465 1.126 . . . . 1.01 112.525 -171.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.592 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.37 120.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 112.91 -1.95 . . . . 1.04 109.199 172.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.626 ' HG ' ' HB3' ' A' ' 349' ' ' LEU . 33.6 p -78.25 -169.06 1.49 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 111.94 -2.391 . . . . 1.6000000000000001 111.421 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.464 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.77 174.75 50.14 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 118.779 -1.676 . . . . 0.14000000000000001 112.05 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 8.5 ptmt -80.31 163.67 55.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 113.174 0.805 . . . . 1.47 113.174 -164.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.622 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 89.4 Cg_exo -55.09 -37.86 93.78 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 123.023 2.482 . . . . 0.28000000000000003 112.287 -176.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.431 ' OG1' HG21 ' A' ' 375' ' ' THR . 12.0 p -64.35 -31.89 73.27 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.29 -1.323 . . . . 1.0800000000000001 110.052 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.539 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -141.59 71.04 25.78 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 123.439 1.59 . . . . 1.1000000000000001 110.032 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 375' ' ' THR . 82.2 Cg_exo -58.3 153.81 44.6 Favored 'Trans proline' 0 C--N 1.307 -1.643 1 C-N-CA 126.369 4.713 . . . . 0.38 114.985 -171.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.525 ' CG2' HG22 ' A' ' 465' ' ' VAL . 2.5 m -79.24 129.86 71.04 Favored Pre-proline 0 N--CA 1.405 -2.718 0 CA-C-N 114.5 -1.227 . . . . 1.1299999999999999 108.55 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 39.4 Cg_exo -68.28 -44.97 3.04 Favored 'Trans proline' 0 CA--C 1.512 -0.601 0 C-N-CA 123.834 3.023 . . . . 0.20999999999999999 112.147 -169.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.655 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.84 138.96 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 123.304 1.526 . . . . 1.0600000000000001 113.645 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 152.86 -119.31 0.95 Allowed Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 112.243 -2.253 . . . . 0.20000000000000001 109.579 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 76.4 t -129.84 108.5 16.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.002 0.43 . . . . 1.5 110.472 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.591 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.4 m-85 -108.55 -173.98 2.41 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.279 -1.378 . . . . 0.28000000000000003 107.279 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -140.83 123.84 16.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 120.09 1.313 . . . . 0.96999999999999997 113.656 -172.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.94 92.56 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 122.961 1.362 . . . . 1.02 109.66 169.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -91.23 9.27 31.98 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.622 -1.627 . . . . 3.1299999999999999 108.265 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.731 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.5 t30 -170.79 127.89 0.76 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.229 -1.351 . . . . 0.42999999999999999 110.475 173.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.668 ' HB3' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -96.95 151.57 19.56 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.727 -0.67 . . . . 1.73 109.873 167.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.712 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 37.8 mm-40 -128.37 160.48 32.08 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.471 1.286 . . . . 0.70999999999999996 114.471 -170.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.798 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 32.1 mt-10 -139.53 127.68 22.48 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 113.112 -1.858 . . . . 0.38 108.881 172.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.73 46.09 23.18 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 123.109 1.433 . . . . 0.40999999999999998 108.964 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.453 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -80.52 166.52 21.1 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 112.759 -2.019 . . . . 1.02 108.967 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 18.7 m -133.0 118.9 19.39 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.988 0.899 . . . . 1.04 111.94 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.1 mp -79.41 88.53 5.01 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.775 -1.557 . . . . 1.27 112.091 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.4 mttt . . . . . 0 C--N 1.288 -2.096 0 CA-C-N 113.561 -1.654 . . . . 0.96999999999999997 113.826 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.441 -0.919 0 CA-C-O 121.1 0.476 . . . . 0.53000000000000003 110.32 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.17 97.27 5.26 Favored Pre-proline 0 N--CA 1.431 -1.387 0 N-CA-C 108.11 -1.07 . . . . 0.45000000000000001 108.11 171.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 18.9 Cg_exo -69.35 109.94 2.35 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 122.012 1.808 . . . . 0.22 109.881 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.594 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -109.08 156.34 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 CA-C-N 112.869 -1.969 . . . . 1.04 107.283 -168.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.798 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.0 m-80 -89.72 -19.9 24.22 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.987 -0.746 . . . . 0.65000000000000002 108.987 -174.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.666 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 91.6 m-85 -159.06 126.58 4.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.346 -0.983 . . . . 0.92000000000000004 108.346 -171.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 25.0 t-105 -145.25 133.92 22.19 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.828 0.823 . . . . 0.10000000000000001 111.253 -167.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.668 ' SD ' ' HB3' ' A' ' 387' ' ' LYS . 11.8 mmt -115.2 94.91 40.72 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.568 -1.271 . . . . 1.01 107.568 172.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.731 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 39.3 Cg_endo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.362 2.041 . . . . 0.5 112.548 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.579 HG13 ' N ' ' A' ' 419' ' ' GLY . 22.1 t . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 121.446 0.641 . . . . 1.45 112.433 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.579 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -177.45 120.19 0.72 Allowed Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.965 -1.254 . . . . 0.20000000000000001 109.965 170.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.642 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.76 143.08 12.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 110.21 -0.293 . . . . 1.0900000000000001 110.21 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.596 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.5 p80 -159.15 160.88 36.06 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.168 -0.469 . . . . 0.10000000000000001 111.702 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.626 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -84.54 148.14 26.65 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.838 -1.171 . . . . 1.0700000000000001 107.838 172.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 445' ' ' THR . 43.3 t -134.29 96.54 3.63 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.67 0.747 . . . . 0.5 110.269 -171.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 114.473 -1.24 . . . . 0.41999999999999998 109.945 -174.877 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 N--CA 1.43 -1.457 0 CA-C-O 122.322 1.058 . . . . 2.1600000000000001 113.417 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.952 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.62 134.2 5.19 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 104.162 -2.533 . . . . 0.91000000000000003 104.162 171.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.36 -157.29 29.4 Favored Glycine 0 C--N 1.276 -2.756 0 C-N-CA 119.28 -1.438 . . . . 0.20000000000000001 110.749 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.405 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.94 174.29 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 119.903 -1.142 . . . . 0.25 111.175 166.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.5 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -51.33 102.68 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 123.198 1.475 . . . . 1.8500000000000001 113.944 -154.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.613 ' HG ' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.07 -35.44 11.92 Favored 'General case' 0 C--O 1.202 -1.4 0 CA-C-N 112.699 -2.046 . . . . 1.8200000000000001 109.087 168.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.731 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -55.72 -26.69 46.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.17999999999999999 112.357 -170.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.731 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.78 -32.42 15.39 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.981 0.896 . . . . 1.05 111.771 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.8 p -87.52 -45.0 10.86 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.946 -1.479 . . . . 1.0600000000000001 111.103 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.613 ' CD ' ' HG ' ' A' ' 433' ' ' LEU . 7.5 mtp-105 -91.04 -20.2 22.34 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.446 -1.252 . . . . 2.3700000000000001 110.18 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.89 46.56 49.17 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.395 -1.275 . . . . 0.23999999999999999 114.308 164.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 110.82 19.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.345 1.073 . . . . 1.7 112.298 -169.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 37.07 -111.19 0.08 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.869 -1.06 . . . . 0.56999999999999995 113.495 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.464 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -146.41 -11.84 0.21 Allowed Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.867 -0.682 . . . . 0.28999999999999998 114.235 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 29.4 p -100.04 -167.99 1.53 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 118.291 1.046 . . . . 0.40000000000000002 112.151 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.447 HG21 ' HB ' ' A' ' 368' ' ' ILE . 2.2 mp -103.39 132.02 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 114.862 -1.063 . . . . 1.04 110.886 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -102.41 94.22 5.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.996 -1.002 . . . . 0.62 110.367 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.673 ' HA ' HG23 ' A' ' 368' ' ' ILE . 2.9 m -89.93 144.08 30.96 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 115.607 -0.724 . . . . 1.02 112.554 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.605 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 74.8 Cg_exo -51.68 147.22 24.71 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 123.945 3.097 . . . . 0.23999999999999999 113.33 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.952 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 27.1 Cg_exo -67.96 -26.24 37.74 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.006 2.471 . . . . 0.31 112.185 -175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.51 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 40.5 p -75.61 -25.4 56.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.078 -0.964 . . . . 1.48 111.876 -176.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.706 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.6 m -99.93 -50.47 10.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.574 -0.739 . . . . 1.03 112.896 -171.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.94 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.67 -2.34 4.8 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.729 -0.788 . . . . 1.02 110.249 -178.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.602 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.1 pttp -81.09 -39.51 25.57 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.484 1.135 . . . . 1.5900000000000001 108.287 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.574 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.7 mm-40 -61.62 -46.84 88.09 Favored 'General case' 0 CA--C 1.47 -2.121 0 CA-C-N 112.319 -2.219 . . . . 0.25 106.571 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.94 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.52 -66.86 0.34 Allowed 'General case' 0 N--CA 1.4 -2.969 0 CA-C-N 109.649 -3.432 . . . . 1.02 112.842 172.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.526 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.8 t80 -44.43 -24.79 0.2 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 124.135 0.897 . . . . 0.17000000000000001 109.727 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.78 -30.35 15.44 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.341 -1.299 . . . . 0.13 111.762 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.574 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -97.8 -43.91 6.95 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 113.22 0.822 . . . . 1.02 113.22 178.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.679 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.84 147.55 9.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 122.451 1.119 . . . . 1.01 110.928 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.49 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -116.28 157.14 25.42 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 113.196 -1.82 . . . . 0.47999999999999998 108.909 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.596 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 5.6 mppt? -58.91 102.1 0.11 Allowed 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.573 -0.899 . . . . 1.7 108.573 169.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.68 -12.13 5.95 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 114.102 -1.408 . . . . 0.22 111.525 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 344' ' ' TYR . 16.2 m -67.12 150.16 98.07 Favored Pre-proline 0 N--CA 1.441 -0.923 0 N-CA-C 108.671 -0.863 . . . . 0.94999999999999996 108.671 171.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.3 Cg_endo -93.87 161.03 2.23 Favored 'Trans proline' 0 N--CA 1.423 -2.647 0 C-N-CA 122.152 1.901 . . . . 0.23000000000000001 109.974 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.754 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -123.51 150.47 27.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 107.389 -1.337 . . . . 1.27 107.389 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.698 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.4 mp -134.15 150.66 51.12 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.748 -0.834 . . . . 1.05 108.748 175.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.699 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -139.01 140.4 38.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 105.418 -2.067 . . . . 1.01 105.418 165.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.534 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 10.8 p90 . . . . . 0 C--O 1.246 0.884 0 O-C-N 123.822 0.701 . . . . 1.0900000000000001 111.086 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 N--CA 1.444 -0.746 0 CA-C-O 121.435 0.636 . . . . 0.42999999999999999 109.359 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 1.129 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 73.1 m -158.25 134.69 9.5 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.376 -1.284 . . . . 1.0 108.983 168.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.68 ' CD2' HD11 ' A' ' 464' ' ' LEU . 39.6 p90 174.27 158.7 0.16 Allowed 'General case' 0 C--O 1.213 -0.865 0 O-C-N 123.478 0.486 . . . . 0.88 110.855 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.675 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.65 152.48 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 164.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.558 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 32.1 tt0 -149.94 143.61 25.35 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.42 -0.809 . . . . 2.0099999999999998 109.748 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 464' ' ' LEU . 2.9 t -136.05 162.41 36.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.929 0.395 . . . . 1.04 111.298 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.513 ' N ' HG13 ' A' ' 347' ' ' VAL . 35.0 t0 -140.13 106.76 5.34 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.162 -1.421 . . . . 0.23999999999999999 107.162 173.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.645 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.36 -33.5 28.79 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-O 122.71 1.243 . . . . 1.02 110.193 -168.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.409 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.4 mt-10 -57.07 -44.85 83.46 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 110.786 -2.915 . . . . 0.59999999999999998 108.192 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.3 m-80 -101.95 5.64 40.89 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 110.906 -2.861 . . . . 0.20999999999999999 111.273 -175.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.582 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.2 mp0 34.79 61.61 0.57 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 112.56 -2.109 . . . . 2.54 113.085 -175.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.593 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.4 t60 -141.76 134.95 29.23 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.615 -0.72 . . . . 0.12 109.818 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.602 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.4 OUTLIER -113.24 156.31 23.53 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.084 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.543 ' CD1' HG12 ' A' ' 362' ' ' VAL . 30.5 m-90 -142.26 154.75 45.01 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.443 -0.798 . . . . 0.11 111.037 -175.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.129 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 88.1 t80 -109.8 153.11 24.85 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 106.503 -1.665 . . . . 1.1000000000000001 106.503 151.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 8.1 m-85 -128.15 117.37 21.46 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 114.957 -1.019 . . . . 0.60999999999999999 110.28 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.3 tppt? -118.32 138.34 52.46 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.948 -1.871 . . . . 0.93999999999999995 105.948 168.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.31 17.37 8.25 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.147 0.795 . . . . 0.42999999999999999 113.147 172.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 78.24 6.47 87.73 Favored Glycine 0 CA--C 1.488 -1.653 0 C-N-CA 120.705 -0.759 . . . . 0.17999999999999999 112.943 -174.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.6 ptmt -127.55 178.19 6.27 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 104.484 -2.413 . . . . 1.0900000000000001 104.484 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 16.4 m -105.07 157.35 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.766 0 N-CA-C 116.21 1.93 . . . . 1.02 116.21 -176.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.622 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -108.13 -27.62 9.98 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 110.461 -3.063 . . . . 1.01 106.233 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.736 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.12 145.35 49.23 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 111.71 -2.495 . . . . 1.02 111.919 -175.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.593 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 2.5 tt0 -141.55 118.12 10.95 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 104.514 -2.402 . . . . 0.47999999999999998 104.514 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.609 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -150.63 165.43 33.37 Favored 'General case' 0 N--CA 1.398 -3.034 0 C-N-CA 117.83 -1.548 . . . . 1.02 111.533 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 30.1 p-10 -104.41 134.19 48.03 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 114.831 -1.077 . . . . 1.8 109.989 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.696 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -132.56 -172.44 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 CA-C-O 122.53 1.157 . . . . 1.01 112.326 -172.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.79 119.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 112.889 -1.959 . . . . 1.04 108.207 172.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.54 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.1 OUTLIER -77.84 -169.39 1.51 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.067 -1.424 . . . . 1.6000000000000001 110.891 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.67 170.68 46.36 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 118.995 -1.574 . . . . 0.14000000000000001 112.127 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -77.13 157.56 80.94 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.473 0.654 . . . . 1.47 112.52 -164.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.625 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 66.3 Cg_exo -53.01 -29.84 46.22 Favored 'Trans proline' 0 CA--C 1.496 -1.405 1 C-N-CA 125.751 4.3 . . . . 0.28000000000000003 113.694 -173.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.421 ' OG1' HG21 ' A' ' 375' ' ' THR . 19.1 p -66.66 -33.29 75.32 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.424 -1.716 . . . . 1.0800000000000001 109.45 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.515 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.0 t -143.15 71.27 18.34 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 113.498 -1.683 . . . . 1.1000000000000001 109.536 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 375' ' ' THR . 88.9 Cg_exo -56.99 146.05 82.3 Favored 'Trans proline' 0 C--N 1.304 -1.774 1 C-N-CA 125.84 4.36 . . . . 0.38 113.181 -172.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.54 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -75.69 145.15 78.09 Favored Pre-proline 0 N--CA 1.423 -1.82 0 N-CA-C 108.306 -0.998 . . . . 1.1299999999999999 108.306 175.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.1 Cg_exo -75.44 -43.64 0.35 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 124.59 3.526 . . . . 0.20999999999999999 111.775 -166.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.654 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 58.24 136.15 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 123.603 1.668 . . . . 1.0600000000000001 113.639 -172.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 152.99 -126.54 2.0 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 111.969 -2.378 . . . . 0.20000000000000001 109.253 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 71.3 t -121.15 108.63 23.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.204 0.526 . . . . 1.5 110.714 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.598 ' HE2' ' CE1' ' A' ' 382' ' ' PHE . 1.8 m-85 -106.8 -174.36 2.52 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.771 -1.566 . . . . 0.28000000000000003 106.771 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -139.56 123.32 17.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.982 1.265 . . . . 0.96999999999999997 113.071 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -90.51 92.5 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-O 123.035 1.398 . . . . 1.02 109.51 170.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -92.33 11.19 26.75 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.318 -1.765 . . . . 3.1299999999999999 108.291 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.765 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.5 t30 -169.38 126.24 0.91 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.265 -1.334 . . . . 0.42999999999999999 110.352 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.649 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -102.52 140.04 37.32 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.774 -1.103 . . . . 1.73 108.96 169.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.729 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 21.2 mm-40 -124.08 159.2 30.47 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.788 1.403 . . . . 0.70999999999999996 114.788 -167.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 49.8 mt-10 -129.2 146.34 51.14 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 112.701 -2.045 . . . . 0.38 106.552 165.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.8 t70 47.51 38.77 8.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 112.505 -2.134 . . . . 0.40999999999999998 110.603 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.486 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -78.93 166.88 21.89 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 112.663 -2.062 . . . . 1.02 109.318 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 19.9 m -131.29 119.43 21.74 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.29 1.043 . . . . 1.04 111.229 171.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.512 HD22 ' CG ' ' A' ' 421' ' ' HIS . 3.0 mp -79.19 88.29 4.89 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.392 -1.731 . . . . 1.27 111.917 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.573 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.1 mttt . . . . . 0 C--N 1.281 -2.392 0 CA-C-N 113.658 -1.61 . . . . 0.96999999999999997 113.127 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.573 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.628 0 CA-C-O 120.995 0.426 . . . . 0.53000000000000003 110.383 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.06 97.49 4.83 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 108.39 -0.967 . . . . 0.45000000000000001 108.39 170.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.9 Cg_exo -68.66 111.41 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.715 0 C-N-CA 122.202 1.935 . . . . 0.22 110.3 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.61 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -110.92 160.3 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.31 -1.768 . . . . 1.04 107.663 -168.108 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.716 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.8 m-80 -94.15 -19.61 20.62 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.902 -0.777 . . . . 0.65000000000000002 108.902 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 88.1 m-85 -158.94 125.95 4.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.892 -1.049 . . . . 0.92000000000000004 108.248 -171.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 18.2 t-105 -144.16 131.17 20.48 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.933 0.873 . . . . 0.10000000000000001 111.557 -166.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.649 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -111.94 93.91 22.86 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.44 -1.319 . . . . 1.01 107.44 171.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.765 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.5 Cg_endo . . . . . 0 C--N 1.35 0.632 0 C-N-CA 122.308 2.005 . . . . 0.5 111.537 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.579 HG13 ' N ' ' A' ' 419' ' ' GLY . 47.2 t . . . . . 0 CA--C 1.535 0.4 0 CA-C-O 121.374 0.607 . . . . 1.45 111.584 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.579 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -173.08 120.98 0.84 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 109.875 -1.29 . . . . 0.20000000000000001 109.875 170.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.699 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -82.17 140.88 15.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.746 -0.465 . . . . 1.0900000000000001 109.746 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.585 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.1 p80 -159.18 161.03 36.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.197 -0.456 . . . . 0.10000000000000001 111.367 -174.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.61 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.4 148.62 26.5 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.214 -1.032 . . . . 1.0700000000000001 108.214 172.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 445' ' ' THR . 40.4 t -133.24 96.38 3.73 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.726 0.774 . . . . 0.5 109.75 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 C--N 1.317 -0.814 0 CA-C-N 114.26 -1.336 . . . . 0.41999999999999998 109.204 -177.286 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.544 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.9 pm0 . . . . . 0 N--CA 1.436 -1.134 0 CA-C-O 122.323 1.059 . . . . 2.1600000000000001 113.35 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.639 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.47 129.9 3.79 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 112.604 -2.089 . . . . 0.91000000000000003 105.74 172.405 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.61 -158.82 31.7 Favored Glycine 0 C--N 1.283 -2.4 0 C-N-CA 119.913 -1.136 . . . . 0.20000000000000001 110.834 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.508 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.21 174.21 0.01 OUTLIER Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.253 -0.975 . . . . 0.25 111.526 167.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.513 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.3 p-10 -51.9 101.72 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 123.262 1.506 . . . . 1.8500000000000001 113.851 -153.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.68 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.93 -37.06 10.85 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 112.459 -2.155 . . . . 1.8200000000000001 109.54 169.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.697 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -54.12 -27.25 32.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.235 -0.893 . . . . 0.17999999999999999 112.395 -170.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.697 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.33 -33.82 15.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.48 0.657 . . . . 1.05 112.466 -177.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.7 p -92.09 -43.03 9.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.854 -1.066 . . . . 1.0600000000000001 110.991 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.68 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.5 mtp180 -93.15 -18.97 21.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.772 -1.104 . . . . 2.3700000000000001 109.492 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.02 49.42 55.53 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 114.74 -1.118 . . . . 0.23999999999999999 115.022 163.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.0 m -82.39 110.62 17.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.784 1.292 . . . . 1.7 111.077 -172.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 38.98 -130.17 0.24 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.619 -1.173 . . . . 0.56999999999999995 113.23 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -122.31 -22.64 2.55 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.337 -0.459 . . . . 0.28999999999999998 113.247 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.478 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.5 p -102.44 -165.35 1.17 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 113.346 0.869 . . . . 0.40000000000000002 113.346 -173.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.531 HG13 ' HG ' ' A' ' 370' ' ' SER . 1.9 mp -93.03 134.06 32.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.282 -0.872 . . . . 1.04 110.732 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.87 97.09 6.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.385 0.612 . . . . 0.62 110.113 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.696 ' HA ' HG23 ' A' ' 368' ' ' ILE . 4.2 m -93.35 144.85 28.94 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 114.726 -1.124 . . . . 1.02 112.851 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.609 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 72.6 Cg_exo -51.13 145.38 26.13 Favored 'Trans proline' 0 CA--C 1.507 -0.838 0 C-N-CA 123.98 3.12 . . . . 0.23999999999999999 113.391 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.639 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.6 Cg_exo -65.55 -26.15 54.58 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.909 2.406 . . . . 0.31 112.309 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.559 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 57.9 p -76.38 -25.29 54.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.794 0.807 . . . . 1.48 111.998 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.736 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.7 m -99.6 -50.16 10.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.628 -0.714 . . . . 1.03 112.766 -170.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.947 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.61 -2.15 4.5 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.754 -0.778 . . . . 1.02 110.371 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.559 ' HE3' ' O ' ' A' ' 448' ' ' SER . 16.9 pttp -80.87 -38.68 27.7 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.521 1.153 . . . . 1.5900000000000001 108.201 173.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.58 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.1 mm-40 -62.69 -46.39 88.39 Favored 'General case' 0 CA--C 1.474 -1.968 0 CA-C-N 112.433 -2.167 . . . . 0.25 106.578 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.947 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.28 -66.06 0.47 Allowed 'General case' 0 N--CA 1.404 -2.752 0 CA-C-N 109.849 -3.341 . . . . 1.02 112.712 172.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.488 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 24.0 t80 -45.72 -23.67 0.28 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 123.941 0.776 . . . . 0.17000000000000001 109.56 176.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.82 -27.1 25.03 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.649 -1.159 . . . . 0.13 111.817 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.568 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -101.99 -43.83 5.66 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 113.57 0.952 . . . . 1.02 113.57 177.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.675 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.4 OUTLIER -74.89 149.76 7.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.486 1.136 . . . . 1.01 111.175 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.521 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -125.0 157.63 35.67 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 112.939 -1.937 . . . . 0.47999999999999998 108.245 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.598 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.1 mppt? -57.82 101.64 0.08 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 109.055 -0.72 . . . . 1.7 109.055 172.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.85 -14.4 5.22 Favored Glycine 0 C--N 1.307 -1.082 0 CA-C-N 114.111 -1.404 . . . . 0.22 111.53 -175.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.576 HG21 ' HA ' ' A' ' 344' ' ' TYR . 17.8 m -66.63 149.27 98.32 Favored Pre-proline 0 N--CA 1.437 -1.076 0 N-CA-C 108.527 -0.916 . . . . 0.94999999999999996 108.527 171.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 7.2 Cg_endo -94.39 164.19 1.94 Allowed 'Trans proline' 0 N--CA 1.419 -2.874 0 C-N-CA 122.159 1.906 . . . . 0.23000000000000001 109.769 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.747 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -126.6 151.65 33.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 107.741 -1.207 . . . . 1.27 107.741 171.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.701 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.3 mp -134.6 151.27 50.96 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 109.079 -0.711 . . . . 1.05 109.079 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.38 142.81 30.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 105.604 -1.998 . . . . 1.01 105.604 164.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.558 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 11.0 p90 . . . . . 0 C--O 1.244 0.785 0 CA-C-O 117.719 -1.134 . . . . 1.0900000000000001 111.562 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.445 -0.721 0 CA-C-O 121.677 0.751 . . . . 0.42999999999999999 109.635 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 96.4 m -158.25 135.65 10.2 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.039 -1.437 . . . . 1.0 108.901 167.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.649 ' CD2' HD11 ' A' ' 464' ' ' LEU . 40.8 p90 174.56 158.3 0.16 Allowed 'General case' 0 C--O 1.213 -0.847 0 O-C-N 123.415 0.447 . . . . 0.88 111.383 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.696 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -78.03 151.68 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 164.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.55 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.43 142.39 24.82 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.606 -0.725 . . . . 2.0099999999999998 109.641 -176.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.693 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.47 161.84 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.162 0.506 . . . . 1.04 111.501 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.513 ' N ' HG13 ' A' ' 347' ' ' VAL . 31.8 t0 -140.3 106.47 5.23 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.18 -1.415 . . . . 0.23999999999999999 107.18 174.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.651 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.24 -32.63 29.63 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 122.807 1.289 . . . . 1.02 110.262 -168.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.73 -45.32 89.9 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.615 -2.993 . . . . 0.59999999999999998 108.304 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -100.6 7.03 44.25 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 111.106 -2.77 . . . . 0.20999999999999999 110.713 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.62 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 19.0 mp0 33.62 60.63 0.49 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 112.683 -2.053 . . . . 2.54 113.0 -175.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.622 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 20.3 t60 -141.71 134.7 28.95 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.383 -0.826 . . . . 0.12 109.73 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.592 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.63 155.97 24.53 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.569 -0.741 . . . . 1.0 110.203 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.553 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.7 m-90 -141.46 155.19 45.87 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.153 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.693 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.0 t80 -110.16 153.18 25.09 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 106.659 -1.608 . . . . 1.1000000000000001 106.659 151.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 8.8 m-85 -128.99 116.13 18.85 Favored 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 115.026 -0.988 . . . . 0.60999999999999999 110.413 -177.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.0 tppt? -116.41 140.23 49.57 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.085 -1.82 . . . . 0.93999999999999995 106.085 168.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.19 18.01 10.35 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.29 0.848 . . . . 0.42999999999999999 113.29 172.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.24 8.34 85.32 Favored Glycine 0 CA--C 1.487 -1.703 0 CA-C-N 115.671 -0.695 . . . . 0.17999999999999999 113.197 -173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 15.4 ptmt -127.12 177.92 6.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 104.792 -2.299 . . . . 1.0900000000000001 104.792 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 14.8 m -105.11 157.32 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.732 0 N-CA-C 116.374 1.99 . . . . 1.02 116.374 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.571 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -108.53 -27.48 9.87 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 110.484 -3.053 . . . . 1.01 106.242 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.02 144.01 48.45 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 111.675 -2.511 . . . . 1.02 111.723 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.622 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -141.23 118.02 11.06 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.388 -2.449 . . . . 0.47999999999999998 104.388 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.592 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.52 163.96 36.39 Favored 'General case' 0 N--CA 1.399 -2.995 0 C-N-CA 118.051 -1.46 . . . . 1.02 111.363 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -102.19 132.9 47.82 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 114.341 -1.3 . . . . 1.8 109.531 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.686 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -131.72 -175.06 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 CA-C-O 122.448 1.118 . . . . 1.01 112.29 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -149.9 118.42 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 112.927 -1.942 . . . . 1.04 108.123 171.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.543 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.2 OUTLIER -78.84 -168.46 1.43 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.132 -1.394 . . . . 1.6000000000000001 110.822 -176.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -83.62 164.94 41.87 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 118.66 -1.733 . . . . 0.14000000000000001 112.076 -173.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.401 ' HG3' ' OG1' ' A' ' 374' ' ' THR . 7.0 ptmt -71.03 155.88 92.74 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.861 0.838 . . . . 1.47 111.998 -165.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.614 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.3 Cg_exo -54.96 -29.44 64.4 Favored 'Trans proline' 0 CA--C 1.496 -1.423 1 C-N-CA 125.502 4.135 . . . . 0.28000000000000003 113.488 -175.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 375' ' ' THR . 14.9 p -69.71 -33.91 73.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.432 -1.713 . . . . 1.0800000000000001 109.476 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.54 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.8 t -142.49 70.67 21.17 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 123.71 1.719 . . . . 1.1000000000000001 109.527 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.5 Cg_exo -57.65 149.88 64.99 Favored 'Trans proline' 0 C--N 1.31 -1.448 1 C-N-CA 126.389 4.726 . . . . 0.38 114.582 -171.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.543 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -79.05 145.04 64.5 Favored Pre-proline 0 N--CA 1.427 -1.619 0 N-CA-C 108.629 -0.878 . . . . 1.1299999999999999 108.629 173.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -77.01 -45.81 0.16 Allowed 'Trans proline' 0 CA--C 1.512 -0.586 0 C-N-CA 124.523 3.482 . . . . 0.20999999999999999 112.163 -168.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.658 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 60.27 137.13 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 123.298 1.523 . . . . 1.0600000000000001 113.557 -172.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.54 -113.3 0.57 Allowed Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 112.003 -2.362 . . . . 0.20000000000000001 109.533 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 381' ' ' VAL . 8.1 p -131.02 116.28 33.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.887 0.851 . . . . 1.5 110.899 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.595 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.3 m-85 -116.22 -174.31 2.53 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.253 -1.388 . . . . 0.28000000000000003 107.253 173.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -140.98 125.05 17.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 120.186 1.357 . . . . 0.96999999999999997 113.436 -172.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -91.12 92.23 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 123.181 1.467 . . . . 1.02 109.609 169.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -93.15 11.12 28.92 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.419 -1.719 . . . . 3.1299999999999999 108.11 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.739 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.4 t30 -169.22 126.97 0.97 Allowed 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 113.952 -1.476 . . . . 0.42999999999999999 110.363 172.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.643 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -98.98 145.22 27.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.041 -0.981 . . . . 1.73 108.927 169.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.718 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 11.3 mm-40 -125.08 158.16 34.49 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 114.888 1.44 . . . . 0.70999999999999996 114.888 -169.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.732 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 50.4 mt-10 -137.44 126.96 25.06 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.913 -1.949 . . . . 0.38 108.436 173.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 31.1 t70 54.16 50.73 15.87 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 123.248 1.499 . . . . 0.40999999999999998 109.082 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.472 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -84.04 166.69 17.51 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 112.83 -1.986 . . . . 1.02 109.27 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 21.7 m -132.7 118.81 19.56 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.204 1.002 . . . . 1.04 111.793 171.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.46 88.72 5.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.585 -1.643 . . . . 1.27 112.136 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.587 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.4 mttt . . . . . 0 C--N 1.282 -2.346 0 CA-C-N 113.561 -1.654 . . . . 0.96999999999999997 113.14 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.587 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 121.031 0.443 . . . . 0.53000000000000003 110.051 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.66 97.47 5.01 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.376 -0.972 . . . . 0.45000000000000001 108.376 171.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.0 Cg_exo -68.87 110.38 2.36 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 121.991 1.794 . . . . 0.22 110.045 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.59 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -109.76 154.87 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 CA-C-N 112.91 -1.95 . . . . 1.04 107.521 -168.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 21.7 m-80 -87.11 -21.57 25.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.909 -0.774 . . . . 0.65000000000000002 108.909 -174.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.662 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 90.3 m-85 -157.59 127.61 6.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.959 -1.018 . . . . 0.92000000000000004 108.677 -170.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.606 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 23.3 t-105 -145.5 133.64 21.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.767 0.794 . . . . 0.10000000000000001 111.151 -167.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.643 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.3 mmt -114.96 93.26 33.86 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 107.747 -1.205 . . . . 1.01 107.747 172.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.739 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.9 Cg_endo . . . . . 0 C--N 1.348 0.522 0 C-N-CA 122.527 2.151 . . . . 0.5 112.515 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.59 HG13 ' N ' ' A' ' 419' ' ' GLY . 38.3 t . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.44 0.638 . . . . 1.45 111.891 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.59 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -177.82 121.51 0.78 Allowed Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.72 -1.352 . . . . 0.20000000000000001 109.72 170.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.657 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.0 mp -81.94 142.66 13.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 120.884 -0.326 . . . . 1.0900000000000001 110.158 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.591 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.6 p80 -159.42 160.99 35.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.336 -0.393 . . . . 0.10000000000000001 111.949 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.59 ' O ' HG21 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -83.65 147.53 27.64 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.141 -1.059 . . . . 1.0700000000000001 108.141 172.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 445' ' ' THR . 2.6 t -133.62 98.94 4.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.633 1.206 . . . . 0.5 110.514 -173.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.461 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 11.2 t70 . . . . . 0 C--N 1.311 -1.103 0 CA-C-N 114.69 -1.141 . . . . 0.41999999999999998 109.593 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.51 ' HG3' ' HG ' ' A' ' 433' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 122.303 1.049 . . . . 2.1600000000000001 112.346 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.479 ' HA ' ' CD2' ' A' ' 433' ' ' LEU . 3.3 m-85 -155.15 130.17 9.45 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 104.517 -2.401 . . . . 0.91000000000000003 104.517 171.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.31 -158.71 31.59 Favored Glycine 0 C--N 1.288 -2.096 0 N-CA-C 110.052 -1.219 . . . . 0.20000000000000001 110.052 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.52 174.54 0.01 OUTLIER Glycine 0 CA--C 1.501 -0.819 0 C-N-CA 120.442 -0.885 . . . . 0.25 111.806 168.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.505 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.0 p-10 -50.91 101.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 123.496 1.617 . . . . 1.8500000000000001 113.597 -152.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.672 ' HG ' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.79 -38.54 10.27 Favored 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 112.316 -2.22 . . . . 1.8200000000000001 109.642 170.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.697 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.8 p-90 -55.39 -27.28 46.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.608 -0.724 . . . . 0.17999999999999999 112.505 -170.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.697 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -88.99 -33.02 17.33 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.717 0.77 . . . . 1.05 112.089 -177.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 7.0 p -89.79 -44.66 9.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.381 -1.281 . . . . 1.0600000000000001 110.918 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.672 ' CD ' ' HG ' ' A' ' 433' ' ' LEU . 7.4 mtp85 -88.23 -19.23 27.12 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.45 -1.25 . . . . 2.3700000000000001 109.92 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.73 46.0 48.12 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.248 -1.342 . . . . 0.23999999999999999 113.327 164.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.0 m -84.45 110.39 18.61 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.32 -0.952 . . . . 1.7 111.837 -168.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 40.12 -129.73 0.36 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.343 -1.298 . . . . 0.56999999999999995 113.056 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -124.44 -20.37 2.42 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.712 -0.756 . . . . 0.28999999999999998 113.547 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.7 p -103.77 -165.71 1.18 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 113.278 0.844 . . . . 0.40000000000000002 113.278 -173.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.525 HG13 ' HG ' ' A' ' 370' ' ' SER . 1.9 mp -92.85 133.18 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 1.04 110.548 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.55 97.55 7.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.728 -0.669 . . . . 0.62 109.462 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.686 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.7 m -92.64 141.51 24.63 Favored Pre-proline 0 N--CA 1.437 -1.081 0 CA-C-N 115.51 -0.768 . . . . 1.02 112.262 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.573 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 64.0 Cg_exo -52.16 144.26 38.82 Favored 'Trans proline' 0 CA--C 1.499 -1.228 0 C-N-CA 123.975 3.117 . . . . 0.23999999999999999 114.786 175.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.572 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 80.3 Cg_exo -52.34 -55.02 4.22 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.301 2.001 . . . . 0.31 110.698 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.503 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 51.9 p -57.23 -23.82 50.59 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 112.251 -2.25 . . . . 1.48 113.74 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.752 ' O ' HD23 ' A' ' 364' ' ' LEU . 27.1 m -98.24 -49.18 11.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 N-CA-C 113.019 0.748 . . . . 1.03 113.019 -173.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.941 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.72 -2.11 6.43 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.52 -0.872 . . . . 1.02 110.235 -178.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.515 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 14.7 pttp -80.98 -38.16 28.07 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 122.651 1.215 . . . . 1.5900000000000001 108.335 173.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.588 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.6 mm-40 -62.17 -46.32 89.49 Favored 'General case' 0 CA--C 1.471 -2.073 0 CA-C-N 112.387 -2.188 . . . . 0.25 106.53 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.941 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.09 -66.35 0.42 Allowed 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 109.837 -3.347 . . . . 1.02 112.786 172.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.7 t80 -46.68 -22.78 0.33 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.673 0.749 . . . . 0.17000000000000001 109.457 175.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.5 -22.46 37.08 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.059 -0.973 . . . . 0.13 111.819 -176.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.592 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -106.34 -44.21 4.59 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 113.777 1.028 . . . . 1.02 113.777 175.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.696 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.52 148.97 8.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 122.44 1.114 . . . . 1.01 111.275 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.531 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -119.11 156.63 29.41 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 113.048 -1.887 . . . . 0.47999999999999998 108.517 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.597 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 3.6 mppt? -59.07 101.75 0.1 Allowed 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.903 -0.777 . . . . 1.7 108.903 171.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.7 -10.65 5.47 Favored Glycine 0 C--N 1.308 -1.019 0 CA-C-N 113.962 -1.472 . . . . 0.22 111.576 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.585 HG21 ' HA ' ' A' ' 344' ' ' TYR . 18.2 m -68.61 150.8 97.55 Favored Pre-proline 0 N--CA 1.443 -0.803 0 N-CA-C 109.073 -0.714 . . . . 0.94999999999999996 109.073 171.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.4 Cg_endo -93.99 163.37 2.14 Favored 'Trans proline' 0 N--CA 1.425 -2.516 0 C-N-CA 122.428 2.085 . . . . 0.23000000000000001 110.128 176.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.741 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -126.87 149.89 32.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 107.668 -1.234 . . . . 1.27 107.668 171.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.691 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.6 mp -134.47 149.89 50.77 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.411 -0.959 . . . . 1.05 108.411 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.693 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -138.25 141.82 36.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 105.434 -2.062 . . . . 1.01 105.434 165.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.55 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 10.2 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 117.723 -1.132 . . . . 1.0900000000000001 111.664 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 . . . . . 0 N--CA 1.445 -0.705 0 CA-C-O 121.291 0.567 . . . . 0.42999999999999999 110.008 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 84.3 m -158.39 135.56 9.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.62 -1.173 . . . . 1.0 109.067 168.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.678 ' CD2' HD11 ' A' ' 464' ' ' LEU . 40.7 p90 174.42 158.63 0.16 Allowed 'General case' 0 CA--C 1.503 -0.829 0 O-C-N 123.386 0.429 . . . . 0.88 111.132 -175.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.687 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.92 152.33 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 164.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.583 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.65 143.05 25.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.64 -0.709 . . . . 2.0099999999999998 109.551 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.59 162.16 37.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.027 0.441 . . . . 1.04 111.378 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.531 ' N ' HG13 ' A' ' 347' ' ' VAL . 20.5 t0 -139.91 107.26 5.53 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.404 -1.332 . . . . 0.23999999999999999 107.404 172.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.658 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.51 -34.38 27.97 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 122.719 1.247 . . . . 1.02 110.52 -167.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -58.41 -45.26 88.75 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.871 -2.877 . . . . 0.59999999999999998 108.252 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -99.99 6.47 45.11 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 111.031 -2.804 . . . . 0.20999999999999999 110.889 -175.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 18.1 mp0 33.53 61.7 0.44 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 112.545 -2.116 . . . . 2.54 113.11 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.584 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 21.8 t60 -141.92 135.18 29.18 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.612 -0.722 . . . . 0.12 109.733 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.585 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -114.23 156.17 24.81 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.233 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.512 ' CD1' HG12 ' A' ' 362' ' ' VAL . 30.0 m-90 -141.17 153.93 45.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.373 -0.831 . . . . 0.11 111.269 -174.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.682 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.1 t80 -109.76 153.21 24.66 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 106.599 -1.63 . . . . 1.1000000000000001 106.599 151.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.5 m-85 -129.25 116.61 19.4 Favored 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 114.699 -1.137 . . . . 0.60999999999999999 110.226 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.5 tppt? -115.88 137.3 52.23 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.703 -1.962 . . . . 0.93999999999999995 105.703 167.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.73 18.31 8.72 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.61 0.967 . . . . 0.42999999999999999 113.61 172.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.31 8.1 86.99 Favored Glycine 0 CA--C 1.487 -1.697 0 CA-C-O 121.779 0.655 . . . . 0.17999999999999999 113.015 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 15.8 ptmt -128.13 176.95 7.25 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 104.569 -2.382 . . . . 1.0900000000000001 104.569 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.4 m -104.38 157.86 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.611 0 N-CA-C 116.289 1.959 . . . . 1.02 116.289 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.584 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.87 -26.61 9.7 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 110.516 -3.038 . . . . 1.01 106.646 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.84 144.96 47.88 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 111.669 -2.514 . . . . 1.02 111.753 -175.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.584 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 5.8 tt0 -139.92 118.15 12.0 Favored 'General case' 0 N--CA 1.408 -2.53 0 N-CA-C 104.411 -2.44 . . . . 0.47999999999999998 104.411 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.638 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -150.09 163.39 38.31 Favored 'General case' 0 N--CA 1.4 -2.971 0 C-N-CA 117.466 -1.693 . . . . 1.02 111.917 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.529 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 18.1 p-10 -103.02 134.33 46.64 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-N 114.293 -1.321 . . . . 1.8 109.57 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.684 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.89 -172.34 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 CA-C-O 122.508 1.147 . . . . 1.01 112.414 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.23 120.89 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 112.832 -1.985 . . . . 1.04 108.423 172.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.559 ' HG ' HG13 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -79.86 -168.14 1.5 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.315 -1.311 . . . . 1.6000000000000001 110.708 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.431 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -83.96 170.33 47.42 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 118.907 -1.616 . . . . 0.14000000000000001 112.152 -173.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 6.0 ptmt -78.6 162.89 63.99 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 113.109 0.781 . . . . 1.47 113.109 -162.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.671 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 74.9 Cg_exo -54.84 -37.53 92.57 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 C-N-CA 123.058 2.505 . . . . 0.28000000000000003 112.56 -175.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.407 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 25.2 p -66.06 -33.96 76.98 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.337 -1.301 . . . . 1.0800000000000001 110.085 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.543 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.5 t -141.56 72.69 25.1 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-O 123.69 1.709 . . . . 1.1000000000000001 109.743 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 375' ' ' THR . 74.3 Cg_exo -61.37 160.5 27.04 Favored 'Trans proline' 0 C--N 1.311 -1.423 1 C-N-CA 126.345 4.697 . . . . 0.38 114.346 -173.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.526 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -91.55 144.71 29.99 Favored Pre-proline 0 N--CA 1.42 -1.96 0 N-CA-C 108.305 -0.998 . . . . 1.1299999999999999 108.305 171.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -76.44 -43.88 0.27 Allowed 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 124.844 3.696 . . . . 0.20999999999999999 112.139 -168.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.644 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 60.96 134.6 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.488 1.613 . . . . 1.0600000000000001 113.562 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 155.14 -116.15 0.71 Allowed Glycine 0 N--CA 1.429 -1.791 0 CA-C-N 111.959 -2.382 . . . . 0.20000000000000001 109.627 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.454 ' O ' HG11 ' A' ' 381' ' ' VAL . 8.4 p -130.34 115.69 33.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.861 0.839 . . . . 1.5 110.899 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.615 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.7 m-85 -115.36 -174.01 2.43 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.34 -1.355 . . . . 0.28000000000000003 107.34 174.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.65 123.49 17.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.881 1.219 . . . . 0.96999999999999997 113.268 -171.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -91.74 91.67 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 CA-C-O 123.189 1.471 . . . . 1.02 109.39 168.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -93.44 10.58 31.74 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 113.106 -1.861 . . . . 3.1299999999999999 107.908 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.751 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.7 t30 -168.78 125.6 0.98 Allowed 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 113.774 -1.557 . . . . 0.42999999999999999 109.939 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.628 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.9 143.52 30.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.902 -1.044 . . . . 1.73 108.86 169.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.773 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 20.4 mm-40 -125.17 155.18 40.36 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 114.441 1.274 . . . . 0.70999999999999996 114.441 -168.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 41.0 mt-10 -136.86 126.55 25.45 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 112.947 -1.933 . . . . 0.38 108.287 171.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.6 t70 57.56 53.34 7.43 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 123.459 1.6 . . . . 0.40999999999999998 109.144 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.462 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -89.29 166.38 13.81 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 112.451 -2.159 . . . . 1.02 108.501 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 31.6 m -132.93 120.03 20.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.092 0.949 . . . . 1.04 111.862 171.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 405' ' ' SER . 8.9 mt -75.75 88.29 2.81 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.828 -1.533 . . . . 1.27 112.796 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 44.9 mttt . . . . . 0 C--N 1.286 -2.154 0 CA-C-N 114.492 -1.231 . . . . 0.96999999999999997 113.751 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.713 0 CA-C-O 121.027 0.441 . . . . 0.53000000000000003 110.07 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.632 ' O ' ' HG ' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.98 97.54 4.85 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.304 -0.998 . . . . 0.45000000000000001 108.304 171.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 14.4 Cg_exo -70.27 108.21 2.13 Favored 'Trans proline' 0 N--CA 1.432 -2.127 0 C-N-CA 121.023 1.149 . . . . 0.22 110.016 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.544 ' CG1' ' HB2' ' A' ' 410' ' ' TRP . 0.4 OUTLIER -106.22 152.4 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.285 0 CA-C-N 112.816 -1.993 . . . . 1.04 108.55 -169.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.8 OUTLIER -86.08 -19.17 30.64 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.753 -0.832 . . . . 0.65000000000000002 108.753 -174.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.668 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 91.4 m-85 -158.05 126.02 5.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.378 -0.828 . . . . 0.92000000000000004 108.938 -171.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.614 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 21.4 t-105 -144.94 134.24 22.96 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.705 0.764 . . . . 0.10000000000000001 111.18 -167.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.628 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.1 mmt -116.44 93.64 40.59 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.746 -1.205 . . . . 1.01 107.746 172.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.751 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.6 Cg_endo . . . . . 0 C--N 1.348 0.502 0 C-N-CA 122.532 2.154 . . . . 0.5 112.95 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 419' ' ' GLY . 36.0 t . . . . . 0 CA--C 1.532 0.288 0 CA-C-O 121.359 0.6 . . . . 1.45 112.298 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.593 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -178.71 120.74 0.72 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.861 -1.296 . . . . 0.20000000000000001 109.861 170.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.642 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.43 141.83 14.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 110.041 -0.355 . . . . 1.0900000000000001 110.041 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.595 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.2 p80 -157.92 161.21 38.22 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 116.091 -0.504 . . . . 0.10000000000000001 111.173 -174.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.629 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.2 OUTLIER -84.18 148.16 26.91 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.178 -1.045 . . . . 1.0700000000000001 108.178 172.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 445' ' ' THR . 45.9 t -134.18 96.1 3.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.707 0.765 . . . . 0.5 109.844 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.434 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 19.6 t70 . . . . . 0 C--N 1.315 -0.913 0 CA-C-N 114.3 -1.318 . . . . 0.41999999999999998 109.921 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.564 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.4 pm0 . . . . . 0 N--CA 1.437 -1.076 0 CA-C-O 122.39 1.091 . . . . 2.1600000000000001 113.242 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.838 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.04 130.88 4.3 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 104.93 -2.248 . . . . 0.91000000000000003 104.93 170.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.46 -158.63 31.62 Favored Glycine 0 C--N 1.284 -2.35 0 C-N-CA 119.806 -1.188 . . . . 0.20000000000000001 110.792 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.492 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.35 175.33 0.01 OUTLIER Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 120.519 -0.848 . . . . 0.25 111.713 167.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.475 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 7.8 p-10 -50.58 101.8 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 123.473 1.606 . . . . 1.8500000000000001 113.445 -153.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.655 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -97.13 -37.69 10.02 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 112.639 -2.073 . . . . 1.8200000000000001 109.478 169.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.73 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -54.13 -28.04 37.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.36 -0.836 . . . . 0.17999999999999999 112.286 -170.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.73 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.67 -35.07 15.16 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.697 0.629 . . . . 1.05 112.697 -178.029 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.2 p -90.98 -40.86 11.43 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.262 -0.881 . . . . 1.0600000000000001 111.014 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.655 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -95.49 -17.21 21.65 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.646 -1.161 . . . . 2.3700000000000001 109.693 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.76 50.11 51.1 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.91 -1.041 . . . . 0.23999999999999999 115.22 161.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.8 m -82.06 109.82 16.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.923 1.362 . . . . 1.7 110.845 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 32.59 -112.16 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.467 -1.242 . . . . 0.56999999999999995 113.418 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.431 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -140.49 -14.6 0.52 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.898 -0.592 . . . . 0.28999999999999998 113.767 -174.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 28.8 p -104.59 -166.32 1.23 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 117.75 0.775 . . . . 0.40000000000000002 112.467 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.559 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.1 mp -96.65 129.63 46.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.839 -1.073 . . . . 1.04 110.465 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.55 93.15 5.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.815 -0.629 . . . . 0.62 110.123 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.684 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.2 m -89.15 142.98 30.44 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.936 -1.029 . . . . 1.02 112.731 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.638 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 75.0 Cg_exo -50.16 146.47 17.72 Favored 'Trans proline' 0 CA--C 1.507 -0.857 0 C-N-CA 124.15 3.234 . . . . 0.23999999999999999 113.323 174.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.838 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 28.3 Cg_exo -67.33 -25.07 42.65 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.887 2.392 . . . . 0.31 111.834 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.499 ' O ' ' HE2' ' A' ' 451' ' ' LYS . 40.4 p -76.61 -26.09 54.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.94 -1.027 . . . . 1.48 112.036 -175.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.709 ' O ' HD23 ' A' ' 364' ' ' LEU . 33.4 m -99.27 -49.75 11.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 112.806 0.669 . . . . 1.03 112.806 -170.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.94 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.51 -2.25 4.49 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.743 -0.783 . . . . 1.02 110.409 -178.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.514 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 40.9 pttt -81.29 -38.74 26.33 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 122.518 1.151 . . . . 1.5900000000000001 108.335 173.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.574 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.1 mm-40 -62.94 -46.7 86.52 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 112.47 -2.15 . . . . 0.25 106.688 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.94 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -46.68 -67.16 0.31 Allowed 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 109.906 -3.316 . . . . 1.02 112.736 172.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.515 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 16.4 t80 -44.91 -24.85 0.25 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 124.191 0.932 . . . . 0.17000000000000001 109.39 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -87.57 -30.12 19.58 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.551 -1.204 . . . . 0.13 111.607 -175.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.584 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -98.27 -44.12 6.69 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 113.21 0.818 . . . . 1.02 113.21 178.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.687 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.75 147.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 122.558 1.17 . . . . 1.01 111.126 179.402 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.495 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -117.61 156.58 27.9 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 112.809 -1.996 . . . . 0.47999999999999998 108.473 -178.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.635 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 42.4 mtmt -55.76 102.73 0.08 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.699 -0.682 . . . . 1.7 109.517 169.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.79 -13.22 5.85 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 113.792 -1.549 . . . . 0.22 111.779 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 344' ' ' TYR . 17.3 m -64.85 150.1 95.29 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 108.996 -0.742 . . . . 0.94999999999999996 108.996 173.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.1 Cg_endo -93.62 160.33 2.36 Favored 'Trans proline' 0 N--CA 1.424 -2.616 0 C-N-CA 122.331 2.021 . . . . 0.23000000000000001 109.962 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.725 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -124.6 149.87 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.317 -1.364 . . . . 1.27 107.317 171.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.678 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.6 mp -134.42 149.99 50.82 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.339 -0.986 . . . . 1.05 108.339 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -137.82 140.95 40.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 105.647 -1.983 . . . . 1.01 105.647 166.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.583 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 5.4 p90 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 117.649 -1.167 . . . . 1.0900000000000001 111.139 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.478 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 4.6 m-20 . . . . . 0 N--CA 1.444 -0.762 0 CA-C-O 121.279 0.561 . . . . 0.42999999999999999 109.993 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 1.095 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 53.2 m -156.86 132.71 9.54 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.358 -1.292 . . . . 1.0 108.268 167.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.739 ' CD2' HD11 ' A' ' 464' ' ' LEU . 42.9 p90 174.73 158.38 0.17 Allowed 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 123.421 0.451 . . . . 0.88 111.002 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.689 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.34 153.71 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 165.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.595 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.71 146.63 28.21 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.826 -1.175 . . . . 2.0099999999999998 107.826 -178.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.709 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.4 155.03 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 C-N-CA 123.579 0.752 . . . . 1.04 110.618 173.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 355' ' ' TRP . 48.0 t0 -137.19 105.33 5.69 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.255 -1.757 . . . . 0.23999999999999999 106.255 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.643 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -79.62 -35.83 38.89 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 123.11 1.433 . . . . 1.02 110.019 -166.039 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.428 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -56.04 -44.98 79.33 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 110.682 -2.963 . . . . 0.59999999999999998 108.037 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 28.1 m-80 -101.02 7.1 43.62 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 110.815 -2.902 . . . . 0.20999999999999999 110.893 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.526 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.6 OUTLIER 32.78 61.44 0.38 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 112.628 -2.078 . . . . 2.54 112.928 -175.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.606 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 24.1 t60 -141.94 135.77 29.73 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.77 -0.65 . . . . 0.12 109.837 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.615 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.65 157.26 22.38 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.155 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.613 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.8 m-90 -142.68 160.06 41.04 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.81 -0.632 . . . . 0.11 111.254 -177.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.095 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 89.6 t80 -112.3 153.9 26.49 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 106.45 -1.685 . . . . 1.1000000000000001 106.45 150.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.5 m-85 -127.51 119.21 25.55 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 115.119 -0.946 . . . . 0.60999999999999999 110.126 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.4 tppt? -120.47 134.88 55.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.124 -1.806 . . . . 0.93999999999999995 106.124 168.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.415 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 72.98 16.32 4.41 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 113.216 0.821 . . . . 0.42999999999999999 113.216 172.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.478 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.68 6.79 88.35 Favored Glycine 0 CA--C 1.486 -1.767 0 C-N-CA 120.995 -0.621 . . . . 0.17999999999999999 113.05 -172.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.3 ptmt -128.49 176.39 7.78 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 104.872 -2.269 . . . . 1.0900000000000001 104.872 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.613 HG12 ' CD1' ' A' ' 355' ' ' TRP . 16.4 m -104.83 156.89 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 116.597 2.073 . . . . 1.02 116.597 -175.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.635 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -107.76 -27.34 10.34 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 110.672 -2.967 . . . . 1.01 106.599 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.9 145.39 49.57 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 111.405 -2.634 . . . . 1.02 111.301 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.606 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -142.1 118.08 10.6 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 104.504 -2.406 . . . . 0.47999999999999998 104.504 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.3 164.87 33.64 Favored 'General case' 0 N--CA 1.402 -2.857 0 C-N-CA 117.997 -1.481 . . . . 1.02 111.803 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.571 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 12.2 p-10 -102.95 132.69 49.0 Favored 'General case' 0 N--CA 1.41 -2.458 0 CA-C-N 114.109 -1.405 . . . . 1.8 109.791 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.702 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.02 -173.48 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-O 122.522 1.153 . . . . 1.01 112.425 -171.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.09 120.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 112.719 -2.037 . . . . 1.04 108.123 172.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.509 ' HG ' HG13 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -78.73 -168.6 1.45 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.23 -1.35 . . . . 1.6000000000000001 110.325 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.534 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.16 170.51 45.15 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 118.601 -1.761 . . . . 0.14000000000000001 112.631 -173.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.5 ptmt -72.96 155.28 90.6 Favored Pre-proline 0 C--O 1.218 -0.603 0 CA-C-O 121.42 0.629 . . . . 1.47 111.576 -166.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.62 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 77.9 Cg_exo -55.04 -28.29 59.37 Favored 'Trans proline' 0 CA--C 1.497 -1.326 0 C-N-CA 125.243 3.962 . . . . 0.28000000000000003 113.665 -173.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.437 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 26.2 p -72.6 -32.28 65.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.621 -1.627 . . . . 1.0800000000000001 109.586 -176.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.568 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 0.4 OUTLIER -141.37 70.56 26.93 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-O 123.426 1.584 . . . . 1.1000000000000001 110.127 178.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 375' ' ' THR . 76.1 Cg_exo -59.4 157.5 30.85 Favored 'Trans proline' 0 C--N 1.311 -1.406 1 C-N-CA 126.309 4.673 . . . . 0.38 113.996 -172.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.466 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.5 OUTLIER -84.97 147.74 48.93 Favored Pre-proline 0 N--CA 1.422 -1.875 0 N-CA-C 108.198 -1.038 . . . . 1.1299999999999999 108.198 174.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -77.6 -42.39 0.27 Allowed 'Trans proline' 0 CA--C 1.514 -0.505 0 C-N-CA 124.124 3.216 . . . . 0.20999999999999999 112.363 -166.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.713 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 54.99 137.83 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 123.604 1.668 . . . . 1.0600000000000001 114.487 -173.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 151.75 -109.91 0.44 Allowed Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 111.997 -2.365 . . . . 0.20000000000000001 109.549 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.75 124.32 56.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.328 0.585 . . . . 1.5 109.724 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.633 ' HE1' ' CE2' ' A' ' 382' ' ' PHE . 4.7 m-85 -123.65 -174.45 2.97 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.497 -1.297 . . . . 0.28000000000000003 107.497 172.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.0 OUTLIER -139.85 123.22 17.07 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 119.471 1.032 . . . . 0.96999999999999997 112.953 -171.072 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.84 91.14 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-O 123.296 1.522 . . . . 1.02 109.032 169.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -93.9 11.82 28.14 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 112.978 -1.919 . . . . 3.1299999999999999 107.873 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.733 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.9 t30 -168.49 124.9 1.01 Allowed 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 113.627 -1.624 . . . . 0.42999999999999999 110.009 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.624 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.19 143.53 31.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.086 -0.961 . . . . 1.73 108.949 170.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 37.1 mm-40 -126.95 158.46 36.77 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 114.961 1.467 . . . . 0.70999999999999996 114.961 -167.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 43.6 mt-10 -138.75 126.65 22.34 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.194 -1.821 . . . . 0.38 108.796 174.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 18.6 t70 52.15 51.88 15.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 123.165 1.459 . . . . 0.40999999999999998 109.231 -173.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -82.92 167.46 17.97 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.764 -2.016 . . . . 1.02 109.005 176.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 15.8 m -132.93 120.53 21.58 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.863 0.84 . . . . 1.04 111.291 169.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.6 mp -78.02 87.2 4.18 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.969 -1.468 . . . . 1.27 111.417 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.561 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 45.8 mttt . . . . . 0 C--N 1.288 -2.071 0 CA-C-N 113.393 -1.731 . . . . 0.96999999999999997 113.573 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.561 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.664 0 CA-C-O 120.971 0.415 . . . . 0.53000000000000003 110.798 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.9 OUTLIER -145.14 97.32 4.82 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 108.305 -0.998 . . . . 0.45000000000000001 108.305 170.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.2 Cg_exo -68.73 111.26 2.55 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 122.089 1.859 . . . . 0.22 110.49 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.605 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -112.74 151.21 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 CA-C-N 113.206 -1.815 . . . . 1.04 107.993 -167.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.712 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.8 OUTLIER -85.12 -19.53 31.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.789 -0.819 . . . . 0.65000000000000002 108.789 -173.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.656 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 97.5 m-85 -159.69 126.62 4.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.404 -0.961 . . . . 0.92000000000000004 108.404 -170.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.1 t-105 -144.14 136.04 26.22 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.7 0.762 . . . . 0.10000000000000001 111.174 -166.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.624 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.1 mmt -118.99 91.26 42.96 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.855 -1.165 . . . . 1.01 107.855 173.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.733 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 35.7 Cg_endo . . . . . 0 CA--C 1.514 -0.521 0 C-N-CA 122.387 2.058 . . . . 0.5 111.289 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.694 HG12 ' CE2' ' A' ' 382' ' ' PHE . 2.4 p . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 112.244 0.461 . . . . 1.45 112.244 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.599 ' N ' HG21 ' A' ' 418' ' ' VAL . . . -174.05 124.0 1.0 Allowed Glycine 0 CA--C 1.497 -1.092 0 N-CA-C 110.355 -1.098 . . . . 0.20000000000000001 110.355 172.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.648 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.4 mp -81.7 142.8 13.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.8 0.333 . . . . 1.0900000000000001 110.453 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.599 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.1 p80 -160.63 162.31 32.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.841 -0.618 . . . . 0.10000000000000001 110.924 -175.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.605 ' O ' HG21 ' A' ' 407' ' ' VAL . 0.2 OUTLIER -86.65 148.32 25.51 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.731 -1.211 . . . . 1.0700000000000001 107.731 172.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 445' ' ' THR . 45.3 t -133.05 96.71 3.83 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.803 0.811 . . . . 0.5 109.943 -170.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 114.134 -1.394 . . . . 0.41999999999999998 109.445 -176.051 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.598 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.2 pm0 . . . . . 0 N--CA 1.43 -1.45 0 CA-C-O 122.304 1.049 . . . . 2.1600000000000001 113.018 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.838 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -156.6 132.87 9.89 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 105.456 -2.054 . . . . 0.91000000000000003 105.456 167.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.14 -159.06 32.14 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 110.497 -1.041 . . . . 0.20000000000000001 110.497 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -46.8 175.34 0.01 OUTLIER Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.372 -0.918 . . . . 0.25 111.71 168.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.526 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 10.1 p-10 -51.69 101.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.453 1.597 . . . . 1.8500000000000001 113.733 -155.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.648 ' CD2' ' HD2' ' A' ' 437' ' ' ARG . 35.6 mt -97.86 -35.34 10.53 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 112.038 -2.347 . . . . 1.8200000000000001 109.467 170.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.686 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.0 p-90 -53.07 -26.95 17.85 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.012 -0.994 . . . . 0.17999999999999999 112.071 -172.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.686 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.28 -35.77 15.09 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.611 -0.722 . . . . 1.05 112.482 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.431 ' H ' HG21 ' A' ' 436' ' ' THR . 1.8 p -88.51 -37.71 15.54 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.468 -0.787 . . . . 1.0600000000000001 110.617 -176.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.648 ' HD2' ' CD2' ' A' ' 433' ' ' LEU . 0.4 OUTLIER -99.25 -19.64 16.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.676 -1.147 . . . . 2.3700000000000001 110.715 -178.382 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.34 49.62 50.42 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 115.988 1.155 . . . . 0.23999999999999999 115.988 162.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.1 m -82.3 111.07 18.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 119.745 1.773 . . . . 1.7 111.105 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 37.74 -113.64 0.11 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.635 0.976 . . . . 0.56999999999999995 113.635 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.534 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -142.91 -14.87 0.31 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.62 -0.718 . . . . 0.28999999999999998 113.838 -173.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 419' ' ' GLY . 26.4 p -101.56 -167.31 1.4 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.994 0.897 . . . . 0.40000000000000002 112.233 -177.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.509 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.3 mp -99.31 128.35 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 115.096 -0.956 . . . . 1.04 110.751 -174.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.32 92.37 5.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.577 -0.738 . . . . 0.62 110.234 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.702 ' HA ' HG23 ' A' ' 368' ' ' ILE . 4.1 m -88.1 143.3 32.77 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.024 -0.989 . . . . 1.02 112.64 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.57 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 74.1 Cg_exo -50.52 143.12 28.82 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 123.67 2.914 . . . . 0.23999999999999999 112.854 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.838 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 31.3 Cg_exo -64.42 -24.08 64.48 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.762 2.308 . . . . 0.31 111.914 -176.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.521 ' O ' ' HE2' ' A' ' 451' ' ' LYS . 36.6 p -78.06 -25.49 47.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.217 -0.901 . . . . 1.48 112.444 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.711 ' O ' HD23 ' A' ' 364' ' ' LEU . 33.2 m -99.71 -48.76 11.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 112.801 0.667 . . . . 1.03 112.801 -171.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.935 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.39 -2.13 4.21 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.925 -0.71 . . . . 1.02 110.379 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.568 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 42.6 pttt -81.17 -39.03 26.14 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.47 1.129 . . . . 1.5900000000000001 108.188 173.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.583 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.9 mm-40 -62.0 -46.24 90.09 Favored 'General case' 0 CA--C 1.473 -1.999 0 CA-C-N 112.545 -2.116 . . . . 0.25 106.593 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.935 HD21 ' SD ' ' A' ' 450' ' ' MET . 4.0 tp -46.61 -67.09 0.31 Allowed 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 109.679 -3.419 . . . . 1.02 112.755 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.52 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 14.6 t80 -45.37 -24.1 0.26 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 123.972 0.795 . . . . 0.17000000000000001 109.584 177.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.52 -26.64 27.07 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.68 -1.145 . . . . 0.13 111.899 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.555 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -100.9 -43.68 6.0 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 113.157 0.799 . . . . 1.02 113.157 176.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.689 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -74.69 146.96 9.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.674 1.226 . . . . 1.01 111.191 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.487 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -117.24 156.1 28.32 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 112.536 -2.12 . . . . 0.47999999999999998 108.499 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.605 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 40.1 mtmt -59.09 101.34 0.09 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.786 0.803 . . . . 1.7 109.614 171.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 132.3 -14.14 5.12 Favored Glycine 0 C--N 1.304 -1.235 0 CA-C-N 113.556 -1.656 . . . . 0.22 111.452 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.563 HG21 ' HA ' ' A' ' 344' ' ' TYR . 14.7 m -65.11 150.31 95.63 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 108.854 -0.795 . . . . 0.94999999999999996 108.854 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.0 Cg_endo -93.5 162.03 2.39 Favored 'Trans proline' 0 N--CA 1.421 -2.746 0 C-N-CA 122.204 1.936 . . . . 0.23000000000000001 109.813 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.737 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -125.68 151.91 32.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.465 -1.309 . . . . 1.27 107.465 171.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.739 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.3 mp -133.84 150.07 51.38 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.27 -1.011 . . . . 1.05 108.27 175.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.713 HG23 ' HA ' ' A' ' 379' ' ' ALA . 0.7 OUTLIER -140.53 137.88 36.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 103.879 -2.637 . . . . 1.01 103.879 163.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.595 ' CE1' ' CD ' ' A' ' 346' ' ' GLU . 1.6 p90 . . . . . 0 C--O 1.25 1.129 0 O-C-N 123.742 0.651 . . . . 1.0900000000000001 111.378 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.431 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 18.6 m-20 . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 121.293 0.568 . . . . 0.42999999999999999 109.68 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 92.7 m -158.59 136.27 10.31 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.794 -1.094 . . . . 1.0 109.02 168.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.743 ' CD2' HD11 ' A' ' 464' ' ' LEU . 39.9 p90 173.92 158.44 0.14 Allowed 'General case' 0 C--O 1.211 -0.963 0 O-C-N 123.582 0.551 . . . . 0.88 111.329 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.695 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.63 153.66 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 164.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.573 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.01 146.28 28.85 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.778 -1.193 . . . . 2.0099999999999998 107.778 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.693 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.05 155.8 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 C-N-CA 123.381 0.673 . . . . 1.04 110.527 174.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.505 ' N ' HG13 ' A' ' 347' ' ' VAL . 31.4 t0 -137.99 106.68 5.89 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.755 -1.572 . . . . 0.23999999999999999 106.755 175.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.659 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.2 OUTLIER -81.03 -34.77 32.61 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-O 123.094 1.426 . . . . 1.02 110.047 -166.487 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 466' ' ' PHE . 0.8 OUTLIER -58.88 -44.94 91.21 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 110.617 -2.992 . . . . 0.59999999999999998 108.064 177.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -101.23 7.94 42.78 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 111.216 -2.72 . . . . 0.20999999999999999 110.88 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.547 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.5 mp0 31.36 62.54 0.24 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 112.673 -2.058 . . . . 2.54 113.316 -175.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.597 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 26.7 t60 -142.85 136.37 28.66 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.724 -0.671 . . . . 0.12 109.661 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.619 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.2 OUTLIER -114.11 156.48 24.12 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.084 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.62 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.4 m-90 -142.25 158.66 43.47 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.648 -0.706 . . . . 0.11 111.191 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.701 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.8 t80 -111.32 154.07 25.05 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.607 -1.627 . . . . 1.1000000000000001 106.607 151.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.4 m-85 -128.13 116.92 20.7 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 115.262 -0.881 . . . . 0.60999999999999999 110.513 -178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.7 tppt? -119.05 140.03 50.75 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.338 -1.727 . . . . 0.93999999999999995 106.338 168.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.49 16.27 9.15 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.174 0.805 . . . . 0.42999999999999999 113.174 174.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.18 6.99 87.82 Favored Glycine 0 CA--C 1.485 -1.815 0 CA-C-N 115.563 -0.744 . . . . 0.17999999999999999 113.024 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.5 ptmt -127.68 178.77 5.91 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 104.375 -2.454 . . . . 1.0900000000000001 104.375 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.62 HG12 ' CD1' ' A' ' 355' ' ' TRP . 16.9 m -104.37 157.76 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 N-CA-C 116.412 2.004 . . . . 1.02 116.412 -176.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.593 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -108.35 -28.04 9.64 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 110.773 -2.921 . . . . 1.01 106.635 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -132.84 144.63 50.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 111.52 -2.582 . . . . 1.02 111.435 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.597 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 5.6 tt0 -138.8 119.33 13.9 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 104.238 -2.504 . . . . 0.47999999999999998 104.238 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.619 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.3 164.84 34.75 Favored 'General case' 0 N--CA 1.401 -2.898 0 C-N-CA 117.644 -1.622 . . . . 1.02 111.989 178.272 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.56 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 16.9 p-10 -103.46 134.2 47.23 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.373 -1.285 . . . . 1.8 109.784 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.676 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -136.8 -172.92 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 CA-C-O 122.417 1.103 . . . . 1.01 112.515 -171.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -153.33 121.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 112.745 -2.025 . . . . 1.04 108.498 172.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.57 ' HG ' HG13 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -79.36 -168.79 1.64 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.268 -1.333 . . . . 1.6000000000000001 110.556 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -85.36 170.79 45.1 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 118.649 -1.738 . . . . 0.14000000000000001 112.465 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 7.0 ptpt -74.61 157.38 86.11 Favored Pre-proline 0 C--O 1.221 -0.404 0 CA-C-O 121.402 0.62 . . . . 1.47 111.893 -166.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.623 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 99.4 Cg_exo -55.81 -30.04 74.75 Favored 'Trans proline' 0 CA--C 1.495 -1.436 0 C-N-CA 125.27 3.98 . . . . 0.28000000000000003 113.15 -172.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.452 ' OG1' HG21 ' A' ' 375' ' ' THR . 16.0 p -68.54 -33.18 73.65 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.304 -1.771 . . . . 1.0800000000000001 109.774 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.556 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -140.88 70.33 29.62 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 123.487 1.613 . . . . 1.1000000000000001 109.522 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.0 Cg_exo -58.61 157.1 28.76 Favored 'Trans proline' 0 C--N 1.307 -1.631 1 C-N-CA 126.191 4.594 . . . . 0.38 114.265 -171.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.491 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -89.61 143.13 30.0 Favored Pre-proline 0 N--CA 1.418 -2.04 0 N-CA-C 108.093 -1.077 . . . . 1.1299999999999999 108.093 171.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -76.33 -44.1 0.27 Allowed 'Trans proline' 0 CA--C 1.508 -0.82 0 C-N-CA 124.565 3.51 . . . . 0.20999999999999999 111.979 -167.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.646 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.37 137.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 123.582 1.658 . . . . 1.0600000000000001 113.605 -172.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 154.39 -110.81 0.46 Allowed Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 112.064 -2.334 . . . . 0.20000000000000001 109.503 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.42 ' O ' HG11 ' A' ' 381' ' ' VAL . 4.5 p -131.24 120.63 47.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.871 0.844 . . . . 1.5 110.232 175.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.616 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.6 m-85 -119.47 -174.59 2.77 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.87 -1.53 . . . . 0.28000000000000003 106.87 172.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -139.54 123.48 17.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 120.07 1.304 . . . . 0.96999999999999997 113.206 -171.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 2.1 p -88.66 91.29 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 123.132 1.444 . . . . 1.02 109.109 168.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -92.38 10.83 28.28 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.276 -1.784 . . . . 3.1299999999999999 108.014 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.733 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.2 t30 -169.03 126.73 0.98 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.836 -1.529 . . . . 0.42999999999999999 110.492 171.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.646 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -97.63 141.8 30.23 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.889 -1.051 . . . . 1.73 108.815 169.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.752 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 14.7 mm-40 -125.97 157.02 38.88 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 114.538 1.31 . . . . 0.70999999999999996 114.538 -168.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.739 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.0 mt-10 -137.41 127.26 25.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 112.912 -1.949 . . . . 0.38 108.461 173.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.2 t70 57.6 47.23 16.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 123.446 1.593 . . . . 0.40999999999999998 109.072 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.435 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -84.27 167.48 16.57 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 112.474 -2.148 . . . . 1.02 109.457 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 19.9 m -132.35 119.09 20.25 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.188 0.994 . . . . 1.04 112.149 171.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 4.1 mp -81.77 91.76 6.54 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.63 -1.623 . . . . 1.27 112.498 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.578 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.7 mttt . . . . . 0 C--N 1.285 -2.236 0 CA-C-N 114.0 -1.454 . . . . 0.96999999999999997 113.572 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.578 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.44 -0.928 0 N-CA-C 109.642 -0.503 . . . . 0.53000000000000003 109.642 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -143.55 97.29 5.54 Favored Pre-proline 0 N--CA 1.432 -1.335 0 N-CA-C 108.176 -1.046 . . . . 0.45000000000000001 108.176 172.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 16.8 Cg_exo -69.44 110.0 2.39 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 121.994 1.796 . . . . 0.22 109.654 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -108.9 154.22 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 CA-C-N 113.057 -1.883 . . . . 1.04 107.688 -168.067 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.739 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.8 m-80 -86.48 -20.43 28.11 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.78 -0.822 . . . . 0.65000000000000002 108.78 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 96.4 m-85 -158.8 127.1 5.21 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.933 -1.031 . . . . 0.92000000000000004 108.749 -171.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.618 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 22.5 t-105 -144.13 135.31 25.51 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.607 0.718 . . . . 0.10000000000000001 111.001 -167.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.646 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.7 mmt -119.51 89.89 41.65 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.22 -1.03 . . . . 1.01 108.22 174.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.733 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 28.1 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 C-N-CA 122.016 1.81 . . . . 0.5 111.062 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 419' ' ' GLY . 39.0 t . . . . . 0 CA--C 1.533 0.291 0 CA-C-O 121.296 0.57 . . . . 1.45 111.342 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.601 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -178.13 123.21 0.86 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 109.719 -1.352 . . . . 0.20000000000000001 109.719 170.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.684 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.5 142.43 13.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.809 -0.441 . . . . 1.0900000000000001 109.809 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.586 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.6 p80 -160.71 162.92 32.69 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.255 -0.43 . . . . 0.10000000000000001 111.482 -174.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.598 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.21 147.76 26.43 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.245 -1.02 . . . . 1.0700000000000001 108.245 172.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.3 t -132.99 96.93 3.88 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.791 0.805 . . . . 0.5 109.835 -172.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.7 t70 . . . . . 0 C--N 1.313 -1.005 0 CA-C-N 114.094 -1.412 . . . . 0.41999999999999998 109.067 -177.785 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.621 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.0 pm0 . . . . . 0 N--CA 1.435 -1.182 0 CA-C-O 122.409 1.1 . . . . 2.1600000000000001 113.237 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.623 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.54 132.08 4.4 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.857 -2.275 . . . . 0.91000000000000003 104.857 171.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.45 -157.39 29.53 Favored Glycine 0 C--N 1.282 -2.441 0 C-N-CA 119.77 -1.205 . . . . 0.20000000000000001 110.885 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.452 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.21 175.95 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.297 -0.954 . . . . 0.25 111.578 166.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.49 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.4 p-10 -51.95 101.57 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 123.276 1.512 . . . . 1.8500000000000001 113.426 -156.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.659 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.63 -35.8 10.93 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 112.631 -2.077 . . . . 1.8200000000000001 109.45 169.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.721 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.7 p-90 -55.37 -28.0 51.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.173 -0.921 . . . . 0.17999999999999999 112.156 -170.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.721 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.63 -35.04 15.21 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.604 0.716 . . . . 1.05 112.122 -177.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.434 ' H ' HG21 ' A' ' 436' ' ' THR . 2.1 p -90.14 -43.7 10.28 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.754 -1.112 . . . . 1.0600000000000001 111.008 -175.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.659 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 3.0 mtp85 -92.35 -19.64 21.9 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.65 -1.159 . . . . 2.3700000000000001 109.732 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 54.48 48.47 64.85 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 113.848 -1.524 . . . . 0.23999999999999999 115.265 164.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 25.0 m -81.76 111.03 17.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 118.853 1.326 . . . . 1.7 111.217 -171.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 36.39 -120.69 0.15 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.741 -1.118 . . . . 0.56999999999999995 113.66 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -133.29 -19.71 0.95 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 116.036 -0.529 . . . . 0.28999999999999998 113.676 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.424 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.1 p -103.56 -165.37 1.15 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 117.507 0.654 . . . . 0.40000000000000002 112.707 -175.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.57 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.1 mp -95.48 130.57 44.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.968 -1.014 . . . . 1.04 110.658 -175.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.5 95.29 6.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.826 -0.625 . . . . 0.62 110.13 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.676 ' HA ' HG23 ' A' ' 368' ' ' ILE . 4.4 m -91.64 142.54 26.85 Favored Pre-proline 0 N--CA 1.437 -1.125 0 CA-C-N 115.042 -0.981 . . . . 1.02 112.668 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.594 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 87.2 Cg_exo -49.9 144.85 20.09 Favored 'Trans proline' 0 CA--C 1.507 -0.871 0 C-N-CA 124.096 3.197 . . . . 0.23999999999999999 113.457 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.623 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.6 Cg_exo -65.41 -28.37 54.43 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 122.783 2.322 . . . . 0.31 112.306 -175.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.47 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 48.1 m -74.74 -23.72 58.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.845 -0.616 . . . . 1.48 112.282 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.718 ' O ' HD23 ' A' ' 364' ' ' LEU . 29.9 m -100.68 -49.08 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 112.932 0.716 . . . . 1.03 112.932 -169.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.933 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.95 -2.09 4.85 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.8 -0.76 . . . . 1.02 110.308 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.562 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.0 pttp -81.63 -38.98 25.12 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.378 1.085 . . . . 1.5900000000000001 108.117 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.583 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.6 mm-40 -62.03 -46.16 90.39 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-N 112.524 -2.126 . . . . 0.25 106.599 -177.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.933 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.9 tp -46.19 -67.06 0.32 Allowed 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 109.678 -3.419 . . . . 1.02 112.778 172.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.5 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 15.3 t80 -45.52 -24.21 0.3 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 123.957 0.785 . . . . 0.17000000000000001 109.48 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -87.91 -26.63 28.62 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 114.684 -1.143 . . . . 0.13 111.743 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.551 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -101.8 -44.11 5.63 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 113.322 0.86 . . . . 1.02 113.322 176.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.695 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -74.1 148.06 8.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.499 1.143 . . . . 1.01 111.25 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.498 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -117.07 157.99 24.93 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 112.745 -2.025 . . . . 0.47999999999999998 108.992 -179.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.647 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 7.3 mppt? -59.2 102.01 0.12 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.551 -0.907 . . . . 1.7 108.551 168.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.22 -12.36 5.52 Favored Glycine 0 C--N 1.308 -1.011 0 CA-C-N 114.22 -1.355 . . . . 0.22 111.726 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.585 HG21 ' HA ' ' A' ' 344' ' ' TYR . 15.9 m -68.25 151.22 97.36 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 108.838 -0.801 . . . . 0.94999999999999996 108.838 171.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.3 Cg_endo -94.1 165.92 2.04 Favored 'Trans proline' 0 N--CA 1.422 -2.694 0 C-N-CA 122.1 1.866 . . . . 0.23000000000000001 109.929 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.732 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -127.3 152.6 35.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.697 -1.223 . . . . 1.27 107.697 170.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.743 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.3 mp -134.01 150.06 51.22 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.05 -1.093 . . . . 1.05 108.05 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.693 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -139.94 138.28 38.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 103.753 -2.684 . . . . 1.01 103.753 164.031 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.573 ' CE1' ' CD ' ' A' ' 346' ' ' GLU . 2.5 p90 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 117.573 -1.204 . . . . 1.0900000000000001 112.109 -177.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 121.626 0.726 . . . . 0.42999999999999999 109.129 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 99.9 m -159.59 136.16 9.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.457 -1.247 . . . . 1.0 108.995 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.634 ' CD2' HD11 ' A' ' 464' ' ' LEU . 38.6 p90 174.67 158.61 0.17 Allowed 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 123.381 0.425 . . . . 0.88 111.117 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.679 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -78.11 152.35 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 164.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.528 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.1 tt0 -149.77 145.82 26.84 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.437 -0.802 . . . . 2.0099999999999998 109.389 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 464' ' ' LEU . 2.8 t -138.23 162.28 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 120.917 0.389 . . . . 1.04 111.184 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.519 ' N ' HG13 ' A' ' 347' ' ' VAL . 33.7 t0 -140.38 106.4 5.2 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.419 -1.326 . . . . 0.23999999999999999 107.419 173.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.65 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -81.63 -35.74 29.67 Favored 'General case' 0 CA--C 1.483 -1.618 0 CA-C-O 122.678 1.228 . . . . 1.02 110.477 -167.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.422 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -56.53 -44.27 80.67 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 110.967 -2.833 . . . . 0.59999999999999998 108.219 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.8 m-80 -101.21 6.78 43.16 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 110.751 -2.932 . . . . 0.20999999999999999 110.923 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.689 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.8 OUTLIER 34.19 61.83 0.5 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 112.558 -2.11 . . . . 2.54 113.139 -176.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.587 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 20.4 t60 -142.11 133.59 26.63 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.782 -0.644 . . . . 0.12 110.236 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.572 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.2 OUTLIER -112.84 155.5 24.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.684 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.5 ' CE2' ' HD2' ' A' ' 353' ' ' HIS . 29.0 m-90 -140.62 153.83 46.21 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.42 -0.809 . . . . 0.11 110.877 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.68 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 84.0 t80 -110.67 151.89 27.17 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 106.385 -1.709 . . . . 1.1000000000000001 106.385 152.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 6.9 m-85 -127.97 115.62 18.8 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 114.602 -1.181 . . . . 0.60999999999999999 110.343 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.1 tppt? -116.53 138.4 51.43 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.474 -1.676 . . . . 0.93999999999999995 106.474 169.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.407 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.54 17.45 9.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.343 0.868 . . . . 0.42999999999999999 113.343 173.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.92 9.81 86.47 Favored Glycine 0 CA--C 1.491 -1.455 0 CA-C-N 115.528 -0.76 . . . . 0.17999999999999999 112.913 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.5 ptmt -130.27 178.36 6.64 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 104.757 -2.312 . . . . 1.0900000000000001 104.757 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 17.9 m -105.08 157.9 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.642 0 N-CA-C 116.338 1.977 . . . . 1.02 116.338 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.569 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -110.46 -27.91 8.79 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 110.571 -3.013 . . . . 1.01 106.558 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.6 145.28 49.89 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 111.568 -2.56 . . . . 1.02 111.362 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.587 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -141.65 118.29 11.0 Favored 'General case' 0 N--CA 1.404 -2.747 0 N-CA-C 104.255 -2.498 . . . . 0.47999999999999998 104.255 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.633 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -150.22 160.81 43.42 Favored 'General case' 0 N--CA 1.396 -3.131 0 C-N-CA 117.822 -1.551 . . . . 1.02 111.244 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 14.9 p-10 -102.83 132.32 49.1 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.38 -1.282 . . . . 1.8 109.001 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.689 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 2.5 pp -132.16 -172.31 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 CA-C-O 122.439 1.114 . . . . 1.01 112.673 -171.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.83 118.9 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 112.985 -1.916 . . . . 1.04 108.905 173.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.621 ' HG ' ' HB3' ' A' ' 349' ' ' LEU . 47.4 p -74.92 -168.93 0.81 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 112.039 -2.346 . . . . 1.6000000000000001 111.662 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.75 175.25 50.46 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 118.944 -1.598 . . . . 0.14000000000000001 111.831 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.408 ' HG2' ' CG2' ' A' ' 375' ' ' THR . 15.3 ptmt -79.1 163.2 61.21 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.813 0.672 . . . . 1.47 112.813 -164.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.641 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 86.3 Cg_exo -55.72 -37.54 95.37 Favored 'Trans proline' 0 CA--C 1.511 -0.65 0 C-N-CA 122.76 2.307 . . . . 0.28000000000000003 112.448 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.421 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 19.2 p -66.28 -32.26 73.56 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.461 -1.245 . . . . 1.0800000000000001 110.175 -174.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.536 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.3 t -141.23 72.4 26.8 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 123.704 1.716 . . . . 1.1000000000000001 109.608 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 375' ' ' THR . 72.5 Cg_exo -59.99 164.09 12.81 Favored 'Trans proline' 0 C--N 1.312 -1.345 1 C-N-CA 126.394 4.729 . . . . 0.38 115.133 -172.214 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.523 ' CG2' HG22 ' A' ' 465' ' ' VAL . 2.1 m -90.12 128.01 51.28 Favored Pre-proline 0 N--CA 1.399 -2.979 0 CA-C-N 113.869 -1.514 . . . . 1.1299999999999999 108.343 171.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 38.7 Cg_exo -69.47 -45.58 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.99 3.127 . . . . 0.20999999999999999 112.014 -170.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.667 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 63.14 143.93 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 123.316 1.532 . . . . 1.0600000000000001 113.943 -175.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 145.74 -110.41 0.54 Allowed Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 111.905 -2.407 . . . . 0.20000000000000001 108.862 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.19 127.55 60.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.822 -0.436 . . . . 1.5 109.822 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.604 ' HE1' ' CE2' ' A' ' 382' ' ' PHE . 7.7 m-85 -121.54 -174.49 2.87 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.253 -1.388 . . . . 0.28000000000000003 107.253 169.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -138.93 121.26 15.96 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 120.792 -1.192 . . . . 0.96999999999999997 113.194 -173.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.487 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -87.82 92.62 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-O 122.881 1.324 . . . . 1.02 109.368 171.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 44.0 p-90 -92.25 10.35 29.97 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 113.575 -1.648 . . . . 3.1299999999999999 108.314 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.748 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.9 t30 -169.6 127.01 0.91 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.098 -1.41 . . . . 0.42999999999999999 110.392 172.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.586 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.46 143.13 31.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.073 -0.967 . . . . 1.73 109.012 169.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.728 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 10.7 mm-40 -125.31 157.74 35.92 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.548 1.314 . . . . 0.70999999999999996 114.548 -168.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.719 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 47.8 mt-10 -137.49 127.24 25.44 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.178 -1.828 . . . . 0.38 108.668 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 19.5 t70 55.01 50.36 15.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 123.366 1.555 . . . . 0.40999999999999998 109.025 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -84.27 167.37 16.68 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 112.495 -2.139 . . . . 1.02 109.522 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 15.8 m -132.43 118.77 19.76 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.102 0.953 . . . . 1.04 111.494 170.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.18 88.37 4.88 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.779 -1.555 . . . . 1.27 112.11 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.57 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 48.0 mttt . . . . . 0 C--N 1.281 -2.39 0 CA-C-N 113.703 -1.59 . . . . 0.96999999999999997 112.971 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.57 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 120.997 0.427 . . . . 0.53000000000000003 110.455 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.43 97.74 4.68 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 108.422 -0.955 . . . . 0.45000000000000001 108.422 169.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.2 Cg_exo -69.03 110.21 2.35 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.037 1.824 . . . . 0.22 110.462 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.575 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -109.9 157.71 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 CA-C-N 113.084 -1.871 . . . . 1.04 107.824 -167.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.719 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.5 m-80 -88.31 -22.18 24.0 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.83 -0.804 . . . . 0.65000000000000002 108.83 -175.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.668 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 93.6 m-85 -158.72 127.65 5.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.936 -1.029 . . . . 0.92000000000000004 108.382 -170.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.617 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 18.1 t-105 -144.41 133.88 23.3 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.665 0.745 . . . . 0.10000000000000001 110.812 -166.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.586 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 13.5 mmt -115.15 89.81 21.71 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.101 -1.074 . . . . 1.01 108.101 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.748 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 35.0 Cg_endo . . . . . 0 CA--C 1.51 -0.701 0 C-N-CA 122.456 2.104 . . . . 0.5 109.408 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.568 HG13 ' N ' ' A' ' 419' ' ' GLY . 24.0 t . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 121.236 0.541 . . . . 1.45 111.872 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.568 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -176.01 121.69 0.82 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.77 -1.332 . . . . 0.20000000000000001 109.77 169.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.657 HG21 ' SD ' ' A' ' 450' ' ' MET . 2.3 mp -81.69 143.08 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.839 -0.344 . . . . 1.0900000000000001 110.163 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.593 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.3 p80 -159.37 161.5 35.7 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.29 -0.414 . . . . 0.10000000000000001 111.461 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.609 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.83 144.8 28.2 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.843 -1.169 . . . . 1.0700000000000001 107.843 172.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 445' ' ' THR . 33.7 t -134.26 98.0 3.99 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.851 0.834 . . . . 0.5 110.576 -170.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.8 t70 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 114.121 -1.399 . . . . 0.41999999999999998 110.062 -175.754 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.437 -1.09 0 CA-C-O 122.737 1.256 . . . . 2.1600000000000001 112.682 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.517 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 1.2 m-85 -154.61 121.9 5.67 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 112.116 -2.311 . . . . 0.91000000000000003 105.901 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 165.81 -157.05 29.36 Favored Glycine 0 C--N 1.283 -2.391 0 C-N-CA 119.862 -1.161 . . . . 0.20000000000000001 110.352 -174.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -38.61 164.78 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.725 0 C-N-CA 120.483 -0.865 . . . . 0.25 111.789 166.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.439 ' HB3' ' CD ' ' A' ' 435' ' ' LYS . 4.4 m-20 -51.68 102.72 0.05 OUTLIER 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 113.446 -1.377 . . . . 1.8500000000000001 113.318 -153.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.569 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.3 OUTLIER -94.11 -38.77 10.94 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 113.327 -1.761 . . . . 1.8200000000000001 108.823 168.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.735 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.4 p-90 -49.79 -32.17 13.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.153 0.502 . . . . 0.17999999999999999 112.047 -169.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.735 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -86.01 -35.32 20.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.483 0.658 . . . . 1.05 111.965 -177.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 10.2 p -88.75 -43.72 11.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.672 -1.149 . . . . 1.0600000000000001 111.15 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.569 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 11.4 mtp85 -91.59 -18.53 23.91 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.817 -1.083 . . . . 2.3700000000000001 109.474 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.636 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.63 47.56 57.64 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.654 -1.157 . . . . 0.23999999999999999 114.129 163.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 43.3 m -84.76 110.52 18.85 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 118.991 -1.084 . . . . 1.7 111.415 -171.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 37.8 -125.75 0.23 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.373 -1.285 . . . . 0.56999999999999995 113.738 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -126.99 -21.29 1.73 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.076 -0.583 . . . . 0.28999999999999998 113.462 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.402 ' CB ' ' H ' ' A' ' 419' ' ' GLY . 28.7 p -104.49 -165.57 1.15 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 112.883 0.697 . . . . 0.40000000000000002 112.883 -173.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.42 HD11 HG12 ' A' ' 465' ' ' VAL . 2.3 mp -92.02 129.24 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.482 -0.781 . . . . 1.04 110.884 -175.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.3 89.72 4.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.657 -0.701 . . . . 0.62 109.727 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.658 ' HA ' HG21 ' A' ' 368' ' ' ILE . 3.0 m -83.26 143.78 45.7 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 115.087 -0.96 . . . . 1.02 112.452 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.633 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 78.8 Cg_exo -50.08 144.51 22.06 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 123.807 3.005 . . . . 0.23999999999999999 113.351 174.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.609 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.4 Cg_exo -64.6 -25.42 62.16 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 122.827 2.351 . . . . 0.31 112.598 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.519 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 67.3 p -78.7 -24.59 44.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.74 0.781 . . . . 1.48 112.085 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.725 ' O ' HD23 ' A' ' 364' ' ' LEU . 33.0 m -99.35 -48.63 11.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 113.137 0.792 . . . . 1.03 113.137 -170.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.93 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.72 -1.95 4.42 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.767 -0.773 . . . . 1.02 110.434 -178.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.519 ' HE3' ' O ' ' A' ' 448' ' ' SER . 16.5 pttp -81.22 -38.46 26.95 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 122.651 1.215 . . . . 1.5900000000000001 108.287 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.583 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.5 mm-40 -62.65 -46.31 88.79 Favored 'General case' 0 CA--C 1.473 -1.981 0 CA-C-N 112.356 -2.202 . . . . 0.25 106.537 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.93 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.92 -66.72 0.36 Allowed 'General case' 0 N--CA 1.401 -2.922 0 CA-C-N 109.711 -3.404 . . . . 1.02 112.923 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.487 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 14.9 t80 -45.58 -24.03 0.3 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.83 0.824 . . . . 0.17000000000000001 109.502 176.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -87.4 -26.54 30.16 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 114.697 -1.138 . . . . 0.13 111.785 -176.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.59 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -103.14 -44.13 5.29 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 113.728 1.01 . . . . 1.02 113.728 177.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.679 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.62 148.06 9.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.292 1.044 . . . . 1.01 111.106 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.502 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -116.02 155.24 28.44 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.281 -1.781 . . . . 0.47999999999999998 108.952 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.578 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 4.8 mppt? -57.91 103.43 0.14 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.624 -0.88 . . . . 1.7 108.624 169.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 126.36 -7.46 7.54 Favored Glycine 0 C--N 1.308 -0.996 0 CA-C-N 113.827 -1.533 . . . . 0.22 111.452 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 344' ' ' TYR . 6.8 m -70.17 150.5 96.06 Favored Pre-proline 0 N--CA 1.442 -0.862 0 N-CA-C 108.592 -0.892 . . . . 0.94999999999999996 108.592 171.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.8 Cg_endo -93.98 160.52 2.18 Favored 'Trans proline' 0 N--CA 1.421 -2.775 0 C-N-CA 122.017 1.811 . . . . 0.23000000000000001 109.749 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.763 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -123.91 151.44 28.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.295 -1.372 . . . . 1.27 107.295 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.684 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.7 mp -134.54 151.28 51.0 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 108.113 -1.069 . . . . 1.05 108.113 174.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.683 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.8 OUTLIER -140.64 141.26 32.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 105.177 -2.157 . . . . 1.01 105.177 166.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.564 ' N ' HD23 ' A' ' 349' ' ' LEU . 12.5 p90 . . . . . 0 C--O 1.245 0.861 0 CA-C-N 118.45 0.568 . . . . 1.0900000000000001 111.553 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.432 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 9.3 m-20 . . . . . 0 N--CA 1.44 -0.933 0 N-CA-C 108.931 -0.766 . . . . 0.42999999999999999 108.931 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 1.11 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 70.0 m -158.34 134.71 9.4 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.538 -1.21 . . . . 1.0 108.944 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' A' ' 464' ' ' LEU . 37.3 p90 173.91 159.27 0.15 Allowed 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 123.421 0.451 . . . . 0.88 110.881 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.68 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.93 152.59 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 164.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.569 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 31.1 tt0 -149.82 144.7 26.15 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.438 -0.801 . . . . 2.0099999999999998 109.249 -177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.695 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -137.3 162.05 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 O-C-N 122.118 -0.364 . . . . 1.04 111.252 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.521 ' N ' HG13 ' A' ' 347' ' ' VAL . 24.4 t0 -140.19 107.0 5.38 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 107.416 -1.327 . . . . 0.23999999999999999 107.416 172.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.664 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.7 -34.08 27.41 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 122.903 1.335 . . . . 1.02 110.671 -167.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -58.69 -44.12 90.19 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 110.769 -2.923 . . . . 0.59999999999999998 108.17 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -101.12 7.01 43.45 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 110.925 -2.852 . . . . 0.20999999999999999 110.916 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.3 mp0 33.06 61.62 0.39 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 112.692 -2.049 . . . . 2.54 113.417 -175.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.591 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 21.6 t60 -142.02 135.01 28.82 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.854 -0.612 . . . . 0.12 109.983 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.602 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.16 156.75 22.68 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.099 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.526 ' CD1' HG12 ' A' ' 362' ' ' VAL . 29.3 m-90 -142.22 154.18 44.59 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.475 -0.784 . . . . 0.11 111.291 -175.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.11 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 88.2 t80 -110.22 153.29 25.0 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.558 -1.645 . . . . 1.1000000000000001 106.558 151.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.3 m-85 -128.32 118.1 22.63 Favored 'General case' 0 C--N 1.269 -2.915 0 CA-C-N 114.796 -1.093 . . . . 0.60999999999999999 110.118 -178.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.6 tppt? -118.62 135.62 54.34 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.118 -1.808 . . . . 0.93999999999999995 106.118 167.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.54 16.48 6.97 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 113.45 0.908 . . . . 0.42999999999999999 113.45 173.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.36 7.58 88.38 Favored Glycine 0 CA--C 1.485 -1.844 0 CA-C-O 121.933 0.741 . . . . 0.17999999999999999 112.778 -174.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 19.4 ptmt -128.77 177.0 7.38 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 104.542 -2.392 . . . . 1.0900000000000001 104.542 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.6 m -104.29 157.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 N-CA-C 116.397 1.999 . . . . 1.02 116.397 -174.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.625 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -108.97 -28.4 9.14 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 110.497 -3.047 . . . . 1.01 106.277 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.745 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -132.93 145.01 50.53 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 111.614 -2.539 . . . . 1.02 111.731 -175.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.591 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.4 tt0 -141.86 117.88 10.6 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 104.516 -2.401 . . . . 0.47999999999999998 104.516 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.605 ' OG1' HG12 ' A' ' 449' ' ' VAL . 0.5 OUTLIER -149.6 164.47 35.04 Favored 'General case' 0 N--CA 1.402 -2.848 0 C-N-CA 117.974 -1.49 . . . . 1.02 111.769 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.519 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 17.6 p-10 -104.9 131.4 52.44 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 114.726 -1.124 . . . . 1.8 109.542 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.667 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -132.79 -171.87 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 CA-C-O 122.438 1.113 . . . . 1.01 112.327 -171.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -149.99 119.56 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 112.959 -1.928 . . . . 1.04 108.296 172.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.3 OUTLIER -75.62 -168.61 0.88 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.026 -1.443 . . . . 1.6000000000000001 110.784 177.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.49 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -86.4 176.15 48.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 118.929 -1.605 . . . . 0.14000000000000001 112.681 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 16.7 ptmt -78.16 156.72 79.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.661 0.743 . . . . 1.47 111.865 -166.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.642 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 85.5 Cg_exo -59.19 -28.6 88.19 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 125.016 3.811 . . . . 0.28000000000000003 113.309 -173.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.467 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 24.4 p -73.22 -32.61 64.86 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.867 -1.515 . . . . 1.0800000000000001 109.941 -175.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.562 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -140.63 70.15 31.25 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-O 123.887 1.803 . . . . 1.1000000000000001 108.92 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 375' ' ' THR . 83.1 Cg_exo -57.58 160.49 14.16 Favored 'Trans proline' 0 CA--C 1.501 -1.172 1 C-N-CA 126.895 5.063 . . . . 0.38 115.854 -169.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.648 HG22 ' OG ' ' A' ' 370' ' ' SER . 1.6 m -86.62 131.81 44.45 Favored Pre-proline 0 N--CA 1.406 -2.641 0 CA-C-N 113.902 -1.499 . . . . 1.1299999999999999 108.709 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.3 Cg_exo -72.73 -45.14 0.55 Allowed 'Trans proline' 0 CA--C 1.514 -0.491 0 C-N-CA 123.861 3.041 . . . . 0.20999999999999999 112.092 -170.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.664 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.59 140.11 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 123.263 1.506 . . . . 1.0600000000000001 113.497 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.19 -113.55 0.59 Allowed Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 112.455 -2.157 . . . . 0.20000000000000001 109.623 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.428 ' O ' HG11 ' A' ' 381' ' ' VAL . 4.7 p -130.2 119.11 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.924 0.869 . . . . 1.5 110.175 176.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.601 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.7 m-85 -118.1 -174.19 2.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.202 -1.407 . . . . 0.28000000000000003 107.202 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -139.94 123.35 17.07 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 120.697 -1.252 . . . . 0.96999999999999997 113.275 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.501 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.65 92.1 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-O 123.084 1.421 . . . . 1.02 109.308 169.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -94.77 12.46 27.87 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 113.393 -1.73 . . . . 3.1299999999999999 108.318 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.749 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.7 t30 -169.1 126.34 0.96 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 113.833 -1.53 . . . . 0.42999999999999999 110.04 171.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.656 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.79 144.4 29.79 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.115 -0.948 . . . . 1.73 109.458 170.268 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.634 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 24.6 mm-40 -127.5 159.99 32.87 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 114.899 1.444 . . . . 0.70999999999999996 114.899 -168.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 51.6 mt-10 -139.04 127.59 23.1 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 113.064 -1.88 . . . . 0.38 108.583 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.7 t70 54.68 46.38 24.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 123.722 1.725 . . . . 0.40999999999999998 108.754 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -80.84 167.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 111.918 -2.401 . . . . 1.02 109.709 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 11.8 m -132.61 118.33 19.04 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.013 0.911 . . . . 1.04 111.878 170.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.9 mp -77.58 87.62 3.89 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.987 -1.461 . . . . 1.27 111.918 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.573 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.3 mttt . . . . . 0 C--N 1.285 -2.207 0 CA-C-N 113.308 -1.769 . . . . 0.96999999999999997 113.397 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.573 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.444 -0.751 0 CA-C-O 121.177 0.513 . . . . 0.53000000000000003 110.836 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -145.26 97.53 4.75 Favored Pre-proline 0 N--CA 1.439 -0.98 0 N-CA-C 108.359 -0.978 . . . . 0.45000000000000001 108.359 170.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.8 Cg_exo -68.22 110.74 2.3 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.974 1.782 . . . . 0.22 110.034 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.677 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -111.36 152.65 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 CA-C-N 113.368 -1.742 . . . . 1.04 108.458 -167.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.609 ' N ' HD21 ' A' ' 408' ' ' ASN . 0.8 OUTLIER -80.58 -23.28 40.0 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.797 -0.446 . . . . 0.65000000000000002 109.797 -174.589 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 97.2 m-85 -161.35 132.04 5.19 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.635 -1.246 . . . . 0.92000000000000004 107.635 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.623 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 20.2 t-105 -146.42 131.84 18.63 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.889 0.852 . . . . 0.10000000000000001 111.443 -166.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.656 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.6 mmt -114.43 93.23 31.1 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.728 -1.212 . . . . 1.01 107.728 172.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.749 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 36.0 Cg_endo . . . . . 0 CA--C 1.513 -0.568 0 C-N-CA 122.393 2.062 . . . . 0.5 111.618 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.583 HG13 ' N ' ' A' ' 419' ' ' GLY . 34.0 t . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.213 0.53 . . . . 1.45 112.23 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.583 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -176.1 119.64 0.71 Allowed Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.498 -1.041 . . . . 0.20000000000000001 110.498 170.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.727 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.3 mp -81.78 143.34 12.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 110.024 -0.361 . . . . 1.0900000000000001 110.024 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.585 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 29.4 p80 -159.82 159.15 32.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.793 0.664 . . . . 0.10000000000000001 112.793 -173.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.769 ' OD1' ' HB2' ' A' ' 450' ' ' MET . 2.3 m-20 -89.61 132.03 35.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.492 -0.559 . . . . 1.0700000000000001 109.492 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 445' ' ' THR . 28.4 t -120.31 97.39 5.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.641 0.734 . . . . 0.5 109.453 -164.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.417 ' HA ' ' CG ' ' A' ' 447' ' ' PRO . 8.5 t70 . . . . . 0 C--N 1.314 -0.97 0 CA-C-N 114.612 -1.176 . . . . 0.41999999999999998 109.993 -172.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.565 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.2 pm0 . . . . . 0 N--CA 1.436 -1.127 0 CA-C-O 122.224 1.011 . . . . 2.1600000000000001 113.602 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 1.087 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.16 130.38 4.1 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 112.605 -2.089 . . . . 0.91000000000000003 105.487 171.093 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.23 -158.08 30.63 Favored Glycine 0 C--N 1.281 -2.494 0 C-N-CA 119.788 -1.196 . . . . 0.20000000000000001 110.817 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.507 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.28 174.65 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.277 -0.963 . . . . 0.25 111.544 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.487 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 5.0 p-10 -51.78 101.46 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 123.399 1.571 . . . . 1.8500000000000001 113.772 -153.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.693 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.02 -35.67 11.31 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 112.489 -2.141 . . . . 1.8200000000000001 109.147 169.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.736 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.1 p-90 -54.81 -28.11 46.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.006 -0.997 . . . . 0.17999999999999999 112.243 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.736 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.98 -38.09 13.06 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.401 0.62 . . . . 1.05 112.377 -177.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.412 ' H ' HG21 ' A' ' 436' ' ' THR . 2.4 p -86.69 -43.41 12.62 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.04 -0.982 . . . . 1.0600000000000001 110.446 -175.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.693 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 2.7 mtp85 -91.49 -18.6 23.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.497 -1.228 . . . . 2.3700000000000001 108.954 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.66 50.1 50.49 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 115.232 0.853 . . . . 0.23999999999999999 115.232 160.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' SER . . . . . 0.412 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 6.4 m -83.25 111.52 19.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 119.072 1.436 . . . . 1.7 111.436 -173.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 29.52 -106.51 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.507 1.129 . . . . 0.56999999999999995 113.699 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.49 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -147.53 -5.45 0.33 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.815 -0.63 . . . . 0.28999999999999998 114.415 -174.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 419' ' ' GLY . 26.5 p -107.22 -167.27 1.25 Allowed 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.323 1.062 . . . . 0.40000000000000002 112.522 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.536 HG13 ' HG ' ' A' ' 370' ' ' SER . 1.9 mp -102.31 131.15 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 115.057 -0.974 . . . . 1.04 110.889 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -100.71 98.51 9.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.839 -1.073 . . . . 0.62 110.129 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.674 HG23 ' CG2' ' A' ' 449' ' ' VAL . 2.0 m -96.59 140.45 22.17 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 113.599 0.962 . . . . 1.02 113.599 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.805 ' O ' HG23 ' A' ' 449' ' ' VAL . 77.3 Cg_exo -54.66 128.05 28.66 Favored 'Trans proline' 0 CA--C 1.498 -1.322 1 C-N-CA 125.452 4.101 . . . . 0.23999999999999999 114.933 177.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 1.087 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 52.8 Cg_exo -58.27 -8.25 4.85 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.972 3.115 . . . . 0.31 114.374 -165.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.56 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 77.9 p -93.21 -19.62 21.25 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.899 -1.046 . . . . 1.48 111.089 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 446' ' ' PRO . 17.0 m -101.16 -49.61 10.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 114.664 1.357 . . . . 1.03 114.664 -172.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.931 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -69.27 -2.33 10.39 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.933 -1.104 . . . . 1.02 109.529 -177.124 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.582 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.4 pttp -77.28 -39.03 49.58 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 122.551 1.167 . . . . 1.5900000000000001 108.121 173.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.588 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.0 mm-40 -63.14 -46.48 87.02 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 112.416 -2.175 . . . . 0.25 106.709 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.931 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.6 -65.91 0.49 Allowed 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 109.935 -3.302 . . . . 1.02 112.719 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.464 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.6 t80 -45.91 -23.33 0.28 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.861 0.725 . . . . 0.17000000000000001 109.459 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.04 -24.05 33.24 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.051 -0.977 . . . . 0.13 111.927 -176.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.58 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -105.42 -43.88 4.86 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 113.808 1.04 . . . . 1.02 113.808 176.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.84 150.35 7.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.42 1.105 . . . . 1.01 111.084 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.517 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.31 156.88 32.96 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 113.247 -1.797 . . . . 0.47999999999999998 108.353 -178.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.523 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.6 mppt? -59.01 101.68 0.1 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.388 0.613 . . . . 1.7 109.399 172.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.06 -12.72 5.54 Favored Glycine 0 C--N 1.305 -1.173 0 CA-C-N 114.107 -1.406 . . . . 0.22 111.428 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.57 HG21 ' HA ' ' A' ' 344' ' ' TYR . 12.9 m -65.82 149.36 97.57 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 108.718 -0.845 . . . . 0.94999999999999996 108.718 171.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.7 Cg_endo -93.79 160.4 2.28 Favored 'Trans proline' 0 N--CA 1.423 -2.651 0 C-N-CA 122.041 1.828 . . . . 0.23000000000000001 109.989 177.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.709 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -124.05 150.87 28.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 107.386 -1.338 . . . . 1.27 107.386 171.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.669 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.6 mp -134.28 149.56 50.93 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.008 -1.108 . . . . 1.05 108.008 175.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.695 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -137.68 140.65 40.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.311 -2.107 . . . . 1.01 105.311 165.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.569 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 9.4 p90 . . . . . 0 C--O 1.245 0.827 0 O-C-N 123.848 0.717 . . . . 1.0900000000000001 110.85 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.405 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 8.7 m-20 . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.674 0.75 . . . . 0.42999999999999999 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 95.9 m -157.89 135.36 10.36 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.423 -1.262 . . . . 1.0 108.763 166.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.621 ' CD2' HD11 ' A' ' 464' ' ' LEU . 38.3 p90 174.6 157.47 0.16 Allowed 'General case' 0 C--O 1.21 -0.986 0 O-C-N 123.362 0.414 . . . . 0.88 111.367 -176.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.694 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.88 152.72 5.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.365 -0.606 . . . . 1.0 109.365 164.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.552 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.99 144.13 25.64 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.817 -0.629 . . . . 2.0099999999999998 109.311 -176.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.689 HG21 ' O ' ' A' ' 464' ' ' LEU . 2.7 t -137.53 162.3 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.057 0.456 . . . . 1.04 111.399 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.53 ' N ' HG13 ' A' ' 347' ' ' VAL . 28.9 t0 -140.44 106.88 5.29 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.38 -1.341 . . . . 0.23999999999999999 107.38 174.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.668 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.2 OUTLIER -84.02 -32.19 25.04 Favored 'General case' 0 CA--C 1.485 -1.538 0 CA-C-O 123.036 1.398 . . . . 1.02 110.02 -169.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.414 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 0.6 OUTLIER -59.03 -45.28 91.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 110.672 -2.967 . . . . 0.59999999999999998 108.179 176.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . 0.445 ' HB2' ' CG ' ' A' ' 348' ' ' ASP . 22.3 m-80 -102.83 8.22 39.33 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 111.006 -2.816 . . . . 0.20999999999999999 110.956 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.565 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.1 mp0 32.53 61.62 0.35 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 112.722 -2.035 . . . . 2.54 113.475 -176.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.602 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.0 t60 -142.47 135.53 28.5 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.625 -0.716 . . . . 0.12 109.754 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.596 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.48 157.34 22.11 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.332 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CD1' HG12 ' A' ' 362' ' ' VAL . 30.7 m-90 -142.89 154.09 43.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.433 -175.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.691 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.6 t80 -110.28 153.2 25.18 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 106.725 -1.583 . . . . 1.1000000000000001 106.725 152.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.3 m-85 -128.37 117.99 22.39 Favored 'General case' 0 C--N 1.272 -2.799 0 CA-C-N 115.073 -0.967 . . . . 0.60999999999999999 110.609 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.3 tppt? -118.15 137.87 52.67 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 105.979 -1.859 . . . . 0.93999999999999995 105.979 167.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.9 15.66 7.83 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.348 0.87 . . . . 0.42999999999999999 113.348 174.075 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.405 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.51 6.46 88.1 Favored Glycine 0 CA--C 1.488 -1.631 0 C-N-CA 120.673 -0.775 . . . . 0.17999999999999999 112.757 -173.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 14.2 ptmt -125.5 175.93 7.18 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 104.576 -2.379 . . . . 1.0900000000000001 104.576 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 15.5 m -103.95 157.48 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.703 0 N-CA-C 116.582 2.067 . . . . 1.02 116.582 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.588 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -108.83 -27.17 9.89 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 110.642 -2.981 . . . . 1.01 106.69 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.73 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -133.57 144.57 49.4 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 111.334 -2.666 . . . . 1.02 111.329 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.602 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 3.2 tt0 -142.54 118.19 10.41 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 104.498 -2.408 . . . . 0.47999999999999998 104.498 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.596 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.69 164.62 34.73 Favored 'General case' 0 N--CA 1.401 -2.887 0 C-N-CA 118.132 -1.427 . . . . 1.02 111.442 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -103.82 133.31 49.03 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.734 -1.121 . . . . 1.8 109.549 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.704 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -133.2 -172.28 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 CA-C-O 122.495 1.141 . . . . 1.01 112.171 -172.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.33 118.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 112.888 -1.96 . . . . 1.04 108.119 172.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.612 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.3 OUTLIER -75.11 -168.92 0.84 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.047 -1.433 . . . . 1.6000000000000001 110.533 178.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 439' ' ' SER . . . -85.49 175.93 49.54 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 118.809 -1.662 . . . . 0.14000000000000001 112.156 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.9 ptmt -78.78 155.44 78.08 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 121.59 0.709 . . . . 1.47 111.466 -167.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.625 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 78.1 Cg_exo -54.96 -27.87 56.39 Favored 'Trans proline' 0 CA--C 1.501 -1.149 1 C-N-CA 125.399 4.066 . . . . 0.28000000000000003 113.399 -174.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.453 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.4 p -71.54 -31.48 67.08 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.662 -1.608 . . . . 1.0800000000000001 109.931 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.543 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 0.7 OUTLIER -140.94 70.3 29.21 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 123.804 1.764 . . . . 1.1000000000000001 108.972 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 375' ' ' THR . 88.1 Cg_exo -57.72 152.09 51.37 Favored 'Trans proline' 0 C--N 1.314 -1.241 1 C-N-CA 126.657 4.904 . . . . 0.38 115.637 -169.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.612 HG22 ' OG ' ' A' ' 370' ' ' SER . 18.3 m -78.74 130.99 68.87 Favored Pre-proline 0 N--CA 1.407 -2.597 0 CA-C-N 113.942 -1.481 . . . . 1.1299999999999999 109.18 173.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.2 Cg_exo -72.1 -46.49 0.53 Allowed 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 123.325 2.683 . . . . 0.20999999999999999 111.734 -173.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.666 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 60.2 142.88 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 123.349 1.547 . . . . 1.0600000000000001 113.424 -174.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 147.49 -109.84 0.49 Allowed Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 112.402 -2.181 . . . . 0.20000000000000001 109.286 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.8 p -130.52 125.91 59.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.369 0.604 . . . . 1.5 110.099 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.616 ' HE1' ' CE2' ' A' ' 382' ' ' PHE . 7.5 m-85 -123.65 -174.32 2.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.0 -1.482 . . . . 0.28000000000000003 107.0 171.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -140.65 122.63 15.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 119.795 1.18 . . . . 0.96999999999999997 112.76 -172.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -87.19 92.24 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 123.013 1.387 . . . . 1.02 109.223 170.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -89.89 7.82 35.31 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 113.442 -1.708 . . . . 3.1299999999999999 107.855 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.762 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 9.0 t30 -170.2 126.88 0.82 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.368 -1.287 . . . . 0.42999999999999999 110.51 174.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.657 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.2 139.53 34.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.706 -1.134 . . . . 1.73 109.016 170.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.777 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 11.4 mm-40 -123.57 158.05 32.3 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.823 1.416 . . . . 0.70999999999999996 114.823 -168.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.76 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 48.5 mt-10 -129.27 144.51 51.25 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.788 -2.006 . . . . 0.38 106.291 165.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.03 34.03 16.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.221 -1.808 . . . . 0.40999999999999998 110.238 171.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.449 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -77.38 167.46 21.64 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 112.779 -2.01 . . . . 1.02 109.186 -175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.6 m -131.63 119.18 21.07 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.157 0.98 . . . . 1.04 111.376 172.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.527 HD22 ' CG ' ' A' ' 421' ' ' HIS . 3.0 mp -77.36 87.57 3.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.638 -1.619 . . . . 1.27 111.73 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HG2' ' HG3' ' A' ' 404' ' ' GLU . 47.5 mttt . . . . . 0 C--N 1.283 -2.288 0 CA-C-N 113.195 -1.821 . . . . 0.96999999999999997 113.072 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG3' ' HG2' ' A' ' 394' ' ' LYS . 2.1 mp0 . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 120.8 0.333 . . . . 0.53000000000000003 110.828 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.23 97.9 4.73 Favored Pre-proline 0 N--CA 1.442 -0.873 0 N-CA-C 108.663 -0.865 . . . . 0.45000000000000001 108.663 171.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.6 Cg_exo -68.64 110.93 2.43 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.294 1.996 . . . . 0.22 110.7 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -111.36 160.02 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-N 113.084 -1.871 . . . . 1.04 107.724 -168.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.76 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 22.3 m-80 -93.26 -18.96 21.88 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.136 -0.69 . . . . 0.65000000000000002 109.136 -175.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 0.777 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 86.3 m-85 -158.59 125.77 4.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.072 -0.967 . . . . 0.92000000000000004 108.451 -171.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.627 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 20.2 t-105 -143.84 134.76 25.34 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.76 0.79 . . . . 0.10000000000000001 111.755 -166.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.657 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.9 mmt -117.34 94.02 44.25 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.055 -1.091 . . . . 1.01 108.055 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.762 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 42.0 Cg_endo . . . . . 0 C--N 1.347 0.499 0 C-N-CA 123.381 2.721 . . . . 0.5 112.369 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 419' ' ' GLY . 20.6 t . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.201 0.524 . . . . 1.45 112.234 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.571 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -176.74 119.71 0.71 Allowed Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.852 -0.899 . . . . 0.20000000000000001 110.852 171.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.684 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.6 mt -81.07 142.87 13.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.769 0.319 . . . . 1.0900000000000001 110.486 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.587 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.0 p80 -159.98 161.04 34.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.01 -0.541 . . . . 0.10000000000000001 111.322 -173.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.628 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -83.62 145.73 28.66 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.042 -1.096 . . . . 1.0700000000000001 108.042 173.007 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 445' ' ' THR . 42.5 t -132.62 96.74 3.89 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.866 0.841 . . . . 0.5 109.616 -172.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 20.0 t70 . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 114.089 -1.414 . . . . 0.41999999999999998 109.389 -176.326 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.517 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.7 pm0 . . . . . 0 N--CA 1.441 -0.921 0 CA-C-O 122.269 1.033 . . . . 2.1600000000000001 113.441 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.986 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.43 131.5 4.27 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 105.146 -2.168 . . . . 0.91000000000000003 105.146 171.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.62 -158.15 30.66 Favored Glycine 0 C--N 1.282 -2.417 0 C-N-CA 119.974 -1.107 . . . . 0.20000000000000001 110.715 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.543 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.52 175.18 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.961 0 C-N-CA 120.418 -0.896 . . . . 0.25 111.803 167.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.518 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.1 p-10 -51.51 101.19 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 123.355 1.55 . . . . 1.8500000000000001 113.336 -155.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.678 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.98 -38.04 10.4 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 112.404 -2.18 . . . . 1.8200000000000001 109.099 170.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.656 ' CZ2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -53.11 -28.34 25.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.159 -0.928 . . . . 0.17999999999999999 112.341 -171.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.656 ' HE3' ' CZ2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.16 -36.51 15.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.527 0.566 . . . . 1.05 112.527 -177.096 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.413 ' H ' HG21 ' A' ' 436' ' ' THR . 1.5 p -89.65 -42.99 11.05 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.064 -0.971 . . . . 1.0600000000000001 110.699 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.678 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.8 mtp180 -92.81 -18.3 23.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.594 -1.185 . . . . 2.3700000000000001 109.752 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.83 48.74 50.25 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.021 -0.99 . . . . 0.23999999999999999 115.257 162.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' SER . . . . . 0.449 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 11.9 p -83.58 110.65 18.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 119.195 1.497 . . . . 1.7 111.447 -173.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 37.41 -124.27 0.21 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.503 -1.226 . . . . 0.56999999999999995 114.086 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -129.47 -19.78 1.47 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.023 -0.608 . . . . 0.28999999999999998 113.408 -173.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.401 ' CB ' ' H ' ' A' ' 419' ' ' GLY . 29.1 p -104.62 -165.86 1.18 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 112.902 0.705 . . . . 0.40000000000000002 112.902 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.536 HG13 ' HG ' ' A' ' 370' ' ' SER . 1.9 mp -95.11 130.98 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 115.212 -0.904 . . . . 1.04 110.64 -175.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.437 HD21 ' N ' ' A' ' 444' ' ' ASN . 1.1 m-80 -105.31 94.61 5.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.716 0.77 . . . . 0.62 110.259 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.704 ' HA ' HG23 ' A' ' 368' ' ' ILE . 2.5 m -90.26 143.64 29.86 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-N 114.147 -1.388 . . . . 1.02 112.89 -176.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.591 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 74.8 Cg_exo -50.02 144.45 21.91 Favored 'Trans proline' 0 CA--C 1.505 -0.939 0 C-N-CA 123.943 3.096 . . . . 0.23999999999999999 113.22 175.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.986 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 33.3 Cg_exo -65.3 -24.58 57.78 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.748 2.299 . . . . 0.31 112.213 -175.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.534 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 70.1 p -78.12 -25.06 47.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.391 -0.822 . . . . 1.48 111.874 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.73 ' O ' HD23 ' A' ' 364' ' ' LEU . 31.8 m -99.58 -49.67 11.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 112.985 0.735 . . . . 1.03 112.985 -170.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.942 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.93 -2.1 4.83 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.65 -0.82 . . . . 1.02 110.446 -178.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.534 ' HE3' ' O ' ' A' ' 448' ' ' SER . 16.3 pttp -81.1 -38.06 27.89 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 122.54 1.162 . . . . 1.5900000000000001 108.238 173.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.582 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.4 mm-40 -62.85 -46.61 87.08 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 112.372 -2.195 . . . . 0.25 106.587 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.942 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.1 tp -47.14 -66.44 0.41 Allowed 'General case' 0 N--CA 1.402 -2.826 0 CA-C-N 109.887 -3.324 . . . . 1.02 112.658 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.474 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 23.5 t80 -46.3 -22.51 0.25 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.769 0.795 . . . . 0.17000000000000001 109.71 175.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.95 -23.31 33.08 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 114.887 -1.051 . . . . 0.13 111.849 -176.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.587 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -106.38 -44.42 4.53 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 113.938 1.088 . . . . 1.02 113.938 176.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.694 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.8 149.21 8.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 122.182 0.991 . . . . 1.01 110.804 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.467 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -120.55 158.16 27.92 Favored 'General case' 0 N--CA 1.413 -2.324 0 CA-C-N 113.427 -1.715 . . . . 0.47999999999999998 109.043 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.546 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.8 mppt? -58.97 102.41 0.12 Allowed 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.911 -0.774 . . . . 1.7 108.911 170.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.37 -12.04 5.77 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 114.051 -1.432 . . . . 0.22 111.449 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 344' ' ' TYR . 18.8 m -68.22 149.9 97.93 Favored Pre-proline 0 N--CA 1.439 -1.005 0 N-CA-C 108.732 -0.84 . . . . 0.94999999999999996 108.732 171.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.6 Cg_endo -94.34 165.93 1.93 Allowed 'Trans proline' 0 N--CA 1.419 -2.87 0 C-N-CA 122.278 1.985 . . . . 0.23000000000000001 109.623 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.694 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -128.81 153.53 38.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.655 -1.239 . . . . 1.27 107.655 170.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.689 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.6 mp -134.1 151.71 51.51 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 108.6 -0.889 . . . . 1.05 108.6 173.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.681 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.61 141.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 105.329 -2.1 . . . . 1.01 105.329 166.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.571 ' N ' HD23 ' A' ' 349' ' ' LEU . 7.8 p90 . . . . . 0 C--O 1.244 0.815 0 O-C-N 123.628 0.58 . . . . 1.0900000000000001 111.119 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.46 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.4 m-20 . . . . . 0 N--CA 1.445 -0.703 0 CA-C-O 121.454 0.645 . . . . 0.42999999999999999 109.973 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 1.135 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 86.6 m -158.28 134.49 9.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.387 -1.278 . . . . 1.0 108.825 166.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.73 ' CD2' HD11 ' A' ' 464' ' ' LEU . 41.1 p90 174.52 158.24 0.16 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 123.42 0.45 . . . . 0.88 110.983 -175.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.673 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.5 OUTLIER -77.4 153.26 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 109.122 -0.695 . . . . 1.0 109.122 165.051 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.573 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.06 147.12 29.22 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.038 -1.097 . . . . 2.0099999999999998 108.038 -177.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.696 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.2 t -138.99 153.78 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 C-N-CA 123.625 0.77 . . . . 1.04 110.422 173.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 347' ' ' VAL . 16.4 t0 -136.85 106.53 6.18 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.98 -1.489 . . . . 0.23999999999999999 106.98 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.623 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -79.01 -35.03 43.46 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 124.049 1.881 . . . . 1.02 110.334 -166.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -55.44 -43.49 75.45 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 110.904 -2.862 . . . . 0.59999999999999998 107.697 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -101.51 4.54 41.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 110.97 -2.832 . . . . 0.20999999999999999 111.395 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.877 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 83.5 mm-40 31.38 62.44 0.24 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 112.852 -1.976 . . . . 2.54 113.465 -172.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.601 ' NE2' ' HG2' ' A' ' 365' ' ' GLU . 29.6 t60 -141.43 136.83 31.74 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.453 -1.249 . . . . 0.12 109.927 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.607 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.2 OUTLIER -112.94 158.98 19.56 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.214 -179.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.583 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.8 m-90 -144.17 160.71 40.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.703 -0.681 . . . . 0.11 111.149 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.135 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 89.4 t80 -113.39 153.56 28.37 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 106.465 -1.68 . . . . 1.1000000000000001 106.465 150.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.4 m-85 -128.01 116.57 20.25 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.129 -0.941 . . . . 0.60999999999999999 110.248 -178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.1 tppt? -117.78 138.44 52.05 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.046 -1.835 . . . . 0.93999999999999995 106.046 168.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.49 16.96 8.11 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.39 0.885 . . . . 0.42999999999999999 113.39 172.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.46 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.34 8.04 87.0 Favored Glycine 0 CA--C 1.485 -1.796 0 CA-C-N 115.643 -0.708 . . . . 0.17999999999999999 113.036 -173.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.2 ptmt -128.11 177.93 6.57 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 104.493 -2.41 . . . . 1.0900000000000001 104.493 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.583 HG12 ' CD1' ' A' ' 355' ' ' TRP . 17.1 m -104.59 158.23 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.747 0 N-CA-C 116.303 1.964 . . . . 1.02 116.303 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.631 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -107.91 -28.51 9.57 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 110.764 -2.925 . . . . 1.01 106.35 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.53 145.36 50.05 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 111.551 -2.568 . . . . 1.02 111.678 -175.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.601 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -142.23 118.77 10.97 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 104.49 -2.411 . . . . 0.47999999999999998 104.49 174.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.634 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.6 OUTLIER -149.6 163.68 37.22 Favored 'General case' 0 N--CA 1.401 -2.89 0 C-N-CA 118.332 -1.347 . . . . 1.02 110.57 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.582 ' OD2' ' HA2' ' A' ' 430' ' ' GLY . 0.5 OUTLIER -100.75 142.3 32.41 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.739 -0.838 . . . . 1.8 108.739 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.69 HG23 ' HA ' ' A' ' 445' ' ' THR . 1.9 pp -137.03 -172.76 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 CA-C-O 122.045 0.926 . . . . 1.01 112.317 -173.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.877 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -152.87 118.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 113.196 -1.82 . . . . 1.04 109.442 171.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.572 ' HG ' ' HB3' ' A' ' 349' ' ' LEU . 54.6 p -78.8 -168.0 1.29 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.062 -2.336 . . . . 1.6000000000000001 111.285 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.9 165.56 40.09 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 118.602 -1.761 . . . . 0.14000000000000001 112.17 -174.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -71.64 156.79 90.89 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.41 0.624 . . . . 1.47 111.474 -168.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.622 ' HG3' ' CZ3' ' A' ' 434' ' ' TRP . 87.9 Cg_exo -55.84 -28.67 68.8 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 125.174 3.916 . . . . 0.28000000000000003 113.612 -173.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.445 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 17.8 p -70.81 -32.38 69.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.421 -1.718 . . . . 1.0800000000000001 109.644 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.55 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -140.98 70.63 28.93 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 123.822 1.772 . . . . 1.1000000000000001 109.033 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 375' ' ' THR . 89.0 Cg_exo -58.08 157.15 26.19 Favored 'Trans proline' 0 C--N 1.312 -1.387 1 C-N-CA 126.592 4.861 . . . . 0.38 115.358 -170.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.491 ' CG2' HG22 ' A' ' 465' ' ' VAL . 1.5 m -82.67 131.87 53.57 Favored Pre-proline 0 N--CA 1.406 -2.648 0 CA-C-N 114.326 -1.306 . . . . 1.1299999999999999 108.482 172.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.6 Cg_exo -72.19 -45.69 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.808 3.005 . . . . 0.20999999999999999 112.334 -171.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.67 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 60.5 140.92 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 123.283 1.516 . . . . 1.0600000000000001 113.791 -173.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 150.06 -110.41 0.47 Allowed Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 112.331 -2.213 . . . . 0.20000000000000001 109.419 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.1 p -130.02 123.18 55.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.694 0.759 . . . . 1.5 109.961 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.618 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 3.5 m-85 -120.27 -173.55 2.59 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.544 -1.651 . . . . 0.28000000000000003 106.544 170.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -144.17 127.35 16.64 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 120.477 -1.389 . . . . 0.96999999999999997 113.576 -171.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.8 p -90.44 92.93 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 122.949 1.357 . . . . 1.02 109.97 171.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -73.49 -10.93 60.24 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.253 -1.794 . . . . 3.1299999999999999 108.067 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.769 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.4 t30 -169.96 133.04 1.15 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.651 -0.704 . . . . 0.42999999999999999 112.093 -175.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.611 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -92.53 154.76 18.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.054 -0.521 . . . . 1.73 110.485 171.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.732 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 35.8 mm-40 -132.59 157.97 43.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 115.013 1.486 . . . . 0.70999999999999996 115.013 -171.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.758 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.8 mt-10 -138.29 126.89 23.47 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.827 -1.988 . . . . 0.38 108.425 173.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.63 49.21 20.86 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 123.371 1.557 . . . . 0.40999999999999998 109.195 -175.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -79.76 168.31 19.47 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 112.665 -2.061 . . . . 1.02 108.577 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.7 m -133.16 119.53 20.02 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.154 0.978 . . . . 1.04 111.808 170.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.7 mp -79.47 88.75 5.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.541 -1.663 . . . . 1.27 112.023 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.575 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.2 mttt . . . . . 0 C--N 1.286 -2.191 0 CA-C-N 113.618 -1.628 . . . . 0.96999999999999997 113.439 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.575 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.807 0 CA-C-O 121.125 0.488 . . . . 0.53000000000000003 109.894 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.33 97.29 5.18 Favored Pre-proline 0 N--CA 1.436 -1.149 0 N-CA-C 107.905 -1.146 . . . . 0.45000000000000001 107.905 169.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.5 Cg_exo -68.26 109.5 2.01 Favored 'Trans proline' 0 N--CA 1.432 -2.098 0 C-N-CA 121.929 1.753 . . . . 0.22 109.584 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -107.65 156.99 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 CA-C-N 112.915 -1.948 . . . . 1.04 107.421 -168.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.758 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.5 m-80 -88.63 -20.67 24.64 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.014 -0.736 . . . . 0.65000000000000002 109.014 -174.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 0.732 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 75.6 m-85 -158.82 126.75 5.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.013 -0.994 . . . . 0.92000000000000004 108.527 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.6 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 26.8 t-105 -144.21 138.69 28.24 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.463 0.649 . . . . 0.10000000000000001 110.93 -167.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.611 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -122.23 92.27 48.94 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.272 -1.01 . . . . 1.01 108.272 175.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.769 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 25.5 Cg_endo . . . . . 0 C--N 1.349 0.582 0 C-N-CA 122.554 2.169 . . . . 0.5 112.853 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.608 HG13 ' N ' ' A' ' 419' ' ' GLY . 25.1 t . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.267 0.556 . . . . 1.45 112.011 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.608 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -178.21 122.53 0.82 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.182 -1.167 . . . . 0.20000000000000001 110.182 170.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.625 HG23 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.37 141.92 14.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 109.956 -0.387 . . . . 1.0900000000000001 109.956 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.588 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.3 p80 -159.9 161.19 34.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 0.10000000000000001 111.448 -175.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.627 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -82.8 149.53 27.15 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 107.889 -1.152 . . . . 1.0700000000000001 107.889 171.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 445' ' ' THR . 47.1 t -133.82 96.84 3.75 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.708 0.766 . . . . 0.5 110.015 -173.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 114.453 -1.249 . . . . 0.41999999999999998 109.734 -176.198 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.545 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.5 pm0 . . . . . 0 N--CA 1.43 -1.44 0 CA-C-O 122.38 1.086 . . . . 2.1600000000000001 112.964 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.885 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.7 OUTLIER -158.33 127.88 5.81 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 112.691 -2.05 . . . . 0.91000000000000003 105.8 169.056 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.582 ' HA2' ' OD2' ' A' ' 367' ' ' ASP . . . 169.06 -158.48 31.07 Favored Glycine 0 C--N 1.286 -2.234 0 C-N-CA 119.871 -1.157 . . . . 0.20000000000000001 111.148 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.494 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.16 165.91 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.781 0 C-N-CA 120.511 -0.852 . . . . 0.25 111.665 168.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 435' ' ' LYS . 22.4 m-20 -52.82 101.93 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.684 -1.258 . . . . 1.8500000000000001 113.096 -155.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.612 ' CD2' ' HD2' ' A' ' 437' ' ' ARG . 33.7 mt -94.96 -33.22 12.84 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 112.943 -1.935 . . . . 1.8200000000000001 109.275 175.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.699 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.0 p-90 -53.87 -27.45 30.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.738 -1.119 . . . . 0.17999999999999999 112.511 -173.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.699 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.05 -34.54 16.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.92 -0.582 . . . . 1.05 111.977 -178.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.405 ' H ' HG21 ' A' ' 436' ' ' THR . 2.9 p -89.72 -41.43 11.91 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.047 -0.978 . . . . 1.0600000000000001 110.787 -176.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.612 ' HD2' ' CD2' ' A' ' 433' ' ' LEU . 0.8 OUTLIER -94.2 -18.11 22.04 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.546 -1.206 . . . . 2.3700000000000001 109.957 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.76 48.49 56.62 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.984 -1.007 . . . . 0.23999999999999999 115.045 163.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 10.1 p -83.71 111.38 19.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.35 1.075 . . . . 1.7 111.936 -171.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 35.92 -118.47 0.12 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.693 -1.139 . . . . 0.56999999999999995 113.298 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -137.06 -16.59 0.74 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.999 -0.62 . . . . 0.28999999999999998 113.841 -175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.78 -167.06 1.32 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.63 0.715 . . . . 0.40000000000000002 112.511 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.457 HG21 ' HB ' ' A' ' 368' ' ' ILE . 2.1 mp -98.74 129.01 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 114.893 -1.049 . . . . 1.04 110.866 -174.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.61 97.89 8.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.473 -0.785 . . . . 0.62 110.422 -177.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.69 ' HA ' HG23 ' A' ' 368' ' ' ILE . 6.8 m -94.1 144.08 27.48 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 115.071 -0.968 . . . . 1.02 112.467 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.634 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 81.7 Cg_exo -51.07 143.48 31.57 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 124.012 3.142 . . . . 0.23999999999999999 113.178 175.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.885 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 31.5 Cg_exo -64.62 -29.96 60.62 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.833 2.355 . . . . 0.31 112.361 -176.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.498 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 38.6 m -72.95 -23.49 60.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.769 -0.651 . . . . 1.48 112.218 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.719 ' O ' HD23 ' A' ' 364' ' ' LEU . 25.2 m -100.82 -47.42 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 113.01 0.744 . . . . 1.03 113.01 -169.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.939 ' SD ' HD22 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.8 -2.22 6.79 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.69 -0.804 . . . . 1.02 110.204 -178.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 452' ' ' GLU . 16.2 pttp -80.24 -38.88 30.1 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.475 1.131 . . . . 1.5900000000000001 108.201 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.577 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.4 mm-40 -61.91 -46.54 88.9 Favored 'General case' 0 CA--C 1.471 -2.066 0 CA-C-N 112.497 -2.138 . . . . 0.25 106.484 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.939 HD22 ' SD ' ' A' ' 450' ' ' MET . 2.9 tp -47.45 -65.89 0.49 Allowed 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 109.973 -3.285 . . . . 1.02 112.608 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 389' ' ' GLU . 21.9 t80 -45.33 -22.98 0.16 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.853 0.835 . . . . 0.17000000000000001 109.728 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -90.65 -26.84 21.62 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.74 -1.118 . . . . 0.13 111.983 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.58 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -102.33 -44.68 5.33 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 113.64 0.978 . . . . 1.02 113.64 177.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.673 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -71.23 147.08 11.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 122.391 1.091 . . . . 1.01 110.793 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.555 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -113.32 157.5 21.74 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 113.033 -1.894 . . . . 0.47999999999999998 108.869 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.622 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 7.2 mtpt -60.74 101.54 0.15 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.063 -1.088 . . . . 1.7 108.063 166.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.86 -7.41 6.46 Favored Glycine 0 C--N 1.308 -1.025 0 CA-C-N 113.957 -1.474 . . . . 0.22 111.631 -174.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.6 HG21 ' HA ' ' A' ' 344' ' ' TYR . 8.0 m -72.96 150.58 90.4 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 108.257 -1.016 . . . . 0.94999999999999996 108.257 170.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 10.1 Cg_endo -95.32 171.94 1.3 Allowed 'Trans proline' 0 N--CA 1.417 -2.972 0 C-N-CA 122.172 1.915 . . . . 0.23000000000000001 109.91 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.76 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -130.88 153.85 39.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.201 -1.037 . . . . 1.27 108.201 171.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.73 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.2 mp -134.08 150.67 51.18 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.637 -0.875 . . . . 1.05 108.637 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.696 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.8 OUTLIER -140.19 140.1 35.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 103.981 -2.6 . . . . 1.01 103.981 162.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.573 ' CE1' ' CD ' ' A' ' 346' ' ' GLU . 4.6 p90 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.399 -1.286 . . . . 1.0900000000000001 111.184 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.443 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 9.1 m-20 . . . . . 0 N--CA 1.444 -0.757 0 N-CA-C 109.457 -0.571 . . . . 0.42999999999999999 109.457 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 1.089 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 91.5 m -157.67 134.63 10.06 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.63 -1.168 . . . . 1.0 108.539 168.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.749 ' CD2' HD11 ' A' ' 464' ' ' LEU . 40.9 p90 174.42 158.32 0.16 Allowed 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 123.503 0.502 . . . . 0.88 111.152 -175.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.689 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.5 OUTLIER -77.26 153.86 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 164.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.639 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.46 146.9 28.6 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.006 -1.109 . . . . 2.0099999999999998 108.006 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.697 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.0 t -139.24 154.31 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 C-N-CA 123.687 0.795 . . . . 1.04 110.449 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 355' ' ' TRP . 17.8 t0 -137.79 105.77 5.68 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.61 -1.626 . . . . 0.23999999999999999 106.61 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.648 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -79.18 -35.97 41.05 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 114.086 -1.416 . . . . 1.02 109.891 -165.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -55.77 -44.76 77.99 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 110.669 -2.968 . . . . 0.59999999999999998 108.124 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -100.56 6.76 44.27 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 110.931 -2.85 . . . . 0.20999999999999999 110.795 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.5 OUTLIER 32.83 60.8 0.4 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 112.786 -2.006 . . . . 2.54 112.868 -174.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.556 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.3 t60 -141.77 136.44 30.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.748 -0.66 . . . . 0.12 109.66 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.614 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.1 OUTLIER -113.81 157.64 22.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.001 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.592 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.7 m-90 -143.35 161.25 38.85 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.179 0.592 . . . . 0.11 111.044 -177.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.089 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 89.1 t80 -113.41 153.56 28.41 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.423 -1.695 . . . . 1.1000000000000001 106.423 150.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.0 m-85 -127.81 117.68 22.3 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.001 -1.0 . . . . 0.60999999999999999 109.954 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.5 tppt? -118.44 137.8 52.91 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.08 -1.822 . . . . 0.93999999999999995 106.08 168.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.417 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 70.21 16.36 7.36 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.276 0.843 . . . . 0.42999999999999999 113.276 172.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.443 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.35 7.47 87.85 Favored Glycine 0 CA--C 1.485 -1.816 0 CA-C-N 115.72 -0.673 . . . . 0.17999999999999999 112.956 -173.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 16.6 ptmt -127.5 177.76 6.54 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 104.66 -2.348 . . . . 1.0900000000000001 104.66 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.592 HG12 ' CD1' ' A' ' 355' ' ' TRP . 17.2 m -104.58 158.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.616 0 N-CA-C 116.427 2.01 . . . . 1.02 116.427 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.632 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.7 -26.25 9.97 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 110.607 -2.997 . . . . 1.01 106.671 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.73 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -135.19 145.12 47.41 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 111.404 -2.635 . . . . 1.02 111.653 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.556 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.6 tt0 -141.25 119.05 11.76 Favored 'General case' 0 N--CA 1.405 -2.684 0 N-CA-C 104.269 -2.493 . . . . 0.47999999999999998 104.269 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.614 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.1 165.17 33.61 Favored 'General case' 0 N--CA 1.4 -2.973 0 C-N-CA 117.958 -1.497 . . . . 1.02 111.501 178.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 29.5 p-10 -103.89 136.68 43.1 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.821 -1.082 . . . . 1.8 109.822 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.68 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -136.58 -173.02 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.247 0 CA-C-O 122.506 1.146 . . . . 1.01 112.483 -171.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.61 119.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 112.811 -1.995 . . . . 1.04 108.102 173.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.503 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.2 OUTLIER -80.47 -168.09 1.59 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.254 -1.339 . . . . 1.6000000000000001 110.479 -178.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.74 169.94 45.34 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 118.811 -1.661 . . . . 0.14000000000000001 112.414 -174.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -74.48 156.24 87.15 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.314 0.578 . . . . 1.47 112.33 -164.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.62 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 85.8 Cg_exo -54.83 -30.89 70.2 Favored 'Trans proline' 0 CA--C 1.497 -1.345 1 C-N-CA 125.537 4.158 . . . . 0.28000000000000003 114.037 -173.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.412 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 21.5 p -67.2 -31.47 71.89 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.703 -1.59 . . . . 1.0800000000000001 109.565 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.537 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -141.87 70.9 24.39 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 113.683 -1.599 . . . . 1.1000000000000001 109.731 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.4 Cg_exo -58.15 142.99 97.45 Favored 'Trans proline' 0 C--N 1.306 -1.679 1 C-N-CA 125.884 4.389 . . . . 0.38 113.307 -172.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.503 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -73.11 144.24 84.61 Favored Pre-proline 0 N--CA 1.422 -1.83 0 N-CA-C 108.154 -1.054 . . . . 1.1299999999999999 108.154 175.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.1 Cg_exo -74.97 -44.1 0.36 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 124.381 3.387 . . . . 0.20999999999999999 111.728 -165.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.663 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 57.93 136.69 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 123.528 1.632 . . . . 1.0600000000000001 113.86 -173.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 155.3 -114.61 0.62 Allowed Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 112.013 -2.358 . . . . 0.20000000000000001 109.377 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.417 ' O ' HG11 ' A' ' 381' ' ' VAL . 9.8 p -130.91 114.72 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 121.822 0.82 . . . . 1.5 111.192 176.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.611 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.4 m-85 -112.42 -174.18 2.4 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.193 -1.41 . . . . 0.28000000000000003 107.193 174.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.3 t80 -140.58 124.47 17.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.19 1.359 . . . . 0.96999999999999997 113.598 -172.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.95 92.04 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 123.066 1.412 . . . . 1.02 109.611 168.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -92.87 10.78 29.65 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.419 -1.719 . . . . 3.1299999999999999 107.982 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.746 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.4 t30 -169.79 126.3 0.86 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 113.873 -1.512 . . . . 0.42999999999999999 110.095 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.648 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.5 144.06 29.94 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.998 -1.001 . . . . 1.73 109.171 170.495 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.743 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 29.8 mm-40 -124.73 158.3 33.59 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 114.896 1.443 . . . . 0.70999999999999996 114.896 -167.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.739 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 56.2 mt-10 -137.05 126.88 25.63 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 112.958 -1.928 . . . . 0.38 108.57 174.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 37.1 t70 54.23 47.35 23.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 123.076 1.417 . . . . 0.40999999999999998 109.228 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.459 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -80.43 166.23 21.45 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 112.922 -1.945 . . . . 1.02 108.891 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 18.7 m -132.3 119.33 20.61 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.136 0.97 . . . . 1.04 111.465 171.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.8 89.02 5.22 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.731 -1.577 . . . . 1.27 111.853 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.602 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.9 mttt . . . . . 0 C--N 1.286 -2.186 0 CA-C-N 113.8 -1.546 . . . . 0.96999999999999997 113.353 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.602 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.44 -0.946 0 CA-C-O 121.062 0.458 . . . . 0.53000000000000003 109.769 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.9 OUTLIER -143.42 96.76 5.69 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 107.916 -1.142 . . . . 0.45000000000000001 107.916 170.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 17.3 Cg_exo -69.52 110.51 2.52 Favored 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.791 1.66 . . . . 0.22 109.728 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.586 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -110.18 151.52 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 112.941 -1.936 . . . . 1.04 107.11 -168.447 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.739 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 22.6 m-80 -85.42 -20.11 30.32 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.962 -0.755 . . . . 0.65000000000000002 108.962 -174.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 0.743 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 81.2 m-85 -158.27 126.11 5.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.995 -1.002 . . . . 0.92000000000000004 108.705 -170.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.608 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 24.5 t-105 -144.48 133.11 22.21 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.758 0.79 . . . . 0.10000000000000001 111.104 -167.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.648 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.9 mmt -114.92 93.66 35.19 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 107.816 -1.179 . . . . 1.01 107.816 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.746 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.6 Cg_endo . . . . . 0 C--N 1.348 0.516 0 C-N-CA 122.455 2.103 . . . . 0.5 112.252 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.583 HG13 ' N ' ' A' ' 419' ' ' GLY . 39.4 t . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 121.401 0.619 . . . . 1.45 112.021 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.583 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -176.95 121.64 0.8 Allowed Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.867 -1.293 . . . . 0.20000000000000001 109.867 169.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.671 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.2 mp -82.02 143.22 12.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 110.106 -0.331 . . . . 1.0900000000000001 110.106 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.589 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.0 p80 -160.28 161.86 33.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.178 -0.464 . . . . 0.10000000000000001 111.514 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.619 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -83.19 145.62 29.07 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.607 -1.257 . . . . 1.0700000000000001 107.607 171.402 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 445' ' ' THR . 29.4 t -133.81 98.33 4.14 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.95 0.881 . . . . 0.5 110.205 -171.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.312 -1.022 0 CA-C-N 114.002 -1.454 . . . . 0.41999999999999998 109.609 -177.074 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.52 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.428 -1.543 0 CA-C-O 122.125 0.964 . . . . 2.1600000000000001 112.049 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.666 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.6 OUTLIER -160.7 129.64 4.77 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 104.949 -2.241 . . . . 0.91000000000000003 104.949 172.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.82 -157.27 29.47 Favored Glycine 0 C--N 1.284 -2.339 0 C-N-CA 119.678 -1.249 . . . . 0.20000000000000001 110.797 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.414 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -44.97 174.01 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.184 -1.008 . . . . 0.25 111.482 167.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.52 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.4 p-10 -52.59 101.95 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 123.28 1.515 . . . . 1.8500000000000001 113.89 -153.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.636 ' HG ' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.93 -36.99 10.88 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 112.651 -2.068 . . . . 1.8200000000000001 109.582 169.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.758 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.5 p-90 -54.44 -26.88 33.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.338 -0.846 . . . . 0.17999999999999999 112.4 -170.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.758 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.72 -35.21 15.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 112.523 0.564 . . . . 1.05 112.523 -177.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.2 p -91.82 -43.71 9.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.031 -0.986 . . . . 1.0600000000000001 110.904 -176.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.636 ' CD ' ' HG ' ' A' ' 433' ' ' LEU . 0.8 OUTLIER -90.09 -19.24 24.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.73 -1.123 . . . . 2.3700000000000001 109.152 -179.085 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.8 47.54 46.74 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.475 -0.784 . . . . 0.23999999999999999 114.952 161.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.9 p -84.65 110.97 19.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 118.622 1.211 . . . . 1.7 111.597 -172.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 37.09 -130.86 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.69 -1.141 . . . . 0.56999999999999995 113.031 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -121.74 -20.06 3.24 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.088 -0.577 . . . . 0.28999999999999998 114.084 -177.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 30.4 p -99.09 -166.83 1.4 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.803 0.801 . . . . 0.40000000000000002 112.867 -173.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.479 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.2 mp -96.73 130.01 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 115.105 -0.952 . . . . 1.04 110.887 -173.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.01 94.56 6.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.945 -0.57 . . . . 0.62 110.418 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.68 ' HA ' HG23 ' A' ' 368' ' ' ILE . 4.6 m -91.26 142.39 27.1 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-N 115.147 -0.933 . . . . 1.02 112.481 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.59 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 89.3 Cg_exo -49.72 143.59 22.17 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 123.925 3.083 . . . . 0.23999999999999999 113.268 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.666 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.2 Cg_exo -65.0 -27.94 57.81 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.836 2.357 . . . . 0.31 112.053 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.48 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 31.6 m -75.56 -22.61 56.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.505 0.669 . . . . 1.48 112.371 -176.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.73 ' O ' HD23 ' A' ' 364' ' ' LEU . 26.3 m -100.99 -48.03 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 112.898 0.703 . . . . 1.03 112.898 -170.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.936 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.18 -2.03 5.22 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.72 -0.792 . . . . 1.02 110.246 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 448' ' ' SER . 14.7 pttp -81.2 -38.78 26.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 122.58 1.181 . . . . 1.5900000000000001 108.143 173.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.581 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.0 mm-40 -62.18 -46.35 89.32 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 112.368 -2.196 . . . . 0.25 106.559 -177.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.936 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.8 tp -46.69 -67.11 0.31 Allowed 'General case' 0 N--CA 1.403 -2.781 0 CA-C-N 109.785 -3.37 . . . . 1.02 112.735 172.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.485 ' CE2' ' HE2' ' A' ' 387' ' ' LYS . 14.6 t80 -45.34 -24.11 0.26 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 124.034 0.834 . . . . 0.17000000000000001 109.469 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.12 -27.15 26.62 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 114.684 -1.144 . . . . 0.13 111.732 -176.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.589 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -101.03 -44.07 5.83 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 113.459 0.911 . . . . 1.02 113.459 176.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.689 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.89 149.91 8.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 122.554 1.168 . . . . 1.01 111.182 -179.485 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.535 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -119.87 156.25 31.08 Favored 'General case' 0 N--CA 1.413 -2.283 0 CA-C-N 112.86 -1.973 . . . . 0.47999999999999998 108.366 -178.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.549 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.3 mppt? -58.8 102.07 0.11 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.555 -0.905 . . . . 1.7 108.555 170.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.62 -11.17 5.75 Favored Glycine 0 C--N 1.305 -1.15 0 CA-C-N 114.069 -1.423 . . . . 0.22 111.535 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 344' ' ' TYR . 10.8 m -68.82 150.47 97.62 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 108.793 -0.817 . . . . 0.94999999999999996 108.793 171.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.0 Cg_endo -93.61 165.02 2.29 Favored 'Trans proline' 0 N--CA 1.423 -2.652 0 C-N-CA 122.17 1.913 . . . . 0.23000000000000001 110.074 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.74 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -126.35 152.12 33.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.497 -1.297 . . . . 1.27 107.497 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.749 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.1 mp -133.79 149.95 51.43 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 108.26 -1.015 . . . . 1.05 108.26 175.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.697 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.08 138.96 37.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 103.932 -2.618 . . . . 1.01 103.932 163.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.639 ' CE1' ' CD ' ' A' ' 346' ' ' GLU . 4.3 p90 . . . . . 0 C--O 1.25 1.116 0 CA-C-N 118.503 0.592 . . . . 1.0900000000000001 111.879 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.451 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.2 m-20 . . . . . 0 CA--C 1.511 -0.527 0 CA-C-O 121.64 0.733 . . . . 0.42999999999999999 110.26 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 98.5 m -157.16 134.58 10.56 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.854 -1.066 . . . . 1.0 110.539 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.647 ' CD2' HD11 ' A' ' 464' ' ' LEU . 37.9 p90 173.65 159.18 0.14 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.831 -0.622 . . . . 0.88 110.923 -178.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.703 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.44 151.23 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.263 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 166.608 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.571 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 34.6 tt0 -149.81 141.09 23.17 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.462 -0.79 . . . . 2.0099999999999998 109.743 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.717 HG21 ' O ' ' A' ' 464' ' ' LEU . 2.7 t -133.0 161.89 40.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.054 0.454 . . . . 1.04 111.312 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.516 ' HA ' ' C ' ' A' ' 466' ' ' PHE . 30.3 t0 -140.15 106.86 5.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.521 -1.289 . . . . 0.23999999999999999 107.521 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.651 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.37 -34.41 28.41 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 123.289 1.518 . . . . 1.02 110.156 -169.389 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.409 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.1 mt-10 -54.93 -43.95 73.82 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.892 -2.867 . . . . 0.59999999999999998 108.015 176.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 18.4 m-80 -103.04 4.74 37.57 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 111.015 -2.811 . . . . 0.20999999999999999 111.48 -175.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.813 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 16.4 mm-40 34.75 61.59 0.57 Allowed 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 112.917 -1.947 . . . . 2.54 113.424 -174.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.615 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 22.6 t60 -141.71 134.75 29.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.105 -0.952 . . . . 0.12 109.638 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.591 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.84 155.8 24.02 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.631 -0.713 . . . . 1.0 109.957 -179.118 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.597 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.4 m-90 -140.88 154.36 46.12 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.533 -0.758 . . . . 0.11 111.257 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.679 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.3 t80 -109.36 153.55 23.78 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.428 -1.694 . . . . 1.1000000000000001 106.428 151.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 11.0 m-85 -126.63 118.76 25.45 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 115.224 -0.898 . . . . 0.60999999999999999 110.163 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.8 tppt? -121.88 136.06 54.91 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.366 -1.716 . . . . 0.93999999999999995 106.366 168.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.448 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.3 OUTLIER 70.73 15.55 6.93 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.141 0.793 . . . . 0.42999999999999999 113.141 175.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.91 5.07 89.66 Favored Glycine 0 CA--C 1.485 -1.801 0 CA-C-O 122.033 0.796 . . . . 0.17999999999999999 112.844 -174.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.1 ptmt -125.79 177.37 6.32 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 104.067 -2.568 . . . . 1.0900000000000001 104.067 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' CD1' ' A' ' 355' ' ' TRP . 14.7 m -104.98 157.51 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.822 0 N-CA-C 116.268 1.951 . . . . 1.02 116.268 -176.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.598 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -107.09 -27.42 10.62 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 110.493 -3.049 . . . . 1.01 106.33 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.59 142.75 48.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 111.352 -2.658 . . . . 1.02 111.488 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.615 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 3.5 tt0 -139.99 117.63 11.56 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 104.218 -2.512 . . . . 0.47999999999999998 104.218 176.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.607 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -149.58 162.54 39.98 Favored 'General case' 0 N--CA 1.397 -3.112 0 C-N-CA 117.715 -1.594 . . . . 1.02 111.598 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 14.9 p-10 -101.54 135.51 42.93 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 113.972 -1.467 . . . . 1.8 109.41 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.716 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -137.28 -174.18 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 CA-C-O 122.318 1.056 . . . . 1.01 112.508 -169.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.813 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -151.81 121.28 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 112.725 -2.034 . . . . 1.04 109.298 172.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.567 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.1 OUTLIER -81.69 -168.67 1.98 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.768 -1.56 . . . . 1.6000000000000001 110.318 -178.308 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.64 167.4 42.54 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.655 -1.736 . . . . 0.14000000000000001 112.328 -174.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -72.53 156.94 89.77 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 121.511 0.672 . . . . 1.47 111.937 -166.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.624 ' HG3' ' CZ3' ' A' ' 434' ' ' TRP . 92.1 Cg_exo -56.08 -28.9 72.07 Favored 'Trans proline' 0 CA--C 1.496 -1.392 1 C-N-CA 125.371 4.048 . . . . 0.28000000000000003 113.603 -173.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.431 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.0 p -70.38 -34.25 72.36 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.329 -1.76 . . . . 1.0800000000000001 109.413 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.563 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.5 t -142.04 69.99 23.41 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 123.645 1.688 . . . . 1.1000000000000001 109.407 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 375' ' ' THR . 79.8 Cg_exo -58.76 155.28 38.5 Favored 'Trans proline' 0 C--N 1.314 -1.279 1 C-N-CA 126.46 4.773 . . . . 0.38 114.608 -171.141 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.567 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.3 OUTLIER -84.42 141.96 39.93 Favored Pre-proline 0 N--CA 1.423 -1.811 0 N-CA-C 108.699 -0.852 . . . . 1.1299999999999999 108.699 173.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.3 Cg_exo -75.92 -43.34 0.33 Allowed 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 124.785 3.657 . . . . 0.20999999999999999 112.219 -167.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.66 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.85 136.31 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.302 1.525 . . . . 1.0600000000000001 113.634 -172.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 152.6 -119.34 0.96 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 112.129 -2.305 . . . . 0.20000000000000001 109.584 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.461 ' O ' HG11 ' A' ' 381' ' ' VAL . 9.8 p -121.97 115.53 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.275 1.036 . . . . 1.5 110.749 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.599 ' HE2' ' CE1' ' A' ' 382' ' ' PHE . 1.8 m-85 -114.03 -172.68 2.14 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.192 -1.781 . . . . 0.28000000000000003 106.192 171.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.666 ' HD2' ' CD1' ' A' ' 385' ' ' TRP . 34.1 t80 -146.11 126.85 14.33 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 118.013 -1.475 . . . . 0.96999999999999997 114.54 -171.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.516 HG13 HG22 ' A' ' 457' ' ' VAL . 1.5 p -85.92 92.21 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 123.064 1.412 . . . . 1.02 109.784 170.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . 0.666 ' CD1' ' HD2' ' A' ' 383' ' ' TYR . 75.2 m95 -70.55 -15.06 62.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.173 -1.831 . . . . 3.1299999999999999 107.976 176.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.763 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.8 t30 -170.05 132.65 1.1 Allowed 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.198 -0.91 . . . . 0.42999999999999999 111.209 -174.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.654 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -93.71 144.84 25.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.636 -0.711 . . . . 1.73 109.268 171.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.76 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 12.8 mm-40 -125.16 157.36 36.61 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 114.381 1.252 . . . . 0.70999999999999996 114.381 -169.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.773 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 51.3 mt-10 -136.3 127.12 27.43 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.143 -1.844 . . . . 0.38 108.403 173.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.4 t70 56.48 45.04 23.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 123.3 1.524 . . . . 0.40999999999999998 109.259 -178.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -79.59 167.24 20.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 112.852 -1.976 . . . . 1.02 109.016 176.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 7.1 m -131.87 119.35 21.07 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.164 0.983 . . . . 1.04 112.06 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.9 mp -82.69 88.55 6.71 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.761 -1.563 . . . . 1.27 112.275 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.539 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 48.7 mttt . . . . . 0 C--N 1.286 -2.159 0 CA-C-N 113.657 -1.611 . . . . 0.96999999999999997 113.551 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.539 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.441 -0.878 0 CA-C-O 121.122 0.487 . . . . 0.53000000000000003 109.743 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -143.83 97.08 5.44 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 108.444 -0.947 . . . . 0.45000000000000001 108.444 171.225 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.8 Cg_exo -68.87 110.07 2.28 Favored 'Trans proline' 0 N--CA 1.43 -2.214 0 C-N-CA 122.022 1.815 . . . . 0.22 109.456 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.575 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -109.56 154.1 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 CA-C-N 112.78 -2.009 . . . . 1.04 107.288 -167.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.773 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.6 m-80 -86.92 -19.85 28.23 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.969 -0.752 . . . . 0.65000000000000002 108.969 -174.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 0.76 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 88.7 m-85 -158.65 125.62 4.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.038 -0.983 . . . . 0.92000000000000004 108.89 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.607 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 27.1 t-105 -144.52 137.08 26.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.678 0.751 . . . . 0.10000000000000001 110.907 -167.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.654 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.6 mmt -120.44 93.8 48.46 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 107.823 -1.177 . . . . 1.01 107.823 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.763 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 33.6 Cg_endo . . . . . 0 C--N 1.348 0.528 0 C-N-CA 122.568 2.179 . . . . 0.5 112.153 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.616 HG13 ' N ' ' A' ' 419' ' ' GLY . 39.9 t . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 121.345 0.593 . . . . 1.45 111.509 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.616 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -177.06 122.87 0.86 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 109.694 -1.362 . . . . 0.20000000000000001 109.694 170.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.689 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.0 mp -81.65 141.69 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 120.589 -0.444 . . . . 1.0900000000000001 109.888 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.592 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.8 p80 -159.98 162.47 34.36 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.971 -0.559 . . . . 0.10000000000000001 111.338 -174.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.601 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.94 143.47 28.96 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.538 -1.282 . . . . 1.0700000000000001 107.538 171.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 445' ' ' THR . 42.3 t -134.64 98.71 4.13 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.702 0.763 . . . . 0.5 110.415 -170.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.437 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 20.0 t70 . . . . . 0 C--N 1.313 -1.013 0 CA-C-N 114.258 -1.337 . . . . 0.41999999999999998 109.803 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 . . . . . 0 CA--C 1.497 -1.083 0 CA-C-O 121.771 0.796 . . . . 2.1600000000000001 111.388 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.511 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -152.89 125.35 8.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.32 -1.733 . . . . 0.91000000000000003 106.32 175.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.77 -158.67 31.62 Favored Glycine 0 C--N 1.28 -2.553 0 N-CA-C 109.501 -1.44 . . . . 0.20000000000000001 109.501 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -44.81 174.63 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.061 -1.066 . . . . 0.25 111.683 168.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.51 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.9 p-10 -50.87 102.82 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 123.274 1.511 . . . . 1.8500000000000001 114.108 -153.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.567 ' CD1' ' HD2' ' A' ' 437' ' ' ARG . 0.2 OUTLIER -95.47 -38.75 10.32 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 112.687 -2.051 . . . . 1.8200000000000001 109.371 167.219 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.704 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.9 p-90 -50.99 -28.85 10.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.413 -0.812 . . . . 0.17999999999999999 112.872 -170.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.704 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.24 -34.07 16.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.621 0.724 . . . . 1.05 111.762 -177.71 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.0 p -88.45 -43.47 11.43 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.539 -1.209 . . . . 1.0600000000000001 110.905 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.567 ' HD2' ' CD1' ' A' ' 433' ' ' LEU . 6.4 mtp85 -93.84 -19.63 20.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.781 -1.099 . . . . 2.3700000000000001 109.582 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.19 47.07 50.73 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.141 -0.936 . . . . 0.23999999999999999 114.63 166.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 36.8 m -84.68 110.84 19.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.761 1.281 . . . . 1.7 111.5 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 39.42 -132.24 0.22 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.551 -1.204 . . . . 0.56999999999999995 113.579 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -121.78 -20.98 3.03 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.924 -0.655 . . . . 0.28999999999999998 113.665 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 30.4 p -101.84 -166.08 1.26 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.175 0.806 . . . . 0.40000000000000002 113.175 -173.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.561 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.0 mp -93.18 130.64 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.994 -1.003 . . . . 1.04 110.412 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.11 89.91 3.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.539 0.685 . . . . 0.62 109.835 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.716 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.0 m -84.01 141.78 40.96 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.731 -1.122 . . . . 1.02 112.423 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.607 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 82.1 Cg_exo -48.85 144.49 15.01 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 123.935 3.09 . . . . 0.23999999999999999 113.117 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.601 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.8 Cg_exo -65.31 -22.3 60.41 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.68 2.253 . . . . 0.31 112.123 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.505 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 79.7 p -82.25 -24.2 34.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.62 0.724 . . . . 1.48 112.026 -174.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.719 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.8 m -99.46 -48.44 11.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.011 0.745 . . . . 1.03 113.011 -169.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.943 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.32 -1.97 3.95 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.669 -0.812 . . . . 1.02 110.385 -178.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 42.2 pttt -81.33 -38.74 26.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 122.456 1.122 . . . . 1.5900000000000001 108.11 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.586 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.8 mm-40 -61.7 -46.4 89.86 Favored 'General case' 0 CA--C 1.471 -2.096 0 CA-C-N 112.48 -2.146 . . . . 0.25 106.423 -177.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.943 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.19 -66.55 0.39 Allowed 'General case' 0 N--CA 1.403 -2.775 0 CA-C-N 109.72 -3.4 . . . . 1.02 112.745 172.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.0 t80 -45.89 -23.35 0.27 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.728 0.775 . . . . 0.17000000000000001 109.458 176.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.47 -26.94 23.97 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 114.888 -1.051 . . . . 0.13 111.893 -176.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.606 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -101.78 -44.21 5.6 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 113.359 0.874 . . . . 1.02 113.359 177.163 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.703 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.4 OUTLIER -73.81 149.22 8.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.582 1.182 . . . . 1.01 110.995 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.543 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -124.6 157.69 34.86 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 112.905 -1.952 . . . . 0.47999999999999998 108.177 -177.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.539 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 37.5 mtpt -55.38 101.47 0.05 Allowed 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 109.034 -0.728 . . . . 1.7 109.034 169.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . 0.42 ' HA2' ' OH ' ' A' ' 383' ' ' TYR . . . 133.08 -14.27 4.9 Favored Glycine 0 C--N 1.302 -1.335 0 CA-C-N 114.222 -1.354 . . . . 0.22 112.124 -175.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.617 HG21 ' HA ' ' A' ' 344' ' ' TYR . 35.6 m -70.36 148.2 95.44 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 108.498 -0.927 . . . . 0.94999999999999996 108.498 168.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 11.8 Cg_endo -97.14 177.21 0.54 Allowed 'Trans proline' 0 N--CA 1.419 -2.873 0 C-N-CA 122.832 2.355 . . . . 0.23000000000000001 110.299 175.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.739 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -134.42 154.25 36.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 119.916 -0.714 . . . . 1.27 109.278 172.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.717 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.4 mp -135.09 152.31 51.54 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 116.028 -0.533 . . . . 1.05 109.915 173.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.692 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.25 142.02 32.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 105.454 -2.054 . . . . 1.01 105.454 163.328 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.571 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 9.0 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.444 -1.265 . . . . 1.0900000000000001 111.341 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . 0.46 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 11.5 m-20 . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 121.252 0.548 . . . . 0.42999999999999999 110.285 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 357' ' ' TYR . 75.8 m -158.03 135.97 10.69 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.856 -1.066 . . . . 1.0 108.995 167.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.785 ' CD2' HD11 ' A' ' 464' ' ' LEU . 43.8 p90 174.11 159.0 0.15 Allowed 'General case' 0 C--O 1.212 -0.912 0 O-C-N 123.35 0.406 . . . . 0.88 111.173 -175.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.694 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -78.25 154.98 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 N-CA-C 109.711 -0.478 . . . . 1.0 109.711 165.101 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 354' ' ' MET . 0.0 OUTLIER -146.92 148.64 32.0 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.873 -1.058 . . . . 2.0099999999999998 108.206 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.682 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 5.6 t -145.02 110.33 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 N-CA-C 113.872 1.064 . . . . 1.04 113.872 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 355' ' ' TRP . 27.7 t0 -92.56 106.71 18.64 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-O 121.946 0.879 . . . . 0.23999999999999999 109.058 176.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.637 HD13 ' HB ' ' A' ' 465' ' ' VAL . 0.3 OUTLIER -77.44 -37.3 51.89 Favored 'General case' 0 CA--C 1.479 -1.772 0 CA-C-N 114.01 -1.45 . . . . 1.02 110.251 -169.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.539 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 3.5 mt-10 -55.04 -44.43 74.67 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 110.766 -2.925 . . . . 0.59999999999999998 108.062 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 21.2 m-80 -102.32 7.21 40.66 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 110.694 -2.957 . . . . 0.20999999999999999 111.051 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.632 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.9 OUTLIER 34.09 61.76 0.49 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 112.852 -1.976 . . . . 2.54 112.833 -175.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.586 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.5 t60 -143.22 132.18 22.88 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.568 -0.742 . . . . 0.12 109.892 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.619 ' CG ' HG21 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -109.38 152.6 25.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.793 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.662 ' CD1' HG12 ' A' ' 362' ' ' VAL . 32.1 m-90 -139.05 157.72 45.48 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.442 -0.799 . . . . 0.11 110.725 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.705 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.5 t80 -109.66 153.81 23.72 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.488 -1.671 . . . . 1.1000000000000001 106.488 151.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.4 m-85 -127.38 118.42 24.08 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 115.073 -0.967 . . . . 0.60999999999999999 109.969 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.42 ' HE2' ' HE2' ' A' ' 356' ' ' TYR . 9.8 tppt? -121.81 125.23 46.03 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.863 -1.162 . . . . 0.93999999999999995 107.863 171.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.83 35.87 2.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 119.092 0.86 . . . . 0.42999999999999999 112.243 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.46 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 62.89 13.29 46.73 Favored Glycine 0 CA--C 1.495 -1.191 0 C-N-CA 120.322 -0.942 . . . . 0.17999999999999999 113.495 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -137.25 172.47 12.95 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.422 -2.436 . . . . 1.0900000000000001 104.422 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.662 HG12 ' CD1' ' A' ' 355' ' ' TRP . 17.6 m -101.02 158.18 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.741 0 N-CA-C 116.48 2.03 . . . . 1.02 116.48 -172.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.597 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.35 -26.55 9.97 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 110.523 -3.035 . . . . 1.01 106.933 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.723 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -133.72 145.58 49.99 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 111.766 -2.47 . . . . 1.02 111.842 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.586 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 5.0 tt0 -140.26 118.35 11.92 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 104.569 -2.382 . . . . 0.47999999999999998 104.569 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.608 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -150.05 162.0 41.25 Favored 'General case' 0 N--CA 1.402 -2.838 0 C-N-CA 117.767 -1.573 . . . . 1.02 112.059 177.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.617 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 17.0 p-10 -101.12 135.8 42.0 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 114.263 -1.335 . . . . 1.8 109.27 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.678 HG21 ' HA ' ' A' ' 445' ' ' THR . 2.6 pp -141.63 -171.84 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 122.443 1.116 . . . . 1.01 112.835 -169.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.47 120.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 CA-C-N 112.959 -1.928 . . . . 1.04 108.982 174.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.514 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.1 OUTLIER -76.23 -167.67 0.81 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.643 -1.617 . . . . 1.6000000000000001 110.953 177.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.477 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.85 175.92 48.93 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.118 -1.515 . . . . 0.14000000000000001 112.341 -174.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -78.91 156.69 77.05 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.508 0.671 . . . . 1.47 112.035 -165.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.64 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.7 Cg_exo -57.79 -29.9 87.47 Favored 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 125.182 3.921 . . . . 0.28000000000000003 113.617 -173.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.458 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 27.0 p -70.86 -32.97 70.15 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.592 -1.64 . . . . 1.0800000000000001 109.661 -175.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.564 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.1 t -140.82 70.87 29.96 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 123.614 1.673 . . . . 1.1000000000000001 109.406 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.5 Cg_exo -59.53 154.35 48.7 Favored 'Trans proline' 0 C--N 1.313 -1.292 1 C-N-CA 126.421 4.748 . . . . 0.38 114.449 -172.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.514 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.5 OUTLIER -83.86 148.14 53.41 Favored Pre-proline 0 N--CA 1.419 -1.979 0 N-CA-C 108.002 -1.11 . . . . 1.1299999999999999 108.002 173.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -79.53 -41.26 0.21 Allowed 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 124.592 3.528 . . . . 0.20999999999999999 112.724 -165.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.672 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.41 134.24 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 123.549 1.642 . . . . 1.0600000000000001 113.75 -172.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 148.02 -125.83 2.19 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 111.95 -2.386 . . . . 0.20000000000000001 109.728 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.492 ' O ' HG11 ' A' ' 381' ' ' VAL . 12.6 p -116.35 112.32 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 122.122 0.963 . . . . 1.5 111.497 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.622 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 1.9 m-85 -112.63 -173.38 2.24 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 106.493 -1.669 . . . . 0.28000000000000003 106.493 172.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.558 ' OH ' ' HA2' ' A' ' 460' ' ' GLY . 38.9 t80 -144.68 125.97 14.77 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.306 -1.358 . . . . 0.96999999999999997 113.657 -169.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.4 p -86.47 94.21 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 122.683 1.23 . . . . 1.02 109.56 169.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . 0.546 ' CD1' ' HD2' ' A' ' 383' ' ' TYR . 75.7 m95 -69.16 -17.17 63.79 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.412 -1.722 . . . . 3.1299999999999999 108.185 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.705 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.6 t30 -169.45 135.07 1.54 Allowed 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.375 -0.829 . . . . 0.42999999999999999 111.145 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.642 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -91.95 129.57 37.88 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.186 -1.042 . . . . 1.73 108.186 171.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 0.5 OUTLIER -110.59 158.59 18.4 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.183 -0.917 . . . . 0.70999999999999996 111.935 -171.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 40.3 mt-10 -134.57 133.36 40.16 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.163 -1.38 . . . . 0.38 108.833 173.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 18.6 t70 53.94 46.58 25.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 123.766 1.746 . . . . 0.40999999999999998 108.71 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.574 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -83.99 165.3 18.73 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 112.183 -2.28 . . . . 1.02 108.79 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 24.3 m -132.66 120.12 21.32 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.153 0.978 . . . . 1.04 111.045 170.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.7 mp -78.14 88.48 4.24 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.512 -1.676 . . . . 1.27 111.413 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.541 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 48.5 mttt . . . . . 0 C--N 1.288 -2.072 0 CA-C-N 113.791 -1.55 . . . . 0.96999999999999997 113.701 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.541 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 1.8 mp0 . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 121.083 0.468 . . . . 0.53000000000000003 110.127 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.29 97.49 5.18 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 108.015 -1.105 . . . . 0.45000000000000001 108.015 170.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.1 Cg_exo -69.32 110.05 2.37 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.008 1.805 . . . . 0.22 110.316 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.574 HG13 ' HB1' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.35 155.39 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 CA-C-N 112.998 -1.91 . . . . 1.04 107.396 -168.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.63 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.0 m-80 -88.49 -21.57 24.11 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.657 -0.868 . . . . 0.65000000000000002 108.657 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 0.651 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.1 m-85 -157.31 126.11 5.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.625 -1.17 . . . . 0.92000000000000004 108.674 -169.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.65 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 14.6 t-105 -142.3 141.41 32.41 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.623 -0.717 . . . . 0.10000000000000001 110.281 -167.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.642 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.5 mmt -126.67 96.75 34.74 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.405 -1.332 . . . . 1.01 107.405 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.705 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 48.2 Cg_endo . . . . . 0 N--CA 1.46 -0.493 0 C-N-CA 122.52 2.147 . . . . 0.5 112.825 -175.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.704 HG12 ' CE2' ' A' ' 382' ' ' PHE . 2.2 p . . . . . 0 N--CA 1.44 -0.946 0 CA-C-O 120.474 0.178 . . . . 1.45 111.249 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 442' ' ' CYS . . . -168.05 128.61 1.74 Allowed Glycine 0 C--O 1.219 -0.827 0 N-CA-C 110.882 -0.887 . . . . 0.20000000000000001 110.882 165.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.605 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.6 mp -84.6 140.0 16.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 122.151 -0.617 . . . . 1.0900000000000001 111.213 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.576 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.0 p80 -161.83 162.86 29.57 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.684 -0.689 . . . . 0.10000000000000001 110.303 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.667 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -81.94 150.88 27.48 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 107.675 -1.232 . . . . 1.0700000000000001 107.675 170.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 445' ' ' THR . 48.0 t -134.12 96.08 3.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.981 0.896 . . . . 0.5 109.647 -172.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--N 1.317 -0.835 0 CA-C-N 113.784 -1.553 . . . . 0.41999999999999998 109.77 -176.363 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.564 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.1 pm0 . . . . . 0 N--CA 1.43 -1.459 0 CA-C-O 122.289 1.042 . . . . 2.1600000000000001 112.71 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.623 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -157.8 129.54 6.89 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 112.681 -2.054 . . . . 0.91000000000000003 105.513 168.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.13 -157.48 29.74 Favored Glycine 0 C--N 1.288 -2.088 0 C-N-CA 119.715 -1.231 . . . . 0.20000000000000001 111.544 -177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.65 170.49 0.01 OUTLIER Glycine 0 CA--C 1.487 -1.671 0 C-N-CA 120.787 -0.72 . . . . 0.25 111.919 167.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.541 ' HB3' ' CD ' ' A' ' 435' ' ' LYS . 2.4 m-20 -52.75 100.89 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.891 0 CA-C-O 122.492 1.139 . . . . 1.8500000000000001 112.957 -155.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.609 ' CD2' ' HD2' ' A' ' 437' ' ' ARG . 36.8 mt -97.16 -35.73 10.69 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 113.006 -1.906 . . . . 1.8200000000000001 109.696 172.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.721 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -52.7 -26.3 13.53 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.111 -0.95 . . . . 0.17999999999999999 112.1 -173.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.721 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.68 -33.99 15.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.747 -0.661 . . . . 1.05 112.69 -178.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.7 p -90.01 -37.88 14.0 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.861 0.839 . . . . 1.0600000000000001 110.76 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.609 ' HD2' ' CD2' ' A' ' 433' ' ' LEU . 3.8 mtp85 -97.65 -18.4 18.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.707 -1.133 . . . . 2.3700000000000001 110.011 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.74 48.81 49.54 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.156 -0.929 . . . . 0.23999999999999999 115.233 162.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' SER . . . . . 0.454 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 9.3 p -84.8 110.32 18.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 118.93 1.365 . . . . 1.7 112.192 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.442 ' HB3' ' H ' ' A' ' 441' ' ' GLY . 63.2 m-70 35.67 -133.21 0.06 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.482 -1.235 . . . . 0.56999999999999995 113.049 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.477 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -119.22 -6.26 10.95 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.204 -0.759 . . . . 0.28999999999999998 111.204 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 419' ' ' GLY . 0.8 OUTLIER -92.4 162.51 14.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.527 0.936 . . . . 0.40000000000000002 113.527 -176.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.665 ' N ' HD11 ' A' ' 443' ' ' ILE . 1.9 mp -87.43 128.97 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 113.764 -1.562 . . . . 1.04 110.141 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.45 88.42 4.12 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.655 -0.702 . . . . 0.62 110.081 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.678 ' HA ' HG21 ' A' ' 368' ' ' ILE . 4.9 m -83.91 142.64 42.09 Favored Pre-proline 0 N--CA 1.431 -1.377 0 CA-C-N 115.029 -0.987 . . . . 1.02 112.412 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.608 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 76.7 Cg_exo -50.42 145.1 22.52 Favored 'Trans proline' 0 CA--C 1.509 -0.733 0 C-N-CA 123.803 3.002 . . . . 0.23999999999999999 113.455 175.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.667 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.2 Cg_exo -65.45 -24.71 56.51 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.864 2.376 . . . . 0.31 112.328 -176.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.513 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 35.7 p -77.58 -24.99 49.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.229 -0.896 . . . . 1.48 112.09 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.723 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.9 m -100.02 -48.51 11.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.714 -0.675 . . . . 1.03 112.557 -171.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.928 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.7 -2.51 5.02 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.635 -0.826 . . . . 1.02 110.375 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.513 ' HE3' ' O ' ' A' ' 448' ' ' SER . 15.8 pttp -80.71 -38.82 28.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.441 1.115 . . . . 1.5900000000000001 108.358 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.581 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.7 mm-40 -62.66 -46.57 87.59 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 112.482 -2.145 . . . . 0.25 106.883 -177.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.928 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.09 -66.37 0.41 Allowed 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 109.847 -3.342 . . . . 1.02 112.536 171.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.583 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 21.1 t80 -44.72 -25.62 0.3 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 124.215 0.947 . . . . 0.17000000000000001 109.609 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -86.87 -29.49 23.28 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 114.599 -1.182 . . . . 0.13 111.555 -176.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.569 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -99.43 -44.86 6.03 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 113.533 0.938 . . . . 1.02 113.533 177.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.694 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.65 148.56 9.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 122.487 1.137 . . . . 1.01 111.106 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.498 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -119.91 158.11 27.35 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 112.88 -1.964 . . . . 0.47999999999999998 108.648 -178.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.586 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.3 mppt? -57.82 101.51 0.08 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.575 -0.898 . . . . 1.7 108.575 168.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . 0.558 ' HA2' ' OH ' ' A' ' 383' ' ' TYR . . . 134.66 -18.36 4.1 Favored Glycine 0 C--N 1.304 -1.246 0 CA-C-N 114.233 -1.349 . . . . 0.22 111.902 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 344' ' ' TYR . 23.1 m -66.57 149.29 98.26 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 108.756 -0.831 . . . . 0.94999999999999996 108.756 171.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 9.8 Cg_endo -95.75 176.29 0.84 Allowed 'Trans proline' 0 N--CA 1.416 -3.052 0 C-N-CA 122.257 1.972 . . . . 0.23000000000000001 109.937 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.756 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -132.8 154.7 40.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.131 -1.063 . . . . 1.27 108.131 171.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.785 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.0 mp -134.26 152.12 51.65 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 108.775 -0.824 . . . . 1.05 108.775 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.682 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.9 OUTLIER -137.73 144.46 31.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 106.047 -1.835 . . . . 1.01 106.047 159.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.539 ' OXT' ' HG3' ' A' ' 350' ' ' GLU . 3.2 p90 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 123.857 0.863 . . . . 1.0900000000000001 110.84 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 109.532 -0.544 . . . . 0.42999999999999999 109.532 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 357' ' ' TYR . 53.6 m -159.35 138.08 10.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.29 -0.868 . . . . 1.0 108.743 167.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.748 ' CD2' HD11 ' A' ' 464' ' ' LEU . 41.2 p90 174.32 158.87 0.16 Allowed 'General case' 0 C--O 1.21 -1.011 0 O-C-N 123.317 0.385 . . . . 0.88 111.149 -176.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.676 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.5 OUTLIER -77.26 154.7 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 N-CA-C 109.216 -0.661 . . . . 1.0 109.216 164.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.57 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.53 146.96 28.55 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.8 -1.185 . . . . 2.0099999999999998 107.8 -178.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.697 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.76 155.62 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 C-N-CA 123.6 0.76 . . . . 1.04 110.375 173.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.504 ' N ' HG13 ' A' ' 347' ' ' VAL . 37.7 t0 -138.13 105.55 5.53 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.539 -1.652 . . . . 0.23999999999999999 106.539 176.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.66 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -80.13 -35.97 35.91 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 114.023 -1.444 . . . . 1.02 109.959 -165.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.38 -44.96 80.72 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 110.678 -2.965 . . . . 0.59999999999999998 107.942 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -99.37 5.03 46.53 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 111.163 -2.744 . . . . 0.20999999999999999 111.1 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.6 OUTLIER 34.29 61.7 0.52 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 112.942 -1.935 . . . . 2.54 113.137 -173.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.629 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 24.5 t60 -142.4 136.91 30.02 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.907 -0.588 . . . . 0.12 109.741 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.6 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.83 158.16 21.39 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 120.947 0.403 . . . . 1.0 110.234 179.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.589 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.5 m-90 -143.13 164.08 31.12 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.485 0.66 . . . . 0.11 111.126 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.694 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.3 t80 -116.01 154.27 30.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.535 -1.654 . . . . 1.1000000000000001 106.535 150.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 13.4 m-85 -127.13 119.2 25.94 Favored 'General case' 0 C--N 1.269 -2.9 0 CA-C-N 115.094 -0.957 . . . . 0.60999999999999999 110.007 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 358' ' ' LYS . 9.9 tppt? -123.3 116.65 23.68 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.377 -0.971 . . . . 0.93999999999999995 108.377 173.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.85 37.69 0.49 Allowed 'General case' 0 C--N 1.308 -1.207 0 O-C-N 123.474 0.484 . . . . 0.42999999999999999 112.297 -176.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 62.94 12.46 42.97 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 120.2 -1.0 . . . . 0.17999999999999999 113.314 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 358' ' ' LYS . 18.5 ptmt -137.63 169.75 17.25 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 104.586 -2.376 . . . . 1.0900000000000001 104.586 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 17.6 m -99.57 157.74 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.619 0 N-CA-C 116.692 2.108 . . . . 1.02 116.692 -170.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.588 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -110.18 -25.88 9.94 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-N 110.375 -3.102 . . . . 1.01 106.673 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -135.64 146.6 48.03 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 111.694 -2.503 . . . . 1.02 111.682 -176.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.629 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -143.7 117.92 9.56 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 104.719 -2.326 . . . . 0.47999999999999998 104.719 175.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.6 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.59 165.25 32.82 Favored 'General case' 0 N--CA 1.4 -2.953 0 C-N-CA 118.121 -1.432 . . . . 1.02 111.558 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.64 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 13.1 p-10 -103.66 132.44 49.91 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.71 -1.132 . . . . 1.8 109.828 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.708 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.0 pp -131.48 -173.5 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 CA-C-O 122.48 1.133 . . . . 1.01 112.415 -172.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.41 120.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 112.805 -1.998 . . . . 1.04 108.312 172.202 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.597 ' HG ' ' HB3' ' A' ' 349' ' ' LEU . 30.2 p -76.87 -169.21 1.23 Allowed 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 112.376 -2.193 . . . . 1.6000000000000001 111.615 -177.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -85.04 166.65 40.93 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 118.718 -1.706 . . . . 0.14000000000000001 111.864 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -73.84 156.99 87.83 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 121.383 0.611 . . . . 1.47 111.758 -167.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.603 ' HG3' ' CZ3' ' A' ' 434' ' ' TRP . 81.4 Cg_exo -54.23 -28.79 53.88 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 125.269 3.98 . . . . 0.28000000000000003 113.439 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.462 ' OG1' HG21 ' A' ' 375' ' ' THR . 16.8 p -69.55 -34.04 73.64 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.295 -1.775 . . . . 1.0800000000000001 109.829 -176.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.556 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -141.61 70.81 25.69 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 123.715 1.721 . . . . 1.1000000000000001 109.128 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 375' ' ' THR . 85.9 Cg_exo -57.41 160.09 14.61 Favored 'Trans proline' 0 C--N 1.31 -1.462 1 C-N-CA 126.453 4.769 . . . . 0.38 115.254 -170.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.535 ' CG2' HG22 ' A' ' 465' ' ' VAL . 2.3 m -86.08 126.56 64.92 Favored Pre-proline 0 N--CA 1.402 -2.837 0 CA-C-N 114.142 -1.39 . . . . 1.1299999999999999 108.616 173.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 29.0 Cg_exo -69.29 -44.66 2.25 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.776 2.984 . . . . 0.20999999999999999 112.21 -168.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.647 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 61.21 137.98 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 123.579 1.657 . . . . 1.0600000000000001 113.912 -175.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 153.36 -111.69 0.5 Allowed Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 111.75 -2.477 . . . . 0.20000000000000001 108.871 -176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.67 125.89 56.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.206 0.527 . . . . 1.5 109.759 173.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 1.62 ' HE1' ' CE2' ' A' ' 382' ' ' PHE . 8.1 m-85 -118.16 -176.14 3.0 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 106.608 -1.627 . . . . 0.28000000000000003 106.608 168.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 2.0 t80 -137.76 120.29 16.06 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 120.698 -1.251 . . . . 0.96999999999999997 112.291 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -86.01 91.35 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-O 123.178 1.466 . . . . 1.02 108.926 171.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -93.66 11.79 27.72 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 113.043 -1.889 . . . . 3.1299999999999999 108.013 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.74 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.0 t30 -167.95 126.21 1.2 Allowed 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 113.588 -1.642 . . . . 0.42999999999999999 110.148 172.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.6 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.64 143.25 31.84 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.201 -0.909 . . . . 1.73 109.129 169.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 30.0 mm-40 -126.11 159.67 32.23 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 115.019 1.489 . . . . 0.70999999999999996 115.019 -167.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.727 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.1 mt-10 -139.11 127.29 22.58 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 112.755 -2.02 . . . . 0.38 108.689 174.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.7 t70 56.19 45.67 22.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 123.498 1.618 . . . . 0.40999999999999998 109.053 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.471 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -81.26 166.3 20.67 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 112.517 -2.129 . . . . 1.02 108.803 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 20.6 m -132.75 119.24 20.06 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 122.252 1.025 . . . . 1.04 111.577 170.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.1 mp -78.7 88.02 4.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.699 -1.591 . . . . 1.27 111.873 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.568 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.7 mttt . . . . . 0 C--N 1.284 -2.27 0 CA-C-N 113.572 -1.649 . . . . 0.96999999999999997 113.032 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.568 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 120.998 0.428 . . . . 0.53000000000000003 110.749 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.02 97.35 4.86 Favored Pre-proline 0 N--CA 1.437 -1.094 0 N-CA-C 108.525 -0.917 . . . . 0.45000000000000001 108.525 170.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.9 Cg_exo -68.47 110.95 2.4 Favored 'Trans proline' 0 N--CA 1.436 -1.886 0 C-N-CA 122.106 1.871 . . . . 0.22 110.159 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.575 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -110.86 152.41 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.168 0 CA-C-N 113.355 -1.748 . . . . 1.04 107.979 -167.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.727 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 19.6 m-80 -85.95 -20.43 28.96 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.958 -0.756 . . . . 0.65000000000000002 108.958 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 0.709 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.4 m-85 -158.85 125.75 4.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.935 -1.03 . . . . 0.92000000000000004 108.493 -170.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.613 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.8 t-105 -143.32 138.18 29.32 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.692 -0.685 . . . . 0.10000000000000001 110.476 -167.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.6 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 14.3 mmt -118.55 91.08 40.96 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.932 -0.766 . . . . 1.01 108.932 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 34.1 Cg_exo . . . . . 0 CA--C 1.511 -0.633 0 C-N-CA 123.367 2.711 . . . . 0.5 109.511 171.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.568 HG13 ' N ' ' A' ' 419' ' ' GLY . 32.3 t . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 121.125 0.488 . . . . 1.45 111.763 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.568 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -175.81 122.58 0.87 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.039 -1.224 . . . . 0.20000000000000001 110.039 170.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.696 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.4 mp -81.63 143.52 12.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 110.05 -0.352 . . . . 1.0900000000000001 110.05 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.589 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.4 p80 -160.32 161.84 33.36 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.10000000000000001 111.617 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.618 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.03 146.63 27.09 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.402 -0.962 . . . . 1.0700000000000001 108.402 173.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 445' ' ' THR . 37.7 t -133.15 96.32 3.73 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.788 0.804 . . . . 0.5 110.074 -171.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . 0.414 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 8.0 t70 . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 114.211 -1.359 . . . . 0.41999999999999998 109.551 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.501 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.7 pm0 . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 122.242 1.02 . . . . 2.1600000000000001 113.291 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.94 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -163.07 132.02 4.03 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 112.608 -2.087 . . . . 0.91000000000000003 105.405 172.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 169.06 -158.61 31.28 Favored Glycine 0 C--N 1.283 -2.401 0 N-CA-C 110.373 -1.091 . . . . 0.20000000000000001 110.373 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.448 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -45.53 174.85 0.01 OUTLIER Glycine 0 CA--C 1.497 -1.045 0 C-N-CA 120.155 -1.022 . . . . 0.25 111.493 167.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.53 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -51.9 101.82 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 123.341 1.543 . . . . 1.8500000000000001 113.834 -154.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.68 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.87 -36.02 11.26 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 112.533 -2.122 . . . . 1.8200000000000001 109.378 170.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.686 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -54.75 -27.47 41.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.213 -0.903 . . . . 0.17999999999999999 112.276 -170.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.686 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.52 -35.37 15.11 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.468 0.651 . . . . 1.05 112.216 -177.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.407 ' H ' HG21 ' A' ' 436' ' ' THR . 1.8 p -90.4 -43.39 10.33 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.991 -1.004 . . . . 1.0600000000000001 110.787 -176.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.68 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.6 mtp180 -93.29 -17.77 23.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.536 -1.211 . . . . 2.3700000000000001 109.607 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.67 49.82 56.28 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.765 -1.107 . . . . 0.23999999999999999 115.101 162.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 50.0 m -83.38 110.28 18.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.736 1.268 . . . . 1.7 111.31 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 37.33 -126.85 0.19 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.303 -1.317 . . . . 0.56999999999999995 114.481 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -128.28 -21.32 1.49 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.14 -0.552 . . . . 0.28999999999999998 113.029 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.439 ' CB ' ' H ' ' A' ' 419' ' ' GLY . 29.2 p -102.11 -166.05 1.25 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.244 0.545 . . . . 0.40000000000000002 112.273 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.426 HD11 HG12 ' A' ' 465' ' ' VAL . 2.2 mp -96.62 131.15 44.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.314 -0.857 . . . . 1.04 110.619 -174.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.99 94.39 5.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.431 0.634 . . . . 0.62 110.252 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.708 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.9 m -90.39 145.53 32.74 Favored Pre-proline 0 C--O 1.211 -0.969 0 CA-C-N 114.713 -1.131 . . . . 1.02 112.85 -176.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.588 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 75.8 Cg_exo -50.44 146.51 19.03 Favored 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 123.971 3.114 . . . . 0.23999999999999999 113.659 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.94 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 27.8 Cg_exo -67.3 -23.38 44.85 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.963 2.442 . . . . 0.31 112.364 -176.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.506 ' O ' ' HE2' ' A' ' 451' ' ' LYS . 34.1 p -80.64 -24.98 38.62 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.363 -0.835 . . . . 1.48 112.079 -175.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.719 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.8 m -99.38 -48.98 11.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.643 -0.708 . . . . 1.03 112.864 -170.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.938 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.95 -2.27 5.07 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.754 -0.779 . . . . 1.02 110.349 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' A' ' 452' ' ' GLU . 41.4 pttt -80.81 -39.51 26.53 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.973 -1.121 . . . . 1.5900000000000001 107.973 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.582 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.7 mm-40 -61.53 -46.35 90.31 Favored 'General case' 0 CA--C 1.472 -2.032 0 CA-C-N 112.499 -2.137 . . . . 0.25 106.356 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.938 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.81 -67.49 0.28 Allowed 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 109.612 -3.449 . . . . 1.02 112.66 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 16.3 t80 -45.46 -23.96 0.27 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 124.008 0.817 . . . . 0.17000000000000001 109.361 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.36 -26.09 29.03 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.925 -1.034 . . . . 0.13 111.845 -176.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.571 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -102.45 -44.31 5.4 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 113.309 0.855 . . . . 1.02 113.309 176.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.676 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.12 147.71 10.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 122.528 1.156 . . . . 1.01 110.747 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.484 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -121.64 153.79 37.66 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-N 112.878 -1.965 . . . . 0.47999999999999998 107.943 -178.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 42.4 mtmt -55.57 103.01 0.08 Allowed 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.783 0.801 . . . . 1.7 110.122 173.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.58 -11.67 6.33 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 113.637 -1.619 . . . . 0.22 111.394 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 344' ' ' TYR . 10.3 m -65.6 150.34 96.21 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 108.443 -0.947 . . . . 0.94999999999999996 108.443 171.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.3 Cg_endo -93.51 163.55 2.37 Favored 'Trans proline' 0 N--CA 1.42 -2.852 0 C-N-CA 122.0 1.8 . . . . 0.23000000000000001 109.644 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.705 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -125.19 152.71 31.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 107.392 -1.336 . . . . 1.27 107.392 170.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.748 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.1 mp -133.02 150.01 52.17 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 108.09 -1.078 . . . . 1.05 108.09 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.697 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.23 138.57 37.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 103.879 -2.638 . . . . 1.01 103.879 163.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.57 ' CE1' ' CD ' ' A' ' 346' ' ' GLU . 2.5 p90 . . . . . 0 C--O 1.247 0.956 0 O-C-N 123.768 0.668 . . . . 1.0900000000000001 110.719 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 111.868 -0.493 . . . . 2.48 111.868 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.587 ' CE1' HD23 ' A' ' 464' ' ' LEU . 1.3 p-80 -138.44 111.06 7.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.732 0.266 . . . . 1.1399999999999999 111.589 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.558 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.1 OUTLIER 57.23 -166.55 0.14 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 113.34 0.867 . . . . 1.01 113.34 166.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -64.24 168.05 5.98 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.302 -1.37 . . . . 1.96 107.302 165.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.443 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.7 m-20 -79.36 83.64 5.36 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.045 -1.062 . . . . 0.42999999999999999 109.456 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 70.6 m -158.08 134.3 9.4 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.467 -1.242 . . . . 1.0 108.715 169.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.623 ' CD2' HD11 ' A' ' 464' ' ' LEU . 37.1 p90 174.61 158.39 0.17 Allowed 'General case' 0 C--O 1.212 -0.876 0 O-C-N 123.316 0.385 . . . . 0.88 111.545 -175.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.705 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -78.23 149.32 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 164.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.525 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.2 tt0 -149.34 139.57 22.24 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.459 -0.791 . . . . 2.0099999999999998 109.902 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.706 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -132.52 161.53 41.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.039 0.447 . . . . 1.04 111.412 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.504 ' N ' HG13 ' A' ' 347' ' ' VAL . 32.5 t0 -140.23 106.35 5.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.385 -1.339 . . . . 0.23999999999999999 107.385 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.642 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -83.02 -34.88 26.18 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 124.071 1.891 . . . . 1.02 110.139 -170.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.422 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.0 OUTLIER -55.63 -41.77 74.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 111.144 -2.753 . . . . 0.59999999999999998 107.757 176.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 19.1 m-80 -105.52 7.66 33.06 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 110.912 -2.858 . . . . 0.20999999999999999 111.666 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.851 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 82.9 mm-40 28.8 63.86 0.12 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 112.825 -1.989 . . . . 2.54 114.294 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.615 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 27.2 t60 -141.87 137.71 31.58 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.665 -1.152 . . . . 0.12 110.125 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.609 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.4 OUTLIER -113.55 157.89 21.48 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.218 0.532 . . . . 1.0 110.385 -178.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.556 ' CD1' HG12 ' A' ' 362' ' ' VAL . 30.5 m-90 -143.3 153.88 43.22 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.274 -0.876 . . . . 0.11 111.137 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.697 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.0 t80 -109.35 153.07 24.46 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.46 -1.681 . . . . 1.1000000000000001 106.46 151.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.9 m-85 -127.43 119.37 25.99 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.946 -1.024 . . . . 0.60999999999999999 110.384 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.8 tppt? -121.1 135.65 55.14 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.408 -1.701 . . . . 0.93999999999999995 106.408 168.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.479 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 72.11 15.77 5.42 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.071 0.767 . . . . 0.42999999999999999 113.071 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.443 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.65 7.09 88.29 Favored Glycine 0 CA--C 1.485 -1.826 0 CA-C-N 115.693 -0.685 . . . . 0.17999999999999999 112.731 -173.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.479 ' HG2' ' HB3' ' A' ' 359' ' ' ASP . 18.1 ptmt -127.93 178.13 6.39 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 104.505 -2.406 . . . . 1.0900000000000001 104.505 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 16.7 m -104.51 157.83 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 N-CA-C 116.475 2.028 . . . . 1.02 116.475 -174.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.584 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -107.86 -27.97 9.91 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-N 110.477 -3.056 . . . . 1.01 106.286 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.12 144.31 48.49 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 111.471 -2.604 . . . . 1.02 111.625 -175.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.615 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 3.4 tt0 -140.34 117.47 11.22 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 104.426 -2.435 . . . . 0.47999999999999998 104.426 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.679 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.6 OUTLIER -149.55 160.39 43.52 Favored 'General case' 0 N--CA 1.393 -3.297 0 C-N-CA 117.871 -1.532 . . . . 1.02 110.636 -179.332 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.75 138.9 38.12 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 108.334 -0.987 . . . . 1.8 108.334 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.695 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.0 pp -136.47 -174.21 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-O 122.11 0.957 . . . . 1.01 112.25 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.851 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.7 OUTLIER -150.12 118.82 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 113.02 -1.9 . . . . 1.04 108.793 172.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.521 ' HG ' HG13 ' A' ' 443' ' ' ILE . 0.2 OUTLIER -78.63 -168.08 1.28 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.555 -1.657 . . . . 1.6000000000000001 110.349 -178.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.43 168.07 43.75 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 118.485 -1.816 . . . . 0.14000000000000001 112.311 -174.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -73.61 158.74 85.92 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.626 0.727 . . . . 1.47 111.9 -166.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.639 ' HG3' ' CZ3' ' A' ' 434' ' ' TRP . 88.1 Cg_exo -57.43 -28.99 82.92 Favored 'Trans proline' 0 CA--C 1.495 -1.426 0 C-N-CA 125.182 3.922 . . . . 0.28000000000000003 113.435 -173.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.441 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.9 p -71.57 -33.71 69.31 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.405 -1.725 . . . . 1.0800000000000001 109.618 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.573 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.6 t -141.36 70.57 26.97 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 123.737 1.732 . . . . 1.1000000000000001 109.584 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 375' ' ' THR . 79.0 Cg_exo -59.46 157.55 30.97 Favored 'Trans proline' 0 C--N 1.314 -1.256 1 C-N-CA 126.494 4.796 . . . . 0.38 114.481 -172.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.497 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -87.35 146.16 39.24 Favored Pre-proline 0 N--CA 1.425 -1.723 0 N-CA-C 108.44 -0.948 . . . . 1.1299999999999999 108.44 174.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.417 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 19.4 Cg_exo -76.08 -44.15 0.28 Allowed 'Trans proline' 0 CA--C 1.511 -0.657 0 C-N-CA 124.8 3.667 . . . . 0.20999999999999999 112.136 -167.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.663 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 57.67 137.88 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 123.249 1.499 . . . . 1.0600000000000001 113.608 -172.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 150.47 -111.02 0.49 Allowed Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 112.592 -2.095 . . . . 0.20000000000000001 110.319 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.435 ' O ' HG11 ' A' ' 381' ' ' VAL . 5.7 p -130.17 113.51 26.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 122.496 1.141 . . . . 1.5 111.078 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.598 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 1.8 m-85 -114.68 -171.21 1.89 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.929 -1.508 . . . . 0.28000000000000003 106.929 173.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 415' ' ' TRP . 1.4 t80 -150.03 124.58 9.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.856 1.207 . . . . 0.96999999999999997 112.838 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 386' ' ' ASN . 2.3 p -89.45 91.95 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-O 123.047 1.403 . . . . 1.02 109.13 169.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -93.8 11.24 29.96 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 113.298 -1.773 . . . . 3.1299999999999999 107.851 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.733 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.0 t30 -169.19 126.18 0.94 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 113.793 -1.548 . . . . 0.42999999999999999 110.086 172.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.642 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.89 143.68 31.47 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.828 -1.078 . . . . 1.73 109.121 171.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.725 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 26.7 mm-40 -126.11 157.61 37.61 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.599 1.333 . . . . 0.70999999999999996 114.599 -167.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.696 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 45.2 mt-10 -135.63 127.16 28.77 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 113.155 -1.839 . . . . 0.38 108.902 172.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.14 49.62 18.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 123.159 1.457 . . . . 0.40999999999999998 109.335 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.451 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -81.88 168.5 17.87 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 112.579 -2.1 . . . . 1.02 109.454 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.0 m -132.27 119.59 21.0 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.904 0.859 . . . . 1.04 111.745 170.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.6 mp -80.2 88.84 5.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.802 -1.545 . . . . 1.27 112.167 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.581 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.5 mttt -101.63 -179.86 4.14 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.657 -1.61 . . . . 0.96999999999999997 113.502 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.39 -161.58 25.69 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.243 -1.344 . . . . 0.46000000000000002 111.614 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.7 m -120.78 137.37 54.55 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 120.239 -0.584 . . . . 1.3500000000000001 111.515 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 399' ' ' ASP . 4.1 m-80 -55.38 154.7 5.88 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 114.718 -1.128 . . . . 0.83999999999999997 110.038 169.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -7.58 0.3 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.34 -1.3 . . . . 2.2799999999999998 111.99 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 397' ' ' ASN . 21.2 m-20 -102.34 -17.37 15.9 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.171 -0.922 . . . . 2.27 109.729 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.53 32.36 6.66 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 119.08 -1.533 . . . . 0.97999999999999998 111.459 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 16.5 p -122.79 97.65 43.84 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.533 -0.833 . . . . 1.3999999999999999 109.309 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 21.1 Cg_endo -60.16 150.67 78.11 Favored 'Trans proline' 0 CA--C 1.501 -1.159 0 C-N-CA 122.909 2.406 . . . . 0.67000000000000004 113.269 -175.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.611 ' HD2' ' CD1' ' A' ' 403' ' ' TYR . 27.9 p90 -148.21 172.33 14.51 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.07 -1.423 . . . . 1.04 112.057 -169.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.581 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -145.19 147.3 32.3 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.246 -1.343 . . . . 0.53000000000000003 109.91 172.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.2 97.35 5.23 Favored Pre-proline 0 N--CA 1.434 -1.254 0 N-CA-C 108.233 -1.025 . . . . 0.45000000000000001 108.233 171.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.2 Cg_exo -69.31 110.59 2.5 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 122.012 1.808 . . . . 0.22 110.047 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.608 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -110.02 158.03 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 CA-C-N 113.132 -1.849 . . . . 1.04 107.582 -168.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.696 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.0 m-80 -89.27 -21.8 23.02 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.031 -0.729 . . . . 0.65000000000000002 109.031 -174.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.635 ' HD1' ' CD2' ' A' ' 409' ' ' TYR . 94.1 m-85 -158.86 127.54 5.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.924 -1.035 . . . . 0.92000000000000004 108.229 -170.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.612 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 21.9 t-105 -144.93 136.26 25.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.692 0.758 . . . . 0.10000000000000001 111.397 -166.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.642 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.8 mmt -119.68 93.65 47.72 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.157 -1.053 . . . . 1.01 108.157 173.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.733 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.2 Cg_endo -68.24 83.38 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.171 1.914 . . . . 0.5 111.351 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.574 HG12 ' HA2' ' A' ' 419' ' ' GLY . 6.8 pt -81.9 173.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.084 -0.71 . . . . 1.05 109.084 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.565 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 1.3 t70 -134.82 -174.83 3.7 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.232 -0.987 . . . . 2.4900000000000002 112.743 -163.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.587 ' CZ2' ' HB2' ' A' ' 383' ' ' TYR . 29.6 p90 50.79 -2.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.251 2.22 . . . . 2.3700000000000001 115.307 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.612 HG22 ' CE1' ' A' ' 382' ' ' PHE . 36.2 p -131.83 -17.92 2.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.176 0.436 . . . . 1.5700000000000001 112.176 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.549 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 93.73 -28.96 9.09 Favored Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 111.195 -0.762 . . . . 0.68000000000000005 111.195 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.612 HG13 ' N ' ' A' ' 419' ' ' GLY . 40.6 t -56.86 172.67 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 123.947 0.899 . . . . 1.45 111.69 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.612 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -176.4 123.47 0.91 Allowed Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.049 -1.221 . . . . 0.20000000000000001 110.049 170.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.69 HG23 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.63 141.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.382 -0.599 . . . . 1.0900000000000001 109.382 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.586 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.6 p80 -159.82 160.1 33.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.295 -0.412 . . . . 0.10000000000000001 111.525 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.587 ' O ' HG21 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -82.59 145.92 29.44 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.02 -1.104 . . . . 1.0700000000000001 108.02 172.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 445' ' ' THR . 37.9 t -134.78 97.68 3.83 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.65 0.738 . . . . 0.5 110.191 -172.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.436 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 24.1 t70 -83.37 -16.95 44.03 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.604 -1.18 . . . . 0.41999999999999998 109.665 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.608 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 7.2 p90 -84.35 -24.9 29.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.999 -1.455 . . . . 0.32000000000000001 111.526 -175.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.577 HE21 ' HG2' ' A' ' 428' ' ' GLU . 2.0 tt0 -99.69 121.13 55.58 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-O 122.955 1.36 . . . . 1.74 110.529 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.644 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 37.3 Cg_endo -90.3 -8.21 4.0 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 124.919 3.746 . . . . 0.87 113.422 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.644 ' OE2' ' HD2' ' A' ' 427' ' ' PRO . 1.1 pm0 -109.56 149.92 28.94 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 122.199 0.999 . . . . 2.1600000000000001 113.283 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.63 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -160.57 128.6 4.55 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 106.384 -1.71 . . . . 0.91000000000000003 106.384 167.501 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.73 -156.71 28.32 Favored Glycine 0 C--N 1.285 -2.286 0 C-N-CA 119.975 -1.107 . . . . 0.20000000000000001 110.682 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.463 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.27 165.35 0.01 OUTLIER Glycine 0 CA--C 1.489 -1.549 0 C-N-CA 120.243 -0.98 . . . . 0.25 111.667 166.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.495 ' HB3' ' HD2' ' A' ' 435' ' ' LYS . 7.5 m-20 -53.48 102.98 0.06 Allowed 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.268 -1.466 . . . . 1.8500000000000001 113.499 -156.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.588 ' CD2' ' HD2' ' A' ' 437' ' ' ARG . 30.0 mt -94.66 -33.99 12.75 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 112.892 -1.958 . . . . 1.8200000000000001 109.452 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.66 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.1 p-90 -52.32 -27.32 14.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.841 -1.072 . . . . 0.17999999999999999 112.501 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.66 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.87 -33.17 16.56 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.276 0.56 . . . . 1.05 112.275 -178.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.412 ' H ' HG21 ' A' ' 436' ' ' THR . 1.5 p -90.62 -38.36 13.18 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.215 -0.902 . . . . 1.0600000000000001 110.765 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.588 ' HD2' ' CD2' ' A' ' 433' ' ' LEU . 1.5 mtp85 -98.49 -17.94 18.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.6 -1.182 . . . . 2.3700000000000001 109.992 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.36 48.05 55.02 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.833 -1.076 . . . . 0.23999999999999999 115.043 163.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.1 p -83.93 110.65 18.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.674 1.237 . . . . 1.7 111.615 -172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 35.13 -121.44 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.444 -1.253 . . . . 0.56999999999999995 113.418 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.448 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -131.75 -19.35 1.17 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.842 -0.617 . . . . 0.28999999999999998 113.703 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.547 ' HB3' ' HAS' ' A' ' 130' ' ' 1RG . 29.4 p -99.95 -167.66 1.49 Allowed 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 117.923 0.862 . . . . 0.40000000000000002 112.61 -174.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.521 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.0 mp -99.03 126.26 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 114.698 -1.137 . . . . 1.04 110.928 -173.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.73 99.92 11.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.69 -0.686 . . . . 0.62 110.064 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.695 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.2 m -97.35 143.09 25.56 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-N 115.235 -0.893 . . . . 1.02 112.379 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.679 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 87.6 Cg_exo -49.59 144.59 18.93 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 124.023 3.149 . . . . 0.23999999999999999 113.36 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.63 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.1 Cg_exo -65.92 -27.26 50.99 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.734 2.289 . . . . 0.31 111.991 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 14.5 m -75.68 -24.12 56.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.453 -0.794 . . . . 1.48 112.18 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.709 ' O ' HD23 ' A' ' 364' ' ' LEU . 29.0 m -100.36 -49.31 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 113.171 0.804 . . . . 1.03 113.171 -168.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.933 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.93 -2.08 4.82 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.888 -0.725 . . . . 1.02 110.191 -178.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.57 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.2 pttp -81.45 -38.51 26.31 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 122.554 1.168 . . . . 1.5900000000000001 108.197 173.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.58 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.4 mm-40 -62.53 -46.5 88.12 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-N 112.418 -2.174 . . . . 0.25 106.463 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.933 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.8 tp -46.34 -66.89 0.34 Allowed 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 109.807 -3.361 . . . . 1.02 112.579 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.506 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 17.4 t80 -45.4 -24.28 0.29 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 124.038 0.836 . . . . 0.17000000000000001 109.617 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.27 -27.36 25.68 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.76 -1.109 . . . . 0.13 111.685 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.578 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -100.83 -44.57 5.73 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 113.304 0.853 . . . . 1.02 113.304 177.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.705 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -74.01 149.92 7.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 122.528 1.156 . . . . 1.01 111.464 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.537 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.24 156.12 34.44 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-N 112.929 -1.941 . . . . 0.47999999999999998 108.121 -177.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.542 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.5 mppt? -56.36 103.03 0.09 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 109.248 -0.649 . . . . 1.7 109.248 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.61 -6.89 6.59 Favored Glycine 0 C--N 1.308 -0.981 0 CA-C-N 114.148 -1.387 . . . . 0.22 111.863 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.575 HG21 ' HA ' ' A' ' 344' ' ' TYR . 7.7 m -69.63 147.81 96.64 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 109.425 -0.583 . . . . 0.94999999999999996 109.425 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.558 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 2.5 Cg_endo -90.26 151.62 4.58 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 122.683 2.255 . . . . 0.23000000000000001 110.005 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.582 ' CG1' ' HB2' ' A' ' 382' ' ' PHE . 1.6 t -121.57 133.54 67.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 114.686 -1.143 . . . . 1.27 109.088 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.676 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.3 mp -133.04 148.5 52.21 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 119.494 -0.882 . . . . 1.05 109.684 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.706 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.11 141.57 33.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.132 -2.174 . . . . 1.01 105.132 166.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.527 ' N ' HD23 ' A' ' 349' ' ' LEU . 12.8 p90 . . . . . 0 C--O 1.246 0.915 0 O-C-N 123.568 0.543 . . . . 1.0900000000000001 111.476 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.723 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 N-CA-C 112.004 -0.438 . . . . 2.48 112.004 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.576 ' CD2' HD12 ' A' ' 464' ' ' LEU . 4.3 p-80 -139.43 103.4 4.71 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.107 0.41 . . . . 1.1399999999999999 112.107 177.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.578 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.1 OUTLIER 60.93 -168.61 0.17 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.12 -0.945 . . . . 1.01 113.058 166.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -58.73 171.2 0.67 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.299 -0.864 . . . . 1.96 110.022 162.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.23 82.34 7.14 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 118.685 -1.206 . . . . 0.42999999999999999 109.318 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 99.5 m -158.95 135.24 9.14 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.288 -1.324 . . . . 1.0 108.78 168.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.64 ' CD2' HD11 ' A' ' 464' ' ' LEU . 40.6 p90 174.64 158.09 0.16 Allowed 'General case' 0 C--O 1.211 -0.964 0 O-C-N 123.326 0.391 . . . . 0.88 111.348 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.681 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.74 151.79 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 164.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.548 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.2 tt0 -149.64 142.69 24.92 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.591 -0.731 . . . . 2.0099999999999998 109.568 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.69 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.67 161.69 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 121.019 0.438 . . . . 1.04 111.019 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.505 ' N ' HG13 ' A' ' 347' ' ' VAL . 31.7 t0 -140.03 105.72 5.13 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.158 -1.423 . . . . 0.23999999999999999 107.158 173.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.618 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -81.24 -35.09 31.64 Favored 'General case' 0 CA--C 1.481 -1.678 0 CA-C-O 122.838 1.304 . . . . 1.02 110.212 -168.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -55.27 -44.89 76.03 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 110.706 -2.952 . . . . 0.59999999999999998 108.063 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -100.44 5.51 44.26 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 110.932 -2.849 . . . . 0.20999999999999999 110.904 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.554 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.6 OUTLIER 34.79 61.15 0.6 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 112.794 -2.003 . . . . 2.54 112.981 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.593 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 21.4 t60 -141.58 134.96 29.57 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.714 -0.675 . . . . 0.12 109.863 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.604 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.37 156.55 23.23 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.238 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.547 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.6 m-90 -142.06 155.33 45.38 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.551 -0.75 . . . . 0.11 111.195 -175.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.692 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.9 t80 -110.42 153.17 25.37 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 106.582 -1.636 . . . . 1.1000000000000001 106.582 151.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.3 m-85 -128.51 115.97 18.96 Favored 'General case' 0 C--N 1.269 -2.893 0 CA-C-N 114.855 -1.066 . . . . 0.60999999999999999 110.289 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.6 tppt? -116.33 140.02 49.78 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.777 -1.934 . . . . 0.93999999999999995 105.777 168.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.46 19.4 10.02 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.358 0.873 . . . . 0.42999999999999999 113.358 171.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 75.17 7.88 82.62 Favored Glycine 0 CA--C 1.489 -1.537 0 CA-C-N 115.573 -0.739 . . . . 0.17999999999999999 113.417 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.0 ptmt -128.0 178.26 6.32 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 104.682 -2.34 . . . . 1.0900000000000001 104.682 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 15.6 m -105.0 157.52 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 N-CA-C 116.205 1.928 . . . . 1.02 116.205 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.575 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.03 -26.52 10.14 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 110.461 -3.063 . . . . 1.01 106.358 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.75 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -135.04 143.7 46.86 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 111.511 -2.586 . . . . 1.02 111.726 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.593 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 2.6 tt0 -142.01 117.77 10.45 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.673 -2.343 . . . . 0.47999999999999998 104.673 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.604 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.81 164.49 35.19 Favored 'General case' 0 N--CA 1.398 -3.053 0 C-N-CA 118.129 -1.428 . . . . 1.02 111.548 -178.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.66 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 10.3 p-10 -103.3 133.12 48.91 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.366 -1.288 . . . . 1.8 109.633 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.665 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -134.07 -173.63 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 122.345 1.069 . . . . 1.01 112.307 -171.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.523 HG12 HE22 ' A' ' 426' ' ' GLN . 0.5 OUTLIER -151.48 121.81 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 112.904 -1.953 . . . . 1.04 108.491 172.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.563 ' HG ' ' HB3' ' A' ' 349' ' ' LEU . 56.9 p -77.69 -168.83 1.3 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 112.678 -2.055 . . . . 1.6000000000000001 111.418 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.48 167.24 42.65 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 118.536 -1.792 . . . . 0.14000000000000001 111.771 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 6.7 ptmt -74.48 155.76 87.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.413 0.625 . . . . 1.47 111.633 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.646 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 78.8 Cg_exo -54.71 -30.07 64.82 Favored 'Trans proline' 0 CA--C 1.498 -1.318 1 C-N-CA 125.386 4.057 . . . . 0.28000000000000003 113.345 -173.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.449 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 20.0 p -70.79 -34.51 71.85 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.568 -1.651 . . . . 1.0800000000000001 109.706 -176.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.573 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.9 t -141.94 69.98 23.92 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 123.78 1.753 . . . . 1.1000000000000001 109.439 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.4 Cg_exo -58.49 166.07 6.75 Favored 'Trans proline' 0 C--N 1.316 -1.157 1 C-N-CA 126.918 5.079 . . . . 0.38 115.81 -170.252 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 0.5 OUTLIER -93.75 140.77 23.14 Favored Pre-proline 0 N--CA 1.419 -1.985 0 CA-C-N 114.458 -1.246 . . . . 1.1299999999999999 108.331 170.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.48 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 19.4 Cg_exo -76.33 -45.96 0.19 Allowed 'Trans proline' 0 CA--C 1.514 -0.48 0 C-N-CA 124.547 3.498 . . . . 0.20999999999999999 112.081 -170.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.653 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 62.48 138.59 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.313 1.53 . . . . 1.0600000000000001 113.597 -172.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 151.59 -111.66 0.51 Allowed Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 112.281 -2.236 . . . . 0.20000000000000001 109.471 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.444 ' O ' HG11 ' A' ' 381' ' ' VAL . 5.9 p -130.92 119.38 44.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.743 0.782 . . . . 1.5 110.461 176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.599 ' HD2' ' CD1' ' A' ' 382' ' ' PHE . 2.8 m-85 -118.23 -173.86 2.54 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.168 -1.419 . . . . 0.28000000000000003 107.168 172.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 1.9 t80 -141.05 123.43 15.82 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 120.623 -1.298 . . . . 0.96999999999999997 112.959 -171.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.48 91.98 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-O 123.105 1.431 . . . . 1.02 109.403 169.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -93.7 11.95 27.24 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.274 -1.785 . . . . 3.1299999999999999 108.199 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.759 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.7 t30 -168.64 126.41 1.06 Allowed 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 113.995 -1.457 . . . . 0.42999999999999999 110.162 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.642 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.34 141.87 33.57 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.747 -1.115 . . . . 1.73 108.94 169.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.752 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 13.9 mm-40 -126.1 157.69 37.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 114.443 1.275 . . . . 0.70999999999999996 114.443 -167.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 47.3 mt-10 -137.73 127.2 24.93 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.013 -1.903 . . . . 0.38 108.613 173.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.6 t70 56.48 47.77 18.1 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.227 1.489 . . . . 0.40999999999999998 109.026 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -83.7 169.28 15.44 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 112.367 -2.197 . . . . 1.02 109.393 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 20.7 m -132.6 121.14 22.76 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.863 0.839 . . . . 1.04 111.693 169.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.512 HD22 ' CG ' ' A' ' 421' ' ' HIS . 3.8 mp -80.35 89.17 5.54 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.829 -1.532 . . . . 1.27 112.601 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.592 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.1 mttt -102.01 178.36 4.63 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.687 -1.597 . . . . 0.96999999999999997 113.117 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 139.28 -158.18 25.27 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.424 -1.262 . . . . 0.46000000000000002 111.988 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.6 m -124.25 138.32 54.41 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.103 -0.639 . . . . 1.3500000000000001 111.62 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.544 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.3 m-80 -58.1 156.88 8.82 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.92 -1.036 . . . . 0.83999999999999997 110.367 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.532 ' HA ' ' CBD' ' A' ' 130' ' ' 1RG . 2.3 t70 -62.76 -1.79 0.96 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.15 -0.932 . . . . 2.2799999999999998 110.743 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.544 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.1 OUTLIER -115.77 6.14 14.32 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.455 -1.248 . . . . 2.27 111.372 -178.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 88.0 20.12 51.03 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 115.09 -0.959 . . . . 0.97999999999999998 112.196 169.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 14.2 p -113.96 100.45 52.42 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 114.339 -0.931 . . . . 1.3999999999999999 109.604 -175.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.594 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.4 Cg_endo -58.6 151.71 60.83 Favored 'Trans proline' 0 CA--C 1.504 -1.004 0 C-N-CA 122.651 2.234 . . . . 0.67000000000000004 113.137 -177.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.64 ' HD2' ' CD1' ' A' ' 403' ' ' TYR . 32.1 p90 -149.8 175.82 11.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.238 -1.346 . . . . 1.04 112.653 -169.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.592 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.7 OUTLIER -145.23 149.77 35.51 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.064 -1.426 . . . . 0.53000000000000003 110.161 172.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.14 97.23 4.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.177 -1.045 . . . . 0.45000000000000001 108.177 169.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.2 Cg_exo -69.02 109.55 2.19 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.851 1.701 . . . . 0.22 110.26 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.612 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -108.97 157.48 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-N 113.194 -1.821 . . . . 1.04 107.697 -167.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.724 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.9 m-80 -89.7 -20.61 23.4 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.016 -0.735 . . . . 0.65000000000000002 109.016 -174.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 87.8 m-85 -158.45 126.43 5.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.968 -1.015 . . . . 0.92000000000000004 108.508 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.617 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.3 t-105 -144.52 134.89 24.43 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.781 0.8 . . . . 0.10000000000000001 111.295 -167.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.642 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -116.71 92.63 38.57 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 107.609 -1.256 . . . . 1.01 107.609 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.759 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.3 Cg_endo -66.92 75.94 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.434 2.09 . . . . 0.5 111.68 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.57 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.3 pt -76.22 179.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 109.057 -0.72 . . . . 1.05 109.057 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 7.3 t70 -150.64 -165.74 2.35 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.011 -0.737 . . . . 2.4900000000000002 109.011 -168.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.65 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 8.4 m-90 82.91 -56.73 0.17 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 123.985 0.803 . . . . 2.3700000000000001 111.252 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 76.2 p -120.67 -5.77 9.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.357 -0.838 . . . . 1.5700000000000001 112.302 -165.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 101.54 -26.67 23.67 Favored Glycine 0 CA--C 1.503 -0.669 0 C-N-CA 120.522 -0.847 . . . . 0.68000000000000005 112.466 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 419' ' ' GLY . 43.1 t -56.19 173.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.343 0.657 . . . . 1.45 111.641 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.589 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -175.06 121.52 0.83 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.17 -1.172 . . . . 0.20000000000000001 110.17 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.678 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.7 141.78 14.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.928 -0.397 . . . . 1.0900000000000001 109.928 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.593 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.5 p80 -159.89 161.59 34.4 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.097 -0.501 . . . . 0.10000000000000001 111.338 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.627 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -82.24 147.68 28.81 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.988 -1.115 . . . . 1.0700000000000001 107.988 171.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 445' ' ' THR . 29.4 t -132.83 96.91 3.9 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.813 0.815 . . . . 0.5 109.843 -173.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.16 -15.84 56.19 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.15 -1.386 . . . . 0.41999999999999998 109.353 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.612 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 13.3 p90 -89.27 -24.64 22.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.08 -1.418 . . . . 0.32000000000000001 111.646 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.551 ' HG2' ' OE2' ' A' ' 428' ' ' GLU . 1.3 tt0 -97.86 114.46 65.06 Favored Pre-proline 0 CA--C 1.505 -0.751 0 CA-C-O 122.754 1.264 . . . . 1.74 110.146 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.561 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 44.6 Cg_endo -86.42 -10.24 6.61 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 124.13 3.22 . . . . 0.87 113.048 -173.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.607 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.0 pm0 -111.59 153.52 26.18 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 122.248 1.023 . . . . 2.1600000000000001 113.464 174.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.701 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.67 129.22 3.51 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 112.722 -2.035 . . . . 0.91000000000000003 105.672 173.033 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.59 -158.07 30.55 Favored Glycine 0 C--N 1.284 -2.361 0 N-CA-C 110.538 -1.025 . . . . 0.20000000000000001 110.538 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.434 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -45.3 174.58 0.01 OUTLIER Glycine 0 CA--C 1.498 -0.979 0 C-N-CA 120.217 -0.992 . . . . 0.25 111.66 167.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.525 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -52.01 101.89 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 123.386 1.565 . . . . 1.8500000000000001 113.76 -154.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.649 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.27 -37.92 10.32 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 112.575 -2.102 . . . . 1.8200000000000001 109.798 170.04 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.671 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.4 p-90 -53.94 -27.28 30.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.442 -0.799 . . . . 0.17999999999999999 112.39 -170.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.671 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.39 -34.07 16.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.593 0.59 . . . . 1.05 112.593 -177.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.4 p -92.75 -42.42 9.58 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.045 -0.979 . . . . 1.0600000000000001 110.812 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.649 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.5 mtp180 -93.89 -18.36 22.05 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.971 -1.013 . . . . 2.3700000000000001 110.062 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.56 50.52 48.1 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 115.811 1.084 . . . . 0.23999999999999999 115.811 161.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 17.5 m -82.56 111.37 18.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 119.145 1.473 . . . . 1.7 111.237 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 34.18 -120.65 0.09 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.827 -1.079 . . . . 0.56999999999999995 113.412 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -130.99 -18.76 1.32 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.986 -0.626 . . . . 0.28999999999999998 113.741 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.479 ' HB3' ' HAS' ' A' ' 130' ' ' 1RG . 29.5 p -103.62 -165.63 1.18 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.816 0.673 . . . . 0.40000000000000002 112.816 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.442 HD11 HG12 ' A' ' 465' ' ' VAL . 2.2 mp -95.86 132.79 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.121 -0.945 . . . . 1.04 110.825 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.82 98.06 7.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.936 -0.575 . . . . 0.62 110.26 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.665 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.5 m -93.88 140.17 22.9 Favored Pre-proline 0 N--CA 1.439 -0.997 0 CA-C-N 115.392 -0.822 . . . . 1.02 113.206 -176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.698 ' O ' HG23 ' A' ' 449' ' ' VAL . 74.1 Cg_exo -51.97 135.75 51.51 Favored 'Trans proline' 0 CA--C 1.496 -1.392 0 C-N-CA 124.629 3.553 . . . . 0.23999999999999999 115.532 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.701 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 50.0 Cg_exo -56.76 -38.82 94.88 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.279 1.319 . . . . 0.31 111.618 -167.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.582 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 21.0 m -62.46 -25.61 68.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.225 0.824 . . . . 1.48 113.225 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.75 ' O ' HD23 ' A' ' 364' ' ' LEU . 22.6 m -98.42 -47.76 12.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 O-C-N 121.33 -0.856 . . . . 1.03 112.997 -169.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.942 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.49 -1.98 5.76 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.613 -0.835 . . . . 1.02 110.344 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 448' ' ' SER . 14.2 pttp -80.78 -38.59 28.28 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 122.67 1.224 . . . . 1.5900000000000001 108.294 173.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.577 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.8 mm-40 -61.6 -46.58 89.24 Favored 'General case' 0 CA--C 1.47 -2.104 0 CA-C-N 112.305 -2.225 . . . . 0.25 106.36 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.942 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -47.23 -66.59 0.38 Allowed 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 109.766 -3.379 . . . . 1.02 112.688 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.499 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 19.0 t80 -45.71 -23.86 0.3 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 123.935 0.772 . . . . 0.17000000000000001 109.581 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.46 -26.64 27.22 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 114.789 -1.096 . . . . 0.13 111.772 -175.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.596 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -101.96 -44.64 5.43 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 113.462 0.912 . . . . 1.02 113.462 177.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.681 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.98 148.03 9.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.495 1.141 . . . . 1.01 111.402 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.5 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -118.04 156.72 28.11 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 113.005 -1.907 . . . . 0.47999999999999998 108.772 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.598 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 43.1 mtmt -57.28 102.99 0.1 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.659 0.742 . . . . 1.7 109.686 170.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.96 -10.78 6.26 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 113.837 -1.529 . . . . 0.22 111.369 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.588 HG21 ' HA ' ' A' ' 344' ' ' TYR . 17.0 m -66.72 149.34 98.34 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 108.842 -0.799 . . . . 0.94999999999999996 108.842 171.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.578 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 4.7 Cg_endo -93.67 159.07 2.35 Favored 'Trans proline' 0 N--CA 1.426 -2.499 0 C-N-CA 122.411 2.074 . . . . 0.23000000000000001 109.866 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.708 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -124.46 148.83 28.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.504 -1.295 . . . . 1.27 107.504 172.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.683 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.7 mp -134.01 150.2 51.23 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.463 -0.94 . . . . 1.05 108.463 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.69 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.8 OUTLIER -138.72 141.99 35.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 105.113 -2.18 . . . . 1.01 105.113 165.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.561 ' N ' HD23 ' A' ' 349' ' ' LEU . 12.1 p90 . . . . . 0 C--O 1.245 0.822 0 O-C-N 123.688 0.617 . . . . 1.0900000000000001 111.064 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.819 ' HB ' ' OAU' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 112.077 -0.409 . . . . 2.48 112.077 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.544 ' CE1' HD23 ' A' ' 464' ' ' LEU . 2.1 p-80 -146.0 106.59 4.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.923 0.342 . . . . 1.1399999999999999 111.923 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.572 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.1 OUTLIER 62.01 -167.23 0.2 Allowed 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.826 0.704 . . . . 1.01 112.785 167.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.34 170.38 3.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.342 -1.355 . . . . 1.96 107.342 164.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.406 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 4.9 m-20 -81.68 83.72 7.01 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 118.888 -1.125 . . . . 0.42999999999999999 109.278 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 88.0 m -158.43 134.72 9.33 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.512 -1.222 . . . . 1.0 109.104 169.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.653 ' CD2' HD11 ' A' ' 464' ' ' LEU . 37.8 p90 174.15 158.82 0.15 Allowed 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 123.42 0.45 . . . . 0.88 111.112 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.69 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.62 151.85 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 164.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.58 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.21 140.91 23.53 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.583 -0.735 . . . . 2.0099999999999998 109.543 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.7 HG21 ' O ' ' A' ' 464' ' ' LEU . 2.7 t -134.7 162.03 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.095 0.474 . . . . 1.04 111.287 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.532 ' HA ' ' C ' ' A' ' 466' ' ' PHE . 27.8 t0 -140.26 106.8 5.32 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.205 -1.406 . . . . 0.23999999999999999 107.205 174.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.676 ' O ' ' HG3' ' A' ' 352' ' ' GLN . 0.3 OUTLIER -83.57 -33.77 25.33 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 123.378 1.561 . . . . 1.02 110.21 -169.281 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.17 -44.88 83.93 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 110.625 -2.989 . . . . 0.59999999999999998 107.908 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -102.4 4.84 39.29 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 111.155 -2.748 . . . . 0.20999999999999999 111.227 -175.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.676 ' HG3' ' O ' ' A' ' 349' ' ' LEU . 29.6 mt-30 32.69 63.54 0.3 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 112.857 -1.974 . . . . 2.54 113.748 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.583 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.3 t60 -142.05 135.31 29.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.914 -1.039 . . . . 0.12 109.332 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.608 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.16 156.4 23.28 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.067 -178.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.546 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.7 m-90 -142.01 155.13 45.42 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.184 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.682 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.3 t80 -110.26 153.31 25.02 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 106.61 -1.626 . . . . 1.1000000000000001 106.61 151.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 11.7 m-85 -127.65 118.77 24.48 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 114.936 -1.029 . . . . 0.60999999999999999 110.416 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.2 tppt? -120.0 136.83 54.41 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.96 -1.867 . . . . 0.93999999999999995 105.96 168.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.55 17.8 7.86 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.481 0.919 . . . . 0.42999999999999999 113.481 174.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.406 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.67 8.34 87.2 Favored Glycine 0 CA--C 1.485 -1.793 0 C-N-CA 120.825 -0.702 . . . . 0.17999999999999999 112.918 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.4 ptmt -129.08 177.7 6.94 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 104.564 -2.384 . . . . 1.0900000000000001 104.564 178.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.1 m -104.12 157.69 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 N-CA-C 116.344 1.979 . . . . 1.02 116.344 -175.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.587 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -108.8 -27.67 9.63 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 110.513 -3.04 . . . . 1.01 106.493 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.735 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.82 144.58 49.07 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 111.495 -2.593 . . . . 1.02 111.535 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.583 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 3.5 tt0 -140.43 118.22 11.71 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 104.53 -2.396 . . . . 0.47999999999999998 104.53 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.614 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -150.05 163.41 38.23 Favored 'General case' 0 N--CA 1.397 -3.089 0 C-N-CA 117.626 -1.63 . . . . 1.02 111.869 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.699 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 11.9 p-10 -101.96 134.14 45.65 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 114.027 -1.442 . . . . 1.8 109.545 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.682 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.11 -173.59 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 CA-C-O 122.26 1.029 . . . . 1.01 112.457 -172.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.47 118.63 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.075 -1.875 . . . . 1.04 107.722 173.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.53 ' HG ' HG13 ' A' ' 443' ' ' ILE . 0.2 OUTLIER -79.42 -167.98 1.38 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.127 -1.397 . . . . 1.6000000000000001 110.773 -177.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.45 164.45 39.88 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 118.639 -1.743 . . . . 0.14000000000000001 112.407 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 11.0 ptmt -70.97 158.05 89.0 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.639 0.733 . . . . 1.47 111.698 -167.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.627 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.4 Cg_exo -57.83 -29.48 86.23 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 125.184 3.923 . . . . 0.28000000000000003 113.348 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.454 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 17.8 p -71.76 -32.76 68.03 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.608 -1.633 . . . . 1.0800000000000001 109.725 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.562 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.5 t -141.07 70.47 28.43 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-O 123.807 1.765 . . . . 1.1000000000000001 109.31 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.0 Cg_exo -58.94 162.79 12.64 Favored 'Trans proline' 0 C--N 1.312 -1.358 1 C-N-CA 126.486 4.791 . . . . 0.38 115.165 -171.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.525 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -96.06 141.99 23.93 Favored Pre-proline 0 N--CA 1.419 -1.979 0 CA-C-N 114.729 -1.123 . . . . 1.1299999999999999 108.503 171.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.6 Cg_exo -76.31 -44.56 0.24 Allowed 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 124.719 3.612 . . . . 0.20999999999999999 111.95 -167.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.654 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 61.49 138.05 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 123.328 1.537 . . . . 1.0600000000000001 113.467 -172.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 153.0 -114.43 0.62 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 112.201 -2.272 . . . . 0.20000000000000001 109.362 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.433 ' O ' HG11 ' A' ' 381' ' ' VAL . 7.3 p -130.73 117.21 37.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.892 0.854 . . . . 1.5 110.661 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.611 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.9 m-85 -115.58 -174.04 2.45 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.147 -1.427 . . . . 0.28000000000000003 107.147 173.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 415' ' ' TRP . 1.0 OUTLIER -139.46 123.49 17.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 119.987 1.267 . . . . 0.96999999999999997 113.41 -171.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.06 92.23 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 123.06 1.41 . . . . 1.02 109.337 168.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -94.22 11.96 28.39 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.428 -1.714 . . . . 3.1299999999999999 108.18 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.755 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 9.0 t30 -169.37 126.65 0.93 Allowed 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 113.972 -1.467 . . . . 0.42999999999999999 110.174 172.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.611 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.16 145.99 26.61 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.064 -0.971 . . . . 1.73 109.098 168.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.737 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 19.5 mm-40 -126.29 159.2 33.76 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 114.509 1.3 . . . . 0.70999999999999996 114.509 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.752 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 40.1 mt-10 -138.37 127.52 24.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.211 -1.813 . . . . 0.38 108.674 173.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.81 45.52 21.48 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 123.338 1.542 . . . . 0.40999999999999998 108.729 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -80.77 166.6 20.84 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 112.513 -2.13 . . . . 1.02 109.177 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 16.9 m -132.08 120.65 22.64 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.091 0.948 . . . . 1.04 111.551 170.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -81.13 88.6 5.99 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.871 -1.513 . . . . 1.27 112.048 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.582 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.3 mttt -102.01 179.29 4.37 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 113.585 -1.643 . . . . 0.96999999999999997 113.129 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.78 -160.88 25.37 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-N 114.17 -1.377 . . . . 0.46000000000000002 111.421 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.5 m -114.22 141.21 47.83 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 120.108 -0.637 . . . . 1.3500000000000001 110.757 170.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.1 m-80 -59.48 156.22 13.58 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.108 -0.951 . . . . 0.83999999999999997 109.349 168.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.95 -3.39 1.61 Allowed 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.873 -1.058 . . . . 2.2799999999999998 110.685 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.0 OUTLIER -113.04 5.88 17.39 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.874 -1.057 . . . . 2.27 111.128 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.16 18.64 49.33 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.423 -0.894 . . . . 0.97999999999999998 112.433 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 11.6 p -113.82 101.27 53.69 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 114.37 -0.915 . . . . 1.3999999999999999 109.832 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 19.3 Cg_endo -59.21 150.68 72.46 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 122.825 2.35 . . . . 0.67000000000000004 113.55 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.611 ' HD2' ' CD1' ' A' ' 403' ' ' TYR . 25.1 p90 -151.83 174.27 13.76 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.328 -1.305 . . . . 1.04 113.041 -170.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.582 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER -144.78 148.04 33.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.875 -1.511 . . . . 0.53000000000000003 110.151 172.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.81 97.33 4.96 Favored Pre-proline 0 N--CA 1.436 -1.153 0 N-CA-C 108.275 -1.009 . . . . 0.45000000000000001 108.275 170.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 18.1 Cg_exo -69.04 111.1 2.57 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.065 1.843 . . . . 0.22 110.023 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.616 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -110.99 153.45 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 CA-C-N 112.958 -1.928 . . . . 1.04 107.626 -167.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 21.5 m-80 -86.14 -20.44 28.64 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.902 -0.777 . . . . 0.65000000000000002 108.902 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.642 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 96.4 m-85 -159.0 127.31 5.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.12 -0.945 . . . . 0.92000000000000004 108.643 -170.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.613 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 23.3 t-105 -145.12 134.35 22.86 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.641 0.734 . . . . 0.10000000000000001 111.185 -167.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.611 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.5 mmt -116.44 93.69 40.72 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.908 -1.145 . . . . 1.01 107.908 173.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.755 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 39.0 Cg_endo -67.81 73.76 0.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.311 2.007 . . . . 0.5 112.239 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.572 HG12 ' HA2' ' A' ' 419' ' ' GLY . 2.9 pt -72.86 175.64 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.134 -1.062 . . . . 1.05 108.134 176.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 416' ' ' THR . 1.1 t70 -151.31 -170.57 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 118.852 -1.139 . . . . 2.4900000000000002 112.749 -167.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.471 ' CZ2' ' HB2' ' A' ' 383' ' ' TYR . 41.2 p90 52.14 -0.99 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.953 2.101 . . . . 2.3700000000000001 114.542 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.501 HG22 ' CE1' ' A' ' 382' ' ' PHE . 35.5 p -130.83 -15.21 3.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.143 0.497 . . . . 1.5700000000000001 111.089 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.457 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 95.29 -32.55 6.1 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.138 -0.785 . . . . 0.68000000000000005 111.138 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 419' ' ' GLY . 36.5 t -56.85 172.33 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.002 0.921 . . . . 1.45 111.943 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.602 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -178.84 121.4 0.75 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 109.931 -1.268 . . . . 0.20000000000000001 109.931 171.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.672 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.66 143.09 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 110.034 -0.358 . . . . 1.0900000000000001 110.034 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.592 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.4 p80 -160.58 162.11 32.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.245 -0.434 . . . . 0.10000000000000001 111.409 -174.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.591 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.45 145.86 27.93 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.947 -1.131 . . . . 1.0700000000000001 107.947 172.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.553 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 30.2 t -134.17 98.63 4.17 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.745 0.783 . . . . 0.5 110.5 -171.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -80.12 -10.79 59.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.117 -1.401 . . . . 0.41999999999999998 109.418 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.616 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 10.5 p90 -95.93 -26.71 15.48 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.592 -1.185 . . . . 0.32000000000000001 112.421 -174.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.553 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -91.65 110.59 44.38 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-O 122.53 1.157 . . . . 1.74 108.619 177.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -84.36 -17.21 5.51 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 124.336 3.357 . . . . 0.87 113.082 -172.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.475 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 0.7 OUTLIER -112.08 156.86 21.54 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 122.205 1.002 . . . . 2.1600000000000001 111.779 174.076 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.699 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.9 OUTLIER -159.58 124.84 4.11 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 105.129 -2.175 . . . . 0.91000000000000003 105.129 173.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.09 -157.75 30.16 Favored Glycine 0 C--N 1.284 -2.333 0 C-N-CA 119.46 -1.352 . . . . 0.20000000000000001 111.354 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -46.26 173.48 0.02 OUTLIER Glycine 0 CA--C 1.501 -0.805 0 C-N-CA 120.609 -0.805 . . . . 0.25 111.694 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.582 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.3 p-10 -52.57 100.8 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 123.743 1.735 . . . . 1.8500000000000001 114.035 -150.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.649 ' HG ' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.55 -43.58 7.53 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 111.805 -2.452 . . . . 1.8200000000000001 109.721 170.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.708 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.5 p-90 -52.12 -27.31 13.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.718 -0.674 . . . . 0.17999999999999999 112.504 -171.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.708 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.89 -32.56 15.98 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.397 0.618 . . . . 1.05 112.452 -177.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.417 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.8 p -94.15 -43.24 8.57 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.951 -1.022 . . . . 1.0600000000000001 111.069 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.649 ' CD ' ' HG ' ' A' ' 433' ' ' LEU . 0.2 OUTLIER -87.59 -20.18 26.77 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.768 -1.106 . . . . 2.3700000000000001 109.153 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.59 47.7 63.02 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 113.631 -1.622 . . . . 0.23999999999999999 115.138 164.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.5 p -82.88 110.23 17.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 118.962 1.381 . . . . 1.7 111.675 -171.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 33.54 -117.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.291 -1.322 . . . . 0.56999999999999995 113.47 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -135.57 -16.32 0.91 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.906 -0.664 . . . . 0.28999999999999998 113.79 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.477 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.1 p -103.57 -166.56 1.27 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.834 0.817 . . . . 0.40000000000000002 112.621 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.53 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.0 mp -96.16 129.41 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.107 -0.952 . . . . 1.04 110.736 -175.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.59 93.41 5.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.976 -0.556 . . . . 0.62 110.332 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.682 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.2 m -89.14 141.98 29.7 Favored Pre-proline 0 N--CA 1.438 -1.038 0 CA-C-N 115.234 -0.894 . . . . 1.02 112.549 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.614 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 87.1 Cg_exo -49.61 144.77 18.58 Favored 'Trans proline' 0 CA--C 1.506 -0.89 0 C-N-CA 124.158 3.239 . . . . 0.23999999999999999 113.549 175.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.613 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.7 Cg_exo -65.12 -27.02 57.19 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.855 2.37 . . . . 0.31 112.234 -175.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.505 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 11.9 m -76.31 -23.9 54.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.863 -0.608 . . . . 1.48 112.237 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.735 ' O ' HD23 ' A' ' 364' ' ' LEU . 30.8 m -100.59 -48.7 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 113.009 0.744 . . . . 1.03 113.009 -169.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.92 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.87 -2.1 4.78 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.847 -0.741 . . . . 1.02 110.353 -178.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.505 ' HE3' ' O ' ' A' ' 448' ' ' SER . 15.8 pttp -80.81 -39.43 26.7 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.085 -1.08 . . . . 1.5900000000000001 108.085 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.58 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.4 mm-40 -61.45 -45.9 92.32 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 112.578 -2.101 . . . . 0.25 106.46 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.92 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.5 tp -47.69 -67.12 0.3 Allowed 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 109.701 -3.409 . . . . 1.02 112.719 172.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.552 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 14.4 t80 -45.93 -23.28 0.27 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.794 0.807 . . . . 0.17000000000000001 109.562 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.15 -26.01 27.29 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.72 -1.127 . . . . 0.13 111.842 -176.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.578 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -102.71 -43.91 5.45 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 113.504 0.927 . . . . 1.02 113.504 177.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.69 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.47 150.38 7.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 122.523 1.154 . . . . 1.01 111.196 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.54 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -120.84 156.77 31.23 Favored 'General case' 0 N--CA 1.414 -2.255 0 CA-C-N 112.978 -1.919 . . . . 0.47999999999999998 108.418 -177.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.563 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 4.2 mppt? -59.34 101.86 0.12 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.888 -0.782 . . . . 1.7 108.888 171.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.3 -11.74 5.81 Favored Glycine 0 C--N 1.306 -1.132 0 CA-C-N 113.955 -1.475 . . . . 0.22 111.482 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.579 HG21 ' HA ' ' A' ' 344' ' ' TYR . 15.6 m -66.65 149.33 98.29 Favored Pre-proline 0 N--CA 1.44 -0.964 0 N-CA-C 108.651 -0.87 . . . . 0.94999999999999996 108.651 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.572 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.6 Cg_endo -93.72 160.63 2.31 Favored 'Trans proline' 0 N--CA 1.422 -2.707 0 C-N-CA 122.196 1.931 . . . . 0.23000000000000001 109.929 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.729 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -123.99 150.07 28.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.281 -1.377 . . . . 1.27 107.281 171.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.7 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.6 mp -134.08 149.06 51.11 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 108.179 -1.045 . . . . 1.05 108.179 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.677 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -137.74 142.25 36.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 105.266 -2.124 . . . . 1.01 105.266 165.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 8.3 p90 . . . . . 0 C--O 1.244 0.79 0 O-C-N 123.83 0.706 . . . . 1.0900000000000001 110.787 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.709 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 111.945 -0.462 . . . . 2.48 111.945 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.587 ' CE1' HD22 ' A' ' 464' ' ' LEU . 1.9 p-80 -122.35 111.88 17.42 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.685 0.242 . . . . 1.1399999999999999 111.523 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.756 ' HG3' ' O ' ' A' ' 341' ' ' GLU . 0.0 OUTLIER 60.97 -172.15 0.14 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 124.121 0.888 . . . . 1.01 111.983 165.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . 0.756 ' O ' ' HG3' ' A' ' 340' ' ' MET . 12.7 pt-20 -63.92 -179.5 0.41 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 107.872 -1.159 . . . . 1.96 107.872 169.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.478 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 13.3 m-20 -82.36 82.69 7.74 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 117.618 -1.633 . . . . 0.42999999999999999 109.341 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 97.2 m -159.78 135.61 8.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.8 -1.091 . . . . 1.0 109.857 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.613 ' CD2' HD11 ' A' ' 464' ' ' LEU . 37.5 p90 173.02 159.7 0.12 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.192 0.308 . . . . 0.88 110.812 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.68 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.97 151.54 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 164.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.579 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 35.1 tt0 -149.72 141.05 23.22 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.486 -0.779 . . . . 2.0099999999999998 109.626 -176.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 464' ' ' LEU . 2.8 t -134.44 161.87 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 122.126 -0.359 . . . . 1.04 111.104 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.524 ' HA ' ' C ' ' A' ' 466' ' ' PHE . 20.7 t0 -140.26 107.21 5.42 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.663 -1.236 . . . . 0.23999999999999999 107.663 173.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.66 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -83.55 -33.35 25.46 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-O 122.77 1.271 . . . . 1.02 110.273 -168.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 466' ' ' PHE . 1.0 OUTLIER -59.72 -43.4 94.16 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 110.87 -2.877 . . . . 0.59999999999999998 108.261 177.03 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -102.83 8.12 39.35 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 111.153 -2.749 . . . . 0.20999999999999999 110.749 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.555 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 15.3 mp0 32.93 61.27 0.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 112.906 -1.952 . . . . 2.54 113.56 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.608 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 24.8 t60 -142.94 137.13 29.2 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.868 -0.605 . . . . 0.12 109.86 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.6 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.4 OUTLIER -114.48 156.53 24.39 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.249 -179.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.541 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.8 m-90 -142.21 154.18 44.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.482 -0.781 . . . . 0.11 111.191 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.696 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.5 t80 -110.15 153.11 25.18 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.491 -1.67 . . . . 1.1000000000000001 106.491 151.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.9 m-85 -127.61 117.12 21.41 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.883 -1.053 . . . . 0.60999999999999999 109.948 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.7 tppt? -118.13 140.05 50.35 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 105.854 -1.906 . . . . 0.93999999999999995 105.854 168.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.65 17.21 10.57 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.597 0.962 . . . . 0.42999999999999999 113.597 171.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.478 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.97 8.06 87.41 Favored Glycine 0 CA--C 1.483 -1.954 0 CA-C-O 122.064 0.813 . . . . 0.17999999999999999 112.961 -175.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 16.1 ptmt -126.83 177.26 6.7 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 104.484 -2.413 . . . . 1.0900000000000001 104.484 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 17.0 m -104.29 157.11 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.841 0 C-N-CA 116.982 -1.887 . . . . 1.02 115.626 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.565 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -106.61 -28.23 10.37 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-N 110.544 -3.025 . . . . 1.01 106.125 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.748 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -133.17 143.48 49.24 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 111.413 -2.63 . . . . 1.02 111.896 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.608 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -139.98 117.55 11.51 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 104.361 -2.459 . . . . 0.47999999999999998 104.361 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.662 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.6 OUTLIER -149.94 161.02 43.12 Favored 'General case' 0 N--CA 1.397 -3.11 0 C-N-CA 117.795 -1.562 . . . . 1.02 110.691 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.17 141.61 32.77 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.448 -0.945 . . . . 1.8 108.448 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.671 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -138.66 -172.82 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 CA-C-O 122.54 1.162 . . . . 1.01 111.947 -173.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.516 HG12 HE22 ' A' ' 426' ' ' GLN . 0.5 OUTLIER -151.86 120.13 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 112.725 -2.034 . . . . 1.04 108.197 173.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.542 ' HG ' HG13 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -80.13 -168.06 1.52 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.977 -1.465 . . . . 1.6000000000000001 110.36 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.418 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.19 168.32 44.54 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 118.528 -1.796 . . . . 0.14000000000000001 112.26 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 5.3 ptmt -73.8 158.11 86.48 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.56 0.695 . . . . 1.47 112.037 -165.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.64 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 82.3 Cg_exo -57.68 -30.66 89.68 Favored 'Trans proline' 0 CA--C 1.493 -1.555 0 C-N-CA 125.273 3.982 . . . . 0.28000000000000003 113.347 -172.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.402 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 22.7 p -68.61 -33.81 74.69 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.346 -1.752 . . . . 1.0800000000000001 109.325 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.68 HG23 ' NAX' ' A' ' 130' ' ' 1RG . 3.5 t -142.88 70.28 19.15 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 123.585 1.659 . . . . 1.1000000000000001 110.37 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 375' ' ' THR . 83.4 Cg_exo -58.99 157.43 29.2 Favored 'Trans proline' 0 C--N 1.314 -1.273 1 C-N-CA 126.601 4.868 . . . . 0.38 115.145 -171.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.517 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -86.37 147.87 45.57 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 115.192 -0.913 . . . . 1.1299999999999999 108.702 173.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -78.08 -44.64 0.16 Allowed 'Trans proline' 0 CA--C 1.512 -0.592 0 C-N-CA 124.853 3.702 . . . . 0.20999999999999999 112.417 -167.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.658 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.49 138.52 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 123.345 1.545 . . . . 1.0600000000000001 113.639 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.69 -115.13 0.68 Allowed Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 112.27 -2.241 . . . . 0.20000000000000001 109.318 -177.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.436 ' O ' HG11 ' A' ' 381' ' ' VAL . 4.6 p -128.35 121.18 54.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.846 0.832 . . . . 1.5 110.266 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.606 ' HD2' ' CD1' ' A' ' 382' ' ' PHE . 2.9 m-85 -118.32 -174.38 2.65 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.87 -1.529 . . . . 0.28000000000000003 106.87 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 2.3 t80 -139.67 123.02 17.09 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 120.801 -1.187 . . . . 0.96999999999999997 112.937 -171.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.41 92.7 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 123.056 1.407 . . . . 1.02 109.544 170.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -92.94 10.82 29.64 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 113.317 -1.765 . . . . 3.1299999999999999 108.334 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.749 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.1 t30 -169.21 126.91 0.96 Allowed 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 114.149 -1.387 . . . . 0.42999999999999999 110.393 172.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.646 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.11 142.7 30.26 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.825 -1.079 . . . . 1.73 108.944 168.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 23.7 mm-40 -123.9 162.44 23.33 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 114.835 1.42 . . . . 0.70999999999999996 114.835 -169.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 43.7 mt-10 -129.86 144.98 51.58 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 112.927 -1.942 . . . . 0.38 105.953 170.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.9 t70 39.51 47.66 1.65 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 122.766 1.269 . . . . 0.40999999999999998 109.834 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.485 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -82.8 168.15 17.42 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 111.937 -2.392 . . . . 1.02 108.977 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 10.2 m -132.04 119.5 21.11 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.948 0.88 . . . . 1.04 111.24 170.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.9 mp -77.27 87.12 3.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.852 -1.522 . . . . 1.27 111.787 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.572 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.3 mttt -102.44 -179.71 4.06 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 113.266 -1.788 . . . . 0.96999999999999997 113.406 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 138.86 -163.28 25.9 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.34 -1.3 . . . . 0.46000000000000002 111.375 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 0.9 OUTLIER -120.08 137.95 53.83 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 119.876 -0.73 . . . . 1.3500000000000001 111.129 172.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.539 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.6 m-80 -56.74 151.32 14.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.979 -1.009 . . . . 0.83999999999999997 109.084 167.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.665 ' OD1' ' HDA' ' A' ' 130' ' ' 1RG . 0.6 OUTLIER -58.7 -2.6 0.23 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.329 -0.85 . . . . 2.2799999999999998 112.201 176.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 397' ' ' ASN . 21.9 t70 -113.17 0.33 14.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 122.013 0.911 . . . . 2.27 110.251 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.18 17.25 32.52 Favored Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 114.746 -1.115 . . . . 0.97999999999999998 112.872 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 14.3 p -110.21 98.96 37.9 Favored Pre-proline 0 C--N 1.301 -1.523 0 CA-C-N 114.723 -0.738 . . . . 1.3999999999999999 109.828 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.7 Cg_endo -59.46 149.92 78.67 Favored 'Trans proline' 0 CA--C 1.499 -1.271 0 C-N-CA 122.574 2.183 . . . . 0.67000000000000004 112.577 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.621 ' HD2' ' CD1' ' A' ' 403' ' ' TYR . 29.9 p90 -147.42 172.14 14.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.228 -1.351 . . . . 1.04 112.251 -169.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.572 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 1.3 mp0 -146.08 148.1 32.28 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.255 -1.339 . . . . 0.53000000000000003 110.779 174.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.79 97.55 4.94 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 107.98 -1.119 . . . . 0.45000000000000001 107.98 170.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 22.7 Cg_exo -68.58 110.24 2.26 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.076 1.851 . . . . 0.22 110.631 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.63 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -110.55 158.4 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 CA-C-N 113.036 -1.893 . . . . 1.04 107.912 -168.305 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.637 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.8 OUTLIER -92.04 -19.43 22.37 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.934 -0.765 . . . . 0.65000000000000002 108.934 -174.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 0.637 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.9 m-85 -160.46 127.88 4.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.025 -1.102 . . . . 0.92000000000000004 108.025 -171.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.0 t-105 -144.93 131.51 19.87 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.746 0.784 . . . . 0.10000000000000001 111.561 -166.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.646 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.4 mmt -112.91 92.32 20.57 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 107.866 -1.161 . . . . 1.01 107.866 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.749 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.7 Cg_endo -67.63 76.14 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.265 1.976 . . . . 0.5 111.626 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.586 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.5 pt -75.16 179.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.028 -0.73 . . . . 1.05 109.028 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.618 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 8.0 t70 -147.05 -167.3 2.74 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.246 -0.65 . . . . 2.4900000000000002 109.246 -168.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.618 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 12.8 m-90 82.8 -67.29 0.08 Allowed 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.962 0.789 . . . . 2.3700000000000001 112.264 177.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 71.4 p -108.01 -9.19 15.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.522 -0.763 . . . . 1.5700000000000001 112.108 -166.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 110.63 -29.85 8.66 Favored Glycine 0 CA--C 1.507 -0.409 0 C-N-CA 120.705 -0.759 . . . . 0.68000000000000005 112.713 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.58 HG13 ' N ' ' A' ' 419' ' ' GLY . 36.6 t -56.26 172.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.484 0.714 . . . . 1.45 112.115 -176.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.586 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -174.87 121.11 0.81 Allowed Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 110.084 -1.206 . . . . 0.20000000000000001 110.084 169.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.629 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.2 mp -82.09 142.22 13.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 110.107 -0.331 . . . . 1.0900000000000001 110.107 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.589 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.0 p80 -159.5 161.73 35.42 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.094 -0.503 . . . . 0.10000000000000001 111.37 -174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.63 ' O ' HG21 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -86.5 148.11 25.67 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.962 -1.125 . . . . 1.0700000000000001 107.962 172.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.6 t -133.14 96.57 3.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.907 0.86 . . . . 0.5 110.136 -171.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -80.14 -16.2 55.42 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.103 -1.408 . . . . 0.41999999999999998 109.281 -176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.618 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 11.4 p90 -88.53 -24.63 22.87 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.825 -1.534 . . . . 0.32000000000000001 111.408 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.53 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 1.6 tt0 -97.68 116.38 65.78 Favored Pre-proline 0 CA--C 1.507 -0.681 0 CA-C-O 122.817 1.294 . . . . 1.74 110.351 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.57 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 42.6 Cg_endo -87.65 -9.78 5.56 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 124.217 3.278 . . . . 0.87 113.22 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.57 ' OE2' ' HD2' ' A' ' 427' ' ' PRO . 1.9 pm0 -111.96 152.42 28.09 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 122.312 1.053 . . . . 2.1600000000000001 113.375 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.927 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.81 128.54 3.3 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 112.587 -2.097 . . . . 0.91000000000000003 105.769 171.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.35 -157.8 30.18 Favored Glycine 0 C--N 1.281 -2.502 0 C-N-CA 119.892 -1.147 . . . . 0.20000000000000001 110.404 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.432 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.88 173.89 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.064 -1.065 . . . . 0.25 111.574 167.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.506 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.4 p-10 -51.47 102.35 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 123.448 1.594 . . . . 1.8500000000000001 113.893 -152.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.647 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.56 -37.5 10.35 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-N 112.6 -2.091 . . . . 1.8200000000000001 109.782 168.187 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.713 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.2 p-90 -53.9 -27.0 27.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.457 -0.792 . . . . 0.17999999999999999 112.274 -170.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.713 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.46 -35.38 15.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.587 0.588 . . . . 1.05 112.587 -178.072 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.9 p -90.1 -42.56 11.02 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.07 -0.968 . . . . 1.0600000000000001 110.943 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.647 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.1 mtp180 -92.94 -18.51 22.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.651 -1.159 . . . . 2.3700000000000001 109.524 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.24 49.17 45.16 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 115.642 1.017 . . . . 0.23999999999999999 115.642 160.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 28.3 m -83.75 111.49 19.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 119.162 1.481 . . . . 1.7 111.598 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 35.99 -115.69 0.1 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.594 0.961 . . . . 0.56999999999999995 113.594 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.418 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -137.35 -20.31 0.56 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.423 -0.808 . . . . 0.28999999999999998 113.64 -174.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.506 ' HB3' ' HAS' ' A' ' 130' ' ' 1RG . 27.1 p -97.66 -167.26 1.5 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.003 0.901 . . . . 0.40000000000000002 112.624 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.542 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.0 mp -99.39 130.14 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 114.864 -1.062 . . . . 1.04 110.535 -175.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.88 94.32 5.75 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.763 -0.653 . . . . 0.62 110.198 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.671 ' HA ' HG23 ' A' ' 368' ' ' ILE . 4.3 m -90.41 144.41 30.78 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.017 -0.992 . . . . 1.02 112.555 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.662 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 73.0 Cg_exo -52.13 145.4 34.37 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 124.114 3.209 . . . . 0.23999999999999999 113.365 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.927 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 36.8 Cg_exo -66.3 -30.6 45.07 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.956 2.437 . . . . 0.31 112.392 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.533 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 13.8 m -72.13 -23.6 61.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.75 -0.659 . . . . 1.48 111.725 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.748 ' O ' HD23 ' A' ' 364' ' ' LEU . 26.4 m -100.51 -49.38 11.17 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 N-CA-C 112.858 0.688 . . . . 1.03 112.858 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.92 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.24 -2.1 5.41 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.707 -0.797 . . . . 1.02 110.29 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.533 ' HE3' ' O ' ' A' ' 448' ' ' SER . 16.4 pttp -81.03 -38.08 28.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.505 1.145 . . . . 1.5900000000000001 108.137 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.574 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.9 mm-40 -62.83 -46.23 88.9 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 112.36 -2.2 . . . . 0.25 106.513 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.92 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.5 tp -47.78 -66.56 0.38 Allowed 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 109.843 -3.344 . . . . 1.02 112.511 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.509 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 22.6 t80 -45.96 -23.27 0.28 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 123.903 0.752 . . . . 0.17000000000000001 109.597 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.92 -25.04 28.18 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.849 -1.068 . . . . 0.13 111.878 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.604 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -103.73 -44.2 5.14 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 113.425 0.898 . . . . 1.02 113.425 176.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.49 150.74 7.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-O 122.44 1.114 . . . . 1.01 111.125 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.538 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.09 155.74 35.05 Favored 'General case' 0 N--CA 1.412 -2.332 0 CA-C-N 112.849 -1.978 . . . . 0.47999999999999998 108.602 -177.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.616 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 43.8 mtmt -55.96 102.14 0.07 Allowed 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.669 0.747 . . . . 1.7 109.696 170.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.18 -8.93 6.67 Favored Glycine 0 C--N 1.304 -1.23 0 CA-C-N 113.762 -1.563 . . . . 0.22 111.716 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.568 HG21 ' HA ' ' A' ' 344' ' ' TYR . 9.0 m -68.37 149.46 98.04 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 108.833 -0.803 . . . . 0.94999999999999996 108.833 172.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.53 ' HD3' ' HE2' ' A' ' 340' ' ' MET . 5.4 Cg_endo -93.82 156.69 2.3 Favored 'Trans proline' 0 N--CA 1.424 -2.579 0 C-N-CA 122.3 2.0 . . . . 0.23000000000000001 109.906 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.711 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -121.9 149.03 25.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.554 -1.276 . . . . 1.27 107.554 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.697 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.6 mp -134.08 149.02 51.1 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.548 -0.908 . . . . 1.05 108.548 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.695 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -137.35 141.4 39.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 105.589 -2.004 . . . . 1.01 105.589 165.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.579 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 7.6 p90 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.469 -1.253 . . . . 1.0900000000000001 110.926 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.753 ' HB ' ' CAM' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.896 -0.481 . . . . 2.48 111.896 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.723 ' CE1' HD23 ' A' ' 464' ' ' LEU . 2.2 p-80 -132.3 105.85 7.56 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.692 0.246 . . . . 1.1399999999999999 111.065 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.556 ' HE3' ' HD3' ' A' ' 462' ' ' PRO . 1.6 mtm 56.22 -162.58 0.17 Allowed 'General case' 0 C--O 1.232 0.163 0 O-C-N 124.136 0.897 . . . . 1.01 111.675 167.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -153.21 0.08 Allowed 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 120.923 -0.311 . . . . 1.96 110.892 166.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.463 ' HB3' ' N ' ' A' ' 360' ' ' GLY . 33.7 m-20 -95.49 83.8 3.87 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.296 -1.362 . . . . 0.42999999999999999 111.83 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 1.137 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 96.8 m -159.28 134.37 8.22 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.021 163.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.677 ' CD2' HD11 ' A' ' 464' ' ' LEU . 39.5 p90 174.63 157.84 0.16 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 120.856 0.36 . . . . 0.88 111.759 -175.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.682 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.2 OUTLIER -77.86 152.59 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 164.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.528 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.1 tt0 -150.52 142.96 24.38 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.741 -0.663 . . . . 2.0099999999999998 109.415 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.693 HG21 ' O ' ' A' ' 464' ' ' LEU . 2.6 t -134.62 162.37 38.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.124 0.488 . . . . 1.04 111.382 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.533 ' HA ' ' C ' ' A' ' 466' ' ' PHE . 29.3 t0 -140.05 106.32 5.26 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.356 -1.35 . . . . 0.23999999999999999 107.356 173.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.668 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -83.11 -34.9 26.0 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 123.365 1.555 . . . . 1.02 110.075 -169.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.42 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 0.4 OUTLIER -54.91 -44.98 74.67 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 110.705 -2.952 . . . . 0.59999999999999998 107.692 176.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 23.5 m-80 -103.36 6.77 38.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 111.219 -2.718 . . . . 0.20999999999999999 111.563 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.736 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 15.6 mm-40 32.82 62.35 0.35 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 112.791 -2.004 . . . . 2.54 113.615 -175.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.621 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.0 t60 -141.47 135.15 29.98 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.213 -0.903 . . . . 0.12 109.475 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.59 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.4 OUTLIER -112.71 157.26 21.51 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.375 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.523 ' CD1' HG12 ' A' ' 362' ' ' VAL . 30.3 m-90 -142.27 155.27 45.21 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.713 -0.676 . . . . 0.11 111.416 -175.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.137 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 88.2 t80 -111.2 153.34 25.96 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 106.811 -1.551 . . . . 1.1000000000000001 106.811 151.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 17.1 m-85 -127.42 119.18 25.56 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.947 -1.024 . . . . 0.60999999999999999 110.048 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.458 ' HB2' ' HE2' ' A' ' 356' ' ' TYR . 10.4 tppt? -123.14 112.89 18.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.097 -0.956 . . . . 0.93999999999999995 108.547 173.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 358' ' ' LYS . 0.2 OUTLIER 75.97 41.26 0.24 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 123.914 0.759 . . . . 0.42999999999999999 112.683 -177.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.463 ' N ' ' HB3' ' A' ' 342' ' ' ASP . . . 59.24 16.79 35.79 Favored Glycine 0 CA--C 1.496 -1.14 0 CA-C-O 122.372 0.984 . . . . 0.17999999999999999 113.232 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 358' ' ' LYS . 14.9 ptmt -140.32 167.66 21.61 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 104.534 -2.395 . . . . 1.0900000000000001 104.534 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.1 m -98.89 157.56 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.735 0 N-CA-C 116.057 1.873 . . . . 1.02 116.057 -171.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.639 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.99 -27.51 9.18 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 110.357 -3.11 . . . . 1.01 106.21 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.4 143.99 47.92 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 111.563 -2.562 . . . . 1.02 111.846 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.621 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 2.9 tt0 -141.37 118.61 11.38 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 104.359 -2.46 . . . . 0.47999999999999998 104.359 175.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.592 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -150.29 165.55 32.67 Favored 'General case' 0 N--CA 1.403 -2.781 0 C-N-CA 118.07 -1.452 . . . . 1.02 112.157 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.711 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 12.4 p-10 -102.05 135.44 43.62 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.174 -1.376 . . . . 1.8 109.63 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.675 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.3 pp -138.24 -173.06 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.252 0 CA-C-O 122.212 1.006 . . . . 1.01 112.754 -170.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.736 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -152.86 120.97 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 112.895 -1.957 . . . . 1.04 109.468 171.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.566 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.6 OUTLIER -77.95 -168.92 1.38 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.874 -1.512 . . . . 1.6000000000000001 110.678 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -86.32 173.3 46.05 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.063 -1.541 . . . . 0.14000000000000001 112.272 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -78.54 158.38 76.19 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.614 0.721 . . . . 1.47 111.921 -166.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.603 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 92.8 Cg_exo -56.64 -28.95 77.54 Favored 'Trans proline' 0 CA--C 1.498 -1.311 0 C-N-CA 125.273 3.982 . . . . 0.28000000000000003 113.234 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.46 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 16.9 p -69.52 -33.99 73.62 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.33 -1.759 . . . . 1.0800000000000001 109.855 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.7 t -140.73 70.35 30.6 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 123.841 1.781 . . . . 1.1000000000000001 108.801 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 375' ' ' THR . 85.4 Cg_exo -57.31 154.33 35.46 Favored 'Trans proline' 0 C--N 1.31 -1.465 1 C-N-CA 126.522 4.814 . . . . 0.38 115.447 -169.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.566 HG22 ' OG ' ' A' ' 370' ' ' SER . 2.2 m -80.6 130.74 63.43 Favored Pre-proline 0 N--CA 1.404 -2.76 0 CA-C-N 114.116 -1.402 . . . . 1.1299999999999999 108.611 172.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.1 Cg_exo -72.0 -43.86 1.07 Allowed 'Trans proline' 0 CA--C 1.511 -0.664 0 C-N-CA 123.599 2.866 . . . . 0.20999999999999999 111.772 -170.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.674 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.19 137.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 123.412 1.577 . . . . 1.0600000000000001 113.542 -173.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 154.3 -121.78 1.17 Allowed Glycine 0 N--CA 1.429 -1.8 0 CA-C-N 112.218 -2.264 . . . . 0.20000000000000001 109.401 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 72.5 t -125.23 110.65 25.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.345 0.593 . . . . 1.5 110.632 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.609 ' HE1' ' CE2' ' A' ' 382' ' ' PHE . 5.1 m-85 -110.32 -173.87 2.35 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.405 -1.331 . . . . 0.28000000000000003 107.405 174.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 2.4 t80 -141.27 121.92 14.26 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 120.844 -1.16 . . . . 0.96999999999999997 112.827 -172.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.6 p -82.81 92.71 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 CA-C-O 122.827 1.299 . . . . 1.02 108.839 170.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 49.6 p-90 -83.95 0.35 48.26 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 113.201 -1.818 . . . . 3.1299999999999999 107.806 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.789 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 5.9 t30 -170.33 128.18 0.84 Allowed 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 114.744 -1.116 . . . . 0.42999999999999999 110.662 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.627 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -95.96 141.95 28.77 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.388 -0.823 . . . . 1.73 109.086 169.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.708 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 9.9 mm-40 -126.75 159.95 32.27 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 114.786 1.402 . . . . 0.70999999999999996 114.786 -167.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 52.2 mt-10 -137.34 128.14 27.19 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.071 -1.877 . . . . 0.38 108.867 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.4 t70 53.91 45.22 28.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 123.386 1.565 . . . . 0.40999999999999998 108.884 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -80.03 167.64 20.18 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 112.104 -2.317 . . . . 1.02 109.477 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 16.9 m -132.46 119.06 20.11 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.051 0.929 . . . . 1.04 111.903 171.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -78.41 88.66 4.4 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.693 -1.594 . . . . 1.27 112.119 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.587 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.7 mttt -102.42 177.8 4.77 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 113.666 -1.606 . . . . 0.96999999999999997 113.811 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.93 -160.8 25.82 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 114.009 -1.45 . . . . 0.46000000000000002 111.414 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.7 m -115.71 144.19 44.31 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 120.279 -0.569 . . . . 1.3500000000000001 110.852 171.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 399' ' ' ASP . 4.8 m-80 -60.25 152.06 25.79 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.377 -0.829 . . . . 0.83999999999999997 109.331 166.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.0 -2.52 0.25 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.095 -0.957 . . . . 2.2799999999999998 112.172 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 397' ' ' ASN . 9.6 m-20 -114.28 0.94 14.32 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.422 0.63 . . . . 2.27 110.562 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.79 18.02 28.78 Favored Glycine 0 N--CA 1.427 -1.906 0 CA-C-N 114.889 -1.05 . . . . 0.97999999999999998 113.177 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 10.8 p -112.45 100.29 49.54 Favored Pre-proline 0 C--N 1.303 -1.413 0 CA-C-O 121.544 0.688 . . . . 1.3999999999999999 109.904 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 19.2 Cg_endo -58.88 152.8 55.07 Favored 'Trans proline' 0 CA--C 1.503 -1.044 0 C-N-CA 122.867 2.378 . . . . 0.67000000000000004 113.349 -176.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.637 ' HD2' ' CD1' ' A' ' 403' ' ' TYR . 27.6 p90 -152.35 173.14 15.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.507 -1.224 . . . . 1.04 112.497 -170.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.587 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER -145.71 147.19 31.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.025 -1.443 . . . . 0.53000000000000003 110.152 172.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.516 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.08 97.23 5.3 Favored Pre-proline 0 N--CA 1.437 -1.114 0 N-CA-C 108.38 -0.97 . . . . 0.45000000000000001 108.38 172.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.9 Cg_exo -68.62 111.44 2.57 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 122.102 1.868 . . . . 0.22 110.268 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.601 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -111.72 155.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 CA-C-N 112.861 -1.972 . . . . 1.04 107.746 -168.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.646 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.1 m-80 -86.86 -20.47 27.42 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.316 -0.624 . . . . 0.65000000000000002 109.316 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 97.7 m-85 -160.24 127.51 4.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.866 -1.061 . . . . 0.92000000000000004 108.189 -171.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.625 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 17.3 t-105 -142.95 131.27 22.11 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.591 0.71 . . . . 0.10000000000000001 111.07 -167.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.627 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 13.3 mmt -116.34 86.67 18.21 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.279 -1.008 . . . . 1.01 108.279 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.789 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 15.0 Cg_endo -59.17 118.38 5.25 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 120.945 1.096 . . . . 0.5 109.372 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.572 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.8 pt -119.66 39.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 123.578 1.656 . . . . 1.05 106.603 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -91.98 125.2 36.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.367 -2.197 . . . . 2.4900000000000002 112.399 -158.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 1.7 p90 155.16 -23.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.371 1.868 . . . . 2.3700000000000001 106.615 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 8.5 t -105.06 -28.55 10.97 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.199 -1.364 . . . . 1.5700000000000001 109.734 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 136.88 -57.59 0.67 Allowed Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.002 -0.618 . . . . 0.68000000000000005 112.361 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 419' ' ' GLY . 22.1 t -54.91 173.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.13 0.972 . . . . 1.45 112.628 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.593 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -178.26 119.24 0.65 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.61 -0.996 . . . . 0.20000000000000001 110.61 170.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.607 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.5 mt -81.13 144.15 11.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 120.836 0.35 . . . . 1.0900000000000001 111.06 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.594 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.9 p80 -159.41 161.54 35.6 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.028 -0.533 . . . . 0.10000000000000001 111.218 -174.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.2 149.51 25.46 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.826 -1.176 . . . . 1.0700000000000001 107.826 171.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 445' ' ' THR . 34.3 t -133.31 96.5 3.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.553 0.692 . . . . 0.5 110.034 -171.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.25 -15.29 53.58 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.736 -1.12 . . . . 0.41999999999999998 109.387 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.601 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 7.7 p90 -86.43 -23.07 26.2 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.658 -1.61 . . . . 0.32000000000000001 111.472 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.587 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 4.3 tt0 -92.92 131.05 34.33 Favored Pre-proline 0 CA--C 1.506 -0.739 0 CA-C-O 121.651 0.739 . . . . 1.74 111.118 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.564 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 64.3 Cg_endo -85.49 -27.03 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 123.193 2.596 . . . . 0.87 113.377 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.587 ' HG2' ' NE2' ' A' ' 426' ' ' GLN . 0.9 OUTLIER -107.96 150.86 26.57 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.563 1.173 . . . . 2.1600000000000001 113.481 -178.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.752 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -157.35 132.04 8.64 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.101 -2.318 . . . . 0.91000000000000003 105.307 167.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.04 -159.57 32.84 Favored Glycine 0 C--N 1.283 -2.363 0 C-N-CA 120.095 -1.05 . . . . 0.20000000000000001 110.511 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.449 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -47.06 175.32 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 120.24 -0.981 . . . . 0.25 111.621 168.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.504 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.4 p-10 -50.53 101.03 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.625 1.678 . . . . 1.8500000000000001 113.764 -154.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.632 ' CD2' ' HD2' ' A' ' 437' ' ' ARG . 34.7 mt -97.68 -37.89 9.73 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.007 -2.36 . . . . 1.8200000000000001 107.858 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.69 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 64.8 p-90 -48.39 -34.39 10.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.182 0.438 . . . . 0.17999999999999999 112.182 -172.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.69 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -83.96 -36.9 22.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.934 -0.576 . . . . 1.05 112.144 -175.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.451 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.8 p -88.09 -41.89 12.75 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.247 -0.888 . . . . 1.0600000000000001 110.534 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.632 ' HD2' ' CD2' ' A' ' 433' ' ' LEU . 0.0 OUTLIER -93.8 -19.19 21.26 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.629 -1.169 . . . . 2.3700000000000001 110.067 -177.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.652 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.5 48.11 55.8 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.744 -1.116 . . . . 0.23999999999999999 114.875 163.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 35.2 m -85.2 111.73 20.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 118.71 1.255 . . . . 1.7 111.794 -173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 36.35 -121.59 0.16 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.717 -1.129 . . . . 0.56999999999999995 113.969 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -134.6 -12.87 1.32 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.106 -0.569 . . . . 0.28999999999999998 113.967 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.511 ' HB3' ' HAS' ' A' ' 130' ' ' 1RG . 28.4 p -104.27 -166.59 1.26 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.987 0.894 . . . . 0.40000000000000002 112.839 -176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.555 HG13 ' HG ' ' A' ' 370' ' ' SER . 1.9 mp -97.49 131.4 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.023 -0.989 . . . . 1.04 110.665 -175.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.71 93.59 5.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.714 -0.676 . . . . 0.62 110.248 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.675 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.2 m -89.01 143.98 32.09 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 114.962 -1.017 . . . . 1.02 112.578 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.592 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 77.1 Cg_exo -52.17 145.58 34.03 Favored 'Trans proline' 0 CA--C 1.506 -0.896 0 C-N-CA 124.055 3.17 . . . . 0.23999999999999999 113.246 174.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.752 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 31.3 Cg_exo -65.39 -26.97 55.18 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.995 2.464 . . . . 0.31 112.552 -176.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.494 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 52.1 p -75.7 -25.08 56.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.9 0.857 . . . . 1.48 112.054 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.738 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.9 m -99.57 -50.49 10.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.556 -0.747 . . . . 1.03 112.806 -171.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.931 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.43 -2.1 4.23 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.796 -0.762 . . . . 1.02 110.37 -177.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.496 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.7 pttp -81.3 -39.04 25.81 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.417 1.104 . . . . 1.5900000000000001 108.05 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.58 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.0 mm-40 -61.63 -46.28 90.47 Favored 'General case' 0 CA--C 1.472 -2.036 0 CA-C-N 112.488 -2.142 . . . . 0.25 106.579 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.931 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.2 tp -47.05 -66.39 0.41 Allowed 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 109.713 -3.403 . . . . 1.02 112.647 172.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.52 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 21.6 t80 -45.9 -23.69 0.31 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 123.9 0.75 . . . . 0.17000000000000001 109.547 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.31 -25.65 27.93 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 114.791 -1.095 . . . . 0.13 111.97 -176.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.634 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -103.61 -44.9 4.98 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 113.566 0.95 . . . . 1.02 113.566 177.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.682 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -71.45 145.96 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.587 1.184 . . . . 1.01 111.026 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.487 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -114.55 156.07 25.3 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 112.894 -1.957 . . . . 0.47999999999999998 108.679 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.608 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 39.5 mtmt -59.31 103.27 0.17 Allowed 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.778 0.799 . . . . 1.7 109.225 169.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 127.82 -10.18 6.72 Favored Glycine 0 C--N 1.302 -1.33 0 CA-C-N 113.592 -1.64 . . . . 0.22 111.403 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 344' ' ' TYR . 6.1 m -67.81 149.75 98.1 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 108.067 -1.086 . . . . 0.94999999999999996 108.067 169.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.556 ' HD3' ' HE3' ' A' ' 340' ' ' MET . 8.4 Cg_endo -94.75 167.3 1.71 Allowed 'Trans proline' 0 N--CA 1.416 -3.08 0 C-N-CA 121.943 1.762 . . . . 0.23000000000000001 109.589 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.73 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -128.37 153.86 38.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.109 -1.071 . . . . 1.27 108.109 171.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.723 HD23 ' CE1' ' A' ' 339' ' ' HIS . 5.7 mp -134.26 151.14 51.12 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 108.621 -0.881 . . . . 1.05 108.621 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.6 OUTLIER -140.01 139.55 36.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 105.135 -2.172 . . . . 1.01 105.135 165.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.533 ' C ' ' HA ' ' A' ' 348' ' ' ASP . 13.4 p90 . . . . . 0 C--O 1.243 0.72 0 O-C-N 123.744 0.652 . . . . 1.0900000000000001 111.219 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.734 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 112.054 -0.418 . . . . 2.48 112.054 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.592 ' CD2' HD12 ' A' ' 464' ' ' LEU . 2.0 p-80 -136.17 102.82 5.12 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.867 0.334 . . . . 1.1399999999999999 111.724 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.547 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.2 OUTLIER 61.99 -165.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.059 0.849 . . . . 1.01 112.458 167.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.27 172.92 3.5 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.11 -1.441 . . . . 1.96 107.11 164.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.425 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 3.2 m-20 -81.9 83.05 7.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.256 -0.978 . . . . 0.42999999999999999 109.34 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 97.6 m -158.55 136.21 10.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.589 -1.187 . . . . 1.0 109.113 169.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.692 ' CD2' HD11 ' A' ' 464' ' ' LEU . 31.9 p90 174.85 157.32 0.16 Allowed 'General case' 0 CA--C 1.5 -0.969 0 O-C-N 123.511 0.507 . . . . 0.88 111.129 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.68 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.6 OUTLIER -76.71 151.64 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 108.495 -0.928 . . . . 1.0 108.495 164.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.822 ' CD ' ' HE1' ' A' ' 466' ' ' PHE . 6.9 tp10 -149.57 146.3 27.26 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.504 -0.771 . . . . 2.0099999999999998 109.902 -173.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.711 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -143.04 160.33 17.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.382 0.611 . . . . 1.04 111.667 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.538 ' N ' HG13 ' A' ' 347' ' ' VAL . 27.1 t0 -141.07 106.47 5.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.378 -1.341 . . . . 0.23999999999999999 107.378 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.652 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.41 -34.61 28.22 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 122.717 1.246 . . . . 1.02 110.42 -167.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.431 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 1.5 mt-10 -57.43 -44.12 84.44 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 110.88 -2.873 . . . . 0.59999999999999998 108.013 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -100.67 5.26 43.73 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 111.045 -2.798 . . . . 0.20999999999999999 111.037 -175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.587 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.5 mp0 34.96 61.54 0.6 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 112.766 -2.016 . . . . 2.54 113.367 -175.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.59 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.5 t60 -142.61 135.46 28.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.785 -0.643 . . . . 0.12 109.664 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.598 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.73 158.27 20.28 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.829 -0.623 . . . . 1.0 109.86 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.587 ' CD1' HG12 ' A' ' 362' ' ' VAL . 32.5 m-90 -143.23 158.55 43.52 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.358 0.663 . . . . 0.11 110.695 -176.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.68 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.4 t80 -111.86 153.36 26.77 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.176 -1.787 . . . . 1.1000000000000001 106.176 150.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 7.9 m-85 -127.74 116.31 20.03 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.13 -0.941 . . . . 0.60999999999999999 110.15 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.3 tppt? -117.97 138.91 51.85 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.215 -1.772 . . . . 0.93999999999999995 106.215 168.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.43 17.14 9.18 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.268 0.84 . . . . 0.42999999999999999 113.268 172.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.38 7.66 87.82 Favored Glycine 0 CA--C 1.488 -1.647 0 C-N-CA 120.801 -0.714 . . . . 0.17999999999999999 112.937 -174.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.3 ptmt -128.68 178.4 6.36 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 104.486 -2.412 . . . . 1.0900000000000001 104.486 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.587 HG12 ' CD1' ' A' ' 355' ' ' TRP . 16.0 m -105.01 158.2 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 116.339 1.977 . . . . 1.02 116.339 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.575 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.36 -26.93 9.76 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 110.625 -2.989 . . . . 1.01 106.456 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.714 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.37 144.53 48.29 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 111.477 -2.601 . . . . 1.02 111.432 -176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.59 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.1 tt0 -141.19 117.77 10.91 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 104.374 -2.454 . . . . 0.47999999999999998 104.374 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.598 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.66 163.5 37.74 Favored 'General case' 0 N--CA 1.399 -2.98 0 C-N-CA 117.896 -1.521 . . . . 1.02 111.306 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.445 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 22.2 p-10 -103.4 136.46 43.11 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 114.907 -1.042 . . . . 1.8 109.484 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.702 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -136.13 -174.04 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 CA-C-O 122.484 1.135 . . . . 1.01 112.559 -170.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.7 OUTLIER -150.54 119.68 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 112.731 -2.031 . . . . 1.04 107.798 173.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.544 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.74 -168.49 1.6 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.269 -1.332 . . . . 1.6000000000000001 110.132 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -83.87 165.39 41.87 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 118.419 -1.848 . . . . 0.14000000000000001 112.636 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.5 ptmt -67.06 155.76 89.53 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.719 -0.74 . . . . 1.47 112.22 -167.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.626 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 95.1 Cg_exo -55.95 -30.74 79.08 Favored 'Trans proline' 0 CA--C 1.495 -1.458 1 C-N-CA 125.332 4.021 . . . . 0.28000000000000003 113.932 -173.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 23.3 p -68.65 -30.67 69.42 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.882 -1.508 . . . . 1.0800000000000001 109.546 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.552 HG23 ' CB ' ' A' ' 398' ' ' ASP . 1.2 t -141.97 70.82 23.88 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 123.266 1.508 . . . . 1.1000000000000001 110.032 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 375' ' ' THR . 72.8 Cg_exo -58.62 148.24 83.0 Favored 'Trans proline' 0 C--N 1.307 -1.614 1 C-N-CA 126.028 4.485 . . . . 0.38 113.603 -172.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.544 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -77.93 144.54 68.31 Favored Pre-proline 0 N--CA 1.423 -1.812 0 N-CA-C 108.546 -0.909 . . . . 1.1299999999999999 108.546 175.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.2 Cg_exo -75.4 -45.07 0.27 Allowed 'Trans proline' 0 CA--C 1.51 -0.722 0 C-N-CA 124.352 3.368 . . . . 0.20999999999999999 111.705 -167.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.662 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 60.21 139.24 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 123.051 1.405 . . . . 1.0600000000000001 113.148 -172.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.8 -117.66 0.84 Allowed Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 112.558 -2.11 . . . . 0.20000000000000001 109.317 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.41 ' O ' HG11 ' A' ' 381' ' ' VAL . 9.4 p -130.38 114.44 28.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.993 0.901 . . . . 1.5 110.616 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.61 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.4 m-85 -113.16 -174.06 2.38 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.246 -1.39 . . . . 0.28000000000000003 107.246 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.425 ' HB2' ' CZ2' ' A' ' 415' ' ' TRP . 1.2 t80 -140.44 123.75 16.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.369 1.44 . . . . 0.96999999999999997 113.513 -172.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -89.93 92.57 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 CA-C-O 123.009 1.385 . . . . 1.02 109.543 169.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -93.12 11.1 28.92 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.416 -1.72 . . . . 3.1299999999999999 108.176 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.727 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.0 t30 -169.21 126.64 0.95 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 113.927 -1.488 . . . . 0.42999999999999999 110.366 172.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.68 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -98.46 140.92 31.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.853 -1.067 . . . . 1.73 109.117 169.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.755 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 18.6 mm-40 -124.05 157.18 35.1 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.547 1.314 . . . . 0.70999999999999996 114.547 -168.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.725 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 44.1 mt-10 -137.13 127.89 27.19 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 112.825 -1.988 . . . . 0.38 108.397 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 32.1 t70 55.22 48.48 19.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 123.346 1.546 . . . . 0.40999999999999998 108.92 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -83.04 167.97 17.38 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 112.629 -2.078 . . . . 1.02 109.153 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 25.9 m -132.68 119.34 20.26 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.071 0.939 . . . . 1.04 111.733 170.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 4.2 mp -80.86 91.38 5.97 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.748 -1.569 . . . . 1.27 112.249 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.566 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.0 mttt -102.14 178.27 4.65 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 113.971 -1.468 . . . . 0.96999999999999997 113.077 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.83 -157.08 24.06 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-N 114.363 -1.29 . . . . 0.46000000000000002 111.514 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 2.4 m -117.65 139.38 51.08 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 120.181 -0.608 . . . . 1.3500000000000001 110.862 170.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 401' ' ' THR . 5.1 m-80 -56.63 152.74 11.5 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.168 -0.924 . . . . 0.83999999999999997 109.288 168.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.552 ' CB ' HG23 ' A' ' 375' ' ' THR . 7.4 p-10 -50.11 -16.78 0.33 Allowed 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 113.268 -1.787 . . . . 2.2799999999999998 112.579 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 397' ' ' ASN . 16.9 t70 -96.14 -20.02 18.93 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 113.931 -1.486 . . . . 2.27 109.447 -173.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.07 31.56 5.31 Favored Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 119.689 -1.243 . . . . 0.97999999999999998 111.848 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 6.9 p -123.81 101.4 36.21 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 114.736 -0.732 . . . . 1.3999999999999999 109.416 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 20.7 Cg_endo -58.42 151.2 62.96 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 C-N-CA 122.912 2.408 . . . . 0.67000000000000004 113.45 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.637 ' HE1' ' CE2' ' A' ' 403' ' ' TYR . 21.5 p90 -153.18 175.63 12.83 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.472 -1.24 . . . . 1.04 112.787 -169.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.566 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -144.35 147.78 33.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.629 -1.623 . . . . 0.53000000000000003 109.801 170.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.488 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.36 97.25 5.17 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.277 -1.009 . . . . 0.45000000000000001 108.277 172.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 16.4 Cg_exo -69.9 109.9 2.45 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 121.797 1.665 . . . . 0.22 109.952 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.587 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -108.97 155.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-N 112.667 -2.06 . . . . 1.04 107.766 -167.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.725 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.0 m-80 -86.85 -20.99 26.68 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.179 -0.674 . . . . 0.65000000000000002 109.179 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 0.755 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 95.0 m-85 -158.7 127.0 5.24 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.353 1.033 . . . . 0.92000000000000004 108.79 -171.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 24.1 t-105 -145.11 137.09 25.7 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.756 0.789 . . . . 0.10000000000000001 110.953 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.68 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.6 mmt -119.87 93.72 47.94 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 107.651 -1.24 . . . . 1.01 107.651 173.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.727 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 40.0 Cg_endo -67.74 74.14 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.356 2.037 . . . . 0.5 112.414 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.571 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.4 pt -72.88 174.27 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.488 -0.93 . . . . 1.05 108.488 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.515 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 20.8 t70 -143.87 -178.74 6.07 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.648 -0.821 . . . . 2.4900000000000002 112.232 -164.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.515 ' CE3' ' HB3' ' A' ' 414' ' ' ASP . 38.0 p90 56.59 -3.2 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.849 2.06 . . . . 2.3700000000000001 114.51 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.504 HG22 ' CD1' ' A' ' 382' ' ' PHE . 38.2 p -128.59 -15.86 4.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.142 0.496 . . . . 1.5700000000000001 111.018 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.632 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 96.6 -33.92 5.35 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.081 -0.808 . . . . 0.68000000000000005 111.081 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 419' ' ' GLY . 29.1 t -56.92 173.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.072 0.949 . . . . 1.45 112.012 -177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.597 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -178.03 122.43 0.82 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.606 -1.398 . . . . 0.20000000000000001 109.606 170.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.647 HG21 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.72 142.52 13.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.799 -0.445 . . . . 1.0900000000000001 109.799 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.594 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.4 p80 -159.83 162.48 34.73 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.196 -0.456 . . . . 0.10000000000000001 111.659 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.634 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.88 143.8 28.03 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.845 -1.169 . . . . 1.0700000000000001 107.845 171.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.51 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 28.5 t -133.83 99.03 4.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.874 0.845 . . . . 0.5 110.701 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.03 -13.51 59.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.132 -1.395 . . . . 0.41999999999999998 109.537 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.587 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 11.7 p90 -92.05 -27.1 18.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.443 -1.253 . . . . 0.32000000000000001 111.853 -175.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.584 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 0.1 OUTLIER -91.73 106.61 17.69 Favored Pre-proline 0 CA--C 1.507 -0.689 0 CA-C-O 122.624 1.202 . . . . 1.74 108.462 175.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 61.9 Cg_endo -82.96 -16.69 7.33 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 124.257 3.305 . . . . 0.87 113.021 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.584 ' HG2' ' NE2' ' A' ' 426' ' ' GLN . 0.5 OUTLIER -109.78 152.98 25.0 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 122.115 0.959 . . . . 2.1600000000000001 111.543 174.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.968 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -154.32 132.58 11.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.201 -2.148 . . . . 0.91000000000000003 105.201 169.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.61 -158.34 30.96 Favored Glycine 0 C--N 1.285 -2.294 0 N-CA-C 110.438 -1.065 . . . . 0.20000000000000001 110.438 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -47.08 174.14 0.02 OUTLIER Glycine 0 CA--C 1.495 -1.192 0 C-N-CA 120.096 -1.05 . . . . 0.25 111.499 168.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.559 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 7.0 p-10 -52.59 101.29 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 123.422 1.582 . . . . 1.8500000000000001 113.883 -154.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.598 ' CD2' ' HD2' ' A' ' 437' ' ' ARG . 41.6 mt -97.47 -34.65 10.93 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 112.203 -2.271 . . . . 1.8200000000000001 109.383 171.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.697 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.2 p-90 -53.74 -26.36 22.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.017 -0.992 . . . . 0.17999999999999999 112.004 -173.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.697 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.11 -36.33 14.06 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.618 -0.719 . . . . 1.05 112.308 -178.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.442 ' H ' HG21 ' A' ' 436' ' ' THR . 2.2 p -88.15 -41.02 13.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.143 -0.935 . . . . 1.0600000000000001 110.381 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.598 ' HD2' ' CD2' ' A' ' 433' ' ' LEU . 2.1 mtp85 -93.06 -20.69 20.29 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.431 -1.258 . . . . 2.3700000000000001 109.704 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.91 45.8 49.86 Favored Glycine 0 N--CA 1.443 -0.834 0 O-C-N 124.284 0.99 . . . . 0.23999999999999999 114.072 166.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 20.8 m -84.69 110.13 18.53 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.654 -1.218 . . . . 1.7 111.367 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.45 ' HB3' ' NAJ' ' A' ' 130' ' ' 1RG . 29.1 m-70 46.11 -145.0 0.21 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.607 -1.179 . . . . 0.56999999999999995 113.629 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 440' ' ' HIS . . . -110.65 -23.41 5.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.506 -0.854 . . . . 0.28999999999999998 113.566 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.444 ' HB3' HASA ' A' ' 130' ' ' 1RG . 31.2 p -101.57 -165.43 1.19 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 113.645 0.98 . . . . 0.40000000000000002 113.645 -170.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.536 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.0 mp -90.23 133.35 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.569 -0.741 . . . . 1.04 110.61 -176.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.11 90.9 3.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.366 0.603 . . . . 0.62 110.286 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.702 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.3 m -85.82 142.33 36.66 Favored Pre-proline 0 N--CA 1.436 -1.126 0 CA-C-N 115.105 -0.952 . . . . 1.02 112.512 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.595 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 82.0 Cg_exo -49.58 145.56 16.7 Favored 'Trans proline' 0 CA--C 1.509 -0.767 0 C-N-CA 123.891 3.06 . . . . 0.23999999999999999 113.572 175.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.968 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 28.4 Cg_exo -66.7 -21.05 52.21 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.827 2.352 . . . . 0.31 112.034 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.552 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 33.4 p -83.35 -24.07 32.23 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.233 -0.894 . . . . 1.48 112.291 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.714 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.8 m -99.64 -47.98 11.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 112.954 0.724 . . . . 1.03 112.954 -171.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.946 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.36 -1.77 3.8 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.789 -0.764 . . . . 1.02 110.462 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.552 ' HE3' ' O ' ' A' ' 448' ' ' SER . 17.2 pttp -81.5 -38.27 26.56 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.698 1.237 . . . . 1.5900000000000001 108.33 173.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.597 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.7 mm-40 -62.57 -46.28 89.05 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-N 112.299 -2.228 . . . . 0.25 106.328 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.946 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -47.28 -66.61 0.38 Allowed 'General case' 0 N--CA 1.406 -2.633 0 CA-C-N 109.832 -3.349 . . . . 1.02 112.956 172.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.488 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.3 t80 -46.26 -22.59 0.25 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.866 0.841 . . . . 0.17000000000000001 109.396 176.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.83 -25.32 30.0 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.674 -1.148 . . . . 0.13 112.008 -176.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.615 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -103.5 -43.7 5.32 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 113.705 1.002 . . . . 1.02 113.705 176.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.87 149.8 7.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.432 1.11 . . . . 1.01 111.278 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.503 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -121.68 156.4 33.13 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 112.99 -1.914 . . . . 0.47999999999999998 108.64 -177.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.515 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 2.5 mppt? -58.66 103.2 0.14 Allowed 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.775 -0.824 . . . . 1.7 108.775 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.75 -9.08 6.11 Favored Glycine 0 C--N 1.307 -1.069 0 CA-C-N 113.935 -1.484 . . . . 0.22 111.616 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.592 HG21 ' HA ' ' A' ' 344' ' ' TYR . 19.0 m -69.31 150.05 97.26 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.972 -0.751 . . . . 0.94999999999999996 108.972 171.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.547 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.7 Cg_endo -93.84 163.06 2.22 Favored 'Trans proline' 0 N--CA 1.423 -2.664 0 C-N-CA 122.34 2.026 . . . . 0.23000000000000001 109.919 176.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.742 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.7 m -126.64 149.23 31.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 107.502 -1.296 . . . . 1.27 107.502 171.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.692 HD11 ' CD2' ' A' ' 344' ' ' TYR . 3.5 mp -134.86 150.3 50.45 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 108.426 -0.953 . . . . 1.05 108.426 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.711 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.94 143.12 28.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 105.72 -1.956 . . . . 1.01 105.72 166.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.822 ' HE1' ' CD ' ' A' ' 346' ' ' GLU . 9.3 p90 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 123.185 0.594 . . . . 1.0900000000000001 110.316 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.713 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.218 -0.353 . . . . 2.48 112.218 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.759 ' CE1' HD23 ' A' ' 464' ' ' LEU . 0.3 OUTLIER -117.72 100.78 7.83 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 122.796 -0.238 . . . . 1.1399999999999999 111.43 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.502 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 1.6 mtm 63.2 -166.92 0.22 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 124.061 0.851 . . . . 1.01 112.351 167.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.51 171.9 2.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.021 -0.536 . . . . 1.96 109.823 161.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.47 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 6.2 m-20 -80.0 83.34 5.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.334 -0.946 . . . . 0.42999999999999999 110.264 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 1.11 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 46.9 m -158.01 135.48 10.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.77 -1.104 . . . . 1.0 108.681 167.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.672 ' CD2' HD11 ' A' ' 464' ' ' LEU . 39.7 p90 174.22 159.18 0.16 Allowed 'General case' 0 C--O 1.214 -0.795 0 O-C-N 123.337 0.398 . . . . 0.88 110.851 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.679 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.99 152.13 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.313 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 164.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.534 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.72 143.14 25.26 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.628 -0.715 . . . . 2.0099999999999998 109.452 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.699 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.9 t -135.15 162.43 38.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 120.733 -0.387 . . . . 1.04 111.213 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.532 ' N ' HG13 ' A' ' 347' ' ' VAL . 36.7 t0 -140.23 106.81 5.33 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.468 -1.308 . . . . 0.23999999999999999 107.468 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.667 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.48 -34.9 27.86 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-O 122.752 1.263 . . . . 1.02 110.436 -167.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.412 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 0.8 OUTLIER -58.02 -44.98 87.6 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 110.797 -2.91 . . . . 0.59999999999999998 108.308 176.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 24.9 m-80 -100.61 5.94 44.01 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 111.012 -2.813 . . . . 0.20999999999999999 111.057 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.7 mp0 35.09 61.32 0.63 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 112.725 -2.034 . . . . 2.54 113.16 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.596 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 21.5 t60 -142.2 134.6 27.91 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.646 -0.706 . . . . 0.12 109.742 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.586 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.71 157.85 20.78 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.822 -0.627 . . . . 1.0 110.106 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.55 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.1 m-90 -142.62 156.02 45.02 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.499 0.72 . . . . 0.11 111.258 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.11 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 89.0 t80 -110.81 153.82 24.84 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 106.424 -1.695 . . . . 1.1000000000000001 106.424 151.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.6 m-85 -127.86 119.09 24.9 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 114.892 -1.049 . . . . 0.60999999999999999 110.351 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.2 tppt? -120.56 132.41 55.15 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.277 -1.749 . . . . 0.93999999999999995 106.277 167.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.438 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 75.1 16.53 2.8 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 113.136 0.791 . . . . 0.42999999999999999 113.136 174.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.47 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.13 5.73 88.99 Favored Glycine 0 CA--C 1.485 -1.828 0 CA-C-O 121.814 0.675 . . . . 0.17999999999999999 112.887 -173.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 19.9 ptmt -128.92 177.23 7.25 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.502 -2.407 . . . . 1.0900000000000001 104.502 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.0 m -103.56 158.22 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 116.713 2.116 . . . . 1.02 116.713 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.638 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.15 -28.65 8.93 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 110.39 -3.096 . . . . 1.01 106.207 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.706 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -133.87 145.91 50.1 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 111.589 -2.551 . . . . 1.02 111.669 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.596 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 3.3 tt0 -143.72 118.47 9.87 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 104.499 -2.408 . . . . 0.47999999999999998 104.499 175.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.605 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -149.81 165.39 32.65 Favored 'General case' 0 N--CA 1.401 -2.915 0 C-N-CA 118.132 -1.427 . . . . 1.02 111.631 -179.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.653 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 15.5 p-10 -103.81 133.33 48.98 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.669 -1.15 . . . . 1.8 110.087 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.673 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -133.77 -173.75 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-O 122.465 1.126 . . . . 1.01 112.525 -171.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.592 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.37 120.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 112.91 -1.95 . . . . 1.04 109.199 172.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.626 ' HG ' ' HB3' ' A' ' 349' ' ' LEU . 33.6 p -78.25 -169.06 1.49 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 111.94 -2.391 . . . . 1.6000000000000001 111.421 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.464 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.77 174.75 50.14 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 118.779 -1.676 . . . . 0.14000000000000001 112.05 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 8.5 ptmt -80.31 163.67 55.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 113.174 0.805 . . . . 1.47 113.174 -164.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.622 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 89.4 Cg_exo -55.09 -37.86 93.78 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 123.023 2.482 . . . . 0.28000000000000003 112.287 -176.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.431 ' OG1' HG21 ' A' ' 375' ' ' THR . 12.0 p -64.35 -31.89 73.27 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.29 -1.323 . . . . 1.0800000000000001 110.052 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.727 HG23 ' NAX' ' A' ' 130' ' ' 1RG . 1.2 t -141.59 71.04 25.78 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 123.439 1.59 . . . . 1.1000000000000001 110.032 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 375' ' ' THR . 82.2 Cg_exo -58.3 153.81 44.6 Favored 'Trans proline' 0 C--N 1.307 -1.643 1 C-N-CA 126.369 4.713 . . . . 0.38 114.985 -171.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.525 ' CG2' HG22 ' A' ' 465' ' ' VAL . 2.5 m -79.24 129.86 71.04 Favored Pre-proline 0 N--CA 1.405 -2.718 0 CA-C-N 114.5 -1.227 . . . . 1.1299999999999999 108.55 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 39.4 Cg_exo -68.28 -44.97 3.04 Favored 'Trans proline' 0 CA--C 1.512 -0.601 0 C-N-CA 123.834 3.023 . . . . 0.20999999999999999 112.147 -169.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.655 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.84 138.96 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 123.304 1.526 . . . . 1.0600000000000001 113.645 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 152.86 -119.31 0.95 Allowed Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 112.243 -2.253 . . . . 0.20000000000000001 109.579 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 76.4 t -129.84 108.5 16.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.002 0.43 . . . . 1.5 110.472 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.591 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.4 m-85 -108.55 -173.98 2.41 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.279 -1.378 . . . . 0.28000000000000003 107.279 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -140.83 123.84 16.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 120.09 1.313 . . . . 0.96999999999999997 113.656 -172.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.94 92.56 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 122.961 1.362 . . . . 1.02 109.66 169.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -91.23 9.27 31.98 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.622 -1.627 . . . . 3.1299999999999999 108.265 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.731 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.5 t30 -170.79 127.89 0.76 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.229 -1.351 . . . . 0.42999999999999999 110.475 173.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.668 ' HB3' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -96.95 151.57 19.56 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.727 -0.67 . . . . 1.73 109.873 167.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.712 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 37.8 mm-40 -128.37 160.48 32.08 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.471 1.286 . . . . 0.70999999999999996 114.471 -170.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.798 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 32.1 mt-10 -139.53 127.68 22.48 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 113.112 -1.858 . . . . 0.38 108.881 172.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.73 46.09 23.18 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 123.109 1.433 . . . . 0.40999999999999998 108.964 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.453 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -80.52 166.52 21.1 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 112.759 -2.019 . . . . 1.02 108.967 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 18.7 m -133.0 118.9 19.39 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.988 0.899 . . . . 1.04 111.94 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.1 mp -79.41 88.53 5.01 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.775 -1.557 . . . . 1.27 112.091 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.4 mttt -102.72 -179.42 3.96 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.561 -1.654 . . . . 0.96999999999999997 113.826 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 139.35 -163.6 26.03 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 114.029 -1.442 . . . . 0.46000000000000002 111.149 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 2.0 m -122.81 138.14 54.73 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.217 -0.593 . . . . 1.3500000000000001 110.934 171.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.4 m-80 -56.0 152.34 10.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.918 -1.037 . . . . 0.83999999999999997 109.238 167.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 130' ' ' 1RG . 0.1 OUTLIER -59.35 -3.23 0.39 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.825 -0.625 . . . . 2.2799999999999998 111.807 176.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 397' ' ' ASN . 25.8 t0 -106.81 -9.22 16.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.916 -1.038 . . . . 2.27 108.781 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.05 36.82 6.99 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 118.794 -1.67 . . . . 0.97999999999999998 111.631 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' THR . . . . . . . . . . . . . 18.6 p -124.94 93.11 46.46 Favored Pre-proline 0 C--N 1.305 -1.368 0 CA-C-N 114.437 -0.881 . . . . 1.3999999999999999 109.008 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.0 Cg_endo -59.31 147.69 89.8 Favored 'Trans proline' 0 CA--C 1.497 -1.333 0 C-N-CA 122.648 2.232 . . . . 0.67000000000000004 112.811 -176.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.625 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 34.4 p90 -145.82 167.37 23.38 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.128 -1.396 . . . . 1.04 111.933 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -145.15 146.33 31.73 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.37 -1.287 . . . . 0.53000000000000003 110.32 175.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.17 97.27 5.26 Favored Pre-proline 0 N--CA 1.431 -1.387 0 N-CA-C 108.11 -1.07 . . . . 0.45000000000000001 108.11 171.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 18.9 Cg_exo -69.35 109.94 2.35 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 122.012 1.808 . . . . 0.22 109.881 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.594 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -109.08 156.34 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 CA-C-N 112.869 -1.969 . . . . 1.04 107.283 -168.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.798 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.0 m-80 -89.72 -19.9 24.22 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.987 -0.746 . . . . 0.65000000000000002 108.987 -174.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.666 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 91.6 m-85 -159.06 126.58 4.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.346 -0.983 . . . . 0.92000000000000004 108.346 -171.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 25.0 t-105 -145.25 133.92 22.19 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.828 0.823 . . . . 0.10000000000000001 111.253 -167.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.668 ' SD ' ' HB3' ' A' ' 387' ' ' LYS . 11.8 mmt -115.2 94.91 40.72 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.568 -1.271 . . . . 1.01 107.568 172.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.731 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 39.3 Cg_endo -68.52 67.61 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.362 2.041 . . . . 0.5 112.548 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.604 HG12 ' HA2' ' A' ' 419' ' ' GLY . 2.1 pt -68.08 170.63 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 108.618 -0.882 . . . . 1.05 108.618 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 416' ' ' THR . 1.8 t70 -149.71 -172.71 4.22 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.012 -1.075 . . . . 2.4900000000000002 112.406 -166.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 37.4 p90 50.61 1.92 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.879 2.072 . . . . 2.3700000000000001 114.47 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.489 HG22 ' CD1' ' A' ' 382' ' ' PHE . 38.1 p -130.76 -14.67 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 1.5700000000000001 110.89 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 98.92 -37.95 3.29 Favored Glycine 0 CA--C 1.501 -0.79 0 N-CA-C 110.927 -0.869 . . . . 0.68000000000000005 110.927 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.579 HG13 ' N ' ' A' ' 419' ' ' GLY . 22.1 t -59.51 172.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 124.234 1.014 . . . . 1.45 112.433 -175.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -177.45 120.19 0.72 Allowed Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.965 -1.254 . . . . 0.20000000000000001 109.965 170.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.642 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.76 143.08 12.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 110.21 -0.293 . . . . 1.0900000000000001 110.21 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.596 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.5 p80 -159.15 160.88 36.06 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.168 -0.469 . . . . 0.10000000000000001 111.702 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.626 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -84.54 148.14 26.65 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.838 -1.171 . . . . 1.0700000000000001 107.838 172.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 445' ' ' THR . 43.3 t -134.29 96.54 3.63 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.67 0.747 . . . . 0.5 110.269 -171.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.21 -18.96 44.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.473 -1.24 . . . . 0.41999999999999998 109.945 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.593 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 11.2 p90 -83.85 -17.9 39.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.183 -1.371 . . . . 0.32000000000000001 111.128 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -102.28 117.13 61.87 Favored Pre-proline 0 CA--C 1.503 -0.858 0 CA-C-O 122.808 1.29 . . . . 1.74 109.862 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.84 -11.24 4.79 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.144 3.23 . . . . 0.87 111.737 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -114.57 151.04 34.05 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 114.298 -1.319 . . . . 2.1600000000000001 113.417 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.952 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.62 134.2 5.19 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 104.162 -2.533 . . . . 0.91000000000000003 104.162 171.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.36 -157.29 29.4 Favored Glycine 0 C--N 1.276 -2.756 0 C-N-CA 119.28 -1.438 . . . . 0.20000000000000001 110.749 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.405 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.94 174.29 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 119.903 -1.142 . . . . 0.25 111.175 166.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.5 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -51.33 102.68 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 123.198 1.475 . . . . 1.8500000000000001 113.944 -154.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.613 ' HG ' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.07 -35.44 11.92 Favored 'General case' 0 C--O 1.202 -1.4 0 CA-C-N 112.699 -2.046 . . . . 1.8200000000000001 109.087 168.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.731 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -55.72 -26.69 46.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.17999999999999999 112.357 -170.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.731 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.78 -32.42 15.39 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.981 0.896 . . . . 1.05 111.771 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.8 p -87.52 -45.0 10.86 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.946 -1.479 . . . . 1.0600000000000001 111.103 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.613 ' CD ' ' HG ' ' A' ' 433' ' ' LEU . 7.5 mtp-105 -91.04 -20.2 22.34 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.446 -1.252 . . . . 2.3700000000000001 110.18 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.89 46.56 49.17 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.395 -1.275 . . . . 0.23999999999999999 114.308 164.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 110.82 19.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.345 1.073 . . . . 1.7 112.298 -169.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.524 ' HB2' ' OAC' ' A' ' 130' ' ' 1RG . 70.5 m-70 37.07 -111.19 0.08 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.869 -1.06 . . . . 0.56999999999999995 113.495 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.464 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -146.41 -11.84 0.21 Allowed Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.867 -0.682 . . . . 0.28999999999999998 114.235 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 29.4 p -100.04 -167.99 1.53 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 118.291 1.046 . . . . 0.40000000000000002 112.151 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.447 HG21 ' HB ' ' A' ' 368' ' ' ILE . 2.2 mp -103.39 132.02 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 114.862 -1.063 . . . . 1.04 110.886 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -102.41 94.22 5.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.996 -1.002 . . . . 0.62 110.367 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.673 ' HA ' HG23 ' A' ' 368' ' ' ILE . 2.9 m -89.93 144.08 30.96 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 115.607 -0.724 . . . . 1.02 112.554 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.605 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 74.8 Cg_exo -51.68 147.22 24.71 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 123.945 3.097 . . . . 0.23999999999999999 113.33 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.952 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 27.1 Cg_exo -67.96 -26.24 37.74 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.006 2.471 . . . . 0.31 112.185 -175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.51 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 40.5 p -75.61 -25.4 56.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.078 -0.964 . . . . 1.48 111.876 -176.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.706 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.6 m -99.93 -50.47 10.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.574 -0.739 . . . . 1.03 112.896 -171.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.94 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.67 -2.34 4.8 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.729 -0.788 . . . . 1.02 110.249 -178.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.602 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.1 pttp -81.09 -39.51 25.57 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.484 1.135 . . . . 1.5900000000000001 108.287 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.574 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.7 mm-40 -61.62 -46.84 88.09 Favored 'General case' 0 CA--C 1.47 -2.121 0 CA-C-N 112.319 -2.219 . . . . 0.25 106.571 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.94 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.52 -66.86 0.34 Allowed 'General case' 0 N--CA 1.4 -2.969 0 CA-C-N 109.649 -3.432 . . . . 1.02 112.842 172.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.526 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.8 t80 -44.43 -24.79 0.2 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 124.135 0.897 . . . . 0.17000000000000001 109.727 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.78 -30.35 15.44 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.341 -1.299 . . . . 0.13 111.762 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.574 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -97.8 -43.91 6.95 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 113.22 0.822 . . . . 1.02 113.22 178.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.679 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.84 147.55 9.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 122.451 1.119 . . . . 1.01 110.928 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.49 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -116.28 157.14 25.42 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 113.196 -1.82 . . . . 0.47999999999999998 108.909 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.596 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 5.6 mppt? -58.91 102.1 0.11 Allowed 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.573 -0.899 . . . . 1.7 108.573 169.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.68 -12.13 5.95 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 114.102 -1.408 . . . . 0.22 111.525 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 344' ' ' TYR . 16.2 m -67.12 150.16 98.07 Favored Pre-proline 0 N--CA 1.441 -0.923 0 N-CA-C 108.671 -0.863 . . . . 0.94999999999999996 108.671 171.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.3 Cg_endo -93.87 161.03 2.23 Favored 'Trans proline' 0 N--CA 1.423 -2.647 0 C-N-CA 122.152 1.901 . . . . 0.23000000000000001 109.974 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.754 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -123.51 150.47 27.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 107.389 -1.337 . . . . 1.27 107.389 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.759 HD23 ' CE1' ' A' ' 339' ' ' HIS . 5.4 mp -134.15 150.66 51.12 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.748 -0.834 . . . . 1.05 108.748 175.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.699 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -139.01 140.4 38.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 105.418 -2.067 . . . . 1.01 105.418 165.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.534 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 10.8 p90 . . . . . 0 C--O 1.246 0.884 0 O-C-N 123.822 0.701 . . . . 1.0900000000000001 111.086 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.934 ' HB ' ' CAM' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 112.008 -0.437 . . . . 2.48 112.008 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.768 ' CE1' HD23 ' A' ' 464' ' ' LEU . 0.3 OUTLIER -101.13 98.61 9.01 Favored 'General case' 0 CA--C 1.508 -0.636 0 O-C-N 122.703 -0.293 . . . . 1.1399999999999999 111.513 178.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.557 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.6 OUTLIER 65.19 -166.11 0.23 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.451 -0.795 . . . . 1.01 112.43 167.131 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.4 171.43 2.48 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.511 -1.292 . . . . 1.96 107.511 165.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.74 83.36 5.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 118.843 -1.143 . . . . 0.42999999999999999 109.359 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 1.129 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 73.1 m -158.25 134.69 9.5 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.376 -1.284 . . . . 1.0 108.983 168.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.68 ' CD2' HD11 ' A' ' 464' ' ' LEU . 39.6 p90 174.27 158.7 0.16 Allowed 'General case' 0 C--O 1.213 -0.865 0 O-C-N 123.478 0.486 . . . . 0.88 110.855 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.675 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.65 152.48 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 164.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.558 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 32.1 tt0 -149.94 143.61 25.35 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.42 -0.809 . . . . 2.0099999999999998 109.748 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 464' ' ' LEU . 2.9 t -136.05 162.41 36.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.929 0.395 . . . . 1.04 111.298 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.513 ' N ' HG13 ' A' ' 347' ' ' VAL . 35.0 t0 -140.13 106.76 5.34 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.162 -1.421 . . . . 0.23999999999999999 107.162 173.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.645 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.36 -33.5 28.79 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-O 122.71 1.243 . . . . 1.02 110.193 -168.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.409 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.4 mt-10 -57.07 -44.85 83.46 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 110.786 -2.915 . . . . 0.59999999999999998 108.192 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.3 m-80 -101.95 5.64 40.89 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 110.906 -2.861 . . . . 0.20999999999999999 111.273 -175.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.582 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.2 mp0 34.79 61.61 0.57 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 112.56 -2.109 . . . . 2.54 113.085 -175.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.593 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.4 t60 -141.76 134.95 29.23 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.615 -0.72 . . . . 0.12 109.818 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.602 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.4 OUTLIER -113.24 156.31 23.53 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.084 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.543 ' CD1' HG12 ' A' ' 362' ' ' VAL . 30.5 m-90 -142.26 154.75 45.01 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.443 -0.798 . . . . 0.11 111.037 -175.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.129 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 88.1 t80 -109.8 153.11 24.85 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 106.503 -1.665 . . . . 1.1000000000000001 106.503 151.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 8.1 m-85 -128.15 117.37 21.46 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 114.957 -1.019 . . . . 0.60999999999999999 110.28 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.3 tppt? -118.32 138.34 52.46 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.948 -1.871 . . . . 0.93999999999999995 105.948 168.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.31 17.37 8.25 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.147 0.795 . . . . 0.42999999999999999 113.147 172.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 78.24 6.47 87.73 Favored Glycine 0 CA--C 1.488 -1.653 0 C-N-CA 120.705 -0.759 . . . . 0.17999999999999999 112.943 -174.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.6 ptmt -127.55 178.19 6.27 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 104.484 -2.413 . . . . 1.0900000000000001 104.484 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 16.4 m -105.07 157.35 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.766 0 N-CA-C 116.21 1.93 . . . . 1.02 116.21 -176.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.622 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -108.13 -27.62 9.98 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 110.461 -3.063 . . . . 1.01 106.233 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.736 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.12 145.35 49.23 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 111.71 -2.495 . . . . 1.02 111.919 -175.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.593 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 2.5 tt0 -141.55 118.12 10.95 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 104.514 -2.402 . . . . 0.47999999999999998 104.514 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.609 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -150.63 165.43 33.37 Favored 'General case' 0 N--CA 1.398 -3.034 0 C-N-CA 117.83 -1.548 . . . . 1.02 111.533 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 30.1 p-10 -104.41 134.19 48.03 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 114.831 -1.077 . . . . 1.8 109.989 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.696 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -132.56 -172.44 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 CA-C-O 122.53 1.157 . . . . 1.01 112.326 -172.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.79 119.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 112.889 -1.959 . . . . 1.04 108.207 172.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.54 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.1 OUTLIER -77.84 -169.39 1.51 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.067 -1.424 . . . . 1.6000000000000001 110.891 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.67 170.68 46.36 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 118.995 -1.574 . . . . 0.14000000000000001 112.127 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -77.13 157.56 80.94 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.473 0.654 . . . . 1.47 112.52 -164.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.625 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 66.3 Cg_exo -53.01 -29.84 46.22 Favored 'Trans proline' 0 CA--C 1.496 -1.405 1 C-N-CA 125.751 4.3 . . . . 0.28000000000000003 113.694 -173.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.421 ' OG1' HG21 ' A' ' 375' ' ' THR . 19.1 p -66.66 -33.29 75.32 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.424 -1.716 . . . . 1.0800000000000001 109.45 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.515 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.0 t -143.15 71.27 18.34 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 113.498 -1.683 . . . . 1.1000000000000001 109.536 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 375' ' ' THR . 88.9 Cg_exo -56.99 146.05 82.3 Favored 'Trans proline' 0 C--N 1.304 -1.774 1 C-N-CA 125.84 4.36 . . . . 0.38 113.181 -172.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.54 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -75.69 145.15 78.09 Favored Pre-proline 0 N--CA 1.423 -1.82 0 N-CA-C 108.306 -0.998 . . . . 1.1299999999999999 108.306 175.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.422 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 21.1 Cg_exo -75.44 -43.64 0.35 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 124.59 3.526 . . . . 0.20999999999999999 111.775 -166.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.654 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 58.24 136.15 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 123.603 1.668 . . . . 1.0600000000000001 113.639 -172.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 152.99 -126.54 2.0 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 111.969 -2.378 . . . . 0.20000000000000001 109.253 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 71.3 t -121.15 108.63 23.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.204 0.526 . . . . 1.5 110.714 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.598 ' HE2' ' CE1' ' A' ' 382' ' ' PHE . 1.8 m-85 -106.8 -174.36 2.52 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.771 -1.566 . . . . 0.28000000000000003 106.771 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 1.9 t80 -139.56 123.32 17.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.982 1.265 . . . . 0.96999999999999997 113.071 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -90.51 92.5 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-O 123.035 1.398 . . . . 1.02 109.51 170.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -92.33 11.19 26.75 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.318 -1.765 . . . . 3.1299999999999999 108.291 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.765 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.5 t30 -169.38 126.24 0.91 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.265 -1.334 . . . . 0.42999999999999999 110.352 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.649 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -102.52 140.04 37.32 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.774 -1.103 . . . . 1.73 108.96 169.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.729 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 21.2 mm-40 -124.08 159.2 30.47 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.788 1.403 . . . . 0.70999999999999996 114.788 -167.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 49.8 mt-10 -129.2 146.34 51.14 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 112.701 -2.045 . . . . 0.38 106.552 165.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.8 t70 47.51 38.77 8.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 112.505 -2.134 . . . . 0.40999999999999998 110.603 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.486 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -78.93 166.88 21.89 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 112.663 -2.062 . . . . 1.02 109.318 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 19.9 m -131.29 119.43 21.74 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.29 1.043 . . . . 1.04 111.229 171.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.512 HD22 ' CG ' ' A' ' 421' ' ' HIS . 3.0 mp -79.19 88.29 4.89 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.392 -1.731 . . . . 1.27 111.917 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.573 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.1 mttt -102.5 178.03 4.7 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 113.658 -1.61 . . . . 0.96999999999999997 113.127 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.72 -157.47 24.17 Favored Glycine 0 N--CA 1.429 -1.829 0 CA-C-N 114.206 -1.361 . . . . 0.46000000000000002 111.653 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.5 m -118.4 137.85 52.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 120.564 -0.454 . . . . 1.3500000000000001 110.371 171.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.566 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.7 m-80 -53.9 149.42 8.93 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.572 -0.899 . . . . 0.83999999999999997 108.572 168.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -1.8 0.07 Allowed 'General case' 0 C--N 1.318 -0.777 0 O-C-N 123.754 0.659 . . . . 2.2799999999999998 112.156 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.566 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.4 OUTLIER -115.69 4.88 14.13 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.715 0.769 . . . . 2.27 110.027 -177.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.06 21.86 29.21 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 114.964 -1.016 . . . . 0.97999999999999998 113.133 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.425 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 8.6 p -116.39 101.2 53.81 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-O 121.479 0.657 . . . . 1.3999999999999999 109.965 -176.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 19.6 Cg_endo -59.15 149.47 80.01 Favored 'Trans proline' 0 CA--C 1.504 -1.008 0 C-N-CA 122.768 2.312 . . . . 0.67000000000000004 113.392 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.647 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 27.1 p90 -153.76 176.04 12.59 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.449 -1.25 . . . . 1.04 113.092 -168.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.573 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.9 OUTLIER -145.71 148.21 32.77 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.833 -1.53 . . . . 0.53000000000000003 110.383 172.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.06 97.49 4.83 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 108.39 -0.967 . . . . 0.45000000000000001 108.39 170.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.9 Cg_exo -68.66 111.41 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.715 0 C-N-CA 122.202 1.935 . . . . 0.22 110.3 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.621 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -110.92 160.3 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.31 -1.768 . . . . 1.04 107.663 -168.108 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.716 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.8 m-80 -94.15 -19.61 20.62 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.902 -0.777 . . . . 0.65000000000000002 108.902 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 88.1 m-85 -158.94 125.95 4.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.892 -1.049 . . . . 0.92000000000000004 108.248 -171.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 18.2 t-105 -144.16 131.17 20.48 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.933 0.873 . . . . 0.10000000000000001 111.557 -166.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.649 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -111.94 93.91 22.86 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.44 -1.319 . . . . 1.01 107.44 171.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.765 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.5 Cg_endo -68.39 67.91 1.06 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.308 2.005 . . . . 0.5 111.537 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.602 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.4 pt -68.48 175.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-O 121.613 0.721 . . . . 1.05 109.496 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.708 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 7.1 t70 -149.17 -166.19 2.49 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.75 -1.204 . . . . 2.4900000000000002 107.75 -170.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.708 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 6.3 m-90 83.83 -47.73 0.12 Allowed 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 123.985 0.803 . . . . 2.3700000000000001 110.791 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.422 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 43.1 p -128.56 -6.11 5.23 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.455 -0.793 . . . . 1.5700000000000001 112.389 -164.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.543 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 97.69 -30.69 8.85 Favored Glycine 0 CA--C 1.505 -0.544 0 C-N-CA 120.731 -0.747 . . . . 0.68000000000000005 112.313 176.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.579 HG13 ' N ' ' A' ' 419' ' ' GLY . 47.2 t -55.04 173.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 123.576 0.75 . . . . 1.45 111.584 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.602 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -173.08 120.98 0.84 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 109.875 -1.29 . . . . 0.20000000000000001 109.875 170.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.699 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -82.17 140.88 15.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.746 -0.465 . . . . 1.0900000000000001 109.746 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.585 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.1 p80 -159.18 161.03 36.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.197 -0.456 . . . . 0.10000000000000001 111.367 -174.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.61 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.4 148.62 26.5 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.214 -1.032 . . . . 1.0700000000000001 108.214 172.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 445' ' ' THR . 40.4 t -133.24 96.38 3.73 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.726 0.774 . . . . 0.5 109.75 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.23 -16.85 53.82 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.26 -1.336 . . . . 0.41999999999999998 109.204 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.621 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 12.0 p90 -88.25 -24.61 23.19 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.788 -1.551 . . . . 0.32000000000000001 111.247 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -97.96 113.46 63.81 Favored Pre-proline 0 CA--C 1.506 -0.726 0 CA-C-O 122.643 1.211 . . . . 1.74 110.416 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.474 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 41.8 Cg_endo -85.96 -10.07 7.22 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 124.241 3.294 . . . . 0.87 112.92 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.544 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.9 pm0 -111.56 152.03 28.03 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 122.323 1.059 . . . . 2.1600000000000001 113.35 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.639 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.47 129.9 3.79 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 112.604 -2.089 . . . . 0.91000000000000003 105.74 172.405 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.61 -158.82 31.7 Favored Glycine 0 C--N 1.283 -2.4 0 C-N-CA 119.913 -1.136 . . . . 0.20000000000000001 110.834 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.508 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.21 174.21 0.01 OUTLIER Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.253 -0.975 . . . . 0.25 111.526 167.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.513 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.3 p-10 -51.9 101.72 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 123.262 1.506 . . . . 1.8500000000000001 113.851 -153.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.68 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.93 -37.06 10.85 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 112.459 -2.155 . . . . 1.8200000000000001 109.54 169.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.697 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -54.12 -27.25 32.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.235 -0.893 . . . . 0.17999999999999999 112.395 -170.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.697 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.33 -33.82 15.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.48 0.657 . . . . 1.05 112.466 -177.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.7 p -92.09 -43.03 9.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.854 -1.066 . . . . 1.0600000000000001 110.991 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.68 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.5 mtp180 -93.15 -18.97 21.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.772 -1.104 . . . . 2.3700000000000001 109.492 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.02 49.42 55.53 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 114.74 -1.118 . . . . 0.23999999999999999 115.022 163.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.0 m -82.39 110.62 17.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.784 1.292 . . . . 1.7 111.077 -172.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 38.98 -130.17 0.24 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.619 -1.173 . . . . 0.56999999999999995 113.23 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -122.31 -22.64 2.55 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.337 -0.459 . . . . 0.28999999999999998 113.247 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.483 ' HB3' HASA ' A' ' 130' ' ' 1RG . 30.5 p -102.44 -165.35 1.17 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 113.346 0.869 . . . . 0.40000000000000002 113.346 -173.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.531 HG13 ' HG ' ' A' ' 370' ' ' SER . 1.9 mp -93.03 134.06 32.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.282 -0.872 . . . . 1.04 110.732 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.87 97.09 6.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.385 0.612 . . . . 0.62 110.113 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.696 ' HA ' HG23 ' A' ' 368' ' ' ILE . 4.2 m -93.35 144.85 28.94 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 114.726 -1.124 . . . . 1.02 112.851 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.609 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 72.6 Cg_exo -51.13 145.38 26.13 Favored 'Trans proline' 0 CA--C 1.507 -0.838 0 C-N-CA 123.98 3.12 . . . . 0.23999999999999999 113.391 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.639 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.6 Cg_exo -65.55 -26.15 54.58 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.909 2.406 . . . . 0.31 112.309 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.559 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 57.9 p -76.38 -25.29 54.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.794 0.807 . . . . 1.48 111.998 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.736 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.7 m -99.6 -50.16 10.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.628 -0.714 . . . . 1.03 112.766 -170.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.947 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.61 -2.15 4.5 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.754 -0.778 . . . . 1.02 110.371 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.559 ' HE3' ' O ' ' A' ' 448' ' ' SER . 16.9 pttp -80.87 -38.68 27.7 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.521 1.153 . . . . 1.5900000000000001 108.201 173.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.58 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.1 mm-40 -62.69 -46.39 88.39 Favored 'General case' 0 CA--C 1.474 -1.968 0 CA-C-N 112.433 -2.167 . . . . 0.25 106.578 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.947 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.28 -66.06 0.47 Allowed 'General case' 0 N--CA 1.404 -2.752 0 CA-C-N 109.849 -3.341 . . . . 1.02 112.712 172.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.488 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 24.0 t80 -45.72 -23.67 0.28 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 123.941 0.776 . . . . 0.17000000000000001 109.56 176.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.82 -27.1 25.03 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.649 -1.159 . . . . 0.13 111.817 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.568 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -101.99 -43.83 5.66 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 113.57 0.952 . . . . 1.02 113.57 177.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.675 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.4 OUTLIER -74.89 149.76 7.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.486 1.136 . . . . 1.01 111.175 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.521 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -125.0 157.63 35.67 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 112.939 -1.937 . . . . 0.47999999999999998 108.245 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.598 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.1 mppt? -57.82 101.64 0.08 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 109.055 -0.72 . . . . 1.7 109.055 172.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.85 -14.4 5.22 Favored Glycine 0 C--N 1.307 -1.082 0 CA-C-N 114.111 -1.404 . . . . 0.22 111.53 -175.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.576 HG21 ' HA ' ' A' ' 344' ' ' TYR . 17.8 m -66.63 149.27 98.32 Favored Pre-proline 0 N--CA 1.437 -1.076 0 N-CA-C 108.527 -0.916 . . . . 0.94999999999999996 108.527 171.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.557 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 7.2 Cg_endo -94.39 164.19 1.94 Allowed 'Trans proline' 0 N--CA 1.419 -2.874 0 C-N-CA 122.159 1.906 . . . . 0.23000000000000001 109.769 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.747 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -126.6 151.65 33.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 107.741 -1.207 . . . . 1.27 107.741 171.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.768 HD23 ' CE1' ' A' ' 339' ' ' HIS . 5.3 mp -134.6 151.27 50.96 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 109.079 -0.711 . . . . 1.05 109.079 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.698 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.38 142.81 30.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 105.604 -1.998 . . . . 1.01 105.604 164.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.558 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 11.0 p90 . . . . . 0 C--O 1.244 0.785 0 CA-C-O 117.719 -1.134 . . . . 1.0900000000000001 111.562 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.725 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.721 -0.552 . . . . 2.48 111.721 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.583 ' CE1' HD22 ' A' ' 464' ' ' LEU . 4.5 p-80 -123.02 101.49 7.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.485 0.55 . . . . 1.1399999999999999 112.485 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.574 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.3 OUTLIER 62.46 -166.82 0.21 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.976 -1.011 . . . . 1.01 113.19 165.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.17 171.9 2.74 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.678 -1.23 . . . . 1.96 107.678 165.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.09 83.64 7.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 118.935 -1.106 . . . . 0.42999999999999999 109.635 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 96.4 m -158.25 135.65 10.2 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.039 -1.437 . . . . 1.0 108.901 167.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.649 ' CD2' HD11 ' A' ' 464' ' ' LEU . 40.8 p90 174.56 158.3 0.16 Allowed 'General case' 0 C--O 1.213 -0.847 0 O-C-N 123.415 0.447 . . . . 0.88 111.383 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.696 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -78.03 151.68 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 164.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.55 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.43 142.39 24.82 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.606 -0.725 . . . . 2.0099999999999998 109.641 -176.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.693 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.47 161.84 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.162 0.506 . . . . 1.04 111.501 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.513 ' N ' HG13 ' A' ' 347' ' ' VAL . 31.8 t0 -140.3 106.47 5.23 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.18 -1.415 . . . . 0.23999999999999999 107.18 174.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.651 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.24 -32.63 29.63 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 122.807 1.289 . . . . 1.02 110.262 -168.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.73 -45.32 89.9 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.615 -2.993 . . . . 0.59999999999999998 108.304 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -100.6 7.03 44.25 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 111.106 -2.77 . . . . 0.20999999999999999 110.713 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.62 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 19.0 mp0 33.62 60.63 0.49 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 112.683 -2.053 . . . . 2.54 113.0 -175.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.622 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 20.3 t60 -141.71 134.7 28.95 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.383 -0.826 . . . . 0.12 109.73 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.592 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.63 155.97 24.53 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.569 -0.741 . . . . 1.0 110.203 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.553 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.7 m-90 -141.46 155.19 45.87 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.153 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.693 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.0 t80 -110.16 153.18 25.09 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 106.659 -1.608 . . . . 1.1000000000000001 106.659 151.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 8.8 m-85 -128.99 116.13 18.85 Favored 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 115.026 -0.988 . . . . 0.60999999999999999 110.413 -177.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.0 tppt? -116.41 140.23 49.57 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.085 -1.82 . . . . 0.93999999999999995 106.085 168.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 67.19 18.01 10.35 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.29 0.848 . . . . 0.42999999999999999 113.29 172.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.24 8.34 85.32 Favored Glycine 0 CA--C 1.487 -1.703 0 CA-C-N 115.671 -0.695 . . . . 0.17999999999999999 113.197 -173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 15.4 ptmt -127.12 177.92 6.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 104.792 -2.299 . . . . 1.0900000000000001 104.792 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 14.8 m -105.11 157.32 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.732 0 N-CA-C 116.374 1.99 . . . . 1.02 116.374 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.571 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -108.53 -27.48 9.87 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 110.484 -3.053 . . . . 1.01 106.242 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.02 144.01 48.45 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 111.675 -2.511 . . . . 1.02 111.723 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.622 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -141.23 118.02 11.06 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.388 -2.449 . . . . 0.47999999999999998 104.388 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.592 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.52 163.96 36.39 Favored 'General case' 0 N--CA 1.399 -2.995 0 C-N-CA 118.051 -1.46 . . . . 1.02 111.363 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -102.19 132.9 47.82 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 114.341 -1.3 . . . . 1.8 109.531 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.686 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -131.72 -175.06 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 CA-C-O 122.448 1.118 . . . . 1.01 112.29 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -149.9 118.42 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 112.927 -1.942 . . . . 1.04 108.123 171.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.543 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.2 OUTLIER -78.84 -168.46 1.43 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.132 -1.394 . . . . 1.6000000000000001 110.822 -176.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -83.62 164.94 41.87 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 118.66 -1.733 . . . . 0.14000000000000001 112.076 -173.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.401 ' HG3' ' OG1' ' A' ' 374' ' ' THR . 7.0 ptmt -71.03 155.88 92.74 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.861 0.838 . . . . 1.47 111.998 -165.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.614 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.3 Cg_exo -54.96 -29.44 64.4 Favored 'Trans proline' 0 CA--C 1.496 -1.423 1 C-N-CA 125.502 4.135 . . . . 0.28000000000000003 113.488 -175.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 375' ' ' THR . 14.9 p -69.71 -33.91 73.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.432 -1.713 . . . . 1.0800000000000001 109.476 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.54 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.8 t -142.49 70.67 21.17 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 123.71 1.719 . . . . 1.1000000000000001 109.527 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.5 Cg_exo -57.65 149.88 64.99 Favored 'Trans proline' 0 C--N 1.31 -1.448 1 C-N-CA 126.389 4.726 . . . . 0.38 114.582 -171.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.543 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -79.05 145.04 64.5 Favored Pre-proline 0 N--CA 1.427 -1.619 0 N-CA-C 108.629 -0.878 . . . . 1.1299999999999999 108.629 173.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -77.01 -45.81 0.16 Allowed 'Trans proline' 0 CA--C 1.512 -0.586 0 C-N-CA 124.523 3.482 . . . . 0.20999999999999999 112.163 -168.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.658 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 60.27 137.13 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 123.298 1.523 . . . . 1.0600000000000001 113.557 -172.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.54 -113.3 0.57 Allowed Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 112.003 -2.362 . . . . 0.20000000000000001 109.533 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.406 ' O ' HG11 ' A' ' 381' ' ' VAL . 8.1 p -131.02 116.28 33.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.887 0.851 . . . . 1.5 110.899 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.595 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.3 m-85 -116.22 -174.31 2.53 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.253 -1.388 . . . . 0.28000000000000003 107.253 173.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 1.6 t80 -140.98 125.05 17.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 120.186 1.357 . . . . 0.96999999999999997 113.436 -172.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -91.12 92.23 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 123.181 1.467 . . . . 1.02 109.609 169.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -93.15 11.12 28.92 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.419 -1.719 . . . . 3.1299999999999999 108.11 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.739 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.4 t30 -169.22 126.97 0.97 Allowed 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 113.952 -1.476 . . . . 0.42999999999999999 110.363 172.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.643 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -98.98 145.22 27.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.041 -0.981 . . . . 1.73 108.927 169.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.718 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 11.3 mm-40 -125.08 158.16 34.49 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 114.888 1.44 . . . . 0.70999999999999996 114.888 -169.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.732 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 50.4 mt-10 -137.44 126.96 25.06 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.913 -1.949 . . . . 0.38 108.436 173.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 31.1 t70 54.16 50.73 15.87 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 123.248 1.499 . . . . 0.40999999999999998 109.082 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.472 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -84.04 166.69 17.51 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 112.83 -1.986 . . . . 1.02 109.27 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 21.7 m -132.7 118.81 19.56 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.204 1.002 . . . . 1.04 111.793 171.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.46 88.72 5.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.585 -1.643 . . . . 1.27 112.136 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.587 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.4 mttt -102.19 178.7 4.52 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 113.561 -1.654 . . . . 0.96999999999999997 113.14 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.32 -157.71 24.58 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 114.125 -1.398 . . . . 0.46000000000000002 111.385 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.8 m -118.46 139.88 50.72 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 120.106 -0.638 . . . . 1.3500000000000001 110.532 170.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.0 m-80 -57.17 153.13 12.35 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.592 -0.892 . . . . 0.83999999999999997 108.592 168.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.406 ' CG ' ' HG1' ' A' ' 375' ' ' THR . 0.4 OUTLIER -61.45 -3.41 0.97 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.496 -0.775 . . . . 2.2799999999999998 110.844 177.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.2 OUTLIER -111.34 6.26 20.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.064 -0.971 . . . . 2.27 110.932 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.1 17.84 55.04 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.34 -0.933 . . . . 0.97999999999999998 112.486 169.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 9.4 p -113.19 100.65 52.02 Favored Pre-proline 0 C--N 1.302 -1.485 0 CA-C-N 114.377 -0.912 . . . . 1.3999999999999999 109.467 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.8 Cg_endo -57.09 153.74 37.24 Favored 'Trans proline' 0 CA--C 1.507 -0.858 0 C-N-CA 122.74 2.293 . . . . 0.67000000000000004 112.791 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.624 ' HD2' ' CD1' ' A' ' 403' ' ' TYR . 23.1 p90 -154.83 173.88 15.86 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.906 -1.043 . . . . 1.04 112.811 -171.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.587 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER -144.19 147.51 33.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.772 -1.558 . . . . 0.53000000000000003 110.051 171.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.66 97.47 5.01 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.376 -0.972 . . . . 0.45000000000000001 108.376 171.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.0 Cg_exo -68.87 110.38 2.36 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 121.991 1.794 . . . . 0.22 110.045 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.599 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -109.76 154.87 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 CA-C-N 112.91 -1.95 . . . . 1.04 107.521 -168.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 21.7 m-80 -87.11 -21.57 25.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.909 -0.774 . . . . 0.65000000000000002 108.909 -174.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.662 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 90.3 m-85 -157.59 127.61 6.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.959 -1.018 . . . . 0.92000000000000004 108.677 -170.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.606 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 23.3 t-105 -145.5 133.64 21.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.767 0.794 . . . . 0.10000000000000001 111.151 -167.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.643 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.3 mmt -114.96 93.26 33.86 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 107.747 -1.205 . . . . 1.01 107.747 172.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.739 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.9 Cg_endo -67.71 70.4 0.75 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.527 2.151 . . . . 0.5 112.515 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.591 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.0 pt -69.18 175.58 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.401 -0.962 . . . . 1.05 108.401 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 416' ' ' THR . 33.7 t0 -149.48 -176.7 5.5 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.657 -1.217 . . . . 2.4900000000000002 112.838 -166.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.463 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 38.7 p90 58.03 -8.92 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.014 2.125 . . . . 2.3700000000000001 114.294 174.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 414' ' ' ASP . 22.8 p -121.87 -14.56 8.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.126 0.489 . . . . 1.5700000000000001 110.775 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 97.19 -31.96 7.17 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.586 -0.734 . . . . 0.68000000000000005 111.286 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.59 HG13 ' N ' ' A' ' 419' ' ' GLY . 38.3 t -59.53 173.23 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 123.954 0.902 . . . . 1.45 111.891 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.591 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -177.82 121.51 0.78 Allowed Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.72 -1.352 . . . . 0.20000000000000001 109.72 170.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.657 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.0 mp -81.94 142.66 13.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 120.884 -0.326 . . . . 1.0900000000000001 110.158 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.591 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.6 p80 -159.42 160.99 35.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.336 -0.393 . . . . 0.10000000000000001 111.949 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.59 ' O ' HG21 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -83.65 147.53 27.64 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.141 -1.059 . . . . 1.0700000000000001 108.141 172.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 2.6 t -133.62 98.94 4.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.633 1.206 . . . . 0.5 110.514 -173.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.461 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 11.2 t70 -80.1 -9.88 59.73 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.69 -1.141 . . . . 0.41999999999999998 109.593 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.599 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 8.7 p90 -96.47 -25.01 15.83 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.527 -1.215 . . . . 0.32000000000000001 113.098 -173.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.646 ' OE1' ' HD2' ' A' ' 427' ' ' PRO . 0.0 OUTLIER -94.43 116.64 66.64 Favored Pre-proline 0 CA--C 1.509 -0.608 0 CA-C-O 122.726 1.25 . . . . 1.74 109.8 -179.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.65 ' HG2' ' OE2' ' A' ' 428' ' ' GLU . 81.4 Cg_endo -82.91 -23.24 3.86 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.228 3.285 . . . . 0.87 114.407 -171.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.65 ' OE2' ' HG2' ' A' ' 427' ' ' PRO . 0.7 OUTLIER -112.01 155.42 23.81 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.303 1.049 . . . . 2.1600000000000001 112.346 172.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.479 ' HA ' ' CD2' ' A' ' 433' ' ' LEU . 3.3 m-85 -155.15 130.17 9.45 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 104.517 -2.401 . . . . 0.91000000000000003 104.517 171.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.31 -158.71 31.59 Favored Glycine 0 C--N 1.288 -2.096 0 N-CA-C 110.052 -1.219 . . . . 0.20000000000000001 110.052 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.52 174.54 0.01 OUTLIER Glycine 0 CA--C 1.501 -0.819 0 C-N-CA 120.442 -0.885 . . . . 0.25 111.806 168.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.505 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.0 p-10 -50.91 101.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 123.496 1.617 . . . . 1.8500000000000001 113.597 -152.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.672 ' HG ' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.79 -38.54 10.27 Favored 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 112.316 -2.22 . . . . 1.8200000000000001 109.642 170.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.697 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.8 p-90 -55.39 -27.28 46.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.608 -0.724 . . . . 0.17999999999999999 112.505 -170.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.697 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -88.99 -33.02 17.33 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.717 0.77 . . . . 1.05 112.089 -177.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 7.0 p -89.79 -44.66 9.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.381 -1.281 . . . . 1.0600000000000001 110.918 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.672 ' CD ' ' HG ' ' A' ' 433' ' ' LEU . 7.4 mtp85 -88.23 -19.23 27.12 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.45 -1.25 . . . . 2.3700000000000001 109.92 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.73 46.0 48.12 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.248 -1.342 . . . . 0.23999999999999999 113.327 164.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.0 m -84.45 110.39 18.61 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.32 -0.952 . . . . 1.7 111.837 -168.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.444 ' HB3' ' NAJ' ' A' ' 130' ' ' 1RG . 42.4 m-70 40.12 -129.73 0.36 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.343 -1.298 . . . . 0.56999999999999995 113.056 176.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -124.44 -20.37 2.42 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.712 -0.756 . . . . 0.28999999999999998 113.547 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.485 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.7 p -103.77 -165.71 1.18 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 113.278 0.844 . . . . 0.40000000000000002 113.278 -173.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.525 HG13 ' HG ' ' A' ' 370' ' ' SER . 1.9 mp -92.85 133.18 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 1.04 110.548 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.55 97.55 7.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.728 -0.669 . . . . 0.62 109.462 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.686 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.7 m -92.64 141.51 24.63 Favored Pre-proline 0 N--CA 1.437 -1.081 0 CA-C-N 115.51 -0.768 . . . . 1.02 112.262 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.573 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 64.0 Cg_exo -52.16 144.26 38.82 Favored 'Trans proline' 0 CA--C 1.499 -1.228 0 C-N-CA 123.975 3.117 . . . . 0.23999999999999999 114.786 175.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.572 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 80.3 Cg_exo -52.34 -55.02 4.22 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.301 2.001 . . . . 0.31 110.698 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.503 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 51.9 p -57.23 -23.82 50.59 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 112.251 -2.25 . . . . 1.48 113.74 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.752 ' O ' HD23 ' A' ' 364' ' ' LEU . 27.1 m -98.24 -49.18 11.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 N-CA-C 113.019 0.748 . . . . 1.03 113.019 -173.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.941 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.72 -2.11 6.43 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.52 -0.872 . . . . 1.02 110.235 -178.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.515 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 14.7 pttp -80.98 -38.16 28.07 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 122.651 1.215 . . . . 1.5900000000000001 108.335 173.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.588 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.6 mm-40 -62.17 -46.32 89.49 Favored 'General case' 0 CA--C 1.471 -2.073 0 CA-C-N 112.387 -2.188 . . . . 0.25 106.53 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.941 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.09 -66.35 0.42 Allowed 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 109.837 -3.347 . . . . 1.02 112.786 172.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.7 t80 -46.68 -22.78 0.33 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.673 0.749 . . . . 0.17000000000000001 109.457 175.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.5 -22.46 37.08 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.059 -0.973 . . . . 0.13 111.819 -176.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.592 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -106.34 -44.21 4.59 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 113.777 1.028 . . . . 1.02 113.777 175.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.696 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.52 148.97 8.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 122.44 1.114 . . . . 1.01 111.275 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.531 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -119.11 156.63 29.41 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 113.048 -1.887 . . . . 0.47999999999999998 108.517 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.597 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 3.6 mppt? -59.07 101.75 0.1 Allowed 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.903 -0.777 . . . . 1.7 108.903 171.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.7 -10.65 5.47 Favored Glycine 0 C--N 1.308 -1.019 0 CA-C-N 113.962 -1.472 . . . . 0.22 111.576 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.585 HG21 ' HA ' ' A' ' 344' ' ' TYR . 18.2 m -68.61 150.8 97.55 Favored Pre-proline 0 N--CA 1.443 -0.803 0 N-CA-C 109.073 -0.714 . . . . 0.94999999999999996 109.073 171.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.574 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.4 Cg_endo -93.99 163.37 2.14 Favored 'Trans proline' 0 N--CA 1.425 -2.516 0 C-N-CA 122.428 2.085 . . . . 0.23000000000000001 110.128 176.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.741 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -126.87 149.89 32.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 107.668 -1.234 . . . . 1.27 107.668 171.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.691 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.6 mp -134.47 149.89 50.77 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.411 -0.959 . . . . 1.05 108.411 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.693 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -138.25 141.82 36.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 105.434 -2.062 . . . . 1.01 105.434 165.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.55 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 10.2 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 117.723 -1.132 . . . . 1.0900000000000001 111.664 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.759 HNAJ ' HH ' ' A' ' 403' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.934 -0.466 . . . . 2.48 111.934 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.584 ' CE1' HD22 ' A' ' 464' ' ' LEU . 2.0 p-80 -135.12 101.42 4.86 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 120.629 0.252 . . . . 1.1399999999999999 111.585 177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.554 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.6 OUTLIER 61.87 -165.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.309 -0.859 . . . . 1.01 112.668 168.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.02 173.8 5.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.144 -1.428 . . . . 1.96 107.144 164.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -80.5 84.23 6.15 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.286 -0.966 . . . . 0.42999999999999999 110.008 -174.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 84.3 m -158.39 135.56 9.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.62 -1.173 . . . . 1.0 109.067 168.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.678 ' CD2' HD11 ' A' ' 464' ' ' LEU . 40.7 p90 174.42 158.63 0.16 Allowed 'General case' 0 CA--C 1.503 -0.829 0 O-C-N 123.386 0.429 . . . . 0.88 111.132 -175.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.687 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.92 152.33 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 109.106 -0.702 . . . . 1.0 109.106 164.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.583 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.65 143.05 25.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.64 -0.709 . . . . 2.0099999999999998 109.551 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.59 162.16 37.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.027 0.441 . . . . 1.04 111.378 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.531 ' N ' HG13 ' A' ' 347' ' ' VAL . 20.5 t0 -139.91 107.26 5.53 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.404 -1.332 . . . . 0.23999999999999999 107.404 172.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.658 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.51 -34.38 27.97 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 122.719 1.247 . . . . 1.02 110.52 -167.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -58.41 -45.26 88.75 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.871 -2.877 . . . . 0.59999999999999998 108.252 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 19.4 m-80 -99.99 6.47 45.11 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 111.031 -2.804 . . . . 0.20999999999999999 110.889 -175.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 18.1 mp0 33.53 61.7 0.44 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 112.545 -2.116 . . . . 2.54 113.11 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.584 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 21.8 t60 -141.92 135.18 29.18 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.612 -0.722 . . . . 0.12 109.733 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.585 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -114.23 156.17 24.81 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.233 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.512 ' CD1' HG12 ' A' ' 362' ' ' VAL . 30.0 m-90 -141.17 153.93 45.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.373 -0.831 . . . . 0.11 111.269 -174.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.682 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.1 t80 -109.76 153.21 24.66 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 106.599 -1.63 . . . . 1.1000000000000001 106.599 151.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.5 m-85 -129.25 116.61 19.4 Favored 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 114.699 -1.137 . . . . 0.60999999999999999 110.226 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.5 tppt? -115.88 137.3 52.23 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.703 -1.962 . . . . 0.93999999999999995 105.703 167.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.73 18.31 8.72 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.61 0.967 . . . . 0.42999999999999999 113.61 172.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.31 8.1 86.99 Favored Glycine 0 CA--C 1.487 -1.697 0 CA-C-O 121.779 0.655 . . . . 0.17999999999999999 113.015 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 15.8 ptmt -128.13 176.95 7.25 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 104.569 -2.382 . . . . 1.0900000000000001 104.569 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.4 m -104.38 157.86 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.611 0 N-CA-C 116.289 1.959 . . . . 1.02 116.289 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.584 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.87 -26.61 9.7 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 110.516 -3.038 . . . . 1.01 106.646 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.84 144.96 47.88 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 111.669 -2.514 . . . . 1.02 111.753 -175.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.584 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 5.8 tt0 -139.92 118.15 12.0 Favored 'General case' 0 N--CA 1.408 -2.53 0 N-CA-C 104.411 -2.44 . . . . 0.47999999999999998 104.411 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.638 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -150.09 163.39 38.31 Favored 'General case' 0 N--CA 1.4 -2.971 0 C-N-CA 117.466 -1.693 . . . . 1.02 111.917 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.529 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 18.1 p-10 -103.02 134.33 46.64 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-N 114.293 -1.321 . . . . 1.8 109.57 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.684 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.89 -172.34 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 CA-C-O 122.508 1.147 . . . . 1.01 112.414 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.512 HG12 HE22 ' A' ' 426' ' ' GLN . 0.5 OUTLIER -152.23 120.89 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 112.832 -1.985 . . . . 1.04 108.423 172.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.559 ' HG ' HG13 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -79.86 -168.14 1.5 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.315 -1.311 . . . . 1.6000000000000001 110.708 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.431 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -83.96 170.33 47.42 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 118.907 -1.616 . . . . 0.14000000000000001 112.152 -173.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 6.0 ptmt -78.6 162.89 63.99 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 113.109 0.781 . . . . 1.47 113.109 -162.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.671 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 74.9 Cg_exo -54.84 -37.53 92.57 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 C-N-CA 123.058 2.505 . . . . 0.28000000000000003 112.56 -175.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.407 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 25.2 p -66.06 -33.96 76.98 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.337 -1.301 . . . . 1.0800000000000001 110.085 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.543 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.5 t -141.56 72.69 25.1 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-O 123.69 1.709 . . . . 1.1000000000000001 109.743 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 375' ' ' THR . 74.3 Cg_exo -61.37 160.5 27.04 Favored 'Trans proline' 0 C--N 1.311 -1.423 1 C-N-CA 126.345 4.697 . . . . 0.38 114.346 -173.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.526 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -91.55 144.71 29.99 Favored Pre-proline 0 N--CA 1.42 -1.96 0 N-CA-C 108.305 -0.998 . . . . 1.1299999999999999 108.305 171.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -76.44 -43.88 0.27 Allowed 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 124.844 3.696 . . . . 0.20999999999999999 112.139 -168.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.644 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 60.96 134.6 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.488 1.613 . . . . 1.0600000000000001 113.562 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 155.14 -116.15 0.71 Allowed Glycine 0 N--CA 1.429 -1.791 0 CA-C-N 111.959 -2.382 . . . . 0.20000000000000001 109.627 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.454 ' O ' HG11 ' A' ' 381' ' ' VAL . 8.4 p -130.34 115.69 33.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.861 0.839 . . . . 1.5 110.899 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.615 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.7 m-85 -115.36 -174.01 2.43 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.34 -1.355 . . . . 0.28000000000000003 107.34 174.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 0.8 OUTLIER -139.65 123.49 17.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.881 1.219 . . . . 0.96999999999999997 113.268 -171.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -91.74 91.67 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 CA-C-O 123.189 1.471 . . . . 1.02 109.39 168.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -93.44 10.58 31.74 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 113.106 -1.861 . . . . 3.1299999999999999 107.908 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.751 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.7 t30 -168.78 125.6 0.98 Allowed 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 113.774 -1.557 . . . . 0.42999999999999999 109.939 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.628 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.9 143.52 30.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.902 -1.044 . . . . 1.73 108.86 169.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.773 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 20.4 mm-40 -125.17 155.18 40.36 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 114.441 1.274 . . . . 0.70999999999999996 114.441 -168.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 41.0 mt-10 -136.86 126.55 25.45 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 112.947 -1.933 . . . . 0.38 108.287 171.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.6 t70 57.56 53.34 7.43 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 123.459 1.6 . . . . 0.40999999999999998 109.144 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.462 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -89.29 166.38 13.81 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 112.451 -2.159 . . . . 1.02 108.501 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 31.6 m -132.93 120.03 20.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.092 0.949 . . . . 1.04 111.862 171.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 405' ' ' SER . 8.9 mt -75.75 88.29 2.81 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.828 -1.533 . . . . 1.27 112.796 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 44.9 mttt -105.18 177.59 4.81 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.492 -1.231 . . . . 0.96999999999999997 113.751 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.68 -159.77 25.02 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.163 -1.381 . . . . 0.46000000000000002 111.55 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.628 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.3 m -115.98 139.54 50.15 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.361 -0.536 . . . . 1.3500000000000001 110.454 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.4 m-80 -56.88 152.94 11.8 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.136 -0.69 . . . . 0.83999999999999997 109.136 168.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -0.1 0.22 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.688 -0.687 . . . . 2.2799999999999998 111.646 176.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 397' ' ' ASN . 33.8 t70 -115.42 0.93 13.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.893 0.854 . . . . 2.27 110.364 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.55 17.28 34.06 Favored Glycine 0 N--CA 1.428 -1.887 0 CA-C-N 114.851 -1.068 . . . . 0.97999999999999998 112.971 171.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 7.7 p -112.47 101.14 51.95 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-O 121.57 0.7 . . . . 1.3999999999999999 109.913 -175.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.6 Cg_endo -58.5 150.41 68.85 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 122.712 2.275 . . . . 0.67000000000000004 112.965 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.596 ' HD2' ' CD1' ' A' ' 403' ' ' TYR . 21.2 p90 -150.47 171.96 16.22 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.57 -1.196 . . . . 1.04 113.054 -169.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -147.15 146.17 29.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.906 -1.497 . . . . 0.53000000000000003 110.07 172.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.632 ' O ' ' HG ' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.98 97.54 4.85 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.304 -0.998 . . . . 0.45000000000000001 108.304 171.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 14.4 Cg_exo -70.27 108.21 2.13 Favored 'Trans proline' 0 N--CA 1.432 -2.127 0 C-N-CA 121.023 1.149 . . . . 0.22 110.016 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.547 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -106.22 152.4 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.285 0 CA-C-N 112.816 -1.993 . . . . 1.04 108.55 -169.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.8 OUTLIER -86.08 -19.17 30.64 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.753 -0.832 . . . . 0.65000000000000002 108.753 -174.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.668 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 91.4 m-85 -158.05 126.02 5.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.378 -0.828 . . . . 0.92000000000000004 108.938 -171.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.614 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 21.4 t-105 -144.94 134.24 22.96 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.705 0.764 . . . . 0.10000000000000001 111.18 -167.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.628 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.1 mmt -116.44 93.64 40.59 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.746 -1.205 . . . . 1.01 107.746 172.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.751 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.6 Cg_endo -68.13 67.68 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.532 2.154 . . . . 0.5 112.95 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.582 HG12 ' HA2' ' A' ' 419' ' ' GLY . 2.1 pt -67.24 174.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.552 -0.906 . . . . 1.05 108.552 176.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.454 ' C ' ' H ' ' A' ' 416' ' ' THR . 3.5 t70 -150.88 -173.23 4.42 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 118.761 -1.176 . . . . 2.4900000000000002 112.771 -166.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.441 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 35.9 p90 52.88 -0.43 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.01 2.124 . . . . 2.3700000000000001 114.633 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 414' ' ' ASP . 37.1 p -130.63 -11.43 3.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.949 0.404 . . . . 1.5700000000000001 111.116 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.459 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 97.14 -36.11 4.08 Favored Glycine 0 CA--C 1.503 -0.688 0 N-CA-C 111.094 -0.803 . . . . 0.68000000000000005 111.094 177.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.593 HG13 ' N ' ' A' ' 419' ' ' GLY . 36.0 t -58.97 172.66 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.126 0.97 . . . . 1.45 112.298 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.593 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -178.71 120.74 0.72 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.861 -1.296 . . . . 0.20000000000000001 109.861 170.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.642 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.43 141.83 14.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 110.041 -0.355 . . . . 1.0900000000000001 110.041 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.595 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.2 p80 -157.92 161.21 38.22 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 116.091 -0.504 . . . . 0.10000000000000001 111.173 -174.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.629 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.2 OUTLIER -84.18 148.16 26.91 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.178 -1.045 . . . . 1.0700000000000001 108.178 172.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 445' ' ' THR . 45.9 t -134.18 96.1 3.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.707 0.765 . . . . 0.5 109.844 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.434 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 19.6 t70 -82.39 -19.66 38.7 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.3 -1.318 . . . . 0.41999999999999998 109.921 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.547 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 14.2 p90 -84.39 -22.13 30.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.182 -1.372 . . . . 0.32000000000000001 111.239 -176.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.526 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 2.3 tt0 -100.38 115.66 65.2 Favored Pre-proline 0 CA--C 1.506 -0.725 0 CA-C-O 122.704 1.24 . . . . 1.74 110.032 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.51 ' HG2' ' OE1' ' A' ' 428' ' ' GLU . 44.8 Cg_endo -86.15 -10.71 6.7 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.271 3.314 . . . . 0.87 113.231 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.564 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.4 pm0 -111.6 153.93 25.6 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 122.39 1.091 . . . . 2.1600000000000001 113.242 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.838 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.04 130.88 4.3 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 104.93 -2.248 . . . . 0.91000000000000003 104.93 170.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.46 -158.63 31.62 Favored Glycine 0 C--N 1.284 -2.35 0 C-N-CA 119.806 -1.188 . . . . 0.20000000000000001 110.792 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.492 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.35 175.33 0.01 OUTLIER Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 120.519 -0.848 . . . . 0.25 111.713 167.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.475 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 7.8 p-10 -50.58 101.8 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 123.473 1.606 . . . . 1.8500000000000001 113.445 -153.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.655 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -97.13 -37.69 10.02 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 112.639 -2.073 . . . . 1.8200000000000001 109.478 169.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.73 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -54.13 -28.04 37.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.36 -0.836 . . . . 0.17999999999999999 112.286 -170.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.73 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.67 -35.07 15.16 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.697 0.629 . . . . 1.05 112.697 -178.029 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.2 p -90.98 -40.86 11.43 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.262 -0.881 . . . . 1.0600000000000001 111.014 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.655 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -95.49 -17.21 21.65 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.646 -1.161 . . . . 2.3700000000000001 109.693 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.76 50.11 51.1 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.91 -1.041 . . . . 0.23999999999999999 115.22 161.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.8 m -82.06 109.82 16.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.923 1.362 . . . . 1.7 110.845 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.405 ' HB2' ' OAC' ' A' ' 130' ' ' 1RG . 67.8 m-70 32.59 -112.16 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.467 -1.242 . . . . 0.56999999999999995 113.418 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.431 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -140.49 -14.6 0.52 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.898 -0.592 . . . . 0.28999999999999998 113.767 -174.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.495 ' HB3' ' HAS' ' A' ' 130' ' ' 1RG . 28.8 p -104.59 -166.32 1.23 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 117.75 0.775 . . . . 0.40000000000000002 112.467 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.559 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.1 mp -96.65 129.63 46.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.839 -1.073 . . . . 1.04 110.465 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.55 93.15 5.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.815 -0.629 . . . . 0.62 110.123 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.684 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.2 m -89.15 142.98 30.44 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.936 -1.029 . . . . 1.02 112.731 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.638 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 75.0 Cg_exo -50.16 146.47 17.72 Favored 'Trans proline' 0 CA--C 1.507 -0.857 0 C-N-CA 124.15 3.234 . . . . 0.23999999999999999 113.323 174.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.838 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 28.3 Cg_exo -67.33 -25.07 42.65 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.887 2.392 . . . . 0.31 111.834 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.499 ' O ' ' HE2' ' A' ' 451' ' ' LYS . 40.4 p -76.61 -26.09 54.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.94 -1.027 . . . . 1.48 112.036 -175.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.709 ' O ' HD23 ' A' ' 364' ' ' LEU . 33.4 m -99.27 -49.75 11.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 112.806 0.669 . . . . 1.03 112.806 -170.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.94 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.51 -2.25 4.49 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.743 -0.783 . . . . 1.02 110.409 -178.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.514 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 40.9 pttt -81.29 -38.74 26.33 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 122.518 1.151 . . . . 1.5900000000000001 108.335 173.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.574 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.1 mm-40 -62.94 -46.7 86.52 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 112.47 -2.15 . . . . 0.25 106.688 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.94 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -46.68 -67.16 0.31 Allowed 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 109.906 -3.316 . . . . 1.02 112.736 172.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.515 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 16.4 t80 -44.91 -24.85 0.25 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 124.191 0.932 . . . . 0.17000000000000001 109.39 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -87.57 -30.12 19.58 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.551 -1.204 . . . . 0.13 111.607 -175.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.584 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -98.27 -44.12 6.69 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 113.21 0.818 . . . . 1.02 113.21 178.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.687 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.75 147.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 122.558 1.17 . . . . 1.01 111.126 179.402 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.495 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -117.61 156.58 27.9 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 112.809 -1.996 . . . . 0.47999999999999998 108.473 -178.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.635 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 42.4 mtmt -55.76 102.73 0.08 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.699 -0.682 . . . . 1.7 109.517 169.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.79 -13.22 5.85 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 113.792 -1.549 . . . . 0.22 111.779 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 344' ' ' TYR . 17.3 m -64.85 150.1 95.29 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 108.996 -0.742 . . . . 0.94999999999999996 108.996 173.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.554 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.1 Cg_endo -93.62 160.33 2.36 Favored 'Trans proline' 0 N--CA 1.424 -2.616 0 C-N-CA 122.331 2.021 . . . . 0.23000000000000001 109.962 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.725 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -124.6 149.87 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.317 -1.364 . . . . 1.27 107.317 171.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.678 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.6 mp -134.42 149.99 50.82 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.339 -0.986 . . . . 1.05 108.339 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.685 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -137.82 140.95 40.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 105.647 -1.983 . . . . 1.01 105.647 166.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.583 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 5.4 p90 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 117.649 -1.167 . . . . 1.0900000000000001 111.139 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.739 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.61 0 N-CA-C 112.167 -0.373 . . . . 2.48 112.167 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.612 ' CE1' HD23 ' A' ' 464' ' ' LEU . 1.5 p-80 -139.21 102.61 4.55 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 111.805 0.298 . . . . 1.1399999999999999 111.805 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.528 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.5 OUTLIER 60.79 -162.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 O-C-N 124.023 0.827 . . . . 1.01 112.762 167.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.24 172.77 6.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.221 -1.399 . . . . 1.96 107.221 163.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.478 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 4.6 m-20 -80.06 83.97 5.86 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 119.246 -0.982 . . . . 0.42999999999999999 109.993 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 1.095 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 53.2 m -156.86 132.71 9.54 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.358 -1.292 . . . . 1.0 108.268 167.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.739 ' CD2' HD11 ' A' ' 464' ' ' LEU . 42.9 p90 174.73 158.38 0.17 Allowed 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 123.421 0.451 . . . . 0.88 111.002 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.689 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.34 153.71 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.387 -0.598 . . . . 1.0 109.387 165.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.595 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.71 146.63 28.21 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.826 -1.175 . . . . 2.0099999999999998 107.826 -178.488 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.709 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.4 155.03 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 C-N-CA 123.579 0.752 . . . . 1.04 110.618 173.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 355' ' ' TRP . 48.0 t0 -137.19 105.33 5.69 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.255 -1.757 . . . . 0.23999999999999999 106.255 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.643 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -79.62 -35.83 38.89 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 123.11 1.433 . . . . 1.02 110.019 -166.039 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.428 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -56.04 -44.98 79.33 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 110.682 -2.963 . . . . 0.59999999999999998 108.037 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 28.1 m-80 -101.02 7.1 43.62 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 110.815 -2.902 . . . . 0.20999999999999999 110.893 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.526 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.6 OUTLIER 32.78 61.44 0.38 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 112.628 -2.078 . . . . 2.54 112.928 -175.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.606 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 24.1 t60 -141.94 135.77 29.73 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.77 -0.65 . . . . 0.12 109.837 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.615 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.65 157.26 22.38 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.155 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.613 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.8 m-90 -142.68 160.06 41.04 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.81 -0.632 . . . . 0.11 111.254 -177.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.095 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 89.6 t80 -112.3 153.9 26.49 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 106.45 -1.685 . . . . 1.1000000000000001 106.45 150.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.5 m-85 -127.51 119.21 25.55 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 115.119 -0.946 . . . . 0.60999999999999999 110.126 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.4 tppt? -120.47 134.88 55.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.124 -1.806 . . . . 0.93999999999999995 106.124 168.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.415 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 72.98 16.32 4.41 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 113.216 0.821 . . . . 0.42999999999999999 113.216 172.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.478 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.68 6.79 88.35 Favored Glycine 0 CA--C 1.486 -1.767 0 C-N-CA 120.995 -0.621 . . . . 0.17999999999999999 113.05 -172.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.3 ptmt -128.49 176.39 7.78 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 104.872 -2.269 . . . . 1.0900000000000001 104.872 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.613 HG12 ' CD1' ' A' ' 355' ' ' TRP . 16.4 m -104.83 156.89 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 116.597 2.073 . . . . 1.02 116.597 -175.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.635 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -107.76 -27.34 10.34 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 110.672 -2.967 . . . . 1.01 106.599 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.9 145.39 49.57 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 111.405 -2.634 . . . . 1.02 111.301 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.606 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -142.1 118.08 10.6 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 104.504 -2.406 . . . . 0.47999999999999998 104.504 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.3 164.87 33.64 Favored 'General case' 0 N--CA 1.402 -2.857 0 C-N-CA 117.997 -1.481 . . . . 1.02 111.803 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.571 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 12.2 p-10 -102.95 132.69 49.0 Favored 'General case' 0 N--CA 1.41 -2.458 0 CA-C-N 114.109 -1.405 . . . . 1.8 109.791 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.702 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.02 -173.48 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-O 122.522 1.153 . . . . 1.01 112.425 -171.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.09 120.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 112.719 -2.037 . . . . 1.04 108.123 172.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.509 ' HG ' HG13 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -78.73 -168.6 1.45 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.23 -1.35 . . . . 1.6000000000000001 110.325 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.534 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.16 170.51 45.15 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 118.601 -1.761 . . . . 0.14000000000000001 112.631 -173.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.5 ptmt -72.96 155.28 90.6 Favored Pre-proline 0 C--O 1.218 -0.603 0 CA-C-O 121.42 0.629 . . . . 1.47 111.576 -166.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.62 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 77.9 Cg_exo -55.04 -28.29 59.37 Favored 'Trans proline' 0 CA--C 1.497 -1.326 0 C-N-CA 125.243 3.962 . . . . 0.28000000000000003 113.665 -173.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.437 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 26.2 p -72.6 -32.28 65.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.621 -1.627 . . . . 1.0800000000000001 109.586 -176.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.581 ' HB ' ' CAZ' ' A' ' 130' ' ' 1RG . 0.4 OUTLIER -141.37 70.56 26.93 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-O 123.426 1.584 . . . . 1.1000000000000001 110.127 178.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 375' ' ' THR . 76.1 Cg_exo -59.4 157.5 30.85 Favored 'Trans proline' 0 C--N 1.311 -1.406 1 C-N-CA 126.309 4.673 . . . . 0.38 113.996 -172.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.466 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.5 OUTLIER -84.97 147.74 48.93 Favored Pre-proline 0 N--CA 1.422 -1.875 0 N-CA-C 108.198 -1.038 . . . . 1.1299999999999999 108.198 174.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -77.6 -42.39 0.27 Allowed 'Trans proline' 0 CA--C 1.514 -0.505 0 C-N-CA 124.124 3.216 . . . . 0.20999999999999999 112.363 -166.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.713 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 54.99 137.83 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 123.604 1.668 . . . . 1.0600000000000001 114.487 -173.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 151.75 -109.91 0.44 Allowed Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 111.997 -2.365 . . . . 0.20000000000000001 109.549 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.75 124.32 56.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.328 0.585 . . . . 1.5 109.724 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.633 ' HE1' ' CE2' ' A' ' 382' ' ' PHE . 4.7 m-85 -123.65 -174.45 2.97 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.497 -1.297 . . . . 0.28000000000000003 107.497 172.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.0 OUTLIER -139.85 123.22 17.07 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 119.471 1.032 . . . . 0.96999999999999997 112.953 -171.072 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.84 91.14 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-O 123.296 1.522 . . . . 1.02 109.032 169.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -93.9 11.82 28.14 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 112.978 -1.919 . . . . 3.1299999999999999 107.873 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.733 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.9 t30 -168.49 124.9 1.01 Allowed 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 113.627 -1.624 . . . . 0.42999999999999999 110.009 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.624 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.19 143.53 31.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.086 -0.961 . . . . 1.73 108.949 170.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 37.1 mm-40 -126.95 158.46 36.77 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 114.961 1.467 . . . . 0.70999999999999996 114.961 -167.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 43.6 mt-10 -138.75 126.65 22.34 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.194 -1.821 . . . . 0.38 108.796 174.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 18.6 t70 52.15 51.88 15.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 123.165 1.459 . . . . 0.40999999999999998 109.231 -173.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -82.92 167.46 17.97 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.764 -2.016 . . . . 1.02 109.005 176.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 15.8 m -132.93 120.53 21.58 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.863 0.84 . . . . 1.04 111.291 169.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.6 mp -78.02 87.2 4.18 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.969 -1.468 . . . . 1.27 111.417 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.561 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 45.8 mttt -105.7 -179.49 3.96 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.393 -1.731 . . . . 0.96999999999999997 113.573 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.49 -162.21 25.76 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.689 -1.596 . . . . 0.46000000000000002 110.619 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.5 m -117.61 138.84 51.68 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 119.926 -0.71 . . . . 1.3500000000000001 109.914 168.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.6 m-80 -55.02 144.73 22.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 106.57 -1.641 . . . . 0.83999999999999997 106.57 165.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.445 ' HB2' ' CBD' ' A' ' 130' ' ' 1RG . 0.1 OUTLIER -60.02 -2.61 0.44 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.154 0.502 . . . . 2.2799999999999998 111.542 179.304 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 397' ' ' ASN . 4.0 t70 -106.92 1.72 24.76 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.273 -0.876 . . . . 2.27 109.693 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.53 20.13 27.9 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.625 -1.17 . . . . 0.97999999999999998 113.029 168.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' THR . . . . . . . . . . . . . 7.1 p -113.36 97.92 44.79 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 114.688 -0.756 . . . . 1.3999999999999999 109.675 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.4 Cg_endo -59.73 150.24 78.2 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 C-N-CA 122.794 2.33 . . . . 0.67000000000000004 112.778 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.611 ' HE1' ' CE2' ' A' ' 403' ' ' TYR . 22.5 p90 -151.37 170.44 19.55 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.3 -1.318 . . . . 1.04 112.063 -170.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.561 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -148.57 146.41 28.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.094 -1.412 . . . . 0.53000000000000003 110.798 175.283 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.9 OUTLIER -145.14 97.32 4.82 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 108.305 -0.998 . . . . 0.45000000000000001 108.305 170.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.2 Cg_exo -68.73 111.26 2.55 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 122.089 1.859 . . . . 0.22 110.49 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.632 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -112.74 151.21 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 CA-C-N 113.206 -1.815 . . . . 1.04 107.993 -167.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.712 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.8 OUTLIER -85.12 -19.53 31.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.789 -0.819 . . . . 0.65000000000000002 108.789 -173.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.656 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 97.5 m-85 -159.69 126.62 4.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.404 -0.961 . . . . 0.92000000000000004 108.404 -170.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.1 t-105 -144.14 136.04 26.22 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.7 0.762 . . . . 0.10000000000000001 111.174 -166.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.624 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.1 mmt -118.99 91.26 42.96 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.855 -1.165 . . . . 1.01 107.855 173.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.733 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 35.7 Cg_endo -66.35 83.41 0.28 Allowed 'Trans proline' 0 CA--C 1.514 -0.521 0 C-N-CA 122.387 2.058 . . . . 0.5 111.289 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 419' ' ' GLY . 4.2 pt -82.74 -178.95 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 115.708 -0.678 . . . . 1.05 109.287 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.674 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 18.1 t70 -148.3 -166.36 2.52 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.658 -0.867 . . . . 2.4900000000000002 108.658 -167.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.674 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 5.9 m-90 86.38 -58.54 0.06 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.927 0.767 . . . . 2.3700000000000001 111.451 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 27.9 p -123.38 -29.94 3.74 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.57 0.952 . . . . 1.5700000000000001 113.57 -163.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 133.03 -32.82 2.69 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 120.252 -0.975 . . . . 0.68000000000000005 111.788 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.694 HG12 ' CE2' ' A' ' 382' ' ' PHE . 2.4 p -53.73 170.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.277 -0.961 . . . . 1.45 112.244 177.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.599 ' N ' HG21 ' A' ' 418' ' ' VAL . . . -174.05 124.0 1.0 Allowed Glycine 0 CA--C 1.497 -1.092 0 N-CA-C 110.355 -1.098 . . . . 0.20000000000000001 110.355 172.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.648 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.4 mp -81.7 142.8 13.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.8 0.333 . . . . 1.0900000000000001 110.453 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.599 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.1 p80 -160.63 162.31 32.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.841 -0.618 . . . . 0.10000000000000001 110.924 -175.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.605 ' O ' HG21 ' A' ' 407' ' ' VAL . 0.2 OUTLIER -86.65 148.32 25.51 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.731 -1.211 . . . . 1.0700000000000001 107.731 172.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 445' ' ' THR . 45.3 t -133.05 96.71 3.83 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.803 0.811 . . . . 0.5 109.943 -170.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.29 -15.16 56.3 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.134 -1.394 . . . . 0.41999999999999998 109.445 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.632 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 10.0 p90 -89.83 -20.5 23.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.164 -1.38 . . . . 0.32000000000000001 111.452 -176.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.528 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 1.9 tt0 -101.82 116.71 62.98 Favored Pre-proline 0 CA--C 1.508 -0.659 0 CA-C-O 122.622 1.201 . . . . 1.74 110.419 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.548 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 42.9 Cg_endo -86.67 -11.34 5.83 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 124.228 3.285 . . . . 0.87 113.616 -173.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.598 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.2 pm0 -111.3 150.64 29.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.304 1.049 . . . . 2.1600000000000001 113.018 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.838 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -156.6 132.87 9.89 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 105.456 -2.054 . . . . 0.91000000000000003 105.456 167.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.14 -159.06 32.14 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 110.497 -1.041 . . . . 0.20000000000000001 110.497 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -46.8 175.34 0.01 OUTLIER Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.372 -0.918 . . . . 0.25 111.71 168.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.526 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 10.1 p-10 -51.69 101.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.453 1.597 . . . . 1.8500000000000001 113.733 -155.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.648 ' CD2' ' HD2' ' A' ' 437' ' ' ARG . 35.6 mt -97.86 -35.34 10.53 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 112.038 -2.347 . . . . 1.8200000000000001 109.467 170.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.686 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.0 p-90 -53.07 -26.95 17.85 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.012 -0.994 . . . . 0.17999999999999999 112.071 -172.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.686 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.28 -35.77 15.09 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.611 -0.722 . . . . 1.05 112.482 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.431 ' H ' HG21 ' A' ' 436' ' ' THR . 1.8 p -88.51 -37.71 15.54 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.468 -0.787 . . . . 1.0600000000000001 110.617 -176.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.648 ' HD2' ' CD2' ' A' ' 433' ' ' LEU . 0.4 OUTLIER -99.25 -19.64 16.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.676 -1.147 . . . . 2.3700000000000001 110.715 -178.382 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.562 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.34 49.62 50.42 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 115.988 1.155 . . . . 0.23999999999999999 115.988 162.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.1 m -82.3 111.07 18.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 119.745 1.773 . . . . 1.7 111.105 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 37.74 -113.64 0.11 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.635 0.976 . . . . 0.56999999999999995 113.635 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.627 ' HA3' ' SAK' ' A' ' 130' ' ' 1RG . . . -142.91 -14.87 0.31 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.62 -0.718 . . . . 0.28999999999999998 113.838 -173.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 419' ' ' GLY . 26.4 p -101.56 -167.31 1.4 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.994 0.897 . . . . 0.40000000000000002 112.233 -177.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.509 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.3 mp -99.31 128.35 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 115.096 -0.956 . . . . 1.04 110.751 -174.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.32 92.37 5.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.577 -0.738 . . . . 0.62 110.234 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.702 ' HA ' HG23 ' A' ' 368' ' ' ILE . 4.1 m -88.1 143.3 32.77 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.024 -0.989 . . . . 1.02 112.64 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.57 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 74.1 Cg_exo -50.52 143.12 28.82 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 123.67 2.914 . . . . 0.23999999999999999 112.854 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.838 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 31.3 Cg_exo -64.42 -24.08 64.48 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.762 2.308 . . . . 0.31 111.914 -176.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.521 ' O ' ' HE2' ' A' ' 451' ' ' LYS . 36.6 p -78.06 -25.49 47.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.217 -0.901 . . . . 1.48 112.444 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.711 ' O ' HD23 ' A' ' 364' ' ' LEU . 33.2 m -99.71 -48.76 11.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 112.801 0.667 . . . . 1.03 112.801 -171.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.935 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.39 -2.13 4.21 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.925 -0.71 . . . . 1.02 110.379 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.568 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 42.6 pttt -81.17 -39.03 26.14 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.47 1.129 . . . . 1.5900000000000001 108.188 173.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.583 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.9 mm-40 -62.0 -46.24 90.09 Favored 'General case' 0 CA--C 1.473 -1.999 0 CA-C-N 112.545 -2.116 . . . . 0.25 106.593 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.935 HD21 ' SD ' ' A' ' 450' ' ' MET . 4.0 tp -46.61 -67.09 0.31 Allowed 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 109.679 -3.419 . . . . 1.02 112.755 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.52 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 14.6 t80 -45.37 -24.1 0.26 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 123.972 0.795 . . . . 0.17000000000000001 109.584 177.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.52 -26.64 27.07 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.68 -1.145 . . . . 0.13 111.899 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.555 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -100.9 -43.68 6.0 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 113.157 0.799 . . . . 1.02 113.157 176.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.689 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -74.69 146.96 9.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.674 1.226 . . . . 1.01 111.191 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.487 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -117.24 156.1 28.32 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 112.536 -2.12 . . . . 0.47999999999999998 108.499 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.605 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 40.1 mtmt -59.09 101.34 0.09 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.786 0.803 . . . . 1.7 109.614 171.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 132.3 -14.14 5.12 Favored Glycine 0 C--N 1.304 -1.235 0 CA-C-N 113.556 -1.656 . . . . 0.22 111.452 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.563 HG21 ' HA ' ' A' ' 344' ' ' TYR . 14.7 m -65.11 150.31 95.63 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 108.854 -0.795 . . . . 0.94999999999999996 108.854 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.0 Cg_endo -93.5 162.03 2.39 Favored 'Trans proline' 0 N--CA 1.421 -2.746 0 C-N-CA 122.204 1.936 . . . . 0.23000000000000001 109.813 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.737 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -125.68 151.91 32.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.465 -1.309 . . . . 1.27 107.465 171.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.739 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.3 mp -133.84 150.07 51.38 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.27 -1.011 . . . . 1.05 108.27 175.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.713 HG23 ' HA ' ' A' ' 379' ' ' ALA . 0.7 OUTLIER -140.53 137.88 36.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 103.879 -2.637 . . . . 1.01 103.879 163.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.595 ' CE1' ' CD ' ' A' ' 346' ' ' GLU . 1.6 p90 . . . . . 0 C--O 1.25 1.129 0 O-C-N 123.742 0.651 . . . . 1.0900000000000001 111.378 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.735 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.116 -0.394 . . . . 2.48 112.116 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.573 ' CE1' HD23 ' A' ' 464' ' ' LEU . 1.6 p-80 -140.45 102.26 4.29 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 111.606 0.224 . . . . 1.1399999999999999 111.606 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.55 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.5 OUTLIER 61.97 -167.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.122 0.889 . . . . 1.01 112.706 167.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -62.63 173.14 1.35 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.826 -0.625 . . . . 1.96 109.829 162.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.431 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 18.6 m-20 -79.1 82.93 5.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.185 -1.006 . . . . 0.42999999999999999 109.68 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 92.7 m -158.59 136.27 10.31 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.794 -1.094 . . . . 1.0 109.02 168.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.743 ' CD2' HD11 ' A' ' 464' ' ' LEU . 39.9 p90 173.92 158.44 0.14 Allowed 'General case' 0 C--O 1.211 -0.963 0 O-C-N 123.582 0.551 . . . . 0.88 111.329 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.695 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.63 153.66 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 164.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.573 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.01 146.28 28.85 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.778 -1.193 . . . . 2.0099999999999998 107.778 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.693 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.05 155.8 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 C-N-CA 123.381 0.673 . . . . 1.04 110.527 174.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.505 ' N ' HG13 ' A' ' 347' ' ' VAL . 31.4 t0 -137.99 106.68 5.89 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.755 -1.572 . . . . 0.23999999999999999 106.755 175.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.659 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.2 OUTLIER -81.03 -34.77 32.61 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-O 123.094 1.426 . . . . 1.02 110.047 -166.487 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 466' ' ' PHE . 0.8 OUTLIER -58.88 -44.94 91.21 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 110.617 -2.992 . . . . 0.59999999999999998 108.064 177.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -101.23 7.94 42.78 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 111.216 -2.72 . . . . 0.20999999999999999 110.88 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.547 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.5 mp0 31.36 62.54 0.24 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 112.673 -2.058 . . . . 2.54 113.316 -175.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.597 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 26.7 t60 -142.85 136.37 28.66 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.724 -0.671 . . . . 0.12 109.661 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.619 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.2 OUTLIER -114.11 156.48 24.12 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.084 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.62 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.4 m-90 -142.25 158.66 43.47 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.648 -0.706 . . . . 0.11 111.191 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.701 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.8 t80 -111.32 154.07 25.05 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.607 -1.627 . . . . 1.1000000000000001 106.607 151.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.4 m-85 -128.13 116.92 20.7 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 115.262 -0.881 . . . . 0.60999999999999999 110.513 -178.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.7 tppt? -119.05 140.03 50.75 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.338 -1.727 . . . . 0.93999999999999995 106.338 168.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.49 16.27 9.15 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.174 0.805 . . . . 0.42999999999999999 113.174 174.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.18 6.99 87.82 Favored Glycine 0 CA--C 1.485 -1.815 0 CA-C-N 115.563 -0.744 . . . . 0.17999999999999999 113.024 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.5 ptmt -127.68 178.77 5.91 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 104.375 -2.454 . . . . 1.0900000000000001 104.375 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.62 HG12 ' CD1' ' A' ' 355' ' ' TRP . 16.9 m -104.37 157.76 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 N-CA-C 116.412 2.004 . . . . 1.02 116.412 -176.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.593 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -108.35 -28.04 9.64 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 110.773 -2.921 . . . . 1.01 106.635 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.718 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -132.84 144.63 50.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 111.52 -2.582 . . . . 1.02 111.435 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.597 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 5.6 tt0 -138.8 119.33 13.9 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 104.238 -2.504 . . . . 0.47999999999999998 104.238 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.619 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.3 164.84 34.75 Favored 'General case' 0 N--CA 1.401 -2.898 0 C-N-CA 117.644 -1.622 . . . . 1.02 111.989 178.272 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.56 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 16.9 p-10 -103.46 134.2 47.23 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.373 -1.285 . . . . 1.8 109.784 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.676 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -136.8 -172.92 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 CA-C-O 122.417 1.103 . . . . 1.01 112.515 -171.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.482 HG12 HE22 ' A' ' 426' ' ' GLN . 0.5 OUTLIER -153.33 121.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 112.745 -2.025 . . . . 1.04 108.498 172.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.57 ' HG ' HG13 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -79.36 -168.79 1.64 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.268 -1.333 . . . . 1.6000000000000001 110.556 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -85.36 170.79 45.1 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 118.649 -1.738 . . . . 0.14000000000000001 112.465 -174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 7.0 ptpt -74.61 157.38 86.11 Favored Pre-proline 0 C--O 1.221 -0.404 0 CA-C-O 121.402 0.62 . . . . 1.47 111.893 -166.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.623 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 99.4 Cg_exo -55.81 -30.04 74.75 Favored 'Trans proline' 0 CA--C 1.495 -1.436 0 C-N-CA 125.27 3.98 . . . . 0.28000000000000003 113.15 -172.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.452 ' OG1' HG21 ' A' ' 375' ' ' THR . 16.0 p -68.54 -33.18 73.65 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.304 -1.771 . . . . 1.0800000000000001 109.774 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.78 ' OG1' ' HA ' ' A' ' 130' ' ' 1RG . 1.2 t -140.88 70.33 29.62 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 123.487 1.613 . . . . 1.1000000000000001 109.522 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.0 Cg_exo -58.61 157.1 28.76 Favored 'Trans proline' 0 C--N 1.307 -1.631 1 C-N-CA 126.191 4.594 . . . . 0.38 114.265 -171.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.491 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -89.61 143.13 30.0 Favored Pre-proline 0 N--CA 1.418 -2.04 0 N-CA-C 108.093 -1.077 . . . . 1.1299999999999999 108.093 171.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.521 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 19.8 Cg_exo -76.33 -44.1 0.27 Allowed 'Trans proline' 0 CA--C 1.508 -0.82 0 C-N-CA 124.565 3.51 . . . . 0.20999999999999999 111.979 -167.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.646 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.37 137.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 123.582 1.658 . . . . 1.0600000000000001 113.605 -172.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 154.39 -110.81 0.46 Allowed Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 112.064 -2.334 . . . . 0.20000000000000001 109.503 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.42 ' O ' HG11 ' A' ' 381' ' ' VAL . 4.5 p -131.24 120.63 47.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.871 0.844 . . . . 1.5 110.232 175.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.616 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.6 m-85 -119.47 -174.59 2.77 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.87 -1.53 . . . . 0.28000000000000003 106.87 172.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.518 ' HB2' ' CH2' ' A' ' 415' ' ' TRP . 1.6 t80 -139.54 123.48 17.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 120.07 1.304 . . . . 0.96999999999999997 113.206 -171.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 2.1 p -88.66 91.29 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 123.132 1.444 . . . . 1.02 109.109 168.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -92.38 10.83 28.28 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.276 -1.784 . . . . 3.1299999999999999 108.014 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.733 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.2 t30 -169.03 126.73 0.98 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.836 -1.529 . . . . 0.42999999999999999 110.492 171.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.646 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -97.63 141.8 30.23 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.889 -1.051 . . . . 1.73 108.815 169.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.752 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 14.7 mm-40 -125.97 157.02 38.88 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 114.538 1.31 . . . . 0.70999999999999996 114.538 -168.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.739 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.0 mt-10 -137.41 127.26 25.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 112.912 -1.949 . . . . 0.38 108.461 173.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.2 t70 57.6 47.23 16.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 123.446 1.593 . . . . 0.40999999999999998 109.072 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.435 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -84.27 167.48 16.57 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 112.474 -2.148 . . . . 1.02 109.457 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 19.9 m -132.35 119.09 20.25 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.188 0.994 . . . . 1.04 112.149 171.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 4.1 mp -81.77 91.76 6.54 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.63 -1.623 . . . . 1.27 112.498 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.578 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.7 mttt -102.29 178.84 4.48 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 114.0 -1.454 . . . . 0.96999999999999997 113.572 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.34 -157.98 24.7 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 119.827 -1.178 . . . . 0.46000000000000002 111.883 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 2.0 m -121.97 136.68 54.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.254 -0.578 . . . . 1.3500000000000001 111.531 172.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.1 m-80 -56.48 156.83 5.64 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.133 -0.94 . . . . 0.83999999999999997 110.16 169.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.418 ' HB3' HG23 ' A' ' 375' ' ' THR . 6.3 p-10 -54.5 -14.65 1.34 Allowed 'General case' 0 CA--C 1.489 -1.396 0 CA-C-N 113.301 -1.772 . . . . 2.2799999999999998 112.092 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 397' ' ' ASN . 17.6 t70 -97.67 -18.49 18.84 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.609 -1.632 . . . . 2.27 109.242 -173.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.88 33.17 5.62 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 119.337 -1.411 . . . . 0.97999999999999998 111.314 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.444 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 11.4 p -123.35 100.64 38.62 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.455 -0.873 . . . . 1.3999999999999999 109.319 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 21.5 Cg_endo -59.65 150.72 74.8 Favored 'Trans proline' 0 CA--C 1.501 -1.133 0 C-N-CA 122.651 2.234 . . . . 0.67000000000000004 113.131 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.626 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 28.3 p90 -150.41 174.64 12.66 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.326 -1.306 . . . . 1.04 112.485 -169.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.578 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.9 OUTLIER -144.13 147.62 33.97 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.727 -1.579 . . . . 0.53000000000000003 109.642 171.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -143.55 97.29 5.54 Favored Pre-proline 0 N--CA 1.432 -1.335 0 N-CA-C 108.176 -1.046 . . . . 0.45000000000000001 108.176 172.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 16.8 Cg_exo -69.44 110.0 2.39 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 121.994 1.796 . . . . 0.22 109.654 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.623 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -108.9 154.22 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 CA-C-N 113.057 -1.883 . . . . 1.04 107.688 -168.067 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.739 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.8 m-80 -86.48 -20.43 28.11 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.78 -0.822 . . . . 0.65000000000000002 108.78 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 96.4 m-85 -158.8 127.1 5.21 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.933 -1.031 . . . . 0.92000000000000004 108.749 -171.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.618 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 22.5 t-105 -144.13 135.31 25.51 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.607 0.718 . . . . 0.10000000000000001 111.001 -167.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.646 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.7 mmt -119.51 89.89 41.65 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.22 -1.03 . . . . 1.01 108.22 174.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.733 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 28.1 Cg_endo -63.63 100.21 0.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.016 1.81 . . . . 0.5 111.062 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 411' ' ' MET . 5.6 pt -102.12 176.51 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.341 -0.985 . . . . 1.05 108.341 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 416' ' ' THR . 2.1 t70 -143.09 -170.21 3.2 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 118.873 -1.131 . . . . 2.4900000000000002 113.011 -165.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.518 ' CH2' ' HB2' ' A' ' 383' ' ' TYR . 25.6 p90 53.4 -5.27 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.986 2.114 . . . . 2.3700000000000001 114.702 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.615 HG22 ' CE1' ' A' ' 382' ' ' PHE . 22.1 p -131.53 -20.25 2.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.056 0.391 . . . . 1.5700000000000001 112.056 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 95.88 -27.38 16.53 Favored Glycine 0 CA--C 1.505 -0.592 0 N-CA-C 111.25 -0.74 . . . . 0.68000000000000005 111.25 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 419' ' ' GLY . 39.0 t -55.11 172.45 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.762 0.825 . . . . 1.45 111.342 -178.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.601 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -178.13 123.21 0.86 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 109.719 -1.352 . . . . 0.20000000000000001 109.719 170.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.684 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.5 142.43 13.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.809 -0.441 . . . . 1.0900000000000001 109.809 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.586 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.6 p80 -160.71 162.92 32.69 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.255 -0.43 . . . . 0.10000000000000001 111.482 -174.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.598 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.21 147.76 26.43 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.245 -1.02 . . . . 1.0700000000000001 108.245 172.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.3 t -132.99 96.93 3.88 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.791 0.805 . . . . 0.5 109.835 -172.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -82.11 -12.49 58.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.094 -1.412 . . . . 0.41999999999999998 109.067 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.623 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 10.2 p90 -92.96 -23.92 18.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.01 -1.45 . . . . 0.32000000000000001 111.757 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.535 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 1.3 tt0 -98.01 115.47 65.75 Favored Pre-proline 0 CA--C 1.507 -0.706 0 CA-C-O 122.711 1.243 . . . . 1.74 110.164 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.526 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 47.3 Cg_endo -86.25 -10.97 6.47 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.151 3.234 . . . . 0.87 113.046 -173.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.621 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.0 pm0 -111.99 154.63 25.01 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.409 1.1 . . . . 2.1600000000000001 113.237 174.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.623 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.54 132.08 4.4 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.857 -2.275 . . . . 0.91000000000000003 104.857 171.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.45 -157.39 29.53 Favored Glycine 0 C--N 1.282 -2.441 0 C-N-CA 119.77 -1.205 . . . . 0.20000000000000001 110.885 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.452 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.21 175.95 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.297 -0.954 . . . . 0.25 111.578 166.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.49 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.4 p-10 -51.95 101.57 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 123.276 1.512 . . . . 1.8500000000000001 113.426 -156.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.659 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.63 -35.8 10.93 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 112.631 -2.077 . . . . 1.8200000000000001 109.45 169.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.721 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.7 p-90 -55.37 -28.0 51.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.173 -0.921 . . . . 0.17999999999999999 112.156 -170.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.721 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.63 -35.04 15.21 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.604 0.716 . . . . 1.05 112.122 -177.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.434 ' H ' HG21 ' A' ' 436' ' ' THR . 2.1 p -90.14 -43.7 10.28 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.754 -1.112 . . . . 1.0600000000000001 111.008 -175.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.659 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 3.0 mtp85 -92.35 -19.64 21.9 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.65 -1.159 . . . . 2.3700000000000001 109.732 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 54.48 48.47 64.85 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 113.848 -1.524 . . . . 0.23999999999999999 115.265 164.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 25.0 m -81.76 111.03 17.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 118.853 1.326 . . . . 1.7 111.217 -171.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.426 ' HB3' ' NAJ' ' A' ' 130' ' ' 1RG . 55.9 m-70 36.39 -120.69 0.15 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.741 -1.118 . . . . 0.56999999999999995 113.66 177.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -133.29 -19.71 0.95 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 116.036 -0.529 . . . . 0.28999999999999998 113.676 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.48 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.1 p -103.56 -165.37 1.15 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 117.507 0.654 . . . . 0.40000000000000002 112.707 -175.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.57 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.1 mp -95.48 130.57 44.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.968 -1.014 . . . . 1.04 110.658 -175.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.5 95.29 6.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.826 -0.625 . . . . 0.62 110.13 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.676 ' HA ' HG23 ' A' ' 368' ' ' ILE . 4.4 m -91.64 142.54 26.85 Favored Pre-proline 0 N--CA 1.437 -1.125 0 CA-C-N 115.042 -0.981 . . . . 1.02 112.668 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.594 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 87.2 Cg_exo -49.9 144.85 20.09 Favored 'Trans proline' 0 CA--C 1.507 -0.871 0 C-N-CA 124.096 3.197 . . . . 0.23999999999999999 113.457 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.623 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.6 Cg_exo -65.41 -28.37 54.43 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 122.783 2.322 . . . . 0.31 112.306 -175.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.47 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 48.1 m -74.74 -23.72 58.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.845 -0.616 . . . . 1.48 112.282 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.718 ' O ' HD23 ' A' ' 364' ' ' LEU . 29.9 m -100.68 -49.08 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 112.932 0.716 . . . . 1.03 112.932 -169.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.933 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.95 -2.09 4.85 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.8 -0.76 . . . . 1.02 110.308 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.562 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.0 pttp -81.63 -38.98 25.12 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.378 1.085 . . . . 1.5900000000000001 108.117 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.583 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.6 mm-40 -62.03 -46.16 90.39 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-N 112.524 -2.126 . . . . 0.25 106.599 -177.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.933 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.9 tp -46.19 -67.06 0.32 Allowed 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 109.678 -3.419 . . . . 1.02 112.778 172.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.5 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 15.3 t80 -45.52 -24.21 0.3 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 123.957 0.785 . . . . 0.17000000000000001 109.48 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -87.91 -26.63 28.62 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 114.684 -1.143 . . . . 0.13 111.743 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.551 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -101.8 -44.11 5.63 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 113.322 0.86 . . . . 1.02 113.322 176.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.695 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -74.1 148.06 8.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.499 1.143 . . . . 1.01 111.25 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.498 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -117.07 157.99 24.93 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 112.745 -2.025 . . . . 0.47999999999999998 108.992 -179.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.647 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 7.3 mppt? -59.2 102.01 0.12 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.551 -0.907 . . . . 1.7 108.551 168.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.22 -12.36 5.52 Favored Glycine 0 C--N 1.308 -1.011 0 CA-C-N 114.22 -1.355 . . . . 0.22 111.726 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.585 HG21 ' HA ' ' A' ' 344' ' ' TYR . 15.9 m -68.25 151.22 97.36 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 108.838 -0.801 . . . . 0.94999999999999996 108.838 171.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.55 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.3 Cg_endo -94.1 165.92 2.04 Favored 'Trans proline' 0 N--CA 1.422 -2.694 0 C-N-CA 122.1 1.866 . . . . 0.23000000000000001 109.929 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.732 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -127.3 152.6 35.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.697 -1.223 . . . . 1.27 107.697 170.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.743 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.3 mp -134.01 150.06 51.22 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.05 -1.093 . . . . 1.05 108.05 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.693 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -139.94 138.28 38.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 103.753 -2.684 . . . . 1.01 103.753 164.031 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.573 ' CE1' ' CD ' ' A' ' 346' ' ' GLU . 2.5 p90 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 117.573 -1.204 . . . . 1.0900000000000001 112.109 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.78 ' HA ' ' OG1' ' A' ' 375' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.49 -0.244 . . . . 2.48 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.563 ' CE1' HD23 ' A' ' 464' ' ' LEU . 1.7 p-80 -146.99 102.12 3.49 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 111.738 0.273 . . . . 1.1399999999999999 111.738 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.573 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.0 OUTLIER 64.37 -168.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.055 0.847 . . . . 1.01 112.569 167.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -56.99 166.08 1.11 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.647 -0.706 . . . . 1.96 109.826 162.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.17 82.44 5.33 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 118.519 -1.272 . . . . 0.42999999999999999 109.129 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 99.9 m -159.59 136.16 9.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.457 -1.247 . . . . 1.0 108.995 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.634 ' CD2' HD11 ' A' ' 464' ' ' LEU . 38.6 p90 174.67 158.61 0.17 Allowed 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 123.381 0.425 . . . . 0.88 111.117 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.679 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -78.11 152.35 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 164.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.528 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.1 tt0 -149.77 145.82 26.84 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.437 -0.802 . . . . 2.0099999999999998 109.389 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 464' ' ' LEU . 2.8 t -138.23 162.28 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 120.917 0.389 . . . . 1.04 111.184 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.519 ' N ' HG13 ' A' ' 347' ' ' VAL . 33.7 t0 -140.38 106.4 5.2 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.419 -1.326 . . . . 0.23999999999999999 107.419 173.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.65 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -81.63 -35.74 29.67 Favored 'General case' 0 CA--C 1.483 -1.618 0 CA-C-O 122.678 1.228 . . . . 1.02 110.477 -167.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.422 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -56.53 -44.27 80.67 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 110.967 -2.833 . . . . 0.59999999999999998 108.219 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.8 m-80 -101.21 6.78 43.16 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 110.751 -2.932 . . . . 0.20999999999999999 110.923 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.689 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.8 OUTLIER 34.19 61.83 0.5 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 112.558 -2.11 . . . . 2.54 113.139 -176.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.587 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 20.4 t60 -142.11 133.59 26.63 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.782 -0.644 . . . . 0.12 110.236 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.572 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.2 OUTLIER -112.84 155.5 24.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.684 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.5 ' CE2' ' HD2' ' A' ' 353' ' ' HIS . 29.0 m-90 -140.62 153.83 46.21 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.42 -0.809 . . . . 0.11 110.877 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.68 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 84.0 t80 -110.67 151.89 27.17 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 106.385 -1.709 . . . . 1.1000000000000001 106.385 152.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 6.9 m-85 -127.97 115.62 18.8 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 114.602 -1.181 . . . . 0.60999999999999999 110.343 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.1 tppt? -116.53 138.4 51.43 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.474 -1.676 . . . . 0.93999999999999995 106.474 169.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.407 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.54 17.45 9.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.343 0.868 . . . . 0.42999999999999999 113.343 173.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.92 9.81 86.47 Favored Glycine 0 CA--C 1.491 -1.455 0 CA-C-N 115.528 -0.76 . . . . 0.17999999999999999 112.913 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.5 ptmt -130.27 178.36 6.64 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 104.757 -2.312 . . . . 1.0900000000000001 104.757 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 17.9 m -105.08 157.9 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.642 0 N-CA-C 116.338 1.977 . . . . 1.02 116.338 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.569 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -110.46 -27.91 8.79 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 110.571 -3.013 . . . . 1.01 106.558 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.6 145.28 49.89 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 111.568 -2.56 . . . . 1.02 111.362 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.587 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -141.65 118.29 11.0 Favored 'General case' 0 N--CA 1.404 -2.747 0 N-CA-C 104.255 -2.498 . . . . 0.47999999999999998 104.255 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.633 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -150.22 160.81 43.42 Favored 'General case' 0 N--CA 1.396 -3.131 0 C-N-CA 117.822 -1.551 . . . . 1.02 111.244 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 14.9 p-10 -102.83 132.32 49.1 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.38 -1.282 . . . . 1.8 109.001 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.689 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 2.5 pp -132.16 -172.31 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 CA-C-O 122.439 1.114 . . . . 1.01 112.673 -171.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.83 118.9 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 112.985 -1.916 . . . . 1.04 108.905 173.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.621 ' HG ' ' HB3' ' A' ' 349' ' ' LEU . 47.4 p -74.92 -168.93 0.81 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 112.039 -2.346 . . . . 1.6000000000000001 111.662 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.75 175.25 50.46 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 118.944 -1.598 . . . . 0.14000000000000001 111.831 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.408 ' HG2' ' CG2' ' A' ' 375' ' ' THR . 15.3 ptmt -79.1 163.2 61.21 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.813 0.672 . . . . 1.47 112.813 -164.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.641 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 86.3 Cg_exo -55.72 -37.54 95.37 Favored 'Trans proline' 0 CA--C 1.511 -0.65 0 C-N-CA 122.76 2.307 . . . . 0.28000000000000003 112.448 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.421 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 19.2 p -66.28 -32.26 73.56 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.461 -1.245 . . . . 1.0800000000000001 110.175 -174.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.536 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.3 t -141.23 72.4 26.8 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 123.704 1.716 . . . . 1.1000000000000001 109.608 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 375' ' ' THR . 72.5 Cg_exo -59.99 164.09 12.81 Favored 'Trans proline' 0 C--N 1.312 -1.345 1 C-N-CA 126.394 4.729 . . . . 0.38 115.133 -172.214 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.523 ' CG2' HG22 ' A' ' 465' ' ' VAL . 2.1 m -90.12 128.01 51.28 Favored Pre-proline 0 N--CA 1.399 -2.979 0 CA-C-N 113.869 -1.514 . . . . 1.1299999999999999 108.343 171.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 38.7 Cg_exo -69.47 -45.58 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.99 3.127 . . . . 0.20999999999999999 112.014 -170.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.667 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 63.14 143.93 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 123.316 1.532 . . . . 1.0600000000000001 113.943 -175.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 145.74 -110.41 0.54 Allowed Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 111.905 -2.407 . . . . 0.20000000000000001 108.862 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.5 p -131.19 127.55 60.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.822 -0.436 . . . . 1.5 109.822 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.604 ' HE1' ' CE2' ' A' ' 382' ' ' PHE . 7.7 m-85 -121.54 -174.49 2.87 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.253 -1.388 . . . . 0.28000000000000003 107.253 169.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.617 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 2.2 t80 -138.93 121.26 15.96 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 120.792 -1.192 . . . . 0.96999999999999997 113.194 -173.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.487 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -87.82 92.62 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-O 122.881 1.324 . . . . 1.02 109.368 171.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 44.0 p-90 -92.25 10.35 29.97 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 113.575 -1.648 . . . . 3.1299999999999999 108.314 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.748 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.9 t30 -169.6 127.01 0.91 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.098 -1.41 . . . . 0.42999999999999999 110.392 172.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.586 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.46 143.13 31.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.073 -0.967 . . . . 1.73 109.012 169.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.728 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 10.7 mm-40 -125.31 157.74 35.92 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.548 1.314 . . . . 0.70999999999999996 114.548 -168.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.719 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 47.8 mt-10 -137.49 127.24 25.44 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.178 -1.828 . . . . 0.38 108.668 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 19.5 t70 55.01 50.36 15.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 123.366 1.555 . . . . 0.40999999999999998 109.025 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -84.27 167.37 16.68 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 112.495 -2.139 . . . . 1.02 109.522 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 15.8 m -132.43 118.77 19.76 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.102 0.953 . . . . 1.04 111.494 170.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.18 88.37 4.88 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.779 -1.555 . . . . 1.27 112.11 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.57 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 48.0 mttt -102.08 179.01 4.44 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 113.703 -1.59 . . . . 0.96999999999999997 112.971 176.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 137.37 -157.52 24.01 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 119.443 -1.361 . . . . 0.46000000000000002 111.785 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.6 m -118.16 138.97 51.93 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 120.369 -0.532 . . . . 1.3500000000000001 110.668 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.1 m-80 -55.87 152.03 10.58 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.41 -0.959 . . . . 0.83999999999999997 108.41 167.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.12 -2.94 0.71 Allowed 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.689 0.618 . . . . 2.2799999999999998 111.096 178.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 397' ' ' ASN . 5.0 t70 -112.26 2.61 16.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.207 -0.906 . . . . 2.27 110.45 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.44 18.39 33.34 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.319 -0.943 . . . . 0.97999999999999998 113.308 170.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.464 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 4.9 p -113.47 100.48 51.9 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 114.969 -0.616 . . . . 1.3999999999999999 109.899 -176.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.1 Cg_endo -58.47 149.81 72.47 Favored 'Trans proline' 0 CA--C 1.504 -1.009 0 C-N-CA 122.853 2.369 . . . . 0.67000000000000004 113.089 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.654 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 24.1 p90 -152.56 174.94 13.31 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.396 -1.274 . . . . 1.04 113.059 -168.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.57 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -144.55 148.22 34.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.996 -1.456 . . . . 0.53000000000000003 110.455 172.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.43 97.74 4.68 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 108.422 -0.955 . . . . 0.45000000000000001 108.422 169.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.2 Cg_exo -69.03 110.21 2.35 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.037 1.824 . . . . 0.22 110.462 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.613 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -109.9 157.71 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 CA-C-N 113.084 -1.871 . . . . 1.04 107.824 -167.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.719 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.5 m-80 -88.31 -22.18 24.0 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.83 -0.804 . . . . 0.65000000000000002 108.83 -175.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.668 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 93.6 m-85 -158.72 127.65 5.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.936 -1.029 . . . . 0.92000000000000004 108.382 -170.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.617 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 18.1 t-105 -144.41 133.88 23.3 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.665 0.745 . . . . 0.10000000000000001 110.812 -166.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.586 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 13.5 mmt -115.15 89.81 21.71 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.101 -1.074 . . . . 1.01 108.101 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.748 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 35.0 Cg_endo -65.87 89.03 0.23 Allowed 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 122.456 2.104 . . . . 0.5 109.408 175.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 8.1 pt -84.18 -157.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.923 -1.035 . . . . 1.05 110.39 -172.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.487 ' OD2' ' HA ' ' A' ' 382' ' ' PHE . 3.0 p30 -90.24 -177.68 5.19 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.656 1.217 . . . . 2.4900000000000002 112.785 -161.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.41 ' CD2' ' N ' ' A' ' 415' ' ' TRP . 0.0 OUTLIER -78.43 32.05 0.19 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 112.399 -2.182 . . . . 2.3700000000000001 112.179 -162.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 11.0 p -99.19 -23.01 15.37 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.585 -0.734 . . . . 1.5700000000000001 109.55 173.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.622 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 129.84 -39.64 1.79 Allowed Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.528 -0.76 . . . . 0.68000000000000005 113.222 171.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.568 HG13 ' N ' ' A' ' 419' ' ' GLY . 24.0 t -62.38 173.59 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 123.134 0.574 . . . . 1.45 111.872 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.568 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -176.01 121.69 0.82 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.77 -1.332 . . . . 0.20000000000000001 109.77 169.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.657 HG21 ' SD ' ' A' ' 450' ' ' MET . 2.3 mp -81.69 143.08 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.839 -0.344 . . . . 1.0900000000000001 110.163 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.593 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.3 p80 -159.37 161.5 35.7 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.29 -0.414 . . . . 0.10000000000000001 111.461 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.609 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.83 144.8 28.2 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.843 -1.169 . . . . 1.0700000000000001 107.843 172.341 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 33.7 t -134.26 98.0 3.99 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.851 0.834 . . . . 0.5 110.576 -170.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -80.62 -20.11 43.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.121 -1.399 . . . . 0.41999999999999998 110.062 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.613 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 13.5 p90 -82.87 -25.2 32.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.216 -1.356 . . . . 0.32000000000000001 111.388 -175.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.1 OUTLIER -87.67 128.98 52.51 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 122.222 1.011 . . . . 1.74 110.318 -176.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.412 ' HD2' ' OE1' ' A' ' 426' ' ' GLN . 64.7 Cg_endo -72.28 -51.73 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 124.146 3.23 . . . . 0.87 113.119 -176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.01 161.01 17.55 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.737 1.256 . . . . 2.1600000000000001 112.682 -169.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.517 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 1.2 m-85 -154.61 121.9 5.67 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 112.116 -2.311 . . . . 0.91000000000000003 105.901 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 165.81 -157.05 29.36 Favored Glycine 0 C--N 1.283 -2.391 0 C-N-CA 119.862 -1.161 . . . . 0.20000000000000001 110.352 -174.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -38.61 164.78 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.725 0 C-N-CA 120.483 -0.865 . . . . 0.25 111.789 166.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.439 ' HB3' ' CD ' ' A' ' 435' ' ' LYS . 4.4 m-20 -51.68 102.72 0.05 OUTLIER 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 113.446 -1.377 . . . . 1.8500000000000001 113.318 -153.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.569 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.3 OUTLIER -94.11 -38.77 10.94 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 113.327 -1.761 . . . . 1.8200000000000001 108.823 168.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.735 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.4 p-90 -49.79 -32.17 13.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.153 0.502 . . . . 0.17999999999999999 112.047 -169.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.735 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -86.01 -35.32 20.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.483 0.658 . . . . 1.05 111.965 -177.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 10.2 p -88.75 -43.72 11.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.672 -1.149 . . . . 1.0600000000000001 111.15 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.569 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 11.4 mtp85 -91.59 -18.53 23.91 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.817 -1.083 . . . . 2.3700000000000001 109.474 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.636 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.63 47.56 57.64 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.654 -1.157 . . . . 0.23999999999999999 114.129 163.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 43.3 m -84.76 110.52 18.85 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 118.991 -1.084 . . . . 1.7 111.415 -171.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.412 ' HB3' ' NAJ' ' A' ' 130' ' ' 1RG . 51.3 m-70 37.8 -125.75 0.23 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.373 -1.285 . . . . 0.56999999999999995 113.738 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -126.99 -21.29 1.73 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.076 -0.583 . . . . 0.28999999999999998 113.462 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.492 ' HB3' ' HAS' ' A' ' 130' ' ' 1RG . 28.7 p -104.49 -165.57 1.15 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 112.883 0.697 . . . . 0.40000000000000002 112.883 -173.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.42 HD11 HG12 ' A' ' 465' ' ' VAL . 2.3 mp -92.02 129.24 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.482 -0.781 . . . . 1.04 110.884 -175.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.3 89.72 4.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.657 -0.701 . . . . 0.62 109.727 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.658 ' HA ' HG21 ' A' ' 368' ' ' ILE . 3.0 m -83.26 143.78 45.7 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 115.087 -0.96 . . . . 1.02 112.452 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.633 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 78.8 Cg_exo -50.08 144.51 22.06 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 123.807 3.005 . . . . 0.23999999999999999 113.351 174.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.609 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.4 Cg_exo -64.6 -25.42 62.16 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 122.827 2.351 . . . . 0.31 112.598 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.519 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 67.3 p -78.7 -24.59 44.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.74 0.781 . . . . 1.48 112.085 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.725 ' O ' HD23 ' A' ' 364' ' ' LEU . 33.0 m -99.35 -48.63 11.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 113.137 0.792 . . . . 1.03 113.137 -170.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.93 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.72 -1.95 4.42 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.767 -0.773 . . . . 1.02 110.434 -178.267 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.519 ' HE3' ' O ' ' A' ' 448' ' ' SER . 16.5 pttp -81.22 -38.46 26.95 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 122.651 1.215 . . . . 1.5900000000000001 108.287 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.583 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.5 mm-40 -62.65 -46.31 88.79 Favored 'General case' 0 CA--C 1.473 -1.981 0 CA-C-N 112.356 -2.202 . . . . 0.25 106.537 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.93 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.92 -66.72 0.36 Allowed 'General case' 0 N--CA 1.401 -2.922 0 CA-C-N 109.711 -3.404 . . . . 1.02 112.923 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.487 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 14.9 t80 -45.58 -24.03 0.3 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.83 0.824 . . . . 0.17000000000000001 109.502 176.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -87.4 -26.54 30.16 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 114.697 -1.138 . . . . 0.13 111.785 -176.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.59 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -103.14 -44.13 5.29 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 113.728 1.01 . . . . 1.02 113.728 177.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.679 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.62 148.06 9.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.292 1.044 . . . . 1.01 111.106 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.502 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -116.02 155.24 28.44 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.281 -1.781 . . . . 0.47999999999999998 108.952 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.578 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 4.8 mppt? -57.91 103.43 0.14 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.624 -0.88 . . . . 1.7 108.624 169.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 126.36 -7.46 7.54 Favored Glycine 0 C--N 1.308 -0.996 0 CA-C-N 113.827 -1.533 . . . . 0.22 111.452 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 344' ' ' TYR . 6.8 m -70.17 150.5 96.06 Favored Pre-proline 0 N--CA 1.442 -0.862 0 N-CA-C 108.592 -0.892 . . . . 0.94999999999999996 108.592 171.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.573 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.8 Cg_endo -93.98 160.52 2.18 Favored 'Trans proline' 0 N--CA 1.421 -2.775 0 C-N-CA 122.017 1.811 . . . . 0.23000000000000001 109.749 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.763 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -123.91 151.44 28.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.295 -1.372 . . . . 1.27 107.295 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.684 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.7 mp -134.54 151.28 51.0 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 108.113 -1.069 . . . . 1.05 108.113 174.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.683 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.8 OUTLIER -140.64 141.26 32.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 105.177 -2.157 . . . . 1.01 105.177 166.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.564 ' N ' HD23 ' A' ' 349' ' ' LEU . 12.5 p90 . . . . . 0 C--O 1.245 0.861 0 CA-C-N 118.45 0.568 . . . . 1.0900000000000001 111.553 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.735 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 111.538 -0.625 . . . . 2.48 111.538 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.525 ' CE1' HD22 ' A' ' 464' ' ' LEU . 4.2 p-80 39.42 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.588 0.959 . . . . 1.1399999999999999 113.588 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.538 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.0 OUTLIER 67.43 -164.71 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.778 -0.646 . . . . 1.01 112.069 168.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.17 171.65 2.22 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.674 -1.232 . . . . 1.96 107.674 164.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.432 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 9.3 m-20 -81.49 83.05 7.09 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 118.69 -1.204 . . . . 0.42999999999999999 108.931 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 1.11 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 70.0 m -158.34 134.71 9.4 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.538 -1.21 . . . . 1.0 108.944 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.643 ' CD2' HD11 ' A' ' 464' ' ' LEU . 37.3 p90 173.91 159.27 0.15 Allowed 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 123.421 0.451 . . . . 0.88 110.881 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.68 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.93 152.59 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 164.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.569 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 31.1 tt0 -149.82 144.7 26.15 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.438 -0.801 . . . . 2.0099999999999998 109.249 -177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.695 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -137.3 162.05 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 O-C-N 122.118 -0.364 . . . . 1.04 111.252 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.521 ' N ' HG13 ' A' ' 347' ' ' VAL . 24.4 t0 -140.19 107.0 5.38 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 107.416 -1.327 . . . . 0.23999999999999999 107.416 172.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.664 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.7 -34.08 27.41 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 122.903 1.335 . . . . 1.02 110.671 -167.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -58.69 -44.12 90.19 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 110.769 -2.923 . . . . 0.59999999999999998 108.17 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -101.12 7.01 43.45 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 110.925 -2.852 . . . . 0.20999999999999999 110.916 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.3 mp0 33.06 61.62 0.39 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 112.692 -2.049 . . . . 2.54 113.417 -175.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.591 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 21.6 t60 -142.02 135.01 28.82 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.854 -0.612 . . . . 0.12 109.983 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.602 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.16 156.75 22.68 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.812 -0.631 . . . . 1.0 110.099 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.526 ' CD1' HG12 ' A' ' 362' ' ' VAL . 29.3 m-90 -142.22 154.18 44.59 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.475 -0.784 . . . . 0.11 111.291 -175.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.11 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 88.2 t80 -110.22 153.29 25.0 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.558 -1.645 . . . . 1.1000000000000001 106.558 151.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.3 m-85 -128.32 118.1 22.63 Favored 'General case' 0 C--N 1.269 -2.915 0 CA-C-N 114.796 -1.093 . . . . 0.60999999999999999 110.118 -178.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.6 tppt? -118.62 135.62 54.34 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.118 -1.808 . . . . 0.93999999999999995 106.118 167.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.54 16.48 6.97 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 113.45 0.908 . . . . 0.42999999999999999 113.45 173.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.36 7.58 88.38 Favored Glycine 0 CA--C 1.485 -1.844 0 CA-C-O 121.933 0.741 . . . . 0.17999999999999999 112.778 -174.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 19.4 ptmt -128.77 177.0 7.38 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 104.542 -2.392 . . . . 1.0900000000000001 104.542 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.6 m -104.29 157.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 N-CA-C 116.397 1.999 . . . . 1.02 116.397 -174.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.625 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -108.97 -28.4 9.14 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 110.497 -3.047 . . . . 1.01 106.277 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.745 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -132.93 145.01 50.53 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 111.614 -2.539 . . . . 1.02 111.731 -175.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.591 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.4 tt0 -141.86 117.88 10.6 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 104.516 -2.401 . . . . 0.47999999999999998 104.516 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.605 ' OG1' HG12 ' A' ' 449' ' ' VAL . 0.5 OUTLIER -149.6 164.47 35.04 Favored 'General case' 0 N--CA 1.402 -2.848 0 C-N-CA 117.974 -1.49 . . . . 1.02 111.769 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.519 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 17.6 p-10 -104.9 131.4 52.44 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 114.726 -1.124 . . . . 1.8 109.542 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.667 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -132.79 -171.87 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 CA-C-O 122.438 1.113 . . . . 1.01 112.327 -171.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -149.99 119.56 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 112.959 -1.928 . . . . 1.04 108.296 172.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.3 OUTLIER -75.62 -168.61 0.88 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.026 -1.443 . . . . 1.6000000000000001 110.784 177.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.49 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -86.4 176.15 48.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 118.929 -1.605 . . . . 0.14000000000000001 112.681 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 16.7 ptmt -78.16 156.72 79.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.661 0.743 . . . . 1.47 111.865 -166.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.642 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 85.5 Cg_exo -59.19 -28.6 88.19 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 125.016 3.811 . . . . 0.28000000000000003 113.309 -173.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.467 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 24.4 p -73.22 -32.61 64.86 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.867 -1.515 . . . . 1.0800000000000001 109.941 -175.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.562 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -140.63 70.15 31.25 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-O 123.887 1.803 . . . . 1.1000000000000001 108.92 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 375' ' ' THR . 83.1 Cg_exo -57.58 160.49 14.16 Favored 'Trans proline' 0 CA--C 1.501 -1.172 1 C-N-CA 126.895 5.063 . . . . 0.38 115.854 -169.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.648 HG22 ' OG ' ' A' ' 370' ' ' SER . 1.6 m -86.62 131.81 44.45 Favored Pre-proline 0 N--CA 1.406 -2.641 0 CA-C-N 113.902 -1.499 . . . . 1.1299999999999999 108.709 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.44 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 24.3 Cg_exo -72.73 -45.14 0.55 Allowed 'Trans proline' 0 CA--C 1.514 -0.491 0 C-N-CA 123.861 3.041 . . . . 0.20999999999999999 112.092 -170.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.664 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.59 140.11 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 123.263 1.506 . . . . 1.0600000000000001 113.497 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.19 -113.55 0.59 Allowed Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 112.455 -2.157 . . . . 0.20000000000000001 109.623 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.428 ' O ' HG11 ' A' ' 381' ' ' VAL . 4.7 p -130.2 119.11 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.924 0.869 . . . . 1.5 110.175 176.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.601 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.7 m-85 -118.1 -174.19 2.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.202 -1.407 . . . . 0.28000000000000003 107.202 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 1.3 t80 -139.94 123.35 17.07 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 120.697 -1.252 . . . . 0.96999999999999997 113.275 -171.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.501 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.65 92.1 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-O 123.084 1.421 . . . . 1.02 109.308 169.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -94.77 12.46 27.87 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 113.393 -1.73 . . . . 3.1299999999999999 108.318 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.749 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.7 t30 -169.1 126.34 0.96 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 113.833 -1.53 . . . . 0.42999999999999999 110.04 171.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.656 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.79 144.4 29.79 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.115 -0.948 . . . . 1.73 109.458 170.268 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.634 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 24.6 mm-40 -127.5 159.99 32.87 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 114.899 1.444 . . . . 0.70999999999999996 114.899 -168.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 51.6 mt-10 -139.04 127.59 23.1 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 113.064 -1.88 . . . . 0.38 108.583 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.7 t70 54.68 46.38 24.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 123.722 1.725 . . . . 0.40999999999999998 108.754 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -80.84 167.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 111.918 -2.401 . . . . 1.02 109.709 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 11.8 m -132.61 118.33 19.04 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.013 0.911 . . . . 1.04 111.878 170.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.9 mp -77.58 87.62 3.89 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.987 -1.461 . . . . 1.27 111.918 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.573 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.3 mttt -101.63 178.16 4.71 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 113.308 -1.769 . . . . 0.96999999999999997 113.397 177.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 138.54 -162.01 25.77 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 114.198 -1.365 . . . . 0.46000000000000002 111.63 -177.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.6 m -115.33 142.01 47.26 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 120.162 -0.615 . . . . 1.3500000000000001 111.104 170.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.4 m-80 -60.06 154.97 18.01 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.064 -0.971 . . . . 0.83999999999999997 109.008 167.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.407 ' HA ' ' HBD' ' A' ' 130' ' ' 1RG . 0.7 OUTLIER -64.0 -2.26 1.87 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.51 -0.768 . . . . 2.2799999999999998 110.672 177.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.1 OUTLIER -111.88 7.47 20.05 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.802 -1.09 . . . . 2.27 111.076 179.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.86 52.11 Favored Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 120.392 -0.909 . . . . 0.97999999999999998 112.455 169.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' THR . . . . . . . . . . . . . 10.9 p -114.58 98.86 50.44 Favored Pre-proline 0 C--N 1.303 -1.451 0 CA-C-N 114.509 -0.846 . . . . 1.3999999999999999 109.8 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.6 Cg_endo -58.86 149.92 75.13 Favored 'Trans proline' 0 CA--C 1.503 -1.042 0 C-N-CA 122.945 2.43 . . . . 0.67000000000000004 113.467 -176.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 403' ' ' TYR . 30.2 p90 -150.26 173.94 13.39 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.121 -1.4 . . . . 1.04 112.917 -168.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.573 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -145.86 148.25 32.66 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.992 -1.458 . . . . 0.53000000000000003 110.836 173.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.511 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -145.26 97.53 4.75 Favored Pre-proline 0 N--CA 1.439 -0.98 0 N-CA-C 108.359 -0.978 . . . . 0.45000000000000001 108.359 170.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.8 Cg_exo -68.22 110.74 2.3 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.974 1.782 . . . . 0.22 110.034 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.677 HG21 ' O ' ' A' ' 422' ' ' ASP . 0.4 OUTLIER -111.36 152.65 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 CA-C-N 113.368 -1.742 . . . . 1.04 108.458 -167.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.609 ' N ' HD21 ' A' ' 408' ' ' ASN . 0.8 OUTLIER -80.58 -23.28 40.0 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.797 -0.446 . . . . 0.65000000000000002 109.797 -174.589 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 97.2 m-85 -161.35 132.04 5.19 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.635 -1.246 . . . . 0.92000000000000004 107.635 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.623 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 20.2 t-105 -146.42 131.84 18.63 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.889 0.852 . . . . 0.10000000000000001 111.443 -166.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.656 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.6 mmt -114.43 93.23 31.1 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.728 -1.212 . . . . 1.01 107.728 172.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.749 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 36.0 Cg_endo -66.87 75.76 0.42 Allowed 'Trans proline' 0 CA--C 1.513 -0.568 0 C-N-CA 122.393 2.062 . . . . 0.5 111.618 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.574 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.3 pt -76.16 178.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 115.61 -0.723 . . . . 1.05 109.11 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.667 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 5.4 t70 -150.33 -166.74 2.63 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.854 -0.795 . . . . 2.4900000000000002 108.854 -167.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.667 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 9.4 m-90 83.44 -52.47 0.15 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.936 0.773 . . . . 2.3700000000000001 111.728 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 63.7 p -125.44 -5.47 7.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.594 -0.73 . . . . 1.5700000000000001 112.159 -165.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.423 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 104.77 -28.86 13.12 Favored Glycine 0 CA--C 1.506 -0.513 0 C-N-CA 120.768 -0.729 . . . . 0.68000000000000005 112.663 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.583 HG13 ' N ' ' A' ' 419' ' ' GLY . 34.0 t -57.06 173.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.711 0.804 . . . . 1.45 112.23 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.583 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -176.1 119.64 0.71 Allowed Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.498 -1.041 . . . . 0.20000000000000001 110.498 170.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.727 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.3 mp -81.78 143.34 12.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 110.024 -0.361 . . . . 1.0900000000000001 110.024 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.585 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 29.4 p80 -159.82 159.15 32.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.793 0.664 . . . . 0.10000000000000001 112.793 -173.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.769 ' OD1' ' HB2' ' A' ' 450' ' ' MET . 2.3 m-20 -89.61 132.03 35.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.492 -0.559 . . . . 1.0700000000000001 109.492 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 445' ' ' THR . 28.4 t -120.31 97.39 5.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.641 0.734 . . . . 0.5 109.453 -164.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.417 ' HA ' ' CG ' ' A' ' 447' ' ' PRO . 8.5 t70 -83.44 -17.69 41.24 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.612 -1.176 . . . . 0.41999999999999998 109.993 -172.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.652 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 9.9 p90 -85.29 -13.66 49.0 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.176 -1.375 . . . . 0.32000000000000001 110.937 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -108.1 114.11 60.07 Favored Pre-proline 0 CA--C 1.503 -0.829 0 CA-C-O 122.816 1.293 . . . . 1.74 110.489 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.485 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 36.2 Cg_endo -88.4 -9.13 5.15 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.093 3.195 . . . . 0.87 112.582 -176.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.565 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.2 pm0 -111.21 150.01 30.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.224 1.011 . . . . 2.1600000000000001 113.602 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 1.087 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.16 130.38 4.1 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 112.605 -2.089 . . . . 0.91000000000000003 105.487 171.093 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.23 -158.08 30.63 Favored Glycine 0 C--N 1.281 -2.494 0 C-N-CA 119.788 -1.196 . . . . 0.20000000000000001 110.817 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.507 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.28 174.65 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.277 -0.963 . . . . 0.25 111.544 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.487 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 5.0 p-10 -51.78 101.46 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 123.399 1.571 . . . . 1.8500000000000001 113.772 -153.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.693 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.02 -35.67 11.31 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 112.489 -2.141 . . . . 1.8200000000000001 109.147 169.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.736 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.1 p-90 -54.81 -28.11 46.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.006 -0.997 . . . . 0.17999999999999999 112.243 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.736 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.98 -38.09 13.06 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.401 0.62 . . . . 1.05 112.377 -177.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.412 ' H ' HG21 ' A' ' 436' ' ' THR . 2.4 p -86.69 -43.41 12.62 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.04 -0.982 . . . . 1.0600000000000001 110.446 -175.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.693 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 2.7 mtp85 -91.49 -18.6 23.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.497 -1.228 . . . . 2.3700000000000001 108.954 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.66 50.1 50.49 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 115.232 0.853 . . . . 0.23999999999999999 115.232 160.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' SER . . . . . 0.412 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 6.4 m -83.25 111.52 19.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 119.072 1.436 . . . . 1.7 111.436 -173.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.567 ' HB2' ' OAC' ' A' ' 130' ' ' 1RG . 87.7 m-70 29.52 -106.51 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.507 1.129 . . . . 0.56999999999999995 113.699 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.49 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -147.53 -5.45 0.33 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.815 -0.63 . . . . 0.28999999999999998 114.415 -174.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 419' ' ' GLY . 26.5 p -107.22 -167.27 1.25 Allowed 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.323 1.062 . . . . 0.40000000000000002 112.522 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.536 HG13 ' HG ' ' A' ' 370' ' ' SER . 1.9 mp -102.31 131.15 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 115.057 -0.974 . . . . 1.04 110.889 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -100.71 98.51 9.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.839 -1.073 . . . . 0.62 110.129 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.674 HG23 ' CG2' ' A' ' 449' ' ' VAL . 2.0 m -96.59 140.45 22.17 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 113.599 0.962 . . . . 1.02 113.599 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.805 ' O ' HG23 ' A' ' 449' ' ' VAL . 77.3 Cg_exo -54.66 128.05 28.66 Favored 'Trans proline' 0 CA--C 1.498 -1.322 1 C-N-CA 125.452 4.101 . . . . 0.23999999999999999 114.933 177.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 1.087 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 52.8 Cg_exo -58.27 -8.25 4.85 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.972 3.115 . . . . 0.31 114.374 -165.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.56 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 77.9 p -93.21 -19.62 21.25 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.899 -1.046 . . . . 1.48 111.089 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 446' ' ' PRO . 17.0 m -101.16 -49.61 10.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 114.664 1.357 . . . . 1.03 114.664 -172.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.931 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -69.27 -2.33 10.39 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.933 -1.104 . . . . 1.02 109.529 -177.124 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.582 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.4 pttp -77.28 -39.03 49.58 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 122.551 1.167 . . . . 1.5900000000000001 108.121 173.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.588 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.0 mm-40 -63.14 -46.48 87.02 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 112.416 -2.175 . . . . 0.25 106.709 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.931 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.6 -65.91 0.49 Allowed 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 109.935 -3.302 . . . . 1.02 112.719 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.464 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.6 t80 -45.91 -23.33 0.28 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.861 0.725 . . . . 0.17000000000000001 109.459 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.04 -24.05 33.24 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.051 -0.977 . . . . 0.13 111.927 -176.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.58 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -105.42 -43.88 4.86 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 113.808 1.04 . . . . 1.02 113.808 176.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.68 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.84 150.35 7.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.42 1.105 . . . . 1.01 111.084 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.517 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.31 156.88 32.96 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 113.247 -1.797 . . . . 0.47999999999999998 108.353 -178.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.523 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.6 mppt? -59.01 101.68 0.1 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.388 0.613 . . . . 1.7 109.399 172.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.06 -12.72 5.54 Favored Glycine 0 C--N 1.305 -1.173 0 CA-C-N 114.107 -1.406 . . . . 0.22 111.428 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.57 HG21 ' HA ' ' A' ' 344' ' ' TYR . 12.9 m -65.82 149.36 97.57 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 108.718 -0.845 . . . . 0.94999999999999996 108.718 171.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.538 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.7 Cg_endo -93.79 160.4 2.28 Favored 'Trans proline' 0 N--CA 1.423 -2.651 0 C-N-CA 122.041 1.828 . . . . 0.23000000000000001 109.989 177.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.709 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -124.05 150.87 28.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 107.386 -1.338 . . . . 1.27 107.386 171.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.669 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.6 mp -134.28 149.56 50.93 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.008 -1.108 . . . . 1.05 108.008 175.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.695 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -137.68 140.65 40.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.311 -2.107 . . . . 1.01 105.311 165.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.569 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 9.4 p90 . . . . . 0 C--O 1.245 0.827 0 O-C-N 123.848 0.717 . . . . 1.0900000000000001 110.85 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.74 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.663 -0.575 . . . . 2.48 111.663 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.563 ' NE2' HD23 ' A' ' 464' ' ' LEU . 1.6 m80 65.2 -177.59 0.18 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 122.823 1.297 . . . . 1.1399999999999999 110.617 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.539 ' HE1' ' HD3' ' A' ' 462' ' ' PRO . 5.5 mtm -57.8 -159.64 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 112.238 -2.256 . . . . 1.01 111.121 163.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -59.23 161.36 5.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.093 -1.077 . . . . 1.96 108.093 159.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.405 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 8.7 m-20 -75.89 85.05 2.83 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.582 -0.847 . . . . 0.42999999999999999 110.93 -168.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 95.9 m -157.89 135.36 10.36 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.423 -1.262 . . . . 1.0 108.763 166.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.621 ' CD2' HD11 ' A' ' 464' ' ' LEU . 38.3 p90 174.6 157.47 0.16 Allowed 'General case' 0 C--O 1.21 -0.986 0 O-C-N 123.362 0.414 . . . . 0.88 111.367 -176.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.694 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.88 152.72 5.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.365 -0.606 . . . . 1.0 109.365 164.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.552 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.99 144.13 25.64 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.817 -0.629 . . . . 2.0099999999999998 109.311 -176.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.689 HG21 ' O ' ' A' ' 464' ' ' LEU . 2.7 t -137.53 162.3 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.057 0.456 . . . . 1.04 111.399 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.53 ' N ' HG13 ' A' ' 347' ' ' VAL . 28.9 t0 -140.44 106.88 5.29 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.38 -1.341 . . . . 0.23999999999999999 107.38 174.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.668 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.2 OUTLIER -84.02 -32.19 25.04 Favored 'General case' 0 CA--C 1.485 -1.538 0 CA-C-O 123.036 1.398 . . . . 1.02 110.02 -169.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.414 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 0.6 OUTLIER -59.03 -45.28 91.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 110.672 -2.967 . . . . 0.59999999999999998 108.179 176.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . 0.445 ' HB2' ' CG ' ' A' ' 348' ' ' ASP . 22.3 m-80 -102.83 8.22 39.33 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 111.006 -2.816 . . . . 0.20999999999999999 110.956 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.565 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.1 mp0 32.53 61.62 0.35 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 112.722 -2.035 . . . . 2.54 113.475 -176.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.602 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.0 t60 -142.47 135.53 28.5 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.625 -0.716 . . . . 0.12 109.754 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.596 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.48 157.34 22.11 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.332 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CD1' HG12 ' A' ' 362' ' ' VAL . 30.7 m-90 -142.89 154.09 43.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.433 -175.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.691 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.6 t80 -110.28 153.2 25.18 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 106.725 -1.583 . . . . 1.1000000000000001 106.725 152.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.3 m-85 -128.37 117.99 22.39 Favored 'General case' 0 C--N 1.272 -2.799 0 CA-C-N 115.073 -0.967 . . . . 0.60999999999999999 110.609 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.3 tppt? -118.15 137.87 52.67 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 105.979 -1.859 . . . . 0.93999999999999995 105.979 167.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.9 15.66 7.83 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.348 0.87 . . . . 0.42999999999999999 113.348 174.075 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.405 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.51 6.46 88.1 Favored Glycine 0 CA--C 1.488 -1.631 0 C-N-CA 120.673 -0.775 . . . . 0.17999999999999999 112.757 -173.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 14.2 ptmt -125.5 175.93 7.18 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 104.576 -2.379 . . . . 1.0900000000000001 104.576 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 15.5 m -103.95 157.48 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.703 0 N-CA-C 116.582 2.067 . . . . 1.02 116.582 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.588 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -108.83 -27.17 9.89 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 110.642 -2.981 . . . . 1.01 106.69 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.73 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -133.57 144.57 49.4 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 111.334 -2.666 . . . . 1.02 111.329 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.602 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 3.2 tt0 -142.54 118.19 10.41 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 104.498 -2.408 . . . . 0.47999999999999998 104.498 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.596 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.69 164.62 34.73 Favored 'General case' 0 N--CA 1.401 -2.887 0 C-N-CA 118.132 -1.427 . . . . 1.02 111.442 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -103.82 133.31 49.03 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.734 -1.121 . . . . 1.8 109.549 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.704 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -133.2 -172.28 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 CA-C-O 122.495 1.141 . . . . 1.01 112.171 -172.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.33 118.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 112.888 -1.96 . . . . 1.04 108.119 172.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.612 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.3 OUTLIER -75.11 -168.92 0.84 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.047 -1.433 . . . . 1.6000000000000001 110.533 178.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 439' ' ' SER . . . -85.49 175.93 49.54 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 118.809 -1.662 . . . . 0.14000000000000001 112.156 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.9 ptmt -78.78 155.44 78.08 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 121.59 0.709 . . . . 1.47 111.466 -167.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.625 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 78.1 Cg_exo -54.96 -27.87 56.39 Favored 'Trans proline' 0 CA--C 1.501 -1.149 1 C-N-CA 125.399 4.066 . . . . 0.28000000000000003 113.399 -174.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.453 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.4 p -71.54 -31.48 67.08 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.662 -1.608 . . . . 1.0800000000000001 109.931 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.543 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 0.7 OUTLIER -140.94 70.3 29.21 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 123.804 1.764 . . . . 1.1000000000000001 108.972 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 375' ' ' THR . 88.1 Cg_exo -57.72 152.09 51.37 Favored 'Trans proline' 0 C--N 1.314 -1.241 1 C-N-CA 126.657 4.904 . . . . 0.38 115.637 -169.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.612 HG22 ' OG ' ' A' ' 370' ' ' SER . 18.3 m -78.74 130.99 68.87 Favored Pre-proline 0 N--CA 1.407 -2.597 0 CA-C-N 113.942 -1.481 . . . . 1.1299999999999999 109.18 173.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.2 Cg_exo -72.1 -46.49 0.53 Allowed 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 123.325 2.683 . . . . 0.20999999999999999 111.734 -173.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.666 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 60.2 142.88 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 123.349 1.547 . . . . 1.0600000000000001 113.424 -174.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 147.49 -109.84 0.49 Allowed Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 112.402 -2.181 . . . . 0.20000000000000001 109.286 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.8 p -130.52 125.91 59.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.369 0.604 . . . . 1.5 110.099 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.616 ' HE1' ' CE2' ' A' ' 382' ' ' PHE . 7.5 m-85 -123.65 -174.32 2.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.0 -1.482 . . . . 0.28000000000000003 107.0 171.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.599 ' HB3' ' CZ3' ' A' ' 415' ' ' TRP . 2.0 t80 -140.65 122.63 15.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 119.795 1.18 . . . . 0.96999999999999997 112.76 -172.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.47 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -87.19 92.24 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 123.013 1.387 . . . . 1.02 109.223 170.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -89.89 7.82 35.31 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 113.442 -1.708 . . . . 3.1299999999999999 107.855 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.762 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 9.0 t30 -170.2 126.88 0.82 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.368 -1.287 . . . . 0.42999999999999999 110.51 174.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.657 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.2 139.53 34.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.706 -1.134 . . . . 1.73 109.016 170.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.777 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 11.4 mm-40 -123.57 158.05 32.3 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.823 1.416 . . . . 0.70999999999999996 114.823 -168.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.76 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 48.5 mt-10 -129.27 144.51 51.25 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.788 -2.006 . . . . 0.38 106.291 165.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.03 34.03 16.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.221 -1.808 . . . . 0.40999999999999998 110.238 171.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.449 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -77.38 167.46 21.64 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 112.779 -2.01 . . . . 1.02 109.186 -175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.6 m -131.63 119.18 21.07 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.157 0.98 . . . . 1.04 111.376 172.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.527 HD22 ' CG ' ' A' ' 421' ' ' HIS . 3.0 mp -77.36 87.57 3.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.638 -1.619 . . . . 1.27 111.73 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HG2' ' HG3' ' A' ' 404' ' ' GLU . 47.5 mttt -102.49 179.62 4.25 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 113.195 -1.821 . . . . 0.96999999999999997 113.072 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.55 -159.01 24.75 Favored Glycine 0 N--CA 1.429 -1.832 0 CA-C-N 114.467 -1.242 . . . . 0.46000000000000002 111.319 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.7 m -118.27 140.41 49.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 120.115 -0.634 . . . . 1.3500000000000001 110.876 170.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.0 m-80 -57.47 154.5 10.9 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.281 -0.872 . . . . 0.83999999999999997 108.94 167.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.04 -1.23 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.771 -0.649 . . . . 2.2799999999999998 110.95 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.0 OUTLIER -114.44 5.21 15.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.131 -0.94 . . . . 2.27 111.33 -179.233 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.44 18.2 42.89 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.329 -0.938 . . . . 0.97999999999999998 112.558 169.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 12.1 p -113.19 99.63 49.45 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 114.34 -0.93 . . . . 1.3999999999999999 109.859 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.8 Cg_endo -58.42 151.69 59.46 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 C-N-CA 123.028 2.485 . . . . 0.67000000000000004 113.438 -176.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.66 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 23.7 p90 -152.54 172.94 15.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.477 -1.238 . . . . 1.04 112.694 -170.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG3' ' HG2' ' A' ' 394' ' ' LYS . 2.1 mp0 -146.24 147.99 32.0 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.249 -1.341 . . . . 0.53000000000000003 110.828 174.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.23 97.9 4.73 Favored Pre-proline 0 N--CA 1.442 -0.873 0 N-CA-C 108.663 -0.865 . . . . 0.45000000000000001 108.663 171.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.6 Cg_exo -68.64 110.93 2.43 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.294 1.996 . . . . 0.22 110.7 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.611 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -111.36 160.02 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-N 113.084 -1.871 . . . . 1.04 107.724 -168.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.76 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 22.3 m-80 -93.26 -18.96 21.88 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.136 -0.69 . . . . 0.65000000000000002 109.136 -175.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 0.777 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 86.3 m-85 -158.59 125.77 4.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.072 -0.967 . . . . 0.92000000000000004 108.451 -171.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.627 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 20.2 t-105 -143.84 134.76 25.34 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.76 0.79 . . . . 0.10000000000000001 111.755 -166.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.657 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.9 mmt -117.34 94.02 44.25 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.055 -1.091 . . . . 1.01 108.055 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.762 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 42.0 Cg_endo -68.03 70.36 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.381 2.721 . . . . 0.5 112.369 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.644 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.9 pt -76.06 65.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 122.642 1.21 . . . . 1.05 110.33 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.52 124.43 33.46 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.984 -1.007 . . . . 2.4900000000000002 109.725 -170.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.599 ' CZ3' ' HB3' ' A' ' 383' ' ' TYR . 0.0 OUTLIER 179.73 -60.76 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.832 -1.544 . . . . 2.3700000000000001 106.832 -165.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 39.9 p -115.29 -21.26 9.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.303 -1.771 . . . . 1.5700000000000001 110.813 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.766 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 134.37 -36.77 2.04 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.704 -0.76 . . . . 0.68000000000000005 113.298 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 419' ' ' GLY . 20.6 t -58.27 173.48 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.254 0.621 . . . . 1.45 112.234 -174.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.644 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -176.74 119.71 0.71 Allowed Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.852 -0.899 . . . . 0.20000000000000001 110.852 171.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.684 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.6 mt -81.07 142.87 13.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.769 0.319 . . . . 1.0900000000000001 110.486 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.587 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.0 p80 -159.98 161.04 34.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.01 -0.541 . . . . 0.10000000000000001 111.322 -173.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.628 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -83.62 145.73 28.66 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.042 -1.096 . . . . 1.0700000000000001 108.042 173.007 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 445' ' ' THR . 42.5 t -132.62 96.74 3.89 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.866 0.841 . . . . 0.5 109.616 -172.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -82.6 -16.72 47.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.089 -1.414 . . . . 0.41999999999999998 109.389 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.611 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 9.0 p90 -87.48 -19.07 28.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.979 -1.464 . . . . 0.32000000000000001 110.914 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -103.24 113.64 65.62 Favored Pre-proline 0 CA--C 1.505 -0.78 0 CA-C-O 122.646 1.212 . . . . 1.74 110.085 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.531 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 40.9 Cg_endo -86.83 -9.36 6.52 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 124.306 3.338 . . . . 0.87 112.889 -175.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.531 ' OE2' ' HD2' ' A' ' 427' ' ' PRO . 1.7 pm0 -111.8 152.69 27.58 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.269 1.033 . . . . 2.1600000000000001 113.441 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.986 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.43 131.5 4.27 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 105.146 -2.168 . . . . 0.91000000000000003 105.146 171.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.62 -158.15 30.66 Favored Glycine 0 C--N 1.282 -2.417 0 C-N-CA 119.974 -1.107 . . . . 0.20000000000000001 110.715 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.543 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.52 175.18 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.961 0 C-N-CA 120.418 -0.896 . . . . 0.25 111.803 167.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.518 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.1 p-10 -51.51 101.19 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 123.355 1.55 . . . . 1.8500000000000001 113.336 -155.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.678 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.98 -38.04 10.4 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 112.404 -2.18 . . . . 1.8200000000000001 109.099 170.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.656 ' CZ2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -53.11 -28.34 25.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.159 -0.928 . . . . 0.17999999999999999 112.341 -171.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.656 ' HE3' ' CZ2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.16 -36.51 15.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.527 0.566 . . . . 1.05 112.527 -177.096 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.413 ' H ' HG21 ' A' ' 436' ' ' THR . 1.5 p -89.65 -42.99 11.05 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.064 -0.971 . . . . 1.0600000000000001 110.699 -176.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.678 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.8 mtp180 -92.81 -18.3 23.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.594 -1.185 . . . . 2.3700000000000001 109.752 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.83 48.74 50.25 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.021 -0.99 . . . . 0.23999999999999999 115.257 162.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' SER . . . . . 0.449 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 11.9 p -83.58 110.65 18.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 119.195 1.497 . . . . 1.7 111.447 -173.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 37.41 -124.27 0.21 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.503 -1.226 . . . . 0.56999999999999995 114.086 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -129.47 -19.78 1.47 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.023 -0.608 . . . . 0.28999999999999998 113.408 -173.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.423 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.1 p -104.62 -165.86 1.18 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 112.902 0.705 . . . . 0.40000000000000002 112.902 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.536 HG13 ' HG ' ' A' ' 370' ' ' SER . 1.9 mp -95.11 130.98 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 115.212 -0.904 . . . . 1.04 110.64 -175.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.437 HD21 ' N ' ' A' ' 444' ' ' ASN . 1.1 m-80 -105.31 94.61 5.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.716 0.77 . . . . 0.62 110.259 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.704 ' HA ' HG23 ' A' ' 368' ' ' ILE . 2.5 m -90.26 143.64 29.86 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-N 114.147 -1.388 . . . . 1.02 112.89 -176.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.591 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 74.8 Cg_exo -50.02 144.45 21.91 Favored 'Trans proline' 0 CA--C 1.505 -0.939 0 C-N-CA 123.943 3.096 . . . . 0.23999999999999999 113.22 175.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.986 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 33.3 Cg_exo -65.3 -24.58 57.78 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.748 2.299 . . . . 0.31 112.213 -175.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.534 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 70.1 p -78.12 -25.06 47.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.391 -0.822 . . . . 1.48 111.874 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.73 ' O ' HD23 ' A' ' 364' ' ' LEU . 31.8 m -99.58 -49.67 11.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 112.985 0.735 . . . . 1.03 112.985 -170.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.942 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.93 -2.1 4.83 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.65 -0.82 . . . . 1.02 110.446 -178.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.534 ' HE3' ' O ' ' A' ' 448' ' ' SER . 16.3 pttp -81.1 -38.06 27.89 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 122.54 1.162 . . . . 1.5900000000000001 108.238 173.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.582 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.4 mm-40 -62.85 -46.61 87.08 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 112.372 -2.195 . . . . 0.25 106.587 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.942 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.1 tp -47.14 -66.44 0.41 Allowed 'General case' 0 N--CA 1.402 -2.826 0 CA-C-N 109.887 -3.324 . . . . 1.02 112.658 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.474 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 23.5 t80 -46.3 -22.51 0.25 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.769 0.795 . . . . 0.17000000000000001 109.71 175.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.95 -23.31 33.08 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 114.887 -1.051 . . . . 0.13 111.849 -176.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.587 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -106.38 -44.42 4.53 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 113.938 1.088 . . . . 1.02 113.938 176.768 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.694 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.8 149.21 8.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 122.182 0.991 . . . . 1.01 110.804 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.467 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -120.55 158.16 27.92 Favored 'General case' 0 N--CA 1.413 -2.324 0 CA-C-N 113.427 -1.715 . . . . 0.47999999999999998 109.043 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.546 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.8 mppt? -58.97 102.41 0.12 Allowed 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.911 -0.774 . . . . 1.7 108.911 170.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.37 -12.04 5.77 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 114.051 -1.432 . . . . 0.22 111.449 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 344' ' ' TYR . 18.8 m -68.22 149.9 97.93 Favored Pre-proline 0 N--CA 1.439 -1.005 0 N-CA-C 108.732 -0.84 . . . . 0.94999999999999996 108.732 171.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.6 Cg_endo -94.34 165.93 1.93 Allowed 'Trans proline' 0 N--CA 1.419 -2.87 0 C-N-CA 122.278 1.985 . . . . 0.23000000000000001 109.623 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.694 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -128.81 153.53 38.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.655 -1.239 . . . . 1.27 107.655 170.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.689 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.6 mp -134.1 151.71 51.51 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 108.6 -0.889 . . . . 1.05 108.6 173.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.681 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.61 141.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 105.329 -2.1 . . . . 1.01 105.329 166.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.571 ' N ' HD23 ' A' ' 349' ' ' LEU . 7.8 p90 . . . . . 0 C--O 1.244 0.815 0 O-C-N 123.628 0.58 . . . . 1.0900000000000001 111.119 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.766 ' HG ' ' O ' ' A' ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 111.974 -0.45 . . . . 2.48 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.637 ' CE1' HD23 ' A' ' 464' ' ' LEU . 3.7 p-80 -139.74 99.85 3.81 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 120.85 0.357 . . . . 1.1399999999999999 111.933 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.527 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.2 OUTLIER 62.45 -169.02 0.19 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.048 -0.978 . . . . 1.01 112.924 166.382 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.24 171.77 2.21 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.759 -0.655 . . . . 1.96 109.476 162.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.46 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.4 m-20 -79.18 83.42 5.24 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.087 -1.045 . . . . 0.42999999999999999 109.973 -177.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 1.135 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 86.6 m -158.28 134.49 9.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.387 -1.278 . . . . 1.0 108.825 166.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.73 ' CD2' HD11 ' A' ' 464' ' ' LEU . 41.1 p90 174.52 158.24 0.16 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 123.42 0.45 . . . . 0.88 110.983 -175.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.673 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.5 OUTLIER -77.4 153.26 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 109.122 -0.695 . . . . 1.0 109.122 165.051 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.573 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.06 147.12 29.22 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.038 -1.097 . . . . 2.0099999999999998 108.038 -177.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.696 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.2 t -138.99 153.78 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 C-N-CA 123.625 0.77 . . . . 1.04 110.422 173.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 347' ' ' VAL . 16.4 t0 -136.85 106.53 6.18 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.98 -1.489 . . . . 0.23999999999999999 106.98 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.623 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -79.01 -35.03 43.46 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 124.049 1.881 . . . . 1.02 110.334 -166.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -55.44 -43.49 75.45 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 110.904 -2.862 . . . . 0.59999999999999998 107.697 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -101.51 4.54 41.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 110.97 -2.832 . . . . 0.20999999999999999 111.395 -175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.877 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 83.5 mm-40 31.38 62.44 0.24 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 112.852 -1.976 . . . . 2.54 113.465 -172.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.601 ' NE2' ' HG2' ' A' ' 365' ' ' GLU . 29.6 t60 -141.43 136.83 31.74 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.453 -1.249 . . . . 0.12 109.927 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.607 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.2 OUTLIER -112.94 158.98 19.56 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.214 -179.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.583 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.8 m-90 -144.17 160.71 40.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.703 -0.681 . . . . 0.11 111.149 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.135 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 89.4 t80 -113.39 153.56 28.37 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 106.465 -1.68 . . . . 1.1000000000000001 106.465 150.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.4 m-85 -128.01 116.57 20.25 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.129 -0.941 . . . . 0.60999999999999999 110.248 -178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.1 tppt? -117.78 138.44 52.05 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.046 -1.835 . . . . 0.93999999999999995 106.046 168.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.49 16.96 8.11 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.39 0.885 . . . . 0.42999999999999999 113.39 172.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.46 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.34 8.04 87.0 Favored Glycine 0 CA--C 1.485 -1.796 0 CA-C-N 115.643 -0.708 . . . . 0.17999999999999999 113.036 -173.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.2 ptmt -128.11 177.93 6.57 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 104.493 -2.41 . . . . 1.0900000000000001 104.493 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.583 HG12 ' CD1' ' A' ' 355' ' ' TRP . 17.1 m -104.59 158.23 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.747 0 N-CA-C 116.303 1.964 . . . . 1.02 116.303 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.631 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -107.91 -28.51 9.57 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 110.764 -2.925 . . . . 1.01 106.35 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.53 145.36 50.05 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 111.551 -2.568 . . . . 1.02 111.678 -175.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.601 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -142.23 118.77 10.97 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 104.49 -2.411 . . . . 0.47999999999999998 104.49 174.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.634 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.6 OUTLIER -149.6 163.68 37.22 Favored 'General case' 0 N--CA 1.401 -2.89 0 C-N-CA 118.332 -1.347 . . . . 1.02 110.57 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.582 ' OD2' ' HA2' ' A' ' 430' ' ' GLY . 0.5 OUTLIER -100.75 142.3 32.41 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.739 -0.838 . . . . 1.8 108.739 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.69 HG23 ' HA ' ' A' ' 445' ' ' THR . 1.9 pp -137.03 -172.76 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 CA-C-O 122.045 0.926 . . . . 1.01 112.317 -173.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.877 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -152.87 118.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 113.196 -1.82 . . . . 1.04 109.442 171.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.572 ' HG ' ' HB3' ' A' ' 349' ' ' LEU . 54.6 p -78.8 -168.0 1.29 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.062 -2.336 . . . . 1.6000000000000001 111.285 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.9 165.56 40.09 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 118.602 -1.761 . . . . 0.14000000000000001 112.17 -174.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -71.64 156.79 90.89 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.41 0.624 . . . . 1.47 111.474 -168.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.622 ' HG3' ' CZ3' ' A' ' 434' ' ' TRP . 87.9 Cg_exo -55.84 -28.67 68.8 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 125.174 3.916 . . . . 0.28000000000000003 113.612 -173.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.445 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 17.8 p -70.81 -32.38 69.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.421 -1.718 . . . . 1.0800000000000001 109.644 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.55 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -140.98 70.63 28.93 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 123.822 1.772 . . . . 1.1000000000000001 109.033 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 375' ' ' THR . 89.0 Cg_exo -58.08 157.15 26.19 Favored 'Trans proline' 0 C--N 1.312 -1.387 1 C-N-CA 126.592 4.861 . . . . 0.38 115.358 -170.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.491 ' CG2' HG22 ' A' ' 465' ' ' VAL . 1.5 m -82.67 131.87 53.57 Favored Pre-proline 0 N--CA 1.406 -2.648 0 CA-C-N 114.326 -1.306 . . . . 1.1299999999999999 108.482 172.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.494 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 24.6 Cg_exo -72.19 -45.69 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.808 3.005 . . . . 0.20999999999999999 112.334 -171.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.67 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 60.5 140.92 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 123.283 1.516 . . . . 1.0600000000000001 113.791 -173.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 150.06 -110.41 0.47 Allowed Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 112.331 -2.213 . . . . 0.20000000000000001 109.419 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.1 p -130.02 123.18 55.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.694 0.759 . . . . 1.5 109.961 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.618 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 3.5 m-85 -120.27 -173.55 2.59 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.544 -1.651 . . . . 0.28000000000000003 106.544 170.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 9.5 t80 -144.17 127.35 16.64 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 120.477 -1.389 . . . . 0.96999999999999997 113.576 -171.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.8 p -90.44 92.93 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 122.949 1.357 . . . . 1.02 109.97 171.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -73.49 -10.93 60.24 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.253 -1.794 . . . . 3.1299999999999999 108.067 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.769 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.4 t30 -169.96 133.04 1.15 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.651 -0.704 . . . . 0.42999999999999999 112.093 -175.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.611 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -92.53 154.76 18.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.054 -0.521 . . . . 1.73 110.485 171.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.732 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 35.8 mm-40 -132.59 157.97 43.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 115.013 1.486 . . . . 0.70999999999999996 115.013 -171.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.758 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.8 mt-10 -138.29 126.89 23.47 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.827 -1.988 . . . . 0.38 108.425 173.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.63 49.21 20.86 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 123.371 1.557 . . . . 0.40999999999999998 109.195 -175.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -79.76 168.31 19.47 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 112.665 -2.061 . . . . 1.02 108.577 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.7 m -133.16 119.53 20.02 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.154 0.978 . . . . 1.04 111.808 170.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.7 mp -79.47 88.75 5.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.541 -1.663 . . . . 1.27 112.023 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.575 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.2 mttt -103.3 178.58 4.52 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 113.618 -1.628 . . . . 0.96999999999999997 113.439 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.97 -160.99 25.48 Favored Glycine 0 N--CA 1.429 -1.805 0 CA-C-N 114.064 -1.425 . . . . 0.46000000000000002 111.58 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.9 m -115.41 137.54 51.94 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.483 -0.487 . . . . 1.3500000000000001 110.417 169.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.1 m-80 -53.9 153.37 4.81 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.659 -0.7 . . . . 0.83999999999999997 109.163 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -2.42 0.4 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.168 -0.924 . . . . 2.2799999999999998 111.3 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 397' ' ' ASN . 10.7 t70 -115.54 2.34 13.8 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.599 0.714 . . . . 2.27 111.272 -178.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.28 18.8 27.66 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.002 -1.094 . . . . 0.97999999999999998 113.232 171.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.452 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 8.0 p -113.36 100.32 51.4 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 114.912 -0.644 . . . . 1.3999999999999999 110.044 -176.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 19.1 Cg_endo -58.54 149.67 73.96 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.597 2.198 . . . . 0.67000000000000004 112.884 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.624 ' HD2' ' CD1' ' A' ' 403' ' ' TYR . 25.8 p90 -152.86 174.47 14.04 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.274 -1.33 . . . . 1.04 112.661 -168.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.575 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -146.73 148.06 31.6 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.906 -1.497 . . . . 0.53000000000000003 109.894 172.228 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.33 97.29 5.18 Favored Pre-proline 0 N--CA 1.436 -1.149 0 N-CA-C 107.905 -1.146 . . . . 0.45000000000000001 107.905 169.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.5 Cg_exo -68.26 109.5 2.01 Favored 'Trans proline' 0 N--CA 1.432 -2.098 0 C-N-CA 121.929 1.753 . . . . 0.22 109.584 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.611 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -107.65 156.99 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 CA-C-N 112.915 -1.948 . . . . 1.04 107.421 -168.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.758 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.5 m-80 -88.63 -20.67 24.64 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.014 -0.736 . . . . 0.65000000000000002 109.014 -174.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 0.732 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 75.6 m-85 -158.82 126.75 5.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.013 -0.994 . . . . 0.92000000000000004 108.527 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.6 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 26.8 t-105 -144.21 138.69 28.24 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.463 0.649 . . . . 0.10000000000000001 110.93 -167.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.611 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -122.23 92.27 48.94 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.272 -1.01 . . . . 1.01 108.272 175.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.769 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 25.5 Cg_endo -63.41 84.44 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.554 2.169 . . . . 0.5 112.853 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.576 HD13 ' CB ' ' A' ' 382' ' ' PHE . 2.4 pt -86.08 177.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.141 -1.059 . . . . 1.05 108.141 175.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 416' ' ' THR . 1.5 t70 -155.11 -169.39 3.16 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 118.989 -1.084 . . . . 2.4900000000000002 113.162 -166.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.413 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 39.9 p90 55.32 -6.3 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.991 2.116 . . . . 2.3700000000000001 114.495 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.494 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 23.2 p -129.53 -13.65 4.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.206 0.527 . . . . 1.5700000000000001 110.934 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.49 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 96.24 -29.44 10.15 Favored Glycine 0 CA--C 1.505 -0.569 0 N-CA-C 111.322 -0.711 . . . . 0.68000000000000005 111.322 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.608 HG13 ' N ' ' A' ' 419' ' ' GLY . 25.1 t -55.11 171.97 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.936 0.895 . . . . 1.45 112.011 -176.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.608 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -178.21 122.53 0.82 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.182 -1.167 . . . . 0.20000000000000001 110.182 170.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.625 HG23 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.37 141.92 14.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 109.956 -0.387 . . . . 1.0900000000000001 109.956 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.588 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.3 p80 -159.9 161.19 34.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 0.10000000000000001 111.448 -175.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.627 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -82.8 149.53 27.15 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 107.889 -1.152 . . . . 1.0700000000000001 107.889 171.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 445' ' ' THR . 47.1 t -133.82 96.84 3.75 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.708 0.766 . . . . 0.5 110.015 -173.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -81.29 -13.39 58.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.453 -1.249 . . . . 0.41999999999999998 109.734 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.611 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 9.3 p90 -92.89 -19.93 21.17 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.23 -1.35 . . . . 0.32000000000000001 111.487 -175.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.517 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 1.7 tt0 -103.36 117.81 59.25 Favored Pre-proline 0 CA--C 1.507 -0.674 0 CA-C-O 122.663 1.221 . . . . 1.74 110.542 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.576 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 44.0 Cg_endo -87.16 -12.09 5.0 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 124.348 3.365 . . . . 0.87 113.874 -173.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.576 ' OE2' ' HD2' ' A' ' 427' ' ' PRO . 1.5 pm0 -110.19 150.62 28.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.38 1.086 . . . . 2.1600000000000001 112.964 174.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.885 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.7 OUTLIER -158.33 127.88 5.81 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 112.691 -2.05 . . . . 0.91000000000000003 105.8 169.056 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.582 ' HA2' ' OD2' ' A' ' 367' ' ' ASP . . . 169.06 -158.48 31.07 Favored Glycine 0 C--N 1.286 -2.234 0 C-N-CA 119.871 -1.157 . . . . 0.20000000000000001 111.148 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.494 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.16 165.91 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.781 0 C-N-CA 120.511 -0.852 . . . . 0.25 111.665 168.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 435' ' ' LYS . 22.4 m-20 -52.82 101.93 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.684 -1.258 . . . . 1.8500000000000001 113.096 -155.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.612 ' CD2' ' HD2' ' A' ' 437' ' ' ARG . 33.7 mt -94.96 -33.22 12.84 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 112.943 -1.935 . . . . 1.8200000000000001 109.275 175.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.699 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.0 p-90 -53.87 -27.45 30.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.738 -1.119 . . . . 0.17999999999999999 112.511 -173.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.699 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.05 -34.54 16.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.92 -0.582 . . . . 1.05 111.977 -178.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.405 ' H ' HG21 ' A' ' 436' ' ' THR . 2.9 p -89.72 -41.43 11.91 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.047 -0.978 . . . . 1.0600000000000001 110.787 -176.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.612 ' HD2' ' CD2' ' A' ' 433' ' ' LEU . 0.8 OUTLIER -94.2 -18.11 22.04 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.546 -1.206 . . . . 2.3700000000000001 109.957 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.76 48.49 56.62 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.984 -1.007 . . . . 0.23999999999999999 115.045 163.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 10.1 p -83.71 111.38 19.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.35 1.075 . . . . 1.7 111.936 -171.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 35.92 -118.47 0.12 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.693 -1.139 . . . . 0.56999999999999995 113.298 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -137.06 -16.59 0.74 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.999 -0.62 . . . . 0.28999999999999998 113.841 -175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.489 ' HB3' ' HAS' ' A' ' 130' ' ' 1RG . 30.3 p -103.78 -167.06 1.32 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.63 0.715 . . . . 0.40000000000000002 112.511 -176.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.457 HG21 ' HB ' ' A' ' 368' ' ' ILE . 2.1 mp -98.74 129.01 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 114.893 -1.049 . . . . 1.04 110.866 -174.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.61 97.89 8.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.473 -0.785 . . . . 0.62 110.422 -177.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.69 ' HA ' HG23 ' A' ' 368' ' ' ILE . 6.8 m -94.1 144.08 27.48 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 115.071 -0.968 . . . . 1.02 112.467 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.634 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 81.7 Cg_exo -51.07 143.48 31.57 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 124.012 3.142 . . . . 0.23999999999999999 113.178 175.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.885 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 31.5 Cg_exo -64.62 -29.96 60.62 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.833 2.355 . . . . 0.31 112.361 -176.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.498 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 38.6 m -72.95 -23.49 60.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.769 -0.651 . . . . 1.48 112.218 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.719 ' O ' HD23 ' A' ' 364' ' ' LEU . 25.2 m -100.82 -47.42 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 113.01 0.744 . . . . 1.03 113.01 -169.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.939 ' SD ' HD22 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.8 -2.22 6.79 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.69 -0.804 . . . . 1.02 110.204 -178.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.5 ' HG3' ' N ' ' A' ' 452' ' ' GLU . 16.2 pttp -80.24 -38.88 30.1 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.475 1.131 . . . . 1.5900000000000001 108.201 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.577 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.4 mm-40 -61.91 -46.54 88.9 Favored 'General case' 0 CA--C 1.471 -2.066 0 CA-C-N 112.497 -2.138 . . . . 0.25 106.484 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.939 HD22 ' SD ' ' A' ' 450' ' ' MET . 2.9 tp -47.45 -65.89 0.49 Allowed 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 109.973 -3.285 . . . . 1.02 112.608 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 389' ' ' GLU . 21.9 t80 -45.33 -22.98 0.16 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.853 0.835 . . . . 0.17000000000000001 109.728 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -90.65 -26.84 21.62 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.74 -1.118 . . . . 0.13 111.983 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.58 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -102.33 -44.68 5.33 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 113.64 0.978 . . . . 1.02 113.64 177.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.673 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -71.23 147.08 11.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 122.391 1.091 . . . . 1.01 110.793 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.555 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -113.32 157.5 21.74 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 113.033 -1.894 . . . . 0.47999999999999998 108.869 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.622 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 7.2 mtpt -60.74 101.54 0.15 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.063 -1.088 . . . . 1.7 108.063 166.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.86 -7.41 6.46 Favored Glycine 0 C--N 1.308 -1.025 0 CA-C-N 113.957 -1.474 . . . . 0.22 111.631 -174.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.6 HG21 ' HA ' ' A' ' 344' ' ' TYR . 8.0 m -72.96 150.58 90.4 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 108.257 -1.016 . . . . 0.94999999999999996 108.257 170.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.527 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 10.1 Cg_endo -95.32 171.94 1.3 Allowed 'Trans proline' 0 N--CA 1.417 -2.972 0 C-N-CA 122.172 1.915 . . . . 0.23000000000000001 109.91 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.76 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -130.88 153.85 39.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.201 -1.037 . . . . 1.27 108.201 171.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.73 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.2 mp -134.08 150.67 51.18 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.637 -0.875 . . . . 1.05 108.637 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.696 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.8 OUTLIER -140.19 140.1 35.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 103.981 -2.6 . . . . 1.01 103.981 162.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.573 ' CE1' ' CD ' ' A' ' 346' ' ' GLU . 4.6 p90 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.399 -1.286 . . . . 1.0900000000000001 111.184 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.807 HNAJ ' HH ' ' A' ' 403' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.73 -0.548 . . . . 2.48 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.632 ' CE1' HD23 ' A' ' 464' ' ' LEU . 2.2 p-80 -137.87 100.09 4.08 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 111.976 0.362 . . . . 1.1399999999999999 111.976 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.536 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.2 OUTLIER 62.16 -163.28 0.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.238 -0.892 . . . . 1.01 112.646 165.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.9 175.88 1.83 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.805 -1.184 . . . . 1.96 107.805 164.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.443 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 9.1 m-20 -82.52 82.89 7.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.06 -1.056 . . . . 0.42999999999999999 109.457 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 1.089 ' CG2' ' HH ' ' A' ' 356' ' ' TYR . 91.5 m -157.67 134.63 10.06 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.63 -1.168 . . . . 1.0 108.539 168.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.749 ' CD2' HD11 ' A' ' 464' ' ' LEU . 40.9 p90 174.42 158.32 0.16 Allowed 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 123.503 0.502 . . . . 0.88 111.152 -175.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.689 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.5 OUTLIER -77.26 153.86 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 109.077 -0.712 . . . . 1.0 109.077 164.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.639 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.46 146.9 28.6 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.006 -1.109 . . . . 2.0099999999999998 108.006 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.697 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.0 t -139.24 154.31 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 C-N-CA 123.687 0.795 . . . . 1.04 110.449 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 355' ' ' TRP . 17.8 t0 -137.79 105.77 5.68 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.61 -1.626 . . . . 0.23999999999999999 106.61 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.648 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -79.18 -35.97 41.05 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 114.086 -1.416 . . . . 1.02 109.891 -165.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -55.77 -44.76 77.99 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 110.669 -2.968 . . . . 0.59999999999999998 108.124 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -100.56 6.76 44.27 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 110.931 -2.85 . . . . 0.20999999999999999 110.795 -175.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.5 OUTLIER 32.83 60.8 0.4 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 112.786 -2.006 . . . . 2.54 112.868 -174.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.556 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.3 t60 -141.77 136.44 30.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.748 -0.66 . . . . 0.12 109.66 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.614 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.1 OUTLIER -113.81 157.64 22.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.001 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.592 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.7 m-90 -143.35 161.25 38.85 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.179 0.592 . . . . 0.11 111.044 -177.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.089 ' HH ' ' CG2' ' A' ' 343' ' ' THR . 89.1 t80 -113.41 153.56 28.41 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.423 -1.695 . . . . 1.1000000000000001 106.423 150.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.0 m-85 -127.81 117.68 22.3 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.001 -1.0 . . . . 0.60999999999999999 109.954 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.5 tppt? -118.44 137.8 52.91 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.08 -1.822 . . . . 0.93999999999999995 106.08 168.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.417 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 70.21 16.36 7.36 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.276 0.843 . . . . 0.42999999999999999 113.276 172.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.443 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.35 7.47 87.85 Favored Glycine 0 CA--C 1.485 -1.816 0 CA-C-N 115.72 -0.673 . . . . 0.17999999999999999 112.956 -173.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 16.6 ptmt -127.5 177.76 6.54 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 104.66 -2.348 . . . . 1.0900000000000001 104.66 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.592 HG12 ' CD1' ' A' ' 355' ' ' TRP . 17.2 m -104.58 158.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.616 0 N-CA-C 116.427 2.01 . . . . 1.02 116.427 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.632 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.7 -26.25 9.97 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 110.607 -2.997 . . . . 1.01 106.671 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.73 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -135.19 145.12 47.41 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 111.404 -2.635 . . . . 1.02 111.653 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.556 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.6 tt0 -141.25 119.05 11.76 Favored 'General case' 0 N--CA 1.405 -2.684 0 N-CA-C 104.269 -2.493 . . . . 0.47999999999999998 104.269 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.614 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.1 165.17 33.61 Favored 'General case' 0 N--CA 1.4 -2.973 0 C-N-CA 117.958 -1.497 . . . . 1.02 111.501 178.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 29.5 p-10 -103.89 136.68 43.1 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.821 -1.082 . . . . 1.8 109.822 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.68 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -136.58 -173.02 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.247 0 CA-C-O 122.506 1.146 . . . . 1.01 112.483 -171.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.61 119.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 112.811 -1.995 . . . . 1.04 108.102 173.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.503 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.2 OUTLIER -80.47 -168.09 1.59 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.254 -1.339 . . . . 1.6000000000000001 110.479 -178.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.74 169.94 45.34 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 118.811 -1.661 . . . . 0.14000000000000001 112.414 -174.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -74.48 156.24 87.15 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.314 0.578 . . . . 1.47 112.33 -164.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.62 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 85.8 Cg_exo -54.83 -30.89 70.2 Favored 'Trans proline' 0 CA--C 1.497 -1.345 1 C-N-CA 125.537 4.158 . . . . 0.28000000000000003 114.037 -173.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.412 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 21.5 p -67.2 -31.47 71.89 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.703 -1.59 . . . . 1.0800000000000001 109.565 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.537 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -141.87 70.9 24.39 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 113.683 -1.599 . . . . 1.1000000000000001 109.731 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.4 Cg_exo -58.15 142.99 97.45 Favored 'Trans proline' 0 C--N 1.306 -1.679 1 C-N-CA 125.884 4.389 . . . . 0.38 113.307 -172.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.503 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -73.11 144.24 84.61 Favored Pre-proline 0 N--CA 1.422 -1.83 0 N-CA-C 108.154 -1.054 . . . . 1.1299999999999999 108.154 175.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.1 Cg_exo -74.97 -44.1 0.36 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 124.381 3.387 . . . . 0.20999999999999999 111.728 -165.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.663 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 57.93 136.69 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 123.528 1.632 . . . . 1.0600000000000001 113.86 -173.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 155.3 -114.61 0.62 Allowed Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 112.013 -2.358 . . . . 0.20000000000000001 109.377 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.417 ' O ' HG11 ' A' ' 381' ' ' VAL . 9.8 p -130.91 114.72 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 121.822 0.82 . . . . 1.5 111.192 176.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.611 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 2.4 m-85 -112.42 -174.18 2.4 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.193 -1.41 . . . . 0.28000000000000003 107.193 174.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.451 ' HB2' ' CZ2' ' A' ' 415' ' ' TRP . 1.3 t80 -140.58 124.47 17.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.19 1.359 . . . . 0.96999999999999997 113.598 -172.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.95 92.04 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 123.066 1.412 . . . . 1.02 109.611 168.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -92.87 10.78 29.65 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.419 -1.719 . . . . 3.1299999999999999 107.982 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.746 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.4 t30 -169.79 126.3 0.86 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 113.873 -1.512 . . . . 0.42999999999999999 110.095 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.648 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.5 144.06 29.94 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.998 -1.001 . . . . 1.73 109.171 170.495 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.743 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 29.8 mm-40 -124.73 158.3 33.59 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 114.896 1.443 . . . . 0.70999999999999996 114.896 -167.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.739 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 56.2 mt-10 -137.05 126.88 25.63 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 112.958 -1.928 . . . . 0.38 108.57 174.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 37.1 t70 54.23 47.35 23.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 123.076 1.417 . . . . 0.40999999999999998 109.228 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.459 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -80.43 166.23 21.45 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 112.922 -1.945 . . . . 1.02 108.891 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 18.7 m -132.3 119.33 20.61 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.136 0.97 . . . . 1.04 111.465 171.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.8 89.02 5.22 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.731 -1.577 . . . . 1.27 111.853 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.602 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.9 mttt -101.57 176.98 5.05 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 113.8 -1.546 . . . . 0.96999999999999997 113.353 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 137.76 -157.08 24.02 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 119.526 -1.321 . . . . 0.46000000000000002 111.898 -177.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.644 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.3 m -115.79 139.42 50.2 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 120.367 -0.533 . . . . 1.3500000000000001 111.604 172.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.2 m-80 -57.31 154.47 10.48 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 114.919 -1.037 . . . . 0.83999999999999997 110.039 168.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.09 -2.61 0.18 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.441 -1.254 . . . . 2.2799999999999998 112.173 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 397' ' ' ASN . 20.9 t70 -117.21 2.54 12.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.676 0.751 . . . . 2.27 111.033 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.73 16.51 36.18 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 119.941 -1.123 . . . . 0.97999999999999998 113.01 172.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 7.0 p -113.2 102.26 54.56 Favored Pre-proline 0 C--N 1.303 -1.421 0 CA-C-N 114.785 -0.708 . . . . 1.3999999999999999 109.675 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.3 Cg_endo -57.66 149.75 65.87 Favored 'Trans proline' 0 CA--C 1.506 -0.894 0 C-N-CA 122.867 2.378 . . . . 0.67000000000000004 113.514 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.612 ' HD2' ' CD1' ' A' ' 403' ' ' TYR . 22.8 p90 -148.79 174.57 12.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.266 -1.334 . . . . 1.04 112.66 -169.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.602 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.7 OUTLIER -143.01 148.33 36.59 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.649 -1.614 . . . . 0.53000000000000003 109.769 170.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.9 OUTLIER -143.42 96.76 5.69 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 107.916 -1.142 . . . . 0.45000000000000001 107.916 170.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 17.3 Cg_exo -69.52 110.51 2.52 Favored 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.791 1.66 . . . . 0.22 109.728 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.618 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -110.18 151.52 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 112.941 -1.936 . . . . 1.04 107.11 -168.447 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.739 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 22.6 m-80 -85.42 -20.11 30.32 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.962 -0.755 . . . . 0.65000000000000002 108.962 -174.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 0.743 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 81.2 m-85 -158.27 126.11 5.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.995 -1.002 . . . . 0.92000000000000004 108.705 -170.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.608 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 24.5 t-105 -144.48 133.11 22.21 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.758 0.79 . . . . 0.10000000000000001 111.104 -167.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.648 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.9 mmt -114.92 93.66 35.19 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 107.816 -1.179 . . . . 1.01 107.816 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.746 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.6 Cg_endo -67.59 71.4 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.455 2.103 . . . . 0.5 112.252 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.592 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.2 pt -70.05 174.31 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.564 -0.902 . . . . 1.05 108.564 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.497 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 1.0 OUTLIER -147.38 -173.75 4.34 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.847 -1.141 . . . . 2.4900000000000002 112.541 -165.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.497 ' CE3' ' HB3' ' A' ' 414' ' ' ASP . 37.7 p90 50.72 0.68 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.853 2.061 . . . . 2.3700000000000001 115.025 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.475 HG22 ' CD1' ' A' ' 382' ' ' PHE . 29.9 p -131.17 -15.23 3.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.055 0.455 . . . . 1.5700000000000001 111.544 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 97.98 -35.47 4.53 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 111.267 -0.733 . . . . 0.68000000000000005 111.267 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.583 HG13 ' N ' ' A' ' 419' ' ' GLY . 39.4 t -59.13 172.79 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 123.926 0.89 . . . . 1.45 112.021 -177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.592 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -176.95 121.64 0.8 Allowed Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.867 -1.293 . . . . 0.20000000000000001 109.867 169.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.671 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.2 mp -82.02 143.22 12.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 110.106 -0.331 . . . . 1.0900000000000001 110.106 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.589 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.0 p80 -160.28 161.86 33.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.178 -0.464 . . . . 0.10000000000000001 111.514 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.619 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -83.19 145.62 29.07 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.607 -1.257 . . . . 1.0700000000000001 107.607 171.402 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.528 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 29.4 t -133.81 98.33 4.14 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.95 0.881 . . . . 0.5 110.205 -171.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.35 -11.23 59.73 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.002 -1.454 . . . . 0.41999999999999998 109.609 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.618 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 11.1 p90 -95.6 -26.99 15.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.43 -1.259 . . . . 0.32000000000000001 112.125 -175.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.558 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -90.45 109.06 31.25 Favored Pre-proline 0 CA--C 1.509 -0.628 0 CA-C-O 122.487 1.137 . . . . 1.74 108.692 177.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 67.8 Cg_endo -82.33 -16.46 8.27 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 124.249 3.299 . . . . 0.87 112.973 -172.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.558 ' HG2' ' NE2' ' A' ' 426' ' ' GLN . 0.9 OUTLIER -111.47 157.48 20.25 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.125 0.964 . . . . 2.1600000000000001 112.049 173.532 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.666 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.6 OUTLIER -160.7 129.64 4.77 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 104.949 -2.241 . . . . 0.91000000000000003 104.949 172.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.82 -157.27 29.47 Favored Glycine 0 C--N 1.284 -2.339 0 C-N-CA 119.678 -1.249 . . . . 0.20000000000000001 110.797 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.414 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -44.97 174.01 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.184 -1.008 . . . . 0.25 111.482 167.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.52 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.4 p-10 -52.59 101.95 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 123.28 1.515 . . . . 1.8500000000000001 113.89 -153.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.636 ' HG ' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.93 -36.99 10.88 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 112.651 -2.068 . . . . 1.8200000000000001 109.582 169.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.758 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.5 p-90 -54.44 -26.88 33.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.338 -0.846 . . . . 0.17999999999999999 112.4 -170.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.758 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.72 -35.21 15.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 112.523 0.564 . . . . 1.05 112.523 -177.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.2 p -91.82 -43.71 9.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.031 -0.986 . . . . 1.0600000000000001 110.904 -176.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.636 ' CD ' ' HG ' ' A' ' 433' ' ' LEU . 0.8 OUTLIER -90.09 -19.24 24.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.73 -1.123 . . . . 2.3700000000000001 109.152 -179.085 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.8 47.54 46.74 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.475 -0.784 . . . . 0.23999999999999999 114.952 161.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.9 p -84.65 110.97 19.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 118.622 1.211 . . . . 1.7 111.597 -172.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 37.09 -130.86 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.69 -1.141 . . . . 0.56999999999999995 113.031 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -121.74 -20.06 3.24 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.088 -0.577 . . . . 0.28999999999999998 114.084 -177.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.472 ' HB3' HASA ' A' ' 130' ' ' 1RG . 30.4 p -99.09 -166.83 1.4 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.803 0.801 . . . . 0.40000000000000002 112.867 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.479 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.2 mp -96.73 130.01 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 115.105 -0.952 . . . . 1.04 110.887 -173.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.01 94.56 6.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.945 -0.57 . . . . 0.62 110.418 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.68 ' HA ' HG23 ' A' ' 368' ' ' ILE . 4.6 m -91.26 142.39 27.1 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-N 115.147 -0.933 . . . . 1.02 112.481 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.59 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 89.3 Cg_exo -49.72 143.59 22.17 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 123.925 3.083 . . . . 0.23999999999999999 113.268 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.666 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.2 Cg_exo -65.0 -27.94 57.81 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.836 2.357 . . . . 0.31 112.053 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.48 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 31.6 m -75.56 -22.61 56.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.505 0.669 . . . . 1.48 112.371 -176.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.73 ' O ' HD23 ' A' ' 364' ' ' LEU . 26.3 m -100.99 -48.03 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 112.898 0.703 . . . . 1.03 112.898 -170.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.936 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.18 -2.03 5.22 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.72 -0.792 . . . . 1.02 110.246 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 448' ' ' SER . 14.7 pttp -81.2 -38.78 26.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 122.58 1.181 . . . . 1.5900000000000001 108.143 173.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.581 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.0 mm-40 -62.18 -46.35 89.32 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 112.368 -2.196 . . . . 0.25 106.559 -177.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.936 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.8 tp -46.69 -67.11 0.31 Allowed 'General case' 0 N--CA 1.403 -2.781 0 CA-C-N 109.785 -3.37 . . . . 1.02 112.735 172.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.485 ' CE2' ' HE2' ' A' ' 387' ' ' LYS . 14.6 t80 -45.34 -24.11 0.26 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 124.034 0.834 . . . . 0.17000000000000001 109.469 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.12 -27.15 26.62 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 114.684 -1.144 . . . . 0.13 111.732 -176.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.589 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -101.03 -44.07 5.83 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 113.459 0.911 . . . . 1.02 113.459 176.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.689 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.89 149.91 8.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 122.554 1.168 . . . . 1.01 111.182 -179.485 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.535 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -119.87 156.25 31.08 Favored 'General case' 0 N--CA 1.413 -2.283 0 CA-C-N 112.86 -1.973 . . . . 0.47999999999999998 108.366 -178.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.549 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.3 mppt? -58.8 102.07 0.11 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.555 -0.905 . . . . 1.7 108.555 170.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.62 -11.17 5.75 Favored Glycine 0 C--N 1.305 -1.15 0 CA-C-N 114.069 -1.423 . . . . 0.22 111.535 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 344' ' ' TYR . 10.8 m -68.82 150.47 97.62 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 108.793 -0.817 . . . . 0.94999999999999996 108.793 171.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.536 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.0 Cg_endo -93.61 165.02 2.29 Favored 'Trans proline' 0 N--CA 1.423 -2.652 0 C-N-CA 122.17 1.913 . . . . 0.23000000000000001 110.074 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.74 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -126.35 152.12 33.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.497 -1.297 . . . . 1.27 107.497 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.749 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.1 mp -133.79 149.95 51.43 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 108.26 -1.015 . . . . 1.05 108.26 175.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.697 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.08 138.96 37.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 103.932 -2.618 . . . . 1.01 103.932 163.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.639 ' CE1' ' CD ' ' A' ' 346' ' ' GLU . 4.3 p90 . . . . . 0 C--O 1.25 1.116 0 CA-C-N 118.503 0.592 . . . . 1.0900000000000001 111.879 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.748 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.49 -0.644 . . . . 2.48 111.49 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.684 ' CE1' HD23 ' A' ' 464' ' ' LEU . 23.4 m80 -133.19 113.12 12.32 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 116.827 0.314 . . . . 1.1399999999999999 111.073 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.494 ' HE1' ' HD3' ' A' ' 462' ' ' PRO . 2.3 mtm 47.95 -148.94 0.17 Allowed 'General case' 0 C--O 1.236 0.342 0 O-C-N 124.612 1.195 . . . . 1.01 111.222 166.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -68.25 153.63 43.37 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 104.179 -2.526 . . . . 1.96 104.179 152.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.451 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.2 m-20 -74.05 86.53 1.84 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 118.867 -1.133 . . . . 0.42999999999999999 110.26 -169.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 98.5 m -157.16 134.58 10.56 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.854 -1.066 . . . . 1.0 110.539 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.647 ' CD2' HD11 ' A' ' 464' ' ' LEU . 37.9 p90 173.65 159.18 0.14 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.831 -0.622 . . . . 0.88 110.923 -178.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.703 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.44 151.23 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.263 0 N-CA-C 109.282 -0.636 . . . . 1.0 109.282 166.608 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.571 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 34.6 tt0 -149.81 141.09 23.17 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.462 -0.79 . . . . 2.0099999999999998 109.743 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.717 HG21 ' O ' ' A' ' 464' ' ' LEU . 2.7 t -133.0 161.89 40.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.054 0.454 . . . . 1.04 111.312 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.516 ' HA ' ' C ' ' A' ' 466' ' ' PHE . 30.3 t0 -140.15 106.86 5.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.521 -1.289 . . . . 0.23999999999999999 107.521 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.651 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -82.37 -34.41 28.41 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 123.289 1.518 . . . . 1.02 110.156 -169.389 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.409 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.1 mt-10 -54.93 -43.95 73.82 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.892 -2.867 . . . . 0.59999999999999998 108.015 176.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 18.4 m-80 -103.04 4.74 37.57 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 111.015 -2.811 . . . . 0.20999999999999999 111.48 -175.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.813 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 16.4 mm-40 34.75 61.59 0.57 Allowed 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 112.917 -1.947 . . . . 2.54 113.424 -174.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.615 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 22.6 t60 -141.71 134.75 29.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.105 -0.952 . . . . 0.12 109.638 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.591 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.84 155.8 24.02 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.631 -0.713 . . . . 1.0 109.957 -179.118 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.597 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.4 m-90 -140.88 154.36 46.12 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.533 -0.758 . . . . 0.11 111.257 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.679 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.3 t80 -109.36 153.55 23.78 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.428 -1.694 . . . . 1.1000000000000001 106.428 151.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 11.0 m-85 -126.63 118.76 25.45 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 115.224 -0.898 . . . . 0.60999999999999999 110.163 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.8 tppt? -121.88 136.06 54.91 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.366 -1.716 . . . . 0.93999999999999995 106.366 168.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.448 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.3 OUTLIER 70.73 15.55 6.93 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.141 0.793 . . . . 0.42999999999999999 113.141 175.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.91 5.07 89.66 Favored Glycine 0 CA--C 1.485 -1.801 0 CA-C-O 122.033 0.796 . . . . 0.17999999999999999 112.844 -174.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.1 ptmt -125.79 177.37 6.32 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 104.067 -2.568 . . . . 1.0900000000000001 104.067 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.597 HG12 ' CD1' ' A' ' 355' ' ' TRP . 14.7 m -104.98 157.51 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.822 0 N-CA-C 116.268 1.951 . . . . 1.02 116.268 -176.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.598 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -107.09 -27.42 10.62 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 110.493 -3.049 . . . . 1.01 106.33 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.59 142.75 48.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 111.352 -2.658 . . . . 1.02 111.488 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.615 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 3.5 tt0 -139.99 117.63 11.56 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 104.218 -2.512 . . . . 0.47999999999999998 104.218 176.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.607 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -149.58 162.54 39.98 Favored 'General case' 0 N--CA 1.397 -3.112 0 C-N-CA 117.715 -1.594 . . . . 1.02 111.598 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 367' ' ' ASP . 14.9 p-10 -101.54 135.51 42.93 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 113.972 -1.467 . . . . 1.8 109.41 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.716 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -137.28 -174.18 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 CA-C-O 122.318 1.056 . . . . 1.01 112.508 -169.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.813 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -151.81 121.28 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 112.725 -2.034 . . . . 1.04 109.298 172.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.567 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.1 OUTLIER -81.69 -168.67 1.98 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.768 -1.56 . . . . 1.6000000000000001 110.318 -178.308 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.64 167.4 42.54 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.655 -1.736 . . . . 0.14000000000000001 112.328 -174.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -72.53 156.94 89.77 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 121.511 0.672 . . . . 1.47 111.937 -166.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.624 ' HG3' ' CZ3' ' A' ' 434' ' ' TRP . 92.1 Cg_exo -56.08 -28.9 72.07 Favored 'Trans proline' 0 CA--C 1.496 -1.392 1 C-N-CA 125.371 4.048 . . . . 0.28000000000000003 113.603 -173.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.431 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.0 p -70.38 -34.25 72.36 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.329 -1.76 . . . . 1.0800000000000001 109.413 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.563 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.5 t -142.04 69.99 23.41 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 123.645 1.688 . . . . 1.1000000000000001 109.407 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 375' ' ' THR . 79.8 Cg_exo -58.76 155.28 38.5 Favored 'Trans proline' 0 C--N 1.314 -1.279 1 C-N-CA 126.46 4.773 . . . . 0.38 114.608 -171.141 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.567 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.3 OUTLIER -84.42 141.96 39.93 Favored Pre-proline 0 N--CA 1.423 -1.811 0 N-CA-C 108.699 -0.852 . . . . 1.1299999999999999 108.699 173.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.465 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 21.3 Cg_exo -75.92 -43.34 0.33 Allowed 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 124.785 3.657 . . . . 0.20999999999999999 112.219 -167.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.66 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.85 136.31 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.302 1.525 . . . . 1.0600000000000001 113.634 -172.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 152.6 -119.34 0.96 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 112.129 -2.305 . . . . 0.20000000000000001 109.584 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.461 ' O ' HG11 ' A' ' 381' ' ' VAL . 9.8 p -121.97 115.53 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.275 1.036 . . . . 1.5 110.749 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.599 ' HE2' ' CE1' ' A' ' 382' ' ' PHE . 1.8 m-85 -114.03 -172.68 2.14 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.192 -1.781 . . . . 0.28000000000000003 106.192 171.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.666 ' HD2' ' CD1' ' A' ' 385' ' ' TRP . 34.1 t80 -146.11 126.85 14.33 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 118.013 -1.475 . . . . 0.96999999999999997 114.54 -171.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.516 HG13 HG22 ' A' ' 457' ' ' VAL . 1.5 p -85.92 92.21 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 123.064 1.412 . . . . 1.02 109.784 170.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . 0.666 ' CD1' ' HD2' ' A' ' 383' ' ' TYR . 75.2 m95 -70.55 -15.06 62.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.173 -1.831 . . . . 3.1299999999999999 107.976 176.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.763 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.8 t30 -170.05 132.65 1.1 Allowed 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.198 -0.91 . . . . 0.42999999999999999 111.209 -174.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.654 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -93.71 144.84 25.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.636 -0.711 . . . . 1.73 109.268 171.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.76 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 12.8 mm-40 -125.16 157.36 36.61 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 114.381 1.252 . . . . 0.70999999999999996 114.381 -169.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.773 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 51.3 mt-10 -136.3 127.12 27.43 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.143 -1.844 . . . . 0.38 108.403 173.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.4 t70 56.48 45.04 23.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 123.3 1.524 . . . . 0.40999999999999998 109.259 -178.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 388' ' ' GLU . . . -79.59 167.24 20.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 112.852 -1.976 . . . . 1.02 109.016 176.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 7.1 m -131.87 119.35 21.07 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.164 0.983 . . . . 1.04 112.06 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.9 mp -82.69 88.55 6.71 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.761 -1.563 . . . . 1.27 112.275 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.539 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 48.7 mttt -101.66 178.06 4.74 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 113.657 -1.611 . . . . 0.96999999999999997 113.551 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.95 -161.59 25.52 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 114.403 -1.271 . . . . 0.46000000000000002 111.648 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.6 m -115.37 138.93 50.46 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 120.222 -0.591 . . . . 1.3500000000000001 110.895 170.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.55 ' C ' ' H ' ' A' ' 399' ' ' ASP . 7.3 m-80 -56.75 155.69 7.4 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.283 -0.871 . . . . 0.83999999999999997 109.307 169.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.36 -1.83 1.27 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.215 -0.902 . . . . 2.2799999999999998 110.716 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 397' ' ' ASN . 21.8 t70 -114.51 2.54 14.63 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.722 -1.127 . . . . 2.27 110.71 -177.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.19 16.81 42.44 Favored Glycine 0 N--CA 1.426 -1.983 0 C-N-CA 120.064 -1.065 . . . . 0.97999999999999998 112.843 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.444 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 10.0 p -110.59 100.1 43.99 Favored Pre-proline 0 C--N 1.302 -1.475 0 CA-C-N 114.658 -0.771 . . . . 1.3999999999999999 109.807 -175.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.5 Cg_endo -58.73 150.61 69.46 Favored 'Trans proline' 0 CA--C 1.503 -1.05 0 C-N-CA 122.727 2.285 . . . . 0.67000000000000004 112.949 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.597 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 23.7 p90 -153.04 173.18 15.77 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.481 -1.236 . . . . 1.04 112.831 -169.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.539 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER -145.16 147.07 32.08 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 113.726 -1.579 . . . . 0.53000000000000003 109.743 171.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -143.83 97.08 5.44 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 108.444 -0.947 . . . . 0.45000000000000001 108.444 171.225 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.8 Cg_exo -68.87 110.07 2.28 Favored 'Trans proline' 0 N--CA 1.43 -2.214 0 C-N-CA 122.022 1.815 . . . . 0.22 109.456 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.635 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -109.56 154.1 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 CA-C-N 112.78 -2.009 . . . . 1.04 107.288 -167.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.773 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.6 m-80 -86.92 -19.85 28.23 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.969 -0.752 . . . . 0.65000000000000002 108.969 -174.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 0.76 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 88.7 m-85 -158.65 125.62 4.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.038 -0.983 . . . . 0.92000000000000004 108.89 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.607 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 27.1 t-105 -144.52 137.08 26.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.678 0.751 . . . . 0.10000000000000001 110.907 -167.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.654 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.6 mmt -120.44 93.8 48.46 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 107.823 -1.177 . . . . 1.01 107.823 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.763 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 33.6 Cg_endo -65.29 84.49 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.568 2.179 . . . . 0.5 112.153 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.582 HD13 ' CB ' ' A' ' 382' ' ' PHE . 3.9 pt -84.94 177.08 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.461 -0.791 . . . . 1.05 109.052 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.542 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 3.3 t70 -143.74 -171.95 3.63 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.512 -0.875 . . . . 2.4900000000000002 112.584 -165.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.542 ' CE3' ' HB3' ' A' ' 414' ' ' ASP . 29.9 p90 50.97 -4.17 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 127.113 2.165 . . . . 2.3700000000000001 115.359 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.647 HG22 ' CE1' ' A' ' 382' ' ' PHE . 24.4 p -131.37 -13.8 3.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.978 0.418 . . . . 1.5700000000000001 111.979 -177.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.484 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 90.33 -29.06 6.87 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.067 -0.813 . . . . 0.68000000000000005 111.067 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.616 HG13 ' N ' ' A' ' 419' ' ' GLY . 39.9 t -55.46 172.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 123.967 0.907 . . . . 1.45 111.509 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.616 ' N ' HG13 ' A' ' 418' ' ' VAL . . . -177.06 122.87 0.86 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 109.694 -1.362 . . . . 0.20000000000000001 109.694 170.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.689 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.0 mp -81.65 141.69 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 120.589 -0.444 . . . . 1.0900000000000001 109.888 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.592 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.8 p80 -159.98 162.47 34.36 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.971 -0.559 . . . . 0.10000000000000001 111.338 -174.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.601 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.94 143.47 28.96 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.538 -1.282 . . . . 1.0700000000000001 107.538 171.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 42.3 t -134.64 98.71 4.13 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.702 0.763 . . . . 0.5 110.415 -170.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.437 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 20.0 t70 -83.76 -14.21 52.05 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.258 -1.337 . . . . 0.41999999999999998 109.803 -175.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.635 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 9.9 p90 -90.11 -17.97 26.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.711 -1.132 . . . . 0.32000000000000001 111.518 -176.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.465 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 8.2 tm0? -95.26 120.75 63.53 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 122.994 1.378 . . . . 1.74 111.073 -172.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.463 ' HD2' ' HG2' ' A' ' 426' ' ' GLN . 56.8 Cg_endo -66.76 -45.51 4.44 Favored 'Trans proline' 0 C--N 1.326 -0.606 0 C-N-CA 124.957 3.772 . . . . 0.87 114.174 -164.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -124.29 162.78 23.02 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.771 0.796 . . . . 2.1600000000000001 111.388 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.511 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -152.89 125.35 8.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.32 -1.733 . . . . 0.91000000000000003 106.32 175.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.77 -158.67 31.62 Favored Glycine 0 C--N 1.28 -2.553 0 N-CA-C 109.501 -1.44 . . . . 0.20000000000000001 109.501 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -44.81 174.63 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.061 -1.066 . . . . 0.25 111.683 168.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.51 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.9 p-10 -50.87 102.82 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 123.274 1.511 . . . . 1.8500000000000001 114.108 -153.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.567 ' CD1' ' HD2' ' A' ' 437' ' ' ARG . 0.2 OUTLIER -95.47 -38.75 10.32 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 112.687 -2.051 . . . . 1.8200000000000001 109.371 167.219 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.704 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.9 p-90 -50.99 -28.85 10.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.413 -0.812 . . . . 0.17999999999999999 112.872 -170.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.704 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.24 -34.07 16.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.621 0.724 . . . . 1.05 111.762 -177.71 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.0 p -88.45 -43.47 11.43 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.539 -1.209 . . . . 1.0600000000000001 110.905 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.567 ' HD2' ' CD1' ' A' ' 433' ' ' LEU . 6.4 mtp85 -93.84 -19.63 20.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.781 -1.099 . . . . 2.3700000000000001 109.582 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.19 47.07 50.73 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.141 -0.936 . . . . 0.23999999999999999 114.63 166.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 36.8 m -84.68 110.84 19.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.761 1.281 . . . . 1.7 111.5 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 39.42 -132.24 0.22 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.551 -1.204 . . . . 0.56999999999999995 113.579 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -121.78 -20.98 3.03 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.924 -0.655 . . . . 0.28999999999999998 113.665 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.521 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.4 p -101.84 -166.08 1.26 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.175 0.806 . . . . 0.40000000000000002 113.175 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.561 HG13 ' HG ' ' A' ' 370' ' ' SER . 2.0 mp -93.18 130.64 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.994 -1.003 . . . . 1.04 110.412 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.11 89.91 3.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.539 0.685 . . . . 0.62 109.835 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.716 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.0 m -84.01 141.78 40.96 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.731 -1.122 . . . . 1.02 112.423 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.607 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 82.1 Cg_exo -48.85 144.49 15.01 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 123.935 3.09 . . . . 0.23999999999999999 113.117 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.601 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.8 Cg_exo -65.31 -22.3 60.41 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.68 2.253 . . . . 0.31 112.123 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.505 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 79.7 p -82.25 -24.2 34.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.62 0.724 . . . . 1.48 112.026 -174.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.719 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.8 m -99.46 -48.44 11.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.011 0.745 . . . . 1.03 113.011 -169.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.943 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.32 -1.97 3.95 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.669 -0.812 . . . . 1.02 110.385 -178.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 42.2 pttt -81.33 -38.74 26.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 122.456 1.122 . . . . 1.5900000000000001 108.11 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.586 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.8 mm-40 -61.7 -46.4 89.86 Favored 'General case' 0 CA--C 1.471 -2.096 0 CA-C-N 112.48 -2.146 . . . . 0.25 106.423 -177.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.943 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.19 -66.55 0.39 Allowed 'General case' 0 N--CA 1.403 -2.775 0 CA-C-N 109.72 -3.4 . . . . 1.02 112.745 172.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.0 t80 -45.89 -23.35 0.27 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.728 0.775 . . . . 0.17000000000000001 109.458 176.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -89.47 -26.94 23.97 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 114.888 -1.051 . . . . 0.13 111.893 -176.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.606 ' HE1' ' CG ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -101.78 -44.21 5.6 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 113.359 0.874 . . . . 1.02 113.359 177.163 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.703 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.4 OUTLIER -73.81 149.22 8.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.582 1.182 . . . . 1.01 110.995 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.543 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -124.6 157.69 34.86 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 112.905 -1.952 . . . . 0.47999999999999998 108.177 -177.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.539 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 37.5 mtpt -55.38 101.47 0.05 Allowed 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 109.034 -0.728 . . . . 1.7 109.034 169.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . 0.42 ' HA2' ' OH ' ' A' ' 383' ' ' TYR . . . 133.08 -14.27 4.9 Favored Glycine 0 C--N 1.302 -1.335 0 CA-C-N 114.222 -1.354 . . . . 0.22 112.124 -175.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.617 HG21 ' HA ' ' A' ' 344' ' ' TYR . 35.6 m -70.36 148.2 95.44 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 108.498 -0.927 . . . . 0.94999999999999996 108.498 168.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 11.8 Cg_endo -97.14 177.21 0.54 Allowed 'Trans proline' 0 N--CA 1.419 -2.873 0 C-N-CA 122.832 2.355 . . . . 0.23000000000000001 110.299 175.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.739 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -134.42 154.25 36.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 119.916 -0.714 . . . . 1.27 109.278 172.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.717 ' O ' HG21 ' A' ' 347' ' ' VAL . 5.4 mp -135.09 152.31 51.54 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 116.028 -0.533 . . . . 1.05 109.915 173.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.692 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.25 142.02 32.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 105.454 -2.054 . . . . 1.01 105.454 163.328 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.571 ' CE1' ' HG3' ' A' ' 346' ' ' GLU . 9.0 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.444 -1.265 . . . . 1.0900000000000001 111.341 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.711 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.931 -0.468 . . . . 2.48 111.931 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.617 ' CE1' HD23 ' A' ' 464' ' ' LEU . 2.7 p-80 -134.54 101.45 4.97 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 112.198 0.444 . . . . 1.1399999999999999 112.198 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.543 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.6 OUTLIER 61.25 -164.06 0.25 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.938 -1.028 . . . . 1.01 113.436 165.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.87 173.4 5.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.556 -1.276 . . . . 1.96 107.556 164.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.46 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 11.5 m-20 -81.05 83.45 6.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 119.224 -0.991 . . . . 0.42999999999999999 110.285 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 357' ' ' TYR . 75.8 m -158.03 135.97 10.69 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.856 -1.066 . . . . 1.0 108.995 167.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.785 ' CD2' HD11 ' A' ' 464' ' ' LEU . 43.8 p90 174.11 159.0 0.15 Allowed 'General case' 0 C--O 1.212 -0.912 0 O-C-N 123.35 0.406 . . . . 0.88 111.173 -175.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.694 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -78.25 154.98 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 N-CA-C 109.711 -0.478 . . . . 1.0 109.711 165.101 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 354' ' ' MET . 0.0 OUTLIER -146.92 148.64 32.0 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.873 -1.058 . . . . 2.0099999999999998 108.206 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.682 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 5.6 t -145.02 110.33 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 N-CA-C 113.872 1.064 . . . . 1.04 113.872 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 355' ' ' TRP . 27.7 t0 -92.56 106.71 18.64 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-O 121.946 0.879 . . . . 0.23999999999999999 109.058 176.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.637 HD13 ' HB ' ' A' ' 465' ' ' VAL . 0.3 OUTLIER -77.44 -37.3 51.89 Favored 'General case' 0 CA--C 1.479 -1.772 0 CA-C-N 114.01 -1.45 . . . . 1.02 110.251 -169.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.539 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 3.5 mt-10 -55.04 -44.43 74.67 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 110.766 -2.925 . . . . 0.59999999999999998 108.062 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 21.2 m-80 -102.32 7.21 40.66 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 110.694 -2.957 . . . . 0.20999999999999999 111.051 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.632 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.9 OUTLIER 34.09 61.76 0.49 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 112.852 -1.976 . . . . 2.54 112.833 -175.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.586 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 23.5 t60 -143.22 132.18 22.88 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.568 -0.742 . . . . 0.12 109.892 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.619 ' CG ' HG21 ' A' ' 347' ' ' VAL . 0.0 OUTLIER -109.38 152.6 25.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.793 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.662 ' CD1' HG12 ' A' ' 362' ' ' VAL . 32.1 m-90 -139.05 157.72 45.48 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.442 -0.799 . . . . 0.11 110.725 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.705 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.5 t80 -109.66 153.81 23.72 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.488 -1.671 . . . . 1.1000000000000001 106.488 151.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.4 m-85 -127.38 118.42 24.08 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 115.073 -0.967 . . . . 0.60999999999999999 109.969 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.42 ' HE2' ' HE2' ' A' ' 356' ' ' TYR . 9.8 tppt? -121.81 125.23 46.03 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.863 -1.162 . . . . 0.93999999999999995 107.863 171.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.83 35.87 2.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 119.092 0.86 . . . . 0.42999999999999999 112.243 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.46 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 62.89 13.29 46.73 Favored Glycine 0 CA--C 1.495 -1.191 0 C-N-CA 120.322 -0.942 . . . . 0.17999999999999999 113.495 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -137.25 172.47 12.95 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.422 -2.436 . . . . 1.0900000000000001 104.422 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.662 HG12 ' CD1' ' A' ' 355' ' ' TRP . 17.6 m -101.02 158.18 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.741 0 N-CA-C 116.48 2.03 . . . . 1.02 116.48 -172.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.597 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -109.35 -26.55 9.97 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 110.523 -3.035 . . . . 1.01 106.933 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.723 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -133.72 145.58 49.99 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 111.766 -2.47 . . . . 1.02 111.842 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.586 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 5.0 tt0 -140.26 118.35 11.92 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 104.569 -2.382 . . . . 0.47999999999999998 104.569 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.608 ' OG1' ' HG2' ' A' ' 446' ' ' PRO . 0.5 OUTLIER -150.05 162.0 41.25 Favored 'General case' 0 N--CA 1.402 -2.838 0 C-N-CA 117.767 -1.573 . . . . 1.02 112.059 177.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.617 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 17.0 p-10 -101.12 135.8 42.0 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 114.263 -1.335 . . . . 1.8 109.27 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.678 HG21 ' HA ' ' A' ' 445' ' ' THR . 2.6 pp -141.63 -171.84 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 122.443 1.116 . . . . 1.01 112.835 -169.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.47 120.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 CA-C-N 112.959 -1.928 . . . . 1.04 108.982 174.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.514 ' OG ' HG22 ' A' ' 377' ' ' THR . 0.1 OUTLIER -76.23 -167.67 0.81 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.643 -1.617 . . . . 1.6000000000000001 110.953 177.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.477 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.85 175.92 48.93 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.118 -1.515 . . . . 0.14000000000000001 112.341 -174.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -78.91 156.69 77.05 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.508 0.671 . . . . 1.47 112.035 -165.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.64 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.7 Cg_exo -57.79 -29.9 87.47 Favored 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 125.182 3.921 . . . . 0.28000000000000003 113.617 -173.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.458 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 27.0 p -70.86 -32.97 70.15 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.592 -1.64 . . . . 1.0800000000000001 109.661 -175.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.564 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.1 t -140.82 70.87 29.96 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 123.614 1.673 . . . . 1.1000000000000001 109.406 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.5 Cg_exo -59.53 154.35 48.7 Favored 'Trans proline' 0 C--N 1.313 -1.292 1 C-N-CA 126.421 4.748 . . . . 0.38 114.449 -172.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.514 HG22 ' OG ' ' A' ' 370' ' ' SER . 0.5 OUTLIER -83.86 148.14 53.41 Favored Pre-proline 0 N--CA 1.419 -1.979 0 N-CA-C 108.002 -1.11 . . . . 1.1299999999999999 108.002 173.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.56 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 15.4 Cg_exo -79.53 -41.26 0.21 Allowed 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 124.592 3.528 . . . . 0.20999999999999999 112.724 -165.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.672 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 59.41 134.24 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 123.549 1.642 . . . . 1.0600000000000001 113.75 -172.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 148.02 -125.83 2.19 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 111.95 -2.386 . . . . 0.20000000000000001 109.728 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.492 ' O ' HG11 ' A' ' 381' ' ' VAL . 12.6 p -116.35 112.32 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 122.122 0.963 . . . . 1.5 111.497 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.622 ' HD1' ' CD2' ' A' ' 382' ' ' PHE . 1.9 m-85 -112.63 -173.38 2.24 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 106.493 -1.669 . . . . 0.28000000000000003 106.493 172.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.558 ' OH ' ' HA2' ' A' ' 460' ' ' GLY . 38.9 t80 -144.68 125.97 14.77 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.306 -1.358 . . . . 0.96999999999999997 113.657 -169.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.4 p -86.47 94.21 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 122.683 1.23 . . . . 1.02 109.56 169.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . 0.546 ' CD1' ' HD2' ' A' ' 383' ' ' TYR . 75.7 m95 -69.16 -17.17 63.79 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.412 -1.722 . . . . 3.1299999999999999 108.185 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.705 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.6 t30 -169.45 135.07 1.54 Allowed 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.375 -0.829 . . . . 0.42999999999999999 111.145 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.642 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -91.95 129.57 37.88 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.186 -1.042 . . . . 1.73 108.186 171.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 0.5 OUTLIER -110.59 158.59 18.4 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.183 -0.917 . . . . 0.70999999999999996 111.935 -171.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 40.3 mt-10 -134.57 133.36 40.16 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.163 -1.38 . . . . 0.38 108.833 173.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 18.6 t70 53.94 46.58 25.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 123.766 1.746 . . . . 0.40999999999999998 108.71 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.574 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -83.99 165.3 18.73 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 112.183 -2.28 . . . . 1.02 108.79 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 24.3 m -132.66 120.12 21.32 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.153 0.978 . . . . 1.04 111.045 170.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.478 ' HG ' HAFB ' A' ' 130' ' ' 1RG . 2.7 mp -78.14 88.48 4.24 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.512 -1.676 . . . . 1.27 111.413 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.541 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 48.5 mttt -104.06 178.4 4.57 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 113.791 -1.55 . . . . 0.96999999999999997 113.701 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.81 -158.98 24.86 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 113.959 -1.473 . . . . 0.46000000000000002 111.358 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 2.8 m -119.87 141.31 49.69 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 120.431 -0.507 . . . . 1.3500000000000001 110.856 171.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 399' ' ' ASP . 4.4 m-80 -58.15 154.77 12.36 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.859 -1.064 . . . . 0.83999999999999997 109.416 168.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.436 ' O ' ' HBC' ' A' ' 130' ' ' 1RG . 2.1 t70 -58.12 -8.43 1.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.705 -1.134 . . . . 2.2799999999999998 111.254 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 397' ' ' ASN . 8.9 m-20 -101.07 -17.61 16.62 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 114.062 -1.427 . . . . 2.27 110.105 -176.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.02 33.62 5.7 Favored Glycine 0 N--CA 1.42 -2.388 0 C-N-CA 118.929 -1.605 . . . . 0.97999999999999998 111.793 -176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' THR . . . . . . . . . . . . . 8.0 p -123.43 98.9 40.38 Favored Pre-proline 0 C--N 1.307 -1.265 0 CA-C-N 114.543 -0.828 . . . . 1.3999999999999999 109.183 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 25.0 Cg_endo -60.23 151.61 72.27 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 C-N-CA 122.833 2.356 . . . . 0.67000000000000004 113.216 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.593 ' HE1' ' CE2' ' A' ' 403' ' ' TYR . 27.3 p90 -151.87 171.87 17.08 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.36 -1.291 . . . . 1.04 112.384 -169.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.541 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 1.8 mp0 -146.84 146.46 30.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 113.949 -1.478 . . . . 0.53000000000000003 110.127 173.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.29 97.49 5.18 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 108.015 -1.105 . . . . 0.45000000000000001 108.015 170.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.1 Cg_exo -69.32 110.05 2.37 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.008 1.805 . . . . 0.22 110.316 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.609 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -108.35 155.39 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 CA-C-N 112.998 -1.91 . . . . 1.04 107.396 -168.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.63 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.0 m-80 -88.49 -21.57 24.11 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.657 -0.868 . . . . 0.65000000000000002 108.657 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 0.651 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.1 m-85 -157.31 126.11 5.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.625 -1.17 . . . . 0.92000000000000004 108.674 -169.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.65 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 14.6 t-105 -142.3 141.41 32.41 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.623 -0.717 . . . . 0.10000000000000001 110.281 -167.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.642 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.5 mmt -126.67 96.75 34.74 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.405 -1.332 . . . . 1.01 107.405 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.705 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 48.2 Cg_endo -67.87 78.13 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.52 2.147 . . . . 0.5 112.825 -175.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.541 HG12 ' HA2' ' A' ' 419' ' ' GLY . 1.4 pt -79.35 173.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 107.691 -1.226 . . . . 1.05 107.691 173.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.604 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 21.6 t70 -154.07 179.65 8.73 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.152 -1.019 . . . . 2.4900000000000002 112.326 -164.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . 0.604 ' CE3' ' HB3' ' A' ' 414' ' ' ASP . 33.4 p90 59.03 2.39 0.26 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.176 1.791 . . . . 2.3700000000000001 114.575 169.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.596 HG21 ' CD1' ' A' ' 415' ' ' TRP . 3.3 p -130.71 -30.69 1.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.024 0.749 . . . . 1.5700000000000001 113.024 -170.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 106.0 -4.08 38.66 Favored Glycine 0 CA--C 1.5 -0.9 0 N-CA-C 110.418 -1.073 . . . . 0.68000000000000005 110.418 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.704 HG12 ' CE2' ' A' ' 382' ' ' PHE . 2.2 p -95.54 164.32 2.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.327 -1.436 . . . . 1.45 111.249 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.541 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -168.05 128.61 1.74 Allowed Glycine 0 C--O 1.219 -0.827 0 N-CA-C 110.882 -0.887 . . . . 0.20000000000000001 110.882 165.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.605 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.6 mp -84.6 140.0 16.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 122.151 -0.617 . . . . 1.0900000000000001 111.213 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.576 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.0 p80 -161.83 162.86 29.57 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.684 -0.689 . . . . 0.10000000000000001 110.303 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.667 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -81.94 150.88 27.48 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 107.675 -1.232 . . . . 1.0700000000000001 107.675 170.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 445' ' ' THR . 48.0 t -134.12 96.08 3.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.981 0.896 . . . . 0.5 109.647 -172.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.42 -19.54 49.74 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.784 -1.553 . . . . 0.41999999999999998 109.77 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.609 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 17.6 p90 -87.18 -23.43 24.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.361 -1.29 . . . . 0.32000000000000001 111.609 -175.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.546 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 2.1 tt0 -97.29 118.2 64.78 Favored Pre-proline 0 CA--C 1.508 -0.635 0 CA-C-O 122.816 1.294 . . . . 1.74 110.492 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.643 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 38.4 Cg_endo -88.65 -11.31 4.07 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 124.365 3.376 . . . . 0.87 113.698 -175.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.643 ' OE2' ' HD2' ' A' ' 427' ' ' PRO . 1.1 pm0 -110.85 150.98 28.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.289 1.042 . . . . 2.1600000000000001 112.71 173.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.623 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -157.8 129.54 6.89 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 112.681 -2.054 . . . . 0.91000000000000003 105.513 168.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.13 -157.48 29.74 Favored Glycine 0 C--N 1.288 -2.088 0 C-N-CA 119.715 -1.231 . . . . 0.20000000000000001 111.544 -177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.65 170.49 0.01 OUTLIER Glycine 0 CA--C 1.487 -1.671 0 C-N-CA 120.787 -0.72 . . . . 0.25 111.919 167.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.541 ' HB3' ' CD ' ' A' ' 435' ' ' LYS . 2.4 m-20 -52.75 100.89 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.891 0 CA-C-O 122.492 1.139 . . . . 1.8500000000000001 112.957 -155.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.609 ' CD2' ' HD2' ' A' ' 437' ' ' ARG . 36.8 mt -97.16 -35.73 10.69 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 113.006 -1.906 . . . . 1.8200000000000001 109.696 172.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.721 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -52.7 -26.3 13.53 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.111 -0.95 . . . . 0.17999999999999999 112.1 -173.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.721 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.68 -33.99 15.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.747 -0.661 . . . . 1.05 112.69 -178.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.7 p -90.01 -37.88 14.0 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.861 0.839 . . . . 1.0600000000000001 110.76 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.609 ' HD2' ' CD2' ' A' ' 433' ' ' LEU . 3.8 mtp85 -97.65 -18.4 18.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.707 -1.133 . . . . 2.3700000000000001 110.011 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.74 48.81 49.54 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.156 -0.929 . . . . 0.23999999999999999 115.233 162.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' SER . . . . . 0.454 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 9.3 p -84.8 110.32 18.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 118.93 1.365 . . . . 1.7 112.192 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.442 ' HB3' ' H ' ' A' ' 441' ' ' GLY . 63.2 m-70 35.67 -133.21 0.06 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.482 -1.235 . . . . 0.56999999999999995 113.049 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.477 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -119.22 -6.26 10.95 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.204 -0.759 . . . . 0.28999999999999998 111.204 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 419' ' ' GLY . 0.8 OUTLIER -92.4 162.51 14.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.527 0.936 . . . . 0.40000000000000002 113.527 -176.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.665 ' N ' HD11 ' A' ' 443' ' ' ILE . 1.9 mp -87.43 128.97 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 113.764 -1.562 . . . . 1.04 110.141 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.45 88.42 4.12 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.655 -0.702 . . . . 0.62 110.081 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.678 ' HA ' HG21 ' A' ' 368' ' ' ILE . 4.9 m -83.91 142.64 42.09 Favored Pre-proline 0 N--CA 1.431 -1.377 0 CA-C-N 115.029 -0.987 . . . . 1.02 112.412 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.608 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 76.7 Cg_exo -50.42 145.1 22.52 Favored 'Trans proline' 0 CA--C 1.509 -0.733 0 C-N-CA 123.803 3.002 . . . . 0.23999999999999999 113.455 175.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.667 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.2 Cg_exo -65.45 -24.71 56.51 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.864 2.376 . . . . 0.31 112.328 -176.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.513 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 35.7 p -77.58 -24.99 49.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.229 -0.896 . . . . 1.48 112.09 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.723 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.9 m -100.02 -48.51 11.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.714 -0.675 . . . . 1.03 112.557 -171.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.928 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.7 -2.51 5.02 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.635 -0.826 . . . . 1.02 110.375 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.513 ' HE3' ' O ' ' A' ' 448' ' ' SER . 15.8 pttp -80.71 -38.82 28.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.441 1.115 . . . . 1.5900000000000001 108.358 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.581 ' HB2' HD23 ' A' ' 364' ' ' LEU . 4.7 mm-40 -62.66 -46.57 87.59 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 112.482 -2.145 . . . . 0.25 106.883 -177.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.928 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.09 -66.37 0.41 Allowed 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 109.847 -3.342 . . . . 1.02 112.536 171.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.583 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 21.1 t80 -44.72 -25.62 0.3 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 124.215 0.947 . . . . 0.17000000000000001 109.609 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -86.87 -29.49 23.28 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 114.599 -1.182 . . . . 0.13 111.555 -176.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.569 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -99.43 -44.86 6.03 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 113.533 0.938 . . . . 1.02 113.533 177.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.694 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.65 148.56 9.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 122.487 1.137 . . . . 1.01 111.106 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.498 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -119.91 158.11 27.35 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 112.88 -1.964 . . . . 0.47999999999999998 108.648 -178.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.586 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.3 mppt? -57.82 101.51 0.08 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.575 -0.898 . . . . 1.7 108.575 168.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . 0.558 ' HA2' ' OH ' ' A' ' 383' ' ' TYR . . . 134.66 -18.36 4.1 Favored Glycine 0 C--N 1.304 -1.246 0 CA-C-N 114.233 -1.349 . . . . 0.22 111.902 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 344' ' ' TYR . 23.1 m -66.57 149.29 98.26 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 108.756 -0.831 . . . . 0.94999999999999996 108.756 171.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.543 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 9.8 Cg_endo -95.75 176.29 0.84 Allowed 'Trans proline' 0 N--CA 1.416 -3.052 0 C-N-CA 122.257 1.972 . . . . 0.23000000000000001 109.937 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.756 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -132.8 154.7 40.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.131 -1.063 . . . . 1.27 108.131 171.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.785 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.0 mp -134.26 152.12 51.65 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 108.775 -0.824 . . . . 1.05 108.775 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.682 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.9 OUTLIER -137.73 144.46 31.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 106.047 -1.835 . . . . 1.01 106.047 159.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.539 ' OXT' ' HG3' ' A' ' 350' ' ' GLU . 3.2 p90 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 123.857 0.863 . . . . 1.0900000000000001 110.84 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.734 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 112.906 -0.077 . . . . 2.48 112.906 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.672 ' CE1' HD23 ' A' ' 464' ' ' LEU . 1.2 p-80 -148.89 100.35 3.07 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 122.579 -0.365 . . . . 1.1399999999999999 111.117 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.573 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.1 OUTLIER 62.91 -166.15 0.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.203 0.939 . . . . 1.01 112.686 167.474 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.1 173.04 2.61 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.9 -1.148 . . . . 1.96 107.9 165.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -81.92 82.5 7.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.025 -1.07 . . . . 0.42999999999999999 109.532 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 357' ' ' TYR . 53.6 m -159.35 138.08 10.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.29 -0.868 . . . . 1.0 108.743 167.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.748 ' CD2' HD11 ' A' ' 464' ' ' LEU . 41.2 p90 174.32 158.87 0.16 Allowed 'General case' 0 C--O 1.21 -1.011 0 O-C-N 123.317 0.385 . . . . 0.88 111.149 -176.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.676 ' CD1' HG13 ' A' ' 457' ' ' VAL . 0.5 OUTLIER -77.26 154.7 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 N-CA-C 109.216 -0.661 . . . . 1.0 109.216 164.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.57 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.53 146.96 28.55 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.8 -1.185 . . . . 2.0099999999999998 107.8 -178.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.697 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.76 155.62 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 C-N-CA 123.6 0.76 . . . . 1.04 110.375 173.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.504 ' N ' HG13 ' A' ' 347' ' ' VAL . 37.7 t0 -138.13 105.55 5.53 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.539 -1.652 . . . . 0.23999999999999999 106.539 176.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.66 ' N ' HD11 ' A' ' 349' ' ' LEU . 0.3 OUTLIER -80.13 -35.97 35.91 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 114.023 -1.444 . . . . 1.02 109.959 -165.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.38 -44.96 80.72 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 110.678 -2.965 . . . . 0.59999999999999998 107.942 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -99.37 5.03 46.53 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 111.163 -2.744 . . . . 0.20999999999999999 111.1 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.6 OUTLIER 34.29 61.7 0.52 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 112.942 -1.935 . . . . 2.54 113.137 -173.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.629 ' HE2' ' HG2' ' A' ' 365' ' ' GLU . 24.5 t60 -142.4 136.91 30.02 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.907 -0.588 . . . . 0.12 109.741 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.6 ' HB3' HG21 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.83 158.16 21.39 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 120.947 0.403 . . . . 1.0 110.234 179.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.589 ' CD1' HG12 ' A' ' 362' ' ' VAL . 31.5 m-90 -143.13 164.08 31.12 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.485 0.66 . . . . 0.11 111.126 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.694 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.3 t80 -116.01 154.27 30.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.535 -1.654 . . . . 1.1000000000000001 106.535 150.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 13.4 m-85 -127.13 119.2 25.94 Favored 'General case' 0 C--N 1.269 -2.9 0 CA-C-N 115.094 -0.957 . . . . 0.60999999999999999 110.007 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 358' ' ' LYS . 9.9 tppt? -123.3 116.65 23.68 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.377 -0.971 . . . . 0.93999999999999995 108.377 173.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.85 37.69 0.49 Allowed 'General case' 0 C--N 1.308 -1.207 0 O-C-N 123.474 0.484 . . . . 0.42999999999999999 112.297 -176.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 62.94 12.46 42.97 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 120.2 -1.0 . . . . 0.17999999999999999 113.314 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 358' ' ' LYS . 18.5 ptmt -137.63 169.75 17.25 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 104.586 -2.376 . . . . 1.0900000000000001 104.586 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 17.6 m -99.57 157.74 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.619 0 N-CA-C 116.692 2.108 . . . . 1.02 116.692 -170.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.588 ' CB ' ' HD2' ' A' ' 356' ' ' TYR . . . -110.18 -25.88 9.94 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-N 110.375 -3.102 . . . . 1.01 106.673 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -135.64 146.6 48.03 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 111.694 -2.503 . . . . 1.02 111.682 -176.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.629 ' HG2' ' HE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -143.7 117.92 9.56 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 104.719 -2.326 . . . . 0.47999999999999998 104.719 175.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.6 HG21 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.59 165.25 32.82 Favored 'General case' 0 N--CA 1.4 -2.953 0 C-N-CA 118.121 -1.432 . . . . 1.02 111.558 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.64 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 13.1 p-10 -103.66 132.44 49.91 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.71 -1.132 . . . . 1.8 109.828 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.708 HG23 ' HA ' ' A' ' 445' ' ' THR . 2.0 pp -131.48 -173.5 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 CA-C-O 122.48 1.133 . . . . 1.01 112.415 -172.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.41 120.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 112.805 -1.998 . . . . 1.04 108.312 172.202 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.597 ' HG ' ' HB3' ' A' ' 349' ' ' LEU . 30.2 p -76.87 -169.21 1.23 Allowed 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 112.376 -2.193 . . . . 1.6000000000000001 111.615 -177.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -85.04 166.65 40.93 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 118.718 -1.706 . . . . 0.14000000000000001 111.864 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -73.84 156.99 87.83 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 121.383 0.611 . . . . 1.47 111.758 -167.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.603 ' HG3' ' CZ3' ' A' ' 434' ' ' TRP . 81.4 Cg_exo -54.23 -28.79 53.88 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 125.269 3.98 . . . . 0.28000000000000003 113.439 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.462 ' OG1' HG21 ' A' ' 375' ' ' THR . 16.8 p -69.55 -34.04 73.64 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.295 -1.775 . . . . 1.0800000000000001 109.829 -176.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.556 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -141.61 70.81 25.69 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 123.715 1.721 . . . . 1.1000000000000001 109.128 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 375' ' ' THR . 85.9 Cg_exo -57.41 160.09 14.61 Favored 'Trans proline' 0 C--N 1.31 -1.462 1 C-N-CA 126.453 4.769 . . . . 0.38 115.254 -170.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.535 ' CG2' HG22 ' A' ' 465' ' ' VAL . 2.3 m -86.08 126.56 64.92 Favored Pre-proline 0 N--CA 1.402 -2.837 0 CA-C-N 114.142 -1.39 . . . . 1.1299999999999999 108.616 173.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 29.0 Cg_exo -69.29 -44.66 2.25 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.776 2.984 . . . . 0.20999999999999999 112.21 -168.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.647 ' HA ' HG23 ' A' ' 465' ' ' VAL . . . 61.21 137.98 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 123.579 1.657 . . . . 1.0600000000000001 113.912 -175.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 153.36 -111.69 0.5 Allowed Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 111.75 -2.477 . . . . 0.20000000000000001 108.871 -176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.67 125.89 56.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.206 0.527 . . . . 1.5 109.759 173.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 1.62 ' HE1' ' CE2' ' A' ' 382' ' ' PHE . 8.1 m-85 -118.16 -176.14 3.0 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 106.608 -1.627 . . . . 0.28000000000000003 106.608 168.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.708 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 2.0 t80 -137.76 120.29 16.06 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 120.698 -1.251 . . . . 0.96999999999999997 112.291 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -86.01 91.35 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-O 123.178 1.466 . . . . 1.02 108.926 171.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -93.66 11.79 27.72 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 113.043 -1.889 . . . . 3.1299999999999999 108.013 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.74 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.0 t30 -167.95 126.21 1.2 Allowed 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 113.588 -1.642 . . . . 0.42999999999999999 110.148 172.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.6 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.64 143.25 31.84 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.201 -0.909 . . . . 1.73 109.129 169.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.709 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 30.0 mm-40 -126.11 159.67 32.23 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 115.019 1.489 . . . . 0.70999999999999996 115.019 -167.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.727 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.1 mt-10 -139.11 127.29 22.58 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 112.755 -2.02 . . . . 0.38 108.689 174.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.7 t70 56.19 45.67 22.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 123.498 1.618 . . . . 0.40999999999999998 109.053 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.471 ' HB1' HG13 ' A' ' 407' ' ' VAL . . . -81.26 166.3 20.67 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 112.517 -2.129 . . . . 1.02 108.803 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 20.6 m -132.75 119.24 20.06 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 122.252 1.025 . . . . 1.04 111.577 170.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.1 mp -78.7 88.02 4.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.699 -1.591 . . . . 1.27 111.873 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.568 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.7 mttt -102.81 179.67 4.21 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.572 -1.649 . . . . 0.96999999999999997 113.032 177.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 137.54 -157.73 24.19 Favored Glycine 0 N--CA 1.428 -1.893 0 C-N-CA 119.422 -1.371 . . . . 0.46000000000000002 111.555 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.4 m -120.77 137.0 54.74 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 120.344 -0.542 . . . . 1.3500000000000001 110.474 172.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.2 m-80 -54.13 150.4 8.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.325 -0.852 . . . . 0.83999999999999997 108.845 168.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.89 -2.07 0.07 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.595 -0.73 . . . . 2.2799999999999998 112.171 175.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 397' ' ' ASN . 8.2 t70 -115.71 1.92 13.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.579 0.704 . . . . 2.27 110.483 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.66 19.36 27.47 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.923 -1.035 . . . . 0.97999999999999998 113.039 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.454 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 11.5 p -113.8 99.83 50.92 Favored Pre-proline 0 C--N 1.303 -1.451 0 CA-C-O 121.538 0.685 . . . . 1.3999999999999999 109.938 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.1 Cg_endo -59.34 149.23 82.46 Favored 'Trans proline' 0 CA--C 1.505 -0.955 0 C-N-CA 122.794 2.33 . . . . 0.67000000000000004 113.135 -177.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.617 ' HD2' ' CD1' ' A' ' 403' ' ' TYR . 26.5 p90 -150.99 174.08 13.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.137 -1.392 . . . . 1.04 112.547 -169.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.568 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -145.47 147.17 31.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.357 -1.292 . . . . 0.53000000000000003 110.749 172.731 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.02 97.35 4.86 Favored Pre-proline 0 N--CA 1.437 -1.094 0 N-CA-C 108.525 -0.917 . . . . 0.45000000000000001 108.525 170.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.9 Cg_exo -68.47 110.95 2.4 Favored 'Trans proline' 0 N--CA 1.436 -1.886 0 C-N-CA 122.106 1.871 . . . . 0.22 110.159 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.615 HG22 ' CZ3' ' A' ' 425' ' ' TRP . 0.4 OUTLIER -110.86 152.41 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.168 0 CA-C-N 113.355 -1.748 . . . . 1.04 107.979 -167.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.727 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 19.6 m-80 -85.95 -20.43 28.96 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.958 -0.756 . . . . 0.65000000000000002 108.958 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 0.709 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.4 m-85 -158.85 125.75 4.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.935 -1.03 . . . . 0.92000000000000004 108.493 -170.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.613 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.8 t-105 -143.32 138.18 29.32 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.692 -0.685 . . . . 0.10000000000000001 110.476 -167.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.609 ' O ' HG22 ' A' ' 413' ' ' ILE . 14.3 mmt -118.55 91.08 40.96 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.932 -0.766 . . . . 1.01 108.932 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 34.1 Cg_exo -59.2 89.79 0.07 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 123.367 2.711 . . . . 0.5 109.511 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 18.8 pt -91.6 -135.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.812 -0.631 . . . . 1.05 112.184 -170.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.487 ' H ' HG13 ' A' ' 413' ' ' ILE . 16.0 t70 -89.64 165.53 14.18 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.063 0.459 . . . . 2.4900000000000002 110.654 -164.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.18 -11.83 58.4 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.135 0.974 . . . . 2.3700000000000001 111.495 -165.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 30.6 p -68.18 -12.77 61.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 113.965 -1.471 . . . . 1.5700000000000001 111.777 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . 0.405 ' HA2' ' HBA' ' A' ' 130' ' ' 1RG . . . 123.82 -40.84 1.87 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.996 -0.621 . . . . 0.68000000000000005 113.133 168.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.568 HG13 ' N ' ' A' ' 419' ' ' GLY . 32.3 t -59.74 171.06 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 122.978 0.511 . . . . 1.45 111.763 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -175.81 122.58 0.87 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.039 -1.224 . . . . 0.20000000000000001 110.039 170.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.696 HG23 ' SD ' ' A' ' 450' ' ' MET . 2.4 mp -81.63 143.52 12.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 110.05 -0.352 . . . . 1.0900000000000001 110.05 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.589 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.4 p80 -160.32 161.84 33.36 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.10000000000000001 111.617 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.618 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.03 146.63 27.09 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.402 -0.962 . . . . 1.0700000000000001 108.402 173.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 445' ' ' THR . 37.7 t -133.15 96.32 3.73 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.788 0.804 . . . . 0.5 110.074 -171.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . 0.414 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 8.0 t70 -82.04 -18.16 44.21 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.211 -1.359 . . . . 0.41999999999999998 109.551 -176.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.615 ' CZ3' HG22 ' A' ' 407' ' ' VAL . 11.7 p90 -86.22 -19.13 30.44 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 113.983 -1.462 . . . . 0.32000000000000001 110.915 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -103.89 113.47 65.37 Favored Pre-proline 0 CA--C 1.505 -0.778 0 CA-C-O 122.588 1.185 . . . . 1.74 109.998 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.445 ' HG2' ' OE1' ' A' ' 428' ' ' GLU . 38.6 Cg_endo -87.47 -9.11 6.0 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 124.231 3.288 . . . . 0.87 112.779 -174.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.501 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.7 pm0 -111.6 152.2 27.88 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.242 1.02 . . . . 2.1600000000000001 113.291 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.94 ' HH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -163.07 132.02 4.03 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 112.608 -2.087 . . . . 0.91000000000000003 105.405 172.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 169.06 -158.61 31.28 Favored Glycine 0 C--N 1.283 -2.401 0 N-CA-C 110.373 -1.091 . . . . 0.20000000000000001 110.373 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.448 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -45.53 174.85 0.01 OUTLIER Glycine 0 CA--C 1.497 -1.045 0 C-N-CA 120.155 -1.022 . . . . 0.25 111.493 167.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.53 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -51.9 101.82 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 123.341 1.543 . . . . 1.8500000000000001 113.834 -154.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.68 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.87 -36.02 11.26 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 112.533 -2.122 . . . . 1.8200000000000001 109.378 170.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.686 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -54.75 -27.47 41.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.213 -0.903 . . . . 0.17999999999999999 112.276 -170.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.686 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.52 -35.37 15.11 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.468 0.651 . . . . 1.05 112.216 -177.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.407 ' H ' HG21 ' A' ' 436' ' ' THR . 1.8 p -90.4 -43.39 10.33 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.991 -1.004 . . . . 1.0600000000000001 110.787 -176.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.68 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.6 mtp180 -93.29 -17.77 23.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.536 -1.211 . . . . 2.3700000000000001 109.607 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.67 49.82 56.28 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.765 -1.107 . . . . 0.23999999999999999 115.101 162.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 50.0 m -83.38 110.28 18.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.736 1.268 . . . . 1.7 111.31 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 37.33 -126.85 0.19 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.303 -1.317 . . . . 0.56999999999999995 114.481 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -128.28 -21.32 1.49 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.14 -0.552 . . . . 0.28999999999999998 113.029 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.439 ' CB ' ' H ' ' A' ' 419' ' ' GLY . 29.2 p -102.11 -166.05 1.25 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.244 0.545 . . . . 0.40000000000000002 112.273 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.426 HD11 HG12 ' A' ' 465' ' ' VAL . 2.2 mp -96.62 131.15 44.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.314 -0.857 . . . . 1.04 110.619 -174.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.99 94.39 5.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.431 0.634 . . . . 0.62 110.252 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.708 ' HA ' HG23 ' A' ' 368' ' ' ILE . 3.9 m -90.39 145.53 32.74 Favored Pre-proline 0 C--O 1.211 -0.969 0 CA-C-N 114.713 -1.131 . . . . 1.02 112.85 -176.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.588 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 75.8 Cg_exo -50.44 146.51 19.03 Favored 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 123.971 3.114 . . . . 0.23999999999999999 113.659 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.94 ' HD3' ' HH ' ' A' ' 429' ' ' TYR . 27.8 Cg_exo -67.3 -23.38 44.85 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.963 2.442 . . . . 0.31 112.364 -176.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.506 ' O ' ' HE2' ' A' ' 451' ' ' LYS . 34.1 p -80.64 -24.98 38.62 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.363 -0.835 . . . . 1.48 112.079 -175.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.719 ' O ' HD23 ' A' ' 364' ' ' LEU . 32.8 m -99.38 -48.98 11.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.643 -0.708 . . . . 1.03 112.864 -170.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.938 ' SD ' HD21 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.95 -2.27 5.07 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.754 -0.779 . . . . 1.02 110.349 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' A' ' 452' ' ' GLU . 41.4 pttt -80.81 -39.51 26.53 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.973 -1.121 . . . . 1.5900000000000001 107.973 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.582 ' HB2' HD23 ' A' ' 364' ' ' LEU . 3.7 mm-40 -61.53 -46.35 90.31 Favored 'General case' 0 CA--C 1.472 -2.032 0 CA-C-N 112.499 -2.137 . . . . 0.25 106.356 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.938 HD21 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.81 -67.49 0.28 Allowed 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 109.612 -3.449 . . . . 1.02 112.66 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 16.3 t80 -45.46 -23.96 0.27 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 124.008 0.817 . . . . 0.17000000000000001 109.361 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 453' ' ' LEU . . . -88.36 -26.09 29.03 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.925 -1.034 . . . . 0.13 111.845 -176.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.571 ' HE1' ' CB ' ' A' ' 356' ' ' TYR . 0.0 OUTLIER -102.45 -44.31 5.4 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 113.309 0.855 . . . . 1.02 113.309 176.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.676 HG13 ' CD1' ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.12 147.71 10.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 122.528 1.156 . . . . 1.01 110.747 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.484 ' N ' HG21 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -121.64 153.79 37.66 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-N 112.878 -1.965 . . . . 0.47999999999999998 107.943 -178.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 42.4 mtmt -55.57 103.01 0.08 Allowed 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.783 0.801 . . . . 1.7 110.122 173.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.58 -11.67 6.33 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 113.637 -1.619 . . . . 0.22 111.394 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 344' ' ' TYR . 10.3 m -65.6 150.34 96.21 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 108.443 -0.947 . . . . 0.94999999999999996 108.443 171.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.573 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.3 Cg_endo -93.51 163.55 2.37 Favored 'Trans proline' 0 N--CA 1.42 -2.852 0 C-N-CA 122.0 1.8 . . . . 0.23000000000000001 109.644 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.705 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -125.19 152.71 31.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 107.392 -1.336 . . . . 1.27 107.392 170.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.748 HD11 ' CD2' ' A' ' 344' ' ' TYR . 5.1 mp -133.02 150.01 52.17 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 108.09 -1.078 . . . . 1.05 108.09 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.697 ' HB ' ' HB ' ' A' ' 347' ' ' VAL . 0.7 OUTLIER -140.23 138.57 37.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 103.879 -2.638 . . . . 1.01 103.879 163.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.57 ' CE1' ' CD ' ' A' ' 346' ' ' GLU . 2.5 p90 . . . . . 0 C--O 1.247 0.956 0 O-C-N 123.768 0.668 . . . . 1.0900000000000001 110.719 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' 1RG . . . . . 0.731 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.468 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.7 m-20 . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 109.456 -0.572 . . . . 0.42999999999999999 109.456 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 357' ' ' TYR . 70.6 m -158.08 134.3 9.4 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.467 -1.242 . . . . 0.14000000000000001 108.715 169.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.638 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.1 p90 174.61 158.39 0.17 Allowed 'General case' 0 C--O 1.212 -0.876 0 O-C-N 123.316 0.385 . . . . 0.14999999999999999 111.545 -175.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -78.23 149.32 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 109.274 -0.639 . . . . 0.080000000000000002 109.274 164.658 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.555 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.2 tt0 -149.34 139.57 22.24 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.459 -0.791 . . . . 2.0099999999999998 109.902 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.745 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -132.52 161.53 41.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.039 0.447 . . . . 0.45000000000000001 111.412 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.542 ' N ' HG12 ' A' ' 347' ' ' VAL . 32.5 t0 -140.23 106.35 5.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.385 -1.339 . . . . 0.23999999999999999 107.385 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.111 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.02 -34.88 26.18 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 124.071 1.891 . . . . 0.16 110.139 -170.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.63 -41.77 74.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 111.144 -2.753 . . . . 0.59999999999999998 107.757 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -105.52 7.66 33.06 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 110.912 -2.858 . . . . 0.20000000000000001 111.666 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.816 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 82.9 mm-40 28.8 63.86 0.12 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 112.825 -1.989 . . . . 2.1499999999999999 114.294 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.518 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 27.2 t60 -141.87 137.71 31.58 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.665 -1.152 . . . . 0.089999999999999997 110.125 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.728 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -113.55 157.89 21.48 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.218 0.532 . . . . 0.070000000000000007 110.385 -178.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.615 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.5 m-90 -143.3 153.88 43.22 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.274 -0.876 . . . . 0.11 111.137 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.7 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.0 t80 -109.35 153.07 24.46 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.46 -1.681 . . . . 0.26000000000000001 106.46 151.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.9 m-85 -127.43 119.37 25.99 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.946 -1.024 . . . . 0.14000000000000001 110.384 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.8 tppt? -121.1 135.65 55.14 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.408 -1.701 . . . . 0.25 106.408 168.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.524 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 72.11 15.77 5.42 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.071 0.767 . . . . 0.42999999999999999 113.071 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.65 7.09 88.29 Favored Glycine 0 CA--C 1.485 -1.826 0 CA-C-N 115.693 -0.685 . . . . 0.17999999999999999 112.731 -173.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' A' ' 359' ' ' ASP . 18.1 ptmt -127.93 178.13 6.39 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 104.505 -2.406 . . . . 0.37 104.505 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.7 m -104.51 157.83 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 N-CA-C 116.475 2.028 . . . . 0.10000000000000001 116.475 -174.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.683 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.86 -27.97 9.91 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-N 110.477 -3.056 . . . . 0.070000000000000007 106.286 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.12 144.31 48.49 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 111.471 -2.604 . . . . 0.059999999999999998 111.625 -175.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.415 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.4 tt0 -140.34 117.47 11.22 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 104.426 -2.435 . . . . 0.47999999999999998 104.426 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.728 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.55 160.39 43.52 Favored 'General case' 0 N--CA 1.393 -3.297 0 C-N-CA 117.871 -1.532 . . . . 0.070000000000000007 110.636 -179.332 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.75 138.9 38.12 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 108.334 -0.987 . . . . 1.8 108.334 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.742 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.0 pp -136.47 -174.21 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-O 122.11 0.957 . . . . 0.12 112.25 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.816 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.7 OUTLIER -150.12 118.82 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 113.02 -1.9 . . . . 0.10000000000000001 108.793 172.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.509 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -78.63 -168.08 1.28 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.555 -1.657 . . . . 1.26 110.349 -178.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.469 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.43 168.07 43.75 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 118.485 -1.816 . . . . 0.14000000000000001 112.311 -174.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.402 ' HG3' ' OG1' ' A' ' 374' ' ' THR . 10.0 ptmt -73.61 158.74 85.92 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.626 0.727 . . . . 0.81000000000000005 111.9 -166.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.641 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 88.1 Cg_exo -57.43 -28.99 82.92 Favored 'Trans proline' 0 CA--C 1.495 -1.426 0 C-N-CA 125.182 3.922 . . . . 0.28000000000000003 113.435 -173.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.452 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.9 p -71.57 -33.71 69.31 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.405 -1.725 . . . . 0.33000000000000002 109.618 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.6 t -141.36 70.57 26.97 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 123.737 1.732 . . . . 0.39000000000000001 109.584 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 375' ' ' THR . 79.0 Cg_exo -59.46 157.55 30.97 Favored 'Trans proline' 0 C--N 1.314 -1.256 1 C-N-CA 126.494 4.796 . . . . 0.38 114.481 -172.237 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.509 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -87.35 146.16 39.24 Favored Pre-proline 0 N--CA 1.425 -1.723 0 N-CA-C 108.44 -0.948 . . . . 0.81999999999999995 108.44 174.455 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.4 Cg_exo -76.08 -44.15 0.28 Allowed 'Trans proline' 0 CA--C 1.511 -0.657 0 C-N-CA 124.8 3.667 . . . . 0.19 112.136 -167.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.781 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 57.67 137.88 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 123.249 1.499 . . . . 0.13 113.608 -172.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 150.47 -111.02 0.49 Allowed Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 112.592 -2.095 . . . . 0.20000000000000001 110.319 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 381' ' ' VAL . 5.7 p -130.17 113.51 26.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 122.496 1.141 . . . . 0.81999999999999995 111.078 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.733 ' HB2' HG12 ' A' ' 463' ' ' VAL . 1.8 m-85 -114.68 -171.21 1.89 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.929 -1.508 . . . . 0.22 106.929 173.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 462' ' ' PRO . 1.4 t80 -150.03 124.58 9.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.856 1.207 . . . . 0.65000000000000002 112.838 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.62 HG12 HG23 ' A' ' 463' ' ' VAL . 2.3 p -89.45 91.95 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-O 123.047 1.403 . . . . 0.16 109.13 169.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -93.8 11.24 29.96 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 113.298 -1.773 . . . . 2.5499999999999998 107.851 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.74 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 28.3 t-20 -169.19 126.18 0.94 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 113.793 -1.548 . . . . 0.42999999999999999 110.086 172.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.66 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.89 143.68 31.47 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.828 -1.078 . . . . 1.1200000000000001 109.121 171.023 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 26.7 mm-40 -126.11 157.61 37.61 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.599 1.333 . . . . 0.70999999999999996 114.599 -167.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 45.2 mt-10 -135.63 127.16 28.77 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 113.155 -1.839 . . . . 0.38 108.902 172.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.14 49.62 18.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 123.159 1.457 . . . . 0.40999999999999998 109.335 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.948 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -81.88 168.5 17.87 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 112.579 -2.1 . . . . 0.12 109.454 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.0 m -132.27 119.59 21.0 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.904 0.859 . . . . 0.17000000000000001 111.745 170.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.6 mp -80.2 88.84 5.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.802 -1.545 . . . . 0.56999999999999995 112.167 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.561 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.5 mttt . . . . . 0 C--N 1.284 -2.271 0 CA-C-N 113.657 -1.61 . . . . 0.33000000000000002 113.502 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.561 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.778 0 CA-C-O 120.977 0.418 . . . . 0.53000000000000003 109.91 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.2 97.35 5.23 Favored Pre-proline 0 N--CA 1.434 -1.254 0 N-CA-C 108.233 -1.025 . . . . 0.19 108.233 171.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.2 Cg_exo -69.31 110.59 2.5 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 122.012 1.808 . . . . 0.19 110.047 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.948 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.02 158.03 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 CA-C-N 113.132 -1.849 . . . . 0.14999999999999999 107.582 -168.137 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.689 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.0 m-80 -89.27 -21.8 23.02 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.031 -0.729 . . . . 0.51000000000000001 109.031 -174.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.744 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 94.1 m-85 -158.86 127.54 5.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.924 -1.035 . . . . 0.27000000000000002 108.229 -170.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.672 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 21.9 t-105 -144.93 136.26 25.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.692 0.758 . . . . 0.089999999999999997 111.397 -166.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.66 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.8 mmt -119.68 93.65 47.72 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.157 -1.053 . . . . 0.14000000000000001 108.157 173.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.2 Cg_endo . . . . . 0 N--CA 1.459 -0.552 0 C-N-CA 122.171 1.914 . . . . 0.5 111.351 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 419' ' ' GLY . 40.6 t . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.425 0.631 . . . . 0.75 111.69 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.605 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.4 123.47 0.91 Allowed Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.049 -1.221 . . . . 0.20000000000000001 110.049 170.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.729 HG22 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.63 141.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.382 -0.599 . . . . 0.28999999999999998 109.382 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.672 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.6 p80 -159.82 160.1 33.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.295 -0.412 . . . . 0.089999999999999997 111.525 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -82.59 145.92 29.44 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.02 -1.104 . . . . 1.0700000000000001 108.02 172.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 445' ' ' THR . 37.9 t -134.78 97.68 3.83 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.65 0.738 . . . . 0.23000000000000001 110.191 -172.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.456 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 24.1 t70 . . . . . 0 C--N 1.314 -0.954 0 CA-C-N 114.604 -1.18 . . . . 0.41999999999999998 109.665 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.545 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.1 pm0 . . . . . 0 N--CA 1.434 -1.248 0 CA-C-O 122.199 0.999 . . . . 2.1600000000000001 113.283 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.644 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -160.57 128.6 4.55 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 106.384 -1.71 . . . . 0.33000000000000002 106.384 167.501 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.73 -156.71 28.32 Favored Glycine 0 C--N 1.285 -2.286 0 C-N-CA 119.975 -1.107 . . . . 0.17000000000000001 110.682 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.27 165.35 0.01 OUTLIER Glycine 0 CA--C 1.489 -1.549 0 C-N-CA 120.243 -0.98 . . . . 0.20999999999999999 111.667 166.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.534 ' HB3' ' HD2' ' A' ' 435' ' ' LYS . 7.5 m-20 -53.48 102.98 0.06 Allowed 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.268 -1.466 . . . . 1.8500000000000001 113.499 -156.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.99 HD22 ' HD2' ' A' ' 437' ' ' ARG . 30.0 mt -94.66 -33.99 12.75 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 112.892 -1.958 . . . . 1.21 109.452 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.674 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.1 p-90 -52.32 -27.32 14.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.841 -1.072 . . . . 0.16 112.501 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.674 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.87 -33.17 16.56 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.276 0.56 . . . . 0.22 112.275 -178.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.5 p -90.62 -38.36 13.18 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.215 -0.902 . . . . 0.25 110.765 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.99 ' HD2' HD22 ' A' ' 433' ' ' LEU . 1.5 mtp85 -98.49 -17.94 18.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.6 -1.182 . . . . 1.8200000000000001 109.992 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.36 48.05 55.02 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.833 -1.076 . . . . 0.23999999999999999 115.043 163.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.1 p -83.93 110.65 18.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.674 1.237 . . . . 1.01 111.615 -172.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 35.13 -121.44 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.444 -1.253 . . . . 0.5 113.418 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.469 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -131.75 -19.35 1.17 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.842 -0.617 . . . . 0.26000000000000001 113.703 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.45 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 29.4 p -99.95 -167.66 1.49 Allowed 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 117.923 0.862 . . . . 0.34999999999999998 112.61 -174.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.453 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -99.03 126.26 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 114.698 -1.137 . . . . 0.12 110.928 -173.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -97.73 99.92 11.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.69 -0.686 . . . . 0.62 110.064 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.742 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -97.35 143.09 25.56 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-N 115.235 -0.893 . . . . 0.10000000000000001 112.379 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.666 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 87.6 Cg_exo -49.59 144.59 18.93 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 124.023 3.149 . . . . 0.23999999999999999 113.36 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.644 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.1 Cg_exo -65.92 -27.26 50.99 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.734 2.289 . . . . 0.31 111.991 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 14.5 m -75.68 -24.12 56.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.453 -0.794 . . . . 1.1000000000000001 112.18 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.81 ' O ' HD21 ' A' ' 364' ' ' LEU . 29.0 m -100.36 -49.31 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 113.171 0.804 . . . . 0.080000000000000002 113.171 -168.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.949 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.93 -2.08 4.82 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.888 -0.725 . . . . 0.070000000000000007 110.191 -178.131 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.615 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.2 pttp -81.45 -38.51 26.31 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 122.554 1.168 . . . . 0.92000000000000004 108.197 173.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.4 mm-40 -62.53 -46.5 88.12 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-N 112.418 -2.174 . . . . 0.25 106.463 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.949 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.8 tp -46.34 -66.89 0.34 Allowed 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 109.807 -3.361 . . . . 0.050000000000000003 112.579 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.48 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 17.4 t80 -45.4 -24.28 0.29 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 124.038 0.836 . . . . 0.13 109.617 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.443 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.27 -27.36 25.68 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.76 -1.109 . . . . 0.13 111.685 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.744 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -100.83 -44.57 5.73 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 113.304 0.853 . . . . 0.059999999999999998 113.304 177.127 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -74.01 149.92 7.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 122.528 1.156 . . . . 0.080000000000000002 111.464 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.24 156.12 34.44 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-N 112.929 -1.941 . . . . 0.47999999999999998 108.121 -177.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.583 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.5 mppt? -56.36 103.03 0.09 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 109.248 -0.649 . . . . 0.98999999999999999 109.248 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.61 -6.89 6.59 Favored Glycine 0 C--N 1.308 -0.981 0 CA-C-N 114.148 -1.387 . . . . 0.19 111.863 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.635 HG21 ' HB ' ' A' ' 457' ' ' VAL . 7.7 m -69.63 147.81 96.64 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 109.425 -0.583 . . . . 0.13 109.425 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 2.5 Cg_endo -90.26 151.62 4.58 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 122.683 2.255 . . . . 0.17999999999999999 110.005 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' A' ' 382' ' ' PHE . 1.6 t -121.57 133.54 67.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 114.686 -1.143 . . . . 0.56999999999999995 109.088 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.686 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.3 mp -133.04 148.5 52.21 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 119.494 -0.882 . . . . 0.13 109.684 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.111 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.11 141.57 33.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.132 -2.174 . . . . 0.10000000000000001 105.132 166.369 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.75 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 12.8 p90 . . . . . 0 C--O 1.246 0.915 0 O-C-N 123.568 0.543 . . . . 1.0900000000000001 111.476 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.567 0.699 . . . . 0.42999999999999999 109.318 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 99.5 m -158.95 135.24 9.14 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.288 -1.324 . . . . 0.14000000000000001 108.78 168.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.652 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.6 p90 174.64 158.09 0.16 Allowed 'General case' 0 C--O 1.211 -0.964 0 O-C-N 123.326 0.391 . . . . 0.14999999999999999 111.348 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.663 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.74 151.79 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 109.107 -0.701 . . . . 0.080000000000000002 109.107 164.412 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.577 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.2 tt0 -149.64 142.69 24.92 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.591 -0.731 . . . . 2.0099999999999998 109.568 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.725 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.67 161.69 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 121.019 0.438 . . . . 0.45000000000000001 111.019 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.534 ' N ' HG12 ' A' ' 347' ' ' VAL . 31.7 t0 -140.03 105.72 5.13 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.158 -1.423 . . . . 0.23999999999999999 107.158 173.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.089 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -81.24 -35.09 31.64 Favored 'General case' 0 CA--C 1.481 -1.678 0 CA-C-O 122.838 1.304 . . . . 0.16 110.212 -168.122 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -55.27 -44.89 76.03 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 110.706 -2.952 . . . . 0.59999999999999998 108.063 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -100.44 5.51 44.26 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 110.932 -2.849 . . . . 0.20000000000000001 110.904 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 21.7 mp0 34.79 61.15 0.6 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 112.794 -2.003 . . . . 2.1499999999999999 112.981 -174.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.494 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.4 t60 -141.58 134.96 29.57 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.714 -0.675 . . . . 0.089999999999999997 109.863 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.729 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.37 156.55 23.23 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.84 -0.618 . . . . 0.070000000000000007 110.238 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.599 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.6 m-90 -142.06 155.33 45.38 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.551 -0.75 . . . . 0.11 111.195 -175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.698 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.9 t80 -110.42 153.17 25.37 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 106.582 -1.636 . . . . 0.26000000000000001 106.582 151.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.3 m-85 -128.51 115.97 18.96 Favored 'General case' 0 C--N 1.269 -2.893 0 CA-C-N 114.855 -1.066 . . . . 0.14000000000000001 110.289 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.6 tppt? -116.33 140.02 49.78 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.777 -1.934 . . . . 0.25 105.777 168.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.46 19.4 10.02 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.358 0.873 . . . . 0.42999999999999999 113.358 171.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 75.17 7.88 82.62 Favored Glycine 0 CA--C 1.489 -1.537 0 CA-C-N 115.573 -0.739 . . . . 0.17999999999999999 113.417 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.0 ptmt -128.0 178.26 6.32 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 104.682 -2.34 . . . . 0.37 104.682 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.599 HG11 ' CD1' ' A' ' 355' ' ' TRP . 15.6 m -105.0 157.52 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 N-CA-C 116.205 1.928 . . . . 0.10000000000000001 116.205 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.68 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.03 -26.52 10.14 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 110.461 -3.063 . . . . 0.070000000000000007 106.358 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.833 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -135.04 143.7 46.86 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 111.511 -2.586 . . . . 0.059999999999999998 111.726 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.409 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 2.6 tt0 -142.01 117.77 10.45 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.673 -2.343 . . . . 0.47999999999999998 104.673 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.729 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.81 164.49 35.19 Favored 'General case' 0 N--CA 1.398 -3.053 0 C-N-CA 118.129 -1.428 . . . . 0.070000000000000007 111.548 -178.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.673 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 10.3 p-10 -103.3 133.12 48.91 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.366 -1.288 . . . . 1.8 109.633 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.702 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -134.07 -173.63 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 122.345 1.069 . . . . 0.12 112.307 -171.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.48 121.81 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 112.904 -1.953 . . . . 0.10000000000000001 108.491 172.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.537 ' HB3' HD12 ' A' ' 349' ' ' LEU . 56.9 p -77.69 -168.83 1.3 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 112.678 -2.055 . . . . 1.26 111.418 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.48 167.24 42.65 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 118.536 -1.792 . . . . 0.14000000000000001 111.771 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 6.7 ptmt -74.48 155.76 87.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.413 0.625 . . . . 0.81000000000000005 111.633 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.704 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 78.8 Cg_exo -54.71 -30.07 64.82 Favored 'Trans proline' 0 CA--C 1.498 -1.318 1 C-N-CA 125.386 4.057 . . . . 0.28000000000000003 113.345 -173.323 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.451 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 20.0 p -70.79 -34.51 71.85 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.568 -1.651 . . . . 0.33000000000000002 109.706 -176.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.9 t -141.94 69.98 23.92 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 123.78 1.753 . . . . 0.39000000000000001 109.439 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.4 Cg_exo -58.49 166.07 6.75 Favored 'Trans proline' 0 C--N 1.316 -1.157 1 C-N-CA 126.918 5.079 . . . . 0.38 115.81 -170.252 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.478 HG21 ' HG ' ' A' ' 349' ' ' LEU . 0.5 OUTLIER -93.75 140.77 23.14 Favored Pre-proline 0 N--CA 1.419 -1.985 0 CA-C-N 114.458 -1.246 . . . . 0.81999999999999995 108.331 170.432 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.4 Cg_exo -76.33 -45.96 0.19 Allowed 'Trans proline' 0 CA--C 1.514 -0.48 0 C-N-CA 124.547 3.498 . . . . 0.19 112.081 -170.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.762 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 62.48 138.59 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.313 1.53 . . . . 0.13 113.597 -172.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.59 -111.66 0.51 Allowed Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 112.281 -2.236 . . . . 0.20000000000000001 109.471 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.92 119.38 44.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.743 0.782 . . . . 0.81999999999999995 110.461 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.725 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.8 m-85 -118.23 -173.86 2.54 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.168 -1.419 . . . . 0.22 107.168 172.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.9 t80 -141.05 123.43 15.82 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 120.623 -1.298 . . . . 0.65000000000000002 112.959 -171.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.48 91.98 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-O 123.105 1.431 . . . . 0.16 109.403 169.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -93.7 11.95 27.24 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.274 -1.785 . . . . 2.5499999999999998 108.199 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.776 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 25.6 t-20 -168.64 126.41 1.06 Allowed 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 113.995 -1.457 . . . . 0.42999999999999999 110.162 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.663 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.34 141.87 33.57 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.747 -1.115 . . . . 1.1200000000000001 108.94 169.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.768 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 13.9 mm-40 -126.1 157.69 37.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 114.443 1.275 . . . . 0.70999999999999996 114.443 -167.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 47.3 mt-10 -137.73 127.2 24.93 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.013 -1.903 . . . . 0.38 108.613 173.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.6 t70 56.48 47.77 18.1 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.227 1.489 . . . . 0.40999999999999998 109.026 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.922 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -83.7 169.28 15.44 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 112.367 -2.197 . . . . 0.12 109.393 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 20.7 m -132.6 121.14 22.76 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.863 0.839 . . . . 0.17000000000000001 111.693 169.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.8 mp -80.35 89.17 5.54 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.829 -1.532 . . . . 0.56999999999999995 112.601 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.579 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.1 mttt . . . . . 0 C--N 1.284 -2.269 0 CA-C-N 113.687 -1.597 . . . . 0.33000000000000002 113.117 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.579 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.444 -0.732 0 CA-C-O 121.13 0.491 . . . . 0.53000000000000003 110.161 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.14 97.23 4.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.177 -1.045 . . . . 0.19 108.177 169.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.2 Cg_exo -69.02 109.55 2.19 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.851 1.701 . . . . 0.19 110.26 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.922 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.97 157.48 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-N 113.194 -1.821 . . . . 0.14999999999999999 107.697 -167.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.72 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.9 m-80 -89.7 -20.61 23.4 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.016 -0.735 . . . . 0.51000000000000001 109.016 -174.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.768 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 87.8 m-85 -158.45 126.43 5.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.968 -1.015 . . . . 0.27000000000000002 108.508 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.68 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.3 t-105 -144.52 134.89 24.43 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.781 0.8 . . . . 0.089999999999999997 111.295 -167.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.663 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -116.71 92.63 38.57 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 107.609 -1.256 . . . . 0.14000000000000001 107.609 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.776 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.3 Cg_endo . . . . . 0 C--N 1.348 0.539 0 C-N-CA 122.434 2.09 . . . . 0.5 111.68 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 419' ' ' GLY . 43.1 t . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 121.123 0.487 . . . . 0.75 111.641 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.6 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -175.06 121.52 0.83 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.17 -1.172 . . . . 0.20000000000000001 110.17 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.708 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.7 141.78 14.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.928 -0.397 . . . . 0.28999999999999998 109.928 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.678 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.5 p80 -159.89 161.59 34.4 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.097 -0.501 . . . . 0.089999999999999997 111.338 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.69 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -82.24 147.68 28.81 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.988 -1.115 . . . . 1.0700000000000001 107.988 171.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 445' ' ' THR . 29.4 t -132.83 96.91 3.9 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.813 0.815 . . . . 0.23000000000000001 109.843 -173.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 N--CA 1.443 -0.787 0 CA-C-N 114.15 -1.386 . . . . 0.41999999999999998 109.353 -177.784 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.644 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.0 pm0 . . . . . 0 N--CA 1.435 -1.196 0 CA-C-O 122.248 1.023 . . . . 2.1600000000000001 113.464 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.713 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.67 129.22 3.51 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 112.722 -2.035 . . . . 0.33000000000000002 105.672 173.033 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.59 -158.07 30.55 Favored Glycine 0 C--N 1.284 -2.361 0 N-CA-C 110.538 -1.025 . . . . 0.17000000000000001 110.538 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -45.3 174.58 0.01 OUTLIER Glycine 0 CA--C 1.498 -0.979 0 C-N-CA 120.217 -0.992 . . . . 0.20999999999999999 111.66 167.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.537 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -52.01 101.89 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 123.386 1.565 . . . . 1.8500000000000001 113.76 -154.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.712 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.27 -37.92 10.32 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 112.575 -2.102 . . . . 1.21 109.798 170.04 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.684 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.4 p-90 -53.94 -27.28 30.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.442 -0.799 . . . . 0.16 112.39 -170.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.704 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -89.39 -34.07 16.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.593 0.59 . . . . 0.22 112.593 -177.186 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.4 p -92.75 -42.42 9.58 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.045 -0.979 . . . . 0.25 110.812 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.712 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.5 mtp180 -93.89 -18.36 22.05 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.971 -1.013 . . . . 1.8200000000000001 110.062 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.56 50.52 48.1 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 115.811 1.084 . . . . 0.23999999999999999 115.811 161.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 17.5 m -82.56 111.37 18.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 119.145 1.473 . . . . 1.01 111.237 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 34.18 -120.65 0.09 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.827 -1.079 . . . . 0.5 113.412 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -130.99 -18.76 1.32 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.986 -0.626 . . . . 0.26000000000000001 113.741 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.464 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 29.5 p -103.62 -165.63 1.18 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.816 0.673 . . . . 0.34999999999999998 112.816 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.51 HD13 HG11 ' A' ' 465' ' ' VAL . 2.2 mp -95.86 132.79 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.121 -0.945 . . . . 0.12 110.825 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -103.82 98.06 7.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.936 -0.575 . . . . 0.62 110.26 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.702 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.5 m -93.88 140.17 22.9 Favored Pre-proline 0 N--CA 1.439 -0.997 0 CA-C-N 115.392 -0.822 . . . . 0.10000000000000001 113.206 -176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.712 ' O ' HG22 ' A' ' 449' ' ' VAL . 74.1 Cg_exo -51.97 135.75 51.51 Favored 'Trans proline' 0 CA--C 1.496 -1.392 0 C-N-CA 124.629 3.553 . . . . 0.23999999999999999 115.532 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.713 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 50.0 Cg_exo -56.76 -38.82 94.88 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.279 1.319 . . . . 0.31 111.618 -167.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.604 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 21.0 m -62.46 -25.61 68.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.225 0.824 . . . . 1.1000000000000001 113.225 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.833 ' O ' HD21 ' A' ' 364' ' ' LEU . 22.6 m -98.42 -47.76 12.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 O-C-N 121.33 -0.856 . . . . 0.080000000000000002 112.997 -169.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.956 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.49 -1.98 5.76 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.613 -0.835 . . . . 0.070000000000000007 110.344 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 448' ' ' SER . 14.2 pttp -80.78 -38.59 28.28 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 122.67 1.224 . . . . 0.92000000000000004 108.294 173.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.8 mm-40 -61.6 -46.58 89.24 Favored 'General case' 0 CA--C 1.47 -2.104 0 CA-C-N 112.305 -2.225 . . . . 0.25 106.36 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.956 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -47.23 -66.59 0.38 Allowed 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 109.766 -3.379 . . . . 0.050000000000000003 112.688 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.473 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 19.0 t80 -45.71 -23.86 0.3 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 123.935 0.772 . . . . 0.13 109.581 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.46 -26.64 27.22 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 114.789 -1.096 . . . . 0.13 111.772 -175.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.736 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.96 -44.64 5.43 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 113.462 0.912 . . . . 0.059999999999999998 113.462 177.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.658 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.98 148.03 9.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.495 1.141 . . . . 0.080000000000000002 111.402 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.04 156.72 28.11 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 113.005 -1.907 . . . . 0.47999999999999998 108.772 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.616 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 43.1 mtmt -57.28 102.99 0.1 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.659 0.742 . . . . 0.98999999999999999 109.686 170.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.96 -10.78 6.26 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 113.837 -1.529 . . . . 0.19 111.369 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.658 HG21 ' HB ' ' A' ' 457' ' ' VAL . 17.0 m -66.72 149.34 98.34 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 108.842 -0.799 . . . . 0.13 108.842 171.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 4.7 Cg_endo -93.67 159.07 2.35 Favored 'Trans proline' 0 N--CA 1.426 -2.499 0 C-N-CA 122.411 2.074 . . . . 0.17999999999999999 109.866 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.725 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -124.46 148.83 28.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.504 -1.295 . . . . 0.56999999999999995 107.504 172.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.694 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.7 mp -134.01 150.2 51.23 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.463 -0.94 . . . . 0.13 108.463 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.089 HG23 HD21 ' A' ' 349' ' ' LEU . 0.8 OUTLIER -138.72 141.99 35.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 105.113 -2.18 . . . . 0.10000000000000001 105.113 165.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.762 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 12.1 p90 . . . . . 0 C--O 1.245 0.822 0 O-C-N 123.688 0.617 . . . . 1.0900000000000001 111.064 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.43 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 4.9 m-20 . . . . . 0 N--CA 1.443 -0.812 0 N-CA-C 109.278 -0.638 . . . . 0.42999999999999999 109.278 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 357' ' ' TYR . 88.0 m -158.43 134.72 9.33 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.512 -1.222 . . . . 0.14000000000000001 109.104 169.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.668 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.8 p90 174.15 158.82 0.15 Allowed 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 123.42 0.45 . . . . 0.14999999999999999 111.112 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.639 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.62 151.85 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 N-CA-C 109.039 -0.726 . . . . 0.080000000000000002 109.039 164.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.611 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.21 140.91 23.53 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.583 -0.735 . . . . 2.0099999999999998 109.543 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.719 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -134.7 162.03 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.095 0.474 . . . . 0.45000000000000001 111.287 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.557 ' N ' HG12 ' A' ' 347' ' ' VAL . 27.8 t0 -140.26 106.8 5.32 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.205 -1.406 . . . . 0.23999999999999999 107.205 174.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.079 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.57 -33.77 25.33 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 123.378 1.561 . . . . 0.16 110.21 -169.281 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.17 -44.88 83.93 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 110.625 -2.989 . . . . 0.59999999999999998 107.908 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -102.4 4.84 39.29 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 111.155 -2.748 . . . . 0.20000000000000001 111.227 -175.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 349' ' ' LEU . 29.6 mt-30 32.69 63.54 0.3 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 112.857 -1.974 . . . . 2.1499999999999999 113.748 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.524 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.3 t60 -142.05 135.31 29.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.914 -1.039 . . . . 0.089999999999999997 109.332 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.756 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.16 156.4 23.28 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.781 -0.645 . . . . 0.070000000000000007 110.067 -178.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.609 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.7 m-90 -142.01 155.13 45.42 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.184 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.693 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 86.3 t80 -110.26 153.31 25.02 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 106.61 -1.626 . . . . 0.26000000000000001 106.61 151.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 11.7 m-85 -127.65 118.77 24.48 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 114.936 -1.029 . . . . 0.14000000000000001 110.416 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.2 tppt? -120.0 136.83 54.41 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.96 -1.867 . . . . 0.25 105.96 168.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.422 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.55 17.8 7.86 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.481 0.919 . . . . 0.42999999999999999 113.481 174.245 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.43 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.67 8.34 87.2 Favored Glycine 0 CA--C 1.485 -1.793 0 C-N-CA 120.825 -0.702 . . . . 0.17999999999999999 112.918 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.4 ptmt -129.08 177.7 6.94 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 104.564 -2.384 . . . . 0.37 104.564 178.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.609 HG11 ' CD1' ' A' ' 355' ' ' TRP . 18.1 m -104.12 157.69 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 N-CA-C 116.344 1.979 . . . . 0.10000000000000001 116.344 -175.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.693 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.8 -27.67 9.63 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 110.513 -3.04 . . . . 0.070000000000000007 106.493 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.817 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.82 144.58 49.07 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 111.495 -2.593 . . . . 0.059999999999999998 111.535 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.441 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.5 tt0 -140.43 118.22 11.71 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 104.53 -2.396 . . . . 0.47999999999999998 104.53 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.756 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.05 163.41 38.23 Favored 'General case' 0 N--CA 1.397 -3.089 0 C-N-CA 117.626 -1.63 . . . . 0.070000000000000007 111.869 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.709 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 11.9 p-10 -101.96 134.14 45.65 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 114.027 -1.442 . . . . 1.8 109.545 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.731 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.11 -173.59 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 CA-C-O 122.26 1.029 . . . . 0.12 112.457 -172.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.47 118.63 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.075 -1.875 . . . . 0.10000000000000001 107.722 173.516 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.521 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -79.42 -167.98 1.38 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.127 -1.397 . . . . 1.26 110.773 -177.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.402 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.45 164.45 39.88 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 118.639 -1.743 . . . . 0.14000000000000001 112.407 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 11.0 ptmt -70.97 158.05 89.0 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.639 0.733 . . . . 0.81000000000000005 111.698 -167.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.674 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.4 Cg_exo -57.83 -29.48 86.23 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 125.184 3.923 . . . . 0.28000000000000003 113.348 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.46 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 17.8 p -71.76 -32.76 68.03 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.608 -1.633 . . . . 0.33000000000000002 109.725 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.538 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.5 t -141.07 70.47 28.43 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-O 123.807 1.765 . . . . 0.39000000000000001 109.31 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.0 Cg_exo -58.94 162.79 12.64 Favored 'Trans proline' 0 C--N 1.312 -1.358 1 C-N-CA 126.486 4.791 . . . . 0.38 115.165 -171.11 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.521 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -96.06 141.99 23.93 Favored Pre-proline 0 N--CA 1.419 -1.979 0 CA-C-N 114.729 -1.123 . . . . 0.81999999999999995 108.503 171.323 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.6 Cg_exo -76.31 -44.56 0.24 Allowed 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 124.719 3.612 . . . . 0.19 111.95 -167.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.784 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 61.49 138.05 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 123.328 1.537 . . . . 0.13 113.467 -172.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 153.0 -114.43 0.62 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 112.201 -2.272 . . . . 0.20000000000000001 109.362 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.73 117.21 37.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.892 0.854 . . . . 0.81999999999999995 110.661 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.744 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.9 m-85 -115.58 -174.04 2.45 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.147 -1.427 . . . . 0.22 107.147 173.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.0 OUTLIER -139.46 123.49 17.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 119.987 1.267 . . . . 0.65000000000000002 113.41 -171.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.06 92.23 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 123.06 1.41 . . . . 0.16 109.337 168.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -94.22 11.96 28.39 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.428 -1.714 . . . . 2.5499999999999998 108.18 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.767 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 28.5 t-20 -169.37 126.65 0.93 Allowed 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 113.972 -1.467 . . . . 0.42999999999999999 110.174 172.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.631 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.16 145.99 26.61 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.064 -0.971 . . . . 1.1200000000000001 109.098 168.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.751 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 19.5 mm-40 -126.29 159.2 33.76 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 114.509 1.3 . . . . 0.70999999999999996 114.509 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.752 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 40.1 mt-10 -138.37 127.52 24.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.211 -1.813 . . . . 0.38 108.674 173.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.81 45.52 21.48 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 123.338 1.542 . . . . 0.40999999999999998 108.729 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.936 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.77 166.6 20.84 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 112.513 -2.13 . . . . 0.12 109.177 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 16.9 m -132.08 120.65 22.64 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.091 0.948 . . . . 0.17000000000000001 111.551 170.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -81.13 88.6 5.99 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.871 -1.513 . . . . 0.56999999999999995 112.048 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.3 mttt . . . . . 0 C--N 1.284 -2.245 0 CA-C-N 113.585 -1.643 . . . . 0.33000000000000002 113.129 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.61 0 CA-C-O 121.12 0.486 . . . . 0.53000000000000003 110.151 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.81 97.33 4.96 Favored Pre-proline 0 N--CA 1.436 -1.153 0 N-CA-C 108.275 -1.009 . . . . 0.19 108.275 170.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 18.1 Cg_exo -69.04 111.1 2.57 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.065 1.843 . . . . 0.19 110.023 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.936 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.99 153.45 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 CA-C-N 112.958 -1.928 . . . . 0.14999999999999999 107.626 -167.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 21.5 m-80 -86.14 -20.44 28.64 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.902 -0.777 . . . . 0.51000000000000001 108.902 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.4 m-85 -159.0 127.31 5.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.12 -0.945 . . . . 0.27000000000000002 108.643 -170.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.677 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 23.3 t-105 -145.12 134.35 22.86 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.641 0.734 . . . . 0.089999999999999997 111.185 -167.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.631 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.5 mmt -116.44 93.69 40.72 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.908 -1.145 . . . . 0.14000000000000001 107.908 173.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.767 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 39.0 Cg_endo . . . . . 0 N--CA 1.46 -0.464 0 C-N-CA 122.311 2.007 . . . . 0.5 112.239 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 419' ' ' GLY . 36.5 t . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 121.321 0.582 . . . . 0.75 111.943 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.84 121.4 0.75 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 109.931 -1.268 . . . . 0.20000000000000001 109.931 171.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.705 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.66 143.09 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 110.034 -0.358 . . . . 0.28999999999999998 110.034 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.677 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.4 p80 -160.58 162.11 32.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.245 -0.434 . . . . 0.089999999999999997 111.409 -174.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.66 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -84.45 145.86 27.93 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.947 -1.131 . . . . 1.0700000000000001 107.947 172.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.2 t -134.17 98.63 4.17 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.745 0.783 . . . . 0.23000000000000001 110.5 -171.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 C--N 1.314 -0.952 0 CA-C-N 114.117 -1.401 . . . . 0.41999999999999998 109.418 -177.981 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.522 ' HG3' ' HG ' ' A' ' 433' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.428 -1.531 0 CA-C-O 122.205 1.002 . . . . 2.1600000000000001 111.779 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.709 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.9 OUTLIER -159.58 124.84 4.11 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 105.129 -2.175 . . . . 0.33000000000000002 105.129 173.316 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.09 -157.75 30.16 Favored Glycine 0 C--N 1.284 -2.333 0 C-N-CA 119.46 -1.352 . . . . 0.17000000000000001 111.354 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -46.26 173.48 0.02 OUTLIER Glycine 0 CA--C 1.501 -0.805 0 C-N-CA 120.609 -0.805 . . . . 0.20999999999999999 111.694 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.598 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 6.3 p-10 -52.57 100.8 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 123.743 1.735 . . . . 1.8500000000000001 114.035 -150.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.722 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.55 -43.58 7.53 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 111.805 -2.452 . . . . 1.21 109.721 170.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.718 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.5 p-90 -52.12 -27.31 13.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.718 -0.674 . . . . 0.16 112.504 -171.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.718 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.89 -32.56 15.98 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.397 0.618 . . . . 0.22 112.452 -177.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.8 p -94.15 -43.24 8.57 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.951 -1.022 . . . . 0.25 111.069 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.722 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.2 OUTLIER -87.59 -20.18 26.77 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.768 -1.106 . . . . 1.8200000000000001 109.153 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.59 47.7 63.02 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 113.631 -1.622 . . . . 0.23999999999999999 115.138 164.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.5 p -82.88 110.23 17.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 118.962 1.381 . . . . 1.01 111.675 -171.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 33.54 -117.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.291 -1.322 . . . . 0.5 113.47 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.402 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -135.57 -16.32 0.91 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.906 -0.664 . . . . 0.26000000000000001 113.79 -174.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 29.1 p -103.57 -166.56 1.27 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.834 0.817 . . . . 0.34999999999999998 112.621 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.429 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -96.16 129.41 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.107 -0.952 . . . . 0.12 110.736 -175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -99.59 93.41 5.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.976 -0.556 . . . . 0.62 110.332 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.731 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -89.14 141.98 29.7 Favored Pre-proline 0 N--CA 1.438 -1.038 0 CA-C-N 115.234 -0.894 . . . . 0.10000000000000001 112.549 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.643 ' HD2' HG21 ' A' ' 366' ' ' THR . 87.1 Cg_exo -49.61 144.77 18.58 Favored 'Trans proline' 0 CA--C 1.506 -0.89 0 C-N-CA 124.158 3.239 . . . . 0.23999999999999999 113.549 175.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.658 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.7 Cg_exo -65.12 -27.02 57.19 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.855 2.37 . . . . 0.31 112.234 -175.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 11.9 m -76.31 -23.9 54.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.863 -0.608 . . . . 1.1000000000000001 112.237 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.817 ' O ' HD21 ' A' ' 364' ' ' LEU . 30.8 m -100.59 -48.7 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 113.009 0.744 . . . . 0.080000000000000002 113.009 -169.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.945 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.87 -2.1 4.78 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.847 -0.741 . . . . 0.070000000000000007 110.353 -178.344 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.8 pttp -80.81 -39.43 26.7 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.085 -1.08 . . . . 0.92000000000000004 108.085 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.4 mm-40 -61.45 -45.9 92.32 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 112.578 -2.101 . . . . 0.25 106.46 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.945 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.5 tp -47.69 -67.12 0.3 Allowed 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 109.701 -3.409 . . . . 0.050000000000000003 112.719 172.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.564 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 14.4 t80 -45.93 -23.28 0.27 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.794 0.807 . . . . 0.13 109.562 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.15 -26.01 27.29 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.72 -1.127 . . . . 0.13 111.842 -176.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.733 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -102.71 -43.91 5.45 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 113.504 0.927 . . . . 0.059999999999999998 113.504 177.197 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.682 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -73.47 150.38 7.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 122.523 1.154 . . . . 0.080000000000000002 111.196 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -120.84 156.77 31.23 Favored 'General case' 0 N--CA 1.414 -2.255 0 CA-C-N 112.978 -1.919 . . . . 0.47999999999999998 108.418 -177.342 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.59 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.2 mppt? -59.34 101.86 0.12 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.888 -0.782 . . . . 0.98999999999999999 108.888 171.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.3 -11.74 5.81 Favored Glycine 0 C--N 1.306 -1.132 0 CA-C-N 113.955 -1.475 . . . . 0.19 111.482 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.682 HG21 ' HB ' ' A' ' 457' ' ' VAL . 15.6 m -66.65 149.33 98.29 Favored Pre-proline 0 N--CA 1.44 -0.964 0 N-CA-C 108.651 -0.87 . . . . 0.13 108.651 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.6 Cg_endo -93.72 160.63 2.31 Favored 'Trans proline' 0 N--CA 1.422 -2.707 0 C-N-CA 122.196 1.931 . . . . 0.17999999999999999 109.929 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.744 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -123.99 150.07 28.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.281 -1.377 . . . . 0.56999999999999995 107.281 171.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.712 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.08 149.06 51.11 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 108.179 -1.045 . . . . 0.13 108.179 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.079 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.74 142.25 36.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 105.266 -2.124 . . . . 0.10000000000000001 105.266 165.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.751 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 8.3 p90 . . . . . 0 C--O 1.244 0.79 0 O-C-N 123.83 0.706 . . . . 1.0900000000000001 110.787 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.502 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 13.3 m-20 . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 109.341 -0.614 . . . . 0.42999999999999999 109.341 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 357' ' ' TYR . 97.2 m -159.78 135.61 8.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.8 -1.091 . . . . 0.14000000000000001 109.857 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.627 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.5 p90 173.02 159.7 0.12 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.192 0.308 . . . . 0.14999999999999999 110.812 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.649 HD12 HD11 ' A' ' 453' ' ' LEU . 0.3 OUTLIER -77.97 151.54 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 109.526 -0.546 . . . . 0.080000000000000002 109.526 164.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.612 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 35.1 tt0 -149.72 141.05 23.22 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.486 -0.779 . . . . 2.0099999999999998 109.626 -176.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.724 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -134.44 161.87 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 122.126 -0.359 . . . . 0.45000000000000001 111.104 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.559 ' N ' HG12 ' A' ' 347' ' ' VAL . 20.7 t0 -140.26 107.21 5.42 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.663 -1.236 . . . . 0.23999999999999999 107.663 173.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.06 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.55 -33.35 25.46 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-O 122.77 1.271 . . . . 0.16 110.273 -168.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 466' ' ' PHE . 1.0 OUTLIER -59.72 -43.4 94.16 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 110.87 -2.877 . . . . 0.59999999999999998 108.261 177.03 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -102.83 8.12 39.35 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 111.153 -2.749 . . . . 0.20000000000000001 110.749 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.56 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 15.3 mp0 32.93 61.27 0.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 112.906 -1.952 . . . . 2.1499999999999999 113.56 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.529 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 24.8 t60 -142.94 137.13 29.2 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.868 -0.605 . . . . 0.089999999999999997 109.86 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.716 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -114.48 156.53 24.39 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.994 -0.548 . . . . 0.070000000000000007 110.249 -179.29 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.595 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -142.21 154.18 44.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.482 -0.781 . . . . 0.11 111.191 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.698 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.5 t80 -110.15 153.11 25.18 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.491 -1.67 . . . . 0.26000000000000001 106.491 151.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.9 m-85 -127.61 117.12 21.41 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.883 -1.053 . . . . 0.14000000000000001 109.948 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.7 tppt? -118.13 140.05 50.35 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 105.854 -1.906 . . . . 0.25 105.854 168.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.65 17.21 10.57 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.597 0.962 . . . . 0.42999999999999999 113.597 171.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.502 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.97 8.06 87.41 Favored Glycine 0 CA--C 1.483 -1.954 0 CA-C-O 122.064 0.813 . . . . 0.17999999999999999 112.961 -175.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 16.1 ptmt -126.83 177.26 6.7 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 104.484 -2.413 . . . . 0.37 104.484 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.595 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.0 m -104.29 157.11 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.841 0 C-N-CA 116.982 -1.887 . . . . 0.10000000000000001 115.626 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.652 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -106.61 -28.23 10.37 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-N 110.544 -3.025 . . . . 0.070000000000000007 106.125 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.832 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -133.17 143.48 49.24 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 111.413 -2.63 . . . . 0.059999999999999998 111.896 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.436 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -139.98 117.55 11.51 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 104.361 -2.459 . . . . 0.47999999999999998 104.361 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.716 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.94 161.02 43.12 Favored 'General case' 0 N--CA 1.397 -3.11 0 C-N-CA 117.795 -1.562 . . . . 0.070000000000000007 110.691 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.17 141.61 32.77 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.448 -0.945 . . . . 1.8 108.448 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.717 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -138.66 -172.82 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 CA-C-O 122.54 1.162 . . . . 0.12 111.947 -173.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.86 120.13 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 112.725 -2.034 . . . . 0.10000000000000001 108.197 173.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.533 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -80.13 -168.06 1.52 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.977 -1.465 . . . . 1.26 110.36 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.439 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.19 168.32 44.54 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 118.528 -1.796 . . . . 0.14000000000000001 112.26 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 5.3 ptmt -73.8 158.11 86.48 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.56 0.695 . . . . 0.81000000000000005 112.037 -165.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.694 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 82.3 Cg_exo -57.68 -30.66 89.68 Favored 'Trans proline' 0 CA--C 1.493 -1.555 0 C-N-CA 125.273 3.982 . . . . 0.28000000000000003 113.347 -172.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.413 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 22.7 p -68.61 -33.81 74.69 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.346 -1.752 . . . . 0.33000000000000002 109.325 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.55 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.5 t -142.88 70.28 19.15 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 123.585 1.659 . . . . 0.39000000000000001 110.37 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 375' ' ' THR . 83.4 Cg_exo -58.99 157.43 29.2 Favored 'Trans proline' 0 C--N 1.314 -1.273 1 C-N-CA 126.601 4.868 . . . . 0.38 115.145 -171.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.533 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -86.37 147.87 45.57 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 115.192 -0.913 . . . . 0.81999999999999995 108.702 173.312 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 16.6 Cg_exo -78.08 -44.64 0.16 Allowed 'Trans proline' 0 CA--C 1.512 -0.592 0 C-N-CA 124.853 3.702 . . . . 0.19 112.417 -167.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.774 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.49 138.52 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 123.345 1.545 . . . . 0.13 113.639 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.69 -115.13 0.68 Allowed Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 112.27 -2.241 . . . . 0.20000000000000001 109.318 -177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.6 p -128.35 121.18 54.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.846 0.832 . . . . 0.81999999999999995 110.266 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.726 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.9 m-85 -118.32 -174.38 2.65 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.87 -1.529 . . . . 0.22 106.87 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -139.67 123.02 17.09 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 120.801 -1.187 . . . . 0.65000000000000002 112.937 -171.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.41 92.7 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 123.056 1.407 . . . . 0.16 109.544 170.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -92.94 10.82 29.64 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 113.317 -1.765 . . . . 2.5499999999999998 108.334 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.762 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.1 t30 -169.21 126.91 0.96 Allowed 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 114.149 -1.387 . . . . 0.42999999999999999 110.393 172.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.668 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.11 142.7 30.26 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.825 -1.079 . . . . 1.1200000000000001 108.944 168.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 410' ' ' TRP . 23.7 mm-40 -123.9 162.44 23.33 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 114.835 1.42 . . . . 0.70999999999999996 114.835 -169.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 43.7 mt-10 -129.86 144.98 51.58 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 112.927 -1.942 . . . . 0.38 105.953 170.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.9 t70 39.51 47.66 1.65 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 122.766 1.269 . . . . 0.40999999999999998 109.834 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.958 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -82.8 168.15 17.42 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 111.937 -2.392 . . . . 0.12 108.977 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 10.2 m -132.04 119.5 21.11 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.948 0.88 . . . . 0.17000000000000001 111.24 170.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.9 mp -77.27 87.12 3.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.852 -1.522 . . . . 0.56999999999999995 111.787 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.546 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.3 mttt . . . . . 0 C--N 1.286 -2.18 0 CA-C-N 113.266 -1.788 . . . . 0.33000000000000002 113.406 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.546 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 1.3 mp0 . . . . . 0 N--CA 1.443 -0.788 0 CA-C-O 121.056 0.455 . . . . 0.53000000000000003 110.779 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.79 97.55 4.94 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 107.98 -1.119 . . . . 0.19 107.98 170.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 22.7 Cg_exo -68.58 110.24 2.26 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.076 1.851 . . . . 0.19 110.631 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.958 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.55 158.4 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 CA-C-N 113.036 -1.893 . . . . 0.14999999999999999 107.912 -168.305 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.631 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 3.3 m-20 -92.04 -19.43 22.37 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.934 -0.765 . . . . 0.51000000000000001 108.934 -174.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.9 m-85 -160.46 127.88 4.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.025 -1.102 . . . . 0.27000000000000002 108.025 -171.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.693 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.0 t-105 -144.93 131.51 19.87 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.746 0.784 . . . . 0.089999999999999997 111.561 -166.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.668 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.4 mmt -112.91 92.32 20.57 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 107.866 -1.161 . . . . 0.14000000000000001 107.866 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.762 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.7 Cg_endo . . . . . 0 N--CA 1.458 -0.572 0 C-N-CA 122.265 1.976 . . . . 0.5 111.626 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 419' ' ' GLY . 36.6 t . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.33 0.585 . . . . 0.75 112.115 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.591 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -174.87 121.11 0.81 Allowed Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 110.084 -1.206 . . . . 0.20000000000000001 110.084 169.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.663 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.2 mp -82.09 142.22 13.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 110.107 -0.331 . . . . 0.28999999999999998 110.107 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.671 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.0 p80 -159.5 161.73 35.42 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.094 -0.503 . . . . 0.089999999999999997 111.37 -174.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.716 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -86.5 148.11 25.67 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.962 -1.125 . . . . 1.0700000000000001 107.962 172.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.6 t -133.14 96.57 3.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.907 0.86 . . . . 0.23000000000000001 110.136 -171.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 C--N 1.314 -0.941 0 CA-C-N 114.103 -1.408 . . . . 0.41999999999999998 109.281 -176.14 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.586 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.9 pm0 . . . . . 0 N--CA 1.438 -1.033 0 CA-C-O 122.312 1.053 . . . . 2.1600000000000001 113.375 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.625 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.81 128.54 3.3 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 112.587 -2.097 . . . . 0.33000000000000002 105.769 171.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.35 -157.8 30.18 Favored Glycine 0 C--N 1.281 -2.502 0 C-N-CA 119.892 -1.147 . . . . 0.17000000000000001 110.404 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.43 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.88 173.89 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.064 -1.065 . . . . 0.20999999999999999 111.574 167.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.517 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.4 p-10 -51.47 102.35 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 123.448 1.594 . . . . 1.8500000000000001 113.893 -152.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.712 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.56 -37.5 10.35 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-N 112.6 -2.091 . . . . 1.21 109.782 168.187 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.719 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.2 p-90 -53.9 -27.0 27.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.457 -0.792 . . . . 0.16 112.274 -170.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.719 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.46 -35.38 15.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.587 0.588 . . . . 0.22 112.587 -178.072 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.423 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.9 p -90.1 -42.56 11.02 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.07 -0.968 . . . . 0.25 110.943 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.712 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.1 mtp180 -92.94 -18.51 22.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.651 -1.159 . . . . 1.8200000000000001 109.524 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.24 49.17 45.16 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 115.642 1.017 . . . . 0.23999999999999999 115.642 160.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 28.3 m -83.75 111.49 19.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 119.162 1.481 . . . . 1.01 111.598 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 35.99 -115.69 0.1 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.594 0.961 . . . . 0.5 113.594 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.439 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -137.35 -20.31 0.56 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.423 -0.808 . . . . 0.26000000000000001 113.64 -174.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 27.1 p -97.66 -167.26 1.5 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.003 0.901 . . . . 0.34999999999999998 112.624 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.477 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -99.39 130.14 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 114.864 -1.062 . . . . 0.12 110.535 -175.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -101.88 94.32 5.75 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.763 -0.653 . . . . 0.62 110.198 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.717 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.3 m -90.41 144.41 30.78 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.017 -0.992 . . . . 0.10000000000000001 112.555 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.654 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 73.0 Cg_exo -52.13 145.4 34.37 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 124.114 3.209 . . . . 0.23999999999999999 113.365 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.68 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 36.8 Cg_exo -66.3 -30.6 45.07 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.956 2.437 . . . . 0.31 112.392 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.516 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 13.8 m -72.13 -23.6 61.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.75 -0.659 . . . . 1.1000000000000001 111.725 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.832 ' O ' HD21 ' A' ' 364' ' ' LEU . 26.4 m -100.51 -49.38 11.17 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 N-CA-C 112.858 0.688 . . . . 0.080000000000000002 112.858 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.943 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.24 -2.1 5.41 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.707 -0.797 . . . . 0.070000000000000007 110.29 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.569 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 16.4 pttp -81.03 -38.08 28.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.505 1.145 . . . . 0.92000000000000004 108.137 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.9 mm-40 -62.83 -46.23 88.9 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 112.36 -2.2 . . . . 0.25 106.513 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.943 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.5 tp -47.78 -66.56 0.38 Allowed 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 109.843 -3.344 . . . . 0.050000000000000003 112.511 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.522 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 22.6 t80 -45.96 -23.27 0.28 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 123.903 0.752 . . . . 0.13 109.597 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.92 -25.04 28.18 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.849 -1.068 . . . . 0.13 111.878 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.737 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.73 -44.2 5.14 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 113.425 0.898 . . . . 0.059999999999999998 113.425 176.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -73.49 150.74 7.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-O 122.44 1.114 . . . . 0.080000000000000002 111.125 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.09 155.74 35.05 Favored 'General case' 0 N--CA 1.412 -2.332 0 CA-C-N 112.849 -1.978 . . . . 0.47999999999999998 108.602 -177.439 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.647 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 43.8 mtmt -55.96 102.14 0.07 Allowed 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.669 0.747 . . . . 0.98999999999999999 109.696 170.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.18 -8.93 6.67 Favored Glycine 0 C--N 1.304 -1.23 0 CA-C-N 113.762 -1.563 . . . . 0.19 111.716 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.658 HG21 ' HB ' ' A' ' 457' ' ' VAL . 9.0 m -68.37 149.46 98.04 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 108.833 -0.803 . . . . 0.13 108.833 172.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.4 Cg_endo -93.82 156.69 2.3 Favored 'Trans proline' 0 N--CA 1.424 -2.579 0 C-N-CA 122.3 2.0 . . . . 0.17999999999999999 109.906 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.726 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -121.9 149.03 25.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.554 -1.276 . . . . 0.56999999999999995 107.554 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.705 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.08 149.02 51.1 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.548 -0.908 . . . . 0.13 108.548 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.06 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.35 141.4 39.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 105.589 -2.004 . . . . 0.10000000000000001 105.589 165.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.669 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 7.6 p90 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.469 -1.253 . . . . 1.0900000000000001 110.926 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.492 ' HB3' ' N ' ' A' ' 360' ' ' GLY . 33.7 m-20 . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 121.598 0.713 . . . . 0.42999999999999999 111.83 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.825 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 96.8 m -159.28 134.37 8.22 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.256 -0.884 . . . . 0.14000000000000001 109.021 163.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.693 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.5 p90 174.63 157.84 0.16 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 120.856 0.36 . . . . 0.14999999999999999 111.759 -175.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.599 HD11 HG11 ' A' ' 457' ' ' VAL . 0.2 OUTLIER -77.86 152.59 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.283 -0.636 . . . . 0.080000000000000002 109.283 164.327 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.558 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.1 tt0 -150.52 142.96 24.38 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.741 -0.663 . . . . 2.0099999999999998 109.415 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.713 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.6 t -134.62 162.37 38.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.124 0.488 . . . . 0.45000000000000001 111.382 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.549 ' N ' HG12 ' A' ' 347' ' ' VAL . 29.3 t0 -140.05 106.32 5.26 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.356 -1.35 . . . . 0.23999999999999999 107.356 173.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.046 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.11 -34.9 26.0 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 123.365 1.555 . . . . 0.16 110.075 -169.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.91 -44.98 74.67 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 110.705 -2.952 . . . . 0.59999999999999998 107.692 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -103.36 6.77 38.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 111.219 -2.718 . . . . 0.20000000000000001 111.563 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.924 ' NE2' ' HA ' ' A' ' 369' ' ' VAL . 10.9 mm100 32.82 62.35 0.35 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 112.791 -2.004 . . . . 2.1499999999999999 113.615 -175.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.491 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.0 t60 -141.47 135.15 29.98 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.213 -0.903 . . . . 0.089999999999999997 109.475 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.742 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -112.71 157.26 21.51 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.941 -0.572 . . . . 0.070000000000000007 110.375 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.59 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.3 m-90 -142.27 155.27 45.21 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.713 -0.676 . . . . 0.11 111.416 -175.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.825 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 88.2 t80 -111.2 153.34 25.96 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 106.811 -1.551 . . . . 0.26000000000000001 106.811 151.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 17.1 m-85 -127.42 119.18 25.56 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.947 -1.024 . . . . 0.14000000000000001 110.048 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.467 ' HB2' ' HE2' ' A' ' 356' ' ' TYR . 10.4 tppt? -123.14 112.89 18.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.097 -0.956 . . . . 0.25 108.547 173.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 358' ' ' LYS . 0.2 OUTLIER 75.97 41.26 0.24 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 123.914 0.759 . . . . 0.42999999999999999 112.683 -177.072 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.492 ' N ' ' HB3' ' A' ' 342' ' ' ASP . . . 59.24 16.79 35.79 Favored Glycine 0 CA--C 1.496 -1.14 0 CA-C-O 122.372 0.984 . . . . 0.17999999999999999 113.232 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 358' ' ' LYS . 14.9 ptmt -140.32 167.66 21.61 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 104.534 -2.395 . . . . 0.37 104.534 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.1 m -98.89 157.56 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.735 0 N-CA-C 116.057 1.873 . . . . 0.10000000000000001 116.057 -171.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.728 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.99 -27.51 9.18 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 110.357 -3.11 . . . . 0.070000000000000007 106.21 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.4 143.99 47.92 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 111.563 -2.562 . . . . 0.059999999999999998 111.846 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.484 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 2.9 tt0 -141.37 118.61 11.38 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 104.359 -2.46 . . . . 0.47999999999999998 104.359 175.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.742 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.29 165.55 32.67 Favored 'General case' 0 N--CA 1.403 -2.781 0 C-N-CA 118.07 -1.452 . . . . 0.070000000000000007 112.157 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.721 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 12.4 p-10 -102.05 135.44 43.62 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.174 -1.376 . . . . 1.8 109.63 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.714 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.3 pp -138.24 -173.06 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.252 0 CA-C-O 122.212 1.006 . . . . 0.12 112.754 -170.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.924 ' HA ' ' NE2' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -152.86 120.97 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 112.895 -1.957 . . . . 0.10000000000000001 109.468 171.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.558 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.6 OUTLIER -77.95 -168.92 1.38 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.874 -1.512 . . . . 1.26 110.678 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.476 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -86.32 173.3 46.05 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.063 -1.541 . . . . 0.14000000000000001 112.272 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -78.54 158.38 76.19 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.614 0.721 . . . . 0.81000000000000005 111.921 -166.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 92.8 Cg_exo -56.64 -28.95 77.54 Favored 'Trans proline' 0 CA--C 1.498 -1.311 0 C-N-CA 125.273 3.982 . . . . 0.28000000000000003 113.234 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.468 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 16.9 p -69.52 -33.99 73.62 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.33 -1.759 . . . . 0.33000000000000002 109.855 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.529 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.7 t -140.73 70.35 30.6 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 123.841 1.781 . . . . 0.39000000000000001 108.801 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 375' ' ' THR . 85.4 Cg_exo -57.31 154.33 35.46 Favored 'Trans proline' 0 C--N 1.31 -1.465 1 C-N-CA 126.522 4.814 . . . . 0.38 115.447 -169.741 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.558 HG21 ' OG ' ' A' ' 370' ' ' SER . 2.2 m -80.6 130.74 63.43 Favored Pre-proline 0 N--CA 1.404 -2.76 0 CA-C-N 114.116 -1.402 . . . . 0.81999999999999995 108.611 172.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.1 Cg_exo -72.0 -43.86 1.07 Allowed 'Trans proline' 0 CA--C 1.511 -0.664 0 C-N-CA 123.599 2.866 . . . . 0.19 111.772 -170.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.807 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.19 137.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 123.412 1.577 . . . . 0.13 113.542 -173.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 154.3 -121.78 1.17 Allowed Glycine 0 N--CA 1.429 -1.8 0 CA-C-N 112.218 -2.264 . . . . 0.20000000000000001 109.401 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.404 HG22 ' CD2' ' A' ' 464' ' ' LEU . 72.5 t -125.23 110.65 25.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.345 0.593 . . . . 0.81999999999999995 110.632 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.75 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 5.1 m-85 -110.32 -173.87 2.35 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.405 -1.331 . . . . 0.22 107.405 174.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 2.4 t80 -141.27 121.92 14.26 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 120.844 -1.16 . . . . 0.65000000000000002 112.827 -172.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.6 p -82.81 92.71 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 CA-C-O 122.827 1.299 . . . . 0.16 108.839 170.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 49.6 p-90 -83.95 0.35 48.26 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 113.201 -1.818 . . . . 2.5499999999999998 107.806 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.791 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 5.9 t30 -170.33 128.18 0.84 Allowed 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 114.744 -1.116 . . . . 0.42999999999999999 110.662 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.651 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -95.96 141.95 28.77 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.388 -0.823 . . . . 1.1200000000000001 109.086 169.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.763 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 9.9 mm-40 -126.75 159.95 32.27 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 114.786 1.402 . . . . 0.70999999999999996 114.786 -167.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 52.2 mt-10 -137.34 128.14 27.19 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.071 -1.877 . . . . 0.38 108.867 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.4 t70 53.91 45.22 28.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 123.386 1.565 . . . . 0.40999999999999998 108.884 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.925 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.03 167.64 20.18 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 112.104 -2.317 . . . . 0.12 109.477 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 16.9 m -132.46 119.06 20.11 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.051 0.929 . . . . 0.17000000000000001 111.903 171.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -78.41 88.66 4.4 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.693 -1.594 . . . . 0.56999999999999995 112.119 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.7 mttt . . . . . 0 C--N 1.285 -2.222 0 CA-C-N 113.666 -1.606 . . . . 0.33000000000000002 113.811 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 121.04 0.448 . . . . 0.53000000000000003 110.152 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.08 97.23 5.3 Favored Pre-proline 0 N--CA 1.437 -1.114 0 N-CA-C 108.38 -0.97 . . . . 0.19 108.38 172.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.9 Cg_exo -68.62 111.44 2.57 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 122.102 1.868 . . . . 0.19 110.268 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.925 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -111.72 155.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 CA-C-N 112.861 -1.972 . . . . 0.14999999999999999 107.746 -168.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.1 m-80 -86.86 -20.47 27.42 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.316 -0.624 . . . . 0.51000000000000001 109.316 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 97.7 m-85 -160.24 127.51 4.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.866 -1.061 . . . . 0.27000000000000002 108.189 -171.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 17.3 t-105 -142.95 131.27 22.11 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.591 0.71 . . . . 0.089999999999999997 111.07 -167.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.651 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 13.3 mmt -116.34 86.67 18.21 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.279 -1.008 . . . . 0.14000000000000001 108.279 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.791 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 15.0 Cg_endo . . . . . 0 N--CA 1.437 -1.799 0 C-N-CA 120.945 1.096 . . . . 0.5 109.372 174.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 419' ' ' GLY . 22.1 t . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 112.628 0.603 . . . . 0.75 112.628 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.595 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.26 119.24 0.65 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.61 -0.996 . . . . 0.20000000000000001 110.61 170.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.639 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.5 mt -81.13 144.15 11.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 120.836 0.35 . . . . 0.28999999999999998 111.06 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.672 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.9 p80 -159.41 161.54 35.6 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.028 -0.533 . . . . 0.089999999999999997 111.218 -174.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.2 149.51 25.46 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.826 -1.176 . . . . 1.0700000000000001 107.826 171.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 445' ' ' THR . 34.3 t -133.31 96.5 3.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.553 0.692 . . . . 0.23000000000000001 110.034 -171.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 114.736 -1.12 . . . . 0.41999999999999998 109.387 -175.568 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.532 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 122.563 1.173 . . . . 2.1600000000000001 113.481 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.721 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -157.35 132.04 8.64 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.101 -2.318 . . . . 0.33000000000000002 105.307 167.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.04 -159.57 32.84 Favored Glycine 0 C--N 1.283 -2.363 0 C-N-CA 120.095 -1.05 . . . . 0.17000000000000001 110.511 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -47.06 175.32 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 120.24 -0.981 . . . . 0.20999999999999999 111.621 168.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.515 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.4 p-10 -50.53 101.03 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.625 1.678 . . . . 1.8500000000000001 113.764 -154.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 1.018 HD22 ' HD2' ' A' ' 437' ' ' ARG . 34.7 mt -97.68 -37.89 9.73 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.007 -2.36 . . . . 1.21 107.858 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.708 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 64.8 p-90 -48.39 -34.39 10.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.182 0.438 . . . . 0.16 112.182 -172.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.708 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -83.96 -36.9 22.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.934 -0.576 . . . . 0.22 112.144 -175.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.486 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.8 p -88.09 -41.89 12.75 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.247 -0.888 . . . . 0.25 110.534 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 1.018 ' HD2' HD22 ' A' ' 433' ' ' LEU . 0.0 OUTLIER -93.8 -19.19 21.26 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.629 -1.169 . . . . 1.8200000000000001 110.067 -177.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.5 48.11 55.8 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.744 -1.116 . . . . 0.23999999999999999 114.875 163.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 35.2 m -85.2 111.73 20.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 118.71 1.255 . . . . 1.01 111.794 -173.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 36.35 -121.59 0.16 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.717 -1.129 . . . . 0.5 113.969 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.476 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -134.6 -12.87 1.32 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.106 -0.569 . . . . 0.26000000000000001 113.967 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 28.4 p -104.27 -166.59 1.26 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.987 0.894 . . . . 0.34999999999999998 112.839 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.443 HD13 HG11 ' A' ' 465' ' ' VAL . 1.9 mp -97.49 131.4 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.023 -0.989 . . . . 0.12 110.665 -175.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -102.71 93.59 5.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.714 -0.676 . . . . 0.62 110.248 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.714 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -89.01 143.98 32.09 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 114.962 -1.017 . . . . 0.10000000000000001 112.578 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.659 ' HD2' HG21 ' A' ' 366' ' ' THR . 77.1 Cg_exo -52.17 145.58 34.03 Favored 'Trans proline' 0 CA--C 1.506 -0.896 0 C-N-CA 124.055 3.17 . . . . 0.23999999999999999 113.246 174.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.677 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.3 Cg_exo -65.39 -26.97 55.18 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.995 2.464 . . . . 0.31 112.552 -176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.479 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 52.1 p -75.7 -25.08 56.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.9 0.857 . . . . 1.1000000000000001 112.054 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.83 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.9 m -99.57 -50.49 10.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.556 -0.747 . . . . 0.080000000000000002 112.806 -171.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.946 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.43 -2.1 4.23 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.796 -0.762 . . . . 0.070000000000000007 110.37 -177.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.543 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.7 pttp -81.3 -39.04 25.81 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.417 1.104 . . . . 0.92000000000000004 108.05 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm-40 -61.63 -46.28 90.47 Favored 'General case' 0 CA--C 1.472 -2.036 0 CA-C-N 112.488 -2.142 . . . . 0.25 106.579 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.946 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.2 tp -47.05 -66.39 0.41 Allowed 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 109.713 -3.403 . . . . 0.050000000000000003 112.647 172.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.492 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 21.6 t80 -45.9 -23.69 0.31 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 123.9 0.75 . . . . 0.13 109.547 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.449 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.31 -25.65 27.93 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 114.791 -1.095 . . . . 0.13 111.97 -176.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.755 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.61 -44.9 4.98 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 113.566 0.95 . . . . 0.059999999999999998 113.566 177.146 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -71.45 145.96 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.587 1.184 . . . . 0.080000000000000002 111.026 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.499 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -114.55 156.07 25.3 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 112.894 -1.957 . . . . 0.47999999999999998 108.679 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.635 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 39.5 mtmt -59.31 103.27 0.17 Allowed 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.778 0.799 . . . . 0.98999999999999999 109.225 169.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 127.82 -10.18 6.72 Favored Glycine 0 C--N 1.302 -1.33 0 CA-C-N 113.592 -1.64 . . . . 0.19 111.403 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.684 HG21 ' HB ' ' A' ' 457' ' ' VAL . 6.1 m -67.81 149.75 98.1 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 108.067 -1.086 . . . . 0.13 108.067 169.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 8.4 Cg_endo -94.75 167.3 1.71 Allowed 'Trans proline' 0 N--CA 1.416 -3.08 0 C-N-CA 121.943 1.762 . . . . 0.17999999999999999 109.589 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.75 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -128.37 153.86 38.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.109 -1.071 . . . . 0.56999999999999995 108.109 171.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.701 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.7 mp -134.26 151.14 51.12 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 108.621 -0.881 . . . . 0.13 108.621 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.046 HG23 HD21 ' A' ' 349' ' ' LEU . 0.6 OUTLIER -140.01 139.55 36.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 105.135 -2.172 . . . . 0.10000000000000001 105.135 165.366 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.695 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 13.4 p90 . . . . . 0 C--O 1.243 0.72 0 O-C-N 123.744 0.652 . . . . 1.0900000000000001 111.219 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.45 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 3.2 m-20 . . . . . 0 N--CA 1.443 -0.811 0 N-CA-C 109.34 -0.615 . . . . 0.42999999999999999 109.34 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 357' ' ' TYR . 97.6 m -158.55 136.21 10.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.589 -1.187 . . . . 0.14000000000000001 109.113 169.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.694 ' CD2' HD13 ' A' ' 464' ' ' LEU . 31.9 p90 174.85 157.32 0.16 Allowed 'General case' 0 CA--C 1.5 -0.969 0 O-C-N 123.511 0.507 . . . . 0.14999999999999999 111.129 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.682 HD11 HG11 ' A' ' 457' ' ' VAL . 0.6 OUTLIER -76.71 151.64 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 108.495 -0.928 . . . . 0.080000000000000002 108.495 164.655 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.766 ' CD ' ' HE1' ' A' ' 466' ' ' PHE . 6.9 tp10 -149.57 146.3 27.26 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.504 -0.771 . . . . 2.0099999999999998 109.902 -173.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.739 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -143.04 160.33 17.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.382 0.611 . . . . 0.45000000000000001 111.667 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.552 ' N ' HG12 ' A' ' 347' ' ' VAL . 27.1 t0 -141.07 106.47 5.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.378 -1.341 . . . . 0.23999999999999999 107.378 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.099 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.41 -34.61 28.22 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 122.717 1.246 . . . . 0.16 110.42 -167.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.443 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 1.5 mt-10 -57.43 -44.12 84.44 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 110.88 -2.873 . . . . 0.59999999999999998 108.013 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.9 m-80 -100.67 5.26 43.73 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 111.045 -2.798 . . . . 0.20000000000000001 111.037 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.594 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.5 mp0 34.96 61.54 0.6 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 112.766 -2.016 . . . . 2.1499999999999999 113.367 -175.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.524 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.5 t60 -142.61 135.46 28.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.785 -0.643 . . . . 0.089999999999999997 109.664 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.736 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.73 158.27 20.28 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.829 -0.623 . . . . 0.070000000000000007 109.86 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.644 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.5 m-90 -143.23 158.55 43.52 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.358 0.663 . . . . 0.11 110.695 -176.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.687 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.4 t80 -111.86 153.36 26.77 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.176 -1.787 . . . . 0.26000000000000001 106.176 150.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 7.9 m-85 -127.74 116.31 20.03 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.13 -0.941 . . . . 0.14000000000000001 110.15 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.3 tppt? -117.97 138.91 51.85 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.215 -1.772 . . . . 0.25 106.215 168.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.416 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.43 17.14 9.18 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.268 0.84 . . . . 0.42999999999999999 113.268 172.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.38 7.66 87.82 Favored Glycine 0 CA--C 1.488 -1.647 0 C-N-CA 120.801 -0.714 . . . . 0.17999999999999999 112.937 -174.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.3 ptmt -128.68 178.4 6.36 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 104.486 -2.412 . . . . 0.37 104.486 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.644 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.0 m -105.01 158.2 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 116.339 1.977 . . . . 0.10000000000000001 116.339 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.681 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.36 -26.93 9.76 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 110.625 -2.989 . . . . 0.070000000000000007 106.456 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.807 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.37 144.53 48.29 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 111.477 -2.601 . . . . 0.059999999999999998 111.432 -176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.431 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.1 tt0 -141.19 117.77 10.91 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 104.374 -2.454 . . . . 0.47999999999999998 104.374 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.736 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.66 163.5 37.74 Favored 'General case' 0 N--CA 1.399 -2.98 0 C-N-CA 117.896 -1.521 . . . . 0.070000000000000007 111.306 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.462 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 22.2 p-10 -103.4 136.46 43.11 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 114.907 -1.042 . . . . 1.8 109.484 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -136.13 -174.04 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 CA-C-O 122.484 1.135 . . . . 0.12 112.559 -170.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.7 OUTLIER -150.54 119.68 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 112.731 -2.031 . . . . 0.10000000000000001 107.798 173.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.525 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.74 -168.49 1.6 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.269 -1.332 . . . . 1.26 110.132 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -83.87 165.39 41.87 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 118.419 -1.848 . . . . 0.14000000000000001 112.636 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.5 ptmt -67.06 155.76 89.53 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.719 -0.74 . . . . 0.81000000000000005 112.22 -167.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.68 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 95.1 Cg_exo -55.95 -30.74 79.08 Favored 'Trans proline' 0 CA--C 1.495 -1.458 1 C-N-CA 125.332 4.021 . . . . 0.28000000000000003 113.932 -173.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.404 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 23.3 p -68.65 -30.67 69.42 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.882 -1.508 . . . . 0.33000000000000002 109.546 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.51 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -141.97 70.82 23.88 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 123.266 1.508 . . . . 0.39000000000000001 110.032 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 375' ' ' THR . 72.8 Cg_exo -58.62 148.24 83.0 Favored 'Trans proline' 0 C--N 1.307 -1.614 1 C-N-CA 126.028 4.485 . . . . 0.38 113.603 -172.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.525 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -77.93 144.54 68.31 Favored Pre-proline 0 N--CA 1.423 -1.812 0 N-CA-C 108.546 -0.909 . . . . 0.81999999999999995 108.546 175.563 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.2 Cg_exo -75.4 -45.07 0.27 Allowed 'Trans proline' 0 CA--C 1.51 -0.722 0 C-N-CA 124.352 3.368 . . . . 0.19 111.705 -167.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.802 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.21 139.24 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 123.051 1.405 . . . . 0.13 113.148 -172.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.8 -117.66 0.84 Allowed Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 112.558 -2.11 . . . . 0.20000000000000001 109.317 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.38 114.44 28.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.993 0.901 . . . . 0.81999999999999995 110.616 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.758 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.4 m-85 -113.16 -174.06 2.38 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.246 -1.39 . . . . 0.22 107.246 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.2 t80 -140.44 123.75 16.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.369 1.44 . . . . 0.65000000000000002 113.513 -172.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -89.93 92.57 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 CA-C-O 123.009 1.385 . . . . 0.16 109.543 169.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -93.12 11.1 28.92 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.416 -1.72 . . . . 2.5499999999999998 108.176 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.74 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 26.5 t-20 -169.21 126.64 0.95 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 113.927 -1.488 . . . . 0.42999999999999999 110.366 172.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.702 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -98.46 140.92 31.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.853 -1.067 . . . . 1.1200000000000001 109.117 169.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.769 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 18.6 mm-40 -124.05 157.18 35.1 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.547 1.314 . . . . 0.70999999999999996 114.547 -168.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 44.1 mt-10 -137.13 127.89 27.19 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 112.825 -1.988 . . . . 0.38 108.397 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 32.1 t70 55.22 48.48 19.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 123.346 1.546 . . . . 0.40999999999999998 108.92 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.922 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -83.04 167.97 17.38 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 112.629 -2.078 . . . . 0.12 109.153 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 25.9 m -132.68 119.34 20.26 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.071 0.939 . . . . 0.17000000000000001 111.733 170.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 4.2 mp -80.86 91.38 5.97 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.748 -1.569 . . . . 0.56999999999999995 112.249 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.547 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.0 mttt . . . . . 0 C--N 1.283 -2.32 0 CA-C-N 113.971 -1.468 . . . . 0.33000000000000002 113.077 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.547 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.812 0 N-CA-C 109.801 -0.444 . . . . 0.53000000000000003 109.801 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.36 97.25 5.17 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.277 -1.009 . . . . 0.19 108.277 172.439 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 16.4 Cg_exo -69.9 109.9 2.45 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 121.797 1.665 . . . . 0.19 109.952 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.922 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.97 155.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-N 112.667 -2.06 . . . . 0.14999999999999999 107.766 -167.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.722 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.0 m-80 -86.85 -20.99 26.68 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.179 -0.674 . . . . 0.51000000000000001 109.179 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.769 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 95.0 m-85 -158.7 127.0 5.24 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.353 1.033 . . . . 0.27000000000000002 108.79 -171.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.68 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 24.1 t-105 -145.11 137.09 25.7 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.756 0.789 . . . . 0.089999999999999997 110.953 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.702 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.6 mmt -119.87 93.72 47.94 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 107.651 -1.24 . . . . 0.14000000000000001 107.651 173.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 40.0 Cg_endo . . . . . 0 C--N 1.35 0.624 0 C-N-CA 122.356 2.037 . . . . 0.5 112.414 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 419' ' ' GLY . 29.1 t . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.431 0.634 . . . . 0.75 112.012 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.595 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.03 122.43 0.82 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.606 -1.398 . . . . 0.20000000000000001 109.606 170.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.689 HG22 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.72 142.52 13.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.799 -0.445 . . . . 0.28999999999999998 109.799 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.68 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 14.4 p-80 -159.83 162.48 34.73 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.196 -0.456 . . . . 0.089999999999999997 111.659 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.702 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.88 143.8 28.03 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.845 -1.169 . . . . 1.0700000000000001 107.845 171.78 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 445' ' ' THR . 28.5 t -133.83 99.03 4.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.874 0.845 . . . . 0.23000000000000001 110.701 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 N--CA 1.44 -0.937 0 CA-C-N 114.132 -1.395 . . . . 0.41999999999999998 109.537 -176.861 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.57 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.426 -1.673 0 CA-C-O 122.115 0.959 . . . . 2.1600000000000001 111.543 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.686 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -154.32 132.58 11.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.201 -2.148 . . . . 0.33000000000000002 105.201 169.287 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.61 -158.34 30.96 Favored Glycine 0 C--N 1.285 -2.294 0 N-CA-C 110.438 -1.065 . . . . 0.17000000000000001 110.438 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.534 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -47.08 174.14 0.02 OUTLIER Glycine 0 CA--C 1.495 -1.192 0 C-N-CA 120.096 -1.05 . . . . 0.20999999999999999 111.499 168.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.569 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 7.0 p-10 -52.59 101.29 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 123.422 1.582 . . . . 1.8500000000000001 113.883 -154.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 1.006 HD22 ' HD2' ' A' ' 437' ' ' ARG . 41.6 mt -97.47 -34.65 10.93 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 112.203 -2.271 . . . . 1.21 109.383 171.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.709 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.2 p-90 -53.74 -26.36 22.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.017 -0.992 . . . . 0.16 112.004 -173.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.709 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.11 -36.33 14.06 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.618 -0.719 . . . . 0.22 112.308 -178.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.432 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.2 p -88.15 -41.02 13.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.143 -0.935 . . . . 0.25 110.381 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 1.006 ' HD2' HD22 ' A' ' 433' ' ' LEU . 2.1 mtp85 -93.06 -20.69 20.29 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.431 -1.258 . . . . 1.8200000000000001 109.704 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.91 45.8 49.86 Favored Glycine 0 N--CA 1.443 -0.834 0 O-C-N 124.284 0.99 . . . . 0.23999999999999999 114.072 166.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 20.8 m -84.69 110.13 18.53 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.654 -1.218 . . . . 1.01 111.367 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.462 ' HB3' ' H ' ' A' ' 441' ' ' GLY . 29.1 m-70 46.11 -145.0 0.21 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.607 -1.179 . . . . 0.5 113.629 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 440' ' ' HIS . . . -110.65 -23.41 5.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.506 -0.854 . . . . 0.26000000000000001 113.566 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.516 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 31.2 p -101.57 -165.43 1.19 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 113.645 0.98 . . . . 0.34999999999999998 113.645 -170.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 370' ' ' SER . 2.0 mp -90.23 133.35 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.569 -0.741 . . . . 0.12 110.61 -176.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -104.11 90.9 3.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.366 0.603 . . . . 0.62 110.286 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.744 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.3 m -85.82 142.33 36.66 Favored Pre-proline 0 N--CA 1.436 -1.126 0 CA-C-N 115.105 -0.952 . . . . 0.10000000000000001 112.512 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.669 ' HD2' HG21 ' A' ' 366' ' ' THR . 82.0 Cg_exo -49.58 145.56 16.7 Favored 'Trans proline' 0 CA--C 1.509 -0.767 0 C-N-CA 123.891 3.06 . . . . 0.23999999999999999 113.572 175.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.702 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.4 Cg_exo -66.7 -21.05 52.21 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.827 2.352 . . . . 0.31 112.034 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.55 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 33.4 p -83.35 -24.07 32.23 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.233 -0.894 . . . . 1.1000000000000001 112.291 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.807 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.8 m -99.64 -47.98 11.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 112.954 0.724 . . . . 0.080000000000000002 112.954 -171.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.968 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.36 -1.77 3.8 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.789 -0.764 . . . . 0.070000000000000007 110.462 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 448' ' ' SER . 17.2 pttp -81.5 -38.27 26.56 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.698 1.237 . . . . 0.92000000000000004 108.33 173.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.7 mm-40 -62.57 -46.28 89.05 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-N 112.299 -2.228 . . . . 0.25 106.328 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.968 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -47.28 -66.61 0.38 Allowed 'General case' 0 N--CA 1.406 -2.633 0 CA-C-N 109.832 -3.349 . . . . 0.050000000000000003 112.956 172.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.495 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.3 t80 -46.26 -22.59 0.25 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.866 0.841 . . . . 0.13 109.396 176.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.459 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.83 -25.32 30.0 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.674 -1.148 . . . . 0.13 112.008 -176.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.759 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.5 -43.7 5.32 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 113.705 1.002 . . . . 0.059999999999999998 113.705 176.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.682 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.87 149.8 7.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.432 1.11 . . . . 0.080000000000000002 111.278 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.405 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -121.68 156.4 33.13 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 112.99 -1.914 . . . . 0.47999999999999998 108.64 -177.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.563 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 2.5 mppt? -58.66 103.2 0.14 Allowed 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.775 -0.824 . . . . 0.98999999999999999 108.775 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.75 -9.08 6.11 Favored Glycine 0 C--N 1.307 -1.069 0 CA-C-N 113.935 -1.484 . . . . 0.19 111.616 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 344' ' ' TYR . 19.0 m -69.31 150.05 97.26 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.972 -0.751 . . . . 0.13 108.972 171.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.7 Cg_endo -93.84 163.06 2.22 Favored 'Trans proline' 0 N--CA 1.423 -2.664 0 C-N-CA 122.34 2.026 . . . . 0.17999999999999999 109.919 176.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.758 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.7 m -126.64 149.23 31.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 107.502 -1.296 . . . . 0.56999999999999995 107.502 171.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.694 HD13 ' CD2' ' A' ' 344' ' ' TYR . 3.5 mp -134.86 150.3 50.45 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 108.426 -0.953 . . . . 0.13 108.426 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.099 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.94 143.12 28.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 105.72 -1.956 . . . . 0.10000000000000001 105.72 166.353 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.766 ' HE1' ' CD ' ' A' ' 346' ' ' GLU . 9.3 p90 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 123.185 0.594 . . . . 1.0900000000000001 110.316 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.496 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 6.2 m-20 . . . . . 0 N--CA 1.445 -0.704 0 CA-C-O 121.046 0.45 . . . . 0.42999999999999999 110.264 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.79 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 46.9 m -158.01 135.48 10.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.77 -1.104 . . . . 0.14000000000000001 108.681 167.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.691 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.7 p90 174.22 159.18 0.16 Allowed 'General case' 0 C--O 1.214 -0.795 0 O-C-N 123.337 0.398 . . . . 0.14999999999999999 110.851 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.642 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.99 152.13 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.313 0 N-CA-C 109.112 -0.699 . . . . 0.080000000000000002 109.112 164.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.569 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.72 143.14 25.26 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.628 -0.715 . . . . 2.0099999999999998 109.452 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.742 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.9 t -135.15 162.43 38.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 120.733 -0.387 . . . . 0.45000000000000001 111.213 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.569 ' N ' HG12 ' A' ' 347' ' ' VAL . 36.7 t0 -140.23 106.81 5.33 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.468 -1.308 . . . . 0.23999999999999999 107.468 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.024 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.48 -34.9 27.86 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-O 122.752 1.263 . . . . 0.16 110.436 -167.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.02 -44.98 87.6 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 110.797 -2.91 . . . . 0.59999999999999998 108.308 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -100.61 5.94 44.01 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 111.012 -2.813 . . . . 0.20000000000000001 111.057 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.7 mp0 35.09 61.32 0.63 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 112.725 -2.034 . . . . 2.1499999999999999 113.16 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.495 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.5 t60 -142.2 134.6 27.91 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.646 -0.706 . . . . 0.089999999999999997 109.742 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.734 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.71 157.85 20.78 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.822 -0.627 . . . . 0.070000000000000007 110.106 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.61 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.1 m-90 -142.62 156.02 45.02 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.499 0.72 . . . . 0.11 111.258 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.79 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.0 t80 -110.81 153.82 24.84 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 106.424 -1.695 . . . . 0.26000000000000001 106.424 151.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.6 m-85 -127.86 119.09 24.9 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 114.892 -1.049 . . . . 0.14000000000000001 110.351 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.2 tppt? -120.56 132.41 55.15 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.277 -1.749 . . . . 0.25 106.277 167.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 75.1 16.53 2.8 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 113.136 0.791 . . . . 0.42999999999999999 113.136 174.384 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.496 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.13 5.73 88.99 Favored Glycine 0 CA--C 1.485 -1.828 0 CA-C-O 121.814 0.675 . . . . 0.17999999999999999 112.887 -173.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 19.9 ptmt -128.92 177.23 7.25 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.502 -2.407 . . . . 0.37 104.502 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.0 m -103.56 158.22 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 116.713 2.116 . . . . 0.10000000000000001 116.713 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.712 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.15 -28.65 8.93 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 110.39 -3.096 . . . . 0.070000000000000007 106.207 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -133.87 145.91 50.1 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 111.589 -2.551 . . . . 0.059999999999999998 111.669 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.471 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.3 tt0 -143.72 118.47 9.87 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 104.499 -2.408 . . . . 0.47999999999999998 104.499 175.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.81 165.39 32.65 Favored 'General case' 0 N--CA 1.401 -2.915 0 C-N-CA 118.132 -1.427 . . . . 0.070000000000000007 111.631 -179.157 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.67 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 15.5 p-10 -103.81 133.33 48.98 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.669 -1.15 . . . . 1.8 110.087 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -133.77 -173.75 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-O 122.465 1.126 . . . . 0.12 112.525 -171.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.37 120.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 112.91 -1.95 . . . . 0.10000000000000001 109.199 172.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.522 ' HB3' HD12 ' A' ' 349' ' ' LEU . 33.6 p -78.25 -169.06 1.49 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 111.94 -2.391 . . . . 1.26 111.421 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.485 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.77 174.75 50.14 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 118.779 -1.676 . . . . 0.14000000000000001 112.05 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.439 ' HG2' ' CG2' ' A' ' 375' ' ' THR . 8.5 ptmt -80.31 163.67 55.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 113.174 0.805 . . . . 0.81000000000000005 113.174 -164.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.685 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 89.4 Cg_exo -55.09 -37.86 93.78 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 123.023 2.482 . . . . 0.28000000000000003 112.287 -176.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.456 ' OG1' HG22 ' A' ' 375' ' ' THR . 12.0 p -64.35 -31.89 73.27 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.29 -1.323 . . . . 0.33000000000000002 110.052 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.519 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -141.59 71.04 25.78 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 123.439 1.59 . . . . 0.39000000000000001 110.032 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 375' ' ' THR . 82.2 Cg_exo -58.3 153.81 44.6 Favored 'Trans proline' 0 C--N 1.307 -1.643 1 C-N-CA 126.369 4.713 . . . . 0.38 114.985 -171.209 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.54 HG21 ' HG ' ' A' ' 349' ' ' LEU . 2.5 m -79.24 129.86 71.04 Favored Pre-proline 0 N--CA 1.405 -2.718 0 CA-C-N 114.5 -1.227 . . . . 0.81999999999999995 108.55 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 39.4 Cg_exo -68.28 -44.97 3.04 Favored 'Trans proline' 0 CA--C 1.512 -0.601 0 C-N-CA 123.834 3.023 . . . . 0.19 112.147 -169.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.795 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.84 138.96 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 123.304 1.526 . . . . 0.13 113.645 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 152.86 -119.31 0.95 Allowed Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 112.243 -2.253 . . . . 0.20000000000000001 109.579 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.429 HG22 HD21 ' A' ' 464' ' ' LEU . 76.4 t -129.84 108.5 16.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.002 0.43 . . . . 0.81999999999999995 110.472 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.769 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.4 m-85 -108.55 -173.98 2.41 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.279 -1.378 . . . . 0.22 107.279 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.3 t80 -140.83 123.84 16.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 120.09 1.313 . . . . 0.65000000000000002 113.656 -172.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.94 92.56 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 122.961 1.362 . . . . 0.16 109.66 169.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -91.23 9.27 31.98 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.622 -1.627 . . . . 2.5499999999999998 108.265 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.744 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.5 t30 -170.79 127.89 0.76 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.229 -1.351 . . . . 0.42999999999999999 110.475 173.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.684 ' HB3' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -96.95 151.57 19.56 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.727 -0.67 . . . . 1.1200000000000001 109.873 167.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 37.8 mm-40 -128.37 160.48 32.08 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.471 1.286 . . . . 0.70999999999999996 114.471 -170.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.8 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 32.1 mt-10 -139.53 127.68 22.48 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 113.112 -1.858 . . . . 0.38 108.881 172.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.73 46.09 23.18 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 123.109 1.433 . . . . 0.40999999999999998 108.964 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.942 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.52 166.52 21.1 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 112.759 -2.019 . . . . 0.12 108.967 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 18.7 m -133.0 118.9 19.39 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.988 0.899 . . . . 0.17000000000000001 111.94 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.1 mp -79.41 88.53 5.01 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.775 -1.557 . . . . 0.56999999999999995 112.091 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.54 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.4 mttt . . . . . 0 C--N 1.288 -2.096 0 CA-C-N 113.561 -1.654 . . . . 0.33000000000000002 113.826 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.54 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.441 -0.919 0 CA-C-O 121.1 0.476 . . . . 0.53000000000000003 110.32 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.17 97.27 5.26 Favored Pre-proline 0 N--CA 1.431 -1.387 0 N-CA-C 108.11 -1.07 . . . . 0.19 108.11 171.436 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 18.9 Cg_exo -69.35 109.94 2.35 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 122.012 1.808 . . . . 0.19 109.881 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.942 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.08 156.34 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 CA-C-N 112.869 -1.969 . . . . 0.14999999999999999 107.283 -168.126 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.8 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.0 m-80 -89.72 -19.9 24.22 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.987 -0.746 . . . . 0.51000000000000001 108.987 -174.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.6 m-85 -159.06 126.58 4.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.346 -0.983 . . . . 0.27000000000000002 108.346 -171.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.685 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 25.0 t-105 -145.25 133.92 22.19 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.828 0.823 . . . . 0.089999999999999997 111.253 -167.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.684 ' SD ' ' HB3' ' A' ' 387' ' ' LYS . 11.8 mmt -115.2 94.91 40.72 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.568 -1.271 . . . . 0.14000000000000001 107.568 172.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.744 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 39.3 Cg_endo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.362 2.041 . . . . 0.5 112.548 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.578 HG12 ' N ' ' A' ' 419' ' ' GLY . 22.1 t . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 121.446 0.641 . . . . 0.75 112.433 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.578 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -177.45 120.19 0.72 Allowed Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.965 -1.254 . . . . 0.20000000000000001 109.965 170.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.67 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.76 143.08 12.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 110.21 -0.293 . . . . 0.28999999999999998 110.21 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.685 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.5 p80 -159.15 160.88 36.06 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.168 -0.469 . . . . 0.089999999999999997 111.702 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.709 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -84.54 148.14 26.65 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.838 -1.171 . . . . 1.0700000000000001 107.838 172.09 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 445' ' ' THR . 43.3 t -134.29 96.54 3.63 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.67 0.747 . . . . 0.23000000000000001 110.269 -171.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 114.473 -1.24 . . . . 0.41999999999999998 109.945 -174.877 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 N--CA 1.43 -1.457 0 CA-C-O 122.322 1.058 . . . . 2.1600000000000001 113.417 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.718 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.62 134.2 5.19 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 104.162 -2.533 . . . . 0.33000000000000002 104.162 171.064 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.36 -157.29 29.4 Favored Glycine 0 C--N 1.276 -2.756 0 C-N-CA 119.28 -1.438 . . . . 0.17000000000000001 110.749 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.406 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.94 174.29 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 119.903 -1.142 . . . . 0.20999999999999999 111.175 166.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.51 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -51.33 102.68 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 123.198 1.475 . . . . 1.8500000000000001 113.944 -154.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.667 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.07 -35.44 11.92 Favored 'General case' 0 C--O 1.202 -1.4 0 CA-C-N 112.699 -2.046 . . . . 1.21 109.087 168.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.734 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -55.72 -26.69 46.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.16 112.357 -170.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.734 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.78 -32.42 15.39 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.981 0.896 . . . . 0.22 111.771 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.8 p -87.52 -45.0 10.86 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.946 -1.479 . . . . 0.25 111.103 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.667 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 7.5 mtp-105 -91.04 -20.2 22.34 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.446 -1.252 . . . . 1.8200000000000001 110.18 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.89 46.56 49.17 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.395 -1.275 . . . . 0.23999999999999999 114.308 164.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 110.82 19.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.345 1.073 . . . . 1.01 112.298 -169.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 37.07 -111.19 0.08 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.869 -1.06 . . . . 0.5 113.495 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.485 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -146.41 -11.84 0.21 Allowed Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.867 -0.682 . . . . 0.26000000000000001 114.235 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 29.4 p -100.04 -167.99 1.53 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 118.291 1.046 . . . . 0.34999999999999998 112.151 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.486 HD13 HG11 ' A' ' 465' ' ' VAL . 2.2 mp -103.39 132.02 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 114.862 -1.063 . . . . 0.12 110.886 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -102.41 94.22 5.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.996 -1.002 . . . . 0.62 110.367 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.726 ' HA ' HG22 ' A' ' 368' ' ' ILE . 2.9 m -89.93 144.08 30.96 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 115.607 -0.724 . . . . 0.10000000000000001 112.554 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.678 ' HD2' HG21 ' A' ' 366' ' ' THR . 74.8 Cg_exo -51.68 147.22 24.71 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 123.945 3.097 . . . . 0.23999999999999999 113.33 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.718 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 27.1 Cg_exo -67.96 -26.24 37.74 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.006 2.471 . . . . 0.31 112.185 -175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.508 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 40.5 p -75.61 -25.4 56.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.078 -0.964 . . . . 1.1000000000000001 111.876 -176.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.804 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.6 m -99.93 -50.47 10.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.574 -0.739 . . . . 0.080000000000000002 112.896 -171.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.954 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.67 -2.34 4.8 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.729 -0.788 . . . . 0.070000000000000007 110.249 -178.035 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.648 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.1 pttp -81.09 -39.51 25.57 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.484 1.135 . . . . 0.92000000000000004 108.287 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.49 ' HG3' HD11 ' A' ' 364' ' ' LEU . 4.7 mm-40 -61.62 -46.84 88.09 Favored 'General case' 0 CA--C 1.47 -2.121 0 CA-C-N 112.319 -2.219 . . . . 0.25 106.571 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.954 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.52 -66.86 0.34 Allowed 'General case' 0 N--CA 1.4 -2.969 0 CA-C-N 109.649 -3.432 . . . . 0.050000000000000003 112.842 172.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.8 t80 -44.43 -24.79 0.2 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 124.135 0.897 . . . . 0.13 109.727 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.78 -30.35 15.44 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.341 -1.299 . . . . 0.13 111.762 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.784 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -97.8 -43.91 6.95 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 113.22 0.822 . . . . 0.059999999999999998 113.22 178.566 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -72.84 147.55 9.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 122.451 1.119 . . . . 0.080000000000000002 110.928 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.488 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -116.28 157.14 25.42 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 113.196 -1.82 . . . . 0.47999999999999998 108.909 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.652 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 5.6 mppt? -58.91 102.1 0.11 Allowed 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.573 -0.899 . . . . 0.98999999999999999 108.573 169.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.68 -12.13 5.95 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 114.102 -1.408 . . . . 0.19 111.525 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.688 HG21 ' HB ' ' A' ' 457' ' ' VAL . 16.2 m -67.12 150.16 98.07 Favored Pre-proline 0 N--CA 1.441 -0.923 0 N-CA-C 108.671 -0.863 . . . . 0.13 108.671 171.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.3 Cg_endo -93.87 161.03 2.23 Favored 'Trans proline' 0 N--CA 1.423 -2.647 0 C-N-CA 122.152 1.901 . . . . 0.17999999999999999 109.974 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.769 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -123.51 150.47 27.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 107.389 -1.337 . . . . 0.56999999999999995 107.389 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.708 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.4 mp -134.15 150.66 51.12 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.748 -0.834 . . . . 0.13 108.748 175.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.024 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -139.01 140.4 38.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 105.418 -2.067 . . . . 0.10000000000000001 105.418 165.228 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.612 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 10.8 p90 . . . . . 0 C--O 1.246 0.884 0 O-C-N 123.822 0.701 . . . . 1.0900000000000001 111.086 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.414 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 12.7 m-20 . . . . . 0 N--CA 1.444 -0.746 0 CA-C-O 121.435 0.636 . . . . 0.42999999999999999 109.359 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.813 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 73.1 m -158.25 134.69 9.5 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.376 -1.284 . . . . 0.14000000000000001 108.983 168.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.697 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.6 p90 174.27 158.7 0.16 Allowed 'General case' 0 C--O 1.213 -0.865 0 O-C-N 123.478 0.486 . . . . 0.14999999999999999 110.855 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.658 HD11 HG11 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.65 152.48 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 109.002 -0.74 . . . . 0.080000000000000002 109.002 164.286 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.587 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 32.1 tt0 -149.94 143.61 25.35 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.42 -0.809 . . . . 2.0099999999999998 109.748 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.741 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.9 t -136.05 162.41 36.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.929 0.395 . . . . 0.45000000000000001 111.298 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.559 ' N ' HG12 ' A' ' 347' ' ' VAL . 35.0 t0 -140.13 106.76 5.34 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.162 -1.421 . . . . 0.23999999999999999 107.162 173.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.098 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.36 -33.5 28.79 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-O 122.71 1.243 . . . . 0.16 110.193 -168.456 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.07 -44.85 83.46 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 110.786 -2.915 . . . . 0.59999999999999998 108.192 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -101.95 5.64 40.89 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 110.906 -2.861 . . . . 0.20000000000000001 111.273 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.2 mp0 34.79 61.61 0.57 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 112.56 -2.109 . . . . 2.1499999999999999 113.085 -175.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.522 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.4 t60 -141.76 134.95 29.23 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.615 -0.72 . . . . 0.089999999999999997 109.818 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.752 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -113.24 156.31 23.53 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.733 -0.667 . . . . 0.070000000000000007 110.084 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.6 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.5 m-90 -142.26 154.75 45.01 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.443 -0.798 . . . . 0.11 111.037 -175.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.813 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 88.1 t80 -109.8 153.11 24.85 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 106.503 -1.665 . . . . 0.26000000000000001 106.503 151.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 8.1 m-85 -128.15 117.37 21.46 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 114.957 -1.019 . . . . 0.14000000000000001 110.28 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.3 tppt? -118.32 138.34 52.46 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.948 -1.871 . . . . 0.25 105.948 168.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 69.31 17.37 8.25 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.147 0.795 . . . . 0.42999999999999999 113.147 172.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.414 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.24 6.47 87.73 Favored Glycine 0 CA--C 1.488 -1.653 0 C-N-CA 120.705 -0.759 . . . . 0.17999999999999999 112.943 -174.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.6 ptmt -127.55 178.19 6.27 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 104.484 -2.413 . . . . 0.37 104.484 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.6 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.4 m -105.07 157.35 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.766 0 N-CA-C 116.21 1.93 . . . . 0.10000000000000001 116.21 -176.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.694 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.13 -27.62 9.98 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 110.461 -3.063 . . . . 0.070000000000000007 106.233 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.821 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.12 145.35 49.23 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 111.71 -2.495 . . . . 0.059999999999999998 111.919 -175.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.522 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 2.5 tt0 -141.55 118.12 10.95 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 104.514 -2.402 . . . . 0.47999999999999998 104.514 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.752 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.63 165.43 33.37 Favored 'General case' 0 N--CA 1.398 -3.034 0 C-N-CA 117.83 -1.548 . . . . 0.070000000000000007 111.533 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.407 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 30.1 p-10 -104.41 134.19 48.03 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 114.831 -1.077 . . . . 1.8 109.989 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.739 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -132.56 -172.44 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 CA-C-O 122.53 1.157 . . . . 0.12 112.326 -172.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.79 119.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 112.889 -1.959 . . . . 0.10000000000000001 108.207 172.401 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.531 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -77.84 -169.39 1.51 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.067 -1.424 . . . . 1.26 110.891 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.67 170.68 46.36 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 118.995 -1.574 . . . . 0.14000000000000001 112.127 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 9.1 ptpt -77.13 157.56 80.94 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.473 0.654 . . . . 0.81000000000000005 112.52 -164.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.681 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 66.3 Cg_exo -53.01 -29.84 46.22 Favored 'Trans proline' 0 CA--C 1.496 -1.405 1 C-N-CA 125.751 4.3 . . . . 0.28000000000000003 113.694 -173.369 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.447 ' OG1' HG22 ' A' ' 375' ' ' THR . 19.1 p -66.66 -33.29 75.32 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.424 -1.716 . . . . 0.33000000000000002 109.45 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.504 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.0 t -143.15 71.27 18.34 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 113.498 -1.683 . . . . 0.39000000000000001 109.536 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 375' ' ' THR . 88.9 Cg_exo -56.99 146.05 82.3 Favored 'Trans proline' 0 C--N 1.304 -1.774 1 C-N-CA 125.84 4.36 . . . . 0.38 113.181 -172.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.531 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -75.69 145.15 78.09 Favored Pre-proline 0 N--CA 1.423 -1.82 0 N-CA-C 108.306 -0.998 . . . . 0.81999999999999995 108.306 175.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.1 Cg_exo -75.44 -43.64 0.35 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 124.59 3.526 . . . . 0.19 111.775 -166.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.8 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 58.24 136.15 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 123.603 1.668 . . . . 0.13 113.639 -172.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.99 -126.54 2.0 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 111.969 -2.378 . . . . 0.20000000000000001 109.253 -176.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.477 HG22 HD21 ' A' ' 464' ' ' LEU . 71.3 t -121.15 108.63 23.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.204 0.526 . . . . 0.81999999999999995 110.714 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.76 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 1.8 m-85 -106.8 -174.36 2.52 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.771 -1.566 . . . . 0.22 106.771 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -139.56 123.32 17.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.982 1.265 . . . . 0.65000000000000002 113.071 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -90.51 92.5 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-O 123.035 1.398 . . . . 0.16 109.51 170.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -92.33 11.19 26.75 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.318 -1.765 . . . . 2.5499999999999998 108.291 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.775 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 25.0 t-20 -169.38 126.24 0.91 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.265 -1.334 . . . . 0.42999999999999999 110.352 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.672 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -102.52 140.04 37.32 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.774 -1.103 . . . . 1.1200000000000001 108.96 169.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.748 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 21.2 mm-40 -124.08 159.2 30.47 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.788 1.403 . . . . 0.70999999999999996 114.788 -167.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.727 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 49.8 mt-10 -129.2 146.34 51.14 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 112.701 -2.045 . . . . 0.38 106.552 165.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.8 t70 47.51 38.77 8.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 112.505 -2.134 . . . . 0.40999999999999998 110.603 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.914 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -78.93 166.88 21.89 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 112.663 -2.062 . . . . 0.12 109.318 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 19.9 m -131.29 119.43 21.74 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.29 1.043 . . . . 0.17000000000000001 111.229 171.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.0 mp -79.19 88.29 4.89 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.392 -1.731 . . . . 0.56999999999999995 111.917 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.547 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.1 mttt . . . . . 0 C--N 1.281 -2.392 0 CA-C-N 113.658 -1.61 . . . . 0.33000000000000002 113.127 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.547 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.628 0 CA-C-O 120.995 0.426 . . . . 0.53000000000000003 110.383 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.06 97.49 4.83 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 108.39 -0.967 . . . . 0.19 108.39 170.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.9 Cg_exo -68.66 111.41 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.715 0 C-N-CA 122.202 1.935 . . . . 0.19 110.3 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.92 160.3 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.31 -1.768 . . . . 0.14999999999999999 107.663 -168.108 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.727 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.8 m-80 -94.15 -19.61 20.62 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.902 -0.777 . . . . 0.51000000000000001 108.902 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.748 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 88.1 m-85 -158.94 125.95 4.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.892 -1.049 . . . . 0.27000000000000002 108.248 -171.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 18.2 t-105 -144.16 131.17 20.48 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.933 0.873 . . . . 0.089999999999999997 111.557 -166.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.672 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -111.94 93.91 22.86 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.44 -1.319 . . . . 0.14000000000000001 107.44 171.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.775 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.5 Cg_endo . . . . . 0 C--N 1.35 0.632 0 C-N-CA 122.308 2.005 . . . . 0.5 111.537 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 419' ' ' GLY . 47.2 t . . . . . 0 CA--C 1.535 0.4 0 CA-C-O 121.374 0.607 . . . . 0.75 111.584 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.588 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -173.08 120.98 0.84 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 109.875 -1.29 . . . . 0.20000000000000001 109.875 170.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.729 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -82.17 140.88 15.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.746 -0.465 . . . . 0.28999999999999998 109.746 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.669 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.1 p80 -159.18 161.03 36.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.197 -0.456 . . . . 0.089999999999999997 111.367 -174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.697 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.4 148.62 26.5 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.214 -1.032 . . . . 1.0700000000000001 108.214 172.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 445' ' ' THR . 40.4 t -133.24 96.38 3.73 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.726 0.774 . . . . 0.23000000000000001 109.75 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 C--N 1.317 -0.814 0 CA-C-N 114.26 -1.336 . . . . 0.41999999999999998 109.204 -177.286 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.574 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.9 pm0 . . . . . 0 N--CA 1.436 -1.134 0 CA-C-O 122.323 1.059 . . . . 2.1600000000000001 113.35 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.651 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.47 129.9 3.79 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 112.604 -2.089 . . . . 0.33000000000000002 105.74 172.405 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.61 -158.82 31.7 Favored Glycine 0 C--N 1.283 -2.4 0 C-N-CA 119.913 -1.136 . . . . 0.17000000000000001 110.834 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.506 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.21 174.21 0.01 OUTLIER Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.253 -0.975 . . . . 0.20999999999999999 111.526 167.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.524 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.3 p-10 -51.9 101.72 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 123.262 1.506 . . . . 1.8500000000000001 113.851 -153.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.735 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.93 -37.06 10.85 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 112.459 -2.155 . . . . 1.21 109.54 169.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.711 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -54.12 -27.25 32.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.235 -0.893 . . . . 0.16 112.395 -170.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.711 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.33 -33.82 15.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.48 0.657 . . . . 0.22 112.466 -177.419 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.7 p -92.09 -43.03 9.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.854 -1.066 . . . . 0.25 110.991 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.735 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.5 mtp180 -93.15 -18.97 21.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.772 -1.104 . . . . 1.8200000000000001 109.492 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.02 49.42 55.53 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 114.74 -1.118 . . . . 0.23999999999999999 115.022 163.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.0 m -82.39 110.62 17.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.784 1.292 . . . . 1.01 111.077 -172.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.412 ' HB3' ' H ' ' A' ' 441' ' ' GLY . 44.6 m-70 38.98 -130.17 0.24 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.619 -1.173 . . . . 0.5 113.23 175.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 440' ' ' HIS . . . -122.31 -22.64 2.55 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.337 -0.459 . . . . 0.26000000000000001 113.247 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.559 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.5 p -102.44 -165.35 1.17 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 113.346 0.869 . . . . 0.34999999999999998 113.346 -173.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.491 ' CD1' HG11 ' A' ' 465' ' ' VAL . 1.9 mp -93.03 134.06 32.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.282 -0.872 . . . . 0.12 110.732 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -107.87 97.09 6.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.385 0.612 . . . . 0.62 110.113 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.739 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.2 m -93.35 144.85 28.94 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 114.726 -1.124 . . . . 0.10000000000000001 112.851 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.661 ' HD2' HG21 ' A' ' 366' ' ' THR . 72.6 Cg_exo -51.13 145.38 26.13 Favored 'Trans proline' 0 CA--C 1.507 -0.838 0 C-N-CA 123.98 3.12 . . . . 0.23999999999999999 113.391 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.697 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.6 Cg_exo -65.55 -26.15 54.58 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.909 2.406 . . . . 0.31 112.309 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.555 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 57.9 p -76.38 -25.29 54.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.794 0.807 . . . . 1.1000000000000001 111.998 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.821 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.7 m -99.6 -50.16 10.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.628 -0.714 . . . . 0.080000000000000002 112.766 -170.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.962 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.61 -2.15 4.5 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.754 -0.778 . . . . 0.070000000000000007 110.371 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 16.9 pttp -80.87 -38.68 27.7 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.521 1.153 . . . . 0.92000000000000004 108.201 173.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.491 ' HG3' HD11 ' A' ' 364' ' ' LEU . 4.1 mm-40 -62.69 -46.39 88.39 Favored 'General case' 0 CA--C 1.474 -1.968 0 CA-C-N 112.433 -2.167 . . . . 0.25 106.578 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.962 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.28 -66.06 0.47 Allowed 'General case' 0 N--CA 1.404 -2.752 0 CA-C-N 109.849 -3.341 . . . . 0.050000000000000003 112.712 172.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.462 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 24.0 t80 -45.72 -23.67 0.28 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 123.941 0.776 . . . . 0.13 109.56 176.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.452 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.82 -27.1 25.03 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.649 -1.159 . . . . 0.13 111.817 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.741 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.99 -43.83 5.66 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 113.57 0.952 . . . . 0.059999999999999998 113.57 177.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.688 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.4 OUTLIER -74.89 149.76 7.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.486 1.136 . . . . 0.080000000000000002 111.175 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -125.0 157.63 35.67 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 112.939 -1.937 . . . . 0.47999999999999998 108.245 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.658 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.1 mppt? -57.82 101.64 0.08 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 109.055 -0.72 . . . . 0.98999999999999999 109.055 172.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.85 -14.4 5.22 Favored Glycine 0 C--N 1.307 -1.082 0 CA-C-N 114.111 -1.404 . . . . 0.19 111.53 -175.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.688 HG21 ' HB ' ' A' ' 457' ' ' VAL . 17.8 m -66.63 149.27 98.32 Favored Pre-proline 0 N--CA 1.437 -1.076 0 N-CA-C 108.527 -0.916 . . . . 0.13 108.527 171.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 7.2 Cg_endo -94.39 164.19 1.94 Allowed 'Trans proline' 0 N--CA 1.419 -2.874 0 C-N-CA 122.159 1.906 . . . . 0.17999999999999999 109.769 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.76 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -126.6 151.65 33.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 107.741 -1.207 . . . . 0.56999999999999995 107.741 171.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.709 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.3 mp -134.6 151.27 50.96 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 109.079 -0.711 . . . . 0.13 109.079 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.098 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.38 142.81 30.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 105.604 -1.998 . . . . 0.10000000000000001 105.604 164.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.721 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 11.0 p90 . . . . . 0 C--O 1.244 0.785 0 CA-C-O 117.719 -1.134 . . . . 1.0900000000000001 111.562 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.445 -0.721 0 CA-C-O 121.677 0.751 . . . . 0.42999999999999999 109.635 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 96.4 m -158.25 135.65 10.2 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.039 -1.437 . . . . 0.14000000000000001 108.901 167.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.667 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.8 p90 174.56 158.3 0.16 Allowed 'General case' 0 C--O 1.213 -0.847 0 O-C-N 123.415 0.447 . . . . 0.14999999999999999 111.383 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.683 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -78.03 151.68 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 109.126 -0.694 . . . . 0.080000000000000002 109.126 164.478 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.577 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.43 142.39 24.82 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.606 -0.725 . . . . 2.0099999999999998 109.641 -176.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.732 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.47 161.84 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.162 0.506 . . . . 0.45000000000000001 111.501 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.557 ' N ' HG12 ' A' ' 347' ' ' VAL . 31.8 t0 -140.3 106.47 5.23 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.18 -1.415 . . . . 0.23999999999999999 107.18 174.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.069 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.24 -32.63 29.63 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 122.807 1.289 . . . . 0.16 110.262 -168.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.73 -45.32 89.9 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.615 -2.993 . . . . 0.59999999999999998 108.304 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -100.6 7.03 44.25 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 111.106 -2.77 . . . . 0.20000000000000001 110.713 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.628 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 19.0 mp0 33.62 60.63 0.49 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 112.683 -2.053 . . . . 2.1499999999999999 113.0 -175.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.501 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 20.3 t60 -141.71 134.7 28.95 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.383 -0.826 . . . . 0.089999999999999997 109.73 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.723 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.63 155.97 24.53 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.569 -0.741 . . . . 0.070000000000000007 110.203 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.611 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.7 m-90 -141.46 155.19 45.87 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.153 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.696 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.0 t80 -110.16 153.18 25.09 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 106.659 -1.608 . . . . 0.26000000000000001 106.659 151.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 8.8 m-85 -128.99 116.13 18.85 Favored 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 115.026 -0.988 . . . . 0.14000000000000001 110.413 -177.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.0 tppt? -116.41 140.23 49.57 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.085 -1.82 . . . . 0.25 106.085 168.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.439 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 67.19 18.01 10.35 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.29 0.848 . . . . 0.42999999999999999 113.29 172.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.24 8.34 85.32 Favored Glycine 0 CA--C 1.487 -1.703 0 CA-C-N 115.671 -0.695 . . . . 0.17999999999999999 113.197 -173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 15.4 ptmt -127.12 177.92 6.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 104.792 -2.299 . . . . 0.37 104.792 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.611 HG11 ' CD1' ' A' ' 355' ' ' TRP . 14.8 m -105.11 157.32 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.732 0 N-CA-C 116.374 1.99 . . . . 0.10000000000000001 116.374 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.671 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.53 -27.48 9.87 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 110.484 -3.053 . . . . 0.070000000000000007 106.242 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.838 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.02 144.01 48.45 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 111.675 -2.511 . . . . 0.059999999999999998 111.723 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.475 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -141.23 118.02 11.06 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.388 -2.449 . . . . 0.47999999999999998 104.388 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.723 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.52 163.96 36.39 Favored 'General case' 0 N--CA 1.399 -2.995 0 C-N-CA 118.051 -1.46 . . . . 0.070000000000000007 111.363 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -102.19 132.9 47.82 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 114.341 -1.3 . . . . 1.8 109.531 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.752 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -131.72 -175.06 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 CA-C-O 122.448 1.118 . . . . 0.12 112.29 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -149.9 118.42 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 112.927 -1.942 . . . . 0.10000000000000001 108.123 171.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -78.84 -168.46 1.43 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.132 -1.394 . . . . 1.26 110.822 -176.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -83.62 164.94 41.87 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 118.66 -1.733 . . . . 0.14000000000000001 112.076 -173.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.431 ' HG3' ' OG1' ' A' ' 374' ' ' THR . 7.0 ptmt -71.03 155.88 92.74 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.861 0.838 . . . . 0.81000000000000005 111.998 -165.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.3 Cg_exo -54.96 -29.44 64.4 Favored 'Trans proline' 0 CA--C 1.496 -1.423 1 C-N-CA 125.502 4.135 . . . . 0.28000000000000003 113.488 -175.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.434 ' OG1' HG22 ' A' ' 375' ' ' THR . 14.9 p -69.71 -33.91 73.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.432 -1.713 . . . . 0.33000000000000002 109.476 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.519 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.8 t -142.49 70.67 21.17 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 123.71 1.719 . . . . 0.39000000000000001 109.527 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.5 Cg_exo -57.65 149.88 64.99 Favored 'Trans proline' 0 C--N 1.31 -1.448 1 C-N-CA 126.389 4.726 . . . . 0.38 114.582 -171.049 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.537 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -79.05 145.04 64.5 Favored Pre-proline 0 N--CA 1.427 -1.619 0 N-CA-C 108.629 -0.878 . . . . 0.81999999999999995 108.629 173.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 17.4 Cg_exo -77.01 -45.81 0.16 Allowed 'Trans proline' 0 CA--C 1.512 -0.586 0 C-N-CA 124.523 3.482 . . . . 0.19 112.163 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.797 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.27 137.13 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 123.298 1.523 . . . . 0.13 113.557 -172.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.54 -113.3 0.57 Allowed Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 112.003 -2.362 . . . . 0.20000000000000001 109.533 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 8.1 p -131.02 116.28 33.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.887 0.851 . . . . 0.81999999999999995 110.899 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.757 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.3 m-85 -116.22 -174.31 2.53 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.253 -1.388 . . . . 0.22 107.253 173.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.6 t80 -140.98 125.05 17.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 120.186 1.357 . . . . 0.65000000000000002 113.436 -172.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -91.12 92.23 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 123.181 1.467 . . . . 0.16 109.609 169.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -93.15 11.12 28.92 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.419 -1.719 . . . . 2.5499999999999998 108.11 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.75 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 27.6 t-20 -169.22 126.97 0.97 Allowed 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 113.952 -1.476 . . . . 0.42999999999999999 110.363 172.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.669 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -98.98 145.22 27.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.041 -0.981 . . . . 1.1200000000000001 108.927 169.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.739 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 11.3 mm-40 -125.08 158.16 34.49 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 114.888 1.44 . . . . 0.70999999999999996 114.888 -169.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.725 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 50.4 mt-10 -137.44 126.96 25.06 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.913 -1.949 . . . . 0.38 108.436 173.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 31.1 t70 54.16 50.73 15.87 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 123.248 1.499 . . . . 0.40999999999999998 109.082 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.946 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -84.04 166.69 17.51 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 112.83 -1.986 . . . . 0.12 109.27 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 21.7 m -132.7 118.81 19.56 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.204 1.002 . . . . 0.17000000000000001 111.793 171.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.46 88.72 5.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.585 -1.643 . . . . 0.56999999999999995 112.136 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.57 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.4 mttt . . . . . 0 C--N 1.282 -2.346 0 CA-C-N 113.561 -1.654 . . . . 0.33000000000000002 113.14 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.57 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 121.031 0.443 . . . . 0.53000000000000003 110.051 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.66 97.47 5.01 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.376 -0.972 . . . . 0.19 108.376 171.567 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.0 Cg_exo -68.87 110.38 2.36 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 121.991 1.794 . . . . 0.19 110.045 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.946 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.76 154.87 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 CA-C-N 112.91 -1.95 . . . . 0.14999999999999999 107.521 -168.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.725 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 21.7 m-80 -87.11 -21.57 25.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.909 -0.774 . . . . 0.51000000000000001 108.909 -174.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 90.3 m-85 -157.59 127.61 6.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.959 -1.018 . . . . 0.27000000000000002 108.677 -170.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.678 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 23.3 t-105 -145.5 133.64 21.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.767 0.794 . . . . 0.089999999999999997 111.151 -167.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.669 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.3 mmt -114.96 93.26 33.86 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 107.747 -1.205 . . . . 0.14000000000000001 107.747 172.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.75 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.9 Cg_endo . . . . . 0 C--N 1.348 0.522 0 C-N-CA 122.527 2.151 . . . . 0.5 112.515 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 419' ' ' GLY . 38.3 t . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.44 0.638 . . . . 0.75 111.891 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -177.82 121.51 0.78 Allowed Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.72 -1.352 . . . . 0.20000000000000001 109.72 170.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.69 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.0 mp -81.94 142.66 13.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 120.884 -0.326 . . . . 0.28999999999999998 110.158 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.678 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.6 p80 -159.42 160.99 35.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.336 -0.393 . . . . 0.089999999999999997 111.949 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.679 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -83.65 147.53 27.64 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.141 -1.059 . . . . 1.0700000000000001 108.141 172.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 445' ' ' THR . 2.6 t -133.62 98.94 4.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.633 1.206 . . . . 0.23000000000000001 110.514 -173.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.465 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 11.2 t70 . . . . . 0 C--N 1.311 -1.103 0 CA-C-N 114.69 -1.141 . . . . 0.41999999999999998 109.593 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.562 ' HG3' ' HG ' ' A' ' 433' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 122.303 1.049 . . . . 2.1600000000000001 112.346 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.484 ' HA ' HD23 ' A' ' 433' ' ' LEU . 3.3 m-85 -155.15 130.17 9.45 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 104.517 -2.401 . . . . 0.33000000000000002 104.517 171.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.31 -158.71 31.59 Favored Glycine 0 C--N 1.288 -2.096 0 N-CA-C 110.052 -1.219 . . . . 0.17000000000000001 110.052 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.484 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.52 174.54 0.01 OUTLIER Glycine 0 CA--C 1.501 -0.819 0 C-N-CA 120.442 -0.885 . . . . 0.20999999999999999 111.806 168.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.518 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.0 p-10 -50.91 101.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 123.496 1.617 . . . . 1.8500000000000001 113.597 -152.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.724 ' HG ' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.79 -38.54 10.27 Favored 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 112.316 -2.22 . . . . 1.21 109.642 170.107 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.715 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.8 p-90 -55.39 -27.28 46.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.608 -0.724 . . . . 0.16 112.505 -170.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.715 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -88.99 -33.02 17.33 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.717 0.77 . . . . 0.22 112.089 -177.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 7.0 p -89.79 -44.66 9.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.381 -1.281 . . . . 0.25 110.918 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.724 ' CD ' ' HG ' ' A' ' 433' ' ' LEU . 7.4 mtp85 -88.23 -19.23 27.12 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.45 -1.25 . . . . 1.8200000000000001 109.92 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.73 46.0 48.12 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.248 -1.342 . . . . 0.23999999999999999 113.327 164.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.0 m -84.45 110.39 18.61 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.32 -0.952 . . . . 1.01 111.837 -168.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 40.12 -129.73 0.36 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.343 -1.298 . . . . 0.5 113.056 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -124.44 -20.37 2.42 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.712 -0.756 . . . . 0.26000000000000001 113.547 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.543 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.7 p -103.77 -165.71 1.18 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 113.278 0.844 . . . . 0.34999999999999998 113.278 -173.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.476 HD13 HG11 ' A' ' 465' ' ' VAL . 1.9 mp -92.85 133.18 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 0.12 110.548 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -102.55 97.55 7.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.728 -0.669 . . . . 0.62 109.462 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.752 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.7 m -92.64 141.51 24.63 Favored Pre-proline 0 N--CA 1.437 -1.081 0 CA-C-N 115.51 -0.768 . . . . 0.10000000000000001 112.262 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.643 ' HD2' HG21 ' A' ' 366' ' ' THR . 64.0 Cg_exo -52.16 144.26 38.82 Favored 'Trans proline' 0 CA--C 1.499 -1.228 0 C-N-CA 123.975 3.117 . . . . 0.23999999999999999 114.786 175.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 80.3 Cg_exo -52.34 -55.02 4.22 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.301 2.001 . . . . 0.31 110.698 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.492 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 51.9 p -57.23 -23.82 50.59 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 112.251 -2.25 . . . . 1.1000000000000001 113.74 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.838 ' O ' HD21 ' A' ' 364' ' ' LEU . 27.1 m -98.24 -49.18 11.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 N-CA-C 113.019 0.748 . . . . 0.080000000000000002 113.019 -173.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.957 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.72 -2.11 6.43 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.52 -0.872 . . . . 0.070000000000000007 110.235 -178.391 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.56 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 14.7 pttp -80.98 -38.16 28.07 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 122.651 1.215 . . . . 0.92000000000000004 108.335 173.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.6 mm-40 -62.17 -46.32 89.49 Favored 'General case' 0 CA--C 1.471 -2.073 0 CA-C-N 112.387 -2.188 . . . . 0.25 106.53 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.957 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.09 -66.35 0.42 Allowed 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 109.837 -3.347 . . . . 0.050000000000000003 112.786 172.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.552 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.7 t80 -46.68 -22.78 0.33 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.673 0.749 . . . . 0.13 109.457 175.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.447 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.5 -22.46 37.08 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.059 -0.973 . . . . 0.13 111.819 -176.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.743 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -106.34 -44.21 4.59 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 113.777 1.028 . . . . 0.059999999999999998 113.777 175.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.66 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.52 148.97 8.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 122.44 1.114 . . . . 0.080000000000000002 111.275 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.11 156.63 29.41 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 113.048 -1.887 . . . . 0.47999999999999998 108.517 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.613 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 3.6 mppt? -59.07 101.75 0.1 Allowed 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.903 -0.777 . . . . 0.98999999999999999 108.903 171.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.7 -10.65 5.47 Favored Glycine 0 C--N 1.308 -1.019 0 CA-C-N 113.962 -1.472 . . . . 0.19 111.576 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.634 HG21 ' HB ' ' A' ' 457' ' ' VAL . 18.2 m -68.61 150.8 97.55 Favored Pre-proline 0 N--CA 1.443 -0.803 0 N-CA-C 109.073 -0.714 . . . . 0.13 109.073 171.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.4 Cg_endo -93.99 163.37 2.14 Favored 'Trans proline' 0 N--CA 1.425 -2.516 0 C-N-CA 122.428 2.085 . . . . 0.17999999999999999 110.128 176.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.757 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -126.87 149.89 32.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 107.668 -1.234 . . . . 0.56999999999999995 107.668 171.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.702 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.47 149.89 50.77 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.411 -0.959 . . . . 0.13 108.411 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.069 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -138.25 141.82 36.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 105.434 -2.062 . . . . 0.10000000000000001 105.434 165.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.764 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 10.2 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 117.723 -1.132 . . . . 1.0900000000000001 111.664 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 . . . . . 0 N--CA 1.445 -0.705 0 CA-C-O 121.291 0.567 . . . . 0.42999999999999999 110.008 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 357' ' ' TYR . 84.3 m -158.39 135.56 9.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.62 -1.173 . . . . 0.14000000000000001 109.067 168.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.696 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.7 p90 174.42 158.63 0.16 Allowed 'General case' 0 CA--C 1.503 -0.829 0 O-C-N 123.386 0.429 . . . . 0.14999999999999999 111.132 -175.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.659 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.92 152.33 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 109.106 -0.702 . . . . 0.080000000000000002 109.106 164.131 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.614 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.65 143.05 25.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.64 -0.709 . . . . 2.0099999999999998 109.551 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.725 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.59 162.16 37.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.027 0.441 . . . . 0.45000000000000001 111.378 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.558 ' N ' HG12 ' A' ' 347' ' ' VAL . 20.5 t0 -139.91 107.26 5.53 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.404 -1.332 . . . . 0.23999999999999999 107.404 172.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.034 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.51 -34.38 27.97 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 122.719 1.247 . . . . 0.16 110.52 -167.738 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.432 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.1 mt-10 -58.41 -45.26 88.75 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.871 -2.877 . . . . 0.59999999999999998 108.252 176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 19.4 m-80 -99.99 6.47 45.11 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 111.031 -2.804 . . . . 0.20000000000000001 110.889 -175.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 18.1 mp0 33.53 61.7 0.44 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 112.545 -2.116 . . . . 2.1499999999999999 113.11 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.8 t60 -141.92 135.18 29.18 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.612 -0.722 . . . . 0.089999999999999997 109.733 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.723 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -114.23 156.17 24.81 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.735 -0.666 . . . . 0.070000000000000007 110.233 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.576 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.0 m-90 -141.17 153.93 45.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.373 -0.831 . . . . 0.11 111.269 -174.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.684 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 86.1 t80 -109.76 153.21 24.66 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 106.599 -1.63 . . . . 0.26000000000000001 106.599 151.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.5 m-85 -129.25 116.61 19.4 Favored 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 114.699 -1.137 . . . . 0.14000000000000001 110.226 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.5 tppt? -115.88 137.3 52.23 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.703 -1.962 . . . . 0.25 105.703 167.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.423 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.73 18.31 8.72 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.61 0.967 . . . . 0.42999999999999999 113.61 172.619 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.31 8.1 86.99 Favored Glycine 0 CA--C 1.487 -1.697 0 CA-C-O 121.779 0.655 . . . . 0.17999999999999999 113.015 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 15.8 ptmt -128.13 176.95 7.25 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 104.569 -2.382 . . . . 0.37 104.569 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.4 m -104.38 157.86 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.611 0 N-CA-C 116.289 1.959 . . . . 0.10000000000000001 116.289 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.684 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.87 -26.61 9.7 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 110.516 -3.038 . . . . 0.070000000000000007 106.646 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.803 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.84 144.96 47.88 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 111.669 -2.514 . . . . 0.059999999999999998 111.753 -175.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.508 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 5.8 tt0 -139.92 118.15 12.0 Favored 'General case' 0 N--CA 1.408 -2.53 0 N-CA-C 104.411 -2.44 . . . . 0.47999999999999998 104.411 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.723 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.09 163.39 38.31 Favored 'General case' 0 N--CA 1.4 -2.971 0 C-N-CA 117.466 -1.693 . . . . 0.070000000000000007 111.917 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 18.1 p-10 -103.02 134.33 46.64 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-N 114.293 -1.321 . . . . 1.8 109.57 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.89 -172.34 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 CA-C-O 122.508 1.147 . . . . 0.12 112.414 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.532 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.23 120.89 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 112.832 -1.985 . . . . 0.10000000000000001 108.423 172.256 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.521 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.86 -168.14 1.5 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.315 -1.311 . . . . 1.26 110.708 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -83.96 170.33 47.42 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 118.907 -1.616 . . . . 0.14000000000000001 112.152 -173.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -78.6 162.89 63.99 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 113.109 0.781 . . . . 0.81000000000000005 113.109 -162.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.731 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 74.9 Cg_exo -54.84 -37.53 92.57 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 C-N-CA 123.058 2.505 . . . . 0.28000000000000003 112.56 -175.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.42 ' OG1' HG22 ' A' ' 375' ' ' THR . 25.2 p -66.06 -33.96 76.98 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.337 -1.301 . . . . 0.33000000000000002 110.085 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.523 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.5 t -141.56 72.69 25.1 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-O 123.69 1.709 . . . . 0.39000000000000001 109.743 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 375' ' ' THR . 74.3 Cg_exo -61.37 160.5 27.04 Favored 'Trans proline' 0 C--N 1.311 -1.423 1 C-N-CA 126.345 4.697 . . . . 0.38 114.346 -173.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.521 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -91.55 144.71 29.99 Favored Pre-proline 0 N--CA 1.42 -1.96 0 N-CA-C 108.305 -0.998 . . . . 0.81999999999999995 108.305 171.355 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 20.4 Cg_exo -76.44 -43.88 0.27 Allowed 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 124.844 3.696 . . . . 0.19 112.139 -168.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.785 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.96 134.6 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.488 1.613 . . . . 0.13 113.562 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 155.14 -116.15 0.71 Allowed Glycine 0 N--CA 1.429 -1.791 0 CA-C-N 111.959 -2.382 . . . . 0.20000000000000001 109.627 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 381' ' ' VAL . 8.4 p -130.34 115.69 33.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.861 0.839 . . . . 0.81999999999999995 110.899 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.743 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.7 m-85 -115.36 -174.01 2.43 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.34 -1.355 . . . . 0.22 107.34 174.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 0.8 OUTLIER -139.65 123.49 17.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.881 1.219 . . . . 0.65000000000000002 113.268 -171.522 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -91.74 91.67 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 CA-C-O 123.189 1.471 . . . . 0.16 109.39 168.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -93.44 10.58 31.74 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 113.106 -1.861 . . . . 2.5499999999999998 107.908 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.757 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.7 t30 -168.78 125.6 0.98 Allowed 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 113.774 -1.557 . . . . 0.42999999999999999 109.939 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.651 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.9 143.52 30.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.902 -1.044 . . . . 1.1200000000000001 108.86 169.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.785 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 20.4 mm-40 -125.17 155.18 40.36 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 114.441 1.274 . . . . 0.70999999999999996 114.441 -168.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.775 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 41.0 mt-10 -136.86 126.55 25.45 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 112.947 -1.933 . . . . 0.38 108.287 171.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.6 t70 57.56 53.34 7.43 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 123.459 1.6 . . . . 0.40999999999999998 109.144 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.914 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -89.29 166.38 13.81 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 112.451 -2.159 . . . . 0.12 108.501 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 31.6 m -132.93 120.03 20.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.092 0.949 . . . . 0.17000000000000001 111.862 171.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.755 HD11 HG21 ' A' ' 407' ' ' VAL . 8.9 mt -75.75 88.29 2.81 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.828 -1.533 . . . . 0.56999999999999995 112.796 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.54 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 44.9 mttt . . . . . 0 C--N 1.286 -2.154 0 CA-C-N 114.492 -1.231 . . . . 0.33000000000000002 113.751 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.54 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.713 0 CA-C-O 121.027 0.441 . . . . 0.53000000000000003 110.07 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.647 ' O ' ' HG ' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.98 97.54 4.85 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.304 -0.998 . . . . 0.19 108.304 171.22 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 14.4 Cg_exo -70.27 108.21 2.13 Favored 'Trans proline' 0 N--CA 1.432 -2.127 0 C-N-CA 121.023 1.149 . . . . 0.19 110.016 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -106.22 152.4 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.285 0 CA-C-N 112.816 -1.993 . . . . 0.14999999999999999 108.55 -169.202 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.775 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 3.1 m-20 -86.08 -19.17 30.64 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.753 -0.832 . . . . 0.51000000000000001 108.753 -174.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.785 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.4 m-85 -158.05 126.02 5.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.378 -0.828 . . . . 0.27000000000000002 108.938 -171.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.675 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 21.4 t-105 -144.94 134.24 22.96 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.705 0.764 . . . . 0.089999999999999997 111.18 -167.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.651 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.1 mmt -116.44 93.64 40.59 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.746 -1.205 . . . . 0.14000000000000001 107.746 172.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.757 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.6 Cg_endo . . . . . 0 C--N 1.348 0.502 0 C-N-CA 122.532 2.154 . . . . 0.5 112.95 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 419' ' ' GLY . 36.0 t . . . . . 0 CA--C 1.532 0.288 0 CA-C-O 121.359 0.6 . . . . 0.75 112.298 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.593 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.71 120.74 0.72 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.861 -1.296 . . . . 0.20000000000000001 109.861 170.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.686 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.43 141.83 14.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 110.041 -0.355 . . . . 0.28999999999999998 110.041 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.675 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.2 p80 -157.92 161.21 38.22 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 116.091 -0.504 . . . . 0.089999999999999997 111.173 -174.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.699 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.2 OUTLIER -84.18 148.16 26.91 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.178 -1.045 . . . . 1.0700000000000001 108.178 172.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 445' ' ' THR . 45.9 t -134.18 96.1 3.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.707 0.765 . . . . 0.23000000000000001 109.844 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 19.6 t70 . . . . . 0 C--N 1.315 -0.913 0 CA-C-N 114.3 -1.318 . . . . 0.41999999999999998 109.921 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.599 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.4 pm0 . . . . . 0 N--CA 1.437 -1.076 0 CA-C-O 122.39 1.091 . . . . 2.1600000000000001 113.242 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.632 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.04 130.88 4.3 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 104.93 -2.248 . . . . 0.33000000000000002 104.93 170.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.46 -158.63 31.62 Favored Glycine 0 C--N 1.284 -2.35 0 C-N-CA 119.806 -1.188 . . . . 0.17000000000000001 110.792 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.35 175.33 0.01 OUTLIER Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 120.519 -0.848 . . . . 0.20999999999999999 111.713 167.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.489 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 7.8 p-10 -50.58 101.8 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 123.473 1.606 . . . . 1.8500000000000001 113.445 -153.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.73 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -97.13 -37.69 10.02 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 112.639 -2.073 . . . . 1.21 109.478 169.237 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.744 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -54.13 -28.04 37.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.36 -0.836 . . . . 0.16 112.286 -170.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.744 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.67 -35.07 15.16 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.697 0.629 . . . . 0.22 112.697 -178.029 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.2 p -90.98 -40.86 11.43 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.262 -0.881 . . . . 0.25 111.014 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.73 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -95.49 -17.21 21.65 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.646 -1.161 . . . . 1.8200000000000001 109.693 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.76 50.11 51.1 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.91 -1.041 . . . . 0.23999999999999999 115.22 161.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.8 m -82.06 109.82 16.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.923 1.362 . . . . 1.01 110.845 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 32.59 -112.16 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.467 -1.242 . . . . 0.5 113.418 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -140.49 -14.6 0.52 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.898 -0.592 . . . . 0.26000000000000001 113.767 -174.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 28.8 p -104.59 -166.32 1.23 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 117.75 0.775 . . . . 0.34999999999999998 112.467 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.438 ' CD1' HG11 ' A' ' 465' ' ' VAL . 2.1 mp -96.65 129.63 46.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.839 -1.073 . . . . 0.12 110.465 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -101.55 93.15 5.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.815 -0.629 . . . . 0.62 110.123 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.726 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -89.15 142.98 30.44 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.936 -1.029 . . . . 0.10000000000000001 112.731 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.657 ' HD2' HG21 ' A' ' 366' ' ' THR . 75.0 Cg_exo -50.16 146.47 17.72 Favored 'Trans proline' 0 CA--C 1.507 -0.857 0 C-N-CA 124.15 3.234 . . . . 0.23999999999999999 113.323 174.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.699 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.3 Cg_exo -67.33 -25.07 42.65 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.887 2.392 . . . . 0.31 111.834 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.511 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 40.4 p -76.61 -26.09 54.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.94 -1.027 . . . . 1.1000000000000001 112.036 -175.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.803 ' O ' HD21 ' A' ' 364' ' ' LEU . 33.4 m -99.27 -49.75 11.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 112.806 0.669 . . . . 0.080000000000000002 112.806 -170.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.954 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.51 -2.25 4.49 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.743 -0.783 . . . . 0.070000000000000007 110.409 -178.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 40.9 pttt -81.29 -38.74 26.33 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 122.518 1.151 . . . . 0.92000000000000004 108.335 173.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.1 mm-40 -62.94 -46.7 86.52 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 112.47 -2.15 . . . . 0.25 106.688 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.954 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -46.68 -67.16 0.31 Allowed 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 109.906 -3.316 . . . . 0.050000000000000003 112.736 172.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.527 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 16.4 t80 -44.91 -24.85 0.25 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 124.191 0.932 . . . . 0.13 109.39 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -87.57 -30.12 19.58 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.551 -1.204 . . . . 0.13 111.607 -175.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.753 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -98.27 -44.12 6.69 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 113.21 0.818 . . . . 0.059999999999999998 113.21 178.069 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -73.75 147.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 122.558 1.17 . . . . 0.080000000000000002 111.126 179.402 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.61 156.58 27.9 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 112.809 -1.996 . . . . 0.47999999999999998 108.473 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 42.4 mtmt -55.76 102.73 0.08 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.699 -0.682 . . . . 0.98999999999999999 109.517 169.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.79 -13.22 5.85 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 113.792 -1.549 . . . . 0.19 111.779 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.665 HG21 ' HB ' ' A' ' 457' ' ' VAL . 17.3 m -64.85 150.1 95.29 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 108.996 -0.742 . . . . 0.13 108.996 173.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.1 Cg_endo -93.62 160.33 2.36 Favored 'Trans proline' 0 N--CA 1.424 -2.616 0 C-N-CA 122.331 2.021 . . . . 0.17999999999999999 109.962 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.743 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -124.6 149.87 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.317 -1.364 . . . . 0.56999999999999995 107.317 171.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.696 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.6 mp -134.42 149.99 50.82 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.339 -0.986 . . . . 0.13 108.339 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.034 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.82 140.95 40.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 105.647 -1.983 . . . . 0.10000000000000001 105.647 166.153 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.683 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 5.4 p90 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 117.649 -1.167 . . . . 1.0900000000000001 111.139 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.505 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 4.6 m-20 . . . . . 0 N--CA 1.444 -0.762 0 CA-C-O 121.279 0.561 . . . . 0.42999999999999999 109.993 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.782 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 53.2 m -156.86 132.71 9.54 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.358 -1.292 . . . . 0.14000000000000001 108.268 167.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.758 ' CD2' HD13 ' A' ' 464' ' ' LEU . 42.9 p90 174.73 158.38 0.17 Allowed 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 123.421 0.451 . . . . 0.14999999999999999 111.002 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.658 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.34 153.71 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.387 -0.598 . . . . 0.080000000000000002 109.387 165.364 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.71 146.63 28.21 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.826 -1.175 . . . . 2.0099999999999998 107.826 -178.488 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.748 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.4 155.03 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 C-N-CA 123.579 0.752 . . . . 0.45000000000000001 110.618 173.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.524 ' N ' HG12 ' A' ' 347' ' ' VAL . 48.0 t0 -137.19 105.33 5.69 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.255 -1.757 . . . . 0.23999999999999999 106.255 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.058 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -79.62 -35.83 38.89 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 123.11 1.433 . . . . 0.16 110.019 -166.039 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.04 -44.98 79.33 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 110.682 -2.963 . . . . 0.59999999999999998 108.037 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -101.02 7.1 43.62 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 110.815 -2.902 . . . . 0.20000000000000001 110.893 -174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 21.6 mp0 32.78 61.44 0.38 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 112.628 -2.078 . . . . 2.1499999999999999 112.928 -175.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.508 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 24.1 t60 -141.94 135.77 29.73 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.77 -0.65 . . . . 0.089999999999999997 109.837 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.777 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.65 157.26 22.38 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.91 -0.586 . . . . 0.070000000000000007 110.155 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.666 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -142.68 160.06 41.04 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.81 -0.632 . . . . 0.11 111.254 -177.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.782 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.6 t80 -112.3 153.9 26.49 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 106.45 -1.685 . . . . 0.26000000000000001 106.45 150.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.5 m-85 -127.51 119.21 25.55 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 115.119 -0.946 . . . . 0.14000000000000001 110.126 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.4 tppt? -120.47 134.88 55.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.124 -1.806 . . . . 0.25 106.124 168.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 72.98 16.32 4.41 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 113.216 0.821 . . . . 0.42999999999999999 113.216 172.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.505 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.68 6.79 88.35 Favored Glycine 0 CA--C 1.486 -1.767 0 C-N-CA 120.995 -0.621 . . . . 0.17999999999999999 113.05 -172.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.3 ptmt -128.49 176.39 7.78 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 104.872 -2.269 . . . . 0.37 104.872 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.666 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.4 m -104.83 156.89 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 116.597 2.073 . . . . 0.10000000000000001 116.597 -175.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.708 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.76 -27.34 10.34 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 110.672 -2.967 . . . . 0.070000000000000007 106.599 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.792 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.9 145.39 49.57 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 111.405 -2.634 . . . . 0.059999999999999998 111.301 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.486 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -142.1 118.08 10.6 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 104.504 -2.406 . . . . 0.47999999999999998 104.504 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.777 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.3 164.87 33.64 Favored 'General case' 0 N--CA 1.402 -2.857 0 C-N-CA 117.997 -1.481 . . . . 0.070000000000000007 111.803 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.585 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 12.2 p-10 -102.95 132.69 49.0 Favored 'General case' 0 N--CA 1.41 -2.458 0 CA-C-N 114.109 -1.405 . . . . 1.8 109.791 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.741 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.02 -173.48 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-O 122.522 1.153 . . . . 0.12 112.425 -171.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.09 120.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 112.719 -2.037 . . . . 0.10000000000000001 108.123 172.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.478 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -78.73 -168.6 1.45 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.23 -1.35 . . . . 1.26 110.325 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.553 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.16 170.51 45.15 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 118.601 -1.761 . . . . 0.14000000000000001 112.631 -173.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.5 ptmt -72.96 155.28 90.6 Favored Pre-proline 0 C--O 1.218 -0.603 0 CA-C-O 121.42 0.629 . . . . 0.81000000000000005 111.576 -166.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.664 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 77.9 Cg_exo -55.04 -28.29 59.37 Favored 'Trans proline' 0 CA--C 1.497 -1.326 0 C-N-CA 125.243 3.962 . . . . 0.28000000000000003 113.665 -173.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.44 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 26.2 p -72.6 -32.28 65.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.621 -1.627 . . . . 0.33000000000000002 109.586 -176.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.548 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 0.4 OUTLIER -141.37 70.56 26.93 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-O 123.426 1.584 . . . . 0.39000000000000001 110.127 178.577 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 375' ' ' THR . 76.1 Cg_exo -59.4 157.5 30.85 Favored 'Trans proline' 0 C--N 1.311 -1.406 1 C-N-CA 126.309 4.673 . . . . 0.38 113.996 -172.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.487 HG21 ' HG ' ' A' ' 349' ' ' LEU . 0.5 OUTLIER -84.97 147.74 48.93 Favored Pre-proline 0 N--CA 1.422 -1.875 0 N-CA-C 108.198 -1.038 . . . . 0.81999999999999995 108.198 174.212 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 15.5 Cg_exo -77.6 -42.39 0.27 Allowed 'Trans proline' 0 CA--C 1.514 -0.505 0 C-N-CA 124.124 3.216 . . . . 0.19 112.363 -166.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 54.99 137.83 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 123.604 1.668 . . . . 0.13 114.487 -173.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.75 -109.91 0.44 Allowed Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 111.997 -2.365 . . . . 0.20000000000000001 109.549 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.75 124.32 56.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.328 0.585 . . . . 0.81999999999999995 109.724 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.748 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 4.7 m-85 -123.65 -174.45 2.97 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.497 -1.297 . . . . 0.22 107.497 172.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.0 OUTLIER -139.85 123.22 17.07 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 119.471 1.032 . . . . 0.65000000000000002 112.953 -171.072 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.84 91.14 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-O 123.296 1.522 . . . . 0.16 109.032 169.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -93.9 11.82 28.14 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 112.978 -1.919 . . . . 2.5499999999999998 107.873 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.744 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.9 t30 -168.49 124.9 1.01 Allowed 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 113.627 -1.624 . . . . 0.42999999999999999 110.009 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.646 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.19 143.53 31.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.086 -0.961 . . . . 1.1200000000000001 108.949 170.213 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.758 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 37.1 mm-40 -126.95 158.46 36.77 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 114.961 1.467 . . . . 0.70999999999999996 114.961 -167.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 43.6 mt-10 -138.75 126.65 22.34 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.194 -1.821 . . . . 0.38 108.796 174.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 18.6 t70 52.15 51.88 15.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 123.165 1.459 . . . . 0.40999999999999998 109.231 -173.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.924 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -82.92 167.46 17.97 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.764 -2.016 . . . . 0.12 109.005 176.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 15.8 m -132.93 120.53 21.58 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.863 0.84 . . . . 0.17000000000000001 111.291 169.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.6 mp -78.02 87.2 4.18 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.969 -1.468 . . . . 0.56999999999999995 111.417 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.553 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 45.8 mttt . . . . . 0 C--N 1.288 -2.071 0 CA-C-N 113.393 -1.731 . . . . 0.33000000000000002 113.573 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.553 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.664 0 CA-C-O 120.971 0.415 . . . . 0.53000000000000003 110.798 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.9 OUTLIER -145.14 97.32 4.82 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 108.305 -0.998 . . . . 0.19 108.305 170.71 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.2 Cg_exo -68.73 111.26 2.55 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 122.089 1.859 . . . . 0.19 110.49 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.924 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -112.74 151.21 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 CA-C-N 113.206 -1.815 . . . . 0.14999999999999999 107.993 -167.725 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.709 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 3.9 m-20 -85.12 -19.53 31.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.789 -0.819 . . . . 0.51000000000000001 108.789 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 97.5 m-85 -159.69 126.62 4.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.404 -0.961 . . . . 0.27000000000000002 108.404 -170.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.69 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 19.1 t-105 -144.14 136.04 26.22 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.7 0.762 . . . . 0.089999999999999997 111.174 -166.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.646 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.1 mmt -118.99 91.26 42.96 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.855 -1.165 . . . . 0.14000000000000001 107.855 173.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.744 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 35.7 Cg_endo . . . . . 0 CA--C 1.514 -0.521 0 C-N-CA 122.387 2.058 . . . . 0.5 111.289 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.699 HG11 ' CE2' ' A' ' 382' ' ' PHE . 2.4 p . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 112.244 0.461 . . . . 0.75 112.244 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 442' ' ' CYS . . . -174.05 124.0 1.0 Allowed Glycine 0 CA--C 1.497 -1.092 0 N-CA-C 110.355 -1.098 . . . . 0.20000000000000001 110.355 172.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.674 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.4 mp -81.7 142.8 13.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.8 0.333 . . . . 0.28999999999999998 110.453 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.69 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.1 p80 -160.63 162.31 32.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.841 -0.618 . . . . 0.089999999999999997 110.924 -175.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.693 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.2 OUTLIER -86.65 148.32 25.51 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.731 -1.211 . . . . 1.0700000000000001 107.731 172.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 445' ' ' THR . 45.3 t -133.05 96.71 3.83 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.803 0.811 . . . . 0.23000000000000001 109.943 -170.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 114.134 -1.394 . . . . 0.41999999999999998 109.445 -176.051 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.622 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.2 pm0 . . . . . 0 N--CA 1.43 -1.45 0 CA-C-O 122.304 1.049 . . . . 2.1600000000000001 113.018 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.66 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -156.6 132.87 9.89 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 105.456 -2.054 . . . . 0.33000000000000002 105.456 167.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.14 -159.06 32.14 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 110.497 -1.041 . . . . 0.17000000000000001 110.497 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.503 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -46.8 175.34 0.01 OUTLIER Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.372 -0.918 . . . . 0.20999999999999999 111.71 168.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.538 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 10.1 p-10 -51.69 101.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.453 1.597 . . . . 1.8500000000000001 113.733 -155.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 1.044 HD22 ' HD2' ' A' ' 437' ' ' ARG . 35.6 mt -97.86 -35.34 10.53 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 112.038 -2.347 . . . . 1.21 109.467 170.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.701 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.0 p-90 -53.07 -26.95 17.85 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.012 -0.994 . . . . 0.16 112.071 -172.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.701 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.28 -35.77 15.09 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.611 -0.722 . . . . 0.22 112.482 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.8 p -88.51 -37.71 15.54 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.468 -0.787 . . . . 0.25 110.617 -176.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 1.044 ' HD2' HD22 ' A' ' 433' ' ' LEU . 0.4 OUTLIER -99.25 -19.64 16.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.676 -1.147 . . . . 1.8200000000000001 110.715 -178.382 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.34 49.62 50.42 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 115.988 1.155 . . . . 0.23999999999999999 115.988 162.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.1 m -82.3 111.07 18.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 119.745 1.773 . . . . 1.01 111.105 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 37.74 -113.64 0.11 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.635 0.976 . . . . 0.5 113.635 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.553 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -142.91 -14.87 0.31 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.62 -0.718 . . . . 0.26000000000000001 113.838 -173.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 26.4 p -101.56 -167.31 1.4 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.994 0.897 . . . . 0.34999999999999998 112.233 -177.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.46 HG12 HG11 ' A' ' 347' ' ' VAL . 2.3 mp -99.31 128.35 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 115.096 -0.956 . . . . 0.12 110.751 -174.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -100.32 92.37 5.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.577 -0.738 . . . . 0.62 110.234 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.741 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.1 m -88.1 143.3 32.77 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.024 -0.989 . . . . 0.10000000000000001 112.64 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.662 ' HD2' HG21 ' A' ' 366' ' ' THR . 74.1 Cg_exo -50.52 143.12 28.82 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 123.67 2.914 . . . . 0.23999999999999999 112.854 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.681 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.3 Cg_exo -64.42 -24.08 64.48 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.762 2.308 . . . . 0.31 111.914 -176.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.5 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 36.6 p -78.06 -25.49 47.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.217 -0.901 . . . . 1.1000000000000001 112.444 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.792 ' O ' HD21 ' A' ' 364' ' ' LEU . 33.2 m -99.71 -48.76 11.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 112.801 0.667 . . . . 0.080000000000000002 112.801 -171.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.952 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.39 -2.13 4.21 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.925 -0.71 . . . . 0.070000000000000007 110.379 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.611 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 42.6 pttt -81.17 -39.03 26.14 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.47 1.129 . . . . 0.92000000000000004 108.188 173.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.9 mm-40 -62.0 -46.24 90.09 Favored 'General case' 0 CA--C 1.473 -1.999 0 CA-C-N 112.545 -2.116 . . . . 0.25 106.593 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.952 HD23 ' SD ' ' A' ' 450' ' ' MET . 4.0 tp -46.61 -67.09 0.31 Allowed 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 109.679 -3.419 . . . . 0.050000000000000003 112.755 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.495 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 14.6 t80 -45.37 -24.1 0.26 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 123.972 0.795 . . . . 0.13 109.584 177.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.52 -26.64 27.07 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.68 -1.145 . . . . 0.13 111.899 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.739 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -100.9 -43.68 6.0 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 113.157 0.799 . . . . 0.059999999999999998 113.157 176.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.669 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -74.69 146.96 9.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.674 1.226 . . . . 0.080000000000000002 111.191 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.24 156.1 28.32 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 112.536 -2.12 . . . . 0.47999999999999998 108.499 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.628 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 40.1 mtmt -59.09 101.34 0.09 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.786 0.803 . . . . 0.98999999999999999 109.614 171.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 132.3 -14.14 5.12 Favored Glycine 0 C--N 1.304 -1.235 0 CA-C-N 113.556 -1.656 . . . . 0.19 111.452 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.669 HG21 ' HB ' ' A' ' 457' ' ' VAL . 14.7 m -65.11 150.31 95.63 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 108.854 -0.795 . . . . 0.13 108.854 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.0 Cg_endo -93.5 162.03 2.39 Favored 'Trans proline' 0 N--CA 1.421 -2.746 0 C-N-CA 122.204 1.936 . . . . 0.17999999999999999 109.813 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.748 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -125.68 151.91 32.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.465 -1.309 . . . . 0.56999999999999995 107.465 171.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.758 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.3 mp -133.84 150.07 51.38 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.27 -1.011 . . . . 0.13 108.27 175.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.058 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.53 137.88 36.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 103.879 -2.637 . . . . 0.10000000000000001 103.879 163.322 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 1.6 p90 . . . . . 0 C--O 1.25 1.129 0 O-C-N 123.742 0.651 . . . . 1.0900000000000001 111.378 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.45 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 18.6 m-20 . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 121.293 0.568 . . . . 0.42999999999999999 109.68 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 92.7 m -158.59 136.27 10.31 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.794 -1.094 . . . . 0.14000000000000001 109.02 168.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.763 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.9 p90 173.92 158.44 0.14 Allowed 'General case' 0 C--O 1.211 -0.963 0 O-C-N 123.582 0.551 . . . . 0.14999999999999999 111.329 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.676 HD11 HG11 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.63 153.66 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.181 -0.674 . . . . 0.080000000000000002 109.181 164.481 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.01 146.28 28.85 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.778 -1.193 . . . . 2.0099999999999998 107.778 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.05 155.8 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 C-N-CA 123.381 0.673 . . . . 0.45000000000000001 110.527 174.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 347' ' ' VAL . 31.4 t0 -137.99 106.68 5.89 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.755 -1.572 . . . . 0.23999999999999999 106.755 175.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 465' ' ' VAL . 0.2 OUTLIER -81.03 -34.77 32.61 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-O 123.094 1.426 . . . . 0.16 110.047 -166.487 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 466' ' ' PHE . 0.8 OUTLIER -58.88 -44.94 91.21 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 110.617 -2.992 . . . . 0.59999999999999998 108.064 177.234 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -101.23 7.94 42.78 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 111.216 -2.72 . . . . 0.20000000000000001 110.88 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.556 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.5 mp0 31.36 62.54 0.24 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 112.673 -2.058 . . . . 2.1499999999999999 113.316 -175.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.523 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 26.7 t60 -142.85 136.37 28.66 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.724 -0.671 . . . . 0.089999999999999997 109.661 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.779 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -114.11 156.48 24.12 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 116.114 -0.494 . . . . 0.070000000000000007 110.084 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.67 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.4 m-90 -142.25 158.66 43.47 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.648 -0.706 . . . . 0.11 111.191 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.703 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.8 t80 -111.32 154.07 25.05 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.607 -1.627 . . . . 0.26000000000000001 106.607 151.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.4 m-85 -128.13 116.92 20.7 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 115.262 -0.881 . . . . 0.14000000000000001 110.513 -178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.7 tppt? -119.05 140.03 50.75 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.338 -1.727 . . . . 0.25 106.338 168.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.408 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.49 16.27 9.15 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.174 0.805 . . . . 0.42999999999999999 113.174 174.137 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.18 6.99 87.82 Favored Glycine 0 CA--C 1.485 -1.815 0 CA-C-N 115.563 -0.744 . . . . 0.17999999999999999 113.024 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.5 ptmt -127.68 178.77 5.91 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 104.375 -2.454 . . . . 0.37 104.375 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.67 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.9 m -104.37 157.76 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 N-CA-C 116.412 2.004 . . . . 0.10000000000000001 116.412 -176.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.69 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.35 -28.04 9.64 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 110.773 -2.921 . . . . 0.070000000000000007 106.635 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -132.84 144.63 50.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 111.52 -2.582 . . . . 0.059999999999999998 111.435 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.521 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 5.6 tt0 -138.8 119.33 13.9 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 104.238 -2.504 . . . . 0.47999999999999998 104.238 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.779 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.3 164.84 34.75 Favored 'General case' 0 N--CA 1.401 -2.898 0 C-N-CA 117.644 -1.622 . . . . 0.070000000000000007 111.989 178.272 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.571 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 16.9 p-10 -103.46 134.2 47.23 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.373 -1.285 . . . . 1.8 109.784 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.721 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -136.8 -172.92 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 CA-C-O 122.417 1.103 . . . . 0.12 112.515 -171.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -153.33 121.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 112.745 -2.025 . . . . 0.10000000000000001 108.498 172.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.485 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.36 -168.79 1.64 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.268 -1.333 . . . . 1.26 110.556 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.404 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.36 170.79 45.1 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 118.649 -1.738 . . . . 0.14000000000000001 112.465 -174.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 7.0 ptpt -74.61 157.38 86.11 Favored Pre-proline 0 C--O 1.221 -0.404 0 CA-C-O 121.402 0.62 . . . . 0.81000000000000005 111.893 -166.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.671 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 99.4 Cg_exo -55.81 -30.04 74.75 Favored 'Trans proline' 0 CA--C 1.495 -1.436 0 C-N-CA 125.27 3.98 . . . . 0.28000000000000003 113.15 -172.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.474 ' OG1' HG22 ' A' ' 375' ' ' THR . 16.0 p -68.54 -33.18 73.65 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.304 -1.771 . . . . 0.33000000000000002 109.774 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.531 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -140.88 70.33 29.62 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 123.487 1.613 . . . . 0.39000000000000001 109.522 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.0 Cg_exo -58.61 157.1 28.76 Favored 'Trans proline' 0 C--N 1.307 -1.631 1 C-N-CA 126.191 4.594 . . . . 0.38 114.265 -171.713 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.485 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -89.61 143.13 30.0 Favored Pre-proline 0 N--CA 1.418 -2.04 0 N-CA-C 108.093 -1.077 . . . . 0.81999999999999995 108.093 171.047 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.8 Cg_exo -76.33 -44.1 0.27 Allowed 'Trans proline' 0 CA--C 1.508 -0.82 0 C-N-CA 124.565 3.51 . . . . 0.19 111.979 -167.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.814 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 59.37 137.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 123.582 1.658 . . . . 0.13 113.605 -172.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 154.39 -110.81 0.46 Allowed Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 112.064 -2.334 . . . . 0.20000000000000001 109.503 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.5 p -131.24 120.63 47.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.871 0.844 . . . . 0.81999999999999995 110.232 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.747 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.6 m-85 -119.47 -174.59 2.77 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.87 -1.53 . . . . 0.22 106.87 172.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.6 t80 -139.54 123.48 17.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 120.07 1.304 . . . . 0.65000000000000002 113.206 -171.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 2.1 p -88.66 91.29 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 123.132 1.444 . . . . 0.16 109.109 168.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -92.38 10.83 28.28 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.276 -1.784 . . . . 2.5499999999999998 108.014 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.735 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 25.5 t-20 -169.03 126.73 0.98 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.836 -1.529 . . . . 0.42999999999999999 110.492 171.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.67 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -97.63 141.8 30.23 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.889 -1.051 . . . . 1.1200000000000001 108.815 169.352 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.77 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 14.7 mm-40 -125.97 157.02 38.88 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 114.538 1.31 . . . . 0.70999999999999996 114.538 -168.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.74 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.0 mt-10 -137.41 127.26 25.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 112.912 -1.949 . . . . 0.38 108.461 173.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.2 t70 57.6 47.23 16.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 123.446 1.593 . . . . 0.40999999999999998 109.072 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.913 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -84.27 167.48 16.57 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 112.474 -2.148 . . . . 0.12 109.457 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 19.9 m -132.35 119.09 20.25 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.188 0.994 . . . . 0.17000000000000001 112.149 171.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 4.1 mp -81.77 91.76 6.54 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.63 -1.623 . . . . 0.56999999999999995 112.498 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.571 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.7 mttt . . . . . 0 C--N 1.285 -2.236 0 CA-C-N 114.0 -1.454 . . . . 0.33000000000000002 113.572 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.571 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.44 -0.928 0 N-CA-C 109.642 -0.503 . . . . 0.53000000000000003 109.642 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -143.55 97.29 5.54 Favored Pre-proline 0 N--CA 1.432 -1.335 0 N-CA-C 108.176 -1.046 . . . . 0.19 108.176 172.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 16.8 Cg_exo -69.44 110.0 2.39 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 121.994 1.796 . . . . 0.19 109.654 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.913 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.9 154.22 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 CA-C-N 113.057 -1.883 . . . . 0.14999999999999999 107.688 -168.067 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.74 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.8 m-80 -86.48 -20.43 28.11 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.78 -0.822 . . . . 0.51000000000000001 108.78 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.77 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.4 m-85 -158.8 127.1 5.21 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.933 -1.031 . . . . 0.27000000000000002 108.749 -171.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 22.5 t-105 -144.13 135.31 25.51 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.607 0.718 . . . . 0.089999999999999997 111.001 -167.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.67 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.7 mmt -119.51 89.89 41.65 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.22 -1.03 . . . . 0.14000000000000001 108.22 174.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 28.1 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 C-N-CA 122.016 1.81 . . . . 0.5 111.062 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 419' ' ' GLY . 39.0 t . . . . . 0 CA--C 1.533 0.291 0 CA-C-O 121.296 0.57 . . . . 0.75 111.342 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.602 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.13 123.21 0.86 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 109.719 -1.352 . . . . 0.20000000000000001 109.719 170.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.713 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.5 142.43 13.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.809 -0.441 . . . . 0.28999999999999998 109.809 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.669 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.6 p80 -160.71 162.92 32.69 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.255 -0.43 . . . . 0.089999999999999997 111.482 -174.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.68 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.21 147.76 26.43 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.245 -1.02 . . . . 1.0700000000000001 108.245 172.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.3 t -132.99 96.93 3.88 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.791 0.805 . . . . 0.23000000000000001 109.835 -172.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.7 t70 . . . . . 0 C--N 1.313 -1.005 0 CA-C-N 114.094 -1.412 . . . . 0.41999999999999998 109.067 -177.785 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.658 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.0 pm0 . . . . . 0 N--CA 1.435 -1.182 0 CA-C-O 122.409 1.1 . . . . 2.1600000000000001 113.237 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.639 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.54 132.08 4.4 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.857 -2.275 . . . . 0.33000000000000002 104.857 171.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.45 -157.39 29.53 Favored Glycine 0 C--N 1.282 -2.441 0 C-N-CA 119.77 -1.205 . . . . 0.17000000000000001 110.885 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.449 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.21 175.95 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.297 -0.954 . . . . 0.20999999999999999 111.578 166.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.505 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.4 p-10 -51.95 101.57 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 123.276 1.512 . . . . 1.8500000000000001 113.426 -156.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.719 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.63 -35.8 10.93 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 112.631 -2.077 . . . . 1.21 109.45 169.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.736 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.7 p-90 -55.37 -28.0 51.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.173 -0.921 . . . . 0.16 112.156 -170.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.736 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.63 -35.04 15.21 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.604 0.716 . . . . 0.22 112.122 -177.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.1 p -90.14 -43.7 10.28 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.754 -1.112 . . . . 0.25 111.008 -175.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.719 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 3.0 mtp85 -92.35 -19.64 21.9 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.65 -1.159 . . . . 1.8200000000000001 109.732 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 54.48 48.47 64.85 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 113.848 -1.524 . . . . 0.23999999999999999 115.265 164.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 25.0 m -81.76 111.03 17.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 118.853 1.326 . . . . 1.01 111.217 -171.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 36.39 -120.69 0.15 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.741 -1.118 . . . . 0.5 113.66 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.404 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -133.29 -19.71 0.95 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 116.036 -0.529 . . . . 0.26000000000000001 113.676 -175.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.52 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.1 p -103.56 -165.37 1.15 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 117.507 0.654 . . . . 0.34999999999999998 112.707 -175.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.471 HG12 HG11 ' A' ' 347' ' ' VAL . 2.1 mp -95.48 130.57 44.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.968 -1.014 . . . . 0.12 110.658 -175.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -102.5 95.29 6.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.826 -0.625 . . . . 0.62 110.13 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.721 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.4 m -91.64 142.54 26.85 Favored Pre-proline 0 N--CA 1.437 -1.125 0 CA-C-N 115.042 -0.981 . . . . 0.10000000000000001 112.668 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.663 ' HD2' HG21 ' A' ' 366' ' ' THR . 87.2 Cg_exo -49.9 144.85 20.09 Favored 'Trans proline' 0 CA--C 1.507 -0.871 0 C-N-CA 124.096 3.197 . . . . 0.23999999999999999 113.457 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.68 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.6 Cg_exo -65.41 -28.37 54.43 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 122.783 2.322 . . . . 0.31 112.306 -175.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 48.1 m -74.74 -23.72 58.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.845 -0.616 . . . . 1.1000000000000001 112.282 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.804 ' O ' HD21 ' A' ' 364' ' ' LEU . 29.9 m -100.68 -49.08 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 112.932 0.716 . . . . 0.080000000000000002 112.932 -169.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.952 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.95 -2.09 4.85 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.8 -0.76 . . . . 0.070000000000000007 110.308 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.609 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.0 pttp -81.63 -38.98 25.12 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.378 1.085 . . . . 0.92000000000000004 108.117 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.6 mm-40 -62.03 -46.16 90.39 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-N 112.524 -2.126 . . . . 0.25 106.599 -177.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.952 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.9 tp -46.19 -67.06 0.32 Allowed 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 109.678 -3.419 . . . . 0.050000000000000003 112.778 172.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.499 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.3 t80 -45.52 -24.21 0.3 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 123.957 0.785 . . . . 0.13 109.48 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -87.91 -26.63 28.62 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 114.684 -1.143 . . . . 0.13 111.743 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.746 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.8 -44.11 5.63 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 113.322 0.86 . . . . 0.059999999999999998 113.322 176.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.676 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -74.1 148.06 8.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.499 1.143 . . . . 0.080000000000000002 111.25 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.416 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -117.07 157.99 24.93 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 112.745 -2.025 . . . . 0.47999999999999998 108.992 -179.305 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.665 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 7.3 mppt? -59.2 102.01 0.12 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.551 -0.907 . . . . 0.98999999999999999 108.551 168.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.22 -12.36 5.52 Favored Glycine 0 C--N 1.308 -1.011 0 CA-C-N 114.22 -1.355 . . . . 0.19 111.726 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.662 HG21 ' HB ' ' A' ' 457' ' ' VAL . 15.9 m -68.25 151.22 97.36 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 108.838 -0.801 . . . . 0.13 108.838 171.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.3 Cg_endo -94.1 165.92 2.04 Favored 'Trans proline' 0 N--CA 1.422 -2.694 0 C-N-CA 122.1 1.866 . . . . 0.17999999999999999 109.929 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.747 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -127.3 152.6 35.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.697 -1.223 . . . . 0.56999999999999995 107.697 170.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.763 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.3 mp -134.01 150.06 51.22 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.05 -1.093 . . . . 0.13 108.05 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.035 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -139.94 138.28 38.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 103.753 -2.684 . . . . 0.10000000000000001 103.753 164.031 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.814 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 2.5 p90 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 117.573 -1.204 . . . . 1.0900000000000001 112.109 -177.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 121.626 0.726 . . . . 0.42999999999999999 109.129 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 99.9 m -159.59 136.16 9.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.457 -1.247 . . . . 0.14000000000000001 108.995 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.656 ' CD2' HD13 ' A' ' 464' ' ' LEU . 38.6 p90 174.67 158.61 0.17 Allowed 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 123.381 0.425 . . . . 0.14999999999999999 111.117 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.66 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -78.11 152.35 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 N-CA-C 109.035 -0.728 . . . . 0.080000000000000002 109.035 164.204 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.559 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.1 tt0 -149.77 145.82 26.84 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.437 -0.802 . . . . 2.0099999999999998 109.389 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.735 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -138.23 162.28 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 120.917 0.389 . . . . 0.45000000000000001 111.184 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 347' ' ' VAL . 33.7 t0 -140.38 106.4 5.2 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.419 -1.326 . . . . 0.23999999999999999 107.419 173.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.091 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -81.63 -35.74 29.67 Favored 'General case' 0 CA--C 1.483 -1.618 0 CA-C-O 122.678 1.228 . . . . 0.16 110.477 -167.349 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.53 -44.27 80.67 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 110.967 -2.833 . . . . 0.59999999999999998 108.219 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -101.21 6.78 43.16 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 110.751 -2.932 . . . . 0.20000000000000001 110.923 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.692 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 21.6 mp0 34.19 61.83 0.5 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 112.558 -2.11 . . . . 2.1499999999999999 113.139 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.522 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 20.4 t60 -142.11 133.59 26.63 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.782 -0.644 . . . . 0.089999999999999997 110.236 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -112.84 155.5 24.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.773 -0.649 . . . . 0.070000000000000007 109.684 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.556 ' CD1' HG11 ' A' ' 362' ' ' VAL . 29.0 m-90 -140.62 153.83 46.21 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.42 -0.809 . . . . 0.11 110.877 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.684 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 84.0 t80 -110.67 151.89 27.17 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 106.385 -1.709 . . . . 0.26000000000000001 106.385 152.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 6.9 m-85 -127.97 115.62 18.8 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 114.602 -1.181 . . . . 0.14000000000000001 110.343 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.1 tppt? -116.53 138.4 51.43 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.474 -1.676 . . . . 0.25 106.474 169.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.446 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.54 17.45 9.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.343 0.868 . . . . 0.42999999999999999 113.343 173.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.92 9.81 86.47 Favored Glycine 0 CA--C 1.491 -1.455 0 CA-C-N 115.528 -0.76 . . . . 0.17999999999999999 112.913 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.5 ptmt -130.27 178.36 6.64 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 104.757 -2.312 . . . . 0.37 104.757 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 17.9 m -105.08 157.9 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.642 0 N-CA-C 116.338 1.977 . . . . 0.10000000000000001 116.338 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.677 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -110.46 -27.91 8.79 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 110.571 -3.013 . . . . 0.070000000000000007 106.558 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.809 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.6 145.28 49.89 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 111.568 -2.56 . . . . 0.059999999999999998 111.362 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.426 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -141.65 118.29 11.0 Favored 'General case' 0 N--CA 1.404 -2.747 0 N-CA-C 104.255 -2.498 . . . . 0.47999999999999998 104.255 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.712 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.22 160.81 43.42 Favored 'General case' 0 N--CA 1.396 -3.131 0 C-N-CA 117.822 -1.551 . . . . 0.070000000000000007 111.244 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 14.9 p-10 -102.83 132.32 49.1 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.38 -1.282 . . . . 1.8 109.001 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.892 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.5 pp -132.16 -172.31 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 CA-C-O 122.439 1.114 . . . . 0.12 112.673 -171.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.83 118.9 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 112.985 -1.916 . . . . 0.10000000000000001 108.905 173.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.488 ' HB3' HD12 ' A' ' 349' ' ' LEU . 47.4 p -74.92 -168.93 0.81 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 112.039 -2.346 . . . . 1.26 111.662 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.75 175.25 50.46 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 118.944 -1.598 . . . . 0.14000000000000001 111.831 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.528 ' HG2' HG23 ' A' ' 375' ' ' THR . 15.3 ptmt -79.1 163.2 61.21 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.813 0.672 . . . . 0.81000000000000005 112.813 -164.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.705 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 86.3 Cg_exo -55.72 -37.54 95.37 Favored 'Trans proline' 0 CA--C 1.511 -0.65 0 C-N-CA 122.76 2.307 . . . . 0.28000000000000003 112.448 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.423 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 19.2 p -66.28 -32.26 73.56 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.461 -1.245 . . . . 0.33000000000000002 110.175 -174.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.528 HG23 ' HG2' ' A' ' 372' ' ' LYS . 1.3 t -141.23 72.4 26.8 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 123.704 1.716 . . . . 0.39000000000000001 109.608 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 375' ' ' THR . 72.5 Cg_exo -59.99 164.09 12.81 Favored 'Trans proline' 0 C--N 1.312 -1.345 1 C-N-CA 126.394 4.729 . . . . 0.38 115.133 -172.214 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.531 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 2.1 m -90.12 128.01 51.28 Favored Pre-proline 0 N--CA 1.399 -2.979 0 CA-C-N 113.869 -1.514 . . . . 0.81999999999999995 108.343 171.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.531 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 38.7 Cg_exo -69.47 -45.58 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.99 3.127 . . . . 0.19 112.014 -170.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.803 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 63.14 143.93 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 123.316 1.532 . . . . 0.13 113.943 -175.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 145.74 -110.41 0.54 Allowed Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 111.905 -2.407 . . . . 0.20000000000000001 108.862 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 464' ' ' LEU . 3.5 p -131.19 127.55 60.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.822 -0.436 . . . . 0.81999999999999995 109.822 174.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.778 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 7.7 m-85 -121.54 -174.49 2.87 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.253 -1.388 . . . . 0.22 107.253 169.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 2.2 t80 -138.93 121.26 15.96 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 120.792 -1.192 . . . . 0.65000000000000002 113.194 -173.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -87.82 92.62 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-O 122.881 1.324 . . . . 0.16 109.368 171.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 44.0 p-90 -92.25 10.35 29.97 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 113.575 -1.648 . . . . 2.5499999999999998 108.314 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.748 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 27.9 t-20 -169.6 127.01 0.91 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.098 -1.41 . . . . 0.42999999999999999 110.392 172.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.608 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.46 143.13 31.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.073 -0.967 . . . . 1.1200000000000001 109.012 169.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.746 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 10.7 mm-40 -125.31 157.74 35.92 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.548 1.314 . . . . 0.70999999999999996 114.548 -168.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.714 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 47.8 mt-10 -137.49 127.24 25.44 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.178 -1.828 . . . . 0.38 108.668 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 19.5 t70 55.01 50.36 15.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 123.366 1.555 . . . . 0.40999999999999998 109.025 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.958 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -84.27 167.37 16.68 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 112.495 -2.139 . . . . 0.12 109.522 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 15.8 m -132.43 118.77 19.76 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.102 0.953 . . . . 0.17000000000000001 111.494 170.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.18 88.37 4.88 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.779 -1.555 . . . . 0.56999999999999995 112.11 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.543 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 48.0 mttt . . . . . 0 C--N 1.281 -2.39 0 CA-C-N 113.703 -1.59 . . . . 0.33000000000000002 112.971 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 120.997 0.427 . . . . 0.53000000000000003 110.455 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.43 97.74 4.68 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 108.422 -0.955 . . . . 0.19 108.422 169.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.2 Cg_exo -69.03 110.21 2.35 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.037 1.824 . . . . 0.19 110.462 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.958 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.9 157.71 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 CA-C-N 113.084 -1.871 . . . . 0.14999999999999999 107.824 -167.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.714 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.5 m-80 -88.31 -22.18 24.0 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.83 -0.804 . . . . 0.51000000000000001 108.83 -175.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.746 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 93.6 m-85 -158.72 127.65 5.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.936 -1.029 . . . . 0.27000000000000002 108.382 -170.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 18.1 t-105 -144.41 133.88 23.3 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.665 0.745 . . . . 0.089999999999999997 110.812 -166.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.608 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 13.5 mmt -115.15 89.81 21.71 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.101 -1.074 . . . . 0.14000000000000001 108.101 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.748 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 35.0 Cg_endo . . . . . 0 CA--C 1.51 -0.701 0 C-N-CA 122.456 2.104 . . . . 0.5 109.408 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 419' ' ' GLY . 24.0 t . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 121.236 0.541 . . . . 0.75 111.872 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.01 121.69 0.82 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.77 -1.332 . . . . 0.20000000000000001 109.77 169.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.707 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.3 mp -81.69 143.08 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.839 -0.344 . . . . 0.28999999999999998 110.163 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.679 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.3 p80 -159.37 161.5 35.7 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.29 -0.414 . . . . 0.089999999999999997 111.461 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.673 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.83 144.8 28.2 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.843 -1.169 . . . . 1.0700000000000001 107.843 172.341 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 445' ' ' THR . 33.7 t -134.26 98.0 3.99 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.851 0.834 . . . . 0.23000000000000001 110.576 -170.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.8 t70 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 114.121 -1.399 . . . . 0.41999999999999998 110.062 -175.754 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.437 -1.09 0 CA-C-O 122.737 1.256 . . . . 2.1600000000000001 112.682 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.529 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 1.2 m-85 -154.61 121.9 5.67 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 112.116 -2.311 . . . . 0.33000000000000002 105.901 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 165.81 -157.05 29.36 Favored Glycine 0 C--N 1.283 -2.391 0 C-N-CA 119.862 -1.161 . . . . 0.17000000000000001 110.352 -174.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -38.61 164.78 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.725 0 C-N-CA 120.483 -0.865 . . . . 0.20999999999999999 111.789 166.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.449 ' HB3' ' CD ' ' A' ' 435' ' ' LYS . 4.4 m-20 -51.68 102.72 0.05 OUTLIER 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 113.446 -1.377 . . . . 1.8500000000000001 113.318 -153.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.646 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.3 OUTLIER -94.11 -38.77 10.94 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 113.327 -1.761 . . . . 1.21 108.823 168.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.746 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.4 p-90 -49.79 -32.17 13.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.153 0.502 . . . . 0.16 112.047 -169.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.746 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -86.01 -35.32 20.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.483 0.658 . . . . 0.22 111.965 -177.12 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 10.2 p -88.75 -43.72 11.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.672 -1.149 . . . . 0.25 111.15 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.646 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 11.4 mtp85 -91.59 -18.53 23.91 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.817 -1.083 . . . . 1.8200000000000001 109.474 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.63 47.56 57.64 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.654 -1.157 . . . . 0.23999999999999999 114.129 163.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 43.3 m -84.76 110.52 18.85 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 118.991 -1.084 . . . . 1.01 111.415 -171.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 37.8 -125.75 0.23 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.373 -1.285 . . . . 0.5 113.738 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -126.99 -21.29 1.73 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.076 -0.583 . . . . 0.26000000000000001 113.462 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.47 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 28.7 p -104.49 -165.57 1.15 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 112.883 0.697 . . . . 0.34999999999999998 112.883 -173.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.476 HD13 HG11 ' A' ' 465' ' ' VAL . 2.3 mp -92.02 129.24 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.482 -0.781 . . . . 0.12 110.884 -175.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -100.3 89.72 4.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.657 -0.701 . . . . 0.62 109.727 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.892 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.0 m -83.26 143.78 45.7 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 115.087 -0.96 . . . . 0.10000000000000001 112.452 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.653 ' HD2' HG21 ' A' ' 366' ' ' THR . 78.8 Cg_exo -50.08 144.51 22.06 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 123.807 3.005 . . . . 0.23999999999999999 113.351 174.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.673 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.4 Cg_exo -64.6 -25.42 62.16 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 122.827 2.351 . . . . 0.31 112.598 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.516 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 67.3 p -78.7 -24.59 44.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.74 0.781 . . . . 1.1000000000000001 112.085 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.809 ' O ' HD21 ' A' ' 364' ' ' LEU . 33.0 m -99.35 -48.63 11.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 113.137 0.792 . . . . 0.080000000000000002 113.137 -170.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.944 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.72 -1.95 4.42 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.767 -0.773 . . . . 0.070000000000000007 110.434 -178.267 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.561 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 16.5 pttp -81.22 -38.46 26.95 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 122.651 1.215 . . . . 0.92000000000000004 108.287 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 4.5 mm-40 -62.65 -46.31 88.79 Favored 'General case' 0 CA--C 1.473 -1.981 0 CA-C-N 112.356 -2.202 . . . . 0.25 106.537 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.944 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.92 -66.72 0.36 Allowed 'General case' 0 N--CA 1.401 -2.922 0 CA-C-N 109.711 -3.404 . . . . 0.050000000000000003 112.923 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.462 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 14.9 t80 -45.58 -24.03 0.3 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.83 0.824 . . . . 0.13 109.502 176.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -87.4 -26.54 30.16 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 114.697 -1.138 . . . . 0.13 111.785 -176.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.739 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.14 -44.13 5.29 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 113.728 1.01 . . . . 0.059999999999999998 113.728 177.806 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.67 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -72.62 148.06 9.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.292 1.044 . . . . 0.080000000000000002 111.106 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.501 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -116.02 155.24 28.44 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.281 -1.781 . . . . 0.47999999999999998 108.952 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.605 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.8 mppt? -57.91 103.43 0.14 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.624 -0.88 . . . . 0.98999999999999999 108.624 169.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 126.36 -7.46 7.54 Favored Glycine 0 C--N 1.308 -0.996 0 CA-C-N 113.827 -1.533 . . . . 0.19 111.452 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.67 HG21 ' HB ' ' A' ' 457' ' ' VAL . 6.8 m -70.17 150.5 96.06 Favored Pre-proline 0 N--CA 1.442 -0.862 0 N-CA-C 108.592 -0.892 . . . . 0.13 108.592 171.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.8 Cg_endo -93.98 160.52 2.18 Favored 'Trans proline' 0 N--CA 1.421 -2.775 0 C-N-CA 122.017 1.811 . . . . 0.17999999999999999 109.749 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.778 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -123.91 151.44 28.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.295 -1.372 . . . . 0.56999999999999995 107.295 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.697 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.7 mp -134.54 151.28 51.0 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 108.113 -1.069 . . . . 0.13 108.113 174.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.091 HG23 HD21 ' A' ' 349' ' ' LEU . 0.8 OUTLIER -140.64 141.26 32.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 105.177 -2.157 . . . . 0.10000000000000001 105.177 166.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.719 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 12.5 p90 . . . . . 0 C--O 1.245 0.861 0 CA-C-N 118.45 0.568 . . . . 1.0900000000000001 111.553 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.455 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 9.3 m-20 . . . . . 0 N--CA 1.44 -0.933 0 N-CA-C 108.931 -0.766 . . . . 0.42999999999999999 108.931 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.809 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 70.0 m -158.34 134.71 9.4 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.538 -1.21 . . . . 0.14000000000000001 108.944 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.651 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.3 p90 173.91 159.27 0.15 Allowed 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 123.421 0.451 . . . . 0.14999999999999999 110.881 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.651 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.93 152.59 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 N-CA-C 109.354 -0.61 . . . . 0.080000000000000002 109.354 164.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.6 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 31.1 tt0 -149.82 144.7 26.15 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.438 -0.801 . . . . 2.0099999999999998 109.249 -177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.734 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -137.3 162.05 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 O-C-N 122.118 -0.364 . . . . 0.45000000000000001 111.252 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.547 ' N ' HG12 ' A' ' 347' ' ' VAL . 24.4 t0 -140.19 107.0 5.38 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 107.416 -1.327 . . . . 0.23999999999999999 107.416 172.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.041 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.7 -34.08 27.41 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 122.903 1.335 . . . . 0.16 110.671 -167.585 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -58.69 -44.12 90.19 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 110.769 -2.923 . . . . 0.59999999999999998 108.17 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -101.12 7.01 43.45 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 110.925 -2.852 . . . . 0.20000000000000001 110.916 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.3 mp0 33.06 61.62 0.39 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 112.692 -2.049 . . . . 2.1499999999999999 113.417 -175.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.514 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.6 t60 -142.02 135.01 28.82 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.854 -0.612 . . . . 0.089999999999999997 109.983 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.77 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.16 156.75 22.68 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.812 -0.631 . . . . 0.070000000000000007 110.099 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.585 ' CD1' HG11 ' A' ' 362' ' ' VAL . 29.3 m-90 -142.22 154.18 44.59 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.475 -0.784 . . . . 0.11 111.291 -175.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.809 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 88.2 t80 -110.22 153.29 25.0 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.558 -1.645 . . . . 0.26000000000000001 106.558 151.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.3 m-85 -128.32 118.1 22.63 Favored 'General case' 0 C--N 1.269 -2.915 0 CA-C-N 114.796 -1.093 . . . . 0.14000000000000001 110.118 -178.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.6 tppt? -118.62 135.62 54.34 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.118 -1.808 . . . . 0.25 106.118 167.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.54 16.48 6.97 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 113.45 0.908 . . . . 0.42999999999999999 113.45 173.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.36 7.58 88.38 Favored Glycine 0 CA--C 1.485 -1.844 0 CA-C-O 121.933 0.741 . . . . 0.17999999999999999 112.778 -174.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 19.4 ptmt -128.77 177.0 7.38 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 104.542 -2.392 . . . . 0.37 104.542 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.6 m -104.29 157.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 N-CA-C 116.397 1.999 . . . . 0.10000000000000001 116.397 -174.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.703 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.97 -28.4 9.14 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 110.497 -3.047 . . . . 0.070000000000000007 106.277 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.817 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -132.93 145.01 50.53 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 111.614 -2.539 . . . . 0.059999999999999998 111.731 -175.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.442 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.4 tt0 -141.86 117.88 10.6 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 104.516 -2.401 . . . . 0.47999999999999998 104.516 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.77 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.6 164.47 35.04 Favored 'General case' 0 N--CA 1.402 -2.848 0 C-N-CA 117.974 -1.49 . . . . 0.070000000000000007 111.769 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.531 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 17.6 p-10 -104.9 131.4 52.44 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 114.726 -1.124 . . . . 1.8 109.542 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -132.79 -171.87 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 CA-C-O 122.438 1.113 . . . . 0.12 112.327 -171.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -149.99 119.56 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 112.959 -1.928 . . . . 0.10000000000000001 108.296 172.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.638 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.3 OUTLIER -75.62 -168.61 0.88 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.026 -1.443 . . . . 1.26 110.784 177.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.51 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -86.4 176.15 48.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 118.929 -1.605 . . . . 0.14000000000000001 112.681 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.474 ' HG2' HG23 ' A' ' 375' ' ' THR . 16.7 ptmt -78.16 156.72 79.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.661 0.743 . . . . 0.81000000000000005 111.865 -166.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.692 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 85.5 Cg_exo -59.19 -28.6 88.19 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 125.016 3.811 . . . . 0.28000000000000003 113.309 -173.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.476 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 24.4 p -73.22 -32.61 64.86 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.867 -1.515 . . . . 0.33000000000000002 109.941 -175.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.541 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -140.63 70.15 31.25 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-O 123.887 1.803 . . . . 0.39000000000000001 108.92 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 375' ' ' THR . 83.1 Cg_exo -57.58 160.49 14.16 Favored 'Trans proline' 0 CA--C 1.501 -1.172 1 C-N-CA 126.895 5.063 . . . . 0.38 115.854 -169.282 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.638 HG21 ' OG ' ' A' ' 370' ' ' SER . 1.6 m -86.62 131.81 44.45 Favored Pre-proline 0 N--CA 1.406 -2.641 0 CA-C-N 113.902 -1.499 . . . . 0.81999999999999995 108.709 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.3 Cg_exo -72.73 -45.14 0.55 Allowed 'Trans proline' 0 CA--C 1.514 -0.491 0 C-N-CA 123.861 3.041 . . . . 0.19 112.092 -170.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.786 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.59 140.11 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 123.263 1.506 . . . . 0.13 113.497 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.19 -113.55 0.59 Allowed Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 112.455 -2.157 . . . . 0.20000000000000001 109.623 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.2 119.11 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.924 0.869 . . . . 0.81999999999999995 110.175 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.724 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.7 m-85 -118.1 -174.19 2.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.202 -1.407 . . . . 0.22 107.202 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.3 t80 -139.94 123.35 17.07 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 120.697 -1.252 . . . . 0.65000000000000002 113.275 -171.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.65 92.1 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-O 123.084 1.421 . . . . 0.16 109.308 169.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -94.77 12.46 27.87 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 113.393 -1.73 . . . . 2.5499999999999998 108.318 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.764 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 28.5 t-20 -169.1 126.34 0.96 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 113.833 -1.53 . . . . 0.42999999999999999 110.04 171.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.673 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.79 144.4 29.79 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.115 -0.948 . . . . 1.1200000000000001 109.458 170.268 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.721 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 24.6 mm-40 -127.5 159.99 32.87 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 114.899 1.444 . . . . 0.70999999999999996 114.899 -168.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.561 ' HG2' ' CE2' ' A' ' 409' ' ' TYR . 51.6 mt-10 -139.04 127.59 23.1 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 113.064 -1.88 . . . . 0.38 108.583 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.7 t70 54.68 46.38 24.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 123.722 1.725 . . . . 0.40999999999999998 108.754 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.92 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.84 167.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 111.918 -2.401 . . . . 0.12 109.709 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 11.8 m -132.61 118.33 19.04 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.013 0.911 . . . . 0.17000000000000001 111.878 170.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.9 mp -77.58 87.62 3.89 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.987 -1.461 . . . . 0.56999999999999995 111.918 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.546 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.3 mttt . . . . . 0 C--N 1.285 -2.207 0 CA-C-N 113.308 -1.769 . . . . 0.33000000000000002 113.397 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.546 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.444 -0.751 0 CA-C-O 121.177 0.513 . . . . 0.53000000000000003 110.836 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -145.26 97.53 4.75 Favored Pre-proline 0 N--CA 1.439 -0.98 0 N-CA-C 108.359 -0.978 . . . . 0.19 108.359 170.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.8 Cg_exo -68.22 110.74 2.3 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.974 1.782 . . . . 0.19 110.034 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.92 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -111.36 152.65 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 CA-C-N 113.368 -1.742 . . . . 0.14999999999999999 108.458 -167.378 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 4.9 m-20 -80.58 -23.28 40.0 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.797 -0.446 . . . . 0.51000000000000001 109.797 -174.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 97.2 m-85 -161.35 132.04 5.19 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.635 -1.246 . . . . 0.27000000000000002 107.635 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 20.2 t-105 -146.42 131.84 18.63 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.889 0.852 . . . . 0.089999999999999997 111.443 -166.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.673 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.6 mmt -114.43 93.23 31.1 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.728 -1.212 . . . . 0.14000000000000001 107.728 172.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.764 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 36.0 Cg_endo . . . . . 0 CA--C 1.513 -0.568 0 C-N-CA 122.393 2.062 . . . . 0.5 111.618 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 419' ' ' GLY . 34.0 t . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.213 0.53 . . . . 0.75 112.23 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.587 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.1 119.64 0.71 Allowed Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.498 -1.041 . . . . 0.20000000000000001 110.498 170.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.749 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.3 mp -81.78 143.34 12.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 110.024 -0.361 . . . . 0.28999999999999998 110.024 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.677 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 29.4 p80 -159.82 159.15 32.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.793 0.664 . . . . 0.089999999999999997 112.793 -173.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.776 ' OD1' ' HB2' ' A' ' 450' ' ' MET . 2.3 m-20 -89.61 132.03 35.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.492 -0.559 . . . . 1.0700000000000001 109.492 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 445' ' ' THR . 28.4 t -120.31 97.39 5.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.641 0.734 . . . . 0.23000000000000001 109.453 -164.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 C--N 1.314 -0.97 0 CA-C-N 114.612 -1.176 . . . . 0.41999999999999998 109.993 -172.878 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.597 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.2 pm0 . . . . . 0 N--CA 1.436 -1.127 0 CA-C-O 122.224 1.011 . . . . 2.1600000000000001 113.602 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.837 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.16 130.38 4.1 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 112.605 -2.089 . . . . 0.33000000000000002 105.487 171.093 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.23 -158.08 30.63 Favored Glycine 0 C--N 1.281 -2.494 0 C-N-CA 119.788 -1.196 . . . . 0.17000000000000001 110.817 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.507 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.28 174.65 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.277 -0.963 . . . . 0.20999999999999999 111.544 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.497 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 5.0 p-10 -51.78 101.46 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 123.399 1.571 . . . . 1.8500000000000001 113.772 -153.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.762 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.02 -35.67 11.31 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 112.489 -2.141 . . . . 1.21 109.147 169.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.74 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.1 p-90 -54.81 -28.11 46.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.006 -0.997 . . . . 0.16 112.243 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.74 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.98 -38.09 13.06 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.401 0.62 . . . . 0.22 112.377 -177.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 436' ' ' THR . 2.4 p -86.69 -43.41 12.62 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.04 -0.982 . . . . 0.25 110.446 -175.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.762 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 2.7 mtp85 -91.49 -18.6 23.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.497 -1.228 . . . . 1.8200000000000001 108.954 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.66 50.1 50.49 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 115.232 0.853 . . . . 0.23999999999999999 115.232 160.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' SER . . . . . 0.43 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 6.4 m -83.25 111.52 19.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 119.072 1.436 . . . . 1.01 111.436 -173.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 29.52 -106.51 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.507 1.129 . . . . 0.5 113.699 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.51 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -147.53 -5.45 0.33 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.815 -0.63 . . . . 0.26000000000000001 114.415 -174.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 26.5 p -107.22 -167.27 1.25 Allowed 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.323 1.062 . . . . 0.34999999999999998 112.522 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 368' ' ' ILE . 1.9 mp -102.31 131.15 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 115.057 -0.974 . . . . 0.12 110.889 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -100.71 98.51 9.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.839 -1.073 . . . . 0.62 110.129 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.714 HG22 ' CG2' ' A' ' 449' ' ' VAL . 2.0 m -96.59 140.45 22.17 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 113.599 0.962 . . . . 0.10000000000000001 113.599 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.819 ' O ' HG22 ' A' ' 449' ' ' VAL . 77.3 Cg_exo -54.66 128.05 28.66 Favored 'Trans proline' 0 CA--C 1.498 -1.322 1 C-N-CA 125.452 4.101 . . . . 0.23999999999999999 114.933 177.5 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.837 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 52.8 Cg_exo -58.27 -8.25 4.85 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.972 3.115 . . . . 0.31 114.374 -165.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.554 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 77.9 p -93.21 -19.62 21.25 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.899 -1.046 . . . . 1.1000000000000001 111.089 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 446' ' ' PRO . 17.0 m -101.16 -49.61 10.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 114.664 1.357 . . . . 0.080000000000000002 114.664 -172.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.944 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -69.27 -2.33 10.39 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.933 -1.104 . . . . 0.070000000000000007 109.529 -177.124 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.629 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.4 pttp -77.28 -39.03 49.58 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 122.551 1.167 . . . . 0.92000000000000004 108.121 173.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm-40 -63.14 -46.48 87.02 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 112.416 -2.175 . . . . 0.25 106.709 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.944 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.6 -65.91 0.49 Allowed 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 109.935 -3.302 . . . . 0.050000000000000003 112.719 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.471 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.6 t80 -45.91 -23.33 0.28 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.861 0.725 . . . . 0.13 109.459 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.45 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.04 -24.05 33.24 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.051 -0.977 . . . . 0.13 111.927 -176.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.718 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -105.42 -43.88 4.86 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 113.808 1.04 . . . . 0.059999999999999998 113.808 176.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.666 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -73.84 150.35 7.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.42 1.105 . . . . 0.080000000000000002 111.084 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.31 156.88 32.96 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 113.247 -1.797 . . . . 0.47999999999999998 108.353 -178.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.569 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.6 mppt? -59.01 101.68 0.1 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.388 0.613 . . . . 0.98999999999999999 109.399 172.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.06 -12.72 5.54 Favored Glycine 0 C--N 1.305 -1.173 0 CA-C-N 114.107 -1.406 . . . . 0.19 111.428 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.666 HG21 ' HB ' ' A' ' 457' ' ' VAL . 12.9 m -65.82 149.36 97.57 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 108.718 -0.845 . . . . 0.13 108.718 171.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.7 Cg_endo -93.79 160.4 2.28 Favored 'Trans proline' 0 N--CA 1.423 -2.651 0 C-N-CA 122.041 1.828 . . . . 0.17999999999999999 109.989 177.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.724 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -124.05 150.87 28.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 107.386 -1.338 . . . . 0.56999999999999995 107.386 171.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.28 149.56 50.93 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.008 -1.108 . . . . 0.13 108.008 175.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.041 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.68 140.65 40.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.311 -2.107 . . . . 0.10000000000000001 105.311 165.802 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.671 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 9.4 p90 . . . . . 0 C--O 1.245 0.827 0 O-C-N 123.848 0.717 . . . . 1.0900000000000001 110.85 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.429 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 8.7 m-20 . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.674 0.75 . . . . 0.42999999999999999 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 357' ' ' TYR . 95.9 m -157.89 135.36 10.36 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.423 -1.262 . . . . 0.14000000000000001 108.763 166.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.634 ' CD2' HD13 ' A' ' 464' ' ' LEU . 38.3 p90 174.6 157.47 0.16 Allowed 'General case' 0 C--O 1.21 -0.986 0 O-C-N 123.362 0.414 . . . . 0.14999999999999999 111.367 -176.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.637 HD12 HD11 ' A' ' 453' ' ' LEU . 0.3 OUTLIER -77.88 152.72 5.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.365 -0.606 . . . . 0.080000000000000002 109.365 164.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.584 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.99 144.13 25.64 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.817 -0.629 . . . . 2.0099999999999998 109.311 -176.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.729 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -137.53 162.3 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.057 0.456 . . . . 0.45000000000000001 111.399 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.569 ' N ' HG12 ' A' ' 347' ' ' VAL . 28.9 t0 -140.44 106.88 5.29 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.38 -1.341 . . . . 0.23999999999999999 107.38 174.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.091 HD21 HG23 ' A' ' 465' ' ' VAL . 0.2 OUTLIER -84.02 -32.19 25.04 Favored 'General case' 0 CA--C 1.485 -1.538 0 CA-C-O 123.036 1.398 . . . . 0.16 110.02 -169.339 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.03 -45.28 91.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 110.672 -2.967 . . . . 0.59999999999999998 108.179 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' ASN . . . . . 0.434 ' HB2' ' CG ' ' A' ' 348' ' ' ASP . 13.3 m120 -102.83 8.22 39.33 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 111.006 -2.816 . . . . 0.20000000000000001 110.956 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.574 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.1 mp0 32.53 61.62 0.35 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 112.722 -2.035 . . . . 2.1499999999999999 113.475 -176.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.519 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.0 t60 -142.47 135.53 28.5 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.625 -0.716 . . . . 0.089999999999999997 109.754 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.756 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.48 157.34 22.11 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.864 -0.607 . . . . 0.070000000000000007 110.332 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.626 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.7 m-90 -142.89 154.09 43.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.433 -175.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.696 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.6 t80 -110.28 153.2 25.18 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 106.725 -1.583 . . . . 0.26000000000000001 106.725 152.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.3 m-85 -128.37 117.99 22.39 Favored 'General case' 0 C--N 1.272 -2.799 0 CA-C-N 115.073 -0.967 . . . . 0.14000000000000001 110.609 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.3 tppt? -118.15 137.87 52.67 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 105.979 -1.859 . . . . 0.25 105.979 167.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.508 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.9 15.66 7.83 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.348 0.87 . . . . 0.42999999999999999 113.348 174.075 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.51 6.46 88.1 Favored Glycine 0 CA--C 1.488 -1.631 0 C-N-CA 120.673 -0.775 . . . . 0.17999999999999999 112.757 -173.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 359' ' ' ASP . 14.2 ptmt -125.5 175.93 7.18 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 104.576 -2.379 . . . . 0.37 104.576 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.626 HG11 ' CD1' ' A' ' 355' ' ' TRP . 15.5 m -103.95 157.48 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.703 0 N-CA-C 116.582 2.067 . . . . 0.10000000000000001 116.582 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.695 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.83 -27.17 9.89 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 110.642 -2.981 . . . . 0.070000000000000007 106.69 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.814 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -133.57 144.57 49.4 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 111.334 -2.666 . . . . 0.059999999999999998 111.329 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.436 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.2 tt0 -142.54 118.19 10.41 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 104.498 -2.408 . . . . 0.47999999999999998 104.498 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.756 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.69 164.62 34.73 Favored 'General case' 0 N--CA 1.401 -2.887 0 C-N-CA 118.132 -1.427 . . . . 0.070000000000000007 111.442 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 20.4 p-10 -103.82 133.31 49.03 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.734 -1.121 . . . . 1.8 109.549 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.743 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -133.2 -172.28 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 CA-C-O 122.495 1.141 . . . . 0.12 112.171 -172.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.33 118.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 112.888 -1.96 . . . . 0.10000000000000001 108.119 172.463 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.585 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.3 OUTLIER -75.11 -168.92 0.84 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.047 -1.433 . . . . 1.26 110.533 178.31 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 439' ' ' SER . . . -85.49 175.93 49.54 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 118.809 -1.662 . . . . 0.14000000000000001 112.156 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.9 ptmt -78.78 155.44 78.08 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 121.59 0.709 . . . . 0.81000000000000005 111.466 -167.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.67 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 78.1 Cg_exo -54.96 -27.87 56.39 Favored 'Trans proline' 0 CA--C 1.501 -1.149 1 C-N-CA 125.399 4.066 . . . . 0.28000000000000003 113.399 -174.801 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.46 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.4 p -71.54 -31.48 67.08 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.662 -1.608 . . . . 0.33000000000000002 109.931 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.534 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 0.7 OUTLIER -140.94 70.3 29.21 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 123.804 1.764 . . . . 0.39000000000000001 108.972 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 375' ' ' THR . 88.1 Cg_exo -57.72 152.09 51.37 Favored 'Trans proline' 0 C--N 1.314 -1.241 1 C-N-CA 126.657 4.904 . . . . 0.38 115.637 -169.572 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.585 HG21 ' OG ' ' A' ' 370' ' ' SER . 18.3 m -78.74 130.99 68.87 Favored Pre-proline 0 N--CA 1.407 -2.597 0 CA-C-N 113.942 -1.481 . . . . 0.81999999999999995 109.18 173.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.2 Cg_exo -72.1 -46.49 0.53 Allowed 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 123.325 2.683 . . . . 0.19 111.734 -173.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.79 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.2 142.88 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 123.349 1.547 . . . . 0.13 113.424 -174.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 147.49 -109.84 0.49 Allowed Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 112.402 -2.181 . . . . 0.20000000000000001 109.286 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.8 p -130.52 125.91 59.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.369 0.604 . . . . 0.81999999999999995 110.099 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.706 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 7.5 m-85 -123.65 -174.32 2.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.0 -1.482 . . . . 0.22 107.0 171.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 2.0 t80 -140.65 122.63 15.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 119.795 1.18 . . . . 0.65000000000000002 112.76 -172.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -87.19 92.24 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 123.013 1.387 . . . . 0.16 109.223 170.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -89.89 7.82 35.31 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 113.442 -1.708 . . . . 2.5499999999999998 107.855 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.776 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 27.3 t-20 -170.2 126.88 0.82 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.368 -1.287 . . . . 0.42999999999999999 110.51 174.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.679 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.2 139.53 34.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.706 -1.134 . . . . 1.1200000000000001 109.016 170.474 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.792 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 11.4 mm-40 -123.57 158.05 32.3 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.823 1.416 . . . . 0.70999999999999996 114.823 -168.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 48.5 mt-10 -129.27 144.51 51.25 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.788 -2.006 . . . . 0.38 106.291 165.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.03 34.03 16.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.221 -1.808 . . . . 0.40999999999999998 110.238 171.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.884 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -77.38 167.46 21.64 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 112.779 -2.01 . . . . 0.12 109.186 -175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.6 m -131.63 119.18 21.07 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.157 0.98 . . . . 0.17000000000000001 111.376 172.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.0 mp -77.36 87.57 3.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.638 -1.619 . . . . 0.56999999999999995 111.73 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.589 ' HG2' ' HG3' ' A' ' 404' ' ' GLU . 47.5 mttt . . . . . 0 C--N 1.283 -2.288 0 CA-C-N 113.195 -1.821 . . . . 0.33000000000000002 113.072 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.589 ' HG3' ' HG2' ' A' ' 394' ' ' LYS . 2.1 mp0 . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 120.8 0.333 . . . . 0.53000000000000003 110.828 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.58 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.23 97.9 4.73 Favored Pre-proline 0 N--CA 1.442 -0.873 0 N-CA-C 108.663 -0.865 . . . . 0.19 108.663 171.029 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.6 Cg_exo -68.64 110.93 2.43 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.294 1.996 . . . . 0.19 110.7 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.884 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -111.36 160.02 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-N 113.084 -1.871 . . . . 0.14999999999999999 107.724 -168.232 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 22.3 m-80 -93.26 -18.96 21.88 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.136 -0.69 . . . . 0.51000000000000001 109.136 -175.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.792 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 86.3 m-85 -158.59 125.77 4.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.072 -0.967 . . . . 0.27000000000000002 108.451 -171.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.693 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 20.2 t-105 -143.84 134.76 25.34 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.76 0.79 . . . . 0.089999999999999997 111.755 -166.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.679 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.9 mmt -117.34 94.02 44.25 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.055 -1.091 . . . . 0.14000000000000001 108.055 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.776 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 42.0 Cg_endo . . . . . 0 C--N 1.347 0.499 0 C-N-CA 123.381 2.721 . . . . 0.5 112.369 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 419' ' ' GLY . 20.6 t . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.201 0.524 . . . . 0.75 112.234 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.588 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.74 119.71 0.71 Allowed Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.852 -0.899 . . . . 0.20000000000000001 110.852 171.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.716 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.6 mt -81.07 142.87 13.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.769 0.319 . . . . 0.28999999999999998 110.486 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.674 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.0 p80 -159.98 161.04 34.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.01 -0.541 . . . . 0.089999999999999997 111.322 -173.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.696 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -83.62 145.73 28.66 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.042 -1.096 . . . . 1.0700000000000001 108.042 173.007 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 445' ' ' THR . 42.5 t -132.62 96.74 3.89 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.866 0.841 . . . . 0.23000000000000001 109.616 -172.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 20.0 t70 . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 114.089 -1.414 . . . . 0.41999999999999998 109.389 -176.326 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.548 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.7 pm0 . . . . . 0 N--CA 1.441 -0.921 0 CA-C-O 122.269 1.033 . . . . 2.1600000000000001 113.441 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.72 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.43 131.5 4.27 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 105.146 -2.168 . . . . 0.33000000000000002 105.146 171.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.62 -158.15 30.66 Favored Glycine 0 C--N 1.282 -2.417 0 C-N-CA 119.974 -1.107 . . . . 0.17000000000000001 110.715 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.545 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.52 175.18 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.961 0 C-N-CA 120.418 -0.896 . . . . 0.20999999999999999 111.803 167.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.529 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.1 p-10 -51.51 101.19 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 123.355 1.55 . . . . 1.8500000000000001 113.336 -155.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.733 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.98 -38.04 10.4 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 112.404 -2.18 . . . . 1.21 109.099 170.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.657 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -53.11 -28.34 25.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.159 -0.928 . . . . 0.16 112.341 -171.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.67 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -89.16 -36.51 15.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.527 0.566 . . . . 0.22 112.527 -177.096 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.5 p -89.65 -42.99 11.05 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.064 -0.971 . . . . 0.25 110.699 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.733 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.8 mtp180 -92.81 -18.3 23.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.594 -1.185 . . . . 1.8200000000000001 109.752 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.83 48.74 50.25 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.021 -0.99 . . . . 0.23999999999999999 115.257 162.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' SER . . . . . 0.466 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 11.9 p -83.58 110.65 18.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 119.195 1.497 . . . . 1.01 111.447 -173.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 37.41 -124.27 0.21 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.503 -1.226 . . . . 0.5 114.086 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -129.47 -19.78 1.47 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.023 -0.608 . . . . 0.26000000000000001 113.408 -173.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 29.1 p -104.62 -165.86 1.18 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 112.902 0.705 . . . . 0.34999999999999998 112.902 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.455 HD13 HG11 ' A' ' 465' ' ' VAL . 1.9 mp -95.11 130.98 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 115.212 -0.904 . . . . 0.12 110.64 -175.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -105.31 94.61 5.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.716 0.77 . . . . 0.62 110.259 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.743 ' HA ' HG22 ' A' ' 368' ' ' ILE . 2.5 m -90.26 143.64 29.86 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-N 114.147 -1.388 . . . . 0.10000000000000001 112.89 -176.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.651 ' HD2' HG21 ' A' ' 366' ' ' THR . 74.8 Cg_exo -50.02 144.45 21.91 Favored 'Trans proline' 0 CA--C 1.505 -0.939 0 C-N-CA 123.943 3.096 . . . . 0.23999999999999999 113.22 175.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.72 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.3 Cg_exo -65.3 -24.58 57.78 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.748 2.299 . . . . 0.31 112.213 -175.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.534 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 70.1 p -78.12 -25.06 47.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.391 -0.822 . . . . 1.1000000000000001 111.874 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.814 ' O ' HD21 ' A' ' 364' ' ' LEU . 31.8 m -99.58 -49.67 11.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 112.985 0.735 . . . . 0.080000000000000002 112.985 -170.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.957 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.93 -2.1 4.83 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.65 -0.82 . . . . 0.070000000000000007 110.446 -178.378 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.566 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 16.3 pttp -81.1 -38.06 27.89 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 122.54 1.162 . . . . 0.92000000000000004 108.238 173.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.4 mm-40 -62.85 -46.61 87.08 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 112.372 -2.195 . . . . 0.25 106.587 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.957 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.1 tp -47.14 -66.44 0.41 Allowed 'General case' 0 N--CA 1.402 -2.826 0 CA-C-N 109.887 -3.324 . . . . 0.050000000000000003 112.658 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.446 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 23.5 t80 -46.3 -22.51 0.25 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.769 0.795 . . . . 0.13 109.71 175.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.45 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.95 -23.31 33.08 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 114.887 -1.051 . . . . 0.13 111.849 -176.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.74 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -106.38 -44.42 4.53 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 113.938 1.088 . . . . 0.059999999999999998 113.938 176.768 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -72.8 149.21 8.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 122.182 0.991 . . . . 0.080000000000000002 110.804 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.45 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -120.55 158.16 27.92 Favored 'General case' 0 N--CA 1.413 -2.324 0 CA-C-N 113.427 -1.715 . . . . 0.47999999999999998 109.043 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.6 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.8 mppt? -58.97 102.41 0.12 Allowed 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.911 -0.774 . . . . 0.98999999999999999 108.911 170.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.37 -12.04 5.77 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 114.051 -1.432 . . . . 0.19 111.449 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.632 HG21 ' HB ' ' A' ' 457' ' ' VAL . 18.8 m -68.22 149.9 97.93 Favored Pre-proline 0 N--CA 1.439 -1.005 0 N-CA-C 108.732 -0.84 . . . . 0.13 108.732 171.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.6 Cg_endo -94.34 165.93 1.93 Allowed 'Trans proline' 0 N--CA 1.419 -2.87 0 C-N-CA 122.278 1.985 . . . . 0.17999999999999999 109.623 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -128.81 153.53 38.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.655 -1.239 . . . . 0.56999999999999995 107.655 170.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.699 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.1 151.71 51.51 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 108.6 -0.889 . . . . 0.13 108.6 173.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.091 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.61 141.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 105.329 -2.1 . . . . 0.10000000000000001 105.329 166.03 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.712 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 7.8 p90 . . . . . 0 C--O 1.244 0.815 0 O-C-N 123.628 0.58 . . . . 1.0900000000000001 111.119 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.484 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.4 m-20 . . . . . 0 N--CA 1.445 -0.703 0 CA-C-O 121.454 0.645 . . . . 0.42999999999999999 109.973 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.809 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 86.6 m -158.28 134.49 9.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.387 -1.278 . . . . 0.14000000000000001 108.825 166.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.743 ' CD2' HD13 ' A' ' 464' ' ' LEU . 41.1 p90 174.52 158.24 0.16 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 123.42 0.45 . . . . 0.14999999999999999 110.983 -175.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.636 HD11 HG11 ' A' ' 457' ' ' VAL . 0.5 OUTLIER -77.4 153.26 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 109.122 -0.695 . . . . 0.080000000000000002 109.122 165.051 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.06 147.12 29.22 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.038 -1.097 . . . . 2.0099999999999998 108.038 -177.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.732 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.2 t -138.99 153.78 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 C-N-CA 123.625 0.77 . . . . 0.45000000000000001 110.422 173.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.496 ' N ' HG12 ' A' ' 347' ' ' VAL . 16.4 t0 -136.85 106.53 6.18 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.98 -1.489 . . . . 0.23999999999999999 106.98 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.028 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -79.01 -35.03 43.46 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 124.049 1.881 . . . . 0.16 110.334 -166.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.425 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.4 mt-10 -55.44 -43.49 75.45 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 110.904 -2.862 . . . . 0.59999999999999998 107.697 176.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 351' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 17.6 m-80 -101.51 4.54 41.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 110.97 -2.832 . . . . 0.20000000000000001 111.395 -175.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.842 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 83.5 mm-40 31.38 62.44 0.24 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 112.852 -1.976 . . . . 2.1499999999999999 113.465 -172.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.628 ' NE2' ' HG2' ' A' ' 365' ' ' GLU . 29.6 t60 -141.43 136.83 31.74 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.453 -1.249 . . . . 0.089999999999999997 109.927 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.732 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -112.94 158.98 19.56 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.057 -0.519 . . . . 0.070000000000000007 110.214 -179.292 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.641 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -144.17 160.71 40.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.703 -0.681 . . . . 0.11 111.149 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.809 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.4 t80 -113.39 153.56 28.37 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 106.465 -1.68 . . . . 0.26000000000000001 106.465 150.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.4 m-85 -128.01 116.57 20.25 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.129 -0.941 . . . . 0.14000000000000001 110.248 -178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.1 tppt? -117.78 138.44 52.05 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.046 -1.835 . . . . 0.25 106.046 168.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.49 16.96 8.11 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.39 0.885 . . . . 0.42999999999999999 113.39 172.355 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.484 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.34 8.04 87.0 Favored Glycine 0 CA--C 1.485 -1.796 0 CA-C-N 115.643 -0.708 . . . . 0.17999999999999999 113.036 -173.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.2 ptmt -128.11 177.93 6.57 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 104.493 -2.41 . . . . 0.37 104.493 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.641 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.1 m -104.59 158.23 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.747 0 N-CA-C 116.303 1.964 . . . . 0.10000000000000001 116.303 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.689 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.91 -28.51 9.57 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 110.764 -2.925 . . . . 0.070000000000000007 106.35 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.798 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.53 145.36 50.05 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 111.551 -2.568 . . . . 0.059999999999999998 111.678 -175.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.628 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -142.23 118.77 10.97 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 104.49 -2.411 . . . . 0.47999999999999998 104.49 174.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.732 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.6 163.68 37.22 Favored 'General case' 0 N--CA 1.401 -2.89 0 C-N-CA 118.332 -1.347 . . . . 0.070000000000000007 110.57 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.588 ' OD2' ' HA2' ' A' ' 430' ' ' GLY . 0.5 OUTLIER -100.75 142.3 32.41 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.739 -0.838 . . . . 1.8 108.739 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.731 HG22 ' HA ' ' A' ' 445' ' ' THR . 1.9 pp -137.03 -172.76 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 CA-C-O 122.045 0.926 . . . . 0.12 112.317 -173.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.842 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -152.87 118.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 113.196 -1.82 . . . . 0.10000000000000001 109.442 171.442 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 349' ' ' LEU . 54.6 p -78.8 -168.0 1.29 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.062 -2.336 . . . . 1.26 111.285 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.415 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.9 165.56 40.09 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 118.602 -1.761 . . . . 0.14000000000000001 112.17 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -71.64 156.79 90.89 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.41 0.624 . . . . 0.81000000000000005 111.474 -168.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.637 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 87.9 Cg_exo -55.84 -28.67 68.8 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 125.174 3.916 . . . . 0.28000000000000003 113.612 -173.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.454 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 17.8 p -70.81 -32.38 69.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.421 -1.718 . . . . 0.33000000000000002 109.644 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.527 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -140.98 70.63 28.93 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 123.822 1.772 . . . . 0.39000000000000001 109.033 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 375' ' ' THR . 89.0 Cg_exo -58.08 157.15 26.19 Favored 'Trans proline' 0 C--N 1.312 -1.387 1 C-N-CA 126.592 4.861 . . . . 0.38 115.358 -170.351 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.51 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 1.5 m -82.67 131.87 53.57 Favored Pre-proline 0 N--CA 1.406 -2.648 0 CA-C-N 114.326 -1.306 . . . . 0.81999999999999995 108.482 172.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.6 Cg_exo -72.19 -45.69 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.808 3.005 . . . . 0.19 112.334 -171.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.817 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 60.5 140.92 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 123.283 1.516 . . . . 0.13 113.791 -173.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 150.06 -110.41 0.47 Allowed Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 112.331 -2.213 . . . . 0.20000000000000001 109.419 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.1 p -130.02 123.18 55.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.694 0.759 . . . . 0.81999999999999995 109.961 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.773 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 3.5 m-85 -120.27 -173.55 2.59 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.544 -1.651 . . . . 0.22 106.544 170.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 9.5 t80 -144.17 127.35 16.64 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 120.477 -1.389 . . . . 0.65000000000000002 113.576 -171.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.8 p -90.44 92.93 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 122.949 1.357 . . . . 0.16 109.97 171.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -73.49 -10.93 60.24 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.253 -1.794 . . . . 2.5499999999999998 108.067 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.782 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.4 t30 -169.96 133.04 1.15 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.651 -0.704 . . . . 0.42999999999999999 112.093 -175.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.631 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -92.53 154.76 18.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.054 -0.521 . . . . 1.1200000000000001 110.485 171.164 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.78 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 35.8 mm-40 -132.59 157.97 43.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 115.013 1.486 . . . . 0.70999999999999996 115.013 -171.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.757 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.8 mt-10 -138.29 126.89 23.47 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.827 -1.988 . . . . 0.38 108.425 173.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.63 49.21 20.86 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 123.371 1.557 . . . . 0.40999999999999998 109.195 -175.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.946 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -79.76 168.31 19.47 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 112.665 -2.061 . . . . 0.12 108.577 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.7 m -133.16 119.53 20.02 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.154 0.978 . . . . 0.17000000000000001 111.808 170.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.567 HD13 ' HB ' ' A' ' 407' ' ' VAL . 3.7 mp -79.47 88.75 5.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.541 -1.663 . . . . 0.56999999999999995 112.023 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.555 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.2 mttt . . . . . 0 C--N 1.286 -2.191 0 CA-C-N 113.618 -1.628 . . . . 0.33000000000000002 113.439 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.555 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.807 0 CA-C-O 121.125 0.488 . . . . 0.53000000000000003 109.894 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.33 97.29 5.18 Favored Pre-proline 0 N--CA 1.436 -1.149 0 N-CA-C 107.905 -1.146 . . . . 0.19 107.905 169.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.5 Cg_exo -68.26 109.5 2.01 Favored 'Trans proline' 0 N--CA 1.432 -2.098 0 C-N-CA 121.929 1.753 . . . . 0.19 109.584 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.946 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -107.65 156.99 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 CA-C-N 112.915 -1.948 . . . . 0.14999999999999999 107.421 -168.143 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.757 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.5 m-80 -88.63 -20.67 24.64 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.014 -0.736 . . . . 0.51000000000000001 109.014 -174.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 75.6 m-85 -158.82 126.75 5.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.013 -0.994 . . . . 0.27000000000000002 108.527 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.675 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 26.8 t-105 -144.21 138.69 28.24 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.463 0.649 . . . . 0.089999999999999997 110.93 -167.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.631 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -122.23 92.27 48.94 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.272 -1.01 . . . . 0.14000000000000001 108.272 175.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.782 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 25.5 Cg_endo . . . . . 0 C--N 1.349 0.582 0 C-N-CA 122.554 2.169 . . . . 0.5 112.853 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 419' ' ' GLY . 25.1 t . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.267 0.556 . . . . 0.75 112.011 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.21 122.53 0.82 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.182 -1.167 . . . . 0.20000000000000001 110.182 170.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.65 HG22 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.37 141.92 14.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 109.956 -0.387 . . . . 0.28999999999999998 109.956 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.675 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.3 p80 -159.9 161.19 34.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 0.089999999999999997 111.448 -175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.703 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -82.8 149.53 27.15 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 107.889 -1.152 . . . . 1.0700000000000001 107.889 171.434 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 445' ' ' THR . 47.1 t -133.82 96.84 3.75 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.708 0.766 . . . . 0.23000000000000001 110.015 -173.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 114.453 -1.249 . . . . 0.41999999999999998 109.734 -176.198 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.573 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.5 pm0 . . . . . 0 N--CA 1.43 -1.44 0 CA-C-O 122.38 1.086 . . . . 2.1600000000000001 112.964 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.585 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.7 OUTLIER -158.33 127.88 5.81 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 112.691 -2.05 . . . . 0.33000000000000002 105.8 169.056 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 430' ' ' GLY . . . . . 0.588 ' HA2' ' OD2' ' A' ' 367' ' ' ASP . . . 169.06 -158.48 31.07 Favored Glycine 0 C--N 1.286 -2.234 0 C-N-CA 119.871 -1.157 . . . . 0.17000000000000001 111.148 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.511 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.16 165.91 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.781 0 C-N-CA 120.511 -0.852 . . . . 0.20999999999999999 111.665 168.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 435' ' ' LYS . 22.4 m-20 -52.82 101.93 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.684 -1.258 . . . . 1.8500000000000001 113.096 -155.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 1.033 HD22 ' HD2' ' A' ' 437' ' ' ARG . 33.7 mt -94.96 -33.22 12.84 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 112.943 -1.935 . . . . 1.21 109.275 175.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.715 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.0 p-90 -53.87 -27.45 30.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.738 -1.119 . . . . 0.16 112.511 -173.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.715 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.05 -34.54 16.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.92 -0.582 . . . . 0.22 111.977 -178.145 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.9 p -89.72 -41.43 11.91 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.047 -0.978 . . . . 0.25 110.787 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 1.033 ' HD2' HD22 ' A' ' 433' ' ' LEU . 0.8 OUTLIER -94.2 -18.11 22.04 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.546 -1.206 . . . . 1.8200000000000001 109.957 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.76 48.49 56.62 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.984 -1.007 . . . . 0.23999999999999999 115.045 163.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 10.1 p -83.71 111.38 19.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.35 1.075 . . . . 1.01 111.936 -171.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 35.92 -118.47 0.12 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.693 -1.139 . . . . 0.5 113.298 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.415 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -137.06 -16.59 0.74 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.999 -0.62 . . . . 0.26000000000000001 113.841 -175.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.454 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.3 p -103.78 -167.06 1.32 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.63 0.715 . . . . 0.34999999999999998 112.511 -176.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.452 HD13 HG11 ' A' ' 465' ' ' VAL . 2.1 mp -98.74 129.01 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 114.893 -1.049 . . . . 0.12 110.866 -174.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -101.61 97.89 8.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.473 -0.785 . . . . 0.62 110.422 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.731 ' HA ' HG22 ' A' ' 368' ' ' ILE . 6.8 m -94.1 144.08 27.48 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 115.071 -0.968 . . . . 0.10000000000000001 112.467 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.637 ' HD2' HG21 ' A' ' 366' ' ' THR . 81.7 Cg_exo -51.07 143.48 31.57 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 124.012 3.142 . . . . 0.23999999999999999 113.178 175.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.703 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.5 Cg_exo -64.62 -29.96 60.62 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.833 2.355 . . . . 0.31 112.361 -176.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 38.6 m -72.95 -23.49 60.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.769 -0.651 . . . . 1.1000000000000001 112.218 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.798 ' O ' HD21 ' A' ' 364' ' ' LEU . 25.2 m -100.82 -47.42 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 113.01 0.744 . . . . 0.080000000000000002 113.01 -169.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.961 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.8 -2.22 6.79 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.69 -0.804 . . . . 0.070000000000000007 110.204 -178.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 448' ' ' SER . 16.2 pttp -80.24 -38.88 30.1 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.475 1.131 . . . . 0.92000000000000004 108.201 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 4.4 mm-40 -61.91 -46.54 88.9 Favored 'General case' 0 CA--C 1.471 -2.066 0 CA-C-N 112.497 -2.138 . . . . 0.25 106.484 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.961 HD23 ' SD ' ' A' ' 450' ' ' MET . 2.9 tp -47.45 -65.89 0.49 Allowed 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 109.973 -3.285 . . . . 0.050000000000000003 112.608 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.471 ' CE2' ' HG3' ' A' ' 389' ' ' GLU . 21.9 t80 -45.33 -22.98 0.16 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.853 0.835 . . . . 0.13 109.728 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.458 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -90.65 -26.84 21.62 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.74 -1.118 . . . . 0.13 111.983 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.747 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -102.33 -44.68 5.33 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 113.64 0.978 . . . . 0.059999999999999998 113.64 177.777 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -71.23 147.08 11.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 122.391 1.091 . . . . 0.080000000000000002 110.793 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.572 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -113.32 157.5 21.74 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 113.033 -1.894 . . . . 0.47999999999999998 108.869 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.653 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 7.2 mtpt -60.74 101.54 0.15 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.063 -1.088 . . . . 0.98999999999999999 108.063 166.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.86 -7.41 6.46 Favored Glycine 0 C--N 1.308 -1.025 0 CA-C-N 113.957 -1.474 . . . . 0.19 111.631 -174.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.673 HG21 ' HB ' ' A' ' 457' ' ' VAL . 8.0 m -72.96 150.58 90.4 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 108.257 -1.016 . . . . 0.13 108.257 170.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 10.1 Cg_endo -95.32 171.94 1.3 Allowed 'Trans proline' 0 N--CA 1.417 -2.972 0 C-N-CA 122.172 1.915 . . . . 0.17999999999999999 109.91 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.773 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -130.88 153.85 39.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.201 -1.037 . . . . 0.56999999999999995 108.201 171.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.743 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.2 mp -134.08 150.67 51.18 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.637 -0.875 . . . . 0.13 108.637 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.028 HG23 HD21 ' A' ' 349' ' ' LEU . 0.8 OUTLIER -140.19 140.1 35.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 103.981 -2.6 . . . . 0.10000000000000001 103.981 162.431 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.817 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 4.6 p90 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.399 -1.286 . . . . 1.0900000000000001 111.184 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.467 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 9.1 m-20 . . . . . 0 N--CA 1.444 -0.757 0 N-CA-C 109.457 -0.571 . . . . 0.42999999999999999 109.457 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.776 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 91.5 m -157.67 134.63 10.06 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.63 -1.168 . . . . 0.14000000000000001 108.539 168.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.765 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.9 p90 174.42 158.32 0.16 Allowed 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 123.503 0.502 . . . . 0.14999999999999999 111.152 -175.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 453' ' ' LEU . 0.5 OUTLIER -77.26 153.86 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 109.077 -0.712 . . . . 0.080000000000000002 109.077 164.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.639 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.46 146.9 28.6 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.006 -1.109 . . . . 2.0099999999999998 108.006 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.727 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.0 t -139.24 154.31 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 C-N-CA 123.687 0.795 . . . . 0.45000000000000001 110.449 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.509 ' N ' HG12 ' A' ' 347' ' ' VAL . 17.8 t0 -137.79 105.77 5.68 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.61 -1.626 . . . . 0.23999999999999999 106.61 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.032 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -79.18 -35.97 41.05 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 114.086 -1.416 . . . . 0.16 109.891 -165.338 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.438 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -55.77 -44.76 77.99 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 110.669 -2.968 . . . . 0.59999999999999998 108.124 177.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 21.7 m-80 -100.56 6.76 44.27 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 110.931 -2.85 . . . . 0.20000000000000001 110.795 -175.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 20.8 mp0 32.83 60.8 0.4 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 112.786 -2.006 . . . . 2.1499999999999999 112.868 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.503 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.3 t60 -141.77 136.44 30.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.748 -0.66 . . . . 0.089999999999999997 109.66 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.77 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.1 OUTLIER -113.81 157.64 22.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.898 -0.592 . . . . 0.070000000000000007 110.001 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.649 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.7 m-90 -143.35 161.25 38.85 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.179 0.592 . . . . 0.11 111.044 -177.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.776 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.1 t80 -113.41 153.56 28.41 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.423 -1.695 . . . . 0.26000000000000001 106.423 150.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.0 m-85 -127.81 117.68 22.3 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.001 -1.0 . . . . 0.14000000000000001 109.954 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.5 tppt? -118.44 137.8 52.91 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.08 -1.822 . . . . 0.25 106.08 168.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.453 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 70.21 16.36 7.36 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.276 0.843 . . . . 0.42999999999999999 113.276 172.183 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.35 7.47 87.85 Favored Glycine 0 CA--C 1.485 -1.816 0 CA-C-N 115.72 -0.673 . . . . 0.17999999999999999 112.956 -173.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 16.6 ptmt -127.5 177.76 6.54 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 104.66 -2.348 . . . . 0.37 104.66 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.649 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.2 m -104.58 158.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.616 0 N-CA-C 116.427 2.01 . . . . 0.10000000000000001 116.427 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.711 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.7 -26.25 9.97 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 110.607 -2.997 . . . . 0.070000000000000007 106.671 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.816 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -135.19 145.12 47.41 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 111.404 -2.635 . . . . 0.059999999999999998 111.653 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.458 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.6 tt0 -141.25 119.05 11.76 Favored 'General case' 0 N--CA 1.405 -2.684 0 N-CA-C 104.269 -2.493 . . . . 0.47999999999999998 104.269 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.77 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.1 165.17 33.61 Favored 'General case' 0 N--CA 1.4 -2.973 0 C-N-CA 117.958 -1.497 . . . . 0.070000000000000007 111.501 178.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.443 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 29.5 p-10 -103.89 136.68 43.1 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.821 -1.082 . . . . 1.8 109.822 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.729 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -136.58 -173.02 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.247 0 CA-C-O 122.506 1.146 . . . . 0.12 112.483 -171.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.61 119.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 112.811 -1.995 . . . . 0.10000000000000001 108.102 173.474 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.496 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -80.47 -168.09 1.59 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.254 -1.339 . . . . 1.26 110.479 -178.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.401 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.74 169.94 45.34 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 118.811 -1.661 . . . . 0.14000000000000001 112.414 -174.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 2.2 ptpt -74.48 156.24 87.15 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.314 0.578 . . . . 0.81000000000000005 112.33 -164.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 85.8 Cg_exo -54.83 -30.89 70.2 Favored 'Trans proline' 0 CA--C 1.497 -1.345 1 C-N-CA 125.537 4.158 . . . . 0.28000000000000003 114.037 -173.137 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.418 ' OG1' HG22 ' A' ' 375' ' ' THR . 21.5 p -67.2 -31.47 71.89 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.703 -1.59 . . . . 0.33000000000000002 109.565 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.52 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -141.87 70.9 24.39 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 113.683 -1.599 . . . . 0.39000000000000001 109.731 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.4 Cg_exo -58.15 142.99 97.45 Favored 'Trans proline' 0 C--N 1.306 -1.679 1 C-N-CA 125.884 4.389 . . . . 0.38 113.307 -172.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.496 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -73.11 144.24 84.61 Favored Pre-proline 0 N--CA 1.422 -1.83 0 N-CA-C 108.154 -1.054 . . . . 0.81999999999999995 108.154 175.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.1 Cg_exo -74.97 -44.1 0.36 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 124.381 3.387 . . . . 0.19 111.728 -165.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.858 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 57.93 136.69 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 123.528 1.632 . . . . 0.13 113.86 -173.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 155.3 -114.61 0.62 Allowed Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 112.013 -2.358 . . . . 0.20000000000000001 109.377 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.91 114.72 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 121.822 0.82 . . . . 0.81999999999999995 111.192 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.756 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.4 m-85 -112.42 -174.18 2.4 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.193 -1.41 . . . . 0.22 107.193 174.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.3 t80 -140.58 124.47 17.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.19 1.359 . . . . 0.65000000000000002 113.598 -172.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.95 92.04 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 123.066 1.412 . . . . 0.16 109.611 168.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -92.87 10.78 29.65 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.419 -1.719 . . . . 2.5499999999999998 107.982 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.753 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.4 t30 -169.79 126.3 0.86 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 113.873 -1.512 . . . . 0.42999999999999999 110.095 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.668 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.5 144.06 29.94 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.998 -1.001 . . . . 1.1200000000000001 109.171 170.495 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.763 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 29.8 mm-40 -124.73 158.3 33.59 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 114.896 1.443 . . . . 0.70999999999999996 114.896 -167.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.736 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 56.2 mt-10 -137.05 126.88 25.63 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 112.958 -1.928 . . . . 0.38 108.57 174.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 37.1 t70 54.23 47.35 23.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 123.076 1.417 . . . . 0.40999999999999998 109.228 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.923 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.43 166.23 21.45 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 112.922 -1.945 . . . . 0.12 108.891 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 18.7 m -132.3 119.33 20.61 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.136 0.97 . . . . 0.17000000000000001 111.465 171.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.8 89.02 5.22 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.731 -1.577 . . . . 0.56999999999999995 111.853 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.596 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.9 mttt . . . . . 0 C--N 1.286 -2.186 0 CA-C-N 113.8 -1.546 . . . . 0.33000000000000002 113.353 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.596 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.44 -0.946 0 CA-C-O 121.062 0.458 . . . . 0.53000000000000003 109.769 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.9 OUTLIER -143.42 96.76 5.69 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 107.916 -1.142 . . . . 0.19 107.916 170.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 17.3 Cg_exo -69.52 110.51 2.52 Favored 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.791 1.66 . . . . 0.19 109.728 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.923 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.18 151.52 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 112.941 -1.936 . . . . 0.14999999999999999 107.11 -168.447 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.736 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 22.6 m-80 -85.42 -20.11 30.32 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.962 -0.755 . . . . 0.51000000000000001 108.962 -174.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.763 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 81.2 m-85 -158.27 126.11 5.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.995 -1.002 . . . . 0.27000000000000002 108.705 -170.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.679 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 24.5 t-105 -144.48 133.11 22.21 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.758 0.79 . . . . 0.089999999999999997 111.104 -167.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.668 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.9 mmt -114.92 93.66 35.19 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 107.816 -1.179 . . . . 0.14000000000000001 107.816 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.753 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.6 Cg_endo . . . . . 0 C--N 1.348 0.516 0 C-N-CA 122.455 2.103 . . . . 0.5 112.252 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 419' ' ' GLY . 39.4 t . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 121.401 0.619 . . . . 0.75 112.021 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.593 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.95 121.64 0.8 Allowed Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.867 -1.293 . . . . 0.20000000000000001 109.867 169.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.699 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.2 mp -82.02 143.22 12.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 110.106 -0.331 . . . . 0.28999999999999998 110.106 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.679 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.0 p80 -160.28 161.86 33.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.178 -0.464 . . . . 0.089999999999999997 111.514 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.684 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -83.19 145.62 29.07 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.607 -1.257 . . . . 1.0700000000000001 107.607 171.402 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 445' ' ' THR . 29.4 t -133.81 98.33 4.14 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.95 0.881 . . . . 0.23000000000000001 110.205 -171.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.312 -1.022 0 CA-C-N 114.002 -1.454 . . . . 0.41999999999999998 109.609 -177.074 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.556 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.428 -1.543 0 CA-C-O 122.125 0.964 . . . . 2.1600000000000001 112.049 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.677 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.6 OUTLIER -160.7 129.64 4.77 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 104.949 -2.241 . . . . 0.33000000000000002 104.949 172.266 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.82 -157.27 29.47 Favored Glycine 0 C--N 1.284 -2.339 0 C-N-CA 119.678 -1.249 . . . . 0.17000000000000001 110.797 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -44.97 174.01 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.184 -1.008 . . . . 0.20999999999999999 111.482 167.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.532 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.4 p-10 -52.59 101.95 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 123.28 1.515 . . . . 1.8500000000000001 113.89 -153.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.711 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.93 -36.99 10.88 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 112.651 -2.068 . . . . 1.21 109.582 169.686 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.757 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.5 p-90 -54.44 -26.88 33.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.338 -0.846 . . . . 0.16 112.4 -170.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.757 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.72 -35.21 15.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 112.523 0.564 . . . . 0.22 112.523 -177.386 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.441 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.2 p -91.82 -43.71 9.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.031 -0.986 . . . . 0.25 110.904 -176.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.711 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.8 OUTLIER -90.09 -19.24 24.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.73 -1.123 . . . . 1.8200000000000001 109.152 -179.085 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.8 47.54 46.74 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.475 -0.784 . . . . 0.23999999999999999 114.952 161.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.9 p -84.65 110.97 19.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 118.622 1.211 . . . . 1.01 111.597 -172.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 37.09 -130.86 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.69 -1.141 . . . . 0.5 113.031 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.401 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -121.74 -20.06 3.24 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.088 -0.577 . . . . 0.26000000000000001 114.084 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.458 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.4 p -99.09 -166.83 1.4 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.803 0.801 . . . . 0.34999999999999998 112.867 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.437 HG12 HG11 ' A' ' 347' ' ' VAL . 2.2 mp -96.73 130.01 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 115.105 -0.952 . . . . 0.12 110.887 -173.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -101.01 94.56 6.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.945 -0.57 . . . . 0.62 110.418 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.729 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.6 m -91.26 142.39 27.1 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-N 115.147 -0.933 . . . . 0.10000000000000001 112.481 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.67 ' HD2' HG21 ' A' ' 366' ' ' THR . 89.3 Cg_exo -49.72 143.59 22.17 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 123.925 3.083 . . . . 0.23999999999999999 113.268 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.684 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.2 Cg_exo -65.0 -27.94 57.81 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.836 2.357 . . . . 0.31 112.053 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.503 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 31.6 m -75.56 -22.61 56.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.505 0.669 . . . . 1.1000000000000001 112.371 -176.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.816 ' O ' HD21 ' A' ' 364' ' ' LEU . 26.3 m -100.99 -48.03 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 112.898 0.703 . . . . 0.080000000000000002 112.898 -170.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.957 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.18 -2.03 5.22 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.72 -0.792 . . . . 0.070000000000000007 110.246 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.505 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 14.7 pttp -81.2 -38.78 26.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 122.58 1.181 . . . . 0.92000000000000004 108.143 173.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm-40 -62.18 -46.35 89.32 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 112.368 -2.196 . . . . 0.25 106.559 -177.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.957 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.8 tp -46.69 -67.11 0.31 Allowed 'General case' 0 N--CA 1.403 -2.781 0 CA-C-N 109.785 -3.37 . . . . 0.050000000000000003 112.735 172.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.492 ' CE2' ' HE2' ' A' ' 387' ' ' LYS . 14.6 t80 -45.34 -24.11 0.26 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 124.034 0.834 . . . . 0.13 109.469 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.452 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.12 -27.15 26.62 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 114.684 -1.144 . . . . 0.13 111.732 -176.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.749 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.03 -44.07 5.83 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 113.459 0.911 . . . . 0.059999999999999998 113.459 176.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.664 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -72.89 149.91 8.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 122.554 1.168 . . . . 0.080000000000000002 111.182 -179.485 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.424 ' H ' ' HG3' ' A' ' 458' ' ' GLU . 0.0 OUTLIER -119.87 156.25 31.08 Favored 'General case' 0 N--CA 1.413 -2.283 0 CA-C-N 112.86 -1.973 . . . . 0.47999999999999998 108.366 -178.422 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.598 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.3 mppt? -58.8 102.07 0.11 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.555 -0.905 . . . . 0.98999999999999999 108.555 170.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.62 -11.17 5.75 Favored Glycine 0 C--N 1.305 -1.15 0 CA-C-N 114.069 -1.423 . . . . 0.19 111.535 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.664 HG21 ' HB ' ' A' ' 457' ' ' VAL . 10.8 m -68.82 150.47 97.62 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 108.793 -0.817 . . . . 0.13 108.793 171.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.0 Cg_endo -93.61 165.02 2.29 Favored 'Trans proline' 0 N--CA 1.423 -2.652 0 C-N-CA 122.17 1.913 . . . . 0.17999999999999999 110.074 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.756 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -126.35 152.12 33.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.497 -1.297 . . . . 0.56999999999999995 107.497 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.765 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.1 mp -133.79 149.95 51.43 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 108.26 -1.015 . . . . 0.13 108.26 175.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.032 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.08 138.96 37.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 103.932 -2.618 . . . . 0.10000000000000001 103.932 163.567 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.858 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 4.3 p90 . . . . . 0 C--O 1.25 1.116 0 CA-C-N 118.503 0.592 . . . . 1.0900000000000001 111.879 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.475 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.2 m-20 . . . . . 0 CA--C 1.511 -0.527 0 CA-C-O 121.64 0.733 . . . . 0.42999999999999999 110.26 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 357' ' ' TYR . 98.5 m -157.16 134.58 10.56 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.854 -1.066 . . . . 0.14000000000000001 110.539 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.674 ' HA ' HG23 ' A' ' 461' ' ' THR . 37.9 p90 173.65 159.18 0.14 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.831 -0.622 . . . . 0.14999999999999999 110.923 -178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.669 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.44 151.23 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.263 0 N-CA-C 109.282 -0.636 . . . . 0.080000000000000002 109.282 166.608 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.605 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 34.6 tt0 -149.81 141.09 23.17 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.462 -0.79 . . . . 2.0099999999999998 109.743 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.738 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -133.0 161.89 40.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.054 0.454 . . . . 0.45000000000000001 111.312 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 347' ' ' VAL . 30.3 t0 -140.15 106.86 5.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.521 -1.289 . . . . 0.23999999999999999 107.521 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.084 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.37 -34.41 28.41 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 123.289 1.518 . . . . 0.16 110.156 -169.389 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.93 -43.95 73.82 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.892 -2.867 . . . . 0.59999999999999998 108.015 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -103.04 4.74 37.57 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 111.015 -2.811 . . . . 0.20000000000000001 111.48 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.857 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 16.4 mm-40 34.75 61.59 0.57 Allowed 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 112.917 -1.947 . . . . 2.1499999999999999 113.424 -174.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 22.6 t60 -141.71 134.75 29.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.105 -0.952 . . . . 0.089999999999999997 109.638 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.721 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.84 155.8 24.02 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.631 -0.713 . . . . 0.070000000000000007 109.957 -179.118 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.646 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.4 m-90 -140.88 154.36 46.12 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.533 -0.758 . . . . 0.11 111.257 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.708 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 87.3 t80 -109.36 153.55 23.78 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.428 -1.694 . . . . 0.26000000000000001 106.428 151.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 11.0 m-85 -126.63 118.76 25.45 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 115.224 -0.898 . . . . 0.14000000000000001 110.163 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.8 tppt? -121.88 136.06 54.91 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.366 -1.716 . . . . 0.25 106.366 168.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.3 OUTLIER 70.73 15.55 6.93 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.141 0.793 . . . . 0.42999999999999999 113.141 175.155 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.91 5.07 89.66 Favored Glycine 0 CA--C 1.485 -1.801 0 CA-C-O 122.033 0.796 . . . . 0.17999999999999999 112.844 -174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.1 ptmt -125.79 177.37 6.32 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 104.067 -2.568 . . . . 0.37 104.067 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.646 HG11 ' CD1' ' A' ' 355' ' ' TRP . 14.7 m -104.98 157.51 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.822 0 N-CA-C 116.268 1.951 . . . . 0.10000000000000001 116.268 -176.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.708 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.09 -27.42 10.62 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 110.493 -3.049 . . . . 0.070000000000000007 106.33 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.59 142.75 48.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 111.352 -2.658 . . . . 0.059999999999999998 111.488 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.45 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.5 tt0 -139.99 117.63 11.56 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 104.218 -2.512 . . . . 0.47999999999999998 104.218 176.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.721 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.58 162.54 39.98 Favored 'General case' 0 N--CA 1.397 -3.112 0 C-N-CA 117.715 -1.594 . . . . 0.070000000000000007 111.598 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 14.9 p-10 -101.54 135.51 42.93 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 113.972 -1.467 . . . . 1.8 109.41 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.745 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -137.28 -174.18 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 CA-C-O 122.318 1.056 . . . . 0.12 112.508 -169.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.857 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -151.81 121.28 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 112.725 -2.034 . . . . 0.10000000000000001 109.298 172.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.559 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -81.69 -168.67 1.98 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.768 -1.56 . . . . 1.26 110.318 -178.308 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.64 167.4 42.54 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.655 -1.736 . . . . 0.14000000000000001 112.328 -174.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -72.53 156.94 89.77 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 121.511 0.672 . . . . 0.81000000000000005 111.937 -166.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.664 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 92.1 Cg_exo -56.08 -28.9 72.07 Favored 'Trans proline' 0 CA--C 1.496 -1.392 1 C-N-CA 125.371 4.048 . . . . 0.28000000000000003 113.603 -173.765 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.441 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.0 p -70.38 -34.25 72.36 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.329 -1.76 . . . . 0.33000000000000002 109.413 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.544 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.5 t -142.04 69.99 23.41 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 123.645 1.688 . . . . 0.39000000000000001 109.407 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 375' ' ' THR . 79.8 Cg_exo -58.76 155.28 38.5 Favored 'Trans proline' 0 C--N 1.314 -1.279 1 C-N-CA 126.46 4.773 . . . . 0.38 114.608 -171.141 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.559 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.3 OUTLIER -84.42 141.96 39.93 Favored Pre-proline 0 N--CA 1.423 -1.811 0 N-CA-C 108.699 -0.852 . . . . 0.81999999999999995 108.699 173.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.3 Cg_exo -75.92 -43.34 0.33 Allowed 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 124.785 3.657 . . . . 0.19 112.219 -167.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.773 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.85 136.31 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.302 1.525 . . . . 0.13 113.634 -172.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.6 -119.34 0.96 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 112.129 -2.305 . . . . 0.20000000000000001 109.584 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 381' ' ' VAL . 9.8 p -121.97 115.53 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.275 1.036 . . . . 0.81999999999999995 110.749 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.751 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 1.8 m-85 -114.03 -172.68 2.14 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.192 -1.781 . . . . 0.22 106.192 171.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.666 ' HD2' ' CD1' ' A' ' 385' ' ' TRP . 34.1 t80 -146.11 126.85 14.33 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 118.013 -1.475 . . . . 0.65000000000000002 114.54 -171.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.5 p -85.92 92.21 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 123.064 1.412 . . . . 0.16 109.784 170.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' TRP . . . . . 0.666 ' CD1' ' HD2' ' A' ' 383' ' ' TYR . 75.2 m95 -70.55 -15.06 62.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.173 -1.831 . . . . 2.5499999999999998 107.976 176.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.78 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.8 t30 -170.05 132.65 1.1 Allowed 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.198 -0.91 . . . . 0.42999999999999999 111.209 -174.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.676 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -93.71 144.84 25.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.636 -0.711 . . . . 1.1200000000000001 109.268 171.675 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.775 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 12.8 mm-40 -125.16 157.36 36.61 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 114.381 1.252 . . . . 0.70999999999999996 114.381 -169.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 51.3 mt-10 -136.3 127.12 27.43 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.143 -1.844 . . . . 0.38 108.403 173.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.4 t70 56.48 45.04 23.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 123.3 1.524 . . . . 0.40999999999999998 109.259 -178.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.933 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -79.59 167.24 20.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 112.852 -1.976 . . . . 0.12 109.016 176.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 7.1 m -131.87 119.35 21.07 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.164 0.983 . . . . 0.17000000000000001 112.06 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.9 mp -82.69 88.55 6.71 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.761 -1.563 . . . . 0.56999999999999995 112.275 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.53 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 48.7 mttt . . . . . 0 C--N 1.286 -2.159 0 CA-C-N 113.657 -1.611 . . . . 0.33000000000000002 113.551 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.53 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.441 -0.878 0 CA-C-O 121.122 0.487 . . . . 0.53000000000000003 109.743 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -143.83 97.08 5.44 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 108.444 -0.947 . . . . 0.19 108.444 171.225 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.8 Cg_exo -68.87 110.07 2.28 Favored 'Trans proline' 0 N--CA 1.43 -2.214 0 C-N-CA 122.022 1.815 . . . . 0.19 109.456 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.933 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.56 154.1 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 CA-C-N 112.78 -2.009 . . . . 0.14999999999999999 107.288 -167.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.6 m-80 -86.92 -19.85 28.23 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.969 -0.752 . . . . 0.51000000000000001 108.969 -174.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.775 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 88.7 m-85 -158.65 125.62 4.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.038 -0.983 . . . . 0.27000000000000002 108.89 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.679 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 27.1 t-105 -144.52 137.08 26.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.678 0.751 . . . . 0.089999999999999997 110.907 -167.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.676 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.6 mmt -120.44 93.8 48.46 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 107.823 -1.177 . . . . 0.14000000000000001 107.823 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.78 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 33.6 Cg_endo . . . . . 0 C--N 1.348 0.528 0 C-N-CA 122.568 2.179 . . . . 0.5 112.153 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 419' ' ' GLY . 39.9 t . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 121.345 0.593 . . . . 0.75 111.509 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.606 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -177.06 122.87 0.86 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 109.694 -1.362 . . . . 0.20000000000000001 109.694 170.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.717 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.0 mp -81.65 141.69 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 120.589 -0.444 . . . . 0.28999999999999998 109.888 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.679 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.8 p80 -159.98 162.47 34.36 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.971 -0.559 . . . . 0.089999999999999997 111.338 -174.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.665 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.94 143.47 28.96 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.538 -1.282 . . . . 1.0700000000000001 107.538 171.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 445' ' ' THR . 42.3 t -134.64 98.71 4.13 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.702 0.763 . . . . 0.23000000000000001 110.415 -170.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.441 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 20.0 t70 . . . . . 0 C--N 1.313 -1.013 0 CA-C-N 114.258 -1.337 . . . . 0.41999999999999998 109.803 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 . . . . . 0 CA--C 1.497 -1.083 0 CA-C-O 121.771 0.796 . . . . 2.1600000000000001 111.388 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.525 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -152.89 125.35 8.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.32 -1.733 . . . . 0.33000000000000002 106.32 175.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.77 -158.67 31.62 Favored Glycine 0 C--N 1.28 -2.553 0 N-CA-C 109.501 -1.44 . . . . 0.17000000000000001 109.501 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -44.81 174.63 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.061 -1.066 . . . . 0.20999999999999999 111.683 168.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.523 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.9 p-10 -50.87 102.82 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 123.274 1.511 . . . . 1.8500000000000001 114.108 -153.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.646 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.2 OUTLIER -95.47 -38.75 10.32 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 112.687 -2.051 . . . . 1.21 109.371 167.219 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.72 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.9 p-90 -50.99 -28.85 10.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.413 -0.812 . . . . 0.16 112.872 -170.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.72 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.24 -34.07 16.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.621 0.724 . . . . 0.22 111.762 -177.71 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.0 p -88.45 -43.47 11.43 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.539 -1.209 . . . . 0.25 110.905 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.646 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 6.4 mtp85 -93.84 -19.63 20.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.781 -1.099 . . . . 1.8200000000000001 109.582 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.19 47.07 50.73 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.141 -0.936 . . . . 0.23999999999999999 114.63 166.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 36.8 m -84.68 110.84 19.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.761 1.281 . . . . 1.01 111.5 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 39.42 -132.24 0.22 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.551 -1.204 . . . . 0.5 113.579 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -121.78 -20.98 3.03 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.924 -0.655 . . . . 0.26000000000000001 113.665 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.46 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.4 p -101.84 -166.08 1.26 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.175 0.806 . . . . 0.34999999999999998 113.175 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.485 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -93.18 130.64 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.994 -1.003 . . . . 0.12 110.412 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -103.11 89.91 3.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.539 0.685 . . . . 0.62 109.835 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.745 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.0 m -84.01 141.78 40.96 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.731 -1.122 . . . . 0.10000000000000001 112.423 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.642 ' HD2' HG21 ' A' ' 366' ' ' THR . 82.1 Cg_exo -48.85 144.49 15.01 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 123.935 3.09 . . . . 0.23999999999999999 113.117 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.665 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.8 Cg_exo -65.31 -22.3 60.41 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.68 2.253 . . . . 0.31 112.123 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.529 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 79.7 p -82.25 -24.2 34.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.62 0.724 . . . . 1.1000000000000001 112.026 -174.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.81 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.8 m -99.46 -48.44 11.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.011 0.745 . . . . 0.080000000000000002 113.011 -169.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.96 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.32 -1.97 3.95 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.669 -0.812 . . . . 0.070000000000000007 110.385 -178.835 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.577 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 42.2 pttt -81.33 -38.74 26.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 122.456 1.122 . . . . 0.92000000000000004 108.11 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 3.8 mm-40 -61.7 -46.4 89.86 Favored 'General case' 0 CA--C 1.471 -2.096 0 CA-C-N 112.48 -2.146 . . . . 0.25 106.423 -177.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.96 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.19 -66.55 0.39 Allowed 'General case' 0 N--CA 1.403 -2.775 0 CA-C-N 109.72 -3.4 . . . . 0.050000000000000003 112.745 172.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.0 t80 -45.89 -23.35 0.27 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.728 0.775 . . . . 0.13 109.458 176.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.453 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.47 -26.94 23.97 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 114.888 -1.051 . . . . 0.13 111.893 -176.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.774 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.78 -44.21 5.6 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 113.359 0.874 . . . . 0.059999999999999998 113.359 177.163 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.669 HG11 HD11 ' A' ' 345' ' ' ILE . 0.4 OUTLIER -73.81 149.22 8.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.582 1.182 . . . . 0.080000000000000002 110.995 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.6 157.69 34.86 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 112.905 -1.952 . . . . 0.47999999999999998 108.177 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.552 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 37.5 mtpt -55.38 101.47 0.05 Allowed 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 109.034 -0.728 . . . . 0.98999999999999999 109.034 169.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' GLY . . . . . 0.422 ' HA2' ' OH ' ' A' ' 383' ' ' TYR . . . 133.08 -14.27 4.9 Favored Glycine 0 C--N 1.302 -1.335 0 CA-C-N 114.222 -1.354 . . . . 0.19 112.124 -175.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.674 HG23 ' HA ' ' A' ' 344' ' ' TYR . 35.6 m -70.36 148.2 95.44 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 108.498 -0.927 . . . . 0.13 108.498 168.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 11.8 Cg_endo -97.14 177.21 0.54 Allowed 'Trans proline' 0 N--CA 1.419 -2.873 0 C-N-CA 122.832 2.355 . . . . 0.17999999999999999 110.299 175.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.751 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -134.42 154.25 36.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 119.916 -0.714 . . . . 0.56999999999999995 109.278 172.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.737 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.4 mp -135.09 152.31 51.54 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 116.028 -0.533 . . . . 0.13 109.915 173.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.084 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.25 142.02 32.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 105.454 -2.054 . . . . 0.10000000000000001 105.454 163.328 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.762 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 9.0 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.444 -1.265 . . . . 1.0900000000000001 111.341 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ASP . . . . . 0.481 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 11.5 m-20 . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 121.252 0.548 . . . . 0.42999999999999999 110.285 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 357' ' ' TYR . 75.8 m -158.03 135.97 10.69 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.856 -1.066 . . . . 0.14000000000000001 108.995 167.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.8 ' CD2' HD13 ' A' ' 464' ' ' LEU . 43.8 p90 174.11 159.0 0.15 Allowed 'General case' 0 C--O 1.212 -0.912 0 O-C-N 123.35 0.406 . . . . 0.14999999999999999 111.173 -175.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.677 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -78.25 154.98 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 N-CA-C 109.711 -0.478 . . . . 0.080000000000000002 109.711 165.101 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.599 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -146.92 148.64 32.0 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.873 -1.058 . . . . 2.0099999999999998 108.206 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.723 HG22 ' HG3' ' A' ' 354' ' ' MET . 5.6 t -145.02 110.33 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 N-CA-C 113.872 1.064 . . . . 0.45000000000000001 113.872 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.503 ' HB2' ' CZ3' ' A' ' 355' ' ' TRP . 27.7 t0 -92.56 106.71 18.64 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-O 121.946 0.879 . . . . 0.23999999999999999 109.058 176.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.027 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -77.44 -37.3 51.89 Favored 'General case' 0 CA--C 1.479 -1.772 0 CA-C-N 114.01 -1.45 . . . . 0.16 110.251 -169.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.542 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 3.5 mt-10 -55.04 -44.43 74.67 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 110.766 -2.925 . . . . 0.59999999999999998 108.062 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -102.32 7.21 40.66 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 110.694 -2.957 . . . . 0.20000000000000001 111.051 -175.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.633 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.9 OUTLIER 34.09 61.76 0.49 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 112.852 -1.976 . . . . 2.1499999999999999 112.833 -175.233 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.57 ' NE2' ' HG2' ' A' ' 365' ' ' GLU . 23.5 t60 -143.22 132.18 22.88 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.568 -0.742 . . . . 0.089999999999999997 109.892 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.801 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.0 OUTLIER -109.38 152.6 25.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.693 -0.685 . . . . 0.070000000000000007 109.793 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.705 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.1 m-90 -139.05 157.72 45.48 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.442 -0.799 . . . . 0.11 110.725 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.709 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.5 t80 -109.66 153.81 23.72 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.488 -1.671 . . . . 0.26000000000000001 106.488 151.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.4 m-85 -127.38 118.42 24.08 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 115.073 -0.967 . . . . 0.14000000000000001 109.969 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 358' ' ' LYS . 9.8 tppt? -121.81 125.23 46.03 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.863 -1.162 . . . . 0.25 107.863 171.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.83 35.87 2.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 119.092 0.86 . . . . 0.42999999999999999 112.243 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' GLY . . . . . 0.481 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 62.89 13.29 46.73 Favored Glycine 0 CA--C 1.495 -1.191 0 C-N-CA 120.322 -0.942 . . . . 0.17999999999999999 113.495 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.8 ptmt -137.25 172.47 12.95 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.422 -2.436 . . . . 0.37 104.422 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.705 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.6 m -101.02 158.18 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.741 0 N-CA-C 116.48 2.03 . . . . 0.10000000000000001 116.48 -172.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.696 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.35 -26.55 9.97 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 110.523 -3.035 . . . . 0.070000000000000007 106.933 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.806 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -133.72 145.58 49.99 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 111.766 -2.47 . . . . 0.059999999999999998 111.842 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.57 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 5.0 tt0 -140.26 118.35 11.92 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 104.569 -2.382 . . . . 0.47999999999999998 104.569 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.801 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.05 162.0 41.25 Favored 'General case' 0 N--CA 1.402 -2.838 0 C-N-CA 117.767 -1.573 . . . . 0.070000000000000007 112.059 177.753 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.632 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 17.0 p-10 -101.12 135.8 42.0 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 114.263 -1.335 . . . . 1.8 109.27 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.926 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.6 pp -141.63 -171.84 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 122.443 1.116 . . . . 0.12 112.835 -169.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.47 120.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 CA-C-N 112.959 -1.928 . . . . 0.10000000000000001 108.982 174.389 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.532 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -76.23 -167.67 0.81 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.643 -1.617 . . . . 1.26 110.953 177.503 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.489 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.85 175.92 48.93 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.118 -1.515 . . . . 0.14000000000000001 112.341 -174.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -78.91 156.69 77.05 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.508 0.671 . . . . 0.81000000000000005 112.035 -165.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.69 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.7 Cg_exo -57.79 -29.9 87.47 Favored 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 125.182 3.921 . . . . 0.28000000000000003 113.617 -173.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.461 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 27.0 p -70.86 -32.97 70.15 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.592 -1.64 . . . . 0.33000000000000002 109.661 -175.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.547 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.1 t -140.82 70.87 29.96 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 123.614 1.673 . . . . 0.39000000000000001 109.406 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.5 Cg_exo -59.53 154.35 48.7 Favored 'Trans proline' 0 C--N 1.313 -1.292 1 C-N-CA 126.421 4.748 . . . . 0.38 114.449 -172.236 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.532 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.5 OUTLIER -83.86 148.14 53.41 Favored Pre-proline 0 N--CA 1.419 -1.979 0 N-CA-C 108.002 -1.11 . . . . 0.81999999999999995 108.002 173.57 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 15.4 Cg_exo -79.53 -41.26 0.21 Allowed 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 124.592 3.528 . . . . 0.19 112.724 -165.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.773 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.41 134.24 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 123.549 1.642 . . . . 0.13 113.75 -172.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 148.02 -125.83 2.19 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 111.95 -2.386 . . . . 0.20000000000000001 109.728 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.6 p -116.35 112.32 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 122.122 0.963 . . . . 0.81999999999999995 111.497 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.769 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 1.9 m-85 -112.63 -173.38 2.24 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 106.493 -1.669 . . . . 0.22 106.493 172.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.57 ' OH ' ' HA2' ' A' ' 460' ' ' GLY . 38.9 t80 -144.68 125.97 14.77 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.306 -1.358 . . . . 0.65000000000000002 113.657 -169.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.4 p -86.47 94.21 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 122.683 1.23 . . . . 0.16 109.56 169.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' TRP . . . . . 0.544 ' CD1' ' HD2' ' A' ' 383' ' ' TYR . 75.7 m95 -69.16 -17.17 63.79 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.412 -1.722 . . . . 2.5499999999999998 108.185 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.733 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.6 t30 -169.45 135.07 1.54 Allowed 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.375 -0.829 . . . . 0.42999999999999999 111.145 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.662 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -91.95 129.57 37.88 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.186 -1.042 . . . . 1.1200000000000001 108.186 171.315 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.668 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 0.5 OUTLIER -110.59 158.59 18.4 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.183 -0.917 . . . . 0.70999999999999996 111.935 -171.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 40.3 mt-10 -134.57 133.36 40.16 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.163 -1.38 . . . . 0.38 108.833 173.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 18.6 t70 53.94 46.58 25.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 123.766 1.746 . . . . 0.40999999999999998 108.71 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.899 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -83.99 165.3 18.73 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 112.183 -2.28 . . . . 0.12 108.79 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 24.3 m -132.66 120.12 21.32 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.153 0.978 . . . . 0.17000000000000001 111.045 170.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.545 HD13 ' HB ' ' A' ' 407' ' ' VAL . 2.7 mp -78.14 88.48 4.24 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.512 -1.676 . . . . 0.56999999999999995 111.413 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.531 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 48.5 mttt . . . . . 0 C--N 1.288 -2.072 0 CA-C-N 113.791 -1.55 . . . . 0.33000000000000002 113.701 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.531 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 1.8 mp0 . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 121.083 0.468 . . . . 0.53000000000000003 110.127 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.29 97.49 5.18 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 108.015 -1.105 . . . . 0.19 108.015 170.231 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.1 Cg_exo -69.32 110.05 2.37 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.008 1.805 . . . . 0.19 110.316 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.899 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.35 155.39 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 CA-C-N 112.998 -1.91 . . . . 0.14999999999999999 107.396 -168.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.0 m-80 -88.49 -21.57 24.11 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.657 -0.868 . . . . 0.51000000000000001 108.657 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.664 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.1 m-85 -157.31 126.11 5.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.625 -1.17 . . . . 0.27000000000000002 108.674 -169.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.668 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 14.6 t-105 -142.3 141.41 32.41 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.623 -0.717 . . . . 0.089999999999999997 110.281 -167.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.662 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.5 mmt -126.67 96.75 34.74 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.405 -1.332 . . . . 0.14000000000000001 107.405 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.733 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 48.2 Cg_endo . . . . . 0 N--CA 1.46 -0.493 0 C-N-CA 122.52 2.147 . . . . 0.5 112.825 -175.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.707 HG11 ' CE2' ' A' ' 382' ' ' PHE . 2.2 p . . . . . 0 N--CA 1.44 -0.946 0 CA-C-O 120.474 0.178 . . . . 0.75 111.249 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 442' ' ' CYS . . . -168.05 128.61 1.74 Allowed Glycine 0 C--O 1.219 -0.827 0 N-CA-C 110.882 -0.887 . . . . 0.20000000000000001 110.882 165.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.626 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.6 mp -84.6 140.0 16.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 122.151 -0.617 . . . . 0.28999999999999998 111.213 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.649 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.0 p80 -161.83 162.86 29.57 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.684 -0.689 . . . . 0.089999999999999997 110.303 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.747 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -81.94 150.88 27.48 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 107.675 -1.232 . . . . 1.0700000000000001 107.675 170.754 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 445' ' ' THR . 48.0 t -134.12 96.08 3.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.981 0.896 . . . . 0.23000000000000001 109.647 -172.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--N 1.317 -0.835 0 CA-C-N 113.784 -1.553 . . . . 0.41999999999999998 109.77 -176.363 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.592 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.1 pm0 . . . . . 0 N--CA 1.43 -1.459 0 CA-C-O 122.289 1.042 . . . . 2.1600000000000001 112.71 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.637 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -157.8 129.54 6.89 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 112.681 -2.054 . . . . 0.33000000000000002 105.513 168.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.13 -157.48 29.74 Favored Glycine 0 C--N 1.288 -2.088 0 C-N-CA 119.715 -1.231 . . . . 0.17000000000000001 111.544 -177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.535 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.65 170.49 0.01 OUTLIER Glycine 0 CA--C 1.487 -1.671 0 C-N-CA 120.787 -0.72 . . . . 0.20999999999999999 111.919 167.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.548 ' HB3' ' CD ' ' A' ' 435' ' ' LYS . 2.4 m-20 -52.75 100.89 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.891 0 CA-C-O 122.492 1.139 . . . . 1.8500000000000001 112.957 -155.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 1.009 HD22 ' HD2' ' A' ' 437' ' ' ARG . 36.8 mt -97.16 -35.73 10.69 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 113.006 -1.906 . . . . 1.21 109.696 172.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.731 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -52.7 -26.3 13.53 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.111 -0.95 . . . . 0.16 112.1 -173.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.731 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.68 -33.99 15.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.747 -0.661 . . . . 0.22 112.69 -178.865 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.7 p -90.01 -37.88 14.0 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.861 0.839 . . . . 0.25 110.76 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 1.009 ' HD2' HD22 ' A' ' 433' ' ' LEU . 3.8 mtp85 -97.65 -18.4 18.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.707 -1.133 . . . . 1.8200000000000001 110.011 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.74 48.81 49.54 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.156 -0.929 . . . . 0.23999999999999999 115.233 162.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' SER . . . . . 0.47 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 9.3 p -84.8 110.32 18.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 118.93 1.365 . . . . 1.01 112.192 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 441' ' ' GLY . 63.2 m-70 35.67 -133.21 0.06 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.482 -1.235 . . . . 0.5 113.049 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.489 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -119.22 -6.26 10.95 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.204 -0.759 . . . . 0.26000000000000001 111.204 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 0.8 OUTLIER -92.4 162.51 14.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.527 0.936 . . . . 0.34999999999999998 113.527 -176.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.532 HG12 HG11 ' A' ' 347' ' ' VAL . 1.9 mp -87.43 128.97 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 113.764 -1.562 . . . . 0.12 110.141 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -98.45 88.42 4.12 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.655 -0.702 . . . . 0.62 110.081 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.926 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.9 m -83.91 142.64 42.09 Favored Pre-proline 0 N--CA 1.431 -1.377 0 CA-C-N 115.029 -0.987 . . . . 0.10000000000000001 112.412 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.7 ' HD2' HG21 ' A' ' 366' ' ' THR . 76.7 Cg_exo -50.42 145.1 22.52 Favored 'Trans proline' 0 CA--C 1.509 -0.733 0 C-N-CA 123.803 3.002 . . . . 0.23999999999999999 113.455 175.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.747 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.2 Cg_exo -65.45 -24.71 56.51 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.864 2.376 . . . . 0.31 112.328 -176.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.515 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 35.7 p -77.58 -24.99 49.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.229 -0.896 . . . . 1.1000000000000001 112.09 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.806 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.9 m -100.02 -48.51 11.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.714 -0.675 . . . . 0.080000000000000002 112.557 -171.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.955 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.7 -2.51 5.02 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.635 -0.826 . . . . 0.070000000000000007 110.375 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.526 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 15.8 pttp -80.71 -38.82 28.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.441 1.115 . . . . 0.92000000000000004 108.358 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.7 mm-40 -62.66 -46.57 87.59 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 112.482 -2.145 . . . . 0.25 106.883 -177.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.955 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.09 -66.37 0.41 Allowed 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 109.847 -3.342 . . . . 0.050000000000000003 112.536 171.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 21.1 t80 -44.72 -25.62 0.3 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 124.215 0.947 . . . . 0.13 109.609 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.447 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -86.87 -29.49 23.28 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 114.599 -1.182 . . . . 0.13 111.555 -176.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.749 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -99.43 -44.86 6.03 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 113.533 0.938 . . . . 0.059999999999999998 113.533 177.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.65 148.56 9.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 122.487 1.137 . . . . 0.080000000000000002 111.106 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' A' ' 458' ' ' GLU . 0.0 OUTLIER -119.91 158.11 27.35 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 112.88 -1.964 . . . . 0.47999999999999998 108.648 -178.43 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.628 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.3 mppt? -57.82 101.51 0.08 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.575 -0.898 . . . . 0.98999999999999999 108.575 168.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' GLY . . . . . 0.57 ' HA2' ' OH ' ' A' ' 383' ' ' TYR . . . 134.66 -18.36 4.1 Favored Glycine 0 C--N 1.304 -1.246 0 CA-C-N 114.233 -1.349 . . . . 0.19 111.902 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 344' ' ' TYR . 23.1 m -66.57 149.29 98.26 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 108.756 -0.831 . . . . 0.13 108.756 171.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 9.8 Cg_endo -95.75 176.29 0.84 Allowed 'Trans proline' 0 N--CA 1.416 -3.052 0 C-N-CA 122.257 1.972 . . . . 0.17999999999999999 109.937 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.769 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -132.8 154.7 40.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.131 -1.063 . . . . 0.56999999999999995 108.131 171.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.0 mp -134.26 152.12 51.65 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 108.775 -0.824 . . . . 0.13 108.775 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.027 HG23 HD21 ' A' ' 349' ' ' LEU . 0.9 OUTLIER -137.73 144.46 31.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 106.047 -1.835 . . . . 0.10000000000000001 106.047 159.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.542 ' OXT' ' HG3' ' A' ' 350' ' ' GLU . 3.2 p90 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 123.857 0.863 . . . . 1.0900000000000001 110.84 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 109.532 -0.544 . . . . 0.42999999999999999 109.532 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 357' ' ' TYR . 53.6 m -159.35 138.08 10.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.29 -0.868 . . . . 0.14000000000000001 108.743 167.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.762 ' CD2' HD13 ' A' ' 464' ' ' LEU . 41.2 p90 174.32 158.87 0.16 Allowed 'General case' 0 C--O 1.21 -1.011 0 O-C-N 123.317 0.385 . . . . 0.14999999999999999 111.149 -176.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.618 HD12 HD11 ' A' ' 453' ' ' LEU . 0.5 OUTLIER -77.26 154.7 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 N-CA-C 109.216 -0.661 . . . . 0.080000000000000002 109.216 164.682 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.53 146.96 28.55 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.8 -1.185 . . . . 2.0099999999999998 107.8 -178.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.736 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.76 155.62 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 C-N-CA 123.6 0.76 . . . . 0.45000000000000001 110.375 173.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.526 ' N ' HG12 ' A' ' 347' ' ' VAL . 37.7 t0 -138.13 105.55 5.53 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.539 -1.652 . . . . 0.23999999999999999 106.539 176.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 1.026 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -80.13 -35.97 35.91 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 114.023 -1.444 . . . . 0.16 109.959 -165.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.402 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 0.7 OUTLIER -56.38 -44.96 80.72 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 110.678 -2.965 . . . . 0.59999999999999998 107.942 176.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -99.37 5.03 46.53 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 111.163 -2.744 . . . . 0.20000000000000001 111.1 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.487 HE21 ' HE1' ' A' ' 434' ' ' TRP . 21.5 mp0 34.29 61.7 0.52 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 112.942 -1.935 . . . . 2.1499999999999999 113.137 -173.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.501 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 24.5 t60 -142.4 136.91 30.02 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.907 -0.588 . . . . 0.089999999999999997 109.741 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.748 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.83 158.16 21.39 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 120.947 0.403 . . . . 0.070000000000000007 110.234 179.63 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.641 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.5 m-90 -143.13 164.08 31.12 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.485 0.66 . . . . 0.11 111.126 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.703 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 86.3 t80 -116.01 154.27 30.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.535 -1.654 . . . . 0.26000000000000001 106.535 150.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 13.4 m-85 -127.13 119.2 25.94 Favored 'General case' 0 C--N 1.269 -2.9 0 CA-C-N 115.094 -0.957 . . . . 0.14000000000000001 110.007 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 361' ' ' LYS . 9.9 tppt? -123.3 116.65 23.68 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.377 -0.971 . . . . 0.25 108.377 173.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.85 37.69 0.49 Allowed 'General case' 0 C--N 1.308 -1.207 0 O-C-N 123.474 0.484 . . . . 0.42999999999999999 112.297 -176.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 62.94 12.46 42.97 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 120.2 -1.0 . . . . 0.17999999999999999 113.314 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 358' ' ' LYS . 18.5 ptmt -137.63 169.75 17.25 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 104.586 -2.376 . . . . 0.37 104.586 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.641 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.6 m -99.57 157.74 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.619 0 N-CA-C 116.692 2.108 . . . . 0.10000000000000001 116.692 -170.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.703 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -110.18 -25.88 9.94 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-N 110.375 -3.102 . . . . 0.070000000000000007 106.673 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -135.64 146.6 48.03 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 111.694 -2.503 . . . . 0.059999999999999998 111.682 -176.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.496 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -143.7 117.92 9.56 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 104.719 -2.326 . . . . 0.47999999999999998 104.719 175.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.748 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.59 165.25 32.82 Favored 'General case' 0 N--CA 1.4 -2.953 0 C-N-CA 118.121 -1.432 . . . . 0.070000000000000007 111.558 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.655 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 13.1 p-10 -103.66 132.44 49.91 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.71 -1.132 . . . . 1.8 109.828 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.0 pp -131.48 -173.5 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 CA-C-O 122.48 1.133 . . . . 0.12 112.415 -172.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.41 120.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 112.805 -1.998 . . . . 0.10000000000000001 108.312 172.202 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.542 ' HB3' HD12 ' A' ' 349' ' ' LEU . 30.2 p -76.87 -169.21 1.23 Allowed 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 112.376 -2.193 . . . . 1.26 111.615 -177.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -85.04 166.65 40.93 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 118.718 -1.706 . . . . 0.14000000000000001 111.864 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -73.84 156.99 87.83 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 121.383 0.611 . . . . 0.81000000000000005 111.758 -167.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.645 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 81.4 Cg_exo -54.23 -28.79 53.88 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 125.269 3.98 . . . . 0.28000000000000003 113.439 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.481 ' OG1' HG22 ' A' ' 375' ' ' THR . 16.8 p -69.55 -34.04 73.64 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.295 -1.775 . . . . 0.33000000000000002 109.829 -176.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.536 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -141.61 70.81 25.69 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 123.715 1.721 . . . . 0.39000000000000001 109.128 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 375' ' ' THR . 85.9 Cg_exo -57.41 160.09 14.61 Favored 'Trans proline' 0 C--N 1.31 -1.462 1 C-N-CA 126.453 4.769 . . . . 0.38 115.254 -170.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.511 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 2.3 m -86.08 126.56 64.92 Favored Pre-proline 0 N--CA 1.402 -2.837 0 CA-C-N 114.142 -1.39 . . . . 0.81999999999999995 108.616 173.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 29.0 Cg_exo -69.29 -44.66 2.25 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.776 2.984 . . . . 0.19 112.21 -168.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.764 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 61.21 137.98 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 123.579 1.657 . . . . 0.13 113.912 -175.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 153.36 -111.69 0.5 Allowed Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 111.75 -2.477 . . . . 0.20000000000000001 108.871 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.67 125.89 56.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.206 0.527 . . . . 0.81999999999999995 109.759 173.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.72 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 8.1 m-85 -118.16 -176.14 3.0 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 106.608 -1.627 . . . . 0.22 106.608 168.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 2.0 t80 -137.76 120.29 16.06 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 120.698 -1.251 . . . . 0.65000000000000002 112.291 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -86.01 91.35 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-O 123.178 1.466 . . . . 0.16 108.926 171.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -93.66 11.79 27.72 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 113.043 -1.889 . . . . 2.5499999999999998 108.013 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.747 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.0 t30 -167.95 126.21 1.2 Allowed 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 113.588 -1.642 . . . . 0.42999999999999999 110.148 172.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.651 ' HD3' ' H ' ' A' ' 387' ' ' LYS . 0.0 OUTLIER -101.64 143.25 31.84 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.201 -0.909 . . . . 1.1200000000000001 109.129 169.652 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.726 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 30.0 mm-40 -126.11 159.67 32.23 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 115.019 1.489 . . . . 0.70999999999999996 115.019 -167.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.1 mt-10 -139.11 127.29 22.58 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 112.755 -2.02 . . . . 0.38 108.689 174.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.7 t70 56.19 45.67 22.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 123.498 1.618 . . . . 0.40999999999999998 109.053 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.925 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -81.26 166.3 20.67 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 112.517 -2.129 . . . . 0.12 108.803 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 20.6 m -132.75 119.24 20.06 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 122.252 1.025 . . . . 0.17000000000000001 111.577 170.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.1 mp -78.7 88.02 4.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.699 -1.591 . . . . 0.56999999999999995 111.873 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.543 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.7 mttt . . . . . 0 C--N 1.284 -2.27 0 CA-C-N 113.572 -1.649 . . . . 0.33000000000000002 113.032 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 120.998 0.428 . . . . 0.53000000000000003 110.749 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.02 97.35 4.86 Favored Pre-proline 0 N--CA 1.437 -1.094 0 N-CA-C 108.525 -0.917 . . . . 0.19 108.525 170.19 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.9 Cg_exo -68.47 110.95 2.4 Favored 'Trans proline' 0 N--CA 1.436 -1.886 0 C-N-CA 122.106 1.871 . . . . 0.19 110.159 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.925 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.86 152.41 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.168 0 CA-C-N 113.355 -1.748 . . . . 0.14999999999999999 107.979 -167.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.724 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 19.6 m-80 -85.95 -20.43 28.96 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.958 -0.756 . . . . 0.51000000000000001 108.958 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.726 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.4 m-85 -158.85 125.75 4.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.935 -1.03 . . . . 0.27000000000000002 108.493 -170.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.676 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 19.8 t-105 -143.32 138.18 29.32 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.692 -0.685 . . . . 0.089999999999999997 110.476 -167.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.619 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 14.3 mmt -118.55 91.08 40.96 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.932 -0.766 . . . . 0.14000000000000001 108.932 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.747 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 34.1 Cg_exo . . . . . 0 CA--C 1.511 -0.633 0 C-N-CA 123.367 2.711 . . . . 0.5 109.511 171.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 419' ' ' GLY . 32.3 t . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 121.125 0.488 . . . . 0.75 111.763 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.581 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -175.81 122.58 0.87 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.039 -1.224 . . . . 0.20000000000000001 110.039 170.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.726 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.4 mp -81.63 143.52 12.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 110.05 -0.352 . . . . 0.28999999999999998 110.05 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.676 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.4 p80 -160.32 161.84 33.36 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.089999999999999997 111.617 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.691 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.03 146.63 27.09 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.402 -0.962 . . . . 1.0700000000000001 108.402 173.006 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 445' ' ' THR . 37.7 t -133.15 96.32 3.73 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.788 0.804 . . . . 0.23000000000000001 110.074 -171.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' ASP . . . . . 0.423 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 8.0 t70 . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 114.211 -1.359 . . . . 0.41999999999999998 109.551 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.537 ' HG3' ' HD3' ' A' ' 437' ' ' ARG . 2.7 pm0 . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 122.242 1.02 . . . . 2.1600000000000001 113.291 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.655 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.5 OUTLIER -163.07 132.02 4.03 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 112.608 -2.087 . . . . 0.33000000000000002 105.405 172.456 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 169.06 -158.61 31.28 Favored Glycine 0 C--N 1.283 -2.401 0 N-CA-C 110.373 -1.091 . . . . 0.17000000000000001 110.373 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -45.53 174.85 0.01 OUTLIER Glycine 0 CA--C 1.497 -1.045 0 C-N-CA 120.155 -1.022 . . . . 0.20999999999999999 111.493 167.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.541 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -51.9 101.82 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 123.341 1.543 . . . . 1.8500000000000001 113.834 -154.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.745 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.87 -36.02 11.26 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 112.533 -2.122 . . . . 1.21 109.378 170.031 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.697 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -54.75 -27.47 41.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.213 -0.903 . . . . 0.16 112.276 -170.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.697 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.52 -35.37 15.11 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.468 0.651 . . . . 0.22 112.216 -177.343 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 p -90.4 -43.39 10.33 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.991 -1.004 . . . . 0.25 110.787 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.745 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.6 mtp180 -93.29 -17.77 23.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.536 -1.211 . . . . 1.8200000000000001 109.607 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.67 49.82 56.28 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.765 -1.107 . . . . 0.23999999999999999 115.101 162.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 50.0 m -83.38 110.28 18.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.736 1.268 . . . . 1.01 111.31 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 37.33 -126.85 0.19 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.303 -1.317 . . . . 0.5 114.481 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -128.28 -21.32 1.49 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.14 -0.552 . . . . 0.26000000000000001 113.029 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.543 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 29.2 p -102.11 -166.05 1.25 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.244 0.545 . . . . 0.34999999999999998 112.273 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.474 HG12 HG11 ' A' ' 347' ' ' VAL . 2.2 mp -96.62 131.15 44.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.314 -0.857 . . . . 0.12 110.619 -174.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -104.99 94.39 5.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.431 0.634 . . . . 0.62 110.252 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.749 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.9 m -90.39 145.53 32.74 Favored Pre-proline 0 C--O 1.211 -0.969 0 CA-C-N 114.713 -1.131 . . . . 0.10000000000000001 112.85 -176.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.672 ' HD2' HG21 ' A' ' 366' ' ' THR . 75.8 Cg_exo -50.44 146.51 19.03 Favored 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 123.971 3.114 . . . . 0.23999999999999999 113.659 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.691 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 27.8 Cg_exo -67.3 -23.38 44.85 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.963 2.442 . . . . 0.31 112.364 -176.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.524 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 34.1 p -80.64 -24.98 38.62 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.363 -0.835 . . . . 1.1000000000000001 112.079 -175.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.804 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.8 m -99.38 -48.98 11.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.643 -0.708 . . . . 0.080000000000000002 112.864 -170.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.954 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.95 -2.27 5.07 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.754 -0.779 . . . . 0.070000000000000007 110.349 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 448' ' ' SER . 41.4 pttt -80.81 -39.51 26.53 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.973 -1.121 . . . . 0.92000000000000004 107.973 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.512 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 3.7 mm-40 -61.53 -46.35 90.31 Favored 'General case' 0 CA--C 1.472 -2.032 0 CA-C-N 112.499 -2.137 . . . . 0.25 106.356 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.954 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.81 -67.49 0.28 Allowed 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 109.612 -3.449 . . . . 0.050000000000000003 112.66 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 16.3 t80 -45.46 -23.96 0.27 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 124.008 0.817 . . . . 0.13 109.361 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.449 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.36 -26.09 29.03 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.925 -1.034 . . . . 0.13 111.845 -176.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.735 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -102.45 -44.31 5.4 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 113.309 0.855 . . . . 0.059999999999999998 113.309 176.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -72.12 147.71 10.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 122.528 1.156 . . . . 0.080000000000000002 110.747 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.64 153.79 37.66 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-N 112.878 -1.965 . . . . 0.47999999999999998 107.943 -178.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 42.4 mtmt -55.57 103.01 0.08 Allowed 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.783 0.801 . . . . 0.98999999999999999 110.122 173.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.58 -11.67 6.33 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 113.637 -1.619 . . . . 0.19 111.394 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.658 HG21 ' HB ' ' A' ' 457' ' ' VAL . 10.3 m -65.6 150.34 96.21 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 108.443 -0.947 . . . . 0.13 108.443 171.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.3 Cg_endo -93.51 163.55 2.37 Favored 'Trans proline' 0 N--CA 1.42 -2.852 0 C-N-CA 122.0 1.8 . . . . 0.17999999999999999 109.644 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.72 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -125.19 152.71 31.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 107.392 -1.336 . . . . 0.56999999999999995 107.392 170.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.762 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.1 mp -133.02 150.01 52.17 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 108.09 -1.078 . . . . 0.13 108.09 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 1.026 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.23 138.57 37.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 103.879 -2.638 . . . . 0.10000000000000001 103.879 163.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.764 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 2.5 p90 . . . . . 0 C--O 1.247 0.956 0 O-C-N 123.768 0.668 . . . . 1.0900000000000001 110.719 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 111.868 -0.493 . . . . 1.8700000000000001 111.868 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.517 ' CE1' HD21 ' A' ' 464' ' ' LEU . 1.3 p-80 -138.44 111.06 7.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.732 0.266 . . . . 0.83999999999999997 111.589 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.558 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.1 OUTLIER 57.23 -166.55 0.14 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 113.34 0.867 . . . . 0.67000000000000004 113.34 166.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -64.24 168.05 5.98 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.302 -1.37 . . . . 1.8500000000000001 107.302 165.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.468 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.7 m-20 -79.36 83.64 5.36 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.045 -1.062 . . . . 0.42999999999999999 109.456 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 357' ' ' TYR . 70.6 m -158.08 134.3 9.4 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.467 -1.242 . . . . 0.14000000000000001 108.715 169.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.638 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.1 p90 174.61 158.39 0.17 Allowed 'General case' 0 C--O 1.212 -0.876 0 O-C-N 123.316 0.385 . . . . 0.14999999999999999 111.545 -175.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -78.23 149.32 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 109.274 -0.639 . . . . 0.080000000000000002 109.274 164.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.555 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.2 tt0 -149.34 139.57 22.24 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.459 -0.791 . . . . 2.0099999999999998 109.902 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.745 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -132.52 161.53 41.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.039 0.447 . . . . 0.45000000000000001 111.412 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.542 ' N ' HG12 ' A' ' 347' ' ' VAL . 32.5 t0 -140.23 106.35 5.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.385 -1.339 . . . . 0.23999999999999999 107.385 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.111 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.02 -34.88 26.18 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 124.071 1.891 . . . . 0.16 110.139 -170.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.63 -41.77 74.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 111.144 -2.753 . . . . 0.59999999999999998 107.757 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -105.52 7.66 33.06 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 110.912 -2.858 . . . . 0.20000000000000001 111.666 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.816 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 82.9 mm-40 28.8 63.86 0.12 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 112.825 -1.989 . . . . 2.1499999999999999 114.294 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.518 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 27.2 t60 -141.87 137.71 31.58 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.665 -1.152 . . . . 0.089999999999999997 110.125 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.728 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -113.55 157.89 21.48 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.218 0.532 . . . . 0.070000000000000007 110.385 -178.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.615 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.5 m-90 -143.3 153.88 43.22 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.274 -0.876 . . . . 0.11 111.137 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.7 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.0 t80 -109.35 153.07 24.46 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.46 -1.681 . . . . 0.26000000000000001 106.46 151.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.9 m-85 -127.43 119.37 25.99 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.946 -1.024 . . . . 0.14000000000000001 110.384 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.8 tppt? -121.1 135.65 55.14 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.408 -1.701 . . . . 0.25 106.408 168.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.524 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 72.11 15.77 5.42 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.071 0.767 . . . . 0.42999999999999999 113.071 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.65 7.09 88.29 Favored Glycine 0 CA--C 1.485 -1.826 0 CA-C-N 115.693 -0.685 . . . . 0.17999999999999999 112.731 -173.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' A' ' 359' ' ' ASP . 18.1 ptmt -127.93 178.13 6.39 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 104.505 -2.406 . . . . 0.37 104.505 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.7 m -104.51 157.83 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 N-CA-C 116.475 2.028 . . . . 0.10000000000000001 116.475 -174.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.683 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.86 -27.97 9.91 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-N 110.477 -3.056 . . . . 0.070000000000000007 106.286 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.12 144.31 48.49 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 111.471 -2.604 . . . . 0.059999999999999998 111.625 -175.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.415 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.4 tt0 -140.34 117.47 11.22 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 104.426 -2.435 . . . . 0.47999999999999998 104.426 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.728 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.55 160.39 43.52 Favored 'General case' 0 N--CA 1.393 -3.297 0 C-N-CA 117.871 -1.532 . . . . 0.070000000000000007 110.636 -179.332 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.75 138.9 38.12 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 108.334 -0.987 . . . . 1.8 108.334 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.742 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.0 pp -136.47 -174.21 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-O 122.11 0.957 . . . . 0.12 112.25 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.816 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.7 OUTLIER -150.12 118.82 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 113.02 -1.9 . . . . 0.10000000000000001 108.793 172.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.509 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -78.63 -168.08 1.28 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.555 -1.657 . . . . 1.26 110.349 -178.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.469 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.43 168.07 43.75 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 118.485 -1.816 . . . . 0.14000000000000001 112.311 -174.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.402 ' HG3' ' OG1' ' A' ' 374' ' ' THR . 10.0 ptmt -73.61 158.74 85.92 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.626 0.727 . . . . 0.81000000000000005 111.9 -166.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.641 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 88.1 Cg_exo -57.43 -28.99 82.92 Favored 'Trans proline' 0 CA--C 1.495 -1.426 0 C-N-CA 125.182 3.922 . . . . 0.28000000000000003 113.435 -173.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.452 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.9 p -71.57 -33.71 69.31 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.405 -1.725 . . . . 0.33000000000000002 109.618 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.6 t -141.36 70.57 26.97 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 123.737 1.732 . . . . 0.39000000000000001 109.584 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 375' ' ' THR . 79.0 Cg_exo -59.46 157.55 30.97 Favored 'Trans proline' 0 C--N 1.314 -1.256 1 C-N-CA 126.494 4.796 . . . . 0.38 114.481 -172.237 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.509 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -87.35 146.16 39.24 Favored Pre-proline 0 N--CA 1.425 -1.723 0 N-CA-C 108.44 -0.948 . . . . 0.81999999999999995 108.44 174.455 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.4 Cg_exo -76.08 -44.15 0.28 Allowed 'Trans proline' 0 CA--C 1.511 -0.657 0 C-N-CA 124.8 3.667 . . . . 0.19 112.136 -167.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.781 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 57.67 137.88 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 123.249 1.499 . . . . 0.13 113.608 -172.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 150.47 -111.02 0.49 Allowed Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 112.592 -2.095 . . . . 0.20000000000000001 110.319 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 381' ' ' VAL . 5.7 p -130.17 113.51 26.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 122.496 1.141 . . . . 0.81999999999999995 111.078 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.733 ' HB2' HG12 ' A' ' 463' ' ' VAL . 1.8 m-85 -114.68 -171.21 1.89 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.929 -1.508 . . . . 0.22 106.929 173.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.604 ' HB2' ' CZ2' ' A' ' 415' ' ' TRP . 1.4 t80 -150.03 124.58 9.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.856 1.207 . . . . 0.65000000000000002 112.838 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.62 HG12 HG23 ' A' ' 463' ' ' VAL . 2.3 p -89.45 91.95 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-O 123.047 1.403 . . . . 0.16 109.13 169.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -93.8 11.24 29.96 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 113.298 -1.773 . . . . 2.5499999999999998 107.851 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.74 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 28.3 t-20 -169.19 126.18 0.94 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 113.793 -1.548 . . . . 0.42999999999999999 110.086 172.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.66 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.89 143.68 31.47 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.828 -1.078 . . . . 1.1200000000000001 109.121 171.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 26.7 mm-40 -126.11 157.61 37.61 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.599 1.333 . . . . 0.70999999999999996 114.599 -167.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 45.2 mt-10 -135.63 127.16 28.77 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 113.155 -1.839 . . . . 0.38 108.902 172.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.14 49.62 18.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 123.159 1.457 . . . . 0.40999999999999998 109.335 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.948 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -81.88 168.5 17.87 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 112.579 -2.1 . . . . 0.12 109.454 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.0 m -132.27 119.59 21.0 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.904 0.859 . . . . 0.17000000000000001 111.745 170.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.6 mp -80.2 88.84 5.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.802 -1.545 . . . . 0.56999999999999995 112.167 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.561 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.5 mttt -101.63 -179.86 4.14 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.657 -1.61 . . . . 0.33000000000000002 113.502 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.39 -161.58 25.69 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.243 -1.344 . . . . 0.46000000000000002 111.614 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.7 m -120.78 137.37 54.55 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 120.239 -0.584 . . . . 0.70999999999999996 111.515 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 399' ' ' ASP . 4.1 m-80 -55.38 154.7 5.88 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 114.718 -1.128 . . . . 0.83999999999999997 110.038 169.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -7.58 0.3 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.34 -1.3 . . . . 2.2799999999999998 111.99 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 397' ' ' ASN . 21.2 m-20 -102.34 -17.37 15.9 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.171 -0.922 . . . . 2.27 109.729 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.53 32.36 6.66 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 119.08 -1.533 . . . . 0.93999999999999995 111.459 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 16.5 p -122.79 97.65 43.84 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.533 -0.833 . . . . 0.81000000000000005 109.309 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 21.1 Cg_endo -60.16 150.67 78.11 Favored 'Trans proline' 0 CA--C 1.501 -1.159 0 C-N-CA 122.909 2.406 . . . . 0.63 113.269 -175.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -148.21 172.33 14.51 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.07 -1.423 . . . . 0.41999999999999998 112.057 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.561 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -145.19 147.3 32.3 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.246 -1.343 . . . . 0.53000000000000003 109.91 172.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.2 97.35 5.23 Favored Pre-proline 0 N--CA 1.434 -1.254 0 N-CA-C 108.233 -1.025 . . . . 0.19 108.233 171.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.2 Cg_exo -69.31 110.59 2.5 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 122.012 1.808 . . . . 0.19 110.047 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.948 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.02 158.03 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 CA-C-N 113.132 -1.849 . . . . 0.14999999999999999 107.582 -168.137 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.689 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.0 m-80 -89.27 -21.8 23.02 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.031 -0.729 . . . . 0.51000000000000001 109.031 -174.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.744 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 94.1 m-85 -158.86 127.54 5.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.924 -1.035 . . . . 0.27000000000000002 108.229 -170.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.672 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 21.9 t-105 -144.93 136.26 25.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.692 0.758 . . . . 0.089999999999999997 111.397 -166.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.66 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.8 mmt -119.68 93.65 47.72 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.157 -1.053 . . . . 0.14000000000000001 108.157 173.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.2 Cg_endo -68.24 83.38 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.171 1.914 . . . . 0.5 111.351 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.588 HG12 ' HA2' ' A' ' 419' ' ' GLY . 6.8 pt -81.9 173.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.084 -0.71 . . . . 0.88 109.084 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.574 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 1.3 t70 -134.82 -174.83 3.7 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.232 -0.987 . . . . 2.4900000000000002 112.743 -163.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.604 ' CZ2' ' HB2' ' A' ' 383' ' ' TYR . 29.6 p90 50.79 -2.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.251 2.22 . . . . 1.9199999999999999 115.307 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.622 HG21 ' CE1' ' A' ' 382' ' ' PHE . 36.2 p -131.83 -17.92 2.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.176 0.436 . . . . 0.94999999999999996 112.176 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.64 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 93.73 -28.96 9.09 Favored Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 111.195 -0.762 . . . . 0.68000000000000005 111.195 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 419' ' ' GLY . 40.6 t -56.86 172.67 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 123.947 0.899 . . . . 0.75 111.69 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.605 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.4 123.47 0.91 Allowed Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.049 -1.221 . . . . 0.20000000000000001 110.049 170.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.729 HG22 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.63 141.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.382 -0.599 . . . . 0.28999999999999998 109.382 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.672 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.6 p80 -159.82 160.1 33.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.295 -0.412 . . . . 0.089999999999999997 111.525 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -82.59 145.92 29.44 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.02 -1.104 . . . . 1.0700000000000001 108.02 172.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 445' ' ' THR . 37.9 t -134.78 97.68 3.83 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.65 0.738 . . . . 0.23000000000000001 110.191 -172.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.456 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 24.1 t70 -83.37 -16.95 44.03 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.604 -1.18 . . . . 0.41999999999999998 109.665 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.74 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 7.2 p90 -84.35 -24.9 29.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.999 -1.455 . . . . 0.32000000000000001 111.526 -175.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.588 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 2.0 tt0 -99.69 121.13 55.58 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-O 122.955 1.36 . . . . 1.74 110.529 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.649 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 37.3 Cg_endo -90.3 -8.21 4.0 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 124.919 3.746 . . . . 0.72999999999999998 113.422 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.649 ' OE2' ' HD2' ' A' ' 427' ' ' PRO . 1.1 pm0 -109.56 149.92 28.94 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 122.199 0.999 . . . . 2.1600000000000001 113.283 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.644 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -160.57 128.6 4.55 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 106.384 -1.71 . . . . 0.33000000000000002 106.384 167.501 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.73 -156.71 28.32 Favored Glycine 0 C--N 1.285 -2.286 0 C-N-CA 119.975 -1.107 . . . . 0.17000000000000001 110.682 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.27 165.35 0.01 OUTLIER Glycine 0 CA--C 1.489 -1.549 0 C-N-CA 120.243 -0.98 . . . . 0.20999999999999999 111.667 166.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.534 ' HB3' ' HD2' ' A' ' 435' ' ' LYS . 7.5 m-20 -53.48 102.98 0.06 Allowed 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.268 -1.466 . . . . 1.8500000000000001 113.499 -156.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.99 HD22 ' HD2' ' A' ' 437' ' ' ARG . 30.0 mt -94.66 -33.99 12.75 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 112.892 -1.958 . . . . 1.21 109.452 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.674 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.1 p-90 -52.32 -27.32 14.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.841 -1.072 . . . . 0.16 112.501 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.674 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.87 -33.17 16.56 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.276 0.56 . . . . 0.22 112.275 -178.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.5 p -90.62 -38.36 13.18 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.215 -0.902 . . . . 0.25 110.765 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.99 ' HD2' HD22 ' A' ' 433' ' ' LEU . 1.5 mtp85 -98.49 -17.94 18.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.6 -1.182 . . . . 1.8200000000000001 109.992 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.36 48.05 55.02 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.833 -1.076 . . . . 0.23999999999999999 115.043 163.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.1 p -83.93 110.65 18.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.674 1.237 . . . . 1.01 111.615 -172.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 35.13 -121.44 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.444 -1.253 . . . . 0.5 113.418 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.469 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -131.75 -19.35 1.17 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.842 -0.617 . . . . 0.26000000000000001 113.703 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.794 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.4 p -99.95 -167.66 1.49 Allowed 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 117.923 0.862 . . . . 0.34999999999999998 112.61 -174.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.453 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -99.03 126.26 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 114.698 -1.137 . . . . 0.12 110.928 -173.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -97.73 99.92 11.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.69 -0.686 . . . . 0.62 110.064 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.742 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -97.35 143.09 25.56 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-N 115.235 -0.893 . . . . 0.10000000000000001 112.379 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.666 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 87.6 Cg_exo -49.59 144.59 18.93 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 124.023 3.149 . . . . 0.23999999999999999 113.36 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.644 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.1 Cg_exo -65.92 -27.26 50.99 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.734 2.289 . . . . 0.31 111.991 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 14.5 m -75.68 -24.12 56.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.453 -0.794 . . . . 1.1000000000000001 112.18 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.81 ' O ' HD21 ' A' ' 364' ' ' LEU . 29.0 m -100.36 -49.31 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 113.171 0.804 . . . . 0.080000000000000002 113.171 -168.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.949 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.93 -2.08 4.82 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.888 -0.725 . . . . 0.070000000000000007 110.191 -178.131 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.615 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.2 pttp -81.45 -38.51 26.31 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 122.554 1.168 . . . . 0.92000000000000004 108.197 173.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.4 mm-40 -62.53 -46.5 88.12 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-N 112.418 -2.174 . . . . 0.25 106.463 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.949 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.8 tp -46.34 -66.89 0.34 Allowed 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 109.807 -3.361 . . . . 0.050000000000000003 112.579 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.48 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 17.4 t80 -45.4 -24.28 0.29 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 124.038 0.836 . . . . 0.13 109.617 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.443 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.27 -27.36 25.68 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.76 -1.109 . . . . 0.13 111.685 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.744 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -100.83 -44.57 5.73 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 113.304 0.853 . . . . 0.059999999999999998 113.304 177.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -74.01 149.92 7.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 122.528 1.156 . . . . 0.080000000000000002 111.464 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.24 156.12 34.44 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-N 112.929 -1.941 . . . . 0.47999999999999998 108.121 -177.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.583 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.5 mppt? -56.36 103.03 0.09 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 109.248 -0.649 . . . . 0.98999999999999999 109.248 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.61 -6.89 6.59 Favored Glycine 0 C--N 1.308 -0.981 0 CA-C-N 114.148 -1.387 . . . . 0.19 111.863 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.635 HG21 ' HB ' ' A' ' 457' ' ' VAL . 7.7 m -69.63 147.81 96.64 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 109.425 -0.583 . . . . 0.13 109.425 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.558 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 2.5 Cg_endo -90.26 151.62 4.58 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 122.683 2.255 . . . . 0.17999999999999999 110.005 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' A' ' 382' ' ' PHE . 1.6 t -121.57 133.54 67.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 114.686 -1.143 . . . . 0.56999999999999995 109.088 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.686 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.3 mp -133.04 148.5 52.21 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 119.494 -0.882 . . . . 0.13 109.684 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.111 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.11 141.57 33.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.132 -2.174 . . . . 0.10000000000000001 105.132 166.369 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.75 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 12.8 p90 . . . . . 0 C--O 1.246 0.915 0 O-C-N 123.568 0.543 . . . . 1.0900000000000001 111.476 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.794 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 N-CA-C 112.004 -0.438 . . . . 1.8700000000000001 112.004 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.555 ' CD2' HD11 ' A' ' 464' ' ' LEU . 4.3 p-80 -139.43 103.4 4.71 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.107 0.41 . . . . 0.83999999999999997 112.107 177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.58 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.1 OUTLIER 60.93 -168.61 0.17 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.12 -0.945 . . . . 0.67000000000000004 113.058 166.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -58.73 171.2 0.67 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.299 -0.864 . . . . 1.8500000000000001 110.022 162.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.23 82.34 7.14 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 118.685 -1.206 . . . . 0.42999999999999999 109.318 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 99.5 m -158.95 135.24 9.14 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.288 -1.324 . . . . 0.14000000000000001 108.78 168.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.652 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.6 p90 174.64 158.09 0.16 Allowed 'General case' 0 C--O 1.211 -0.964 0 O-C-N 123.326 0.391 . . . . 0.14999999999999999 111.348 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.663 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.74 151.79 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 109.107 -0.701 . . . . 0.080000000000000002 109.107 164.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.577 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.2 tt0 -149.64 142.69 24.92 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.591 -0.731 . . . . 2.0099999999999998 109.568 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.725 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.67 161.69 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 121.019 0.438 . . . . 0.45000000000000001 111.019 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.534 ' N ' HG12 ' A' ' 347' ' ' VAL . 31.7 t0 -140.03 105.72 5.13 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.158 -1.423 . . . . 0.23999999999999999 107.158 173.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.089 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -81.24 -35.09 31.64 Favored 'General case' 0 CA--C 1.481 -1.678 0 CA-C-O 122.838 1.304 . . . . 0.16 110.212 -168.122 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -55.27 -44.89 76.03 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 110.706 -2.952 . . . . 0.59999999999999998 108.063 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -100.44 5.51 44.26 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 110.932 -2.849 . . . . 0.20000000000000001 110.904 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 21.7 mp0 34.79 61.15 0.6 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 112.794 -2.003 . . . . 2.1499999999999999 112.981 -174.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.494 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.4 t60 -141.58 134.96 29.57 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.714 -0.675 . . . . 0.089999999999999997 109.863 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.729 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.37 156.55 23.23 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.84 -0.618 . . . . 0.070000000000000007 110.238 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.599 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.6 m-90 -142.06 155.33 45.38 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.551 -0.75 . . . . 0.11 111.195 -175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.698 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.9 t80 -110.42 153.17 25.37 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 106.582 -1.636 . . . . 0.26000000000000001 106.582 151.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.3 m-85 -128.51 115.97 18.96 Favored 'General case' 0 C--N 1.269 -2.893 0 CA-C-N 114.855 -1.066 . . . . 0.14000000000000001 110.289 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.6 tppt? -116.33 140.02 49.78 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.777 -1.934 . . . . 0.25 105.777 168.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.46 19.4 10.02 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.358 0.873 . . . . 0.42999999999999999 113.358 171.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 75.17 7.88 82.62 Favored Glycine 0 CA--C 1.489 -1.537 0 CA-C-N 115.573 -0.739 . . . . 0.17999999999999999 113.417 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.0 ptmt -128.0 178.26 6.32 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 104.682 -2.34 . . . . 0.37 104.682 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.599 HG11 ' CD1' ' A' ' 355' ' ' TRP . 15.6 m -105.0 157.52 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 N-CA-C 116.205 1.928 . . . . 0.10000000000000001 116.205 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.68 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.03 -26.52 10.14 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 110.461 -3.063 . . . . 0.070000000000000007 106.358 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.833 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -135.04 143.7 46.86 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 111.511 -2.586 . . . . 0.059999999999999998 111.726 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.409 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 2.6 tt0 -142.01 117.77 10.45 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.673 -2.343 . . . . 0.47999999999999998 104.673 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.729 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.81 164.49 35.19 Favored 'General case' 0 N--CA 1.398 -3.053 0 C-N-CA 118.129 -1.428 . . . . 0.070000000000000007 111.548 -178.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.673 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 10.3 p-10 -103.3 133.12 48.91 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.366 -1.288 . . . . 1.8 109.633 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.702 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -134.07 -173.63 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 122.345 1.069 . . . . 0.12 112.307 -171.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.578 HG11 HE22 ' A' ' 426' ' ' GLN . 0.5 OUTLIER -151.48 121.81 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 112.904 -1.953 . . . . 0.10000000000000001 108.491 172.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.537 ' HB3' HD12 ' A' ' 349' ' ' LEU . 56.9 p -77.69 -168.83 1.3 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 112.678 -2.055 . . . . 1.26 111.418 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.48 167.24 42.65 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 118.536 -1.792 . . . . 0.14000000000000001 111.771 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 6.7 ptmt -74.48 155.76 87.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.413 0.625 . . . . 0.81000000000000005 111.633 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.704 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 78.8 Cg_exo -54.71 -30.07 64.82 Favored 'Trans proline' 0 CA--C 1.498 -1.318 1 C-N-CA 125.386 4.057 . . . . 0.28000000000000003 113.345 -173.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.451 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 20.0 p -70.79 -34.51 71.85 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.568 -1.651 . . . . 0.33000000000000002 109.706 -176.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.9 t -141.94 69.98 23.92 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 123.78 1.753 . . . . 0.39000000000000001 109.439 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.4 Cg_exo -58.49 166.07 6.75 Favored 'Trans proline' 0 C--N 1.316 -1.157 1 C-N-CA 126.918 5.079 . . . . 0.38 115.81 -170.252 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.478 HG21 ' HG ' ' A' ' 349' ' ' LEU . 0.5 OUTLIER -93.75 140.77 23.14 Favored Pre-proline 0 N--CA 1.419 -1.985 0 CA-C-N 114.458 -1.246 . . . . 0.81999999999999995 108.331 170.432 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.513 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 19.4 Cg_exo -76.33 -45.96 0.19 Allowed 'Trans proline' 0 CA--C 1.514 -0.48 0 C-N-CA 124.547 3.498 . . . . 0.19 112.081 -170.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.762 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 62.48 138.59 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.313 1.53 . . . . 0.13 113.597 -172.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.59 -111.66 0.51 Allowed Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 112.281 -2.236 . . . . 0.20000000000000001 109.471 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.92 119.38 44.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.743 0.782 . . . . 0.81999999999999995 110.461 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.725 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.8 m-85 -118.23 -173.86 2.54 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.168 -1.419 . . . . 0.22 107.168 172.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 1.9 t80 -141.05 123.43 15.82 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 120.623 -1.298 . . . . 0.65000000000000002 112.959 -171.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.48 91.98 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-O 123.105 1.431 . . . . 0.16 109.403 169.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -93.7 11.95 27.24 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.274 -1.785 . . . . 2.5499999999999998 108.199 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.776 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 25.6 t-20 -168.64 126.41 1.06 Allowed 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 113.995 -1.457 . . . . 0.42999999999999999 110.162 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.663 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.34 141.87 33.57 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.747 -1.115 . . . . 1.1200000000000001 108.94 169.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.768 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 13.9 mm-40 -126.1 157.69 37.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 114.443 1.275 . . . . 0.70999999999999996 114.443 -167.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 47.3 mt-10 -137.73 127.2 24.93 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.013 -1.903 . . . . 0.38 108.613 173.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.6 t70 56.48 47.77 18.1 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.227 1.489 . . . . 0.40999999999999998 109.026 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.922 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -83.7 169.28 15.44 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 112.367 -2.197 . . . . 0.12 109.393 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 20.7 m -132.6 121.14 22.76 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.863 0.839 . . . . 0.17000000000000001 111.693 169.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.8 mp -80.35 89.17 5.54 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.829 -1.532 . . . . 0.56999999999999995 112.601 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.579 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.1 mttt -102.01 178.36 4.63 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.687 -1.597 . . . . 0.33000000000000002 113.117 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 139.28 -158.18 25.27 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.424 -1.262 . . . . 0.46000000000000002 111.988 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.6 m -124.25 138.32 54.41 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.103 -0.639 . . . . 0.70999999999999996 111.62 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.3 m-80 -58.1 156.88 8.82 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.92 -1.036 . . . . 0.83999999999999997 110.367 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ASP . . . . . 0.573 ' HA ' ' CBD' ' A' ' 130' ' ' 1RG . 2.3 t70 -62.76 -1.79 0.96 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.15 -0.932 . . . . 2.2799999999999998 110.743 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.1 OUTLIER -115.77 6.14 14.32 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.455 -1.248 . . . . 2.27 111.372 -178.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 88.0 20.12 51.03 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 115.09 -0.959 . . . . 0.93999999999999995 112.196 169.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.441 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 14.2 p -113.96 100.45 52.42 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 114.339 -0.931 . . . . 0.81000000000000005 109.604 -175.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.4 Cg_endo -58.6 151.71 60.83 Favored 'Trans proline' 0 CA--C 1.504 -1.004 0 C-N-CA 122.651 2.234 . . . . 0.63 113.137 -177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -149.8 175.82 11.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.238 -1.346 . . . . 0.41999999999999998 112.653 -169.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.579 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.7 OUTLIER -145.23 149.77 35.51 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.064 -1.426 . . . . 0.53000000000000003 110.161 172.293 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.14 97.23 4.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.177 -1.045 . . . . 0.19 108.177 169.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.2 Cg_exo -69.02 109.55 2.19 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.851 1.701 . . . . 0.19 110.26 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.922 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.97 157.48 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-N 113.194 -1.821 . . . . 0.14999999999999999 107.697 -167.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.72 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.9 m-80 -89.7 -20.61 23.4 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.016 -0.735 . . . . 0.51000000000000001 109.016 -174.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.768 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 87.8 m-85 -158.45 126.43 5.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.968 -1.015 . . . . 0.27000000000000002 108.508 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.68 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.3 t-105 -144.52 134.89 24.43 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.781 0.8 . . . . 0.089999999999999997 111.295 -167.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.663 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -116.71 92.63 38.57 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 107.609 -1.256 . . . . 0.14000000000000001 107.609 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.776 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.3 Cg_endo -66.92 75.94 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.434 2.09 . . . . 0.5 111.68 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.3 pt -76.22 179.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 109.057 -0.72 . . . . 0.88 109.057 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.658 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 7.3 t70 -150.64 -165.74 2.35 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.011 -0.737 . . . . 2.4900000000000002 109.011 -168.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.658 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 8.4 m-90 82.91 -56.73 0.17 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 123.985 0.803 . . . . 1.9199999999999999 111.252 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.513 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 76.2 p -120.67 -5.77 9.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.357 -0.838 . . . . 0.94999999999999996 112.302 -165.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.434 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 101.54 -26.67 23.67 Favored Glycine 0 CA--C 1.503 -0.669 0 C-N-CA 120.522 -0.847 . . . . 0.68000000000000005 112.466 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 419' ' ' GLY . 43.1 t -56.19 173.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.343 0.657 . . . . 0.75 111.641 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.6 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -175.06 121.52 0.83 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.17 -1.172 . . . . 0.20000000000000001 110.17 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.708 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.7 141.78 14.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.928 -0.397 . . . . 0.28999999999999998 109.928 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.678 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.5 p80 -159.89 161.59 34.4 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.097 -0.501 . . . . 0.089999999999999997 111.338 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.69 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -82.24 147.68 28.81 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.988 -1.115 . . . . 1.0700000000000001 107.988 171.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 445' ' ' THR . 29.4 t -132.83 96.91 3.9 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.813 0.815 . . . . 0.23000000000000001 109.843 -173.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.16 -15.84 56.19 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.15 -1.386 . . . . 0.41999999999999998 109.353 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.751 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 13.3 p90 -89.27 -24.64 22.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.08 -1.418 . . . . 0.32000000000000001 111.646 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.578 HE22 HG11 ' A' ' 369' ' ' VAL . 1.3 tt0 -97.86 114.46 65.06 Favored Pre-proline 0 CA--C 1.505 -0.751 0 CA-C-O 122.754 1.264 . . . . 1.74 110.146 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.562 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 44.6 Cg_endo -86.42 -10.24 6.61 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 124.13 3.22 . . . . 0.72999999999999998 113.048 -173.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.644 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.0 pm0 -111.59 153.52 26.18 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 122.248 1.023 . . . . 2.1600000000000001 113.464 174.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.713 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.67 129.22 3.51 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 112.722 -2.035 . . . . 0.33000000000000002 105.672 173.033 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.59 -158.07 30.55 Favored Glycine 0 C--N 1.284 -2.361 0 N-CA-C 110.538 -1.025 . . . . 0.17000000000000001 110.538 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -45.3 174.58 0.01 OUTLIER Glycine 0 CA--C 1.498 -0.979 0 C-N-CA 120.217 -0.992 . . . . 0.20999999999999999 111.66 167.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.537 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -52.01 101.89 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 123.386 1.565 . . . . 1.8500000000000001 113.76 -154.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.712 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.27 -37.92 10.32 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 112.575 -2.102 . . . . 1.21 109.798 170.04 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.684 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.4 p-90 -53.94 -27.28 30.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.442 -0.799 . . . . 0.16 112.39 -170.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.704 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -89.39 -34.07 16.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.593 0.59 . . . . 0.22 112.593 -177.186 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.4 p -92.75 -42.42 9.58 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.045 -0.979 . . . . 0.25 110.812 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.712 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.5 mtp180 -93.89 -18.36 22.05 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.971 -1.013 . . . . 1.8200000000000001 110.062 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.56 50.52 48.1 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 115.811 1.084 . . . . 0.23999999999999999 115.811 161.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 17.5 m -82.56 111.37 18.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 119.145 1.473 . . . . 1.01 111.237 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.539 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 59.0 m-70 34.18 -120.65 0.09 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.827 -1.079 . . . . 0.5 113.412 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -130.99 -18.76 1.32 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.986 -0.626 . . . . 0.26000000000000001 113.741 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.783 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.5 p -103.62 -165.63 1.18 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.816 0.673 . . . . 0.34999999999999998 112.816 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.51 HD13 HG11 ' A' ' 465' ' ' VAL . 2.2 mp -95.86 132.79 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.121 -0.945 . . . . 0.12 110.825 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -103.82 98.06 7.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.936 -0.575 . . . . 0.62 110.26 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.702 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.5 m -93.88 140.17 22.9 Favored Pre-proline 0 N--CA 1.439 -0.997 0 CA-C-N 115.392 -0.822 . . . . 0.10000000000000001 113.206 -176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.712 ' O ' HG22 ' A' ' 449' ' ' VAL . 74.1 Cg_exo -51.97 135.75 51.51 Favored 'Trans proline' 0 CA--C 1.496 -1.392 0 C-N-CA 124.629 3.553 . . . . 0.23999999999999999 115.532 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.713 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 50.0 Cg_exo -56.76 -38.82 94.88 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.279 1.319 . . . . 0.31 111.618 -167.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.604 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 21.0 m -62.46 -25.61 68.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.225 0.824 . . . . 1.1000000000000001 113.225 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.833 ' O ' HD21 ' A' ' 364' ' ' LEU . 22.6 m -98.42 -47.76 12.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 O-C-N 121.33 -0.856 . . . . 0.080000000000000002 112.997 -169.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.956 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.49 -1.98 5.76 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.613 -0.835 . . . . 0.070000000000000007 110.344 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 448' ' ' SER . 14.2 pttp -80.78 -38.59 28.28 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 122.67 1.224 . . . . 0.92000000000000004 108.294 173.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.8 mm-40 -61.6 -46.58 89.24 Favored 'General case' 0 CA--C 1.47 -2.104 0 CA-C-N 112.305 -2.225 . . . . 0.25 106.36 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.956 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -47.23 -66.59 0.38 Allowed 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 109.766 -3.379 . . . . 0.050000000000000003 112.688 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.473 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 19.0 t80 -45.71 -23.86 0.3 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 123.935 0.772 . . . . 0.13 109.581 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.46 -26.64 27.22 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 114.789 -1.096 . . . . 0.13 111.772 -175.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.736 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.96 -44.64 5.43 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 113.462 0.912 . . . . 0.059999999999999998 113.462 177.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.658 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.98 148.03 9.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.495 1.141 . . . . 0.080000000000000002 111.402 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.04 156.72 28.11 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 113.005 -1.907 . . . . 0.47999999999999998 108.772 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.616 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 43.1 mtmt -57.28 102.99 0.1 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.659 0.742 . . . . 0.98999999999999999 109.686 170.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.96 -10.78 6.26 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 113.837 -1.529 . . . . 0.19 111.369 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.658 HG21 ' HB ' ' A' ' 457' ' ' VAL . 17.0 m -66.72 149.34 98.34 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 108.842 -0.799 . . . . 0.13 108.842 171.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.58 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 4.7 Cg_endo -93.67 159.07 2.35 Favored 'Trans proline' 0 N--CA 1.426 -2.499 0 C-N-CA 122.411 2.074 . . . . 0.17999999999999999 109.866 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.725 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -124.46 148.83 28.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.504 -1.295 . . . . 0.56999999999999995 107.504 172.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.694 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.7 mp -134.01 150.2 51.23 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.463 -0.94 . . . . 0.13 108.463 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.089 HG23 HD21 ' A' ' 349' ' ' LEU . 0.8 OUTLIER -138.72 141.99 35.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 105.113 -2.18 . . . . 0.10000000000000001 105.113 165.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.762 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 12.1 p90 . . . . . 0 C--O 1.245 0.822 0 O-C-N 123.688 0.617 . . . . 1.0900000000000001 111.064 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.813 ' HBA' ' OAU' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 112.077 -0.409 . . . . 1.8700000000000001 112.077 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.5 ' CD2' HD11 ' A' ' 464' ' ' LEU . 2.1 p-80 -146.0 106.59 4.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.923 0.342 . . . . 0.83999999999999997 111.923 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.577 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.1 OUTLIER 62.01 -167.23 0.2 Allowed 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.826 0.704 . . . . 0.67000000000000004 112.785 167.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.34 170.38 3.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.342 -1.355 . . . . 1.8500000000000001 107.342 164.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.43 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 4.9 m-20 -81.68 83.72 7.01 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 118.888 -1.125 . . . . 0.42999999999999999 109.278 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 357' ' ' TYR . 88.0 m -158.43 134.72 9.33 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.512 -1.222 . . . . 0.14000000000000001 109.104 169.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.668 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.8 p90 174.15 158.82 0.15 Allowed 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 123.42 0.45 . . . . 0.14999999999999999 111.112 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.639 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.62 151.85 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 N-CA-C 109.039 -0.726 . . . . 0.080000000000000002 109.039 164.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.611 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.21 140.91 23.53 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.583 -0.735 . . . . 2.0099999999999998 109.543 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.719 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -134.7 162.03 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.095 0.474 . . . . 0.45000000000000001 111.287 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.557 ' N ' HG12 ' A' ' 347' ' ' VAL . 27.8 t0 -140.26 106.8 5.32 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.205 -1.406 . . . . 0.23999999999999999 107.205 174.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.079 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.57 -33.77 25.33 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 123.378 1.561 . . . . 0.16 110.21 -169.281 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.17 -44.88 83.93 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 110.625 -2.989 . . . . 0.59999999999999998 107.908 176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -102.4 4.84 39.29 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 111.155 -2.748 . . . . 0.20000000000000001 111.227 -175.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 349' ' ' LEU . 29.6 mt-30 32.69 63.54 0.3 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 112.857 -1.974 . . . . 2.1499999999999999 113.748 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.524 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.3 t60 -142.05 135.31 29.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.914 -1.039 . . . . 0.089999999999999997 109.332 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.756 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.16 156.4 23.28 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.781 -0.645 . . . . 0.070000000000000007 110.067 -178.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.609 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.7 m-90 -142.01 155.13 45.42 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.184 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.693 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 86.3 t80 -110.26 153.31 25.02 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 106.61 -1.626 . . . . 0.26000000000000001 106.61 151.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 11.7 m-85 -127.65 118.77 24.48 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 114.936 -1.029 . . . . 0.14000000000000001 110.416 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.2 tppt? -120.0 136.83 54.41 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.96 -1.867 . . . . 0.25 105.96 168.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.422 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.55 17.8 7.86 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.481 0.919 . . . . 0.42999999999999999 113.481 174.245 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.43 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.67 8.34 87.2 Favored Glycine 0 CA--C 1.485 -1.793 0 C-N-CA 120.825 -0.702 . . . . 0.17999999999999999 112.918 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.4 ptmt -129.08 177.7 6.94 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 104.564 -2.384 . . . . 0.37 104.564 178.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.609 HG11 ' CD1' ' A' ' 355' ' ' TRP . 18.1 m -104.12 157.69 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 N-CA-C 116.344 1.979 . . . . 0.10000000000000001 116.344 -175.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.693 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.8 -27.67 9.63 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 110.513 -3.04 . . . . 0.070000000000000007 106.493 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.817 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.82 144.58 49.07 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 111.495 -2.593 . . . . 0.059999999999999998 111.535 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.441 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.5 tt0 -140.43 118.22 11.71 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 104.53 -2.396 . . . . 0.47999999999999998 104.53 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.756 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.05 163.41 38.23 Favored 'General case' 0 N--CA 1.397 -3.089 0 C-N-CA 117.626 -1.63 . . . . 0.070000000000000007 111.869 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.709 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 11.9 p-10 -101.96 134.14 45.65 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 114.027 -1.442 . . . . 1.8 109.545 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.731 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.11 -173.59 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 CA-C-O 122.26 1.029 . . . . 0.12 112.457 -172.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.47 118.63 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.075 -1.875 . . . . 0.10000000000000001 107.722 173.516 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.521 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -79.42 -167.98 1.38 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.127 -1.397 . . . . 1.26 110.773 -177.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.402 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.45 164.45 39.88 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 118.639 -1.743 . . . . 0.14000000000000001 112.407 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 11.0 ptmt -70.97 158.05 89.0 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.639 0.733 . . . . 0.81000000000000005 111.698 -167.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.674 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.4 Cg_exo -57.83 -29.48 86.23 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 125.184 3.923 . . . . 0.28000000000000003 113.348 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.46 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 17.8 p -71.76 -32.76 68.03 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.608 -1.633 . . . . 0.33000000000000002 109.725 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.538 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.5 t -141.07 70.47 28.43 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-O 123.807 1.765 . . . . 0.39000000000000001 109.31 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.0 Cg_exo -58.94 162.79 12.64 Favored 'Trans proline' 0 C--N 1.312 -1.358 1 C-N-CA 126.486 4.791 . . . . 0.38 115.165 -171.11 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.521 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -96.06 141.99 23.93 Favored Pre-proline 0 N--CA 1.419 -1.979 0 CA-C-N 114.729 -1.123 . . . . 0.81999999999999995 108.503 171.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.6 Cg_exo -76.31 -44.56 0.24 Allowed 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 124.719 3.612 . . . . 0.19 111.95 -167.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.784 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 61.49 138.05 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 123.328 1.537 . . . . 0.13 113.467 -172.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 153.0 -114.43 0.62 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 112.201 -2.272 . . . . 0.20000000000000001 109.362 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.73 117.21 37.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.892 0.854 . . . . 0.81999999999999995 110.661 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.744 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.9 m-85 -115.58 -174.04 2.45 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.147 -1.427 . . . . 0.22 107.147 173.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.49 ' HB2' ' CZ2' ' A' ' 415' ' ' TRP . 1.0 OUTLIER -139.46 123.49 17.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 119.987 1.267 . . . . 0.65000000000000002 113.41 -171.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.06 92.23 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 123.06 1.41 . . . . 0.16 109.337 168.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -94.22 11.96 28.39 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.428 -1.714 . . . . 2.5499999999999998 108.18 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.767 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 28.5 t-20 -169.37 126.65 0.93 Allowed 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 113.972 -1.467 . . . . 0.42999999999999999 110.174 172.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.631 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.16 145.99 26.61 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.064 -0.971 . . . . 1.1200000000000001 109.098 168.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.751 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 19.5 mm-40 -126.29 159.2 33.76 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 114.509 1.3 . . . . 0.70999999999999996 114.509 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.752 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 40.1 mt-10 -138.37 127.52 24.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.211 -1.813 . . . . 0.38 108.674 173.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.81 45.52 21.48 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 123.338 1.542 . . . . 0.40999999999999998 108.729 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.936 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.77 166.6 20.84 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 112.513 -2.13 . . . . 0.12 109.177 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 16.9 m -132.08 120.65 22.64 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.091 0.948 . . . . 0.17000000000000001 111.551 170.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -81.13 88.6 5.99 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.871 -1.513 . . . . 0.56999999999999995 112.048 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.3 mttt -102.01 179.29 4.37 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 113.585 -1.643 . . . . 0.33000000000000002 113.129 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.78 -160.88 25.37 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-N 114.17 -1.377 . . . . 0.46000000000000002 111.421 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.5 m -114.22 141.21 47.83 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 120.108 -0.637 . . . . 0.70999999999999996 110.757 170.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.1 m-80 -59.48 156.22 13.58 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.108 -0.951 . . . . 0.83999999999999997 109.349 168.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.95 -3.39 1.61 Allowed 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.873 -1.058 . . . . 2.2799999999999998 110.685 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.0 OUTLIER -113.04 5.88 17.39 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.874 -1.057 . . . . 2.27 111.128 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.16 18.64 49.33 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.423 -0.894 . . . . 0.93999999999999995 112.433 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.427 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 11.6 p -113.82 101.27 53.69 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 114.37 -0.915 . . . . 0.81000000000000005 109.832 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 19.3 Cg_endo -59.21 150.68 72.46 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 122.825 2.35 . . . . 0.63 113.55 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -151.83 174.27 13.76 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.328 -1.305 . . . . 0.41999999999999998 113.041 -170.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER -144.78 148.04 33.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.875 -1.511 . . . . 0.53000000000000003 110.151 172.23 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.81 97.33 4.96 Favored Pre-proline 0 N--CA 1.436 -1.153 0 N-CA-C 108.275 -1.009 . . . . 0.19 108.275 170.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 18.1 Cg_exo -69.04 111.1 2.57 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.065 1.843 . . . . 0.19 110.023 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.936 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.99 153.45 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 CA-C-N 112.958 -1.928 . . . . 0.14999999999999999 107.626 -167.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 21.5 m-80 -86.14 -20.44 28.64 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.902 -0.777 . . . . 0.51000000000000001 108.902 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.4 m-85 -159.0 127.31 5.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.12 -0.945 . . . . 0.27000000000000002 108.643 -170.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.677 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 23.3 t-105 -145.12 134.35 22.86 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.641 0.734 . . . . 0.089999999999999997 111.185 -167.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.631 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.5 mmt -116.44 93.69 40.72 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.908 -1.145 . . . . 0.14000000000000001 107.908 173.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.767 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 39.0 Cg_endo -67.81 73.76 0.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.311 2.007 . . . . 0.5 112.239 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.58 HG12 ' HA2' ' A' ' 419' ' ' GLY . 2.9 pt -72.86 175.64 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.134 -1.062 . . . . 0.88 108.134 176.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 416' ' ' THR . 1.1 t70 -151.31 -170.57 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 118.852 -1.139 . . . . 2.4900000000000002 112.749 -167.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.49 ' CZ2' ' HB2' ' A' ' 383' ' ' TYR . 41.2 p90 52.14 -0.99 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.953 2.101 . . . . 1.9199999999999999 114.542 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.512 HG21 ' CE1' ' A' ' 382' ' ' PHE . 35.5 p -130.83 -15.21 3.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.143 0.497 . . . . 0.94999999999999996 111.089 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.548 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 95.29 -32.55 6.1 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.138 -0.785 . . . . 0.68000000000000005 111.138 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 419' ' ' GLY . 36.5 t -56.85 172.33 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.002 0.921 . . . . 0.75 111.943 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.84 121.4 0.75 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 109.931 -1.268 . . . . 0.20000000000000001 109.931 171.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.705 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.66 143.09 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 110.034 -0.358 . . . . 0.28999999999999998 110.034 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.677 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.4 p80 -160.58 162.11 32.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.245 -0.434 . . . . 0.089999999999999997 111.409 -174.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.66 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -84.45 145.86 27.93 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.947 -1.131 . . . . 1.0700000000000001 107.947 172.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.579 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 30.2 t -134.17 98.63 4.17 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.745 0.783 . . . . 0.23000000000000001 110.5 -171.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -80.12 -10.79 59.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.117 -1.401 . . . . 0.41999999999999998 109.418 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.727 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 10.5 p90 -95.93 -26.71 15.48 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.592 -1.185 . . . . 0.32000000000000001 112.421 -174.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.579 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 1.2 mm-40 -91.65 110.59 44.38 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-O 122.53 1.157 . . . . 1.74 108.619 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 61.4 Cg_endo -84.36 -17.21 5.51 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 124.336 3.357 . . . . 0.72999999999999998 113.082 -172.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.522 ' HG3' ' HG ' ' A' ' 433' ' ' LEU . 0.7 OUTLIER -112.08 156.86 21.54 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 122.205 1.002 . . . . 2.1600000000000001 111.779 174.076 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.709 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.9 OUTLIER -159.58 124.84 4.11 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 105.129 -2.175 . . . . 0.33000000000000002 105.129 173.316 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.09 -157.75 30.16 Favored Glycine 0 C--N 1.284 -2.333 0 C-N-CA 119.46 -1.352 . . . . 0.17000000000000001 111.354 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -46.26 173.48 0.02 OUTLIER Glycine 0 CA--C 1.501 -0.805 0 C-N-CA 120.609 -0.805 . . . . 0.20999999999999999 111.694 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.598 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 6.3 p-10 -52.57 100.8 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 123.743 1.735 . . . . 1.8500000000000001 114.035 -150.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.722 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.55 -43.58 7.53 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 111.805 -2.452 . . . . 1.21 109.721 170.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.718 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.5 p-90 -52.12 -27.31 13.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.718 -0.674 . . . . 0.16 112.504 -171.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.718 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.89 -32.56 15.98 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.397 0.618 . . . . 0.22 112.452 -177.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.8 p -94.15 -43.24 8.57 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.951 -1.022 . . . . 0.25 111.069 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.722 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.2 OUTLIER -87.59 -20.18 26.77 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.768 -1.106 . . . . 1.8200000000000001 109.153 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.59 47.7 63.02 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 113.631 -1.622 . . . . 0.23999999999999999 115.138 164.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.5 p -82.88 110.23 17.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 118.962 1.381 . . . . 1.01 111.675 -171.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.442 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 72.2 m-70 33.54 -117.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.291 -1.322 . . . . 0.5 113.47 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.402 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -135.57 -16.32 0.91 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.906 -0.664 . . . . 0.26000000000000001 113.79 -174.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.802 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.1 p -103.57 -166.56 1.27 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.834 0.817 . . . . 0.34999999999999998 112.621 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.429 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -96.16 129.41 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.107 -0.952 . . . . 0.12 110.736 -175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.59 93.41 5.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.976 -0.556 . . . . 0.62 110.332 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.731 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -89.14 141.98 29.7 Favored Pre-proline 0 N--CA 1.438 -1.038 0 CA-C-N 115.234 -0.894 . . . . 0.10000000000000001 112.549 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.643 ' HD2' HG21 ' A' ' 366' ' ' THR . 87.1 Cg_exo -49.61 144.77 18.58 Favored 'Trans proline' 0 CA--C 1.506 -0.89 0 C-N-CA 124.158 3.239 . . . . 0.23999999999999999 113.549 175.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.658 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.7 Cg_exo -65.12 -27.02 57.19 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.855 2.37 . . . . 0.31 112.234 -175.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 11.9 m -76.31 -23.9 54.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.863 -0.608 . . . . 1.1000000000000001 112.237 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.817 ' O ' HD21 ' A' ' 364' ' ' LEU . 30.8 m -100.59 -48.7 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 113.009 0.744 . . . . 0.080000000000000002 113.009 -169.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.945 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.87 -2.1 4.78 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.847 -0.741 . . . . 0.070000000000000007 110.353 -178.344 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.8 pttp -80.81 -39.43 26.7 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.085 -1.08 . . . . 0.92000000000000004 108.085 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.4 mm-40 -61.45 -45.9 92.32 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 112.578 -2.101 . . . . 0.25 106.46 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.945 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.5 tp -47.69 -67.12 0.3 Allowed 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 109.701 -3.409 . . . . 0.050000000000000003 112.719 172.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.564 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 14.4 t80 -45.93 -23.28 0.27 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.794 0.807 . . . . 0.13 109.562 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.15 -26.01 27.29 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.72 -1.127 . . . . 0.13 111.842 -176.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.733 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -102.71 -43.91 5.45 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 113.504 0.927 . . . . 0.059999999999999998 113.504 177.197 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.682 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -73.47 150.38 7.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 122.523 1.154 . . . . 0.080000000000000002 111.196 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -120.84 156.77 31.23 Favored 'General case' 0 N--CA 1.414 -2.255 0 CA-C-N 112.978 -1.919 . . . . 0.47999999999999998 108.418 -177.342 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.59 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.2 mppt? -59.34 101.86 0.12 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.888 -0.782 . . . . 0.98999999999999999 108.888 171.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.3 -11.74 5.81 Favored Glycine 0 C--N 1.306 -1.132 0 CA-C-N 113.955 -1.475 . . . . 0.19 111.482 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.682 HG21 ' HB ' ' A' ' 457' ' ' VAL . 15.6 m -66.65 149.33 98.29 Favored Pre-proline 0 N--CA 1.44 -0.964 0 N-CA-C 108.651 -0.87 . . . . 0.13 108.651 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.577 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.6 Cg_endo -93.72 160.63 2.31 Favored 'Trans proline' 0 N--CA 1.422 -2.707 0 C-N-CA 122.196 1.931 . . . . 0.17999999999999999 109.929 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.744 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -123.99 150.07 28.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.281 -1.377 . . . . 0.56999999999999995 107.281 171.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.712 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.08 149.06 51.11 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 108.179 -1.045 . . . . 0.13 108.179 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.079 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.74 142.25 36.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 105.266 -2.124 . . . . 0.10000000000000001 105.266 165.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.751 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 8.3 p90 . . . . . 0 C--O 1.244 0.79 0 O-C-N 123.83 0.706 . . . . 1.0900000000000001 110.787 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.802 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 111.945 -0.462 . . . . 1.8700000000000001 111.945 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.549 ' CE1' HD21 ' A' ' 464' ' ' LEU . 1.9 p-80 -122.35 111.88 17.42 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.685 0.242 . . . . 0.83999999999999997 111.523 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.798 ' HG3' ' O ' ' A' ' 341' ' ' GLU . 0.0 OUTLIER 60.97 -172.15 0.14 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 124.121 0.888 . . . . 0.67000000000000004 111.983 165.4 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLU . . . . . 0.798 ' O ' ' HG3' ' A' ' 340' ' ' MET . 12.7 pt-20 -63.92 -179.5 0.41 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 107.872 -1.159 . . . . 1.8500000000000001 107.872 169.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.502 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 13.3 m-20 -82.36 82.69 7.74 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 117.618 -1.633 . . . . 0.42999999999999999 109.341 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 357' ' ' TYR . 97.2 m -159.78 135.61 8.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.8 -1.091 . . . . 0.14000000000000001 109.857 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.627 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.5 p90 173.02 159.7 0.12 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.192 0.308 . . . . 0.14999999999999999 110.812 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.649 HD12 HD11 ' A' ' 453' ' ' LEU . 0.3 OUTLIER -77.97 151.54 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 109.526 -0.546 . . . . 0.080000000000000002 109.526 164.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.612 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 35.1 tt0 -149.72 141.05 23.22 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.486 -0.779 . . . . 2.0099999999999998 109.626 -176.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.724 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -134.44 161.87 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 122.126 -0.359 . . . . 0.45000000000000001 111.104 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.559 ' N ' HG12 ' A' ' 347' ' ' VAL . 20.7 t0 -140.26 107.21 5.42 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.663 -1.236 . . . . 0.23999999999999999 107.663 173.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.06 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.55 -33.35 25.46 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-O 122.77 1.271 . . . . 0.16 110.273 -168.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 466' ' ' PHE . 1.0 OUTLIER -59.72 -43.4 94.16 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 110.87 -2.877 . . . . 0.59999999999999998 108.261 177.03 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -102.83 8.12 39.35 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 111.153 -2.749 . . . . 0.20000000000000001 110.749 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.56 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 15.3 mp0 32.93 61.27 0.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 112.906 -1.952 . . . . 2.1499999999999999 113.56 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.529 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 24.8 t60 -142.94 137.13 29.2 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.868 -0.605 . . . . 0.089999999999999997 109.86 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.716 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -114.48 156.53 24.39 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.994 -0.548 . . . . 0.070000000000000007 110.249 -179.29 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.595 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -142.21 154.18 44.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.482 -0.781 . . . . 0.11 111.191 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.698 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.5 t80 -110.15 153.11 25.18 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.491 -1.67 . . . . 0.26000000000000001 106.491 151.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.9 m-85 -127.61 117.12 21.41 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.883 -1.053 . . . . 0.14000000000000001 109.948 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.7 tppt? -118.13 140.05 50.35 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 105.854 -1.906 . . . . 0.25 105.854 168.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.65 17.21 10.57 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.597 0.962 . . . . 0.42999999999999999 113.597 171.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.502 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.97 8.06 87.41 Favored Glycine 0 CA--C 1.483 -1.954 0 CA-C-O 122.064 0.813 . . . . 0.17999999999999999 112.961 -175.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 16.1 ptmt -126.83 177.26 6.7 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 104.484 -2.413 . . . . 0.37 104.484 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.595 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.0 m -104.29 157.11 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.841 0 C-N-CA 116.982 -1.887 . . . . 0.10000000000000001 115.626 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.652 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -106.61 -28.23 10.37 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-N 110.544 -3.025 . . . . 0.070000000000000007 106.125 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.832 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -133.17 143.48 49.24 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 111.413 -2.63 . . . . 0.059999999999999998 111.896 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.436 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -139.98 117.55 11.51 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 104.361 -2.459 . . . . 0.47999999999999998 104.361 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.716 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.94 161.02 43.12 Favored 'General case' 0 N--CA 1.397 -3.11 0 C-N-CA 117.795 -1.562 . . . . 0.070000000000000007 110.691 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.17 141.61 32.77 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.448 -0.945 . . . . 1.8 108.448 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.717 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -138.66 -172.82 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 CA-C-O 122.54 1.162 . . . . 0.12 111.947 -173.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.86 120.13 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 112.725 -2.034 . . . . 0.10000000000000001 108.197 173.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.533 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -80.13 -168.06 1.52 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.977 -1.465 . . . . 1.26 110.36 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.439 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.19 168.32 44.54 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 118.528 -1.796 . . . . 0.14000000000000001 112.26 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 5.3 ptmt -73.8 158.11 86.48 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.56 0.695 . . . . 0.81000000000000005 112.037 -165.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.694 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 82.3 Cg_exo -57.68 -30.66 89.68 Favored 'Trans proline' 0 CA--C 1.493 -1.555 0 C-N-CA 125.273 3.982 . . . . 0.28000000000000003 113.347 -172.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.413 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 22.7 p -68.61 -33.81 74.69 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.346 -1.752 . . . . 0.33000000000000002 109.325 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.713 HG21 ' NAX' ' A' ' 130' ' ' 1RG . 3.5 t -142.88 70.28 19.15 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 123.585 1.659 . . . . 0.39000000000000001 110.37 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 375' ' ' THR . 83.4 Cg_exo -58.99 157.43 29.2 Favored 'Trans proline' 0 C--N 1.314 -1.273 1 C-N-CA 126.601 4.868 . . . . 0.38 115.145 -171.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.533 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -86.37 147.87 45.57 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 115.192 -0.913 . . . . 0.81999999999999995 108.702 173.312 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 16.6 Cg_exo -78.08 -44.64 0.16 Allowed 'Trans proline' 0 CA--C 1.512 -0.592 0 C-N-CA 124.853 3.702 . . . . 0.19 112.417 -167.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.774 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.49 138.52 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 123.345 1.545 . . . . 0.13 113.639 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.69 -115.13 0.68 Allowed Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 112.27 -2.241 . . . . 0.20000000000000001 109.318 -177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.6 p -128.35 121.18 54.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.846 0.832 . . . . 0.81999999999999995 110.266 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.726 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.9 m-85 -118.32 -174.38 2.65 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.87 -1.529 . . . . 0.22 106.87 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 2.3 t80 -139.67 123.02 17.09 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 120.801 -1.187 . . . . 0.65000000000000002 112.937 -171.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.41 92.7 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 123.056 1.407 . . . . 0.16 109.544 170.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -92.94 10.82 29.64 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 113.317 -1.765 . . . . 2.5499999999999998 108.334 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.762 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.1 t30 -169.21 126.91 0.96 Allowed 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 114.149 -1.387 . . . . 0.42999999999999999 110.393 172.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.668 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.11 142.7 30.26 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.825 -1.079 . . . . 1.1200000000000001 108.944 168.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 410' ' ' TRP . 23.7 mm-40 -123.9 162.44 23.33 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 114.835 1.42 . . . . 0.70999999999999996 114.835 -169.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 43.7 mt-10 -129.86 144.98 51.58 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 112.927 -1.942 . . . . 0.38 105.953 170.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.9 t70 39.51 47.66 1.65 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 122.766 1.269 . . . . 0.40999999999999998 109.834 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.958 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -82.8 168.15 17.42 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 111.937 -2.392 . . . . 0.12 108.977 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 10.2 m -132.04 119.5 21.11 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.948 0.88 . . . . 0.17000000000000001 111.24 170.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.9 mp -77.27 87.12 3.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.852 -1.522 . . . . 0.56999999999999995 111.787 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.546 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.3 mttt -102.44 -179.71 4.06 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 113.266 -1.788 . . . . 0.33000000000000002 113.406 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 138.86 -163.28 25.9 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.34 -1.3 . . . . 0.46000000000000002 111.375 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 0.9 OUTLIER -120.08 137.95 53.83 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 119.876 -0.73 . . . . 0.70999999999999996 111.129 172.051 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.6 m-80 -56.74 151.32 14.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.979 -1.009 . . . . 0.83999999999999997 109.084 167.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ASP . . . . . 0.664 ' HB2' ' CAY' ' A' ' 130' ' ' 1RG . 0.6 OUTLIER -58.7 -2.6 0.23 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.329 -0.85 . . . . 2.2799999999999998 112.201 176.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 397' ' ' ASN . 21.9 t70 -113.17 0.33 14.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 122.013 0.911 . . . . 2.27 110.251 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.18 17.25 32.52 Favored Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 114.746 -1.115 . . . . 0.93999999999999995 112.872 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.422 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 14.3 p -110.21 98.96 37.9 Favored Pre-proline 0 C--N 1.301 -1.523 0 CA-C-N 114.723 -0.738 . . . . 0.81000000000000005 109.828 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.7 Cg_endo -59.46 149.92 78.67 Favored 'Trans proline' 0 CA--C 1.499 -1.271 0 C-N-CA 122.574 2.183 . . . . 0.63 112.577 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 29.9 p90 -147.42 172.14 14.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.228 -1.351 . . . . 0.41999999999999998 112.251 -169.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.546 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 1.3 mp0 -146.08 148.1 32.28 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.255 -1.339 . . . . 0.53000000000000003 110.779 174.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.79 97.55 4.94 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 107.98 -1.119 . . . . 0.19 107.98 170.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 22.7 Cg_exo -68.58 110.24 2.26 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.076 1.851 . . . . 0.19 110.631 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.958 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.55 158.4 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 CA-C-N 113.036 -1.893 . . . . 0.14999999999999999 107.912 -168.305 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.631 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 3.3 m-20 -92.04 -19.43 22.37 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.934 -0.765 . . . . 0.51000000000000001 108.934 -174.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.9 m-85 -160.46 127.88 4.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.025 -1.102 . . . . 0.27000000000000002 108.025 -171.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.693 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.0 t-105 -144.93 131.51 19.87 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.746 0.784 . . . . 0.089999999999999997 111.561 -166.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.668 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.4 mmt -112.91 92.32 20.57 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 107.866 -1.161 . . . . 0.14000000000000001 107.866 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.762 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.7 Cg_endo -67.63 76.14 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.265 1.976 . . . . 0.5 111.626 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.604 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.5 pt -75.16 179.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.028 -0.73 . . . . 0.88 109.028 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.616 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 8.0 t70 -147.05 -167.3 2.74 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.246 -0.65 . . . . 2.4900000000000002 109.246 -168.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.616 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 12.8 m-90 82.8 -67.29 0.08 Allowed 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.962 0.789 . . . . 1.9199999999999999 112.264 177.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.406 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 71.4 p -108.01 -9.19 15.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.522 -0.763 . . . . 0.94999999999999996 112.108 -166.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.455 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 110.63 -29.85 8.66 Favored Glycine 0 CA--C 1.507 -0.409 0 C-N-CA 120.705 -0.759 . . . . 0.68000000000000005 112.713 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 419' ' ' GLY . 36.6 t -56.26 172.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.484 0.714 . . . . 0.75 112.115 -176.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -174.87 121.11 0.81 Allowed Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 110.084 -1.206 . . . . 0.20000000000000001 110.084 169.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.663 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.2 mp -82.09 142.22 13.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 110.107 -0.331 . . . . 0.28999999999999998 110.107 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.671 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.0 p80 -159.5 161.73 35.42 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.094 -0.503 . . . . 0.089999999999999997 111.37 -174.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.716 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -86.5 148.11 25.67 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.962 -1.125 . . . . 1.0700000000000001 107.962 172.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.6 t -133.14 96.57 3.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.907 0.86 . . . . 0.23000000000000001 110.136 -171.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -80.14 -16.2 55.42 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.103 -1.408 . . . . 0.41999999999999998 109.281 -176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.788 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 11.4 p90 -88.53 -24.63 22.87 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.825 -1.534 . . . . 0.32000000000000001 111.408 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.451 ' HG2' ' OE2' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -97.68 116.38 65.78 Favored Pre-proline 0 CA--C 1.507 -0.681 0 CA-C-O 122.817 1.294 . . . . 1.74 110.351 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.568 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 42.6 Cg_endo -87.65 -9.78 5.56 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 124.217 3.278 . . . . 0.72999999999999998 113.22 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.586 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.9 pm0 -111.96 152.42 28.09 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 122.312 1.053 . . . . 2.1600000000000001 113.375 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.625 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.81 128.54 3.3 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 112.587 -2.097 . . . . 0.33000000000000002 105.769 171.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.35 -157.8 30.18 Favored Glycine 0 C--N 1.281 -2.502 0 C-N-CA 119.892 -1.147 . . . . 0.17000000000000001 110.404 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.43 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.88 173.89 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.064 -1.065 . . . . 0.20999999999999999 111.574 167.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.517 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.4 p-10 -51.47 102.35 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 123.448 1.594 . . . . 1.8500000000000001 113.893 -152.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.712 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.56 -37.5 10.35 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-N 112.6 -2.091 . . . . 1.21 109.782 168.187 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.719 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.2 p-90 -53.9 -27.0 27.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.457 -0.792 . . . . 0.16 112.274 -170.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.719 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.46 -35.38 15.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.587 0.588 . . . . 0.22 112.587 -178.072 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.423 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.9 p -90.1 -42.56 11.02 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.07 -0.968 . . . . 0.25 110.943 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.712 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.1 mtp180 -92.94 -18.51 22.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.651 -1.159 . . . . 1.8200000000000001 109.524 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.24 49.17 45.16 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 115.642 1.017 . . . . 0.23999999999999999 115.642 160.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 28.3 m -83.75 111.49 19.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 119.162 1.481 . . . . 1.01 111.598 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 35.99 -115.69 0.1 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.594 0.961 . . . . 0.5 113.594 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.439 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -137.35 -20.31 0.56 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.423 -0.808 . . . . 0.26000000000000001 113.64 -174.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.803 ' HB3' HASB ' A' ' 130' ' ' 1RG . 27.1 p -97.66 -167.26 1.5 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.003 0.901 . . . . 0.34999999999999998 112.624 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.477 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -99.39 130.14 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 114.864 -1.062 . . . . 0.12 110.535 -175.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -101.88 94.32 5.75 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.763 -0.653 . . . . 0.62 110.198 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.717 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.3 m -90.41 144.41 30.78 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.017 -0.992 . . . . 0.10000000000000001 112.555 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.654 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 73.0 Cg_exo -52.13 145.4 34.37 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 124.114 3.209 . . . . 0.23999999999999999 113.365 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.68 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 36.8 Cg_exo -66.3 -30.6 45.07 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.956 2.437 . . . . 0.31 112.392 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.516 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 13.8 m -72.13 -23.6 61.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.75 -0.659 . . . . 1.1000000000000001 111.725 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.832 ' O ' HD21 ' A' ' 364' ' ' LEU . 26.4 m -100.51 -49.38 11.17 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 N-CA-C 112.858 0.688 . . . . 0.080000000000000002 112.858 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.943 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.24 -2.1 5.41 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.707 -0.797 . . . . 0.070000000000000007 110.29 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.569 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 16.4 pttp -81.03 -38.08 28.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.505 1.145 . . . . 0.92000000000000004 108.137 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.9 mm-40 -62.83 -46.23 88.9 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 112.36 -2.2 . . . . 0.25 106.513 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.943 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.5 tp -47.78 -66.56 0.38 Allowed 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 109.843 -3.344 . . . . 0.050000000000000003 112.511 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.522 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 22.6 t80 -45.96 -23.27 0.28 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 123.903 0.752 . . . . 0.13 109.597 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.92 -25.04 28.18 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.849 -1.068 . . . . 0.13 111.878 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.737 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.73 -44.2 5.14 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 113.425 0.898 . . . . 0.059999999999999998 113.425 176.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -73.49 150.74 7.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-O 122.44 1.114 . . . . 0.080000000000000002 111.125 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.09 155.74 35.05 Favored 'General case' 0 N--CA 1.412 -2.332 0 CA-C-N 112.849 -1.978 . . . . 0.47999999999999998 108.602 -177.439 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.647 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 43.8 mtmt -55.96 102.14 0.07 Allowed 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.669 0.747 . . . . 0.98999999999999999 109.696 170.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.18 -8.93 6.67 Favored Glycine 0 C--N 1.304 -1.23 0 CA-C-N 113.762 -1.563 . . . . 0.19 111.716 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.658 HG21 ' HB ' ' A' ' 457' ' ' VAL . 9.0 m -68.37 149.46 98.04 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 108.833 -0.803 . . . . 0.13 108.833 172.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.4 Cg_endo -93.82 156.69 2.3 Favored 'Trans proline' 0 N--CA 1.424 -2.579 0 C-N-CA 122.3 2.0 . . . . 0.17999999999999999 109.906 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.726 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -121.9 149.03 25.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.554 -1.276 . . . . 0.56999999999999995 107.554 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.705 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.08 149.02 51.1 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.548 -0.908 . . . . 0.13 108.548 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.06 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.35 141.4 39.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 105.589 -2.004 . . . . 0.10000000000000001 105.589 165.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.669 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 7.6 p90 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.469 -1.253 . . . . 1.0900000000000001 110.926 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.803 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.896 -0.481 . . . . 1.8700000000000001 111.896 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.717 ' CE1' HD21 ' A' ' 464' ' ' LEU . 2.2 p-80 -132.3 105.85 7.56 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.692 0.246 . . . . 0.83999999999999997 111.065 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.561 ' HE2' ' HD3' ' A' ' 462' ' ' PRO . 1.6 mtm 56.22 -162.58 0.17 Allowed 'General case' 0 C--O 1.232 0.163 0 O-C-N 124.136 0.897 . . . . 0.67000000000000004 111.675 167.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -153.21 0.08 Allowed 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 120.923 -0.311 . . . . 1.8500000000000001 110.892 166.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.492 ' HB3' ' N ' ' A' ' 360' ' ' GLY . 33.7 m-20 -95.49 83.8 3.87 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.296 -1.362 . . . . 0.42999999999999999 111.83 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.825 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 96.8 m -159.28 134.37 8.22 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.256 -0.884 . . . . 0.14000000000000001 109.021 163.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.693 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.5 p90 174.63 157.84 0.16 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 120.856 0.36 . . . . 0.14999999999999999 111.759 -175.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.599 HD11 HG11 ' A' ' 457' ' ' VAL . 0.2 OUTLIER -77.86 152.59 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.283 -0.636 . . . . 0.080000000000000002 109.283 164.327 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.558 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.1 tt0 -150.52 142.96 24.38 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.741 -0.663 . . . . 2.0099999999999998 109.415 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.713 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.6 t -134.62 162.37 38.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.124 0.488 . . . . 0.45000000000000001 111.382 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.549 ' N ' HG12 ' A' ' 347' ' ' VAL . 29.3 t0 -140.05 106.32 5.26 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.356 -1.35 . . . . 0.23999999999999999 107.356 173.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.046 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.11 -34.9 26.0 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 123.365 1.555 . . . . 0.16 110.075 -169.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.91 -44.98 74.67 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 110.705 -2.952 . . . . 0.59999999999999998 107.692 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -103.36 6.77 38.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 111.219 -2.718 . . . . 0.20000000000000001 111.563 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.924 ' NE2' ' HA ' ' A' ' 369' ' ' VAL . 10.9 mm100 32.82 62.35 0.35 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 112.791 -2.004 . . . . 2.1499999999999999 113.615 -175.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.491 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.0 t60 -141.47 135.15 29.98 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.213 -0.903 . . . . 0.089999999999999997 109.475 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.742 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -112.71 157.26 21.51 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.941 -0.572 . . . . 0.070000000000000007 110.375 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.59 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.3 m-90 -142.27 155.27 45.21 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.713 -0.676 . . . . 0.11 111.416 -175.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.825 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 88.2 t80 -111.2 153.34 25.96 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 106.811 -1.551 . . . . 0.26000000000000001 106.811 151.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 17.1 m-85 -127.42 119.18 25.56 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.947 -1.024 . . . . 0.14000000000000001 110.048 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.467 ' HB2' ' HE2' ' A' ' 356' ' ' TYR . 10.4 tppt? -123.14 112.89 18.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.097 -0.956 . . . . 0.25 108.547 173.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 358' ' ' LYS . 0.2 OUTLIER 75.97 41.26 0.24 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 123.914 0.759 . . . . 0.42999999999999999 112.683 -177.072 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.492 ' N ' ' HB3' ' A' ' 342' ' ' ASP . . . 59.24 16.79 35.79 Favored Glycine 0 CA--C 1.496 -1.14 0 CA-C-O 122.372 0.984 . . . . 0.17999999999999999 113.232 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 358' ' ' LYS . 14.9 ptmt -140.32 167.66 21.61 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 104.534 -2.395 . . . . 0.37 104.534 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.1 m -98.89 157.56 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.735 0 N-CA-C 116.057 1.873 . . . . 0.10000000000000001 116.057 -171.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.728 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.99 -27.51 9.18 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 110.357 -3.11 . . . . 0.070000000000000007 106.21 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.4 143.99 47.92 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 111.563 -2.562 . . . . 0.059999999999999998 111.846 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.484 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 2.9 tt0 -141.37 118.61 11.38 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 104.359 -2.46 . . . . 0.47999999999999998 104.359 175.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.742 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.29 165.55 32.67 Favored 'General case' 0 N--CA 1.403 -2.781 0 C-N-CA 118.07 -1.452 . . . . 0.070000000000000007 112.157 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.721 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 12.4 p-10 -102.05 135.44 43.62 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.174 -1.376 . . . . 1.8 109.63 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.714 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.3 pp -138.24 -173.06 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.252 0 CA-C-O 122.212 1.006 . . . . 0.12 112.754 -170.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.924 ' HA ' ' NE2' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -152.86 120.97 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 112.895 -1.957 . . . . 0.10000000000000001 109.468 171.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.558 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.6 OUTLIER -77.95 -168.92 1.38 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.874 -1.512 . . . . 1.26 110.678 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.476 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -86.32 173.3 46.05 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.063 -1.541 . . . . 0.14000000000000001 112.272 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -78.54 158.38 76.19 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.614 0.721 . . . . 0.81000000000000005 111.921 -166.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 92.8 Cg_exo -56.64 -28.95 77.54 Favored 'Trans proline' 0 CA--C 1.498 -1.311 0 C-N-CA 125.273 3.982 . . . . 0.28000000000000003 113.234 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.468 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 16.9 p -69.52 -33.99 73.62 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.33 -1.759 . . . . 0.33000000000000002 109.855 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.529 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.7 t -140.73 70.35 30.6 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 123.841 1.781 . . . . 0.39000000000000001 108.801 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 375' ' ' THR . 85.4 Cg_exo -57.31 154.33 35.46 Favored 'Trans proline' 0 C--N 1.31 -1.465 1 C-N-CA 126.522 4.814 . . . . 0.38 115.447 -169.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.558 HG21 ' OG ' ' A' ' 370' ' ' SER . 2.2 m -80.6 130.74 63.43 Favored Pre-proline 0 N--CA 1.404 -2.76 0 CA-C-N 114.116 -1.402 . . . . 0.81999999999999995 108.611 172.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.1 Cg_exo -72.0 -43.86 1.07 Allowed 'Trans proline' 0 CA--C 1.511 -0.664 0 C-N-CA 123.599 2.866 . . . . 0.19 111.772 -170.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.807 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.19 137.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 123.412 1.577 . . . . 0.13 113.542 -173.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 154.3 -121.78 1.17 Allowed Glycine 0 N--CA 1.429 -1.8 0 CA-C-N 112.218 -2.264 . . . . 0.20000000000000001 109.401 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.404 HG22 ' CD2' ' A' ' 464' ' ' LEU . 72.5 t -125.23 110.65 25.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.345 0.593 . . . . 0.81999999999999995 110.632 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.75 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 5.1 m-85 -110.32 -173.87 2.35 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.405 -1.331 . . . . 0.22 107.405 174.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 2.4 t80 -141.27 121.92 14.26 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 120.844 -1.16 . . . . 0.65000000000000002 112.827 -172.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.6 p -82.81 92.71 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 CA-C-O 122.827 1.299 . . . . 0.16 108.839 170.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 49.6 p-90 -83.95 0.35 48.26 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 113.201 -1.818 . . . . 2.5499999999999998 107.806 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.791 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 5.9 t30 -170.33 128.18 0.84 Allowed 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 114.744 -1.116 . . . . 0.42999999999999999 110.662 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.651 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -95.96 141.95 28.77 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.388 -0.823 . . . . 1.1200000000000001 109.086 169.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.763 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 9.9 mm-40 -126.75 159.95 32.27 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 114.786 1.402 . . . . 0.70999999999999996 114.786 -167.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 52.2 mt-10 -137.34 128.14 27.19 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.071 -1.877 . . . . 0.38 108.867 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.4 t70 53.91 45.22 28.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 123.386 1.565 . . . . 0.40999999999999998 108.884 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.925 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.03 167.64 20.18 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 112.104 -2.317 . . . . 0.12 109.477 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 16.9 m -132.46 119.06 20.11 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.051 0.929 . . . . 0.17000000000000001 111.903 171.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -78.41 88.66 4.4 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.693 -1.594 . . . . 0.56999999999999995 112.119 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.7 mttt -102.42 177.8 4.77 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 113.666 -1.606 . . . . 0.33000000000000002 113.811 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.93 -160.8 25.82 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 114.009 -1.45 . . . . 0.46000000000000002 111.414 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.7 m -115.71 144.19 44.31 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 120.279 -0.569 . . . . 0.70999999999999996 110.852 171.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 399' ' ' ASP . 4.8 m-80 -60.25 152.06 25.79 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.377 -0.829 . . . . 0.83999999999999997 109.331 166.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.0 -2.52 0.25 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.095 -0.957 . . . . 2.2799999999999998 112.172 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 397' ' ' ASN . 9.6 m-20 -114.28 0.94 14.32 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.422 0.63 . . . . 2.27 110.562 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.79 18.02 28.78 Favored Glycine 0 N--CA 1.427 -1.906 0 CA-C-N 114.889 -1.05 . . . . 0.93999999999999995 113.177 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 10.8 p -112.45 100.29 49.54 Favored Pre-proline 0 C--N 1.303 -1.413 0 CA-C-O 121.544 0.688 . . . . 0.81000000000000005 109.904 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 19.2 Cg_endo -58.88 152.8 55.07 Favored 'Trans proline' 0 CA--C 1.503 -1.044 0 C-N-CA 122.867 2.378 . . . . 0.63 113.349 -176.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -152.35 173.14 15.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.507 -1.224 . . . . 0.41999999999999998 112.497 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER -145.71 147.19 31.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.025 -1.443 . . . . 0.53000000000000003 110.152 172.501 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.08 97.23 5.3 Favored Pre-proline 0 N--CA 1.437 -1.114 0 N-CA-C 108.38 -0.97 . . . . 0.19 108.38 172.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.9 Cg_exo -68.62 111.44 2.57 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 122.102 1.868 . . . . 0.19 110.268 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.925 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -111.72 155.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 CA-C-N 112.861 -1.972 . . . . 0.14999999999999999 107.746 -168.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.1 m-80 -86.86 -20.47 27.42 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.316 -0.624 . . . . 0.51000000000000001 109.316 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 97.7 m-85 -160.24 127.51 4.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.866 -1.061 . . . . 0.27000000000000002 108.189 -171.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 17.3 t-105 -142.95 131.27 22.11 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.591 0.71 . . . . 0.089999999999999997 111.07 -167.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.651 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 13.3 mmt -116.34 86.67 18.21 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.279 -1.008 . . . . 0.14000000000000001 108.279 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.791 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 15.0 Cg_endo -59.17 118.38 5.25 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 120.945 1.096 . . . . 0.5 109.372 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.8 pt -119.66 39.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 123.578 1.656 . . . . 0.88 106.603 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -91.98 125.2 36.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.367 -2.197 . . . . 2.4900000000000002 112.399 -158.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 1.7 p90 155.16 -23.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.371 1.868 . . . . 1.9199999999999999 106.615 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 8.5 t -105.06 -28.55 10.97 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.199 -1.364 . . . . 0.94999999999999996 109.734 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.478 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 136.88 -57.59 0.67 Allowed Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.002 -0.618 . . . . 0.68000000000000005 112.361 171.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 419' ' ' GLY . 22.1 t -54.91 173.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.13 0.972 . . . . 0.75 112.628 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.595 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.26 119.24 0.65 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.61 -0.996 . . . . 0.20000000000000001 110.61 170.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.639 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.5 mt -81.13 144.15 11.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 120.836 0.35 . . . . 0.28999999999999998 111.06 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.672 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.9 p80 -159.41 161.54 35.6 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.028 -0.533 . . . . 0.089999999999999997 111.218 -174.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.2 149.51 25.46 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.826 -1.176 . . . . 1.0700000000000001 107.826 171.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 445' ' ' THR . 34.3 t -133.31 96.5 3.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.553 0.692 . . . . 0.23000000000000001 110.034 -171.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.25 -15.29 53.58 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.736 -1.12 . . . . 0.41999999999999998 109.387 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.788 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 7.7 p90 -86.43 -23.07 26.2 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.658 -1.61 . . . . 0.32000000000000001 111.472 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.536 ' HG2' ' HD2' ' A' ' 427' ' ' PRO . 1.4 tt0 -92.92 131.05 34.33 Favored Pre-proline 0 CA--C 1.506 -0.739 0 CA-C-O 121.651 0.739 . . . . 1.74 111.118 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.556 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 64.3 Cg_endo -85.49 -27.03 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 123.193 2.596 . . . . 0.72999999999999998 113.377 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.556 ' OE2' ' HD2' ' A' ' 427' ' ' PRO . 0.9 OUTLIER -107.96 150.86 26.57 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.563 1.173 . . . . 2.1600000000000001 113.481 -178.014 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.721 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -157.35 132.04 8.64 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.101 -2.318 . . . . 0.33000000000000002 105.307 167.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.04 -159.57 32.84 Favored Glycine 0 C--N 1.283 -2.363 0 C-N-CA 120.095 -1.05 . . . . 0.17000000000000001 110.511 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -47.06 175.32 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 120.24 -0.981 . . . . 0.20999999999999999 111.621 168.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.515 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.4 p-10 -50.53 101.03 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.625 1.678 . . . . 1.8500000000000001 113.764 -154.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 1.018 HD22 ' HD2' ' A' ' 437' ' ' ARG . 34.7 mt -97.68 -37.89 9.73 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.007 -2.36 . . . . 1.21 107.858 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.708 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 64.8 p-90 -48.39 -34.39 10.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.182 0.438 . . . . 0.16 112.182 -172.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.708 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -83.96 -36.9 22.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.934 -0.576 . . . . 0.22 112.144 -175.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.486 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.8 p -88.09 -41.89 12.75 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.247 -0.888 . . . . 0.25 110.534 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 1.018 ' HD2' HD22 ' A' ' 433' ' ' LEU . 0.0 OUTLIER -93.8 -19.19 21.26 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.629 -1.169 . . . . 1.8200000000000001 110.067 -177.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.5 48.11 55.8 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.744 -1.116 . . . . 0.23999999999999999 114.875 163.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 35.2 m -85.2 111.73 20.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 118.71 1.255 . . . . 1.01 111.794 -173.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.434 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 66.3 m-70 36.35 -121.59 0.16 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.717 -1.129 . . . . 0.5 113.969 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.476 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -134.6 -12.87 1.32 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.106 -0.569 . . . . 0.26000000000000001 113.967 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.856 ' HB3' HASB ' A' ' 130' ' ' 1RG . 28.4 p -104.27 -166.59 1.26 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.987 0.894 . . . . 0.34999999999999998 112.839 -176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.443 HD13 HG11 ' A' ' 465' ' ' VAL . 1.9 mp -97.49 131.4 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.023 -0.989 . . . . 0.12 110.665 -175.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -102.71 93.59 5.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.714 -0.676 . . . . 0.62 110.248 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.714 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -89.01 143.98 32.09 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 114.962 -1.017 . . . . 0.10000000000000001 112.578 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.659 ' HD2' HG21 ' A' ' 366' ' ' THR . 77.1 Cg_exo -52.17 145.58 34.03 Favored 'Trans proline' 0 CA--C 1.506 -0.896 0 C-N-CA 124.055 3.17 . . . . 0.23999999999999999 113.246 174.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.677 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.3 Cg_exo -65.39 -26.97 55.18 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.995 2.464 . . . . 0.31 112.552 -176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.479 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 52.1 p -75.7 -25.08 56.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.9 0.857 . . . . 1.1000000000000001 112.054 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.83 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.9 m -99.57 -50.49 10.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.556 -0.747 . . . . 0.080000000000000002 112.806 -171.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.946 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.43 -2.1 4.23 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.796 -0.762 . . . . 0.070000000000000007 110.37 -177.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.543 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.7 pttp -81.3 -39.04 25.81 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.417 1.104 . . . . 0.92000000000000004 108.05 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm-40 -61.63 -46.28 90.47 Favored 'General case' 0 CA--C 1.472 -2.036 0 CA-C-N 112.488 -2.142 . . . . 0.25 106.579 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.946 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.2 tp -47.05 -66.39 0.41 Allowed 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 109.713 -3.403 . . . . 0.050000000000000003 112.647 172.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.492 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 21.6 t80 -45.9 -23.69 0.31 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 123.9 0.75 . . . . 0.13 109.547 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.449 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.31 -25.65 27.93 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 114.791 -1.095 . . . . 0.13 111.97 -176.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.755 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.61 -44.9 4.98 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 113.566 0.95 . . . . 0.059999999999999998 113.566 177.146 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -71.45 145.96 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.587 1.184 . . . . 0.080000000000000002 111.026 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.499 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -114.55 156.07 25.3 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 112.894 -1.957 . . . . 0.47999999999999998 108.679 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.635 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 39.5 mtmt -59.31 103.27 0.17 Allowed 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.778 0.799 . . . . 0.98999999999999999 109.225 169.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 127.82 -10.18 6.72 Favored Glycine 0 C--N 1.302 -1.33 0 CA-C-N 113.592 -1.64 . . . . 0.19 111.403 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.684 HG21 ' HB ' ' A' ' 457' ' ' VAL . 6.1 m -67.81 149.75 98.1 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 108.067 -1.086 . . . . 0.13 108.067 169.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.561 ' HD3' ' HE2' ' A' ' 340' ' ' MET . 8.4 Cg_endo -94.75 167.3 1.71 Allowed 'Trans proline' 0 N--CA 1.416 -3.08 0 C-N-CA 121.943 1.762 . . . . 0.17999999999999999 109.589 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.75 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -128.37 153.86 38.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.109 -1.071 . . . . 0.56999999999999995 108.109 171.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.717 HD21 ' CE1' ' A' ' 339' ' ' HIS . 5.7 mp -134.26 151.14 51.12 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 108.621 -0.881 . . . . 0.13 108.621 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.046 HG23 HD21 ' A' ' 349' ' ' LEU . 0.6 OUTLIER -140.01 139.55 36.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 105.135 -2.172 . . . . 0.10000000000000001 105.135 165.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.695 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 13.4 p90 . . . . . 0 C--O 1.243 0.72 0 O-C-N 123.744 0.652 . . . . 1.0900000000000001 111.219 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.856 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 112.054 -0.418 . . . . 1.8700000000000001 112.054 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.57 ' CD2' HD11 ' A' ' 464' ' ' LEU . 2.0 p-80 -136.17 102.82 5.12 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.867 0.334 . . . . 0.83999999999999997 111.724 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.554 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.2 OUTLIER 61.99 -165.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.059 0.849 . . . . 0.67000000000000004 112.458 167.647 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.27 172.92 3.5 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.11 -1.441 . . . . 1.8500000000000001 107.11 164.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.45 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 3.2 m-20 -81.9 83.05 7.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.256 -0.978 . . . . 0.42999999999999999 109.34 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 357' ' ' TYR . 97.6 m -158.55 136.21 10.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.589 -1.187 . . . . 0.14000000000000001 109.113 169.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.694 ' CD2' HD13 ' A' ' 464' ' ' LEU . 31.9 p90 174.85 157.32 0.16 Allowed 'General case' 0 CA--C 1.5 -0.969 0 O-C-N 123.511 0.507 . . . . 0.14999999999999999 111.129 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.682 HD11 HG11 ' A' ' 457' ' ' VAL . 0.6 OUTLIER -76.71 151.64 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 108.495 -0.928 . . . . 0.080000000000000002 108.495 164.655 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.766 ' CD ' ' HE1' ' A' ' 466' ' ' PHE . 6.9 tp10 -149.57 146.3 27.26 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.504 -0.771 . . . . 2.0099999999999998 109.902 -173.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.739 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -143.04 160.33 17.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.382 0.611 . . . . 0.45000000000000001 111.667 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.552 ' N ' HG12 ' A' ' 347' ' ' VAL . 27.1 t0 -141.07 106.47 5.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.378 -1.341 . . . . 0.23999999999999999 107.378 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.099 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.41 -34.61 28.22 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 122.717 1.246 . . . . 0.16 110.42 -167.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.443 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 1.5 mt-10 -57.43 -44.12 84.44 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 110.88 -2.873 . . . . 0.59999999999999998 108.013 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.9 m-80 -100.67 5.26 43.73 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 111.045 -2.798 . . . . 0.20000000000000001 111.037 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.594 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.5 mp0 34.96 61.54 0.6 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 112.766 -2.016 . . . . 2.1499999999999999 113.367 -175.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.524 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.5 t60 -142.61 135.46 28.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.785 -0.643 . . . . 0.089999999999999997 109.664 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.736 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.73 158.27 20.28 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.829 -0.623 . . . . 0.070000000000000007 109.86 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.644 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.5 m-90 -143.23 158.55 43.52 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.358 0.663 . . . . 0.11 110.695 -176.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.687 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.4 t80 -111.86 153.36 26.77 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.176 -1.787 . . . . 0.26000000000000001 106.176 150.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 7.9 m-85 -127.74 116.31 20.03 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.13 -0.941 . . . . 0.14000000000000001 110.15 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.3 tppt? -117.97 138.91 51.85 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.215 -1.772 . . . . 0.25 106.215 168.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.416 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.43 17.14 9.18 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.268 0.84 . . . . 0.42999999999999999 113.268 172.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.38 7.66 87.82 Favored Glycine 0 CA--C 1.488 -1.647 0 C-N-CA 120.801 -0.714 . . . . 0.17999999999999999 112.937 -174.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.3 ptmt -128.68 178.4 6.36 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 104.486 -2.412 . . . . 0.37 104.486 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.644 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.0 m -105.01 158.2 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 116.339 1.977 . . . . 0.10000000000000001 116.339 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.681 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.36 -26.93 9.76 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 110.625 -2.989 . . . . 0.070000000000000007 106.456 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.807 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.37 144.53 48.29 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 111.477 -2.601 . . . . 0.059999999999999998 111.432 -176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.431 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.1 tt0 -141.19 117.77 10.91 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 104.374 -2.454 . . . . 0.47999999999999998 104.374 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.736 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.66 163.5 37.74 Favored 'General case' 0 N--CA 1.399 -2.98 0 C-N-CA 117.896 -1.521 . . . . 0.070000000000000007 111.306 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.462 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 22.2 p-10 -103.4 136.46 43.11 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 114.907 -1.042 . . . . 1.8 109.484 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -136.13 -174.04 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 CA-C-O 122.484 1.135 . . . . 0.12 112.559 -170.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.7 OUTLIER -150.54 119.68 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 112.731 -2.031 . . . . 0.10000000000000001 107.798 173.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.525 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.74 -168.49 1.6 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.269 -1.332 . . . . 1.26 110.132 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -83.87 165.39 41.87 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 118.419 -1.848 . . . . 0.14000000000000001 112.636 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.5 ptmt -67.06 155.76 89.53 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.719 -0.74 . . . . 0.81000000000000005 112.22 -167.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.68 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 95.1 Cg_exo -55.95 -30.74 79.08 Favored 'Trans proline' 0 CA--C 1.495 -1.458 1 C-N-CA 125.332 4.021 . . . . 0.28000000000000003 113.932 -173.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.404 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 23.3 p -68.65 -30.67 69.42 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.882 -1.508 . . . . 0.33000000000000002 109.546 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.535 HG21 ' CB ' ' A' ' 398' ' ' ASP . 1.2 t -141.97 70.82 23.88 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 123.266 1.508 . . . . 0.39000000000000001 110.032 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 375' ' ' THR . 72.8 Cg_exo -58.62 148.24 83.0 Favored 'Trans proline' 0 C--N 1.307 -1.614 1 C-N-CA 126.028 4.485 . . . . 0.38 113.603 -172.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.525 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -77.93 144.54 68.31 Favored Pre-proline 0 N--CA 1.423 -1.812 0 N-CA-C 108.546 -0.909 . . . . 0.81999999999999995 108.546 175.563 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.2 Cg_exo -75.4 -45.07 0.27 Allowed 'Trans proline' 0 CA--C 1.51 -0.722 0 C-N-CA 124.352 3.368 . . . . 0.19 111.705 -167.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.802 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.21 139.24 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 123.051 1.405 . . . . 0.13 113.148 -172.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.8 -117.66 0.84 Allowed Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 112.558 -2.11 . . . . 0.20000000000000001 109.317 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.38 114.44 28.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.993 0.901 . . . . 0.81999999999999995 110.616 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.758 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.4 m-85 -113.16 -174.06 2.38 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.246 -1.39 . . . . 0.22 107.246 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.447 ' HB2' ' CZ2' ' A' ' 415' ' ' TRP . 1.2 t80 -140.44 123.75 16.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.369 1.44 . . . . 0.65000000000000002 113.513 -172.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -89.93 92.57 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 CA-C-O 123.009 1.385 . . . . 0.16 109.543 169.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -93.12 11.1 28.92 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.416 -1.72 . . . . 2.5499999999999998 108.176 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.74 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 26.5 t-20 -169.21 126.64 0.95 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 113.927 -1.488 . . . . 0.42999999999999999 110.366 172.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.702 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -98.46 140.92 31.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.853 -1.067 . . . . 1.1200000000000001 109.117 169.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.769 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 18.6 mm-40 -124.05 157.18 35.1 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.547 1.314 . . . . 0.70999999999999996 114.547 -168.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 44.1 mt-10 -137.13 127.89 27.19 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 112.825 -1.988 . . . . 0.38 108.397 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 32.1 t70 55.22 48.48 19.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 123.346 1.546 . . . . 0.40999999999999998 108.92 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.922 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -83.04 167.97 17.38 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 112.629 -2.078 . . . . 0.12 109.153 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 25.9 m -132.68 119.34 20.26 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.071 0.939 . . . . 0.17000000000000001 111.733 170.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 4.2 mp -80.86 91.38 5.97 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.748 -1.569 . . . . 0.56999999999999995 112.249 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.547 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.0 mttt -102.14 178.27 4.65 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 113.971 -1.468 . . . . 0.33000000000000002 113.077 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.83 -157.08 24.06 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-N 114.363 -1.29 . . . . 0.46000000000000002 111.514 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 2.4 m -117.65 139.38 51.08 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 120.181 -0.608 . . . . 0.70999999999999996 110.862 170.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 401' ' ' THR . 5.1 m-80 -56.63 152.74 11.5 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.168 -0.924 . . . . 0.83999999999999997 109.288 168.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ASP . . . . . 0.535 ' CB ' HG21 ' A' ' 375' ' ' THR . 7.4 p-10 -50.11 -16.78 0.33 Allowed 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 113.268 -1.787 . . . . 2.2799999999999998 112.579 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 397' ' ' ASN . 16.9 t70 -96.14 -20.02 18.93 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 113.931 -1.486 . . . . 2.27 109.447 -173.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.07 31.56 5.31 Favored Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 119.689 -1.243 . . . . 0.93999999999999995 111.848 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 6.9 p -123.81 101.4 36.21 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 114.736 -0.732 . . . . 0.81000000000000005 109.416 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 20.7 Cg_endo -58.42 151.2 62.96 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 C-N-CA 122.912 2.408 . . . . 0.63 113.45 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.5 ' OH ' ' HAD' ' A' ' 130' ' ' 1RG . 21.5 p90 -153.18 175.63 12.83 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.472 -1.24 . . . . 0.41999999999999998 112.787 -169.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.547 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -144.35 147.78 33.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.629 -1.623 . . . . 0.53000000000000003 109.801 170.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.36 97.25 5.17 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.277 -1.009 . . . . 0.19 108.277 172.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 16.4 Cg_exo -69.9 109.9 2.45 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 121.797 1.665 . . . . 0.19 109.952 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.922 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.97 155.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-N 112.667 -2.06 . . . . 0.14999999999999999 107.766 -167.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.722 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.0 m-80 -86.85 -20.99 26.68 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.179 -0.674 . . . . 0.51000000000000001 109.179 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.769 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 95.0 m-85 -158.7 127.0 5.24 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.353 1.033 . . . . 0.27000000000000002 108.79 -171.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.68 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 24.1 t-105 -145.11 137.09 25.7 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.756 0.789 . . . . 0.089999999999999997 110.953 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.702 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.6 mmt -119.87 93.72 47.94 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 107.651 -1.24 . . . . 0.14000000000000001 107.651 173.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 40.0 Cg_endo -67.74 74.14 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.356 2.037 . . . . 0.5 112.414 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.582 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.4 pt -72.88 174.27 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.488 -0.93 . . . . 0.88 108.488 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.517 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 20.8 t70 -143.87 -178.74 6.07 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.648 -0.821 . . . . 2.4900000000000002 112.232 -164.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.517 ' CE3' ' HB3' ' A' ' 414' ' ' ASP . 38.0 p90 56.59 -3.2 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.849 2.06 . . . . 1.9199999999999999 114.51 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.522 HG21 ' CD1' ' A' ' 382' ' ' PHE . 38.2 p -128.59 -15.86 4.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.142 0.496 . . . . 0.94999999999999996 111.018 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.615 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 96.6 -33.92 5.35 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.081 -0.808 . . . . 0.68000000000000005 111.081 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 419' ' ' GLY . 29.1 t -56.92 173.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.072 0.949 . . . . 0.75 112.012 -177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.595 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.03 122.43 0.82 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.606 -1.398 . . . . 0.20000000000000001 109.606 170.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.689 HG22 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.72 142.52 13.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.799 -0.445 . . . . 0.28999999999999998 109.799 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.68 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.4 p80 -159.83 162.48 34.73 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.196 -0.456 . . . . 0.089999999999999997 111.659 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.702 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.88 143.8 28.03 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.845 -1.169 . . . . 1.0700000000000001 107.845 171.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.537 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 28.5 t -133.83 99.03 4.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.874 0.845 . . . . 0.23000000000000001 110.701 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.03 -13.51 59.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.132 -1.395 . . . . 0.41999999999999998 109.537 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.712 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 11.7 p90 -92.05 -27.1 18.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.443 -1.253 . . . . 0.32000000000000001 111.853 -175.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.537 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -91.73 106.61 17.69 Favored Pre-proline 0 CA--C 1.507 -0.689 0 CA-C-O 122.624 1.202 . . . . 1.74 108.462 175.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 61.9 Cg_endo -82.96 -16.69 7.33 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 124.257 3.305 . . . . 0.72999999999999998 113.021 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.57 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 0.5 OUTLIER -109.78 152.98 25.0 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 122.115 0.959 . . . . 2.1600000000000001 111.543 174.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.686 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -154.32 132.58 11.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.201 -2.148 . . . . 0.33000000000000002 105.201 169.287 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.61 -158.34 30.96 Favored Glycine 0 C--N 1.285 -2.294 0 N-CA-C 110.438 -1.065 . . . . 0.17000000000000001 110.438 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.534 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -47.08 174.14 0.02 OUTLIER Glycine 0 CA--C 1.495 -1.192 0 C-N-CA 120.096 -1.05 . . . . 0.20999999999999999 111.499 168.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.569 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 7.0 p-10 -52.59 101.29 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 123.422 1.582 . . . . 1.8500000000000001 113.883 -154.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 1.006 HD22 ' HD2' ' A' ' 437' ' ' ARG . 41.6 mt -97.47 -34.65 10.93 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 112.203 -2.271 . . . . 1.21 109.383 171.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.709 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.2 p-90 -53.74 -26.36 22.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.017 -0.992 . . . . 0.16 112.004 -173.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.709 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.11 -36.33 14.06 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.618 -0.719 . . . . 0.22 112.308 -178.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.432 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.2 p -88.15 -41.02 13.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.143 -0.935 . . . . 0.25 110.381 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 1.006 ' HD2' HD22 ' A' ' 433' ' ' LEU . 2.1 mtp85 -93.06 -20.69 20.29 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.431 -1.258 . . . . 1.8200000000000001 109.704 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.91 45.8 49.86 Favored Glycine 0 N--CA 1.443 -0.834 0 O-C-N 124.284 0.99 . . . . 0.23999999999999999 114.072 166.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 20.8 m -84.69 110.13 18.53 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.654 -1.218 . . . . 1.01 111.367 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.671 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 29.1 m-70 46.11 -145.0 0.21 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.607 -1.179 . . . . 0.5 113.629 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 440' ' ' HIS . . . -110.65 -23.41 5.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.506 -0.854 . . . . 0.26000000000000001 113.566 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.711 ' HB3' HASB ' A' ' 130' ' ' 1RG . 31.2 p -101.57 -165.43 1.19 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 113.645 0.98 . . . . 0.34999999999999998 113.645 -170.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 370' ' ' SER . 2.0 mp -90.23 133.35 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.569 -0.741 . . . . 0.12 110.61 -176.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.11 90.9 3.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.366 0.603 . . . . 0.62 110.286 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.744 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.3 m -85.82 142.33 36.66 Favored Pre-proline 0 N--CA 1.436 -1.126 0 CA-C-N 115.105 -0.952 . . . . 0.10000000000000001 112.512 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.669 ' HD2' HG21 ' A' ' 366' ' ' THR . 82.0 Cg_exo -49.58 145.56 16.7 Favored 'Trans proline' 0 CA--C 1.509 -0.767 0 C-N-CA 123.891 3.06 . . . . 0.23999999999999999 113.572 175.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.702 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.4 Cg_exo -66.7 -21.05 52.21 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.827 2.352 . . . . 0.31 112.034 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.55 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 33.4 p -83.35 -24.07 32.23 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.233 -0.894 . . . . 1.1000000000000001 112.291 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.807 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.8 m -99.64 -47.98 11.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 112.954 0.724 . . . . 0.080000000000000002 112.954 -171.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.968 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.36 -1.77 3.8 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.789 -0.764 . . . . 0.070000000000000007 110.462 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 448' ' ' SER . 17.2 pttp -81.5 -38.27 26.56 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.698 1.237 . . . . 0.92000000000000004 108.33 173.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.7 mm-40 -62.57 -46.28 89.05 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-N 112.299 -2.228 . . . . 0.25 106.328 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.968 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -47.28 -66.61 0.38 Allowed 'General case' 0 N--CA 1.406 -2.633 0 CA-C-N 109.832 -3.349 . . . . 0.050000000000000003 112.956 172.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.495 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.3 t80 -46.26 -22.59 0.25 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.866 0.841 . . . . 0.13 109.396 176.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.459 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.83 -25.32 30.0 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.674 -1.148 . . . . 0.13 112.008 -176.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.759 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.5 -43.7 5.32 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 113.705 1.002 . . . . 0.059999999999999998 113.705 176.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.682 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.87 149.8 7.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.432 1.11 . . . . 0.080000000000000002 111.278 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.405 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -121.68 156.4 33.13 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 112.99 -1.914 . . . . 0.47999999999999998 108.64 -177.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.563 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 2.5 mppt? -58.66 103.2 0.14 Allowed 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.775 -0.824 . . . . 0.98999999999999999 108.775 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.75 -9.08 6.11 Favored Glycine 0 C--N 1.307 -1.069 0 CA-C-N 113.935 -1.484 . . . . 0.19 111.616 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 344' ' ' TYR . 19.0 m -69.31 150.05 97.26 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.972 -0.751 . . . . 0.13 108.972 171.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.554 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.7 Cg_endo -93.84 163.06 2.22 Favored 'Trans proline' 0 N--CA 1.423 -2.664 0 C-N-CA 122.34 2.026 . . . . 0.17999999999999999 109.919 176.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.758 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.7 m -126.64 149.23 31.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 107.502 -1.296 . . . . 0.56999999999999995 107.502 171.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.694 HD13 ' CD2' ' A' ' 344' ' ' TYR . 3.5 mp -134.86 150.3 50.45 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 108.426 -0.953 . . . . 0.13 108.426 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.099 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.94 143.12 28.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 105.72 -1.956 . . . . 0.10000000000000001 105.72 166.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.766 ' HE1' ' CD ' ' A' ' 346' ' ' GLU . 9.3 p90 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 123.185 0.594 . . . . 1.0900000000000001 110.316 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.716 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.218 -0.353 . . . . 1.8700000000000001 112.218 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.748 ' CE1' HD21 ' A' ' 464' ' ' LEU . 0.3 OUTLIER -117.72 100.78 7.83 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 122.796 -0.238 . . . . 0.83999999999999997 111.43 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.507 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 1.6 mtm 63.2 -166.92 0.22 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 124.061 0.851 . . . . 0.67000000000000004 112.351 167.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.51 171.9 2.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.021 -0.536 . . . . 1.8500000000000001 109.823 161.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.496 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 6.2 m-20 -80.0 83.34 5.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.334 -0.946 . . . . 0.42999999999999999 110.264 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.79 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 46.9 m -158.01 135.48 10.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.77 -1.104 . . . . 0.14000000000000001 108.681 167.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.691 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.7 p90 174.22 159.18 0.16 Allowed 'General case' 0 C--O 1.214 -0.795 0 O-C-N 123.337 0.398 . . . . 0.14999999999999999 110.851 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.642 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.99 152.13 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.313 0 N-CA-C 109.112 -0.699 . . . . 0.080000000000000002 109.112 164.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.569 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.72 143.14 25.26 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.628 -0.715 . . . . 2.0099999999999998 109.452 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.742 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.9 t -135.15 162.43 38.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 120.733 -0.387 . . . . 0.45000000000000001 111.213 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.569 ' N ' HG12 ' A' ' 347' ' ' VAL . 36.7 t0 -140.23 106.81 5.33 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.468 -1.308 . . . . 0.23999999999999999 107.468 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.024 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.48 -34.9 27.86 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-O 122.752 1.263 . . . . 0.16 110.436 -167.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.02 -44.98 87.6 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 110.797 -2.91 . . . . 0.59999999999999998 108.308 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -100.61 5.94 44.01 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 111.012 -2.813 . . . . 0.20000000000000001 111.057 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.7 mp0 35.09 61.32 0.63 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 112.725 -2.034 . . . . 2.1499999999999999 113.16 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.495 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.5 t60 -142.2 134.6 27.91 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.646 -0.706 . . . . 0.089999999999999997 109.742 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.734 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.71 157.85 20.78 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.822 -0.627 . . . . 0.070000000000000007 110.106 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.61 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.1 m-90 -142.62 156.02 45.02 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.499 0.72 . . . . 0.11 111.258 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.79 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.0 t80 -110.81 153.82 24.84 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 106.424 -1.695 . . . . 0.26000000000000001 106.424 151.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.6 m-85 -127.86 119.09 24.9 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 114.892 -1.049 . . . . 0.14000000000000001 110.351 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.2 tppt? -120.56 132.41 55.15 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.277 -1.749 . . . . 0.25 106.277 167.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 75.1 16.53 2.8 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 113.136 0.791 . . . . 0.42999999999999999 113.136 174.384 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.496 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.13 5.73 88.99 Favored Glycine 0 CA--C 1.485 -1.828 0 CA-C-O 121.814 0.675 . . . . 0.17999999999999999 112.887 -173.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 19.9 ptmt -128.92 177.23 7.25 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.502 -2.407 . . . . 0.37 104.502 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.0 m -103.56 158.22 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 116.713 2.116 . . . . 0.10000000000000001 116.713 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.712 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.15 -28.65 8.93 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 110.39 -3.096 . . . . 0.070000000000000007 106.207 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -133.87 145.91 50.1 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 111.589 -2.551 . . . . 0.059999999999999998 111.669 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.471 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.3 tt0 -143.72 118.47 9.87 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 104.499 -2.408 . . . . 0.47999999999999998 104.499 175.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.81 165.39 32.65 Favored 'General case' 0 N--CA 1.401 -2.915 0 C-N-CA 118.132 -1.427 . . . . 0.070000000000000007 111.631 -179.157 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.67 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 15.5 p-10 -103.81 133.33 48.98 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.669 -1.15 . . . . 1.8 110.087 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -133.77 -173.75 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-O 122.465 1.126 . . . . 0.12 112.525 -171.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.37 120.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 112.91 -1.95 . . . . 0.10000000000000001 109.199 172.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.522 ' HB3' HD12 ' A' ' 349' ' ' LEU . 33.6 p -78.25 -169.06 1.49 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 111.94 -2.391 . . . . 1.26 111.421 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.485 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.77 174.75 50.14 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 118.779 -1.676 . . . . 0.14000000000000001 112.05 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.439 ' HG2' ' CG2' ' A' ' 375' ' ' THR . 8.5 ptmt -80.31 163.67 55.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 113.174 0.805 . . . . 0.81000000000000005 113.174 -164.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.685 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 89.4 Cg_exo -55.09 -37.86 93.78 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 123.023 2.482 . . . . 0.28000000000000003 112.287 -176.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.456 ' OG1' HG22 ' A' ' 375' ' ' THR . 12.0 p -64.35 -31.89 73.27 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.29 -1.323 . . . . 0.33000000000000002 110.052 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.744 HG21 ' NAX' ' A' ' 130' ' ' 1RG . 1.2 t -141.59 71.04 25.78 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 123.439 1.59 . . . . 0.39000000000000001 110.032 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 375' ' ' THR . 82.2 Cg_exo -58.3 153.81 44.6 Favored 'Trans proline' 0 C--N 1.307 -1.643 1 C-N-CA 126.369 4.713 . . . . 0.38 114.985 -171.209 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.54 HG21 ' HG ' ' A' ' 349' ' ' LEU . 2.5 m -79.24 129.86 71.04 Favored Pre-proline 0 N--CA 1.405 -2.718 0 CA-C-N 114.5 -1.227 . . . . 0.81999999999999995 108.55 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 39.4 Cg_exo -68.28 -44.97 3.04 Favored 'Trans proline' 0 CA--C 1.512 -0.601 0 C-N-CA 123.834 3.023 . . . . 0.19 112.147 -169.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.795 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.84 138.96 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 123.304 1.526 . . . . 0.13 113.645 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 152.86 -119.31 0.95 Allowed Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 112.243 -2.253 . . . . 0.20000000000000001 109.579 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.429 HG22 HD21 ' A' ' 464' ' ' LEU . 76.4 t -129.84 108.5 16.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.002 0.43 . . . . 0.81999999999999995 110.472 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.769 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.4 m-85 -108.55 -173.98 2.41 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.279 -1.378 . . . . 0.22 107.279 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.3 t80 -140.83 123.84 16.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 120.09 1.313 . . . . 0.65000000000000002 113.656 -172.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.94 92.56 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 122.961 1.362 . . . . 0.16 109.66 169.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -91.23 9.27 31.98 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.622 -1.627 . . . . 2.5499999999999998 108.265 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.744 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.5 t30 -170.79 127.89 0.76 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.229 -1.351 . . . . 0.42999999999999999 110.475 173.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.684 ' HB3' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -96.95 151.57 19.56 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.727 -0.67 . . . . 1.1200000000000001 109.873 167.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 37.8 mm-40 -128.37 160.48 32.08 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.471 1.286 . . . . 0.70999999999999996 114.471 -170.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.8 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 32.1 mt-10 -139.53 127.68 22.48 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 113.112 -1.858 . . . . 0.38 108.881 172.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.73 46.09 23.18 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 123.109 1.433 . . . . 0.40999999999999998 108.964 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.942 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.52 166.52 21.1 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 112.759 -2.019 . . . . 0.12 108.967 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 18.7 m -133.0 118.9 19.39 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.988 0.899 . . . . 0.17000000000000001 111.94 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.1 mp -79.41 88.53 5.01 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.775 -1.557 . . . . 0.56999999999999995 112.091 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.54 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.4 mttt -102.72 -179.42 3.96 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.561 -1.654 . . . . 0.33000000000000002 113.826 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 139.35 -163.6 26.03 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 114.029 -1.442 . . . . 0.46000000000000002 111.149 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 2.0 m -122.81 138.14 54.73 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.217 -0.593 . . . . 0.70999999999999996 110.934 171.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.4 m-80 -56.0 152.34 10.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.918 -1.037 . . . . 0.83999999999999997 109.238 167.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ASP . . . . . 0.573 ' HB2' ' CAY' ' A' ' 130' ' ' 1RG . 0.1 OUTLIER -59.35 -3.23 0.39 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.825 -0.625 . . . . 2.2799999999999998 111.807 176.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 397' ' ' ASN . 25.8 t0 -106.81 -9.22 16.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.916 -1.038 . . . . 2.27 108.781 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.05 36.82 6.99 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 118.794 -1.67 . . . . 0.93999999999999995 111.631 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 18.6 p -124.94 93.11 46.46 Favored Pre-proline 0 C--N 1.305 -1.368 0 CA-C-N 114.437 -0.881 . . . . 0.81000000000000005 109.008 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.0 Cg_endo -59.31 147.69 89.8 Favored 'Trans proline' 0 CA--C 1.497 -1.333 0 C-N-CA 122.648 2.232 . . . . 0.63 112.811 -176.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 34.4 p90 -145.82 167.37 23.38 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.128 -1.396 . . . . 0.41999999999999998 111.933 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.54 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -145.15 146.33 31.73 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.37 -1.287 . . . . 0.53000000000000003 110.32 175.09 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.17 97.27 5.26 Favored Pre-proline 0 N--CA 1.431 -1.387 0 N-CA-C 108.11 -1.07 . . . . 0.19 108.11 171.436 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 18.9 Cg_exo -69.35 109.94 2.35 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 122.012 1.808 . . . . 0.19 109.881 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.942 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.08 156.34 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 CA-C-N 112.869 -1.969 . . . . 0.14999999999999999 107.283 -168.126 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.8 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.0 m-80 -89.72 -19.9 24.22 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.987 -0.746 . . . . 0.51000000000000001 108.987 -174.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.6 m-85 -159.06 126.58 4.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.346 -0.983 . . . . 0.27000000000000002 108.346 -171.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.685 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 25.0 t-105 -145.25 133.92 22.19 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.828 0.823 . . . . 0.089999999999999997 111.253 -167.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.684 ' SD ' ' HB3' ' A' ' 387' ' ' LYS . 11.8 mmt -115.2 94.91 40.72 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.568 -1.271 . . . . 0.14000000000000001 107.568 172.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.744 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 39.3 Cg_endo -68.52 67.61 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.362 2.041 . . . . 0.5 112.548 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.617 HG12 ' HA2' ' A' ' 419' ' ' GLY . 2.1 pt -68.08 170.63 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 108.618 -0.882 . . . . 0.88 108.618 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 416' ' ' THR . 1.8 t70 -149.71 -172.71 4.22 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.012 -1.075 . . . . 2.4900000000000002 112.406 -166.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 37.4 p90 50.61 1.92 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.879 2.072 . . . . 1.9199999999999999 114.47 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.496 HG21 ' CD1' ' A' ' 382' ' ' PHE . 38.1 p -130.76 -14.67 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.94999999999999996 110.89 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.437 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 98.92 -37.95 3.29 Favored Glycine 0 CA--C 1.501 -0.79 0 N-CA-C 110.927 -0.869 . . . . 0.68000000000000005 110.927 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.578 HG12 ' N ' ' A' ' 419' ' ' GLY . 22.1 t -59.51 172.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 124.234 1.014 . . . . 0.75 112.433 -175.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.617 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -177.45 120.19 0.72 Allowed Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.965 -1.254 . . . . 0.20000000000000001 109.965 170.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.67 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.76 143.08 12.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 110.21 -0.293 . . . . 0.28999999999999998 110.21 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.685 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.5 p80 -159.15 160.88 36.06 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.168 -0.469 . . . . 0.089999999999999997 111.702 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.709 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -84.54 148.14 26.65 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.838 -1.171 . . . . 1.0700000000000001 107.838 172.09 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 445' ' ' THR . 43.3 t -134.29 96.54 3.63 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.67 0.747 . . . . 0.23000000000000001 110.269 -171.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.21 -18.96 44.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.473 -1.24 . . . . 0.41999999999999998 109.945 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.75 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 11.2 p90 -83.85 -17.9 39.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.183 -1.371 . . . . 0.32000000000000001 111.128 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -102.28 117.13 61.87 Favored Pre-proline 0 CA--C 1.503 -0.858 0 CA-C-O 122.808 1.29 . . . . 1.74 109.862 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.84 -11.24 4.79 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.144 3.23 . . . . 0.72999999999999998 111.737 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 428' ' ' GLU . 5.2 pt-20 -114.57 151.04 34.05 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 114.298 -1.319 . . . . 2.1600000000000001 113.417 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.718 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.62 134.2 5.19 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 104.162 -2.533 . . . . 0.33000000000000002 104.162 171.064 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.36 -157.29 29.4 Favored Glycine 0 C--N 1.276 -2.756 0 C-N-CA 119.28 -1.438 . . . . 0.17000000000000001 110.749 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.406 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.94 174.29 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 119.903 -1.142 . . . . 0.20999999999999999 111.175 166.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.51 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -51.33 102.68 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 123.198 1.475 . . . . 1.8500000000000001 113.944 -154.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.667 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.07 -35.44 11.92 Favored 'General case' 0 C--O 1.202 -1.4 0 CA-C-N 112.699 -2.046 . . . . 1.21 109.087 168.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.734 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -55.72 -26.69 46.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.16 112.357 -170.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.734 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.78 -32.42 15.39 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.981 0.896 . . . . 0.22 111.771 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.8 p -87.52 -45.0 10.86 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.946 -1.479 . . . . 0.25 111.103 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.667 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 7.5 mtp-105 -91.04 -20.2 22.34 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.446 -1.252 . . . . 1.8200000000000001 110.18 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.89 46.56 49.17 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.395 -1.275 . . . . 0.23999999999999999 114.308 164.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 110.82 19.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.345 1.073 . . . . 1.01 112.298 -169.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.538 ' HB2' ' OAC' ' A' ' 130' ' ' 1RG . 35.1 m170 37.07 -111.19 0.08 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.869 -1.06 . . . . 0.5 113.495 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.485 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -146.41 -11.84 0.21 Allowed Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.867 -0.682 . . . . 0.26000000000000001 114.235 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.832 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.4 p -100.04 -167.99 1.53 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 118.291 1.046 . . . . 0.34999999999999998 112.151 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.486 HD13 HG11 ' A' ' 465' ' ' VAL . 2.2 mp -103.39 132.02 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 114.862 -1.063 . . . . 0.12 110.886 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -102.41 94.22 5.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.996 -1.002 . . . . 0.62 110.367 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.726 ' HA ' HG22 ' A' ' 368' ' ' ILE . 2.9 m -89.93 144.08 30.96 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 115.607 -0.724 . . . . 0.10000000000000001 112.554 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.678 ' HD2' HG21 ' A' ' 366' ' ' THR . 74.8 Cg_exo -51.68 147.22 24.71 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 123.945 3.097 . . . . 0.23999999999999999 113.33 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.718 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 27.1 Cg_exo -67.96 -26.24 37.74 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.006 2.471 . . . . 0.31 112.185 -175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.508 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 40.5 p -75.61 -25.4 56.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.078 -0.964 . . . . 1.1000000000000001 111.876 -176.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.804 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.6 m -99.93 -50.47 10.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.574 -0.739 . . . . 0.080000000000000002 112.896 -171.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.954 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.67 -2.34 4.8 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.729 -0.788 . . . . 0.070000000000000007 110.249 -178.035 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.648 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.1 pttp -81.09 -39.51 25.57 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.484 1.135 . . . . 0.92000000000000004 108.287 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.49 ' HG3' HD11 ' A' ' 364' ' ' LEU . 4.7 mm-40 -61.62 -46.84 88.09 Favored 'General case' 0 CA--C 1.47 -2.121 0 CA-C-N 112.319 -2.219 . . . . 0.25 106.571 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.954 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.52 -66.86 0.34 Allowed 'General case' 0 N--CA 1.4 -2.969 0 CA-C-N 109.649 -3.432 . . . . 0.050000000000000003 112.842 172.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.8 t80 -44.43 -24.79 0.2 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 124.135 0.897 . . . . 0.13 109.727 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.78 -30.35 15.44 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.341 -1.299 . . . . 0.13 111.762 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.784 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -97.8 -43.91 6.95 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 113.22 0.822 . . . . 0.059999999999999998 113.22 178.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -72.84 147.55 9.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 122.451 1.119 . . . . 0.080000000000000002 110.928 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.488 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -116.28 157.14 25.42 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 113.196 -1.82 . . . . 0.47999999999999998 108.909 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.652 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 5.6 mppt? -58.91 102.1 0.11 Allowed 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.573 -0.899 . . . . 0.98999999999999999 108.573 169.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.68 -12.13 5.95 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 114.102 -1.408 . . . . 0.19 111.525 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.688 HG21 ' HB ' ' A' ' 457' ' ' VAL . 16.2 m -67.12 150.16 98.07 Favored Pre-proline 0 N--CA 1.441 -0.923 0 N-CA-C 108.671 -0.863 . . . . 0.13 108.671 171.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.3 Cg_endo -93.87 161.03 2.23 Favored 'Trans proline' 0 N--CA 1.423 -2.647 0 C-N-CA 122.152 1.901 . . . . 0.17999999999999999 109.974 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.769 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -123.51 150.47 27.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 107.389 -1.337 . . . . 0.56999999999999995 107.389 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.748 HD21 ' CE1' ' A' ' 339' ' ' HIS . 5.4 mp -134.15 150.66 51.12 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.748 -0.834 . . . . 0.13 108.748 175.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.024 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -139.01 140.4 38.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 105.418 -2.067 . . . . 0.10000000000000001 105.418 165.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.612 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 10.8 p90 . . . . . 0 C--O 1.246 0.884 0 O-C-N 123.822 0.701 . . . . 1.0900000000000001 111.086 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.951 ' HBA' ' CAM' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 112.008 -0.437 . . . . 1.8700000000000001 112.008 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.744 ' CE1' HD21 ' A' ' 464' ' ' LEU . 0.3 OUTLIER -101.13 98.61 9.01 Favored 'General case' 0 CA--C 1.508 -0.636 0 O-C-N 122.703 -0.293 . . . . 0.83999999999999997 111.513 178.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.563 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.6 OUTLIER 65.19 -166.11 0.23 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.451 -0.795 . . . . 0.67000000000000004 112.43 167.131 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.4 171.43 2.48 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.511 -1.292 . . . . 1.8500000000000001 107.511 165.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.414 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 12.7 m-20 -79.74 83.36 5.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 118.843 -1.143 . . . . 0.42999999999999999 109.359 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.813 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 73.1 m -158.25 134.69 9.5 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.376 -1.284 . . . . 0.14000000000000001 108.983 168.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.697 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.6 p90 174.27 158.7 0.16 Allowed 'General case' 0 C--O 1.213 -0.865 0 O-C-N 123.478 0.486 . . . . 0.14999999999999999 110.855 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.658 HD11 HG11 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.65 152.48 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 109.002 -0.74 . . . . 0.080000000000000002 109.002 164.286 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.587 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 32.1 tt0 -149.94 143.61 25.35 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.42 -0.809 . . . . 2.0099999999999998 109.748 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.741 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.9 t -136.05 162.41 36.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.929 0.395 . . . . 0.45000000000000001 111.298 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.559 ' N ' HG12 ' A' ' 347' ' ' VAL . 35.0 t0 -140.13 106.76 5.34 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.162 -1.421 . . . . 0.23999999999999999 107.162 173.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.098 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.36 -33.5 28.79 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-O 122.71 1.243 . . . . 0.16 110.193 -168.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -57.07 -44.85 83.46 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 110.786 -2.915 . . . . 0.59999999999999998 108.192 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -101.95 5.64 40.89 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 110.906 -2.861 . . . . 0.20000000000000001 111.273 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.2 mp0 34.79 61.61 0.57 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 112.56 -2.109 . . . . 2.1499999999999999 113.085 -175.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.522 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.4 t60 -141.76 134.95 29.23 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.615 -0.72 . . . . 0.089999999999999997 109.818 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.752 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -113.24 156.31 23.53 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.733 -0.667 . . . . 0.070000000000000007 110.084 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.6 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.5 m-90 -142.26 154.75 45.01 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.443 -0.798 . . . . 0.11 111.037 -175.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.813 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 88.1 t80 -109.8 153.11 24.85 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 106.503 -1.665 . . . . 0.26000000000000001 106.503 151.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 8.1 m-85 -128.15 117.37 21.46 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 114.957 -1.019 . . . . 0.14000000000000001 110.28 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.3 tppt? -118.32 138.34 52.46 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.948 -1.871 . . . . 0.25 105.948 168.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 69.31 17.37 8.25 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.147 0.795 . . . . 0.42999999999999999 113.147 172.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.414 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.24 6.47 87.73 Favored Glycine 0 CA--C 1.488 -1.653 0 C-N-CA 120.705 -0.759 . . . . 0.17999999999999999 112.943 -174.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.6 ptmt -127.55 178.19 6.27 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 104.484 -2.413 . . . . 0.37 104.484 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.6 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.4 m -105.07 157.35 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.766 0 N-CA-C 116.21 1.93 . . . . 0.10000000000000001 116.21 -176.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.694 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.13 -27.62 9.98 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 110.461 -3.063 . . . . 0.070000000000000007 106.233 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.821 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.12 145.35 49.23 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 111.71 -2.495 . . . . 0.059999999999999998 111.919 -175.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.522 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 2.5 tt0 -141.55 118.12 10.95 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 104.514 -2.402 . . . . 0.47999999999999998 104.514 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.752 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.63 165.43 33.37 Favored 'General case' 0 N--CA 1.398 -3.034 0 C-N-CA 117.83 -1.548 . . . . 0.070000000000000007 111.533 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.407 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 30.1 p-10 -104.41 134.19 48.03 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 114.831 -1.077 . . . . 1.8 109.989 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.739 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -132.56 -172.44 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 CA-C-O 122.53 1.157 . . . . 0.12 112.326 -172.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.79 119.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 112.889 -1.959 . . . . 0.10000000000000001 108.207 172.401 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.531 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -77.84 -169.39 1.51 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.067 -1.424 . . . . 1.26 110.891 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.67 170.68 46.36 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 118.995 -1.574 . . . . 0.14000000000000001 112.127 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 9.1 ptpt -77.13 157.56 80.94 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.473 0.654 . . . . 0.81000000000000005 112.52 -164.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.681 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 66.3 Cg_exo -53.01 -29.84 46.22 Favored 'Trans proline' 0 CA--C 1.496 -1.405 1 C-N-CA 125.751 4.3 . . . . 0.28000000000000003 113.694 -173.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.447 ' OG1' HG22 ' A' ' 375' ' ' THR . 19.1 p -66.66 -33.29 75.32 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.424 -1.716 . . . . 0.33000000000000002 109.45 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.504 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.0 t -143.15 71.27 18.34 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 113.498 -1.683 . . . . 0.39000000000000001 109.536 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 375' ' ' THR . 88.9 Cg_exo -56.99 146.05 82.3 Favored 'Trans proline' 0 C--N 1.304 -1.774 1 C-N-CA 125.84 4.36 . . . . 0.38 113.181 -172.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.531 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -75.69 145.15 78.09 Favored Pre-proline 0 N--CA 1.423 -1.82 0 N-CA-C 108.306 -0.998 . . . . 0.81999999999999995 108.306 175.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.1 Cg_exo -75.44 -43.64 0.35 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 124.59 3.526 . . . . 0.19 111.775 -166.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.8 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 58.24 136.15 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 123.603 1.668 . . . . 0.13 113.639 -172.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.99 -126.54 2.0 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 111.969 -2.378 . . . . 0.20000000000000001 109.253 -176.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.477 HG22 HD21 ' A' ' 464' ' ' LEU . 71.3 t -121.15 108.63 23.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.204 0.526 . . . . 0.81999999999999995 110.714 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.76 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 1.8 m-85 -106.8 -174.36 2.52 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.771 -1.566 . . . . 0.22 106.771 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 1.9 t80 -139.56 123.32 17.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.982 1.265 . . . . 0.65000000000000002 113.071 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -90.51 92.5 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-O 123.035 1.398 . . . . 0.16 109.51 170.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -92.33 11.19 26.75 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.318 -1.765 . . . . 2.5499999999999998 108.291 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.775 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 25.0 t-20 -169.38 126.24 0.91 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.265 -1.334 . . . . 0.42999999999999999 110.352 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.672 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -102.52 140.04 37.32 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.774 -1.103 . . . . 1.1200000000000001 108.96 169.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.748 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 21.2 mm-40 -124.08 159.2 30.47 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.788 1.403 . . . . 0.70999999999999996 114.788 -167.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.727 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 49.8 mt-10 -129.2 146.34 51.14 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 112.701 -2.045 . . . . 0.38 106.552 165.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.8 t70 47.51 38.77 8.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 112.505 -2.134 . . . . 0.40999999999999998 110.603 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.914 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -78.93 166.88 21.89 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 112.663 -2.062 . . . . 0.12 109.318 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 19.9 m -131.29 119.43 21.74 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.29 1.043 . . . . 0.17000000000000001 111.229 171.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.0 mp -79.19 88.29 4.89 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.392 -1.731 . . . . 0.56999999999999995 111.917 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.547 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.1 mttt -102.5 178.03 4.7 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 113.658 -1.61 . . . . 0.33000000000000002 113.127 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.72 -157.47 24.17 Favored Glycine 0 N--CA 1.429 -1.829 0 CA-C-N 114.206 -1.361 . . . . 0.46000000000000002 111.653 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.5 m -118.4 137.85 52.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 120.564 -0.454 . . . . 0.70999999999999996 110.371 171.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 399' ' ' ASP . 2.2 m120 -53.9 149.42 8.93 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.572 -0.899 . . . . 0.83999999999999997 108.572 168.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -1.8 0.07 Allowed 'General case' 0 C--N 1.318 -0.777 0 O-C-N 123.754 0.659 . . . . 2.2799999999999998 112.156 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.4 OUTLIER -115.69 4.88 14.13 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.715 0.769 . . . . 2.27 110.027 -177.499 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.06 21.86 29.21 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 114.964 -1.016 . . . . 0.93999999999999995 113.133 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.457 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 8.6 p -116.39 101.2 53.81 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-O 121.479 0.657 . . . . 0.81000000000000005 109.965 -176.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 19.6 Cg_endo -59.15 149.47 80.01 Favored 'Trans proline' 0 CA--C 1.504 -1.008 0 C-N-CA 122.768 2.312 . . . . 0.63 113.392 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.444 ' OH ' ' HAD' ' A' ' 130' ' ' 1RG . 27.1 p90 -153.76 176.04 12.59 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.449 -1.25 . . . . 0.41999999999999998 113.092 -168.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.547 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.9 OUTLIER -145.71 148.21 32.77 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.833 -1.53 . . . . 0.53000000000000003 110.383 172.32 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.06 97.49 4.83 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 108.39 -0.967 . . . . 0.19 108.39 170.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.9 Cg_exo -68.66 111.41 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.715 0 C-N-CA 122.202 1.935 . . . . 0.19 110.3 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.92 160.3 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.31 -1.768 . . . . 0.14999999999999999 107.663 -168.108 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.727 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.8 m-80 -94.15 -19.61 20.62 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.902 -0.777 . . . . 0.51000000000000001 108.902 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.748 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 88.1 m-85 -158.94 125.95 4.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.892 -1.049 . . . . 0.27000000000000002 108.248 -171.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 18.2 t-105 -144.16 131.17 20.48 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.933 0.873 . . . . 0.089999999999999997 111.557 -166.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.672 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -111.94 93.91 22.86 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.44 -1.319 . . . . 0.14000000000000001 107.44 171.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.775 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.5 Cg_endo -68.39 67.91 1.06 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.308 2.005 . . . . 0.5 111.537 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.613 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.4 pt -68.48 175.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-O 121.613 0.721 . . . . 0.88 109.496 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.708 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 7.1 t70 -149.17 -166.19 2.49 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.75 -1.204 . . . . 2.4900000000000002 107.75 -170.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.708 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 6.3 m-90 83.83 -47.73 0.12 Allowed 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 123.985 0.803 . . . . 1.9199999999999999 110.791 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.436 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 43.1 p -128.56 -6.11 5.23 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.455 -0.793 . . . . 0.94999999999999996 112.389 -164.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 97.69 -30.69 8.85 Favored Glycine 0 CA--C 1.505 -0.544 0 C-N-CA 120.731 -0.747 . . . . 0.68000000000000005 112.313 176.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 419' ' ' GLY . 47.2 t -55.04 173.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 123.576 0.75 . . . . 0.75 111.584 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.613 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -173.08 120.98 0.84 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 109.875 -1.29 . . . . 0.20000000000000001 109.875 170.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.729 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -82.17 140.88 15.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.746 -0.465 . . . . 0.28999999999999998 109.746 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.669 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.1 p80 -159.18 161.03 36.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.197 -0.456 . . . . 0.089999999999999997 111.367 -174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.697 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.4 148.62 26.5 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.214 -1.032 . . . . 1.0700000000000001 108.214 172.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 445' ' ' THR . 40.4 t -133.24 96.38 3.73 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.726 0.774 . . . . 0.23000000000000001 109.75 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.23 -16.85 53.82 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.26 -1.336 . . . . 0.41999999999999998 109.204 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.779 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 12.0 p90 -88.25 -24.61 23.19 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.788 -1.551 . . . . 0.32000000000000001 111.247 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -97.96 113.46 63.81 Favored Pre-proline 0 CA--C 1.506 -0.726 0 CA-C-O 122.643 1.211 . . . . 1.74 110.416 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.475 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 41.8 Cg_endo -85.96 -10.07 7.22 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 124.241 3.294 . . . . 0.72999999999999998 112.92 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.574 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.9 pm0 -111.56 152.03 28.03 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 122.323 1.059 . . . . 2.1600000000000001 113.35 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.651 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.47 129.9 3.79 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 112.604 -2.089 . . . . 0.33000000000000002 105.74 172.405 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.61 -158.82 31.7 Favored Glycine 0 C--N 1.283 -2.4 0 C-N-CA 119.913 -1.136 . . . . 0.17000000000000001 110.834 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.506 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.21 174.21 0.01 OUTLIER Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.253 -0.975 . . . . 0.20999999999999999 111.526 167.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.524 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.3 p-10 -51.9 101.72 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 123.262 1.506 . . . . 1.8500000000000001 113.851 -153.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.735 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.93 -37.06 10.85 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 112.459 -2.155 . . . . 1.21 109.54 169.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.711 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -54.12 -27.25 32.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.235 -0.893 . . . . 0.16 112.395 -170.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.711 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.33 -33.82 15.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.48 0.657 . . . . 0.22 112.466 -177.419 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.7 p -92.09 -43.03 9.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.854 -1.066 . . . . 0.25 110.991 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.735 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.5 mtp180 -93.15 -18.97 21.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.772 -1.104 . . . . 1.8200000000000001 109.492 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.02 49.42 55.53 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 114.74 -1.118 . . . . 0.23999999999999999 115.022 163.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.0 m -82.39 110.62 17.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.784 1.292 . . . . 1.01 111.077 -172.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.502 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 44.6 m-70 38.98 -130.17 0.24 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.619 -1.173 . . . . 0.5 113.23 175.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 440' ' ' HIS . . . -122.31 -22.64 2.55 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.337 -0.459 . . . . 0.26000000000000001 113.247 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.601 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.5 p -102.44 -165.35 1.17 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 113.346 0.869 . . . . 0.34999999999999998 113.346 -173.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.491 ' CD1' HG11 ' A' ' 465' ' ' VAL . 1.9 mp -93.03 134.06 32.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.282 -0.872 . . . . 0.12 110.732 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -107.87 97.09 6.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.385 0.612 . . . . 0.62 110.113 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.739 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.2 m -93.35 144.85 28.94 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 114.726 -1.124 . . . . 0.10000000000000001 112.851 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.661 ' HD2' HG21 ' A' ' 366' ' ' THR . 72.6 Cg_exo -51.13 145.38 26.13 Favored 'Trans proline' 0 CA--C 1.507 -0.838 0 C-N-CA 123.98 3.12 . . . . 0.23999999999999999 113.391 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.697 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.6 Cg_exo -65.55 -26.15 54.58 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.909 2.406 . . . . 0.31 112.309 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.555 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 57.9 p -76.38 -25.29 54.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.794 0.807 . . . . 1.1000000000000001 111.998 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.821 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.7 m -99.6 -50.16 10.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.628 -0.714 . . . . 0.080000000000000002 112.766 -170.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.962 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.61 -2.15 4.5 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.754 -0.778 . . . . 0.070000000000000007 110.371 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 16.9 pttp -80.87 -38.68 27.7 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.521 1.153 . . . . 0.92000000000000004 108.201 173.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.491 ' HG3' HD11 ' A' ' 364' ' ' LEU . 4.1 mm-40 -62.69 -46.39 88.39 Favored 'General case' 0 CA--C 1.474 -1.968 0 CA-C-N 112.433 -2.167 . . . . 0.25 106.578 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.962 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.28 -66.06 0.47 Allowed 'General case' 0 N--CA 1.404 -2.752 0 CA-C-N 109.849 -3.341 . . . . 0.050000000000000003 112.712 172.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.462 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 24.0 t80 -45.72 -23.67 0.28 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 123.941 0.776 . . . . 0.13 109.56 176.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.452 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.82 -27.1 25.03 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.649 -1.159 . . . . 0.13 111.817 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.741 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.99 -43.83 5.66 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 113.57 0.952 . . . . 0.059999999999999998 113.57 177.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.688 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.4 OUTLIER -74.89 149.76 7.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.486 1.136 . . . . 0.080000000000000002 111.175 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -125.0 157.63 35.67 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 112.939 -1.937 . . . . 0.47999999999999998 108.245 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.658 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.1 mppt? -57.82 101.64 0.08 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 109.055 -0.72 . . . . 0.98999999999999999 109.055 172.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.85 -14.4 5.22 Favored Glycine 0 C--N 1.307 -1.082 0 CA-C-N 114.111 -1.404 . . . . 0.19 111.53 -175.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.688 HG21 ' HB ' ' A' ' 457' ' ' VAL . 17.8 m -66.63 149.27 98.32 Favored Pre-proline 0 N--CA 1.437 -1.076 0 N-CA-C 108.527 -0.916 . . . . 0.13 108.527 171.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.563 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 7.2 Cg_endo -94.39 164.19 1.94 Allowed 'Trans proline' 0 N--CA 1.419 -2.874 0 C-N-CA 122.159 1.906 . . . . 0.17999999999999999 109.769 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.76 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -126.6 151.65 33.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 107.741 -1.207 . . . . 0.56999999999999995 107.741 171.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.744 HD21 ' CE1' ' A' ' 339' ' ' HIS . 5.3 mp -134.6 151.27 50.96 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 109.079 -0.711 . . . . 0.13 109.079 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.098 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.38 142.81 30.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 105.604 -1.998 . . . . 0.10000000000000001 105.604 164.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.721 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 11.0 p90 . . . . . 0 C--O 1.244 0.785 0 CA-C-O 117.719 -1.134 . . . . 1.0900000000000001 111.562 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.732 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.721 -0.552 . . . . 1.8700000000000001 111.721 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.539 ' CE1' HD21 ' A' ' 464' ' ' LEU . 4.5 p-80 -123.02 101.49 7.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.485 0.55 . . . . 0.83999999999999997 112.485 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.572 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.3 OUTLIER 62.46 -166.82 0.21 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.976 -1.011 . . . . 0.67000000000000004 113.19 165.053 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.17 171.9 2.74 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.678 -1.23 . . . . 1.8500000000000001 107.678 165.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.09 83.64 7.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 118.935 -1.106 . . . . 0.42999999999999999 109.635 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 96.4 m -158.25 135.65 10.2 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.039 -1.437 . . . . 0.14000000000000001 108.901 167.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.667 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.8 p90 174.56 158.3 0.16 Allowed 'General case' 0 C--O 1.213 -0.847 0 O-C-N 123.415 0.447 . . . . 0.14999999999999999 111.383 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.683 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -78.03 151.68 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 109.126 -0.694 . . . . 0.080000000000000002 109.126 164.478 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.577 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.43 142.39 24.82 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.606 -0.725 . . . . 2.0099999999999998 109.641 -176.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.732 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.47 161.84 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.162 0.506 . . . . 0.45000000000000001 111.501 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.557 ' N ' HG12 ' A' ' 347' ' ' VAL . 31.8 t0 -140.3 106.47 5.23 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.18 -1.415 . . . . 0.23999999999999999 107.18 174.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.069 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.24 -32.63 29.63 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 122.807 1.289 . . . . 0.16 110.262 -168.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.73 -45.32 89.9 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.615 -2.993 . . . . 0.59999999999999998 108.304 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -100.6 7.03 44.25 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 111.106 -2.77 . . . . 0.20000000000000001 110.713 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.628 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 19.0 mp0 33.62 60.63 0.49 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 112.683 -2.053 . . . . 2.1499999999999999 113.0 -175.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.501 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 20.3 t60 -141.71 134.7 28.95 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.383 -0.826 . . . . 0.089999999999999997 109.73 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.723 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.63 155.97 24.53 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.569 -0.741 . . . . 0.070000000000000007 110.203 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.611 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.7 m-90 -141.46 155.19 45.87 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.153 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.696 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.0 t80 -110.16 153.18 25.09 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 106.659 -1.608 . . . . 0.26000000000000001 106.659 151.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 8.8 m-85 -128.99 116.13 18.85 Favored 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 115.026 -0.988 . . . . 0.14000000000000001 110.413 -177.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.0 tppt? -116.41 140.23 49.57 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.085 -1.82 . . . . 0.25 106.085 168.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.439 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 67.19 18.01 10.35 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.29 0.848 . . . . 0.42999999999999999 113.29 172.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.24 8.34 85.32 Favored Glycine 0 CA--C 1.487 -1.703 0 CA-C-N 115.671 -0.695 . . . . 0.17999999999999999 113.197 -173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 15.4 ptmt -127.12 177.92 6.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 104.792 -2.299 . . . . 0.37 104.792 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.611 HG11 ' CD1' ' A' ' 355' ' ' TRP . 14.8 m -105.11 157.32 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.732 0 N-CA-C 116.374 1.99 . . . . 0.10000000000000001 116.374 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.671 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.53 -27.48 9.87 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 110.484 -3.053 . . . . 0.070000000000000007 106.242 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.838 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.02 144.01 48.45 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 111.675 -2.511 . . . . 0.059999999999999998 111.723 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.475 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -141.23 118.02 11.06 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.388 -2.449 . . . . 0.47999999999999998 104.388 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.723 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.52 163.96 36.39 Favored 'General case' 0 N--CA 1.399 -2.995 0 C-N-CA 118.051 -1.46 . . . . 0.070000000000000007 111.363 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -102.19 132.9 47.82 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 114.341 -1.3 . . . . 1.8 109.531 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.752 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -131.72 -175.06 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 CA-C-O 122.448 1.118 . . . . 0.12 112.29 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -149.9 118.42 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 112.927 -1.942 . . . . 0.10000000000000001 108.123 171.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -78.84 -168.46 1.43 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.132 -1.394 . . . . 1.26 110.822 -176.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -83.62 164.94 41.87 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 118.66 -1.733 . . . . 0.14000000000000001 112.076 -173.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.431 ' HG3' ' OG1' ' A' ' 374' ' ' THR . 7.0 ptmt -71.03 155.88 92.74 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.861 0.838 . . . . 0.81000000000000005 111.998 -165.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.3 Cg_exo -54.96 -29.44 64.4 Favored 'Trans proline' 0 CA--C 1.496 -1.423 1 C-N-CA 125.502 4.135 . . . . 0.28000000000000003 113.488 -175.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.434 ' OG1' HG22 ' A' ' 375' ' ' THR . 14.9 p -69.71 -33.91 73.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.432 -1.713 . . . . 0.33000000000000002 109.476 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.519 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.8 t -142.49 70.67 21.17 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 123.71 1.719 . . . . 0.39000000000000001 109.527 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.5 Cg_exo -57.65 149.88 64.99 Favored 'Trans proline' 0 C--N 1.31 -1.448 1 C-N-CA 126.389 4.726 . . . . 0.38 114.582 -171.049 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.537 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -79.05 145.04 64.5 Favored Pre-proline 0 N--CA 1.427 -1.619 0 N-CA-C 108.629 -0.878 . . . . 0.81999999999999995 108.629 173.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 17.4 Cg_exo -77.01 -45.81 0.16 Allowed 'Trans proline' 0 CA--C 1.512 -0.586 0 C-N-CA 124.523 3.482 . . . . 0.19 112.163 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.797 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.27 137.13 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 123.298 1.523 . . . . 0.13 113.557 -172.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.54 -113.3 0.57 Allowed Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 112.003 -2.362 . . . . 0.20000000000000001 109.533 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 8.1 p -131.02 116.28 33.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.887 0.851 . . . . 0.81999999999999995 110.899 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.757 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.3 m-85 -116.22 -174.31 2.53 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.253 -1.388 . . . . 0.22 107.253 173.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 1.6 t80 -140.98 125.05 17.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 120.186 1.357 . . . . 0.65000000000000002 113.436 -172.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -91.12 92.23 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 123.181 1.467 . . . . 0.16 109.609 169.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -93.15 11.12 28.92 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.419 -1.719 . . . . 2.5499999999999998 108.11 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.75 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 27.6 t-20 -169.22 126.97 0.97 Allowed 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 113.952 -1.476 . . . . 0.42999999999999999 110.363 172.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.669 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -98.98 145.22 27.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.041 -0.981 . . . . 1.1200000000000001 108.927 169.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.739 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 11.3 mm-40 -125.08 158.16 34.49 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 114.888 1.44 . . . . 0.70999999999999996 114.888 -169.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.725 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 50.4 mt-10 -137.44 126.96 25.06 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.913 -1.949 . . . . 0.38 108.436 173.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 31.1 t70 54.16 50.73 15.87 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 123.248 1.499 . . . . 0.40999999999999998 109.082 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.946 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -84.04 166.69 17.51 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 112.83 -1.986 . . . . 0.12 109.27 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 21.7 m -132.7 118.81 19.56 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.204 1.002 . . . . 0.17000000000000001 111.793 171.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.46 88.72 5.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.585 -1.643 . . . . 0.56999999999999995 112.136 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.57 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.4 mttt -102.19 178.7 4.52 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 113.561 -1.654 . . . . 0.33000000000000002 113.14 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.32 -157.71 24.58 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 114.125 -1.398 . . . . 0.46000000000000002 111.385 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.8 m -118.46 139.88 50.72 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 120.106 -0.638 . . . . 0.70999999999999996 110.532 170.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.0 m-80 -57.17 153.13 12.35 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.592 -0.892 . . . . 0.83999999999999997 108.592 168.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -3.41 0.97 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.496 -0.775 . . . . 2.2799999999999998 110.844 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.2 OUTLIER -111.34 6.26 20.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.064 -0.971 . . . . 2.27 110.932 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.1 17.84 55.04 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.34 -0.933 . . . . 0.93999999999999995 112.486 169.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 9.4 p -113.19 100.65 52.02 Favored Pre-proline 0 C--N 1.302 -1.485 0 CA-C-N 114.377 -0.912 . . . . 0.81000000000000005 109.467 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.8 Cg_endo -57.09 153.74 37.24 Favored 'Trans proline' 0 CA--C 1.507 -0.858 0 C-N-CA 122.74 2.293 . . . . 0.63 112.791 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -154.83 173.88 15.86 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.906 -1.043 . . . . 0.41999999999999998 112.811 -171.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.57 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER -144.19 147.51 33.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.772 -1.558 . . . . 0.53000000000000003 110.051 171.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.66 97.47 5.01 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.376 -0.972 . . . . 0.19 108.376 171.567 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.0 Cg_exo -68.87 110.38 2.36 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 121.991 1.794 . . . . 0.19 110.045 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.946 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.76 154.87 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 CA-C-N 112.91 -1.95 . . . . 0.14999999999999999 107.521 -168.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.725 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 21.7 m-80 -87.11 -21.57 25.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.909 -0.774 . . . . 0.51000000000000001 108.909 -174.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 90.3 m-85 -157.59 127.61 6.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.959 -1.018 . . . . 0.27000000000000002 108.677 -170.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.678 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 23.3 t-105 -145.5 133.64 21.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.767 0.794 . . . . 0.089999999999999997 111.151 -167.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.669 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.3 mmt -114.96 93.26 33.86 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 107.747 -1.205 . . . . 0.14000000000000001 107.747 172.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.75 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.9 Cg_endo -67.71 70.4 0.75 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.527 2.151 . . . . 0.5 112.515 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.602 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.0 pt -69.18 175.58 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.401 -0.962 . . . . 0.88 108.401 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 416' ' ' THR . 33.7 t0 -149.48 -176.7 5.5 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.657 -1.217 . . . . 2.4900000000000002 112.838 -166.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.447 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 38.7 p90 58.03 -8.92 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.014 2.125 . . . . 1.9199999999999999 114.294 174.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.466 HG21 ' CD1' ' A' ' 382' ' ' PHE . 22.8 p -121.87 -14.56 8.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.126 0.489 . . . . 0.94999999999999996 110.775 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.434 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 97.19 -31.96 7.17 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.586 -0.734 . . . . 0.68000000000000005 111.286 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 419' ' ' GLY . 38.3 t -59.53 173.23 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 123.954 0.902 . . . . 0.75 111.891 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.602 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -177.82 121.51 0.78 Allowed Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.72 -1.352 . . . . 0.20000000000000001 109.72 170.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.69 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.0 mp -81.94 142.66 13.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 120.884 -0.326 . . . . 0.28999999999999998 110.158 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.678 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.6 p80 -159.42 160.99 35.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.336 -0.393 . . . . 0.089999999999999997 111.949 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.679 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -83.65 147.53 27.64 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.141 -1.059 . . . . 1.0700000000000001 108.141 172.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.59 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 2.6 t -133.62 98.94 4.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.633 1.206 . . . . 0.23000000000000001 110.514 -173.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.465 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 11.2 t70 -80.1 -9.88 59.73 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.69 -1.141 . . . . 0.41999999999999998 109.593 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.756 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 8.7 p90 -96.47 -25.01 15.83 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.527 -1.215 . . . . 0.32000000000000001 113.098 -173.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.652 ' OE1' ' HD2' ' A' ' 427' ' ' PRO . 0.0 OUTLIER -94.43 116.64 66.64 Favored Pre-proline 0 CA--C 1.509 -0.608 0 CA-C-O 122.726 1.25 . . . . 1.74 109.8 -179.343 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.664 ' HG2' ' OE2' ' A' ' 428' ' ' GLU . 81.4 Cg_endo -82.91 -23.24 3.86 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.228 3.285 . . . . 0.72999999999999998 114.407 -171.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.664 ' OE2' ' HG2' ' A' ' 427' ' ' PRO . 0.7 OUTLIER -112.01 155.42 23.81 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.303 1.049 . . . . 2.1600000000000001 112.346 172.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.484 ' HA ' HD23 ' A' ' 433' ' ' LEU . 3.3 m-85 -155.15 130.17 9.45 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 104.517 -2.401 . . . . 0.33000000000000002 104.517 171.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.31 -158.71 31.59 Favored Glycine 0 C--N 1.288 -2.096 0 N-CA-C 110.052 -1.219 . . . . 0.17000000000000001 110.052 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.484 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.52 174.54 0.01 OUTLIER Glycine 0 CA--C 1.501 -0.819 0 C-N-CA 120.442 -0.885 . . . . 0.20999999999999999 111.806 168.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.518 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.0 p-10 -50.91 101.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 123.496 1.617 . . . . 1.8500000000000001 113.597 -152.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.724 ' HG ' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.79 -38.54 10.27 Favored 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 112.316 -2.22 . . . . 1.21 109.642 170.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.715 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.8 p-90 -55.39 -27.28 46.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.608 -0.724 . . . . 0.16 112.505 -170.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.715 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -88.99 -33.02 17.33 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.717 0.77 . . . . 0.22 112.089 -177.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 7.0 p -89.79 -44.66 9.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.381 -1.281 . . . . 0.25 110.918 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.724 ' CD ' ' HG ' ' A' ' 433' ' ' LEU . 7.4 mtp85 -88.23 -19.23 27.12 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.45 -1.25 . . . . 1.8200000000000001 109.92 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.73 46.0 48.12 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.248 -1.342 . . . . 0.23999999999999999 113.327 164.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.0 m -84.45 110.39 18.61 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.32 -0.952 . . . . 1.01 111.837 -168.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.552 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 42.4 m-70 40.12 -129.73 0.36 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.343 -1.298 . . . . 0.5 113.056 176.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -124.44 -20.37 2.42 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.712 -0.756 . . . . 0.26000000000000001 113.547 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.65 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.7 p -103.77 -165.71 1.18 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 113.278 0.844 . . . . 0.34999999999999998 113.278 -173.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.476 HD13 HG11 ' A' ' 465' ' ' VAL . 1.9 mp -92.85 133.18 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 0.12 110.548 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -102.55 97.55 7.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.728 -0.669 . . . . 0.62 109.462 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.752 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.7 m -92.64 141.51 24.63 Favored Pre-proline 0 N--CA 1.437 -1.081 0 CA-C-N 115.51 -0.768 . . . . 0.10000000000000001 112.262 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.643 ' HD2' HG21 ' A' ' 366' ' ' THR . 64.0 Cg_exo -52.16 144.26 38.82 Favored 'Trans proline' 0 CA--C 1.499 -1.228 0 C-N-CA 123.975 3.117 . . . . 0.23999999999999999 114.786 175.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 80.3 Cg_exo -52.34 -55.02 4.22 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.301 2.001 . . . . 0.31 110.698 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.492 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 51.9 p -57.23 -23.82 50.59 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 112.251 -2.25 . . . . 1.1000000000000001 113.74 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.838 ' O ' HD21 ' A' ' 364' ' ' LEU . 27.1 m -98.24 -49.18 11.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 N-CA-C 113.019 0.748 . . . . 0.080000000000000002 113.019 -173.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.957 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.72 -2.11 6.43 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.52 -0.872 . . . . 0.070000000000000007 110.235 -178.391 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.56 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 14.7 pttp -80.98 -38.16 28.07 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 122.651 1.215 . . . . 0.92000000000000004 108.335 173.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.6 mm-40 -62.17 -46.32 89.49 Favored 'General case' 0 CA--C 1.471 -2.073 0 CA-C-N 112.387 -2.188 . . . . 0.25 106.53 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.957 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.09 -66.35 0.42 Allowed 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 109.837 -3.347 . . . . 0.050000000000000003 112.786 172.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.552 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.7 t80 -46.68 -22.78 0.33 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.673 0.749 . . . . 0.13 109.457 175.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.447 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.5 -22.46 37.08 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.059 -0.973 . . . . 0.13 111.819 -176.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.743 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -106.34 -44.21 4.59 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 113.777 1.028 . . . . 0.059999999999999998 113.777 175.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.66 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.52 148.97 8.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 122.44 1.114 . . . . 0.080000000000000002 111.275 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.11 156.63 29.41 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 113.048 -1.887 . . . . 0.47999999999999998 108.517 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.613 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 3.6 mppt? -59.07 101.75 0.1 Allowed 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.903 -0.777 . . . . 0.98999999999999999 108.903 171.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.7 -10.65 5.47 Favored Glycine 0 C--N 1.308 -1.019 0 CA-C-N 113.962 -1.472 . . . . 0.19 111.576 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.634 HG21 ' HB ' ' A' ' 457' ' ' VAL . 18.2 m -68.61 150.8 97.55 Favored Pre-proline 0 N--CA 1.443 -0.803 0 N-CA-C 109.073 -0.714 . . . . 0.13 109.073 171.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.572 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.4 Cg_endo -93.99 163.37 2.14 Favored 'Trans proline' 0 N--CA 1.425 -2.516 0 C-N-CA 122.428 2.085 . . . . 0.17999999999999999 110.128 176.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.757 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -126.87 149.89 32.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 107.668 -1.234 . . . . 0.56999999999999995 107.668 171.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.702 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.47 149.89 50.77 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.411 -0.959 . . . . 0.13 108.411 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.069 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -138.25 141.82 36.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 105.434 -2.062 . . . . 0.10000000000000001 105.434 165.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.764 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 10.2 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 117.723 -1.132 . . . . 1.0900000000000001 111.664 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.747 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.934 -0.466 . . . . 1.8700000000000001 111.934 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.565 ' CE1' HD21 ' A' ' 464' ' ' LEU . 2.0 p-80 -135.12 101.42 4.86 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 120.629 0.252 . . . . 0.83999999999999997 111.585 177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.56 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.6 OUTLIER 61.87 -165.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.309 -0.859 . . . . 0.67000000000000004 112.668 168.095 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.02 173.8 5.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.144 -1.428 . . . . 1.8500000000000001 107.144 164.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -80.5 84.23 6.15 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.286 -0.966 . . . . 0.42999999999999999 110.008 -174.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 357' ' ' TYR . 84.3 m -158.39 135.56 9.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.62 -1.173 . . . . 0.14000000000000001 109.067 168.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.696 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.7 p90 174.42 158.63 0.16 Allowed 'General case' 0 CA--C 1.503 -0.829 0 O-C-N 123.386 0.429 . . . . 0.14999999999999999 111.132 -175.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.659 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.92 152.33 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 109.106 -0.702 . . . . 0.080000000000000002 109.106 164.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.614 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.65 143.05 25.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.64 -0.709 . . . . 2.0099999999999998 109.551 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.725 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.59 162.16 37.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.027 0.441 . . . . 0.45000000000000001 111.378 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.558 ' N ' HG12 ' A' ' 347' ' ' VAL . 20.5 t0 -139.91 107.26 5.53 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.404 -1.332 . . . . 0.23999999999999999 107.404 172.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.034 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.51 -34.38 27.97 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 122.719 1.247 . . . . 0.16 110.52 -167.738 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.432 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.1 mt-10 -58.41 -45.26 88.75 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.871 -2.877 . . . . 0.59999999999999998 108.252 176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 19.4 m-80 -99.99 6.47 45.11 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 111.031 -2.804 . . . . 0.20000000000000001 110.889 -175.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 18.1 mp0 33.53 61.7 0.44 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 112.545 -2.116 . . . . 2.1499999999999999 113.11 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.8 t60 -141.92 135.18 29.18 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.612 -0.722 . . . . 0.089999999999999997 109.733 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.723 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -114.23 156.17 24.81 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.735 -0.666 . . . . 0.070000000000000007 110.233 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.576 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.0 m-90 -141.17 153.93 45.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.373 -0.831 . . . . 0.11 111.269 -174.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.684 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 86.1 t80 -109.76 153.21 24.66 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 106.599 -1.63 . . . . 0.26000000000000001 106.599 151.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.5 m-85 -129.25 116.61 19.4 Favored 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 114.699 -1.137 . . . . 0.14000000000000001 110.226 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.5 tppt? -115.88 137.3 52.23 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.703 -1.962 . . . . 0.25 105.703 167.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.423 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.73 18.31 8.72 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.61 0.967 . . . . 0.42999999999999999 113.61 172.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.31 8.1 86.99 Favored Glycine 0 CA--C 1.487 -1.697 0 CA-C-O 121.779 0.655 . . . . 0.17999999999999999 113.015 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 15.8 ptmt -128.13 176.95 7.25 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 104.569 -2.382 . . . . 0.37 104.569 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.4 m -104.38 157.86 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.611 0 N-CA-C 116.289 1.959 . . . . 0.10000000000000001 116.289 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.684 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.87 -26.61 9.7 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 110.516 -3.038 . . . . 0.070000000000000007 106.646 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.803 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.84 144.96 47.88 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 111.669 -2.514 . . . . 0.059999999999999998 111.753 -175.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.508 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 5.8 tt0 -139.92 118.15 12.0 Favored 'General case' 0 N--CA 1.408 -2.53 0 N-CA-C 104.411 -2.44 . . . . 0.47999999999999998 104.411 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.723 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.09 163.39 38.31 Favored 'General case' 0 N--CA 1.4 -2.971 0 C-N-CA 117.466 -1.693 . . . . 0.070000000000000007 111.917 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 18.1 p-10 -103.02 134.33 46.64 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-N 114.293 -1.321 . . . . 1.8 109.57 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.89 -172.34 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 CA-C-O 122.508 1.147 . . . . 0.12 112.414 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.532 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.23 120.89 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 112.832 -1.985 . . . . 0.10000000000000001 108.423 172.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.521 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.86 -168.14 1.5 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.315 -1.311 . . . . 1.26 110.708 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -83.96 170.33 47.42 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 118.907 -1.616 . . . . 0.14000000000000001 112.152 -173.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -78.6 162.89 63.99 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 113.109 0.781 . . . . 0.81000000000000005 113.109 -162.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.731 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 74.9 Cg_exo -54.84 -37.53 92.57 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 C-N-CA 123.058 2.505 . . . . 0.28000000000000003 112.56 -175.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.42 ' OG1' HG22 ' A' ' 375' ' ' THR . 25.2 p -66.06 -33.96 76.98 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.337 -1.301 . . . . 0.33000000000000002 110.085 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.523 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.5 t -141.56 72.69 25.1 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-O 123.69 1.709 . . . . 0.39000000000000001 109.743 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 375' ' ' THR . 74.3 Cg_exo -61.37 160.5 27.04 Favored 'Trans proline' 0 C--N 1.311 -1.423 1 C-N-CA 126.345 4.697 . . . . 0.38 114.346 -173.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.521 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -91.55 144.71 29.99 Favored Pre-proline 0 N--CA 1.42 -1.96 0 N-CA-C 108.305 -0.998 . . . . 0.81999999999999995 108.305 171.355 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 20.4 Cg_exo -76.44 -43.88 0.27 Allowed 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 124.844 3.696 . . . . 0.19 112.139 -168.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.785 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.96 134.6 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.488 1.613 . . . . 0.13 113.562 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 155.14 -116.15 0.71 Allowed Glycine 0 N--CA 1.429 -1.791 0 CA-C-N 111.959 -2.382 . . . . 0.20000000000000001 109.627 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 381' ' ' VAL . 8.4 p -130.34 115.69 33.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.861 0.839 . . . . 0.81999999999999995 110.899 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.743 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.7 m-85 -115.36 -174.01 2.43 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.34 -1.355 . . . . 0.22 107.34 174.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 0.8 OUTLIER -139.65 123.49 17.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.881 1.219 . . . . 0.65000000000000002 113.268 -171.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -91.74 91.67 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 CA-C-O 123.189 1.471 . . . . 0.16 109.39 168.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -93.44 10.58 31.74 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 113.106 -1.861 . . . . 2.5499999999999998 107.908 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.757 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.7 t30 -168.78 125.6 0.98 Allowed 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 113.774 -1.557 . . . . 0.42999999999999999 109.939 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.651 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.9 143.52 30.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.902 -1.044 . . . . 1.1200000000000001 108.86 169.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.785 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 20.4 mm-40 -125.17 155.18 40.36 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 114.441 1.274 . . . . 0.70999999999999996 114.441 -168.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.775 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 41.0 mt-10 -136.86 126.55 25.45 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 112.947 -1.933 . . . . 0.38 108.287 171.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.6 t70 57.56 53.34 7.43 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 123.459 1.6 . . . . 0.40999999999999998 109.144 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.914 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -89.29 166.38 13.81 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 112.451 -2.159 . . . . 0.12 108.501 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 31.6 m -132.93 120.03 20.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.092 0.949 . . . . 0.17000000000000001 111.862 171.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.755 HD11 HG21 ' A' ' 407' ' ' VAL . 8.9 mt -75.75 88.29 2.81 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.828 -1.533 . . . . 0.56999999999999995 112.796 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.54 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 44.9 mttt -105.18 177.59 4.81 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.492 -1.231 . . . . 0.33000000000000002 113.751 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.68 -159.77 25.02 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.163 -1.381 . . . . 0.46000000000000002 111.55 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.676 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.3 m -115.98 139.54 50.15 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.361 -0.536 . . . . 0.70999999999999996 110.454 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' A' ' 399' ' ' ASP . 2.4 m120 -56.88 152.94 11.8 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.136 -0.69 . . . . 0.83999999999999997 109.136 168.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -0.1 0.22 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.688 -0.687 . . . . 2.2799999999999998 111.646 176.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 397' ' ' ASN . 33.8 t70 -115.42 0.93 13.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.893 0.854 . . . . 2.27 110.364 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.55 17.28 34.06 Favored Glycine 0 N--CA 1.428 -1.887 0 CA-C-N 114.851 -1.068 . . . . 0.93999999999999995 112.971 171.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.436 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 7.7 p -112.47 101.14 51.95 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-O 121.57 0.7 . . . . 0.81000000000000005 109.913 -175.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.6 Cg_endo -58.5 150.41 68.85 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 122.712 2.275 . . . . 0.63 112.965 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 21.2 p90 -150.47 171.96 16.22 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.57 -1.196 . . . . 0.41999999999999998 113.054 -169.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.54 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -147.15 146.17 29.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.906 -1.497 . . . . 0.53000000000000003 110.07 172.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.647 ' O ' ' HG ' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.98 97.54 4.85 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.304 -0.998 . . . . 0.19 108.304 171.22 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 14.4 Cg_exo -70.27 108.21 2.13 Favored 'Trans proline' 0 N--CA 1.432 -2.127 0 C-N-CA 121.023 1.149 . . . . 0.19 110.016 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -106.22 152.4 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.285 0 CA-C-N 112.816 -1.993 . . . . 0.14999999999999999 108.55 -169.202 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.775 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 3.1 m-20 -86.08 -19.17 30.64 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.753 -0.832 . . . . 0.51000000000000001 108.753 -174.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.785 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.4 m-85 -158.05 126.02 5.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.378 -0.828 . . . . 0.27000000000000002 108.938 -171.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.675 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 21.4 t-105 -144.94 134.24 22.96 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.705 0.764 . . . . 0.089999999999999997 111.18 -167.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.651 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.1 mmt -116.44 93.64 40.59 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.746 -1.205 . . . . 0.14000000000000001 107.746 172.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.757 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.6 Cg_endo -68.13 67.68 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.532 2.154 . . . . 0.5 112.95 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.592 HG12 ' HA2' ' A' ' 419' ' ' GLY . 2.1 pt -67.24 174.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.552 -0.906 . . . . 0.88 108.552 176.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 416' ' ' THR . 3.5 t70 -150.88 -173.23 4.42 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 118.761 -1.176 . . . . 2.4900000000000002 112.771 -166.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.435 ' CZ2' ' HB2' ' A' ' 383' ' ' TYR . 35.9 p90 52.88 -0.43 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.01 2.124 . . . . 1.9199999999999999 114.633 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.449 HG21 ' CD1' ' A' ' 382' ' ' PHE . 37.1 p -130.63 -11.43 3.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.949 0.404 . . . . 0.94999999999999996 111.116 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.537 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 97.14 -36.11 4.08 Favored Glycine 0 CA--C 1.503 -0.688 0 N-CA-C 111.094 -0.803 . . . . 0.68000000000000005 111.094 177.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 419' ' ' GLY . 36.0 t -58.97 172.66 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.126 0.97 . . . . 0.75 112.298 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.593 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.71 120.74 0.72 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.861 -1.296 . . . . 0.20000000000000001 109.861 170.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.686 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.43 141.83 14.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 110.041 -0.355 . . . . 0.28999999999999998 110.041 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.675 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.2 p80 -157.92 161.21 38.22 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 116.091 -0.504 . . . . 0.089999999999999997 111.173 -174.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.699 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.2 OUTLIER -84.18 148.16 26.91 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.178 -1.045 . . . . 1.0700000000000001 108.178 172.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 445' ' ' THR . 45.9 t -134.18 96.1 3.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.707 0.765 . . . . 0.23000000000000001 109.844 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 19.6 t70 -82.39 -19.66 38.7 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.3 -1.318 . . . . 0.41999999999999998 109.921 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.765 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 14.2 p90 -84.39 -22.13 30.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.182 -1.372 . . . . 0.32000000000000001 111.239 -176.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.431 ' HG2' ' OE2' ' A' ' 428' ' ' GLU . 0.5 OUTLIER -100.38 115.66 65.2 Favored Pre-proline 0 CA--C 1.506 -0.725 0 CA-C-O 122.704 1.24 . . . . 1.74 110.032 -179.447 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.534 ' HG2' ' OE1' ' A' ' 428' ' ' GLU . 44.8 Cg_endo -86.15 -10.71 6.7 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.271 3.314 . . . . 0.72999999999999998 113.231 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.599 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.4 pm0 -111.6 153.93 25.6 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 122.39 1.091 . . . . 2.1600000000000001 113.242 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.632 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.04 130.88 4.3 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 104.93 -2.248 . . . . 0.33000000000000002 104.93 170.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.46 -158.63 31.62 Favored Glycine 0 C--N 1.284 -2.35 0 C-N-CA 119.806 -1.188 . . . . 0.17000000000000001 110.792 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.35 175.33 0.01 OUTLIER Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 120.519 -0.848 . . . . 0.20999999999999999 111.713 167.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.489 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 7.8 p-10 -50.58 101.8 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 123.473 1.606 . . . . 1.8500000000000001 113.445 -153.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.73 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -97.13 -37.69 10.02 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 112.639 -2.073 . . . . 1.21 109.478 169.237 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.744 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -54.13 -28.04 37.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.36 -0.836 . . . . 0.16 112.286 -170.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.744 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.67 -35.07 15.16 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.697 0.629 . . . . 0.22 112.697 -178.029 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.2 p -90.98 -40.86 11.43 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.262 -0.881 . . . . 0.25 111.014 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.73 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -95.49 -17.21 21.65 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.646 -1.161 . . . . 1.8200000000000001 109.693 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.76 50.11 51.1 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.91 -1.041 . . . . 0.23999999999999999 115.22 161.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.8 m -82.06 109.82 16.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.923 1.362 . . . . 1.01 110.845 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.424 ' HB2' ' OAC' ' A' ' 130' ' ' 1RG . 67.8 m-70 32.59 -112.16 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.467 -1.242 . . . . 0.5 113.418 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -140.49 -14.6 0.52 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.898 -0.592 . . . . 0.26000000000000001 113.767 -174.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.852 ' HB3' HASB ' A' ' 130' ' ' 1RG . 28.8 p -104.59 -166.32 1.23 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 117.75 0.775 . . . . 0.34999999999999998 112.467 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.438 ' CD1' HG11 ' A' ' 465' ' ' VAL . 2.1 mp -96.65 129.63 46.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.839 -1.073 . . . . 0.12 110.465 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -101.55 93.15 5.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.815 -0.629 . . . . 0.62 110.123 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.726 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -89.15 142.98 30.44 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.936 -1.029 . . . . 0.10000000000000001 112.731 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.657 ' HD2' HG21 ' A' ' 366' ' ' THR . 75.0 Cg_exo -50.16 146.47 17.72 Favored 'Trans proline' 0 CA--C 1.507 -0.857 0 C-N-CA 124.15 3.234 . . . . 0.23999999999999999 113.323 174.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.699 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.3 Cg_exo -67.33 -25.07 42.65 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.887 2.392 . . . . 0.31 111.834 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.511 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 40.4 p -76.61 -26.09 54.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.94 -1.027 . . . . 1.1000000000000001 112.036 -175.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.803 ' O ' HD21 ' A' ' 364' ' ' LEU . 33.4 m -99.27 -49.75 11.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 112.806 0.669 . . . . 0.080000000000000002 112.806 -170.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.954 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.51 -2.25 4.49 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.743 -0.783 . . . . 0.070000000000000007 110.409 -178.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 40.9 pttt -81.29 -38.74 26.33 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 122.518 1.151 . . . . 0.92000000000000004 108.335 173.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.1 mm-40 -62.94 -46.7 86.52 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 112.47 -2.15 . . . . 0.25 106.688 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.954 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -46.68 -67.16 0.31 Allowed 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 109.906 -3.316 . . . . 0.050000000000000003 112.736 172.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.527 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 16.4 t80 -44.91 -24.85 0.25 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 124.191 0.932 . . . . 0.13 109.39 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -87.57 -30.12 19.58 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.551 -1.204 . . . . 0.13 111.607 -175.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.753 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -98.27 -44.12 6.69 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 113.21 0.818 . . . . 0.059999999999999998 113.21 178.069 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -73.75 147.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 122.558 1.17 . . . . 0.080000000000000002 111.126 179.402 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.61 156.58 27.9 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 112.809 -1.996 . . . . 0.47999999999999998 108.473 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 42.4 mtmt -55.76 102.73 0.08 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.699 -0.682 . . . . 0.98999999999999999 109.517 169.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.79 -13.22 5.85 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 113.792 -1.549 . . . . 0.19 111.779 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.665 HG21 ' HB ' ' A' ' 457' ' ' VAL . 17.3 m -64.85 150.1 95.29 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 108.996 -0.742 . . . . 0.13 108.996 173.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.56 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.1 Cg_endo -93.62 160.33 2.36 Favored 'Trans proline' 0 N--CA 1.424 -2.616 0 C-N-CA 122.331 2.021 . . . . 0.17999999999999999 109.962 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.743 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -124.6 149.87 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.317 -1.364 . . . . 0.56999999999999995 107.317 171.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.696 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.6 mp -134.42 149.99 50.82 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.339 -0.986 . . . . 0.13 108.339 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.034 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.82 140.95 40.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 105.647 -1.983 . . . . 0.10000000000000001 105.647 166.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.683 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 5.4 p90 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 117.649 -1.167 . . . . 1.0900000000000001 111.139 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.852 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.61 0 N-CA-C 112.167 -0.373 . . . . 1.8700000000000001 112.167 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.566 ' CE1' HD21 ' A' ' 464' ' ' LEU . 1.5 p-80 -139.21 102.61 4.55 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 111.805 0.298 . . . . 0.83999999999999997 111.805 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.537 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.5 OUTLIER 60.79 -162.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 O-C-N 124.023 0.827 . . . . 0.67000000000000004 112.762 167.136 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.24 172.77 6.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.221 -1.399 . . . . 1.8500000000000001 107.221 163.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.505 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 4.6 m-20 -80.06 83.97 5.86 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 119.246 -0.982 . . . . 0.42999999999999999 109.993 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.782 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 53.2 m -156.86 132.71 9.54 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.358 -1.292 . . . . 0.14000000000000001 108.268 167.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.758 ' CD2' HD13 ' A' ' 464' ' ' LEU . 42.9 p90 174.73 158.38 0.17 Allowed 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 123.421 0.451 . . . . 0.14999999999999999 111.002 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.658 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.34 153.71 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.387 -0.598 . . . . 0.080000000000000002 109.387 165.364 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.71 146.63 28.21 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.826 -1.175 . . . . 2.0099999999999998 107.826 -178.488 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.748 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.4 155.03 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 C-N-CA 123.579 0.752 . . . . 0.45000000000000001 110.618 173.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.524 ' N ' HG12 ' A' ' 347' ' ' VAL . 48.0 t0 -137.19 105.33 5.69 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.255 -1.757 . . . . 0.23999999999999999 106.255 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.058 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -79.62 -35.83 38.89 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 123.11 1.433 . . . . 0.16 110.019 -166.039 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.04 -44.98 79.33 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 110.682 -2.963 . . . . 0.59999999999999998 108.037 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -101.02 7.1 43.62 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 110.815 -2.902 . . . . 0.20000000000000001 110.893 -174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 21.6 mp0 32.78 61.44 0.38 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 112.628 -2.078 . . . . 2.1499999999999999 112.928 -175.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.508 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 24.1 t60 -141.94 135.77 29.73 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.77 -0.65 . . . . 0.089999999999999997 109.837 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.777 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.65 157.26 22.38 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.91 -0.586 . . . . 0.070000000000000007 110.155 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.666 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -142.68 160.06 41.04 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.81 -0.632 . . . . 0.11 111.254 -177.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.782 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.6 t80 -112.3 153.9 26.49 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 106.45 -1.685 . . . . 0.26000000000000001 106.45 150.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.5 m-85 -127.51 119.21 25.55 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 115.119 -0.946 . . . . 0.14000000000000001 110.126 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.4 tppt? -120.47 134.88 55.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.124 -1.806 . . . . 0.25 106.124 168.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 72.98 16.32 4.41 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 113.216 0.821 . . . . 0.42999999999999999 113.216 172.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.505 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.68 6.79 88.35 Favored Glycine 0 CA--C 1.486 -1.767 0 C-N-CA 120.995 -0.621 . . . . 0.17999999999999999 113.05 -172.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.3 ptmt -128.49 176.39 7.78 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 104.872 -2.269 . . . . 0.37 104.872 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.666 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.4 m -104.83 156.89 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 116.597 2.073 . . . . 0.10000000000000001 116.597 -175.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.708 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.76 -27.34 10.34 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 110.672 -2.967 . . . . 0.070000000000000007 106.599 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.792 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.9 145.39 49.57 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 111.405 -2.634 . . . . 0.059999999999999998 111.301 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.486 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -142.1 118.08 10.6 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 104.504 -2.406 . . . . 0.47999999999999998 104.504 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.777 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.3 164.87 33.64 Favored 'General case' 0 N--CA 1.402 -2.857 0 C-N-CA 117.997 -1.481 . . . . 0.070000000000000007 111.803 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.585 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 12.2 p-10 -102.95 132.69 49.0 Favored 'General case' 0 N--CA 1.41 -2.458 0 CA-C-N 114.109 -1.405 . . . . 1.8 109.791 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.741 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.02 -173.48 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-O 122.522 1.153 . . . . 0.12 112.425 -171.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.09 120.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 112.719 -2.037 . . . . 0.10000000000000001 108.123 172.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.478 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -78.73 -168.6 1.45 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.23 -1.35 . . . . 1.26 110.325 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.553 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.16 170.51 45.15 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 118.601 -1.761 . . . . 0.14000000000000001 112.631 -173.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.5 ptmt -72.96 155.28 90.6 Favored Pre-proline 0 C--O 1.218 -0.603 0 CA-C-O 121.42 0.629 . . . . 0.81000000000000005 111.576 -166.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.664 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 77.9 Cg_exo -55.04 -28.29 59.37 Favored 'Trans proline' 0 CA--C 1.497 -1.326 0 C-N-CA 125.243 3.962 . . . . 0.28000000000000003 113.665 -173.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.44 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 26.2 p -72.6 -32.28 65.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.621 -1.627 . . . . 0.33000000000000002 109.586 -176.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.616 ' HB ' ' CAZ' ' A' ' 130' ' ' 1RG . 0.4 OUTLIER -141.37 70.56 26.93 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-O 123.426 1.584 . . . . 0.39000000000000001 110.127 178.577 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 375' ' ' THR . 76.1 Cg_exo -59.4 157.5 30.85 Favored 'Trans proline' 0 C--N 1.311 -1.406 1 C-N-CA 126.309 4.673 . . . . 0.38 113.996 -172.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.487 HG21 ' HG ' ' A' ' 349' ' ' LEU . 0.5 OUTLIER -84.97 147.74 48.93 Favored Pre-proline 0 N--CA 1.422 -1.875 0 N-CA-C 108.198 -1.038 . . . . 0.81999999999999995 108.198 174.212 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 15.5 Cg_exo -77.6 -42.39 0.27 Allowed 'Trans proline' 0 CA--C 1.514 -0.505 0 C-N-CA 124.124 3.216 . . . . 0.19 112.363 -166.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 54.99 137.83 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 123.604 1.668 . . . . 0.13 114.487 -173.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.75 -109.91 0.44 Allowed Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 111.997 -2.365 . . . . 0.20000000000000001 109.549 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.75 124.32 56.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.328 0.585 . . . . 0.81999999999999995 109.724 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.748 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 4.7 m-85 -123.65 -174.45 2.97 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.497 -1.297 . . . . 0.22 107.497 172.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.0 OUTLIER -139.85 123.22 17.07 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 119.471 1.032 . . . . 0.65000000000000002 112.953 -171.072 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.84 91.14 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-O 123.296 1.522 . . . . 0.16 109.032 169.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -93.9 11.82 28.14 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 112.978 -1.919 . . . . 2.5499999999999998 107.873 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.744 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.9 t30 -168.49 124.9 1.01 Allowed 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 113.627 -1.624 . . . . 0.42999999999999999 110.009 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.646 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.19 143.53 31.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.086 -0.961 . . . . 1.1200000000000001 108.949 170.213 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.758 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 37.1 mm-40 -126.95 158.46 36.77 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 114.961 1.467 . . . . 0.70999999999999996 114.961 -167.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 43.6 mt-10 -138.75 126.65 22.34 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.194 -1.821 . . . . 0.38 108.796 174.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 18.6 t70 52.15 51.88 15.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 123.165 1.459 . . . . 0.40999999999999998 109.231 -173.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.924 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -82.92 167.46 17.97 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.764 -2.016 . . . . 0.12 109.005 176.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 15.8 m -132.93 120.53 21.58 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.863 0.84 . . . . 0.17000000000000001 111.291 169.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.6 mp -78.02 87.2 4.18 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.969 -1.468 . . . . 0.56999999999999995 111.417 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.553 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 45.8 mttt -105.7 -179.49 3.96 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.393 -1.731 . . . . 0.33000000000000002 113.573 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.49 -162.21 25.76 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.689 -1.596 . . . . 0.46000000000000002 110.619 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.5 m -117.61 138.84 51.68 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 119.926 -0.71 . . . . 0.70999999999999996 109.914 168.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 399' ' ' ASP . 2.7 m120 -55.02 144.73 22.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 106.57 -1.641 . . . . 0.83999999999999997 106.57 165.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ASP . . . . . 0.457 ' HB2' ' CBD' ' A' ' 130' ' ' 1RG . 0.1 OUTLIER -60.02 -2.61 0.44 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.154 0.502 . . . . 2.2799999999999998 111.542 179.304 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 397' ' ' ASN . 4.0 t70 -106.92 1.72 24.76 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.273 -0.876 . . . . 2.27 109.693 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.53 20.13 27.9 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.625 -1.17 . . . . 0.93999999999999995 113.029 168.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 7.1 p -113.36 97.92 44.79 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 114.688 -0.756 . . . . 0.81000000000000005 109.675 -176.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.4 Cg_endo -59.73 150.24 78.2 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 C-N-CA 122.794 2.33 . . . . 0.63 112.778 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -151.37 170.44 19.55 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.3 -1.318 . . . . 0.41999999999999998 112.063 -170.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.553 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -148.57 146.41 28.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.094 -1.412 . . . . 0.53000000000000003 110.798 175.283 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.9 OUTLIER -145.14 97.32 4.82 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 108.305 -0.998 . . . . 0.19 108.305 170.71 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.2 Cg_exo -68.73 111.26 2.55 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 122.089 1.859 . . . . 0.19 110.49 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.924 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -112.74 151.21 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 CA-C-N 113.206 -1.815 . . . . 0.14999999999999999 107.993 -167.725 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.709 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 3.9 m-20 -85.12 -19.53 31.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.789 -0.819 . . . . 0.51000000000000001 108.789 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 97.5 m-85 -159.69 126.62 4.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.404 -0.961 . . . . 0.27000000000000002 108.404 -170.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.69 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 19.1 t-105 -144.14 136.04 26.22 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.7 0.762 . . . . 0.089999999999999997 111.174 -166.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.646 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.1 mmt -118.99 91.26 42.96 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.855 -1.165 . . . . 0.14000000000000001 107.855 173.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.744 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 35.7 Cg_endo -66.35 83.41 0.28 Allowed 'Trans proline' 0 CA--C 1.514 -0.521 0 C-N-CA 122.387 2.058 . . . . 0.5 111.289 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.606 HG12 ' HA2' ' A' ' 419' ' ' GLY . 4.2 pt -82.74 -178.95 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 115.708 -0.678 . . . . 0.88 109.287 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.679 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 18.1 t70 -148.3 -166.36 2.52 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.658 -0.867 . . . . 2.4900000000000002 108.658 -167.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.679 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 5.9 m-90 86.38 -58.54 0.06 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.927 0.767 . . . . 1.9199999999999999 111.451 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 27.9 p -123.38 -29.94 3.74 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.57 0.952 . . . . 0.94999999999999996 113.57 -163.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 133.03 -32.82 2.69 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 120.252 -0.975 . . . . 0.68000000000000005 111.788 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.699 HG11 ' CE2' ' A' ' 382' ' ' PHE . 2.4 p -53.73 170.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.277 -0.961 . . . . 0.75 112.244 177.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.606 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -174.05 124.0 1.0 Allowed Glycine 0 CA--C 1.497 -1.092 0 N-CA-C 110.355 -1.098 . . . . 0.20000000000000001 110.355 172.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.674 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.4 mp -81.7 142.8 13.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.8 0.333 . . . . 0.28999999999999998 110.453 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.69 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.1 p80 -160.63 162.31 32.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.841 -0.618 . . . . 0.089999999999999997 110.924 -175.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.693 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.2 OUTLIER -86.65 148.32 25.51 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.731 -1.211 . . . . 1.0700000000000001 107.731 172.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 445' ' ' THR . 45.3 t -133.05 96.71 3.83 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.803 0.811 . . . . 0.23000000000000001 109.943 -170.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.29 -15.16 56.3 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.134 -1.394 . . . . 0.41999999999999998 109.445 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.771 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 10.0 p90 -89.83 -20.5 23.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.164 -1.38 . . . . 0.32000000000000001 111.452 -176.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.555 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 1.9 tt0 -101.82 116.71 62.98 Favored Pre-proline 0 CA--C 1.508 -0.659 0 CA-C-O 122.622 1.201 . . . . 1.74 110.419 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.542 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 42.9 Cg_endo -86.67 -11.34 5.83 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 124.228 3.285 . . . . 0.72999999999999998 113.616 -173.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.622 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.2 pm0 -111.3 150.64 29.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.304 1.049 . . . . 2.1600000000000001 113.018 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.66 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -156.6 132.87 9.89 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 105.456 -2.054 . . . . 0.33000000000000002 105.456 167.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.14 -159.06 32.14 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 110.497 -1.041 . . . . 0.17000000000000001 110.497 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.503 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -46.8 175.34 0.01 OUTLIER Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.372 -0.918 . . . . 0.20999999999999999 111.71 168.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.538 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 10.1 p-10 -51.69 101.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.453 1.597 . . . . 1.8500000000000001 113.733 -155.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 1.044 HD22 ' HD2' ' A' ' 437' ' ' ARG . 35.6 mt -97.86 -35.34 10.53 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 112.038 -2.347 . . . . 1.21 109.467 170.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.701 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.0 p-90 -53.07 -26.95 17.85 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.012 -0.994 . . . . 0.16 112.071 -172.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.701 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.28 -35.77 15.09 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.611 -0.722 . . . . 0.22 112.482 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.8 p -88.51 -37.71 15.54 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.468 -0.787 . . . . 0.25 110.617 -176.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 1.044 ' HD2' HD22 ' A' ' 433' ' ' LEU . 0.4 OUTLIER -99.25 -19.64 16.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.676 -1.147 . . . . 1.8200000000000001 110.715 -178.382 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.34 49.62 50.42 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 115.988 1.155 . . . . 0.23999999999999999 115.988 162.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.1 m -82.3 111.07 18.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 119.745 1.773 . . . . 1.01 111.105 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 37.74 -113.64 0.11 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.635 0.976 . . . . 0.5 113.635 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.62 ' HA3' ' SAK' ' A' ' 130' ' ' 1RG . . . -142.91 -14.87 0.31 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.62 -0.718 . . . . 0.26000000000000001 113.838 -173.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.562 ' HB3' HASB ' A' ' 130' ' ' 1RG . 26.4 p -101.56 -167.31 1.4 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.994 0.897 . . . . 0.34999999999999998 112.233 -177.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.46 HG12 HG11 ' A' ' 347' ' ' VAL . 2.3 mp -99.31 128.35 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 115.096 -0.956 . . . . 0.12 110.751 -174.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -100.32 92.37 5.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.577 -0.738 . . . . 0.62 110.234 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.741 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.1 m -88.1 143.3 32.77 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.024 -0.989 . . . . 0.10000000000000001 112.64 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.662 ' HD2' HG21 ' A' ' 366' ' ' THR . 74.1 Cg_exo -50.52 143.12 28.82 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 123.67 2.914 . . . . 0.23999999999999999 112.854 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.681 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.3 Cg_exo -64.42 -24.08 64.48 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.762 2.308 . . . . 0.31 111.914 -176.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.5 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 36.6 p -78.06 -25.49 47.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.217 -0.901 . . . . 1.1000000000000001 112.444 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.792 ' O ' HD21 ' A' ' 364' ' ' LEU . 33.2 m -99.71 -48.76 11.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 112.801 0.667 . . . . 0.080000000000000002 112.801 -171.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.952 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.39 -2.13 4.21 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.925 -0.71 . . . . 0.070000000000000007 110.379 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.611 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 42.6 pttt -81.17 -39.03 26.14 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.47 1.129 . . . . 0.92000000000000004 108.188 173.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.9 mm-40 -62.0 -46.24 90.09 Favored 'General case' 0 CA--C 1.473 -1.999 0 CA-C-N 112.545 -2.116 . . . . 0.25 106.593 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.952 HD23 ' SD ' ' A' ' 450' ' ' MET . 4.0 tp -46.61 -67.09 0.31 Allowed 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 109.679 -3.419 . . . . 0.050000000000000003 112.755 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.495 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 14.6 t80 -45.37 -24.1 0.26 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 123.972 0.795 . . . . 0.13 109.584 177.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.52 -26.64 27.07 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.68 -1.145 . . . . 0.13 111.899 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.739 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -100.9 -43.68 6.0 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 113.157 0.799 . . . . 0.059999999999999998 113.157 176.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.669 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -74.69 146.96 9.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.674 1.226 . . . . 0.080000000000000002 111.191 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.24 156.1 28.32 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 112.536 -2.12 . . . . 0.47999999999999998 108.499 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.628 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 40.1 mtmt -59.09 101.34 0.09 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.786 0.803 . . . . 0.98999999999999999 109.614 171.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 132.3 -14.14 5.12 Favored Glycine 0 C--N 1.304 -1.235 0 CA-C-N 113.556 -1.656 . . . . 0.19 111.452 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.669 HG21 ' HB ' ' A' ' 457' ' ' VAL . 14.7 m -65.11 150.31 95.63 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 108.854 -0.795 . . . . 0.13 108.854 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.537 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.0 Cg_endo -93.5 162.03 2.39 Favored 'Trans proline' 0 N--CA 1.421 -2.746 0 C-N-CA 122.204 1.936 . . . . 0.17999999999999999 109.813 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.748 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -125.68 151.91 32.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.465 -1.309 . . . . 0.56999999999999995 107.465 171.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.758 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.3 mp -133.84 150.07 51.38 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.27 -1.011 . . . . 0.13 108.27 175.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.058 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.53 137.88 36.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 103.879 -2.637 . . . . 0.10000000000000001 103.879 163.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 1.6 p90 . . . . . 0 C--O 1.25 1.129 0 O-C-N 123.742 0.651 . . . . 1.0900000000000001 111.378 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.741 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.116 -0.394 . . . . 1.8700000000000001 112.116 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.541 ' CD2' HD11 ' A' ' 464' ' ' LEU . 1.6 p-80 -140.45 102.26 4.29 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 111.606 0.224 . . . . 0.83999999999999997 111.606 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.556 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.5 OUTLIER 61.97 -167.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.122 0.889 . . . . 0.67000000000000004 112.706 167.756 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -62.63 173.14 1.35 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.826 -0.625 . . . . 1.8500000000000001 109.829 162.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.45 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 18.6 m-20 -79.1 82.93 5.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.185 -1.006 . . . . 0.42999999999999999 109.68 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 92.7 m -158.59 136.27 10.31 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.794 -1.094 . . . . 0.14000000000000001 109.02 168.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.763 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.9 p90 173.92 158.44 0.14 Allowed 'General case' 0 C--O 1.211 -0.963 0 O-C-N 123.582 0.551 . . . . 0.14999999999999999 111.329 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.676 HD11 HG11 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.63 153.66 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.181 -0.674 . . . . 0.080000000000000002 109.181 164.481 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.01 146.28 28.85 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.778 -1.193 . . . . 2.0099999999999998 107.778 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.05 155.8 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 C-N-CA 123.381 0.673 . . . . 0.45000000000000001 110.527 174.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 347' ' ' VAL . 31.4 t0 -137.99 106.68 5.89 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.755 -1.572 . . . . 0.23999999999999999 106.755 175.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 465' ' ' VAL . 0.2 OUTLIER -81.03 -34.77 32.61 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-O 123.094 1.426 . . . . 0.16 110.047 -166.487 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 466' ' ' PHE . 0.8 OUTLIER -58.88 -44.94 91.21 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 110.617 -2.992 . . . . 0.59999999999999998 108.064 177.234 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -101.23 7.94 42.78 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 111.216 -2.72 . . . . 0.20000000000000001 110.88 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.556 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.5 mp0 31.36 62.54 0.24 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 112.673 -2.058 . . . . 2.1499999999999999 113.316 -175.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.523 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 26.7 t60 -142.85 136.37 28.66 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.724 -0.671 . . . . 0.089999999999999997 109.661 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.779 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -114.11 156.48 24.12 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 116.114 -0.494 . . . . 0.070000000000000007 110.084 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.67 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.4 m-90 -142.25 158.66 43.47 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.648 -0.706 . . . . 0.11 111.191 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.703 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.8 t80 -111.32 154.07 25.05 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.607 -1.627 . . . . 0.26000000000000001 106.607 151.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.4 m-85 -128.13 116.92 20.7 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 115.262 -0.881 . . . . 0.14000000000000001 110.513 -178.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.7 tppt? -119.05 140.03 50.75 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.338 -1.727 . . . . 0.25 106.338 168.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.408 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.49 16.27 9.15 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.174 0.805 . . . . 0.42999999999999999 113.174 174.137 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.18 6.99 87.82 Favored Glycine 0 CA--C 1.485 -1.815 0 CA-C-N 115.563 -0.744 . . . . 0.17999999999999999 113.024 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.5 ptmt -127.68 178.77 5.91 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 104.375 -2.454 . . . . 0.37 104.375 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.67 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.9 m -104.37 157.76 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 N-CA-C 116.412 2.004 . . . . 0.10000000000000001 116.412 -176.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.69 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.35 -28.04 9.64 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 110.773 -2.921 . . . . 0.070000000000000007 106.635 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -132.84 144.63 50.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 111.52 -2.582 . . . . 0.059999999999999998 111.435 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.521 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 5.6 tt0 -138.8 119.33 13.9 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 104.238 -2.504 . . . . 0.47999999999999998 104.238 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.779 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.3 164.84 34.75 Favored 'General case' 0 N--CA 1.401 -2.898 0 C-N-CA 117.644 -1.622 . . . . 0.070000000000000007 111.989 178.272 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.571 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 16.9 p-10 -103.46 134.2 47.23 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.373 -1.285 . . . . 1.8 109.784 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.721 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -136.8 -172.92 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 CA-C-O 122.417 1.103 . . . . 0.12 112.515 -171.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.528 HG11 HE22 ' A' ' 426' ' ' GLN . 0.5 OUTLIER -153.33 121.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 112.745 -2.025 . . . . 0.10000000000000001 108.498 172.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.485 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.36 -168.79 1.64 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.268 -1.333 . . . . 1.26 110.556 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.404 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.36 170.79 45.1 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 118.649 -1.738 . . . . 0.14000000000000001 112.465 -174.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 7.0 ptpt -74.61 157.38 86.11 Favored Pre-proline 0 C--O 1.221 -0.404 0 CA-C-O 121.402 0.62 . . . . 0.81000000000000005 111.893 -166.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.671 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 99.4 Cg_exo -55.81 -30.04 74.75 Favored 'Trans proline' 0 CA--C 1.495 -1.436 0 C-N-CA 125.27 3.98 . . . . 0.28000000000000003 113.15 -172.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.474 ' OG1' HG22 ' A' ' 375' ' ' THR . 16.0 p -68.54 -33.18 73.65 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.304 -1.771 . . . . 0.33000000000000002 109.774 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.796 ' OG1' ' HA ' ' A' ' 130' ' ' 1RG . 1.2 t -140.88 70.33 29.62 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 123.487 1.613 . . . . 0.39000000000000001 109.522 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.0 Cg_exo -58.61 157.1 28.76 Favored 'Trans proline' 0 C--N 1.307 -1.631 1 C-N-CA 126.191 4.594 . . . . 0.38 114.265 -171.713 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.485 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -89.61 143.13 30.0 Favored Pre-proline 0 N--CA 1.418 -2.04 0 N-CA-C 108.093 -1.077 . . . . 0.81999999999999995 108.093 171.047 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.56 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 19.8 Cg_exo -76.33 -44.1 0.27 Allowed 'Trans proline' 0 CA--C 1.508 -0.82 0 C-N-CA 124.565 3.51 . . . . 0.19 111.979 -167.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.814 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 59.37 137.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 123.582 1.658 . . . . 0.13 113.605 -172.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 154.39 -110.81 0.46 Allowed Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 112.064 -2.334 . . . . 0.20000000000000001 109.503 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.5 p -131.24 120.63 47.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.871 0.844 . . . . 0.81999999999999995 110.232 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.747 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.6 m-85 -119.47 -174.59 2.77 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.87 -1.53 . . . . 0.22 106.87 172.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.54 ' HB2' ' CH2' ' A' ' 415' ' ' TRP . 1.6 t80 -139.54 123.48 17.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 120.07 1.304 . . . . 0.65000000000000002 113.206 -171.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 2.1 p -88.66 91.29 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 123.132 1.444 . . . . 0.16 109.109 168.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -92.38 10.83 28.28 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.276 -1.784 . . . . 2.5499999999999998 108.014 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.735 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 25.5 t-20 -169.03 126.73 0.98 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.836 -1.529 . . . . 0.42999999999999999 110.492 171.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.67 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -97.63 141.8 30.23 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.889 -1.051 . . . . 1.1200000000000001 108.815 169.352 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.77 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 14.7 mm-40 -125.97 157.02 38.88 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 114.538 1.31 . . . . 0.70999999999999996 114.538 -168.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.74 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.0 mt-10 -137.41 127.26 25.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 112.912 -1.949 . . . . 0.38 108.461 173.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.2 t70 57.6 47.23 16.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 123.446 1.593 . . . . 0.40999999999999998 109.072 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.913 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -84.27 167.48 16.57 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 112.474 -2.148 . . . . 0.12 109.457 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 19.9 m -132.35 119.09 20.25 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.188 0.994 . . . . 0.17000000000000001 112.149 171.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 4.1 mp -81.77 91.76 6.54 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.63 -1.623 . . . . 0.56999999999999995 112.498 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.571 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.7 mttt -102.29 178.84 4.48 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 114.0 -1.454 . . . . 0.33000000000000002 113.572 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.34 -157.98 24.7 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 119.827 -1.178 . . . . 0.46000000000000002 111.883 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 2.0 m -121.97 136.68 54.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.254 -0.578 . . . . 0.70999999999999996 111.531 172.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 401' ' ' THR . 6.1 m-80 -56.48 156.83 5.64 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.133 -0.94 . . . . 0.83999999999999997 110.16 169.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ASP . . . . . 0.458 ' HB3' HG21 ' A' ' 375' ' ' THR . 6.3 p-10 -54.5 -14.65 1.34 Allowed 'General case' 0 CA--C 1.489 -1.396 0 CA-C-N 113.301 -1.772 . . . . 2.2799999999999998 112.092 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 397' ' ' ASN . 17.6 t70 -97.67 -18.49 18.84 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.609 -1.632 . . . . 2.27 109.242 -173.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.88 33.17 5.62 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 119.337 -1.411 . . . . 0.93999999999999995 111.314 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.463 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 11.4 p -123.35 100.64 38.62 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.455 -0.873 . . . . 0.81000000000000005 109.319 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 21.5 Cg_endo -59.65 150.72 74.8 Favored 'Trans proline' 0 CA--C 1.501 -1.133 0 C-N-CA 122.651 2.234 . . . . 0.63 113.131 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -150.41 174.64 12.66 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.326 -1.306 . . . . 0.41999999999999998 112.485 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.571 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.9 OUTLIER -144.13 147.62 33.97 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.727 -1.579 . . . . 0.53000000000000003 109.642 171.302 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -143.55 97.29 5.54 Favored Pre-proline 0 N--CA 1.432 -1.335 0 N-CA-C 108.176 -1.046 . . . . 0.19 108.176 172.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 16.8 Cg_exo -69.44 110.0 2.39 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 121.994 1.796 . . . . 0.19 109.654 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.913 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.9 154.22 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 CA-C-N 113.057 -1.883 . . . . 0.14999999999999999 107.688 -168.067 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.74 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.8 m-80 -86.48 -20.43 28.11 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.78 -0.822 . . . . 0.51000000000000001 108.78 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.77 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.4 m-85 -158.8 127.1 5.21 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.933 -1.031 . . . . 0.27000000000000002 108.749 -171.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 22.5 t-105 -144.13 135.31 25.51 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.607 0.718 . . . . 0.089999999999999997 111.001 -167.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.67 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.7 mmt -119.51 89.89 41.65 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.22 -1.03 . . . . 0.14000000000000001 108.22 174.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 28.1 Cg_endo -63.63 100.21 0.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.016 1.81 . . . . 0.5 111.062 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 411' ' ' MET . 5.6 pt -102.12 176.51 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.341 -0.985 . . . . 0.88 108.341 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 416' ' ' THR . 2.1 t70 -143.09 -170.21 3.2 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 118.873 -1.131 . . . . 2.4900000000000002 113.011 -165.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.54 ' CH2' ' HB2' ' A' ' 383' ' ' TYR . 25.6 p90 53.4 -5.27 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.986 2.114 . . . . 1.9199999999999999 114.702 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.622 HG21 ' CE1' ' A' ' 382' ' ' PHE . 22.1 p -131.53 -20.25 2.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.056 0.391 . . . . 0.94999999999999996 112.056 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.48 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 95.88 -27.38 16.53 Favored Glycine 0 CA--C 1.505 -0.592 0 N-CA-C 111.25 -0.74 . . . . 0.68000000000000005 111.25 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 419' ' ' GLY . 39.0 t -55.11 172.45 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.762 0.825 . . . . 0.75 111.342 -178.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.602 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.13 123.21 0.86 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 109.719 -1.352 . . . . 0.20000000000000001 109.719 170.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.713 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.5 142.43 13.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.809 -0.441 . . . . 0.28999999999999998 109.809 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.669 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.6 p80 -160.71 162.92 32.69 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.255 -0.43 . . . . 0.089999999999999997 111.482 -174.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.68 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.21 147.76 26.43 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.245 -1.02 . . . . 1.0700000000000001 108.245 172.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.3 t -132.99 96.93 3.88 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.791 0.805 . . . . 0.23000000000000001 109.835 -172.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -82.11 -12.49 58.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.094 -1.412 . . . . 0.41999999999999998 109.067 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.76 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 10.2 p90 -92.96 -23.92 18.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.01 -1.45 . . . . 0.32000000000000001 111.757 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.557 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 1.3 tt0 -98.01 115.47 65.75 Favored Pre-proline 0 CA--C 1.507 -0.706 0 CA-C-O 122.711 1.243 . . . . 1.74 110.164 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.524 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 47.3 Cg_endo -86.25 -10.97 6.47 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.151 3.234 . . . . 0.72999999999999998 113.046 -173.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.658 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.0 pm0 -111.99 154.63 25.01 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.409 1.1 . . . . 2.1600000000000001 113.237 174.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.639 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.54 132.08 4.4 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.857 -2.275 . . . . 0.33000000000000002 104.857 171.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.45 -157.39 29.53 Favored Glycine 0 C--N 1.282 -2.441 0 C-N-CA 119.77 -1.205 . . . . 0.17000000000000001 110.885 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.449 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.21 175.95 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.297 -0.954 . . . . 0.20999999999999999 111.578 166.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.505 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.4 p-10 -51.95 101.57 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 123.276 1.512 . . . . 1.8500000000000001 113.426 -156.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.719 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.63 -35.8 10.93 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 112.631 -2.077 . . . . 1.21 109.45 169.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.736 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.7 p-90 -55.37 -28.0 51.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.173 -0.921 . . . . 0.16 112.156 -170.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.736 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.63 -35.04 15.21 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.604 0.716 . . . . 0.22 112.122 -177.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.1 p -90.14 -43.7 10.28 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.754 -1.112 . . . . 0.25 111.008 -175.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.719 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 3.0 mtp85 -92.35 -19.64 21.9 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.65 -1.159 . . . . 1.8200000000000001 109.732 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 54.48 48.47 64.85 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 113.848 -1.524 . . . . 0.23999999999999999 115.265 164.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 25.0 m -81.76 111.03 17.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 118.853 1.326 . . . . 1.01 111.217 -171.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.672 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 55.9 m-70 36.39 -120.69 0.15 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.741 -1.118 . . . . 0.5 113.66 177.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.418 ' HA3' ' HB ' ' A' ' 130' ' ' 1RG . . . -133.29 -19.71 0.95 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 116.036 -0.529 . . . . 0.26000000000000001 113.676 -175.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.808 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.1 p -103.56 -165.37 1.15 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 117.507 0.654 . . . . 0.34999999999999998 112.707 -175.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.471 HG12 HG11 ' A' ' 347' ' ' VAL . 2.1 mp -95.48 130.57 44.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.968 -1.014 . . . . 0.12 110.658 -175.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -102.5 95.29 6.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.826 -0.625 . . . . 0.62 110.13 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.721 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.4 m -91.64 142.54 26.85 Favored Pre-proline 0 N--CA 1.437 -1.125 0 CA-C-N 115.042 -0.981 . . . . 0.10000000000000001 112.668 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.663 ' HD2' HG21 ' A' ' 366' ' ' THR . 87.2 Cg_exo -49.9 144.85 20.09 Favored 'Trans proline' 0 CA--C 1.507 -0.871 0 C-N-CA 124.096 3.197 . . . . 0.23999999999999999 113.457 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.68 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.6 Cg_exo -65.41 -28.37 54.43 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 122.783 2.322 . . . . 0.31 112.306 -175.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 48.1 m -74.74 -23.72 58.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.845 -0.616 . . . . 1.1000000000000001 112.282 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.804 ' O ' HD21 ' A' ' 364' ' ' LEU . 29.9 m -100.68 -49.08 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 112.932 0.716 . . . . 0.080000000000000002 112.932 -169.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.952 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.95 -2.09 4.85 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.8 -0.76 . . . . 0.070000000000000007 110.308 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.609 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.0 pttp -81.63 -38.98 25.12 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.378 1.085 . . . . 0.92000000000000004 108.117 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.6 mm-40 -62.03 -46.16 90.39 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-N 112.524 -2.126 . . . . 0.25 106.599 -177.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.952 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.9 tp -46.19 -67.06 0.32 Allowed 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 109.678 -3.419 . . . . 0.050000000000000003 112.778 172.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.499 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.3 t80 -45.52 -24.21 0.3 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 123.957 0.785 . . . . 0.13 109.48 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -87.91 -26.63 28.62 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 114.684 -1.143 . . . . 0.13 111.743 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.746 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.8 -44.11 5.63 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 113.322 0.86 . . . . 0.059999999999999998 113.322 176.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.676 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -74.1 148.06 8.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.499 1.143 . . . . 0.080000000000000002 111.25 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.416 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -117.07 157.99 24.93 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 112.745 -2.025 . . . . 0.47999999999999998 108.992 -179.305 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.665 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 7.3 mppt? -59.2 102.01 0.12 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.551 -0.907 . . . . 0.98999999999999999 108.551 168.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.22 -12.36 5.52 Favored Glycine 0 C--N 1.308 -1.011 0 CA-C-N 114.22 -1.355 . . . . 0.19 111.726 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.662 HG21 ' HB ' ' A' ' 457' ' ' VAL . 15.9 m -68.25 151.22 97.36 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 108.838 -0.801 . . . . 0.13 108.838 171.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.556 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.3 Cg_endo -94.1 165.92 2.04 Favored 'Trans proline' 0 N--CA 1.422 -2.694 0 C-N-CA 122.1 1.866 . . . . 0.17999999999999999 109.929 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.747 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -127.3 152.6 35.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.697 -1.223 . . . . 0.56999999999999995 107.697 170.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.763 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.3 mp -134.01 150.06 51.22 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.05 -1.093 . . . . 0.13 108.05 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.035 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -139.94 138.28 38.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 103.753 -2.684 . . . . 0.10000000000000001 103.753 164.031 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.814 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 2.5 p90 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 117.573 -1.204 . . . . 1.0900000000000001 112.109 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.808 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.49 -0.244 . . . . 1.8700000000000001 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.523 ' CD2' HD11 ' A' ' 464' ' ' LEU . 1.7 p-80 -146.99 102.12 3.49 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 111.738 0.273 . . . . 0.83999999999999997 111.738 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.577 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.0 OUTLIER 64.37 -168.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.055 0.847 . . . . 0.67000000000000004 112.569 167.646 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -56.99 166.08 1.11 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.647 -0.706 . . . . 1.8500000000000001 109.826 162.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.17 82.44 5.33 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 118.519 -1.272 . . . . 0.42999999999999999 109.129 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 99.9 m -159.59 136.16 9.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.457 -1.247 . . . . 0.14000000000000001 108.995 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.656 ' CD2' HD13 ' A' ' 464' ' ' LEU . 38.6 p90 174.67 158.61 0.17 Allowed 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 123.381 0.425 . . . . 0.14999999999999999 111.117 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.66 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -78.11 152.35 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 N-CA-C 109.035 -0.728 . . . . 0.080000000000000002 109.035 164.204 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.559 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.1 tt0 -149.77 145.82 26.84 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.437 -0.802 . . . . 2.0099999999999998 109.389 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.735 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -138.23 162.28 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 120.917 0.389 . . . . 0.45000000000000001 111.184 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 347' ' ' VAL . 33.7 t0 -140.38 106.4 5.2 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.419 -1.326 . . . . 0.23999999999999999 107.419 173.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.091 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -81.63 -35.74 29.67 Favored 'General case' 0 CA--C 1.483 -1.618 0 CA-C-O 122.678 1.228 . . . . 0.16 110.477 -167.349 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.53 -44.27 80.67 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 110.967 -2.833 . . . . 0.59999999999999998 108.219 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -101.21 6.78 43.16 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 110.751 -2.932 . . . . 0.20000000000000001 110.923 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.692 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 21.6 mp0 34.19 61.83 0.5 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 112.558 -2.11 . . . . 2.1499999999999999 113.139 -176.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.522 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 20.4 t60 -142.11 133.59 26.63 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.782 -0.644 . . . . 0.089999999999999997 110.236 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -112.84 155.5 24.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.773 -0.649 . . . . 0.070000000000000007 109.684 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.556 ' CD1' HG11 ' A' ' 362' ' ' VAL . 29.0 m-90 -140.62 153.83 46.21 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.42 -0.809 . . . . 0.11 110.877 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.684 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 84.0 t80 -110.67 151.89 27.17 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 106.385 -1.709 . . . . 0.26000000000000001 106.385 152.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 6.9 m-85 -127.97 115.62 18.8 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 114.602 -1.181 . . . . 0.14000000000000001 110.343 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.1 tppt? -116.53 138.4 51.43 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.474 -1.676 . . . . 0.25 106.474 169.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.446 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.54 17.45 9.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.343 0.868 . . . . 0.42999999999999999 113.343 173.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.92 9.81 86.47 Favored Glycine 0 CA--C 1.491 -1.455 0 CA-C-N 115.528 -0.76 . . . . 0.17999999999999999 112.913 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.5 ptmt -130.27 178.36 6.64 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 104.757 -2.312 . . . . 0.37 104.757 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 17.9 m -105.08 157.9 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.642 0 N-CA-C 116.338 1.977 . . . . 0.10000000000000001 116.338 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.677 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -110.46 -27.91 8.79 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 110.571 -3.013 . . . . 0.070000000000000007 106.558 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.809 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.6 145.28 49.89 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 111.568 -2.56 . . . . 0.059999999999999998 111.362 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.426 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -141.65 118.29 11.0 Favored 'General case' 0 N--CA 1.404 -2.747 0 N-CA-C 104.255 -2.498 . . . . 0.47999999999999998 104.255 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.712 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.22 160.81 43.42 Favored 'General case' 0 N--CA 1.396 -3.131 0 C-N-CA 117.822 -1.551 . . . . 0.070000000000000007 111.244 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 14.9 p-10 -102.83 132.32 49.1 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.38 -1.282 . . . . 1.8 109.001 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.892 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.5 pp -132.16 -172.31 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 CA-C-O 122.439 1.114 . . . . 0.12 112.673 -171.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.83 118.9 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 112.985 -1.916 . . . . 0.10000000000000001 108.905 173.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.488 ' HB3' HD12 ' A' ' 349' ' ' LEU . 47.4 p -74.92 -168.93 0.81 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 112.039 -2.346 . . . . 1.26 111.662 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.75 175.25 50.46 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 118.944 -1.598 . . . . 0.14000000000000001 111.831 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.528 ' HG2' HG23 ' A' ' 375' ' ' THR . 15.3 ptmt -79.1 163.2 61.21 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.813 0.672 . . . . 0.81000000000000005 112.813 -164.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.705 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 86.3 Cg_exo -55.72 -37.54 95.37 Favored 'Trans proline' 0 CA--C 1.511 -0.65 0 C-N-CA 122.76 2.307 . . . . 0.28000000000000003 112.448 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.423 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 19.2 p -66.28 -32.26 73.56 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.461 -1.245 . . . . 0.33000000000000002 110.175 -174.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.528 HG23 ' HG2' ' A' ' 372' ' ' LYS . 1.3 t -141.23 72.4 26.8 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 123.704 1.716 . . . . 0.39000000000000001 109.608 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 375' ' ' THR . 72.5 Cg_exo -59.99 164.09 12.81 Favored 'Trans proline' 0 C--N 1.312 -1.345 1 C-N-CA 126.394 4.729 . . . . 0.38 115.133 -172.214 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.531 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 2.1 m -90.12 128.01 51.28 Favored Pre-proline 0 N--CA 1.399 -2.979 0 CA-C-N 113.869 -1.514 . . . . 0.81999999999999995 108.343 171.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.531 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 38.7 Cg_exo -69.47 -45.58 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.99 3.127 . . . . 0.19 112.014 -170.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.803 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 63.14 143.93 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 123.316 1.532 . . . . 0.13 113.943 -175.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 145.74 -110.41 0.54 Allowed Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 111.905 -2.407 . . . . 0.20000000000000001 108.862 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 464' ' ' LEU . 3.5 p -131.19 127.55 60.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.822 -0.436 . . . . 0.81999999999999995 109.822 174.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.778 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 7.7 m-85 -121.54 -174.49 2.87 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.253 -1.388 . . . . 0.22 107.253 169.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 2.2 t80 -138.93 121.26 15.96 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 120.792 -1.192 . . . . 0.65000000000000002 113.194 -173.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -87.82 92.62 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-O 122.881 1.324 . . . . 0.16 109.368 171.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 44.0 p-90 -92.25 10.35 29.97 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 113.575 -1.648 . . . . 2.5499999999999998 108.314 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.748 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 27.9 t-20 -169.6 127.01 0.91 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.098 -1.41 . . . . 0.42999999999999999 110.392 172.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.608 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.46 143.13 31.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.073 -0.967 . . . . 1.1200000000000001 109.012 169.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.746 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 10.7 mm-40 -125.31 157.74 35.92 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.548 1.314 . . . . 0.70999999999999996 114.548 -168.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.714 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 47.8 mt-10 -137.49 127.24 25.44 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.178 -1.828 . . . . 0.38 108.668 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 19.5 t70 55.01 50.36 15.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 123.366 1.555 . . . . 0.40999999999999998 109.025 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.958 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -84.27 167.37 16.68 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 112.495 -2.139 . . . . 0.12 109.522 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 15.8 m -132.43 118.77 19.76 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.102 0.953 . . . . 0.17000000000000001 111.494 170.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.18 88.37 4.88 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.779 -1.555 . . . . 0.56999999999999995 112.11 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.543 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 48.0 mttt -102.08 179.01 4.44 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 113.703 -1.59 . . . . 0.33000000000000002 112.971 176.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 137.37 -157.52 24.01 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 119.443 -1.361 . . . . 0.46000000000000002 111.785 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.667 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.6 m -118.16 138.97 51.93 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 120.369 -0.532 . . . . 0.70999999999999996 110.668 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.478 ' C ' ' H ' ' A' ' 399' ' ' ASP . 2.5 m120 -55.87 152.03 10.58 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.41 -0.959 . . . . 0.83999999999999997 108.41 167.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.12 -2.94 0.71 Allowed 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.689 0.618 . . . . 2.2799999999999998 111.096 178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 397' ' ' ASN . 5.0 t70 -112.26 2.61 16.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.207 -0.906 . . . . 2.27 110.45 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.44 18.39 33.34 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.319 -0.943 . . . . 0.93999999999999995 113.308 170.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.489 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 4.9 p -113.47 100.48 51.9 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 114.969 -0.616 . . . . 0.81000000000000005 109.899 -176.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.1 Cg_endo -58.47 149.81 72.47 Favored 'Trans proline' 0 CA--C 1.504 -1.009 0 C-N-CA 122.853 2.369 . . . . 0.63 113.089 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.48 ' OH ' ' HAD' ' A' ' 130' ' ' 1RG . 24.1 p90 -152.56 174.94 13.31 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.396 -1.274 . . . . 0.41999999999999998 113.059 -168.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -144.55 148.22 34.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.996 -1.456 . . . . 0.53000000000000003 110.455 172.075 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.43 97.74 4.68 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 108.422 -0.955 . . . . 0.19 108.422 169.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.2 Cg_exo -69.03 110.21 2.35 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.037 1.824 . . . . 0.19 110.462 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.958 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.9 157.71 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 CA-C-N 113.084 -1.871 . . . . 0.14999999999999999 107.824 -167.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.714 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.5 m-80 -88.31 -22.18 24.0 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.83 -0.804 . . . . 0.51000000000000001 108.83 -175.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.746 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 93.6 m-85 -158.72 127.65 5.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.936 -1.029 . . . . 0.27000000000000002 108.382 -170.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 18.1 t-105 -144.41 133.88 23.3 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.665 0.745 . . . . 0.089999999999999997 110.812 -166.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.608 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 13.5 mmt -115.15 89.81 21.71 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.101 -1.074 . . . . 0.14000000000000001 108.101 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.748 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 35.0 Cg_endo -65.87 89.03 0.23 Allowed 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 122.456 2.104 . . . . 0.5 109.408 175.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 8.1 pt -84.18 -157.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.923 -1.035 . . . . 0.88 110.39 -172.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.531 ' OD2' ' HA ' ' A' ' 382' ' ' PHE . 3.0 p30 -90.24 -177.68 5.19 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.656 1.217 . . . . 2.4900000000000002 112.785 -161.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.41 ' CD2' ' N ' ' A' ' 415' ' ' TRP . 0.0 OUTLIER -78.43 32.05 0.19 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 112.399 -2.182 . . . . 1.9199999999999999 112.179 -162.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 11.0 p -99.19 -23.01 15.37 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.585 -0.734 . . . . 0.94999999999999996 109.55 173.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.594 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 129.84 -39.64 1.79 Allowed Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.528 -0.76 . . . . 0.68000000000000005 113.222 171.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 419' ' ' GLY . 24.0 t -62.38 173.59 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 123.134 0.574 . . . . 0.75 111.872 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.01 121.69 0.82 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.77 -1.332 . . . . 0.20000000000000001 109.77 169.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.707 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.3 mp -81.69 143.08 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.839 -0.344 . . . . 0.28999999999999998 110.163 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.679 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.3 p80 -159.37 161.5 35.7 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.29 -0.414 . . . . 0.089999999999999997 111.461 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.673 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.83 144.8 28.2 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.843 -1.169 . . . . 1.0700000000000001 107.843 172.341 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 33.7 t -134.26 98.0 3.99 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.851 0.834 . . . . 0.23000000000000001 110.576 -170.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -80.62 -20.11 43.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.121 -1.399 . . . . 0.41999999999999998 110.062 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.752 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 13.5 p90 -82.87 -25.2 32.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.216 -1.356 . . . . 0.32000000000000001 111.388 -175.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.518 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.1 OUTLIER -87.67 128.98 52.51 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 122.222 1.011 . . . . 1.74 110.318 -176.072 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.28 -51.73 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 124.146 3.23 . . . . 0.72999999999999998 113.119 -176.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.01 161.01 17.55 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.737 1.256 . . . . 2.1600000000000001 112.682 -169.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.529 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 1.2 m-85 -154.61 121.9 5.67 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 112.116 -2.311 . . . . 0.33000000000000002 105.901 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 165.81 -157.05 29.36 Favored Glycine 0 C--N 1.283 -2.391 0 C-N-CA 119.862 -1.161 . . . . 0.17000000000000001 110.352 -174.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -38.61 164.78 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.725 0 C-N-CA 120.483 -0.865 . . . . 0.20999999999999999 111.789 166.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.449 ' HB3' ' CD ' ' A' ' 435' ' ' LYS . 4.4 m-20 -51.68 102.72 0.05 OUTLIER 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 113.446 -1.377 . . . . 1.8500000000000001 113.318 -153.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.646 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.3 OUTLIER -94.11 -38.77 10.94 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 113.327 -1.761 . . . . 1.21 108.823 168.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.746 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.4 p-90 -49.79 -32.17 13.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.153 0.502 . . . . 0.16 112.047 -169.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.746 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -86.01 -35.32 20.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.483 0.658 . . . . 0.22 111.965 -177.12 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 10.2 p -88.75 -43.72 11.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.672 -1.149 . . . . 0.25 111.15 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.646 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 11.4 mtp85 -91.59 -18.53 23.91 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.817 -1.083 . . . . 1.8200000000000001 109.474 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.63 47.56 57.64 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.654 -1.157 . . . . 0.23999999999999999 114.129 163.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 43.3 m -84.76 110.52 18.85 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 118.991 -1.084 . . . . 1.01 111.415 -171.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.595 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 51.3 m-70 37.8 -125.75 0.23 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.373 -1.285 . . . . 0.5 113.738 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -126.99 -21.29 1.73 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.076 -0.583 . . . . 0.26000000000000001 113.462 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.654 ' HB3' HASB ' A' ' 130' ' ' 1RG . 28.7 p -104.49 -165.57 1.15 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 112.883 0.697 . . . . 0.34999999999999998 112.883 -173.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.476 HD13 HG11 ' A' ' 465' ' ' VAL . 2.3 mp -92.02 129.24 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.482 -0.781 . . . . 0.12 110.884 -175.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -100.3 89.72 4.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.657 -0.701 . . . . 0.62 109.727 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.892 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.0 m -83.26 143.78 45.7 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 115.087 -0.96 . . . . 0.10000000000000001 112.452 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.653 ' HD2' HG21 ' A' ' 366' ' ' THR . 78.8 Cg_exo -50.08 144.51 22.06 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 123.807 3.005 . . . . 0.23999999999999999 113.351 174.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.673 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.4 Cg_exo -64.6 -25.42 62.16 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 122.827 2.351 . . . . 0.31 112.598 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.516 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 67.3 p -78.7 -24.59 44.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.74 0.781 . . . . 1.1000000000000001 112.085 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.809 ' O ' HD21 ' A' ' 364' ' ' LEU . 33.0 m -99.35 -48.63 11.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 113.137 0.792 . . . . 0.080000000000000002 113.137 -170.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.944 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.72 -1.95 4.42 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.767 -0.773 . . . . 0.070000000000000007 110.434 -178.267 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.561 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 16.5 pttp -81.22 -38.46 26.95 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 122.651 1.215 . . . . 0.92000000000000004 108.287 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 4.5 mm-40 -62.65 -46.31 88.79 Favored 'General case' 0 CA--C 1.473 -1.981 0 CA-C-N 112.356 -2.202 . . . . 0.25 106.537 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.944 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.92 -66.72 0.36 Allowed 'General case' 0 N--CA 1.401 -2.922 0 CA-C-N 109.711 -3.404 . . . . 0.050000000000000003 112.923 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.462 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 14.9 t80 -45.58 -24.03 0.3 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.83 0.824 . . . . 0.13 109.502 176.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -87.4 -26.54 30.16 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 114.697 -1.138 . . . . 0.13 111.785 -176.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.739 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.14 -44.13 5.29 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 113.728 1.01 . . . . 0.059999999999999998 113.728 177.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.67 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -72.62 148.06 9.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.292 1.044 . . . . 0.080000000000000002 111.106 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.501 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -116.02 155.24 28.44 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.281 -1.781 . . . . 0.47999999999999998 108.952 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.605 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.8 mppt? -57.91 103.43 0.14 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.624 -0.88 . . . . 0.98999999999999999 108.624 169.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 126.36 -7.46 7.54 Favored Glycine 0 C--N 1.308 -0.996 0 CA-C-N 113.827 -1.533 . . . . 0.19 111.452 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.67 HG21 ' HB ' ' A' ' 457' ' ' VAL . 6.8 m -70.17 150.5 96.06 Favored Pre-proline 0 N--CA 1.442 -0.862 0 N-CA-C 108.592 -0.892 . . . . 0.13 108.592 171.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.577 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.8 Cg_endo -93.98 160.52 2.18 Favored 'Trans proline' 0 N--CA 1.421 -2.775 0 C-N-CA 122.017 1.811 . . . . 0.17999999999999999 109.749 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.778 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -123.91 151.44 28.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.295 -1.372 . . . . 0.56999999999999995 107.295 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.697 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.7 mp -134.54 151.28 51.0 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 108.113 -1.069 . . . . 0.13 108.113 174.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.091 HG23 HD21 ' A' ' 349' ' ' LEU . 0.8 OUTLIER -140.64 141.26 32.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 105.177 -2.157 . . . . 0.10000000000000001 105.177 166.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.719 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 12.5 p90 . . . . . 0 C--O 1.245 0.861 0 CA-C-N 118.45 0.568 . . . . 1.0900000000000001 111.553 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.738 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 111.538 -0.625 . . . . 1.8700000000000001 111.538 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.485 ' CE1' HD21 ' A' ' 464' ' ' LEU . 4.2 p-80 39.42 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.588 0.959 . . . . 0.83999999999999997 113.588 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.546 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.0 OUTLIER 67.43 -164.71 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.778 -0.646 . . . . 0.67000000000000004 112.069 168.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.17 171.65 2.22 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.674 -1.232 . . . . 1.8500000000000001 107.674 164.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.455 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 9.3 m-20 -81.49 83.05 7.09 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 118.69 -1.204 . . . . 0.42999999999999999 108.931 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.809 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 70.0 m -158.34 134.71 9.4 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.538 -1.21 . . . . 0.14000000000000001 108.944 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.651 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.3 p90 173.91 159.27 0.15 Allowed 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 123.421 0.451 . . . . 0.14999999999999999 110.881 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.651 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.93 152.59 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 N-CA-C 109.354 -0.61 . . . . 0.080000000000000002 109.354 164.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.6 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 31.1 tt0 -149.82 144.7 26.15 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.438 -0.801 . . . . 2.0099999999999998 109.249 -177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.734 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -137.3 162.05 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 O-C-N 122.118 -0.364 . . . . 0.45000000000000001 111.252 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.547 ' N ' HG12 ' A' ' 347' ' ' VAL . 24.4 t0 -140.19 107.0 5.38 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 107.416 -1.327 . . . . 0.23999999999999999 107.416 172.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.041 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.7 -34.08 27.41 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 122.903 1.335 . . . . 0.16 110.671 -167.585 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -58.69 -44.12 90.19 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 110.769 -2.923 . . . . 0.59999999999999998 108.17 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -101.12 7.01 43.45 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 110.925 -2.852 . . . . 0.20000000000000001 110.916 -175.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.3 mp0 33.06 61.62 0.39 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 112.692 -2.049 . . . . 2.1499999999999999 113.417 -175.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.514 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.6 t60 -142.02 135.01 28.82 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.854 -0.612 . . . . 0.089999999999999997 109.983 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.77 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.16 156.75 22.68 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.812 -0.631 . . . . 0.070000000000000007 110.099 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.585 ' CD1' HG11 ' A' ' 362' ' ' VAL . 29.3 m-90 -142.22 154.18 44.59 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.475 -0.784 . . . . 0.11 111.291 -175.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.809 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 88.2 t80 -110.22 153.29 25.0 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.558 -1.645 . . . . 0.26000000000000001 106.558 151.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.3 m-85 -128.32 118.1 22.63 Favored 'General case' 0 C--N 1.269 -2.915 0 CA-C-N 114.796 -1.093 . . . . 0.14000000000000001 110.118 -178.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.6 tppt? -118.62 135.62 54.34 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.118 -1.808 . . . . 0.25 106.118 167.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.54 16.48 6.97 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 113.45 0.908 . . . . 0.42999999999999999 113.45 173.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.36 7.58 88.38 Favored Glycine 0 CA--C 1.485 -1.844 0 CA-C-O 121.933 0.741 . . . . 0.17999999999999999 112.778 -174.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 19.4 ptmt -128.77 177.0 7.38 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 104.542 -2.392 . . . . 0.37 104.542 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.6 m -104.29 157.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 N-CA-C 116.397 1.999 . . . . 0.10000000000000001 116.397 -174.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.703 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.97 -28.4 9.14 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 110.497 -3.047 . . . . 0.070000000000000007 106.277 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.817 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -132.93 145.01 50.53 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 111.614 -2.539 . . . . 0.059999999999999998 111.731 -175.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.442 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.4 tt0 -141.86 117.88 10.6 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 104.516 -2.401 . . . . 0.47999999999999998 104.516 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.77 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.6 164.47 35.04 Favored 'General case' 0 N--CA 1.402 -2.848 0 C-N-CA 117.974 -1.49 . . . . 0.070000000000000007 111.769 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.531 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 17.6 p-10 -104.9 131.4 52.44 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 114.726 -1.124 . . . . 1.8 109.542 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -132.79 -171.87 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 CA-C-O 122.438 1.113 . . . . 0.12 112.327 -171.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -149.99 119.56 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 112.959 -1.928 . . . . 0.10000000000000001 108.296 172.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.638 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.3 OUTLIER -75.62 -168.61 0.88 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.026 -1.443 . . . . 1.26 110.784 177.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.51 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -86.4 176.15 48.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 118.929 -1.605 . . . . 0.14000000000000001 112.681 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.474 ' HG2' HG23 ' A' ' 375' ' ' THR . 16.7 ptmt -78.16 156.72 79.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.661 0.743 . . . . 0.81000000000000005 111.865 -166.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.692 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 85.5 Cg_exo -59.19 -28.6 88.19 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 125.016 3.811 . . . . 0.28000000000000003 113.309 -173.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.476 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 24.4 p -73.22 -32.61 64.86 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.867 -1.515 . . . . 0.33000000000000002 109.941 -175.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.541 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -140.63 70.15 31.25 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-O 123.887 1.803 . . . . 0.39000000000000001 108.92 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 375' ' ' THR . 83.1 Cg_exo -57.58 160.49 14.16 Favored 'Trans proline' 0 CA--C 1.501 -1.172 1 C-N-CA 126.895 5.063 . . . . 0.38 115.854 -169.282 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.638 HG21 ' OG ' ' A' ' 370' ' ' SER . 1.6 m -86.62 131.81 44.45 Favored Pre-proline 0 N--CA 1.406 -2.641 0 CA-C-N 113.902 -1.499 . . . . 0.81999999999999995 108.709 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.3 Cg_exo -72.73 -45.14 0.55 Allowed 'Trans proline' 0 CA--C 1.514 -0.491 0 C-N-CA 123.861 3.041 . . . . 0.19 112.092 -170.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.786 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.59 140.11 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 123.263 1.506 . . . . 0.13 113.497 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.19 -113.55 0.59 Allowed Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 112.455 -2.157 . . . . 0.20000000000000001 109.623 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.2 119.11 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.924 0.869 . . . . 0.81999999999999995 110.175 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.724 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.7 m-85 -118.1 -174.19 2.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.202 -1.407 . . . . 0.22 107.202 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 1.3 t80 -139.94 123.35 17.07 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 120.697 -1.252 . . . . 0.65000000000000002 113.275 -171.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.65 92.1 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-O 123.084 1.421 . . . . 0.16 109.308 169.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -94.77 12.46 27.87 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 113.393 -1.73 . . . . 2.5499999999999998 108.318 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.764 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 28.5 t-20 -169.1 126.34 0.96 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 113.833 -1.53 . . . . 0.42999999999999999 110.04 171.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.673 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.79 144.4 29.79 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.115 -0.948 . . . . 1.1200000000000001 109.458 170.268 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.721 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 24.6 mm-40 -127.5 159.99 32.87 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 114.899 1.444 . . . . 0.70999999999999996 114.899 -168.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.561 ' HG2' ' CE2' ' A' ' 409' ' ' TYR . 51.6 mt-10 -139.04 127.59 23.1 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 113.064 -1.88 . . . . 0.38 108.583 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.7 t70 54.68 46.38 24.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 123.722 1.725 . . . . 0.40999999999999998 108.754 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.92 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.84 167.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 111.918 -2.401 . . . . 0.12 109.709 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 11.8 m -132.61 118.33 19.04 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.013 0.911 . . . . 0.17000000000000001 111.878 170.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.9 mp -77.58 87.62 3.89 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.987 -1.461 . . . . 0.56999999999999995 111.918 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.546 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.3 mttt -101.63 178.16 4.71 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 113.308 -1.769 . . . . 0.33000000000000002 113.397 177.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 138.54 -162.01 25.77 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 114.198 -1.365 . . . . 0.46000000000000002 111.63 -177.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.6 m -115.33 142.01 47.26 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 120.162 -0.615 . . . . 0.70999999999999996 111.104 170.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.4 m-80 -60.06 154.97 18.01 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.064 -0.971 . . . . 0.83999999999999997 109.008 167.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ASP . . . . . 0.452 ' HA ' ' HBD' ' A' ' 130' ' ' 1RG . 0.7 OUTLIER -64.0 -2.26 1.87 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.51 -0.768 . . . . 2.2799999999999998 110.672 177.768 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.1 OUTLIER -111.88 7.47 20.05 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.802 -1.09 . . . . 2.27 111.076 179.412 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.86 52.11 Favored Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 120.392 -0.909 . . . . 0.93999999999999995 112.455 169.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 10.9 p -114.58 98.86 50.44 Favored Pre-proline 0 C--N 1.303 -1.451 0 CA-C-N 114.509 -0.846 . . . . 0.81000000000000005 109.8 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.6 Cg_endo -58.86 149.92 75.13 Favored 'Trans proline' 0 CA--C 1.503 -1.042 0 C-N-CA 122.945 2.43 . . . . 0.63 113.467 -176.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 30.2 p90 -150.26 173.94 13.39 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.121 -1.4 . . . . 0.41999999999999998 112.917 -168.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.546 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -145.86 148.25 32.66 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.992 -1.458 . . . . 0.53000000000000003 110.836 173.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -145.26 97.53 4.75 Favored Pre-proline 0 N--CA 1.439 -0.98 0 N-CA-C 108.359 -0.978 . . . . 0.19 108.359 170.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.8 Cg_exo -68.22 110.74 2.3 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.974 1.782 . . . . 0.19 110.034 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.92 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -111.36 152.65 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 CA-C-N 113.368 -1.742 . . . . 0.14999999999999999 108.458 -167.378 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 4.9 m-20 -80.58 -23.28 40.0 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.797 -0.446 . . . . 0.51000000000000001 109.797 -174.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 97.2 m-85 -161.35 132.04 5.19 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.635 -1.246 . . . . 0.27000000000000002 107.635 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 20.2 t-105 -146.42 131.84 18.63 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.889 0.852 . . . . 0.089999999999999997 111.443 -166.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.673 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.6 mmt -114.43 93.23 31.1 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.728 -1.212 . . . . 0.14000000000000001 107.728 172.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.764 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 36.0 Cg_endo -66.87 75.76 0.42 Allowed 'Trans proline' 0 CA--C 1.513 -0.568 0 C-N-CA 122.393 2.062 . . . . 0.5 111.618 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.584 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.3 pt -76.16 178.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 115.61 -0.723 . . . . 0.88 109.11 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.667 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 5.4 t70 -150.33 -166.74 2.63 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.854 -0.795 . . . . 2.4900000000000002 108.854 -167.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.667 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 9.4 m-90 83.44 -52.47 0.15 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.936 0.773 . . . . 1.9199999999999999 111.728 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.463 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 63.7 p -125.44 -5.47 7.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.594 -0.73 . . . . 0.94999999999999996 112.159 -165.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.508 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 104.77 -28.86 13.12 Favored Glycine 0 CA--C 1.506 -0.513 0 C-N-CA 120.768 -0.729 . . . . 0.68000000000000005 112.663 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 419' ' ' GLY . 34.0 t -57.06 173.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.711 0.804 . . . . 0.75 112.23 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.587 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.1 119.64 0.71 Allowed Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.498 -1.041 . . . . 0.20000000000000001 110.498 170.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.749 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.3 mp -81.78 143.34 12.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 110.024 -0.361 . . . . 0.28999999999999998 110.024 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.677 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 29.4 p80 -159.82 159.15 32.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.793 0.664 . . . . 0.089999999999999997 112.793 -173.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.776 ' OD1' ' HB2' ' A' ' 450' ' ' MET . 2.3 m-20 -89.61 132.03 35.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.492 -0.559 . . . . 1.0700000000000001 109.492 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 445' ' ' THR . 28.4 t -120.31 97.39 5.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.641 0.734 . . . . 0.23000000000000001 109.453 -164.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -83.44 -17.69 41.24 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.612 -1.176 . . . . 0.41999999999999998 109.993 -172.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.772 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 9.9 p90 -85.29 -13.66 49.0 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.176 -1.375 . . . . 0.32000000000000001 110.937 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -108.1 114.11 60.07 Favored Pre-proline 0 CA--C 1.503 -0.829 0 CA-C-O 122.816 1.293 . . . . 1.74 110.489 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.49 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 36.2 Cg_endo -88.4 -9.13 5.15 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.093 3.195 . . . . 0.72999999999999998 112.582 -176.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.597 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.2 pm0 -111.21 150.01 30.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.224 1.011 . . . . 2.1600000000000001 113.602 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.837 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.16 130.38 4.1 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 112.605 -2.089 . . . . 0.33000000000000002 105.487 171.093 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.23 -158.08 30.63 Favored Glycine 0 C--N 1.281 -2.494 0 C-N-CA 119.788 -1.196 . . . . 0.17000000000000001 110.817 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.507 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.28 174.65 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.277 -0.963 . . . . 0.20999999999999999 111.544 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.497 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 5.0 p-10 -51.78 101.46 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 123.399 1.571 . . . . 1.8500000000000001 113.772 -153.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.762 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.02 -35.67 11.31 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 112.489 -2.141 . . . . 1.21 109.147 169.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.74 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.1 p-90 -54.81 -28.11 46.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.006 -0.997 . . . . 0.16 112.243 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.74 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.98 -38.09 13.06 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.401 0.62 . . . . 0.22 112.377 -177.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 436' ' ' THR . 2.4 p -86.69 -43.41 12.62 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.04 -0.982 . . . . 0.25 110.446 -175.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.762 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 2.7 mtp85 -91.49 -18.6 23.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.497 -1.228 . . . . 1.8200000000000001 108.954 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.66 50.1 50.49 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 115.232 0.853 . . . . 0.23999999999999999 115.232 160.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' SER . . . . . 0.43 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 6.4 m -83.25 111.52 19.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 119.072 1.436 . . . . 1.01 111.436 -173.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.588 ' HB2' ' OAC' ' A' ' 130' ' ' 1RG . 87.7 m-70 29.52 -106.51 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.507 1.129 . . . . 0.5 113.699 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.51 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -147.53 -5.45 0.33 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.815 -0.63 . . . . 0.26000000000000001 114.415 -174.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.826 ' HB3' HASB ' A' ' 130' ' ' 1RG . 26.5 p -107.22 -167.27 1.25 Allowed 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.323 1.062 . . . . 0.34999999999999998 112.522 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 368' ' ' ILE . 1.9 mp -102.31 131.15 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 115.057 -0.974 . . . . 0.12 110.889 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -100.71 98.51 9.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.839 -1.073 . . . . 0.62 110.129 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.714 HG22 ' CG2' ' A' ' 449' ' ' VAL . 2.0 m -96.59 140.45 22.17 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 113.599 0.962 . . . . 0.10000000000000001 113.599 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.819 ' O ' HG22 ' A' ' 449' ' ' VAL . 77.3 Cg_exo -54.66 128.05 28.66 Favored 'Trans proline' 0 CA--C 1.498 -1.322 1 C-N-CA 125.452 4.101 . . . . 0.23999999999999999 114.933 177.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.837 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 52.8 Cg_exo -58.27 -8.25 4.85 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.972 3.115 . . . . 0.31 114.374 -165.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.554 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 77.9 p -93.21 -19.62 21.25 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.899 -1.046 . . . . 1.1000000000000001 111.089 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 446' ' ' PRO . 17.0 m -101.16 -49.61 10.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 114.664 1.357 . . . . 0.080000000000000002 114.664 -172.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.944 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -69.27 -2.33 10.39 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.933 -1.104 . . . . 0.070000000000000007 109.529 -177.124 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.629 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.4 pttp -77.28 -39.03 49.58 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 122.551 1.167 . . . . 0.92000000000000004 108.121 173.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm-40 -63.14 -46.48 87.02 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 112.416 -2.175 . . . . 0.25 106.709 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.944 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.6 -65.91 0.49 Allowed 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 109.935 -3.302 . . . . 0.050000000000000003 112.719 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.471 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.6 t80 -45.91 -23.33 0.28 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.861 0.725 . . . . 0.13 109.459 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.45 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.04 -24.05 33.24 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.051 -0.977 . . . . 0.13 111.927 -176.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.718 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -105.42 -43.88 4.86 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 113.808 1.04 . . . . 0.059999999999999998 113.808 176.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.666 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -73.84 150.35 7.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.42 1.105 . . . . 0.080000000000000002 111.084 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.31 156.88 32.96 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 113.247 -1.797 . . . . 0.47999999999999998 108.353 -178.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.569 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.6 mppt? -59.01 101.68 0.1 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.388 0.613 . . . . 0.98999999999999999 109.399 172.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.06 -12.72 5.54 Favored Glycine 0 C--N 1.305 -1.173 0 CA-C-N 114.107 -1.406 . . . . 0.19 111.428 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.666 HG21 ' HB ' ' A' ' 457' ' ' VAL . 12.9 m -65.82 149.36 97.57 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 108.718 -0.845 . . . . 0.13 108.718 171.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.546 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.7 Cg_endo -93.79 160.4 2.28 Favored 'Trans proline' 0 N--CA 1.423 -2.651 0 C-N-CA 122.041 1.828 . . . . 0.17999999999999999 109.989 177.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.724 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -124.05 150.87 28.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 107.386 -1.338 . . . . 0.56999999999999995 107.386 171.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.28 149.56 50.93 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.008 -1.108 . . . . 0.13 108.008 175.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.041 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.68 140.65 40.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.311 -2.107 . . . . 0.10000000000000001 105.311 165.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.671 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 9.4 p90 . . . . . 0 C--O 1.245 0.827 0 O-C-N 123.848 0.717 . . . . 1.0900000000000001 110.85 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.826 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.663 -0.575 . . . . 1.8700000000000001 111.663 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.424 ' CD2' HD11 ' A' ' 464' ' ' LEU . 1.6 m80 65.2 -177.59 0.18 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 122.823 1.297 . . . . 0.83999999999999997 110.617 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.485 ' HE2' ' HD3' ' A' ' 462' ' ' PRO . 5.5 mtm -57.8 -159.64 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 112.238 -2.256 . . . . 0.67000000000000004 111.121 163.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -59.23 161.36 5.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.093 -1.077 . . . . 1.8500000000000001 108.093 159.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.429 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 8.7 m-20 -75.89 85.05 2.83 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.582 -0.847 . . . . 0.42999999999999999 110.93 -168.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 357' ' ' TYR . 95.9 m -157.89 135.36 10.36 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.423 -1.262 . . . . 0.14000000000000001 108.763 166.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.634 ' CD2' HD13 ' A' ' 464' ' ' LEU . 38.3 p90 174.6 157.47 0.16 Allowed 'General case' 0 C--O 1.21 -0.986 0 O-C-N 123.362 0.414 . . . . 0.14999999999999999 111.367 -176.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.637 HD12 HD11 ' A' ' 453' ' ' LEU . 0.3 OUTLIER -77.88 152.72 5.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.365 -0.606 . . . . 0.080000000000000002 109.365 164.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.584 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.99 144.13 25.64 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.817 -0.629 . . . . 2.0099999999999998 109.311 -176.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.729 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -137.53 162.3 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.057 0.456 . . . . 0.45000000000000001 111.399 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.569 ' N ' HG12 ' A' ' 347' ' ' VAL . 28.9 t0 -140.44 106.88 5.29 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.38 -1.341 . . . . 0.23999999999999999 107.38 174.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.091 HD21 HG23 ' A' ' 465' ' ' VAL . 0.2 OUTLIER -84.02 -32.19 25.04 Favored 'General case' 0 CA--C 1.485 -1.538 0 CA-C-O 123.036 1.398 . . . . 0.16 110.02 -169.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.03 -45.28 91.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 110.672 -2.967 . . . . 0.59999999999999998 108.179 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ASN . . . . . 0.434 ' HB2' ' CG ' ' A' ' 348' ' ' ASP . 13.3 m120 -102.83 8.22 39.33 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 111.006 -2.816 . . . . 0.20000000000000001 110.956 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.574 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.1 mp0 32.53 61.62 0.35 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 112.722 -2.035 . . . . 2.1499999999999999 113.475 -176.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.519 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.0 t60 -142.47 135.53 28.5 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.625 -0.716 . . . . 0.089999999999999997 109.754 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.756 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.48 157.34 22.11 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.864 -0.607 . . . . 0.070000000000000007 110.332 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.626 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.7 m-90 -142.89 154.09 43.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.433 -175.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.696 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.6 t80 -110.28 153.2 25.18 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 106.725 -1.583 . . . . 0.26000000000000001 106.725 152.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.3 m-85 -128.37 117.99 22.39 Favored 'General case' 0 C--N 1.272 -2.799 0 CA-C-N 115.073 -0.967 . . . . 0.14000000000000001 110.609 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.3 tppt? -118.15 137.87 52.67 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 105.979 -1.859 . . . . 0.25 105.979 167.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.508 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.9 15.66 7.83 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.348 0.87 . . . . 0.42999999999999999 113.348 174.075 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.51 6.46 88.1 Favored Glycine 0 CA--C 1.488 -1.631 0 C-N-CA 120.673 -0.775 . . . . 0.17999999999999999 112.757 -173.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 359' ' ' ASP . 14.2 ptmt -125.5 175.93 7.18 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 104.576 -2.379 . . . . 0.37 104.576 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.626 HG11 ' CD1' ' A' ' 355' ' ' TRP . 15.5 m -103.95 157.48 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.703 0 N-CA-C 116.582 2.067 . . . . 0.10000000000000001 116.582 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.695 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.83 -27.17 9.89 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 110.642 -2.981 . . . . 0.070000000000000007 106.69 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.814 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -133.57 144.57 49.4 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 111.334 -2.666 . . . . 0.059999999999999998 111.329 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.436 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.2 tt0 -142.54 118.19 10.41 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 104.498 -2.408 . . . . 0.47999999999999998 104.498 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.756 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.69 164.62 34.73 Favored 'General case' 0 N--CA 1.401 -2.887 0 C-N-CA 118.132 -1.427 . . . . 0.070000000000000007 111.442 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 20.4 p-10 -103.82 133.31 49.03 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.734 -1.121 . . . . 1.8 109.549 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.743 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -133.2 -172.28 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 CA-C-O 122.495 1.141 . . . . 0.12 112.171 -172.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.33 118.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 112.888 -1.96 . . . . 0.10000000000000001 108.119 172.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.585 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.3 OUTLIER -75.11 -168.92 0.84 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.047 -1.433 . . . . 1.26 110.533 178.31 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 439' ' ' SER . . . -85.49 175.93 49.54 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 118.809 -1.662 . . . . 0.14000000000000001 112.156 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.9 ptmt -78.78 155.44 78.08 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 121.59 0.709 . . . . 0.81000000000000005 111.466 -167.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.67 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 78.1 Cg_exo -54.96 -27.87 56.39 Favored 'Trans proline' 0 CA--C 1.501 -1.149 1 C-N-CA 125.399 4.066 . . . . 0.28000000000000003 113.399 -174.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.46 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.4 p -71.54 -31.48 67.08 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.662 -1.608 . . . . 0.33000000000000002 109.931 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.534 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 0.7 OUTLIER -140.94 70.3 29.21 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 123.804 1.764 . . . . 0.39000000000000001 108.972 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 375' ' ' THR . 88.1 Cg_exo -57.72 152.09 51.37 Favored 'Trans proline' 0 C--N 1.314 -1.241 1 C-N-CA 126.657 4.904 . . . . 0.38 115.637 -169.572 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.585 HG21 ' OG ' ' A' ' 370' ' ' SER . 18.3 m -78.74 130.99 68.87 Favored Pre-proline 0 N--CA 1.407 -2.597 0 CA-C-N 113.942 -1.481 . . . . 0.81999999999999995 109.18 173.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.2 Cg_exo -72.1 -46.49 0.53 Allowed 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 123.325 2.683 . . . . 0.19 111.734 -173.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.79 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.2 142.88 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 123.349 1.547 . . . . 0.13 113.424 -174.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 147.49 -109.84 0.49 Allowed Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 112.402 -2.181 . . . . 0.20000000000000001 109.286 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.8 p -130.52 125.91 59.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.369 0.604 . . . . 0.81999999999999995 110.099 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.706 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 7.5 m-85 -123.65 -174.32 2.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.0 -1.482 . . . . 0.22 107.0 171.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.615 ' HB3' ' CZ3' ' A' ' 415' ' ' TRP . 2.0 t80 -140.65 122.63 15.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 119.795 1.18 . . . . 0.65000000000000002 112.76 -172.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -87.19 92.24 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 123.013 1.387 . . . . 0.16 109.223 170.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -89.89 7.82 35.31 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 113.442 -1.708 . . . . 2.5499999999999998 107.855 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.776 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 27.3 t-20 -170.2 126.88 0.82 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.368 -1.287 . . . . 0.42999999999999999 110.51 174.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.679 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.2 139.53 34.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.706 -1.134 . . . . 1.1200000000000001 109.016 170.474 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.792 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 11.4 mm-40 -123.57 158.05 32.3 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.823 1.416 . . . . 0.70999999999999996 114.823 -168.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 48.5 mt-10 -129.27 144.51 51.25 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.788 -2.006 . . . . 0.38 106.291 165.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.03 34.03 16.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.221 -1.808 . . . . 0.40999999999999998 110.238 171.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.884 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -77.38 167.46 21.64 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 112.779 -2.01 . . . . 0.12 109.186 -175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.6 m -131.63 119.18 21.07 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.157 0.98 . . . . 0.17000000000000001 111.376 172.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.0 mp -77.36 87.57 3.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.638 -1.619 . . . . 0.56999999999999995 111.73 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.589 ' HG2' ' HG3' ' A' ' 404' ' ' GLU . 47.5 mttt -102.49 179.62 4.25 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 113.195 -1.821 . . . . 0.33000000000000002 113.072 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.55 -159.01 24.75 Favored Glycine 0 N--CA 1.429 -1.832 0 CA-C-N 114.467 -1.242 . . . . 0.46000000000000002 111.319 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.7 m -118.27 140.41 49.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 120.115 -0.634 . . . . 0.70999999999999996 110.876 170.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.0 m-80 -57.47 154.5 10.9 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.281 -0.872 . . . . 0.83999999999999997 108.94 167.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.04 -1.23 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.771 -0.649 . . . . 2.2799999999999998 110.95 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.0 OUTLIER -114.44 5.21 15.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.131 -0.94 . . . . 2.27 111.33 -179.233 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.44 18.2 42.89 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.329 -0.938 . . . . 0.93999999999999995 112.558 169.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 12.1 p -113.19 99.63 49.45 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 114.34 -0.93 . . . . 0.81000000000000005 109.859 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.8 Cg_endo -58.42 151.69 59.46 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 C-N-CA 123.028 2.485 . . . . 0.63 113.438 -176.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.534 ' OH ' ' HAD' ' A' ' 130' ' ' 1RG . 23.7 p90 -152.54 172.94 15.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.477 -1.238 . . . . 0.41999999999999998 112.694 -170.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.589 ' HG3' ' HG2' ' A' ' 394' ' ' LYS . 2.1 mp0 -146.24 147.99 32.0 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.249 -1.341 . . . . 0.53000000000000003 110.828 174.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.58 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.23 97.9 4.73 Favored Pre-proline 0 N--CA 1.442 -0.873 0 N-CA-C 108.663 -0.865 . . . . 0.19 108.663 171.029 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.6 Cg_exo -68.64 110.93 2.43 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.294 1.996 . . . . 0.19 110.7 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.884 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -111.36 160.02 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-N 113.084 -1.871 . . . . 0.14999999999999999 107.724 -168.232 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 22.3 m-80 -93.26 -18.96 21.88 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.136 -0.69 . . . . 0.51000000000000001 109.136 -175.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.792 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 86.3 m-85 -158.59 125.77 4.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.072 -0.967 . . . . 0.27000000000000002 108.451 -171.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.693 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 20.2 t-105 -143.84 134.76 25.34 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.76 0.79 . . . . 0.089999999999999997 111.755 -166.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.679 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.9 mmt -117.34 94.02 44.25 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.055 -1.091 . . . . 0.14000000000000001 108.055 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.776 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 42.0 Cg_endo -68.03 70.36 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.381 2.721 . . . . 0.5 112.369 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.668 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.9 pt -76.06 65.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 122.642 1.21 . . . . 0.88 110.33 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.52 124.43 33.46 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.984 -1.007 . . . . 2.4900000000000002 109.725 -170.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.615 ' CZ3' ' HB3' ' A' ' 383' ' ' TYR . 0.0 OUTLIER 179.73 -60.76 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.832 -1.544 . . . . 1.9199999999999999 106.832 -165.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 39.9 p -115.29 -21.26 9.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.303 -1.771 . . . . 0.94999999999999996 110.813 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.747 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 134.37 -36.77 2.04 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.704 -0.76 . . . . 0.68000000000000005 113.298 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 419' ' ' GLY . 20.6 t -58.27 173.48 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.254 0.621 . . . . 0.75 112.234 -174.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.668 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -176.74 119.71 0.71 Allowed Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.852 -0.899 . . . . 0.20000000000000001 110.852 171.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.716 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.6 mt -81.07 142.87 13.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.769 0.319 . . . . 0.28999999999999998 110.486 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.674 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.0 p80 -159.98 161.04 34.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.01 -0.541 . . . . 0.089999999999999997 111.322 -173.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.696 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -83.62 145.73 28.66 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.042 -1.096 . . . . 1.0700000000000001 108.042 173.007 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 445' ' ' THR . 42.5 t -132.62 96.74 3.89 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.866 0.841 . . . . 0.23000000000000001 109.616 -172.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -82.6 -16.72 47.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.089 -1.414 . . . . 0.41999999999999998 109.389 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.762 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 9.0 p90 -87.48 -19.07 28.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.979 -1.464 . . . . 0.32000000000000001 110.914 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -103.24 113.64 65.62 Favored Pre-proline 0 CA--C 1.505 -0.78 0 CA-C-O 122.646 1.212 . . . . 1.74 110.085 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.531 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 40.9 Cg_endo -86.83 -9.36 6.52 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 124.306 3.338 . . . . 0.72999999999999998 112.889 -175.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.548 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.7 pm0 -111.8 152.69 27.58 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.269 1.033 . . . . 2.1600000000000001 113.441 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.72 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.43 131.5 4.27 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 105.146 -2.168 . . . . 0.33000000000000002 105.146 171.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.62 -158.15 30.66 Favored Glycine 0 C--N 1.282 -2.417 0 C-N-CA 119.974 -1.107 . . . . 0.17000000000000001 110.715 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.545 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.52 175.18 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.961 0 C-N-CA 120.418 -0.896 . . . . 0.20999999999999999 111.803 167.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.529 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.1 p-10 -51.51 101.19 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 123.355 1.55 . . . . 1.8500000000000001 113.336 -155.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.733 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.98 -38.04 10.4 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 112.404 -2.18 . . . . 1.21 109.099 170.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.657 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -53.11 -28.34 25.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.159 -0.928 . . . . 0.16 112.341 -171.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.67 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -89.16 -36.51 15.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.527 0.566 . . . . 0.22 112.527 -177.096 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.5 p -89.65 -42.99 11.05 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.064 -0.971 . . . . 0.25 110.699 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.733 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.8 mtp180 -92.81 -18.3 23.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.594 -1.185 . . . . 1.8200000000000001 109.752 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.83 48.74 50.25 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.021 -0.99 . . . . 0.23999999999999999 115.257 162.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' SER . . . . . 0.466 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 11.9 p -83.58 110.65 18.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 119.195 1.497 . . . . 1.01 111.447 -173.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.529 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 40.5 m-70 37.41 -124.27 0.21 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.503 -1.226 . . . . 0.5 114.086 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -129.47 -19.78 1.47 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.023 -0.608 . . . . 0.26000000000000001 113.408 -173.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.685 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.1 p -104.62 -165.86 1.18 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 112.902 0.705 . . . . 0.34999999999999998 112.902 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.455 HD13 HG11 ' A' ' 465' ' ' VAL . 1.9 mp -95.11 130.98 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 115.212 -0.904 . . . . 0.12 110.64 -175.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -105.31 94.61 5.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.716 0.77 . . . . 0.62 110.259 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.743 ' HA ' HG22 ' A' ' 368' ' ' ILE . 2.5 m -90.26 143.64 29.86 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-N 114.147 -1.388 . . . . 0.10000000000000001 112.89 -176.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.651 ' HD2' HG21 ' A' ' 366' ' ' THR . 74.8 Cg_exo -50.02 144.45 21.91 Favored 'Trans proline' 0 CA--C 1.505 -0.939 0 C-N-CA 123.943 3.096 . . . . 0.23999999999999999 113.22 175.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.72 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.3 Cg_exo -65.3 -24.58 57.78 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.748 2.299 . . . . 0.31 112.213 -175.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.534 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 70.1 p -78.12 -25.06 47.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.391 -0.822 . . . . 1.1000000000000001 111.874 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.814 ' O ' HD21 ' A' ' 364' ' ' LEU . 31.8 m -99.58 -49.67 11.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 112.985 0.735 . . . . 0.080000000000000002 112.985 -170.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.957 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.93 -2.1 4.83 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.65 -0.82 . . . . 0.070000000000000007 110.446 -178.378 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.566 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 16.3 pttp -81.1 -38.06 27.89 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 122.54 1.162 . . . . 0.92000000000000004 108.238 173.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.4 mm-40 -62.85 -46.61 87.08 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 112.372 -2.195 . . . . 0.25 106.587 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.957 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.1 tp -47.14 -66.44 0.41 Allowed 'General case' 0 N--CA 1.402 -2.826 0 CA-C-N 109.887 -3.324 . . . . 0.050000000000000003 112.658 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.446 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 23.5 t80 -46.3 -22.51 0.25 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.769 0.795 . . . . 0.13 109.71 175.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.45 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.95 -23.31 33.08 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 114.887 -1.051 . . . . 0.13 111.849 -176.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.74 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -106.38 -44.42 4.53 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 113.938 1.088 . . . . 0.059999999999999998 113.938 176.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -72.8 149.21 8.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 122.182 0.991 . . . . 0.080000000000000002 110.804 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.45 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -120.55 158.16 27.92 Favored 'General case' 0 N--CA 1.413 -2.324 0 CA-C-N 113.427 -1.715 . . . . 0.47999999999999998 109.043 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.6 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.8 mppt? -58.97 102.41 0.12 Allowed 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.911 -0.774 . . . . 0.98999999999999999 108.911 170.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.37 -12.04 5.77 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 114.051 -1.432 . . . . 0.19 111.449 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.632 HG21 ' HB ' ' A' ' 457' ' ' VAL . 18.8 m -68.22 149.9 97.93 Favored Pre-proline 0 N--CA 1.439 -1.005 0 N-CA-C 108.732 -0.84 . . . . 0.13 108.732 171.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.6 Cg_endo -94.34 165.93 1.93 Allowed 'Trans proline' 0 N--CA 1.419 -2.87 0 C-N-CA 122.278 1.985 . . . . 0.17999999999999999 109.623 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -128.81 153.53 38.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.655 -1.239 . . . . 0.56999999999999995 107.655 170.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.699 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.1 151.71 51.51 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 108.6 -0.889 . . . . 0.13 108.6 173.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.091 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.61 141.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 105.329 -2.1 . . . . 0.10000000000000001 105.329 166.03 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.712 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 7.8 p90 . . . . . 0 C--O 1.244 0.815 0 O-C-N 123.628 0.58 . . . . 1.0900000000000001 111.119 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.747 ' HG ' ' O ' ' A' ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 111.974 -0.45 . . . . 1.8700000000000001 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.586 ' CE1' HD21 ' A' ' 464' ' ' LEU . 3.7 p-80 -139.74 99.85 3.81 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 120.85 0.357 . . . . 0.83999999999999997 111.933 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.535 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.2 OUTLIER 62.45 -169.02 0.19 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.048 -0.978 . . . . 0.67000000000000004 112.924 166.382 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.24 171.77 2.21 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.759 -0.655 . . . . 1.8500000000000001 109.476 162.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.484 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.4 m-20 -79.18 83.42 5.24 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.087 -1.045 . . . . 0.42999999999999999 109.973 -177.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.809 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 86.6 m -158.28 134.49 9.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.387 -1.278 . . . . 0.14000000000000001 108.825 166.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.743 ' CD2' HD13 ' A' ' 464' ' ' LEU . 41.1 p90 174.52 158.24 0.16 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 123.42 0.45 . . . . 0.14999999999999999 110.983 -175.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.636 HD11 HG11 ' A' ' 457' ' ' VAL . 0.5 OUTLIER -77.4 153.26 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 109.122 -0.695 . . . . 0.080000000000000002 109.122 165.051 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.06 147.12 29.22 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.038 -1.097 . . . . 2.0099999999999998 108.038 -177.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.732 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.2 t -138.99 153.78 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 C-N-CA 123.625 0.77 . . . . 0.45000000000000001 110.422 173.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.496 ' N ' HG12 ' A' ' 347' ' ' VAL . 16.4 t0 -136.85 106.53 6.18 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.98 -1.489 . . . . 0.23999999999999999 106.98 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.028 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -79.01 -35.03 43.46 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 124.049 1.881 . . . . 0.16 110.334 -166.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.425 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.4 mt-10 -55.44 -43.49 75.45 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 110.904 -2.862 . . . . 0.59999999999999998 107.697 176.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 17.6 m-80 -101.51 4.54 41.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 110.97 -2.832 . . . . 0.20000000000000001 111.395 -175.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.842 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 83.5 mm-40 31.38 62.44 0.24 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 112.852 -1.976 . . . . 2.1499999999999999 113.465 -172.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.628 ' NE2' ' HG2' ' A' ' 365' ' ' GLU . 29.6 t60 -141.43 136.83 31.74 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.453 -1.249 . . . . 0.089999999999999997 109.927 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.732 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -112.94 158.98 19.56 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.057 -0.519 . . . . 0.070000000000000007 110.214 -179.292 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.641 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -144.17 160.71 40.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.703 -0.681 . . . . 0.11 111.149 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.809 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.4 t80 -113.39 153.56 28.37 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 106.465 -1.68 . . . . 0.26000000000000001 106.465 150.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.4 m-85 -128.01 116.57 20.25 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.129 -0.941 . . . . 0.14000000000000001 110.248 -178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.1 tppt? -117.78 138.44 52.05 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.046 -1.835 . . . . 0.25 106.046 168.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.49 16.96 8.11 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.39 0.885 . . . . 0.42999999999999999 113.39 172.355 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.484 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.34 8.04 87.0 Favored Glycine 0 CA--C 1.485 -1.796 0 CA-C-N 115.643 -0.708 . . . . 0.17999999999999999 113.036 -173.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.2 ptmt -128.11 177.93 6.57 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 104.493 -2.41 . . . . 0.37 104.493 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.641 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.1 m -104.59 158.23 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.747 0 N-CA-C 116.303 1.964 . . . . 0.10000000000000001 116.303 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.689 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.91 -28.51 9.57 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 110.764 -2.925 . . . . 0.070000000000000007 106.35 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.798 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.53 145.36 50.05 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 111.551 -2.568 . . . . 0.059999999999999998 111.678 -175.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.628 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -142.23 118.77 10.97 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 104.49 -2.411 . . . . 0.47999999999999998 104.49 174.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.732 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.6 163.68 37.22 Favored 'General case' 0 N--CA 1.401 -2.89 0 C-N-CA 118.332 -1.347 . . . . 0.070000000000000007 110.57 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.588 ' OD2' ' HA2' ' A' ' 430' ' ' GLY . 0.5 OUTLIER -100.75 142.3 32.41 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.739 -0.838 . . . . 1.8 108.739 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.731 HG22 ' HA ' ' A' ' 445' ' ' THR . 1.9 pp -137.03 -172.76 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 CA-C-O 122.045 0.926 . . . . 0.12 112.317 -173.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.842 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -152.87 118.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 113.196 -1.82 . . . . 0.10000000000000001 109.442 171.442 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 349' ' ' LEU . 54.6 p -78.8 -168.0 1.29 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.062 -2.336 . . . . 1.26 111.285 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.415 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.9 165.56 40.09 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 118.602 -1.761 . . . . 0.14000000000000001 112.17 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -71.64 156.79 90.89 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.41 0.624 . . . . 0.81000000000000005 111.474 -168.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.637 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 87.9 Cg_exo -55.84 -28.67 68.8 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 125.174 3.916 . . . . 0.28000000000000003 113.612 -173.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.454 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 17.8 p -70.81 -32.38 69.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.421 -1.718 . . . . 0.33000000000000002 109.644 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.527 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -140.98 70.63 28.93 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 123.822 1.772 . . . . 0.39000000000000001 109.033 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 375' ' ' THR . 89.0 Cg_exo -58.08 157.15 26.19 Favored 'Trans proline' 0 C--N 1.312 -1.387 1 C-N-CA 126.592 4.861 . . . . 0.38 115.358 -170.351 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.51 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 1.5 m -82.67 131.87 53.57 Favored Pre-proline 0 N--CA 1.406 -2.648 0 CA-C-N 114.326 -1.306 . . . . 0.81999999999999995 108.482 172.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.534 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 24.6 Cg_exo -72.19 -45.69 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.808 3.005 . . . . 0.19 112.334 -171.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.817 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 60.5 140.92 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 123.283 1.516 . . . . 0.13 113.791 -173.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 150.06 -110.41 0.47 Allowed Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 112.331 -2.213 . . . . 0.20000000000000001 109.419 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.1 p -130.02 123.18 55.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.694 0.759 . . . . 0.81999999999999995 109.961 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.773 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 3.5 m-85 -120.27 -173.55 2.59 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.544 -1.651 . . . . 0.22 106.544 170.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 9.5 t80 -144.17 127.35 16.64 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 120.477 -1.389 . . . . 0.65000000000000002 113.576 -171.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.8 p -90.44 92.93 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 122.949 1.357 . . . . 0.16 109.97 171.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -73.49 -10.93 60.24 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.253 -1.794 . . . . 2.5499999999999998 108.067 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.782 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.4 t30 -169.96 133.04 1.15 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.651 -0.704 . . . . 0.42999999999999999 112.093 -175.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.631 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -92.53 154.76 18.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.054 -0.521 . . . . 1.1200000000000001 110.485 171.164 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.78 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 35.8 mm-40 -132.59 157.97 43.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 115.013 1.486 . . . . 0.70999999999999996 115.013 -171.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.757 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.8 mt-10 -138.29 126.89 23.47 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.827 -1.988 . . . . 0.38 108.425 173.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.63 49.21 20.86 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 123.371 1.557 . . . . 0.40999999999999998 109.195 -175.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.946 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -79.76 168.31 19.47 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 112.665 -2.061 . . . . 0.12 108.577 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.7 m -133.16 119.53 20.02 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.154 0.978 . . . . 0.17000000000000001 111.808 170.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.567 HD13 ' HB ' ' A' ' 407' ' ' VAL . 3.7 mp -79.47 88.75 5.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.541 -1.663 . . . . 0.56999999999999995 112.023 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.555 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.2 mttt -103.3 178.58 4.52 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 113.618 -1.628 . . . . 0.33000000000000002 113.439 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.97 -160.99 25.48 Favored Glycine 0 N--CA 1.429 -1.805 0 CA-C-N 114.064 -1.425 . . . . 0.46000000000000002 111.58 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.9 m -115.41 137.54 51.94 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.483 -0.487 . . . . 0.70999999999999996 110.417 169.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 399' ' ' ASP . 2.2 m120 -53.9 153.37 4.81 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.659 -0.7 . . . . 0.83999999999999997 109.163 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -2.42 0.4 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.168 -0.924 . . . . 2.2799999999999998 111.3 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 397' ' ' ASN . 10.7 t70 -115.54 2.34 13.8 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.599 0.714 . . . . 2.27 111.272 -178.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.28 18.8 27.66 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.002 -1.094 . . . . 0.93999999999999995 113.232 171.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.479 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 8.0 p -113.36 100.32 51.4 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 114.912 -0.644 . . . . 0.81000000000000005 110.044 -176.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 19.1 Cg_endo -58.54 149.67 73.96 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.597 2.198 . . . . 0.63 112.884 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -152.86 174.47 14.04 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.274 -1.33 . . . . 0.41999999999999998 112.661 -168.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.555 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -146.73 148.06 31.6 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.906 -1.497 . . . . 0.53000000000000003 109.894 172.228 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.33 97.29 5.18 Favored Pre-proline 0 N--CA 1.436 -1.149 0 N-CA-C 107.905 -1.146 . . . . 0.19 107.905 169.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.5 Cg_exo -68.26 109.5 2.01 Favored 'Trans proline' 0 N--CA 1.432 -2.098 0 C-N-CA 121.929 1.753 . . . . 0.19 109.584 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.946 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -107.65 156.99 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 CA-C-N 112.915 -1.948 . . . . 0.14999999999999999 107.421 -168.143 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.757 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.5 m-80 -88.63 -20.67 24.64 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.014 -0.736 . . . . 0.51000000000000001 109.014 -174.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 75.6 m-85 -158.82 126.75 5.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.013 -0.994 . . . . 0.27000000000000002 108.527 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.675 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 26.8 t-105 -144.21 138.69 28.24 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.463 0.649 . . . . 0.089999999999999997 110.93 -167.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.631 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -122.23 92.27 48.94 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.272 -1.01 . . . . 0.14000000000000001 108.272 175.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.782 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 25.5 Cg_endo -63.41 84.44 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.554 2.169 . . . . 0.5 112.853 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 411' ' ' MET . 2.4 pt -86.08 177.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.141 -1.059 . . . . 0.88 108.141 175.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 416' ' ' THR . 1.5 t70 -155.11 -169.39 3.16 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 118.989 -1.084 . . . . 2.4900000000000002 113.162 -166.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 39.9 p90 55.32 -6.3 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.991 2.116 . . . . 1.9199999999999999 114.495 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.534 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 23.2 p -129.53 -13.65 4.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.206 0.527 . . . . 0.94999999999999996 110.934 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.583 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 96.24 -29.44 10.15 Favored Glycine 0 CA--C 1.505 -0.569 0 N-CA-C 111.322 -0.711 . . . . 0.68000000000000005 111.322 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 419' ' ' GLY . 25.1 t -55.11 171.97 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.936 0.895 . . . . 0.75 112.011 -176.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.21 122.53 0.82 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.182 -1.167 . . . . 0.20000000000000001 110.182 170.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.65 HG22 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.37 141.92 14.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 109.956 -0.387 . . . . 0.28999999999999998 109.956 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.675 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.3 p80 -159.9 161.19 34.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 0.089999999999999997 111.448 -175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.703 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -82.8 149.53 27.15 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 107.889 -1.152 . . . . 1.0700000000000001 107.889 171.434 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 445' ' ' THR . 47.1 t -133.82 96.84 3.75 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.708 0.766 . . . . 0.23000000000000001 110.015 -173.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -81.29 -13.39 58.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.453 -1.249 . . . . 0.41999999999999998 109.734 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.754 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 9.3 p90 -92.89 -19.93 21.17 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.23 -1.35 . . . . 0.32000000000000001 111.487 -175.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.474 ' HG2' ' OE2' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -103.36 117.81 59.25 Favored Pre-proline 0 CA--C 1.507 -0.674 0 CA-C-O 122.663 1.221 . . . . 1.74 110.542 -179.272 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.569 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 44.0 Cg_endo -87.16 -12.09 5.0 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 124.348 3.365 . . . . 0.72999999999999998 113.874 -173.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.573 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.5 pm0 -110.19 150.62 28.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.38 1.086 . . . . 2.1600000000000001 112.964 174.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.585 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.7 OUTLIER -158.33 127.88 5.81 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 112.691 -2.05 . . . . 0.33000000000000002 105.8 169.056 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.588 ' HA2' ' OD2' ' A' ' 367' ' ' ASP . . . 169.06 -158.48 31.07 Favored Glycine 0 C--N 1.286 -2.234 0 C-N-CA 119.871 -1.157 . . . . 0.17000000000000001 111.148 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.511 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.16 165.91 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.781 0 C-N-CA 120.511 -0.852 . . . . 0.20999999999999999 111.665 168.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 435' ' ' LYS . 22.4 m-20 -52.82 101.93 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.684 -1.258 . . . . 1.8500000000000001 113.096 -155.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 1.033 HD22 ' HD2' ' A' ' 437' ' ' ARG . 33.7 mt -94.96 -33.22 12.84 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 112.943 -1.935 . . . . 1.21 109.275 175.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.715 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.0 p-90 -53.87 -27.45 30.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.738 -1.119 . . . . 0.16 112.511 -173.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.715 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.05 -34.54 16.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.92 -0.582 . . . . 0.22 111.977 -178.145 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.9 p -89.72 -41.43 11.91 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.047 -0.978 . . . . 0.25 110.787 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 1.033 ' HD2' HD22 ' A' ' 433' ' ' LEU . 0.8 OUTLIER -94.2 -18.11 22.04 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.546 -1.206 . . . . 1.8200000000000001 109.957 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.76 48.49 56.62 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.984 -1.007 . . . . 0.23999999999999999 115.045 163.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 10.1 p -83.71 111.38 19.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.35 1.075 . . . . 1.01 111.936 -171.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.48 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 62.8 m-70 35.92 -118.47 0.12 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.693 -1.139 . . . . 0.5 113.298 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.415 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -137.06 -16.59 0.74 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.999 -0.62 . . . . 0.26000000000000001 113.841 -175.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.835 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.3 p -103.78 -167.06 1.32 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.63 0.715 . . . . 0.34999999999999998 112.511 -176.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.452 HD13 HG11 ' A' ' 465' ' ' VAL . 2.1 mp -98.74 129.01 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 114.893 -1.049 . . . . 0.12 110.866 -174.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -101.61 97.89 8.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.473 -0.785 . . . . 0.62 110.422 -177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.731 ' HA ' HG22 ' A' ' 368' ' ' ILE . 6.8 m -94.1 144.08 27.48 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 115.071 -0.968 . . . . 0.10000000000000001 112.467 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.637 ' HD2' HG21 ' A' ' 366' ' ' THR . 81.7 Cg_exo -51.07 143.48 31.57 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 124.012 3.142 . . . . 0.23999999999999999 113.178 175.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.703 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.5 Cg_exo -64.62 -29.96 60.62 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.833 2.355 . . . . 0.31 112.361 -176.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 38.6 m -72.95 -23.49 60.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.769 -0.651 . . . . 1.1000000000000001 112.218 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.798 ' O ' HD21 ' A' ' 364' ' ' LEU . 25.2 m -100.82 -47.42 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 113.01 0.744 . . . . 0.080000000000000002 113.01 -169.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.961 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.8 -2.22 6.79 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.69 -0.804 . . . . 0.070000000000000007 110.204 -178.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 448' ' ' SER . 16.2 pttp -80.24 -38.88 30.1 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.475 1.131 . . . . 0.92000000000000004 108.201 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 4.4 mm-40 -61.91 -46.54 88.9 Favored 'General case' 0 CA--C 1.471 -2.066 0 CA-C-N 112.497 -2.138 . . . . 0.25 106.484 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.961 HD23 ' SD ' ' A' ' 450' ' ' MET . 2.9 tp -47.45 -65.89 0.49 Allowed 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 109.973 -3.285 . . . . 0.050000000000000003 112.608 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.471 ' CE2' ' HG3' ' A' ' 389' ' ' GLU . 21.9 t80 -45.33 -22.98 0.16 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.853 0.835 . . . . 0.13 109.728 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.458 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -90.65 -26.84 21.62 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.74 -1.118 . . . . 0.13 111.983 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.747 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -102.33 -44.68 5.33 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 113.64 0.978 . . . . 0.059999999999999998 113.64 177.777 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -71.23 147.08 11.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 122.391 1.091 . . . . 0.080000000000000002 110.793 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.572 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -113.32 157.5 21.74 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 113.033 -1.894 . . . . 0.47999999999999998 108.869 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.653 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 7.2 mtpt -60.74 101.54 0.15 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.063 -1.088 . . . . 0.98999999999999999 108.063 166.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.86 -7.41 6.46 Favored Glycine 0 C--N 1.308 -1.025 0 CA-C-N 113.957 -1.474 . . . . 0.19 111.631 -174.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.673 HG21 ' HB ' ' A' ' 457' ' ' VAL . 8.0 m -72.96 150.58 90.4 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 108.257 -1.016 . . . . 0.13 108.257 170.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.535 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 10.1 Cg_endo -95.32 171.94 1.3 Allowed 'Trans proline' 0 N--CA 1.417 -2.972 0 C-N-CA 122.172 1.915 . . . . 0.17999999999999999 109.91 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.773 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -130.88 153.85 39.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.201 -1.037 . . . . 0.56999999999999995 108.201 171.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.743 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.2 mp -134.08 150.67 51.18 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.637 -0.875 . . . . 0.13 108.637 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.028 HG23 HD21 ' A' ' 349' ' ' LEU . 0.8 OUTLIER -140.19 140.1 35.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 103.981 -2.6 . . . . 0.10000000000000001 103.981 162.431 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.817 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 4.6 p90 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.399 -1.286 . . . . 1.0900000000000001 111.184 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.835 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.73 -0.548 . . . . 1.8700000000000001 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.592 ' CE1' HD21 ' A' ' 464' ' ' LEU . 2.2 p-80 -137.87 100.09 4.08 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 111.976 0.362 . . . . 0.83999999999999997 111.976 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.544 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.2 OUTLIER 62.16 -163.28 0.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.238 -0.892 . . . . 0.67000000000000004 112.646 165.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.9 175.88 1.83 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.805 -1.184 . . . . 1.8500000000000001 107.805 164.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.467 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 9.1 m-20 -82.52 82.89 7.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.06 -1.056 . . . . 0.42999999999999999 109.457 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.776 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 91.5 m -157.67 134.63 10.06 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.63 -1.168 . . . . 0.14000000000000001 108.539 168.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.765 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.9 p90 174.42 158.32 0.16 Allowed 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 123.503 0.502 . . . . 0.14999999999999999 111.152 -175.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 453' ' ' LEU . 0.5 OUTLIER -77.26 153.86 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 109.077 -0.712 . . . . 0.080000000000000002 109.077 164.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.639 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.46 146.9 28.6 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.006 -1.109 . . . . 2.0099999999999998 108.006 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.727 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.0 t -139.24 154.31 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 C-N-CA 123.687 0.795 . . . . 0.45000000000000001 110.449 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.509 ' N ' HG12 ' A' ' 347' ' ' VAL . 17.8 t0 -137.79 105.77 5.68 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.61 -1.626 . . . . 0.23999999999999999 106.61 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.032 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -79.18 -35.97 41.05 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 114.086 -1.416 . . . . 0.16 109.891 -165.338 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.438 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -55.77 -44.76 77.99 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 110.669 -2.968 . . . . 0.59999999999999998 108.124 177.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 21.7 m-80 -100.56 6.76 44.27 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 110.931 -2.85 . . . . 0.20000000000000001 110.795 -175.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 20.8 mp0 32.83 60.8 0.4 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 112.786 -2.006 . . . . 2.1499999999999999 112.868 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.503 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.3 t60 -141.77 136.44 30.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.748 -0.66 . . . . 0.089999999999999997 109.66 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.77 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.1 OUTLIER -113.81 157.64 22.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.898 -0.592 . . . . 0.070000000000000007 110.001 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.649 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.7 m-90 -143.35 161.25 38.85 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.179 0.592 . . . . 0.11 111.044 -177.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.776 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.1 t80 -113.41 153.56 28.41 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.423 -1.695 . . . . 0.26000000000000001 106.423 150.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.0 m-85 -127.81 117.68 22.3 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.001 -1.0 . . . . 0.14000000000000001 109.954 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.5 tppt? -118.44 137.8 52.91 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.08 -1.822 . . . . 0.25 106.08 168.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.453 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 70.21 16.36 7.36 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.276 0.843 . . . . 0.42999999999999999 113.276 172.183 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.35 7.47 87.85 Favored Glycine 0 CA--C 1.485 -1.816 0 CA-C-N 115.72 -0.673 . . . . 0.17999999999999999 112.956 -173.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 16.6 ptmt -127.5 177.76 6.54 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 104.66 -2.348 . . . . 0.37 104.66 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.649 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.2 m -104.58 158.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.616 0 N-CA-C 116.427 2.01 . . . . 0.10000000000000001 116.427 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.711 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.7 -26.25 9.97 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 110.607 -2.997 . . . . 0.070000000000000007 106.671 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.816 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -135.19 145.12 47.41 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 111.404 -2.635 . . . . 0.059999999999999998 111.653 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.458 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.6 tt0 -141.25 119.05 11.76 Favored 'General case' 0 N--CA 1.405 -2.684 0 N-CA-C 104.269 -2.493 . . . . 0.47999999999999998 104.269 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.77 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.1 165.17 33.61 Favored 'General case' 0 N--CA 1.4 -2.973 0 C-N-CA 117.958 -1.497 . . . . 0.070000000000000007 111.501 178.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.443 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 29.5 p-10 -103.89 136.68 43.1 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.821 -1.082 . . . . 1.8 109.822 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.729 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -136.58 -173.02 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.247 0 CA-C-O 122.506 1.146 . . . . 0.12 112.483 -171.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.61 119.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 112.811 -1.995 . . . . 0.10000000000000001 108.102 173.474 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.496 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -80.47 -168.09 1.59 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.254 -1.339 . . . . 1.26 110.479 -178.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.401 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.74 169.94 45.34 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 118.811 -1.661 . . . . 0.14000000000000001 112.414 -174.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 2.2 ptpt -74.48 156.24 87.15 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.314 0.578 . . . . 0.81000000000000005 112.33 -164.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 85.8 Cg_exo -54.83 -30.89 70.2 Favored 'Trans proline' 0 CA--C 1.497 -1.345 1 C-N-CA 125.537 4.158 . . . . 0.28000000000000003 114.037 -173.137 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.418 ' OG1' HG22 ' A' ' 375' ' ' THR . 21.5 p -67.2 -31.47 71.89 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.703 -1.59 . . . . 0.33000000000000002 109.565 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.52 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -141.87 70.9 24.39 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 113.683 -1.599 . . . . 0.39000000000000001 109.731 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.4 Cg_exo -58.15 142.99 97.45 Favored 'Trans proline' 0 C--N 1.306 -1.679 1 C-N-CA 125.884 4.389 . . . . 0.38 113.307 -172.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.496 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -73.11 144.24 84.61 Favored Pre-proline 0 N--CA 1.422 -1.83 0 N-CA-C 108.154 -1.054 . . . . 0.81999999999999995 108.154 175.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.1 Cg_exo -74.97 -44.1 0.36 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 124.381 3.387 . . . . 0.19 111.728 -165.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.858 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 57.93 136.69 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 123.528 1.632 . . . . 0.13 113.86 -173.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 155.3 -114.61 0.62 Allowed Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 112.013 -2.358 . . . . 0.20000000000000001 109.377 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.91 114.72 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 121.822 0.82 . . . . 0.81999999999999995 111.192 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.756 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.4 m-85 -112.42 -174.18 2.4 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.193 -1.41 . . . . 0.22 107.193 174.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 415' ' ' TRP . 1.3 t80 -140.58 124.47 17.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.19 1.359 . . . . 0.65000000000000002 113.598 -172.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.95 92.04 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 123.066 1.412 . . . . 0.16 109.611 168.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -92.87 10.78 29.65 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.419 -1.719 . . . . 2.5499999999999998 107.982 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.753 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.4 t30 -169.79 126.3 0.86 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 113.873 -1.512 . . . . 0.42999999999999999 110.095 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.668 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.5 144.06 29.94 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.998 -1.001 . . . . 1.1200000000000001 109.171 170.495 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.763 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 29.8 mm-40 -124.73 158.3 33.59 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 114.896 1.443 . . . . 0.70999999999999996 114.896 -167.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.736 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 56.2 mt-10 -137.05 126.88 25.63 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 112.958 -1.928 . . . . 0.38 108.57 174.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 37.1 t70 54.23 47.35 23.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 123.076 1.417 . . . . 0.40999999999999998 109.228 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.923 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.43 166.23 21.45 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 112.922 -1.945 . . . . 0.12 108.891 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 18.7 m -132.3 119.33 20.61 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.136 0.97 . . . . 0.17000000000000001 111.465 171.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.8 89.02 5.22 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.731 -1.577 . . . . 0.56999999999999995 111.853 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.596 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.9 mttt -101.57 176.98 5.05 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 113.8 -1.546 . . . . 0.33000000000000002 113.353 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 137.76 -157.08 24.02 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 119.526 -1.321 . . . . 0.46000000000000002 111.898 -177.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.3 m -115.79 139.42 50.2 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 120.367 -0.533 . . . . 0.70999999999999996 111.604 172.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 401' ' ' THR . 5.2 m-80 -57.31 154.47 10.48 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 114.919 -1.037 . . . . 0.83999999999999997 110.039 168.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.09 -2.61 0.18 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.441 -1.254 . . . . 2.2799999999999998 112.173 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 397' ' ' ASN . 20.9 t70 -117.21 2.54 12.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.676 0.751 . . . . 2.27 111.033 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.73 16.51 36.18 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 119.941 -1.123 . . . . 0.93999999999999995 113.01 172.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 7.0 p -113.2 102.26 54.56 Favored Pre-proline 0 C--N 1.303 -1.421 0 CA-C-N 114.785 -0.708 . . . . 0.81000000000000005 109.675 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.3 Cg_endo -57.66 149.75 65.87 Favored 'Trans proline' 0 CA--C 1.506 -0.894 0 C-N-CA 122.867 2.378 . . . . 0.63 113.514 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -148.79 174.57 12.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.266 -1.334 . . . . 0.41999999999999998 112.66 -169.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.596 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.7 OUTLIER -143.01 148.33 36.59 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.649 -1.614 . . . . 0.53000000000000003 109.769 170.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.9 OUTLIER -143.42 96.76 5.69 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 107.916 -1.142 . . . . 0.19 107.916 170.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 17.3 Cg_exo -69.52 110.51 2.52 Favored 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.791 1.66 . . . . 0.19 109.728 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.923 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.18 151.52 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 112.941 -1.936 . . . . 0.14999999999999999 107.11 -168.447 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.736 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 22.6 m-80 -85.42 -20.11 30.32 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.962 -0.755 . . . . 0.51000000000000001 108.962 -174.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.763 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 81.2 m-85 -158.27 126.11 5.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.995 -1.002 . . . . 0.27000000000000002 108.705 -170.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.679 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 24.5 t-105 -144.48 133.11 22.21 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.758 0.79 . . . . 0.089999999999999997 111.104 -167.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.668 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.9 mmt -114.92 93.66 35.19 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 107.816 -1.179 . . . . 0.14000000000000001 107.816 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.753 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.6 Cg_endo -67.59 71.4 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.455 2.103 . . . . 0.5 112.252 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.606 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.2 pt -70.05 174.31 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.564 -0.902 . . . . 0.88 108.564 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.511 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 1.0 OUTLIER -147.38 -173.75 4.34 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.847 -1.141 . . . . 2.4900000000000002 112.541 -165.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.511 ' CE3' ' HB3' ' A' ' 414' ' ' ASP . 37.7 p90 50.72 0.68 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.853 2.061 . . . . 1.9199999999999999 115.025 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.483 HG21 ' CD1' ' A' ' 382' ' ' PHE . 29.9 p -131.17 -15.23 3.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.055 0.455 . . . . 0.94999999999999996 111.544 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.432 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 97.98 -35.47 4.53 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 111.267 -0.733 . . . . 0.68000000000000005 111.267 177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 419' ' ' GLY . 39.4 t -59.13 172.79 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 123.926 0.89 . . . . 0.75 112.021 -177.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.606 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -176.95 121.64 0.8 Allowed Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.867 -1.293 . . . . 0.20000000000000001 109.867 169.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.699 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.2 mp -82.02 143.22 12.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 110.106 -0.331 . . . . 0.28999999999999998 110.106 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.679 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.0 p80 -160.28 161.86 33.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.178 -0.464 . . . . 0.089999999999999997 111.514 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.684 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -83.19 145.62 29.07 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.607 -1.257 . . . . 1.0700000000000001 107.607 171.402 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.552 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 29.4 t -133.81 98.33 4.14 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.95 0.881 . . . . 0.23000000000000001 110.205 -171.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.35 -11.23 59.73 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.002 -1.454 . . . . 0.41999999999999998 109.609 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.729 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 11.1 p90 -95.6 -26.99 15.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.43 -1.259 . . . . 0.32000000000000001 112.125 -175.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.552 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.1 OUTLIER -90.45 109.06 31.25 Favored Pre-proline 0 CA--C 1.509 -0.628 0 CA-C-O 122.487 1.137 . . . . 1.74 108.692 177.035 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.483 ' HD2' ' NE2' ' A' ' 426' ' ' GLN . 67.8 Cg_endo -82.33 -16.46 8.27 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 124.249 3.299 . . . . 0.72999999999999998 112.973 -172.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.556 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 0.9 OUTLIER -111.47 157.48 20.25 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.125 0.964 . . . . 2.1600000000000001 112.049 173.532 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.677 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.6 OUTLIER -160.7 129.64 4.77 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 104.949 -2.241 . . . . 0.33000000000000002 104.949 172.266 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.82 -157.27 29.47 Favored Glycine 0 C--N 1.284 -2.339 0 C-N-CA 119.678 -1.249 . . . . 0.17000000000000001 110.797 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -44.97 174.01 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.184 -1.008 . . . . 0.20999999999999999 111.482 167.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.532 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.4 p-10 -52.59 101.95 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 123.28 1.515 . . . . 1.8500000000000001 113.89 -153.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.711 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.93 -36.99 10.88 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 112.651 -2.068 . . . . 1.21 109.582 169.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.757 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.5 p-90 -54.44 -26.88 33.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.338 -0.846 . . . . 0.16 112.4 -170.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.757 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.72 -35.21 15.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 112.523 0.564 . . . . 0.22 112.523 -177.386 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.441 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.2 p -91.82 -43.71 9.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.031 -0.986 . . . . 0.25 110.904 -176.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.711 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.8 OUTLIER -90.09 -19.24 24.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.73 -1.123 . . . . 1.8200000000000001 109.152 -179.085 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.8 47.54 46.74 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.475 -0.784 . . . . 0.23999999999999999 114.952 161.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.9 p -84.65 110.97 19.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 118.622 1.211 . . . . 1.01 111.597 -172.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 37.09 -130.86 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.69 -1.141 . . . . 0.5 113.031 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.401 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -121.74 -20.06 3.24 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.088 -0.577 . . . . 0.26000000000000001 114.084 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.773 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.4 p -99.09 -166.83 1.4 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.803 0.801 . . . . 0.34999999999999998 112.867 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.437 HG12 HG11 ' A' ' 347' ' ' VAL . 2.2 mp -96.73 130.01 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 115.105 -0.952 . . . . 0.12 110.887 -173.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.01 94.56 6.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.945 -0.57 . . . . 0.62 110.418 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.729 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.6 m -91.26 142.39 27.1 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-N 115.147 -0.933 . . . . 0.10000000000000001 112.481 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.67 ' HD2' HG21 ' A' ' 366' ' ' THR . 89.3 Cg_exo -49.72 143.59 22.17 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 123.925 3.083 . . . . 0.23999999999999999 113.268 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.684 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.2 Cg_exo -65.0 -27.94 57.81 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.836 2.357 . . . . 0.31 112.053 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.503 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 31.6 m -75.56 -22.61 56.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.505 0.669 . . . . 1.1000000000000001 112.371 -176.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.816 ' O ' HD21 ' A' ' 364' ' ' LEU . 26.3 m -100.99 -48.03 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 112.898 0.703 . . . . 0.080000000000000002 112.898 -170.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.957 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.18 -2.03 5.22 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.72 -0.792 . . . . 0.070000000000000007 110.246 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.505 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 14.7 pttp -81.2 -38.78 26.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 122.58 1.181 . . . . 0.92000000000000004 108.143 173.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm-40 -62.18 -46.35 89.32 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 112.368 -2.196 . . . . 0.25 106.559 -177.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.957 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.8 tp -46.69 -67.11 0.31 Allowed 'General case' 0 N--CA 1.403 -2.781 0 CA-C-N 109.785 -3.37 . . . . 0.050000000000000003 112.735 172.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.492 ' CE2' ' HE2' ' A' ' 387' ' ' LYS . 14.6 t80 -45.34 -24.11 0.26 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 124.034 0.834 . . . . 0.13 109.469 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.452 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.12 -27.15 26.62 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 114.684 -1.144 . . . . 0.13 111.732 -176.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.749 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.03 -44.07 5.83 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 113.459 0.911 . . . . 0.059999999999999998 113.459 176.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.664 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -72.89 149.91 8.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 122.554 1.168 . . . . 0.080000000000000002 111.182 -179.485 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.424 ' H ' ' HG3' ' A' ' 458' ' ' GLU . 0.0 OUTLIER -119.87 156.25 31.08 Favored 'General case' 0 N--CA 1.413 -2.283 0 CA-C-N 112.86 -1.973 . . . . 0.47999999999999998 108.366 -178.422 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.598 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.3 mppt? -58.8 102.07 0.11 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.555 -0.905 . . . . 0.98999999999999999 108.555 170.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.62 -11.17 5.75 Favored Glycine 0 C--N 1.305 -1.15 0 CA-C-N 114.069 -1.423 . . . . 0.19 111.535 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.664 HG21 ' HB ' ' A' ' 457' ' ' VAL . 10.8 m -68.82 150.47 97.62 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 108.793 -0.817 . . . . 0.13 108.793 171.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.544 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.0 Cg_endo -93.61 165.02 2.29 Favored 'Trans proline' 0 N--CA 1.423 -2.652 0 C-N-CA 122.17 1.913 . . . . 0.17999999999999999 110.074 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.756 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -126.35 152.12 33.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.497 -1.297 . . . . 0.56999999999999995 107.497 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.765 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.1 mp -133.79 149.95 51.43 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 108.26 -1.015 . . . . 0.13 108.26 175.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.032 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.08 138.96 37.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 103.932 -2.618 . . . . 0.10000000000000001 103.932 163.567 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.858 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 4.3 p90 . . . . . 0 C--O 1.25 1.116 0 CA-C-N 118.503 0.592 . . . . 1.0900000000000001 111.879 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.773 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.49 -0.644 . . . . 1.8700000000000001 111.49 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.644 ' CE1' HD21 ' A' ' 464' ' ' LEU . 23.4 m80 -133.19 113.12 12.32 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 116.827 0.314 . . . . 0.83999999999999997 111.073 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.417 ' HE1' ' HA ' ' A' ' 461' ' ' THR . 2.3 mtm 47.95 -148.94 0.17 Allowed 'General case' 0 C--O 1.236 0.342 0 O-C-N 124.612 1.195 . . . . 0.67000000000000004 111.222 166.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -68.25 153.63 43.37 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 104.179 -2.526 . . . . 1.8500000000000001 104.179 152.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.475 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.2 m-20 -74.05 86.53 1.84 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 118.867 -1.133 . . . . 0.42999999999999999 110.26 -169.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 357' ' ' TYR . 98.5 m -157.16 134.58 10.56 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.854 -1.066 . . . . 0.14000000000000001 110.539 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.674 ' HA ' HG23 ' A' ' 461' ' ' THR . 37.9 p90 173.65 159.18 0.14 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.831 -0.622 . . . . 0.14999999999999999 110.923 -178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.669 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.44 151.23 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.263 0 N-CA-C 109.282 -0.636 . . . . 0.080000000000000002 109.282 166.608 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.605 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 34.6 tt0 -149.81 141.09 23.17 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.462 -0.79 . . . . 2.0099999999999998 109.743 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.738 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -133.0 161.89 40.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.054 0.454 . . . . 0.45000000000000001 111.312 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 347' ' ' VAL . 30.3 t0 -140.15 106.86 5.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.521 -1.289 . . . . 0.23999999999999999 107.521 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.084 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.37 -34.41 28.41 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 123.289 1.518 . . . . 0.16 110.156 -169.389 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.93 -43.95 73.82 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.892 -2.867 . . . . 0.59999999999999998 108.015 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -103.04 4.74 37.57 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 111.015 -2.811 . . . . 0.20000000000000001 111.48 -175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.857 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 16.4 mm-40 34.75 61.59 0.57 Allowed 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 112.917 -1.947 . . . . 2.1499999999999999 113.424 -174.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 22.6 t60 -141.71 134.75 29.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.105 -0.952 . . . . 0.089999999999999997 109.638 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.721 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.84 155.8 24.02 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.631 -0.713 . . . . 0.070000000000000007 109.957 -179.118 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.646 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.4 m-90 -140.88 154.36 46.12 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.533 -0.758 . . . . 0.11 111.257 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.708 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 87.3 t80 -109.36 153.55 23.78 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.428 -1.694 . . . . 0.26000000000000001 106.428 151.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 11.0 m-85 -126.63 118.76 25.45 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 115.224 -0.898 . . . . 0.14000000000000001 110.163 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.8 tppt? -121.88 136.06 54.91 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.366 -1.716 . . . . 0.25 106.366 168.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.3 OUTLIER 70.73 15.55 6.93 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.141 0.793 . . . . 0.42999999999999999 113.141 175.155 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.91 5.07 89.66 Favored Glycine 0 CA--C 1.485 -1.801 0 CA-C-O 122.033 0.796 . . . . 0.17999999999999999 112.844 -174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.1 ptmt -125.79 177.37 6.32 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 104.067 -2.568 . . . . 0.37 104.067 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.646 HG11 ' CD1' ' A' ' 355' ' ' TRP . 14.7 m -104.98 157.51 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.822 0 N-CA-C 116.268 1.951 . . . . 0.10000000000000001 116.268 -176.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.708 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.09 -27.42 10.62 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 110.493 -3.049 . . . . 0.070000000000000007 106.33 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.59 142.75 48.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 111.352 -2.658 . . . . 0.059999999999999998 111.488 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.45 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.5 tt0 -139.99 117.63 11.56 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 104.218 -2.512 . . . . 0.47999999999999998 104.218 176.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.721 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.58 162.54 39.98 Favored 'General case' 0 N--CA 1.397 -3.112 0 C-N-CA 117.715 -1.594 . . . . 0.070000000000000007 111.598 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 14.9 p-10 -101.54 135.51 42.93 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 113.972 -1.467 . . . . 1.8 109.41 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.745 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -137.28 -174.18 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 CA-C-O 122.318 1.056 . . . . 0.12 112.508 -169.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.857 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -151.81 121.28 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 112.725 -2.034 . . . . 0.10000000000000001 109.298 172.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.559 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -81.69 -168.67 1.98 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.768 -1.56 . . . . 1.26 110.318 -178.308 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.64 167.4 42.54 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.655 -1.736 . . . . 0.14000000000000001 112.328 -174.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -72.53 156.94 89.77 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 121.511 0.672 . . . . 0.81000000000000005 111.937 -166.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.664 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 92.1 Cg_exo -56.08 -28.9 72.07 Favored 'Trans proline' 0 CA--C 1.496 -1.392 1 C-N-CA 125.371 4.048 . . . . 0.28000000000000003 113.603 -173.765 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.441 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.0 p -70.38 -34.25 72.36 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.329 -1.76 . . . . 0.33000000000000002 109.413 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.544 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.5 t -142.04 69.99 23.41 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 123.645 1.688 . . . . 0.39000000000000001 109.407 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 375' ' ' THR . 79.8 Cg_exo -58.76 155.28 38.5 Favored 'Trans proline' 0 C--N 1.314 -1.279 1 C-N-CA 126.46 4.773 . . . . 0.38 114.608 -171.141 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.559 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.3 OUTLIER -84.42 141.96 39.93 Favored Pre-proline 0 N--CA 1.423 -1.811 0 N-CA-C 108.699 -0.852 . . . . 0.81999999999999995 108.699 173.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.495 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 21.3 Cg_exo -75.92 -43.34 0.33 Allowed 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 124.785 3.657 . . . . 0.19 112.219 -167.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.773 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.85 136.31 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.302 1.525 . . . . 0.13 113.634 -172.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.6 -119.34 0.96 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 112.129 -2.305 . . . . 0.20000000000000001 109.584 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 381' ' ' VAL . 9.8 p -121.97 115.53 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.275 1.036 . . . . 0.81999999999999995 110.749 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.751 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 1.8 m-85 -114.03 -172.68 2.14 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.192 -1.781 . . . . 0.22 106.192 171.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.666 ' HD2' ' CD1' ' A' ' 385' ' ' TRP . 34.1 t80 -146.11 126.85 14.33 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 118.013 -1.475 . . . . 0.65000000000000002 114.54 -171.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.5 p -85.92 92.21 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 123.064 1.412 . . . . 0.16 109.784 170.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' TRP . . . . . 0.666 ' CD1' ' HD2' ' A' ' 383' ' ' TYR . 75.2 m95 -70.55 -15.06 62.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.173 -1.831 . . . . 2.5499999999999998 107.976 176.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.78 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.8 t30 -170.05 132.65 1.1 Allowed 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.198 -0.91 . . . . 0.42999999999999999 111.209 -174.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.676 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -93.71 144.84 25.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.636 -0.711 . . . . 1.1200000000000001 109.268 171.675 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.775 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 12.8 mm-40 -125.16 157.36 36.61 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 114.381 1.252 . . . . 0.70999999999999996 114.381 -169.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 51.3 mt-10 -136.3 127.12 27.43 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.143 -1.844 . . . . 0.38 108.403 173.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.4 t70 56.48 45.04 23.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 123.3 1.524 . . . . 0.40999999999999998 109.259 -178.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.933 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -79.59 167.24 20.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 112.852 -1.976 . . . . 0.12 109.016 176.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 7.1 m -131.87 119.35 21.07 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.164 0.983 . . . . 0.17000000000000001 112.06 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.9 mp -82.69 88.55 6.71 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.761 -1.563 . . . . 0.56999999999999995 112.275 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.53 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 48.7 mttt -101.66 178.06 4.74 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 113.657 -1.611 . . . . 0.33000000000000002 113.551 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.95 -161.59 25.52 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 114.403 -1.271 . . . . 0.46000000000000002 111.648 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.6 m -115.37 138.93 50.46 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 120.222 -0.591 . . . . 0.70999999999999996 110.895 170.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.489 ' C ' ' H ' ' A' ' 399' ' ' ASP . 7.3 m-80 -56.75 155.69 7.4 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.283 -0.871 . . . . 0.83999999999999997 109.307 169.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.36 -1.83 1.27 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.215 -0.902 . . . . 2.2799999999999998 110.716 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 397' ' ' ASN . 21.8 t70 -114.51 2.54 14.63 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.722 -1.127 . . . . 2.27 110.71 -177.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.19 16.81 42.44 Favored Glycine 0 N--CA 1.426 -1.983 0 C-N-CA 120.064 -1.065 . . . . 0.93999999999999995 112.843 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.467 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 10.0 p -110.59 100.1 43.99 Favored Pre-proline 0 C--N 1.302 -1.475 0 CA-C-N 114.658 -0.771 . . . . 0.81000000000000005 109.807 -175.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.5 Cg_endo -58.73 150.61 69.46 Favored 'Trans proline' 0 CA--C 1.503 -1.05 0 C-N-CA 122.727 2.285 . . . . 0.63 112.949 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -153.04 173.18 15.77 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.481 -1.236 . . . . 0.41999999999999998 112.831 -169.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.53 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER -145.16 147.07 32.08 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 113.726 -1.579 . . . . 0.53000000000000003 109.743 171.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -143.83 97.08 5.44 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 108.444 -0.947 . . . . 0.19 108.444 171.225 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.8 Cg_exo -68.87 110.07 2.28 Favored 'Trans proline' 0 N--CA 1.43 -2.214 0 C-N-CA 122.022 1.815 . . . . 0.19 109.456 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.933 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.56 154.1 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 CA-C-N 112.78 -2.009 . . . . 0.14999999999999999 107.288 -167.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.6 m-80 -86.92 -19.85 28.23 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.969 -0.752 . . . . 0.51000000000000001 108.969 -174.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.775 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 88.7 m-85 -158.65 125.62 4.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.038 -0.983 . . . . 0.27000000000000002 108.89 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.679 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 27.1 t-105 -144.52 137.08 26.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.678 0.751 . . . . 0.089999999999999997 110.907 -167.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.676 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.6 mmt -120.44 93.8 48.46 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 107.823 -1.177 . . . . 0.14000000000000001 107.823 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.78 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 33.6 Cg_endo -65.29 84.49 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.568 2.179 . . . . 0.5 112.153 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 411' ' ' MET . 3.9 pt -84.94 177.08 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.461 -0.791 . . . . 0.88 109.052 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.549 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 3.3 t70 -143.74 -171.95 3.63 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.512 -0.875 . . . . 2.4900000000000002 112.584 -165.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.549 ' CE3' ' HB3' ' A' ' 414' ' ' ASP . 29.9 p90 50.97 -4.17 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 127.113 2.165 . . . . 1.9199999999999999 115.359 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.655 HG21 ' CE1' ' A' ' 382' ' ' PHE . 24.4 p -131.37 -13.8 3.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.978 0.418 . . . . 0.94999999999999996 111.979 -177.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.582 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 90.33 -29.06 6.87 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.067 -0.813 . . . . 0.68000000000000005 111.067 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 419' ' ' GLY . 39.9 t -55.46 172.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 123.967 0.907 . . . . 0.75 111.509 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.606 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -177.06 122.87 0.86 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 109.694 -1.362 . . . . 0.20000000000000001 109.694 170.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.717 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.0 mp -81.65 141.69 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 120.589 -0.444 . . . . 0.28999999999999998 109.888 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.679 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.8 p80 -159.98 162.47 34.36 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.971 -0.559 . . . . 0.089999999999999997 111.338 -174.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.665 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.94 143.47 28.96 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.538 -1.282 . . . . 1.0700000000000001 107.538 171.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 42.3 t -134.64 98.71 4.13 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.702 0.763 . . . . 0.23000000000000001 110.415 -170.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.441 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 20.0 t70 -83.76 -14.21 52.05 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.258 -1.337 . . . . 0.41999999999999998 109.803 -175.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.739 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 9.9 p90 -90.11 -17.97 26.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.711 -1.132 . . . . 0.32000000000000001 111.518 -176.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.591 ' HG3' HD21 ' A' ' 444' ' ' ASN . 0.0 OUTLIER -95.26 120.75 63.53 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 122.994 1.378 . . . . 1.74 111.073 -172.472 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 426' ' ' GLN . 56.8 Cg_endo -66.76 -45.51 4.44 Favored 'Trans proline' 0 C--N 1.326 -0.606 0 C-N-CA 124.957 3.772 . . . . 0.72999999999999998 114.174 -164.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -124.29 162.78 23.02 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.771 0.796 . . . . 2.1600000000000001 111.388 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.525 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -152.89 125.35 8.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.32 -1.733 . . . . 0.33000000000000002 106.32 175.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.77 -158.67 31.62 Favored Glycine 0 C--N 1.28 -2.553 0 N-CA-C 109.501 -1.44 . . . . 0.17000000000000001 109.501 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -44.81 174.63 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.061 -1.066 . . . . 0.20999999999999999 111.683 168.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.523 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.9 p-10 -50.87 102.82 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 123.274 1.511 . . . . 1.8500000000000001 114.108 -153.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.646 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.2 OUTLIER -95.47 -38.75 10.32 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 112.687 -2.051 . . . . 1.21 109.371 167.219 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.72 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.9 p-90 -50.99 -28.85 10.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.413 -0.812 . . . . 0.16 112.872 -170.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.72 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.24 -34.07 16.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.621 0.724 . . . . 0.22 111.762 -177.71 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.0 p -88.45 -43.47 11.43 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.539 -1.209 . . . . 0.25 110.905 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.646 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 6.4 mtp85 -93.84 -19.63 20.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.781 -1.099 . . . . 1.8200000000000001 109.582 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.19 47.07 50.73 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.141 -0.936 . . . . 0.23999999999999999 114.63 166.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 36.8 m -84.68 110.84 19.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.761 1.281 . . . . 1.01 111.5 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.528 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 28.3 m170 39.42 -132.24 0.22 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.551 -1.204 . . . . 0.5 113.579 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -121.78 -20.98 3.03 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.924 -0.655 . . . . 0.26000000000000001 113.665 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.778 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.4 p -101.84 -166.08 1.26 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.175 0.806 . . . . 0.34999999999999998 113.175 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.485 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -93.18 130.64 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.994 -1.003 . . . . 0.12 110.412 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.591 HD21 ' HG3' ' A' ' 426' ' ' GLN . 6.1 m-20 -103.11 89.91 3.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.539 0.685 . . . . 0.62 109.835 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.745 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.0 m -84.01 141.78 40.96 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.731 -1.122 . . . . 0.10000000000000001 112.423 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.642 ' HD2' HG21 ' A' ' 366' ' ' THR . 82.1 Cg_exo -48.85 144.49 15.01 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 123.935 3.09 . . . . 0.23999999999999999 113.117 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.665 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.8 Cg_exo -65.31 -22.3 60.41 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.68 2.253 . . . . 0.31 112.123 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.529 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 79.7 p -82.25 -24.2 34.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.62 0.724 . . . . 1.1000000000000001 112.026 -174.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.81 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.8 m -99.46 -48.44 11.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.011 0.745 . . . . 0.080000000000000002 113.011 -169.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.96 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.32 -1.97 3.95 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.669 -0.812 . . . . 0.070000000000000007 110.385 -178.835 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.577 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 42.2 pttt -81.33 -38.74 26.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 122.456 1.122 . . . . 0.92000000000000004 108.11 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 3.8 mm-40 -61.7 -46.4 89.86 Favored 'General case' 0 CA--C 1.471 -2.096 0 CA-C-N 112.48 -2.146 . . . . 0.25 106.423 -177.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.96 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.19 -66.55 0.39 Allowed 'General case' 0 N--CA 1.403 -2.775 0 CA-C-N 109.72 -3.4 . . . . 0.050000000000000003 112.745 172.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.0 t80 -45.89 -23.35 0.27 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.728 0.775 . . . . 0.13 109.458 176.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.453 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.47 -26.94 23.97 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 114.888 -1.051 . . . . 0.13 111.893 -176.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.774 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.78 -44.21 5.6 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 113.359 0.874 . . . . 0.059999999999999998 113.359 177.163 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.669 HG11 HD11 ' A' ' 345' ' ' ILE . 0.4 OUTLIER -73.81 149.22 8.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.582 1.182 . . . . 0.080000000000000002 110.995 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.6 157.69 34.86 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 112.905 -1.952 . . . . 0.47999999999999998 108.177 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.552 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 37.5 mtpt -55.38 101.47 0.05 Allowed 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 109.034 -0.728 . . . . 0.98999999999999999 109.034 169.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' GLY . . . . . 0.422 ' HA2' ' OH ' ' A' ' 383' ' ' TYR . . . 133.08 -14.27 4.9 Favored Glycine 0 C--N 1.302 -1.335 0 CA-C-N 114.222 -1.354 . . . . 0.19 112.124 -175.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.674 HG23 ' HA ' ' A' ' 344' ' ' TYR . 35.6 m -70.36 148.2 95.44 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 108.498 -0.927 . . . . 0.13 108.498 168.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 11.8 Cg_endo -97.14 177.21 0.54 Allowed 'Trans proline' 0 N--CA 1.419 -2.873 0 C-N-CA 122.832 2.355 . . . . 0.17999999999999999 110.299 175.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.751 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -134.42 154.25 36.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 119.916 -0.714 . . . . 0.56999999999999995 109.278 172.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.737 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.4 mp -135.09 152.31 51.54 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 116.028 -0.533 . . . . 0.13 109.915 173.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.084 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.25 142.02 32.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 105.454 -2.054 . . . . 0.10000000000000001 105.454 163.328 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.762 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 9.0 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.444 -1.265 . . . . 1.0900000000000001 111.341 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.778 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.931 -0.468 . . . . 1.8700000000000001 111.931 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.574 ' CE1' HD21 ' A' ' 464' ' ' LEU . 2.7 p-80 -134.54 101.45 4.97 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 112.198 0.444 . . . . 0.83999999999999997 112.198 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.549 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.6 OUTLIER 61.25 -164.06 0.25 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.938 -1.028 . . . . 0.67000000000000004 113.436 165.269 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.87 173.4 5.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.556 -1.276 . . . . 1.8500000000000001 107.556 164.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.481 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 11.5 m-20 -81.05 83.45 6.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 119.224 -0.991 . . . . 0.42999999999999999 110.285 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 357' ' ' TYR . 75.8 m -158.03 135.97 10.69 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.856 -1.066 . . . . 0.14000000000000001 108.995 167.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.8 ' CD2' HD13 ' A' ' 464' ' ' LEU . 43.8 p90 174.11 159.0 0.15 Allowed 'General case' 0 C--O 1.212 -0.912 0 O-C-N 123.35 0.406 . . . . 0.14999999999999999 111.173 -175.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.677 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -78.25 154.98 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 N-CA-C 109.711 -0.478 . . . . 0.080000000000000002 109.711 165.101 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.599 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -146.92 148.64 32.0 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.873 -1.058 . . . . 2.0099999999999998 108.206 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.723 HG22 ' HG3' ' A' ' 354' ' ' MET . 5.6 t -145.02 110.33 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 N-CA-C 113.872 1.064 . . . . 0.45000000000000001 113.872 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.503 ' HB2' ' CZ3' ' A' ' 355' ' ' TRP . 27.7 t0 -92.56 106.71 18.64 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-O 121.946 0.879 . . . . 0.23999999999999999 109.058 176.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.027 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -77.44 -37.3 51.89 Favored 'General case' 0 CA--C 1.479 -1.772 0 CA-C-N 114.01 -1.45 . . . . 0.16 110.251 -169.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.542 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 3.5 mt-10 -55.04 -44.43 74.67 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 110.766 -2.925 . . . . 0.59999999999999998 108.062 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -102.32 7.21 40.66 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 110.694 -2.957 . . . . 0.20000000000000001 111.051 -175.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.633 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.9 OUTLIER 34.09 61.76 0.49 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 112.852 -1.976 . . . . 2.1499999999999999 112.833 -175.233 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.57 ' NE2' ' HG2' ' A' ' 365' ' ' GLU . 23.5 t60 -143.22 132.18 22.88 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.568 -0.742 . . . . 0.089999999999999997 109.892 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.801 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.0 OUTLIER -109.38 152.6 25.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.693 -0.685 . . . . 0.070000000000000007 109.793 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.705 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.1 m-90 -139.05 157.72 45.48 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.442 -0.799 . . . . 0.11 110.725 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.709 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.5 t80 -109.66 153.81 23.72 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.488 -1.671 . . . . 0.26000000000000001 106.488 151.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.4 m-85 -127.38 118.42 24.08 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 115.073 -0.967 . . . . 0.14000000000000001 109.969 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 358' ' ' LYS . 9.8 tppt? -121.81 125.23 46.03 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.863 -1.162 . . . . 0.25 107.863 171.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.83 35.87 2.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 119.092 0.86 . . . . 0.42999999999999999 112.243 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' GLY . . . . . 0.481 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 62.89 13.29 46.73 Favored Glycine 0 CA--C 1.495 -1.191 0 C-N-CA 120.322 -0.942 . . . . 0.17999999999999999 113.495 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.8 ptmt -137.25 172.47 12.95 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.422 -2.436 . . . . 0.37 104.422 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.705 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.6 m -101.02 158.18 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.741 0 N-CA-C 116.48 2.03 . . . . 0.10000000000000001 116.48 -172.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.696 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.35 -26.55 9.97 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 110.523 -3.035 . . . . 0.070000000000000007 106.933 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.806 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -133.72 145.58 49.99 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 111.766 -2.47 . . . . 0.059999999999999998 111.842 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.57 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 5.0 tt0 -140.26 118.35 11.92 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 104.569 -2.382 . . . . 0.47999999999999998 104.569 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.801 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.05 162.0 41.25 Favored 'General case' 0 N--CA 1.402 -2.838 0 C-N-CA 117.767 -1.573 . . . . 0.070000000000000007 112.059 177.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.632 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 17.0 p-10 -101.12 135.8 42.0 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 114.263 -1.335 . . . . 1.8 109.27 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.926 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.6 pp -141.63 -171.84 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 122.443 1.116 . . . . 0.12 112.835 -169.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.47 120.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 CA-C-N 112.959 -1.928 . . . . 0.10000000000000001 108.982 174.389 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.532 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -76.23 -167.67 0.81 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.643 -1.617 . . . . 1.26 110.953 177.503 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.489 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.85 175.92 48.93 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.118 -1.515 . . . . 0.14000000000000001 112.341 -174.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -78.91 156.69 77.05 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.508 0.671 . . . . 0.81000000000000005 112.035 -165.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.69 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.7 Cg_exo -57.79 -29.9 87.47 Favored 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 125.182 3.921 . . . . 0.28000000000000003 113.617 -173.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.461 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 27.0 p -70.86 -32.97 70.15 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.592 -1.64 . . . . 0.33000000000000002 109.661 -175.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.547 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.1 t -140.82 70.87 29.96 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 123.614 1.673 . . . . 0.39000000000000001 109.406 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.5 Cg_exo -59.53 154.35 48.7 Favored 'Trans proline' 0 C--N 1.313 -1.292 1 C-N-CA 126.421 4.748 . . . . 0.38 114.449 -172.236 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.532 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.5 OUTLIER -83.86 148.14 53.41 Favored Pre-proline 0 N--CA 1.419 -1.979 0 N-CA-C 108.002 -1.11 . . . . 0.81999999999999995 108.002 173.57 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.596 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 15.4 Cg_exo -79.53 -41.26 0.21 Allowed 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 124.592 3.528 . . . . 0.19 112.724 -165.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.773 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.41 134.24 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 123.549 1.642 . . . . 0.13 113.75 -172.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 148.02 -125.83 2.19 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 111.95 -2.386 . . . . 0.20000000000000001 109.728 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.6 p -116.35 112.32 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 122.122 0.963 . . . . 0.81999999999999995 111.497 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.769 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 1.9 m-85 -112.63 -173.38 2.24 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 106.493 -1.669 . . . . 0.22 106.493 172.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.57 ' OH ' ' HA2' ' A' ' 460' ' ' GLY . 38.9 t80 -144.68 125.97 14.77 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.306 -1.358 . . . . 0.65000000000000002 113.657 -169.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.4 p -86.47 94.21 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 122.683 1.23 . . . . 0.16 109.56 169.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' TRP . . . . . 0.544 ' CD1' ' HD2' ' A' ' 383' ' ' TYR . 75.7 m95 -69.16 -17.17 63.79 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.412 -1.722 . . . . 2.5499999999999998 108.185 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.733 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.6 t30 -169.45 135.07 1.54 Allowed 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.375 -0.829 . . . . 0.42999999999999999 111.145 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.662 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -91.95 129.57 37.88 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.186 -1.042 . . . . 1.1200000000000001 108.186 171.315 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.668 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 0.5 OUTLIER -110.59 158.59 18.4 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.183 -0.917 . . . . 0.70999999999999996 111.935 -171.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 40.3 mt-10 -134.57 133.36 40.16 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.163 -1.38 . . . . 0.38 108.833 173.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 18.6 t70 53.94 46.58 25.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 123.766 1.746 . . . . 0.40999999999999998 108.71 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.899 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -83.99 165.3 18.73 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 112.183 -2.28 . . . . 0.12 108.79 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 24.3 m -132.66 120.12 21.32 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.153 0.978 . . . . 0.17000000000000001 111.045 170.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.545 HD13 ' HB ' ' A' ' 407' ' ' VAL . 2.7 mp -78.14 88.48 4.24 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.512 -1.676 . . . . 0.56999999999999995 111.413 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.531 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 48.5 mttt -104.06 178.4 4.57 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 113.791 -1.55 . . . . 0.33000000000000002 113.701 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.81 -158.98 24.86 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 113.959 -1.473 . . . . 0.46000000000000002 111.358 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 2.8 m -119.87 141.31 49.69 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 120.431 -0.507 . . . . 0.70999999999999996 110.856 171.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 399' ' ' ASP . 4.4 m-80 -58.15 154.77 12.36 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.859 -1.064 . . . . 0.83999999999999997 109.416 168.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ASP . . . . . 0.442 ' O ' ' HBC' ' A' ' 130' ' ' 1RG . 2.1 t70 -58.12 -8.43 1.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.705 -1.134 . . . . 2.2799999999999998 111.254 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 397' ' ' ASN . 8.9 m-20 -101.07 -17.61 16.62 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 114.062 -1.427 . . . . 2.27 110.105 -176.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.02 33.62 5.7 Favored Glycine 0 N--CA 1.42 -2.388 0 C-N-CA 118.929 -1.605 . . . . 0.93999999999999995 111.793 -176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' THR . . . . . . . . . . . . . 8.0 p -123.43 98.9 40.38 Favored Pre-proline 0 C--N 1.307 -1.265 0 CA-C-N 114.543 -0.828 . . . . 0.81000000000000005 109.183 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 25.0 Cg_endo -60.23 151.61 72.27 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 C-N-CA 122.833 2.356 . . . . 0.63 113.216 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -151.87 171.87 17.08 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.36 -1.291 . . . . 0.41999999999999998 112.384 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.531 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 1.8 mp0 -146.84 146.46 30.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 113.949 -1.478 . . . . 0.53000000000000003 110.127 173.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.29 97.49 5.18 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 108.015 -1.105 . . . . 0.19 108.015 170.231 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.1 Cg_exo -69.32 110.05 2.37 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.008 1.805 . . . . 0.19 110.316 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.899 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.35 155.39 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 CA-C-N 112.998 -1.91 . . . . 0.14999999999999999 107.396 -168.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.0 m-80 -88.49 -21.57 24.11 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.657 -0.868 . . . . 0.51000000000000001 108.657 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.664 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.1 m-85 -157.31 126.11 5.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.625 -1.17 . . . . 0.27000000000000002 108.674 -169.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.668 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 14.6 t-105 -142.3 141.41 32.41 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.623 -0.717 . . . . 0.089999999999999997 110.281 -167.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.662 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.5 mmt -126.67 96.75 34.74 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.405 -1.332 . . . . 0.14000000000000001 107.405 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.733 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 48.2 Cg_endo -67.87 78.13 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.52 2.147 . . . . 0.5 112.825 -175.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 418' ' ' VAL . 1.4 pt -79.35 173.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 107.691 -1.226 . . . . 0.88 107.691 173.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.609 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 21.6 t70 -154.07 179.65 8.73 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.152 -1.019 . . . . 2.4900000000000002 112.326 -164.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' TRP . . . . . 0.609 ' CE3' ' HB3' ' A' ' 414' ' ' ASP . 33.4 p90 59.03 2.39 0.26 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.176 1.791 . . . . 1.9199999999999999 114.575 169.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.608 HG23 ' CD1' ' A' ' 415' ' ' TRP . 3.3 p -130.71 -30.69 1.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.024 0.749 . . . . 0.94999999999999996 113.024 -170.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 106.0 -4.08 38.66 Favored Glycine 0 CA--C 1.5 -0.9 0 N-CA-C 110.418 -1.073 . . . . 0.68000000000000005 110.418 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.707 HG11 ' CE2' ' A' ' 382' ' ' PHE . 2.2 p -95.54 164.32 2.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.327 -1.436 . . . . 0.75 111.249 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -168.05 128.61 1.74 Allowed Glycine 0 C--O 1.219 -0.827 0 N-CA-C 110.882 -0.887 . . . . 0.20000000000000001 110.882 165.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.626 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.6 mp -84.6 140.0 16.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 122.151 -0.617 . . . . 0.28999999999999998 111.213 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.649 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.0 p80 -161.83 162.86 29.57 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.684 -0.689 . . . . 0.089999999999999997 110.303 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.747 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -81.94 150.88 27.48 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 107.675 -1.232 . . . . 1.0700000000000001 107.675 170.754 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 445' ' ' THR . 48.0 t -134.12 96.08 3.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.981 0.896 . . . . 0.23000000000000001 109.647 -172.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.42 -19.54 49.74 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.784 -1.553 . . . . 0.41999999999999998 109.77 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.755 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 17.6 p90 -87.18 -23.43 24.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.361 -1.29 . . . . 0.32000000000000001 111.609 -175.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.427 ' OE1' ' HG2' ' A' ' 428' ' ' GLU . 0.4 OUTLIER -97.29 118.2 64.78 Favored Pre-proline 0 CA--C 1.508 -0.635 0 CA-C-O 122.816 1.294 . . . . 1.74 110.492 -178.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.638 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 38.4 Cg_endo -88.65 -11.31 4.07 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 124.365 3.376 . . . . 0.72999999999999998 113.698 -175.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.638 ' OE2' ' HD2' ' A' ' 427' ' ' PRO . 1.1 pm0 -110.85 150.98 28.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.289 1.042 . . . . 2.1600000000000001 112.71 173.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.637 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -157.8 129.54 6.89 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 112.681 -2.054 . . . . 0.33000000000000002 105.513 168.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.13 -157.48 29.74 Favored Glycine 0 C--N 1.288 -2.088 0 C-N-CA 119.715 -1.231 . . . . 0.17000000000000001 111.544 -177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.535 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.65 170.49 0.01 OUTLIER Glycine 0 CA--C 1.487 -1.671 0 C-N-CA 120.787 -0.72 . . . . 0.20999999999999999 111.919 167.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.548 ' HB3' ' CD ' ' A' ' 435' ' ' LYS . 2.4 m-20 -52.75 100.89 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.891 0 CA-C-O 122.492 1.139 . . . . 1.8500000000000001 112.957 -155.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 1.009 HD22 ' HD2' ' A' ' 437' ' ' ARG . 36.8 mt -97.16 -35.73 10.69 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 113.006 -1.906 . . . . 1.21 109.696 172.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.731 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -52.7 -26.3 13.53 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.111 -0.95 . . . . 0.16 112.1 -173.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.731 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.68 -33.99 15.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.747 -0.661 . . . . 0.22 112.69 -178.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.7 p -90.01 -37.88 14.0 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.861 0.839 . . . . 0.25 110.76 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 1.009 ' HD2' HD22 ' A' ' 433' ' ' LEU . 3.8 mtp85 -97.65 -18.4 18.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.707 -1.133 . . . . 1.8200000000000001 110.011 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.74 48.81 49.54 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.156 -0.929 . . . . 0.23999999999999999 115.233 162.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' SER . . . . . 0.47 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 9.3 p -84.8 110.32 18.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 118.93 1.365 . . . . 1.01 112.192 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.424 ' HB3' ' OAC' ' A' ' 130' ' ' 1RG . 63.2 m-70 35.67 -133.21 0.06 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.482 -1.235 . . . . 0.5 113.049 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.489 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -119.22 -6.26 10.95 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.204 -0.759 . . . . 0.26000000000000001 111.204 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 0.8 OUTLIER -92.4 162.51 14.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.527 0.936 . . . . 0.34999999999999998 113.527 -176.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.532 HG12 HG11 ' A' ' 347' ' ' VAL . 1.9 mp -87.43 128.97 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 113.764 -1.562 . . . . 0.12 110.141 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.41 ' HB3' HE21 ' A' ' 426' ' ' GLN . 6.5 m-20 -98.45 88.42 4.12 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.655 -0.702 . . . . 0.62 110.081 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.926 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.9 m -83.91 142.64 42.09 Favored Pre-proline 0 N--CA 1.431 -1.377 0 CA-C-N 115.029 -0.987 . . . . 0.10000000000000001 112.412 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.7 ' HD2' HG21 ' A' ' 366' ' ' THR . 76.7 Cg_exo -50.42 145.1 22.52 Favored 'Trans proline' 0 CA--C 1.509 -0.733 0 C-N-CA 123.803 3.002 . . . . 0.23999999999999999 113.455 175.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.747 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.2 Cg_exo -65.45 -24.71 56.51 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.864 2.376 . . . . 0.31 112.328 -176.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.515 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 35.7 p -77.58 -24.99 49.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.229 -0.896 . . . . 1.1000000000000001 112.09 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.806 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.9 m -100.02 -48.51 11.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.714 -0.675 . . . . 0.080000000000000002 112.557 -171.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.955 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.7 -2.51 5.02 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.635 -0.826 . . . . 0.070000000000000007 110.375 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.526 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 15.8 pttp -80.71 -38.82 28.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.441 1.115 . . . . 0.92000000000000004 108.358 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.7 mm-40 -62.66 -46.57 87.59 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 112.482 -2.145 . . . . 0.25 106.883 -177.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.955 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.09 -66.37 0.41 Allowed 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 109.847 -3.342 . . . . 0.050000000000000003 112.536 171.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 21.1 t80 -44.72 -25.62 0.3 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 124.215 0.947 . . . . 0.13 109.609 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.447 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -86.87 -29.49 23.28 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 114.599 -1.182 . . . . 0.13 111.555 -176.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.749 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -99.43 -44.86 6.03 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 113.533 0.938 . . . . 0.059999999999999998 113.533 177.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.65 148.56 9.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 122.487 1.137 . . . . 0.080000000000000002 111.106 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' A' ' 458' ' ' GLU . 0.0 OUTLIER -119.91 158.11 27.35 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 112.88 -1.964 . . . . 0.47999999999999998 108.648 -178.43 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.628 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.3 mppt? -57.82 101.51 0.08 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.575 -0.898 . . . . 0.98999999999999999 108.575 168.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' GLY . . . . . 0.57 ' HA2' ' OH ' ' A' ' 383' ' ' TYR . . . 134.66 -18.36 4.1 Favored Glycine 0 C--N 1.304 -1.246 0 CA-C-N 114.233 -1.349 . . . . 0.19 111.902 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 344' ' ' TYR . 23.1 m -66.57 149.29 98.26 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 108.756 -0.831 . . . . 0.13 108.756 171.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.549 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 9.8 Cg_endo -95.75 176.29 0.84 Allowed 'Trans proline' 0 N--CA 1.416 -3.052 0 C-N-CA 122.257 1.972 . . . . 0.17999999999999999 109.937 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.769 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -132.8 154.7 40.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.131 -1.063 . . . . 0.56999999999999995 108.131 171.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.0 mp -134.26 152.12 51.65 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 108.775 -0.824 . . . . 0.13 108.775 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.027 HG23 HD21 ' A' ' 349' ' ' LEU . 0.9 OUTLIER -137.73 144.46 31.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 106.047 -1.835 . . . . 0.10000000000000001 106.047 159.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.542 ' OXT' ' HG3' ' A' ' 350' ' ' GLU . 3.2 p90 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 123.857 0.863 . . . . 1.0900000000000001 110.84 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.74 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 112.906 -0.077 . . . . 1.8700000000000001 112.906 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.636 ' CE1' HD21 ' A' ' 464' ' ' LEU . 1.2 p-80 -148.89 100.35 3.07 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 122.579 -0.365 . . . . 0.83999999999999997 111.117 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.574 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.1 OUTLIER 62.91 -166.15 0.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.203 0.939 . . . . 0.67000000000000004 112.686 167.474 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.1 173.04 2.61 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.9 -1.148 . . . . 1.8500000000000001 107.9 165.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -81.92 82.5 7.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.025 -1.07 . . . . 0.42999999999999999 109.532 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 357' ' ' TYR . 53.6 m -159.35 138.08 10.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.29 -0.868 . . . . 0.14000000000000001 108.743 167.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.762 ' CD2' HD13 ' A' ' 464' ' ' LEU . 41.2 p90 174.32 158.87 0.16 Allowed 'General case' 0 C--O 1.21 -1.011 0 O-C-N 123.317 0.385 . . . . 0.14999999999999999 111.149 -176.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.618 HD12 HD11 ' A' ' 453' ' ' LEU . 0.5 OUTLIER -77.26 154.7 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 N-CA-C 109.216 -0.661 . . . . 0.080000000000000002 109.216 164.682 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.53 146.96 28.55 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.8 -1.185 . . . . 2.0099999999999998 107.8 -178.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.736 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.76 155.62 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 C-N-CA 123.6 0.76 . . . . 0.45000000000000001 110.375 173.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.526 ' N ' HG12 ' A' ' 347' ' ' VAL . 37.7 t0 -138.13 105.55 5.53 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.539 -1.652 . . . . 0.23999999999999999 106.539 176.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 1.026 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -80.13 -35.97 35.91 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 114.023 -1.444 . . . . 0.16 109.959 -165.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.402 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 0.7 OUTLIER -56.38 -44.96 80.72 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 110.678 -2.965 . . . . 0.59999999999999998 107.942 176.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -99.37 5.03 46.53 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 111.163 -2.744 . . . . 0.20000000000000001 111.1 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.487 HE21 ' HE1' ' A' ' 434' ' ' TRP . 21.5 mp0 34.29 61.7 0.52 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 112.942 -1.935 . . . . 2.1499999999999999 113.137 -173.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.501 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 24.5 t60 -142.4 136.91 30.02 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.907 -0.588 . . . . 0.089999999999999997 109.741 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.748 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.83 158.16 21.39 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 120.947 0.403 . . . . 0.070000000000000007 110.234 179.63 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.641 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.5 m-90 -143.13 164.08 31.12 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.485 0.66 . . . . 0.11 111.126 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.703 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 86.3 t80 -116.01 154.27 30.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.535 -1.654 . . . . 0.26000000000000001 106.535 150.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 13.4 m-85 -127.13 119.2 25.94 Favored 'General case' 0 C--N 1.269 -2.9 0 CA-C-N 115.094 -0.957 . . . . 0.14000000000000001 110.007 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 361' ' ' LYS . 9.9 tppt? -123.3 116.65 23.68 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.377 -0.971 . . . . 0.25 108.377 173.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.85 37.69 0.49 Allowed 'General case' 0 C--N 1.308 -1.207 0 O-C-N 123.474 0.484 . . . . 0.42999999999999999 112.297 -176.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 62.94 12.46 42.97 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 120.2 -1.0 . . . . 0.17999999999999999 113.314 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 358' ' ' LYS . 18.5 ptmt -137.63 169.75 17.25 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 104.586 -2.376 . . . . 0.37 104.586 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.641 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.6 m -99.57 157.74 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.619 0 N-CA-C 116.692 2.108 . . . . 0.10000000000000001 116.692 -170.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.703 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -110.18 -25.88 9.94 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-N 110.375 -3.102 . . . . 0.070000000000000007 106.673 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -135.64 146.6 48.03 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 111.694 -2.503 . . . . 0.059999999999999998 111.682 -176.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.496 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -143.7 117.92 9.56 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 104.719 -2.326 . . . . 0.47999999999999998 104.719 175.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.748 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.59 165.25 32.82 Favored 'General case' 0 N--CA 1.4 -2.953 0 C-N-CA 118.121 -1.432 . . . . 0.070000000000000007 111.558 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.655 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 13.1 p-10 -103.66 132.44 49.91 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.71 -1.132 . . . . 1.8 109.828 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.0 pp -131.48 -173.5 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 CA-C-O 122.48 1.133 . . . . 0.12 112.415 -172.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.41 120.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 112.805 -1.998 . . . . 0.10000000000000001 108.312 172.202 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.542 ' HB3' HD12 ' A' ' 349' ' ' LEU . 30.2 p -76.87 -169.21 1.23 Allowed 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 112.376 -2.193 . . . . 1.26 111.615 -177.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -85.04 166.65 40.93 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 118.718 -1.706 . . . . 0.14000000000000001 111.864 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -73.84 156.99 87.83 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 121.383 0.611 . . . . 0.81000000000000005 111.758 -167.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.645 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 81.4 Cg_exo -54.23 -28.79 53.88 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 125.269 3.98 . . . . 0.28000000000000003 113.439 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.481 ' OG1' HG22 ' A' ' 375' ' ' THR . 16.8 p -69.55 -34.04 73.64 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.295 -1.775 . . . . 0.33000000000000002 109.829 -176.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.536 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -141.61 70.81 25.69 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 123.715 1.721 . . . . 0.39000000000000001 109.128 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 375' ' ' THR . 85.9 Cg_exo -57.41 160.09 14.61 Favored 'Trans proline' 0 C--N 1.31 -1.462 1 C-N-CA 126.453 4.769 . . . . 0.38 115.254 -170.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.511 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 2.3 m -86.08 126.56 64.92 Favored Pre-proline 0 N--CA 1.402 -2.837 0 CA-C-N 114.142 -1.39 . . . . 0.81999999999999995 108.616 173.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 29.0 Cg_exo -69.29 -44.66 2.25 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.776 2.984 . . . . 0.19 112.21 -168.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.764 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 61.21 137.98 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 123.579 1.657 . . . . 0.13 113.912 -175.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 153.36 -111.69 0.5 Allowed Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 111.75 -2.477 . . . . 0.20000000000000001 108.871 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.67 125.89 56.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.206 0.527 . . . . 0.81999999999999995 109.759 173.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.72 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 8.1 m-85 -118.16 -176.14 3.0 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 106.608 -1.627 . . . . 0.22 106.608 168.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.712 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 2.0 t80 -137.76 120.29 16.06 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 120.698 -1.251 . . . . 0.65000000000000002 112.291 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -86.01 91.35 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-O 123.178 1.466 . . . . 0.16 108.926 171.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -93.66 11.79 27.72 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 113.043 -1.889 . . . . 2.5499999999999998 108.013 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.747 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.0 t30 -167.95 126.21 1.2 Allowed 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 113.588 -1.642 . . . . 0.42999999999999999 110.148 172.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.651 ' HD3' ' H ' ' A' ' 387' ' ' LYS . 0.0 OUTLIER -101.64 143.25 31.84 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.201 -0.909 . . . . 1.1200000000000001 109.129 169.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.726 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 30.0 mm-40 -126.11 159.67 32.23 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 115.019 1.489 . . . . 0.70999999999999996 115.019 -167.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.1 mt-10 -139.11 127.29 22.58 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 112.755 -2.02 . . . . 0.38 108.689 174.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.7 t70 56.19 45.67 22.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 123.498 1.618 . . . . 0.40999999999999998 109.053 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.925 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -81.26 166.3 20.67 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 112.517 -2.129 . . . . 0.12 108.803 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 20.6 m -132.75 119.24 20.06 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 122.252 1.025 . . . . 0.17000000000000001 111.577 170.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.1 mp -78.7 88.02 4.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.699 -1.591 . . . . 0.56999999999999995 111.873 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.543 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.7 mttt -102.81 179.67 4.21 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.572 -1.649 . . . . 0.33000000000000002 113.032 177.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 137.54 -157.73 24.19 Favored Glycine 0 N--CA 1.428 -1.893 0 C-N-CA 119.422 -1.371 . . . . 0.46000000000000002 111.555 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.4 m -120.77 137.0 54.74 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 120.344 -0.542 . . . . 0.70999999999999996 110.474 172.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.2 m-80 -54.13 150.4 8.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.325 -0.852 . . . . 0.83999999999999997 108.845 168.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.89 -2.07 0.07 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.595 -0.73 . . . . 2.2799999999999998 112.171 175.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 397' ' ' ASN . 8.2 t70 -115.71 1.92 13.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.579 0.704 . . . . 2.27 110.483 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.66 19.36 27.47 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.923 -1.035 . . . . 0.93999999999999995 113.039 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.486 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 11.5 p -113.8 99.83 50.92 Favored Pre-proline 0 C--N 1.303 -1.451 0 CA-C-O 121.538 0.685 . . . . 0.81000000000000005 109.938 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.1 Cg_endo -59.34 149.23 82.46 Favored 'Trans proline' 0 CA--C 1.505 -0.955 0 C-N-CA 122.794 2.33 . . . . 0.63 113.135 -177.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -150.99 174.08 13.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.137 -1.392 . . . . 0.41999999999999998 112.547 -169.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -145.47 147.17 31.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.357 -1.292 . . . . 0.53000000000000003 110.749 172.731 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.02 97.35 4.86 Favored Pre-proline 0 N--CA 1.437 -1.094 0 N-CA-C 108.525 -0.917 . . . . 0.19 108.525 170.19 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.9 Cg_exo -68.47 110.95 2.4 Favored 'Trans proline' 0 N--CA 1.436 -1.886 0 C-N-CA 122.106 1.871 . . . . 0.19 110.159 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.925 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.86 152.41 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.168 0 CA-C-N 113.355 -1.748 . . . . 0.14999999999999999 107.979 -167.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.724 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 19.6 m-80 -85.95 -20.43 28.96 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.958 -0.756 . . . . 0.51000000000000001 108.958 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.726 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.4 m-85 -158.85 125.75 4.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.935 -1.03 . . . . 0.27000000000000002 108.493 -170.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.676 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 19.8 t-105 -143.32 138.18 29.32 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.692 -0.685 . . . . 0.089999999999999997 110.476 -167.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.646 ' O ' HG23 ' A' ' 413' ' ' ILE . 14.3 mmt -118.55 91.08 40.96 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.932 -0.766 . . . . 0.14000000000000001 108.932 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.747 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 34.1 Cg_exo -59.2 89.79 0.07 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 123.367 2.711 . . . . 0.5 109.511 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 18.8 pt -91.6 -135.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.812 -0.631 . . . . 0.88 112.184 -170.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.449 ' H ' HG13 ' A' ' 413' ' ' ILE . 16.0 t70 -89.64 165.53 14.18 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.063 0.459 . . . . 2.4900000000000002 110.654 -164.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.18 -11.83 58.4 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.135 0.974 . . . . 1.9199999999999999 111.495 -165.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 30.6 p -68.18 -12.77 61.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 113.965 -1.471 . . . . 0.94999999999999996 111.777 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' GLY . . . . . 0.412 ' HA2' ' HB ' ' A' ' 130' ' ' 1RG . . . 123.82 -40.84 1.87 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.996 -0.621 . . . . 0.68000000000000005 113.133 168.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 419' ' ' GLY . 32.3 t -59.74 171.06 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 122.978 0.511 . . . . 0.75 111.763 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.626 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -175.81 122.58 0.87 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.039 -1.224 . . . . 0.20000000000000001 110.039 170.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.726 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.4 mp -81.63 143.52 12.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 110.05 -0.352 . . . . 0.28999999999999998 110.05 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.676 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.4 p80 -160.32 161.84 33.36 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.089999999999999997 111.617 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.691 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.03 146.63 27.09 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.402 -0.962 . . . . 1.0700000000000001 108.402 173.006 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 445' ' ' THR . 37.7 t -133.15 96.32 3.73 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.788 0.804 . . . . 0.23000000000000001 110.074 -171.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' ASP . . . . . 0.423 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 8.0 t70 -82.04 -18.16 44.21 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.211 -1.359 . . . . 0.41999999999999998 109.551 -176.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.75 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 11.7 p90 -86.22 -19.13 30.44 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 113.983 -1.462 . . . . 0.32000000000000001 110.915 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -103.89 113.47 65.37 Favored Pre-proline 0 CA--C 1.505 -0.778 0 CA-C-O 122.588 1.185 . . . . 1.74 109.998 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.461 ' HG2' ' OE1' ' A' ' 428' ' ' GLU . 38.6 Cg_endo -87.47 -9.11 6.0 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 124.231 3.288 . . . . 0.72999999999999998 112.779 -174.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.537 ' HG3' ' HD3' ' A' ' 437' ' ' ARG . 2.7 pm0 -111.6 152.2 27.88 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.242 1.02 . . . . 2.1600000000000001 113.291 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.655 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.5 OUTLIER -163.07 132.02 4.03 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 112.608 -2.087 . . . . 0.33000000000000002 105.405 172.456 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 169.06 -158.61 31.28 Favored Glycine 0 C--N 1.283 -2.401 0 N-CA-C 110.373 -1.091 . . . . 0.17000000000000001 110.373 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -45.53 174.85 0.01 OUTLIER Glycine 0 CA--C 1.497 -1.045 0 C-N-CA 120.155 -1.022 . . . . 0.20999999999999999 111.493 167.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.541 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -51.9 101.82 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 123.341 1.543 . . . . 1.8500000000000001 113.834 -154.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.745 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.87 -36.02 11.26 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 112.533 -2.122 . . . . 1.21 109.378 170.031 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.697 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -54.75 -27.47 41.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.213 -0.903 . . . . 0.16 112.276 -170.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.697 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.52 -35.37 15.11 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.468 0.651 . . . . 0.22 112.216 -177.343 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 p -90.4 -43.39 10.33 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.991 -1.004 . . . . 0.25 110.787 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.745 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.6 mtp180 -93.29 -17.77 23.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.536 -1.211 . . . . 1.8200000000000001 109.607 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.67 49.82 56.28 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.765 -1.107 . . . . 0.23999999999999999 115.101 162.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 50.0 m -83.38 110.28 18.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.736 1.268 . . . . 1.01 111.31 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 37.33 -126.85 0.19 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.303 -1.317 . . . . 0.5 114.481 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -128.28 -21.32 1.49 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.14 -0.552 . . . . 0.26000000000000001 113.029 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.555 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.2 p -102.11 -166.05 1.25 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.244 0.545 . . . . 0.34999999999999998 112.273 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.474 HG12 HG11 ' A' ' 347' ' ' VAL . 2.2 mp -96.62 131.15 44.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.314 -0.857 . . . . 0.12 110.619 -174.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -104.99 94.39 5.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.431 0.634 . . . . 0.62 110.252 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.749 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.9 m -90.39 145.53 32.74 Favored Pre-proline 0 C--O 1.211 -0.969 0 CA-C-N 114.713 -1.131 . . . . 0.10000000000000001 112.85 -176.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.672 ' HD2' HG21 ' A' ' 366' ' ' THR . 75.8 Cg_exo -50.44 146.51 19.03 Favored 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 123.971 3.114 . . . . 0.23999999999999999 113.659 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.691 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 27.8 Cg_exo -67.3 -23.38 44.85 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.963 2.442 . . . . 0.31 112.364 -176.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.524 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 34.1 p -80.64 -24.98 38.62 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.363 -0.835 . . . . 1.1000000000000001 112.079 -175.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.804 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.8 m -99.38 -48.98 11.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.643 -0.708 . . . . 0.080000000000000002 112.864 -170.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.954 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.95 -2.27 5.07 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.754 -0.779 . . . . 0.070000000000000007 110.349 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 448' ' ' SER . 41.4 pttt -80.81 -39.51 26.53 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.973 -1.121 . . . . 0.92000000000000004 107.973 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.512 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 3.7 mm-40 -61.53 -46.35 90.31 Favored 'General case' 0 CA--C 1.472 -2.032 0 CA-C-N 112.499 -2.137 . . . . 0.25 106.356 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.954 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.81 -67.49 0.28 Allowed 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 109.612 -3.449 . . . . 0.050000000000000003 112.66 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 16.3 t80 -45.46 -23.96 0.27 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 124.008 0.817 . . . . 0.13 109.361 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.449 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.36 -26.09 29.03 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.925 -1.034 . . . . 0.13 111.845 -176.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.735 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -102.45 -44.31 5.4 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 113.309 0.855 . . . . 0.059999999999999998 113.309 176.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -72.12 147.71 10.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 122.528 1.156 . . . . 0.080000000000000002 110.747 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.64 153.79 37.66 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-N 112.878 -1.965 . . . . 0.47999999999999998 107.943 -178.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 42.4 mtmt -55.57 103.01 0.08 Allowed 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.783 0.801 . . . . 0.98999999999999999 110.122 173.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.58 -11.67 6.33 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 113.637 -1.619 . . . . 0.19 111.394 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.658 HG21 ' HB ' ' A' ' 457' ' ' VAL . 10.3 m -65.6 150.34 96.21 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 108.443 -0.947 . . . . 0.13 108.443 171.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.574 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.3 Cg_endo -93.51 163.55 2.37 Favored 'Trans proline' 0 N--CA 1.42 -2.852 0 C-N-CA 122.0 1.8 . . . . 0.17999999999999999 109.644 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.72 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -125.19 152.71 31.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 107.392 -1.336 . . . . 0.56999999999999995 107.392 170.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.762 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.1 mp -133.02 150.01 52.17 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 108.09 -1.078 . . . . 0.13 108.09 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 1.026 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.23 138.57 37.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 103.879 -2.638 . . . . 0.10000000000000001 103.879 163.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.764 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 2.5 p90 . . . . . 0 C--O 1.247 0.956 0 O-C-N 123.768 0.668 . . . . 1.0900000000000001 110.719 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' 1RG . . . . . 0.736 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.468 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.7 m-20 . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 109.456 -0.572 . . . . 0.42999999999999999 109.456 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 357' ' ' TYR . 70.6 m -158.08 134.3 9.4 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.467 -1.242 . . . . 0.14000000000000001 108.715 169.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.638 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.1 p90 174.61 158.39 0.17 Allowed 'General case' 0 C--O 1.212 -0.876 0 O-C-N 123.316 0.385 . . . . 0.14999999999999999 111.545 -175.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -78.23 149.32 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 109.274 -0.639 . . . . 0.080000000000000002 109.274 164.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.555 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.2 tt0 -149.34 139.57 22.24 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.459 -0.791 . . . . 2.0099999999999998 109.902 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.745 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -132.52 161.53 41.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.039 0.447 . . . . 0.45000000000000001 111.412 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.542 ' N ' HG12 ' A' ' 347' ' ' VAL . 32.5 t0 -140.23 106.35 5.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.385 -1.339 . . . . 0.23999999999999999 107.385 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.111 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.02 -34.88 26.18 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 124.071 1.891 . . . . 0.16 110.139 -170.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.474 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.0 OUTLIER -55.63 -41.77 74.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 111.144 -2.753 . . . . 0.59999999999999998 107.757 176.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 19.1 m-80 -105.52 7.66 33.06 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 110.912 -2.858 . . . . 0.20000000000000001 111.666 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.816 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 82.9 mm-40 28.8 63.86 0.12 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 112.825 -1.989 . . . . 2.1499999999999999 114.294 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.518 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 27.2 t60 -141.87 137.71 31.58 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.665 -1.152 . . . . 0.089999999999999997 110.125 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.728 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -113.55 157.89 21.48 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.218 0.532 . . . . 0.070000000000000007 110.385 -178.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.615 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.5 m-90 -143.3 153.88 43.22 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.274 -0.876 . . . . 0.11 111.137 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.7 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.0 t80 -109.35 153.07 24.46 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.46 -1.681 . . . . 0.26000000000000001 106.46 151.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.9 m-85 -127.43 119.37 25.99 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.946 -1.024 . . . . 0.14000000000000001 110.384 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.8 tppt? -121.1 135.65 55.14 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.408 -1.701 . . . . 0.25 106.408 168.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.524 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 72.11 15.77 5.42 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.071 0.767 . . . . 0.42999999999999999 113.071 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.65 7.09 88.29 Favored Glycine 0 CA--C 1.485 -1.826 0 CA-C-N 115.693 -0.685 . . . . 0.17999999999999999 112.731 -173.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' A' ' 359' ' ' ASP . 18.1 ptmt -127.93 178.13 6.39 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 104.505 -2.406 . . . . 0.37 104.505 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.7 m -104.51 157.83 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 N-CA-C 116.475 2.028 . . . . 0.10000000000000001 116.475 -174.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.683 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.86 -27.97 9.91 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-N 110.477 -3.056 . . . . 0.070000000000000007 106.286 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.12 144.31 48.49 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 111.471 -2.604 . . . . 0.059999999999999998 111.625 -175.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.415 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.4 tt0 -140.34 117.47 11.22 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 104.426 -2.435 . . . . 0.47999999999999998 104.426 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.728 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.55 160.39 43.52 Favored 'General case' 0 N--CA 1.393 -3.297 0 C-N-CA 117.871 -1.532 . . . . 0.070000000000000007 110.636 -179.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.75 138.9 38.12 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 108.334 -0.987 . . . . 1.8 108.334 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.742 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.0 pp -136.47 -174.21 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-O 122.11 0.957 . . . . 0.12 112.25 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.816 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.7 OUTLIER -150.12 118.82 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 113.02 -1.9 . . . . 0.10000000000000001 108.793 172.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.509 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -78.63 -168.08 1.28 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.555 -1.657 . . . . 1.26 110.349 -178.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.469 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.43 168.07 43.75 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 118.485 -1.816 . . . . 0.14000000000000001 112.311 -174.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.402 ' HG3' ' OG1' ' A' ' 374' ' ' THR . 10.0 ptmt -73.61 158.74 85.92 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.626 0.727 . . . . 0.81000000000000005 111.9 -166.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.641 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 88.1 Cg_exo -57.43 -28.99 82.92 Favored 'Trans proline' 0 CA--C 1.495 -1.426 0 C-N-CA 125.182 3.922 . . . . 0.28000000000000003 113.435 -173.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.452 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.9 p -71.57 -33.71 69.31 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.405 -1.725 . . . . 0.33000000000000002 109.618 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.6 t -141.36 70.57 26.97 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 123.737 1.732 . . . . 0.39000000000000001 109.584 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 375' ' ' THR . 79.0 Cg_exo -59.46 157.55 30.97 Favored 'Trans proline' 0 C--N 1.314 -1.256 1 C-N-CA 126.494 4.796 . . . . 0.38 114.481 -172.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.509 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -87.35 146.16 39.24 Favored Pre-proline 0 N--CA 1.425 -1.723 0 N-CA-C 108.44 -0.948 . . . . 0.81999999999999995 108.44 174.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.4 Cg_exo -76.08 -44.15 0.28 Allowed 'Trans proline' 0 CA--C 1.511 -0.657 0 C-N-CA 124.8 3.667 . . . . 0.19 112.136 -167.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.781 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 57.67 137.88 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 123.249 1.499 . . . . 0.13 113.608 -172.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 150.47 -111.02 0.49 Allowed Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 112.592 -2.095 . . . . 0.20000000000000001 110.319 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 381' ' ' VAL . 5.7 p -130.17 113.51 26.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 122.496 1.141 . . . . 0.81999999999999995 111.078 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.733 ' HB2' HG12 ' A' ' 463' ' ' VAL . 1.8 m-85 -114.68 -171.21 1.89 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.929 -1.508 . . . . 0.22 106.929 173.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 462' ' ' PRO . 1.4 t80 -150.03 124.58 9.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.856 1.207 . . . . 0.65000000000000002 112.838 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.62 HG12 HG23 ' A' ' 463' ' ' VAL . 2.3 p -89.45 91.95 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-O 123.047 1.403 . . . . 0.16 109.13 169.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -93.8 11.24 29.96 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 113.298 -1.773 . . . . 2.5499999999999998 107.851 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.74 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.0 t30 -169.19 126.18 0.94 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 113.793 -1.548 . . . . 0.42999999999999999 110.086 172.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.66 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.89 143.68 31.47 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.828 -1.078 . . . . 1.1200000000000001 109.121 171.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 26.7 mm-40 -126.11 157.61 37.61 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.599 1.333 . . . . 0.70999999999999996 114.599 -167.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 45.2 mt-10 -135.63 127.16 28.77 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 113.155 -1.839 . . . . 0.38 108.902 172.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.14 49.62 18.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 123.159 1.457 . . . . 0.40999999999999998 109.335 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.948 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -81.88 168.5 17.87 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 112.579 -2.1 . . . . 0.12 109.454 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.0 m -132.27 119.59 21.0 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.904 0.859 . . . . 0.17000000000000001 111.745 170.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.6 mp -80.2 88.84 5.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.802 -1.545 . . . . 0.56999999999999995 112.167 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.561 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.5 mttt . . . . . 0 C--N 1.284 -2.271 0 CA-C-N 113.657 -1.61 . . . . 0.33000000000000002 113.502 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.561 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.778 0 CA-C-O 120.977 0.418 . . . . 0.53000000000000003 109.91 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.2 97.35 5.23 Favored Pre-proline 0 N--CA 1.434 -1.254 0 N-CA-C 108.233 -1.025 . . . . 0.19 108.233 171.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.2 Cg_exo -69.31 110.59 2.5 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 122.012 1.808 . . . . 0.19 110.047 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.948 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.02 158.03 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 CA-C-N 113.132 -1.849 . . . . 0.14999999999999999 107.582 -168.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.689 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.0 m-80 -89.27 -21.8 23.02 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.031 -0.729 . . . . 0.51000000000000001 109.031 -174.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.744 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 94.1 m-85 -158.86 127.54 5.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.924 -1.035 . . . . 0.27000000000000002 108.229 -170.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.672 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 21.9 t-105 -144.93 136.26 25.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.692 0.758 . . . . 0.089999999999999997 111.397 -166.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.66 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.8 mmt -119.68 93.65 47.72 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.157 -1.053 . . . . 0.14000000000000001 108.157 173.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.2 Cg_endo . . . . . 0 N--CA 1.459 -0.552 0 C-N-CA 122.171 1.914 . . . . 0.5 111.351 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 419' ' ' GLY . 40.6 t . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.425 0.631 . . . . 0.75 111.69 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.605 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.4 123.47 0.91 Allowed Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.049 -1.221 . . . . 0.20000000000000001 110.049 170.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.729 HG22 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.63 141.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.382 -0.599 . . . . 0.28999999999999998 109.382 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.672 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.6 p80 -159.82 160.1 33.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.295 -0.412 . . . . 0.089999999999999997 111.525 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -82.59 145.92 29.44 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.02 -1.104 . . . . 1.0700000000000001 108.02 172.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 445' ' ' THR . 37.9 t -134.78 97.68 3.83 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.65 0.738 . . . . 0.23000000000000001 110.191 -172.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.456 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 24.1 t70 . . . . . 0 C--N 1.314 -0.954 0 CA-C-N 114.604 -1.18 . . . . 0.41999999999999998 109.665 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.545 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.1 pm0 . . . . . 0 N--CA 1.434 -1.248 0 CA-C-O 122.199 0.999 . . . . 2.1600000000000001 113.283 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.644 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -160.57 128.6 4.55 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 106.384 -1.71 . . . . 0.33000000000000002 106.384 167.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.73 -156.71 28.32 Favored Glycine 0 C--N 1.285 -2.286 0 C-N-CA 119.975 -1.107 . . . . 0.17000000000000001 110.682 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.27 165.35 0.01 OUTLIER Glycine 0 CA--C 1.489 -1.549 0 C-N-CA 120.243 -0.98 . . . . 0.20999999999999999 111.667 166.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.534 ' HB3' ' HD2' ' A' ' 435' ' ' LYS . 7.5 m-20 -53.48 102.98 0.06 Allowed 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.268 -1.466 . . . . 1.8500000000000001 113.499 -156.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.99 HD22 ' HD2' ' A' ' 437' ' ' ARG . 30.0 mt -94.66 -33.99 12.75 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 112.892 -1.958 . . . . 1.21 109.452 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.674 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.1 p-90 -52.32 -27.32 14.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.841 -1.072 . . . . 0.16 112.501 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.674 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.87 -33.17 16.56 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.276 0.56 . . . . 0.22 112.275 -178.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.5 p -90.62 -38.36 13.18 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.215 -0.902 . . . . 0.25 110.765 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.99 ' HD2' HD22 ' A' ' 433' ' ' LEU . 1.5 mtp85 -98.49 -17.94 18.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.6 -1.182 . . . . 1.8200000000000001 109.992 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.36 48.05 55.02 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.833 -1.076 . . . . 0.23999999999999999 115.043 163.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.1 p -83.93 110.65 18.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.674 1.237 . . . . 1.01 111.615 -172.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 35.13 -121.44 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.444 -1.253 . . . . 0.5 113.418 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.469 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -131.75 -19.35 1.17 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.842 -0.617 . . . . 0.26000000000000001 113.703 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.45 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 29.4 p -99.95 -167.66 1.49 Allowed 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 117.923 0.862 . . . . 0.34999999999999998 112.61 -174.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.453 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -99.03 126.26 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 114.698 -1.137 . . . . 0.12 110.928 -173.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.73 99.92 11.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.69 -0.686 . . . . 0.62 110.064 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.742 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -97.35 143.09 25.56 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-N 115.235 -0.893 . . . . 0.10000000000000001 112.379 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.666 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 87.6 Cg_exo -49.59 144.59 18.93 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 124.023 3.149 . . . . 0.23999999999999999 113.36 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.644 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.1 Cg_exo -65.92 -27.26 50.99 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.734 2.289 . . . . 0.31 111.991 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 14.5 m -75.68 -24.12 56.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.453 -0.794 . . . . 1.1000000000000001 112.18 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.81 ' O ' HD21 ' A' ' 364' ' ' LEU . 29.0 m -100.36 -49.31 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 113.171 0.804 . . . . 0.080000000000000002 113.171 -168.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.949 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.93 -2.08 4.82 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.888 -0.725 . . . . 0.070000000000000007 110.191 -178.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.615 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.2 pttp -81.45 -38.51 26.31 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 122.554 1.168 . . . . 0.92000000000000004 108.197 173.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.4 mm-40 -62.53 -46.5 88.12 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-N 112.418 -2.174 . . . . 0.25 106.463 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.949 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.8 tp -46.34 -66.89 0.34 Allowed 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 109.807 -3.361 . . . . 0.050000000000000003 112.579 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.48 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 17.4 t80 -45.4 -24.28 0.29 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 124.038 0.836 . . . . 0.13 109.617 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.443 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.27 -27.36 25.68 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.76 -1.109 . . . . 0.13 111.685 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.744 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -100.83 -44.57 5.73 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 113.304 0.853 . . . . 0.059999999999999998 113.304 177.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -74.01 149.92 7.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 122.528 1.156 . . . . 0.080000000000000002 111.464 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.24 156.12 34.44 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-N 112.929 -1.941 . . . . 0.47999999999999998 108.121 -177.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.583 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.5 mppt? -56.36 103.03 0.09 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 109.248 -0.649 . . . . 0.98999999999999999 109.248 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.61 -6.89 6.59 Favored Glycine 0 C--N 1.308 -0.981 0 CA-C-N 114.148 -1.387 . . . . 0.19 111.863 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.635 HG21 ' HB ' ' A' ' 457' ' ' VAL . 7.7 m -69.63 147.81 96.64 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 109.425 -0.583 . . . . 0.13 109.425 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 2.5 Cg_endo -90.26 151.62 4.58 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 122.683 2.255 . . . . 0.17999999999999999 110.005 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' A' ' 382' ' ' PHE . 1.6 t -121.57 133.54 67.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 114.686 -1.143 . . . . 0.56999999999999995 109.088 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.686 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.3 mp -133.04 148.5 52.21 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 119.494 -0.882 . . . . 0.13 109.684 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.111 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.11 141.57 33.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.132 -2.174 . . . . 0.10000000000000001 105.132 166.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.75 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 12.8 p90 . . . . . 0 C--O 1.246 0.915 0 O-C-N 123.568 0.543 . . . . 1.0900000000000001 111.476 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 N--CA 1.446 -0.67 0 CA-C-O 121.567 0.699 . . . . 0.42999999999999999 109.318 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 99.5 m -158.95 135.24 9.14 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.288 -1.324 . . . . 0.14000000000000001 108.78 168.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.652 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.6 p90 174.64 158.09 0.16 Allowed 'General case' 0 C--O 1.211 -0.964 0 O-C-N 123.326 0.391 . . . . 0.14999999999999999 111.348 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.663 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.74 151.79 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 109.107 -0.701 . . . . 0.080000000000000002 109.107 164.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.577 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.2 tt0 -149.64 142.69 24.92 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.591 -0.731 . . . . 2.0099999999999998 109.568 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.725 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.67 161.69 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 121.019 0.438 . . . . 0.45000000000000001 111.019 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.534 ' N ' HG12 ' A' ' 347' ' ' VAL . 31.7 t0 -140.03 105.72 5.13 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.158 -1.423 . . . . 0.23999999999999999 107.158 173.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.089 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -81.24 -35.09 31.64 Favored 'General case' 0 CA--C 1.481 -1.678 0 CA-C-O 122.838 1.304 . . . . 0.16 110.212 -168.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.444 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.8 mt-10 -55.27 -44.89 76.03 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 110.706 -2.952 . . . . 0.59999999999999998 108.063 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 18.3 m-80 -100.44 5.51 44.26 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 110.932 -2.849 . . . . 0.20000000000000001 110.904 -175.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.6 OUTLIER 34.79 61.15 0.6 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 112.794 -2.003 . . . . 2.1499999999999999 112.981 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.494 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.4 t60 -141.58 134.96 29.57 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.714 -0.675 . . . . 0.089999999999999997 109.863 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.729 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.37 156.55 23.23 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.84 -0.618 . . . . 0.070000000000000007 110.238 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.599 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.6 m-90 -142.06 155.33 45.38 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.551 -0.75 . . . . 0.11 111.195 -175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.698 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.9 t80 -110.42 153.17 25.37 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 106.582 -1.636 . . . . 0.26000000000000001 106.582 151.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.3 m-85 -128.51 115.97 18.96 Favored 'General case' 0 C--N 1.269 -2.893 0 CA-C-N 114.855 -1.066 . . . . 0.14000000000000001 110.289 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.6 tppt? -116.33 140.02 49.78 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.777 -1.934 . . . . 0.25 105.777 168.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.46 19.4 10.02 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.358 0.873 . . . . 0.42999999999999999 113.358 171.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 75.17 7.88 82.62 Favored Glycine 0 CA--C 1.489 -1.537 0 CA-C-N 115.573 -0.739 . . . . 0.17999999999999999 113.417 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.0 ptmt -128.0 178.26 6.32 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 104.682 -2.34 . . . . 0.37 104.682 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.599 HG11 ' CD1' ' A' ' 355' ' ' TRP . 15.6 m -105.0 157.52 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 N-CA-C 116.205 1.928 . . . . 0.10000000000000001 116.205 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.68 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.03 -26.52 10.14 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 110.461 -3.063 . . . . 0.070000000000000007 106.358 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.833 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -135.04 143.7 46.86 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 111.511 -2.586 . . . . 0.059999999999999998 111.726 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.409 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 2.6 tt0 -142.01 117.77 10.45 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.673 -2.343 . . . . 0.47999999999999998 104.673 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.729 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.81 164.49 35.19 Favored 'General case' 0 N--CA 1.398 -3.053 0 C-N-CA 118.129 -1.428 . . . . 0.070000000000000007 111.548 -178.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.673 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 10.3 p-10 -103.3 133.12 48.91 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.366 -1.288 . . . . 1.8 109.633 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.702 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -134.07 -173.63 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 122.345 1.069 . . . . 0.12 112.307 -171.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.48 121.81 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 112.904 -1.953 . . . . 0.10000000000000001 108.491 172.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.537 ' HB3' HD12 ' A' ' 349' ' ' LEU . 56.9 p -77.69 -168.83 1.3 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 112.678 -2.055 . . . . 1.26 111.418 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.48 167.24 42.65 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 118.536 -1.792 . . . . 0.14000000000000001 111.771 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 6.7 ptmt -74.48 155.76 87.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.413 0.625 . . . . 0.81000000000000005 111.633 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.704 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 78.8 Cg_exo -54.71 -30.07 64.82 Favored 'Trans proline' 0 CA--C 1.498 -1.318 1 C-N-CA 125.386 4.057 . . . . 0.28000000000000003 113.345 -173.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.451 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 20.0 p -70.79 -34.51 71.85 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.568 -1.651 . . . . 0.33000000000000002 109.706 -176.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.9 t -141.94 69.98 23.92 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 123.78 1.753 . . . . 0.39000000000000001 109.439 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.4 Cg_exo -58.49 166.07 6.75 Favored 'Trans proline' 0 C--N 1.316 -1.157 1 C-N-CA 126.918 5.079 . . . . 0.38 115.81 -170.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.478 HG21 ' HG ' ' A' ' 349' ' ' LEU . 0.5 OUTLIER -93.75 140.77 23.14 Favored Pre-proline 0 N--CA 1.419 -1.985 0 CA-C-N 114.458 -1.246 . . . . 0.81999999999999995 108.331 170.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.4 Cg_exo -76.33 -45.96 0.19 Allowed 'Trans proline' 0 CA--C 1.514 -0.48 0 C-N-CA 124.547 3.498 . . . . 0.19 112.081 -170.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.762 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 62.48 138.59 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.313 1.53 . . . . 0.13 113.597 -172.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.59 -111.66 0.51 Allowed Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 112.281 -2.236 . . . . 0.20000000000000001 109.471 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.92 119.38 44.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.743 0.782 . . . . 0.81999999999999995 110.461 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.725 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.8 m-85 -118.23 -173.86 2.54 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.168 -1.419 . . . . 0.22 107.168 172.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.9 t80 -141.05 123.43 15.82 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 120.623 -1.298 . . . . 0.65000000000000002 112.959 -171.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.48 91.98 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-O 123.105 1.431 . . . . 0.16 109.403 169.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -93.7 11.95 27.24 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.274 -1.785 . . . . 2.5499999999999998 108.199 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.776 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.7 t30 -168.64 126.41 1.06 Allowed 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 113.995 -1.457 . . . . 0.42999999999999999 110.162 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.663 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.34 141.87 33.57 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.747 -1.115 . . . . 1.1200000000000001 108.94 169.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.768 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 13.9 mm-40 -126.1 157.69 37.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 114.443 1.275 . . . . 0.70999999999999996 114.443 -167.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 47.3 mt-10 -137.73 127.2 24.93 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.013 -1.903 . . . . 0.38 108.613 173.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.6 t70 56.48 47.77 18.1 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.227 1.489 . . . . 0.40999999999999998 109.026 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.922 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -83.7 169.28 15.44 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 112.367 -2.197 . . . . 0.12 109.393 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 20.7 m -132.6 121.14 22.76 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.863 0.839 . . . . 0.17000000000000001 111.693 169.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.8 mp -80.35 89.17 5.54 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.829 -1.532 . . . . 0.56999999999999995 112.601 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.579 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.1 mttt . . . . . 0 C--N 1.284 -2.269 0 CA-C-N 113.687 -1.597 . . . . 0.33000000000000002 113.117 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.579 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.444 -0.732 0 CA-C-O 121.13 0.491 . . . . 0.53000000000000003 110.161 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.14 97.23 4.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.177 -1.045 . . . . 0.19 108.177 169.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.2 Cg_exo -69.02 109.55 2.19 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.851 1.701 . . . . 0.19 110.26 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.922 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.97 157.48 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-N 113.194 -1.821 . . . . 0.14999999999999999 107.697 -167.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.72 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.9 m-80 -89.7 -20.61 23.4 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.016 -0.735 . . . . 0.51000000000000001 109.016 -174.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.768 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 87.8 m-85 -158.45 126.43 5.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.968 -1.015 . . . . 0.27000000000000002 108.508 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.68 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.3 t-105 -144.52 134.89 24.43 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.781 0.8 . . . . 0.089999999999999997 111.295 -167.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.663 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -116.71 92.63 38.57 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 107.609 -1.256 . . . . 0.14000000000000001 107.609 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.776 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.3 Cg_endo . . . . . 0 C--N 1.348 0.539 0 C-N-CA 122.434 2.09 . . . . 0.5 111.68 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 419' ' ' GLY . 43.1 t . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 121.123 0.487 . . . . 0.75 111.641 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.6 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -175.06 121.52 0.83 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.17 -1.172 . . . . 0.20000000000000001 110.17 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.708 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.7 141.78 14.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.928 -0.397 . . . . 0.28999999999999998 109.928 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.678 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.5 p80 -159.89 161.59 34.4 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.097 -0.501 . . . . 0.089999999999999997 111.338 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.69 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -82.24 147.68 28.81 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.988 -1.115 . . . . 1.0700000000000001 107.988 171.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 445' ' ' THR . 29.4 t -132.83 96.91 3.9 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.813 0.815 . . . . 0.23000000000000001 109.843 -173.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 N--CA 1.443 -0.787 0 CA-C-N 114.15 -1.386 . . . . 0.41999999999999998 109.353 -177.784 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.644 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.0 pm0 . . . . . 0 N--CA 1.435 -1.196 0 CA-C-O 122.248 1.023 . . . . 2.1600000000000001 113.464 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.713 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.67 129.22 3.51 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 112.722 -2.035 . . . . 0.33000000000000002 105.672 173.033 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.59 -158.07 30.55 Favored Glycine 0 C--N 1.284 -2.361 0 N-CA-C 110.538 -1.025 . . . . 0.17000000000000001 110.538 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.433 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -45.3 174.58 0.01 OUTLIER Glycine 0 CA--C 1.498 -0.979 0 C-N-CA 120.217 -0.992 . . . . 0.20999999999999999 111.66 167.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.537 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -52.01 101.89 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 123.386 1.565 . . . . 1.8500000000000001 113.76 -154.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.712 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.27 -37.92 10.32 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 112.575 -2.102 . . . . 1.21 109.798 170.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.684 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.4 p-90 -53.94 -27.28 30.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.442 -0.799 . . . . 0.16 112.39 -170.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.704 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -89.39 -34.07 16.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.593 0.59 . . . . 0.22 112.593 -177.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.4 p -92.75 -42.42 9.58 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.045 -0.979 . . . . 0.25 110.812 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.712 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.5 mtp180 -93.89 -18.36 22.05 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.971 -1.013 . . . . 1.8200000000000001 110.062 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.56 50.52 48.1 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 115.811 1.084 . . . . 0.23999999999999999 115.811 161.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 17.5 m -82.56 111.37 18.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 119.145 1.473 . . . . 1.01 111.237 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 34.18 -120.65 0.09 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.827 -1.079 . . . . 0.5 113.412 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -130.99 -18.76 1.32 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.986 -0.626 . . . . 0.26000000000000001 113.741 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.464 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 29.5 p -103.62 -165.63 1.18 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.816 0.673 . . . . 0.34999999999999998 112.816 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.51 HD13 HG11 ' A' ' 465' ' ' VAL . 2.2 mp -95.86 132.79 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.121 -0.945 . . . . 0.12 110.825 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.82 98.06 7.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.936 -0.575 . . . . 0.62 110.26 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.702 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.5 m -93.88 140.17 22.9 Favored Pre-proline 0 N--CA 1.439 -0.997 0 CA-C-N 115.392 -0.822 . . . . 0.10000000000000001 113.206 -176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.712 ' O ' HG22 ' A' ' 449' ' ' VAL . 74.1 Cg_exo -51.97 135.75 51.51 Favored 'Trans proline' 0 CA--C 1.496 -1.392 0 C-N-CA 124.629 3.553 . . . . 0.23999999999999999 115.532 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.713 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 50.0 Cg_exo -56.76 -38.82 94.88 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.279 1.319 . . . . 0.31 111.618 -167.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.604 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 21.0 m -62.46 -25.61 68.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.225 0.824 . . . . 1.1000000000000001 113.225 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.833 ' O ' HD21 ' A' ' 364' ' ' LEU . 22.6 m -98.42 -47.76 12.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 O-C-N 121.33 -0.856 . . . . 0.080000000000000002 112.997 -169.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.956 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.49 -1.98 5.76 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.613 -0.835 . . . . 0.070000000000000007 110.344 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 448' ' ' SER . 14.2 pttp -80.78 -38.59 28.28 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 122.67 1.224 . . . . 0.92000000000000004 108.294 173.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.8 mm-40 -61.6 -46.58 89.24 Favored 'General case' 0 CA--C 1.47 -2.104 0 CA-C-N 112.305 -2.225 . . . . 0.25 106.36 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.956 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -47.23 -66.59 0.38 Allowed 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 109.766 -3.379 . . . . 0.050000000000000003 112.688 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.473 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 19.0 t80 -45.71 -23.86 0.3 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 123.935 0.772 . . . . 0.13 109.581 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.46 -26.64 27.22 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 114.789 -1.096 . . . . 0.13 111.772 -175.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.736 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.96 -44.64 5.43 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 113.462 0.912 . . . . 0.059999999999999998 113.462 177.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.658 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.98 148.03 9.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.495 1.141 . . . . 0.080000000000000002 111.402 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.04 156.72 28.11 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 113.005 -1.907 . . . . 0.47999999999999998 108.772 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.616 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 43.1 mtmt -57.28 102.99 0.1 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.659 0.742 . . . . 0.98999999999999999 109.686 170.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.96 -10.78 6.26 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 113.837 -1.529 . . . . 0.19 111.369 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.658 HG21 ' HB ' ' A' ' 457' ' ' VAL . 17.0 m -66.72 149.34 98.34 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 108.842 -0.799 . . . . 0.13 108.842 171.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 4.7 Cg_endo -93.67 159.07 2.35 Favored 'Trans proline' 0 N--CA 1.426 -2.499 0 C-N-CA 122.411 2.074 . . . . 0.17999999999999999 109.866 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.725 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -124.46 148.83 28.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.504 -1.295 . . . . 0.56999999999999995 107.504 172.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.694 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.7 mp -134.01 150.2 51.23 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.463 -0.94 . . . . 0.13 108.463 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.089 HG23 HD21 ' A' ' 349' ' ' LEU . 0.8 OUTLIER -138.72 141.99 35.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 105.113 -2.18 . . . . 0.10000000000000001 105.113 165.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.762 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 12.1 p90 . . . . . 0 C--O 1.245 0.822 0 O-C-N 123.688 0.617 . . . . 1.0900000000000001 111.064 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.43 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 4.9 m-20 . . . . . 0 N--CA 1.443 -0.812 0 N-CA-C 109.278 -0.638 . . . . 0.42999999999999999 109.278 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 357' ' ' TYR . 88.0 m -158.43 134.72 9.33 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.512 -1.222 . . . . 0.14000000000000001 109.104 169.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.668 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.8 p90 174.15 158.82 0.15 Allowed 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 123.42 0.45 . . . . 0.14999999999999999 111.112 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.639 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.62 151.85 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 N-CA-C 109.039 -0.726 . . . . 0.080000000000000002 109.039 164.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.611 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.21 140.91 23.53 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.583 -0.735 . . . . 2.0099999999999998 109.543 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.719 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -134.7 162.03 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.095 0.474 . . . . 0.45000000000000001 111.287 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.557 ' N ' HG12 ' A' ' 347' ' ' VAL . 27.8 t0 -140.26 106.8 5.32 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.205 -1.406 . . . . 0.23999999999999999 107.205 174.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.079 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.57 -33.77 25.33 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 123.378 1.561 . . . . 0.16 110.21 -169.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.444 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.4 mt-10 -57.17 -44.88 83.93 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 110.625 -2.989 . . . . 0.59999999999999998 107.908 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 19.2 m-80 -102.4 4.84 39.29 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 111.155 -2.748 . . . . 0.20000000000000001 111.227 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 349' ' ' LEU . 29.6 mt-30 32.69 63.54 0.3 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 112.857 -1.974 . . . . 2.1499999999999999 113.748 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.524 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.3 t60 -142.05 135.31 29.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.914 -1.039 . . . . 0.089999999999999997 109.332 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.756 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.16 156.4 23.28 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.781 -0.645 . . . . 0.070000000000000007 110.067 -178.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.609 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.7 m-90 -142.01 155.13 45.42 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.184 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.693 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 86.3 t80 -110.26 153.31 25.02 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 106.61 -1.626 . . . . 0.26000000000000001 106.61 151.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 11.7 m-85 -127.65 118.77 24.48 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 114.936 -1.029 . . . . 0.14000000000000001 110.416 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.2 tppt? -120.0 136.83 54.41 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.96 -1.867 . . . . 0.25 105.96 168.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.422 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.55 17.8 7.86 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.481 0.919 . . . . 0.42999999999999999 113.481 174.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.43 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.67 8.34 87.2 Favored Glycine 0 CA--C 1.485 -1.793 0 C-N-CA 120.825 -0.702 . . . . 0.17999999999999999 112.918 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.4 ptmt -129.08 177.7 6.94 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 104.564 -2.384 . . . . 0.37 104.564 178.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.609 HG11 ' CD1' ' A' ' 355' ' ' TRP . 18.1 m -104.12 157.69 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 N-CA-C 116.344 1.979 . . . . 0.10000000000000001 116.344 -175.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.693 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.8 -27.67 9.63 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 110.513 -3.04 . . . . 0.070000000000000007 106.493 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.817 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.82 144.58 49.07 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 111.495 -2.593 . . . . 0.059999999999999998 111.535 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.441 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.5 tt0 -140.43 118.22 11.71 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 104.53 -2.396 . . . . 0.47999999999999998 104.53 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.756 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.05 163.41 38.23 Favored 'General case' 0 N--CA 1.397 -3.089 0 C-N-CA 117.626 -1.63 . . . . 0.070000000000000007 111.869 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.709 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 11.9 p-10 -101.96 134.14 45.65 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 114.027 -1.442 . . . . 1.8 109.545 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.731 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.11 -173.59 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 CA-C-O 122.26 1.029 . . . . 0.12 112.457 -172.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.47 118.63 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.075 -1.875 . . . . 0.10000000000000001 107.722 173.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.521 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -79.42 -167.98 1.38 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.127 -1.397 . . . . 1.26 110.773 -177.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.402 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.45 164.45 39.88 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 118.639 -1.743 . . . . 0.14000000000000001 112.407 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 11.0 ptmt -70.97 158.05 89.0 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.639 0.733 . . . . 0.81000000000000005 111.698 -167.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.674 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.4 Cg_exo -57.83 -29.48 86.23 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 125.184 3.923 . . . . 0.28000000000000003 113.348 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.46 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 17.8 p -71.76 -32.76 68.03 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.608 -1.633 . . . . 0.33000000000000002 109.725 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.538 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.5 t -141.07 70.47 28.43 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-O 123.807 1.765 . . . . 0.39000000000000001 109.31 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.0 Cg_exo -58.94 162.79 12.64 Favored 'Trans proline' 0 C--N 1.312 -1.358 1 C-N-CA 126.486 4.791 . . . . 0.38 115.165 -171.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.521 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -96.06 141.99 23.93 Favored Pre-proline 0 N--CA 1.419 -1.979 0 CA-C-N 114.729 -1.123 . . . . 0.81999999999999995 108.503 171.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.6 Cg_exo -76.31 -44.56 0.24 Allowed 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 124.719 3.612 . . . . 0.19 111.95 -167.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.784 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 61.49 138.05 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 123.328 1.537 . . . . 0.13 113.467 -172.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 153.0 -114.43 0.62 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 112.201 -2.272 . . . . 0.20000000000000001 109.362 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.73 117.21 37.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.892 0.854 . . . . 0.81999999999999995 110.661 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.744 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.9 m-85 -115.58 -174.04 2.45 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.147 -1.427 . . . . 0.22 107.147 173.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.0 OUTLIER -139.46 123.49 17.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 119.987 1.267 . . . . 0.65000000000000002 113.41 -171.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.06 92.23 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 123.06 1.41 . . . . 0.16 109.337 168.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -94.22 11.96 28.39 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.428 -1.714 . . . . 2.5499999999999998 108.18 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.767 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 9.0 t30 -169.37 126.65 0.93 Allowed 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 113.972 -1.467 . . . . 0.42999999999999999 110.174 172.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.631 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.16 145.99 26.61 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.064 -0.971 . . . . 1.1200000000000001 109.098 168.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.751 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 19.5 mm-40 -126.29 159.2 33.76 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 114.509 1.3 . . . . 0.70999999999999996 114.509 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.752 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 40.1 mt-10 -138.37 127.52 24.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.211 -1.813 . . . . 0.38 108.674 173.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.81 45.52 21.48 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 123.338 1.542 . . . . 0.40999999999999998 108.729 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.936 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.77 166.6 20.84 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 112.513 -2.13 . . . . 0.12 109.177 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 16.9 m -132.08 120.65 22.64 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.091 0.948 . . . . 0.17000000000000001 111.551 170.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -81.13 88.6 5.99 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.871 -1.513 . . . . 0.56999999999999995 112.048 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.3 mttt . . . . . 0 C--N 1.284 -2.245 0 CA-C-N 113.585 -1.643 . . . . 0.33000000000000002 113.129 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.61 0 CA-C-O 121.12 0.486 . . . . 0.53000000000000003 110.151 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.81 97.33 4.96 Favored Pre-proline 0 N--CA 1.436 -1.153 0 N-CA-C 108.275 -1.009 . . . . 0.19 108.275 170.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 18.1 Cg_exo -69.04 111.1 2.57 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.065 1.843 . . . . 0.19 110.023 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.936 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.99 153.45 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 CA-C-N 112.958 -1.928 . . . . 0.14999999999999999 107.626 -167.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 21.5 m-80 -86.14 -20.44 28.64 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.902 -0.777 . . . . 0.51000000000000001 108.902 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.4 m-85 -159.0 127.31 5.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.12 -0.945 . . . . 0.27000000000000002 108.643 -170.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.677 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 23.3 t-105 -145.12 134.35 22.86 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.641 0.734 . . . . 0.089999999999999997 111.185 -167.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.631 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.5 mmt -116.44 93.69 40.72 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.908 -1.145 . . . . 0.14000000000000001 107.908 173.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.767 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 39.0 Cg_endo . . . . . 0 N--CA 1.46 -0.464 0 C-N-CA 122.311 2.007 . . . . 0.5 112.239 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 419' ' ' GLY . 36.5 t . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 121.321 0.582 . . . . 0.75 111.943 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.84 121.4 0.75 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 109.931 -1.268 . . . . 0.20000000000000001 109.931 171.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.705 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.66 143.09 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 110.034 -0.358 . . . . 0.28999999999999998 110.034 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.677 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.4 p80 -160.58 162.11 32.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.245 -0.434 . . . . 0.089999999999999997 111.409 -174.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.66 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -84.45 145.86 27.93 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.947 -1.131 . . . . 1.0700000000000001 107.947 172.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.2 t -134.17 98.63 4.17 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.745 0.783 . . . . 0.23000000000000001 110.5 -171.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 C--N 1.314 -0.952 0 CA-C-N 114.117 -1.401 . . . . 0.41999999999999998 109.418 -177.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.522 ' HG3' ' HG ' ' A' ' 433' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.428 -1.531 0 CA-C-O 122.205 1.002 . . . . 2.1600000000000001 111.779 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.709 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.9 OUTLIER -159.58 124.84 4.11 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 105.129 -2.175 . . . . 0.33000000000000002 105.129 173.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.09 -157.75 30.16 Favored Glycine 0 C--N 1.284 -2.333 0 C-N-CA 119.46 -1.352 . . . . 0.17000000000000001 111.354 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -46.26 173.48 0.02 OUTLIER Glycine 0 CA--C 1.501 -0.805 0 C-N-CA 120.609 -0.805 . . . . 0.20999999999999999 111.694 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.598 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 6.3 p-10 -52.57 100.8 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 123.743 1.735 . . . . 1.8500000000000001 114.035 -150.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.722 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.55 -43.58 7.53 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 111.805 -2.452 . . . . 1.21 109.721 170.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.718 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.5 p-90 -52.12 -27.31 13.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.718 -0.674 . . . . 0.16 112.504 -171.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.718 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.89 -32.56 15.98 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.397 0.618 . . . . 0.22 112.452 -177.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.8 p -94.15 -43.24 8.57 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.951 -1.022 . . . . 0.25 111.069 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.722 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.2 OUTLIER -87.59 -20.18 26.77 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.768 -1.106 . . . . 1.8200000000000001 109.153 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.59 47.7 63.02 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 113.631 -1.622 . . . . 0.23999999999999999 115.138 164.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.5 p -82.88 110.23 17.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 118.962 1.381 . . . . 1.01 111.675 -171.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 33.54 -117.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.291 -1.322 . . . . 0.5 113.47 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.402 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -135.57 -16.32 0.91 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.906 -0.664 . . . . 0.26000000000000001 113.79 -174.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 29.1 p -103.57 -166.56 1.27 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.834 0.817 . . . . 0.34999999999999998 112.621 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.429 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -96.16 129.41 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.107 -0.952 . . . . 0.12 110.736 -175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.59 93.41 5.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.976 -0.556 . . . . 0.62 110.332 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.731 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -89.14 141.98 29.7 Favored Pre-proline 0 N--CA 1.438 -1.038 0 CA-C-N 115.234 -0.894 . . . . 0.10000000000000001 112.549 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.643 ' HD2' HG21 ' A' ' 366' ' ' THR . 87.1 Cg_exo -49.61 144.77 18.58 Favored 'Trans proline' 0 CA--C 1.506 -0.89 0 C-N-CA 124.158 3.239 . . . . 0.23999999999999999 113.549 175.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.658 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.7 Cg_exo -65.12 -27.02 57.19 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.855 2.37 . . . . 0.31 112.234 -175.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 11.9 m -76.31 -23.9 54.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.863 -0.608 . . . . 1.1000000000000001 112.237 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.817 ' O ' HD21 ' A' ' 364' ' ' LEU . 30.8 m -100.59 -48.7 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 113.009 0.744 . . . . 0.080000000000000002 113.009 -169.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.945 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.87 -2.1 4.78 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.847 -0.741 . . . . 0.070000000000000007 110.353 -178.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.8 pttp -80.81 -39.43 26.7 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.085 -1.08 . . . . 0.92000000000000004 108.085 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.4 mm-40 -61.45 -45.9 92.32 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 112.578 -2.101 . . . . 0.25 106.46 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.945 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.5 tp -47.69 -67.12 0.3 Allowed 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 109.701 -3.409 . . . . 0.050000000000000003 112.719 172.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.564 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 14.4 t80 -45.93 -23.28 0.27 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.794 0.807 . . . . 0.13 109.562 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.15 -26.01 27.29 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.72 -1.127 . . . . 0.13 111.842 -176.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.733 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -102.71 -43.91 5.45 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 113.504 0.927 . . . . 0.059999999999999998 113.504 177.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.682 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -73.47 150.38 7.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 122.523 1.154 . . . . 0.080000000000000002 111.196 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -120.84 156.77 31.23 Favored 'General case' 0 N--CA 1.414 -2.255 0 CA-C-N 112.978 -1.919 . . . . 0.47999999999999998 108.418 -177.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.59 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.2 mppt? -59.34 101.86 0.12 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.888 -0.782 . . . . 0.98999999999999999 108.888 171.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.3 -11.74 5.81 Favored Glycine 0 C--N 1.306 -1.132 0 CA-C-N 113.955 -1.475 . . . . 0.19 111.482 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.682 HG21 ' HB ' ' A' ' 457' ' ' VAL . 15.6 m -66.65 149.33 98.29 Favored Pre-proline 0 N--CA 1.44 -0.964 0 N-CA-C 108.651 -0.87 . . . . 0.13 108.651 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.6 Cg_endo -93.72 160.63 2.31 Favored 'Trans proline' 0 N--CA 1.422 -2.707 0 C-N-CA 122.196 1.931 . . . . 0.17999999999999999 109.929 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.744 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -123.99 150.07 28.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.281 -1.377 . . . . 0.56999999999999995 107.281 171.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.712 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.08 149.06 51.11 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 108.179 -1.045 . . . . 0.13 108.179 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.079 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.74 142.25 36.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 105.266 -2.124 . . . . 0.10000000000000001 105.266 165.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.751 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 8.3 p90 . . . . . 0 C--O 1.244 0.79 0 O-C-N 123.83 0.706 . . . . 1.0900000000000001 110.787 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.502 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 13.3 m-20 . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 109.341 -0.614 . . . . 0.42999999999999999 109.341 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 357' ' ' TYR . 97.2 m -159.78 135.61 8.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.8 -1.091 . . . . 0.14000000000000001 109.857 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.627 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.5 p90 173.02 159.7 0.12 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.192 0.308 . . . . 0.14999999999999999 110.812 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.649 HD12 HD11 ' A' ' 453' ' ' LEU . 0.3 OUTLIER -77.97 151.54 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 109.526 -0.546 . . . . 0.080000000000000002 109.526 164.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.612 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 35.1 tt0 -149.72 141.05 23.22 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.486 -0.779 . . . . 2.0099999999999998 109.626 -176.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.724 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -134.44 161.87 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 122.126 -0.359 . . . . 0.45000000000000001 111.104 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.559 ' N ' HG12 ' A' ' 347' ' ' VAL . 20.7 t0 -140.26 107.21 5.42 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.663 -1.236 . . . . 0.23999999999999999 107.663 173.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.06 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.55 -33.35 25.46 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-O 122.77 1.271 . . . . 0.16 110.273 -168.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.442 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.0 OUTLIER -59.72 -43.4 94.16 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 110.87 -2.877 . . . . 0.59999999999999998 108.261 177.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 19.1 m-80 -102.83 8.12 39.35 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 111.153 -2.749 . . . . 0.20000000000000001 110.749 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.56 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 15.3 mp0 32.93 61.27 0.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 112.906 -1.952 . . . . 2.1499999999999999 113.56 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.529 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 24.8 t60 -142.94 137.13 29.2 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.868 -0.605 . . . . 0.089999999999999997 109.86 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.716 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -114.48 156.53 24.39 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.994 -0.548 . . . . 0.070000000000000007 110.249 -179.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.595 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -142.21 154.18 44.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.482 -0.781 . . . . 0.11 111.191 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.698 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.5 t80 -110.15 153.11 25.18 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.491 -1.67 . . . . 0.26000000000000001 106.491 151.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.9 m-85 -127.61 117.12 21.41 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.883 -1.053 . . . . 0.14000000000000001 109.948 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.7 tppt? -118.13 140.05 50.35 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 105.854 -1.906 . . . . 0.25 105.854 168.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.65 17.21 10.57 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.597 0.962 . . . . 0.42999999999999999 113.597 171.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.502 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.97 8.06 87.41 Favored Glycine 0 CA--C 1.483 -1.954 0 CA-C-O 122.064 0.813 . . . . 0.17999999999999999 112.961 -175.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 16.1 ptmt -126.83 177.26 6.7 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 104.484 -2.413 . . . . 0.37 104.484 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.595 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.0 m -104.29 157.11 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.841 0 C-N-CA 116.982 -1.887 . . . . 0.10000000000000001 115.626 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.652 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -106.61 -28.23 10.37 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-N 110.544 -3.025 . . . . 0.070000000000000007 106.125 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.832 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -133.17 143.48 49.24 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 111.413 -2.63 . . . . 0.059999999999999998 111.896 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.436 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -139.98 117.55 11.51 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 104.361 -2.459 . . . . 0.47999999999999998 104.361 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.716 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.94 161.02 43.12 Favored 'General case' 0 N--CA 1.397 -3.11 0 C-N-CA 117.795 -1.562 . . . . 0.070000000000000007 110.691 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.17 141.61 32.77 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.448 -0.945 . . . . 1.8 108.448 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.717 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -138.66 -172.82 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 CA-C-O 122.54 1.162 . . . . 0.12 111.947 -173.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.86 120.13 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 112.725 -2.034 . . . . 0.10000000000000001 108.197 173.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.533 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -80.13 -168.06 1.52 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.977 -1.465 . . . . 1.26 110.36 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.439 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.19 168.32 44.54 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 118.528 -1.796 . . . . 0.14000000000000001 112.26 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 5.3 ptmt -73.8 158.11 86.48 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.56 0.695 . . . . 0.81000000000000005 112.037 -165.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.694 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 82.3 Cg_exo -57.68 -30.66 89.68 Favored 'Trans proline' 0 CA--C 1.493 -1.555 0 C-N-CA 125.273 3.982 . . . . 0.28000000000000003 113.347 -172.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.413 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 22.7 p -68.61 -33.81 74.69 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.346 -1.752 . . . . 0.33000000000000002 109.325 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.55 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.5 t -142.88 70.28 19.15 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 123.585 1.659 . . . . 0.39000000000000001 110.37 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 375' ' ' THR . 83.4 Cg_exo -58.99 157.43 29.2 Favored 'Trans proline' 0 C--N 1.314 -1.273 1 C-N-CA 126.601 4.868 . . . . 0.38 115.145 -171.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.533 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -86.37 147.87 45.57 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 115.192 -0.913 . . . . 0.81999999999999995 108.702 173.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 16.6 Cg_exo -78.08 -44.64 0.16 Allowed 'Trans proline' 0 CA--C 1.512 -0.592 0 C-N-CA 124.853 3.702 . . . . 0.19 112.417 -167.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.774 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.49 138.52 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 123.345 1.545 . . . . 0.13 113.639 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.69 -115.13 0.68 Allowed Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 112.27 -2.241 . . . . 0.20000000000000001 109.318 -177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.6 p -128.35 121.18 54.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.846 0.832 . . . . 0.81999999999999995 110.266 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.726 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.9 m-85 -118.32 -174.38 2.65 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.87 -1.529 . . . . 0.22 106.87 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -139.67 123.02 17.09 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 120.801 -1.187 . . . . 0.65000000000000002 112.937 -171.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.41 92.7 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 123.056 1.407 . . . . 0.16 109.544 170.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -92.94 10.82 29.64 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 113.317 -1.765 . . . . 2.5499999999999998 108.334 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.762 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.1 t30 -169.21 126.91 0.96 Allowed 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 114.149 -1.387 . . . . 0.42999999999999999 110.393 172.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.668 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.11 142.7 30.26 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.825 -1.079 . . . . 1.1200000000000001 108.944 168.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 410' ' ' TRP . 23.7 mm-40 -123.9 162.44 23.33 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 114.835 1.42 . . . . 0.70999999999999996 114.835 -169.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 43.7 mt-10 -129.86 144.98 51.58 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 112.927 -1.942 . . . . 0.38 105.953 170.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.9 t70 39.51 47.66 1.65 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 122.766 1.269 . . . . 0.40999999999999998 109.834 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.958 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -82.8 168.15 17.42 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 111.937 -2.392 . . . . 0.12 108.977 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 10.2 m -132.04 119.5 21.11 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.948 0.88 . . . . 0.17000000000000001 111.24 170.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.9 mp -77.27 87.12 3.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.852 -1.522 . . . . 0.56999999999999995 111.787 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.546 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.3 mttt . . . . . 0 C--N 1.286 -2.18 0 CA-C-N 113.266 -1.788 . . . . 0.33000000000000002 113.406 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.546 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 1.3 mp0 . . . . . 0 N--CA 1.443 -0.788 0 CA-C-O 121.056 0.455 . . . . 0.53000000000000003 110.779 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.79 97.55 4.94 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 107.98 -1.119 . . . . 0.19 107.98 170.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 22.7 Cg_exo -68.58 110.24 2.26 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.076 1.851 . . . . 0.19 110.631 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.958 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.55 158.4 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 CA-C-N 113.036 -1.893 . . . . 0.14999999999999999 107.912 -168.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.631 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.8 OUTLIER -92.04 -19.43 22.37 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.934 -0.765 . . . . 0.51000000000000001 108.934 -174.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.9 m-85 -160.46 127.88 4.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.025 -1.102 . . . . 0.27000000000000002 108.025 -171.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.693 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.0 t-105 -144.93 131.51 19.87 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.746 0.784 . . . . 0.089999999999999997 111.561 -166.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.668 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.4 mmt -112.91 92.32 20.57 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 107.866 -1.161 . . . . 0.14000000000000001 107.866 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.762 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.7 Cg_endo . . . . . 0 N--CA 1.458 -0.572 0 C-N-CA 122.265 1.976 . . . . 0.5 111.626 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 419' ' ' GLY . 36.6 t . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.33 0.585 . . . . 0.75 112.115 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.591 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -174.87 121.11 0.81 Allowed Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 110.084 -1.206 . . . . 0.20000000000000001 110.084 169.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.663 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.2 mp -82.09 142.22 13.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 110.107 -0.331 . . . . 0.28999999999999998 110.107 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.671 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.0 p80 -159.5 161.73 35.42 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.094 -0.503 . . . . 0.089999999999999997 111.37 -174.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.716 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -86.5 148.11 25.67 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.962 -1.125 . . . . 1.0700000000000001 107.962 172.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.6 t -133.14 96.57 3.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.907 0.86 . . . . 0.23000000000000001 110.136 -171.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 C--N 1.314 -0.941 0 CA-C-N 114.103 -1.408 . . . . 0.41999999999999998 109.281 -176.14 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.586 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.9 pm0 . . . . . 0 N--CA 1.438 -1.033 0 CA-C-O 122.312 1.053 . . . . 2.1600000000000001 113.375 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.625 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.81 128.54 3.3 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 112.587 -2.097 . . . . 0.33000000000000002 105.769 171.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.35 -157.8 30.18 Favored Glycine 0 C--N 1.281 -2.502 0 C-N-CA 119.892 -1.147 . . . . 0.17000000000000001 110.404 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.43 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.88 173.89 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.064 -1.065 . . . . 0.20999999999999999 111.574 167.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.517 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.4 p-10 -51.47 102.35 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 123.448 1.594 . . . . 1.8500000000000001 113.893 -152.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.712 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.56 -37.5 10.35 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-N 112.6 -2.091 . . . . 1.21 109.782 168.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.719 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.2 p-90 -53.9 -27.0 27.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.457 -0.792 . . . . 0.16 112.274 -170.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.719 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.46 -35.38 15.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.587 0.588 . . . . 0.22 112.587 -178.072 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.423 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.9 p -90.1 -42.56 11.02 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.07 -0.968 . . . . 0.25 110.943 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.712 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.1 mtp180 -92.94 -18.51 22.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.651 -1.159 . . . . 1.8200000000000001 109.524 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.24 49.17 45.16 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 115.642 1.017 . . . . 0.23999999999999999 115.642 160.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 28.3 m -83.75 111.49 19.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 119.162 1.481 . . . . 1.01 111.598 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 35.99 -115.69 0.1 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.594 0.961 . . . . 0.5 113.594 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.439 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -137.35 -20.31 0.56 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.423 -0.808 . . . . 0.26000000000000001 113.64 -174.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 27.1 p -97.66 -167.26 1.5 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.003 0.901 . . . . 0.34999999999999998 112.624 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.477 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -99.39 130.14 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 114.864 -1.062 . . . . 0.12 110.535 -175.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.88 94.32 5.75 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.763 -0.653 . . . . 0.62 110.198 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.717 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.3 m -90.41 144.41 30.78 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.017 -0.992 . . . . 0.10000000000000001 112.555 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.654 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 73.0 Cg_exo -52.13 145.4 34.37 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 124.114 3.209 . . . . 0.23999999999999999 113.365 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.68 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 36.8 Cg_exo -66.3 -30.6 45.07 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.956 2.437 . . . . 0.31 112.392 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.516 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 13.8 m -72.13 -23.6 61.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.75 -0.659 . . . . 1.1000000000000001 111.725 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.832 ' O ' HD21 ' A' ' 364' ' ' LEU . 26.4 m -100.51 -49.38 11.17 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 N-CA-C 112.858 0.688 . . . . 0.080000000000000002 112.858 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.943 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.24 -2.1 5.41 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.707 -0.797 . . . . 0.070000000000000007 110.29 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.569 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 16.4 pttp -81.03 -38.08 28.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.505 1.145 . . . . 0.92000000000000004 108.137 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.9 mm-40 -62.83 -46.23 88.9 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 112.36 -2.2 . . . . 0.25 106.513 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.943 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.5 tp -47.78 -66.56 0.38 Allowed 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 109.843 -3.344 . . . . 0.050000000000000003 112.511 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.522 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 22.6 t80 -45.96 -23.27 0.28 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 123.903 0.752 . . . . 0.13 109.597 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.92 -25.04 28.18 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.849 -1.068 . . . . 0.13 111.878 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.737 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.73 -44.2 5.14 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 113.425 0.898 . . . . 0.059999999999999998 113.425 176.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -73.49 150.74 7.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-O 122.44 1.114 . . . . 0.080000000000000002 111.125 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.09 155.74 35.05 Favored 'General case' 0 N--CA 1.412 -2.332 0 CA-C-N 112.849 -1.978 . . . . 0.47999999999999998 108.602 -177.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.647 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 43.8 mtmt -55.96 102.14 0.07 Allowed 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.669 0.747 . . . . 0.98999999999999999 109.696 170.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.18 -8.93 6.67 Favored Glycine 0 C--N 1.304 -1.23 0 CA-C-N 113.762 -1.563 . . . . 0.19 111.716 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.658 HG21 ' HB ' ' A' ' 457' ' ' VAL . 9.0 m -68.37 149.46 98.04 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 108.833 -0.803 . . . . 0.13 108.833 172.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.4 Cg_endo -93.82 156.69 2.3 Favored 'Trans proline' 0 N--CA 1.424 -2.579 0 C-N-CA 122.3 2.0 . . . . 0.17999999999999999 109.906 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.726 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -121.9 149.03 25.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.554 -1.276 . . . . 0.56999999999999995 107.554 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.705 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.08 149.02 51.1 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.548 -0.908 . . . . 0.13 108.548 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.06 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.35 141.4 39.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 105.589 -2.004 . . . . 0.10000000000000001 105.589 165.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.669 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 7.6 p90 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.469 -1.253 . . . . 1.0900000000000001 110.926 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.492 ' HB3' ' N ' ' A' ' 360' ' ' GLY . 33.7 m-20 . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 121.598 0.713 . . . . 0.42999999999999999 111.83 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.825 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 96.8 m -159.28 134.37 8.22 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.256 -0.884 . . . . 0.14000000000000001 109.021 163.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.693 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.5 p90 174.63 157.84 0.16 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 120.856 0.36 . . . . 0.14999999999999999 111.759 -175.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.599 HD11 HG11 ' A' ' 457' ' ' VAL . 0.2 OUTLIER -77.86 152.59 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.283 -0.636 . . . . 0.080000000000000002 109.283 164.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.558 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.1 tt0 -150.52 142.96 24.38 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.741 -0.663 . . . . 2.0099999999999998 109.415 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.713 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.6 t -134.62 162.37 38.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.124 0.488 . . . . 0.45000000000000001 111.382 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.549 ' N ' HG12 ' A' ' 347' ' ' VAL . 29.3 t0 -140.05 106.32 5.26 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.356 -1.35 . . . . 0.23999999999999999 107.356 173.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.046 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.11 -34.9 26.0 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 123.365 1.555 . . . . 0.16 110.075 -169.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.474 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 0.4 OUTLIER -54.91 -44.98 74.67 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 110.705 -2.952 . . . . 0.59999999999999998 107.692 176.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 23.5 m-80 -103.36 6.77 38.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 111.219 -2.718 . . . . 0.20000000000000001 111.563 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.774 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 15.6 mm-40 32.82 62.35 0.35 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 112.791 -2.004 . . . . 2.1499999999999999 113.615 -175.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.491 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.0 t60 -141.47 135.15 29.98 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.213 -0.903 . . . . 0.089999999999999997 109.475 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.742 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -112.71 157.26 21.51 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.941 -0.572 . . . . 0.070000000000000007 110.375 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.59 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.3 m-90 -142.27 155.27 45.21 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.713 -0.676 . . . . 0.11 111.416 -175.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.825 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 88.2 t80 -111.2 153.34 25.96 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 106.811 -1.551 . . . . 0.26000000000000001 106.811 151.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 17.1 m-85 -127.42 119.18 25.56 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.947 -1.024 . . . . 0.14000000000000001 110.048 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.467 ' HB2' ' HE2' ' A' ' 356' ' ' TYR . 10.4 tppt? -123.14 112.89 18.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.097 -0.956 . . . . 0.25 108.547 173.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 358' ' ' LYS . 0.2 OUTLIER 75.97 41.26 0.24 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 123.914 0.759 . . . . 0.42999999999999999 112.683 -177.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.492 ' N ' ' HB3' ' A' ' 342' ' ' ASP . . . 59.24 16.79 35.79 Favored Glycine 0 CA--C 1.496 -1.14 0 CA-C-O 122.372 0.984 . . . . 0.17999999999999999 113.232 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 358' ' ' LYS . 14.9 ptmt -140.32 167.66 21.61 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 104.534 -2.395 . . . . 0.37 104.534 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.1 m -98.89 157.56 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.735 0 N-CA-C 116.057 1.873 . . . . 0.10000000000000001 116.057 -171.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.728 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.99 -27.51 9.18 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 110.357 -3.11 . . . . 0.070000000000000007 106.21 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.4 143.99 47.92 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 111.563 -2.562 . . . . 0.059999999999999998 111.846 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.484 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 2.9 tt0 -141.37 118.61 11.38 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 104.359 -2.46 . . . . 0.47999999999999998 104.359 175.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.742 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.29 165.55 32.67 Favored 'General case' 0 N--CA 1.403 -2.781 0 C-N-CA 118.07 -1.452 . . . . 0.070000000000000007 112.157 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.721 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 12.4 p-10 -102.05 135.44 43.62 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.174 -1.376 . . . . 1.8 109.63 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.714 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.3 pp -138.24 -173.06 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.252 0 CA-C-O 122.212 1.006 . . . . 0.12 112.754 -170.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.774 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -152.86 120.97 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 112.895 -1.957 . . . . 0.10000000000000001 109.468 171.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.596 ' H ' HE22 ' A' ' 352' ' ' GLN . 0.6 OUTLIER -77.95 -168.92 1.38 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.874 -1.512 . . . . 1.26 110.678 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.476 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -86.32 173.3 46.05 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.063 -1.541 . . . . 0.14000000000000001 112.272 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -78.54 158.38 76.19 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.614 0.721 . . . . 0.81000000000000005 111.921 -166.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 92.8 Cg_exo -56.64 -28.95 77.54 Favored 'Trans proline' 0 CA--C 1.498 -1.311 0 C-N-CA 125.273 3.982 . . . . 0.28000000000000003 113.234 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.468 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 16.9 p -69.52 -33.99 73.62 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.33 -1.759 . . . . 0.33000000000000002 109.855 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.529 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.7 t -140.73 70.35 30.6 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 123.841 1.781 . . . . 0.39000000000000001 108.801 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 375' ' ' THR . 85.4 Cg_exo -57.31 154.33 35.46 Favored 'Trans proline' 0 C--N 1.31 -1.465 1 C-N-CA 126.522 4.814 . . . . 0.38 115.447 -169.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.558 HG21 ' OG ' ' A' ' 370' ' ' SER . 2.2 m -80.6 130.74 63.43 Favored Pre-proline 0 N--CA 1.404 -2.76 0 CA-C-N 114.116 -1.402 . . . . 0.81999999999999995 108.611 172.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.1 Cg_exo -72.0 -43.86 1.07 Allowed 'Trans proline' 0 CA--C 1.511 -0.664 0 C-N-CA 123.599 2.866 . . . . 0.19 111.772 -170.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.807 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.19 137.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 123.412 1.577 . . . . 0.13 113.542 -173.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 154.3 -121.78 1.17 Allowed Glycine 0 N--CA 1.429 -1.8 0 CA-C-N 112.218 -2.264 . . . . 0.20000000000000001 109.401 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.404 HG22 ' CD2' ' A' ' 464' ' ' LEU . 72.5 t -125.23 110.65 25.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.345 0.593 . . . . 0.81999999999999995 110.632 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.75 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 5.1 m-85 -110.32 -173.87 2.35 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.405 -1.331 . . . . 0.22 107.405 174.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 2.4 t80 -141.27 121.92 14.26 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 120.844 -1.16 . . . . 0.65000000000000002 112.827 -172.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.6 p -82.81 92.71 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 CA-C-O 122.827 1.299 . . . . 0.16 108.839 170.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 49.6 p-90 -83.95 0.35 48.26 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 113.201 -1.818 . . . . 2.5499999999999998 107.806 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.791 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 5.9 t30 -170.33 128.18 0.84 Allowed 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 114.744 -1.116 . . . . 0.42999999999999999 110.662 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.651 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -95.96 141.95 28.77 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.388 -0.823 . . . . 1.1200000000000001 109.086 169.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.763 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 9.9 mm-40 -126.75 159.95 32.27 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 114.786 1.402 . . . . 0.70999999999999996 114.786 -167.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 52.2 mt-10 -137.34 128.14 27.19 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.071 -1.877 . . . . 0.38 108.867 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.4 t70 53.91 45.22 28.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 123.386 1.565 . . . . 0.40999999999999998 108.884 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.925 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.03 167.64 20.18 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 112.104 -2.317 . . . . 0.12 109.477 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 16.9 m -132.46 119.06 20.11 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.051 0.929 . . . . 0.17000000000000001 111.903 171.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -78.41 88.66 4.4 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.693 -1.594 . . . . 0.56999999999999995 112.119 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.7 mttt . . . . . 0 C--N 1.285 -2.222 0 CA-C-N 113.666 -1.606 . . . . 0.33000000000000002 113.811 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 121.04 0.448 . . . . 0.53000000000000003 110.152 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.08 97.23 5.3 Favored Pre-proline 0 N--CA 1.437 -1.114 0 N-CA-C 108.38 -0.97 . . . . 0.19 108.38 172.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.9 Cg_exo -68.62 111.44 2.57 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 122.102 1.868 . . . . 0.19 110.268 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.925 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -111.72 155.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 CA-C-N 112.861 -1.972 . . . . 0.14999999999999999 107.746 -168.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.1 m-80 -86.86 -20.47 27.42 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.316 -0.624 . . . . 0.51000000000000001 109.316 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 97.7 m-85 -160.24 127.51 4.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.866 -1.061 . . . . 0.27000000000000002 108.189 -171.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 17.3 t-105 -142.95 131.27 22.11 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.591 0.71 . . . . 0.089999999999999997 111.07 -167.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.651 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 13.3 mmt -116.34 86.67 18.21 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.279 -1.008 . . . . 0.14000000000000001 108.279 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.791 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 15.0 Cg_endo . . . . . 0 N--CA 1.437 -1.799 0 C-N-CA 120.945 1.096 . . . . 0.5 109.372 174.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 419' ' ' GLY . 22.1 t . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 112.628 0.603 . . . . 0.75 112.628 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.595 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.26 119.24 0.65 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.61 -0.996 . . . . 0.20000000000000001 110.61 170.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.639 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.5 mt -81.13 144.15 11.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 120.836 0.35 . . . . 0.28999999999999998 111.06 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.672 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.9 p80 -159.41 161.54 35.6 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.028 -0.533 . . . . 0.089999999999999997 111.218 -174.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.2 149.51 25.46 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.826 -1.176 . . . . 1.0700000000000001 107.826 171.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 445' ' ' THR . 34.3 t -133.31 96.5 3.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.553 0.692 . . . . 0.23000000000000001 110.034 -171.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 114.736 -1.12 . . . . 0.41999999999999998 109.387 -175.568 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.532 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 122.563 1.173 . . . . 2.1600000000000001 113.481 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.721 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -157.35 132.04 8.64 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.101 -2.318 . . . . 0.33000000000000002 105.307 167.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.04 -159.57 32.84 Favored Glycine 0 C--N 1.283 -2.363 0 C-N-CA 120.095 -1.05 . . . . 0.17000000000000001 110.511 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -47.06 175.32 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 120.24 -0.981 . . . . 0.20999999999999999 111.621 168.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.515 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.4 p-10 -50.53 101.03 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.625 1.678 . . . . 1.8500000000000001 113.764 -154.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 1.018 HD22 ' HD2' ' A' ' 437' ' ' ARG . 34.7 mt -97.68 -37.89 9.73 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.007 -2.36 . . . . 1.21 107.858 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.708 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 64.8 p-90 -48.39 -34.39 10.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.182 0.438 . . . . 0.16 112.182 -172.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.708 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -83.96 -36.9 22.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.934 -0.576 . . . . 0.22 112.144 -175.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.486 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.8 p -88.09 -41.89 12.75 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.247 -0.888 . . . . 0.25 110.534 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 1.018 ' HD2' HD22 ' A' ' 433' ' ' LEU . 0.0 OUTLIER -93.8 -19.19 21.26 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.629 -1.169 . . . . 1.8200000000000001 110.067 -177.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.5 48.11 55.8 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.744 -1.116 . . . . 0.23999999999999999 114.875 163.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 35.2 m -85.2 111.73 20.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 118.71 1.255 . . . . 1.01 111.794 -173.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 36.35 -121.59 0.16 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.717 -1.129 . . . . 0.5 113.969 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.476 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -134.6 -12.87 1.32 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.106 -0.569 . . . . 0.26000000000000001 113.967 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 28.4 p -104.27 -166.59 1.26 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.987 0.894 . . . . 0.34999999999999998 112.839 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.443 HD13 HG11 ' A' ' 465' ' ' VAL . 1.9 mp -97.49 131.4 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.023 -0.989 . . . . 0.12 110.665 -175.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.71 93.59 5.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.714 -0.676 . . . . 0.62 110.248 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.714 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -89.01 143.98 32.09 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 114.962 -1.017 . . . . 0.10000000000000001 112.578 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.659 ' HD2' HG21 ' A' ' 366' ' ' THR . 77.1 Cg_exo -52.17 145.58 34.03 Favored 'Trans proline' 0 CA--C 1.506 -0.896 0 C-N-CA 124.055 3.17 . . . . 0.23999999999999999 113.246 174.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.677 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.3 Cg_exo -65.39 -26.97 55.18 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.995 2.464 . . . . 0.31 112.552 -176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.479 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 52.1 p -75.7 -25.08 56.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.9 0.857 . . . . 1.1000000000000001 112.054 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.83 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.9 m -99.57 -50.49 10.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.556 -0.747 . . . . 0.080000000000000002 112.806 -171.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.946 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.43 -2.1 4.23 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.796 -0.762 . . . . 0.070000000000000007 110.37 -177.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.543 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.7 pttp -81.3 -39.04 25.81 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.417 1.104 . . . . 0.92000000000000004 108.05 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm-40 -61.63 -46.28 90.47 Favored 'General case' 0 CA--C 1.472 -2.036 0 CA-C-N 112.488 -2.142 . . . . 0.25 106.579 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.946 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.2 tp -47.05 -66.39 0.41 Allowed 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 109.713 -3.403 . . . . 0.050000000000000003 112.647 172.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.492 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 21.6 t80 -45.9 -23.69 0.31 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 123.9 0.75 . . . . 0.13 109.547 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.449 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.31 -25.65 27.93 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 114.791 -1.095 . . . . 0.13 111.97 -176.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.755 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.61 -44.9 4.98 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 113.566 0.95 . . . . 0.059999999999999998 113.566 177.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -71.45 145.96 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.587 1.184 . . . . 0.080000000000000002 111.026 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.499 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -114.55 156.07 25.3 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 112.894 -1.957 . . . . 0.47999999999999998 108.679 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.635 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 39.5 mtmt -59.31 103.27 0.17 Allowed 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.778 0.799 . . . . 0.98999999999999999 109.225 169.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 127.82 -10.18 6.72 Favored Glycine 0 C--N 1.302 -1.33 0 CA-C-N 113.592 -1.64 . . . . 0.19 111.403 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.684 HG21 ' HB ' ' A' ' 457' ' ' VAL . 6.1 m -67.81 149.75 98.1 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 108.067 -1.086 . . . . 0.13 108.067 169.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 8.4 Cg_endo -94.75 167.3 1.71 Allowed 'Trans proline' 0 N--CA 1.416 -3.08 0 C-N-CA 121.943 1.762 . . . . 0.17999999999999999 109.589 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.75 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -128.37 153.86 38.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.109 -1.071 . . . . 0.56999999999999995 108.109 171.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.701 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.7 mp -134.26 151.14 51.12 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 108.621 -0.881 . . . . 0.13 108.621 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.046 HG23 HD21 ' A' ' 349' ' ' LEU . 0.6 OUTLIER -140.01 139.55 36.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 105.135 -2.172 . . . . 0.10000000000000001 105.135 165.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.695 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 13.4 p90 . . . . . 0 C--O 1.243 0.72 0 O-C-N 123.744 0.652 . . . . 1.0900000000000001 111.219 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.45 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 3.2 m-20 . . . . . 0 N--CA 1.443 -0.811 0 N-CA-C 109.34 -0.615 . . . . 0.42999999999999999 109.34 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 357' ' ' TYR . 97.6 m -158.55 136.21 10.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.589 -1.187 . . . . 0.14000000000000001 109.113 169.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.694 ' CD2' HD13 ' A' ' 464' ' ' LEU . 31.9 p90 174.85 157.32 0.16 Allowed 'General case' 0 CA--C 1.5 -0.969 0 O-C-N 123.511 0.507 . . . . 0.14999999999999999 111.129 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.682 HD11 HG11 ' A' ' 457' ' ' VAL . 0.6 OUTLIER -76.71 151.64 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 108.495 -0.928 . . . . 0.080000000000000002 108.495 164.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.766 ' CD ' ' HE1' ' A' ' 466' ' ' PHE . 6.9 tp10 -149.57 146.3 27.26 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.504 -0.771 . . . . 2.0099999999999998 109.902 -173.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.739 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -143.04 160.33 17.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.382 0.611 . . . . 0.45000000000000001 111.667 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.552 ' N ' HG12 ' A' ' 347' ' ' VAL . 27.1 t0 -141.07 106.47 5.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.378 -1.341 . . . . 0.23999999999999999 107.378 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.099 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.41 -34.61 28.22 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 122.717 1.246 . . . . 0.16 110.42 -167.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.443 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 1.5 mt-10 -57.43 -44.12 84.44 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 110.88 -2.873 . . . . 0.59999999999999998 108.013 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.9 m-80 -100.67 5.26 43.73 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 111.045 -2.798 . . . . 0.20000000000000001 111.037 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.594 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.5 mp0 34.96 61.54 0.6 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 112.766 -2.016 . . . . 2.1499999999999999 113.367 -175.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.524 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.5 t60 -142.61 135.46 28.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.785 -0.643 . . . . 0.089999999999999997 109.664 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.736 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.73 158.27 20.28 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.829 -0.623 . . . . 0.070000000000000007 109.86 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.644 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.5 m-90 -143.23 158.55 43.52 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.358 0.663 . . . . 0.11 110.695 -176.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.687 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.4 t80 -111.86 153.36 26.77 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.176 -1.787 . . . . 0.26000000000000001 106.176 150.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 7.9 m-85 -127.74 116.31 20.03 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.13 -0.941 . . . . 0.14000000000000001 110.15 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.3 tppt? -117.97 138.91 51.85 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.215 -1.772 . . . . 0.25 106.215 168.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.416 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.43 17.14 9.18 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.268 0.84 . . . . 0.42999999999999999 113.268 172.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.38 7.66 87.82 Favored Glycine 0 CA--C 1.488 -1.647 0 C-N-CA 120.801 -0.714 . . . . 0.17999999999999999 112.937 -174.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.3 ptmt -128.68 178.4 6.36 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 104.486 -2.412 . . . . 0.37 104.486 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.644 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.0 m -105.01 158.2 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 116.339 1.977 . . . . 0.10000000000000001 116.339 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.681 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.36 -26.93 9.76 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 110.625 -2.989 . . . . 0.070000000000000007 106.456 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.807 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.37 144.53 48.29 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 111.477 -2.601 . . . . 0.059999999999999998 111.432 -176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.431 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.1 tt0 -141.19 117.77 10.91 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 104.374 -2.454 . . . . 0.47999999999999998 104.374 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.736 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.66 163.5 37.74 Favored 'General case' 0 N--CA 1.399 -2.98 0 C-N-CA 117.896 -1.521 . . . . 0.070000000000000007 111.306 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.462 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 22.2 p-10 -103.4 136.46 43.11 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 114.907 -1.042 . . . . 1.8 109.484 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -136.13 -174.04 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 CA-C-O 122.484 1.135 . . . . 0.12 112.559 -170.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.7 OUTLIER -150.54 119.68 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 112.731 -2.031 . . . . 0.10000000000000001 107.798 173.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.525 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.74 -168.49 1.6 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.269 -1.332 . . . . 1.26 110.132 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -83.87 165.39 41.87 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 118.419 -1.848 . . . . 0.14000000000000001 112.636 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.5 ptmt -67.06 155.76 89.53 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.719 -0.74 . . . . 0.81000000000000005 112.22 -167.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.68 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 95.1 Cg_exo -55.95 -30.74 79.08 Favored 'Trans proline' 0 CA--C 1.495 -1.458 1 C-N-CA 125.332 4.021 . . . . 0.28000000000000003 113.932 -173.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.404 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 23.3 p -68.65 -30.67 69.42 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.882 -1.508 . . . . 0.33000000000000002 109.546 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.51 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -141.97 70.82 23.88 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 123.266 1.508 . . . . 0.39000000000000001 110.032 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 375' ' ' THR . 72.8 Cg_exo -58.62 148.24 83.0 Favored 'Trans proline' 0 C--N 1.307 -1.614 1 C-N-CA 126.028 4.485 . . . . 0.38 113.603 -172.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.525 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -77.93 144.54 68.31 Favored Pre-proline 0 N--CA 1.423 -1.812 0 N-CA-C 108.546 -0.909 . . . . 0.81999999999999995 108.546 175.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.2 Cg_exo -75.4 -45.07 0.27 Allowed 'Trans proline' 0 CA--C 1.51 -0.722 0 C-N-CA 124.352 3.368 . . . . 0.19 111.705 -167.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.802 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.21 139.24 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 123.051 1.405 . . . . 0.13 113.148 -172.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.8 -117.66 0.84 Allowed Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 112.558 -2.11 . . . . 0.20000000000000001 109.317 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.38 114.44 28.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.993 0.901 . . . . 0.81999999999999995 110.616 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.758 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.4 m-85 -113.16 -174.06 2.38 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.246 -1.39 . . . . 0.22 107.246 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.2 t80 -140.44 123.75 16.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.369 1.44 . . . . 0.65000000000000002 113.513 -172.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -89.93 92.57 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 CA-C-O 123.009 1.385 . . . . 0.16 109.543 169.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -93.12 11.1 28.92 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.416 -1.72 . . . . 2.5499999999999998 108.176 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.74 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.0 t30 -169.21 126.64 0.95 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 113.927 -1.488 . . . . 0.42999999999999999 110.366 172.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.702 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -98.46 140.92 31.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.853 -1.067 . . . . 1.1200000000000001 109.117 169.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.769 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 18.6 mm-40 -124.05 157.18 35.1 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.547 1.314 . . . . 0.70999999999999996 114.547 -168.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 44.1 mt-10 -137.13 127.89 27.19 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 112.825 -1.988 . . . . 0.38 108.397 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 32.1 t70 55.22 48.48 19.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 123.346 1.546 . . . . 0.40999999999999998 108.92 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.922 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -83.04 167.97 17.38 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 112.629 -2.078 . . . . 0.12 109.153 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 25.9 m -132.68 119.34 20.26 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.071 0.939 . . . . 0.17000000000000001 111.733 170.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 4.2 mp -80.86 91.38 5.97 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.748 -1.569 . . . . 0.56999999999999995 112.249 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.547 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.0 mttt . . . . . 0 C--N 1.283 -2.32 0 CA-C-N 113.971 -1.468 . . . . 0.33000000000000002 113.077 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.547 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.812 0 N-CA-C 109.801 -0.444 . . . . 0.53000000000000003 109.801 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.36 97.25 5.17 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.277 -1.009 . . . . 0.19 108.277 172.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 16.4 Cg_exo -69.9 109.9 2.45 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 121.797 1.665 . . . . 0.19 109.952 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.922 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.97 155.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-N 112.667 -2.06 . . . . 0.14999999999999999 107.766 -167.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.722 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.0 m-80 -86.85 -20.99 26.68 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.179 -0.674 . . . . 0.51000000000000001 109.179 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.769 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 95.0 m-85 -158.7 127.0 5.24 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.353 1.033 . . . . 0.27000000000000002 108.79 -171.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.68 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 24.1 t-105 -145.11 137.09 25.7 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.756 0.789 . . . . 0.089999999999999997 110.953 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.702 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.6 mmt -119.87 93.72 47.94 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 107.651 -1.24 . . . . 0.14000000000000001 107.651 173.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 40.0 Cg_endo . . . . . 0 C--N 1.35 0.624 0 C-N-CA 122.356 2.037 . . . . 0.5 112.414 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 419' ' ' GLY . 29.1 t . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.431 0.634 . . . . 0.75 112.012 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.595 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.03 122.43 0.82 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.606 -1.398 . . . . 0.20000000000000001 109.606 170.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.689 HG22 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.72 142.52 13.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.799 -0.445 . . . . 0.28999999999999998 109.799 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.68 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.4 p80 -159.83 162.48 34.73 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.196 -0.456 . . . . 0.089999999999999997 111.659 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.702 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.88 143.8 28.03 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.845 -1.169 . . . . 1.0700000000000001 107.845 171.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 445' ' ' THR . 28.5 t -133.83 99.03 4.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.874 0.845 . . . . 0.23000000000000001 110.701 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 N--CA 1.44 -0.937 0 CA-C-N 114.132 -1.395 . . . . 0.41999999999999998 109.537 -176.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.57 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.426 -1.673 0 CA-C-O 122.115 0.959 . . . . 2.1600000000000001 111.543 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.686 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -154.32 132.58 11.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.201 -2.148 . . . . 0.33000000000000002 105.201 169.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.61 -158.34 30.96 Favored Glycine 0 C--N 1.285 -2.294 0 N-CA-C 110.438 -1.065 . . . . 0.17000000000000001 110.438 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.534 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -47.08 174.14 0.02 OUTLIER Glycine 0 CA--C 1.495 -1.192 0 C-N-CA 120.096 -1.05 . . . . 0.20999999999999999 111.499 168.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.569 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 7.0 p-10 -52.59 101.29 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 123.422 1.582 . . . . 1.8500000000000001 113.883 -154.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 1.006 HD22 ' HD2' ' A' ' 437' ' ' ARG . 41.6 mt -97.47 -34.65 10.93 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 112.203 -2.271 . . . . 1.21 109.383 171.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.709 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.2 p-90 -53.74 -26.36 22.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.017 -0.992 . . . . 0.16 112.004 -173.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.709 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.11 -36.33 14.06 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.618 -0.719 . . . . 0.22 112.308 -178.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.432 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.2 p -88.15 -41.02 13.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.143 -0.935 . . . . 0.25 110.381 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 1.006 ' HD2' HD22 ' A' ' 433' ' ' LEU . 2.1 mtp85 -93.06 -20.69 20.29 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.431 -1.258 . . . . 1.8200000000000001 109.704 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.91 45.8 49.86 Favored Glycine 0 N--CA 1.443 -0.834 0 O-C-N 124.284 0.99 . . . . 0.23999999999999999 114.072 166.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 20.8 m -84.69 110.13 18.53 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.654 -1.218 . . . . 1.01 111.367 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.462 ' HB3' ' H ' ' A' ' 441' ' ' GLY . 29.1 m-70 46.11 -145.0 0.21 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.607 -1.179 . . . . 0.5 113.629 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 440' ' ' HIS . . . -110.65 -23.41 5.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.506 -0.854 . . . . 0.26000000000000001 113.566 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.516 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 31.2 p -101.57 -165.43 1.19 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 113.645 0.98 . . . . 0.34999999999999998 113.645 -170.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 370' ' ' SER . 2.0 mp -90.23 133.35 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.569 -0.741 . . . . 0.12 110.61 -176.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.11 90.9 3.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.366 0.603 . . . . 0.62 110.286 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.744 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.3 m -85.82 142.33 36.66 Favored Pre-proline 0 N--CA 1.436 -1.126 0 CA-C-N 115.105 -0.952 . . . . 0.10000000000000001 112.512 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.669 ' HD2' HG21 ' A' ' 366' ' ' THR . 82.0 Cg_exo -49.58 145.56 16.7 Favored 'Trans proline' 0 CA--C 1.509 -0.767 0 C-N-CA 123.891 3.06 . . . . 0.23999999999999999 113.572 175.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.702 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.4 Cg_exo -66.7 -21.05 52.21 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.827 2.352 . . . . 0.31 112.034 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.55 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 33.4 p -83.35 -24.07 32.23 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.233 -0.894 . . . . 1.1000000000000001 112.291 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.807 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.8 m -99.64 -47.98 11.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 112.954 0.724 . . . . 0.080000000000000002 112.954 -171.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.968 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.36 -1.77 3.8 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.789 -0.764 . . . . 0.070000000000000007 110.462 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 448' ' ' SER . 17.2 pttp -81.5 -38.27 26.56 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.698 1.237 . . . . 0.92000000000000004 108.33 173.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.7 mm-40 -62.57 -46.28 89.05 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-N 112.299 -2.228 . . . . 0.25 106.328 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.968 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -47.28 -66.61 0.38 Allowed 'General case' 0 N--CA 1.406 -2.633 0 CA-C-N 109.832 -3.349 . . . . 0.050000000000000003 112.956 172.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.495 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.3 t80 -46.26 -22.59 0.25 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.866 0.841 . . . . 0.13 109.396 176.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.459 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.83 -25.32 30.0 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.674 -1.148 . . . . 0.13 112.008 -176.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.759 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.5 -43.7 5.32 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 113.705 1.002 . . . . 0.059999999999999998 113.705 176.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.682 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.87 149.8 7.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.432 1.11 . . . . 0.080000000000000002 111.278 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.405 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -121.68 156.4 33.13 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 112.99 -1.914 . . . . 0.47999999999999998 108.64 -177.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.563 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 2.5 mppt? -58.66 103.2 0.14 Allowed 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.775 -0.824 . . . . 0.98999999999999999 108.775 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.75 -9.08 6.11 Favored Glycine 0 C--N 1.307 -1.069 0 CA-C-N 113.935 -1.484 . . . . 0.19 111.616 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 344' ' ' TYR . 19.0 m -69.31 150.05 97.26 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.972 -0.751 . . . . 0.13 108.972 171.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.7 Cg_endo -93.84 163.06 2.22 Favored 'Trans proline' 0 N--CA 1.423 -2.664 0 C-N-CA 122.34 2.026 . . . . 0.17999999999999999 109.919 176.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.758 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.7 m -126.64 149.23 31.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 107.502 -1.296 . . . . 0.56999999999999995 107.502 171.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.694 HD13 ' CD2' ' A' ' 344' ' ' TYR . 3.5 mp -134.86 150.3 50.45 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 108.426 -0.953 . . . . 0.13 108.426 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.099 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.94 143.12 28.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 105.72 -1.956 . . . . 0.10000000000000001 105.72 166.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.766 ' HE1' ' CD ' ' A' ' 346' ' ' GLU . 9.3 p90 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 123.185 0.594 . . . . 1.0900000000000001 110.316 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.496 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 6.2 m-20 . . . . . 0 N--CA 1.445 -0.704 0 CA-C-O 121.046 0.45 . . . . 0.42999999999999999 110.264 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.79 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 46.9 m -158.01 135.48 10.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.77 -1.104 . . . . 0.14000000000000001 108.681 167.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.691 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.7 p90 174.22 159.18 0.16 Allowed 'General case' 0 C--O 1.214 -0.795 0 O-C-N 123.337 0.398 . . . . 0.14999999999999999 110.851 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.642 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.99 152.13 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.313 0 N-CA-C 109.112 -0.699 . . . . 0.080000000000000002 109.112 164.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.569 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.72 143.14 25.26 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.628 -0.715 . . . . 2.0099999999999998 109.452 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.742 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.9 t -135.15 162.43 38.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 120.733 -0.387 . . . . 0.45000000000000001 111.213 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.569 ' N ' HG12 ' A' ' 347' ' ' VAL . 36.7 t0 -140.23 106.81 5.33 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.468 -1.308 . . . . 0.23999999999999999 107.468 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.024 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.48 -34.9 27.86 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-O 122.752 1.263 . . . . 0.16 110.436 -167.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.459 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 0.8 OUTLIER -58.02 -44.98 87.6 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 110.797 -2.91 . . . . 0.59999999999999998 108.308 176.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 24.9 m-80 -100.61 5.94 44.01 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 111.012 -2.813 . . . . 0.20000000000000001 111.057 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.7 mp0 35.09 61.32 0.63 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 112.725 -2.034 . . . . 2.1499999999999999 113.16 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.495 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.5 t60 -142.2 134.6 27.91 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.646 -0.706 . . . . 0.089999999999999997 109.742 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.734 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.71 157.85 20.78 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.822 -0.627 . . . . 0.070000000000000007 110.106 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.61 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.1 m-90 -142.62 156.02 45.02 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.499 0.72 . . . . 0.11 111.258 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.79 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.0 t80 -110.81 153.82 24.84 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 106.424 -1.695 . . . . 0.26000000000000001 106.424 151.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.6 m-85 -127.86 119.09 24.9 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 114.892 -1.049 . . . . 0.14000000000000001 110.351 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.2 tppt? -120.56 132.41 55.15 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.277 -1.749 . . . . 0.25 106.277 167.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 75.1 16.53 2.8 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 113.136 0.791 . . . . 0.42999999999999999 113.136 174.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.496 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.13 5.73 88.99 Favored Glycine 0 CA--C 1.485 -1.828 0 CA-C-O 121.814 0.675 . . . . 0.17999999999999999 112.887 -173.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 19.9 ptmt -128.92 177.23 7.25 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.502 -2.407 . . . . 0.37 104.502 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.0 m -103.56 158.22 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 116.713 2.116 . . . . 0.10000000000000001 116.713 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.712 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.15 -28.65 8.93 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 110.39 -3.096 . . . . 0.070000000000000007 106.207 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -133.87 145.91 50.1 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 111.589 -2.551 . . . . 0.059999999999999998 111.669 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.471 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.3 tt0 -143.72 118.47 9.87 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 104.499 -2.408 . . . . 0.47999999999999998 104.499 175.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.81 165.39 32.65 Favored 'General case' 0 N--CA 1.401 -2.915 0 C-N-CA 118.132 -1.427 . . . . 0.070000000000000007 111.631 -179.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.67 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 15.5 p-10 -103.81 133.33 48.98 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.669 -1.15 . . . . 1.8 110.087 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -133.77 -173.75 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-O 122.465 1.126 . . . . 0.12 112.525 -171.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.37 120.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 112.91 -1.95 . . . . 0.10000000000000001 109.199 172.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.522 ' HB3' HD12 ' A' ' 349' ' ' LEU . 33.6 p -78.25 -169.06 1.49 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 111.94 -2.391 . . . . 1.26 111.421 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.485 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.77 174.75 50.14 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 118.779 -1.676 . . . . 0.14000000000000001 112.05 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.439 ' HG2' ' CG2' ' A' ' 375' ' ' THR . 8.5 ptmt -80.31 163.67 55.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 113.174 0.805 . . . . 0.81000000000000005 113.174 -164.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.685 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 89.4 Cg_exo -55.09 -37.86 93.78 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 123.023 2.482 . . . . 0.28000000000000003 112.287 -176.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.456 ' OG1' HG22 ' A' ' 375' ' ' THR . 12.0 p -64.35 -31.89 73.27 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.29 -1.323 . . . . 0.33000000000000002 110.052 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.519 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -141.59 71.04 25.78 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 123.439 1.59 . . . . 0.39000000000000001 110.032 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 375' ' ' THR . 82.2 Cg_exo -58.3 153.81 44.6 Favored 'Trans proline' 0 C--N 1.307 -1.643 1 C-N-CA 126.369 4.713 . . . . 0.38 114.985 -171.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.54 HG21 ' HG ' ' A' ' 349' ' ' LEU . 2.5 m -79.24 129.86 71.04 Favored Pre-proline 0 N--CA 1.405 -2.718 0 CA-C-N 114.5 -1.227 . . . . 0.81999999999999995 108.55 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 39.4 Cg_exo -68.28 -44.97 3.04 Favored 'Trans proline' 0 CA--C 1.512 -0.601 0 C-N-CA 123.834 3.023 . . . . 0.19 112.147 -169.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.795 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.84 138.96 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 123.304 1.526 . . . . 0.13 113.645 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 152.86 -119.31 0.95 Allowed Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 112.243 -2.253 . . . . 0.20000000000000001 109.579 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.429 HG22 HD21 ' A' ' 464' ' ' LEU . 76.4 t -129.84 108.5 16.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.002 0.43 . . . . 0.81999999999999995 110.472 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.769 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.4 m-85 -108.55 -173.98 2.41 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.279 -1.378 . . . . 0.22 107.279 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.3 t80 -140.83 123.84 16.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 120.09 1.313 . . . . 0.65000000000000002 113.656 -172.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.94 92.56 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 122.961 1.362 . . . . 0.16 109.66 169.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -91.23 9.27 31.98 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.622 -1.627 . . . . 2.5499999999999998 108.265 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.744 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.5 t30 -170.79 127.89 0.76 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.229 -1.351 . . . . 0.42999999999999999 110.475 173.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.684 ' HB3' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -96.95 151.57 19.56 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.727 -0.67 . . . . 1.1200000000000001 109.873 167.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 37.8 mm-40 -128.37 160.48 32.08 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.471 1.286 . . . . 0.70999999999999996 114.471 -170.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.8 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 32.1 mt-10 -139.53 127.68 22.48 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 113.112 -1.858 . . . . 0.38 108.881 172.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.73 46.09 23.18 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 123.109 1.433 . . . . 0.40999999999999998 108.964 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.942 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.52 166.52 21.1 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 112.759 -2.019 . . . . 0.12 108.967 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 18.7 m -133.0 118.9 19.39 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.988 0.899 . . . . 0.17000000000000001 111.94 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.1 mp -79.41 88.53 5.01 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.775 -1.557 . . . . 0.56999999999999995 112.091 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.54 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.4 mttt . . . . . 0 C--N 1.288 -2.096 0 CA-C-N 113.561 -1.654 . . . . 0.33000000000000002 113.826 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.54 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.441 -0.919 0 CA-C-O 121.1 0.476 . . . . 0.53000000000000003 110.32 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.17 97.27 5.26 Favored Pre-proline 0 N--CA 1.431 -1.387 0 N-CA-C 108.11 -1.07 . . . . 0.19 108.11 171.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 18.9 Cg_exo -69.35 109.94 2.35 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 122.012 1.808 . . . . 0.19 109.881 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.942 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.08 156.34 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 CA-C-N 112.869 -1.969 . . . . 0.14999999999999999 107.283 -168.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.8 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.0 m-80 -89.72 -19.9 24.22 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.987 -0.746 . . . . 0.51000000000000001 108.987 -174.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.6 m-85 -159.06 126.58 4.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.346 -0.983 . . . . 0.27000000000000002 108.346 -171.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.685 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 25.0 t-105 -145.25 133.92 22.19 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.828 0.823 . . . . 0.089999999999999997 111.253 -167.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.684 ' SD ' ' HB3' ' A' ' 387' ' ' LYS . 11.8 mmt -115.2 94.91 40.72 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.568 -1.271 . . . . 0.14000000000000001 107.568 172.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.744 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 39.3 Cg_endo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.362 2.041 . . . . 0.5 112.548 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.578 HG12 ' N ' ' A' ' 419' ' ' GLY . 22.1 t . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 121.446 0.641 . . . . 0.75 112.433 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.578 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -177.45 120.19 0.72 Allowed Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.965 -1.254 . . . . 0.20000000000000001 109.965 170.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.67 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.76 143.08 12.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 110.21 -0.293 . . . . 0.28999999999999998 110.21 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.685 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.5 p80 -159.15 160.88 36.06 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.168 -0.469 . . . . 0.089999999999999997 111.702 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.709 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -84.54 148.14 26.65 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.838 -1.171 . . . . 1.0700000000000001 107.838 172.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 445' ' ' THR . 43.3 t -134.29 96.54 3.63 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.67 0.747 . . . . 0.23000000000000001 110.269 -171.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 114.473 -1.24 . . . . 0.41999999999999998 109.945 -174.877 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 N--CA 1.43 -1.457 0 CA-C-O 122.322 1.058 . . . . 2.1600000000000001 113.417 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.718 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.62 134.2 5.19 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 104.162 -2.533 . . . . 0.33000000000000002 104.162 171.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.36 -157.29 29.4 Favored Glycine 0 C--N 1.276 -2.756 0 C-N-CA 119.28 -1.438 . . . . 0.17000000000000001 110.749 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.406 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.94 174.29 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 119.903 -1.142 . . . . 0.20999999999999999 111.175 166.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.51 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -51.33 102.68 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 123.198 1.475 . . . . 1.8500000000000001 113.944 -154.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.667 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.07 -35.44 11.92 Favored 'General case' 0 C--O 1.202 -1.4 0 CA-C-N 112.699 -2.046 . . . . 1.21 109.087 168.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.734 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -55.72 -26.69 46.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.16 112.357 -170.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.734 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.78 -32.42 15.39 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.981 0.896 . . . . 0.22 111.771 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.8 p -87.52 -45.0 10.86 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.946 -1.479 . . . . 0.25 111.103 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.667 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 7.5 mtp-105 -91.04 -20.2 22.34 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.446 -1.252 . . . . 1.8200000000000001 110.18 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.89 46.56 49.17 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.395 -1.275 . . . . 0.23999999999999999 114.308 164.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 110.82 19.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.345 1.073 . . . . 1.01 112.298 -169.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 37.07 -111.19 0.08 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.869 -1.06 . . . . 0.5 113.495 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.485 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -146.41 -11.84 0.21 Allowed Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.867 -0.682 . . . . 0.26000000000000001 114.235 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 29.4 p -100.04 -167.99 1.53 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 118.291 1.046 . . . . 0.34999999999999998 112.151 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.486 HD13 HG11 ' A' ' 465' ' ' VAL . 2.2 mp -103.39 132.02 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 114.862 -1.063 . . . . 0.12 110.886 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -102.41 94.22 5.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.996 -1.002 . . . . 0.62 110.367 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.726 ' HA ' HG22 ' A' ' 368' ' ' ILE . 2.9 m -89.93 144.08 30.96 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 115.607 -0.724 . . . . 0.10000000000000001 112.554 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.678 ' HD2' HG21 ' A' ' 366' ' ' THR . 74.8 Cg_exo -51.68 147.22 24.71 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 123.945 3.097 . . . . 0.23999999999999999 113.33 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.718 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 27.1 Cg_exo -67.96 -26.24 37.74 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.006 2.471 . . . . 0.31 112.185 -175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.508 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 40.5 p -75.61 -25.4 56.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.078 -0.964 . . . . 1.1000000000000001 111.876 -176.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.804 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.6 m -99.93 -50.47 10.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.574 -0.739 . . . . 0.080000000000000002 112.896 -171.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.954 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.67 -2.34 4.8 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.729 -0.788 . . . . 0.070000000000000007 110.249 -178.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.648 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.1 pttp -81.09 -39.51 25.57 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.484 1.135 . . . . 0.92000000000000004 108.287 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.49 ' HG3' HD11 ' A' ' 364' ' ' LEU . 4.7 mm-40 -61.62 -46.84 88.09 Favored 'General case' 0 CA--C 1.47 -2.121 0 CA-C-N 112.319 -2.219 . . . . 0.25 106.571 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.954 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.52 -66.86 0.34 Allowed 'General case' 0 N--CA 1.4 -2.969 0 CA-C-N 109.649 -3.432 . . . . 0.050000000000000003 112.842 172.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.8 t80 -44.43 -24.79 0.2 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 124.135 0.897 . . . . 0.13 109.727 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.78 -30.35 15.44 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.341 -1.299 . . . . 0.13 111.762 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.784 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -97.8 -43.91 6.95 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 113.22 0.822 . . . . 0.059999999999999998 113.22 178.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -72.84 147.55 9.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 122.451 1.119 . . . . 0.080000000000000002 110.928 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.488 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -116.28 157.14 25.42 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 113.196 -1.82 . . . . 0.47999999999999998 108.909 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.652 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 5.6 mppt? -58.91 102.1 0.11 Allowed 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.573 -0.899 . . . . 0.98999999999999999 108.573 169.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.68 -12.13 5.95 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 114.102 -1.408 . . . . 0.19 111.525 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.688 HG21 ' HB ' ' A' ' 457' ' ' VAL . 16.2 m -67.12 150.16 98.07 Favored Pre-proline 0 N--CA 1.441 -0.923 0 N-CA-C 108.671 -0.863 . . . . 0.13 108.671 171.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.3 Cg_endo -93.87 161.03 2.23 Favored 'Trans proline' 0 N--CA 1.423 -2.647 0 C-N-CA 122.152 1.901 . . . . 0.17999999999999999 109.974 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.769 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -123.51 150.47 27.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 107.389 -1.337 . . . . 0.56999999999999995 107.389 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.708 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.4 mp -134.15 150.66 51.12 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.748 -0.834 . . . . 0.13 108.748 175.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.024 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -139.01 140.4 38.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 105.418 -2.067 . . . . 0.10000000000000001 105.418 165.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.612 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 10.8 p90 . . . . . 0 C--O 1.246 0.884 0 O-C-N 123.822 0.701 . . . . 1.0900000000000001 111.086 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.414 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 12.7 m-20 . . . . . 0 N--CA 1.444 -0.746 0 CA-C-O 121.435 0.636 . . . . 0.42999999999999999 109.359 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.813 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 73.1 m -158.25 134.69 9.5 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.376 -1.284 . . . . 0.14000000000000001 108.983 168.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.697 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.6 p90 174.27 158.7 0.16 Allowed 'General case' 0 C--O 1.213 -0.865 0 O-C-N 123.478 0.486 . . . . 0.14999999999999999 110.855 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.658 HD11 HG11 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.65 152.48 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 109.002 -0.74 . . . . 0.080000000000000002 109.002 164.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.587 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 32.1 tt0 -149.94 143.61 25.35 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.42 -0.809 . . . . 2.0099999999999998 109.748 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.741 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.9 t -136.05 162.41 36.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.929 0.395 . . . . 0.45000000000000001 111.298 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.559 ' N ' HG12 ' A' ' 347' ' ' VAL . 35.0 t0 -140.13 106.76 5.34 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.162 -1.421 . . . . 0.23999999999999999 107.162 173.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.098 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.36 -33.5 28.79 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-O 122.71 1.243 . . . . 0.16 110.193 -168.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.463 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.4 mt-10 -57.07 -44.85 83.46 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 110.786 -2.915 . . . . 0.59999999999999998 108.192 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.3 m-80 -101.95 5.64 40.89 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 110.906 -2.861 . . . . 0.20000000000000001 111.273 -175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.2 mp0 34.79 61.61 0.57 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 112.56 -2.109 . . . . 2.1499999999999999 113.085 -175.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.522 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.4 t60 -141.76 134.95 29.23 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.615 -0.72 . . . . 0.089999999999999997 109.818 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.752 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -113.24 156.31 23.53 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.733 -0.667 . . . . 0.070000000000000007 110.084 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.6 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.5 m-90 -142.26 154.75 45.01 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.443 -0.798 . . . . 0.11 111.037 -175.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.813 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 88.1 t80 -109.8 153.11 24.85 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 106.503 -1.665 . . . . 0.26000000000000001 106.503 151.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 8.1 m-85 -128.15 117.37 21.46 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 114.957 -1.019 . . . . 0.14000000000000001 110.28 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.3 tppt? -118.32 138.34 52.46 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.948 -1.871 . . . . 0.25 105.948 168.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 69.31 17.37 8.25 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.147 0.795 . . . . 0.42999999999999999 113.147 172.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.414 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.24 6.47 87.73 Favored Glycine 0 CA--C 1.488 -1.653 0 C-N-CA 120.705 -0.759 . . . . 0.17999999999999999 112.943 -174.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.6 ptmt -127.55 178.19 6.27 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 104.484 -2.413 . . . . 0.37 104.484 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.6 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.4 m -105.07 157.35 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.766 0 N-CA-C 116.21 1.93 . . . . 0.10000000000000001 116.21 -176.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.694 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.13 -27.62 9.98 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 110.461 -3.063 . . . . 0.070000000000000007 106.233 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.821 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.12 145.35 49.23 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 111.71 -2.495 . . . . 0.059999999999999998 111.919 -175.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.522 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 2.5 tt0 -141.55 118.12 10.95 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 104.514 -2.402 . . . . 0.47999999999999998 104.514 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.752 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.63 165.43 33.37 Favored 'General case' 0 N--CA 1.398 -3.034 0 C-N-CA 117.83 -1.548 . . . . 0.070000000000000007 111.533 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.407 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 30.1 p-10 -104.41 134.19 48.03 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 114.831 -1.077 . . . . 1.8 109.989 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.739 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -132.56 -172.44 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 CA-C-O 122.53 1.157 . . . . 0.12 112.326 -172.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.79 119.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 112.889 -1.959 . . . . 0.10000000000000001 108.207 172.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.531 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -77.84 -169.39 1.51 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.067 -1.424 . . . . 1.26 110.891 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.67 170.68 46.36 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 118.995 -1.574 . . . . 0.14000000000000001 112.127 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 9.1 ptpt -77.13 157.56 80.94 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.473 0.654 . . . . 0.81000000000000005 112.52 -164.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.681 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 66.3 Cg_exo -53.01 -29.84 46.22 Favored 'Trans proline' 0 CA--C 1.496 -1.405 1 C-N-CA 125.751 4.3 . . . . 0.28000000000000003 113.694 -173.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.447 ' OG1' HG22 ' A' ' 375' ' ' THR . 19.1 p -66.66 -33.29 75.32 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.424 -1.716 . . . . 0.33000000000000002 109.45 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.504 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.0 t -143.15 71.27 18.34 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 113.498 -1.683 . . . . 0.39000000000000001 109.536 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 375' ' ' THR . 88.9 Cg_exo -56.99 146.05 82.3 Favored 'Trans proline' 0 C--N 1.304 -1.774 1 C-N-CA 125.84 4.36 . . . . 0.38 113.181 -172.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.531 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -75.69 145.15 78.09 Favored Pre-proline 0 N--CA 1.423 -1.82 0 N-CA-C 108.306 -0.998 . . . . 0.81999999999999995 108.306 175.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.1 Cg_exo -75.44 -43.64 0.35 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 124.59 3.526 . . . . 0.19 111.775 -166.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.8 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 58.24 136.15 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 123.603 1.668 . . . . 0.13 113.639 -172.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.99 -126.54 2.0 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 111.969 -2.378 . . . . 0.20000000000000001 109.253 -176.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.477 HG22 HD21 ' A' ' 464' ' ' LEU . 71.3 t -121.15 108.63 23.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.204 0.526 . . . . 0.81999999999999995 110.714 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.76 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 1.8 m-85 -106.8 -174.36 2.52 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.771 -1.566 . . . . 0.22 106.771 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -139.56 123.32 17.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.982 1.265 . . . . 0.65000000000000002 113.071 -172.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -90.51 92.5 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-O 123.035 1.398 . . . . 0.16 109.51 170.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -92.33 11.19 26.75 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.318 -1.765 . . . . 2.5499999999999998 108.291 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.775 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.5 t30 -169.38 126.24 0.91 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.265 -1.334 . . . . 0.42999999999999999 110.352 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.672 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -102.52 140.04 37.32 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.774 -1.103 . . . . 1.1200000000000001 108.96 169.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.748 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 21.2 mm-40 -124.08 159.2 30.47 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.788 1.403 . . . . 0.70999999999999996 114.788 -167.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.727 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 49.8 mt-10 -129.2 146.34 51.14 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 112.701 -2.045 . . . . 0.38 106.552 165.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.8 t70 47.51 38.77 8.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 112.505 -2.134 . . . . 0.40999999999999998 110.603 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.914 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -78.93 166.88 21.89 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 112.663 -2.062 . . . . 0.12 109.318 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 19.9 m -131.29 119.43 21.74 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.29 1.043 . . . . 0.17000000000000001 111.229 171.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.0 mp -79.19 88.29 4.89 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.392 -1.731 . . . . 0.56999999999999995 111.917 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.547 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.1 mttt . . . . . 0 C--N 1.281 -2.392 0 CA-C-N 113.658 -1.61 . . . . 0.33000000000000002 113.127 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.547 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.628 0 CA-C-O 120.995 0.426 . . . . 0.53000000000000003 110.383 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.06 97.49 4.83 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 108.39 -0.967 . . . . 0.19 108.39 170.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.9 Cg_exo -68.66 111.41 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.715 0 C-N-CA 122.202 1.935 . . . . 0.19 110.3 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.92 160.3 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.31 -1.768 . . . . 0.14999999999999999 107.663 -168.108 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.727 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.8 m-80 -94.15 -19.61 20.62 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.902 -0.777 . . . . 0.51000000000000001 108.902 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.748 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 88.1 m-85 -158.94 125.95 4.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.892 -1.049 . . . . 0.27000000000000002 108.248 -171.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 18.2 t-105 -144.16 131.17 20.48 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.933 0.873 . . . . 0.089999999999999997 111.557 -166.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.672 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -111.94 93.91 22.86 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.44 -1.319 . . . . 0.14000000000000001 107.44 171.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.775 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.5 Cg_endo . . . . . 0 C--N 1.35 0.632 0 C-N-CA 122.308 2.005 . . . . 0.5 111.537 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 419' ' ' GLY . 47.2 t . . . . . 0 CA--C 1.535 0.4 0 CA-C-O 121.374 0.607 . . . . 0.75 111.584 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.588 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -173.08 120.98 0.84 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 109.875 -1.29 . . . . 0.20000000000000001 109.875 170.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.729 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -82.17 140.88 15.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.746 -0.465 . . . . 0.28999999999999998 109.746 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.669 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.1 p80 -159.18 161.03 36.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.197 -0.456 . . . . 0.089999999999999997 111.367 -174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.697 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.4 148.62 26.5 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.214 -1.032 . . . . 1.0700000000000001 108.214 172.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 445' ' ' THR . 40.4 t -133.24 96.38 3.73 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.726 0.774 . . . . 0.23000000000000001 109.75 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 C--N 1.317 -0.814 0 CA-C-N 114.26 -1.336 . . . . 0.41999999999999998 109.204 -177.286 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.574 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.9 pm0 . . . . . 0 N--CA 1.436 -1.134 0 CA-C-O 122.323 1.059 . . . . 2.1600000000000001 113.35 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.651 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.47 129.9 3.79 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 112.604 -2.089 . . . . 0.33000000000000002 105.74 172.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.61 -158.82 31.7 Favored Glycine 0 C--N 1.283 -2.4 0 C-N-CA 119.913 -1.136 . . . . 0.17000000000000001 110.834 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.506 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.21 174.21 0.01 OUTLIER Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.253 -0.975 . . . . 0.20999999999999999 111.526 167.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.524 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.3 p-10 -51.9 101.72 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 123.262 1.506 . . . . 1.8500000000000001 113.851 -153.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.735 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.93 -37.06 10.85 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 112.459 -2.155 . . . . 1.21 109.54 169.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.711 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -54.12 -27.25 32.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.235 -0.893 . . . . 0.16 112.395 -170.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.711 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.33 -33.82 15.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.48 0.657 . . . . 0.22 112.466 -177.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.7 p -92.09 -43.03 9.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.854 -1.066 . . . . 0.25 110.991 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.735 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.5 mtp180 -93.15 -18.97 21.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.772 -1.104 . . . . 1.8200000000000001 109.492 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.02 49.42 55.53 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 114.74 -1.118 . . . . 0.23999999999999999 115.022 163.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.0 m -82.39 110.62 17.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.784 1.292 . . . . 1.01 111.077 -172.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.412 ' HB3' ' H ' ' A' ' 441' ' ' GLY . 44.6 m-70 38.98 -130.17 0.24 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.619 -1.173 . . . . 0.5 113.23 175.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 440' ' ' HIS . . . -122.31 -22.64 2.55 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.337 -0.459 . . . . 0.26000000000000001 113.247 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.559 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.5 p -102.44 -165.35 1.17 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 113.346 0.869 . . . . 0.34999999999999998 113.346 -173.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.491 ' CD1' HG11 ' A' ' 465' ' ' VAL . 1.9 mp -93.03 134.06 32.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.282 -0.872 . . . . 0.12 110.732 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.87 97.09 6.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.385 0.612 . . . . 0.62 110.113 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.739 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.2 m -93.35 144.85 28.94 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 114.726 -1.124 . . . . 0.10000000000000001 112.851 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.661 ' HD2' HG21 ' A' ' 366' ' ' THR . 72.6 Cg_exo -51.13 145.38 26.13 Favored 'Trans proline' 0 CA--C 1.507 -0.838 0 C-N-CA 123.98 3.12 . . . . 0.23999999999999999 113.391 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.697 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.6 Cg_exo -65.55 -26.15 54.58 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.909 2.406 . . . . 0.31 112.309 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.555 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 57.9 p -76.38 -25.29 54.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.794 0.807 . . . . 1.1000000000000001 111.998 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.821 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.7 m -99.6 -50.16 10.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.628 -0.714 . . . . 0.080000000000000002 112.766 -170.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.962 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.61 -2.15 4.5 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.754 -0.778 . . . . 0.070000000000000007 110.371 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 16.9 pttp -80.87 -38.68 27.7 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.521 1.153 . . . . 0.92000000000000004 108.201 173.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.491 ' HG3' HD11 ' A' ' 364' ' ' LEU . 4.1 mm-40 -62.69 -46.39 88.39 Favored 'General case' 0 CA--C 1.474 -1.968 0 CA-C-N 112.433 -2.167 . . . . 0.25 106.578 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.962 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.28 -66.06 0.47 Allowed 'General case' 0 N--CA 1.404 -2.752 0 CA-C-N 109.849 -3.341 . . . . 0.050000000000000003 112.712 172.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.462 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 24.0 t80 -45.72 -23.67 0.28 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 123.941 0.776 . . . . 0.13 109.56 176.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.452 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.82 -27.1 25.03 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.649 -1.159 . . . . 0.13 111.817 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.741 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.99 -43.83 5.66 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 113.57 0.952 . . . . 0.059999999999999998 113.57 177.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.688 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.4 OUTLIER -74.89 149.76 7.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.486 1.136 . . . . 0.080000000000000002 111.175 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -125.0 157.63 35.67 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 112.939 -1.937 . . . . 0.47999999999999998 108.245 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.658 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.1 mppt? -57.82 101.64 0.08 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 109.055 -0.72 . . . . 0.98999999999999999 109.055 172.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.85 -14.4 5.22 Favored Glycine 0 C--N 1.307 -1.082 0 CA-C-N 114.111 -1.404 . . . . 0.19 111.53 -175.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.688 HG21 ' HB ' ' A' ' 457' ' ' VAL . 17.8 m -66.63 149.27 98.32 Favored Pre-proline 0 N--CA 1.437 -1.076 0 N-CA-C 108.527 -0.916 . . . . 0.13 108.527 171.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 7.2 Cg_endo -94.39 164.19 1.94 Allowed 'Trans proline' 0 N--CA 1.419 -2.874 0 C-N-CA 122.159 1.906 . . . . 0.17999999999999999 109.769 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.76 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -126.6 151.65 33.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 107.741 -1.207 . . . . 0.56999999999999995 107.741 171.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.709 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.3 mp -134.6 151.27 50.96 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 109.079 -0.711 . . . . 0.13 109.079 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.098 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.38 142.81 30.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 105.604 -1.998 . . . . 0.10000000000000001 105.604 164.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.721 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 11.0 p90 . . . . . 0 C--O 1.244 0.785 0 CA-C-O 117.719 -1.134 . . . . 1.0900000000000001 111.562 -178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.445 -0.721 0 CA-C-O 121.677 0.751 . . . . 0.42999999999999999 109.635 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 96.4 m -158.25 135.65 10.2 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.039 -1.437 . . . . 0.14000000000000001 108.901 167.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.667 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.8 p90 174.56 158.3 0.16 Allowed 'General case' 0 C--O 1.213 -0.847 0 O-C-N 123.415 0.447 . . . . 0.14999999999999999 111.383 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.683 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -78.03 151.68 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 109.126 -0.694 . . . . 0.080000000000000002 109.126 164.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.577 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.43 142.39 24.82 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.606 -0.725 . . . . 2.0099999999999998 109.641 -176.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.732 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.47 161.84 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.162 0.506 . . . . 0.45000000000000001 111.501 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.557 ' N ' HG12 ' A' ' 347' ' ' VAL . 31.8 t0 -140.3 106.47 5.23 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.18 -1.415 . . . . 0.23999999999999999 107.18 174.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.069 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.24 -32.63 29.63 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 122.807 1.289 . . . . 0.16 110.262 -168.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.42 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -58.73 -45.32 89.9 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.615 -2.993 . . . . 0.59999999999999998 108.304 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 18.5 m-80 -100.6 7.03 44.25 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 111.106 -2.77 . . . . 0.20000000000000001 110.713 -175.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.628 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 19.0 mp0 33.62 60.63 0.49 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 112.683 -2.053 . . . . 2.1499999999999999 113.0 -175.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.501 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 20.3 t60 -141.71 134.7 28.95 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.383 -0.826 . . . . 0.089999999999999997 109.73 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.723 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.63 155.97 24.53 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.569 -0.741 . . . . 0.070000000000000007 110.203 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.611 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.7 m-90 -141.46 155.19 45.87 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.153 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.696 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.0 t80 -110.16 153.18 25.09 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 106.659 -1.608 . . . . 0.26000000000000001 106.659 151.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 8.8 m-85 -128.99 116.13 18.85 Favored 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 115.026 -0.988 . . . . 0.14000000000000001 110.413 -177.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.0 tppt? -116.41 140.23 49.57 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.085 -1.82 . . . . 0.25 106.085 168.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.439 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 67.19 18.01 10.35 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.29 0.848 . . . . 0.42999999999999999 113.29 172.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.24 8.34 85.32 Favored Glycine 0 CA--C 1.487 -1.703 0 CA-C-N 115.671 -0.695 . . . . 0.17999999999999999 113.197 -173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 15.4 ptmt -127.12 177.92 6.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 104.792 -2.299 . . . . 0.37 104.792 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.611 HG11 ' CD1' ' A' ' 355' ' ' TRP . 14.8 m -105.11 157.32 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.732 0 N-CA-C 116.374 1.99 . . . . 0.10000000000000001 116.374 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.671 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.53 -27.48 9.87 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 110.484 -3.053 . . . . 0.070000000000000007 106.242 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.838 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.02 144.01 48.45 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 111.675 -2.511 . . . . 0.059999999999999998 111.723 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.475 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -141.23 118.02 11.06 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.388 -2.449 . . . . 0.47999999999999998 104.388 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.723 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.52 163.96 36.39 Favored 'General case' 0 N--CA 1.399 -2.995 0 C-N-CA 118.051 -1.46 . . . . 0.070000000000000007 111.363 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -102.19 132.9 47.82 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 114.341 -1.3 . . . . 1.8 109.531 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.752 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -131.72 -175.06 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 CA-C-O 122.448 1.118 . . . . 0.12 112.29 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -149.9 118.42 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 112.927 -1.942 . . . . 0.10000000000000001 108.123 171.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -78.84 -168.46 1.43 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.132 -1.394 . . . . 1.26 110.822 -176.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -83.62 164.94 41.87 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 118.66 -1.733 . . . . 0.14000000000000001 112.076 -173.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.431 ' HG3' ' OG1' ' A' ' 374' ' ' THR . 7.0 ptmt -71.03 155.88 92.74 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.861 0.838 . . . . 0.81000000000000005 111.998 -165.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.3 Cg_exo -54.96 -29.44 64.4 Favored 'Trans proline' 0 CA--C 1.496 -1.423 1 C-N-CA 125.502 4.135 . . . . 0.28000000000000003 113.488 -175.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.434 ' OG1' HG22 ' A' ' 375' ' ' THR . 14.9 p -69.71 -33.91 73.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.432 -1.713 . . . . 0.33000000000000002 109.476 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.519 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.8 t -142.49 70.67 21.17 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 123.71 1.719 . . . . 0.39000000000000001 109.527 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.5 Cg_exo -57.65 149.88 64.99 Favored 'Trans proline' 0 C--N 1.31 -1.448 1 C-N-CA 126.389 4.726 . . . . 0.38 114.582 -171.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.537 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -79.05 145.04 64.5 Favored Pre-proline 0 N--CA 1.427 -1.619 0 N-CA-C 108.629 -0.878 . . . . 0.81999999999999995 108.629 173.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 17.4 Cg_exo -77.01 -45.81 0.16 Allowed 'Trans proline' 0 CA--C 1.512 -0.586 0 C-N-CA 124.523 3.482 . . . . 0.19 112.163 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.797 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.27 137.13 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 123.298 1.523 . . . . 0.13 113.557 -172.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.54 -113.3 0.57 Allowed Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 112.003 -2.362 . . . . 0.20000000000000001 109.533 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 8.1 p -131.02 116.28 33.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.887 0.851 . . . . 0.81999999999999995 110.899 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.757 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.3 m-85 -116.22 -174.31 2.53 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.253 -1.388 . . . . 0.22 107.253 173.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.6 t80 -140.98 125.05 17.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 120.186 1.357 . . . . 0.65000000000000002 113.436 -172.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -91.12 92.23 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 123.181 1.467 . . . . 0.16 109.609 169.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -93.15 11.12 28.92 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.419 -1.719 . . . . 2.5499999999999998 108.11 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.75 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.4 t30 -169.22 126.97 0.97 Allowed 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 113.952 -1.476 . . . . 0.42999999999999999 110.363 172.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.669 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -98.98 145.22 27.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.041 -0.981 . . . . 1.1200000000000001 108.927 169.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.739 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 11.3 mm-40 -125.08 158.16 34.49 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 114.888 1.44 . . . . 0.70999999999999996 114.888 -169.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.725 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 50.4 mt-10 -137.44 126.96 25.06 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.913 -1.949 . . . . 0.38 108.436 173.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 31.1 t70 54.16 50.73 15.87 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 123.248 1.499 . . . . 0.40999999999999998 109.082 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.946 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -84.04 166.69 17.51 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 112.83 -1.986 . . . . 0.12 109.27 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 21.7 m -132.7 118.81 19.56 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.204 1.002 . . . . 0.17000000000000001 111.793 171.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.46 88.72 5.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.585 -1.643 . . . . 0.56999999999999995 112.136 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.57 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.4 mttt . . . . . 0 C--N 1.282 -2.346 0 CA-C-N 113.561 -1.654 . . . . 0.33000000000000002 113.14 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.57 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 121.031 0.443 . . . . 0.53000000000000003 110.051 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.66 97.47 5.01 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.376 -0.972 . . . . 0.19 108.376 171.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.0 Cg_exo -68.87 110.38 2.36 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 121.991 1.794 . . . . 0.19 110.045 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.946 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.76 154.87 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 CA-C-N 112.91 -1.95 . . . . 0.14999999999999999 107.521 -168.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.725 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 21.7 m-80 -87.11 -21.57 25.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.909 -0.774 . . . . 0.51000000000000001 108.909 -174.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 90.3 m-85 -157.59 127.61 6.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.959 -1.018 . . . . 0.27000000000000002 108.677 -170.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.678 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 23.3 t-105 -145.5 133.64 21.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.767 0.794 . . . . 0.089999999999999997 111.151 -167.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.669 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.3 mmt -114.96 93.26 33.86 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 107.747 -1.205 . . . . 0.14000000000000001 107.747 172.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.75 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.9 Cg_endo . . . . . 0 C--N 1.348 0.522 0 C-N-CA 122.527 2.151 . . . . 0.5 112.515 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 419' ' ' GLY . 38.3 t . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.44 0.638 . . . . 0.75 111.891 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -177.82 121.51 0.78 Allowed Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.72 -1.352 . . . . 0.20000000000000001 109.72 170.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.69 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.0 mp -81.94 142.66 13.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 120.884 -0.326 . . . . 0.28999999999999998 110.158 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.678 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.6 p80 -159.42 160.99 35.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.336 -0.393 . . . . 0.089999999999999997 111.949 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.679 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -83.65 147.53 27.64 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.141 -1.059 . . . . 1.0700000000000001 108.141 172.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 445' ' ' THR . 2.6 t -133.62 98.94 4.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.633 1.206 . . . . 0.23000000000000001 110.514 -173.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.465 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 11.2 t70 . . . . . 0 C--N 1.311 -1.103 0 CA-C-N 114.69 -1.141 . . . . 0.41999999999999998 109.593 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.562 ' HG3' ' HG ' ' A' ' 433' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 122.303 1.049 . . . . 2.1600000000000001 112.346 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.484 ' HA ' HD23 ' A' ' 433' ' ' LEU . 3.3 m-85 -155.15 130.17 9.45 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 104.517 -2.401 . . . . 0.33000000000000002 104.517 171.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.31 -158.71 31.59 Favored Glycine 0 C--N 1.288 -2.096 0 N-CA-C 110.052 -1.219 . . . . 0.17000000000000001 110.052 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.484 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.52 174.54 0.01 OUTLIER Glycine 0 CA--C 1.501 -0.819 0 C-N-CA 120.442 -0.885 . . . . 0.20999999999999999 111.806 168.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.518 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.0 p-10 -50.91 101.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 123.496 1.617 . . . . 1.8500000000000001 113.597 -152.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.724 ' HG ' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.79 -38.54 10.27 Favored 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 112.316 -2.22 . . . . 1.21 109.642 170.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.715 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.8 p-90 -55.39 -27.28 46.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.608 -0.724 . . . . 0.16 112.505 -170.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.715 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -88.99 -33.02 17.33 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.717 0.77 . . . . 0.22 112.089 -177.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 7.0 p -89.79 -44.66 9.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.381 -1.281 . . . . 0.25 110.918 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.724 ' CD ' ' HG ' ' A' ' 433' ' ' LEU . 7.4 mtp85 -88.23 -19.23 27.12 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.45 -1.25 . . . . 1.8200000000000001 109.92 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.73 46.0 48.12 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.248 -1.342 . . . . 0.23999999999999999 113.327 164.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.0 m -84.45 110.39 18.61 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.32 -0.952 . . . . 1.01 111.837 -168.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 40.12 -129.73 0.36 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.343 -1.298 . . . . 0.5 113.056 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -124.44 -20.37 2.42 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.712 -0.756 . . . . 0.26000000000000001 113.547 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.543 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.7 p -103.77 -165.71 1.18 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 113.278 0.844 . . . . 0.34999999999999998 113.278 -173.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.476 HD13 HG11 ' A' ' 465' ' ' VAL . 1.9 mp -92.85 133.18 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 0.12 110.548 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.55 97.55 7.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.728 -0.669 . . . . 0.62 109.462 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.752 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.7 m -92.64 141.51 24.63 Favored Pre-proline 0 N--CA 1.437 -1.081 0 CA-C-N 115.51 -0.768 . . . . 0.10000000000000001 112.262 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.643 ' HD2' HG21 ' A' ' 366' ' ' THR . 64.0 Cg_exo -52.16 144.26 38.82 Favored 'Trans proline' 0 CA--C 1.499 -1.228 0 C-N-CA 123.975 3.117 . . . . 0.23999999999999999 114.786 175.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 80.3 Cg_exo -52.34 -55.02 4.22 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.301 2.001 . . . . 0.31 110.698 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.492 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 51.9 p -57.23 -23.82 50.59 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 112.251 -2.25 . . . . 1.1000000000000001 113.74 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.838 ' O ' HD21 ' A' ' 364' ' ' LEU . 27.1 m -98.24 -49.18 11.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 N-CA-C 113.019 0.748 . . . . 0.080000000000000002 113.019 -173.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.957 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.72 -2.11 6.43 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.52 -0.872 . . . . 0.070000000000000007 110.235 -178.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.56 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 14.7 pttp -80.98 -38.16 28.07 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 122.651 1.215 . . . . 0.92000000000000004 108.335 173.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.6 mm-40 -62.17 -46.32 89.49 Favored 'General case' 0 CA--C 1.471 -2.073 0 CA-C-N 112.387 -2.188 . . . . 0.25 106.53 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.957 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.09 -66.35 0.42 Allowed 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 109.837 -3.347 . . . . 0.050000000000000003 112.786 172.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.552 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.7 t80 -46.68 -22.78 0.33 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.673 0.749 . . . . 0.13 109.457 175.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.447 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.5 -22.46 37.08 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.059 -0.973 . . . . 0.13 111.819 -176.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.743 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -106.34 -44.21 4.59 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 113.777 1.028 . . . . 0.059999999999999998 113.777 175.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.66 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.52 148.97 8.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 122.44 1.114 . . . . 0.080000000000000002 111.275 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.11 156.63 29.41 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 113.048 -1.887 . . . . 0.47999999999999998 108.517 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.613 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 3.6 mppt? -59.07 101.75 0.1 Allowed 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.903 -0.777 . . . . 0.98999999999999999 108.903 171.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.7 -10.65 5.47 Favored Glycine 0 C--N 1.308 -1.019 0 CA-C-N 113.962 -1.472 . . . . 0.19 111.576 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.634 HG21 ' HB ' ' A' ' 457' ' ' VAL . 18.2 m -68.61 150.8 97.55 Favored Pre-proline 0 N--CA 1.443 -0.803 0 N-CA-C 109.073 -0.714 . . . . 0.13 109.073 171.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.4 Cg_endo -93.99 163.37 2.14 Favored 'Trans proline' 0 N--CA 1.425 -2.516 0 C-N-CA 122.428 2.085 . . . . 0.17999999999999999 110.128 176.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.757 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -126.87 149.89 32.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 107.668 -1.234 . . . . 0.56999999999999995 107.668 171.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.702 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.47 149.89 50.77 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.411 -0.959 . . . . 0.13 108.411 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.069 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -138.25 141.82 36.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 105.434 -2.062 . . . . 0.10000000000000001 105.434 165.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.764 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 10.2 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 117.723 -1.132 . . . . 1.0900000000000001 111.664 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 . . . . . 0 N--CA 1.445 -0.705 0 CA-C-O 121.291 0.567 . . . . 0.42999999999999999 110.008 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 357' ' ' TYR . 84.3 m -158.39 135.56 9.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.62 -1.173 . . . . 0.14000000000000001 109.067 168.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.696 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.7 p90 174.42 158.63 0.16 Allowed 'General case' 0 CA--C 1.503 -0.829 0 O-C-N 123.386 0.429 . . . . 0.14999999999999999 111.132 -175.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.659 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.92 152.33 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 109.106 -0.702 . . . . 0.080000000000000002 109.106 164.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.614 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.65 143.05 25.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.64 -0.709 . . . . 2.0099999999999998 109.551 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.725 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.59 162.16 37.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.027 0.441 . . . . 0.45000000000000001 111.378 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.558 ' N ' HG12 ' A' ' 347' ' ' VAL . 20.5 t0 -139.91 107.26 5.53 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.404 -1.332 . . . . 0.23999999999999999 107.404 172.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.034 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.51 -34.38 27.97 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 122.719 1.247 . . . . 0.16 110.52 -167.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.432 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.1 mt-10 -58.41 -45.26 88.75 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.871 -2.877 . . . . 0.59999999999999998 108.252 176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 19.4 m-80 -99.99 6.47 45.11 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 111.031 -2.804 . . . . 0.20000000000000001 110.889 -175.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 18.1 mp0 33.53 61.7 0.44 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 112.545 -2.116 . . . . 2.1499999999999999 113.11 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.8 t60 -141.92 135.18 29.18 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.612 -0.722 . . . . 0.089999999999999997 109.733 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.723 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -114.23 156.17 24.81 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.735 -0.666 . . . . 0.070000000000000007 110.233 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.576 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.0 m-90 -141.17 153.93 45.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.373 -0.831 . . . . 0.11 111.269 -174.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.684 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 86.1 t80 -109.76 153.21 24.66 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 106.599 -1.63 . . . . 0.26000000000000001 106.599 151.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.5 m-85 -129.25 116.61 19.4 Favored 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 114.699 -1.137 . . . . 0.14000000000000001 110.226 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.5 tppt? -115.88 137.3 52.23 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.703 -1.962 . . . . 0.25 105.703 167.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.423 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.73 18.31 8.72 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.61 0.967 . . . . 0.42999999999999999 113.61 172.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.31 8.1 86.99 Favored Glycine 0 CA--C 1.487 -1.697 0 CA-C-O 121.779 0.655 . . . . 0.17999999999999999 113.015 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 15.8 ptmt -128.13 176.95 7.25 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 104.569 -2.382 . . . . 0.37 104.569 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.4 m -104.38 157.86 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.611 0 N-CA-C 116.289 1.959 . . . . 0.10000000000000001 116.289 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.684 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.87 -26.61 9.7 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 110.516 -3.038 . . . . 0.070000000000000007 106.646 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.803 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.84 144.96 47.88 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 111.669 -2.514 . . . . 0.059999999999999998 111.753 -175.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.508 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 5.8 tt0 -139.92 118.15 12.0 Favored 'General case' 0 N--CA 1.408 -2.53 0 N-CA-C 104.411 -2.44 . . . . 0.47999999999999998 104.411 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.723 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.09 163.39 38.31 Favored 'General case' 0 N--CA 1.4 -2.971 0 C-N-CA 117.466 -1.693 . . . . 0.070000000000000007 111.917 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 18.1 p-10 -103.02 134.33 46.64 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-N 114.293 -1.321 . . . . 1.8 109.57 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.89 -172.34 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 CA-C-O 122.508 1.147 . . . . 0.12 112.414 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.532 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.23 120.89 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 112.832 -1.985 . . . . 0.10000000000000001 108.423 172.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.521 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.86 -168.14 1.5 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.315 -1.311 . . . . 1.26 110.708 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -83.96 170.33 47.42 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 118.907 -1.616 . . . . 0.14000000000000001 112.152 -173.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -78.6 162.89 63.99 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 113.109 0.781 . . . . 0.81000000000000005 113.109 -162.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.731 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 74.9 Cg_exo -54.84 -37.53 92.57 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 C-N-CA 123.058 2.505 . . . . 0.28000000000000003 112.56 -175.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.42 ' OG1' HG22 ' A' ' 375' ' ' THR . 25.2 p -66.06 -33.96 76.98 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.337 -1.301 . . . . 0.33000000000000002 110.085 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.523 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.5 t -141.56 72.69 25.1 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-O 123.69 1.709 . . . . 0.39000000000000001 109.743 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 375' ' ' THR . 74.3 Cg_exo -61.37 160.5 27.04 Favored 'Trans proline' 0 C--N 1.311 -1.423 1 C-N-CA 126.345 4.697 . . . . 0.38 114.346 -173.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.521 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -91.55 144.71 29.99 Favored Pre-proline 0 N--CA 1.42 -1.96 0 N-CA-C 108.305 -0.998 . . . . 0.81999999999999995 108.305 171.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 20.4 Cg_exo -76.44 -43.88 0.27 Allowed 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 124.844 3.696 . . . . 0.19 112.139 -168.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.785 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.96 134.6 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.488 1.613 . . . . 0.13 113.562 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 155.14 -116.15 0.71 Allowed Glycine 0 N--CA 1.429 -1.791 0 CA-C-N 111.959 -2.382 . . . . 0.20000000000000001 109.627 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 381' ' ' VAL . 8.4 p -130.34 115.69 33.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.861 0.839 . . . . 0.81999999999999995 110.899 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.743 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.7 m-85 -115.36 -174.01 2.43 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.34 -1.355 . . . . 0.22 107.34 174.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 0.8 OUTLIER -139.65 123.49 17.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.881 1.219 . . . . 0.65000000000000002 113.268 -171.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -91.74 91.67 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 CA-C-O 123.189 1.471 . . . . 0.16 109.39 168.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -93.44 10.58 31.74 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 113.106 -1.861 . . . . 2.5499999999999998 107.908 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.757 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.7 t30 -168.78 125.6 0.98 Allowed 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 113.774 -1.557 . . . . 0.42999999999999999 109.939 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.651 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.9 143.52 30.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.902 -1.044 . . . . 1.1200000000000001 108.86 169.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.785 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 20.4 mm-40 -125.17 155.18 40.36 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 114.441 1.274 . . . . 0.70999999999999996 114.441 -168.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.775 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 41.0 mt-10 -136.86 126.55 25.45 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 112.947 -1.933 . . . . 0.38 108.287 171.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.6 t70 57.56 53.34 7.43 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 123.459 1.6 . . . . 0.40999999999999998 109.144 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.914 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -89.29 166.38 13.81 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 112.451 -2.159 . . . . 0.12 108.501 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 31.6 m -132.93 120.03 20.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.092 0.949 . . . . 0.17000000000000001 111.862 171.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.755 HD11 HG21 ' A' ' 407' ' ' VAL . 8.9 mt -75.75 88.29 2.81 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.828 -1.533 . . . . 0.56999999999999995 112.796 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.54 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 44.9 mttt . . . . . 0 C--N 1.286 -2.154 0 CA-C-N 114.492 -1.231 . . . . 0.33000000000000002 113.751 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.54 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.713 0 CA-C-O 121.027 0.441 . . . . 0.53000000000000003 110.07 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.647 ' O ' ' HG ' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.98 97.54 4.85 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.304 -0.998 . . . . 0.19 108.304 171.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 14.4 Cg_exo -70.27 108.21 2.13 Favored 'Trans proline' 0 N--CA 1.432 -2.127 0 C-N-CA 121.023 1.149 . . . . 0.19 110.016 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -106.22 152.4 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.285 0 CA-C-N 112.816 -1.993 . . . . 0.14999999999999999 108.55 -169.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.775 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.8 OUTLIER -86.08 -19.17 30.64 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.753 -0.832 . . . . 0.51000000000000001 108.753 -174.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.785 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.4 m-85 -158.05 126.02 5.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.378 -0.828 . . . . 0.27000000000000002 108.938 -171.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.675 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 21.4 t-105 -144.94 134.24 22.96 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.705 0.764 . . . . 0.089999999999999997 111.18 -167.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.651 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.1 mmt -116.44 93.64 40.59 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.746 -1.205 . . . . 0.14000000000000001 107.746 172.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.757 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.6 Cg_endo . . . . . 0 C--N 1.348 0.502 0 C-N-CA 122.532 2.154 . . . . 0.5 112.95 -178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 419' ' ' GLY . 36.0 t . . . . . 0 CA--C 1.532 0.288 0 CA-C-O 121.359 0.6 . . . . 0.75 112.298 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.593 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.71 120.74 0.72 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.861 -1.296 . . . . 0.20000000000000001 109.861 170.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.686 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.43 141.83 14.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 110.041 -0.355 . . . . 0.28999999999999998 110.041 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.675 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.2 p80 -157.92 161.21 38.22 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 116.091 -0.504 . . . . 0.089999999999999997 111.173 -174.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.699 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.2 OUTLIER -84.18 148.16 26.91 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.178 -1.045 . . . . 1.0700000000000001 108.178 172.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 445' ' ' THR . 45.9 t -134.18 96.1 3.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.707 0.765 . . . . 0.23000000000000001 109.844 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 19.6 t70 . . . . . 0 C--N 1.315 -0.913 0 CA-C-N 114.3 -1.318 . . . . 0.41999999999999998 109.921 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.599 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.4 pm0 . . . . . 0 N--CA 1.437 -1.076 0 CA-C-O 122.39 1.091 . . . . 2.1600000000000001 113.242 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.632 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.04 130.88 4.3 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 104.93 -2.248 . . . . 0.33000000000000002 104.93 170.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.46 -158.63 31.62 Favored Glycine 0 C--N 1.284 -2.35 0 C-N-CA 119.806 -1.188 . . . . 0.17000000000000001 110.792 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.35 175.33 0.01 OUTLIER Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 120.519 -0.848 . . . . 0.20999999999999999 111.713 167.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.489 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 7.8 p-10 -50.58 101.8 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 123.473 1.606 . . . . 1.8500000000000001 113.445 -153.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.73 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -97.13 -37.69 10.02 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 112.639 -2.073 . . . . 1.21 109.478 169.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.744 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -54.13 -28.04 37.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.36 -0.836 . . . . 0.16 112.286 -170.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.744 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.67 -35.07 15.16 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.697 0.629 . . . . 0.22 112.697 -178.029 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.2 p -90.98 -40.86 11.43 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.262 -0.881 . . . . 0.25 111.014 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.73 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -95.49 -17.21 21.65 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.646 -1.161 . . . . 1.8200000000000001 109.693 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.76 50.11 51.1 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.91 -1.041 . . . . 0.23999999999999999 115.22 161.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.8 m -82.06 109.82 16.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.923 1.362 . . . . 1.01 110.845 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 32.59 -112.16 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.467 -1.242 . . . . 0.5 113.418 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -140.49 -14.6 0.52 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.898 -0.592 . . . . 0.26000000000000001 113.767 -174.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . . . . . . . . . 28.8 p -104.59 -166.32 1.23 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 117.75 0.775 . . . . 0.34999999999999998 112.467 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.438 ' CD1' HG11 ' A' ' 465' ' ' VAL . 2.1 mp -96.65 129.63 46.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.839 -1.073 . . . . 0.12 110.465 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.55 93.15 5.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.815 -0.629 . . . . 0.62 110.123 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.726 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -89.15 142.98 30.44 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.936 -1.029 . . . . 0.10000000000000001 112.731 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.657 ' HD2' HG21 ' A' ' 366' ' ' THR . 75.0 Cg_exo -50.16 146.47 17.72 Favored 'Trans proline' 0 CA--C 1.507 -0.857 0 C-N-CA 124.15 3.234 . . . . 0.23999999999999999 113.323 174.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.699 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.3 Cg_exo -67.33 -25.07 42.65 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.887 2.392 . . . . 0.31 111.834 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.511 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 40.4 p -76.61 -26.09 54.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.94 -1.027 . . . . 1.1000000000000001 112.036 -175.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.803 ' O ' HD21 ' A' ' 364' ' ' LEU . 33.4 m -99.27 -49.75 11.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 112.806 0.669 . . . . 0.080000000000000002 112.806 -170.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.954 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.51 -2.25 4.49 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.743 -0.783 . . . . 0.070000000000000007 110.409 -178.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 40.9 pttt -81.29 -38.74 26.33 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 122.518 1.151 . . . . 0.92000000000000004 108.335 173.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.1 mm-40 -62.94 -46.7 86.52 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 112.47 -2.15 . . . . 0.25 106.688 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.954 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -46.68 -67.16 0.31 Allowed 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 109.906 -3.316 . . . . 0.050000000000000003 112.736 172.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.527 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 16.4 t80 -44.91 -24.85 0.25 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 124.191 0.932 . . . . 0.13 109.39 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -87.57 -30.12 19.58 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.551 -1.204 . . . . 0.13 111.607 -175.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.753 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -98.27 -44.12 6.69 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 113.21 0.818 . . . . 0.059999999999999998 113.21 178.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -73.75 147.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 122.558 1.17 . . . . 0.080000000000000002 111.126 179.402 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.61 156.58 27.9 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 112.809 -1.996 . . . . 0.47999999999999998 108.473 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 42.4 mtmt -55.76 102.73 0.08 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.699 -0.682 . . . . 0.98999999999999999 109.517 169.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.79 -13.22 5.85 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 113.792 -1.549 . . . . 0.19 111.779 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.665 HG21 ' HB ' ' A' ' 457' ' ' VAL . 17.3 m -64.85 150.1 95.29 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 108.996 -0.742 . . . . 0.13 108.996 173.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.1 Cg_endo -93.62 160.33 2.36 Favored 'Trans proline' 0 N--CA 1.424 -2.616 0 C-N-CA 122.331 2.021 . . . . 0.17999999999999999 109.962 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.743 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -124.6 149.87 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.317 -1.364 . . . . 0.56999999999999995 107.317 171.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.696 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.6 mp -134.42 149.99 50.82 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.339 -0.986 . . . . 0.13 108.339 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.034 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.82 140.95 40.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 105.647 -1.983 . . . . 0.10000000000000001 105.647 166.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.683 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 5.4 p90 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 117.649 -1.167 . . . . 1.0900000000000001 111.139 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.505 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 4.6 m-20 . . . . . 0 N--CA 1.444 -0.762 0 CA-C-O 121.279 0.561 . . . . 0.42999999999999999 109.993 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.782 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 53.2 m -156.86 132.71 9.54 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.358 -1.292 . . . . 0.14000000000000001 108.268 167.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.758 ' CD2' HD13 ' A' ' 464' ' ' LEU . 42.9 p90 174.73 158.38 0.17 Allowed 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 123.421 0.451 . . . . 0.14999999999999999 111.002 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.658 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.34 153.71 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.387 -0.598 . . . . 0.080000000000000002 109.387 165.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.71 146.63 28.21 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.826 -1.175 . . . . 2.0099999999999998 107.826 -178.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.748 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.4 155.03 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 C-N-CA 123.579 0.752 . . . . 0.45000000000000001 110.618 173.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.524 ' N ' HG12 ' A' ' 347' ' ' VAL . 48.0 t0 -137.19 105.33 5.69 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.255 -1.757 . . . . 0.23999999999999999 106.255 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.058 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -79.62 -35.83 38.89 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 123.11 1.433 . . . . 0.16 110.019 -166.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.474 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -56.04 -44.98 79.33 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 110.682 -2.963 . . . . 0.59999999999999998 108.037 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 28.1 m-80 -101.02 7.1 43.62 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 110.815 -2.902 . . . . 0.20000000000000001 110.893 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.6 OUTLIER 32.78 61.44 0.38 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 112.628 -2.078 . . . . 2.1499999999999999 112.928 -175.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.508 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 24.1 t60 -141.94 135.77 29.73 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.77 -0.65 . . . . 0.089999999999999997 109.837 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.777 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.65 157.26 22.38 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.91 -0.586 . . . . 0.070000000000000007 110.155 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.666 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -142.68 160.06 41.04 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.81 -0.632 . . . . 0.11 111.254 -177.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.782 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.6 t80 -112.3 153.9 26.49 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 106.45 -1.685 . . . . 0.26000000000000001 106.45 150.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.5 m-85 -127.51 119.21 25.55 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 115.119 -0.946 . . . . 0.14000000000000001 110.126 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.4 tppt? -120.47 134.88 55.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.124 -1.806 . . . . 0.25 106.124 168.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 72.98 16.32 4.41 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 113.216 0.821 . . . . 0.42999999999999999 113.216 172.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.505 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.68 6.79 88.35 Favored Glycine 0 CA--C 1.486 -1.767 0 C-N-CA 120.995 -0.621 . . . . 0.17999999999999999 113.05 -172.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.3 ptmt -128.49 176.39 7.78 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 104.872 -2.269 . . . . 0.37 104.872 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.666 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.4 m -104.83 156.89 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 116.597 2.073 . . . . 0.10000000000000001 116.597 -175.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.708 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.76 -27.34 10.34 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 110.672 -2.967 . . . . 0.070000000000000007 106.599 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.792 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.9 145.39 49.57 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 111.405 -2.634 . . . . 0.059999999999999998 111.301 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.486 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -142.1 118.08 10.6 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 104.504 -2.406 . . . . 0.47999999999999998 104.504 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.777 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.3 164.87 33.64 Favored 'General case' 0 N--CA 1.402 -2.857 0 C-N-CA 117.997 -1.481 . . . . 0.070000000000000007 111.803 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.585 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 12.2 p-10 -102.95 132.69 49.0 Favored 'General case' 0 N--CA 1.41 -2.458 0 CA-C-N 114.109 -1.405 . . . . 1.8 109.791 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.741 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.02 -173.48 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-O 122.522 1.153 . . . . 0.12 112.425 -171.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.09 120.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 112.719 -2.037 . . . . 0.10000000000000001 108.123 172.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.478 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -78.73 -168.6 1.45 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.23 -1.35 . . . . 1.26 110.325 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.553 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.16 170.51 45.15 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 118.601 -1.761 . . . . 0.14000000000000001 112.631 -173.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.5 ptmt -72.96 155.28 90.6 Favored Pre-proline 0 C--O 1.218 -0.603 0 CA-C-O 121.42 0.629 . . . . 0.81000000000000005 111.576 -166.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.664 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 77.9 Cg_exo -55.04 -28.29 59.37 Favored 'Trans proline' 0 CA--C 1.497 -1.326 0 C-N-CA 125.243 3.962 . . . . 0.28000000000000003 113.665 -173.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.44 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 26.2 p -72.6 -32.28 65.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.621 -1.627 . . . . 0.33000000000000002 109.586 -176.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.548 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 0.4 OUTLIER -141.37 70.56 26.93 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-O 123.426 1.584 . . . . 0.39000000000000001 110.127 178.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 375' ' ' THR . 76.1 Cg_exo -59.4 157.5 30.85 Favored 'Trans proline' 0 C--N 1.311 -1.406 1 C-N-CA 126.309 4.673 . . . . 0.38 113.996 -172.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.487 HG21 ' HG ' ' A' ' 349' ' ' LEU . 0.5 OUTLIER -84.97 147.74 48.93 Favored Pre-proline 0 N--CA 1.422 -1.875 0 N-CA-C 108.198 -1.038 . . . . 0.81999999999999995 108.198 174.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 15.5 Cg_exo -77.6 -42.39 0.27 Allowed 'Trans proline' 0 CA--C 1.514 -0.505 0 C-N-CA 124.124 3.216 . . . . 0.19 112.363 -166.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 54.99 137.83 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 123.604 1.668 . . . . 0.13 114.487 -173.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.75 -109.91 0.44 Allowed Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 111.997 -2.365 . . . . 0.20000000000000001 109.549 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.75 124.32 56.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.328 0.585 . . . . 0.81999999999999995 109.724 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.748 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 4.7 m-85 -123.65 -174.45 2.97 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.497 -1.297 . . . . 0.22 107.497 172.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.0 OUTLIER -139.85 123.22 17.07 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 119.471 1.032 . . . . 0.65000000000000002 112.953 -171.072 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.84 91.14 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-O 123.296 1.522 . . . . 0.16 109.032 169.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -93.9 11.82 28.14 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 112.978 -1.919 . . . . 2.5499999999999998 107.873 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.744 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.9 t30 -168.49 124.9 1.01 Allowed 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 113.627 -1.624 . . . . 0.42999999999999999 110.009 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.646 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.19 143.53 31.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.086 -0.961 . . . . 1.1200000000000001 108.949 170.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.758 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 37.1 mm-40 -126.95 158.46 36.77 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 114.961 1.467 . . . . 0.70999999999999996 114.961 -167.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 43.6 mt-10 -138.75 126.65 22.34 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.194 -1.821 . . . . 0.38 108.796 174.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 18.6 t70 52.15 51.88 15.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 123.165 1.459 . . . . 0.40999999999999998 109.231 -173.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.924 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -82.92 167.46 17.97 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.764 -2.016 . . . . 0.12 109.005 176.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 15.8 m -132.93 120.53 21.58 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.863 0.84 . . . . 0.17000000000000001 111.291 169.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.6 mp -78.02 87.2 4.18 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.969 -1.468 . . . . 0.56999999999999995 111.417 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.553 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 45.8 mttt . . . . . 0 C--N 1.288 -2.071 0 CA-C-N 113.393 -1.731 . . . . 0.33000000000000002 113.573 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.553 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.664 0 CA-C-O 120.971 0.415 . . . . 0.53000000000000003 110.798 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.9 OUTLIER -145.14 97.32 4.82 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 108.305 -0.998 . . . . 0.19 108.305 170.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.2 Cg_exo -68.73 111.26 2.55 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 122.089 1.859 . . . . 0.19 110.49 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.924 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -112.74 151.21 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 CA-C-N 113.206 -1.815 . . . . 0.14999999999999999 107.993 -167.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.709 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.8 OUTLIER -85.12 -19.53 31.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.789 -0.819 . . . . 0.51000000000000001 108.789 -173.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 97.5 m-85 -159.69 126.62 4.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.404 -0.961 . . . . 0.27000000000000002 108.404 -170.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.69 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 19.1 t-105 -144.14 136.04 26.22 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.7 0.762 . . . . 0.089999999999999997 111.174 -166.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.646 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.1 mmt -118.99 91.26 42.96 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.855 -1.165 . . . . 0.14000000000000001 107.855 173.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.744 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 35.7 Cg_endo . . . . . 0 CA--C 1.514 -0.521 0 C-N-CA 122.387 2.058 . . . . 0.5 111.289 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.699 HG11 ' CE2' ' A' ' 382' ' ' PHE . 2.4 p . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 112.244 0.461 . . . . 0.75 112.244 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 442' ' ' CYS . . . -174.05 124.0 1.0 Allowed Glycine 0 CA--C 1.497 -1.092 0 N-CA-C 110.355 -1.098 . . . . 0.20000000000000001 110.355 172.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.674 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.4 mp -81.7 142.8 13.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.8 0.333 . . . . 0.28999999999999998 110.453 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.69 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.1 p80 -160.63 162.31 32.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.841 -0.618 . . . . 0.089999999999999997 110.924 -175.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.693 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.2 OUTLIER -86.65 148.32 25.51 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.731 -1.211 . . . . 1.0700000000000001 107.731 172.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 445' ' ' THR . 45.3 t -133.05 96.71 3.83 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.803 0.811 . . . . 0.23000000000000001 109.943 -170.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 114.134 -1.394 . . . . 0.41999999999999998 109.445 -176.051 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.622 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.2 pm0 . . . . . 0 N--CA 1.43 -1.45 0 CA-C-O 122.304 1.049 . . . . 2.1600000000000001 113.018 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.66 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -156.6 132.87 9.89 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 105.456 -2.054 . . . . 0.33000000000000002 105.456 167.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.14 -159.06 32.14 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 110.497 -1.041 . . . . 0.17000000000000001 110.497 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.503 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -46.8 175.34 0.01 OUTLIER Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.372 -0.918 . . . . 0.20999999999999999 111.71 168.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.538 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 10.1 p-10 -51.69 101.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.453 1.597 . . . . 1.8500000000000001 113.733 -155.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 1.044 HD22 ' HD2' ' A' ' 437' ' ' ARG . 35.6 mt -97.86 -35.34 10.53 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 112.038 -2.347 . . . . 1.21 109.467 170.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.701 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.0 p-90 -53.07 -26.95 17.85 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.012 -0.994 . . . . 0.16 112.071 -172.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.701 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.28 -35.77 15.09 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.611 -0.722 . . . . 0.22 112.482 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.8 p -88.51 -37.71 15.54 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.468 -0.787 . . . . 0.25 110.617 -176.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 1.044 ' HD2' HD22 ' A' ' 433' ' ' LEU . 0.4 OUTLIER -99.25 -19.64 16.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.676 -1.147 . . . . 1.8200000000000001 110.715 -178.382 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.34 49.62 50.42 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 115.988 1.155 . . . . 0.23999999999999999 115.988 162.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.1 m -82.3 111.07 18.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 119.745 1.773 . . . . 1.01 111.105 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 37.74 -113.64 0.11 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.635 0.976 . . . . 0.5 113.635 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.553 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -142.91 -14.87 0.31 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.62 -0.718 . . . . 0.26000000000000001 113.838 -173.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 26.4 p -101.56 -167.31 1.4 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.994 0.897 . . . . 0.34999999999999998 112.233 -177.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.46 HG12 HG11 ' A' ' 347' ' ' VAL . 2.3 mp -99.31 128.35 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 115.096 -0.956 . . . . 0.12 110.751 -174.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.32 92.37 5.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.577 -0.738 . . . . 0.62 110.234 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.741 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.1 m -88.1 143.3 32.77 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.024 -0.989 . . . . 0.10000000000000001 112.64 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.662 ' HD2' HG21 ' A' ' 366' ' ' THR . 74.1 Cg_exo -50.52 143.12 28.82 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 123.67 2.914 . . . . 0.23999999999999999 112.854 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.681 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.3 Cg_exo -64.42 -24.08 64.48 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.762 2.308 . . . . 0.31 111.914 -176.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.5 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 36.6 p -78.06 -25.49 47.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.217 -0.901 . . . . 1.1000000000000001 112.444 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.792 ' O ' HD21 ' A' ' 364' ' ' LEU . 33.2 m -99.71 -48.76 11.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 112.801 0.667 . . . . 0.080000000000000002 112.801 -171.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.952 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.39 -2.13 4.21 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.925 -0.71 . . . . 0.070000000000000007 110.379 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.611 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 42.6 pttt -81.17 -39.03 26.14 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.47 1.129 . . . . 0.92000000000000004 108.188 173.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.9 mm-40 -62.0 -46.24 90.09 Favored 'General case' 0 CA--C 1.473 -1.999 0 CA-C-N 112.545 -2.116 . . . . 0.25 106.593 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.952 HD23 ' SD ' ' A' ' 450' ' ' MET . 4.0 tp -46.61 -67.09 0.31 Allowed 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 109.679 -3.419 . . . . 0.050000000000000003 112.755 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.495 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 14.6 t80 -45.37 -24.1 0.26 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 123.972 0.795 . . . . 0.13 109.584 177.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.52 -26.64 27.07 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.68 -1.145 . . . . 0.13 111.899 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.739 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -100.9 -43.68 6.0 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 113.157 0.799 . . . . 0.059999999999999998 113.157 176.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.669 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -74.69 146.96 9.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.674 1.226 . . . . 0.080000000000000002 111.191 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.24 156.1 28.32 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 112.536 -2.12 . . . . 0.47999999999999998 108.499 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.628 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 40.1 mtmt -59.09 101.34 0.09 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.786 0.803 . . . . 0.98999999999999999 109.614 171.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 132.3 -14.14 5.12 Favored Glycine 0 C--N 1.304 -1.235 0 CA-C-N 113.556 -1.656 . . . . 0.19 111.452 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.669 HG21 ' HB ' ' A' ' 457' ' ' VAL . 14.7 m -65.11 150.31 95.63 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 108.854 -0.795 . . . . 0.13 108.854 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.0 Cg_endo -93.5 162.03 2.39 Favored 'Trans proline' 0 N--CA 1.421 -2.746 0 C-N-CA 122.204 1.936 . . . . 0.17999999999999999 109.813 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.748 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -125.68 151.91 32.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.465 -1.309 . . . . 0.56999999999999995 107.465 171.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.758 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.3 mp -133.84 150.07 51.38 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.27 -1.011 . . . . 0.13 108.27 175.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.058 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.53 137.88 36.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 103.879 -2.637 . . . . 0.10000000000000001 103.879 163.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 1.6 p90 . . . . . 0 C--O 1.25 1.129 0 O-C-N 123.742 0.651 . . . . 1.0900000000000001 111.378 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.45 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 18.6 m-20 . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 121.293 0.568 . . . . 0.42999999999999999 109.68 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 92.7 m -158.59 136.27 10.31 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.794 -1.094 . . . . 0.14000000000000001 109.02 168.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.763 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.9 p90 173.92 158.44 0.14 Allowed 'General case' 0 C--O 1.211 -0.963 0 O-C-N 123.582 0.551 . . . . 0.14999999999999999 111.329 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.676 HD11 HG11 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.63 153.66 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.181 -0.674 . . . . 0.080000000000000002 109.181 164.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.01 146.28 28.85 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.778 -1.193 . . . . 2.0099999999999998 107.778 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.05 155.8 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 C-N-CA 123.381 0.673 . . . . 0.45000000000000001 110.527 174.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 347' ' ' VAL . 31.4 t0 -137.99 106.68 5.89 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.755 -1.572 . . . . 0.23999999999999999 106.755 175.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 465' ' ' VAL . 0.2 OUTLIER -81.03 -34.77 32.61 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-O 123.094 1.426 . . . . 0.16 110.047 -166.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 466' ' ' PHE . 0.8 OUTLIER -58.88 -44.94 91.21 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 110.617 -2.992 . . . . 0.59999999999999998 108.064 177.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.441 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 27.9 m-80 -101.23 7.94 42.78 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 111.216 -2.72 . . . . 0.20000000000000001 110.88 -175.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.556 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.5 mp0 31.36 62.54 0.24 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 112.673 -2.058 . . . . 2.1499999999999999 113.316 -175.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.523 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 26.7 t60 -142.85 136.37 28.66 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.724 -0.671 . . . . 0.089999999999999997 109.661 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.779 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -114.11 156.48 24.12 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 116.114 -0.494 . . . . 0.070000000000000007 110.084 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.67 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.4 m-90 -142.25 158.66 43.47 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.648 -0.706 . . . . 0.11 111.191 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.703 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.8 t80 -111.32 154.07 25.05 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.607 -1.627 . . . . 0.26000000000000001 106.607 151.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.4 m-85 -128.13 116.92 20.7 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 115.262 -0.881 . . . . 0.14000000000000001 110.513 -178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.7 tppt? -119.05 140.03 50.75 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.338 -1.727 . . . . 0.25 106.338 168.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.408 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.49 16.27 9.15 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.174 0.805 . . . . 0.42999999999999999 113.174 174.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.18 6.99 87.82 Favored Glycine 0 CA--C 1.485 -1.815 0 CA-C-N 115.563 -0.744 . . . . 0.17999999999999999 113.024 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.5 ptmt -127.68 178.77 5.91 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 104.375 -2.454 . . . . 0.37 104.375 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.67 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.9 m -104.37 157.76 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 N-CA-C 116.412 2.004 . . . . 0.10000000000000001 116.412 -176.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.69 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.35 -28.04 9.64 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 110.773 -2.921 . . . . 0.070000000000000007 106.635 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -132.84 144.63 50.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 111.52 -2.582 . . . . 0.059999999999999998 111.435 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.521 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 5.6 tt0 -138.8 119.33 13.9 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 104.238 -2.504 . . . . 0.47999999999999998 104.238 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.779 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.3 164.84 34.75 Favored 'General case' 0 N--CA 1.401 -2.898 0 C-N-CA 117.644 -1.622 . . . . 0.070000000000000007 111.989 178.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.571 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 16.9 p-10 -103.46 134.2 47.23 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.373 -1.285 . . . . 1.8 109.784 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.721 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -136.8 -172.92 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 CA-C-O 122.417 1.103 . . . . 0.12 112.515 -171.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -153.33 121.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 112.745 -2.025 . . . . 0.10000000000000001 108.498 172.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.485 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.36 -168.79 1.64 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.268 -1.333 . . . . 1.26 110.556 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.404 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.36 170.79 45.1 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 118.649 -1.738 . . . . 0.14000000000000001 112.465 -174.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 7.0 ptpt -74.61 157.38 86.11 Favored Pre-proline 0 C--O 1.221 -0.404 0 CA-C-O 121.402 0.62 . . . . 0.81000000000000005 111.893 -166.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.671 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 99.4 Cg_exo -55.81 -30.04 74.75 Favored 'Trans proline' 0 CA--C 1.495 -1.436 0 C-N-CA 125.27 3.98 . . . . 0.28000000000000003 113.15 -172.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.474 ' OG1' HG22 ' A' ' 375' ' ' THR . 16.0 p -68.54 -33.18 73.65 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.304 -1.771 . . . . 0.33000000000000002 109.774 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.531 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -140.88 70.33 29.62 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 123.487 1.613 . . . . 0.39000000000000001 109.522 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.0 Cg_exo -58.61 157.1 28.76 Favored 'Trans proline' 0 C--N 1.307 -1.631 1 C-N-CA 126.191 4.594 . . . . 0.38 114.265 -171.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.485 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -89.61 143.13 30.0 Favored Pre-proline 0 N--CA 1.418 -2.04 0 N-CA-C 108.093 -1.077 . . . . 0.81999999999999995 108.093 171.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.8 Cg_exo -76.33 -44.1 0.27 Allowed 'Trans proline' 0 CA--C 1.508 -0.82 0 C-N-CA 124.565 3.51 . . . . 0.19 111.979 -167.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.814 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 59.37 137.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 123.582 1.658 . . . . 0.13 113.605 -172.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 154.39 -110.81 0.46 Allowed Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 112.064 -2.334 . . . . 0.20000000000000001 109.503 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.5 p -131.24 120.63 47.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.871 0.844 . . . . 0.81999999999999995 110.232 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.747 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.6 m-85 -119.47 -174.59 2.77 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.87 -1.53 . . . . 0.22 106.87 172.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.6 t80 -139.54 123.48 17.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 120.07 1.304 . . . . 0.65000000000000002 113.206 -171.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 2.1 p -88.66 91.29 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 123.132 1.444 . . . . 0.16 109.109 168.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -92.38 10.83 28.28 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.276 -1.784 . . . . 2.5499999999999998 108.014 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.735 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.2 t30 -169.03 126.73 0.98 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.836 -1.529 . . . . 0.42999999999999999 110.492 171.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.67 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -97.63 141.8 30.23 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.889 -1.051 . . . . 1.1200000000000001 108.815 169.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.77 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 14.7 mm-40 -125.97 157.02 38.88 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 114.538 1.31 . . . . 0.70999999999999996 114.538 -168.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.74 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.0 mt-10 -137.41 127.26 25.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 112.912 -1.949 . . . . 0.38 108.461 173.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.2 t70 57.6 47.23 16.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 123.446 1.593 . . . . 0.40999999999999998 109.072 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.913 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -84.27 167.48 16.57 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 112.474 -2.148 . . . . 0.12 109.457 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 19.9 m -132.35 119.09 20.25 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.188 0.994 . . . . 0.17000000000000001 112.149 171.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 4.1 mp -81.77 91.76 6.54 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.63 -1.623 . . . . 0.56999999999999995 112.498 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.571 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.7 mttt . . . . . 0 C--N 1.285 -2.236 0 CA-C-N 114.0 -1.454 . . . . 0.33000000000000002 113.572 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.571 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.44 -0.928 0 N-CA-C 109.642 -0.503 . . . . 0.53000000000000003 109.642 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -143.55 97.29 5.54 Favored Pre-proline 0 N--CA 1.432 -1.335 0 N-CA-C 108.176 -1.046 . . . . 0.19 108.176 172.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 16.8 Cg_exo -69.44 110.0 2.39 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 121.994 1.796 . . . . 0.19 109.654 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.913 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.9 154.22 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 CA-C-N 113.057 -1.883 . . . . 0.14999999999999999 107.688 -168.067 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.74 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.8 m-80 -86.48 -20.43 28.11 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.78 -0.822 . . . . 0.51000000000000001 108.78 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.77 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.4 m-85 -158.8 127.1 5.21 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.933 -1.031 . . . . 0.27000000000000002 108.749 -171.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 22.5 t-105 -144.13 135.31 25.51 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.607 0.718 . . . . 0.089999999999999997 111.001 -167.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.67 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.7 mmt -119.51 89.89 41.65 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.22 -1.03 . . . . 0.14000000000000001 108.22 174.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 28.1 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 C-N-CA 122.016 1.81 . . . . 0.5 111.062 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 419' ' ' GLY . 39.0 t . . . . . 0 CA--C 1.533 0.291 0 CA-C-O 121.296 0.57 . . . . 0.75 111.342 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.602 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.13 123.21 0.86 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 109.719 -1.352 . . . . 0.20000000000000001 109.719 170.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.713 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.5 142.43 13.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.809 -0.441 . . . . 0.28999999999999998 109.809 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.669 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.6 p80 -160.71 162.92 32.69 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.255 -0.43 . . . . 0.089999999999999997 111.482 -174.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.68 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.21 147.76 26.43 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.245 -1.02 . . . . 1.0700000000000001 108.245 172.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.3 t -132.99 96.93 3.88 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.791 0.805 . . . . 0.23000000000000001 109.835 -172.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.7 t70 . . . . . 0 C--N 1.313 -1.005 0 CA-C-N 114.094 -1.412 . . . . 0.41999999999999998 109.067 -177.785 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.658 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.0 pm0 . . . . . 0 N--CA 1.435 -1.182 0 CA-C-O 122.409 1.1 . . . . 2.1600000000000001 113.237 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.639 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.54 132.08 4.4 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.857 -2.275 . . . . 0.33000000000000002 104.857 171.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.45 -157.39 29.53 Favored Glycine 0 C--N 1.282 -2.441 0 C-N-CA 119.77 -1.205 . . . . 0.17000000000000001 110.885 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.449 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.21 175.95 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.297 -0.954 . . . . 0.20999999999999999 111.578 166.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.505 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.4 p-10 -51.95 101.57 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 123.276 1.512 . . . . 1.8500000000000001 113.426 -156.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.719 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.63 -35.8 10.93 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 112.631 -2.077 . . . . 1.21 109.45 169.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.736 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.7 p-90 -55.37 -28.0 51.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.173 -0.921 . . . . 0.16 112.156 -170.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.736 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.63 -35.04 15.21 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.604 0.716 . . . . 0.22 112.122 -177.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.1 p -90.14 -43.7 10.28 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.754 -1.112 . . . . 0.25 111.008 -175.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.719 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 3.0 mtp85 -92.35 -19.64 21.9 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.65 -1.159 . . . . 1.8200000000000001 109.732 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 54.48 48.47 64.85 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 113.848 -1.524 . . . . 0.23999999999999999 115.265 164.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 25.0 m -81.76 111.03 17.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 118.853 1.326 . . . . 1.01 111.217 -171.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 36.39 -120.69 0.15 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.741 -1.118 . . . . 0.5 113.66 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.404 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -133.29 -19.71 0.95 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 116.036 -0.529 . . . . 0.26000000000000001 113.676 -175.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.52 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.1 p -103.56 -165.37 1.15 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 117.507 0.654 . . . . 0.34999999999999998 112.707 -175.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.471 HG12 HG11 ' A' ' 347' ' ' VAL . 2.1 mp -95.48 130.57 44.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.968 -1.014 . . . . 0.12 110.658 -175.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.5 95.29 6.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.826 -0.625 . . . . 0.62 110.13 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.721 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.4 m -91.64 142.54 26.85 Favored Pre-proline 0 N--CA 1.437 -1.125 0 CA-C-N 115.042 -0.981 . . . . 0.10000000000000001 112.668 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.663 ' HD2' HG21 ' A' ' 366' ' ' THR . 87.2 Cg_exo -49.9 144.85 20.09 Favored 'Trans proline' 0 CA--C 1.507 -0.871 0 C-N-CA 124.096 3.197 . . . . 0.23999999999999999 113.457 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.68 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.6 Cg_exo -65.41 -28.37 54.43 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 122.783 2.322 . . . . 0.31 112.306 -175.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 48.1 m -74.74 -23.72 58.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.845 -0.616 . . . . 1.1000000000000001 112.282 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.804 ' O ' HD21 ' A' ' 364' ' ' LEU . 29.9 m -100.68 -49.08 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 112.932 0.716 . . . . 0.080000000000000002 112.932 -169.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.952 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.95 -2.09 4.85 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.8 -0.76 . . . . 0.070000000000000007 110.308 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.609 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.0 pttp -81.63 -38.98 25.12 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.378 1.085 . . . . 0.92000000000000004 108.117 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.6 mm-40 -62.03 -46.16 90.39 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-N 112.524 -2.126 . . . . 0.25 106.599 -177.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.952 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.9 tp -46.19 -67.06 0.32 Allowed 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 109.678 -3.419 . . . . 0.050000000000000003 112.778 172.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.499 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.3 t80 -45.52 -24.21 0.3 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 123.957 0.785 . . . . 0.13 109.48 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -87.91 -26.63 28.62 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 114.684 -1.143 . . . . 0.13 111.743 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.746 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.8 -44.11 5.63 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 113.322 0.86 . . . . 0.059999999999999998 113.322 176.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.676 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -74.1 148.06 8.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.499 1.143 . . . . 0.080000000000000002 111.25 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.416 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -117.07 157.99 24.93 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 112.745 -2.025 . . . . 0.47999999999999998 108.992 -179.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.665 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 7.3 mppt? -59.2 102.01 0.12 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.551 -0.907 . . . . 0.98999999999999999 108.551 168.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.22 -12.36 5.52 Favored Glycine 0 C--N 1.308 -1.011 0 CA-C-N 114.22 -1.355 . . . . 0.19 111.726 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.662 HG21 ' HB ' ' A' ' 457' ' ' VAL . 15.9 m -68.25 151.22 97.36 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 108.838 -0.801 . . . . 0.13 108.838 171.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.3 Cg_endo -94.1 165.92 2.04 Favored 'Trans proline' 0 N--CA 1.422 -2.694 0 C-N-CA 122.1 1.866 . . . . 0.17999999999999999 109.929 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.747 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -127.3 152.6 35.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.697 -1.223 . . . . 0.56999999999999995 107.697 170.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.763 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.3 mp -134.01 150.06 51.22 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.05 -1.093 . . . . 0.13 108.05 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.035 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -139.94 138.28 38.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 103.753 -2.684 . . . . 0.10000000000000001 103.753 164.031 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.814 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 2.5 p90 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 117.573 -1.204 . . . . 1.0900000000000001 112.109 -177.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.446 -0.672 0 CA-C-O 121.626 0.726 . . . . 0.42999999999999999 109.129 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 99.9 m -159.59 136.16 9.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.457 -1.247 . . . . 0.14000000000000001 108.995 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.656 ' CD2' HD13 ' A' ' 464' ' ' LEU . 38.6 p90 174.67 158.61 0.17 Allowed 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 123.381 0.425 . . . . 0.14999999999999999 111.117 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.66 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -78.11 152.35 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 N-CA-C 109.035 -0.728 . . . . 0.080000000000000002 109.035 164.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.559 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.1 tt0 -149.77 145.82 26.84 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.437 -0.802 . . . . 2.0099999999999998 109.389 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.735 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -138.23 162.28 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 120.917 0.389 . . . . 0.45000000000000001 111.184 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 347' ' ' VAL . 33.7 t0 -140.38 106.4 5.2 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.419 -1.326 . . . . 0.23999999999999999 107.419 173.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.091 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -81.63 -35.74 29.67 Favored 'General case' 0 CA--C 1.483 -1.618 0 CA-C-O 122.678 1.228 . . . . 0.16 110.477 -167.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.475 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -56.53 -44.27 80.67 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 110.967 -2.833 . . . . 0.59999999999999998 108.219 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.475 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.8 m-80 -101.21 6.78 43.16 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 110.751 -2.932 . . . . 0.20000000000000001 110.923 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.692 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.8 OUTLIER 34.19 61.83 0.5 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 112.558 -2.11 . . . . 2.1499999999999999 113.139 -176.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.522 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 20.4 t60 -142.11 133.59 26.63 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.782 -0.644 . . . . 0.089999999999999997 110.236 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -112.84 155.5 24.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.773 -0.649 . . . . 0.070000000000000007 109.684 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.556 ' CD1' HG11 ' A' ' 362' ' ' VAL . 29.0 m-90 -140.62 153.83 46.21 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.42 -0.809 . . . . 0.11 110.877 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.684 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 84.0 t80 -110.67 151.89 27.17 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 106.385 -1.709 . . . . 0.26000000000000001 106.385 152.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 6.9 m-85 -127.97 115.62 18.8 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 114.602 -1.181 . . . . 0.14000000000000001 110.343 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.1 tppt? -116.53 138.4 51.43 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.474 -1.676 . . . . 0.25 106.474 169.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.446 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.54 17.45 9.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.343 0.868 . . . . 0.42999999999999999 113.343 173.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.92 9.81 86.47 Favored Glycine 0 CA--C 1.491 -1.455 0 CA-C-N 115.528 -0.76 . . . . 0.17999999999999999 112.913 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.5 ptmt -130.27 178.36 6.64 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 104.757 -2.312 . . . . 0.37 104.757 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 17.9 m -105.08 157.9 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.642 0 N-CA-C 116.338 1.977 . . . . 0.10000000000000001 116.338 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.677 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -110.46 -27.91 8.79 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 110.571 -3.013 . . . . 0.070000000000000007 106.558 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.809 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.6 145.28 49.89 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 111.568 -2.56 . . . . 0.059999999999999998 111.362 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.426 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -141.65 118.29 11.0 Favored 'General case' 0 N--CA 1.404 -2.747 0 N-CA-C 104.255 -2.498 . . . . 0.47999999999999998 104.255 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.712 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.22 160.81 43.42 Favored 'General case' 0 N--CA 1.396 -3.131 0 C-N-CA 117.822 -1.551 . . . . 0.070000000000000007 111.244 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 14.9 p-10 -102.83 132.32 49.1 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.38 -1.282 . . . . 1.8 109.001 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.892 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.5 pp -132.16 -172.31 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 CA-C-O 122.439 1.114 . . . . 0.12 112.673 -171.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.83 118.9 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 112.985 -1.916 . . . . 0.10000000000000001 108.905 173.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.488 ' HB3' HD12 ' A' ' 349' ' ' LEU . 47.4 p -74.92 -168.93 0.81 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 112.039 -2.346 . . . . 1.26 111.662 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.75 175.25 50.46 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 118.944 -1.598 . . . . 0.14000000000000001 111.831 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.528 ' HG2' HG23 ' A' ' 375' ' ' THR . 15.3 ptmt -79.1 163.2 61.21 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.813 0.672 . . . . 0.81000000000000005 112.813 -164.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.705 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 86.3 Cg_exo -55.72 -37.54 95.37 Favored 'Trans proline' 0 CA--C 1.511 -0.65 0 C-N-CA 122.76 2.307 . . . . 0.28000000000000003 112.448 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.423 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 19.2 p -66.28 -32.26 73.56 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.461 -1.245 . . . . 0.33000000000000002 110.175 -174.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.528 HG23 ' HG2' ' A' ' 372' ' ' LYS . 1.3 t -141.23 72.4 26.8 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 123.704 1.716 . . . . 0.39000000000000001 109.608 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 375' ' ' THR . 72.5 Cg_exo -59.99 164.09 12.81 Favored 'Trans proline' 0 C--N 1.312 -1.345 1 C-N-CA 126.394 4.729 . . . . 0.38 115.133 -172.214 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.531 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 2.1 m -90.12 128.01 51.28 Favored Pre-proline 0 N--CA 1.399 -2.979 0 CA-C-N 113.869 -1.514 . . . . 0.81999999999999995 108.343 171.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.531 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 38.7 Cg_exo -69.47 -45.58 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.99 3.127 . . . . 0.19 112.014 -170.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.803 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 63.14 143.93 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 123.316 1.532 . . . . 0.13 113.943 -175.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 145.74 -110.41 0.54 Allowed Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 111.905 -2.407 . . . . 0.20000000000000001 108.862 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 464' ' ' LEU . 3.5 p -131.19 127.55 60.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.822 -0.436 . . . . 0.81999999999999995 109.822 174.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.778 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 7.7 m-85 -121.54 -174.49 2.87 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.253 -1.388 . . . . 0.22 107.253 169.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 2.2 t80 -138.93 121.26 15.96 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 120.792 -1.192 . . . . 0.65000000000000002 113.194 -173.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -87.82 92.62 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-O 122.881 1.324 . . . . 0.16 109.368 171.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 44.0 p-90 -92.25 10.35 29.97 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 113.575 -1.648 . . . . 2.5499999999999998 108.314 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.748 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.9 t30 -169.6 127.01 0.91 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.098 -1.41 . . . . 0.42999999999999999 110.392 172.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.608 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.46 143.13 31.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.073 -0.967 . . . . 1.1200000000000001 109.012 169.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.746 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 10.7 mm-40 -125.31 157.74 35.92 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.548 1.314 . . . . 0.70999999999999996 114.548 -168.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.714 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 47.8 mt-10 -137.49 127.24 25.44 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.178 -1.828 . . . . 0.38 108.668 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 19.5 t70 55.01 50.36 15.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 123.366 1.555 . . . . 0.40999999999999998 109.025 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.958 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -84.27 167.37 16.68 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 112.495 -2.139 . . . . 0.12 109.522 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 15.8 m -132.43 118.77 19.76 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.102 0.953 . . . . 0.17000000000000001 111.494 170.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.18 88.37 4.88 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.779 -1.555 . . . . 0.56999999999999995 112.11 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.543 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 48.0 mttt . . . . . 0 C--N 1.281 -2.39 0 CA-C-N 113.703 -1.59 . . . . 0.33000000000000002 112.971 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 120.997 0.427 . . . . 0.53000000000000003 110.455 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.43 97.74 4.68 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 108.422 -0.955 . . . . 0.19 108.422 169.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.2 Cg_exo -69.03 110.21 2.35 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.037 1.824 . . . . 0.19 110.462 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.958 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.9 157.71 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 CA-C-N 113.084 -1.871 . . . . 0.14999999999999999 107.824 -167.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.714 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.5 m-80 -88.31 -22.18 24.0 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.83 -0.804 . . . . 0.51000000000000001 108.83 -175.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.746 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 93.6 m-85 -158.72 127.65 5.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.936 -1.029 . . . . 0.27000000000000002 108.382 -170.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 18.1 t-105 -144.41 133.88 23.3 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.665 0.745 . . . . 0.089999999999999997 110.812 -166.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.608 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 13.5 mmt -115.15 89.81 21.71 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.101 -1.074 . . . . 0.14000000000000001 108.101 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.748 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 35.0 Cg_endo . . . . . 0 CA--C 1.51 -0.701 0 C-N-CA 122.456 2.104 . . . . 0.5 109.408 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 419' ' ' GLY . 24.0 t . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 121.236 0.541 . . . . 0.75 111.872 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.01 121.69 0.82 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.77 -1.332 . . . . 0.20000000000000001 109.77 169.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.707 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.3 mp -81.69 143.08 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.839 -0.344 . . . . 0.28999999999999998 110.163 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.679 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.3 p80 -159.37 161.5 35.7 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.29 -0.414 . . . . 0.089999999999999997 111.461 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.673 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.83 144.8 28.2 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.843 -1.169 . . . . 1.0700000000000001 107.843 172.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 445' ' ' THR . 33.7 t -134.26 98.0 3.99 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.851 0.834 . . . . 0.23000000000000001 110.576 -170.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.8 t70 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 114.121 -1.399 . . . . 0.41999999999999998 110.062 -175.754 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 N--CA 1.437 -1.09 0 CA-C-O 122.737 1.256 . . . . 2.1600000000000001 112.682 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.529 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 1.2 m-85 -154.61 121.9 5.67 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 112.116 -2.311 . . . . 0.33000000000000002 105.901 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 165.81 -157.05 29.36 Favored Glycine 0 C--N 1.283 -2.391 0 C-N-CA 119.862 -1.161 . . . . 0.17000000000000001 110.352 -174.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -38.61 164.78 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.725 0 C-N-CA 120.483 -0.865 . . . . 0.20999999999999999 111.789 166.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.449 ' HB3' ' CD ' ' A' ' 435' ' ' LYS . 4.4 m-20 -51.68 102.72 0.05 OUTLIER 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 113.446 -1.377 . . . . 1.8500000000000001 113.318 -153.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.646 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.3 OUTLIER -94.11 -38.77 10.94 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 113.327 -1.761 . . . . 1.21 108.823 168.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.746 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.4 p-90 -49.79 -32.17 13.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.153 0.502 . . . . 0.16 112.047 -169.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.746 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -86.01 -35.32 20.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.483 0.658 . . . . 0.22 111.965 -177.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 10.2 p -88.75 -43.72 11.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.672 -1.149 . . . . 0.25 111.15 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.646 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 11.4 mtp85 -91.59 -18.53 23.91 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.817 -1.083 . . . . 1.8200000000000001 109.474 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.63 47.56 57.64 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.654 -1.157 . . . . 0.23999999999999999 114.129 163.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 43.3 m -84.76 110.52 18.85 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 118.991 -1.084 . . . . 1.01 111.415 -171.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 37.8 -125.75 0.23 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.373 -1.285 . . . . 0.5 113.738 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -126.99 -21.29 1.73 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.076 -0.583 . . . . 0.26000000000000001 113.462 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.47 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 28.7 p -104.49 -165.57 1.15 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 112.883 0.697 . . . . 0.34999999999999998 112.883 -173.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.476 HD13 HG11 ' A' ' 465' ' ' VAL . 2.3 mp -92.02 129.24 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.482 -0.781 . . . . 0.12 110.884 -175.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.3 89.72 4.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.657 -0.701 . . . . 0.62 109.727 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.892 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.0 m -83.26 143.78 45.7 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 115.087 -0.96 . . . . 0.10000000000000001 112.452 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.653 ' HD2' HG21 ' A' ' 366' ' ' THR . 78.8 Cg_exo -50.08 144.51 22.06 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 123.807 3.005 . . . . 0.23999999999999999 113.351 174.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.673 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.4 Cg_exo -64.6 -25.42 62.16 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 122.827 2.351 . . . . 0.31 112.598 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.516 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 67.3 p -78.7 -24.59 44.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.74 0.781 . . . . 1.1000000000000001 112.085 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.809 ' O ' HD21 ' A' ' 364' ' ' LEU . 33.0 m -99.35 -48.63 11.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 113.137 0.792 . . . . 0.080000000000000002 113.137 -170.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.944 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.72 -1.95 4.42 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.767 -0.773 . . . . 0.070000000000000007 110.434 -178.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.561 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 16.5 pttp -81.22 -38.46 26.95 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 122.651 1.215 . . . . 0.92000000000000004 108.287 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 4.5 mm-40 -62.65 -46.31 88.79 Favored 'General case' 0 CA--C 1.473 -1.981 0 CA-C-N 112.356 -2.202 . . . . 0.25 106.537 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.944 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.92 -66.72 0.36 Allowed 'General case' 0 N--CA 1.401 -2.922 0 CA-C-N 109.711 -3.404 . . . . 0.050000000000000003 112.923 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.462 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 14.9 t80 -45.58 -24.03 0.3 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.83 0.824 . . . . 0.13 109.502 176.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -87.4 -26.54 30.16 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 114.697 -1.138 . . . . 0.13 111.785 -176.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.739 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.14 -44.13 5.29 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 113.728 1.01 . . . . 0.059999999999999998 113.728 177.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.67 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -72.62 148.06 9.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.292 1.044 . . . . 0.080000000000000002 111.106 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.501 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -116.02 155.24 28.44 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.281 -1.781 . . . . 0.47999999999999998 108.952 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.605 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.8 mppt? -57.91 103.43 0.14 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.624 -0.88 . . . . 0.98999999999999999 108.624 169.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 126.36 -7.46 7.54 Favored Glycine 0 C--N 1.308 -0.996 0 CA-C-N 113.827 -1.533 . . . . 0.19 111.452 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.67 HG21 ' HB ' ' A' ' 457' ' ' VAL . 6.8 m -70.17 150.5 96.06 Favored Pre-proline 0 N--CA 1.442 -0.862 0 N-CA-C 108.592 -0.892 . . . . 0.13 108.592 171.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.8 Cg_endo -93.98 160.52 2.18 Favored 'Trans proline' 0 N--CA 1.421 -2.775 0 C-N-CA 122.017 1.811 . . . . 0.17999999999999999 109.749 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.778 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -123.91 151.44 28.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.295 -1.372 . . . . 0.56999999999999995 107.295 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.697 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.7 mp -134.54 151.28 51.0 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 108.113 -1.069 . . . . 0.13 108.113 174.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.091 HG23 HD21 ' A' ' 349' ' ' LEU . 0.8 OUTLIER -140.64 141.26 32.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 105.177 -2.157 . . . . 0.10000000000000001 105.177 166.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.719 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 12.5 p90 . . . . . 0 C--O 1.245 0.861 0 CA-C-N 118.45 0.568 . . . . 1.0900000000000001 111.553 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.455 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 9.3 m-20 . . . . . 0 N--CA 1.44 -0.933 0 N-CA-C 108.931 -0.766 . . . . 0.42999999999999999 108.931 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.809 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 70.0 m -158.34 134.71 9.4 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.538 -1.21 . . . . 0.14000000000000001 108.944 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.651 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.3 p90 173.91 159.27 0.15 Allowed 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 123.421 0.451 . . . . 0.14999999999999999 110.881 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.651 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.93 152.59 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 N-CA-C 109.354 -0.61 . . . . 0.080000000000000002 109.354 164.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.6 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 31.1 tt0 -149.82 144.7 26.15 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.438 -0.801 . . . . 2.0099999999999998 109.249 -177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.734 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -137.3 162.05 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 O-C-N 122.118 -0.364 . . . . 0.45000000000000001 111.252 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.547 ' N ' HG12 ' A' ' 347' ' ' VAL . 24.4 t0 -140.19 107.0 5.38 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 107.416 -1.327 . . . . 0.23999999999999999 107.416 172.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.041 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.7 -34.08 27.41 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 122.903 1.335 . . . . 0.16 110.671 -167.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.439 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.3 mt-10 -58.69 -44.12 90.19 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 110.769 -2.923 . . . . 0.59999999999999998 108.17 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 21.3 m-80 -101.12 7.01 43.45 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 110.925 -2.852 . . . . 0.20000000000000001 110.916 -175.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.3 mp0 33.06 61.62 0.39 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 112.692 -2.049 . . . . 2.1499999999999999 113.417 -175.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.514 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.6 t60 -142.02 135.01 28.82 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.854 -0.612 . . . . 0.089999999999999997 109.983 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.77 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.16 156.75 22.68 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.812 -0.631 . . . . 0.070000000000000007 110.099 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.585 ' CD1' HG11 ' A' ' 362' ' ' VAL . 29.3 m-90 -142.22 154.18 44.59 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.475 -0.784 . . . . 0.11 111.291 -175.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.809 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 88.2 t80 -110.22 153.29 25.0 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.558 -1.645 . . . . 0.26000000000000001 106.558 151.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.3 m-85 -128.32 118.1 22.63 Favored 'General case' 0 C--N 1.269 -2.915 0 CA-C-N 114.796 -1.093 . . . . 0.14000000000000001 110.118 -178.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.6 tppt? -118.62 135.62 54.34 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.118 -1.808 . . . . 0.25 106.118 167.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.54 16.48 6.97 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 113.45 0.908 . . . . 0.42999999999999999 113.45 173.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.36 7.58 88.38 Favored Glycine 0 CA--C 1.485 -1.844 0 CA-C-O 121.933 0.741 . . . . 0.17999999999999999 112.778 -174.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 19.4 ptmt -128.77 177.0 7.38 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 104.542 -2.392 . . . . 0.37 104.542 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.6 m -104.29 157.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 N-CA-C 116.397 1.999 . . . . 0.10000000000000001 116.397 -174.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.703 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.97 -28.4 9.14 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 110.497 -3.047 . . . . 0.070000000000000007 106.277 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.817 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -132.93 145.01 50.53 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 111.614 -2.539 . . . . 0.059999999999999998 111.731 -175.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.442 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.4 tt0 -141.86 117.88 10.6 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 104.516 -2.401 . . . . 0.47999999999999998 104.516 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.77 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.6 164.47 35.04 Favored 'General case' 0 N--CA 1.402 -2.848 0 C-N-CA 117.974 -1.49 . . . . 0.070000000000000007 111.769 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.531 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 17.6 p-10 -104.9 131.4 52.44 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 114.726 -1.124 . . . . 1.8 109.542 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -132.79 -171.87 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 CA-C-O 122.438 1.113 . . . . 0.12 112.327 -171.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -149.99 119.56 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 112.959 -1.928 . . . . 0.10000000000000001 108.296 172.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.638 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.3 OUTLIER -75.62 -168.61 0.88 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.026 -1.443 . . . . 1.26 110.784 177.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.51 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -86.4 176.15 48.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 118.929 -1.605 . . . . 0.14000000000000001 112.681 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.474 ' HG2' HG23 ' A' ' 375' ' ' THR . 16.7 ptmt -78.16 156.72 79.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.661 0.743 . . . . 0.81000000000000005 111.865 -166.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.692 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 85.5 Cg_exo -59.19 -28.6 88.19 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 125.016 3.811 . . . . 0.28000000000000003 113.309 -173.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.476 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 24.4 p -73.22 -32.61 64.86 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.867 -1.515 . . . . 0.33000000000000002 109.941 -175.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.541 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -140.63 70.15 31.25 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-O 123.887 1.803 . . . . 0.39000000000000001 108.92 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 375' ' ' THR . 83.1 Cg_exo -57.58 160.49 14.16 Favored 'Trans proline' 0 CA--C 1.501 -1.172 1 C-N-CA 126.895 5.063 . . . . 0.38 115.854 -169.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.638 HG21 ' OG ' ' A' ' 370' ' ' SER . 1.6 m -86.62 131.81 44.45 Favored Pre-proline 0 N--CA 1.406 -2.641 0 CA-C-N 113.902 -1.499 . . . . 0.81999999999999995 108.709 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.3 Cg_exo -72.73 -45.14 0.55 Allowed 'Trans proline' 0 CA--C 1.514 -0.491 0 C-N-CA 123.861 3.041 . . . . 0.19 112.092 -170.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.786 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.59 140.11 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 123.263 1.506 . . . . 0.13 113.497 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.19 -113.55 0.59 Allowed Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 112.455 -2.157 . . . . 0.20000000000000001 109.623 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.2 119.11 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.924 0.869 . . . . 0.81999999999999995 110.175 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.724 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.7 m-85 -118.1 -174.19 2.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.202 -1.407 . . . . 0.22 107.202 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.3 t80 -139.94 123.35 17.07 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 120.697 -1.252 . . . . 0.65000000000000002 113.275 -171.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.65 92.1 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-O 123.084 1.421 . . . . 0.16 109.308 169.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -94.77 12.46 27.87 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 113.393 -1.73 . . . . 2.5499999999999998 108.318 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.764 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.7 t30 -169.1 126.34 0.96 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 113.833 -1.53 . . . . 0.42999999999999999 110.04 171.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.673 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.79 144.4 29.79 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.115 -0.948 . . . . 1.1200000000000001 109.458 170.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.721 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 24.6 mm-40 -127.5 159.99 32.87 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 114.899 1.444 . . . . 0.70999999999999996 114.899 -168.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.561 ' HG2' ' CE2' ' A' ' 409' ' ' TYR . 51.6 mt-10 -139.04 127.59 23.1 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 113.064 -1.88 . . . . 0.38 108.583 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.7 t70 54.68 46.38 24.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 123.722 1.725 . . . . 0.40999999999999998 108.754 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.92 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.84 167.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 111.918 -2.401 . . . . 0.12 109.709 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 11.8 m -132.61 118.33 19.04 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.013 0.911 . . . . 0.17000000000000001 111.878 170.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.9 mp -77.58 87.62 3.89 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.987 -1.461 . . . . 0.56999999999999995 111.918 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.546 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.3 mttt . . . . . 0 C--N 1.285 -2.207 0 CA-C-N 113.308 -1.769 . . . . 0.33000000000000002 113.397 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.546 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.444 -0.751 0 CA-C-O 121.177 0.513 . . . . 0.53000000000000003 110.836 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -145.26 97.53 4.75 Favored Pre-proline 0 N--CA 1.439 -0.98 0 N-CA-C 108.359 -0.978 . . . . 0.19 108.359 170.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.8 Cg_exo -68.22 110.74 2.3 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.974 1.782 . . . . 0.19 110.034 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.92 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -111.36 152.65 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 CA-C-N 113.368 -1.742 . . . . 0.14999999999999999 108.458 -167.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.616 ' N ' HD22 ' A' ' 408' ' ' ASN . 0.8 OUTLIER -80.58 -23.28 40.0 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.797 -0.446 . . . . 0.51000000000000001 109.797 -174.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 97.2 m-85 -161.35 132.04 5.19 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.635 -1.246 . . . . 0.27000000000000002 107.635 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 20.2 t-105 -146.42 131.84 18.63 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.889 0.852 . . . . 0.089999999999999997 111.443 -166.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.673 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.6 mmt -114.43 93.23 31.1 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.728 -1.212 . . . . 0.14000000000000001 107.728 172.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.764 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 36.0 Cg_endo . . . . . 0 CA--C 1.513 -0.568 0 C-N-CA 122.393 2.062 . . . . 0.5 111.618 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 419' ' ' GLY . 34.0 t . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.213 0.53 . . . . 0.75 112.23 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.587 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.1 119.64 0.71 Allowed Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.498 -1.041 . . . . 0.20000000000000001 110.498 170.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.749 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.3 mp -81.78 143.34 12.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 110.024 -0.361 . . . . 0.28999999999999998 110.024 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.677 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 29.4 p80 -159.82 159.15 32.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.793 0.664 . . . . 0.089999999999999997 112.793 -173.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.776 ' OD1' ' HB2' ' A' ' 450' ' ' MET . 2.3 m-20 -89.61 132.03 35.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.492 -0.559 . . . . 1.0700000000000001 109.492 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 445' ' ' THR . 28.4 t -120.31 97.39 5.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.641 0.734 . . . . 0.23000000000000001 109.453 -164.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 C--N 1.314 -0.97 0 CA-C-N 114.612 -1.176 . . . . 0.41999999999999998 109.993 -172.878 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.597 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.2 pm0 . . . . . 0 N--CA 1.436 -1.127 0 CA-C-O 122.224 1.011 . . . . 2.1600000000000001 113.602 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.837 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.16 130.38 4.1 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 112.605 -2.089 . . . . 0.33000000000000002 105.487 171.093 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.23 -158.08 30.63 Favored Glycine 0 C--N 1.281 -2.494 0 C-N-CA 119.788 -1.196 . . . . 0.17000000000000001 110.817 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.507 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.28 174.65 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.277 -0.963 . . . . 0.20999999999999999 111.544 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.497 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 5.0 p-10 -51.78 101.46 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 123.399 1.571 . . . . 1.8500000000000001 113.772 -153.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.762 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.02 -35.67 11.31 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 112.489 -2.141 . . . . 1.21 109.147 169.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.74 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.1 p-90 -54.81 -28.11 46.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.006 -0.997 . . . . 0.16 112.243 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.74 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.98 -38.09 13.06 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.401 0.62 . . . . 0.22 112.377 -177.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 436' ' ' THR . 2.4 p -86.69 -43.41 12.62 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.04 -0.982 . . . . 0.25 110.446 -175.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.762 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 2.7 mtp85 -91.49 -18.6 23.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.497 -1.228 . . . . 1.8200000000000001 108.954 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.66 50.1 50.49 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 115.232 0.853 . . . . 0.23999999999999999 115.232 160.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . 0.43 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 6.4 m -83.25 111.52 19.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 119.072 1.436 . . . . 1.01 111.436 -173.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 29.52 -106.51 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.507 1.129 . . . . 0.5 113.699 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.51 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -147.53 -5.45 0.33 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.815 -0.63 . . . . 0.26000000000000001 114.415 -174.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 26.5 p -107.22 -167.27 1.25 Allowed 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.323 1.062 . . . . 0.34999999999999998 112.522 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 368' ' ' ILE . 1.9 mp -102.31 131.15 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 115.057 -0.974 . . . . 0.12 110.889 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -100.71 98.51 9.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.839 -1.073 . . . . 0.62 110.129 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.714 HG22 ' CG2' ' A' ' 449' ' ' VAL . 2.0 m -96.59 140.45 22.17 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 113.599 0.962 . . . . 0.10000000000000001 113.599 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.819 ' O ' HG22 ' A' ' 449' ' ' VAL . 77.3 Cg_exo -54.66 128.05 28.66 Favored 'Trans proline' 0 CA--C 1.498 -1.322 1 C-N-CA 125.452 4.101 . . . . 0.23999999999999999 114.933 177.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.837 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 52.8 Cg_exo -58.27 -8.25 4.85 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.972 3.115 . . . . 0.31 114.374 -165.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.554 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 77.9 p -93.21 -19.62 21.25 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.899 -1.046 . . . . 1.1000000000000001 111.089 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 446' ' ' PRO . 17.0 m -101.16 -49.61 10.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 114.664 1.357 . . . . 0.080000000000000002 114.664 -172.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.944 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -69.27 -2.33 10.39 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.933 -1.104 . . . . 0.070000000000000007 109.529 -177.124 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.629 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.4 pttp -77.28 -39.03 49.58 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 122.551 1.167 . . . . 0.92000000000000004 108.121 173.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm-40 -63.14 -46.48 87.02 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 112.416 -2.175 . . . . 0.25 106.709 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.944 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.6 -65.91 0.49 Allowed 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 109.935 -3.302 . . . . 0.050000000000000003 112.719 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.471 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.6 t80 -45.91 -23.33 0.28 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.861 0.725 . . . . 0.13 109.459 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.45 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.04 -24.05 33.24 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.051 -0.977 . . . . 0.13 111.927 -176.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.718 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -105.42 -43.88 4.86 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 113.808 1.04 . . . . 0.059999999999999998 113.808 176.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.666 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -73.84 150.35 7.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.42 1.105 . . . . 0.080000000000000002 111.084 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.31 156.88 32.96 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 113.247 -1.797 . . . . 0.47999999999999998 108.353 -178.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.569 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.6 mppt? -59.01 101.68 0.1 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.388 0.613 . . . . 0.98999999999999999 109.399 172.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.06 -12.72 5.54 Favored Glycine 0 C--N 1.305 -1.173 0 CA-C-N 114.107 -1.406 . . . . 0.19 111.428 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.666 HG21 ' HB ' ' A' ' 457' ' ' VAL . 12.9 m -65.82 149.36 97.57 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 108.718 -0.845 . . . . 0.13 108.718 171.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.7 Cg_endo -93.79 160.4 2.28 Favored 'Trans proline' 0 N--CA 1.423 -2.651 0 C-N-CA 122.041 1.828 . . . . 0.17999999999999999 109.989 177.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.724 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -124.05 150.87 28.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 107.386 -1.338 . . . . 0.56999999999999995 107.386 171.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.28 149.56 50.93 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.008 -1.108 . . . . 0.13 108.008 175.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.041 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.68 140.65 40.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.311 -2.107 . . . . 0.10000000000000001 105.311 165.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.671 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 9.4 p90 . . . . . 0 C--O 1.245 0.827 0 O-C-N 123.848 0.717 . . . . 1.0900000000000001 110.85 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.429 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 8.7 m-20 . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.674 0.75 . . . . 0.42999999999999999 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 357' ' ' TYR . 95.9 m -157.89 135.36 10.36 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.423 -1.262 . . . . 0.14000000000000001 108.763 166.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.634 ' CD2' HD13 ' A' ' 464' ' ' LEU . 38.3 p90 174.6 157.47 0.16 Allowed 'General case' 0 C--O 1.21 -0.986 0 O-C-N 123.362 0.414 . . . . 0.14999999999999999 111.367 -176.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.637 HD12 HD11 ' A' ' 453' ' ' LEU . 0.3 OUTLIER -77.88 152.72 5.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.365 -0.606 . . . . 0.080000000000000002 109.365 164.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.584 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.99 144.13 25.64 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.817 -0.629 . . . . 2.0099999999999998 109.311 -176.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.729 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -137.53 162.3 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.057 0.456 . . . . 0.45000000000000001 111.399 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.569 ' N ' HG12 ' A' ' 347' ' ' VAL . 28.9 t0 -140.44 106.88 5.29 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.38 -1.341 . . . . 0.23999999999999999 107.38 174.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.091 HD21 HG23 ' A' ' 465' ' ' VAL . 0.2 OUTLIER -84.02 -32.19 25.04 Favored 'General case' 0 CA--C 1.485 -1.538 0 CA-C-O 123.036 1.398 . . . . 0.16 110.02 -169.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.468 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 0.6 OUTLIER -59.03 -45.28 91.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 110.672 -2.967 . . . . 0.59999999999999998 108.179 176.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.3 m-80 -102.83 8.22 39.33 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 111.006 -2.816 . . . . 0.20000000000000001 110.956 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.574 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.1 mp0 32.53 61.62 0.35 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 112.722 -2.035 . . . . 2.1499999999999999 113.475 -176.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.519 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.0 t60 -142.47 135.53 28.5 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.625 -0.716 . . . . 0.089999999999999997 109.754 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.756 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.48 157.34 22.11 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.864 -0.607 . . . . 0.070000000000000007 110.332 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.626 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.7 m-90 -142.89 154.09 43.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.433 -175.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.696 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.6 t80 -110.28 153.2 25.18 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 106.725 -1.583 . . . . 0.26000000000000001 106.725 152.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.3 m-85 -128.37 117.99 22.39 Favored 'General case' 0 C--N 1.272 -2.799 0 CA-C-N 115.073 -0.967 . . . . 0.14000000000000001 110.609 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.3 tppt? -118.15 137.87 52.67 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 105.979 -1.859 . . . . 0.25 105.979 167.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.508 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.9 15.66 7.83 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.348 0.87 . . . . 0.42999999999999999 113.348 174.075 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.51 6.46 88.1 Favored Glycine 0 CA--C 1.488 -1.631 0 C-N-CA 120.673 -0.775 . . . . 0.17999999999999999 112.757 -173.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 359' ' ' ASP . 14.2 ptmt -125.5 175.93 7.18 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 104.576 -2.379 . . . . 0.37 104.576 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.626 HG11 ' CD1' ' A' ' 355' ' ' TRP . 15.5 m -103.95 157.48 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.703 0 N-CA-C 116.582 2.067 . . . . 0.10000000000000001 116.582 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.695 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.83 -27.17 9.89 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 110.642 -2.981 . . . . 0.070000000000000007 106.69 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.814 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -133.57 144.57 49.4 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 111.334 -2.666 . . . . 0.059999999999999998 111.329 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.436 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.2 tt0 -142.54 118.19 10.41 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 104.498 -2.408 . . . . 0.47999999999999998 104.498 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.756 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.69 164.62 34.73 Favored 'General case' 0 N--CA 1.401 -2.887 0 C-N-CA 118.132 -1.427 . . . . 0.070000000000000007 111.442 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 20.4 p-10 -103.82 133.31 49.03 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.734 -1.121 . . . . 1.8 109.549 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.743 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -133.2 -172.28 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 CA-C-O 122.495 1.141 . . . . 0.12 112.171 -172.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.33 118.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 112.888 -1.96 . . . . 0.10000000000000001 108.119 172.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.585 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.3 OUTLIER -75.11 -168.92 0.84 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.047 -1.433 . . . . 1.26 110.533 178.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 439' ' ' SER . . . -85.49 175.93 49.54 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 118.809 -1.662 . . . . 0.14000000000000001 112.156 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.9 ptmt -78.78 155.44 78.08 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 121.59 0.709 . . . . 0.81000000000000005 111.466 -167.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.67 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 78.1 Cg_exo -54.96 -27.87 56.39 Favored 'Trans proline' 0 CA--C 1.501 -1.149 1 C-N-CA 125.399 4.066 . . . . 0.28000000000000003 113.399 -174.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.46 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.4 p -71.54 -31.48 67.08 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.662 -1.608 . . . . 0.33000000000000002 109.931 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.534 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 0.7 OUTLIER -140.94 70.3 29.21 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 123.804 1.764 . . . . 0.39000000000000001 108.972 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 375' ' ' THR . 88.1 Cg_exo -57.72 152.09 51.37 Favored 'Trans proline' 0 C--N 1.314 -1.241 1 C-N-CA 126.657 4.904 . . . . 0.38 115.637 -169.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.585 HG21 ' OG ' ' A' ' 370' ' ' SER . 18.3 m -78.74 130.99 68.87 Favored Pre-proline 0 N--CA 1.407 -2.597 0 CA-C-N 113.942 -1.481 . . . . 0.81999999999999995 109.18 173.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.2 Cg_exo -72.1 -46.49 0.53 Allowed 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 123.325 2.683 . . . . 0.19 111.734 -173.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.79 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.2 142.88 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 123.349 1.547 . . . . 0.13 113.424 -174.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 147.49 -109.84 0.49 Allowed Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 112.402 -2.181 . . . . 0.20000000000000001 109.286 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.8 p -130.52 125.91 59.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.369 0.604 . . . . 0.81999999999999995 110.099 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.706 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 7.5 m-85 -123.65 -174.32 2.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.0 -1.482 . . . . 0.22 107.0 171.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 2.0 t80 -140.65 122.63 15.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 119.795 1.18 . . . . 0.65000000000000002 112.76 -172.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -87.19 92.24 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 123.013 1.387 . . . . 0.16 109.223 170.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -89.89 7.82 35.31 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 113.442 -1.708 . . . . 2.5499999999999998 107.855 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.776 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 9.0 t30 -170.2 126.88 0.82 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.368 -1.287 . . . . 0.42999999999999999 110.51 174.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.679 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.2 139.53 34.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.706 -1.134 . . . . 1.1200000000000001 109.016 170.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.792 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 11.4 mm-40 -123.57 158.05 32.3 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.823 1.416 . . . . 0.70999999999999996 114.823 -168.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 48.5 mt-10 -129.27 144.51 51.25 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.788 -2.006 . . . . 0.38 106.291 165.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.03 34.03 16.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.221 -1.808 . . . . 0.40999999999999998 110.238 171.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.884 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -77.38 167.46 21.64 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 112.779 -2.01 . . . . 0.12 109.186 -175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.6 m -131.63 119.18 21.07 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.157 0.98 . . . . 0.17000000000000001 111.376 172.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.0 mp -77.36 87.57 3.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.638 -1.619 . . . . 0.56999999999999995 111.73 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.589 ' HG2' ' HG3' ' A' ' 404' ' ' GLU . 47.5 mttt . . . . . 0 C--N 1.283 -2.288 0 CA-C-N 113.195 -1.821 . . . . 0.33000000000000002 113.072 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.589 ' HG3' ' HG2' ' A' ' 394' ' ' LYS . 2.1 mp0 . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 120.8 0.333 . . . . 0.53000000000000003 110.828 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.58 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.23 97.9 4.73 Favored Pre-proline 0 N--CA 1.442 -0.873 0 N-CA-C 108.663 -0.865 . . . . 0.19 108.663 171.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.6 Cg_exo -68.64 110.93 2.43 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.294 1.996 . . . . 0.19 110.7 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.884 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -111.36 160.02 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-N 113.084 -1.871 . . . . 0.14999999999999999 107.724 -168.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 22.3 m-80 -93.26 -18.96 21.88 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.136 -0.69 . . . . 0.51000000000000001 109.136 -175.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.792 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 86.3 m-85 -158.59 125.77 4.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.072 -0.967 . . . . 0.27000000000000002 108.451 -171.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.693 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 20.2 t-105 -143.84 134.76 25.34 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.76 0.79 . . . . 0.089999999999999997 111.755 -166.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.679 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.9 mmt -117.34 94.02 44.25 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.055 -1.091 . . . . 0.14000000000000001 108.055 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.776 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 42.0 Cg_endo . . . . . 0 C--N 1.347 0.499 0 C-N-CA 123.381 2.721 . . . . 0.5 112.369 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 419' ' ' GLY . 20.6 t . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.201 0.524 . . . . 0.75 112.234 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.588 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.74 119.71 0.71 Allowed Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.852 -0.899 . . . . 0.20000000000000001 110.852 171.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.716 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.6 mt -81.07 142.87 13.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.769 0.319 . . . . 0.28999999999999998 110.486 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.674 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.0 p80 -159.98 161.04 34.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.01 -0.541 . . . . 0.089999999999999997 111.322 -173.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.696 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -83.62 145.73 28.66 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.042 -1.096 . . . . 1.0700000000000001 108.042 173.007 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 445' ' ' THR . 42.5 t -132.62 96.74 3.89 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.866 0.841 . . . . 0.23000000000000001 109.616 -172.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 20.0 t70 . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 114.089 -1.414 . . . . 0.41999999999999998 109.389 -176.326 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.548 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.7 pm0 . . . . . 0 N--CA 1.441 -0.921 0 CA-C-O 122.269 1.033 . . . . 2.1600000000000001 113.441 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.72 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.43 131.5 4.27 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 105.146 -2.168 . . . . 0.33000000000000002 105.146 171.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.62 -158.15 30.66 Favored Glycine 0 C--N 1.282 -2.417 0 C-N-CA 119.974 -1.107 . . . . 0.17000000000000001 110.715 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.545 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.52 175.18 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.961 0 C-N-CA 120.418 -0.896 . . . . 0.20999999999999999 111.803 167.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.529 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.1 p-10 -51.51 101.19 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 123.355 1.55 . . . . 1.8500000000000001 113.336 -155.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.733 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.98 -38.04 10.4 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 112.404 -2.18 . . . . 1.21 109.099 170.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.657 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -53.11 -28.34 25.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.159 -0.928 . . . . 0.16 112.341 -171.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.67 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -89.16 -36.51 15.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.527 0.566 . . . . 0.22 112.527 -177.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.5 p -89.65 -42.99 11.05 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.064 -0.971 . . . . 0.25 110.699 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.733 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.8 mtp180 -92.81 -18.3 23.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.594 -1.185 . . . . 1.8200000000000001 109.752 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.83 48.74 50.25 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.021 -0.99 . . . . 0.23999999999999999 115.257 162.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . 0.466 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 11.9 p -83.58 110.65 18.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 119.195 1.497 . . . . 1.01 111.447 -173.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 37.41 -124.27 0.21 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.503 -1.226 . . . . 0.5 114.086 177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -129.47 -19.78 1.47 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.023 -0.608 . . . . 0.26000000000000001 113.408 -173.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 29.1 p -104.62 -165.86 1.18 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 112.902 0.705 . . . . 0.34999999999999998 112.902 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.455 HD13 HG11 ' A' ' 465' ' ' VAL . 1.9 mp -95.11 130.98 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 115.212 -0.904 . . . . 0.12 110.64 -175.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 444' ' ' ASN . 1.1 m-80 -105.31 94.61 5.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.716 0.77 . . . . 0.62 110.259 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.743 ' HA ' HG22 ' A' ' 368' ' ' ILE . 2.5 m -90.26 143.64 29.86 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-N 114.147 -1.388 . . . . 0.10000000000000001 112.89 -176.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.651 ' HD2' HG21 ' A' ' 366' ' ' THR . 74.8 Cg_exo -50.02 144.45 21.91 Favored 'Trans proline' 0 CA--C 1.505 -0.939 0 C-N-CA 123.943 3.096 . . . . 0.23999999999999999 113.22 175.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.72 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.3 Cg_exo -65.3 -24.58 57.78 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.748 2.299 . . . . 0.31 112.213 -175.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.534 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 70.1 p -78.12 -25.06 47.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.391 -0.822 . . . . 1.1000000000000001 111.874 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.814 ' O ' HD21 ' A' ' 364' ' ' LEU . 31.8 m -99.58 -49.67 11.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 112.985 0.735 . . . . 0.080000000000000002 112.985 -170.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.957 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.93 -2.1 4.83 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.65 -0.82 . . . . 0.070000000000000007 110.446 -178.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.566 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 16.3 pttp -81.1 -38.06 27.89 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 122.54 1.162 . . . . 0.92000000000000004 108.238 173.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.4 mm-40 -62.85 -46.61 87.08 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 112.372 -2.195 . . . . 0.25 106.587 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.957 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.1 tp -47.14 -66.44 0.41 Allowed 'General case' 0 N--CA 1.402 -2.826 0 CA-C-N 109.887 -3.324 . . . . 0.050000000000000003 112.658 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.446 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 23.5 t80 -46.3 -22.51 0.25 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.769 0.795 . . . . 0.13 109.71 175.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.45 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.95 -23.31 33.08 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 114.887 -1.051 . . . . 0.13 111.849 -176.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.74 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -106.38 -44.42 4.53 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 113.938 1.088 . . . . 0.059999999999999998 113.938 176.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -72.8 149.21 8.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 122.182 0.991 . . . . 0.080000000000000002 110.804 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.45 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -120.55 158.16 27.92 Favored 'General case' 0 N--CA 1.413 -2.324 0 CA-C-N 113.427 -1.715 . . . . 0.47999999999999998 109.043 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.6 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.8 mppt? -58.97 102.41 0.12 Allowed 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.911 -0.774 . . . . 0.98999999999999999 108.911 170.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.37 -12.04 5.77 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 114.051 -1.432 . . . . 0.19 111.449 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.632 HG21 ' HB ' ' A' ' 457' ' ' VAL . 18.8 m -68.22 149.9 97.93 Favored Pre-proline 0 N--CA 1.439 -1.005 0 N-CA-C 108.732 -0.84 . . . . 0.13 108.732 171.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.6 Cg_endo -94.34 165.93 1.93 Allowed 'Trans proline' 0 N--CA 1.419 -2.87 0 C-N-CA 122.278 1.985 . . . . 0.17999999999999999 109.623 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -128.81 153.53 38.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.655 -1.239 . . . . 0.56999999999999995 107.655 170.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.699 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.1 151.71 51.51 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 108.6 -0.889 . . . . 0.13 108.6 173.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.091 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.61 141.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 105.329 -2.1 . . . . 0.10000000000000001 105.329 166.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.712 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 7.8 p90 . . . . . 0 C--O 1.244 0.815 0 O-C-N 123.628 0.58 . . . . 1.0900000000000001 111.119 -177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.484 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.4 m-20 . . . . . 0 N--CA 1.445 -0.703 0 CA-C-O 121.454 0.645 . . . . 0.42999999999999999 109.973 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.809 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 86.6 m -158.28 134.49 9.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.387 -1.278 . . . . 0.14000000000000001 108.825 166.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.743 ' CD2' HD13 ' A' ' 464' ' ' LEU . 41.1 p90 174.52 158.24 0.16 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 123.42 0.45 . . . . 0.14999999999999999 110.983 -175.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.636 HD11 HG11 ' A' ' 457' ' ' VAL . 0.5 OUTLIER -77.4 153.26 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 109.122 -0.695 . . . . 0.080000000000000002 109.122 165.051 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.06 147.12 29.22 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.038 -1.097 . . . . 2.0099999999999998 108.038 -177.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.732 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.2 t -138.99 153.78 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 C-N-CA 123.625 0.77 . . . . 0.45000000000000001 110.422 173.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.496 ' N ' HG12 ' A' ' 347' ' ' VAL . 16.4 t0 -136.85 106.53 6.18 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.98 -1.489 . . . . 0.23999999999999999 106.98 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.028 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -79.01 -35.03 43.46 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 124.049 1.881 . . . . 0.16 110.334 -166.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.425 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.4 mt-10 -55.44 -43.49 75.45 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 110.904 -2.862 . . . . 0.59999999999999998 107.697 176.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 17.6 m-80 -101.51 4.54 41.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 110.97 -2.832 . . . . 0.20000000000000001 111.395 -175.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.842 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 83.5 mm-40 31.38 62.44 0.24 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 112.852 -1.976 . . . . 2.1499999999999999 113.465 -172.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.628 ' NE2' ' HG2' ' A' ' 365' ' ' GLU . 29.6 t60 -141.43 136.83 31.74 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.453 -1.249 . . . . 0.089999999999999997 109.927 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.732 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -112.94 158.98 19.56 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.057 -0.519 . . . . 0.070000000000000007 110.214 -179.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.641 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -144.17 160.71 40.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.703 -0.681 . . . . 0.11 111.149 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.809 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.4 t80 -113.39 153.56 28.37 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 106.465 -1.68 . . . . 0.26000000000000001 106.465 150.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.4 m-85 -128.01 116.57 20.25 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.129 -0.941 . . . . 0.14000000000000001 110.248 -178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.1 tppt? -117.78 138.44 52.05 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.046 -1.835 . . . . 0.25 106.046 168.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.49 16.96 8.11 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.39 0.885 . . . . 0.42999999999999999 113.39 172.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.484 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.34 8.04 87.0 Favored Glycine 0 CA--C 1.485 -1.796 0 CA-C-N 115.643 -0.708 . . . . 0.17999999999999999 113.036 -173.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.2 ptmt -128.11 177.93 6.57 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 104.493 -2.41 . . . . 0.37 104.493 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.641 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.1 m -104.59 158.23 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.747 0 N-CA-C 116.303 1.964 . . . . 0.10000000000000001 116.303 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.689 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.91 -28.51 9.57 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 110.764 -2.925 . . . . 0.070000000000000007 106.35 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.798 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.53 145.36 50.05 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 111.551 -2.568 . . . . 0.059999999999999998 111.678 -175.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.628 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -142.23 118.77 10.97 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 104.49 -2.411 . . . . 0.47999999999999998 104.49 174.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.732 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.6 163.68 37.22 Favored 'General case' 0 N--CA 1.401 -2.89 0 C-N-CA 118.332 -1.347 . . . . 0.070000000000000007 110.57 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.588 ' OD2' ' HA2' ' A' ' 430' ' ' GLY . 0.5 OUTLIER -100.75 142.3 32.41 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.739 -0.838 . . . . 1.8 108.739 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.731 HG22 ' HA ' ' A' ' 445' ' ' THR . 1.9 pp -137.03 -172.76 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 CA-C-O 122.045 0.926 . . . . 0.12 112.317 -173.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.842 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -152.87 118.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 113.196 -1.82 . . . . 0.10000000000000001 109.442 171.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 349' ' ' LEU . 54.6 p -78.8 -168.0 1.29 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.062 -2.336 . . . . 1.26 111.285 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.415 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.9 165.56 40.09 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 118.602 -1.761 . . . . 0.14000000000000001 112.17 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -71.64 156.79 90.89 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.41 0.624 . . . . 0.81000000000000005 111.474 -168.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.637 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 87.9 Cg_exo -55.84 -28.67 68.8 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 125.174 3.916 . . . . 0.28000000000000003 113.612 -173.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.454 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 17.8 p -70.81 -32.38 69.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.421 -1.718 . . . . 0.33000000000000002 109.644 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.527 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -140.98 70.63 28.93 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 123.822 1.772 . . . . 0.39000000000000001 109.033 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 375' ' ' THR . 89.0 Cg_exo -58.08 157.15 26.19 Favored 'Trans proline' 0 C--N 1.312 -1.387 1 C-N-CA 126.592 4.861 . . . . 0.38 115.358 -170.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.51 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 1.5 m -82.67 131.87 53.57 Favored Pre-proline 0 N--CA 1.406 -2.648 0 CA-C-N 114.326 -1.306 . . . . 0.81999999999999995 108.482 172.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.6 Cg_exo -72.19 -45.69 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.808 3.005 . . . . 0.19 112.334 -171.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.817 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 60.5 140.92 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 123.283 1.516 . . . . 0.13 113.791 -173.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 150.06 -110.41 0.47 Allowed Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 112.331 -2.213 . . . . 0.20000000000000001 109.419 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.1 p -130.02 123.18 55.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.694 0.759 . . . . 0.81999999999999995 109.961 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.773 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 3.5 m-85 -120.27 -173.55 2.59 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.544 -1.651 . . . . 0.22 106.544 170.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 9.5 t80 -144.17 127.35 16.64 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 120.477 -1.389 . . . . 0.65000000000000002 113.576 -171.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.8 p -90.44 92.93 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 122.949 1.357 . . . . 0.16 109.97 171.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -73.49 -10.93 60.24 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.253 -1.794 . . . . 2.5499999999999998 108.067 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.782 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.4 t30 -169.96 133.04 1.15 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.651 -0.704 . . . . 0.42999999999999999 112.093 -175.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.631 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -92.53 154.76 18.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.054 -0.521 . . . . 1.1200000000000001 110.485 171.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.78 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 35.8 mm-40 -132.59 157.97 43.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 115.013 1.486 . . . . 0.70999999999999996 115.013 -171.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.757 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.8 mt-10 -138.29 126.89 23.47 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.827 -1.988 . . . . 0.38 108.425 173.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.63 49.21 20.86 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 123.371 1.557 . . . . 0.40999999999999998 109.195 -175.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.946 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -79.76 168.31 19.47 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 112.665 -2.061 . . . . 0.12 108.577 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.7 m -133.16 119.53 20.02 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.154 0.978 . . . . 0.17000000000000001 111.808 170.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.567 HD13 ' HB ' ' A' ' 407' ' ' VAL . 3.7 mp -79.47 88.75 5.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.541 -1.663 . . . . 0.56999999999999995 112.023 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.555 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.2 mttt . . . . . 0 C--N 1.286 -2.191 0 CA-C-N 113.618 -1.628 . . . . 0.33000000000000002 113.439 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.555 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.443 -0.807 0 CA-C-O 121.125 0.488 . . . . 0.53000000000000003 109.894 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.33 97.29 5.18 Favored Pre-proline 0 N--CA 1.436 -1.149 0 N-CA-C 107.905 -1.146 . . . . 0.19 107.905 169.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.5 Cg_exo -68.26 109.5 2.01 Favored 'Trans proline' 0 N--CA 1.432 -2.098 0 C-N-CA 121.929 1.753 . . . . 0.19 109.584 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.946 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -107.65 156.99 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 CA-C-N 112.915 -1.948 . . . . 0.14999999999999999 107.421 -168.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.757 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.5 m-80 -88.63 -20.67 24.64 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.014 -0.736 . . . . 0.51000000000000001 109.014 -174.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 75.6 m-85 -158.82 126.75 5.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.013 -0.994 . . . . 0.27000000000000002 108.527 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.675 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 26.8 t-105 -144.21 138.69 28.24 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.463 0.649 . . . . 0.089999999999999997 110.93 -167.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.631 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -122.23 92.27 48.94 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.272 -1.01 . . . . 0.14000000000000001 108.272 175.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.782 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 25.5 Cg_endo . . . . . 0 C--N 1.349 0.582 0 C-N-CA 122.554 2.169 . . . . 0.5 112.853 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 419' ' ' GLY . 25.1 t . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 121.267 0.556 . . . . 0.75 112.011 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.21 122.53 0.82 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.182 -1.167 . . . . 0.20000000000000001 110.182 170.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.65 HG22 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.37 141.92 14.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 109.956 -0.387 . . . . 0.28999999999999998 109.956 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.675 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.3 p80 -159.9 161.19 34.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 0.089999999999999997 111.448 -175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.703 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -82.8 149.53 27.15 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 107.889 -1.152 . . . . 1.0700000000000001 107.889 171.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 445' ' ' THR . 47.1 t -133.82 96.84 3.75 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.708 0.766 . . . . 0.23000000000000001 110.015 -173.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 114.453 -1.249 . . . . 0.41999999999999998 109.734 -176.198 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.573 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.5 pm0 . . . . . 0 N--CA 1.43 -1.44 0 CA-C-O 122.38 1.086 . . . . 2.1600000000000001 112.964 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.585 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.7 OUTLIER -158.33 127.88 5.81 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 112.691 -2.05 . . . . 0.33000000000000002 105.8 169.056 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . 0.588 ' HA2' ' OD2' ' A' ' 367' ' ' ASP . . . 169.06 -158.48 31.07 Favored Glycine 0 C--N 1.286 -2.234 0 C-N-CA 119.871 -1.157 . . . . 0.17000000000000001 111.148 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.511 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.16 165.91 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.781 0 C-N-CA 120.511 -0.852 . . . . 0.20999999999999999 111.665 168.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 435' ' ' LYS . 22.4 m-20 -52.82 101.93 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.684 -1.258 . . . . 1.8500000000000001 113.096 -155.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 1.033 HD22 ' HD2' ' A' ' 437' ' ' ARG . 33.7 mt -94.96 -33.22 12.84 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 112.943 -1.935 . . . . 1.21 109.275 175.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.715 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.0 p-90 -53.87 -27.45 30.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.738 -1.119 . . . . 0.16 112.511 -173.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.715 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.05 -34.54 16.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.92 -0.582 . . . . 0.22 111.977 -178.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.9 p -89.72 -41.43 11.91 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.047 -0.978 . . . . 0.25 110.787 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 1.033 ' HD2' HD22 ' A' ' 433' ' ' LEU . 0.8 OUTLIER -94.2 -18.11 22.04 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.546 -1.206 . . . . 1.8200000000000001 109.957 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.76 48.49 56.62 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.984 -1.007 . . . . 0.23999999999999999 115.045 163.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 10.1 p -83.71 111.38 19.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.35 1.075 . . . . 1.01 111.936 -171.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 35.92 -118.47 0.12 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.693 -1.139 . . . . 0.5 113.298 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.415 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -137.06 -16.59 0.74 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.999 -0.62 . . . . 0.26000000000000001 113.841 -175.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.454 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.3 p -103.78 -167.06 1.32 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.63 0.715 . . . . 0.34999999999999998 112.511 -176.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.452 HD13 HG11 ' A' ' 465' ' ' VAL . 2.1 mp -98.74 129.01 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 114.893 -1.049 . . . . 0.12 110.866 -174.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.4 ' N ' HD22 ' A' ' 444' ' ' ASN . 0.9 OUTLIER -101.61 97.89 8.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.473 -0.785 . . . . 0.62 110.422 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.731 ' HA ' HG22 ' A' ' 368' ' ' ILE . 6.8 m -94.1 144.08 27.48 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 115.071 -0.968 . . . . 0.10000000000000001 112.467 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.637 ' HD2' HG21 ' A' ' 366' ' ' THR . 81.7 Cg_exo -51.07 143.48 31.57 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 124.012 3.142 . . . . 0.23999999999999999 113.178 175.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.703 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.5 Cg_exo -64.62 -29.96 60.62 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.833 2.355 . . . . 0.31 112.361 -176.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 38.6 m -72.95 -23.49 60.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.769 -0.651 . . . . 1.1000000000000001 112.218 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.798 ' O ' HD21 ' A' ' 364' ' ' LEU . 25.2 m -100.82 -47.42 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 113.01 0.744 . . . . 0.080000000000000002 113.01 -169.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.961 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.8 -2.22 6.79 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.69 -0.804 . . . . 0.070000000000000007 110.204 -178.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 448' ' ' SER . 16.2 pttp -80.24 -38.88 30.1 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.475 1.131 . . . . 0.92000000000000004 108.201 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 4.4 mm-40 -61.91 -46.54 88.9 Favored 'General case' 0 CA--C 1.471 -2.066 0 CA-C-N 112.497 -2.138 . . . . 0.25 106.484 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.961 HD23 ' SD ' ' A' ' 450' ' ' MET . 2.9 tp -47.45 -65.89 0.49 Allowed 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 109.973 -3.285 . . . . 0.050000000000000003 112.608 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.471 ' CE2' ' HG3' ' A' ' 389' ' ' GLU . 21.9 t80 -45.33 -22.98 0.16 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.853 0.835 . . . . 0.13 109.728 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.458 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -90.65 -26.84 21.62 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.74 -1.118 . . . . 0.13 111.983 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.747 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -102.33 -44.68 5.33 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 113.64 0.978 . . . . 0.059999999999999998 113.64 177.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -71.23 147.08 11.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 122.391 1.091 . . . . 0.080000000000000002 110.793 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.572 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -113.32 157.5 21.74 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 113.033 -1.894 . . . . 0.47999999999999998 108.869 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.653 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 7.2 mtpt -60.74 101.54 0.15 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.063 -1.088 . . . . 0.98999999999999999 108.063 166.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.86 -7.41 6.46 Favored Glycine 0 C--N 1.308 -1.025 0 CA-C-N 113.957 -1.474 . . . . 0.19 111.631 -174.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.673 HG21 ' HB ' ' A' ' 457' ' ' VAL . 8.0 m -72.96 150.58 90.4 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 108.257 -1.016 . . . . 0.13 108.257 170.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 10.1 Cg_endo -95.32 171.94 1.3 Allowed 'Trans proline' 0 N--CA 1.417 -2.972 0 C-N-CA 122.172 1.915 . . . . 0.17999999999999999 109.91 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.773 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -130.88 153.85 39.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.201 -1.037 . . . . 0.56999999999999995 108.201 171.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.743 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.2 mp -134.08 150.67 51.18 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.637 -0.875 . . . . 0.13 108.637 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.028 HG23 HD21 ' A' ' 349' ' ' LEU . 0.8 OUTLIER -140.19 140.1 35.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 103.981 -2.6 . . . . 0.10000000000000001 103.981 162.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.817 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 4.6 p90 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.399 -1.286 . . . . 1.0900000000000001 111.184 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.467 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 9.1 m-20 . . . . . 0 N--CA 1.444 -0.757 0 N-CA-C 109.457 -0.571 . . . . 0.42999999999999999 109.457 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.776 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 91.5 m -157.67 134.63 10.06 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.63 -1.168 . . . . 0.14000000000000001 108.539 168.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.765 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.9 p90 174.42 158.32 0.16 Allowed 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 123.503 0.502 . . . . 0.14999999999999999 111.152 -175.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 453' ' ' LEU . 0.5 OUTLIER -77.26 153.86 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 109.077 -0.712 . . . . 0.080000000000000002 109.077 164.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.639 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.46 146.9 28.6 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.006 -1.109 . . . . 2.0099999999999998 108.006 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.727 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.0 t -139.24 154.31 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 C-N-CA 123.687 0.795 . . . . 0.45000000000000001 110.449 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.509 ' N ' HG12 ' A' ' 347' ' ' VAL . 17.8 t0 -137.79 105.77 5.68 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.61 -1.626 . . . . 0.23999999999999999 106.61 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.032 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -79.18 -35.97 41.05 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 114.086 -1.416 . . . . 0.16 109.891 -165.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.438 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -55.77 -44.76 77.99 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 110.669 -2.968 . . . . 0.59999999999999998 108.124 177.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 21.7 m-80 -100.56 6.76 44.27 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 110.931 -2.85 . . . . 0.20000000000000001 110.795 -175.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.5 OUTLIER 32.83 60.8 0.4 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 112.786 -2.006 . . . . 2.1499999999999999 112.868 -174.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.503 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.3 t60 -141.77 136.44 30.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.748 -0.66 . . . . 0.089999999999999997 109.66 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.77 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.1 OUTLIER -113.81 157.64 22.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.898 -0.592 . . . . 0.070000000000000007 110.001 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.649 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.7 m-90 -143.35 161.25 38.85 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.179 0.592 . . . . 0.11 111.044 -177.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.776 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.1 t80 -113.41 153.56 28.41 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.423 -1.695 . . . . 0.26000000000000001 106.423 150.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.0 m-85 -127.81 117.68 22.3 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.001 -1.0 . . . . 0.14000000000000001 109.954 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.5 tppt? -118.44 137.8 52.91 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.08 -1.822 . . . . 0.25 106.08 168.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.453 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 70.21 16.36 7.36 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.276 0.843 . . . . 0.42999999999999999 113.276 172.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.35 7.47 87.85 Favored Glycine 0 CA--C 1.485 -1.816 0 CA-C-N 115.72 -0.673 . . . . 0.17999999999999999 112.956 -173.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 16.6 ptmt -127.5 177.76 6.54 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 104.66 -2.348 . . . . 0.37 104.66 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.649 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.2 m -104.58 158.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.616 0 N-CA-C 116.427 2.01 . . . . 0.10000000000000001 116.427 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.711 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.7 -26.25 9.97 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 110.607 -2.997 . . . . 0.070000000000000007 106.671 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.816 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -135.19 145.12 47.41 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 111.404 -2.635 . . . . 0.059999999999999998 111.653 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.458 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.6 tt0 -141.25 119.05 11.76 Favored 'General case' 0 N--CA 1.405 -2.684 0 N-CA-C 104.269 -2.493 . . . . 0.47999999999999998 104.269 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.77 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.1 165.17 33.61 Favored 'General case' 0 N--CA 1.4 -2.973 0 C-N-CA 117.958 -1.497 . . . . 0.070000000000000007 111.501 178.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.443 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 29.5 p-10 -103.89 136.68 43.1 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.821 -1.082 . . . . 1.8 109.822 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.729 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -136.58 -173.02 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.247 0 CA-C-O 122.506 1.146 . . . . 0.12 112.483 -171.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.61 119.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 112.811 -1.995 . . . . 0.10000000000000001 108.102 173.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.496 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -80.47 -168.09 1.59 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.254 -1.339 . . . . 1.26 110.479 -178.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.401 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.74 169.94 45.34 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 118.811 -1.661 . . . . 0.14000000000000001 112.414 -174.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 2.2 ptpt -74.48 156.24 87.15 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.314 0.578 . . . . 0.81000000000000005 112.33 -164.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 85.8 Cg_exo -54.83 -30.89 70.2 Favored 'Trans proline' 0 CA--C 1.497 -1.345 1 C-N-CA 125.537 4.158 . . . . 0.28000000000000003 114.037 -173.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.418 ' OG1' HG22 ' A' ' 375' ' ' THR . 21.5 p -67.2 -31.47 71.89 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.703 -1.59 . . . . 0.33000000000000002 109.565 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.52 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -141.87 70.9 24.39 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 113.683 -1.599 . . . . 0.39000000000000001 109.731 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.4 Cg_exo -58.15 142.99 97.45 Favored 'Trans proline' 0 C--N 1.306 -1.679 1 C-N-CA 125.884 4.389 . . . . 0.38 113.307 -172.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.496 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -73.11 144.24 84.61 Favored Pre-proline 0 N--CA 1.422 -1.83 0 N-CA-C 108.154 -1.054 . . . . 0.81999999999999995 108.154 175.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.1 Cg_exo -74.97 -44.1 0.36 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 124.381 3.387 . . . . 0.19 111.728 -165.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.858 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 57.93 136.69 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 123.528 1.632 . . . . 0.13 113.86 -173.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 155.3 -114.61 0.62 Allowed Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 112.013 -2.358 . . . . 0.20000000000000001 109.377 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.91 114.72 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 121.822 0.82 . . . . 0.81999999999999995 111.192 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.756 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.4 m-85 -112.42 -174.18 2.4 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.193 -1.41 . . . . 0.22 107.193 174.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.3 t80 -140.58 124.47 17.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.19 1.359 . . . . 0.65000000000000002 113.598 -172.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.95 92.04 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 123.066 1.412 . . . . 0.16 109.611 168.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -92.87 10.78 29.65 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.419 -1.719 . . . . 2.5499999999999998 107.982 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.753 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.4 t30 -169.79 126.3 0.86 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 113.873 -1.512 . . . . 0.42999999999999999 110.095 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.668 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.5 144.06 29.94 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.998 -1.001 . . . . 1.1200000000000001 109.171 170.495 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.763 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 29.8 mm-40 -124.73 158.3 33.59 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 114.896 1.443 . . . . 0.70999999999999996 114.896 -167.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.736 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 56.2 mt-10 -137.05 126.88 25.63 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 112.958 -1.928 . . . . 0.38 108.57 174.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 37.1 t70 54.23 47.35 23.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 123.076 1.417 . . . . 0.40999999999999998 109.228 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.923 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.43 166.23 21.45 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 112.922 -1.945 . . . . 0.12 108.891 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 18.7 m -132.3 119.33 20.61 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.136 0.97 . . . . 0.17000000000000001 111.465 171.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.8 89.02 5.22 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.731 -1.577 . . . . 0.56999999999999995 111.853 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.596 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.9 mttt . . . . . 0 C--N 1.286 -2.186 0 CA-C-N 113.8 -1.546 . . . . 0.33000000000000002 113.353 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.596 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.44 -0.946 0 CA-C-O 121.062 0.458 . . . . 0.53000000000000003 109.769 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.9 OUTLIER -143.42 96.76 5.69 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 107.916 -1.142 . . . . 0.19 107.916 170.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 17.3 Cg_exo -69.52 110.51 2.52 Favored 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.791 1.66 . . . . 0.19 109.728 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.923 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.18 151.52 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 112.941 -1.936 . . . . 0.14999999999999999 107.11 -168.447 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.736 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 22.6 m-80 -85.42 -20.11 30.32 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.962 -0.755 . . . . 0.51000000000000001 108.962 -174.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.763 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 81.2 m-85 -158.27 126.11 5.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.995 -1.002 . . . . 0.27000000000000002 108.705 -170.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.679 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 24.5 t-105 -144.48 133.11 22.21 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.758 0.79 . . . . 0.089999999999999997 111.104 -167.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.668 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.9 mmt -114.92 93.66 35.19 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 107.816 -1.179 . . . . 0.14000000000000001 107.816 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.753 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.6 Cg_endo . . . . . 0 C--N 1.348 0.516 0 C-N-CA 122.455 2.103 . . . . 0.5 112.252 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 419' ' ' GLY . 39.4 t . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 121.401 0.619 . . . . 0.75 112.021 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.593 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.95 121.64 0.8 Allowed Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.867 -1.293 . . . . 0.20000000000000001 109.867 169.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.699 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.2 mp -82.02 143.22 12.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 110.106 -0.331 . . . . 0.28999999999999998 110.106 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.679 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.0 p80 -160.28 161.86 33.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.178 -0.464 . . . . 0.089999999999999997 111.514 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.684 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -83.19 145.62 29.07 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.607 -1.257 . . . . 1.0700000000000001 107.607 171.402 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 445' ' ' THR . 29.4 t -133.81 98.33 4.14 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.95 0.881 . . . . 0.23000000000000001 110.205 -171.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.312 -1.022 0 CA-C-N 114.002 -1.454 . . . . 0.41999999999999998 109.609 -177.074 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.556 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.428 -1.543 0 CA-C-O 122.125 0.964 . . . . 2.1600000000000001 112.049 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.677 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.6 OUTLIER -160.7 129.64 4.77 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 104.949 -2.241 . . . . 0.33000000000000002 104.949 172.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.82 -157.27 29.47 Favored Glycine 0 C--N 1.284 -2.339 0 C-N-CA 119.678 -1.249 . . . . 0.17000000000000001 110.797 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.417 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -44.97 174.01 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.184 -1.008 . . . . 0.20999999999999999 111.482 167.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.532 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.4 p-10 -52.59 101.95 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 123.28 1.515 . . . . 1.8500000000000001 113.89 -153.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.711 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.93 -36.99 10.88 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 112.651 -2.068 . . . . 1.21 109.582 169.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.757 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.5 p-90 -54.44 -26.88 33.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.338 -0.846 . . . . 0.16 112.4 -170.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.757 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.72 -35.21 15.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 112.523 0.564 . . . . 0.22 112.523 -177.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.441 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.2 p -91.82 -43.71 9.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.031 -0.986 . . . . 0.25 110.904 -176.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.711 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.8 OUTLIER -90.09 -19.24 24.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.73 -1.123 . . . . 1.8200000000000001 109.152 -179.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.8 47.54 46.74 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.475 -0.784 . . . . 0.23999999999999999 114.952 161.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.9 p -84.65 110.97 19.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 118.622 1.211 . . . . 1.01 111.597 -172.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 37.09 -130.86 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.69 -1.141 . . . . 0.5 113.031 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.401 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -121.74 -20.06 3.24 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.088 -0.577 . . . . 0.26000000000000001 114.084 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.458 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.4 p -99.09 -166.83 1.4 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.803 0.801 . . . . 0.34999999999999998 112.867 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.437 HG12 HG11 ' A' ' 347' ' ' VAL . 2.2 mp -96.73 130.01 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 115.105 -0.952 . . . . 0.12 110.887 -173.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.01 94.56 6.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.945 -0.57 . . . . 0.62 110.418 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.729 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.6 m -91.26 142.39 27.1 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-N 115.147 -0.933 . . . . 0.10000000000000001 112.481 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.67 ' HD2' HG21 ' A' ' 366' ' ' THR . 89.3 Cg_exo -49.72 143.59 22.17 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 123.925 3.083 . . . . 0.23999999999999999 113.268 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.684 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.2 Cg_exo -65.0 -27.94 57.81 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.836 2.357 . . . . 0.31 112.053 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.503 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 31.6 m -75.56 -22.61 56.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.505 0.669 . . . . 1.1000000000000001 112.371 -176.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.816 ' O ' HD21 ' A' ' 364' ' ' LEU . 26.3 m -100.99 -48.03 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 112.898 0.703 . . . . 0.080000000000000002 112.898 -170.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.957 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.18 -2.03 5.22 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.72 -0.792 . . . . 0.070000000000000007 110.246 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.505 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 14.7 pttp -81.2 -38.78 26.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 122.58 1.181 . . . . 0.92000000000000004 108.143 173.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm-40 -62.18 -46.35 89.32 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 112.368 -2.196 . . . . 0.25 106.559 -177.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.957 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.8 tp -46.69 -67.11 0.31 Allowed 'General case' 0 N--CA 1.403 -2.781 0 CA-C-N 109.785 -3.37 . . . . 0.050000000000000003 112.735 172.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.492 ' CE2' ' HE2' ' A' ' 387' ' ' LYS . 14.6 t80 -45.34 -24.11 0.26 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 124.034 0.834 . . . . 0.13 109.469 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.452 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.12 -27.15 26.62 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 114.684 -1.144 . . . . 0.13 111.732 -176.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.749 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.03 -44.07 5.83 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 113.459 0.911 . . . . 0.059999999999999998 113.459 176.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.664 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -72.89 149.91 8.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 122.554 1.168 . . . . 0.080000000000000002 111.182 -179.485 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.424 ' H ' ' HG3' ' A' ' 458' ' ' GLU . 0.0 OUTLIER -119.87 156.25 31.08 Favored 'General case' 0 N--CA 1.413 -2.283 0 CA-C-N 112.86 -1.973 . . . . 0.47999999999999998 108.366 -178.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.598 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.3 mppt? -58.8 102.07 0.11 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.555 -0.905 . . . . 0.98999999999999999 108.555 170.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.62 -11.17 5.75 Favored Glycine 0 C--N 1.305 -1.15 0 CA-C-N 114.069 -1.423 . . . . 0.19 111.535 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.664 HG21 ' HB ' ' A' ' 457' ' ' VAL . 10.8 m -68.82 150.47 97.62 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 108.793 -0.817 . . . . 0.13 108.793 171.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.0 Cg_endo -93.61 165.02 2.29 Favored 'Trans proline' 0 N--CA 1.423 -2.652 0 C-N-CA 122.17 1.913 . . . . 0.17999999999999999 110.074 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.756 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -126.35 152.12 33.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.497 -1.297 . . . . 0.56999999999999995 107.497 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.765 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.1 mp -133.79 149.95 51.43 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 108.26 -1.015 . . . . 0.13 108.26 175.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.032 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.08 138.96 37.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 103.932 -2.618 . . . . 0.10000000000000001 103.932 163.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.858 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 4.3 p90 . . . . . 0 C--O 1.25 1.116 0 CA-C-N 118.503 0.592 . . . . 1.0900000000000001 111.879 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.475 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.2 m-20 . . . . . 0 CA--C 1.511 -0.527 0 CA-C-O 121.64 0.733 . . . . 0.42999999999999999 110.26 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 357' ' ' TYR . 98.5 m -157.16 134.58 10.56 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.854 -1.066 . . . . 0.14000000000000001 110.539 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.674 ' HA ' HG23 ' A' ' 461' ' ' THR . 37.9 p90 173.65 159.18 0.14 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.831 -0.622 . . . . 0.14999999999999999 110.923 -178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.669 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.44 151.23 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.263 0 N-CA-C 109.282 -0.636 . . . . 0.080000000000000002 109.282 166.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.605 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 34.6 tt0 -149.81 141.09 23.17 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.462 -0.79 . . . . 2.0099999999999998 109.743 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.738 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -133.0 161.89 40.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.054 0.454 . . . . 0.45000000000000001 111.312 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 347' ' ' VAL . 30.3 t0 -140.15 106.86 5.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.521 -1.289 . . . . 0.23999999999999999 107.521 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.084 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.37 -34.41 28.41 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 123.289 1.518 . . . . 0.16 110.156 -169.389 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.46 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.1 mt-10 -54.93 -43.95 73.82 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.892 -2.867 . . . . 0.59999999999999998 108.015 176.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 18.4 m-80 -103.04 4.74 37.57 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 111.015 -2.811 . . . . 0.20000000000000001 111.48 -175.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.857 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 16.4 mm-40 34.75 61.59 0.57 Allowed 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 112.917 -1.947 . . . . 2.1499999999999999 113.424 -174.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 22.6 t60 -141.71 134.75 29.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.105 -0.952 . . . . 0.089999999999999997 109.638 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.721 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.84 155.8 24.02 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.631 -0.713 . . . . 0.070000000000000007 109.957 -179.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.646 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.4 m-90 -140.88 154.36 46.12 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.533 -0.758 . . . . 0.11 111.257 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.708 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 87.3 t80 -109.36 153.55 23.78 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.428 -1.694 . . . . 0.26000000000000001 106.428 151.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 11.0 m-85 -126.63 118.76 25.45 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 115.224 -0.898 . . . . 0.14000000000000001 110.163 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.8 tppt? -121.88 136.06 54.91 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.366 -1.716 . . . . 0.25 106.366 168.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.3 OUTLIER 70.73 15.55 6.93 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.141 0.793 . . . . 0.42999999999999999 113.141 175.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.91 5.07 89.66 Favored Glycine 0 CA--C 1.485 -1.801 0 CA-C-O 122.033 0.796 . . . . 0.17999999999999999 112.844 -174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.1 ptmt -125.79 177.37 6.32 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 104.067 -2.568 . . . . 0.37 104.067 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.646 HG11 ' CD1' ' A' ' 355' ' ' TRP . 14.7 m -104.98 157.51 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.822 0 N-CA-C 116.268 1.951 . . . . 0.10000000000000001 116.268 -176.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.708 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.09 -27.42 10.62 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 110.493 -3.049 . . . . 0.070000000000000007 106.33 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.59 142.75 48.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 111.352 -2.658 . . . . 0.059999999999999998 111.488 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.45 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.5 tt0 -139.99 117.63 11.56 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 104.218 -2.512 . . . . 0.47999999999999998 104.218 176.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.721 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.58 162.54 39.98 Favored 'General case' 0 N--CA 1.397 -3.112 0 C-N-CA 117.715 -1.594 . . . . 0.070000000000000007 111.598 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 14.9 p-10 -101.54 135.51 42.93 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 113.972 -1.467 . . . . 1.8 109.41 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.745 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -137.28 -174.18 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 CA-C-O 122.318 1.056 . . . . 0.12 112.508 -169.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.857 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -151.81 121.28 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 112.725 -2.034 . . . . 0.10000000000000001 109.298 172.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.559 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -81.69 -168.67 1.98 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.768 -1.56 . . . . 1.26 110.318 -178.308 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.64 167.4 42.54 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.655 -1.736 . . . . 0.14000000000000001 112.328 -174.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -72.53 156.94 89.77 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 121.511 0.672 . . . . 0.81000000000000005 111.937 -166.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.664 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 92.1 Cg_exo -56.08 -28.9 72.07 Favored 'Trans proline' 0 CA--C 1.496 -1.392 1 C-N-CA 125.371 4.048 . . . . 0.28000000000000003 113.603 -173.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.441 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.0 p -70.38 -34.25 72.36 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.329 -1.76 . . . . 0.33000000000000002 109.413 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.544 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.5 t -142.04 69.99 23.41 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 123.645 1.688 . . . . 0.39000000000000001 109.407 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 375' ' ' THR . 79.8 Cg_exo -58.76 155.28 38.5 Favored 'Trans proline' 0 C--N 1.314 -1.279 1 C-N-CA 126.46 4.773 . . . . 0.38 114.608 -171.141 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.559 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.3 OUTLIER -84.42 141.96 39.93 Favored Pre-proline 0 N--CA 1.423 -1.811 0 N-CA-C 108.699 -0.852 . . . . 0.81999999999999995 108.699 173.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.3 Cg_exo -75.92 -43.34 0.33 Allowed 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 124.785 3.657 . . . . 0.19 112.219 -167.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.773 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.85 136.31 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.302 1.525 . . . . 0.13 113.634 -172.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.6 -119.34 0.96 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 112.129 -2.305 . . . . 0.20000000000000001 109.584 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 381' ' ' VAL . 9.8 p -121.97 115.53 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.275 1.036 . . . . 0.81999999999999995 110.749 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.751 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 1.8 m-85 -114.03 -172.68 2.14 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.192 -1.781 . . . . 0.22 106.192 171.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.666 ' HD2' ' CD1' ' A' ' 385' ' ' TRP . 34.1 t80 -146.11 126.85 14.33 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 118.013 -1.475 . . . . 0.65000000000000002 114.54 -171.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.5 p -85.92 92.21 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 123.064 1.412 . . . . 0.16 109.784 170.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . 0.666 ' CD1' ' HD2' ' A' ' 383' ' ' TYR . 75.2 m95 -70.55 -15.06 62.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.173 -1.831 . . . . 2.5499999999999998 107.976 176.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.78 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.8 t30 -170.05 132.65 1.1 Allowed 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.198 -0.91 . . . . 0.42999999999999999 111.209 -174.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.676 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -93.71 144.84 25.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.636 -0.711 . . . . 1.1200000000000001 109.268 171.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.775 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 12.8 mm-40 -125.16 157.36 36.61 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 114.381 1.252 . . . . 0.70999999999999996 114.381 -169.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 51.3 mt-10 -136.3 127.12 27.43 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.143 -1.844 . . . . 0.38 108.403 173.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.4 t70 56.48 45.04 23.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 123.3 1.524 . . . . 0.40999999999999998 109.259 -178.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.933 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -79.59 167.24 20.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 112.852 -1.976 . . . . 0.12 109.016 176.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 7.1 m -131.87 119.35 21.07 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.164 0.983 . . . . 0.17000000000000001 112.06 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.9 mp -82.69 88.55 6.71 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.761 -1.563 . . . . 0.56999999999999995 112.275 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.53 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 48.7 mttt . . . . . 0 C--N 1.286 -2.159 0 CA-C-N 113.657 -1.611 . . . . 0.33000000000000002 113.551 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.53 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.441 -0.878 0 CA-C-O 121.122 0.487 . . . . 0.53000000000000003 109.743 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -143.83 97.08 5.44 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 108.444 -0.947 . . . . 0.19 108.444 171.225 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.8 Cg_exo -68.87 110.07 2.28 Favored 'Trans proline' 0 N--CA 1.43 -2.214 0 C-N-CA 122.022 1.815 . . . . 0.19 109.456 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.933 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.56 154.1 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 CA-C-N 112.78 -2.009 . . . . 0.14999999999999999 107.288 -167.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.6 m-80 -86.92 -19.85 28.23 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.969 -0.752 . . . . 0.51000000000000001 108.969 -174.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.775 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 88.7 m-85 -158.65 125.62 4.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.038 -0.983 . . . . 0.27000000000000002 108.89 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.679 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 27.1 t-105 -144.52 137.08 26.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.678 0.751 . . . . 0.089999999999999997 110.907 -167.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.676 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.6 mmt -120.44 93.8 48.46 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 107.823 -1.177 . . . . 0.14000000000000001 107.823 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.78 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 33.6 Cg_endo . . . . . 0 C--N 1.348 0.528 0 C-N-CA 122.568 2.179 . . . . 0.5 112.153 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 419' ' ' GLY . 39.9 t . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 121.345 0.593 . . . . 0.75 111.509 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.606 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -177.06 122.87 0.86 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 109.694 -1.362 . . . . 0.20000000000000001 109.694 170.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.717 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.0 mp -81.65 141.69 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 120.589 -0.444 . . . . 0.28999999999999998 109.888 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.679 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.8 p80 -159.98 162.47 34.36 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.971 -0.559 . . . . 0.089999999999999997 111.338 -174.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.665 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.94 143.47 28.96 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.538 -1.282 . . . . 1.0700000000000001 107.538 171.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 445' ' ' THR . 42.3 t -134.64 98.71 4.13 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.702 0.763 . . . . 0.23000000000000001 110.415 -170.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.441 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 20.0 t70 . . . . . 0 C--N 1.313 -1.013 0 CA-C-N 114.258 -1.337 . . . . 0.41999999999999998 109.803 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 . . . . . 0 CA--C 1.497 -1.083 0 CA-C-O 121.771 0.796 . . . . 2.1600000000000001 111.388 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.525 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -152.89 125.35 8.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.32 -1.733 . . . . 0.33000000000000002 106.32 175.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.77 -158.67 31.62 Favored Glycine 0 C--N 1.28 -2.553 0 N-CA-C 109.501 -1.44 . . . . 0.17000000000000001 109.501 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -44.81 174.63 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.061 -1.066 . . . . 0.20999999999999999 111.683 168.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.523 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.9 p-10 -50.87 102.82 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 123.274 1.511 . . . . 1.8500000000000001 114.108 -153.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.646 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.2 OUTLIER -95.47 -38.75 10.32 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 112.687 -2.051 . . . . 1.21 109.371 167.219 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.72 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.9 p-90 -50.99 -28.85 10.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.413 -0.812 . . . . 0.16 112.872 -170.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.72 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.24 -34.07 16.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.621 0.724 . . . . 0.22 111.762 -177.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.0 p -88.45 -43.47 11.43 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.539 -1.209 . . . . 0.25 110.905 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.646 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 6.4 mtp85 -93.84 -19.63 20.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.781 -1.099 . . . . 1.8200000000000001 109.582 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.19 47.07 50.73 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.141 -0.936 . . . . 0.23999999999999999 114.63 166.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 36.8 m -84.68 110.84 19.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.761 1.281 . . . . 1.01 111.5 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 39.42 -132.24 0.22 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.551 -1.204 . . . . 0.5 113.579 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -121.78 -20.98 3.03 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.924 -0.655 . . . . 0.26000000000000001 113.665 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.46 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 30.4 p -101.84 -166.08 1.26 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.175 0.806 . . . . 0.34999999999999998 113.175 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.485 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -93.18 130.64 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.994 -1.003 . . . . 0.12 110.412 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.11 89.91 3.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.539 0.685 . . . . 0.62 109.835 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.745 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.0 m -84.01 141.78 40.96 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.731 -1.122 . . . . 0.10000000000000001 112.423 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.642 ' HD2' HG21 ' A' ' 366' ' ' THR . 82.1 Cg_exo -48.85 144.49 15.01 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 123.935 3.09 . . . . 0.23999999999999999 113.117 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.665 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.8 Cg_exo -65.31 -22.3 60.41 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.68 2.253 . . . . 0.31 112.123 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.529 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 79.7 p -82.25 -24.2 34.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.62 0.724 . . . . 1.1000000000000001 112.026 -174.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.81 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.8 m -99.46 -48.44 11.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.011 0.745 . . . . 0.080000000000000002 113.011 -169.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.96 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.32 -1.97 3.95 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.669 -0.812 . . . . 0.070000000000000007 110.385 -178.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.577 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 42.2 pttt -81.33 -38.74 26.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 122.456 1.122 . . . . 0.92000000000000004 108.11 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 3.8 mm-40 -61.7 -46.4 89.86 Favored 'General case' 0 CA--C 1.471 -2.096 0 CA-C-N 112.48 -2.146 . . . . 0.25 106.423 -177.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.96 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.19 -66.55 0.39 Allowed 'General case' 0 N--CA 1.403 -2.775 0 CA-C-N 109.72 -3.4 . . . . 0.050000000000000003 112.745 172.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.0 t80 -45.89 -23.35 0.27 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.728 0.775 . . . . 0.13 109.458 176.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.453 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.47 -26.94 23.97 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 114.888 -1.051 . . . . 0.13 111.893 -176.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.774 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.78 -44.21 5.6 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 113.359 0.874 . . . . 0.059999999999999998 113.359 177.163 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.669 HG11 HD11 ' A' ' 345' ' ' ILE . 0.4 OUTLIER -73.81 149.22 8.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.582 1.182 . . . . 0.080000000000000002 110.995 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.6 157.69 34.86 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 112.905 -1.952 . . . . 0.47999999999999998 108.177 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.552 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 37.5 mtpt -55.38 101.47 0.05 Allowed 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 109.034 -0.728 . . . . 0.98999999999999999 109.034 169.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . 0.422 ' HA2' ' OH ' ' A' ' 383' ' ' TYR . . . 133.08 -14.27 4.9 Favored Glycine 0 C--N 1.302 -1.335 0 CA-C-N 114.222 -1.354 . . . . 0.19 112.124 -175.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.674 HG23 ' HA ' ' A' ' 344' ' ' TYR . 35.6 m -70.36 148.2 95.44 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 108.498 -0.927 . . . . 0.13 108.498 168.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 11.8 Cg_endo -97.14 177.21 0.54 Allowed 'Trans proline' 0 N--CA 1.419 -2.873 0 C-N-CA 122.832 2.355 . . . . 0.17999999999999999 110.299 175.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.751 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -134.42 154.25 36.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 119.916 -0.714 . . . . 0.56999999999999995 109.278 172.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.737 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.4 mp -135.09 152.31 51.54 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 116.028 -0.533 . . . . 0.13 109.915 173.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.084 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.25 142.02 32.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 105.454 -2.054 . . . . 0.10000000000000001 105.454 163.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.762 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 9.0 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.444 -1.265 . . . . 1.0900000000000001 111.341 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . 0.481 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 11.5 m-20 . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 121.252 0.548 . . . . 0.42999999999999999 110.285 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 357' ' ' TYR . 75.8 m -158.03 135.97 10.69 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.856 -1.066 . . . . 0.14000000000000001 108.995 167.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.8 ' CD2' HD13 ' A' ' 464' ' ' LEU . 43.8 p90 174.11 159.0 0.15 Allowed 'General case' 0 C--O 1.212 -0.912 0 O-C-N 123.35 0.406 . . . . 0.14999999999999999 111.173 -175.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.677 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -78.25 154.98 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 N-CA-C 109.711 -0.478 . . . . 0.080000000000000002 109.711 165.101 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.599 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -146.92 148.64 32.0 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.873 -1.058 . . . . 2.0099999999999998 108.206 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.723 HG22 ' HG3' ' A' ' 354' ' ' MET . 5.6 t -145.02 110.33 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 N-CA-C 113.872 1.064 . . . . 0.45000000000000001 113.872 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.503 ' HB2' ' CZ3' ' A' ' 355' ' ' TRP . 27.7 t0 -92.56 106.71 18.64 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-O 121.946 0.879 . . . . 0.23999999999999999 109.058 176.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.027 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -77.44 -37.3 51.89 Favored 'General case' 0 CA--C 1.479 -1.772 0 CA-C-N 114.01 -1.45 . . . . 0.16 110.251 -169.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.542 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 3.5 mt-10 -55.04 -44.43 74.67 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 110.766 -2.925 . . . . 0.59999999999999998 108.062 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . 0.472 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 21.2 m-80 -102.32 7.21 40.66 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 110.694 -2.957 . . . . 0.20000000000000001 111.051 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.633 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.9 OUTLIER 34.09 61.76 0.49 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 112.852 -1.976 . . . . 2.1499999999999999 112.833 -175.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.57 ' NE2' ' HG2' ' A' ' 365' ' ' GLU . 23.5 t60 -143.22 132.18 22.88 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.568 -0.742 . . . . 0.089999999999999997 109.892 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.801 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.0 OUTLIER -109.38 152.6 25.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.693 -0.685 . . . . 0.070000000000000007 109.793 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.705 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.1 m-90 -139.05 157.72 45.48 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.442 -0.799 . . . . 0.11 110.725 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.709 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.5 t80 -109.66 153.81 23.72 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.488 -1.671 . . . . 0.26000000000000001 106.488 151.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.4 m-85 -127.38 118.42 24.08 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 115.073 -0.967 . . . . 0.14000000000000001 109.969 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 358' ' ' LYS . 9.8 tppt? -121.81 125.23 46.03 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.863 -1.162 . . . . 0.25 107.863 171.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.83 35.87 2.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 119.092 0.86 . . . . 0.42999999999999999 112.243 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . 0.481 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 62.89 13.29 46.73 Favored Glycine 0 CA--C 1.495 -1.191 0 C-N-CA 120.322 -0.942 . . . . 0.17999999999999999 113.495 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.8 ptmt -137.25 172.47 12.95 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.422 -2.436 . . . . 0.37 104.422 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.705 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.6 m -101.02 158.18 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.741 0 N-CA-C 116.48 2.03 . . . . 0.10000000000000001 116.48 -172.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.696 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.35 -26.55 9.97 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 110.523 -3.035 . . . . 0.070000000000000007 106.933 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.806 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -133.72 145.58 49.99 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 111.766 -2.47 . . . . 0.059999999999999998 111.842 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.57 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 5.0 tt0 -140.26 118.35 11.92 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 104.569 -2.382 . . . . 0.47999999999999998 104.569 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.801 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.05 162.0 41.25 Favored 'General case' 0 N--CA 1.402 -2.838 0 C-N-CA 117.767 -1.573 . . . . 0.070000000000000007 112.059 177.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.632 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 17.0 p-10 -101.12 135.8 42.0 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 114.263 -1.335 . . . . 1.8 109.27 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.926 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.6 pp -141.63 -171.84 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 122.443 1.116 . . . . 0.12 112.835 -169.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.47 120.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 CA-C-N 112.959 -1.928 . . . . 0.10000000000000001 108.982 174.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.532 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -76.23 -167.67 0.81 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.643 -1.617 . . . . 1.26 110.953 177.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.489 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.85 175.92 48.93 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.118 -1.515 . . . . 0.14000000000000001 112.341 -174.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -78.91 156.69 77.05 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.508 0.671 . . . . 0.81000000000000005 112.035 -165.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.69 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.7 Cg_exo -57.79 -29.9 87.47 Favored 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 125.182 3.921 . . . . 0.28000000000000003 113.617 -173.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.461 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 27.0 p -70.86 -32.97 70.15 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.592 -1.64 . . . . 0.33000000000000002 109.661 -175.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.547 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.1 t -140.82 70.87 29.96 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 123.614 1.673 . . . . 0.39000000000000001 109.406 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.5 Cg_exo -59.53 154.35 48.7 Favored 'Trans proline' 0 C--N 1.313 -1.292 1 C-N-CA 126.421 4.748 . . . . 0.38 114.449 -172.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.532 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.5 OUTLIER -83.86 148.14 53.41 Favored Pre-proline 0 N--CA 1.419 -1.979 0 N-CA-C 108.002 -1.11 . . . . 0.81999999999999995 108.002 173.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 15.4 Cg_exo -79.53 -41.26 0.21 Allowed 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 124.592 3.528 . . . . 0.19 112.724 -165.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.773 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.41 134.24 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 123.549 1.642 . . . . 0.13 113.75 -172.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 148.02 -125.83 2.19 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 111.95 -2.386 . . . . 0.20000000000000001 109.728 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.6 p -116.35 112.32 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 122.122 0.963 . . . . 0.81999999999999995 111.497 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.769 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 1.9 m-85 -112.63 -173.38 2.24 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 106.493 -1.669 . . . . 0.22 106.493 172.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.57 ' OH ' ' HA2' ' A' ' 460' ' ' GLY . 38.9 t80 -144.68 125.97 14.77 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.306 -1.358 . . . . 0.65000000000000002 113.657 -169.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.4 p -86.47 94.21 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 122.683 1.23 . . . . 0.16 109.56 169.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . 0.544 ' CD1' ' HD2' ' A' ' 383' ' ' TYR . 75.7 m95 -69.16 -17.17 63.79 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.412 -1.722 . . . . 2.5499999999999998 108.185 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.733 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.6 t30 -169.45 135.07 1.54 Allowed 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.375 -0.829 . . . . 0.42999999999999999 111.145 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.662 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -91.95 129.57 37.88 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.186 -1.042 . . . . 1.1200000000000001 108.186 171.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.668 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 0.5 OUTLIER -110.59 158.59 18.4 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.183 -0.917 . . . . 0.70999999999999996 111.935 -171.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 40.3 mt-10 -134.57 133.36 40.16 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.163 -1.38 . . . . 0.38 108.833 173.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 18.6 t70 53.94 46.58 25.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 123.766 1.746 . . . . 0.40999999999999998 108.71 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.899 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -83.99 165.3 18.73 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 112.183 -2.28 . . . . 0.12 108.79 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 24.3 m -132.66 120.12 21.32 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.153 0.978 . . . . 0.17000000000000001 111.045 170.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.545 HD13 ' HB ' ' A' ' 407' ' ' VAL . 2.7 mp -78.14 88.48 4.24 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.512 -1.676 . . . . 0.56999999999999995 111.413 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.531 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 48.5 mttt . . . . . 0 C--N 1.288 -2.072 0 CA-C-N 113.791 -1.55 . . . . 0.33000000000000002 113.701 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.531 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 1.8 mp0 . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 121.083 0.468 . . . . 0.53000000000000003 110.127 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.29 97.49 5.18 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 108.015 -1.105 . . . . 0.19 108.015 170.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.1 Cg_exo -69.32 110.05 2.37 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.008 1.805 . . . . 0.19 110.316 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.899 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.35 155.39 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 CA-C-N 112.998 -1.91 . . . . 0.14999999999999999 107.396 -168.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.0 m-80 -88.49 -21.57 24.11 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.657 -0.868 . . . . 0.51000000000000001 108.657 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.664 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.1 m-85 -157.31 126.11 5.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.625 -1.17 . . . . 0.27000000000000002 108.674 -169.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.668 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 14.6 t-105 -142.3 141.41 32.41 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.623 -0.717 . . . . 0.089999999999999997 110.281 -167.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.662 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.5 mmt -126.67 96.75 34.74 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.405 -1.332 . . . . 0.14000000000000001 107.405 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.733 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 48.2 Cg_endo . . . . . 0 N--CA 1.46 -0.493 0 C-N-CA 122.52 2.147 . . . . 0.5 112.825 -175.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.707 HG11 ' CE2' ' A' ' 382' ' ' PHE . 2.2 p . . . . . 0 N--CA 1.44 -0.946 0 CA-C-O 120.474 0.178 . . . . 0.75 111.249 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 442' ' ' CYS . . . -168.05 128.61 1.74 Allowed Glycine 0 C--O 1.219 -0.827 0 N-CA-C 110.882 -0.887 . . . . 0.20000000000000001 110.882 165.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.626 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.6 mp -84.6 140.0 16.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 122.151 -0.617 . . . . 0.28999999999999998 111.213 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.649 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.0 p80 -161.83 162.86 29.57 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.684 -0.689 . . . . 0.089999999999999997 110.303 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.747 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -81.94 150.88 27.48 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 107.675 -1.232 . . . . 1.0700000000000001 107.675 170.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 445' ' ' THR . 48.0 t -134.12 96.08 3.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.981 0.896 . . . . 0.23000000000000001 109.647 -172.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--N 1.317 -0.835 0 CA-C-N 113.784 -1.553 . . . . 0.41999999999999998 109.77 -176.363 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.592 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.1 pm0 . . . . . 0 N--CA 1.43 -1.459 0 CA-C-O 122.289 1.042 . . . . 2.1600000000000001 112.71 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.637 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -157.8 129.54 6.89 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 112.681 -2.054 . . . . 0.33000000000000002 105.513 168.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.13 -157.48 29.74 Favored Glycine 0 C--N 1.288 -2.088 0 C-N-CA 119.715 -1.231 . . . . 0.17000000000000001 111.544 -177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.535 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.65 170.49 0.01 OUTLIER Glycine 0 CA--C 1.487 -1.671 0 C-N-CA 120.787 -0.72 . . . . 0.20999999999999999 111.919 167.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.548 ' HB3' ' CD ' ' A' ' 435' ' ' LYS . 2.4 m-20 -52.75 100.89 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.891 0 CA-C-O 122.492 1.139 . . . . 1.8500000000000001 112.957 -155.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 1.009 HD22 ' HD2' ' A' ' 437' ' ' ARG . 36.8 mt -97.16 -35.73 10.69 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 113.006 -1.906 . . . . 1.21 109.696 172.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.731 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -52.7 -26.3 13.53 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.111 -0.95 . . . . 0.16 112.1 -173.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.731 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.68 -33.99 15.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.747 -0.661 . . . . 0.22 112.69 -178.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.7 p -90.01 -37.88 14.0 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.861 0.839 . . . . 0.25 110.76 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 1.009 ' HD2' HD22 ' A' ' 433' ' ' LEU . 3.8 mtp85 -97.65 -18.4 18.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.707 -1.133 . . . . 1.8200000000000001 110.011 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.74 48.81 49.54 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.156 -0.929 . . . . 0.23999999999999999 115.233 162.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . 0.47 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 9.3 p -84.8 110.32 18.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 118.93 1.365 . . . . 1.01 112.192 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 441' ' ' GLY . 63.2 m-70 35.67 -133.21 0.06 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.482 -1.235 . . . . 0.5 113.049 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.489 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -119.22 -6.26 10.95 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.204 -0.759 . . . . 0.26000000000000001 111.204 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 0.8 OUTLIER -92.4 162.51 14.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.527 0.936 . . . . 0.34999999999999998 113.527 -176.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.532 HG12 HG11 ' A' ' 347' ' ' VAL . 1.9 mp -87.43 128.97 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 113.764 -1.562 . . . . 0.12 110.141 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.45 88.42 4.12 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.655 -0.702 . . . . 0.62 110.081 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.926 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.9 m -83.91 142.64 42.09 Favored Pre-proline 0 N--CA 1.431 -1.377 0 CA-C-N 115.029 -0.987 . . . . 0.10000000000000001 112.412 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.7 ' HD2' HG21 ' A' ' 366' ' ' THR . 76.7 Cg_exo -50.42 145.1 22.52 Favored 'Trans proline' 0 CA--C 1.509 -0.733 0 C-N-CA 123.803 3.002 . . . . 0.23999999999999999 113.455 175.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.747 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.2 Cg_exo -65.45 -24.71 56.51 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.864 2.376 . . . . 0.31 112.328 -176.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.515 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 35.7 p -77.58 -24.99 49.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.229 -0.896 . . . . 1.1000000000000001 112.09 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.806 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.9 m -100.02 -48.51 11.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.714 -0.675 . . . . 0.080000000000000002 112.557 -171.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.955 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.7 -2.51 5.02 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.635 -0.826 . . . . 0.070000000000000007 110.375 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.526 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 15.8 pttp -80.71 -38.82 28.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.441 1.115 . . . . 0.92000000000000004 108.358 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.7 mm-40 -62.66 -46.57 87.59 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 112.482 -2.145 . . . . 0.25 106.883 -177.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.955 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.09 -66.37 0.41 Allowed 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 109.847 -3.342 . . . . 0.050000000000000003 112.536 171.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 21.1 t80 -44.72 -25.62 0.3 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 124.215 0.947 . . . . 0.13 109.609 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.447 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -86.87 -29.49 23.28 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 114.599 -1.182 . . . . 0.13 111.555 -176.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.749 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -99.43 -44.86 6.03 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 113.533 0.938 . . . . 0.059999999999999998 113.533 177.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.65 148.56 9.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 122.487 1.137 . . . . 0.080000000000000002 111.106 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' A' ' 458' ' ' GLU . 0.0 OUTLIER -119.91 158.11 27.35 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 112.88 -1.964 . . . . 0.47999999999999998 108.648 -178.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.628 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.3 mppt? -57.82 101.51 0.08 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.575 -0.898 . . . . 0.98999999999999999 108.575 168.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . 0.57 ' HA2' ' OH ' ' A' ' 383' ' ' TYR . . . 134.66 -18.36 4.1 Favored Glycine 0 C--N 1.304 -1.246 0 CA-C-N 114.233 -1.349 . . . . 0.19 111.902 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 344' ' ' TYR . 23.1 m -66.57 149.29 98.26 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 108.756 -0.831 . . . . 0.13 108.756 171.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 9.8 Cg_endo -95.75 176.29 0.84 Allowed 'Trans proline' 0 N--CA 1.416 -3.052 0 C-N-CA 122.257 1.972 . . . . 0.17999999999999999 109.937 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.769 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -132.8 154.7 40.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.131 -1.063 . . . . 0.56999999999999995 108.131 171.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.0 mp -134.26 152.12 51.65 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 108.775 -0.824 . . . . 0.13 108.775 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.027 HG23 HD21 ' A' ' 349' ' ' LEU . 0.9 OUTLIER -137.73 144.46 31.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 106.047 -1.835 . . . . 0.10000000000000001 106.047 159.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.542 ' OXT' ' HG3' ' A' ' 350' ' ' GLU . 3.2 p90 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 123.857 0.863 . . . . 1.0900000000000001 110.84 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 109.532 -0.544 . . . . 0.42999999999999999 109.532 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 357' ' ' TYR . 53.6 m -159.35 138.08 10.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.29 -0.868 . . . . 0.14000000000000001 108.743 167.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.762 ' CD2' HD13 ' A' ' 464' ' ' LEU . 41.2 p90 174.32 158.87 0.16 Allowed 'General case' 0 C--O 1.21 -1.011 0 O-C-N 123.317 0.385 . . . . 0.14999999999999999 111.149 -176.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.618 HD12 HD11 ' A' ' 453' ' ' LEU . 0.5 OUTLIER -77.26 154.7 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 N-CA-C 109.216 -0.661 . . . . 0.080000000000000002 109.216 164.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.53 146.96 28.55 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.8 -1.185 . . . . 2.0099999999999998 107.8 -178.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.736 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.76 155.62 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 C-N-CA 123.6 0.76 . . . . 0.45000000000000001 110.375 173.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.526 ' N ' HG12 ' A' ' 347' ' ' VAL . 37.7 t0 -138.13 105.55 5.53 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.539 -1.652 . . . . 0.23999999999999999 106.539 176.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 1.026 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -80.13 -35.97 35.91 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 114.023 -1.444 . . . . 0.16 109.959 -165.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.402 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 0.7 OUTLIER -56.38 -44.96 80.72 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 110.678 -2.965 . . . . 0.59999999999999998 107.942 176.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -99.37 5.03 46.53 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 111.163 -2.744 . . . . 0.20000000000000001 111.1 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.6 OUTLIER 34.29 61.7 0.52 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 112.942 -1.935 . . . . 2.1499999999999999 113.137 -173.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.501 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 24.5 t60 -142.4 136.91 30.02 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.907 -0.588 . . . . 0.089999999999999997 109.741 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.748 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.83 158.16 21.39 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 120.947 0.403 . . . . 0.070000000000000007 110.234 179.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.641 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.5 m-90 -143.13 164.08 31.12 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.485 0.66 . . . . 0.11 111.126 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.703 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 86.3 t80 -116.01 154.27 30.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.535 -1.654 . . . . 0.26000000000000001 106.535 150.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 13.4 m-85 -127.13 119.2 25.94 Favored 'General case' 0 C--N 1.269 -2.9 0 CA-C-N 115.094 -0.957 . . . . 0.14000000000000001 110.007 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 361' ' ' LYS . 9.9 tppt? -123.3 116.65 23.68 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.377 -0.971 . . . . 0.25 108.377 173.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.85 37.69 0.49 Allowed 'General case' 0 C--N 1.308 -1.207 0 O-C-N 123.474 0.484 . . . . 0.42999999999999999 112.297 -176.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 62.94 12.46 42.97 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 120.2 -1.0 . . . . 0.17999999999999999 113.314 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 358' ' ' LYS . 18.5 ptmt -137.63 169.75 17.25 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 104.586 -2.376 . . . . 0.37 104.586 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.641 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.6 m -99.57 157.74 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.619 0 N-CA-C 116.692 2.108 . . . . 0.10000000000000001 116.692 -170.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.703 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -110.18 -25.88 9.94 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-N 110.375 -3.102 . . . . 0.070000000000000007 106.673 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -135.64 146.6 48.03 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 111.694 -2.503 . . . . 0.059999999999999998 111.682 -176.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.496 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -143.7 117.92 9.56 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 104.719 -2.326 . . . . 0.47999999999999998 104.719 175.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.748 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.59 165.25 32.82 Favored 'General case' 0 N--CA 1.4 -2.953 0 C-N-CA 118.121 -1.432 . . . . 0.070000000000000007 111.558 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.655 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 13.1 p-10 -103.66 132.44 49.91 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.71 -1.132 . . . . 1.8 109.828 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.0 pp -131.48 -173.5 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 CA-C-O 122.48 1.133 . . . . 0.12 112.415 -172.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.41 120.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 112.805 -1.998 . . . . 0.10000000000000001 108.312 172.202 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.542 ' HB3' HD12 ' A' ' 349' ' ' LEU . 30.2 p -76.87 -169.21 1.23 Allowed 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 112.376 -2.193 . . . . 1.26 111.615 -177.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -85.04 166.65 40.93 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 118.718 -1.706 . . . . 0.14000000000000001 111.864 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -73.84 156.99 87.83 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 121.383 0.611 . . . . 0.81000000000000005 111.758 -167.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.645 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 81.4 Cg_exo -54.23 -28.79 53.88 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 125.269 3.98 . . . . 0.28000000000000003 113.439 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.481 ' OG1' HG22 ' A' ' 375' ' ' THR . 16.8 p -69.55 -34.04 73.64 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.295 -1.775 . . . . 0.33000000000000002 109.829 -176.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.536 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -141.61 70.81 25.69 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 123.715 1.721 . . . . 0.39000000000000001 109.128 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 375' ' ' THR . 85.9 Cg_exo -57.41 160.09 14.61 Favored 'Trans proline' 0 C--N 1.31 -1.462 1 C-N-CA 126.453 4.769 . . . . 0.38 115.254 -170.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.511 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 2.3 m -86.08 126.56 64.92 Favored Pre-proline 0 N--CA 1.402 -2.837 0 CA-C-N 114.142 -1.39 . . . . 0.81999999999999995 108.616 173.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 29.0 Cg_exo -69.29 -44.66 2.25 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.776 2.984 . . . . 0.19 112.21 -168.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.764 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 61.21 137.98 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 123.579 1.657 . . . . 0.13 113.912 -175.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 153.36 -111.69 0.5 Allowed Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 111.75 -2.477 . . . . 0.20000000000000001 108.871 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.67 125.89 56.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.206 0.527 . . . . 0.81999999999999995 109.759 173.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.72 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 8.1 m-85 -118.16 -176.14 3.0 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 106.608 -1.627 . . . . 0.22 106.608 168.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 2.0 t80 -137.76 120.29 16.06 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 120.698 -1.251 . . . . 0.65000000000000002 112.291 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -86.01 91.35 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-O 123.178 1.466 . . . . 0.16 108.926 171.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -93.66 11.79 27.72 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 113.043 -1.889 . . . . 2.5499999999999998 108.013 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.747 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.0 t30 -167.95 126.21 1.2 Allowed 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 113.588 -1.642 . . . . 0.42999999999999999 110.148 172.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.651 ' HD3' ' H ' ' A' ' 387' ' ' LYS . 0.0 OUTLIER -101.64 143.25 31.84 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.201 -0.909 . . . . 1.1200000000000001 109.129 169.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.726 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 30.0 mm-40 -126.11 159.67 32.23 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 115.019 1.489 . . . . 0.70999999999999996 115.019 -167.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.1 mt-10 -139.11 127.29 22.58 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 112.755 -2.02 . . . . 0.38 108.689 174.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.7 t70 56.19 45.67 22.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 123.498 1.618 . . . . 0.40999999999999998 109.053 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.925 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -81.26 166.3 20.67 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 112.517 -2.129 . . . . 0.12 108.803 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 20.6 m -132.75 119.24 20.06 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 122.252 1.025 . . . . 0.17000000000000001 111.577 170.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.1 mp -78.7 88.02 4.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.699 -1.591 . . . . 0.56999999999999995 111.873 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.543 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.7 mttt . . . . . 0 C--N 1.284 -2.27 0 CA-C-N 113.572 -1.649 . . . . 0.33000000000000002 113.032 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 120.998 0.428 . . . . 0.53000000000000003 110.749 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.02 97.35 4.86 Favored Pre-proline 0 N--CA 1.437 -1.094 0 N-CA-C 108.525 -0.917 . . . . 0.19 108.525 170.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.9 Cg_exo -68.47 110.95 2.4 Favored 'Trans proline' 0 N--CA 1.436 -1.886 0 C-N-CA 122.106 1.871 . . . . 0.19 110.159 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.925 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.86 152.41 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.168 0 CA-C-N 113.355 -1.748 . . . . 0.14999999999999999 107.979 -167.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.724 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 19.6 m-80 -85.95 -20.43 28.96 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.958 -0.756 . . . . 0.51000000000000001 108.958 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.726 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.4 m-85 -158.85 125.75 4.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.935 -1.03 . . . . 0.27000000000000002 108.493 -170.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.676 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 19.8 t-105 -143.32 138.18 29.32 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.692 -0.685 . . . . 0.089999999999999997 110.476 -167.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.619 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 14.3 mmt -118.55 91.08 40.96 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.932 -0.766 . . . . 0.14000000000000001 108.932 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.747 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 34.1 Cg_exo . . . . . 0 CA--C 1.511 -0.633 0 C-N-CA 123.367 2.711 . . . . 0.5 109.511 171.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 419' ' ' GLY . 32.3 t . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 121.125 0.488 . . . . 0.75 111.763 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.581 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -175.81 122.58 0.87 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.039 -1.224 . . . . 0.20000000000000001 110.039 170.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.726 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.4 mp -81.63 143.52 12.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 110.05 -0.352 . . . . 0.28999999999999998 110.05 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.676 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.4 p80 -160.32 161.84 33.36 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.089999999999999997 111.617 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.691 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.03 146.63 27.09 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.402 -0.962 . . . . 1.0700000000000001 108.402 173.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 445' ' ' THR . 37.7 t -133.15 96.32 3.73 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.788 0.804 . . . . 0.23000000000000001 110.074 -171.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . 0.423 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 8.0 t70 . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 114.211 -1.359 . . . . 0.41999999999999998 109.551 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.537 ' HG3' ' HD3' ' A' ' 437' ' ' ARG . 2.7 pm0 . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 122.242 1.02 . . . . 2.1600000000000001 113.291 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.655 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.5 OUTLIER -163.07 132.02 4.03 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 112.608 -2.087 . . . . 0.33000000000000002 105.405 172.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 169.06 -158.61 31.28 Favored Glycine 0 C--N 1.283 -2.401 0 N-CA-C 110.373 -1.091 . . . . 0.17000000000000001 110.373 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.452 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -45.53 174.85 0.01 OUTLIER Glycine 0 CA--C 1.497 -1.045 0 C-N-CA 120.155 -1.022 . . . . 0.20999999999999999 111.493 167.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.541 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -51.9 101.82 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 123.341 1.543 . . . . 1.8500000000000001 113.834 -154.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.745 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.87 -36.02 11.26 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 112.533 -2.122 . . . . 1.21 109.378 170.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.697 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -54.75 -27.47 41.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.213 -0.903 . . . . 0.16 112.276 -170.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.697 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.52 -35.37 15.11 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.468 0.651 . . . . 0.22 112.216 -177.343 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 p -90.4 -43.39 10.33 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.991 -1.004 . . . . 0.25 110.787 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.745 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.6 mtp180 -93.29 -17.77 23.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.536 -1.211 . . . . 1.8200000000000001 109.607 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.67 49.82 56.28 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.765 -1.107 . . . . 0.23999999999999999 115.101 162.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 50.0 m -83.38 110.28 18.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.736 1.268 . . . . 1.01 111.31 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 37.33 -126.85 0.19 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.303 -1.317 . . . . 0.5 114.481 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -128.28 -21.32 1.49 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.14 -0.552 . . . . 0.26000000000000001 113.029 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.543 ' HB2' ' H ' ' A' ' 419' ' ' GLY . 29.2 p -102.11 -166.05 1.25 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.244 0.545 . . . . 0.34999999999999998 112.273 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.474 HG12 HG11 ' A' ' 347' ' ' VAL . 2.2 mp -96.62 131.15 44.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.314 -0.857 . . . . 0.12 110.619 -174.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.405 HD22 ' N ' ' A' ' 444' ' ' ASN . 0.9 OUTLIER -104.99 94.39 5.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.431 0.634 . . . . 0.62 110.252 -178.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.749 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.9 m -90.39 145.53 32.74 Favored Pre-proline 0 C--O 1.211 -0.969 0 CA-C-N 114.713 -1.131 . . . . 0.10000000000000001 112.85 -176.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.672 ' HD2' HG21 ' A' ' 366' ' ' THR . 75.8 Cg_exo -50.44 146.51 19.03 Favored 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 123.971 3.114 . . . . 0.23999999999999999 113.659 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.691 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 27.8 Cg_exo -67.3 -23.38 44.85 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.963 2.442 . . . . 0.31 112.364 -176.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.524 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 34.1 p -80.64 -24.98 38.62 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.363 -0.835 . . . . 1.1000000000000001 112.079 -175.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.804 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.8 m -99.38 -48.98 11.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.643 -0.708 . . . . 0.080000000000000002 112.864 -170.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.954 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.95 -2.27 5.07 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.754 -0.779 . . . . 0.070000000000000007 110.349 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 448' ' ' SER . 41.4 pttt -80.81 -39.51 26.53 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.973 -1.121 . . . . 0.92000000000000004 107.973 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.512 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 3.7 mm-40 -61.53 -46.35 90.31 Favored 'General case' 0 CA--C 1.472 -2.032 0 CA-C-N 112.499 -2.137 . . . . 0.25 106.356 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.954 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.81 -67.49 0.28 Allowed 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 109.612 -3.449 . . . . 0.050000000000000003 112.66 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 16.3 t80 -45.46 -23.96 0.27 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 124.008 0.817 . . . . 0.13 109.361 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.449 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.36 -26.09 29.03 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.925 -1.034 . . . . 0.13 111.845 -176.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.735 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -102.45 -44.31 5.4 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 113.309 0.855 . . . . 0.059999999999999998 113.309 176.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -72.12 147.71 10.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 122.528 1.156 . . . . 0.080000000000000002 110.747 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.64 153.79 37.66 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-N 112.878 -1.965 . . . . 0.47999999999999998 107.943 -178.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 42.4 mtmt -55.57 103.01 0.08 Allowed 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.783 0.801 . . . . 0.98999999999999999 110.122 173.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.58 -11.67 6.33 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 113.637 -1.619 . . . . 0.19 111.394 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.658 HG21 ' HB ' ' A' ' 457' ' ' VAL . 10.3 m -65.6 150.34 96.21 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 108.443 -0.947 . . . . 0.13 108.443 171.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.3 Cg_endo -93.51 163.55 2.37 Favored 'Trans proline' 0 N--CA 1.42 -2.852 0 C-N-CA 122.0 1.8 . . . . 0.17999999999999999 109.644 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.72 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -125.19 152.71 31.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 107.392 -1.336 . . . . 0.56999999999999995 107.392 170.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.762 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.1 mp -133.02 150.01 52.17 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 108.09 -1.078 . . . . 0.13 108.09 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 1.026 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.23 138.57 37.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 103.879 -2.638 . . . . 0.10000000000000001 103.879 163.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.764 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 2.5 p90 . . . . . 0 C--O 1.247 0.956 0 O-C-N 123.768 0.668 . . . . 1.0900000000000001 110.719 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 111.868 -0.493 . . . . 1.8700000000000001 111.868 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.517 ' CE1' HD21 ' A' ' 464' ' ' LEU . 1.3 p-80 -138.44 111.06 7.57 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.732 0.266 . . . . 0.83999999999999997 111.589 177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.558 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.1 OUTLIER 57.23 -166.55 0.14 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 113.34 0.867 . . . . 0.67000000000000004 113.34 166.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -64.24 168.05 5.98 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.302 -1.37 . . . . 1.8500000000000001 107.302 165.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.468 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.7 m-20 -79.36 83.64 5.36 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.045 -1.062 . . . . 0.42999999999999999 109.456 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 357' ' ' TYR . 70.6 m -158.08 134.3 9.4 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.467 -1.242 . . . . 0.14000000000000001 108.715 169.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.638 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.1 p90 174.61 158.39 0.17 Allowed 'General case' 0 C--O 1.212 -0.876 0 O-C-N 123.316 0.385 . . . . 0.14999999999999999 111.545 -175.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.665 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -78.23 149.32 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.188 0 N-CA-C 109.274 -0.639 . . . . 0.080000000000000002 109.274 164.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.555 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.2 tt0 -149.34 139.57 22.24 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.459 -0.791 . . . . 2.0099999999999998 109.902 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.745 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -132.52 161.53 41.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.039 0.447 . . . . 0.45000000000000001 111.412 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.542 ' N ' HG12 ' A' ' 347' ' ' VAL . 32.5 t0 -140.23 106.35 5.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.385 -1.339 . . . . 0.23999999999999999 107.385 174.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.111 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.02 -34.88 26.18 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 124.071 1.891 . . . . 0.16 110.139 -170.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.474 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.0 OUTLIER -55.63 -41.77 74.02 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 111.144 -2.753 . . . . 0.59999999999999998 107.757 176.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 19.1 m-80 -105.52 7.66 33.06 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 110.912 -2.858 . . . . 0.20000000000000001 111.666 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.816 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 82.9 mm-40 28.8 63.86 0.12 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 112.825 -1.989 . . . . 2.1499999999999999 114.294 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.518 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 27.2 t60 -141.87 137.71 31.58 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.665 -1.152 . . . . 0.089999999999999997 110.125 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.728 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -113.55 157.89 21.48 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.218 0.532 . . . . 0.070000000000000007 110.385 -178.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.615 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.5 m-90 -143.3 153.88 43.22 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.274 -0.876 . . . . 0.11 111.137 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.7 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.0 t80 -109.35 153.07 24.46 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.46 -1.681 . . . . 0.26000000000000001 106.46 151.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.9 m-85 -127.43 119.37 25.99 Favored 'General case' 0 C--N 1.268 -2.951 0 CA-C-N 114.946 -1.024 . . . . 0.14000000000000001 110.384 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.8 tppt? -121.1 135.65 55.14 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.408 -1.701 . . . . 0.25 106.408 168.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.524 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 72.11 15.77 5.42 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.071 0.767 . . . . 0.42999999999999999 113.071 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.65 7.09 88.29 Favored Glycine 0 CA--C 1.485 -1.826 0 CA-C-N 115.693 -0.685 . . . . 0.17999999999999999 112.731 -173.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' A' ' 359' ' ' ASP . 18.1 ptmt -127.93 178.13 6.39 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 104.505 -2.406 . . . . 0.37 104.505 177.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.7 m -104.51 157.83 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 N-CA-C 116.475 2.028 . . . . 0.10000000000000001 116.475 -174.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.683 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.86 -27.97 9.91 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-N 110.477 -3.056 . . . . 0.070000000000000007 106.286 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.12 144.31 48.49 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 111.471 -2.604 . . . . 0.059999999999999998 111.625 -175.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.415 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.4 tt0 -140.34 117.47 11.22 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 104.426 -2.435 . . . . 0.47999999999999998 104.426 175.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.728 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.55 160.39 43.52 Favored 'General case' 0 N--CA 1.393 -3.297 0 C-N-CA 117.871 -1.532 . . . . 0.070000000000000007 110.636 -179.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.75 138.9 38.12 Favored 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 108.334 -0.987 . . . . 1.8 108.334 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.742 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.0 pp -136.47 -174.21 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.277 0 CA-C-O 122.11 0.957 . . . . 0.12 112.25 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.816 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.7 OUTLIER -150.12 118.82 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 113.02 -1.9 . . . . 0.10000000000000001 108.793 172.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.509 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -78.63 -168.08 1.28 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.555 -1.657 . . . . 1.26 110.349 -178.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.469 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.43 168.07 43.75 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 118.485 -1.816 . . . . 0.14000000000000001 112.311 -174.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.402 ' HG3' ' OG1' ' A' ' 374' ' ' THR . 10.0 ptmt -73.61 158.74 85.92 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-O 121.626 0.727 . . . . 0.81000000000000005 111.9 -166.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.641 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 88.1 Cg_exo -57.43 -28.99 82.92 Favored 'Trans proline' 0 CA--C 1.495 -1.426 0 C-N-CA 125.182 3.922 . . . . 0.28000000000000003 113.435 -173.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.452 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.9 p -71.57 -33.71 69.31 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.405 -1.725 . . . . 0.33000000000000002 109.618 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.6 t -141.36 70.57 26.97 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-O 123.737 1.732 . . . . 0.39000000000000001 109.584 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 375' ' ' THR . 79.0 Cg_exo -59.46 157.55 30.97 Favored 'Trans proline' 0 C--N 1.314 -1.256 1 C-N-CA 126.494 4.796 . . . . 0.38 114.481 -172.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.509 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -87.35 146.16 39.24 Favored Pre-proline 0 N--CA 1.425 -1.723 0 N-CA-C 108.44 -0.948 . . . . 0.81999999999999995 108.44 174.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.4 Cg_exo -76.08 -44.15 0.28 Allowed 'Trans proline' 0 CA--C 1.511 -0.657 0 C-N-CA 124.8 3.667 . . . . 0.19 112.136 -167.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.781 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 57.67 137.88 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 123.249 1.499 . . . . 0.13 113.608 -172.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 150.47 -111.02 0.49 Allowed Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 112.592 -2.095 . . . . 0.20000000000000001 110.319 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 381' ' ' VAL . 5.7 p -130.17 113.51 26.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 122.496 1.141 . . . . 0.81999999999999995 111.078 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.733 ' HB2' HG12 ' A' ' 463' ' ' VAL . 1.8 m-85 -114.68 -171.21 1.89 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.929 -1.508 . . . . 0.22 106.929 173.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.604 ' HB2' ' CZ2' ' A' ' 415' ' ' TRP . 1.4 t80 -150.03 124.58 9.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.856 1.207 . . . . 0.65000000000000002 112.838 -172.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.62 HG12 HG23 ' A' ' 463' ' ' VAL . 2.3 p -89.45 91.95 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-O 123.047 1.403 . . . . 0.16 109.13 169.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -93.8 11.24 29.96 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 113.298 -1.773 . . . . 2.5499999999999998 107.851 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.74 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.0 t30 -169.19 126.18 0.94 Allowed 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 113.793 -1.548 . . . . 0.42999999999999999 110.086 172.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.66 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.89 143.68 31.47 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.828 -1.078 . . . . 1.1200000000000001 109.121 171.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 26.7 mm-40 -126.11 157.61 37.61 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.599 1.333 . . . . 0.70999999999999996 114.599 -167.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 45.2 mt-10 -135.63 127.16 28.77 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 113.155 -1.839 . . . . 0.38 108.902 172.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.14 49.62 18.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 123.159 1.457 . . . . 0.40999999999999998 109.335 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.948 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -81.88 168.5 17.87 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 112.579 -2.1 . . . . 0.12 109.454 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.0 m -132.27 119.59 21.0 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.904 0.859 . . . . 0.17000000000000001 111.745 170.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.6 mp -80.2 88.84 5.45 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.802 -1.545 . . . . 0.56999999999999995 112.167 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.561 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.5 mttt -101.63 -179.86 4.14 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.657 -1.61 . . . . 0.33000000000000002 113.502 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.39 -161.58 25.69 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 114.243 -1.344 . . . . 0.46000000000000002 111.614 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.7 m -120.78 137.37 54.55 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 120.239 -0.584 . . . . 0.70999999999999996 111.515 172.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 399' ' ' ASP . 4.1 m-80 -55.38 154.7 5.88 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 114.718 -1.128 . . . . 0.83999999999999997 110.038 169.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.71 -7.58 0.3 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.34 -1.3 . . . . 2.2799999999999998 111.99 176.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.466 ' H ' ' C ' ' A' ' 397' ' ' ASN . 21.2 m-20 -102.34 -17.37 15.9 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 115.171 -0.922 . . . . 2.27 109.729 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.53 32.36 6.66 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 119.08 -1.533 . . . . 0.93999999999999995 111.459 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 16.5 p -122.79 97.65 43.84 Favored Pre-proline 0 C--N 1.309 -1.164 0 CA-C-N 114.533 -0.833 . . . . 0.81000000000000005 109.309 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 21.1 Cg_endo -60.16 150.67 78.11 Favored 'Trans proline' 0 CA--C 1.501 -1.159 0 C-N-CA 122.909 2.406 . . . . 0.63 113.269 -175.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -148.21 172.33 14.51 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.07 -1.423 . . . . 0.41999999999999998 112.057 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.561 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -145.19 147.3 32.3 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.246 -1.343 . . . . 0.53000000000000003 109.91 172.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.2 97.35 5.23 Favored Pre-proline 0 N--CA 1.434 -1.254 0 N-CA-C 108.233 -1.025 . . . . 0.19 108.233 171.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.2 Cg_exo -69.31 110.59 2.5 Favored 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 122.012 1.808 . . . . 0.19 110.047 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.948 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.02 158.03 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 CA-C-N 113.132 -1.849 . . . . 0.14999999999999999 107.582 -168.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.689 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.0 m-80 -89.27 -21.8 23.02 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.031 -0.729 . . . . 0.51000000000000001 109.031 -174.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.744 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 94.1 m-85 -158.86 127.54 5.33 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.924 -1.035 . . . . 0.27000000000000002 108.229 -170.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.672 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 21.9 t-105 -144.93 136.26 25.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.692 0.758 . . . . 0.089999999999999997 111.397 -166.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.66 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.8 mmt -119.68 93.65 47.72 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 108.157 -1.053 . . . . 0.14000000000000001 108.157 173.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.2 Cg_endo -68.24 83.38 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.171 1.914 . . . . 0.5 111.351 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.588 HG12 ' HA2' ' A' ' 419' ' ' GLY . 6.8 pt -81.9 173.3 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.084 -0.71 . . . . 0.88 109.084 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.574 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 1.3 t70 -134.82 -174.83 3.7 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.232 -0.987 . . . . 2.4900000000000002 112.743 -163.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.604 ' CZ2' ' HB2' ' A' ' 383' ' ' TYR . 29.6 p90 50.79 -2.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.251 2.22 . . . . 1.9199999999999999 115.307 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.622 HG21 ' CE1' ' A' ' 382' ' ' PHE . 36.2 p -131.83 -17.92 2.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.176 0.436 . . . . 0.94999999999999996 112.176 -175.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.64 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 93.73 -28.96 9.09 Favored Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 111.195 -0.762 . . . . 0.68000000000000005 111.195 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 419' ' ' GLY . 40.6 t -56.86 172.67 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 123.947 0.899 . . . . 0.75 111.69 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.605 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.4 123.47 0.91 Allowed Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.049 -1.221 . . . . 0.20000000000000001 110.049 170.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.729 HG22 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.63 141.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.382 -0.599 . . . . 0.28999999999999998 109.382 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.672 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.6 p80 -159.82 160.1 33.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.295 -0.412 . . . . 0.089999999999999997 111.525 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.669 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -82.59 145.92 29.44 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.02 -1.104 . . . . 1.0700000000000001 108.02 172.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 445' ' ' THR . 37.9 t -134.78 97.68 3.83 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.65 0.738 . . . . 0.23000000000000001 110.191 -172.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.456 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 24.1 t70 -83.37 -16.95 44.03 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.604 -1.18 . . . . 0.41999999999999998 109.665 -175.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.74 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 7.2 p90 -84.35 -24.9 29.54 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 113.999 -1.455 . . . . 0.32000000000000001 111.526 -175.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.588 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 2.0 tt0 -99.69 121.13 55.58 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-O 122.955 1.36 . . . . 1.74 110.529 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.649 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 37.3 Cg_endo -90.3 -8.21 4.0 Favored 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 124.919 3.746 . . . . 0.72999999999999998 113.422 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.649 ' OE2' ' HD2' ' A' ' 427' ' ' PRO . 1.1 pm0 -109.56 149.92 28.94 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 122.199 0.999 . . . . 2.1600000000000001 113.283 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.644 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -160.57 128.6 4.55 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 106.384 -1.71 . . . . 0.33000000000000002 106.384 167.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.73 -156.71 28.32 Favored Glycine 0 C--N 1.285 -2.286 0 C-N-CA 119.975 -1.107 . . . . 0.17000000000000001 110.682 -175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.27 165.35 0.01 OUTLIER Glycine 0 CA--C 1.489 -1.549 0 C-N-CA 120.243 -0.98 . . . . 0.20999999999999999 111.667 166.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.534 ' HB3' ' HD2' ' A' ' 435' ' ' LYS . 7.5 m-20 -53.48 102.98 0.06 Allowed 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.268 -1.466 . . . . 1.8500000000000001 113.499 -156.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.99 HD22 ' HD2' ' A' ' 437' ' ' ARG . 30.0 mt -94.66 -33.99 12.75 Favored 'General case' 0 C--O 1.208 -1.1 0 CA-C-N 112.892 -1.958 . . . . 1.21 109.452 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.674 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.1 p-90 -52.32 -27.32 14.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.841 -1.072 . . . . 0.16 112.501 -174.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.674 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.87 -33.17 16.56 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.276 0.56 . . . . 0.22 112.275 -178.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.5 p -90.62 -38.36 13.18 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.215 -0.902 . . . . 0.25 110.765 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.99 ' HD2' HD22 ' A' ' 433' ' ' LEU . 1.5 mtp85 -98.49 -17.94 18.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.6 -1.182 . . . . 1.8200000000000001 109.992 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.36 48.05 55.02 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.833 -1.076 . . . . 0.23999999999999999 115.043 163.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.1 p -83.93 110.65 18.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.674 1.237 . . . . 1.01 111.615 -172.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 35.13 -121.44 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.444 -1.253 . . . . 0.5 113.418 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.469 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -131.75 -19.35 1.17 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.842 -0.617 . . . . 0.26000000000000001 113.703 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.794 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.4 p -99.95 -167.66 1.49 Allowed 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 117.923 0.862 . . . . 0.34999999999999998 112.61 -174.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.453 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -99.03 126.26 52.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-N 114.698 -1.137 . . . . 0.12 110.928 -173.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.73 99.92 11.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.69 -0.686 . . . . 0.62 110.064 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.742 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -97.35 143.09 25.56 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-N 115.235 -0.893 . . . . 0.10000000000000001 112.379 -175.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.666 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 87.6 Cg_exo -49.59 144.59 18.93 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 124.023 3.149 . . . . 0.23999999999999999 113.36 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.644 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 34.1 Cg_exo -65.92 -27.26 50.99 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.734 2.289 . . . . 0.31 111.991 -174.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 14.5 m -75.68 -24.12 56.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.453 -0.794 . . . . 1.1000000000000001 112.18 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.81 ' O ' HD21 ' A' ' 364' ' ' LEU . 29.0 m -100.36 -49.31 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 113.171 0.804 . . . . 0.080000000000000002 113.171 -168.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.949 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.93 -2.08 4.82 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.888 -0.725 . . . . 0.070000000000000007 110.191 -178.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.615 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.2 pttp -81.45 -38.51 26.31 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 122.554 1.168 . . . . 0.92000000000000004 108.197 173.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.4 mm-40 -62.53 -46.5 88.12 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-N 112.418 -2.174 . . . . 0.25 106.463 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.949 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.8 tp -46.34 -66.89 0.34 Allowed 'General case' 0 N--CA 1.404 -2.753 0 CA-C-N 109.807 -3.361 . . . . 0.050000000000000003 112.579 172.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.48 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 17.4 t80 -45.4 -24.28 0.29 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 124.038 0.836 . . . . 0.13 109.617 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.443 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.27 -27.36 25.68 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.76 -1.109 . . . . 0.13 111.685 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.744 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -100.83 -44.57 5.73 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 113.304 0.853 . . . . 0.059999999999999998 113.304 177.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -74.01 149.92 7.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 122.528 1.156 . . . . 0.080000000000000002 111.464 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.24 156.12 34.44 Favored 'General case' 0 N--CA 1.416 -2.135 0 CA-C-N 112.929 -1.941 . . . . 0.47999999999999998 108.121 -177.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.583 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.5 mppt? -56.36 103.03 0.09 Allowed 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 109.248 -0.649 . . . . 0.98999999999999999 109.248 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.61 -6.89 6.59 Favored Glycine 0 C--N 1.308 -0.981 0 CA-C-N 114.148 -1.387 . . . . 0.19 111.863 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.635 HG21 ' HB ' ' A' ' 457' ' ' VAL . 7.7 m -69.63 147.81 96.64 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 109.425 -0.583 . . . . 0.13 109.425 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.558 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 2.5 Cg_endo -90.26 151.62 4.58 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 122.683 2.255 . . . . 0.17999999999999999 110.005 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' A' ' 382' ' ' PHE . 1.6 t -121.57 133.54 67.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 114.686 -1.143 . . . . 0.56999999999999995 109.088 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.686 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.3 mp -133.04 148.5 52.21 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 119.494 -0.882 . . . . 0.13 109.684 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.111 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.11 141.57 33.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.132 -2.174 . . . . 0.10000000000000001 105.132 166.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.75 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 12.8 p90 . . . . . 0 C--O 1.246 0.915 0 O-C-N 123.568 0.543 . . . . 1.0900000000000001 111.476 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.794 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 N-CA-C 112.004 -0.438 . . . . 1.8700000000000001 112.004 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.555 ' CD2' HD11 ' A' ' 464' ' ' LEU . 4.3 p-80 -139.43 103.4 4.71 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.107 0.41 . . . . 0.83999999999999997 112.107 177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.58 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.1 OUTLIER 60.93 -168.61 0.17 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.12 -0.945 . . . . 0.67000000000000004 113.058 166.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -58.73 171.2 0.67 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.299 -0.864 . . . . 1.8500000000000001 110.022 162.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.23 82.34 7.14 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 118.685 -1.206 . . . . 0.42999999999999999 109.318 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 99.5 m -158.95 135.24 9.14 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.288 -1.324 . . . . 0.14000000000000001 108.78 168.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.652 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.6 p90 174.64 158.09 0.16 Allowed 'General case' 0 C--O 1.211 -0.964 0 O-C-N 123.326 0.391 . . . . 0.14999999999999999 111.348 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.663 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.74 151.79 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 109.107 -0.701 . . . . 0.080000000000000002 109.107 164.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.577 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.2 tt0 -149.64 142.69 24.92 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.591 -0.731 . . . . 2.0099999999999998 109.568 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.725 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.67 161.69 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 121.019 0.438 . . . . 0.45000000000000001 111.019 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.534 ' N ' HG12 ' A' ' 347' ' ' VAL . 31.7 t0 -140.03 105.72 5.13 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.158 -1.423 . . . . 0.23999999999999999 107.158 173.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.089 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -81.24 -35.09 31.64 Favored 'General case' 0 CA--C 1.481 -1.678 0 CA-C-O 122.838 1.304 . . . . 0.16 110.212 -168.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.444 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.8 mt-10 -55.27 -44.89 76.03 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-N 110.706 -2.952 . . . . 0.59999999999999998 108.063 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 18.3 m-80 -100.44 5.51 44.26 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 110.932 -2.849 . . . . 0.20000000000000001 110.904 -175.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.557 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.6 OUTLIER 34.79 61.15 0.6 Allowed 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 112.794 -2.003 . . . . 2.1499999999999999 112.981 -174.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.494 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.4 t60 -141.58 134.96 29.57 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.714 -0.675 . . . . 0.089999999999999997 109.863 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.729 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.37 156.55 23.23 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.84 -0.618 . . . . 0.070000000000000007 110.238 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.599 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.6 m-90 -142.06 155.33 45.38 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.551 -0.75 . . . . 0.11 111.195 -175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.698 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.9 t80 -110.42 153.17 25.37 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 106.582 -1.636 . . . . 0.26000000000000001 106.582 151.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.3 m-85 -128.51 115.97 18.96 Favored 'General case' 0 C--N 1.269 -2.893 0 CA-C-N 114.855 -1.066 . . . . 0.14000000000000001 110.289 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.6 tppt? -116.33 140.02 49.78 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 105.777 -1.934 . . . . 0.25 105.777 168.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.46 19.4 10.02 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.358 0.873 . . . . 0.42999999999999999 113.358 171.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 75.17 7.88 82.62 Favored Glycine 0 CA--C 1.489 -1.537 0 CA-C-N 115.573 -0.739 . . . . 0.17999999999999999 113.417 -173.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.0 ptmt -128.0 178.26 6.32 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 104.682 -2.34 . . . . 0.37 104.682 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.599 HG11 ' CD1' ' A' ' 355' ' ' TRP . 15.6 m -105.0 157.52 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 N-CA-C 116.205 1.928 . . . . 0.10000000000000001 116.205 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.68 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.03 -26.52 10.14 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 110.461 -3.063 . . . . 0.070000000000000007 106.358 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.833 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -135.04 143.7 46.86 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 111.511 -2.586 . . . . 0.059999999999999998 111.726 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.409 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 2.6 tt0 -142.01 117.77 10.45 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.673 -2.343 . . . . 0.47999999999999998 104.673 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.729 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.81 164.49 35.19 Favored 'General case' 0 N--CA 1.398 -3.053 0 C-N-CA 118.129 -1.428 . . . . 0.070000000000000007 111.548 -178.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.673 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 10.3 p-10 -103.3 133.12 48.91 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.366 -1.288 . . . . 1.8 109.633 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.702 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -134.07 -173.63 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 122.345 1.069 . . . . 0.12 112.307 -171.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.578 HG11 HE22 ' A' ' 426' ' ' GLN . 0.5 OUTLIER -151.48 121.81 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 112.904 -1.953 . . . . 0.10000000000000001 108.491 172.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.537 ' HB3' HD12 ' A' ' 349' ' ' LEU . 56.9 p -77.69 -168.83 1.3 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 112.678 -2.055 . . . . 1.26 111.418 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.48 167.24 42.65 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 118.536 -1.792 . . . . 0.14000000000000001 111.771 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 6.7 ptmt -74.48 155.76 87.39 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.413 0.625 . . . . 0.81000000000000005 111.633 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.704 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 78.8 Cg_exo -54.71 -30.07 64.82 Favored 'Trans proline' 0 CA--C 1.498 -1.318 1 C-N-CA 125.386 4.057 . . . . 0.28000000000000003 113.345 -173.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.451 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 20.0 p -70.79 -34.51 71.85 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.568 -1.651 . . . . 0.33000000000000002 109.706 -176.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.9 t -141.94 69.98 23.92 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 123.78 1.753 . . . . 0.39000000000000001 109.439 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.4 Cg_exo -58.49 166.07 6.75 Favored 'Trans proline' 0 C--N 1.316 -1.157 1 C-N-CA 126.918 5.079 . . . . 0.38 115.81 -170.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.478 HG21 ' HG ' ' A' ' 349' ' ' LEU . 0.5 OUTLIER -93.75 140.77 23.14 Favored Pre-proline 0 N--CA 1.419 -1.985 0 CA-C-N 114.458 -1.246 . . . . 0.81999999999999995 108.331 170.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.513 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 19.4 Cg_exo -76.33 -45.96 0.19 Allowed 'Trans proline' 0 CA--C 1.514 -0.48 0 C-N-CA 124.547 3.498 . . . . 0.19 112.081 -170.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.762 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 62.48 138.59 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.313 1.53 . . . . 0.13 113.597 -172.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.59 -111.66 0.51 Allowed Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 112.281 -2.236 . . . . 0.20000000000000001 109.471 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.92 119.38 44.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.743 0.782 . . . . 0.81999999999999995 110.461 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.725 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.8 m-85 -118.23 -173.86 2.54 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.168 -1.419 . . . . 0.22 107.168 172.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 1.9 t80 -141.05 123.43 15.82 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 120.623 -1.298 . . . . 0.65000000000000002 112.959 -171.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.48 91.98 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-O 123.105 1.431 . . . . 0.16 109.403 169.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -93.7 11.95 27.24 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.274 -1.785 . . . . 2.5499999999999998 108.199 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.776 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.7 t30 -168.64 126.41 1.06 Allowed 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 113.995 -1.457 . . . . 0.42999999999999999 110.162 171.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.663 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.34 141.87 33.57 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.747 -1.115 . . . . 1.1200000000000001 108.94 169.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.768 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 13.9 mm-40 -126.1 157.69 37.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 114.443 1.275 . . . . 0.70999999999999996 114.443 -167.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.72 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 47.3 mt-10 -137.73 127.2 24.93 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.013 -1.903 . . . . 0.38 108.613 173.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.6 t70 56.48 47.77 18.1 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 123.227 1.489 . . . . 0.40999999999999998 109.026 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.922 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -83.7 169.28 15.44 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 112.367 -2.197 . . . . 0.12 109.393 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 20.7 m -132.6 121.14 22.76 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.863 0.839 . . . . 0.17000000000000001 111.693 169.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.8 mp -80.35 89.17 5.54 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.829 -1.532 . . . . 0.56999999999999995 112.601 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.579 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.1 mttt -102.01 178.36 4.63 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 113.687 -1.597 . . . . 0.33000000000000002 113.117 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 139.28 -158.18 25.27 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.424 -1.262 . . . . 0.46000000000000002 111.988 -176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.6 m -124.25 138.32 54.41 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 120.103 -0.639 . . . . 0.70999999999999996 111.62 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.3 m-80 -58.1 156.88 8.82 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 114.92 -1.036 . . . . 0.83999999999999997 110.367 170.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . 0.573 ' HA ' ' CBD' ' A' ' 130' ' ' 1RG . 2.3 t70 -62.76 -1.79 0.96 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.15 -0.932 . . . . 2.2799999999999998 110.743 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.1 OUTLIER -115.77 6.14 14.32 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.455 -1.248 . . . . 2.27 111.372 -178.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 88.0 20.12 51.03 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 115.09 -0.959 . . . . 0.93999999999999995 112.196 169.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.441 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 14.2 p -113.96 100.45 52.42 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 114.339 -0.931 . . . . 0.81000000000000005 109.604 -175.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.4 Cg_endo -58.6 151.71 60.83 Favored 'Trans proline' 0 CA--C 1.504 -1.004 0 C-N-CA 122.651 2.234 . . . . 0.63 113.137 -177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -149.8 175.82 11.27 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.238 -1.346 . . . . 0.41999999999999998 112.653 -169.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.579 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.7 OUTLIER -145.23 149.77 35.51 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.064 -1.426 . . . . 0.53000000000000003 110.161 172.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.14 97.23 4.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.177 -1.045 . . . . 0.19 108.177 169.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.2 Cg_exo -69.02 109.55 2.19 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.851 1.701 . . . . 0.19 110.26 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.922 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.97 157.48 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-N 113.194 -1.821 . . . . 0.14999999999999999 107.697 -167.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.72 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.9 m-80 -89.7 -20.61 23.4 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.016 -0.735 . . . . 0.51000000000000001 109.016 -174.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.768 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 87.8 m-85 -158.45 126.43 5.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.968 -1.015 . . . . 0.27000000000000002 108.508 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.68 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.3 t-105 -144.52 134.89 24.43 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.781 0.8 . . . . 0.089999999999999997 111.295 -167.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.663 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -116.71 92.63 38.57 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 107.609 -1.256 . . . . 0.14000000000000001 107.609 172.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.776 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.3 Cg_endo -66.92 75.94 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.434 2.09 . . . . 0.5 111.68 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.581 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.3 pt -76.22 179.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 109.057 -0.72 . . . . 0.88 109.057 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.658 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 7.3 t70 -150.64 -165.74 2.35 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.011 -0.737 . . . . 2.4900000000000002 109.011 -168.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.658 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 8.4 m-90 82.91 -56.73 0.17 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 123.985 0.803 . . . . 1.9199999999999999 111.252 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.513 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 76.2 p -120.67 -5.77 9.7 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.357 -0.838 . . . . 0.94999999999999996 112.302 -165.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.434 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 101.54 -26.67 23.67 Favored Glycine 0 CA--C 1.503 -0.669 0 C-N-CA 120.522 -0.847 . . . . 0.68000000000000005 112.466 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 419' ' ' GLY . 43.1 t -56.19 173.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.343 0.657 . . . . 0.75 111.641 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.6 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -175.06 121.52 0.83 Allowed Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.17 -1.172 . . . . 0.20000000000000001 110.17 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.708 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.7 141.78 14.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.928 -0.397 . . . . 0.28999999999999998 109.928 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.678 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.5 p80 -159.89 161.59 34.4 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 116.097 -0.501 . . . . 0.089999999999999997 111.338 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.69 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -82.24 147.68 28.81 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.988 -1.115 . . . . 1.0700000000000001 107.988 171.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 445' ' ' THR . 29.4 t -132.83 96.91 3.9 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.813 0.815 . . . . 0.23000000000000001 109.843 -173.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.16 -15.84 56.19 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.15 -1.386 . . . . 0.41999999999999998 109.353 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.751 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 13.3 p90 -89.27 -24.64 22.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.08 -1.418 . . . . 0.32000000000000001 111.646 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.578 HE22 HG11 ' A' ' 369' ' ' VAL . 1.3 tt0 -97.86 114.46 65.06 Favored Pre-proline 0 CA--C 1.505 -0.751 0 CA-C-O 122.754 1.264 . . . . 1.74 110.146 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.562 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 44.6 Cg_endo -86.42 -10.24 6.61 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 124.13 3.22 . . . . 0.72999999999999998 113.048 -173.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.644 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.0 pm0 -111.59 153.52 26.18 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 122.248 1.023 . . . . 2.1600000000000001 113.464 174.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.713 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.67 129.22 3.51 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 112.722 -2.035 . . . . 0.33000000000000002 105.672 173.033 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.59 -158.07 30.55 Favored Glycine 0 C--N 1.284 -2.361 0 N-CA-C 110.538 -1.025 . . . . 0.17000000000000001 110.538 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.433 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -45.3 174.58 0.01 OUTLIER Glycine 0 CA--C 1.498 -0.979 0 C-N-CA 120.217 -0.992 . . . . 0.20999999999999999 111.66 167.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.537 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -52.01 101.89 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 123.386 1.565 . . . . 1.8500000000000001 113.76 -154.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.712 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.27 -37.92 10.32 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 112.575 -2.102 . . . . 1.21 109.798 170.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.684 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.4 p-90 -53.94 -27.28 30.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.442 -0.799 . . . . 0.16 112.39 -170.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.704 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -89.39 -34.07 16.64 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.593 0.59 . . . . 0.22 112.593 -177.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.4 p -92.75 -42.42 9.58 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.045 -0.979 . . . . 0.25 110.812 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.712 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.5 mtp180 -93.89 -18.36 22.05 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.971 -1.013 . . . . 1.8200000000000001 110.062 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.56 50.52 48.1 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 115.811 1.084 . . . . 0.23999999999999999 115.811 161.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 17.5 m -82.56 111.37 18.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 119.145 1.473 . . . . 1.01 111.237 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.539 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 59.0 m-70 34.18 -120.65 0.09 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.827 -1.079 . . . . 0.5 113.412 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -130.99 -18.76 1.32 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.986 -0.626 . . . . 0.26000000000000001 113.741 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.783 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.5 p -103.62 -165.63 1.18 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 112.816 0.673 . . . . 0.34999999999999998 112.816 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.51 HD13 HG11 ' A' ' 465' ' ' VAL . 2.2 mp -95.86 132.79 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.121 -0.945 . . . . 0.12 110.825 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.82 98.06 7.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.936 -0.575 . . . . 0.62 110.26 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.702 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.5 m -93.88 140.17 22.9 Favored Pre-proline 0 N--CA 1.439 -0.997 0 CA-C-N 115.392 -0.822 . . . . 0.10000000000000001 113.206 -176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.712 ' O ' HG22 ' A' ' 449' ' ' VAL . 74.1 Cg_exo -51.97 135.75 51.51 Favored 'Trans proline' 0 CA--C 1.496 -1.392 0 C-N-CA 124.629 3.553 . . . . 0.23999999999999999 115.532 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.713 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 50.0 Cg_exo -56.76 -38.82 94.88 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.279 1.319 . . . . 0.31 111.618 -167.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.604 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 21.0 m -62.46 -25.61 68.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.225 0.824 . . . . 1.1000000000000001 113.225 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.833 ' O ' HD21 ' A' ' 364' ' ' LEU . 22.6 m -98.42 -47.76 12.26 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 O-C-N 121.33 -0.856 . . . . 0.080000000000000002 112.997 -169.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.956 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.49 -1.98 5.76 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.613 -0.835 . . . . 0.070000000000000007 110.344 -179.176 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 448' ' ' SER . 14.2 pttp -80.78 -38.59 28.28 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 122.67 1.224 . . . . 0.92000000000000004 108.294 173.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.8 mm-40 -61.6 -46.58 89.24 Favored 'General case' 0 CA--C 1.47 -2.104 0 CA-C-N 112.305 -2.225 . . . . 0.25 106.36 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.956 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -47.23 -66.59 0.38 Allowed 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 109.766 -3.379 . . . . 0.050000000000000003 112.688 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.473 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 19.0 t80 -45.71 -23.86 0.3 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 123.935 0.772 . . . . 0.13 109.581 176.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.46 -26.64 27.22 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 114.789 -1.096 . . . . 0.13 111.772 -175.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.736 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.96 -44.64 5.43 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 113.462 0.912 . . . . 0.059999999999999998 113.462 177.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.658 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.98 148.03 9.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.495 1.141 . . . . 0.080000000000000002 111.402 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.04 156.72 28.11 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 113.005 -1.907 . . . . 0.47999999999999998 108.772 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.616 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 43.1 mtmt -57.28 102.99 0.1 Allowed 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.659 0.742 . . . . 0.98999999999999999 109.686 170.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.96 -10.78 6.26 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 113.837 -1.529 . . . . 0.19 111.369 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.658 HG21 ' HB ' ' A' ' 457' ' ' VAL . 17.0 m -66.72 149.34 98.34 Favored Pre-proline 0 N--CA 1.438 -1.04 0 N-CA-C 108.842 -0.799 . . . . 0.13 108.842 171.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.58 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 4.7 Cg_endo -93.67 159.07 2.35 Favored 'Trans proline' 0 N--CA 1.426 -2.499 0 C-N-CA 122.411 2.074 . . . . 0.17999999999999999 109.866 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.725 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -124.46 148.83 28.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 107.504 -1.295 . . . . 0.56999999999999995 107.504 172.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.694 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.7 mp -134.01 150.2 51.23 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.463 -0.94 . . . . 0.13 108.463 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.089 HG23 HD21 ' A' ' 349' ' ' LEU . 0.8 OUTLIER -138.72 141.99 35.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 105.113 -2.18 . . . . 0.10000000000000001 105.113 165.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.762 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 12.1 p90 . . . . . 0 C--O 1.245 0.822 0 O-C-N 123.688 0.617 . . . . 1.0900000000000001 111.064 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.813 ' HBA' ' OAU' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 112.077 -0.409 . . . . 1.8700000000000001 112.077 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.5 ' CD2' HD11 ' A' ' 464' ' ' LEU . 2.1 p-80 -146.0 106.59 4.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.923 0.342 . . . . 0.83999999999999997 111.923 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.577 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.1 OUTLIER 62.01 -167.23 0.2 Allowed 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.826 0.704 . . . . 0.67000000000000004 112.785 167.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -63.34 170.38 3.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.342 -1.355 . . . . 1.8500000000000001 107.342 164.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.43 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 4.9 m-20 -81.68 83.72 7.01 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 118.888 -1.125 . . . . 0.42999999999999999 109.278 -176.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 357' ' ' TYR . 88.0 m -158.43 134.72 9.33 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.512 -1.222 . . . . 0.14000000000000001 109.104 169.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.668 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.8 p90 174.15 158.82 0.15 Allowed 'General case' 0 CA--C 1.501 -0.926 0 O-C-N 123.42 0.45 . . . . 0.14999999999999999 111.112 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.639 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.62 151.85 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.231 0 N-CA-C 109.039 -0.726 . . . . 0.080000000000000002 109.039 164.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.611 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.21 140.91 23.53 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.583 -0.735 . . . . 2.0099999999999998 109.543 -176.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.719 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -134.7 162.03 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.095 0.474 . . . . 0.45000000000000001 111.287 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.557 ' N ' HG12 ' A' ' 347' ' ' VAL . 27.8 t0 -140.26 106.8 5.32 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.205 -1.406 . . . . 0.23999999999999999 107.205 174.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.079 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.57 -33.77 25.33 Favored 'General case' 0 CA--C 1.488 -1.41 0 CA-C-O 123.378 1.561 . . . . 0.16 110.21 -169.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.444 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.4 mt-10 -57.17 -44.88 83.93 Favored 'General case' 0 CA--C 1.49 -1.332 0 CA-C-N 110.625 -2.989 . . . . 0.59999999999999998 107.908 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 19.2 m-80 -102.4 4.84 39.29 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 111.155 -2.748 . . . . 0.20000000000000001 111.227 -175.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 349' ' ' LEU . 29.6 mt-30 32.69 63.54 0.3 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 112.857 -1.974 . . . . 2.1499999999999999 113.748 -175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.524 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.3 t60 -142.05 135.31 29.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.914 -1.039 . . . . 0.089999999999999997 109.332 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.756 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.16 156.4 23.28 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.781 -0.645 . . . . 0.070000000000000007 110.067 -178.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.609 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.7 m-90 -142.01 155.13 45.42 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.184 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.693 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 86.3 t80 -110.26 153.31 25.02 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 106.61 -1.626 . . . . 0.26000000000000001 106.61 151.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 11.7 m-85 -127.65 118.77 24.48 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 114.936 -1.029 . . . . 0.14000000000000001 110.416 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.2 tppt? -120.0 136.83 54.41 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.96 -1.867 . . . . 0.25 105.96 168.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.422 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.55 17.8 7.86 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 113.481 0.919 . . . . 0.42999999999999999 113.481 174.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.43 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.67 8.34 87.2 Favored Glycine 0 CA--C 1.485 -1.793 0 C-N-CA 120.825 -0.702 . . . . 0.17999999999999999 112.918 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.4 ptmt -129.08 177.7 6.94 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 104.564 -2.384 . . . . 0.37 104.564 178.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.609 HG11 ' CD1' ' A' ' 355' ' ' TRP . 18.1 m -104.12 157.69 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.752 0 N-CA-C 116.344 1.979 . . . . 0.10000000000000001 116.344 -175.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.693 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.8 -27.67 9.63 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 110.513 -3.04 . . . . 0.070000000000000007 106.493 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.817 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.82 144.58 49.07 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 111.495 -2.593 . . . . 0.059999999999999998 111.535 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.441 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.5 tt0 -140.43 118.22 11.71 Favored 'General case' 0 N--CA 1.406 -2.64 0 N-CA-C 104.53 -2.396 . . . . 0.47999999999999998 104.53 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.756 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.05 163.41 38.23 Favored 'General case' 0 N--CA 1.397 -3.089 0 C-N-CA 117.626 -1.63 . . . . 0.070000000000000007 111.869 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.709 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 11.9 p-10 -101.96 134.14 45.65 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 114.027 -1.442 . . . . 1.8 109.545 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.731 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.11 -173.59 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 CA-C-O 122.26 1.029 . . . . 0.12 112.457 -172.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.47 118.63 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.075 -1.875 . . . . 0.10000000000000001 107.722 173.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.521 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -79.42 -167.98 1.38 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.127 -1.397 . . . . 1.26 110.773 -177.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.402 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.45 164.45 39.88 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 118.639 -1.743 . . . . 0.14000000000000001 112.407 -173.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 11.0 ptmt -70.97 158.05 89.0 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.639 0.733 . . . . 0.81000000000000005 111.698 -167.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.674 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.4 Cg_exo -57.83 -29.48 86.23 Favored 'Trans proline' 0 CA--C 1.5 -1.191 0 C-N-CA 125.184 3.923 . . . . 0.28000000000000003 113.348 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.46 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 17.8 p -71.76 -32.76 68.03 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.608 -1.633 . . . . 0.33000000000000002 109.725 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.538 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.5 t -141.07 70.47 28.43 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-O 123.807 1.765 . . . . 0.39000000000000001 109.31 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.0 Cg_exo -58.94 162.79 12.64 Favored 'Trans proline' 0 C--N 1.312 -1.358 1 C-N-CA 126.486 4.791 . . . . 0.38 115.165 -171.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.521 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -96.06 141.99 23.93 Favored Pre-proline 0 N--CA 1.419 -1.979 0 CA-C-N 114.729 -1.123 . . . . 0.81999999999999995 108.503 171.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 19.6 Cg_exo -76.31 -44.56 0.24 Allowed 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 124.719 3.612 . . . . 0.19 111.95 -167.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.784 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 61.49 138.05 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 123.328 1.537 . . . . 0.13 113.467 -172.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 153.0 -114.43 0.62 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 112.201 -2.272 . . . . 0.20000000000000001 109.362 -178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.73 117.21 37.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.892 0.854 . . . . 0.81999999999999995 110.661 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.744 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.9 m-85 -115.58 -174.04 2.45 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.147 -1.427 . . . . 0.22 107.147 173.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.49 ' HB2' ' CZ2' ' A' ' 415' ' ' TRP . 1.0 OUTLIER -139.46 123.49 17.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 119.987 1.267 . . . . 0.65000000000000002 113.41 -171.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.06 92.23 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 123.06 1.41 . . . . 0.16 109.337 168.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -94.22 11.96 28.39 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 113.428 -1.714 . . . . 2.5499999999999998 108.18 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.767 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 9.0 t30 -169.37 126.65 0.93 Allowed 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 113.972 -1.467 . . . . 0.42999999999999999 110.174 172.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.631 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.16 145.99 26.61 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.064 -0.971 . . . . 1.1200000000000001 109.098 168.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.751 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 19.5 mm-40 -126.29 159.2 33.76 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 114.509 1.3 . . . . 0.70999999999999996 114.509 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.752 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 40.1 mt-10 -138.37 127.52 24.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.211 -1.813 . . . . 0.38 108.674 173.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.9 t70 56.81 45.52 21.48 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 123.338 1.542 . . . . 0.40999999999999998 108.729 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.936 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.77 166.6 20.84 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 112.513 -2.13 . . . . 0.12 109.177 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 16.9 m -132.08 120.65 22.64 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.091 0.948 . . . . 0.17000000000000001 111.551 170.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -81.13 88.6 5.99 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.871 -1.513 . . . . 0.56999999999999995 112.048 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.3 mttt -102.01 179.29 4.37 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 113.585 -1.643 . . . . 0.33000000000000002 113.129 177.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.78 -160.88 25.37 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-N 114.17 -1.377 . . . . 0.46000000000000002 111.421 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.5 m -114.22 141.21 47.83 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 120.108 -0.637 . . . . 0.70999999999999996 110.757 170.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.1 m-80 -59.48 156.22 13.58 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.108 -0.951 . . . . 0.83999999999999997 109.349 168.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.95 -3.39 1.61 Allowed 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 114.873 -1.058 . . . . 2.2799999999999998 110.685 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.0 OUTLIER -113.04 5.88 17.39 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.874 -1.057 . . . . 2.27 111.128 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.16 18.64 49.33 Favored Glycine 0 N--CA 1.434 -1.486 0 C-N-CA 120.423 -0.894 . . . . 0.93999999999999995 112.433 170.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.427 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 11.6 p -113.82 101.27 53.69 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 114.37 -0.915 . . . . 0.81000000000000005 109.832 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 19.3 Cg_endo -59.21 150.68 72.46 Favored 'Trans proline' 0 CA--C 1.506 -0.919 0 C-N-CA 122.825 2.35 . . . . 0.63 113.55 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -151.83 174.27 13.76 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.328 -1.305 . . . . 0.41999999999999998 113.041 -170.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER -144.78 148.04 33.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.875 -1.511 . . . . 0.53000000000000003 110.151 172.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.81 97.33 4.96 Favored Pre-proline 0 N--CA 1.436 -1.153 0 N-CA-C 108.275 -1.009 . . . . 0.19 108.275 170.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 18.1 Cg_exo -69.04 111.1 2.57 Favored 'Trans proline' 0 N--CA 1.435 -1.931 0 C-N-CA 122.065 1.843 . . . . 0.19 110.023 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.936 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.99 153.45 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 CA-C-N 112.958 -1.928 . . . . 0.14999999999999999 107.626 -167.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.752 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 21.5 m-80 -86.14 -20.44 28.64 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.902 -0.777 . . . . 0.51000000000000001 108.902 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.4 m-85 -159.0 127.31 5.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.12 -0.945 . . . . 0.27000000000000002 108.643 -170.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.677 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 23.3 t-105 -145.12 134.35 22.86 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.641 0.734 . . . . 0.089999999999999997 111.185 -167.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.631 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.5 mmt -116.44 93.69 40.72 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.908 -1.145 . . . . 0.14000000000000001 107.908 173.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.767 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 39.0 Cg_endo -67.81 73.76 0.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.311 2.007 . . . . 0.5 112.239 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.58 HG12 ' HA2' ' A' ' 419' ' ' GLY . 2.9 pt -72.86 175.64 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.134 -1.062 . . . . 0.88 108.134 176.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 416' ' ' THR . 1.1 t70 -151.31 -170.57 3.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 118.852 -1.139 . . . . 2.4900000000000002 112.749 -167.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.49 ' CZ2' ' HB2' ' A' ' 383' ' ' TYR . 41.2 p90 52.14 -0.99 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.953 2.101 . . . . 1.9199999999999999 114.542 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.512 HG21 ' CE1' ' A' ' 382' ' ' PHE . 35.5 p -130.83 -15.21 3.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.143 0.497 . . . . 0.94999999999999996 111.089 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.548 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 95.29 -32.55 6.1 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.138 -0.785 . . . . 0.68000000000000005 111.138 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 419' ' ' GLY . 36.5 t -56.85 172.33 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.002 0.921 . . . . 0.75 111.943 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.597 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.84 121.4 0.75 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 109.931 -1.268 . . . . 0.20000000000000001 109.931 171.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.705 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.66 143.09 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 110.034 -0.358 . . . . 0.28999999999999998 110.034 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.677 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.4 p80 -160.58 162.11 32.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.245 -0.434 . . . . 0.089999999999999997 111.409 -174.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.66 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -84.45 145.86 27.93 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.947 -1.131 . . . . 1.0700000000000001 107.947 172.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.579 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 30.2 t -134.17 98.63 4.17 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.745 0.783 . . . . 0.23000000000000001 110.5 -171.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -80.12 -10.79 59.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.117 -1.401 . . . . 0.41999999999999998 109.418 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.727 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 10.5 p90 -95.93 -26.71 15.48 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.592 -1.185 . . . . 0.32000000000000001 112.421 -174.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.579 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.9 OUTLIER -91.65 110.59 44.38 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-O 122.53 1.157 . . . . 1.74 108.619 177.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 61.4 Cg_endo -84.36 -17.21 5.51 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 124.336 3.357 . . . . 0.72999999999999998 113.082 -172.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.522 ' HG3' ' HG ' ' A' ' 433' ' ' LEU . 0.7 OUTLIER -112.08 156.86 21.54 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-O 122.205 1.002 . . . . 2.1600000000000001 111.779 174.076 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.709 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.9 OUTLIER -159.58 124.84 4.11 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 105.129 -2.175 . . . . 0.33000000000000002 105.129 173.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.09 -157.75 30.16 Favored Glycine 0 C--N 1.284 -2.333 0 C-N-CA 119.46 -1.352 . . . . 0.17000000000000001 111.354 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -46.26 173.48 0.02 OUTLIER Glycine 0 CA--C 1.501 -0.805 0 C-N-CA 120.609 -0.805 . . . . 0.20999999999999999 111.694 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.598 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 6.3 p-10 -52.57 100.8 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 123.743 1.735 . . . . 1.8500000000000001 114.035 -150.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.722 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.55 -43.58 7.53 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 111.805 -2.452 . . . . 1.21 109.721 170.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.718 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.5 p-90 -52.12 -27.31 13.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.718 -0.674 . . . . 0.16 112.504 -171.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.718 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.89 -32.56 15.98 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.397 0.618 . . . . 0.22 112.452 -177.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.8 p -94.15 -43.24 8.57 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.951 -1.022 . . . . 0.25 111.069 -176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.722 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.2 OUTLIER -87.59 -20.18 26.77 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.768 -1.106 . . . . 1.8200000000000001 109.153 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.59 47.7 63.02 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 113.631 -1.622 . . . . 0.23999999999999999 115.138 164.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.5 p -82.88 110.23 17.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 118.962 1.381 . . . . 1.01 111.675 -171.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.442 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 72.2 m-70 33.54 -117.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.291 -1.322 . . . . 0.5 113.47 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.402 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -135.57 -16.32 0.91 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.906 -0.664 . . . . 0.26000000000000001 113.79 -174.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.802 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.1 p -103.57 -166.56 1.27 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.834 0.817 . . . . 0.34999999999999998 112.621 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.429 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -96.16 129.41 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.107 -0.952 . . . . 0.12 110.736 -175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.59 93.41 5.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.976 -0.556 . . . . 0.62 110.332 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.731 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -89.14 141.98 29.7 Favored Pre-proline 0 N--CA 1.438 -1.038 0 CA-C-N 115.234 -0.894 . . . . 0.10000000000000001 112.549 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.643 ' HD2' HG21 ' A' ' 366' ' ' THR . 87.1 Cg_exo -49.61 144.77 18.58 Favored 'Trans proline' 0 CA--C 1.506 -0.89 0 C-N-CA 124.158 3.239 . . . . 0.23999999999999999 113.549 175.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.658 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.7 Cg_exo -65.12 -27.02 57.19 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.855 2.37 . . . . 0.31 112.234 -175.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 11.9 m -76.31 -23.9 54.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.863 -0.608 . . . . 1.1000000000000001 112.237 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.817 ' O ' HD21 ' A' ' 364' ' ' LEU . 30.8 m -100.59 -48.7 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 113.009 0.744 . . . . 0.080000000000000002 113.009 -169.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.945 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.87 -2.1 4.78 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.847 -0.741 . . . . 0.070000000000000007 110.353 -178.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.8 pttp -80.81 -39.43 26.7 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.085 -1.08 . . . . 0.92000000000000004 108.085 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.4 mm-40 -61.45 -45.9 92.32 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 112.578 -2.101 . . . . 0.25 106.46 -177.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.945 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.5 tp -47.69 -67.12 0.3 Allowed 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 109.701 -3.409 . . . . 0.050000000000000003 112.719 172.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.564 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 14.4 t80 -45.93 -23.28 0.27 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.794 0.807 . . . . 0.13 109.562 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.15 -26.01 27.29 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.72 -1.127 . . . . 0.13 111.842 -176.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.733 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -102.71 -43.91 5.45 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 113.504 0.927 . . . . 0.059999999999999998 113.504 177.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.682 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -73.47 150.38 7.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 122.523 1.154 . . . . 0.080000000000000002 111.196 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -120.84 156.77 31.23 Favored 'General case' 0 N--CA 1.414 -2.255 0 CA-C-N 112.978 -1.919 . . . . 0.47999999999999998 108.418 -177.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.59 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.2 mppt? -59.34 101.86 0.12 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.888 -0.782 . . . . 0.98999999999999999 108.888 171.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.3 -11.74 5.81 Favored Glycine 0 C--N 1.306 -1.132 0 CA-C-N 113.955 -1.475 . . . . 0.19 111.482 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.682 HG21 ' HB ' ' A' ' 457' ' ' VAL . 15.6 m -66.65 149.33 98.29 Favored Pre-proline 0 N--CA 1.44 -0.964 0 N-CA-C 108.651 -0.87 . . . . 0.13 108.651 171.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.577 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.6 Cg_endo -93.72 160.63 2.31 Favored 'Trans proline' 0 N--CA 1.422 -2.707 0 C-N-CA 122.196 1.931 . . . . 0.17999999999999999 109.929 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.744 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -123.99 150.07 28.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.281 -1.377 . . . . 0.56999999999999995 107.281 171.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.712 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.08 149.06 51.11 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 108.179 -1.045 . . . . 0.13 108.179 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.079 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.74 142.25 36.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 105.266 -2.124 . . . . 0.10000000000000001 105.266 165.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.751 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 8.3 p90 . . . . . 0 C--O 1.244 0.79 0 O-C-N 123.83 0.706 . . . . 1.0900000000000001 110.787 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.802 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 111.945 -0.462 . . . . 1.8700000000000001 111.945 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.549 ' CE1' HD21 ' A' ' 464' ' ' LEU . 1.9 p-80 -122.35 111.88 17.42 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.685 0.242 . . . . 0.83999999999999997 111.523 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.798 ' HG3' ' O ' ' A' ' 341' ' ' GLU . 0.0 OUTLIER 60.97 -172.15 0.14 Allowed 'General case' 0 CA--C 1.543 0.696 0 O-C-N 124.121 0.888 . . . . 0.67000000000000004 111.983 165.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . 0.798 ' O ' ' HG3' ' A' ' 340' ' ' MET . 12.7 pt-20 -63.92 -179.5 0.41 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 107.872 -1.159 . . . . 1.8500000000000001 107.872 169.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.502 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 13.3 m-20 -82.36 82.69 7.74 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 117.618 -1.633 . . . . 0.42999999999999999 109.341 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 357' ' ' TYR . 97.2 m -159.78 135.61 8.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.8 -1.091 . . . . 0.14000000000000001 109.857 168.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.627 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.5 p90 173.02 159.7 0.12 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 123.192 0.308 . . . . 0.14999999999999999 110.812 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.649 HD12 HD11 ' A' ' 453' ' ' LEU . 0.3 OUTLIER -77.97 151.54 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 109.526 -0.546 . . . . 0.080000000000000002 109.526 164.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.612 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 35.1 tt0 -149.72 141.05 23.22 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.486 -0.779 . . . . 2.0099999999999998 109.626 -176.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.724 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -134.44 161.87 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 122.126 -0.359 . . . . 0.45000000000000001 111.104 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.559 ' N ' HG12 ' A' ' 347' ' ' VAL . 20.7 t0 -140.26 107.21 5.42 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.663 -1.236 . . . . 0.23999999999999999 107.663 173.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.06 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.55 -33.35 25.46 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-O 122.77 1.271 . . . . 0.16 110.273 -168.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.442 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.0 OUTLIER -59.72 -43.4 94.16 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 110.87 -2.877 . . . . 0.59999999999999998 108.261 177.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 19.1 m-80 -102.83 8.12 39.35 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 111.153 -2.749 . . . . 0.20000000000000001 110.749 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.56 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 15.3 mp0 32.93 61.27 0.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 112.906 -1.952 . . . . 2.1499999999999999 113.56 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.529 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 24.8 t60 -142.94 137.13 29.2 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.868 -0.605 . . . . 0.089999999999999997 109.86 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.716 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -114.48 156.53 24.39 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.994 -0.548 . . . . 0.070000000000000007 110.249 -179.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.595 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -142.21 154.18 44.6 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.482 -0.781 . . . . 0.11 111.191 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.698 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.5 t80 -110.15 153.11 25.18 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.491 -1.67 . . . . 0.26000000000000001 106.491 151.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.9 m-85 -127.61 117.12 21.41 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.883 -1.053 . . . . 0.14000000000000001 109.948 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.7 tppt? -118.13 140.05 50.35 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 105.854 -1.906 . . . . 0.25 105.854 168.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 66.65 17.21 10.57 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.597 0.962 . . . . 0.42999999999999999 113.597 171.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.502 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.97 8.06 87.41 Favored Glycine 0 CA--C 1.483 -1.954 0 CA-C-O 122.064 0.813 . . . . 0.17999999999999999 112.961 -175.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 16.1 ptmt -126.83 177.26 6.7 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 104.484 -2.413 . . . . 0.37 104.484 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.595 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.0 m -104.29 157.11 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.841 0 C-N-CA 116.982 -1.887 . . . . 0.10000000000000001 115.626 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.652 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -106.61 -28.23 10.37 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-N 110.544 -3.025 . . . . 0.070000000000000007 106.125 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.832 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -133.17 143.48 49.24 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 111.413 -2.63 . . . . 0.059999999999999998 111.896 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.436 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -139.98 117.55 11.51 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 104.361 -2.459 . . . . 0.47999999999999998 104.361 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.716 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.94 161.02 43.12 Favored 'General case' 0 N--CA 1.397 -3.11 0 C-N-CA 117.795 -1.562 . . . . 0.070000000000000007 110.691 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.17 141.61 32.77 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.448 -0.945 . . . . 1.8 108.448 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.717 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -138.66 -172.82 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 CA-C-O 122.54 1.162 . . . . 0.12 111.947 -173.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.561 HG11 HE22 ' A' ' 426' ' ' GLN . 0.5 OUTLIER -151.86 120.13 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 112.725 -2.034 . . . . 0.10000000000000001 108.197 173.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.533 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -80.13 -168.06 1.52 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.977 -1.465 . . . . 1.26 110.36 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.439 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.19 168.32 44.54 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 118.528 -1.796 . . . . 0.14000000000000001 112.26 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 5.3 ptmt -73.8 158.11 86.48 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 121.56 0.695 . . . . 0.81000000000000005 112.037 -165.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.694 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 82.3 Cg_exo -57.68 -30.66 89.68 Favored 'Trans proline' 0 CA--C 1.493 -1.555 0 C-N-CA 125.273 3.982 . . . . 0.28000000000000003 113.347 -172.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.413 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 22.7 p -68.61 -33.81 74.69 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.346 -1.752 . . . . 0.33000000000000002 109.325 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.713 HG21 ' NAX' ' A' ' 130' ' ' 1RG . 3.5 t -142.88 70.28 19.15 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 123.585 1.659 . . . . 0.39000000000000001 110.37 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 375' ' ' THR . 83.4 Cg_exo -58.99 157.43 29.2 Favored 'Trans proline' 0 C--N 1.314 -1.273 1 C-N-CA 126.601 4.868 . . . . 0.38 115.145 -171.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.533 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -86.37 147.87 45.57 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 115.192 -0.913 . . . . 0.81999999999999995 108.702 173.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 16.6 Cg_exo -78.08 -44.64 0.16 Allowed 'Trans proline' 0 CA--C 1.512 -0.592 0 C-N-CA 124.853 3.702 . . . . 0.19 112.417 -167.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.774 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.49 138.52 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 123.345 1.545 . . . . 0.13 113.639 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.69 -115.13 0.68 Allowed Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 112.27 -2.241 . . . . 0.20000000000000001 109.318 -177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.6 p -128.35 121.18 54.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.846 0.832 . . . . 0.81999999999999995 110.266 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.726 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.9 m-85 -118.32 -174.38 2.65 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 106.87 -1.529 . . . . 0.22 106.87 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 2.3 t80 -139.67 123.02 17.09 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 120.801 -1.187 . . . . 0.65000000000000002 112.937 -171.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.41 92.7 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 123.056 1.407 . . . . 0.16 109.544 170.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -92.94 10.82 29.64 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 113.317 -1.765 . . . . 2.5499999999999998 108.334 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.762 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.1 t30 -169.21 126.91 0.96 Allowed 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 114.149 -1.387 . . . . 0.42999999999999999 110.393 172.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.668 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.11 142.7 30.26 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.825 -1.079 . . . . 1.1200000000000001 108.944 168.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.693 ' HB2' ' HB3' ' A' ' 410' ' ' TRP . 23.7 mm-40 -123.9 162.44 23.33 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 114.835 1.42 . . . . 0.70999999999999996 114.835 -169.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 43.7 mt-10 -129.86 144.98 51.58 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 112.927 -1.942 . . . . 0.38 105.953 170.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.9 t70 39.51 47.66 1.65 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 122.766 1.269 . . . . 0.40999999999999998 109.834 172.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.958 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -82.8 168.15 17.42 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 111.937 -2.392 . . . . 0.12 108.977 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 10.2 m -132.04 119.5 21.11 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.948 0.88 . . . . 0.17000000000000001 111.24 170.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.9 mp -77.27 87.12 3.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.852 -1.522 . . . . 0.56999999999999995 111.787 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.546 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.3 mttt -102.44 -179.71 4.06 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 113.266 -1.788 . . . . 0.33000000000000002 113.406 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 138.86 -163.28 25.9 Favored Glycine 0 N--CA 1.432 -1.611 0 CA-C-N 114.34 -1.3 . . . . 0.46000000000000002 111.375 -176.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 0.9 OUTLIER -120.08 137.95 53.83 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 119.876 -0.73 . . . . 0.70999999999999996 111.129 172.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.6 m-80 -56.74 151.32 14.33 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 114.979 -1.009 . . . . 0.83999999999999997 109.084 167.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . 0.664 ' HB2' ' CAY' ' A' ' 130' ' ' 1RG . 0.6 OUTLIER -58.7 -2.6 0.23 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.329 -0.85 . . . . 2.2799999999999998 112.201 176.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 397' ' ' ASN . 21.9 t70 -113.17 0.33 14.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 122.013 0.911 . . . . 2.27 110.251 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.18 17.25 32.52 Favored Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 114.746 -1.115 . . . . 0.93999999999999995 112.872 171.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.422 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 14.3 p -110.21 98.96 37.9 Favored Pre-proline 0 C--N 1.301 -1.523 0 CA-C-N 114.723 -0.738 . . . . 0.81000000000000005 109.828 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.7 Cg_endo -59.46 149.92 78.67 Favored 'Trans proline' 0 CA--C 1.499 -1.271 0 C-N-CA 122.574 2.183 . . . . 0.63 112.577 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 29.9 p90 -147.42 172.14 14.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.228 -1.351 . . . . 0.41999999999999998 112.251 -169.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.546 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 1.3 mp0 -146.08 148.1 32.28 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.255 -1.339 . . . . 0.53000000000000003 110.779 174.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.79 97.55 4.94 Favored Pre-proline 0 N--CA 1.438 -1.048 0 N-CA-C 107.98 -1.119 . . . . 0.19 107.98 170.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 22.7 Cg_exo -68.58 110.24 2.26 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.076 1.851 . . . . 0.19 110.631 -177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.958 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.55 158.4 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 CA-C-N 113.036 -1.893 . . . . 0.14999999999999999 107.912 -168.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.631 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.8 OUTLIER -92.04 -19.43 22.37 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.934 -0.765 . . . . 0.51000000000000001 108.934 -174.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.9 m-85 -160.46 127.88 4.42 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.025 -1.102 . . . . 0.27000000000000002 108.025 -171.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.693 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 19.0 t-105 -144.93 131.51 19.87 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.746 0.784 . . . . 0.089999999999999997 111.561 -166.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.668 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.4 mmt -112.91 92.32 20.57 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 107.866 -1.161 . . . . 0.14000000000000001 107.866 172.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.762 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.7 Cg_endo -67.63 76.14 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.265 1.976 . . . . 0.5 111.626 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.604 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.5 pt -75.16 179.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.028 -0.73 . . . . 0.88 109.028 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.616 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 8.0 t70 -147.05 -167.3 2.74 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.246 -0.65 . . . . 2.4900000000000002 109.246 -168.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.616 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 12.8 m-90 82.8 -67.29 0.08 Allowed 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.962 0.789 . . . . 1.9199999999999999 112.264 177.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.406 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 71.4 p -108.01 -9.19 15.69 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.522 -0.763 . . . . 0.94999999999999996 112.108 -166.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.455 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 110.63 -29.85 8.66 Favored Glycine 0 CA--C 1.507 -0.409 0 C-N-CA 120.705 -0.759 . . . . 0.68000000000000005 112.713 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 419' ' ' GLY . 36.6 t -56.26 172.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.484 0.714 . . . . 0.75 112.115 -176.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.604 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -174.87 121.11 0.81 Allowed Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 110.084 -1.206 . . . . 0.20000000000000001 110.084 169.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.663 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.2 mp -82.09 142.22 13.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 110.107 -0.331 . . . . 0.28999999999999998 110.107 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.671 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.0 p80 -159.5 161.73 35.42 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.094 -0.503 . . . . 0.089999999999999997 111.37 -174.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.716 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -86.5 148.11 25.67 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.962 -1.125 . . . . 1.0700000000000001 107.962 172.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.6 t -133.14 96.57 3.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.907 0.86 . . . . 0.23000000000000001 110.136 -171.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -80.14 -16.2 55.42 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.103 -1.408 . . . . 0.41999999999999998 109.281 -176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.788 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 11.4 p90 -88.53 -24.63 22.87 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 113.825 -1.534 . . . . 0.32000000000000001 111.408 -177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.561 HE22 HG11 ' A' ' 369' ' ' VAL . 1.6 tt0 -97.68 116.38 65.78 Favored Pre-proline 0 CA--C 1.507 -0.681 0 CA-C-O 122.817 1.294 . . . . 1.74 110.351 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.568 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 42.6 Cg_endo -87.65 -9.78 5.56 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 124.217 3.278 . . . . 0.72999999999999998 113.22 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.586 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.9 pm0 -111.96 152.42 28.09 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 122.312 1.053 . . . . 2.1600000000000001 113.375 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.625 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.81 128.54 3.3 Favored 'General case' 0 CA--C 1.492 -1.27 0 CA-C-N 112.587 -2.097 . . . . 0.33000000000000002 105.769 171.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.35 -157.8 30.18 Favored Glycine 0 C--N 1.281 -2.502 0 C-N-CA 119.892 -1.147 . . . . 0.17000000000000001 110.404 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.43 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.88 173.89 0.01 OUTLIER Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.064 -1.065 . . . . 0.20999999999999999 111.574 167.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.517 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.4 p-10 -51.47 102.35 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 123.448 1.594 . . . . 1.8500000000000001 113.893 -152.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.712 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.56 -37.5 10.35 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-N 112.6 -2.091 . . . . 1.21 109.782 168.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.719 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.2 p-90 -53.9 -27.0 27.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.457 -0.792 . . . . 0.16 112.274 -170.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.719 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.46 -35.38 15.16 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 112.587 0.588 . . . . 0.22 112.587 -178.072 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.423 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.9 p -90.1 -42.56 11.02 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.07 -0.968 . . . . 0.25 110.943 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.712 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.1 mtp180 -92.94 -18.51 22.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.651 -1.159 . . . . 1.8200000000000001 109.524 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.24 49.17 45.16 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 115.642 1.017 . . . . 0.23999999999999999 115.642 160.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 28.3 m -83.75 111.49 19.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 119.162 1.481 . . . . 1.01 111.598 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 35.99 -115.69 0.1 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.594 0.961 . . . . 0.5 113.594 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.439 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -137.35 -20.31 0.56 Allowed Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.423 -0.808 . . . . 0.26000000000000001 113.64 -174.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.803 ' HB3' HASB ' A' ' 130' ' ' 1RG . 27.1 p -97.66 -167.26 1.5 Allowed 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.003 0.901 . . . . 0.34999999999999998 112.624 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.477 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -99.39 130.14 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 114.864 -1.062 . . . . 0.12 110.535 -175.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.88 94.32 5.75 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.763 -0.653 . . . . 0.62 110.198 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.717 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.3 m -90.41 144.41 30.78 Favored Pre-proline 0 N--CA 1.439 -0.984 0 CA-C-N 115.017 -0.992 . . . . 0.10000000000000001 112.555 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.654 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 73.0 Cg_exo -52.13 145.4 34.37 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 124.114 3.209 . . . . 0.23999999999999999 113.365 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.68 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 36.8 Cg_exo -66.3 -30.6 45.07 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.956 2.437 . . . . 0.31 112.392 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.516 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 13.8 m -72.13 -23.6 61.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.75 -0.659 . . . . 1.1000000000000001 111.725 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.832 ' O ' HD21 ' A' ' 364' ' ' LEU . 26.4 m -100.51 -49.38 11.17 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.945 0 N-CA-C 112.858 0.688 . . . . 0.080000000000000002 112.858 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.943 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.24 -2.1 5.41 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.707 -0.797 . . . . 0.070000000000000007 110.29 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.569 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 16.4 pttp -81.03 -38.08 28.05 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 122.505 1.145 . . . . 0.92000000000000004 108.137 173.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.9 mm-40 -62.83 -46.23 88.9 Favored 'General case' 0 CA--C 1.471 -2.084 0 CA-C-N 112.36 -2.2 . . . . 0.25 106.513 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.943 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.5 tp -47.78 -66.56 0.38 Allowed 'General case' 0 N--CA 1.405 -2.721 0 CA-C-N 109.843 -3.344 . . . . 0.050000000000000003 112.511 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.522 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 22.6 t80 -45.96 -23.27 0.28 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 123.903 0.752 . . . . 0.13 109.597 175.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.92 -25.04 28.18 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.849 -1.068 . . . . 0.13 111.878 -176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.737 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.73 -44.2 5.14 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 113.425 0.898 . . . . 0.059999999999999998 113.425 176.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -73.49 150.74 7.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-O 122.44 1.114 . . . . 0.080000000000000002 111.125 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.09 155.74 35.05 Favored 'General case' 0 N--CA 1.412 -2.332 0 CA-C-N 112.849 -1.978 . . . . 0.47999999999999998 108.602 -177.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.647 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 43.8 mtmt -55.96 102.14 0.07 Allowed 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.669 0.747 . . . . 0.98999999999999999 109.696 170.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.18 -8.93 6.67 Favored Glycine 0 C--N 1.304 -1.23 0 CA-C-N 113.762 -1.563 . . . . 0.19 111.716 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.658 HG21 ' HB ' ' A' ' 457' ' ' VAL . 9.0 m -68.37 149.46 98.04 Favored Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 108.833 -0.803 . . . . 0.13 108.833 172.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.4 Cg_endo -93.82 156.69 2.3 Favored 'Trans proline' 0 N--CA 1.424 -2.579 0 C-N-CA 122.3 2.0 . . . . 0.17999999999999999 109.906 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.726 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -121.9 149.03 25.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.554 -1.276 . . . . 0.56999999999999995 107.554 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.705 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.08 149.02 51.1 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.548 -0.908 . . . . 0.13 108.548 176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.06 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.35 141.4 39.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 105.589 -2.004 . . . . 0.10000000000000001 105.589 165.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.669 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 7.6 p90 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 117.469 -1.253 . . . . 1.0900000000000001 110.926 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.803 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.896 -0.481 . . . . 1.8700000000000001 111.896 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.717 ' CE1' HD21 ' A' ' 464' ' ' LEU . 2.2 p-80 -132.3 105.85 7.56 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.692 0.246 . . . . 0.83999999999999997 111.065 174.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.561 ' HE2' ' HD3' ' A' ' 462' ' ' PRO . 1.6 mtm 56.22 -162.58 0.17 Allowed 'General case' 0 C--O 1.232 0.163 0 O-C-N 124.136 0.897 . . . . 0.67000000000000004 111.675 167.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -153.21 0.08 Allowed 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 120.923 -0.311 . . . . 1.8500000000000001 110.892 166.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.492 ' HB3' ' N ' ' A' ' 360' ' ' GLY . 33.7 m-20 -95.49 83.8 3.87 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.296 -1.362 . . . . 0.42999999999999999 111.83 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.825 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 96.8 m -159.28 134.37 8.22 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.256 -0.884 . . . . 0.14000000000000001 109.021 163.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.693 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.5 p90 174.63 157.84 0.16 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-O 120.856 0.36 . . . . 0.14999999999999999 111.759 -175.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.599 HD11 HG11 ' A' ' 457' ' ' VAL . 0.2 OUTLIER -77.86 152.59 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 109.283 -0.636 . . . . 0.080000000000000002 109.283 164.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.558 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.1 tt0 -150.52 142.96 24.38 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.741 -0.663 . . . . 2.0099999999999998 109.415 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.713 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.6 t -134.62 162.37 38.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.124 0.488 . . . . 0.45000000000000001 111.382 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.549 ' N ' HG12 ' A' ' 347' ' ' VAL . 29.3 t0 -140.05 106.32 5.26 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.356 -1.35 . . . . 0.23999999999999999 107.356 173.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.046 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -83.11 -34.9 26.0 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 123.365 1.555 . . . . 0.16 110.075 -169.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.474 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 0.4 OUTLIER -54.91 -44.98 74.67 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 110.705 -2.952 . . . . 0.59999999999999998 107.692 176.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 23.5 m-80 -103.36 6.77 38.05 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 111.219 -2.718 . . . . 0.20000000000000001 111.563 -175.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.774 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 15.6 mm-40 32.82 62.35 0.35 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 112.791 -2.004 . . . . 2.1499999999999999 113.615 -175.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.491 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.0 t60 -141.47 135.15 29.98 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.213 -0.903 . . . . 0.089999999999999997 109.475 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.742 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -112.71 157.26 21.51 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.941 -0.572 . . . . 0.070000000000000007 110.375 -179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.59 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.3 m-90 -142.27 155.27 45.21 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.713 -0.676 . . . . 0.11 111.416 -175.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.825 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 88.2 t80 -111.2 153.34 25.96 Favored 'General case' 0 CA--C 1.483 -1.608 0 N-CA-C 106.811 -1.551 . . . . 0.26000000000000001 106.811 151.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 17.1 m-85 -127.42 119.18 25.56 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.947 -1.024 . . . . 0.14000000000000001 110.048 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.467 ' HB2' ' HE2' ' A' ' 356' ' ' TYR . 10.4 tppt? -123.14 112.89 18.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.097 -0.956 . . . . 0.25 108.547 173.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 358' ' ' LYS . 0.2 OUTLIER 75.97 41.26 0.24 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 123.914 0.759 . . . . 0.42999999999999999 112.683 -177.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.492 ' N ' ' HB3' ' A' ' 342' ' ' ASP . . . 59.24 16.79 35.79 Favored Glycine 0 CA--C 1.496 -1.14 0 CA-C-O 122.372 0.984 . . . . 0.17999999999999999 113.232 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 358' ' ' LYS . 14.9 ptmt -140.32 167.66 21.61 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 104.534 -2.395 . . . . 0.37 104.534 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.1 m -98.89 157.56 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.735 0 N-CA-C 116.057 1.873 . . . . 0.10000000000000001 116.057 -171.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.728 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.99 -27.51 9.18 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 110.357 -3.11 . . . . 0.070000000000000007 106.21 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.4 143.99 47.92 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 111.563 -2.562 . . . . 0.059999999999999998 111.846 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.484 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 2.9 tt0 -141.37 118.61 11.38 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 104.359 -2.46 . . . . 0.47999999999999998 104.359 175.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.742 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.29 165.55 32.67 Favored 'General case' 0 N--CA 1.403 -2.781 0 C-N-CA 118.07 -1.452 . . . . 0.070000000000000007 112.157 -179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.721 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 12.4 p-10 -102.05 135.44 43.62 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.174 -1.376 . . . . 1.8 109.63 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.714 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.3 pp -138.24 -173.06 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.252 0 CA-C-O 122.212 1.006 . . . . 0.12 112.754 -170.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.774 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -152.86 120.97 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 112.895 -1.957 . . . . 0.10000000000000001 109.468 171.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.596 ' H ' HE22 ' A' ' 352' ' ' GLN . 0.6 OUTLIER -77.95 -168.92 1.38 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.874 -1.512 . . . . 1.26 110.678 178.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.476 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -86.32 173.3 46.05 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.063 -1.541 . . . . 0.14000000000000001 112.272 -174.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 8.6 ptpt -78.54 158.38 76.19 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.614 0.721 . . . . 0.81000000000000005 111.921 -166.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 92.8 Cg_exo -56.64 -28.95 77.54 Favored 'Trans proline' 0 CA--C 1.498 -1.311 0 C-N-CA 125.273 3.982 . . . . 0.28000000000000003 113.234 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.468 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 16.9 p -69.52 -33.99 73.62 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.33 -1.759 . . . . 0.33000000000000002 109.855 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.529 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.7 t -140.73 70.35 30.6 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 123.841 1.781 . . . . 0.39000000000000001 108.801 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 375' ' ' THR . 85.4 Cg_exo -57.31 154.33 35.46 Favored 'Trans proline' 0 C--N 1.31 -1.465 1 C-N-CA 126.522 4.814 . . . . 0.38 115.447 -169.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.558 HG21 ' OG ' ' A' ' 370' ' ' SER . 2.2 m -80.6 130.74 63.43 Favored Pre-proline 0 N--CA 1.404 -2.76 0 CA-C-N 114.116 -1.402 . . . . 0.81999999999999995 108.611 172.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.1 Cg_exo -72.0 -43.86 1.07 Allowed 'Trans proline' 0 CA--C 1.511 -0.664 0 C-N-CA 123.599 2.866 . . . . 0.19 111.772 -170.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.807 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.19 137.73 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 123.412 1.577 . . . . 0.13 113.542 -173.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 154.3 -121.78 1.17 Allowed Glycine 0 N--CA 1.429 -1.8 0 CA-C-N 112.218 -2.264 . . . . 0.20000000000000001 109.401 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.404 HG22 ' CD2' ' A' ' 464' ' ' LEU . 72.5 t -125.23 110.65 25.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.345 0.593 . . . . 0.81999999999999995 110.632 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.75 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 5.1 m-85 -110.32 -173.87 2.35 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.405 -1.331 . . . . 0.22 107.405 174.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 2.4 t80 -141.27 121.92 14.26 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 120.844 -1.16 . . . . 0.65000000000000002 112.827 -172.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.6 p -82.81 92.71 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 CA-C-O 122.827 1.299 . . . . 0.16 108.839 170.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 49.6 p-90 -83.95 0.35 48.26 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 113.201 -1.818 . . . . 2.5499999999999998 107.806 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.791 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 5.9 t30 -170.33 128.18 0.84 Allowed 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 114.744 -1.116 . . . . 0.42999999999999999 110.662 177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.651 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -95.96 141.95 28.77 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.388 -0.823 . . . . 1.1200000000000001 109.086 169.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.763 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 9.9 mm-40 -126.75 159.95 32.27 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 114.786 1.402 . . . . 0.70999999999999996 114.786 -167.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 52.2 mt-10 -137.34 128.14 27.19 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.071 -1.877 . . . . 0.38 108.867 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.4 t70 53.91 45.22 28.18 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 123.386 1.565 . . . . 0.40999999999999998 108.884 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.925 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.03 167.64 20.18 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 112.104 -2.317 . . . . 0.12 109.477 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 16.9 m -132.46 119.06 20.11 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.051 0.929 . . . . 0.17000000000000001 111.903 171.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -78.41 88.66 4.4 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.693 -1.594 . . . . 0.56999999999999995 112.119 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.7 mttt -102.42 177.8 4.77 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 113.666 -1.606 . . . . 0.33000000000000002 113.811 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.93 -160.8 25.82 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 114.009 -1.45 . . . . 0.46000000000000002 111.414 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.7 m -115.71 144.19 44.31 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 120.279 -0.569 . . . . 0.70999999999999996 110.852 171.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 399' ' ' ASP . 4.8 m-80 -60.25 152.06 25.79 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.377 -0.829 . . . . 0.83999999999999997 109.331 166.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.0 -2.52 0.25 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.095 -0.957 . . . . 2.2799999999999998 112.172 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 397' ' ' ASN . 9.6 m-20 -114.28 0.94 14.32 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.422 0.63 . . . . 2.27 110.562 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.79 18.02 28.78 Favored Glycine 0 N--CA 1.427 -1.906 0 CA-C-N 114.889 -1.05 . . . . 0.93999999999999995 113.177 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 10.8 p -112.45 100.29 49.54 Favored Pre-proline 0 C--N 1.303 -1.413 0 CA-C-O 121.544 0.688 . . . . 0.81000000000000005 109.904 -175.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 19.2 Cg_endo -58.88 152.8 55.07 Favored 'Trans proline' 0 CA--C 1.503 -1.044 0 C-N-CA 122.867 2.378 . . . . 0.63 113.349 -176.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -152.35 173.14 15.43 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.507 -1.224 . . . . 0.41999999999999998 112.497 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER -145.71 147.19 31.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.025 -1.443 . . . . 0.53000000000000003 110.152 172.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.08 97.23 5.3 Favored Pre-proline 0 N--CA 1.437 -1.114 0 N-CA-C 108.38 -0.97 . . . . 0.19 108.38 172.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.9 Cg_exo -68.62 111.44 2.57 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 122.102 1.868 . . . . 0.19 110.268 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.925 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -111.72 155.18 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 CA-C-N 112.861 -1.972 . . . . 0.14999999999999999 107.746 -168.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.1 m-80 -86.86 -20.47 27.42 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.316 -0.624 . . . . 0.51000000000000001 109.316 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 97.7 m-85 -160.24 127.51 4.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.866 -1.061 . . . . 0.27000000000000002 108.189 -171.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.682 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 17.3 t-105 -142.95 131.27 22.11 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.591 0.71 . . . . 0.089999999999999997 111.07 -167.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.651 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 13.3 mmt -116.34 86.67 18.21 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.279 -1.008 . . . . 0.14000000000000001 108.279 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.791 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 15.0 Cg_endo -59.17 118.38 5.25 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 120.945 1.096 . . . . 0.5 109.372 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.578 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.8 pt -119.66 39.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 123.578 1.656 . . . . 0.88 106.603 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -91.98 125.2 36.58 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 112.367 -2.197 . . . . 2.4900000000000002 112.399 -158.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 1.7 p90 155.16 -23.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.371 1.868 . . . . 1.9199999999999999 106.615 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 8.5 t -105.06 -28.55 10.97 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.199 -1.364 . . . . 0.94999999999999996 109.734 172.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.478 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 136.88 -57.59 0.67 Allowed Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.002 -0.618 . . . . 0.68000000000000005 112.361 171.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 419' ' ' GLY . 22.1 t -54.91 173.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.13 0.972 . . . . 0.75 112.628 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.595 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.26 119.24 0.65 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.61 -0.996 . . . . 0.20000000000000001 110.61 170.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.639 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.5 mt -81.13 144.15 11.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 120.836 0.35 . . . . 0.28999999999999998 111.06 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.672 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.9 p80 -159.41 161.54 35.6 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.028 -0.533 . . . . 0.089999999999999997 111.218 -174.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.2 149.51 25.46 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.826 -1.176 . . . . 1.0700000000000001 107.826 171.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 445' ' ' THR . 34.3 t -133.31 96.5 3.75 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.553 0.692 . . . . 0.23000000000000001 110.034 -171.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.25 -15.29 53.58 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.736 -1.12 . . . . 0.41999999999999998 109.387 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.788 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 7.7 p90 -86.43 -23.07 26.2 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.658 -1.61 . . . . 0.32000000000000001 111.472 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.626 HE21 ' HG2' ' A' ' 428' ' ' GLU . 4.3 tt0 -92.92 131.05 34.33 Favored Pre-proline 0 CA--C 1.506 -0.739 0 CA-C-O 121.651 0.739 . . . . 1.74 111.118 -177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.556 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 64.3 Cg_endo -85.49 -27.03 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 123.193 2.596 . . . . 0.72999999999999998 113.377 176.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.626 ' HG2' HE21 ' A' ' 426' ' ' GLN . 0.9 OUTLIER -107.96 150.86 26.57 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 122.563 1.173 . . . . 2.1600000000000001 113.481 -178.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.721 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -157.35 132.04 8.64 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.101 -2.318 . . . . 0.33000000000000002 105.307 167.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.04 -159.57 32.84 Favored Glycine 0 C--N 1.283 -2.363 0 C-N-CA 120.095 -1.05 . . . . 0.17000000000000001 110.511 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -47.06 175.32 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 120.24 -0.981 . . . . 0.20999999999999999 111.621 168.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.515 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.4 p-10 -50.53 101.03 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.625 1.678 . . . . 1.8500000000000001 113.764 -154.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 1.018 HD22 ' HD2' ' A' ' 437' ' ' ARG . 34.7 mt -97.68 -37.89 9.73 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.007 -2.36 . . . . 1.21 107.858 168.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.708 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 64.8 p-90 -48.39 -34.39 10.74 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.182 0.438 . . . . 0.16 112.182 -172.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.708 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -83.96 -36.9 22.9 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.934 -0.576 . . . . 0.22 112.144 -175.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.486 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.8 p -88.09 -41.89 12.75 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.247 -0.888 . . . . 0.25 110.534 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 1.018 ' HD2' HD22 ' A' ' 433' ' ' LEU . 0.0 OUTLIER -93.8 -19.19 21.26 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.629 -1.169 . . . . 1.8200000000000001 110.067 -177.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.5 48.11 55.8 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 114.744 -1.116 . . . . 0.23999999999999999 114.875 163.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 35.2 m -85.2 111.73 20.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 118.71 1.255 . . . . 1.01 111.794 -173.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.434 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 66.3 m-70 36.35 -121.59 0.16 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.717 -1.129 . . . . 0.5 113.969 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.476 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -134.6 -12.87 1.32 Allowed Glycine 0 CA--C 1.522 0.485 0 C-N-CA 121.106 -0.569 . . . . 0.26000000000000001 113.967 -175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.856 ' HB3' HASB ' A' ' 130' ' ' 1RG . 28.4 p -104.27 -166.59 1.26 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.987 0.894 . . . . 0.34999999999999998 112.839 -176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.443 HD13 HG11 ' A' ' 465' ' ' VAL . 1.9 mp -97.49 131.4 44.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.023 -0.989 . . . . 0.12 110.665 -175.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.71 93.59 5.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.714 -0.676 . . . . 0.62 110.248 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.714 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -89.01 143.98 32.09 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 114.962 -1.017 . . . . 0.10000000000000001 112.578 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.659 ' HD2' HG21 ' A' ' 366' ' ' THR . 77.1 Cg_exo -52.17 145.58 34.03 Favored 'Trans proline' 0 CA--C 1.506 -0.896 0 C-N-CA 124.055 3.17 . . . . 0.23999999999999999 113.246 174.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.677 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.3 Cg_exo -65.39 -26.97 55.18 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.995 2.464 . . . . 0.31 112.552 -176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.479 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 52.1 p -75.7 -25.08 56.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.9 0.857 . . . . 1.1000000000000001 112.054 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.83 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.9 m -99.57 -50.49 10.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.556 -0.747 . . . . 0.080000000000000002 112.806 -171.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.946 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.43 -2.1 4.23 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.796 -0.762 . . . . 0.070000000000000007 110.37 -177.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.543 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.7 pttp -81.3 -39.04 25.81 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 122.417 1.104 . . . . 0.92000000000000004 108.05 173.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm-40 -61.63 -46.28 90.47 Favored 'General case' 0 CA--C 1.472 -2.036 0 CA-C-N 112.488 -2.142 . . . . 0.25 106.579 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.946 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.2 tp -47.05 -66.39 0.41 Allowed 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 109.713 -3.403 . . . . 0.050000000000000003 112.647 172.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.492 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 21.6 t80 -45.9 -23.69 0.31 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 123.9 0.75 . . . . 0.13 109.547 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.449 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.31 -25.65 27.93 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 114.791 -1.095 . . . . 0.13 111.97 -176.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.755 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.61 -44.9 4.98 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 113.566 0.95 . . . . 0.059999999999999998 113.566 177.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -71.45 145.96 12.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 122.587 1.184 . . . . 0.080000000000000002 111.026 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.499 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -114.55 156.07 25.3 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 112.894 -1.957 . . . . 0.47999999999999998 108.679 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.635 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 39.5 mtmt -59.31 103.27 0.17 Allowed 'General case' 0 N--CA 1.434 -1.229 0 CA-C-O 121.778 0.799 . . . . 0.98999999999999999 109.225 169.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 127.82 -10.18 6.72 Favored Glycine 0 C--N 1.302 -1.33 0 CA-C-N 113.592 -1.64 . . . . 0.19 111.403 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.684 HG21 ' HB ' ' A' ' 457' ' ' VAL . 6.1 m -67.81 149.75 98.1 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 108.067 -1.086 . . . . 0.13 108.067 169.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.561 ' HD3' ' HE2' ' A' ' 340' ' ' MET . 8.4 Cg_endo -94.75 167.3 1.71 Allowed 'Trans proline' 0 N--CA 1.416 -3.08 0 C-N-CA 121.943 1.762 . . . . 0.17999999999999999 109.589 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.75 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -128.37 153.86 38.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 108.109 -1.071 . . . . 0.56999999999999995 108.109 171.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.717 HD21 ' CE1' ' A' ' 339' ' ' HIS . 5.7 mp -134.26 151.14 51.12 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 108.621 -0.881 . . . . 0.13 108.621 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.046 HG23 HD21 ' A' ' 349' ' ' LEU . 0.6 OUTLIER -140.01 139.55 36.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 105.135 -2.172 . . . . 0.10000000000000001 105.135 165.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.695 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 13.4 p90 . . . . . 0 C--O 1.243 0.72 0 O-C-N 123.744 0.652 . . . . 1.0900000000000001 111.219 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.856 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 112.054 -0.418 . . . . 1.8700000000000001 112.054 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.57 ' CD2' HD11 ' A' ' 464' ' ' LEU . 2.0 p-80 -136.17 102.82 5.12 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.867 0.334 . . . . 0.83999999999999997 111.724 176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.554 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.2 OUTLIER 61.99 -165.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.059 0.849 . . . . 0.67000000000000004 112.458 167.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -66.27 172.92 3.5 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.11 -1.441 . . . . 1.8500000000000001 107.11 164.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.45 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 3.2 m-20 -81.9 83.05 7.33 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 119.256 -0.978 . . . . 0.42999999999999999 109.34 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 357' ' ' TYR . 97.6 m -158.55 136.21 10.31 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.589 -1.187 . . . . 0.14000000000000001 109.113 169.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.694 ' CD2' HD13 ' A' ' 464' ' ' LEU . 31.9 p90 174.85 157.32 0.16 Allowed 'General case' 0 CA--C 1.5 -0.969 0 O-C-N 123.511 0.507 . . . . 0.14999999999999999 111.129 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.682 HD11 HG11 ' A' ' 457' ' ' VAL . 0.6 OUTLIER -76.71 151.64 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 N-CA-C 108.495 -0.928 . . . . 0.080000000000000002 108.495 164.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.766 ' CD ' ' HE1' ' A' ' 466' ' ' PHE . 6.9 tp10 -149.57 146.3 27.26 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.504 -0.771 . . . . 2.0099999999999998 109.902 -173.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.739 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -143.04 160.33 17.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.382 0.611 . . . . 0.45000000000000001 111.667 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.552 ' N ' HG12 ' A' ' 347' ' ' VAL . 27.1 t0 -141.07 106.47 5.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.378 -1.341 . . . . 0.23999999999999999 107.378 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.099 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.41 -34.61 28.22 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 122.717 1.246 . . . . 0.16 110.42 -167.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.443 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 1.5 mt-10 -57.43 -44.12 84.44 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 110.88 -2.873 . . . . 0.59999999999999998 108.013 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.9 m-80 -100.67 5.26 43.73 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 111.045 -2.798 . . . . 0.20000000000000001 111.037 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.594 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.5 mp0 34.96 61.54 0.6 Allowed 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 112.766 -2.016 . . . . 2.1499999999999999 113.367 -175.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.524 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.5 t60 -142.61 135.46 28.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.785 -0.643 . . . . 0.089999999999999997 109.664 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.736 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.73 158.27 20.28 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.829 -0.623 . . . . 0.070000000000000007 109.86 179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.644 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.5 m-90 -143.23 158.55 43.52 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.358 0.663 . . . . 0.11 110.695 -176.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.687 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 86.4 t80 -111.86 153.36 26.77 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 106.176 -1.787 . . . . 0.26000000000000001 106.176 150.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 7.9 m-85 -127.74 116.31 20.03 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.13 -0.941 . . . . 0.14000000000000001 110.15 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.3 tppt? -117.97 138.91 51.85 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.215 -1.772 . . . . 0.25 106.215 168.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.416 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.43 17.14 9.18 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.268 0.84 . . . . 0.42999999999999999 113.268 172.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.38 7.66 87.82 Favored Glycine 0 CA--C 1.488 -1.647 0 C-N-CA 120.801 -0.714 . . . . 0.17999999999999999 112.937 -174.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.3 ptmt -128.68 178.4 6.36 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 104.486 -2.412 . . . . 0.37 104.486 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.644 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.0 m -105.01 158.2 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 116.339 1.977 . . . . 0.10000000000000001 116.339 -176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.681 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.36 -26.93 9.76 Favored 'General case' 0 N--CA 1.411 -2.415 0 CA-C-N 110.625 -2.989 . . . . 0.070000000000000007 106.456 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.807 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.37 144.53 48.29 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 111.477 -2.601 . . . . 0.059999999999999998 111.432 -176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.431 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.1 tt0 -141.19 117.77 10.91 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 104.374 -2.454 . . . . 0.47999999999999998 104.374 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.736 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.66 163.5 37.74 Favored 'General case' 0 N--CA 1.399 -2.98 0 C-N-CA 117.896 -1.521 . . . . 0.070000000000000007 111.306 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.462 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 22.2 p-10 -103.4 136.46 43.11 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 114.907 -1.042 . . . . 1.8 109.484 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -136.13 -174.04 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 CA-C-O 122.484 1.135 . . . . 0.12 112.559 -170.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.7 OUTLIER -150.54 119.68 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 112.731 -2.031 . . . . 0.10000000000000001 107.798 173.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.525 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.74 -168.49 1.6 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.269 -1.332 . . . . 1.26 110.132 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -83.87 165.39 41.87 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 118.419 -1.848 . . . . 0.14000000000000001 112.636 -173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.5 ptmt -67.06 155.76 89.53 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.719 -0.74 . . . . 0.81000000000000005 112.22 -167.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.68 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 95.1 Cg_exo -55.95 -30.74 79.08 Favored 'Trans proline' 0 CA--C 1.495 -1.458 1 C-N-CA 125.332 4.021 . . . . 0.28000000000000003 113.932 -173.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.404 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 23.3 p -68.65 -30.67 69.42 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.882 -1.508 . . . . 0.33000000000000002 109.546 -176.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.535 HG21 ' CB ' ' A' ' 398' ' ' ASP . 1.2 t -141.97 70.82 23.88 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-O 123.266 1.508 . . . . 0.39000000000000001 110.032 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 375' ' ' THR . 72.8 Cg_exo -58.62 148.24 83.0 Favored 'Trans proline' 0 C--N 1.307 -1.614 1 C-N-CA 126.028 4.485 . . . . 0.38 113.603 -172.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.525 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -77.93 144.54 68.31 Favored Pre-proline 0 N--CA 1.423 -1.812 0 N-CA-C 108.546 -0.909 . . . . 0.81999999999999995 108.546 175.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.2 Cg_exo -75.4 -45.07 0.27 Allowed 'Trans proline' 0 CA--C 1.51 -0.722 0 C-N-CA 124.352 3.368 . . . . 0.19 111.705 -167.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.802 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.21 139.24 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 123.051 1.405 . . . . 0.13 113.148 -172.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.8 -117.66 0.84 Allowed Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 112.558 -2.11 . . . . 0.20000000000000001 109.317 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.38 114.44 28.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.993 0.901 . . . . 0.81999999999999995 110.616 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.758 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.4 m-85 -113.16 -174.06 2.38 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.246 -1.39 . . . . 0.22 107.246 174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.447 ' HB2' ' CZ2' ' A' ' 415' ' ' TRP . 1.2 t80 -140.44 123.75 16.83 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.369 1.44 . . . . 0.65000000000000002 113.513 -172.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -89.93 92.57 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 CA-C-O 123.009 1.385 . . . . 0.16 109.543 169.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -93.12 11.1 28.92 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.416 -1.72 . . . . 2.5499999999999998 108.176 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.74 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.0 t30 -169.21 126.64 0.95 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 113.927 -1.488 . . . . 0.42999999999999999 110.366 172.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.702 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -98.46 140.92 31.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.853 -1.067 . . . . 1.1200000000000001 109.117 169.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.769 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 18.6 mm-40 -124.05 157.18 35.1 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 114.547 1.314 . . . . 0.70999999999999996 114.547 -168.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 44.1 mt-10 -137.13 127.89 27.19 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 112.825 -1.988 . . . . 0.38 108.397 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 32.1 t70 55.22 48.48 19.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 123.346 1.546 . . . . 0.40999999999999998 108.92 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.922 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -83.04 167.97 17.38 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 112.629 -2.078 . . . . 0.12 109.153 177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 25.9 m -132.68 119.34 20.26 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.071 0.939 . . . . 0.17000000000000001 111.733 170.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 4.2 mp -80.86 91.38 5.97 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.748 -1.569 . . . . 0.56999999999999995 112.249 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.547 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.0 mttt -102.14 178.27 4.65 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 113.971 -1.468 . . . . 0.33000000000000002 113.077 177.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.83 -157.08 24.06 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-N 114.363 -1.29 . . . . 0.46000000000000002 111.514 -178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 2.4 m -117.65 139.38 51.08 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 120.181 -0.608 . . . . 0.70999999999999996 110.862 170.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 401' ' ' THR . 5.1 m-80 -56.63 152.74 11.5 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 115.168 -0.924 . . . . 0.83999999999999997 109.288 168.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . 0.535 ' CB ' HG21 ' A' ' 375' ' ' THR . 7.4 p-10 -50.11 -16.78 0.33 Allowed 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 113.268 -1.787 . . . . 2.2799999999999998 112.579 175.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 397' ' ' ASN . 16.9 t70 -96.14 -20.02 18.93 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 113.931 -1.486 . . . . 2.27 109.447 -173.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.07 31.56 5.31 Favored Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 119.689 -1.243 . . . . 0.93999999999999995 111.848 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 6.9 p -123.81 101.4 36.21 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 114.736 -0.732 . . . . 0.81000000000000005 109.416 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 20.7 Cg_endo -58.42 151.2 62.96 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 C-N-CA 122.912 2.408 . . . . 0.63 113.45 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.5 ' OH ' ' HAD' ' A' ' 130' ' ' 1RG . 21.5 p90 -153.18 175.63 12.83 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.472 -1.24 . . . . 0.41999999999999998 112.787 -169.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.547 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -144.35 147.78 33.88 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.629 -1.623 . . . . 0.53000000000000003 109.801 170.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.36 97.25 5.17 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.277 -1.009 . . . . 0.19 108.277 172.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 16.4 Cg_exo -69.9 109.9 2.45 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 121.797 1.665 . . . . 0.19 109.952 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.922 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.97 155.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-N 112.667 -2.06 . . . . 0.14999999999999999 107.766 -167.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.722 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.0 m-80 -86.85 -20.99 26.68 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.179 -0.674 . . . . 0.51000000000000001 109.179 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.769 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 95.0 m-85 -158.7 127.0 5.24 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.353 1.033 . . . . 0.27000000000000002 108.79 -171.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.68 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 24.1 t-105 -145.11 137.09 25.7 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.756 0.789 . . . . 0.089999999999999997 110.953 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.702 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.6 mmt -119.87 93.72 47.94 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 107.651 -1.24 . . . . 0.14000000000000001 107.651 173.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.74 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 40.0 Cg_endo -67.74 74.14 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.356 2.037 . . . . 0.5 112.414 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.582 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.4 pt -72.88 174.27 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.488 -0.93 . . . . 0.88 108.488 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.517 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 20.8 t70 -143.87 -178.74 6.07 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 119.648 -0.821 . . . . 2.4900000000000002 112.232 -164.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.517 ' CE3' ' HB3' ' A' ' 414' ' ' ASP . 38.0 p90 56.59 -3.2 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.849 2.06 . . . . 1.9199999999999999 114.51 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.522 HG21 ' CD1' ' A' ' 382' ' ' PHE . 38.2 p -128.59 -15.86 4.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.142 0.496 . . . . 0.94999999999999996 111.018 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.615 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 96.6 -33.92 5.35 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.081 -0.808 . . . . 0.68000000000000005 111.081 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 419' ' ' GLY . 29.1 t -56.92 173.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 124.072 0.949 . . . . 0.75 112.012 -177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.595 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.03 122.43 0.82 Allowed Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.606 -1.398 . . . . 0.20000000000000001 109.606 170.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.689 HG22 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.72 142.52 13.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.799 -0.445 . . . . 0.28999999999999998 109.799 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.68 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.4 p80 -159.83 162.48 34.73 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.196 -0.456 . . . . 0.089999999999999997 111.659 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.702 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.88 143.8 28.03 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.845 -1.169 . . . . 1.0700000000000001 107.845 171.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.537 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 28.5 t -133.83 99.03 4.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.874 0.845 . . . . 0.23000000000000001 110.701 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.03 -13.51 59.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.132 -1.395 . . . . 0.41999999999999998 109.537 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.712 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 11.7 p90 -92.05 -27.1 18.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.443 -1.253 . . . . 0.32000000000000001 111.853 -175.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.674 HE22 ' HD3' ' A' ' 437' ' ' ARG . 0.1 OUTLIER -91.73 106.61 17.69 Favored Pre-proline 0 CA--C 1.507 -0.689 0 CA-C-O 122.624 1.202 . . . . 1.74 108.462 175.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 61.9 Cg_endo -82.96 -16.69 7.33 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 124.257 3.305 . . . . 0.72999999999999998 113.021 -172.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.61 ' HG2' ' NE2' ' A' ' 426' ' ' GLN . 0.5 OUTLIER -109.78 152.98 25.0 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 122.115 0.959 . . . . 2.1600000000000001 111.543 174.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.686 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -154.32 132.58 11.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.201 -2.148 . . . . 0.33000000000000002 105.201 169.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.61 -158.34 30.96 Favored Glycine 0 C--N 1.285 -2.294 0 N-CA-C 110.438 -1.065 . . . . 0.17000000000000001 110.438 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.534 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -47.08 174.14 0.02 OUTLIER Glycine 0 CA--C 1.495 -1.192 0 C-N-CA 120.096 -1.05 . . . . 0.20999999999999999 111.499 168.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.569 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 7.0 p-10 -52.59 101.29 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 123.422 1.582 . . . . 1.8500000000000001 113.883 -154.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 1.006 HD22 ' HD2' ' A' ' 437' ' ' ARG . 41.6 mt -97.47 -34.65 10.93 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 112.203 -2.271 . . . . 1.21 109.383 171.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.709 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.2 p-90 -53.74 -26.36 22.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.017 -0.992 . . . . 0.16 112.004 -173.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.709 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.11 -36.33 14.06 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.618 -0.719 . . . . 0.22 112.308 -178.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.432 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.2 p -88.15 -41.02 13.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.143 -0.935 . . . . 0.25 110.381 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 1.006 ' HD2' HD22 ' A' ' 433' ' ' LEU . 2.1 mtp85 -93.06 -20.69 20.29 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.431 -1.258 . . . . 1.8200000000000001 109.704 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.91 45.8 49.86 Favored Glycine 0 N--CA 1.443 -0.834 0 O-C-N 124.284 0.99 . . . . 0.23999999999999999 114.072 166.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 20.8 m -84.69 110.13 18.53 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 118.654 -1.218 . . . . 1.01 111.367 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.671 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 29.1 m-70 46.11 -145.0 0.21 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.607 -1.179 . . . . 0.5 113.629 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 440' ' ' HIS . . . -110.65 -23.41 5.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.506 -0.854 . . . . 0.26000000000000001 113.566 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.711 ' HB3' HASB ' A' ' 130' ' ' 1RG . 31.2 p -101.57 -165.43 1.19 Allowed 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 113.645 0.98 . . . . 0.34999999999999998 113.645 -170.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 370' ' ' SER . 2.0 mp -90.23 133.35 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.569 -0.741 . . . . 0.12 110.61 -176.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.11 90.9 3.73 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.366 0.603 . . . . 0.62 110.286 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.744 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.3 m -85.82 142.33 36.66 Favored Pre-proline 0 N--CA 1.436 -1.126 0 CA-C-N 115.105 -0.952 . . . . 0.10000000000000001 112.512 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.669 ' HD2' HG21 ' A' ' 366' ' ' THR . 82.0 Cg_exo -49.58 145.56 16.7 Favored 'Trans proline' 0 CA--C 1.509 -0.767 0 C-N-CA 123.891 3.06 . . . . 0.23999999999999999 113.572 175.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.702 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.4 Cg_exo -66.7 -21.05 52.21 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.827 2.352 . . . . 0.31 112.034 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.55 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 33.4 p -83.35 -24.07 32.23 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.233 -0.894 . . . . 1.1000000000000001 112.291 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.807 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.8 m -99.64 -47.98 11.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 112.954 0.724 . . . . 0.080000000000000002 112.954 -171.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.968 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.36 -1.77 3.8 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 119.789 -0.764 . . . . 0.070000000000000007 110.462 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 448' ' ' SER . 17.2 pttp -81.5 -38.27 26.56 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 122.698 1.237 . . . . 0.92000000000000004 108.33 173.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.7 mm-40 -62.57 -46.28 89.05 Favored 'General case' 0 CA--C 1.475 -1.936 0 CA-C-N 112.299 -2.228 . . . . 0.25 106.328 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.968 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -47.28 -66.61 0.38 Allowed 'General case' 0 N--CA 1.406 -2.633 0 CA-C-N 109.832 -3.349 . . . . 0.050000000000000003 112.956 172.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.495 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.3 t80 -46.26 -22.59 0.25 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.866 0.841 . . . . 0.13 109.396 176.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.459 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.83 -25.32 30.0 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.674 -1.148 . . . . 0.13 112.008 -176.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.759 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.5 -43.7 5.32 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 113.705 1.002 . . . . 0.059999999999999998 113.705 176.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.682 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.87 149.8 7.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.432 1.11 . . . . 0.080000000000000002 111.278 -179.155 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.405 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -121.68 156.4 33.13 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 112.99 -1.914 . . . . 0.47999999999999998 108.64 -177.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.563 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 2.5 mppt? -58.66 103.2 0.14 Allowed 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.775 -0.824 . . . . 0.98999999999999999 108.775 171.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.75 -9.08 6.11 Favored Glycine 0 C--N 1.307 -1.069 0 CA-C-N 113.935 -1.484 . . . . 0.19 111.616 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 344' ' ' TYR . 19.0 m -69.31 150.05 97.26 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 108.972 -0.751 . . . . 0.13 108.972 171.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.554 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.7 Cg_endo -93.84 163.06 2.22 Favored 'Trans proline' 0 N--CA 1.423 -2.664 0 C-N-CA 122.34 2.026 . . . . 0.17999999999999999 109.919 176.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.758 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.7 m -126.64 149.23 31.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 107.502 -1.296 . . . . 0.56999999999999995 107.502 171.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.694 HD13 ' CD2' ' A' ' 344' ' ' TYR . 3.5 mp -134.86 150.3 50.45 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 108.426 -0.953 . . . . 0.13 108.426 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.099 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.94 143.12 28.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 105.72 -1.956 . . . . 0.10000000000000001 105.72 166.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.766 ' HE1' ' CD ' ' A' ' 346' ' ' GLU . 9.3 p90 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 123.185 0.594 . . . . 1.0900000000000001 110.316 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.716 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.218 -0.353 . . . . 1.8700000000000001 112.218 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.748 ' CE1' HD21 ' A' ' 464' ' ' LEU . 0.3 OUTLIER -117.72 100.78 7.83 Favored 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 122.796 -0.238 . . . . 0.83999999999999997 111.43 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.507 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 1.6 mtm 63.2 -166.92 0.22 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 124.061 0.851 . . . . 0.67000000000000004 112.351 167.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -63.51 171.9 2.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.021 -0.536 . . . . 1.8500000000000001 109.823 161.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.496 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 6.2 m-20 -80.0 83.34 5.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 119.334 -0.946 . . . . 0.42999999999999999 110.264 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.79 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 46.9 m -158.01 135.48 10.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.77 -1.104 . . . . 0.14000000000000001 108.681 167.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.691 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.7 p90 174.22 159.18 0.16 Allowed 'General case' 0 C--O 1.214 -0.795 0 O-C-N 123.337 0.398 . . . . 0.14999999999999999 110.851 -175.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.642 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.99 152.13 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.313 0 N-CA-C 109.112 -0.699 . . . . 0.080000000000000002 109.112 164.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.569 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.72 143.14 25.26 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.628 -0.715 . . . . 2.0099999999999998 109.452 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.742 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.9 t -135.15 162.43 38.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 120.733 -0.387 . . . . 0.45000000000000001 111.213 177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.569 ' N ' HG12 ' A' ' 347' ' ' VAL . 36.7 t0 -140.23 106.81 5.33 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.468 -1.308 . . . . 0.23999999999999999 107.468 173.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.024 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.48 -34.9 27.86 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-O 122.752 1.263 . . . . 0.16 110.436 -167.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.459 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 0.8 OUTLIER -58.02 -44.98 87.6 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 110.797 -2.91 . . . . 0.59999999999999998 108.308 176.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 24.9 m-80 -100.61 5.94 44.01 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 111.012 -2.813 . . . . 0.20000000000000001 111.057 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.7 mp0 35.09 61.32 0.63 Allowed 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 112.725 -2.034 . . . . 2.1499999999999999 113.16 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.495 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.5 t60 -142.2 134.6 27.91 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.646 -0.706 . . . . 0.089999999999999997 109.742 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.734 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.71 157.85 20.78 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 115.822 -0.627 . . . . 0.070000000000000007 110.106 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.61 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.1 m-90 -142.62 156.02 45.02 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 123.499 0.72 . . . . 0.11 111.258 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.79 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.0 t80 -110.81 153.82 24.84 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 106.424 -1.695 . . . . 0.26000000000000001 106.424 151.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.6 m-85 -127.86 119.09 24.9 Favored 'General case' 0 C--N 1.27 -2.886 0 CA-C-N 114.892 -1.049 . . . . 0.14000000000000001 110.351 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.2 tppt? -120.56 132.41 55.15 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.277 -1.749 . . . . 0.25 106.277 167.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 75.1 16.53 2.8 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 113.136 0.791 . . . . 0.42999999999999999 113.136 174.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.496 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.13 5.73 88.99 Favored Glycine 0 CA--C 1.485 -1.828 0 CA-C-O 121.814 0.675 . . . . 0.17999999999999999 112.887 -173.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 19.9 ptmt -128.92 177.23 7.25 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.502 -2.407 . . . . 0.37 104.502 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.0 m -103.56 158.22 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 116.713 2.116 . . . . 0.10000000000000001 116.713 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.712 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.15 -28.65 8.93 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 110.39 -3.096 . . . . 0.070000000000000007 106.207 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -133.87 145.91 50.1 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 111.589 -2.551 . . . . 0.059999999999999998 111.669 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.471 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.3 tt0 -143.72 118.47 9.87 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 104.499 -2.408 . . . . 0.47999999999999998 104.499 175.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.81 165.39 32.65 Favored 'General case' 0 N--CA 1.401 -2.915 0 C-N-CA 118.132 -1.427 . . . . 0.070000000000000007 111.631 -179.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.67 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 15.5 p-10 -103.81 133.33 48.98 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 114.669 -1.15 . . . . 1.8 110.087 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -133.77 -173.75 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-O 122.465 1.126 . . . . 0.12 112.525 -171.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.618 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.37 120.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-N 112.91 -1.95 . . . . 0.10000000000000001 109.199 172.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.522 ' HB3' HD12 ' A' ' 349' ' ' LEU . 33.6 p -78.25 -169.06 1.49 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 111.94 -2.391 . . . . 1.26 111.421 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.485 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.77 174.75 50.14 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 118.779 -1.676 . . . . 0.14000000000000001 112.05 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.439 ' HG2' ' CG2' ' A' ' 375' ' ' THR . 8.5 ptmt -80.31 163.67 55.93 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 113.174 0.805 . . . . 0.81000000000000005 113.174 -164.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.685 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 89.4 Cg_exo -55.09 -37.86 93.78 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 123.023 2.482 . . . . 0.28000000000000003 112.287 -176.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.456 ' OG1' HG22 ' A' ' 375' ' ' THR . 12.0 p -64.35 -31.89 73.27 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.29 -1.323 . . . . 0.33000000000000002 110.052 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.744 HG21 ' NAX' ' A' ' 130' ' ' 1RG . 1.2 t -141.59 71.04 25.78 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 123.439 1.59 . . . . 0.39000000000000001 110.032 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 375' ' ' THR . 82.2 Cg_exo -58.3 153.81 44.6 Favored 'Trans proline' 0 C--N 1.307 -1.643 1 C-N-CA 126.369 4.713 . . . . 0.38 114.985 -171.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.54 HG21 ' HG ' ' A' ' 349' ' ' LEU . 2.5 m -79.24 129.86 71.04 Favored Pre-proline 0 N--CA 1.405 -2.718 0 CA-C-N 114.5 -1.227 . . . . 0.81999999999999995 108.55 172.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 39.4 Cg_exo -68.28 -44.97 3.04 Favored 'Trans proline' 0 CA--C 1.512 -0.601 0 C-N-CA 123.834 3.023 . . . . 0.19 112.147 -169.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.795 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.84 138.96 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 123.304 1.526 . . . . 0.13 113.645 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 152.86 -119.31 0.95 Allowed Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 112.243 -2.253 . . . . 0.20000000000000001 109.579 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.429 HG22 HD21 ' A' ' 464' ' ' LEU . 76.4 t -129.84 108.5 16.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.002 0.43 . . . . 0.81999999999999995 110.472 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.769 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.4 m-85 -108.55 -173.98 2.41 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.279 -1.378 . . . . 0.22 107.279 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.3 t80 -140.83 123.84 16.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 120.09 1.313 . . . . 0.65000000000000002 113.656 -172.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.94 92.56 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 122.961 1.362 . . . . 0.16 109.66 169.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -91.23 9.27 31.98 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.622 -1.627 . . . . 2.5499999999999998 108.265 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.744 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.5 t30 -170.79 127.89 0.76 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.229 -1.351 . . . . 0.42999999999999999 110.475 173.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.684 ' HB3' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -96.95 151.57 19.56 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.727 -0.67 . . . . 1.1200000000000001 109.873 167.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.754 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 37.8 mm-40 -128.37 160.48 32.08 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.471 1.286 . . . . 0.70999999999999996 114.471 -170.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.8 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 32.1 mt-10 -139.53 127.68 22.48 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 113.112 -1.858 . . . . 0.38 108.881 172.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.73 46.09 23.18 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 123.109 1.433 . . . . 0.40999999999999998 108.964 -177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.942 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.52 166.52 21.1 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 112.759 -2.019 . . . . 0.12 108.967 177.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 18.7 m -133.0 118.9 19.39 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.988 0.899 . . . . 0.17000000000000001 111.94 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.1 mp -79.41 88.53 5.01 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.775 -1.557 . . . . 0.56999999999999995 112.091 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.54 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.4 mttt -102.72 -179.42 3.96 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.561 -1.654 . . . . 0.33000000000000002 113.826 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 139.35 -163.6 26.03 Favored Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 114.029 -1.442 . . . . 0.46000000000000002 111.149 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 2.0 m -122.81 138.14 54.73 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 120.217 -0.593 . . . . 0.70999999999999996 110.934 171.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.4 m-80 -56.0 152.34 10.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.918 -1.037 . . . . 0.83999999999999997 109.238 167.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . 0.573 ' HB2' ' CAY' ' A' ' 130' ' ' 1RG . 0.1 OUTLIER -59.35 -3.23 0.39 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.825 -0.625 . . . . 2.2799999999999998 111.807 176.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 397' ' ' ASN . 25.8 t0 -106.81 -9.22 16.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.916 -1.038 . . . . 2.27 108.781 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.05 36.82 6.99 Favored Glycine 0 N--CA 1.422 -2.292 0 C-N-CA 118.794 -1.67 . . . . 0.93999999999999995 111.631 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 18.6 p -124.94 93.11 46.46 Favored Pre-proline 0 C--N 1.305 -1.368 0 CA-C-N 114.437 -0.881 . . . . 0.81000000000000005 109.008 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.0 Cg_endo -59.31 147.69 89.8 Favored 'Trans proline' 0 CA--C 1.497 -1.333 0 C-N-CA 122.648 2.232 . . . . 0.63 112.811 -176.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 34.4 p90 -145.82 167.37 23.38 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.128 -1.396 . . . . 0.41999999999999998 111.933 -167.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.54 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -145.15 146.33 31.73 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.37 -1.287 . . . . 0.53000000000000003 110.32 175.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.17 97.27 5.26 Favored Pre-proline 0 N--CA 1.431 -1.387 0 N-CA-C 108.11 -1.07 . . . . 0.19 108.11 171.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 18.9 Cg_exo -69.35 109.94 2.35 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 122.012 1.808 . . . . 0.19 109.881 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.942 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.08 156.34 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 CA-C-N 112.869 -1.969 . . . . 0.14999999999999999 107.283 -168.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.8 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.0 m-80 -89.72 -19.9 24.22 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.987 -0.746 . . . . 0.51000000000000001 108.987 -174.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.6 m-85 -159.06 126.58 4.9 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.346 -0.983 . . . . 0.27000000000000002 108.346 -171.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.685 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 25.0 t-105 -145.25 133.92 22.19 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.828 0.823 . . . . 0.089999999999999997 111.253 -167.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.684 ' SD ' ' HB3' ' A' ' 387' ' ' LYS . 11.8 mmt -115.2 94.91 40.72 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.568 -1.271 . . . . 0.14000000000000001 107.568 172.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.744 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 39.3 Cg_endo -68.52 67.61 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.362 2.041 . . . . 0.5 112.548 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.617 HG12 ' HA2' ' A' ' 419' ' ' GLY . 2.1 pt -68.08 170.63 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 N-CA-C 108.618 -0.882 . . . . 0.88 108.618 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 416' ' ' THR . 1.8 t70 -149.71 -172.71 4.22 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.012 -1.075 . . . . 2.4900000000000002 112.406 -166.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 37.4 p90 50.61 1.92 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.879 2.072 . . . . 1.9199999999999999 114.47 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.496 HG21 ' CD1' ' A' ' 382' ' ' PHE . 38.1 p -130.76 -14.67 3.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.94999999999999996 110.89 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.437 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 98.92 -37.95 3.29 Favored Glycine 0 CA--C 1.501 -0.79 0 N-CA-C 110.927 -0.869 . . . . 0.68000000000000005 110.927 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.578 HG12 ' N ' ' A' ' 419' ' ' GLY . 22.1 t -59.51 172.77 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 124.234 1.014 . . . . 0.75 112.433 -175.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.617 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -177.45 120.19 0.72 Allowed Glycine 0 N--CA 1.435 -1.387 0 N-CA-C 109.965 -1.254 . . . . 0.20000000000000001 109.965 170.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.67 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.76 143.08 12.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 110.21 -0.293 . . . . 0.28999999999999998 110.21 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.685 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.5 p80 -159.15 160.88 36.06 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.168 -0.469 . . . . 0.089999999999999997 111.702 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.709 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -84.54 148.14 26.65 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.838 -1.171 . . . . 1.0700000000000001 107.838 172.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 445' ' ' THR . 43.3 t -134.29 96.54 3.63 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.67 0.747 . . . . 0.23000000000000001 110.269 -171.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.21 -18.96 44.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.473 -1.24 . . . . 0.41999999999999998 109.945 -174.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.75 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 11.2 p90 -83.85 -17.9 39.36 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.183 -1.371 . . . . 0.32000000000000001 111.128 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -102.28 117.13 61.87 Favored Pre-proline 0 CA--C 1.503 -0.858 0 CA-C-O 122.808 1.29 . . . . 1.74 109.862 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -87.84 -11.24 4.79 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 124.144 3.23 . . . . 0.72999999999999998 111.737 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 428' ' ' GLU . 5.2 pt-20 -114.57 151.04 34.05 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 114.298 -1.319 . . . . 2.1600000000000001 113.417 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.718 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.62 134.2 5.19 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 104.162 -2.533 . . . . 0.33000000000000002 104.162 171.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.36 -157.29 29.4 Favored Glycine 0 C--N 1.276 -2.756 0 C-N-CA 119.28 -1.438 . . . . 0.17000000000000001 110.749 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.406 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.94 174.29 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 119.903 -1.142 . . . . 0.20999999999999999 111.175 166.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.51 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -51.33 102.68 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 123.198 1.475 . . . . 1.8500000000000001 113.944 -154.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.667 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.07 -35.44 11.92 Favored 'General case' 0 C--O 1.202 -1.4 0 CA-C-N 112.699 -2.046 . . . . 1.21 109.087 168.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.734 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -55.72 -26.69 46.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.292 -0.867 . . . . 0.16 112.357 -170.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.734 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.78 -32.42 15.39 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.981 0.896 . . . . 0.22 111.771 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.8 p -87.52 -45.0 10.86 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.946 -1.479 . . . . 0.25 111.103 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.667 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 7.5 mtp-105 -91.04 -20.2 22.34 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.446 -1.252 . . . . 1.8200000000000001 110.18 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.89 46.56 49.17 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.395 -1.275 . . . . 0.23999999999999999 114.308 164.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.77 110.82 19.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.345 1.073 . . . . 1.01 112.298 -169.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.538 ' HB2' ' OAC' ' A' ' 130' ' ' 1RG . 70.5 m-70 37.07 -111.19 0.08 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.869 -1.06 . . . . 0.5 113.495 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.485 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -146.41 -11.84 0.21 Allowed Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.867 -0.682 . . . . 0.26000000000000001 114.235 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.832 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.4 p -100.04 -167.99 1.53 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 118.291 1.046 . . . . 0.34999999999999998 112.151 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.486 HD13 HG11 ' A' ' 465' ' ' VAL . 2.2 mp -103.39 132.02 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 114.862 -1.063 . . . . 0.12 110.886 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -102.41 94.22 5.57 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.996 -1.002 . . . . 0.62 110.367 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.726 ' HA ' HG22 ' A' ' 368' ' ' ILE . 2.9 m -89.93 144.08 30.96 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 115.607 -0.724 . . . . 0.10000000000000001 112.554 -178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.678 ' HD2' HG21 ' A' ' 366' ' ' THR . 74.8 Cg_exo -51.68 147.22 24.71 Favored 'Trans proline' 0 CA--C 1.51 -0.724 0 C-N-CA 123.945 3.097 . . . . 0.23999999999999999 113.33 173.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.718 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 27.1 Cg_exo -67.96 -26.24 37.74 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.006 2.471 . . . . 0.31 112.185 -175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.508 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 40.5 p -75.61 -25.4 56.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.078 -0.964 . . . . 1.1000000000000001 111.876 -176.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.804 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.6 m -99.93 -50.47 10.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.574 -0.739 . . . . 0.080000000000000002 112.896 -171.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.954 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.67 -2.34 4.8 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.729 -0.788 . . . . 0.070000000000000007 110.249 -178.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.648 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.1 pttp -81.09 -39.51 25.57 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.484 1.135 . . . . 0.92000000000000004 108.287 173.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.49 ' HG3' HD11 ' A' ' 364' ' ' LEU . 4.7 mm-40 -61.62 -46.84 88.09 Favored 'General case' 0 CA--C 1.47 -2.121 0 CA-C-N 112.319 -2.219 . . . . 0.25 106.571 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.954 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.52 -66.86 0.34 Allowed 'General case' 0 N--CA 1.4 -2.969 0 CA-C-N 109.649 -3.432 . . . . 0.050000000000000003 112.842 172.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.534 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.8 t80 -44.43 -24.79 0.2 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 124.135 0.897 . . . . 0.13 109.727 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.78 -30.35 15.44 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.341 -1.299 . . . . 0.13 111.762 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.784 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -97.8 -43.91 6.95 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 113.22 0.822 . . . . 0.059999999999999998 113.22 178.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -72.84 147.55 9.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 122.451 1.119 . . . . 0.080000000000000002 110.928 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.488 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -116.28 157.14 25.42 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 113.196 -1.82 . . . . 0.47999999999999998 108.909 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.652 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 5.6 mppt? -58.91 102.1 0.11 Allowed 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.573 -0.899 . . . . 0.98999999999999999 108.573 169.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.68 -12.13 5.95 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 114.102 -1.408 . . . . 0.19 111.525 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.688 HG21 ' HB ' ' A' ' 457' ' ' VAL . 16.2 m -67.12 150.16 98.07 Favored Pre-proline 0 N--CA 1.441 -0.923 0 N-CA-C 108.671 -0.863 . . . . 0.13 108.671 171.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.3 Cg_endo -93.87 161.03 2.23 Favored 'Trans proline' 0 N--CA 1.423 -2.647 0 C-N-CA 122.152 1.901 . . . . 0.17999999999999999 109.974 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.769 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -123.51 150.47 27.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 107.389 -1.337 . . . . 0.56999999999999995 107.389 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.748 HD21 ' CE1' ' A' ' 339' ' ' HIS . 5.4 mp -134.15 150.66 51.12 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.748 -0.834 . . . . 0.13 108.748 175.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.024 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -139.01 140.4 38.57 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 105.418 -2.067 . . . . 0.10000000000000001 105.418 165.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.612 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 10.8 p90 . . . . . 0 C--O 1.246 0.884 0 O-C-N 123.822 0.701 . . . . 1.0900000000000001 111.086 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.951 ' HBA' ' CAM' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 112.008 -0.437 . . . . 1.8700000000000001 112.008 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.744 ' CE1' HD21 ' A' ' 464' ' ' LEU . 0.3 OUTLIER -101.13 98.61 9.01 Favored 'General case' 0 CA--C 1.508 -0.636 0 O-C-N 122.703 -0.293 . . . . 0.83999999999999997 111.513 178.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.563 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.6 OUTLIER 65.19 -166.11 0.23 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.451 -0.795 . . . . 0.67000000000000004 112.43 167.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.4 171.43 2.48 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.511 -1.292 . . . . 1.8500000000000001 107.511 165.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.414 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 12.7 m-20 -79.74 83.36 5.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 118.843 -1.143 . . . . 0.42999999999999999 109.359 -178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.813 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 73.1 m -158.25 134.69 9.5 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.376 -1.284 . . . . 0.14000000000000001 108.983 168.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.697 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.6 p90 174.27 158.7 0.16 Allowed 'General case' 0 C--O 1.213 -0.865 0 O-C-N 123.478 0.486 . . . . 0.14999999999999999 110.855 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.658 HD11 HG11 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.65 152.48 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 109.002 -0.74 . . . . 0.080000000000000002 109.002 164.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.587 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 32.1 tt0 -149.94 143.61 25.35 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.42 -0.809 . . . . 2.0099999999999998 109.748 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.741 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.9 t -136.05 162.41 36.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 120.929 0.395 . . . . 0.45000000000000001 111.298 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.559 ' N ' HG12 ' A' ' 347' ' ' VAL . 35.0 t0 -140.13 106.76 5.34 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.162 -1.421 . . . . 0.23999999999999999 107.162 173.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.098 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.36 -33.5 28.79 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-O 122.71 1.243 . . . . 0.16 110.193 -168.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.463 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.4 mt-10 -57.07 -44.85 83.46 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-N 110.786 -2.915 . . . . 0.59999999999999998 108.192 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.463 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.3 m-80 -101.95 5.64 40.89 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 110.906 -2.861 . . . . 0.20000000000000001 111.273 -175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.588 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.2 mp0 34.79 61.61 0.57 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 112.56 -2.109 . . . . 2.1499999999999999 113.085 -175.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.522 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.4 t60 -141.76 134.95 29.23 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.615 -0.72 . . . . 0.089999999999999997 109.818 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.752 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.4 OUTLIER -113.24 156.31 23.53 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.733 -0.667 . . . . 0.070000000000000007 110.084 -179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.6 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.5 m-90 -142.26 154.75 45.01 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.443 -0.798 . . . . 0.11 111.037 -175.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.813 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 88.1 t80 -109.8 153.11 24.85 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 106.503 -1.665 . . . . 0.26000000000000001 106.503 151.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 8.1 m-85 -128.15 117.37 21.46 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 114.957 -1.019 . . . . 0.14000000000000001 110.28 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.3 tppt? -118.32 138.34 52.46 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.948 -1.871 . . . . 0.25 105.948 168.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 69.31 17.37 8.25 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.147 0.795 . . . . 0.42999999999999999 113.147 172.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.414 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.24 6.47 87.73 Favored Glycine 0 CA--C 1.488 -1.653 0 C-N-CA 120.705 -0.759 . . . . 0.17999999999999999 112.943 -174.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.6 ptmt -127.55 178.19 6.27 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 104.484 -2.413 . . . . 0.37 104.484 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.6 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.4 m -105.07 157.35 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.766 0 N-CA-C 116.21 1.93 . . . . 0.10000000000000001 116.21 -176.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.694 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.13 -27.62 9.98 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 110.461 -3.063 . . . . 0.070000000000000007 106.233 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.821 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.1 tp -134.12 145.35 49.23 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 111.71 -2.495 . . . . 0.059999999999999998 111.919 -175.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.522 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 2.5 tt0 -141.55 118.12 10.95 Favored 'General case' 0 N--CA 1.408 -2.545 0 N-CA-C 104.514 -2.402 . . . . 0.47999999999999998 104.514 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.752 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.63 165.43 33.37 Favored 'General case' 0 N--CA 1.398 -3.034 0 C-N-CA 117.83 -1.548 . . . . 0.070000000000000007 111.533 179.229 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.407 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 30.1 p-10 -104.41 134.19 48.03 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 114.831 -1.077 . . . . 1.8 109.989 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.739 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -132.56 -172.44 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 CA-C-O 122.53 1.157 . . . . 0.12 112.326 -172.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.79 119.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 112.889 -1.959 . . . . 0.10000000000000001 108.207 172.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.531 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -77.84 -169.39 1.51 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.067 -1.424 . . . . 1.26 110.891 -179.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.67 170.68 46.36 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 118.995 -1.574 . . . . 0.14000000000000001 112.127 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 9.1 ptpt -77.13 157.56 80.94 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.473 0.654 . . . . 0.81000000000000005 112.52 -164.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.681 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 66.3 Cg_exo -53.01 -29.84 46.22 Favored 'Trans proline' 0 CA--C 1.496 -1.405 1 C-N-CA 125.751 4.3 . . . . 0.28000000000000003 113.694 -173.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.447 ' OG1' HG22 ' A' ' 375' ' ' THR . 19.1 p -66.66 -33.29 75.32 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 113.424 -1.716 . . . . 0.33000000000000002 109.45 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.504 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.0 t -143.15 71.27 18.34 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 113.498 -1.683 . . . . 0.39000000000000001 109.536 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 375' ' ' THR . 88.9 Cg_exo -56.99 146.05 82.3 Favored 'Trans proline' 0 C--N 1.304 -1.774 1 C-N-CA 125.84 4.36 . . . . 0.38 113.181 -172.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.531 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -75.69 145.15 78.09 Favored Pre-proline 0 N--CA 1.423 -1.82 0 N-CA-C 108.306 -0.998 . . . . 0.81999999999999995 108.306 175.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.1 Cg_exo -75.44 -43.64 0.35 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 124.59 3.526 . . . . 0.19 111.775 -166.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.8 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 58.24 136.15 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 123.603 1.668 . . . . 0.13 113.639 -172.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.99 -126.54 2.0 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 111.969 -2.378 . . . . 0.20000000000000001 109.253 -176.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.477 HG22 HD21 ' A' ' 464' ' ' LEU . 71.3 t -121.15 108.63 23.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 121.204 0.526 . . . . 0.81999999999999995 110.714 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.76 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 1.8 m-85 -106.8 -174.36 2.52 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.771 -1.566 . . . . 0.22 106.771 174.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 1.9 t80 -139.56 123.32 17.5 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.982 1.265 . . . . 0.65000000000000002 113.071 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -90.51 92.5 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 CA-C-O 123.035 1.398 . . . . 0.16 109.51 170.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -92.33 11.19 26.75 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.318 -1.765 . . . . 2.5499999999999998 108.291 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.775 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.5 t30 -169.38 126.24 0.91 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.265 -1.334 . . . . 0.42999999999999999 110.352 173.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.672 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -102.52 140.04 37.32 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.774 -1.103 . . . . 1.1200000000000001 108.96 169.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.748 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 21.2 mm-40 -124.08 159.2 30.47 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.788 1.403 . . . . 0.70999999999999996 114.788 -167.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.727 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 49.8 mt-10 -129.2 146.34 51.14 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 112.701 -2.045 . . . . 0.38 106.552 165.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.8 t70 47.51 38.77 8.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 112.505 -2.134 . . . . 0.40999999999999998 110.603 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.914 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -78.93 166.88 21.89 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 112.663 -2.062 . . . . 0.12 109.318 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 19.9 m -131.29 119.43 21.74 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.29 1.043 . . . . 0.17000000000000001 111.229 171.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.0 mp -79.19 88.29 4.89 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.392 -1.731 . . . . 0.56999999999999995 111.917 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.547 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.1 mttt -102.5 178.03 4.7 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 113.658 -1.61 . . . . 0.33000000000000002 113.127 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.72 -157.47 24.17 Favored Glycine 0 N--CA 1.429 -1.829 0 CA-C-N 114.206 -1.361 . . . . 0.46000000000000002 111.653 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.5 m -118.4 137.85 52.85 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 120.564 -0.454 . . . . 0.70999999999999996 110.371 171.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.7 m-80 -53.9 149.42 8.93 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.572 -0.899 . . . . 0.83999999999999997 108.572 168.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -1.8 0.07 Allowed 'General case' 0 C--N 1.318 -0.777 0 O-C-N 123.754 0.659 . . . . 2.2799999999999998 112.156 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.4 OUTLIER -115.69 4.88 14.13 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.715 0.769 . . . . 2.27 110.027 -177.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 93.06 21.86 29.21 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 114.964 -1.016 . . . . 0.93999999999999995 113.133 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.457 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 8.6 p -116.39 101.2 53.81 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-O 121.479 0.657 . . . . 0.81000000000000005 109.965 -176.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 19.6 Cg_endo -59.15 149.47 80.01 Favored 'Trans proline' 0 CA--C 1.504 -1.008 0 C-N-CA 122.768 2.312 . . . . 0.63 113.392 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.444 ' OH ' ' HAD' ' A' ' 130' ' ' 1RG . 27.1 p90 -153.76 176.04 12.59 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.449 -1.25 . . . . 0.41999999999999998 113.092 -168.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.547 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.9 OUTLIER -145.71 148.21 32.77 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.833 -1.53 . . . . 0.53000000000000003 110.383 172.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.06 97.49 4.83 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 108.39 -0.967 . . . . 0.19 108.39 170.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.9 Cg_exo -68.66 111.41 2.57 Favored 'Trans proline' 0 N--CA 1.439 -1.715 0 C-N-CA 122.202 1.935 . . . . 0.19 110.3 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.92 160.3 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.31 -1.768 . . . . 0.14999999999999999 107.663 -168.108 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.727 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.8 m-80 -94.15 -19.61 20.62 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.902 -0.777 . . . . 0.51000000000000001 108.902 -175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.748 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 88.1 m-85 -158.94 125.95 4.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.892 -1.049 . . . . 0.27000000000000002 108.248 -171.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 18.2 t-105 -144.16 131.17 20.48 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.933 0.873 . . . . 0.089999999999999997 111.557 -166.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.672 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -111.94 93.91 22.86 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 107.44 -1.319 . . . . 0.14000000000000001 107.44 171.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.775 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.5 Cg_endo -68.39 67.91 1.06 Allowed 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.308 2.005 . . . . 0.5 111.537 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.613 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.4 pt -68.48 175.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-O 121.613 0.721 . . . . 0.88 109.496 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.708 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 7.1 t70 -149.17 -166.19 2.49 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.75 -1.204 . . . . 2.4900000000000002 107.75 -170.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.708 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 6.3 m-90 83.83 -47.73 0.12 Allowed 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 123.985 0.803 . . . . 1.9199999999999999 110.791 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.436 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 43.1 p -128.56 -6.11 5.23 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.455 -0.793 . . . . 0.94999999999999996 112.389 -164.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 97.69 -30.69 8.85 Favored Glycine 0 CA--C 1.505 -0.544 0 C-N-CA 120.731 -0.747 . . . . 0.68000000000000005 112.313 176.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 419' ' ' GLY . 47.2 t -55.04 173.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 123.576 0.75 . . . . 0.75 111.584 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.613 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -173.08 120.98 0.84 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 109.875 -1.29 . . . . 0.20000000000000001 109.875 170.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.729 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -82.17 140.88 15.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.746 -0.465 . . . . 0.28999999999999998 109.746 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.669 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.1 p80 -159.18 161.03 36.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.197 -0.456 . . . . 0.089999999999999997 111.367 -174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.697 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.4 148.62 26.5 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 108.214 -1.032 . . . . 1.0700000000000001 108.214 172.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 445' ' ' THR . 40.4 t -133.24 96.38 3.73 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.726 0.774 . . . . 0.23000000000000001 109.75 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -80.23 -16.85 53.82 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.26 -1.336 . . . . 0.41999999999999998 109.204 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.779 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 12.0 p90 -88.25 -24.61 23.19 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.788 -1.551 . . . . 0.32000000000000001 111.247 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -97.96 113.46 63.81 Favored Pre-proline 0 CA--C 1.506 -0.726 0 CA-C-O 122.643 1.211 . . . . 1.74 110.416 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.475 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 41.8 Cg_endo -85.96 -10.07 7.22 Favored 'Trans proline' 0 C--N 1.32 -0.963 0 C-N-CA 124.241 3.294 . . . . 0.72999999999999998 112.92 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.574 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.9 pm0 -111.56 152.03 28.03 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 122.323 1.059 . . . . 2.1600000000000001 113.35 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.651 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.47 129.9 3.79 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 112.604 -2.089 . . . . 0.33000000000000002 105.74 172.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.61 -158.82 31.7 Favored Glycine 0 C--N 1.283 -2.4 0 C-N-CA 119.913 -1.136 . . . . 0.17000000000000001 110.834 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.506 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.21 174.21 0.01 OUTLIER Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.253 -0.975 . . . . 0.20999999999999999 111.526 167.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.524 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.3 p-10 -51.9 101.72 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 123.262 1.506 . . . . 1.8500000000000001 113.851 -153.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.735 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.93 -37.06 10.85 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 112.459 -2.155 . . . . 1.21 109.54 169.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.711 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -54.12 -27.25 32.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.235 -0.893 . . . . 0.16 112.395 -170.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.711 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -91.33 -33.82 15.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.48 0.657 . . . . 0.22 112.466 -177.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.7 p -92.09 -43.03 9.61 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.854 -1.066 . . . . 0.25 110.991 -176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.735 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.5 mtp180 -93.15 -18.97 21.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.772 -1.104 . . . . 1.8200000000000001 109.492 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.02 49.42 55.53 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 114.74 -1.118 . . . . 0.23999999999999999 115.022 163.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.0 m -82.39 110.62 17.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 118.784 1.292 . . . . 1.01 111.077 -172.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.502 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 44.6 m-70 38.98 -130.17 0.24 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.619 -1.173 . . . . 0.5 113.23 175.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 440' ' ' HIS . . . -122.31 -22.64 2.55 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.337 -0.459 . . . . 0.26000000000000001 113.247 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.601 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.5 p -102.44 -165.35 1.17 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 113.346 0.869 . . . . 0.34999999999999998 113.346 -173.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.491 ' CD1' HG11 ' A' ' 465' ' ' VAL . 1.9 mp -93.03 134.06 32.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.282 -0.872 . . . . 0.12 110.732 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.87 97.09 6.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.385 0.612 . . . . 0.62 110.113 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.739 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.2 m -93.35 144.85 28.94 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 114.726 -1.124 . . . . 0.10000000000000001 112.851 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.661 ' HD2' HG21 ' A' ' 366' ' ' THR . 72.6 Cg_exo -51.13 145.38 26.13 Favored 'Trans proline' 0 CA--C 1.507 -0.838 0 C-N-CA 123.98 3.12 . . . . 0.23999999999999999 113.391 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.697 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.6 Cg_exo -65.55 -26.15 54.58 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.909 2.406 . . . . 0.31 112.309 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.555 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 57.9 p -76.38 -25.29 54.43 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.794 0.807 . . . . 1.1000000000000001 111.998 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.821 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.7 m -99.6 -50.16 10.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.628 -0.714 . . . . 0.080000000000000002 112.766 -170.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.962 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.61 -2.15 4.5 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.754 -0.778 . . . . 0.070000000000000007 110.371 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 16.9 pttp -80.87 -38.68 27.7 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 122.521 1.153 . . . . 0.92000000000000004 108.201 173.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.491 ' HG3' HD11 ' A' ' 364' ' ' LEU . 4.1 mm-40 -62.69 -46.39 88.39 Favored 'General case' 0 CA--C 1.474 -1.968 0 CA-C-N 112.433 -2.167 . . . . 0.25 106.578 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.962 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.28 -66.06 0.47 Allowed 'General case' 0 N--CA 1.404 -2.752 0 CA-C-N 109.849 -3.341 . . . . 0.050000000000000003 112.712 172.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.462 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 24.0 t80 -45.72 -23.67 0.28 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 123.941 0.776 . . . . 0.13 109.56 176.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.452 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.82 -27.1 25.03 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 114.649 -1.159 . . . . 0.13 111.817 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.741 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.99 -43.83 5.66 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 113.57 0.952 . . . . 0.059999999999999998 113.57 177.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.688 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.4 OUTLIER -74.89 149.76 7.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.486 1.136 . . . . 0.080000000000000002 111.175 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -125.0 157.63 35.67 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-N 112.939 -1.937 . . . . 0.47999999999999998 108.245 -176.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.658 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.1 mppt? -57.82 101.64 0.08 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 109.055 -0.72 . . . . 0.98999999999999999 109.055 172.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.85 -14.4 5.22 Favored Glycine 0 C--N 1.307 -1.082 0 CA-C-N 114.111 -1.404 . . . . 0.19 111.53 -175.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.688 HG21 ' HB ' ' A' ' 457' ' ' VAL . 17.8 m -66.63 149.27 98.32 Favored Pre-proline 0 N--CA 1.437 -1.076 0 N-CA-C 108.527 -0.916 . . . . 0.13 108.527 171.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.563 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 7.2 Cg_endo -94.39 164.19 1.94 Allowed 'Trans proline' 0 N--CA 1.419 -2.874 0 C-N-CA 122.159 1.906 . . . . 0.17999999999999999 109.769 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.76 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -126.6 151.65 33.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 107.741 -1.207 . . . . 0.56999999999999995 107.741 171.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.744 HD21 ' CE1' ' A' ' 339' ' ' HIS . 5.3 mp -134.6 151.27 50.96 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 109.079 -0.711 . . . . 0.13 109.079 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.098 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.38 142.81 30.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 105.604 -1.998 . . . . 0.10000000000000001 105.604 164.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.721 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 11.0 p90 . . . . . 0 C--O 1.244 0.785 0 CA-C-O 117.719 -1.134 . . . . 1.0900000000000001 111.562 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.732 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.69 0 N-CA-C 111.721 -0.552 . . . . 1.8700000000000001 111.721 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.539 ' CE1' HD21 ' A' ' 464' ' ' LEU . 4.5 p-80 -123.02 101.49 7.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.485 0.55 . . . . 0.83999999999999997 112.485 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.572 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.3 OUTLIER 62.46 -166.82 0.21 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.976 -1.011 . . . . 0.67000000000000004 113.19 165.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.17 171.9 2.74 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.678 -1.23 . . . . 1.8500000000000001 107.678 165.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.09 83.64 7.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 118.935 -1.106 . . . . 0.42999999999999999 109.635 -177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 96.4 m -158.25 135.65 10.2 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.039 -1.437 . . . . 0.14000000000000001 108.901 167.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.667 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.8 p90 174.56 158.3 0.16 Allowed 'General case' 0 C--O 1.213 -0.847 0 O-C-N 123.415 0.447 . . . . 0.14999999999999999 111.383 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.683 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -78.03 151.68 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 N-CA-C 109.126 -0.694 . . . . 0.080000000000000002 109.126 164.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.577 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.43 142.39 24.82 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.606 -0.725 . . . . 2.0099999999999998 109.641 -176.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.732 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.47 161.84 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.162 0.506 . . . . 0.45000000000000001 111.501 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.557 ' N ' HG12 ' A' ' 347' ' ' VAL . 31.8 t0 -140.3 106.47 5.23 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.18 -1.415 . . . . 0.23999999999999999 107.18 174.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.069 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.24 -32.63 29.63 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 122.807 1.289 . . . . 0.16 110.262 -168.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.42 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -58.73 -45.32 89.9 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.615 -2.993 . . . . 0.59999999999999998 108.304 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 18.5 m-80 -100.6 7.03 44.25 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 111.106 -2.77 . . . . 0.20000000000000001 110.713 -175.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.628 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 19.0 mp0 33.62 60.63 0.49 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 112.683 -2.053 . . . . 2.1499999999999999 113.0 -175.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.501 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 20.3 t60 -141.71 134.7 28.95 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.383 -0.826 . . . . 0.089999999999999997 109.73 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.723 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.63 155.97 24.53 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.569 -0.741 . . . . 0.070000000000000007 110.203 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.611 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.7 m-90 -141.46 155.19 45.87 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.153 -175.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.696 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.0 t80 -110.16 153.18 25.09 Favored 'General case' 0 CA--C 1.483 -1.625 0 N-CA-C 106.659 -1.608 . . . . 0.26000000000000001 106.659 151.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 8.8 m-85 -128.99 116.13 18.85 Favored 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 115.026 -0.988 . . . . 0.14000000000000001 110.413 -177.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.0 tppt? -116.41 140.23 49.57 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.085 -1.82 . . . . 0.25 106.085 168.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.439 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 67.19 18.01 10.35 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 113.29 0.848 . . . . 0.42999999999999999 113.29 172.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.24 8.34 85.32 Favored Glycine 0 CA--C 1.487 -1.703 0 CA-C-N 115.671 -0.695 . . . . 0.17999999999999999 113.197 -173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 15.4 ptmt -127.12 177.92 6.35 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 104.792 -2.299 . . . . 0.37 104.792 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.611 HG11 ' CD1' ' A' ' 355' ' ' TRP . 14.8 m -105.11 157.32 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.732 0 N-CA-C 116.374 1.99 . . . . 0.10000000000000001 116.374 -177.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.671 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.53 -27.48 9.87 Favored 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 110.484 -3.053 . . . . 0.070000000000000007 106.242 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.838 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.02 144.01 48.45 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 111.675 -2.511 . . . . 0.059999999999999998 111.723 -175.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.475 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -141.23 118.02 11.06 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 104.388 -2.449 . . . . 0.47999999999999998 104.388 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.723 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.52 163.96 36.39 Favored 'General case' 0 N--CA 1.399 -2.995 0 C-N-CA 118.051 -1.46 . . . . 0.070000000000000007 111.363 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -102.19 132.9 47.82 Favored 'General case' 0 C--N 1.276 -2.604 0 CA-C-N 114.341 -1.3 . . . . 1.8 109.531 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.752 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -131.72 -175.06 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.289 0 CA-C-O 122.448 1.118 . . . . 0.12 112.29 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -149.9 118.42 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 112.927 -1.942 . . . . 0.10000000000000001 108.123 171.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -78.84 -168.46 1.43 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.132 -1.394 . . . . 1.26 110.822 -176.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -83.62 164.94 41.87 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 118.66 -1.733 . . . . 0.14000000000000001 112.076 -173.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.431 ' HG3' ' OG1' ' A' ' 374' ' ' THR . 7.0 ptmt -71.03 155.88 92.74 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.861 0.838 . . . . 0.81000000000000005 111.998 -165.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.3 Cg_exo -54.96 -29.44 64.4 Favored 'Trans proline' 0 CA--C 1.496 -1.423 1 C-N-CA 125.502 4.135 . . . . 0.28000000000000003 113.488 -175.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.434 ' OG1' HG22 ' A' ' 375' ' ' THR . 14.9 p -69.71 -33.91 73.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.432 -1.713 . . . . 0.33000000000000002 109.476 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.519 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.8 t -142.49 70.67 21.17 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-O 123.71 1.719 . . . . 0.39000000000000001 109.527 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 375' ' ' THR . 86.5 Cg_exo -57.65 149.88 64.99 Favored 'Trans proline' 0 C--N 1.31 -1.448 1 C-N-CA 126.389 4.726 . . . . 0.38 114.582 -171.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.537 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -79.05 145.04 64.5 Favored Pre-proline 0 N--CA 1.427 -1.619 0 N-CA-C 108.629 -0.878 . . . . 0.81999999999999995 108.629 173.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 17.4 Cg_exo -77.01 -45.81 0.16 Allowed 'Trans proline' 0 CA--C 1.512 -0.586 0 C-N-CA 124.523 3.482 . . . . 0.19 112.163 -168.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.797 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.27 137.13 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 123.298 1.523 . . . . 0.13 113.557 -172.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.54 -113.3 0.57 Allowed Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 112.003 -2.362 . . . . 0.20000000000000001 109.533 -178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 8.1 p -131.02 116.28 33.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.887 0.851 . . . . 0.81999999999999995 110.899 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.757 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.3 m-85 -116.22 -174.31 2.53 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.253 -1.388 . . . . 0.22 107.253 173.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 1.6 t80 -140.98 125.05 17.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 120.186 1.357 . . . . 0.65000000000000002 113.436 -172.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -91.12 92.23 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 123.181 1.467 . . . . 0.16 109.609 169.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -93.15 11.12 28.92 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.419 -1.719 . . . . 2.5499999999999998 108.11 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.75 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.4 t30 -169.22 126.97 0.97 Allowed 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 113.952 -1.476 . . . . 0.42999999999999999 110.363 172.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.669 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -98.98 145.22 27.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.041 -0.981 . . . . 1.1200000000000001 108.927 169.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.739 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 11.3 mm-40 -125.08 158.16 34.49 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 114.888 1.44 . . . . 0.70999999999999996 114.888 -169.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.725 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 50.4 mt-10 -137.44 126.96 25.06 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 112.913 -1.949 . . . . 0.38 108.436 173.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 31.1 t70 54.16 50.73 15.87 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 123.248 1.499 . . . . 0.40999999999999998 109.082 -176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.946 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -84.04 166.69 17.51 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 112.83 -1.986 . . . . 0.12 109.27 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 21.7 m -132.7 118.81 19.56 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.204 1.002 . . . . 0.17000000000000001 111.793 171.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.46 88.72 5.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.585 -1.643 . . . . 0.56999999999999995 112.136 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.57 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.4 mttt -102.19 178.7 4.52 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 113.561 -1.654 . . . . 0.33000000000000002 113.14 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.32 -157.71 24.58 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 114.125 -1.398 . . . . 0.46000000000000002 111.385 -178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.8 m -118.46 139.88 50.72 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 120.106 -0.638 . . . . 0.70999999999999996 110.532 170.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.0 m-80 -57.17 153.13 12.35 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.592 -0.892 . . . . 0.83999999999999997 108.592 168.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -3.41 0.97 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.496 -0.775 . . . . 2.2799999999999998 110.844 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.2 OUTLIER -111.34 6.26 20.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.064 -0.971 . . . . 2.27 110.932 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.1 17.84 55.04 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.34 -0.933 . . . . 0.93999999999999995 112.486 169.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 9.4 p -113.19 100.65 52.02 Favored Pre-proline 0 C--N 1.302 -1.485 0 CA-C-N 114.377 -0.912 . . . . 0.81000000000000005 109.467 -175.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.8 Cg_endo -57.09 153.74 37.24 Favored 'Trans proline' 0 CA--C 1.507 -0.858 0 C-N-CA 122.74 2.293 . . . . 0.63 112.791 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -154.83 173.88 15.86 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.906 -1.043 . . . . 0.41999999999999998 112.811 -171.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.57 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER -144.19 147.51 33.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.772 -1.558 . . . . 0.53000000000000003 110.051 171.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -144.66 97.47 5.01 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.376 -0.972 . . . . 0.19 108.376 171.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 19.0 Cg_exo -68.87 110.38 2.36 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 121.991 1.794 . . . . 0.19 110.045 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.946 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.76 154.87 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 CA-C-N 112.91 -1.95 . . . . 0.14999999999999999 107.521 -168.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.725 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 21.7 m-80 -87.11 -21.57 25.92 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.909 -0.774 . . . . 0.51000000000000001 108.909 -174.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 90.3 m-85 -157.59 127.61 6.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.959 -1.018 . . . . 0.27000000000000002 108.677 -170.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.678 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 23.3 t-105 -145.5 133.64 21.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.767 0.794 . . . . 0.089999999999999997 111.151 -167.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.669 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.3 mmt -114.96 93.26 33.86 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 107.747 -1.205 . . . . 0.14000000000000001 107.747 172.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.75 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.9 Cg_endo -67.71 70.4 0.75 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.527 2.151 . . . . 0.5 112.515 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.602 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.0 pt -69.18 175.58 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 108.401 -0.962 . . . . 0.88 108.401 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 416' ' ' THR . 33.7 t0 -149.48 -176.7 5.5 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.657 -1.217 . . . . 2.4900000000000002 112.838 -166.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.447 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 38.7 p90 58.03 -8.92 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.014 2.125 . . . . 1.9199999999999999 114.294 174.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.466 HG21 ' CD1' ' A' ' 382' ' ' PHE . 22.8 p -121.87 -14.56 8.05 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.126 0.489 . . . . 0.94999999999999996 110.775 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.434 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 97.19 -31.96 7.17 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.586 -0.734 . . . . 0.68000000000000005 111.286 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 419' ' ' GLY . 38.3 t -59.53 173.23 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 123.954 0.902 . . . . 0.75 111.891 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.602 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -177.82 121.51 0.78 Allowed Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.72 -1.352 . . . . 0.20000000000000001 109.72 170.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.69 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.0 mp -81.94 142.66 13.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 120.884 -0.326 . . . . 0.28999999999999998 110.158 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.678 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.6 p80 -159.42 160.99 35.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 116.336 -0.393 . . . . 0.089999999999999997 111.949 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.679 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -83.65 147.53 27.64 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.141 -1.059 . . . . 1.0700000000000001 108.141 172.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.59 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 2.6 t -133.62 98.94 4.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.633 1.206 . . . . 0.23000000000000001 110.514 -173.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.465 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 11.2 t70 -80.1 -9.88 59.73 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.69 -1.141 . . . . 0.41999999999999998 109.593 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.756 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 8.7 p90 -96.47 -25.01 15.83 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.527 -1.215 . . . . 0.32000000000000001 113.098 -173.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.652 ' OE1' ' HD2' ' A' ' 427' ' ' PRO . 0.0 OUTLIER -94.43 116.64 66.64 Favored Pre-proline 0 CA--C 1.509 -0.608 0 CA-C-O 122.726 1.25 . . . . 1.74 109.8 -179.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.664 ' HG2' ' OE2' ' A' ' 428' ' ' GLU . 81.4 Cg_endo -82.91 -23.24 3.86 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.228 3.285 . . . . 0.72999999999999998 114.407 -171.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.664 ' OE2' ' HG2' ' A' ' 427' ' ' PRO . 0.7 OUTLIER -112.01 155.42 23.81 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.303 1.049 . . . . 2.1600000000000001 112.346 172.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.484 ' HA ' HD23 ' A' ' 433' ' ' LEU . 3.3 m-85 -155.15 130.17 9.45 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 104.517 -2.401 . . . . 0.33000000000000002 104.517 171.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.31 -158.71 31.59 Favored Glycine 0 C--N 1.288 -2.096 0 N-CA-C 110.052 -1.219 . . . . 0.17000000000000001 110.052 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.484 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.52 174.54 0.01 OUTLIER Glycine 0 CA--C 1.501 -0.819 0 C-N-CA 120.442 -0.885 . . . . 0.20999999999999999 111.806 168.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.518 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.0 p-10 -50.91 101.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 123.496 1.617 . . . . 1.8500000000000001 113.597 -152.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.724 ' HG ' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.79 -38.54 10.27 Favored 'General case' 0 C--O 1.203 -1.389 0 CA-C-N 112.316 -2.22 . . . . 1.21 109.642 170.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.715 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.8 p-90 -55.39 -27.28 46.58 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.608 -0.724 . . . . 0.16 112.505 -170.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.715 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -88.99 -33.02 17.33 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.717 0.77 . . . . 0.22 112.089 -177.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 7.0 p -89.79 -44.66 9.83 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.381 -1.281 . . . . 0.25 110.918 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.724 ' CD ' ' HG ' ' A' ' 433' ' ' LEU . 7.4 mtp85 -88.23 -19.23 27.12 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.45 -1.25 . . . . 1.8200000000000001 109.92 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.73 46.0 48.12 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.248 -1.342 . . . . 0.23999999999999999 113.327 164.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.0 m -84.45 110.39 18.61 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 119.32 -0.952 . . . . 1.01 111.837 -168.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.552 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 42.4 m-70 40.12 -129.73 0.36 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.343 -1.298 . . . . 0.5 113.056 176.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -124.44 -20.37 2.42 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.712 -0.756 . . . . 0.26000000000000001 113.547 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.65 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.7 p -103.77 -165.71 1.18 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 113.278 0.844 . . . . 0.34999999999999998 113.278 -173.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.476 HD13 HG11 ' A' ' 465' ' ' VAL . 1.9 mp -92.85 133.18 34.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 0.12 110.548 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.55 97.55 7.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.728 -0.669 . . . . 0.62 109.462 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.752 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.7 m -92.64 141.51 24.63 Favored Pre-proline 0 N--CA 1.437 -1.081 0 CA-C-N 115.51 -0.768 . . . . 0.10000000000000001 112.262 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.643 ' HD2' HG21 ' A' ' 366' ' ' THR . 64.0 Cg_exo -52.16 144.26 38.82 Favored 'Trans proline' 0 CA--C 1.499 -1.228 0 C-N-CA 123.975 3.117 . . . . 0.23999999999999999 114.786 175.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.635 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 80.3 Cg_exo -52.34 -55.02 4.22 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.301 2.001 . . . . 0.31 110.698 -174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.492 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 51.9 p -57.23 -23.82 50.59 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 112.251 -2.25 . . . . 1.1000000000000001 113.74 -170.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.838 ' O ' HD21 ' A' ' 364' ' ' LEU . 27.1 m -98.24 -49.18 11.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.88 0 N-CA-C 113.019 0.748 . . . . 0.080000000000000002 113.019 -173.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.957 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.72 -2.11 6.43 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.52 -0.872 . . . . 0.070000000000000007 110.235 -178.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.56 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 14.7 pttp -80.98 -38.16 28.07 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 122.651 1.215 . . . . 0.92000000000000004 108.335 173.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.6 mm-40 -62.17 -46.32 89.49 Favored 'General case' 0 CA--C 1.471 -2.073 0 CA-C-N 112.387 -2.188 . . . . 0.25 106.53 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.957 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.09 -66.35 0.42 Allowed 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 109.837 -3.347 . . . . 0.050000000000000003 112.786 172.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.552 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.7 t80 -46.68 -22.78 0.33 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.673 0.749 . . . . 0.13 109.457 175.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.447 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.5 -22.46 37.08 Favored Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.059 -0.973 . . . . 0.13 111.819 -176.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.743 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -106.34 -44.21 4.59 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 113.777 1.028 . . . . 0.059999999999999998 113.777 175.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.66 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -73.52 148.97 8.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-O 122.44 1.114 . . . . 0.080000000000000002 111.275 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.11 156.63 29.41 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 113.048 -1.887 . . . . 0.47999999999999998 108.517 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.613 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 3.6 mppt? -59.07 101.75 0.1 Allowed 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.903 -0.777 . . . . 0.98999999999999999 108.903 171.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.7 -10.65 5.47 Favored Glycine 0 C--N 1.308 -1.019 0 CA-C-N 113.962 -1.472 . . . . 0.19 111.576 -175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.634 HG21 ' HB ' ' A' ' 457' ' ' VAL . 18.2 m -68.61 150.8 97.55 Favored Pre-proline 0 N--CA 1.443 -0.803 0 N-CA-C 109.073 -0.714 . . . . 0.13 109.073 171.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.572 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.4 Cg_endo -93.99 163.37 2.14 Favored 'Trans proline' 0 N--CA 1.425 -2.516 0 C-N-CA 122.428 2.085 . . . . 0.17999999999999999 110.128 176.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.757 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -126.87 149.89 32.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 107.668 -1.234 . . . . 0.56999999999999995 107.668 171.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.702 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.47 149.89 50.77 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.411 -0.959 . . . . 0.13 108.411 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.069 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -138.25 141.82 36.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 105.434 -2.062 . . . . 0.10000000000000001 105.434 165.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.764 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 10.2 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 117.723 -1.132 . . . . 1.0900000000000001 111.664 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.747 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.934 -0.466 . . . . 1.8700000000000001 111.934 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.565 ' CE1' HD21 ' A' ' 464' ' ' LEU . 2.0 p-80 -135.12 101.42 4.86 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 120.629 0.252 . . . . 0.83999999999999997 111.585 177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.56 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.6 OUTLIER 61.87 -165.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.309 -0.859 . . . . 0.67000000000000004 112.668 168.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.02 173.8 5.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.144 -1.428 . . . . 1.8500000000000001 107.144 164.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -80.5 84.23 6.15 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.286 -0.966 . . . . 0.42999999999999999 110.008 -174.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 357' ' ' TYR . 84.3 m -158.39 135.56 9.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.62 -1.173 . . . . 0.14000000000000001 109.067 168.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.696 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.7 p90 174.42 158.63 0.16 Allowed 'General case' 0 CA--C 1.503 -0.829 0 O-C-N 123.386 0.429 . . . . 0.14999999999999999 111.132 -175.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.659 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.92 152.33 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 109.106 -0.702 . . . . 0.080000000000000002 109.106 164.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.614 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.65 143.05 25.26 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.64 -0.709 . . . . 2.0099999999999998 109.551 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.725 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -135.59 162.16 37.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.027 0.441 . . . . 0.45000000000000001 111.378 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.558 ' N ' HG12 ' A' ' 347' ' ' VAL . 20.5 t0 -139.91 107.26 5.53 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 107.404 -1.332 . . . . 0.23999999999999999 107.404 172.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.034 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.51 -34.38 27.97 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 122.719 1.247 . . . . 0.16 110.52 -167.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.432 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.1 mt-10 -58.41 -45.26 88.75 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.871 -2.877 . . . . 0.59999999999999998 108.252 176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 19.4 m-80 -99.99 6.47 45.11 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 111.031 -2.804 . . . . 0.20000000000000001 110.889 -175.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 18.1 mp0 33.53 61.7 0.44 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 112.545 -2.116 . . . . 2.1499999999999999 113.11 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.8 t60 -141.92 135.18 29.18 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.612 -0.722 . . . . 0.089999999999999997 109.733 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.723 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -114.23 156.17 24.81 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.735 -0.666 . . . . 0.070000000000000007 110.233 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.576 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.0 m-90 -141.17 153.93 45.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.373 -0.831 . . . . 0.11 111.269 -174.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.684 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 86.1 t80 -109.76 153.21 24.66 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 106.599 -1.63 . . . . 0.26000000000000001 106.599 151.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.5 m-85 -129.25 116.61 19.4 Favored 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 114.699 -1.137 . . . . 0.14000000000000001 110.226 -178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.5 tppt? -115.88 137.3 52.23 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 105.703 -1.962 . . . . 0.25 105.703 167.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.423 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.73 18.31 8.72 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 113.61 0.967 . . . . 0.42999999999999999 113.61 172.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.31 8.1 86.99 Favored Glycine 0 CA--C 1.487 -1.697 0 CA-C-O 121.779 0.655 . . . . 0.17999999999999999 113.015 -174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 15.8 ptmt -128.13 176.95 7.25 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 104.569 -2.382 . . . . 0.37 104.569 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.4 m -104.38 157.86 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.611 0 N-CA-C 116.289 1.959 . . . . 0.10000000000000001 116.289 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.684 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.87 -26.61 9.7 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 110.516 -3.038 . . . . 0.070000000000000007 106.646 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.803 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -134.84 144.96 47.88 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 111.669 -2.514 . . . . 0.059999999999999998 111.753 -175.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.508 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 5.8 tt0 -139.92 118.15 12.0 Favored 'General case' 0 N--CA 1.408 -2.53 0 N-CA-C 104.411 -2.44 . . . . 0.47999999999999998 104.411 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.723 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.09 163.39 38.31 Favored 'General case' 0 N--CA 1.4 -2.971 0 C-N-CA 117.466 -1.693 . . . . 0.070000000000000007 111.917 179.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 18.1 p-10 -103.02 134.33 46.64 Favored 'General case' 0 C--N 1.281 -2.413 0 CA-C-N 114.293 -1.321 . . . . 1.8 109.57 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.89 -172.34 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 CA-C-O 122.508 1.147 . . . . 0.12 112.414 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.549 HG11 HE22 ' A' ' 426' ' ' GLN . 0.5 OUTLIER -152.23 120.89 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 112.832 -1.985 . . . . 0.10000000000000001 108.423 172.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.521 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.86 -168.14 1.5 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.315 -1.311 . . . . 1.26 110.708 -179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -83.96 170.33 47.42 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 118.907 -1.616 . . . . 0.14000000000000001 112.152 -173.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -78.6 162.89 63.99 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 113.109 0.781 . . . . 0.81000000000000005 113.109 -162.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.731 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 74.9 Cg_exo -54.84 -37.53 92.57 Favored 'Trans proline' 0 CA--C 1.509 -0.725 0 C-N-CA 123.058 2.505 . . . . 0.28000000000000003 112.56 -175.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.42 ' OG1' HG22 ' A' ' 375' ' ' THR . 25.2 p -66.06 -33.96 76.98 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.337 -1.301 . . . . 0.33000000000000002 110.085 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.523 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.5 t -141.56 72.69 25.1 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-O 123.69 1.709 . . . . 0.39000000000000001 109.743 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 375' ' ' THR . 74.3 Cg_exo -61.37 160.5 27.04 Favored 'Trans proline' 0 C--N 1.311 -1.423 1 C-N-CA 126.345 4.697 . . . . 0.38 114.346 -173.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.521 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -91.55 144.71 29.99 Favored Pre-proline 0 N--CA 1.42 -1.96 0 N-CA-C 108.305 -0.998 . . . . 0.81999999999999995 108.305 171.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 20.4 Cg_exo -76.44 -43.88 0.27 Allowed 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 124.844 3.696 . . . . 0.19 112.139 -168.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.785 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.96 134.6 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.488 1.613 . . . . 0.13 113.562 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 155.14 -116.15 0.71 Allowed Glycine 0 N--CA 1.429 -1.791 0 CA-C-N 111.959 -2.382 . . . . 0.20000000000000001 109.627 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 381' ' ' VAL . 8.4 p -130.34 115.69 33.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.861 0.839 . . . . 0.81999999999999995 110.899 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.743 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.7 m-85 -115.36 -174.01 2.43 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.34 -1.355 . . . . 0.22 107.34 174.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 0.8 OUTLIER -139.65 123.49 17.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.881 1.219 . . . . 0.65000000000000002 113.268 -171.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -91.74 91.67 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 CA-C-O 123.189 1.471 . . . . 0.16 109.39 168.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -93.44 10.58 31.74 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 113.106 -1.861 . . . . 2.5499999999999998 107.908 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.757 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.7 t30 -168.78 125.6 0.98 Allowed 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 113.774 -1.557 . . . . 0.42999999999999999 109.939 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.651 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.9 143.52 30.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.902 -1.044 . . . . 1.1200000000000001 108.86 169.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.785 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 20.4 mm-40 -125.17 155.18 40.36 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 114.441 1.274 . . . . 0.70999999999999996 114.441 -168.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.775 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 41.0 mt-10 -136.86 126.55 25.45 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 112.947 -1.933 . . . . 0.38 108.287 171.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.6 t70 57.56 53.34 7.43 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 123.459 1.6 . . . . 0.40999999999999998 109.144 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.914 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -89.29 166.38 13.81 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 112.451 -2.159 . . . . 0.12 108.501 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 31.6 m -132.93 120.03 20.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.092 0.949 . . . . 0.17000000000000001 111.862 171.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.755 HD11 HG21 ' A' ' 407' ' ' VAL . 8.9 mt -75.75 88.29 2.81 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 113.828 -1.533 . . . . 0.56999999999999995 112.796 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.54 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 44.9 mttt -105.18 177.59 4.81 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 114.492 -1.231 . . . . 0.33000000000000002 113.751 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.68 -159.77 25.02 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.163 -1.381 . . . . 0.46000000000000002 111.55 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.676 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.3 m -115.98 139.54 50.15 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 120.361 -0.536 . . . . 0.70999999999999996 110.454 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.4 m-80 -56.88 152.94 11.8 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.136 -0.69 . . . . 0.83999999999999997 109.136 168.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -0.1 0.22 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.688 -0.687 . . . . 2.2799999999999998 111.646 176.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 397' ' ' ASN . 33.8 t70 -115.42 0.93 13.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.893 0.854 . . . . 2.27 110.364 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.55 17.28 34.06 Favored Glycine 0 N--CA 1.428 -1.887 0 CA-C-N 114.851 -1.068 . . . . 0.93999999999999995 112.971 171.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.436 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 7.7 p -112.47 101.14 51.95 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-O 121.57 0.7 . . . . 0.81000000000000005 109.913 -175.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.6 Cg_endo -58.5 150.41 68.85 Favored 'Trans proline' 0 CA--C 1.504 -0.987 0 C-N-CA 122.712 2.275 . . . . 0.63 112.965 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 21.2 p90 -150.47 171.96 16.22 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.57 -1.196 . . . . 0.41999999999999998 113.054 -169.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.54 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -147.15 146.17 29.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.906 -1.497 . . . . 0.53000000000000003 110.07 172.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.647 ' O ' ' HG ' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.98 97.54 4.85 Favored Pre-proline 0 N--CA 1.435 -1.179 0 N-CA-C 108.304 -0.998 . . . . 0.19 108.304 171.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 14.4 Cg_exo -70.27 108.21 2.13 Favored 'Trans proline' 0 N--CA 1.432 -2.127 0 C-N-CA 121.023 1.149 . . . . 0.19 110.016 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -106.22 152.4 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.285 0 CA-C-N 112.816 -1.993 . . . . 0.14999999999999999 108.55 -169.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.775 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.8 OUTLIER -86.08 -19.17 30.64 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.753 -0.832 . . . . 0.51000000000000001 108.753 -174.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.785 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.4 m-85 -158.05 126.02 5.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.378 -0.828 . . . . 0.27000000000000002 108.938 -171.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.675 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 21.4 t-105 -144.94 134.24 22.96 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.705 0.764 . . . . 0.089999999999999997 111.18 -167.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.651 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.1 mmt -116.44 93.64 40.59 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.746 -1.205 . . . . 0.14000000000000001 107.746 172.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.757 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 38.6 Cg_endo -68.13 67.68 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.532 2.154 . . . . 0.5 112.95 -178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.592 HG12 ' HA2' ' A' ' 419' ' ' GLY . 2.1 pt -67.24 174.45 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.552 -0.906 . . . . 0.88 108.552 176.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 416' ' ' THR . 3.5 t70 -150.88 -173.23 4.42 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 118.761 -1.176 . . . . 2.4900000000000002 112.771 -166.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.435 ' CZ2' ' HB2' ' A' ' 383' ' ' TYR . 35.9 p90 52.88 -0.43 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.01 2.124 . . . . 1.9199999999999999 114.633 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.449 HG21 ' CD1' ' A' ' 382' ' ' PHE . 37.1 p -130.63 -11.43 3.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.949 0.404 . . . . 0.94999999999999996 111.116 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.537 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 97.14 -36.11 4.08 Favored Glycine 0 CA--C 1.503 -0.688 0 N-CA-C 111.094 -0.803 . . . . 0.68000000000000005 111.094 177.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 419' ' ' GLY . 36.0 t -58.97 172.66 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.126 0.97 . . . . 0.75 112.298 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.593 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.71 120.74 0.72 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 109.861 -1.296 . . . . 0.20000000000000001 109.861 170.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.686 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.43 141.83 14.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 110.041 -0.355 . . . . 0.28999999999999998 110.041 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.675 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.2 p80 -157.92 161.21 38.22 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 116.091 -0.504 . . . . 0.089999999999999997 111.173 -174.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.699 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.2 OUTLIER -84.18 148.16 26.91 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.178 -1.045 . . . . 1.0700000000000001 108.178 172.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 445' ' ' THR . 45.9 t -134.18 96.1 3.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.707 0.765 . . . . 0.23000000000000001 109.844 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 19.6 t70 -82.39 -19.66 38.7 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.3 -1.318 . . . . 0.41999999999999998 109.921 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.765 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 14.2 p90 -84.39 -22.13 30.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.182 -1.372 . . . . 0.32000000000000001 111.239 -176.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.551 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 2.3 tt0 -100.38 115.66 65.2 Favored Pre-proline 0 CA--C 1.506 -0.725 0 CA-C-O 122.704 1.24 . . . . 1.74 110.032 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.534 ' HG2' ' OE1' ' A' ' 428' ' ' GLU . 44.8 Cg_endo -86.15 -10.71 6.7 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 124.271 3.314 . . . . 0.72999999999999998 113.231 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.599 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.4 pm0 -111.6 153.93 25.6 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 122.39 1.091 . . . . 2.1600000000000001 113.242 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.632 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.04 130.88 4.3 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 104.93 -2.248 . . . . 0.33000000000000002 104.93 170.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.46 -158.63 31.62 Favored Glycine 0 C--N 1.284 -2.35 0 C-N-CA 119.806 -1.188 . . . . 0.17000000000000001 110.792 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -44.35 175.33 0.01 OUTLIER Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 120.519 -0.848 . . . . 0.20999999999999999 111.713 167.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.489 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 7.8 p-10 -50.58 101.8 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 123.473 1.606 . . . . 1.8500000000000001 113.445 -153.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.73 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -97.13 -37.69 10.02 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-N 112.639 -2.073 . . . . 1.21 109.478 169.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.744 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.6 p-90 -54.13 -28.04 37.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.36 -0.836 . . . . 0.16 112.286 -170.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.744 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.67 -35.07 15.16 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.697 0.629 . . . . 0.22 112.697 -178.029 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.2 p -90.98 -40.86 11.43 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.262 -0.881 . . . . 0.25 111.014 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.73 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -95.49 -17.21 21.65 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.646 -1.161 . . . . 1.8200000000000001 109.693 -178.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.76 50.11 51.1 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 114.91 -1.041 . . . . 0.23999999999999999 115.22 161.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.8 m -82.06 109.82 16.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.923 1.362 . . . . 1.01 110.845 -173.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.424 ' HB2' ' OAC' ' A' ' 130' ' ' 1RG . 67.8 m-70 32.59 -112.16 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.467 -1.242 . . . . 0.5 113.418 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -140.49 -14.6 0.52 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.898 -0.592 . . . . 0.26000000000000001 113.767 -174.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.852 ' HB3' HASB ' A' ' 130' ' ' 1RG . 28.8 p -104.59 -166.32 1.23 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 117.75 0.775 . . . . 0.34999999999999998 112.467 -176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.438 ' CD1' HG11 ' A' ' 465' ' ' VAL . 2.1 mp -96.65 129.63 46.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.839 -1.073 . . . . 0.12 110.465 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.55 93.15 5.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.815 -0.629 . . . . 0.62 110.123 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.726 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.2 m -89.15 142.98 30.44 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.936 -1.029 . . . . 0.10000000000000001 112.731 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.657 ' HD2' HG21 ' A' ' 366' ' ' THR . 75.0 Cg_exo -50.16 146.47 17.72 Favored 'Trans proline' 0 CA--C 1.507 -0.857 0 C-N-CA 124.15 3.234 . . . . 0.23999999999999999 113.323 174.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.699 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.3 Cg_exo -67.33 -25.07 42.65 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.887 2.392 . . . . 0.31 111.834 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.511 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 40.4 p -76.61 -26.09 54.6 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.94 -1.027 . . . . 1.1000000000000001 112.036 -175.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.803 ' O ' HD21 ' A' ' 364' ' ' LEU . 33.4 m -99.27 -49.75 11.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 112.806 0.669 . . . . 0.080000000000000002 112.806 -170.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.954 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.51 -2.25 4.49 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.743 -0.783 . . . . 0.070000000000000007 110.409 -178.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 40.9 pttt -81.29 -38.74 26.33 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 122.518 1.151 . . . . 0.92000000000000004 108.335 173.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.1 mm-40 -62.94 -46.7 86.52 Favored 'General case' 0 CA--C 1.473 -1.994 0 CA-C-N 112.47 -2.15 . . . . 0.25 106.688 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.954 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.7 tp -46.68 -67.16 0.31 Allowed 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 109.906 -3.316 . . . . 0.050000000000000003 112.736 172.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.527 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 16.4 t80 -44.91 -24.85 0.25 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 124.191 0.932 . . . . 0.13 109.39 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -87.57 -30.12 19.58 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 114.551 -1.204 . . . . 0.13 111.607 -175.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.753 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -98.27 -44.12 6.69 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 113.21 0.818 . . . . 0.059999999999999998 113.21 178.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -73.75 147.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 122.558 1.17 . . . . 0.080000000000000002 111.126 179.402 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.61 156.58 27.9 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 112.809 -1.996 . . . . 0.47999999999999998 108.473 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 42.4 mtmt -55.76 102.73 0.08 Allowed 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.699 -0.682 . . . . 0.98999999999999999 109.517 169.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 129.79 -13.22 5.85 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 113.792 -1.549 . . . . 0.19 111.779 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.665 HG21 ' HB ' ' A' ' 457' ' ' VAL . 17.3 m -64.85 150.1 95.29 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 108.996 -0.742 . . . . 0.13 108.996 173.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.56 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.1 Cg_endo -93.62 160.33 2.36 Favored 'Trans proline' 0 N--CA 1.424 -2.616 0 C-N-CA 122.331 2.021 . . . . 0.17999999999999999 109.962 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.743 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -124.6 149.87 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.317 -1.364 . . . . 0.56999999999999995 107.317 171.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.696 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.6 mp -134.42 149.99 50.82 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.339 -0.986 . . . . 0.13 108.339 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.034 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.82 140.95 40.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 105.647 -1.983 . . . . 0.10000000000000001 105.647 166.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.683 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 5.4 p90 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 117.649 -1.167 . . . . 1.0900000000000001 111.139 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.852 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.61 0 N-CA-C 112.167 -0.373 . . . . 1.8700000000000001 112.167 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.566 ' CE1' HD21 ' A' ' 464' ' ' LEU . 1.5 p-80 -139.21 102.61 4.55 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 111.805 0.298 . . . . 0.83999999999999997 111.805 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.537 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.5 OUTLIER 60.79 -162.95 0.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 O-C-N 124.023 0.827 . . . . 0.67000000000000004 112.762 167.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.24 172.77 6.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.221 -1.399 . . . . 1.8500000000000001 107.221 163.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.505 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 4.6 m-20 -80.06 83.97 5.86 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 119.246 -0.982 . . . . 0.42999999999999999 109.993 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.782 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 53.2 m -156.86 132.71 9.54 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.358 -1.292 . . . . 0.14000000000000001 108.268 167.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.758 ' CD2' HD13 ' A' ' 464' ' ' LEU . 42.9 p90 174.73 158.38 0.17 Allowed 'General case' 0 CA--C 1.5 -0.944 0 O-C-N 123.421 0.451 . . . . 0.14999999999999999 111.002 -173.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.658 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.34 153.71 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 109.387 -0.598 . . . . 0.080000000000000002 109.387 165.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.71 146.63 28.21 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.826 -1.175 . . . . 2.0099999999999998 107.826 -178.488 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.748 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.4 155.03 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 C-N-CA 123.579 0.752 . . . . 0.45000000000000001 110.618 173.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.524 ' N ' HG12 ' A' ' 347' ' ' VAL . 48.0 t0 -137.19 105.33 5.69 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.255 -1.757 . . . . 0.23999999999999999 106.255 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.058 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -79.62 -35.83 38.89 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 123.11 1.433 . . . . 0.16 110.019 -166.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.474 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -56.04 -44.98 79.33 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 110.682 -2.963 . . . . 0.59999999999999998 108.037 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 28.1 m-80 -101.02 7.1 43.62 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 110.815 -2.902 . . . . 0.20000000000000001 110.893 -174.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.6 OUTLIER 32.78 61.44 0.38 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 112.628 -2.078 . . . . 2.1499999999999999 112.928 -175.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.508 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 24.1 t60 -141.94 135.77 29.73 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.77 -0.65 . . . . 0.089999999999999997 109.837 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.777 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.65 157.26 22.38 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.91 -0.586 . . . . 0.070000000000000007 110.155 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.666 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -142.68 160.06 41.04 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.81 -0.632 . . . . 0.11 111.254 -177.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.782 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.6 t80 -112.3 153.9 26.49 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 106.45 -1.685 . . . . 0.26000000000000001 106.45 150.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.5 m-85 -127.51 119.21 25.55 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 115.119 -0.946 . . . . 0.14000000000000001 110.126 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.4 tppt? -120.47 134.88 55.21 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.124 -1.806 . . . . 0.25 106.124 168.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.456 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 72.98 16.32 4.41 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 113.216 0.821 . . . . 0.42999999999999999 113.216 172.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.505 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.68 6.79 88.35 Favored Glycine 0 CA--C 1.486 -1.767 0 C-N-CA 120.995 -0.621 . . . . 0.17999999999999999 113.05 -172.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.3 ptmt -128.49 176.39 7.78 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 104.872 -2.269 . . . . 0.37 104.872 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.666 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.4 m -104.83 156.89 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 116.597 2.073 . . . . 0.10000000000000001 116.597 -175.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.708 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.76 -27.34 10.34 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 110.672 -2.967 . . . . 0.070000000000000007 106.599 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.792 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.9 145.39 49.57 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 111.405 -2.634 . . . . 0.059999999999999998 111.301 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.486 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -142.1 118.08 10.6 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 104.504 -2.406 . . . . 0.47999999999999998 104.504 175.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.777 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.3 164.87 33.64 Favored 'General case' 0 N--CA 1.402 -2.857 0 C-N-CA 117.997 -1.481 . . . . 0.070000000000000007 111.803 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.585 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 12.2 p-10 -102.95 132.69 49.0 Favored 'General case' 0 N--CA 1.41 -2.458 0 CA-C-N 114.109 -1.405 . . . . 1.8 109.791 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.741 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -135.02 -173.48 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 CA-C-O 122.522 1.153 . . . . 0.12 112.425 -171.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.09 120.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 112.719 -2.037 . . . . 0.10000000000000001 108.123 172.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.478 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -78.73 -168.6 1.45 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.23 -1.35 . . . . 1.26 110.325 179.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.553 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.16 170.51 45.15 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 118.601 -1.761 . . . . 0.14000000000000001 112.631 -173.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.5 ptmt -72.96 155.28 90.6 Favored Pre-proline 0 C--O 1.218 -0.603 0 CA-C-O 121.42 0.629 . . . . 0.81000000000000005 111.576 -166.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.664 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 77.9 Cg_exo -55.04 -28.29 59.37 Favored 'Trans proline' 0 CA--C 1.497 -1.326 0 C-N-CA 125.243 3.962 . . . . 0.28000000000000003 113.665 -173.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.44 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 26.2 p -72.6 -32.28 65.83 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 113.621 -1.627 . . . . 0.33000000000000002 109.586 -176.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.616 ' HB ' ' CAZ' ' A' ' 130' ' ' 1RG . 0.4 OUTLIER -141.37 70.56 26.93 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-O 123.426 1.584 . . . . 0.39000000000000001 110.127 178.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 375' ' ' THR . 76.1 Cg_exo -59.4 157.5 30.85 Favored 'Trans proline' 0 C--N 1.311 -1.406 1 C-N-CA 126.309 4.673 . . . . 0.38 113.996 -172.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.487 HG21 ' HG ' ' A' ' 349' ' ' LEU . 0.5 OUTLIER -84.97 147.74 48.93 Favored Pre-proline 0 N--CA 1.422 -1.875 0 N-CA-C 108.198 -1.038 . . . . 0.81999999999999995 108.198 174.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 15.5 Cg_exo -77.6 -42.39 0.27 Allowed 'Trans proline' 0 CA--C 1.514 -0.505 0 C-N-CA 124.124 3.216 . . . . 0.19 112.363 -166.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 54.99 137.83 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 123.604 1.668 . . . . 0.13 114.487 -173.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.75 -109.91 0.44 Allowed Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 111.997 -2.365 . . . . 0.20000000000000001 109.549 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.0 p -130.75 124.32 56.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.328 0.585 . . . . 0.81999999999999995 109.724 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.748 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 4.7 m-85 -123.65 -174.45 2.97 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.497 -1.297 . . . . 0.22 107.497 172.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 1.0 OUTLIER -139.85 123.22 17.07 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 119.471 1.032 . . . . 0.65000000000000002 112.953 -171.072 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.84 91.14 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-O 123.296 1.522 . . . . 0.16 109.032 169.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -93.9 11.82 28.14 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 112.978 -1.919 . . . . 2.5499999999999998 107.873 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.744 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.9 t30 -168.49 124.9 1.01 Allowed 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 113.627 -1.624 . . . . 0.42999999999999999 110.009 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.646 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -101.19 143.53 31.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.086 -0.961 . . . . 1.1200000000000001 108.949 170.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.758 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 37.1 mm-40 -126.95 158.46 36.77 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 114.961 1.467 . . . . 0.70999999999999996 114.961 -167.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.709 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 43.6 mt-10 -138.75 126.65 22.34 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.194 -1.821 . . . . 0.38 108.796 174.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 18.6 t70 52.15 51.88 15.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 123.165 1.459 . . . . 0.40999999999999998 109.231 -173.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.924 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -82.92 167.46 17.97 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 112.764 -2.016 . . . . 0.12 109.005 176.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 15.8 m -132.93 120.53 21.58 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.863 0.84 . . . . 0.17000000000000001 111.291 169.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.6 mp -78.02 87.2 4.18 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 113.969 -1.468 . . . . 0.56999999999999995 111.417 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.553 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 45.8 mttt -105.7 -179.49 3.96 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 113.393 -1.731 . . . . 0.33000000000000002 113.573 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.49 -162.21 25.76 Favored Glycine 0 N--CA 1.424 -2.116 0 CA-C-N 113.689 -1.596 . . . . 0.46000000000000002 110.619 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.5 m -117.61 138.84 51.68 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 119.926 -0.71 . . . . 0.70999999999999996 109.914 168.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.6 m-80 -55.02 144.73 22.48 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 106.57 -1.641 . . . . 0.83999999999999997 106.57 165.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . 0.457 ' HB2' ' CBD' ' A' ' 130' ' ' 1RG . 0.1 OUTLIER -60.02 -2.61 0.44 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.154 0.502 . . . . 2.2799999999999998 111.542 179.304 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 397' ' ' ASN . 4.0 t70 -106.92 1.72 24.76 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.273 -0.876 . . . . 2.27 109.693 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.53 20.13 27.9 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 114.625 -1.17 . . . . 0.93999999999999995 113.029 168.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 7.1 p -113.36 97.92 44.79 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-N 114.688 -0.756 . . . . 0.81000000000000005 109.675 -176.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.4 Cg_endo -59.73 150.24 78.2 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 C-N-CA 122.794 2.33 . . . . 0.63 112.778 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -151.37 170.44 19.55 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.3 -1.318 . . . . 0.41999999999999998 112.063 -170.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.553 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -148.57 146.41 28.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.094 -1.412 . . . . 0.53000000000000003 110.798 175.283 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.9 OUTLIER -145.14 97.32 4.82 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 108.305 -0.998 . . . . 0.19 108.305 170.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.2 Cg_exo -68.73 111.26 2.55 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 122.089 1.859 . . . . 0.19 110.49 -178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.924 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -112.74 151.21 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 CA-C-N 113.206 -1.815 . . . . 0.14999999999999999 107.993 -167.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.709 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.8 OUTLIER -85.12 -19.53 31.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.789 -0.819 . . . . 0.51000000000000001 108.789 -173.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 97.5 m-85 -159.69 126.62 4.54 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.404 -0.961 . . . . 0.27000000000000002 108.404 -170.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.69 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 19.1 t-105 -144.14 136.04 26.22 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.7 0.762 . . . . 0.089999999999999997 111.174 -166.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.646 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.1 mmt -118.99 91.26 42.96 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.855 -1.165 . . . . 0.14000000000000001 107.855 173.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.744 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 35.7 Cg_endo -66.35 83.41 0.28 Allowed 'Trans proline' 0 CA--C 1.514 -0.521 0 C-N-CA 122.387 2.058 . . . . 0.5 111.289 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.606 HG12 ' HA2' ' A' ' 419' ' ' GLY . 4.2 pt -82.74 -178.95 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 115.708 -0.678 . . . . 0.88 109.287 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.679 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 18.1 t70 -148.3 -166.36 2.52 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.658 -0.867 . . . . 2.4900000000000002 108.658 -167.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.679 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 5.9 m-90 86.38 -58.54 0.06 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.927 0.767 . . . . 1.9199999999999999 111.451 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 27.9 p -123.38 -29.94 3.74 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.57 0.952 . . . . 0.94999999999999996 113.57 -163.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 133.03 -32.82 2.69 Favored Glycine 0 CA--C 1.499 -0.939 0 C-N-CA 120.252 -0.975 . . . . 0.68000000000000005 111.788 174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.699 HG11 ' CE2' ' A' ' 382' ' ' PHE . 2.4 p -53.73 170.14 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.277 -0.961 . . . . 0.75 112.244 177.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.606 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -174.05 124.0 1.0 Allowed Glycine 0 CA--C 1.497 -1.092 0 N-CA-C 110.355 -1.098 . . . . 0.20000000000000001 110.355 172.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.674 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.4 mp -81.7 142.8 13.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.8 0.333 . . . . 0.28999999999999998 110.453 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.69 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.1 p80 -160.63 162.31 32.71 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.841 -0.618 . . . . 0.089999999999999997 110.924 -175.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.693 ' O ' HG22 ' A' ' 407' ' ' VAL . 0.2 OUTLIER -86.65 148.32 25.51 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.731 -1.211 . . . . 1.0700000000000001 107.731 172.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 445' ' ' THR . 45.3 t -133.05 96.71 3.83 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.803 0.811 . . . . 0.23000000000000001 109.943 -170.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -81.29 -15.16 56.3 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.134 -1.394 . . . . 0.41999999999999998 109.445 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.771 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 10.0 p90 -89.83 -20.5 23.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.164 -1.38 . . . . 0.32000000000000001 111.452 -176.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.555 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 1.9 tt0 -101.82 116.71 62.98 Favored Pre-proline 0 CA--C 1.508 -0.659 0 CA-C-O 122.622 1.201 . . . . 1.74 110.419 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.542 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 42.9 Cg_endo -86.67 -11.34 5.83 Favored 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 124.228 3.285 . . . . 0.72999999999999998 113.616 -173.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.622 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.2 pm0 -111.3 150.64 29.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.304 1.049 . . . . 2.1600000000000001 113.018 174.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.66 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -156.6 132.87 9.89 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 105.456 -2.054 . . . . 0.33000000000000002 105.456 167.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.14 -159.06 32.14 Favored Glycine 0 C--N 1.285 -2.295 0 N-CA-C 110.497 -1.041 . . . . 0.17000000000000001 110.497 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.503 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -46.8 175.34 0.01 OUTLIER Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.372 -0.918 . . . . 0.20999999999999999 111.71 168.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.538 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 10.1 p-10 -51.69 101.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 123.453 1.597 . . . . 1.8500000000000001 113.733 -155.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 1.044 HD22 ' HD2' ' A' ' 437' ' ' ARG . 35.6 mt -97.86 -35.34 10.53 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 112.038 -2.347 . . . . 1.21 109.467 170.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.701 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.0 p-90 -53.07 -26.95 17.85 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.012 -0.994 . . . . 0.16 112.071 -172.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.701 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.28 -35.77 15.09 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.611 -0.722 . . . . 0.22 112.482 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.446 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.8 p -88.51 -37.71 15.54 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.468 -0.787 . . . . 0.25 110.617 -176.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 1.044 ' HD2' HD22 ' A' ' 433' ' ' LEU . 0.4 OUTLIER -99.25 -19.64 16.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.676 -1.147 . . . . 1.8200000000000001 110.715 -178.382 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.34 49.62 50.42 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 115.988 1.155 . . . . 0.23999999999999999 115.988 162.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 44.1 m -82.3 111.07 18.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 119.745 1.773 . . . . 1.01 111.105 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.401 ' HE1' HD21 ' A' ' 397' ' ' ASN . 25.5 m-70 37.74 -113.64 0.11 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.635 0.976 . . . . 0.5 113.635 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.62 ' HA3' ' SAK' ' A' ' 130' ' ' 1RG . . . -142.91 -14.87 0.31 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.62 -0.718 . . . . 0.26000000000000001 113.838 -173.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.562 ' HB3' HASB ' A' ' 130' ' ' 1RG . 26.4 p -101.56 -167.31 1.4 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.994 0.897 . . . . 0.34999999999999998 112.233 -177.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.46 HG12 HG11 ' A' ' 347' ' ' VAL . 2.3 mp -99.31 128.35 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 115.096 -0.956 . . . . 0.12 110.751 -174.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.32 92.37 5.15 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.577 -0.738 . . . . 0.62 110.234 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.741 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.1 m -88.1 143.3 32.77 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.024 -0.989 . . . . 0.10000000000000001 112.64 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.662 ' HD2' HG21 ' A' ' 366' ' ' THR . 74.1 Cg_exo -50.52 143.12 28.82 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 123.67 2.914 . . . . 0.23999999999999999 112.854 175.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.681 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.3 Cg_exo -64.42 -24.08 64.48 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.762 2.308 . . . . 0.31 111.914 -176.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.5 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 36.6 p -78.06 -25.49 47.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.217 -0.901 . . . . 1.1000000000000001 112.444 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.792 ' O ' HD21 ' A' ' 364' ' ' LEU . 33.2 m -99.71 -48.76 11.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 112.801 0.667 . . . . 0.080000000000000002 112.801 -171.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.952 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.39 -2.13 4.21 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.925 -0.71 . . . . 0.070000000000000007 110.379 -178.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.611 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 42.6 pttt -81.17 -39.03 26.14 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.47 1.129 . . . . 0.92000000000000004 108.188 173.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 3.9 mm-40 -62.0 -46.24 90.09 Favored 'General case' 0 CA--C 1.473 -1.999 0 CA-C-N 112.545 -2.116 . . . . 0.25 106.593 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.952 HD23 ' SD ' ' A' ' 450' ' ' MET . 4.0 tp -46.61 -67.09 0.31 Allowed 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 109.679 -3.419 . . . . 0.050000000000000003 112.755 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.495 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 14.6 t80 -45.37 -24.1 0.26 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 123.972 0.795 . . . . 0.13 109.584 177.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.52 -26.64 27.07 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.68 -1.145 . . . . 0.13 111.899 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.739 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -100.9 -43.68 6.0 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 113.157 0.799 . . . . 0.059999999999999998 113.157 176.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.669 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -74.69 146.96 9.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 122.674 1.226 . . . . 0.080000000000000002 111.191 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.24 156.1 28.32 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 112.536 -2.12 . . . . 0.47999999999999998 108.499 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.628 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 40.1 mtmt -59.09 101.34 0.09 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.786 0.803 . . . . 0.98999999999999999 109.614 171.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 132.3 -14.14 5.12 Favored Glycine 0 C--N 1.304 -1.235 0 CA-C-N 113.556 -1.656 . . . . 0.19 111.452 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.669 HG21 ' HB ' ' A' ' 457' ' ' VAL . 14.7 m -65.11 150.31 95.63 Favored Pre-proline 0 N--CA 1.441 -0.907 0 N-CA-C 108.854 -0.795 . . . . 0.13 108.854 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.537 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.0 Cg_endo -93.5 162.03 2.39 Favored 'Trans proline' 0 N--CA 1.421 -2.746 0 C-N-CA 122.204 1.936 . . . . 0.17999999999999999 109.813 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.748 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -125.68 151.91 32.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.465 -1.309 . . . . 0.56999999999999995 107.465 171.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.758 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.3 mp -133.84 150.07 51.38 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 108.27 -1.011 . . . . 0.13 108.27 175.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.058 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.53 137.88 36.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 103.879 -2.637 . . . . 0.10000000000000001 103.879 163.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 1.6 p90 . . . . . 0 C--O 1.25 1.129 0 O-C-N 123.742 0.651 . . . . 1.0900000000000001 111.378 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.741 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.116 -0.394 . . . . 1.8700000000000001 112.116 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.541 ' CD2' HD11 ' A' ' 464' ' ' LEU . 1.6 p-80 -140.45 102.26 4.29 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 111.606 0.224 . . . . 0.83999999999999997 111.606 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.556 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.5 OUTLIER 61.97 -167.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.122 0.889 . . . . 0.67000000000000004 112.706 167.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -62.63 173.14 1.35 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.826 -0.625 . . . . 1.8500000000000001 109.829 162.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.45 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 18.6 m-20 -79.1 82.93 5.22 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.185 -1.006 . . . . 0.42999999999999999 109.68 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 92.7 m -158.59 136.27 10.31 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.794 -1.094 . . . . 0.14000000000000001 109.02 168.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.763 ' CD2' HD13 ' A' ' 464' ' ' LEU . 39.9 p90 173.92 158.44 0.14 Allowed 'General case' 0 C--O 1.211 -0.963 0 O-C-N 123.582 0.551 . . . . 0.14999999999999999 111.329 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.676 HD11 HG11 ' A' ' 457' ' ' VAL . 0.4 OUTLIER -77.63 153.66 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.181 -0.674 . . . . 0.080000000000000002 109.181 164.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.01 146.28 28.85 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.778 -1.193 . . . . 2.0099999999999998 107.778 -178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.05 155.8 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 C-N-CA 123.381 0.673 . . . . 0.45000000000000001 110.527 174.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 347' ' ' VAL . 31.4 t0 -137.99 106.68 5.89 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.755 -1.572 . . . . 0.23999999999999999 106.755 175.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.035 HD21 HG23 ' A' ' 465' ' ' VAL . 0.2 OUTLIER -81.03 -34.77 32.61 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-O 123.094 1.426 . . . . 0.16 110.047 -166.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 466' ' ' PHE . 0.8 OUTLIER -58.88 -44.94 91.21 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 110.617 -2.992 . . . . 0.59999999999999998 108.064 177.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.441 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 27.9 m-80 -101.23 7.94 42.78 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 111.216 -2.72 . . . . 0.20000000000000001 110.88 -175.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.556 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.5 mp0 31.36 62.54 0.24 Allowed 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 112.673 -2.058 . . . . 2.1499999999999999 113.316 -175.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.523 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 26.7 t60 -142.85 136.37 28.66 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.724 -0.671 . . . . 0.089999999999999997 109.661 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.779 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -114.11 156.48 24.12 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 116.114 -0.494 . . . . 0.070000000000000007 110.084 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.67 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.4 m-90 -142.25 158.66 43.47 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.648 -0.706 . . . . 0.11 111.191 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.703 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.8 t80 -111.32 154.07 25.05 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 106.607 -1.627 . . . . 0.26000000000000001 106.607 151.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.4 m-85 -128.13 116.92 20.7 Favored 'General case' 0 C--N 1.269 -2.92 0 CA-C-N 115.262 -0.881 . . . . 0.14000000000000001 110.513 -178.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.7 tppt? -119.05 140.03 50.75 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.338 -1.727 . . . . 0.25 106.338 168.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.408 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.49 16.27 9.15 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 113.174 0.805 . . . . 0.42999999999999999 113.174 174.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.18 6.99 87.82 Favored Glycine 0 CA--C 1.485 -1.815 0 CA-C-N 115.563 -0.744 . . . . 0.17999999999999999 113.024 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.5 ptmt -127.68 178.77 5.91 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 104.375 -2.454 . . . . 0.37 104.375 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.67 HG11 ' CD1' ' A' ' 355' ' ' TRP . 16.9 m -104.37 157.76 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.704 0 N-CA-C 116.412 2.004 . . . . 0.10000000000000001 116.412 -176.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.69 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.35 -28.04 9.64 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-N 110.773 -2.921 . . . . 0.070000000000000007 106.635 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -132.84 144.63 50.34 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 111.52 -2.582 . . . . 0.059999999999999998 111.435 -175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.521 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 5.6 tt0 -138.8 119.33 13.9 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 104.238 -2.504 . . . . 0.47999999999999998 104.238 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.779 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.3 164.84 34.75 Favored 'General case' 0 N--CA 1.401 -2.898 0 C-N-CA 117.644 -1.622 . . . . 0.070000000000000007 111.989 178.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.571 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 16.9 p-10 -103.46 134.2 47.23 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.373 -1.285 . . . . 1.8 109.784 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.721 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -136.8 -172.92 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.494 -1.2 0 CA-C-O 122.417 1.103 . . . . 0.12 112.515 -171.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.528 HG11 HE22 ' A' ' 426' ' ' GLN . 0.5 OUTLIER -153.33 121.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 112.745 -2.025 . . . . 0.10000000000000001 108.498 172.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.485 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -79.36 -168.79 1.64 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.268 -1.333 . . . . 1.26 110.556 179.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.404 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.36 170.79 45.1 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 118.649 -1.738 . . . . 0.14000000000000001 112.465 -174.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 7.0 ptpt -74.61 157.38 86.11 Favored Pre-proline 0 C--O 1.221 -0.404 0 CA-C-O 121.402 0.62 . . . . 0.81000000000000005 111.893 -166.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.671 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 99.4 Cg_exo -55.81 -30.04 74.75 Favored 'Trans proline' 0 CA--C 1.495 -1.436 0 C-N-CA 125.27 3.98 . . . . 0.28000000000000003 113.15 -172.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.474 ' OG1' HG22 ' A' ' 375' ' ' THR . 16.0 p -68.54 -33.18 73.65 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.304 -1.771 . . . . 0.33000000000000002 109.774 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.796 ' OG1' ' HA ' ' A' ' 130' ' ' 1RG . 1.2 t -140.88 70.33 29.62 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-O 123.487 1.613 . . . . 0.39000000000000001 109.522 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.0 Cg_exo -58.61 157.1 28.76 Favored 'Trans proline' 0 C--N 1.307 -1.631 1 C-N-CA 126.191 4.594 . . . . 0.38 114.265 -171.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.485 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -89.61 143.13 30.0 Favored Pre-proline 0 N--CA 1.418 -2.04 0 N-CA-C 108.093 -1.077 . . . . 0.81999999999999995 108.093 171.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.56 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 19.8 Cg_exo -76.33 -44.1 0.27 Allowed 'Trans proline' 0 CA--C 1.508 -0.82 0 C-N-CA 124.565 3.51 . . . . 0.19 111.979 -167.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.814 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 59.37 137.12 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 123.582 1.658 . . . . 0.13 113.605 -172.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 154.39 -110.81 0.46 Allowed Glycine 0 N--CA 1.431 -1.635 0 CA-C-N 112.064 -2.334 . . . . 0.20000000000000001 109.503 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.5 p -131.24 120.63 47.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.871 0.844 . . . . 0.81999999999999995 110.232 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.747 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.6 m-85 -119.47 -174.59 2.77 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.87 -1.53 . . . . 0.22 106.87 172.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.54 ' HB2' ' CH2' ' A' ' 415' ' ' TRP . 1.6 t80 -139.54 123.48 17.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 120.07 1.304 . . . . 0.65000000000000002 113.206 -171.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 2.1 p -88.66 91.29 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 CA-C-O 123.132 1.444 . . . . 0.16 109.109 168.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 41.7 p-90 -92.38 10.83 28.28 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.276 -1.784 . . . . 2.5499999999999998 108.014 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.735 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.2 t30 -169.03 126.73 0.98 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.836 -1.529 . . . . 0.42999999999999999 110.492 171.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.67 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -97.63 141.8 30.23 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.889 -1.051 . . . . 1.1200000000000001 108.815 169.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.77 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 14.7 mm-40 -125.97 157.02 38.88 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 114.538 1.31 . . . . 0.70999999999999996 114.538 -168.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.74 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.0 mt-10 -137.41 127.26 25.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 112.912 -1.949 . . . . 0.38 108.461 173.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.2 t70 57.6 47.23 16.29 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 123.446 1.593 . . . . 0.40999999999999998 109.072 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.913 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -84.27 167.48 16.57 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 112.474 -2.148 . . . . 0.12 109.457 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 19.9 m -132.35 119.09 20.25 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.188 0.994 . . . . 0.17000000000000001 112.149 171.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 4.1 mp -81.77 91.76 6.54 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.63 -1.623 . . . . 0.56999999999999995 112.498 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.571 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 45.7 mttt -102.29 178.84 4.48 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 114.0 -1.454 . . . . 0.33000000000000002 113.572 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 138.34 -157.98 24.7 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 119.827 -1.178 . . . . 0.46000000000000002 111.883 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 2.0 m -121.97 136.68 54.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 120.254 -0.578 . . . . 0.70999999999999996 111.531 172.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 401' ' ' THR . 6.1 m-80 -56.48 156.83 5.64 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.133 -0.94 . . . . 0.83999999999999997 110.16 169.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . 0.458 ' HB3' HG21 ' A' ' 375' ' ' THR . 6.3 p-10 -54.5 -14.65 1.34 Allowed 'General case' 0 CA--C 1.489 -1.396 0 CA-C-N 113.301 -1.772 . . . . 2.2799999999999998 112.092 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 397' ' ' ASN . 17.6 t70 -97.67 -18.49 18.84 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.609 -1.632 . . . . 2.27 109.242 -173.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.88 33.17 5.62 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 119.337 -1.411 . . . . 0.93999999999999995 111.314 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.463 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 11.4 p -123.35 100.64 38.62 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 114.455 -0.873 . . . . 0.81000000000000005 109.319 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 21.5 Cg_endo -59.65 150.72 74.8 Favored 'Trans proline' 0 CA--C 1.501 -1.133 0 C-N-CA 122.651 2.234 . . . . 0.63 113.131 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -150.41 174.64 12.66 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.326 -1.306 . . . . 0.41999999999999998 112.485 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.571 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.9 OUTLIER -144.13 147.62 33.97 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 113.727 -1.579 . . . . 0.53000000000000003 109.642 171.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -143.55 97.29 5.54 Favored Pre-proline 0 N--CA 1.432 -1.335 0 N-CA-C 108.176 -1.046 . . . . 0.19 108.176 172.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 16.8 Cg_exo -69.44 110.0 2.39 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 121.994 1.796 . . . . 0.19 109.654 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.913 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.9 154.22 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 CA-C-N 113.057 -1.883 . . . . 0.14999999999999999 107.688 -168.067 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.74 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.8 m-80 -86.48 -20.43 28.11 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.78 -0.822 . . . . 0.51000000000000001 108.78 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.77 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 96.4 m-85 -158.8 127.1 5.21 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.933 -1.031 . . . . 0.27000000000000002 108.749 -171.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 22.5 t-105 -144.13 135.31 25.51 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.607 0.718 . . . . 0.089999999999999997 111.001 -167.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.67 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 11.7 mmt -119.51 89.89 41.65 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.22 -1.03 . . . . 0.14000000000000001 108.22 174.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.735 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 28.1 Cg_endo -63.63 100.21 0.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.016 1.81 . . . . 0.5 111.062 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 411' ' ' MET . 5.6 pt -102.12 176.51 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.341 -0.985 . . . . 0.88 108.341 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 416' ' ' THR . 2.1 t70 -143.09 -170.21 3.2 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 118.873 -1.131 . . . . 2.4900000000000002 113.011 -165.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.54 ' CH2' ' HB2' ' A' ' 383' ' ' TYR . 25.6 p90 53.4 -5.27 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.986 2.114 . . . . 1.9199999999999999 114.702 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.622 HG21 ' CE1' ' A' ' 382' ' ' PHE . 22.1 p -131.53 -20.25 2.64 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.056 0.391 . . . . 0.94999999999999996 112.056 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.48 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 95.88 -27.38 16.53 Favored Glycine 0 CA--C 1.505 -0.592 0 N-CA-C 111.25 -0.74 . . . . 0.68000000000000005 111.25 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 419' ' ' GLY . 39.0 t -55.11 172.45 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.762 0.825 . . . . 0.75 111.342 -178.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.602 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.13 123.21 0.86 Allowed Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 109.719 -1.352 . . . . 0.20000000000000001 109.719 170.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.713 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.1 mp -81.5 142.43 13.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.809 -0.441 . . . . 0.28999999999999998 109.809 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.669 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 32.6 p80 -160.71 162.92 32.69 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.255 -0.43 . . . . 0.089999999999999997 111.482 -174.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.68 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.21 147.76 26.43 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.245 -1.02 . . . . 1.0700000000000001 108.245 172.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 445' ' ' THR . 30.3 t -132.99 96.93 3.88 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.791 0.805 . . . . 0.23000000000000001 109.835 -172.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -82.11 -12.49 58.17 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.094 -1.412 . . . . 0.41999999999999998 109.067 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.76 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 10.2 p90 -92.96 -23.92 18.56 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.01 -1.45 . . . . 0.32000000000000001 111.757 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.557 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 1.3 tt0 -98.01 115.47 65.75 Favored Pre-proline 0 CA--C 1.507 -0.706 0 CA-C-O 122.711 1.243 . . . . 1.74 110.164 178.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.524 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 47.3 Cg_endo -86.25 -10.97 6.47 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.151 3.234 . . . . 0.72999999999999998 113.046 -173.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.658 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.0 pm0 -111.99 154.63 25.01 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.409 1.1 . . . . 2.1600000000000001 113.237 174.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.639 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -162.54 132.08 4.4 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.857 -2.275 . . . . 0.33000000000000002 104.857 171.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.45 -157.39 29.53 Favored Glycine 0 C--N 1.282 -2.441 0 C-N-CA 119.77 -1.205 . . . . 0.17000000000000001 110.885 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.449 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.21 175.95 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.297 -0.954 . . . . 0.20999999999999999 111.578 166.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.505 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.4 p-10 -51.95 101.57 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 123.276 1.512 . . . . 1.8500000000000001 113.426 -156.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.719 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.63 -35.8 10.93 Favored 'General case' 0 C--O 1.208 -1.11 0 CA-C-N 112.631 -2.077 . . . . 1.21 109.45 169.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.736 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.7 p-90 -55.37 -28.0 51.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.173 -0.921 . . . . 0.16 112.156 -170.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.736 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.63 -35.04 15.21 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.604 0.716 . . . . 0.22 112.122 -177.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.1 p -90.14 -43.7 10.28 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.754 -1.112 . . . . 0.25 111.008 -175.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.719 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 3.0 mtp85 -92.35 -19.64 21.9 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.65 -1.159 . . . . 1.8200000000000001 109.732 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 54.48 48.47 64.85 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 113.848 -1.524 . . . . 0.23999999999999999 115.265 164.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 25.0 m -81.76 111.03 17.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 118.853 1.326 . . . . 1.01 111.217 -171.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.672 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 55.9 m-70 36.39 -120.69 0.15 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.741 -1.118 . . . . 0.5 113.66 177.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.418 ' HA3' ' HB ' ' A' ' 130' ' ' 1RG . . . -133.29 -19.71 0.95 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 116.036 -0.529 . . . . 0.26000000000000001 113.676 -175.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.808 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.1 p -103.56 -165.37 1.15 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 117.507 0.654 . . . . 0.34999999999999998 112.707 -175.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.471 HG12 HG11 ' A' ' 347' ' ' VAL . 2.1 mp -95.48 130.57 44.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.968 -1.014 . . . . 0.12 110.658 -175.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.5 95.29 6.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.826 -0.625 . . . . 0.62 110.13 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.721 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.4 m -91.64 142.54 26.85 Favored Pre-proline 0 N--CA 1.437 -1.125 0 CA-C-N 115.042 -0.981 . . . . 0.10000000000000001 112.668 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.663 ' HD2' HG21 ' A' ' 366' ' ' THR . 87.2 Cg_exo -49.9 144.85 20.09 Favored 'Trans proline' 0 CA--C 1.507 -0.871 0 C-N-CA 124.096 3.197 . . . . 0.23999999999999999 113.457 175.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.68 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.6 Cg_exo -65.41 -28.37 54.43 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 122.783 2.322 . . . . 0.31 112.306 -175.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 48.1 m -74.74 -23.72 58.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.845 -0.616 . . . . 1.1000000000000001 112.282 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.804 ' O ' HD21 ' A' ' 364' ' ' LEU . 29.9 m -100.68 -49.08 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 112.932 0.716 . . . . 0.080000000000000002 112.932 -169.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.952 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.95 -2.09 4.85 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.8 -0.76 . . . . 0.070000000000000007 110.308 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.609 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.0 pttp -81.63 -38.98 25.12 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 122.378 1.085 . . . . 0.92000000000000004 108.117 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.6 mm-40 -62.03 -46.16 90.39 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-N 112.524 -2.126 . . . . 0.25 106.599 -177.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.952 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.9 tp -46.19 -67.06 0.32 Allowed 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 109.678 -3.419 . . . . 0.050000000000000003 112.778 172.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.499 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.3 t80 -45.52 -24.21 0.3 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 123.957 0.785 . . . . 0.13 109.48 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -87.91 -26.63 28.62 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 114.684 -1.143 . . . . 0.13 111.743 -175.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.746 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.8 -44.11 5.63 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 113.322 0.86 . . . . 0.059999999999999998 113.322 176.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.676 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -74.1 148.06 8.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 122.499 1.143 . . . . 0.080000000000000002 111.25 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.416 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -117.07 157.99 24.93 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 112.745 -2.025 . . . . 0.47999999999999998 108.992 -179.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.665 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 7.3 mppt? -59.2 102.01 0.12 Allowed 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.551 -0.907 . . . . 0.98999999999999999 108.551 168.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.22 -12.36 5.52 Favored Glycine 0 C--N 1.308 -1.011 0 CA-C-N 114.22 -1.355 . . . . 0.19 111.726 -175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.662 HG21 ' HB ' ' A' ' 457' ' ' VAL . 15.9 m -68.25 151.22 97.36 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 108.838 -0.801 . . . . 0.13 108.838 171.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.556 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.3 Cg_endo -94.1 165.92 2.04 Favored 'Trans proline' 0 N--CA 1.422 -2.694 0 C-N-CA 122.1 1.866 . . . . 0.17999999999999999 109.929 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.747 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -127.3 152.6 35.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.697 -1.223 . . . . 0.56999999999999995 107.697 170.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.763 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.3 mp -134.01 150.06 51.22 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.05 -1.093 . . . . 0.13 108.05 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.035 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -139.94 138.28 38.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 103.753 -2.684 . . . . 0.10000000000000001 103.753 164.031 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.814 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 2.5 p90 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 117.573 -1.204 . . . . 1.0900000000000001 112.109 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.808 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 112.49 -0.244 . . . . 1.8700000000000001 112.49 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.523 ' CD2' HD11 ' A' ' 464' ' ' LEU . 1.7 p-80 -146.99 102.12 3.49 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 111.738 0.273 . . . . 0.83999999999999997 111.738 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.577 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.0 OUTLIER 64.37 -168.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.055 0.847 . . . . 0.67000000000000004 112.569 167.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -56.99 166.08 1.11 Allowed 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.647 -0.706 . . . . 1.8500000000000001 109.826 162.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.17 82.44 5.33 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 118.519 -1.272 . . . . 0.42999999999999999 109.129 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 357' ' ' TYR . 99.9 m -159.59 136.16 9.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.457 -1.247 . . . . 0.14000000000000001 108.995 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.656 ' CD2' HD13 ' A' ' 464' ' ' LEU . 38.6 p90 174.67 158.61 0.17 Allowed 'General case' 0 CA--C 1.503 -0.833 0 O-C-N 123.381 0.425 . . . . 0.14999999999999999 111.117 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.66 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -78.11 152.35 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 N-CA-C 109.035 -0.728 . . . . 0.080000000000000002 109.035 164.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.559 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.1 tt0 -149.77 145.82 26.84 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.437 -0.802 . . . . 2.0099999999999998 109.389 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.735 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -138.23 162.28 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 120.917 0.389 . . . . 0.45000000000000001 111.184 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 347' ' ' VAL . 33.7 t0 -140.38 106.4 5.2 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.419 -1.326 . . . . 0.23999999999999999 107.419 173.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.091 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -81.63 -35.74 29.67 Favored 'General case' 0 CA--C 1.483 -1.618 0 CA-C-O 122.678 1.228 . . . . 0.16 110.477 -167.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.475 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -56.53 -44.27 80.67 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 110.967 -2.833 . . . . 0.59999999999999998 108.219 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.475 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.8 m-80 -101.21 6.78 43.16 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 110.751 -2.932 . . . . 0.20000000000000001 110.923 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.692 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.8 OUTLIER 34.19 61.83 0.5 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 112.558 -2.11 . . . . 2.1499999999999999 113.139 -176.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.522 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 20.4 t60 -142.11 133.59 26.63 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.782 -0.644 . . . . 0.089999999999999997 110.236 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -112.84 155.5 24.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.773 -0.649 . . . . 0.070000000000000007 109.684 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.556 ' CD1' HG11 ' A' ' 362' ' ' VAL . 29.0 m-90 -140.62 153.83 46.21 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.42 -0.809 . . . . 0.11 110.877 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.684 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 84.0 t80 -110.67 151.89 27.17 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 106.385 -1.709 . . . . 0.26000000000000001 106.385 152.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 6.9 m-85 -127.97 115.62 18.8 Favored 'General case' 0 C--N 1.269 -2.897 0 CA-C-N 114.602 -1.181 . . . . 0.14000000000000001 110.343 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.1 tppt? -116.53 138.4 51.43 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.474 -1.676 . . . . 0.25 106.474 169.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.446 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 68.54 17.45 9.03 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.343 0.868 . . . . 0.42999999999999999 113.343 173.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.92 9.81 86.47 Favored Glycine 0 CA--C 1.491 -1.455 0 CA-C-N 115.528 -0.76 . . . . 0.17999999999999999 112.913 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 17.5 ptmt -130.27 178.36 6.64 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 104.757 -2.312 . . . . 0.37 104.757 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 17.9 m -105.08 157.9 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.642 0 N-CA-C 116.338 1.977 . . . . 0.10000000000000001 116.338 -175.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.677 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -110.46 -27.91 8.79 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 110.571 -3.013 . . . . 0.070000000000000007 106.558 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.809 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.6 145.28 49.89 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 111.568 -2.56 . . . . 0.059999999999999998 111.362 -176.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.426 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -141.65 118.29 11.0 Favored 'General case' 0 N--CA 1.404 -2.747 0 N-CA-C 104.255 -2.498 . . . . 0.47999999999999998 104.255 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.712 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.22 160.81 43.42 Favored 'General case' 0 N--CA 1.396 -3.131 0 C-N-CA 117.822 -1.551 . . . . 0.070000000000000007 111.244 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 14.9 p-10 -102.83 132.32 49.1 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.38 -1.282 . . . . 1.8 109.001 -178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.892 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.5 pp -132.16 -172.31 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 CA-C-O 122.439 1.114 . . . . 0.12 112.673 -171.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.83 118.9 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 112.985 -1.916 . . . . 0.10000000000000001 108.905 173.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.488 ' HB3' HD12 ' A' ' 349' ' ' LEU . 47.4 p -74.92 -168.93 0.81 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 112.039 -2.346 . . . . 1.26 111.662 -179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.75 175.25 50.46 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 118.944 -1.598 . . . . 0.14000000000000001 111.831 -176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.528 ' HG2' HG23 ' A' ' 375' ' ' THR . 15.3 ptmt -79.1 163.2 61.21 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.813 0.672 . . . . 0.81000000000000005 112.813 -164.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.705 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 86.3 Cg_exo -55.72 -37.54 95.37 Favored 'Trans proline' 0 CA--C 1.511 -0.65 0 C-N-CA 122.76 2.307 . . . . 0.28000000000000003 112.448 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.423 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 19.2 p -66.28 -32.26 73.56 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.461 -1.245 . . . . 0.33000000000000002 110.175 -174.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.528 HG23 ' HG2' ' A' ' 372' ' ' LYS . 1.3 t -141.23 72.4 26.8 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 123.704 1.716 . . . . 0.39000000000000001 109.608 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 375' ' ' THR . 72.5 Cg_exo -59.99 164.09 12.81 Favored 'Trans proline' 0 C--N 1.312 -1.345 1 C-N-CA 126.394 4.729 . . . . 0.38 115.133 -172.214 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.531 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 2.1 m -90.12 128.01 51.28 Favored Pre-proline 0 N--CA 1.399 -2.979 0 CA-C-N 113.869 -1.514 . . . . 0.81999999999999995 108.343 171.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.531 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 38.7 Cg_exo -69.47 -45.58 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.99 3.127 . . . . 0.19 112.014 -170.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.803 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 63.14 143.93 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 123.316 1.532 . . . . 0.13 113.943 -175.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 145.74 -110.41 0.54 Allowed Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 111.905 -2.407 . . . . 0.20000000000000001 108.862 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 464' ' ' LEU . 3.5 p -131.19 127.55 60.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.822 -0.436 . . . . 0.81999999999999995 109.822 174.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.778 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 7.7 m-85 -121.54 -174.49 2.87 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.253 -1.388 . . . . 0.22 107.253 169.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 2.2 t80 -138.93 121.26 15.96 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 120.792 -1.192 . . . . 0.65000000000000002 113.194 -173.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -87.82 92.62 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-O 122.881 1.324 . . . . 0.16 109.368 171.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 44.0 p-90 -92.25 10.35 29.97 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 113.575 -1.648 . . . . 2.5499999999999998 108.314 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.748 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.9 t30 -169.6 127.01 0.91 Allowed 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.098 -1.41 . . . . 0.42999999999999999 110.392 172.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.608 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.46 143.13 31.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.073 -0.967 . . . . 1.1200000000000001 109.012 169.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.746 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 10.7 mm-40 -125.31 157.74 35.92 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.548 1.314 . . . . 0.70999999999999996 114.548 -168.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.714 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 47.8 mt-10 -137.49 127.24 25.44 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.178 -1.828 . . . . 0.38 108.668 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 19.5 t70 55.01 50.36 15.62 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 123.366 1.555 . . . . 0.40999999999999998 109.025 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.958 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -84.27 167.37 16.68 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 112.495 -2.139 . . . . 0.12 109.522 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 15.8 m -132.43 118.77 19.76 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.102 0.953 . . . . 0.17000000000000001 111.494 170.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.18 88.37 4.88 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.779 -1.555 . . . . 0.56999999999999995 112.11 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.543 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 48.0 mttt -102.08 179.01 4.44 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 113.703 -1.59 . . . . 0.33000000000000002 112.971 176.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 137.37 -157.52 24.01 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 119.443 -1.361 . . . . 0.46000000000000002 111.785 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.667 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.6 m -118.16 138.97 51.93 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 120.369 -0.532 . . . . 0.70999999999999996 110.668 170.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.478 ' C ' ' H ' ' A' ' 399' ' ' ASP . 6.1 m-80 -55.87 152.03 10.58 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.41 -0.959 . . . . 0.83999999999999997 108.41 167.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.12 -2.94 0.71 Allowed 'General case' 0 C--N 1.322 -0.591 0 O-C-N 123.689 0.618 . . . . 2.2799999999999998 111.096 178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 397' ' ' ASN . 5.0 t70 -112.26 2.61 16.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.207 -0.906 . . . . 2.27 110.45 -177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 95.44 18.39 33.34 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.319 -0.943 . . . . 0.93999999999999995 113.308 170.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.489 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 4.9 p -113.47 100.48 51.9 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 114.969 -0.616 . . . . 0.81000000000000005 109.899 -176.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.667 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.1 Cg_endo -58.47 149.81 72.47 Favored 'Trans proline' 0 CA--C 1.504 -1.009 0 C-N-CA 122.853 2.369 . . . . 0.63 113.089 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.48 ' OH ' ' HAD' ' A' ' 130' ' ' 1RG . 24.1 p90 -152.56 174.94 13.31 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.396 -1.274 . . . . 0.41999999999999998 113.059 -168.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -144.55 148.22 34.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.996 -1.456 . . . . 0.53000000000000003 110.455 172.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.43 97.74 4.68 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 108.422 -0.955 . . . . 0.19 108.422 169.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.2 Cg_exo -69.03 110.21 2.35 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.037 1.824 . . . . 0.19 110.462 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.958 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.9 157.71 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 CA-C-N 113.084 -1.871 . . . . 0.14999999999999999 107.824 -167.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.714 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.5 m-80 -88.31 -22.18 24.0 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.83 -0.804 . . . . 0.51000000000000001 108.83 -175.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.746 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 93.6 m-85 -158.72 127.65 5.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.936 -1.029 . . . . 0.27000000000000002 108.382 -170.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 18.1 t-105 -144.41 133.88 23.3 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.665 0.745 . . . . 0.089999999999999997 110.812 -166.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.608 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 13.5 mmt -115.15 89.81 21.71 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.101 -1.074 . . . . 0.14000000000000001 108.101 172.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.748 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 35.0 Cg_endo -65.87 89.03 0.23 Allowed 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 122.456 2.104 . . . . 0.5 109.408 175.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.65 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 8.1 pt -84.18 -157.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 114.923 -1.035 . . . . 0.88 110.39 -172.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.531 ' OD2' ' HA ' ' A' ' 382' ' ' PHE . 3.0 p30 -90.24 -177.68 5.19 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.656 1.217 . . . . 2.4900000000000002 112.785 -161.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.41 ' CD2' ' N ' ' A' ' 415' ' ' TRP . 0.0 OUTLIER -78.43 32.05 0.19 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 112.399 -2.182 . . . . 1.9199999999999999 112.179 -162.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 11.0 p -99.19 -23.01 15.37 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.585 -0.734 . . . . 0.94999999999999996 109.55 173.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.594 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 129.84 -39.64 1.79 Allowed Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.528 -0.76 . . . . 0.68000000000000005 113.222 171.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 419' ' ' GLY . 24.0 t -62.38 173.59 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 123.134 0.574 . . . . 0.75 111.872 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.598 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.01 121.69 0.82 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.77 -1.332 . . . . 0.20000000000000001 109.77 169.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.707 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.3 mp -81.69 143.08 12.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 120.839 -0.344 . . . . 0.28999999999999998 110.163 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.679 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.3 p80 -159.37 161.5 35.7 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.29 -0.414 . . . . 0.089999999999999997 111.461 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.673 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.83 144.8 28.2 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.843 -1.169 . . . . 1.0700000000000001 107.843 172.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 33.7 t -134.26 98.0 3.99 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.851 0.834 . . . . 0.23000000000000001 110.576 -170.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -80.62 -20.11 43.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.121 -1.399 . . . . 0.41999999999999998 110.062 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.752 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 13.5 p90 -82.87 -25.2 32.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.216 -1.356 . . . . 0.32000000000000001 111.388 -175.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.518 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.1 OUTLIER -87.67 128.98 52.51 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 122.222 1.011 . . . . 1.74 110.318 -176.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.28 -51.73 0.2 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 124.146 3.23 . . . . 0.72999999999999998 113.119 -176.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -113.01 161.01 17.55 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.737 1.256 . . . . 2.1600000000000001 112.682 -169.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.529 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 1.2 m-85 -154.61 121.9 5.67 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 112.116 -2.311 . . . . 0.33000000000000002 105.901 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 165.81 -157.05 29.36 Favored Glycine 0 C--N 1.283 -2.391 0 C-N-CA 119.862 -1.161 . . . . 0.17000000000000001 110.352 -174.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -38.61 164.78 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.725 0 C-N-CA 120.483 -0.865 . . . . 0.20999999999999999 111.789 166.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.449 ' HB3' ' CD ' ' A' ' 435' ' ' LYS . 4.4 m-20 -51.68 102.72 0.05 OUTLIER 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 113.446 -1.377 . . . . 1.8500000000000001 113.318 -153.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.646 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.3 OUTLIER -94.11 -38.77 10.94 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 113.327 -1.761 . . . . 1.21 108.823 168.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.746 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.4 p-90 -49.79 -32.17 13.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.153 0.502 . . . . 0.16 112.047 -169.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.746 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -86.01 -35.32 20.43 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.483 0.658 . . . . 0.22 111.965 -177.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 10.2 p -88.75 -43.72 11.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.672 -1.149 . . . . 0.25 111.15 -175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.646 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 11.4 mtp85 -91.59 -18.53 23.91 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.817 -1.083 . . . . 1.8200000000000001 109.474 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.63 47.56 57.64 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.654 -1.157 . . . . 0.23999999999999999 114.129 163.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 43.3 m -84.76 110.52 18.85 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 118.991 -1.084 . . . . 1.01 111.415 -171.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.595 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 51.3 m-70 37.8 -125.75 0.23 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.373 -1.285 . . . . 0.5 113.738 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -126.99 -21.29 1.73 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.076 -0.583 . . . . 0.26000000000000001 113.462 -174.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.654 ' HB3' HASB ' A' ' 130' ' ' 1RG . 28.7 p -104.49 -165.57 1.15 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 112.883 0.697 . . . . 0.34999999999999998 112.883 -173.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.476 HD13 HG11 ' A' ' 465' ' ' VAL . 2.3 mp -92.02 129.24 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.482 -0.781 . . . . 0.12 110.884 -175.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.3 89.72 4.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.657 -0.701 . . . . 0.62 109.727 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.892 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.0 m -83.26 143.78 45.7 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 115.087 -0.96 . . . . 0.10000000000000001 112.452 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.653 ' HD2' HG21 ' A' ' 366' ' ' THR . 78.8 Cg_exo -50.08 144.51 22.06 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 C-N-CA 123.807 3.005 . . . . 0.23999999999999999 113.351 174.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.673 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.4 Cg_exo -64.6 -25.42 62.16 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 122.827 2.351 . . . . 0.31 112.598 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.516 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 67.3 p -78.7 -24.59 44.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.74 0.781 . . . . 1.1000000000000001 112.085 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.809 ' O ' HD21 ' A' ' 364' ' ' LEU . 33.0 m -99.35 -48.63 11.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 113.137 0.792 . . . . 0.080000000000000002 113.137 -170.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.944 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.72 -1.95 4.42 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.767 -0.773 . . . . 0.070000000000000007 110.434 -178.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.561 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 16.5 pttp -81.22 -38.46 26.95 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 122.651 1.215 . . . . 0.92000000000000004 108.287 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 4.5 mm-40 -62.65 -46.31 88.79 Favored 'General case' 0 CA--C 1.473 -1.981 0 CA-C-N 112.356 -2.202 . . . . 0.25 106.537 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.944 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.92 -66.72 0.36 Allowed 'General case' 0 N--CA 1.401 -2.922 0 CA-C-N 109.711 -3.404 . . . . 0.050000000000000003 112.923 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.462 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 14.9 t80 -45.58 -24.03 0.3 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.83 0.824 . . . . 0.13 109.502 176.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -87.4 -26.54 30.16 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-N 114.697 -1.138 . . . . 0.13 111.785 -176.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.739 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -103.14 -44.13 5.29 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 113.728 1.01 . . . . 0.059999999999999998 113.728 177.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.67 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -72.62 148.06 9.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 122.292 1.044 . . . . 0.080000000000000002 111.106 -179.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.501 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -116.02 155.24 28.44 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.281 -1.781 . . . . 0.47999999999999998 108.952 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.605 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.8 mppt? -57.91 103.43 0.14 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.624 -0.88 . . . . 0.98999999999999999 108.624 169.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 126.36 -7.46 7.54 Favored Glycine 0 C--N 1.308 -0.996 0 CA-C-N 113.827 -1.533 . . . . 0.19 111.452 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.67 HG21 ' HB ' ' A' ' 457' ' ' VAL . 6.8 m -70.17 150.5 96.06 Favored Pre-proline 0 N--CA 1.442 -0.862 0 N-CA-C 108.592 -0.892 . . . . 0.13 108.592 171.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.577 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.8 Cg_endo -93.98 160.52 2.18 Favored 'Trans proline' 0 N--CA 1.421 -2.775 0 C-N-CA 122.017 1.811 . . . . 0.17999999999999999 109.749 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.778 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -123.91 151.44 28.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.295 -1.372 . . . . 0.56999999999999995 107.295 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.697 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.7 mp -134.54 151.28 51.0 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 108.113 -1.069 . . . . 0.13 108.113 174.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.091 HG23 HD21 ' A' ' 349' ' ' LEU . 0.8 OUTLIER -140.64 141.26 32.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 N-CA-C 105.177 -2.157 . . . . 0.10000000000000001 105.177 166.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.719 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 12.5 p90 . . . . . 0 C--O 1.245 0.861 0 CA-C-N 118.45 0.568 . . . . 1.0900000000000001 111.553 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.738 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 111.538 -0.625 . . . . 1.8700000000000001 111.538 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.485 ' CE1' HD21 ' A' ' 464' ' ' LEU . 4.2 p-80 39.42 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.588 0.959 . . . . 0.83999999999999997 113.588 -173.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.546 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.0 OUTLIER 67.43 -164.71 0.21 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.778 -0.646 . . . . 0.67000000000000004 112.069 168.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.17 171.65 2.22 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.674 -1.232 . . . . 1.8500000000000001 107.674 164.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.455 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 9.3 m-20 -81.49 83.05 7.09 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 118.69 -1.204 . . . . 0.42999999999999999 108.931 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.809 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 70.0 m -158.34 134.71 9.4 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.538 -1.21 . . . . 0.14000000000000001 108.944 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.651 ' CD2' HD13 ' A' ' 464' ' ' LEU . 37.3 p90 173.91 159.27 0.15 Allowed 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 123.421 0.451 . . . . 0.14999999999999999 110.881 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.651 HD12 HD11 ' A' ' 453' ' ' LEU . 0.4 OUTLIER -77.93 152.59 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 N-CA-C 109.354 -0.61 . . . . 0.080000000000000002 109.354 164.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.6 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 31.1 tt0 -149.82 144.7 26.15 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.438 -0.801 . . . . 2.0099999999999998 109.249 -177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.734 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.8 t -137.3 162.05 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 O-C-N 122.118 -0.364 . . . . 0.45000000000000001 111.252 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.547 ' N ' HG12 ' A' ' 347' ' ' VAL . 24.4 t0 -140.19 107.0 5.38 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 107.416 -1.327 . . . . 0.23999999999999999 107.416 172.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.041 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.7 -34.08 27.41 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-O 122.903 1.335 . . . . 0.16 110.671 -167.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.439 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.3 mt-10 -58.69 -44.12 90.19 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 110.769 -2.923 . . . . 0.59999999999999998 108.17 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 21.3 m-80 -101.12 7.01 43.45 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 110.925 -2.852 . . . . 0.20000000000000001 110.916 -175.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 17.3 mp0 33.06 61.62 0.39 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 112.692 -2.049 . . . . 2.1499999999999999 113.417 -175.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.514 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 21.6 t60 -142.02 135.01 28.82 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.854 -0.612 . . . . 0.089999999999999997 109.983 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.77 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.16 156.75 22.68 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.812 -0.631 . . . . 0.070000000000000007 110.099 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.585 ' CD1' HG11 ' A' ' 362' ' ' VAL . 29.3 m-90 -142.22 154.18 44.59 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.475 -0.784 . . . . 0.11 111.291 -175.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.809 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 88.2 t80 -110.22 153.29 25.0 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.558 -1.645 . . . . 0.26000000000000001 106.558 151.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.3 m-85 -128.32 118.1 22.63 Favored 'General case' 0 C--N 1.269 -2.915 0 CA-C-N 114.796 -1.093 . . . . 0.14000000000000001 110.118 -178.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.6 tppt? -118.62 135.62 54.34 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.118 -1.808 . . . . 0.25 106.118 167.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.54 16.48 6.97 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 113.45 0.908 . . . . 0.42999999999999999 113.45 173.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.36 7.58 88.38 Favored Glycine 0 CA--C 1.485 -1.844 0 CA-C-O 121.933 0.741 . . . . 0.17999999999999999 112.778 -174.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 19.4 ptmt -128.77 177.0 7.38 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 104.542 -2.392 . . . . 0.37 104.542 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.598 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . 18.6 m -104.29 157.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 N-CA-C 116.397 1.999 . . . . 0.10000000000000001 116.397 -174.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.703 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.97 -28.4 9.14 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 110.497 -3.047 . . . . 0.070000000000000007 106.277 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.817 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -132.93 145.01 50.53 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 111.614 -2.539 . . . . 0.059999999999999998 111.731 -175.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.442 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.4 tt0 -141.86 117.88 10.6 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 104.516 -2.401 . . . . 0.47999999999999998 104.516 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.77 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.6 164.47 35.04 Favored 'General case' 0 N--CA 1.402 -2.848 0 C-N-CA 117.974 -1.49 . . . . 0.070000000000000007 111.769 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.531 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 17.6 p-10 -104.9 131.4 52.44 Favored 'General case' 0 N--CA 1.411 -2.375 0 CA-C-N 114.726 -1.124 . . . . 1.8 109.542 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -132.79 -171.87 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 CA-C-O 122.438 1.113 . . . . 0.12 112.327 -171.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -149.99 119.56 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 112.959 -1.928 . . . . 0.10000000000000001 108.296 172.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.638 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.3 OUTLIER -75.62 -168.61 0.88 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.026 -1.443 . . . . 1.26 110.784 177.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.51 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -86.4 176.15 48.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 118.929 -1.605 . . . . 0.14000000000000001 112.681 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.474 ' HG2' HG23 ' A' ' 375' ' ' THR . 16.7 ptmt -78.16 156.72 79.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-O 121.661 0.743 . . . . 0.81000000000000005 111.865 -166.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.692 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 85.5 Cg_exo -59.19 -28.6 88.19 Favored 'Trans proline' 0 CA--C 1.502 -1.1 0 C-N-CA 125.016 3.811 . . . . 0.28000000000000003 113.309 -173.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.476 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 24.4 p -73.22 -32.61 64.86 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.867 -1.515 . . . . 0.33000000000000002 109.941 -175.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.541 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -140.63 70.15 31.25 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-O 123.887 1.803 . . . . 0.39000000000000001 108.92 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 375' ' ' THR . 83.1 Cg_exo -57.58 160.49 14.16 Favored 'Trans proline' 0 CA--C 1.501 -1.172 1 C-N-CA 126.895 5.063 . . . . 0.38 115.854 -169.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.638 HG21 ' OG ' ' A' ' 370' ' ' SER . 1.6 m -86.62 131.81 44.45 Favored Pre-proline 0 N--CA 1.406 -2.641 0 CA-C-N 113.902 -1.499 . . . . 0.81999999999999995 108.709 173.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.3 Cg_exo -72.73 -45.14 0.55 Allowed 'Trans proline' 0 CA--C 1.514 -0.491 0 C-N-CA 123.861 3.041 . . . . 0.19 112.092 -170.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.786 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.59 140.11 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 123.263 1.506 . . . . 0.13 113.497 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 151.19 -113.55 0.59 Allowed Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 112.455 -2.157 . . . . 0.20000000000000001 109.623 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.2 119.11 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.924 0.869 . . . . 0.81999999999999995 110.175 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.724 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.7 m-85 -118.1 -174.19 2.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.202 -1.407 . . . . 0.22 107.202 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 1.3 t80 -139.94 123.35 17.07 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 120.697 -1.252 . . . . 0.65000000000000002 113.275 -171.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.65 92.1 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.902 0 CA-C-O 123.084 1.421 . . . . 0.16 109.308 169.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -94.77 12.46 27.87 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 113.393 -1.73 . . . . 2.5499999999999998 108.318 177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.764 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.7 t30 -169.1 126.34 0.96 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 113.833 -1.53 . . . . 0.42999999999999999 110.04 171.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.673 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.79 144.4 29.79 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.115 -0.948 . . . . 1.1200000000000001 109.458 170.268 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.721 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 24.6 mm-40 -127.5 159.99 32.87 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 114.899 1.444 . . . . 0.70999999999999996 114.899 -168.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.561 ' HG2' ' CE2' ' A' ' 409' ' ' TYR . 51.6 mt-10 -139.04 127.59 23.1 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 113.064 -1.88 . . . . 0.38 108.583 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.7 t70 54.68 46.38 24.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 123.722 1.725 . . . . 0.40999999999999998 108.754 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.92 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.84 167.94 19.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 111.918 -2.401 . . . . 0.12 109.709 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 11.8 m -132.61 118.33 19.04 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.013 0.911 . . . . 0.17000000000000001 111.878 170.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 2.9 mp -77.58 87.62 3.89 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.987 -1.461 . . . . 0.56999999999999995 111.918 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.546 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.3 mttt -101.63 178.16 4.71 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 113.308 -1.769 . . . . 0.33000000000000002 113.397 177.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 138.54 -162.01 25.77 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 114.198 -1.365 . . . . 0.46000000000000002 111.63 -177.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.6 m -115.33 142.01 47.26 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 120.162 -0.615 . . . . 0.70999999999999996 111.104 170.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.4 m-80 -60.06 154.97 18.01 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.064 -0.971 . . . . 0.83999999999999997 109.008 167.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . 0.452 ' HA ' ' HBD' ' A' ' 130' ' ' 1RG . 0.7 OUTLIER -64.0 -2.26 1.87 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.51 -0.768 . . . . 2.2799999999999998 110.672 177.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.1 OUTLIER -111.88 7.47 20.05 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.802 -1.09 . . . . 2.27 111.076 179.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 87.94 19.86 52.11 Favored Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 120.392 -0.909 . . . . 0.93999999999999995 112.455 169.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 10.9 p -114.58 98.86 50.44 Favored Pre-proline 0 C--N 1.303 -1.451 0 CA-C-N 114.509 -0.846 . . . . 0.81000000000000005 109.8 -175.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.6 Cg_endo -58.86 149.92 75.13 Favored 'Trans proline' 0 CA--C 1.503 -1.042 0 C-N-CA 122.945 2.43 . . . . 0.63 113.467 -176.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 30.2 p90 -150.26 173.94 13.39 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.121 -1.4 . . . . 0.41999999999999998 112.917 -168.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.546 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -145.86 148.25 32.66 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 113.992 -1.458 . . . . 0.53000000000000003 110.836 173.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -145.26 97.53 4.75 Favored Pre-proline 0 N--CA 1.439 -0.98 0 N-CA-C 108.359 -0.978 . . . . 0.19 108.359 170.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.8 Cg_exo -68.22 110.74 2.3 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.974 1.782 . . . . 0.19 110.034 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.92 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -111.36 152.65 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 CA-C-N 113.368 -1.742 . . . . 0.14999999999999999 108.458 -167.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.616 ' N ' HD22 ' A' ' 408' ' ' ASN . 0.8 OUTLIER -80.58 -23.28 40.0 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.797 -0.446 . . . . 0.51000000000000001 109.797 -174.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 97.2 m-85 -161.35 132.04 5.19 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.635 -1.246 . . . . 0.27000000000000002 107.635 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.677 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 20.2 t-105 -146.42 131.84 18.63 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.889 0.852 . . . . 0.089999999999999997 111.443 -166.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.673 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.6 mmt -114.43 93.23 31.1 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.728 -1.212 . . . . 0.14000000000000001 107.728 172.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.764 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 36.0 Cg_endo -66.87 75.76 0.42 Allowed 'Trans proline' 0 CA--C 1.513 -0.568 0 C-N-CA 122.393 2.062 . . . . 0.5 111.618 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.584 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.3 pt -76.16 178.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-N 115.61 -0.723 . . . . 0.88 109.11 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.667 ' O ' ' HB2' ' A' ' 415' ' ' TRP . 5.4 t70 -150.33 -166.74 2.63 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.854 -0.795 . . . . 2.4900000000000002 108.854 -167.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.667 ' HB2' ' O ' ' A' ' 414' ' ' ASP . 9.4 m-90 83.44 -52.47 0.15 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.936 0.773 . . . . 1.9199999999999999 111.728 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.463 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 63.7 p -125.44 -5.47 7.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.594 -0.73 . . . . 0.94999999999999996 112.159 -165.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.508 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 104.77 -28.86 13.12 Favored Glycine 0 CA--C 1.506 -0.513 0 C-N-CA 120.768 -0.729 . . . . 0.68000000000000005 112.663 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 419' ' ' GLY . 34.0 t -57.06 173.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.711 0.804 . . . . 0.75 112.23 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.587 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -176.1 119.64 0.71 Allowed Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.498 -1.041 . . . . 0.20000000000000001 110.498 170.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.749 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.3 mp -81.78 143.34 12.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 110.024 -0.361 . . . . 0.28999999999999998 110.024 -178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.677 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 29.4 p80 -159.82 159.15 32.26 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.793 0.664 . . . . 0.089999999999999997 112.793 -173.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.776 ' OD1' ' HB2' ' A' ' 450' ' ' MET . 2.3 m-20 -89.61 132.03 35.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.492 -0.559 . . . . 1.0700000000000001 109.492 172.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 445' ' ' THR . 28.4 t -120.31 97.39 5.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.641 0.734 . . . . 0.23000000000000001 109.453 -164.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -83.44 -17.69 41.24 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.612 -1.176 . . . . 0.41999999999999998 109.993 -172.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.772 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 9.9 p90 -85.29 -13.66 49.0 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.176 -1.375 . . . . 0.32000000000000001 110.937 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -108.1 114.11 60.07 Favored Pre-proline 0 CA--C 1.503 -0.829 0 CA-C-O 122.816 1.293 . . . . 1.74 110.489 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.49 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 36.2 Cg_endo -88.4 -9.13 5.15 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.093 3.195 . . . . 0.72999999999999998 112.582 -176.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.597 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 2.2 pm0 -111.21 150.01 30.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.224 1.011 . . . . 2.1600000000000001 113.602 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.837 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.16 130.38 4.1 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 112.605 -2.089 . . . . 0.33000000000000002 105.487 171.093 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.23 -158.08 30.63 Favored Glycine 0 C--N 1.281 -2.494 0 C-N-CA 119.788 -1.196 . . . . 0.17000000000000001 110.817 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.507 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.28 174.65 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.277 -0.963 . . . . 0.20999999999999999 111.544 167.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.497 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 5.0 p-10 -51.78 101.46 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 123.399 1.571 . . . . 1.8500000000000001 113.772 -153.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.762 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -96.02 -35.67 11.31 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 112.489 -2.141 . . . . 1.21 109.147 169.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.74 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 68.1 p-90 -54.81 -28.11 46.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.006 -0.997 . . . . 0.16 112.243 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.74 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.98 -38.09 13.06 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.401 0.62 . . . . 0.22 112.377 -177.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 436' ' ' THR . 2.4 p -86.69 -43.41 12.62 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.04 -0.982 . . . . 0.25 110.446 -175.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.762 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 2.7 mtp85 -91.49 -18.6 23.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.497 -1.228 . . . . 1.8200000000000001 108.954 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.66 50.1 50.49 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 115.232 0.853 . . . . 0.23999999999999999 115.232 160.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . 0.43 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 6.4 m -83.25 111.52 19.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 119.072 1.436 . . . . 1.01 111.436 -173.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.588 ' HB2' ' OAC' ' A' ' 130' ' ' 1RG . 87.7 m-70 29.52 -106.51 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.507 1.129 . . . . 0.5 113.699 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.51 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -147.53 -5.45 0.33 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.815 -0.63 . . . . 0.26000000000000001 114.415 -174.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.826 ' HB3' HASB ' A' ' 130' ' ' 1RG . 26.5 p -107.22 -167.27 1.25 Allowed 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.323 1.062 . . . . 0.34999999999999998 112.522 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 368' ' ' ILE . 1.9 mp -102.31 131.15 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 CA-C-N 115.057 -0.974 . . . . 0.12 110.889 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -100.71 98.51 9.04 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.839 -1.073 . . . . 0.62 110.129 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.714 HG22 ' CG2' ' A' ' 449' ' ' VAL . 2.0 m -96.59 140.45 22.17 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 113.599 0.962 . . . . 0.10000000000000001 113.599 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.819 ' O ' HG22 ' A' ' 449' ' ' VAL . 77.3 Cg_exo -54.66 128.05 28.66 Favored 'Trans proline' 0 CA--C 1.498 -1.322 1 C-N-CA 125.452 4.101 . . . . 0.23999999999999999 114.933 177.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.837 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 52.8 Cg_exo -58.27 -8.25 4.85 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 123.972 3.115 . . . . 0.31 114.374 -165.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.554 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 77.9 p -93.21 -19.62 21.25 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.899 -1.046 . . . . 1.1000000000000001 111.089 -177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 446' ' ' PRO . 17.0 m -101.16 -49.61 10.82 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 114.664 1.357 . . . . 0.080000000000000002 114.664 -172.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.944 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -69.27 -2.33 10.39 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.933 -1.104 . . . . 0.070000000000000007 109.529 -177.124 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.629 ' HA ' ' CD2' ' A' ' 409' ' ' TYR . 15.4 pttp -77.28 -39.03 49.58 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-O 122.551 1.167 . . . . 0.92000000000000004 108.121 173.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm-40 -63.14 -46.48 87.02 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 112.416 -2.175 . . . . 0.25 106.709 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.944 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.6 -65.91 0.49 Allowed 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 109.935 -3.302 . . . . 0.050000000000000003 112.719 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.471 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 15.6 t80 -45.91 -23.33 0.28 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 123.861 0.725 . . . . 0.13 109.459 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.45 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.04 -24.05 33.24 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.051 -0.977 . . . . 0.13 111.927 -176.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.718 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -105.42 -43.88 4.86 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 113.808 1.04 . . . . 0.059999999999999998 113.808 176.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.666 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -73.84 150.35 7.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.42 1.105 . . . . 0.080000000000000002 111.084 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 457' ' ' VAL . 0.0 OUTLIER -122.31 156.88 32.96 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 113.247 -1.797 . . . . 0.47999999999999998 108.353 -178.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.569 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.6 mppt? -59.01 101.68 0.1 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.388 0.613 . . . . 0.98999999999999999 109.399 172.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 131.06 -12.72 5.54 Favored Glycine 0 C--N 1.305 -1.173 0 CA-C-N 114.107 -1.406 . . . . 0.19 111.428 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.666 HG21 ' HB ' ' A' ' 457' ' ' VAL . 12.9 m -65.82 149.36 97.57 Favored Pre-proline 0 N--CA 1.44 -0.962 0 N-CA-C 108.718 -0.845 . . . . 0.13 108.718 171.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.546 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.7 Cg_endo -93.79 160.4 2.28 Favored 'Trans proline' 0 N--CA 1.423 -2.651 0 C-N-CA 122.041 1.828 . . . . 0.17999999999999999 109.989 177.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.724 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -124.05 150.87 28.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 107.386 -1.338 . . . . 0.56999999999999995 107.386 171.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.28 149.56 50.93 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.008 -1.108 . . . . 0.13 108.008 175.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.041 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -137.68 140.65 40.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 105.311 -2.107 . . . . 0.10000000000000001 105.311 165.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.671 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 9.4 p90 . . . . . 0 C--O 1.245 0.827 0 O-C-N 123.848 0.717 . . . . 1.0900000000000001 110.85 -176.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.826 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.663 -0.575 . . . . 1.8700000000000001 111.663 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.424 ' CD2' HD11 ' A' ' 464' ' ' LEU . 1.6 m80 65.2 -177.59 0.18 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-O 122.823 1.297 . . . . 0.83999999999999997 110.617 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.485 ' HE2' ' HD3' ' A' ' 462' ' ' PRO . 5.5 mtm -57.8 -159.64 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 112.238 -2.256 . . . . 0.67000000000000004 111.121 163.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -59.23 161.36 5.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.093 -1.077 . . . . 1.8500000000000001 108.093 159.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.429 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 8.7 m-20 -75.89 85.05 2.83 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 119.582 -0.847 . . . . 0.42999999999999999 110.93 -168.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 357' ' ' TYR . 95.9 m -157.89 135.36 10.36 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.423 -1.262 . . . . 0.14000000000000001 108.763 166.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.634 ' CD2' HD13 ' A' ' 464' ' ' LEU . 38.3 p90 174.6 157.47 0.16 Allowed 'General case' 0 C--O 1.21 -0.986 0 O-C-N 123.362 0.414 . . . . 0.14999999999999999 111.367 -176.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.637 HD12 HD11 ' A' ' 453' ' ' LEU . 0.3 OUTLIER -77.88 152.72 5.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.365 -0.606 . . . . 0.080000000000000002 109.365 164.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.584 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 33.4 tt0 -149.99 144.13 25.64 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.817 -0.629 . . . . 2.0099999999999998 109.311 -176.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.729 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -137.53 162.3 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.057 0.456 . . . . 0.45000000000000001 111.399 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.569 ' N ' HG12 ' A' ' 347' ' ' VAL . 28.9 t0 -140.44 106.88 5.29 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 107.38 -1.341 . . . . 0.23999999999999999 107.38 174.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.091 HD21 HG23 ' A' ' 465' ' ' VAL . 0.2 OUTLIER -84.02 -32.19 25.04 Favored 'General case' 0 CA--C 1.485 -1.538 0 CA-C-O 123.036 1.398 . . . . 0.16 110.02 -169.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.468 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 0.6 OUTLIER -59.03 -45.28 91.13 Favored 'General case' 0 CA--C 1.491 -1.321 0 CA-C-N 110.672 -2.967 . . . . 0.59999999999999998 108.179 176.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 22.3 m-80 -102.83 8.22 39.33 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 111.006 -2.816 . . . . 0.20000000000000001 110.956 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.574 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 16.1 mp0 32.53 61.62 0.35 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 112.722 -2.035 . . . . 2.1499999999999999 113.475 -176.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.519 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.0 t60 -142.47 135.53 28.5 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.625 -0.716 . . . . 0.089999999999999997 109.754 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.756 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -113.48 157.34 22.11 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.864 -0.607 . . . . 0.070000000000000007 110.332 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.626 ' CD1' HG11 ' A' ' 362' ' ' VAL . 30.7 m-90 -142.89 154.09 43.77 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.563 -0.744 . . . . 0.11 111.433 -175.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.696 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 85.6 t80 -110.28 153.2 25.18 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 106.725 -1.583 . . . . 0.26000000000000001 106.725 152.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 12.3 m-85 -128.37 117.99 22.39 Favored 'General case' 0 C--N 1.272 -2.799 0 CA-C-N 115.073 -0.967 . . . . 0.14000000000000001 110.609 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.3 tppt? -118.15 137.87 52.67 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 105.979 -1.859 . . . . 0.25 105.979 167.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.508 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.9 15.66 7.83 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 113.348 0.87 . . . . 0.42999999999999999 113.348 174.075 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.51 6.46 88.1 Favored Glycine 0 CA--C 1.488 -1.631 0 C-N-CA 120.673 -0.775 . . . . 0.17999999999999999 112.757 -173.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 359' ' ' ASP . 14.2 ptmt -125.5 175.93 7.18 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 104.576 -2.379 . . . . 0.37 104.576 178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.626 HG11 ' CD1' ' A' ' 355' ' ' TRP . 15.5 m -103.95 157.48 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.703 0 N-CA-C 116.582 2.067 . . . . 0.10000000000000001 116.582 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.695 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -108.83 -27.17 9.89 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 110.642 -2.981 . . . . 0.070000000000000007 106.69 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.814 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -133.57 144.57 49.4 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 111.334 -2.666 . . . . 0.059999999999999998 111.329 -176.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.436 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.2 tt0 -142.54 118.19 10.41 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 104.498 -2.408 . . . . 0.47999999999999998 104.498 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.756 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.69 164.62 34.73 Favored 'General case' 0 N--CA 1.401 -2.887 0 C-N-CA 118.132 -1.427 . . . . 0.070000000000000007 111.442 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 20.4 p-10 -103.82 133.31 49.03 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 114.734 -1.121 . . . . 1.8 109.549 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.743 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -133.2 -172.28 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.282 0 CA-C-O 122.495 1.141 . . . . 0.12 112.171 -172.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -152.33 118.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 CA-C-N 112.888 -1.96 . . . . 0.10000000000000001 108.119 172.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.585 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.3 OUTLIER -75.11 -168.92 0.84 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.047 -1.433 . . . . 1.26 110.533 178.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 439' ' ' SER . . . -85.49 175.93 49.54 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 118.809 -1.662 . . . . 0.14000000000000001 112.156 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 434' ' ' TRP . 4.9 ptmt -78.78 155.44 78.08 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-O 121.59 0.709 . . . . 0.81000000000000005 111.466 -167.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.67 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 78.1 Cg_exo -54.96 -27.87 56.39 Favored 'Trans proline' 0 CA--C 1.501 -1.149 1 C-N-CA 125.399 4.066 . . . . 0.28000000000000003 113.399 -174.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.46 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.4 p -71.54 -31.48 67.08 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.662 -1.608 . . . . 0.33000000000000002 109.931 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.534 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 0.7 OUTLIER -140.94 70.3 29.21 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-O 123.804 1.764 . . . . 0.39000000000000001 108.972 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 375' ' ' THR . 88.1 Cg_exo -57.72 152.09 51.37 Favored 'Trans proline' 0 C--N 1.314 -1.241 1 C-N-CA 126.657 4.904 . . . . 0.38 115.637 -169.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.585 HG21 ' OG ' ' A' ' 370' ' ' SER . 18.3 m -78.74 130.99 68.87 Favored Pre-proline 0 N--CA 1.407 -2.597 0 CA-C-N 113.942 -1.481 . . . . 0.81999999999999995 109.18 173.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 24.2 Cg_exo -72.1 -46.49 0.53 Allowed 'Trans proline' 0 CA--C 1.514 -0.479 0 C-N-CA 123.325 2.683 . . . . 0.19 111.734 -173.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.79 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 60.2 142.88 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 123.349 1.547 . . . . 0.13 113.424 -174.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 147.49 -109.84 0.49 Allowed Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 112.402 -2.181 . . . . 0.20000000000000001 109.286 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 3.8 p -130.52 125.91 59.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.369 0.604 . . . . 0.81999999999999995 110.099 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.706 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 7.5 m-85 -123.65 -174.32 2.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.0 -1.482 . . . . 0.22 107.0 171.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.615 ' HB3' ' CZ3' ' A' ' 415' ' ' TRP . 2.0 t80 -140.65 122.63 15.56 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 119.795 1.18 . . . . 0.65000000000000002 112.76 -172.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.0 p -87.19 92.24 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-O 123.013 1.387 . . . . 0.16 109.223 170.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -89.89 7.82 35.31 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 113.442 -1.708 . . . . 2.5499999999999998 107.855 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.776 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 9.0 t30 -170.2 126.88 0.82 Allowed 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.368 -1.287 . . . . 0.42999999999999999 110.51 174.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.679 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -99.2 139.53 34.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.706 -1.134 . . . . 1.1200000000000001 109.016 170.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.792 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 11.4 mm-40 -123.57 158.05 32.3 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 114.823 1.416 . . . . 0.70999999999999996 114.823 -168.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 48.5 mt-10 -129.27 144.51 51.25 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.788 -2.006 . . . . 0.38 106.291 165.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.7 t70 53.03 34.03 16.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.221 -1.808 . . . . 0.40999999999999998 110.238 171.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.884 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -77.38 167.46 21.64 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 112.779 -2.01 . . . . 0.12 109.186 -175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.6 m -131.63 119.18 21.07 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.157 0.98 . . . . 0.17000000000000001 111.376 172.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.0 mp -77.36 87.57 3.75 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.638 -1.619 . . . . 0.56999999999999995 111.73 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.589 ' HG2' ' HG3' ' A' ' 404' ' ' GLU . 47.5 mttt -102.49 179.62 4.25 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 113.195 -1.821 . . . . 0.33000000000000002 113.072 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.55 -159.01 24.75 Favored Glycine 0 N--CA 1.429 -1.832 0 CA-C-N 114.467 -1.242 . . . . 0.46000000000000002 111.319 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.7 m -118.27 140.41 49.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 120.115 -0.634 . . . . 0.70999999999999996 110.876 170.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.0 m-80 -57.47 154.5 10.9 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.281 -0.872 . . . . 0.83999999999999997 108.94 167.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.04 -1.23 0.88 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.771 -0.649 . . . . 2.2799999999999998 110.95 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 397' ' ' ASN . 0.0 OUTLIER -114.44 5.21 15.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.131 -0.94 . . . . 2.27 111.33 -179.233 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 92.44 18.2 42.89 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.329 -0.938 . . . . 0.93999999999999995 112.558 169.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 12.1 p -113.19 99.63 49.45 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 114.34 -0.93 . . . . 0.81000000000000005 109.859 -175.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.8 Cg_endo -58.42 151.69 59.46 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 C-N-CA 123.028 2.485 . . . . 0.63 113.438 -176.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.534 ' OH ' ' HAD' ' A' ' 130' ' ' 1RG . 23.7 p90 -152.54 172.94 15.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.477 -1.238 . . . . 0.41999999999999998 112.694 -170.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.589 ' HG3' ' HG2' ' A' ' 394' ' ' LYS . 2.1 mp0 -146.24 147.99 32.0 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.249 -1.341 . . . . 0.53000000000000003 110.828 174.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.58 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.23 97.9 4.73 Favored Pre-proline 0 N--CA 1.442 -0.873 0 N-CA-C 108.663 -0.865 . . . . 0.19 108.663 171.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.6 Cg_exo -68.64 110.93 2.43 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 122.294 1.996 . . . . 0.19 110.7 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.884 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -111.36 160.02 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 CA-C-N 113.084 -1.871 . . . . 0.14999999999999999 107.724 -168.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 22.3 m-80 -93.26 -18.96 21.88 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.136 -0.69 . . . . 0.51000000000000001 109.136 -175.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.792 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 86.3 m-85 -158.59 125.77 4.91 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.072 -0.967 . . . . 0.27000000000000002 108.451 -171.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.693 ' HB3' ' HB2' ' A' ' 388' ' ' GLU . 20.2 t-105 -143.84 134.76 25.34 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.76 0.79 . . . . 0.089999999999999997 111.755 -166.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.679 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.9 mmt -117.34 94.02 44.25 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.055 -1.091 . . . . 0.14000000000000001 108.055 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.776 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 42.0 Cg_endo -68.03 70.36 0.86 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.381 2.721 . . . . 0.5 112.369 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.668 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.9 pt -76.06 65.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 122.642 1.21 . . . . 0.88 110.33 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.52 124.43 33.46 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.984 -1.007 . . . . 2.4900000000000002 109.725 -170.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.615 ' CZ3' ' HB3' ' A' ' 383' ' ' TYR . 0.0 OUTLIER 179.73 -60.76 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.832 -1.544 . . . . 1.9199999999999999 106.832 -165.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 39.9 p -115.29 -21.26 9.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.303 -1.771 . . . . 0.94999999999999996 110.813 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.747 ' O ' ' HG ' ' A' ' 130' ' ' 1RG . . . 134.37 -36.77 2.04 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.704 -0.76 . . . . 0.68000000000000005 113.298 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 419' ' ' GLY . 20.6 t -58.27 173.48 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 123.254 0.621 . . . . 0.75 112.234 -174.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.668 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -176.74 119.71 0.71 Allowed Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.852 -0.899 . . . . 0.20000000000000001 110.852 171.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.716 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.6 mt -81.07 142.87 13.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.769 0.319 . . . . 0.28999999999999998 110.486 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.674 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.0 p80 -159.98 161.04 34.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.01 -0.541 . . . . 0.089999999999999997 111.322 -173.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.696 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -83.62 145.73 28.66 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.042 -1.096 . . . . 1.0700000000000001 108.042 173.007 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 445' ' ' THR . 42.5 t -132.62 96.74 3.89 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.866 0.841 . . . . 0.23000000000000001 109.616 -172.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -82.6 -16.72 47.34 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.089 -1.414 . . . . 0.41999999999999998 109.389 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.762 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 9.0 p90 -87.48 -19.07 28.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.979 -1.464 . . . . 0.32000000000000001 110.914 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -103.24 113.64 65.62 Favored Pre-proline 0 CA--C 1.505 -0.78 0 CA-C-O 122.646 1.212 . . . . 1.74 110.085 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.531 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 40.9 Cg_endo -86.83 -9.36 6.52 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 C-N-CA 124.306 3.338 . . . . 0.72999999999999998 112.889 -175.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.548 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.7 pm0 -111.8 152.69 27.58 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 122.269 1.033 . . . . 2.1600000000000001 113.441 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.72 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.5 OUTLIER -162.43 131.5 4.27 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 105.146 -2.168 . . . . 0.33000000000000002 105.146 171.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.62 -158.15 30.66 Favored Glycine 0 C--N 1.282 -2.417 0 C-N-CA 119.974 -1.107 . . . . 0.17000000000000001 110.715 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.545 ' HA2' ' OE1' ' A' ' 352' ' ' GLN . . . -45.52 175.18 0.01 OUTLIER Glycine 0 CA--C 1.499 -0.961 0 C-N-CA 120.418 -0.896 . . . . 0.20999999999999999 111.803 167.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.529 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.1 p-10 -51.51 101.19 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 123.355 1.55 . . . . 1.8500000000000001 113.336 -155.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.733 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.98 -38.04 10.4 Favored 'General case' 0 C--O 1.209 -1.061 0 CA-C-N 112.404 -2.18 . . . . 1.21 109.099 170.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.657 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -53.11 -28.34 25.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.159 -0.928 . . . . 0.16 112.341 -171.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.67 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 0.0 OUTLIER -89.16 -36.51 15.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 112.527 0.566 . . . . 0.22 112.527 -177.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.5 p -89.65 -42.99 11.05 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.064 -0.971 . . . . 0.25 110.699 -176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.733 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.8 mtp180 -92.81 -18.3 23.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.594 -1.185 . . . . 1.8200000000000001 109.752 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.573 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.83 48.74 50.25 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.021 -0.99 . . . . 0.23999999999999999 115.257 162.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . 0.466 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 11.9 p -83.58 110.65 18.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 119.195 1.497 . . . . 1.01 111.447 -173.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.529 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 40.5 m-70 37.41 -124.27 0.21 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.503 -1.226 . . . . 0.5 114.086 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -129.47 -19.78 1.47 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.023 -0.608 . . . . 0.26000000000000001 113.408 -173.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.685 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.1 p -104.62 -165.86 1.18 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 112.902 0.705 . . . . 0.34999999999999998 112.902 -174.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.455 HD13 HG11 ' A' ' 465' ' ' VAL . 1.9 mp -95.11 130.98 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 115.212 -0.904 . . . . 0.12 110.64 -175.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 444' ' ' ASN . 1.1 m-80 -105.31 94.61 5.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.716 0.77 . . . . 0.62 110.259 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.743 ' HA ' HG22 ' A' ' 368' ' ' ILE . 2.5 m -90.26 143.64 29.86 Favored Pre-proline 0 N--CA 1.438 -1.035 0 CA-C-N 114.147 -1.388 . . . . 0.10000000000000001 112.89 -176.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.651 ' HD2' HG21 ' A' ' 366' ' ' THR . 74.8 Cg_exo -50.02 144.45 21.91 Favored 'Trans proline' 0 CA--C 1.505 -0.939 0 C-N-CA 123.943 3.096 . . . . 0.23999999999999999 113.22 175.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.72 ' HD3' ' OH ' ' A' ' 429' ' ' TYR . 33.3 Cg_exo -65.3 -24.58 57.78 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.748 2.299 . . . . 0.31 112.213 -175.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.534 ' O ' ' HE3' ' A' ' 451' ' ' LYS . 70.1 p -78.12 -25.06 47.28 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.391 -0.822 . . . . 1.1000000000000001 111.874 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.814 ' O ' HD21 ' A' ' 364' ' ' LEU . 31.8 m -99.58 -49.67 11.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 112.985 0.735 . . . . 0.080000000000000002 112.985 -170.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.957 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.93 -2.1 4.83 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.65 -0.82 . . . . 0.070000000000000007 110.446 -178.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.566 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 16.3 pttp -81.1 -38.06 27.89 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 122.54 1.162 . . . . 0.92000000000000004 108.238 173.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.4 mm-40 -62.85 -46.61 87.08 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 112.372 -2.195 . . . . 0.25 106.587 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.957 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.1 tp -47.14 -66.44 0.41 Allowed 'General case' 0 N--CA 1.402 -2.826 0 CA-C-N 109.887 -3.324 . . . . 0.050000000000000003 112.658 172.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.446 ' HD2' ' N ' ' A' ' 388' ' ' GLU . 23.5 t80 -46.3 -22.51 0.25 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.769 0.795 . . . . 0.13 109.71 175.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.45 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.95 -23.31 33.08 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 114.887 -1.051 . . . . 0.13 111.849 -176.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.74 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -106.38 -44.42 4.53 Favored 'General case' 0 CA--C 1.501 -0.924 0 N-CA-C 113.938 1.088 . . . . 0.059999999999999998 113.938 176.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -72.8 149.21 8.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 122.182 0.991 . . . . 0.080000000000000002 110.804 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.45 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -120.55 158.16 27.92 Favored 'General case' 0 N--CA 1.413 -2.324 0 CA-C-N 113.427 -1.715 . . . . 0.47999999999999998 109.043 -179.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.6 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.8 mppt? -58.97 102.41 0.12 Allowed 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 108.911 -0.774 . . . . 0.98999999999999999 108.911 170.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.37 -12.04 5.77 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 114.051 -1.432 . . . . 0.19 111.449 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.632 HG21 ' HB ' ' A' ' 457' ' ' VAL . 18.8 m -68.22 149.9 97.93 Favored Pre-proline 0 N--CA 1.439 -1.005 0 N-CA-C 108.732 -0.84 . . . . 0.13 108.732 171.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 5.6 Cg_endo -94.34 165.93 1.93 Allowed 'Trans proline' 0 N--CA 1.419 -2.87 0 C-N-CA 122.278 1.985 . . . . 0.17999999999999999 109.623 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.706 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.8 m -128.81 153.53 38.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.655 -1.239 . . . . 0.56999999999999995 107.655 170.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.699 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.6 mp -134.1 151.71 51.51 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 108.6 -0.889 . . . . 0.13 108.6 173.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.091 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.61 141.04 33.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 105.329 -2.1 . . . . 0.10000000000000001 105.329 166.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.712 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 7.8 p90 . . . . . 0 C--O 1.244 0.815 0 O-C-N 123.628 0.58 . . . . 1.0900000000000001 111.119 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.747 ' HG ' ' O ' ' A' ' 417' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 111.974 -0.45 . . . . 1.8700000000000001 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.586 ' CE1' HD21 ' A' ' 464' ' ' LEU . 3.7 p-80 -139.74 99.85 3.81 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 120.85 0.357 . . . . 0.83999999999999997 111.933 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.535 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.2 OUTLIER 62.45 -169.02 0.19 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.048 -0.978 . . . . 0.67000000000000004 112.924 166.382 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.24 171.77 2.21 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.759 -0.655 . . . . 1.8500000000000001 109.476 162.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.484 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.4 m-20 -79.18 83.42 5.24 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 119.087 -1.045 . . . . 0.42999999999999999 109.973 -177.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.809 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 86.6 m -158.28 134.49 9.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.387 -1.278 . . . . 0.14000000000000001 108.825 166.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.743 ' CD2' HD13 ' A' ' 464' ' ' LEU . 41.1 p90 174.52 158.24 0.16 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 123.42 0.45 . . . . 0.14999999999999999 110.983 -175.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.636 HD11 HG11 ' A' ' 457' ' ' VAL . 0.5 OUTLIER -77.4 153.26 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 109.122 -0.695 . . . . 0.080000000000000002 109.122 165.051 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.06 147.12 29.22 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.038 -1.097 . . . . 2.0099999999999998 108.038 -177.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.732 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.2 t -138.99 153.78 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 C-N-CA 123.625 0.77 . . . . 0.45000000000000001 110.422 173.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.496 ' N ' HG12 ' A' ' 347' ' ' VAL . 16.4 t0 -136.85 106.53 6.18 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.98 -1.489 . . . . 0.23999999999999999 106.98 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.028 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -79.01 -35.03 43.46 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 124.049 1.881 . . . . 0.16 110.334 -166.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.425 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.4 mt-10 -55.44 -43.49 75.45 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 110.904 -2.862 . . . . 0.59999999999999998 107.697 176.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 17.6 m-80 -101.51 4.54 41.24 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 110.97 -2.832 . . . . 0.20000000000000001 111.395 -175.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.842 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 83.5 mm-40 31.38 62.44 0.24 Allowed 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 112.852 -1.976 . . . . 2.1499999999999999 113.465 -172.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.628 ' NE2' ' HG2' ' A' ' 365' ' ' GLU . 29.6 t60 -141.43 136.83 31.74 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.453 -1.249 . . . . 0.089999999999999997 109.927 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.732 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -112.94 158.98 19.56 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 116.057 -0.519 . . . . 0.070000000000000007 110.214 -179.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.641 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -144.17 160.71 40.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.703 -0.681 . . . . 0.11 111.149 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.809 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.4 t80 -113.39 153.56 28.37 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 106.465 -1.68 . . . . 0.26000000000000001 106.465 150.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 9.4 m-85 -128.01 116.57 20.25 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.129 -0.941 . . . . 0.14000000000000001 110.248 -178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.1 tppt? -117.78 138.44 52.05 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.046 -1.835 . . . . 0.25 106.046 168.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.42 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.4 OUTLIER 69.49 16.96 8.11 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 113.39 0.885 . . . . 0.42999999999999999 113.39 172.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.484 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 77.34 8.04 87.0 Favored Glycine 0 CA--C 1.485 -1.796 0 CA-C-N 115.643 -0.708 . . . . 0.17999999999999999 113.036 -173.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.2 ptmt -128.11 177.93 6.57 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 104.493 -2.41 . . . . 0.37 104.493 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.641 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.1 m -104.59 158.23 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.747 0 N-CA-C 116.303 1.964 . . . . 0.10000000000000001 116.303 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.689 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.91 -28.51 9.57 Favored 'General case' 0 N--CA 1.408 -2.528 0 CA-C-N 110.764 -2.925 . . . . 0.070000000000000007 106.35 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.798 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.53 145.36 50.05 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 111.551 -2.568 . . . . 0.059999999999999998 111.678 -175.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.628 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.3 tt0 -142.23 118.77 10.97 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 104.49 -2.411 . . . . 0.47999999999999998 104.49 174.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.732 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.6 OUTLIER -149.6 163.68 37.22 Favored 'General case' 0 N--CA 1.401 -2.89 0 C-N-CA 118.332 -1.347 . . . . 0.070000000000000007 110.57 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.588 ' OD2' ' HA2' ' A' ' 430' ' ' GLY . 0.5 OUTLIER -100.75 142.3 32.41 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.739 -0.838 . . . . 1.8 108.739 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.731 HG22 ' HA ' ' A' ' 445' ' ' THR . 1.9 pp -137.03 -172.76 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 CA-C-O 122.045 0.926 . . . . 0.12 112.317 -173.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.842 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -152.87 118.14 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 113.196 -1.82 . . . . 0.10000000000000001 109.442 171.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 349' ' ' LEU . 54.6 p -78.8 -168.0 1.29 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 112.062 -2.336 . . . . 1.26 111.285 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.415 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.9 165.56 40.09 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 118.602 -1.761 . . . . 0.14000000000000001 112.17 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -71.64 156.79 90.89 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.41 0.624 . . . . 0.81000000000000005 111.474 -168.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.637 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 87.9 Cg_exo -55.84 -28.67 68.8 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 125.174 3.916 . . . . 0.28000000000000003 113.612 -173.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.454 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 17.8 p -70.81 -32.38 69.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.421 -1.718 . . . . 0.33000000000000002 109.644 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.527 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.2 t -140.98 70.63 28.93 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 123.822 1.772 . . . . 0.39000000000000001 109.033 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 375' ' ' THR . 89.0 Cg_exo -58.08 157.15 26.19 Favored 'Trans proline' 0 C--N 1.312 -1.387 1 C-N-CA 126.592 4.861 . . . . 0.38 115.358 -170.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.51 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 1.5 m -82.67 131.87 53.57 Favored Pre-proline 0 N--CA 1.406 -2.648 0 CA-C-N 114.326 -1.306 . . . . 0.81999999999999995 108.482 172.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.534 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 24.6 Cg_exo -72.19 -45.69 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.808 3.005 . . . . 0.19 112.334 -171.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.817 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 60.5 140.92 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 123.283 1.516 . . . . 0.13 113.791 -173.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 150.06 -110.41 0.47 Allowed Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 112.331 -2.213 . . . . 0.20000000000000001 109.419 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.1 p -130.02 123.18 55.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.694 0.759 . . . . 0.81999999999999995 109.961 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.773 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 3.5 m-85 -120.27 -173.55 2.59 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.544 -1.651 . . . . 0.22 106.544 170.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 9.5 t80 -144.17 127.35 16.64 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 120.477 -1.389 . . . . 0.65000000000000002 113.576 -171.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.8 p -90.44 92.93 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-O 122.949 1.357 . . . . 0.16 109.97 171.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -73.49 -10.93 60.24 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.253 -1.794 . . . . 2.5499999999999998 108.067 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.782 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.4 t30 -169.96 133.04 1.15 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.651 -0.704 . . . . 0.42999999999999999 112.093 -175.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.631 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -92.53 154.76 18.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.054 -0.521 . . . . 1.1200000000000001 110.485 171.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.78 ' HB3' ' HB2' ' A' ' 391' ' ' ALA . 35.8 mm-40 -132.59 157.97 43.4 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 115.013 1.486 . . . . 0.70999999999999996 115.013 -171.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.757 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.8 mt-10 -138.29 126.89 23.47 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.827 -1.988 . . . . 0.38 108.425 173.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.63 49.21 20.86 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 123.371 1.557 . . . . 0.40999999999999998 109.195 -175.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.946 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -79.76 168.31 19.47 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 112.665 -2.061 . . . . 0.12 108.577 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 17.7 m -133.16 119.53 20.02 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.154 0.978 . . . . 0.17000000000000001 111.808 170.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.567 HD13 ' HB ' ' A' ' 407' ' ' VAL . 3.7 mp -79.47 88.75 5.04 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.541 -1.663 . . . . 0.56999999999999995 112.023 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.555 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.2 mttt -103.3 178.58 4.52 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 113.618 -1.628 . . . . 0.33000000000000002 113.439 178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.97 -160.99 25.48 Favored Glycine 0 N--CA 1.429 -1.805 0 CA-C-N 114.064 -1.425 . . . . 0.46000000000000002 111.58 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.9 m -115.41 137.54 51.94 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.483 -0.487 . . . . 0.70999999999999996 110.417 169.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.459 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.1 m-80 -53.9 153.37 4.81 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.659 -0.7 . . . . 0.83999999999999997 109.163 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.93 -2.42 0.4 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.168 -0.924 . . . . 2.2799999999999998 111.3 177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 397' ' ' ASN . 10.7 t70 -115.54 2.34 13.8 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.599 0.714 . . . . 2.27 111.272 -178.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 97.28 18.8 27.66 Favored Glycine 0 N--CA 1.431 -1.665 0 C-N-CA 120.002 -1.094 . . . . 0.93999999999999995 113.232 171.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.479 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 8.0 p -113.36 100.32 51.4 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 114.912 -0.644 . . . . 0.81000000000000005 110.044 -176.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.66 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 19.1 Cg_endo -58.54 149.67 73.96 Favored 'Trans proline' 0 CA--C 1.501 -1.145 0 C-N-CA 122.597 2.198 . . . . 0.63 112.884 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -152.86 174.47 14.04 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.274 -1.33 . . . . 0.41999999999999998 112.661 -168.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.555 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -146.73 148.06 31.6 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.906 -1.497 . . . . 0.53000000000000003 109.894 172.228 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.33 97.29 5.18 Favored Pre-proline 0 N--CA 1.436 -1.149 0 N-CA-C 107.905 -1.146 . . . . 0.19 107.905 169.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 21.5 Cg_exo -68.26 109.5 2.01 Favored 'Trans proline' 0 N--CA 1.432 -2.098 0 C-N-CA 121.929 1.753 . . . . 0.19 109.584 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.946 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -107.65 156.99 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 CA-C-N 112.915 -1.948 . . . . 0.14999999999999999 107.421 -168.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.757 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 23.5 m-80 -88.63 -20.67 24.64 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.014 -0.736 . . . . 0.51000000000000001 109.014 -174.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 75.6 m-85 -158.82 126.75 5.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.013 -0.994 . . . . 0.27000000000000002 108.527 -171.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.675 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 26.8 t-105 -144.21 138.69 28.24 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.463 0.649 . . . . 0.089999999999999997 110.93 -167.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.631 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 12.0 mmt -122.23 92.27 48.94 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 108.272 -1.01 . . . . 0.14000000000000001 108.272 175.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.782 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 25.5 Cg_endo -63.41 84.44 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.554 2.169 . . . . 0.5 112.853 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 411' ' ' MET . 2.4 pt -86.08 177.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 108.141 -1.059 . . . . 0.88 108.141 175.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 416' ' ' THR . 1.5 t70 -155.11 -169.39 3.16 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 118.989 -1.084 . . . . 2.4900000000000002 113.162 -166.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 39.9 p90 55.32 -6.3 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 126.991 2.116 . . . . 1.9199999999999999 114.495 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.534 ' HB ' ' HG2' ' A' ' 378' ' ' PRO . 23.2 p -129.53 -13.65 4.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.206 0.527 . . . . 0.94999999999999996 110.934 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.583 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 96.24 -29.44 10.15 Favored Glycine 0 CA--C 1.505 -0.569 0 N-CA-C 111.322 -0.711 . . . . 0.68000000000000005 111.322 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 419' ' ' GLY . 25.1 t -55.11 171.97 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.936 0.895 . . . . 0.75 112.011 -176.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.599 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -178.21 122.53 0.82 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.182 -1.167 . . . . 0.20000000000000001 110.182 170.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.65 HG22 ' SD ' ' A' ' 450' ' ' MET . 1.9 mp -81.37 141.92 14.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 109.956 -0.387 . . . . 0.28999999999999998 109.956 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.675 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 34.3 p80 -159.9 161.19 34.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 0.089999999999999997 111.448 -175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.703 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -82.8 149.53 27.15 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 107.889 -1.152 . . . . 1.0700000000000001 107.889 171.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 445' ' ' THR . 47.1 t -133.82 96.84 3.75 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.708 0.766 . . . . 0.23000000000000001 110.015 -173.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -81.29 -13.39 58.5 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.453 -1.249 . . . . 0.41999999999999998 109.734 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.754 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 9.3 p90 -92.89 -19.93 21.17 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.23 -1.35 . . . . 0.32000000000000001 111.487 -175.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.568 HE22 HG11 ' A' ' 369' ' ' VAL . 1.7 tt0 -103.36 117.81 59.25 Favored Pre-proline 0 CA--C 1.507 -0.674 0 CA-C-O 122.663 1.221 . . . . 1.74 110.542 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.569 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 44.0 Cg_endo -87.16 -12.09 5.0 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 124.348 3.365 . . . . 0.72999999999999998 113.874 -173.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.573 ' HG3' ' CD ' ' A' ' 437' ' ' ARG . 1.5 pm0 -110.19 150.62 28.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.38 1.086 . . . . 2.1600000000000001 112.964 174.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.585 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.7 OUTLIER -158.33 127.88 5.81 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 112.691 -2.05 . . . . 0.33000000000000002 105.8 169.056 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.588 ' HA2' ' OD2' ' A' ' 367' ' ' ASP . . . 169.06 -158.48 31.07 Favored Glycine 0 C--N 1.286 -2.234 0 C-N-CA 119.871 -1.157 . . . . 0.17000000000000001 111.148 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.511 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.16 165.91 0.01 OUTLIER Glycine 0 CA--C 1.486 -1.781 0 C-N-CA 120.511 -0.852 . . . . 0.20999999999999999 111.665 168.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 435' ' ' LYS . 22.4 m-20 -52.82 101.93 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 113.684 -1.258 . . . . 1.8500000000000001 113.096 -155.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 1.033 HD22 ' HD2' ' A' ' 437' ' ' ARG . 33.7 mt -94.96 -33.22 12.84 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-N 112.943 -1.935 . . . . 1.21 109.275 175.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.715 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.0 p-90 -53.87 -27.45 30.13 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.738 -1.119 . . . . 0.16 112.511 -173.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.715 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.05 -34.54 16.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.92 -0.582 . . . . 0.22 111.977 -178.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.9 p -89.72 -41.43 11.91 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.047 -0.978 . . . . 0.25 110.787 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 1.033 ' HD2' HD22 ' A' ' 433' ' ' LEU . 0.8 OUTLIER -94.2 -18.11 22.04 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.546 -1.206 . . . . 1.8200000000000001 109.957 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 52.76 48.49 56.62 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 114.984 -1.007 . . . . 0.23999999999999999 115.045 163.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 10.1 p -83.71 111.38 19.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 118.35 1.075 . . . . 1.01 111.936 -171.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.48 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 62.8 m-70 35.92 -118.47 0.12 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.693 -1.139 . . . . 0.5 113.298 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.415 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -137.06 -16.59 0.74 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.999 -0.62 . . . . 0.26000000000000001 113.841 -175.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.835 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.3 p -103.78 -167.06 1.32 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.63 0.715 . . . . 0.34999999999999998 112.511 -176.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.452 HD13 HG11 ' A' ' 465' ' ' VAL . 2.1 mp -98.74 129.01 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 114.893 -1.049 . . . . 0.12 110.866 -174.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.4 ' N ' HD22 ' A' ' 444' ' ' ASN . 0.9 OUTLIER -101.61 97.89 8.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.473 -0.785 . . . . 0.62 110.422 -177.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.731 ' HA ' HG22 ' A' ' 368' ' ' ILE . 6.8 m -94.1 144.08 27.48 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 115.071 -0.968 . . . . 0.10000000000000001 112.467 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.637 ' HD2' HG21 ' A' ' 366' ' ' THR . 81.7 Cg_exo -51.07 143.48 31.57 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 124.012 3.142 . . . . 0.23999999999999999 113.178 175.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.703 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.5 Cg_exo -64.62 -29.96 60.62 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.833 2.355 . . . . 0.31 112.361 -176.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.512 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 38.6 m -72.95 -23.49 60.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.769 -0.651 . . . . 1.1000000000000001 112.218 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.798 ' O ' HD21 ' A' ' 364' ' ' LEU . 25.2 m -100.82 -47.42 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.905 0 N-CA-C 113.01 0.744 . . . . 0.080000000000000002 113.01 -169.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.961 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.8 -2.22 6.79 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.69 -0.804 . . . . 0.070000000000000007 110.204 -178.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 448' ' ' SER . 16.2 pttp -80.24 -38.88 30.1 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 122.475 1.131 . . . . 0.92000000000000004 108.201 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 4.4 mm-40 -61.91 -46.54 88.9 Favored 'General case' 0 CA--C 1.471 -2.066 0 CA-C-N 112.497 -2.138 . . . . 0.25 106.484 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.961 HD23 ' SD ' ' A' ' 450' ' ' MET . 2.9 tp -47.45 -65.89 0.49 Allowed 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 109.973 -3.285 . . . . 0.050000000000000003 112.608 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.471 ' CE2' ' HG3' ' A' ' 389' ' ' GLU . 21.9 t80 -45.33 -22.98 0.16 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.853 0.835 . . . . 0.13 109.728 175.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.458 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -90.65 -26.84 21.62 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.74 -1.118 . . . . 0.13 111.983 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.747 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -102.33 -44.68 5.33 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 113.64 0.978 . . . . 0.059999999999999998 113.64 177.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -71.23 147.08 11.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 122.391 1.091 . . . . 0.080000000000000002 110.793 -179.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.572 ' HG3' ' OG1' ' A' ' 461' ' ' THR . 0.0 OUTLIER -113.32 157.5 21.74 Favored 'General case' 0 N--CA 1.413 -2.316 0 CA-C-N 113.033 -1.894 . . . . 0.47999999999999998 108.869 -179.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.653 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 7.2 mtpt -60.74 101.54 0.15 Allowed 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.063 -1.088 . . . . 0.98999999999999999 108.063 166.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.86 -7.41 6.46 Favored Glycine 0 C--N 1.308 -1.025 0 CA-C-N 113.957 -1.474 . . . . 0.19 111.631 -174.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.673 HG21 ' HB ' ' A' ' 457' ' ' VAL . 8.0 m -72.96 150.58 90.4 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 108.257 -1.016 . . . . 0.13 108.257 170.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.535 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 10.1 Cg_endo -95.32 171.94 1.3 Allowed 'Trans proline' 0 N--CA 1.417 -2.972 0 C-N-CA 122.172 1.915 . . . . 0.17999999999999999 109.91 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.773 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -130.88 153.85 39.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.201 -1.037 . . . . 0.56999999999999995 108.201 171.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.743 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.2 mp -134.08 150.67 51.18 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.637 -0.875 . . . . 0.13 108.637 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.028 HG23 HD21 ' A' ' 349' ' ' LEU . 0.8 OUTLIER -140.19 140.1 35.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 103.981 -2.6 . . . . 0.10000000000000001 103.981 162.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.817 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 4.6 p90 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.399 -1.286 . . . . 1.0900000000000001 111.184 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.835 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.73 -0.548 . . . . 1.8700000000000001 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.592 ' CE1' HD21 ' A' ' 464' ' ' LEU . 2.2 p-80 -137.87 100.09 4.08 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 111.976 0.362 . . . . 0.83999999999999997 111.976 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.544 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.2 OUTLIER 62.16 -163.28 0.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.238 -0.892 . . . . 0.67000000000000004 112.646 165.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.9 175.88 1.83 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.805 -1.184 . . . . 1.8500000000000001 107.805 164.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.467 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 9.1 m-20 -82.52 82.89 7.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.06 -1.056 . . . . 0.42999999999999999 109.457 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.776 ' CG2' ' OH ' ' A' ' 356' ' ' TYR . 91.5 m -157.67 134.63 10.06 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.63 -1.168 . . . . 0.14000000000000001 108.539 168.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.765 ' CD2' HD13 ' A' ' 464' ' ' LEU . 40.9 p90 174.42 158.32 0.16 Allowed 'General case' 0 CA--C 1.5 -0.954 0 O-C-N 123.503 0.502 . . . . 0.14999999999999999 111.152 -175.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 453' ' ' LEU . 0.5 OUTLIER -77.26 153.86 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 109.077 -0.712 . . . . 0.080000000000000002 109.077 164.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.639 ' CD ' ' CE1' ' A' ' 466' ' ' PHE . 0.0 OUTLIER -148.46 146.9 28.6 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.006 -1.109 . . . . 2.0099999999999998 108.006 -178.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.727 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.0 t -139.24 154.31 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 C-N-CA 123.687 0.795 . . . . 0.45000000000000001 110.449 173.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.509 ' N ' HG12 ' A' ' 347' ' ' VAL . 17.8 t0 -137.79 105.77 5.68 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.61 -1.626 . . . . 0.23999999999999999 106.61 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.032 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -79.18 -35.97 41.05 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 114.086 -1.416 . . . . 0.16 109.891 -165.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.438 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.6 mt-10 -55.77 -44.76 77.99 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 110.669 -2.968 . . . . 0.59999999999999998 108.124 177.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 21.7 m-80 -100.56 6.76 44.27 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 110.931 -2.85 . . . . 0.20000000000000001 110.795 -175.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.5 OUTLIER 32.83 60.8 0.4 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 112.786 -2.006 . . . . 2.1499999999999999 112.868 -174.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.503 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 23.3 t60 -141.77 136.44 30.72 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.748 -0.66 . . . . 0.089999999999999997 109.66 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.77 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.1 OUTLIER -113.81 157.64 22.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.898 -0.592 . . . . 0.070000000000000007 110.001 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.649 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.7 m-90 -143.35 161.25 38.85 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.179 0.592 . . . . 0.11 111.044 -177.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.776 ' OH ' ' CG2' ' A' ' 343' ' ' THR . 89.1 t80 -113.41 153.56 28.41 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 106.423 -1.695 . . . . 0.26000000000000001 106.423 150.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.0 m-85 -127.81 117.68 22.3 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.001 -1.0 . . . . 0.14000000000000001 109.954 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 9.5 tppt? -118.44 137.8 52.91 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.08 -1.822 . . . . 0.25 106.08 168.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.453 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.2 OUTLIER 70.21 16.36 7.36 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 113.276 0.843 . . . . 0.42999999999999999 113.276 172.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 78.35 7.47 87.85 Favored Glycine 0 CA--C 1.485 -1.816 0 CA-C-N 115.72 -0.673 . . . . 0.17999999999999999 112.956 -173.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 16.6 ptmt -127.5 177.76 6.54 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 104.66 -2.348 . . . . 0.37 104.66 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.649 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.2 m -104.58 158.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.616 0 N-CA-C 116.427 2.01 . . . . 0.10000000000000001 116.427 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.711 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.7 -26.25 9.97 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 110.607 -2.997 . . . . 0.070000000000000007 106.671 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.816 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -135.19 145.12 47.41 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 111.404 -2.635 . . . . 0.059999999999999998 111.653 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.458 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.6 tt0 -141.25 119.05 11.76 Favored 'General case' 0 N--CA 1.405 -2.684 0 N-CA-C 104.269 -2.493 . . . . 0.47999999999999998 104.269 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.77 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.1 165.17 33.61 Favored 'General case' 0 N--CA 1.4 -2.973 0 C-N-CA 117.958 -1.497 . . . . 0.070000000000000007 111.501 178.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.443 ' CG ' ' HB2' ' A' ' 429' ' ' TYR . 29.5 p-10 -103.89 136.68 43.1 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.821 -1.082 . . . . 1.8 109.822 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.729 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.1 pp -136.58 -173.02 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.247 0 CA-C-O 122.506 1.146 . . . . 0.12 112.483 -171.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.61 119.32 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 112.811 -1.995 . . . . 0.10000000000000001 108.102 173.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.496 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.2 OUTLIER -80.47 -168.09 1.59 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.254 -1.339 . . . . 1.26 110.479 -178.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.401 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -84.74 169.94 45.34 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 118.811 -1.661 . . . . 0.14000000000000001 112.414 -174.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 373' ' ' PRO . 2.2 ptpt -74.48 156.24 87.15 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.314 0.578 . . . . 0.81000000000000005 112.33 -164.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.659 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 85.8 Cg_exo -54.83 -30.89 70.2 Favored 'Trans proline' 0 CA--C 1.497 -1.345 1 C-N-CA 125.537 4.158 . . . . 0.28000000000000003 114.037 -173.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.418 ' OG1' HG22 ' A' ' 375' ' ' THR . 21.5 p -67.2 -31.47 71.89 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.703 -1.59 . . . . 0.33000000000000002 109.565 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.52 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -141.87 70.9 24.39 Favored Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 113.683 -1.599 . . . . 0.39000000000000001 109.731 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.4 Cg_exo -58.15 142.99 97.45 Favored 'Trans proline' 0 C--N 1.306 -1.679 1 C-N-CA 125.884 4.389 . . . . 0.38 113.307 -172.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.496 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.4 OUTLIER -73.11 144.24 84.61 Favored Pre-proline 0 N--CA 1.422 -1.83 0 N-CA-C 108.154 -1.054 . . . . 0.81999999999999995 108.154 175.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 21.1 Cg_exo -74.97 -44.1 0.36 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 124.381 3.387 . . . . 0.19 111.728 -165.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.858 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 57.93 136.69 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 123.528 1.632 . . . . 0.13 113.86 -173.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 155.3 -114.61 0.62 Allowed Glycine 0 N--CA 1.432 -1.631 0 CA-C-N 112.013 -2.358 . . . . 0.20000000000000001 109.377 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.91 114.72 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 121.822 0.82 . . . . 0.81999999999999995 111.192 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.756 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 2.4 m-85 -112.42 -174.18 2.4 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.193 -1.41 . . . . 0.22 107.193 174.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 415' ' ' TRP . 1.3 t80 -140.58 124.47 17.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.19 1.359 . . . . 0.65000000000000002 113.598 -172.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -90.95 92.04 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 123.066 1.412 . . . . 0.16 109.611 168.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -92.87 10.78 29.65 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.419 -1.719 . . . . 2.5499999999999998 107.982 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.753 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.4 t30 -169.79 126.3 0.86 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 113.873 -1.512 . . . . 0.42999999999999999 110.095 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.668 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -100.5 144.06 29.94 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.998 -1.001 . . . . 1.1200000000000001 109.171 170.495 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.763 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 29.8 mm-40 -124.73 158.3 33.59 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 114.896 1.443 . . . . 0.70999999999999996 114.896 -167.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.736 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 56.2 mt-10 -137.05 126.88 25.63 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 112.958 -1.928 . . . . 0.38 108.57 174.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 37.1 t70 54.23 47.35 23.29 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 123.076 1.417 . . . . 0.40999999999999998 109.228 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.923 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -80.43 166.23 21.45 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 112.922 -1.945 . . . . 0.12 108.891 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 18.7 m -132.3 119.33 20.61 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.136 0.97 . . . . 0.17000000000000001 111.465 171.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.4 mp -79.8 89.02 5.22 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.731 -1.577 . . . . 0.56999999999999995 111.853 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.596 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 47.9 mttt -101.57 176.98 5.05 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 113.8 -1.546 . . . . 0.33000000000000002 113.353 178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 137.76 -157.08 24.02 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 119.526 -1.321 . . . . 0.46000000000000002 111.898 -177.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.3 m -115.79 139.42 50.2 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 120.367 -0.533 . . . . 0.70999999999999996 111.604 172.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 401' ' ' THR . 5.2 m-80 -57.31 154.47 10.48 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 114.919 -1.037 . . . . 0.83999999999999997 110.039 168.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -58.09 -2.61 0.18 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.441 -1.254 . . . . 2.2799999999999998 112.173 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 397' ' ' ASN . 20.9 t70 -117.21 2.54 12.59 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.676 0.751 . . . . 2.27 111.033 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.73 16.51 36.18 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 119.941 -1.123 . . . . 0.93999999999999995 113.01 172.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 397' ' ' ASN . 7.0 p -113.2 102.26 54.56 Favored Pre-proline 0 C--N 1.303 -1.421 0 CA-C-N 114.785 -0.708 . . . . 0.81000000000000005 109.675 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.3 Cg_endo -57.66 149.75 65.87 Favored 'Trans proline' 0 CA--C 1.506 -0.894 0 C-N-CA 122.867 2.378 . . . . 0.63 113.514 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -148.79 174.57 12.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.266 -1.334 . . . . 0.41999999999999998 112.66 -169.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.596 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.7 OUTLIER -143.01 148.33 36.59 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.649 -1.614 . . . . 0.53000000000000003 109.769 170.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.9 OUTLIER -143.42 96.76 5.69 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 107.916 -1.142 . . . . 0.19 107.916 170.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 17.3 Cg_exo -69.52 110.51 2.52 Favored 'Trans proline' 0 N--CA 1.431 -2.171 0 C-N-CA 121.791 1.66 . . . . 0.19 109.728 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.923 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.18 151.52 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 112.941 -1.936 . . . . 0.14999999999999999 107.11 -168.447 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.736 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 22.6 m-80 -85.42 -20.11 30.32 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.962 -0.755 . . . . 0.51000000000000001 108.962 -174.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.763 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 81.2 m-85 -158.27 126.11 5.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.995 -1.002 . . . . 0.27000000000000002 108.705 -170.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.679 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 24.5 t-105 -144.48 133.11 22.21 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.758 0.79 . . . . 0.089999999999999997 111.104 -167.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.668 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.9 mmt -114.92 93.66 35.19 Favored Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 107.816 -1.179 . . . . 0.14000000000000001 107.816 172.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.753 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 37.6 Cg_endo -67.59 71.4 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.455 2.103 . . . . 0.5 112.252 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.606 HG12 ' HA2' ' A' ' 419' ' ' GLY . 3.2 pt -70.05 174.31 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.564 -0.902 . . . . 0.88 108.564 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.511 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 1.0 OUTLIER -147.38 -173.75 4.34 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.847 -1.141 . . . . 2.4900000000000002 112.541 -165.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.511 ' CE3' ' HB3' ' A' ' 414' ' ' ASP . 37.7 p90 50.72 0.68 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 126.853 2.061 . . . . 1.9199999999999999 115.025 176.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.483 HG21 ' CD1' ' A' ' 382' ' ' PHE . 29.9 p -131.17 -15.23 3.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.055 0.455 . . . . 0.94999999999999996 111.544 -178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.432 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 97.98 -35.47 4.53 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 111.267 -0.733 . . . . 0.68000000000000005 111.267 177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 419' ' ' GLY . 39.4 t -59.13 172.79 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 123.926 0.89 . . . . 0.75 112.021 -177.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.606 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -176.95 121.64 0.8 Allowed Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 109.867 -1.293 . . . . 0.20000000000000001 109.867 169.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.699 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.2 mp -82.02 143.22 12.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 110.106 -0.331 . . . . 0.28999999999999998 110.106 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.679 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.0 p80 -160.28 161.86 33.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.178 -0.464 . . . . 0.089999999999999997 111.514 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.684 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -83.19 145.62 29.07 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.607 -1.257 . . . . 1.0700000000000001 107.607 171.402 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.552 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 29.4 t -133.81 98.33 4.14 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.95 0.881 . . . . 0.23000000000000001 110.205 -171.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.35 -11.23 59.73 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.002 -1.454 . . . . 0.41999999999999998 109.609 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.729 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 11.1 p90 -95.6 -26.99 15.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.43 -1.259 . . . . 0.32000000000000001 112.125 -175.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.581 ' NE2' ' HG2' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -90.45 109.06 31.25 Favored Pre-proline 0 CA--C 1.509 -0.628 0 CA-C-O 122.487 1.137 . . . . 1.74 108.692 177.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 67.8 Cg_endo -82.33 -16.46 8.27 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 124.249 3.299 . . . . 0.72999999999999998 112.973 -172.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.581 ' HG2' ' NE2' ' A' ' 426' ' ' GLN . 0.9 OUTLIER -111.47 157.48 20.25 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 122.125 0.964 . . . . 2.1600000000000001 112.049 173.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.677 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.6 OUTLIER -160.7 129.64 4.77 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 104.949 -2.241 . . . . 0.33000000000000002 104.949 172.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.82 -157.27 29.47 Favored Glycine 0 C--N 1.284 -2.339 0 C-N-CA 119.678 -1.249 . . . . 0.17000000000000001 110.797 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.417 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -44.97 174.01 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.184 -1.008 . . . . 0.20999999999999999 111.482 167.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.532 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 6.4 p-10 -52.59 101.95 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 123.28 1.515 . . . . 1.8500000000000001 113.89 -153.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.711 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.93 -36.99 10.88 Favored 'General case' 0 C--O 1.209 -1.044 0 CA-C-N 112.651 -2.068 . . . . 1.21 109.582 169.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.757 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.5 p-90 -54.44 -26.88 33.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.338 -0.846 . . . . 0.16 112.4 -170.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.757 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.72 -35.21 15.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 112.523 0.564 . . . . 0.22 112.523 -177.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.441 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 2.2 p -91.82 -43.71 9.37 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.031 -0.986 . . . . 0.25 110.904 -176.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.711 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 0.8 OUTLIER -90.09 -19.24 24.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.73 -1.123 . . . . 1.8200000000000001 109.152 -179.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 50.8 47.54 46.74 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.475 -0.784 . . . . 0.23999999999999999 114.952 161.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.9 p -84.65 110.97 19.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 118.622 1.211 . . . . 1.01 111.597 -172.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 37.09 -130.86 0.13 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.69 -1.141 . . . . 0.5 113.031 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.401 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -121.74 -20.06 3.24 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.088 -0.577 . . . . 0.26000000000000001 114.084 -177.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.773 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.4 p -99.09 -166.83 1.4 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 117.803 0.801 . . . . 0.34999999999999998 112.867 -173.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.437 HG12 HG11 ' A' ' 347' ' ' VAL . 2.2 mp -96.73 130.01 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 115.105 -0.952 . . . . 0.12 110.887 -173.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.01 94.56 6.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.945 -0.57 . . . . 0.62 110.418 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.729 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.6 m -91.26 142.39 27.1 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-N 115.147 -0.933 . . . . 0.10000000000000001 112.481 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.67 ' HD2' HG21 ' A' ' 366' ' ' THR . 89.3 Cg_exo -49.72 143.59 22.17 Favored 'Trans proline' 0 CA--C 1.506 -0.922 0 C-N-CA 123.925 3.083 . . . . 0.23999999999999999 113.268 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.684 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.2 Cg_exo -65.0 -27.94 57.81 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.836 2.357 . . . . 0.31 112.053 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.503 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 31.6 m -75.56 -22.61 56.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.505 0.669 . . . . 1.1000000000000001 112.371 -176.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.816 ' O ' HD21 ' A' ' 364' ' ' LEU . 26.3 m -100.99 -48.03 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 N-CA-C 112.898 0.703 . . . . 0.080000000000000002 112.898 -170.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.957 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -67.18 -2.03 5.22 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.72 -0.792 . . . . 0.070000000000000007 110.246 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.505 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 14.7 pttp -81.2 -38.78 26.48 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 122.58 1.181 . . . . 0.92000000000000004 108.143 173.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.0 mm-40 -62.18 -46.35 89.32 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 112.368 -2.196 . . . . 0.25 106.559 -177.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.957 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.8 tp -46.69 -67.11 0.31 Allowed 'General case' 0 N--CA 1.403 -2.781 0 CA-C-N 109.785 -3.37 . . . . 0.050000000000000003 112.735 172.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.492 ' CE2' ' HE2' ' A' ' 387' ' ' LYS . 14.6 t80 -45.34 -24.11 0.26 Allowed 'General case' 0 C--N 1.306 -1.318 0 O-C-N 124.034 0.834 . . . . 0.13 109.469 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.452 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.12 -27.15 26.62 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 114.684 -1.144 . . . . 0.13 111.732 -176.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.749 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.03 -44.07 5.83 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 113.459 0.911 . . . . 0.059999999999999998 113.459 176.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.664 ' HB ' HG21 ' A' ' 461' ' ' THR . 0.5 OUTLIER -72.89 149.91 8.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 122.554 1.168 . . . . 0.080000000000000002 111.182 -179.485 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.424 ' H ' ' HG3' ' A' ' 458' ' ' GLU . 0.0 OUTLIER -119.87 156.25 31.08 Favored 'General case' 0 N--CA 1.413 -2.283 0 CA-C-N 112.86 -1.973 . . . . 0.47999999999999998 108.366 -178.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.598 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 4.3 mppt? -58.8 102.07 0.11 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.555 -0.905 . . . . 0.98999999999999999 108.555 170.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 130.62 -11.17 5.75 Favored Glycine 0 C--N 1.305 -1.15 0 CA-C-N 114.069 -1.423 . . . . 0.19 111.535 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.664 HG21 ' HB ' ' A' ' 457' ' ' VAL . 10.8 m -68.82 150.47 97.62 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 108.793 -0.817 . . . . 0.13 108.793 171.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.544 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.0 Cg_endo -93.61 165.02 2.29 Favored 'Trans proline' 0 N--CA 1.423 -2.652 0 C-N-CA 122.17 1.913 . . . . 0.17999999999999999 110.074 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.756 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -126.35 152.12 33.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.497 -1.297 . . . . 0.56999999999999995 107.497 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.765 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.1 mp -133.79 149.95 51.43 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 108.26 -1.015 . . . . 0.13 108.26 175.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.032 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.08 138.96 37.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 103.932 -2.618 . . . . 0.10000000000000001 103.932 163.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.858 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 4.3 p90 . . . . . 0 C--O 1.25 1.116 0 CA-C-N 118.503 0.592 . . . . 1.0900000000000001 111.879 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.773 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.49 -0.644 . . . . 1.8700000000000001 111.49 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.644 ' CE1' HD21 ' A' ' 464' ' ' LEU . 23.4 m80 -133.19 113.12 12.32 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 116.827 0.314 . . . . 0.83999999999999997 111.073 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.417 ' HE1' ' HA ' ' A' ' 461' ' ' THR . 2.3 mtm 47.95 -148.94 0.17 Allowed 'General case' 0 C--O 1.236 0.342 0 O-C-N 124.612 1.195 . . . . 0.67000000000000004 111.222 166.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -68.25 153.63 43.37 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 104.179 -2.526 . . . . 1.8500000000000001 104.179 152.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.475 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 15.2 m-20 -74.05 86.53 1.84 Allowed 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 118.867 -1.133 . . . . 0.42999999999999999 110.26 -169.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 357' ' ' TYR . 98.5 m -157.16 134.58 10.56 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.854 -1.066 . . . . 0.14000000000000001 110.539 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.674 ' HA ' HG23 ' A' ' 461' ' ' THR . 37.9 p90 173.65 159.18 0.14 Allowed 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.831 -0.622 . . . . 0.14999999999999999 110.923 -178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.669 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -77.44 151.23 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.263 0 N-CA-C 109.282 -0.636 . . . . 0.080000000000000002 109.282 166.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.605 ' HG3' ' CE1' ' A' ' 466' ' ' PHE . 34.6 tt0 -149.81 141.09 23.17 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.462 -0.79 . . . . 2.0099999999999998 109.743 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.738 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 2.7 t -133.0 161.89 40.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.054 0.454 . . . . 0.45000000000000001 111.312 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 347' ' ' VAL . 30.3 t0 -140.15 106.86 5.36 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.521 -1.289 . . . . 0.23999999999999999 107.521 173.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.084 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -82.37 -34.41 28.41 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 123.289 1.518 . . . . 0.16 110.156 -169.389 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.46 ' HB2' ' ND2' ' A' ' 351' ' ' ASN . 1.1 mt-10 -54.93 -43.95 73.82 Favored 'General case' 0 CA--C 1.489 -1.389 0 CA-C-N 110.892 -2.867 . . . . 0.59999999999999998 108.015 176.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 18.4 m-80 -103.04 4.74 37.57 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 111.015 -2.811 . . . . 0.20000000000000001 111.48 -175.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.857 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 16.4 mm-40 34.75 61.59 0.57 Allowed 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 112.917 -1.947 . . . . 2.1499999999999999 113.424 -174.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.512 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 22.6 t60 -141.71 134.75 29.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.105 -0.952 . . . . 0.089999999999999997 109.638 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.721 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.3 OUTLIER -112.84 155.8 24.02 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 115.631 -0.713 . . . . 0.070000000000000007 109.957 -179.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.646 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.4 m-90 -140.88 154.36 46.12 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.533 -0.758 . . . . 0.11 111.257 -175.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.708 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 87.3 t80 -109.36 153.55 23.78 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 106.428 -1.694 . . . . 0.26000000000000001 106.428 151.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 11.0 m-85 -126.63 118.76 25.45 Favored 'General case' 0 C--N 1.269 -2.933 0 CA-C-N 115.224 -0.898 . . . . 0.14000000000000001 110.163 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 361' ' ' LYS . 8.8 tppt? -121.88 136.06 54.91 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.366 -1.716 . . . . 0.25 106.366 168.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 361' ' ' LYS . 0.3 OUTLIER 70.73 15.55 6.93 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.141 0.793 . . . . 0.42999999999999999 113.141 175.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.475 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 79.91 5.07 89.66 Favored Glycine 0 CA--C 1.485 -1.801 0 CA-C-O 122.033 0.796 . . . . 0.17999999999999999 112.844 -174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.1 ptmt -125.79 177.37 6.32 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 104.067 -2.568 . . . . 0.37 104.067 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.646 HG11 ' CD1' ' A' ' 355' ' ' TRP . 14.7 m -104.98 157.51 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.822 0 N-CA-C 116.268 1.951 . . . . 0.10000000000000001 116.268 -176.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.708 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -107.09 -27.42 10.62 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 110.493 -3.049 . . . . 0.070000000000000007 106.33 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.81 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -133.59 142.75 48.27 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 111.352 -2.658 . . . . 0.059999999999999998 111.488 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.45 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 3.5 tt0 -139.99 117.63 11.56 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 104.218 -2.512 . . . . 0.47999999999999998 104.218 176.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.721 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.58 162.54 39.98 Favored 'General case' 0 N--CA 1.397 -3.112 0 C-N-CA 117.715 -1.594 . . . . 0.070000000000000007 111.598 -179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 14.9 p-10 -101.54 135.51 42.93 Favored 'General case' 0 C--N 1.275 -2.653 0 CA-C-N 113.972 -1.467 . . . . 1.8 109.41 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.745 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.2 pp -137.28 -174.18 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.522 0 CA-C-O 122.318 1.056 . . . . 0.12 112.508 -169.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.857 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.5 OUTLIER -151.81 121.28 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 CA-C-N 112.725 -2.034 . . . . 0.10000000000000001 109.298 172.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.559 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -81.69 -168.67 1.98 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.768 -1.56 . . . . 1.26 110.318 -178.308 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -84.64 167.4 42.54 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.655 -1.736 . . . . 0.14000000000000001 112.328 -174.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -72.53 156.94 89.77 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 121.511 0.672 . . . . 0.81000000000000005 111.937 -166.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.664 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 92.1 Cg_exo -56.08 -28.9 72.07 Favored 'Trans proline' 0 CA--C 1.496 -1.392 1 C-N-CA 125.371 4.048 . . . . 0.28000000000000003 113.603 -173.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.441 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 18.0 p -70.38 -34.25 72.36 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.329 -1.76 . . . . 0.33000000000000002 109.413 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.544 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.5 t -142.04 69.99 23.41 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 123.645 1.688 . . . . 0.39000000000000001 109.407 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 375' ' ' THR . 79.8 Cg_exo -58.76 155.28 38.5 Favored 'Trans proline' 0 C--N 1.314 -1.279 1 C-N-CA 126.46 4.773 . . . . 0.38 114.608 -171.141 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.559 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.3 OUTLIER -84.42 141.96 39.93 Favored Pre-proline 0 N--CA 1.423 -1.811 0 N-CA-C 108.699 -0.852 . . . . 0.81999999999999995 108.699 173.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.495 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 21.3 Cg_exo -75.92 -43.34 0.33 Allowed 'Trans proline' 0 CA--C 1.51 -0.694 0 C-N-CA 124.785 3.657 . . . . 0.19 112.219 -167.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.773 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.85 136.31 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 123.302 1.525 . . . . 0.13 113.634 -172.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 152.6 -119.34 0.96 Allowed Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 112.129 -2.305 . . . . 0.20000000000000001 109.584 -177.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 381' ' ' VAL . 9.8 p -121.97 115.53 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.275 1.036 . . . . 0.81999999999999995 110.749 176.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.751 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 1.8 m-85 -114.03 -172.68 2.14 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.192 -1.781 . . . . 0.22 106.192 171.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.666 ' HD2' ' CD1' ' A' ' 385' ' ' TRP . 34.1 t80 -146.11 126.85 14.33 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 118.013 -1.475 . . . . 0.65000000000000002 114.54 -171.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.5 p -85.92 92.21 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 123.064 1.412 . . . . 0.16 109.784 170.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . 0.666 ' CD1' ' HD2' ' A' ' 383' ' ' TYR . 75.2 m95 -70.55 -15.06 62.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 113.173 -1.831 . . . . 2.5499999999999998 107.976 176.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.78 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.8 t30 -170.05 132.65 1.1 Allowed 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.198 -0.91 . . . . 0.42999999999999999 111.209 -174.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.676 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -93.71 144.84 25.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.636 -0.711 . . . . 1.1200000000000001 109.268 171.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.775 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 12.8 mm-40 -125.16 157.36 36.61 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 114.381 1.252 . . . . 0.70999999999999996 114.381 -169.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 51.3 mt-10 -136.3 127.12 27.43 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.143 -1.844 . . . . 0.38 108.403 173.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.4 t70 56.48 45.04 23.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 123.3 1.524 . . . . 0.40999999999999998 109.259 -178.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.933 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -79.59 167.24 20.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 112.852 -1.976 . . . . 0.12 109.016 176.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 7.1 m -131.87 119.35 21.07 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 122.164 0.983 . . . . 0.17000000000000001 112.06 172.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.9 mp -82.69 88.55 6.71 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.761 -1.563 . . . . 0.56999999999999995 112.275 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.53 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 48.7 mttt -101.66 178.06 4.74 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 113.657 -1.611 . . . . 0.33000000000000002 113.551 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.95 -161.59 25.52 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 114.403 -1.271 . . . . 0.46000000000000002 111.648 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.6 m -115.37 138.93 50.46 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 120.222 -0.591 . . . . 0.70999999999999996 110.895 170.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.489 ' C ' ' H ' ' A' ' 399' ' ' ASP . 7.3 m-80 -56.75 155.69 7.4 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.283 -0.871 . . . . 0.83999999999999997 109.307 169.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.36 -1.83 1.27 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.215 -0.902 . . . . 2.2799999999999998 110.716 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 397' ' ' ASN . 21.8 t70 -114.51 2.54 14.63 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.722 -1.127 . . . . 2.27 110.71 -177.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 94.19 16.81 42.44 Favored Glycine 0 N--CA 1.426 -1.983 0 C-N-CA 120.064 -1.065 . . . . 0.93999999999999995 112.843 171.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.467 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 10.0 p -110.59 100.1 43.99 Favored Pre-proline 0 C--N 1.302 -1.475 0 CA-C-N 114.658 -0.771 . . . . 0.81000000000000005 109.807 -175.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.5 Cg_endo -58.73 150.61 69.46 Favored 'Trans proline' 0 CA--C 1.503 -1.05 0 C-N-CA 122.727 2.285 . . . . 0.63 112.949 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -153.04 173.18 15.77 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.481 -1.236 . . . . 0.41999999999999998 112.831 -169.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.53 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 0.8 OUTLIER -145.16 147.07 32.08 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 113.726 -1.579 . . . . 0.53000000000000003 109.743 171.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.8 OUTLIER -143.83 97.08 5.44 Favored Pre-proline 0 N--CA 1.429 -1.491 0 N-CA-C 108.444 -0.947 . . . . 0.19 108.444 171.225 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.8 Cg_exo -68.87 110.07 2.28 Favored 'Trans proline' 0 N--CA 1.43 -2.214 0 C-N-CA 122.022 1.815 . . . . 0.19 109.456 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.933 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -109.56 154.1 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.252 0 CA-C-N 112.78 -2.009 . . . . 0.14999999999999999 107.288 -167.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.6 m-80 -86.92 -19.85 28.23 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.969 -0.752 . . . . 0.51000000000000001 108.969 -174.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.775 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 88.7 m-85 -158.65 125.62 4.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.038 -0.983 . . . . 0.27000000000000002 108.89 -170.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.679 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 27.1 t-105 -144.52 137.08 26.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.678 0.751 . . . . 0.089999999999999997 110.907 -167.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.676 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.6 mmt -120.44 93.8 48.46 Favored Pre-proline 0 C--N 1.3 -1.57 0 N-CA-C 107.823 -1.177 . . . . 0.14000000000000001 107.823 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.78 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 33.6 Cg_endo -65.29 84.49 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.568 2.179 . . . . 0.5 112.153 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 411' ' ' MET . 3.9 pt -84.94 177.08 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.461 -0.791 . . . . 0.88 109.052 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.549 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 3.3 t70 -143.74 -171.95 3.63 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.512 -0.875 . . . . 2.4900000000000002 112.584 -165.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.549 ' CE3' ' HB3' ' A' ' 414' ' ' ASP . 29.9 p90 50.97 -4.17 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 127.113 2.165 . . . . 1.9199999999999999 115.359 178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.655 HG21 ' CE1' ' A' ' 382' ' ' PHE . 24.4 p -131.37 -13.8 3.39 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.978 0.418 . . . . 0.94999999999999996 111.979 -177.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.582 ' O ' ' HAH' ' A' ' 130' ' ' 1RG . . . 90.33 -29.06 6.87 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.067 -0.813 . . . . 0.68000000000000005 111.067 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 419' ' ' GLY . 39.9 t -55.46 172.63 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 123.967 0.907 . . . . 0.75 111.509 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.606 ' N ' HG12 ' A' ' 418' ' ' VAL . . . -177.06 122.87 0.86 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 109.694 -1.362 . . . . 0.20000000000000001 109.694 170.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.717 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.0 mp -81.65 141.69 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 120.589 -0.444 . . . . 0.28999999999999998 109.888 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.679 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.8 p80 -159.98 162.47 34.36 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.971 -0.559 . . . . 0.089999999999999997 111.338 -174.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.665 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -84.94 143.47 28.96 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.538 -1.282 . . . . 1.0700000000000001 107.538 171.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 42.3 t -134.64 98.71 4.13 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.702 0.763 . . . . 0.23000000000000001 110.415 -170.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.441 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 20.0 t70 -83.76 -14.21 52.05 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.258 -1.337 . . . . 0.41999999999999998 109.803 -175.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.739 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 9.9 p90 -90.11 -17.97 26.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.711 -1.132 . . . . 0.32000000000000001 111.518 -176.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.486 HE22 HG11 ' A' ' 369' ' ' VAL . 8.2 tm0? -95.26 120.75 63.53 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 122.994 1.378 . . . . 1.74 111.073 -172.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 426' ' ' GLN . 56.8 Cg_endo -66.76 -45.51 4.44 Favored 'Trans proline' 0 C--N 1.326 -0.606 0 C-N-CA 124.957 3.772 . . . . 0.72999999999999998 114.174 -164.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -124.29 162.78 23.02 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.771 0.796 . . . . 2.1600000000000001 111.388 -172.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.525 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.3 OUTLIER -152.89 125.35 8.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.32 -1.733 . . . . 0.33000000000000002 106.32 175.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 167.77 -158.67 31.62 Favored Glycine 0 C--N 1.28 -2.553 0 N-CA-C 109.501 -1.44 . . . . 0.17000000000000001 109.501 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . . . . . . . . . . . -44.81 174.63 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.061 -1.066 . . . . 0.20999999999999999 111.683 168.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.523 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 9.9 p-10 -50.87 102.82 0.05 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 123.274 1.511 . . . . 1.8500000000000001 114.108 -153.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.646 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.2 OUTLIER -95.47 -38.75 10.32 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 112.687 -2.051 . . . . 1.21 109.371 167.219 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.72 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 66.9 p-90 -50.99 -28.85 10.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.413 -0.812 . . . . 0.16 112.872 -170.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.72 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -89.24 -34.07 16.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.621 0.724 . . . . 0.22 111.762 -177.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.0 p -88.45 -43.47 11.43 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.539 -1.209 . . . . 0.25 110.905 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.646 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 6.4 mtp85 -93.84 -19.63 20.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.781 -1.099 . . . . 1.8200000000000001 109.582 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.19 47.07 50.73 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.141 -0.936 . . . . 0.23999999999999999 114.63 166.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 36.8 m -84.68 110.84 19.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 118.761 1.281 . . . . 1.01 111.5 -171.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.528 ' HB3' HNAJ ' A' ' 130' ' ' 1RG . 52.4 m-70 39.42 -132.24 0.22 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.551 -1.204 . . . . 0.5 113.579 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -121.78 -20.98 3.03 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.924 -0.655 . . . . 0.26000000000000001 113.665 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.778 ' HB3' HASB ' A' ' 130' ' ' 1RG . 30.4 p -101.84 -166.08 1.26 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.175 0.806 . . . . 0.34999999999999998 113.175 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.485 HD13 HG11 ' A' ' 465' ' ' VAL . 2.0 mp -93.18 130.64 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.994 -1.003 . . . . 0.12 110.412 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.11 89.91 3.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.539 0.685 . . . . 0.62 109.835 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.745 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.0 m -84.01 141.78 40.96 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.731 -1.122 . . . . 0.10000000000000001 112.423 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.642 ' HD2' HG21 ' A' ' 366' ' ' THR . 82.1 Cg_exo -48.85 144.49 15.01 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 123.935 3.09 . . . . 0.23999999999999999 113.117 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.665 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.8 Cg_exo -65.31 -22.3 60.41 Favored 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 122.68 2.253 . . . . 0.31 112.123 -175.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.529 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 79.7 p -82.25 -24.2 34.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.62 0.724 . . . . 1.1000000000000001 112.026 -174.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.81 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.8 m -99.46 -48.44 11.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 113.011 0.745 . . . . 0.080000000000000002 113.011 -169.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.96 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.32 -1.97 3.95 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.669 -0.812 . . . . 0.070000000000000007 110.385 -178.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.577 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 42.2 pttt -81.33 -38.74 26.22 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 122.456 1.122 . . . . 0.92000000000000004 108.11 173.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 3.8 mm-40 -61.7 -46.4 89.86 Favored 'General case' 0 CA--C 1.471 -2.096 0 CA-C-N 112.48 -2.146 . . . . 0.25 106.423 -177.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.96 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -47.19 -66.55 0.39 Allowed 'General case' 0 N--CA 1.403 -2.775 0 CA-C-N 109.72 -3.4 . . . . 0.050000000000000003 112.745 172.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 17.0 t80 -45.89 -23.35 0.27 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.728 0.775 . . . . 0.13 109.458 176.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.453 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -89.47 -26.94 23.97 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 114.888 -1.051 . . . . 0.13 111.893 -176.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.774 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -101.78 -44.21 5.6 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 113.359 0.874 . . . . 0.059999999999999998 113.359 177.163 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.669 HG11 HD11 ' A' ' 345' ' ' ILE . 0.4 OUTLIER -73.81 149.22 8.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 122.582 1.182 . . . . 0.080000000000000002 110.995 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.6 157.69 34.86 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 112.905 -1.952 . . . . 0.47999999999999998 108.177 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.552 ' CG ' ' HA ' ' A' ' 386' ' ' ASN . 37.5 mtpt -55.38 101.47 0.05 Allowed 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 109.034 -0.728 . . . . 0.98999999999999999 109.034 169.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . 0.422 ' HA2' ' OH ' ' A' ' 383' ' ' TYR . . . 133.08 -14.27 4.9 Favored Glycine 0 C--N 1.302 -1.335 0 CA-C-N 114.222 -1.354 . . . . 0.19 112.124 -175.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.674 HG23 ' HA ' ' A' ' 344' ' ' TYR . 35.6 m -70.36 148.2 95.44 Favored Pre-proline 0 N--CA 1.431 -1.382 0 N-CA-C 108.498 -0.927 . . . . 0.13 108.498 168.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 344' ' ' TYR . 11.8 Cg_endo -97.14 177.21 0.54 Allowed 'Trans proline' 0 N--CA 1.419 -2.873 0 C-N-CA 122.832 2.355 . . . . 0.17999999999999999 110.299 175.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.751 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 2.9 m -134.42 154.25 36.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 119.916 -0.714 . . . . 0.56999999999999995 109.278 172.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.737 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.4 mp -135.09 152.31 51.54 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 116.028 -0.533 . . . . 0.13 109.915 173.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.084 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.25 142.02 32.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 105.454 -2.054 . . . . 0.10000000000000001 105.454 163.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.762 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 9.0 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 117.444 -1.265 . . . . 1.0900000000000001 111.341 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.778 HASB ' HB3' ' A' ' 442' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.931 -0.468 . . . . 1.8700000000000001 111.931 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.574 ' CE1' HD21 ' A' ' 464' ' ' LEU . 2.7 p-80 -134.54 101.45 4.97 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 112.198 0.444 . . . . 0.83999999999999997 112.198 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.549 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.6 OUTLIER 61.25 -164.06 0.25 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.938 -1.028 . . . . 0.67000000000000004 113.436 165.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.87 173.4 5.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.556 -1.276 . . . . 1.8500000000000001 107.556 164.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.481 ' HB3' ' CA ' ' A' ' 360' ' ' GLY . 11.5 m-20 -81.05 83.45 6.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 119.224 -0.991 . . . . 0.42999999999999999 110.285 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 357' ' ' TYR . 75.8 m -158.03 135.97 10.69 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.856 -1.066 . . . . 0.14000000000000001 108.995 167.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.8 ' CD2' HD13 ' A' ' 464' ' ' LEU . 43.8 p90 174.11 159.0 0.15 Allowed 'General case' 0 C--O 1.212 -0.912 0 O-C-N 123.35 0.406 . . . . 0.14999999999999999 111.173 -175.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.677 HD11 HG11 ' A' ' 457' ' ' VAL . 0.3 OUTLIER -78.25 154.98 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 N-CA-C 109.711 -0.478 . . . . 0.080000000000000002 109.711 165.101 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.599 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -146.92 148.64 32.0 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 114.873 -1.058 . . . . 2.0099999999999998 108.206 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.723 HG22 ' HG3' ' A' ' 354' ' ' MET . 5.6 t -145.02 110.33 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.35 0 N-CA-C 113.872 1.064 . . . . 0.45000000000000001 113.872 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.503 ' HB2' ' CZ3' ' A' ' 355' ' ' TRP . 27.7 t0 -92.56 106.71 18.64 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-O 121.946 0.879 . . . . 0.23999999999999999 109.058 176.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.027 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -77.44 -37.3 51.89 Favored 'General case' 0 CA--C 1.479 -1.772 0 CA-C-N 114.01 -1.45 . . . . 0.16 110.251 -169.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.542 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 3.5 mt-10 -55.04 -44.43 74.67 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 110.766 -2.925 . . . . 0.59999999999999998 108.062 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . 0.472 ' ND2' ' HB2' ' A' ' 350' ' ' GLU . 21.2 m-80 -102.32 7.21 40.66 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 110.694 -2.957 . . . . 0.20000000000000001 111.051 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.633 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.9 OUTLIER 34.09 61.76 0.49 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 112.852 -1.976 . . . . 2.1499999999999999 112.833 -175.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.57 ' NE2' ' HG2' ' A' ' 365' ' ' GLU . 23.5 t60 -143.22 132.18 22.88 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.568 -0.742 . . . . 0.089999999999999997 109.892 -178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.801 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.0 OUTLIER -109.38 152.6 25.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.693 -0.685 . . . . 0.070000000000000007 109.793 -179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.705 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.1 m-90 -139.05 157.72 45.48 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.442 -0.799 . . . . 0.11 110.725 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.709 ' HB2' ' CD1' ' A' ' 453' ' ' LEU . 87.5 t80 -109.66 153.81 23.72 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 106.488 -1.671 . . . . 0.26000000000000001 106.488 151.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 10.4 m-85 -127.38 118.42 24.08 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 115.073 -0.967 . . . . 0.14000000000000001 109.969 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 358' ' ' LYS . 9.8 tppt? -121.81 125.23 46.03 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.863 -1.162 . . . . 0.25 107.863 171.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.83 35.87 2.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 119.092 0.86 . . . . 0.42999999999999999 112.243 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . 0.481 ' CA ' ' HB3' ' A' ' 342' ' ' ASP . . . 62.89 13.29 46.73 Favored Glycine 0 CA--C 1.495 -1.191 0 C-N-CA 120.322 -0.942 . . . . 0.17999999999999999 113.495 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 358' ' ' LYS . 18.8 ptmt -137.25 172.47 12.95 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 104.422 -2.436 . . . . 0.37 104.422 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.705 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.6 m -101.02 158.18 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.741 0 N-CA-C 116.48 2.03 . . . . 0.10000000000000001 116.48 -172.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.696 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -109.35 -26.55 9.97 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 110.523 -3.035 . . . . 0.070000000000000007 106.933 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.806 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.3 tp -133.72 145.58 49.99 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 111.766 -2.47 . . . . 0.059999999999999998 111.842 -175.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.57 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 5.0 tt0 -140.26 118.35 11.92 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 104.569 -2.382 . . . . 0.47999999999999998 104.569 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.801 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -150.05 162.0 41.25 Favored 'General case' 0 N--CA 1.402 -2.838 0 C-N-CA 117.767 -1.573 . . . . 0.070000000000000007 112.059 177.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.632 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 17.0 p-10 -101.12 135.8 42.0 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 114.263 -1.335 . . . . 1.8 109.27 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.926 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.6 pp -141.63 -171.84 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.305 0 CA-C-O 122.443 1.116 . . . . 0.12 112.835 -169.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.614 HG11 HE22 ' A' ' 426' ' ' GLN . 0.5 OUTLIER -152.47 120.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 CA-C-N 112.959 -1.928 . . . . 0.10000000000000001 108.982 174.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.532 ' OG ' HG21 ' A' ' 377' ' ' THR . 0.1 OUTLIER -76.23 -167.67 0.81 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 113.643 -1.617 . . . . 1.26 110.953 177.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.489 ' HA3' ' HA2' ' A' ' 441' ' ' GLY . . . -85.85 175.92 48.93 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 119.118 -1.515 . . . . 0.14000000000000001 112.341 -174.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -78.91 156.69 77.05 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.508 0.671 . . . . 0.81000000000000005 112.035 -165.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.69 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 80.7 Cg_exo -57.79 -29.9 87.47 Favored 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 125.182 3.921 . . . . 0.28000000000000003 113.617 -173.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.461 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 27.0 p -70.86 -32.97 70.15 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 113.592 -1.64 . . . . 0.33000000000000002 109.661 -175.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.547 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.1 t -140.82 70.87 29.96 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 123.614 1.673 . . . . 0.39000000000000001 109.406 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 375' ' ' THR . 71.5 Cg_exo -59.53 154.35 48.7 Favored 'Trans proline' 0 C--N 1.313 -1.292 1 C-N-CA 126.421 4.748 . . . . 0.38 114.449 -172.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.532 HG21 ' OG ' ' A' ' 370' ' ' SER . 0.5 OUTLIER -83.86 148.14 53.41 Favored Pre-proline 0 N--CA 1.419 -1.979 0 N-CA-C 108.002 -1.11 . . . . 0.81999999999999995 108.002 173.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.596 ' HG2' ' HB ' ' A' ' 416' ' ' THR . 15.4 Cg_exo -79.53 -41.26 0.21 Allowed 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 124.592 3.528 . . . . 0.19 112.724 -165.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.773 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 59.41 134.24 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 123.549 1.642 . . . . 0.13 113.75 -172.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 148.02 -125.83 2.19 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 111.95 -2.386 . . . . 0.20000000000000001 109.728 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.6 p -116.35 112.32 38.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 122.122 0.963 . . . . 0.81999999999999995 111.497 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.769 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 1.9 m-85 -112.63 -173.38 2.24 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 106.493 -1.669 . . . . 0.22 106.493 172.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.57 ' OH ' ' HA2' ' A' ' 460' ' ' GLY . 38.9 t80 -144.68 125.97 14.77 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.306 -1.358 . . . . 0.65000000000000002 113.657 -169.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 411' ' ' MET . 1.4 p -86.47 94.21 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-O 122.683 1.23 . . . . 0.16 109.56 169.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . 0.544 ' CD1' ' HD2' ' A' ' 383' ' ' TYR . 75.7 m95 -69.16 -17.17 63.79 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.412 -1.722 . . . . 2.5499999999999998 108.185 177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.733 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 8.6 t30 -169.45 135.07 1.54 Allowed 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.375 -0.829 . . . . 0.42999999999999999 111.145 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.662 ' HA ' ' SD ' ' A' ' 411' ' ' MET . 0.0 OUTLIER -91.95 129.57 37.88 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.186 -1.042 . . . . 1.1200000000000001 108.186 171.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.668 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 0.5 OUTLIER -110.59 158.59 18.4 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.183 -0.917 . . . . 0.70999999999999996 111.935 -171.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 40.3 mt-10 -134.57 133.36 40.16 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.163 -1.38 . . . . 0.38 108.833 173.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 18.6 t70 53.94 46.58 25.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 123.766 1.746 . . . . 0.40999999999999998 108.71 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.899 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -83.99 165.3 18.73 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 112.183 -2.28 . . . . 0.12 108.79 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 24.3 m -132.66 120.12 21.32 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.153 0.978 . . . . 0.17000000000000001 111.045 170.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.545 HD13 ' HB ' ' A' ' 407' ' ' VAL . 2.7 mp -78.14 88.48 4.24 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.512 -1.676 . . . . 0.56999999999999995 111.413 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.531 ' HG2' ' CG ' ' A' ' 404' ' ' GLU . 48.5 mttt -104.06 178.4 4.57 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 113.791 -1.55 . . . . 0.33000000000000002 113.701 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . . . . . . . . . . . 137.81 -158.98 24.86 Favored Glycine 0 N--CA 1.428 -1.855 0 CA-C-N 113.959 -1.473 . . . . 0.46000000000000002 111.358 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 2.8 m -119.87 141.31 49.69 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 120.431 -0.507 . . . . 0.70999999999999996 110.856 171.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 399' ' ' ASP . 4.4 m-80 -58.15 154.77 12.36 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.859 -1.064 . . . . 0.83999999999999997 109.416 168.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . 0.442 ' O ' ' HBC' ' A' ' 130' ' ' 1RG . 2.1 t70 -58.12 -8.43 1.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.705 -1.134 . . . . 2.2799999999999998 111.254 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 397' ' ' ASN . 8.9 m-20 -101.07 -17.61 16.62 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 114.062 -1.427 . . . . 2.27 110.105 -176.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.02 33.62 5.7 Favored Glycine 0 N--CA 1.42 -2.388 0 C-N-CA 118.929 -1.605 . . . . 0.93999999999999995 111.793 -176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . . . . . . . . . 8.0 p -123.43 98.9 40.38 Favored Pre-proline 0 C--N 1.307 -1.265 0 CA-C-N 114.543 -0.828 . . . . 0.81000000000000005 109.183 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 25.0 Cg_endo -60.23 151.61 72.27 Favored 'Trans proline' 0 CA--C 1.503 -1.03 0 C-N-CA 122.833 2.356 . . . . 0.63 113.216 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -151.87 171.87 17.08 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.36 -1.291 . . . . 0.41999999999999998 112.384 -169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.531 ' CG ' ' HG2' ' A' ' 394' ' ' LYS . 1.8 mp0 -146.84 146.46 30.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 113.949 -1.478 . . . . 0.53000000000000003 110.127 173.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -144.29 97.49 5.18 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 108.015 -1.105 . . . . 0.19 108.015 170.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.1 Cg_exo -69.32 110.05 2.37 Favored 'Trans proline' 0 N--CA 1.436 -1.881 0 C-N-CA 122.008 1.805 . . . . 0.19 110.316 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.899 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -108.35 155.39 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 CA-C-N 112.998 -1.91 . . . . 0.14999999999999999 107.396 -168.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 20.0 m-80 -88.49 -21.57 24.11 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.657 -0.868 . . . . 0.51000000000000001 108.657 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.664 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.1 m-85 -157.31 126.11 5.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.625 -1.17 . . . . 0.27000000000000002 108.674 -169.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.668 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 14.6 t-105 -142.3 141.41 32.41 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.623 -0.717 . . . . 0.089999999999999997 110.281 -167.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.662 ' SD ' ' HA ' ' A' ' 387' ' ' LYS . 10.5 mmt -126.67 96.75 34.74 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.405 -1.332 . . . . 0.14000000000000001 107.405 174.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.733 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 48.2 Cg_endo -67.87 78.13 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.52 2.147 . . . . 0.5 112.825 -175.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 418' ' ' VAL . 1.4 pt -79.35 173.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 107.691 -1.226 . . . . 0.88 107.691 173.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.609 ' HB3' ' CE3' ' A' ' 415' ' ' TRP . 21.6 t70 -154.07 179.65 8.73 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.152 -1.019 . . . . 2.4900000000000002 112.326 -164.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . 0.609 ' CE3' ' HB3' ' A' ' 414' ' ' ASP . 33.4 p90 59.03 2.39 0.26 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.176 1.791 . . . . 1.9199999999999999 114.575 169.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.608 HG23 ' CD1' ' A' ' 415' ' ' TRP . 3.3 p -130.71 -30.69 1.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.024 0.749 . . . . 0.94999999999999996 113.024 -170.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 106.0 -4.08 38.66 Favored Glycine 0 CA--C 1.5 -0.9 0 N-CA-C 110.418 -1.073 . . . . 0.68000000000000005 110.418 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.707 HG11 ' CE2' ' A' ' 382' ' ' PHE . 2.2 p -95.54 164.32 2.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 113.327 -1.436 . . . . 0.75 111.249 174.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -168.05 128.61 1.74 Allowed Glycine 0 C--O 1.219 -0.827 0 N-CA-C 110.882 -0.887 . . . . 0.20000000000000001 110.882 165.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.626 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.6 mp -84.6 140.0 16.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 122.151 -0.617 . . . . 0.28999999999999998 111.213 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.649 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.0 p80 -161.83 162.86 29.57 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.684 -0.689 . . . . 0.089999999999999997 110.303 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.747 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -81.94 150.88 27.48 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 107.675 -1.232 . . . . 1.0700000000000001 107.675 170.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 445' ' ' THR . 48.0 t -134.12 96.08 3.55 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.981 0.896 . . . . 0.23000000000000001 109.647 -172.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.42 -19.54 49.74 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.784 -1.553 . . . . 0.41999999999999998 109.77 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.755 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 17.6 p90 -87.18 -23.43 24.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.361 -1.29 . . . . 0.32000000000000001 111.609 -175.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.614 HE22 HG11 ' A' ' 369' ' ' VAL . 2.1 tt0 -97.29 118.2 64.78 Favored Pre-proline 0 CA--C 1.508 -0.635 0 CA-C-O 122.816 1.294 . . . . 1.74 110.492 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.638 ' HD2' ' OE2' ' A' ' 428' ' ' GLU . 38.4 Cg_endo -88.65 -11.31 4.07 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 124.365 3.376 . . . . 0.72999999999999998 113.698 -175.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.638 ' OE2' ' HD2' ' A' ' 427' ' ' PRO . 1.1 pm0 -110.85 150.98 28.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.289 1.042 . . . . 2.1600000000000001 112.71 173.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.637 ' OH ' ' HD3' ' A' ' 447' ' ' PRO . 0.4 OUTLIER -157.8 129.54 6.89 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 112.681 -2.054 . . . . 0.33000000000000002 105.513 168.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 168.13 -157.48 29.74 Favored Glycine 0 C--N 1.288 -2.088 0 C-N-CA 119.715 -1.231 . . . . 0.17000000000000001 111.544 -177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.535 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -41.65 170.49 0.01 OUTLIER Glycine 0 CA--C 1.487 -1.671 0 C-N-CA 120.787 -0.72 . . . . 0.20999999999999999 111.919 167.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.548 ' HB3' ' CD ' ' A' ' 435' ' ' LYS . 2.4 m-20 -52.75 100.89 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.891 0 CA-C-O 122.492 1.139 . . . . 1.8500000000000001 112.957 -155.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 1.009 HD22 ' HD2' ' A' ' 437' ' ' ARG . 36.8 mt -97.16 -35.73 10.69 Favored 'General case' 0 C--O 1.208 -1.122 0 CA-C-N 113.006 -1.906 . . . . 1.21 109.696 172.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.731 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -52.7 -26.3 13.53 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.111 -0.95 . . . . 0.16 112.1 -173.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.731 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.68 -33.99 15.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.747 -0.661 . . . . 0.22 112.69 -178.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 437' ' ' ARG . 1.7 p -90.01 -37.88 14.0 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.861 0.839 . . . . 0.25 110.76 -176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 1.009 ' HD2' HD22 ' A' ' 433' ' ' LEU . 3.8 mtp85 -97.65 -18.4 18.92 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.707 -1.133 . . . . 1.8200000000000001 110.011 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 51.74 48.81 49.54 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.156 -0.929 . . . . 0.23999999999999999 115.233 162.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . 0.47 ' O ' ' HA2' ' A' ' 371' ' ' GLY . 9.3 p -84.8 110.32 18.72 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 118.93 1.365 . . . . 1.01 112.192 -173.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.424 ' HB3' ' OAC' ' A' ' 130' ' ' 1RG . 63.2 m-70 35.67 -133.21 0.06 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.482 -1.235 . . . . 0.5 113.049 177.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.489 ' HA2' ' HA3' ' A' ' 371' ' ' GLY . . . -119.22 -6.26 10.95 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.204 -0.759 . . . . 0.26000000000000001 111.204 172.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 419' ' ' GLY . 0.8 OUTLIER -92.4 162.51 14.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.527 0.936 . . . . 0.34999999999999998 113.527 -176.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.532 HG12 HG11 ' A' ' 347' ' ' VAL . 1.9 mp -87.43 128.97 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.515 0 CA-C-N 113.764 -1.562 . . . . 0.12 110.141 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.45 88.42 4.12 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.655 -0.702 . . . . 0.62 110.081 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.926 ' HA ' HG22 ' A' ' 368' ' ' ILE . 4.9 m -83.91 142.64 42.09 Favored Pre-proline 0 N--CA 1.431 -1.377 0 CA-C-N 115.029 -0.987 . . . . 0.10000000000000001 112.412 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.7 ' HD2' HG21 ' A' ' 366' ' ' THR . 76.7 Cg_exo -50.42 145.1 22.52 Favored 'Trans proline' 0 CA--C 1.509 -0.733 0 C-N-CA 123.803 3.002 . . . . 0.23999999999999999 113.455 175.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.747 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.2 Cg_exo -65.45 -24.71 56.51 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.864 2.376 . . . . 0.31 112.328 -176.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.515 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 35.7 p -77.58 -24.99 49.61 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.229 -0.896 . . . . 1.1000000000000001 112.09 -175.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.806 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.9 m -100.02 -48.51 11.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.714 -0.675 . . . . 0.080000000000000002 112.557 -171.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.955 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.7 -2.51 5.02 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.635 -0.826 . . . . 0.070000000000000007 110.375 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.526 ' HA ' ' CD1' ' A' ' 409' ' ' TYR . 15.8 pttp -80.71 -38.82 28.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.441 1.115 . . . . 0.92000000000000004 108.358 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 449' ' ' VAL . 4.7 mm-40 -62.66 -46.57 87.59 Favored 'General case' 0 CA--C 1.473 -2.016 0 CA-C-N 112.482 -2.145 . . . . 0.25 106.883 -177.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.955 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.09 -66.37 0.41 Allowed 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 109.847 -3.342 . . . . 0.050000000000000003 112.536 171.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 21.1 t80 -44.72 -25.62 0.3 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 124.215 0.947 . . . . 0.13 109.609 175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.447 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -86.87 -29.49 23.28 Favored Glycine 0 N--CA 1.438 -1.224 0 CA-C-N 114.599 -1.182 . . . . 0.13 111.555 -176.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.749 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -99.43 -44.86 6.03 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 113.533 0.938 . . . . 0.059999999999999998 113.533 177.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -72.65 148.56 9.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 122.487 1.137 . . . . 0.080000000000000002 111.106 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' A' ' 458' ' ' GLU . 0.0 OUTLIER -119.91 158.11 27.35 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 112.88 -1.964 . . . . 0.47999999999999998 108.648 -178.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.628 ' HG3' ' HA ' ' A' ' 386' ' ' ASN . 3.3 mppt? -57.82 101.51 0.08 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 108.575 -0.898 . . . . 0.98999999999999999 108.575 168.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . 0.57 ' HA2' ' OH ' ' A' ' 383' ' ' TYR . . . 134.66 -18.36 4.1 Favored Glycine 0 C--N 1.304 -1.246 0 CA-C-N 114.233 -1.349 . . . . 0.19 111.902 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 344' ' ' TYR . 23.1 m -66.57 149.29 98.26 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 108.756 -0.831 . . . . 0.13 108.756 171.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.549 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 9.8 Cg_endo -95.75 176.29 0.84 Allowed 'Trans proline' 0 N--CA 1.416 -3.052 0 C-N-CA 122.257 1.972 . . . . 0.17999999999999999 109.937 175.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.769 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.1 m -132.8 154.7 40.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.131 -1.063 . . . . 0.56999999999999995 108.131 171.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.0 mp -134.26 152.12 51.65 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 108.775 -0.824 . . . . 0.13 108.775 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.027 HG23 HD21 ' A' ' 349' ' ' LEU . 0.9 OUTLIER -137.73 144.46 31.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 106.047 -1.835 . . . . 0.10000000000000001 106.047 159.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.542 ' OXT' ' HG3' ' A' ' 350' ' ' GLU . 3.2 p90 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 123.857 0.863 . . . . 1.0900000000000001 110.84 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.74 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 112.906 -0.077 . . . . 1.8700000000000001 112.906 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.636 ' CE1' HD21 ' A' ' 464' ' ' LEU . 1.2 p-80 -148.89 100.35 3.07 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 122.579 -0.365 . . . . 0.83999999999999997 111.117 174.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.574 ' CE ' ' HD3' ' A' ' 462' ' ' PRO . 0.1 OUTLIER 62.91 -166.15 0.23 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.203 0.939 . . . . 0.67000000000000004 112.686 167.474 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.1 173.04 2.61 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.9 -1.148 . . . . 1.8500000000000001 107.9 165.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -81.92 82.5 7.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 119.025 -1.07 . . . . 0.42999999999999999 109.532 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 357' ' ' TYR . 53.6 m -159.35 138.08 10.87 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.29 -0.868 . . . . 0.14000000000000001 108.743 167.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.762 ' CD2' HD13 ' A' ' 464' ' ' LEU . 41.2 p90 174.32 158.87 0.16 Allowed 'General case' 0 C--O 1.21 -1.011 0 O-C-N 123.317 0.385 . . . . 0.14999999999999999 111.149 -176.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.618 HD12 HD11 ' A' ' 453' ' ' LEU . 0.5 OUTLIER -77.26 154.7 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 N-CA-C 109.216 -0.661 . . . . 0.080000000000000002 109.216 164.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -148.53 146.96 28.55 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.8 -1.185 . . . . 2.0099999999999998 107.8 -178.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.736 ' HB ' ' HB ' ' A' ' 465' ' ' VAL . 3.1 t -139.76 155.62 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 C-N-CA 123.6 0.76 . . . . 0.45000000000000001 110.375 173.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.526 ' N ' HG12 ' A' ' 347' ' ' VAL . 37.7 t0 -138.13 105.55 5.53 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 106.539 -1.652 . . . . 0.23999999999999999 106.539 176.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 1.026 HD21 HG23 ' A' ' 465' ' ' VAL . 0.3 OUTLIER -80.13 -35.97 35.91 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-N 114.023 -1.444 . . . . 0.16 109.959 -165.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.402 ' HG3' ' OXT' ' A' ' 466' ' ' PHE . 0.7 OUTLIER -56.38 -44.96 80.72 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 110.678 -2.965 . . . . 0.59999999999999998 107.942 176.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -99.37 5.03 46.53 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 111.163 -2.744 . . . . 0.20000000000000001 111.1 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 0.6 OUTLIER 34.29 61.7 0.52 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 112.942 -1.935 . . . . 2.1499999999999999 113.137 -173.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.501 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 24.5 t60 -142.4 136.91 30.02 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.907 -0.588 . . . . 0.089999999999999997 109.741 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.748 ' HB3' HG22 ' A' ' 366' ' ' THR . 0.2 OUTLIER -113.83 158.16 21.39 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 120.947 0.403 . . . . 0.070000000000000007 110.234 179.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.641 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.5 m-90 -143.13 164.08 31.12 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.485 0.66 . . . . 0.11 111.126 -178.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.703 ' HD2' ' HB3' ' A' ' 363' ' ' ALA . 86.3 t80 -116.01 154.27 30.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.535 -1.654 . . . . 0.26000000000000001 106.535 150.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 362' ' ' VAL . 13.4 m-85 -127.13 119.2 25.94 Favored 'General case' 0 C--N 1.269 -2.9 0 CA-C-N 115.094 -0.957 . . . . 0.14000000000000001 110.007 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 361' ' ' LYS . 9.9 tppt? -123.3 116.65 23.68 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.377 -0.971 . . . . 0.25 108.377 173.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.85 37.69 0.49 Allowed 'General case' 0 C--N 1.308 -1.207 0 O-C-N 123.474 0.484 . . . . 0.42999999999999999 112.297 -176.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 62.94 12.46 42.97 Favored Glycine 0 CA--C 1.496 -1.105 0 C-N-CA 120.2 -1.0 . . . . 0.17999999999999999 113.314 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 358' ' ' LYS . 18.5 ptmt -137.63 169.75 17.25 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 104.586 -2.376 . . . . 0.37 104.586 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.641 HG11 ' CD1' ' A' ' 355' ' ' TRP . 17.6 m -99.57 157.74 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.619 0 N-CA-C 116.692 2.108 . . . . 0.10000000000000001 116.692 -170.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.703 ' HB3' ' HD2' ' A' ' 356' ' ' TYR . . . -110.18 -25.88 9.94 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-N 110.375 -3.102 . . . . 0.070000000000000007 106.673 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 449' ' ' VAL . 1.2 tp -135.64 146.6 48.03 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 111.694 -2.503 . . . . 0.059999999999999998 111.682 -176.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.496 ' HG2' ' NE2' ' A' ' 353' ' ' HIS . 4.2 tt0 -143.7 117.92 9.56 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 104.719 -2.326 . . . . 0.47999999999999998 104.719 175.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.748 HG22 ' HB3' ' A' ' 354' ' ' MET . 0.5 OUTLIER -149.59 165.25 32.82 Favored 'General case' 0 N--CA 1.4 -2.953 0 C-N-CA 118.121 -1.432 . . . . 0.070000000000000007 111.558 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.655 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 13.1 p-10 -103.66 132.44 49.91 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 114.71 -1.132 . . . . 1.8 109.828 -178.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 445' ' ' THR . 2.0 pp -131.48 -173.5 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 CA-C-O 122.48 1.133 . . . . 0.12 112.415 -172.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 433' ' ' LEU . 0.5 OUTLIER -151.41 120.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 112.805 -1.998 . . . . 0.10000000000000001 108.312 172.202 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.542 ' HB3' HD12 ' A' ' 349' ' ' LEU . 30.2 p -76.87 -169.21 1.23 Allowed 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 112.376 -2.193 . . . . 1.26 111.615 -177.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -85.04 166.65 40.93 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 118.718 -1.706 . . . . 0.14000000000000001 111.864 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -73.84 156.99 87.83 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 121.383 0.611 . . . . 0.81000000000000005 111.758 -167.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.645 ' HD3' ' HA ' ' A' ' 435' ' ' LYS . 81.4 Cg_exo -54.23 -28.79 53.88 Favored 'Trans proline' 0 CA--C 1.498 -1.277 0 C-N-CA 125.269 3.98 . . . . 0.28000000000000003 113.439 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.481 ' OG1' HG22 ' A' ' 375' ' ' THR . 16.8 p -69.55 -34.04 73.64 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.295 -1.775 . . . . 0.33000000000000002 109.829 -176.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.536 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 1.4 t -141.61 70.81 25.69 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 123.715 1.721 . . . . 0.39000000000000001 109.128 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 375' ' ' THR . 85.9 Cg_exo -57.41 160.09 14.61 Favored 'Trans proline' 0 C--N 1.31 -1.462 1 C-N-CA 126.453 4.769 . . . . 0.38 115.254 -170.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.511 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 2.3 m -86.08 126.56 64.92 Favored Pre-proline 0 N--CA 1.402 -2.837 0 CA-C-N 114.142 -1.39 . . . . 0.81999999999999995 108.616 173.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 377' ' ' THR . 29.0 Cg_exo -69.29 -44.66 2.25 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.776 2.984 . . . . 0.19 112.21 -168.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.764 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 61.21 137.98 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 123.579 1.657 . . . . 0.13 113.912 -175.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 465' ' ' VAL . . . 153.36 -111.69 0.5 Allowed Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 111.75 -2.477 . . . . 0.20000000000000001 108.871 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 2.5 p -131.67 125.89 56.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 121.206 0.527 . . . . 0.81999999999999995 109.759 173.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.72 ' HB2' ' CG2' ' A' ' 463' ' ' VAL . 8.1 m-85 -118.16 -176.14 3.0 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 106.608 -1.627 . . . . 0.22 106.608 168.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.712 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 2.0 t80 -137.76 120.29 16.06 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 120.698 -1.251 . . . . 0.65000000000000002 112.291 -172.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 386' ' ' ASN . 2.1 p -86.01 91.35 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 CA-C-O 123.178 1.466 . . . . 0.16 108.926 171.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -93.66 11.79 27.72 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 113.043 -1.889 . . . . 2.5499999999999998 108.013 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.747 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 7.0 t30 -167.95 126.21 1.2 Allowed 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 113.588 -1.642 . . . . 0.42999999999999999 110.148 172.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.651 ' HD3' ' H ' ' A' ' 387' ' ' LYS . 0.0 OUTLIER -101.64 143.25 31.84 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.201 -0.909 . . . . 1.1200000000000001 109.129 169.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.726 ' O ' ' HA ' ' A' ' 409' ' ' TYR . 30.0 mm-40 -126.11 159.67 32.23 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 115.019 1.489 . . . . 0.70999999999999996 115.019 -167.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 46.1 mt-10 -139.11 127.29 22.58 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 112.755 -2.02 . . . . 0.38 108.689 174.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.7 t70 56.19 45.67 22.84 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 123.498 1.618 . . . . 0.40999999999999998 109.053 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.925 ' HB3' HG12 ' A' ' 407' ' ' VAL . . . -81.26 166.3 20.67 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 112.517 -2.129 . . . . 0.12 108.803 177.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 406' ' ' PRO . 20.6 m -132.75 119.24 20.06 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 122.252 1.025 . . . . 0.17000000000000001 111.577 170.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 3.1 mp -78.7 88.02 4.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.699 -1.591 . . . . 0.56999999999999995 111.873 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.543 ' HE2' ' HG2' ' A' ' 404' ' ' GLU . 46.7 mttt -102.81 179.67 4.21 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.572 -1.649 . . . . 0.33000000000000002 113.032 177.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 137.54 -157.73 24.19 Favored Glycine 0 N--CA 1.428 -1.893 0 C-N-CA 119.422 -1.371 . . . . 0.46000000000000002 111.555 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.624 ' HA ' ' HA ' ' A' ' 402' ' ' PRO . 1.4 m -120.77 137.0 54.74 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 120.344 -0.542 . . . . 0.70999999999999996 110.474 172.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 399' ' ' ASP . 5.2 m-80 -54.13 150.4 8.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.325 -0.852 . . . . 0.83999999999999997 108.845 168.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.89 -2.07 0.07 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.595 -0.73 . . . . 2.2799999999999998 112.171 175.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 397' ' ' ASN . 8.2 t70 -115.71 1.92 13.58 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.579 0.704 . . . . 2.27 110.483 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.66 19.36 27.47 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.923 -1.035 . . . . 0.93999999999999995 113.039 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.486 ' HA ' ' HD2' ' A' ' 402' ' ' PRO . 11.5 p -113.8 99.83 50.92 Favored Pre-proline 0 C--N 1.303 -1.451 0 CA-C-O 121.538 0.685 . . . . 0.81000000000000005 109.938 -175.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 396' ' ' THR . 18.1 Cg_endo -59.34 149.23 82.46 Favored 'Trans proline' 0 CA--C 1.505 -0.955 0 C-N-CA 122.794 2.33 . . . . 0.63 113.135 -177.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -150.99 174.08 13.56 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.137 -1.392 . . . . 0.41999999999999998 112.547 -169.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 394' ' ' LYS . 0.6 OUTLIER -145.47 147.17 31.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.357 -1.292 . . . . 0.53000000000000003 110.749 172.731 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 0.7 OUTLIER -145.02 97.35 4.86 Favored Pre-proline 0 N--CA 1.437 -1.094 0 N-CA-C 108.525 -0.917 . . . . 0.19 108.525 170.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 392' ' ' THR . 20.9 Cg_exo -68.47 110.95 2.4 Favored 'Trans proline' 0 N--CA 1.436 -1.886 0 C-N-CA 122.106 1.871 . . . . 0.19 110.159 -179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.925 HG12 ' HB3' ' A' ' 391' ' ' ALA . 0.4 OUTLIER -110.86 152.41 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.168 0 CA-C-N 113.355 -1.748 . . . . 0.14999999999999999 107.979 -167.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.724 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 19.6 m-80 -85.95 -20.43 28.96 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.958 -0.756 . . . . 0.51000000000000001 108.958 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.726 ' HA ' ' O ' ' A' ' 388' ' ' GLU . 91.4 m-85 -158.85 125.75 4.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.935 -1.03 . . . . 0.27000000000000002 108.493 -170.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.676 ' HE3' ' HB3' ' A' ' 421' ' ' HIS . 19.8 t-105 -143.32 138.18 29.32 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.692 -0.685 . . . . 0.089999999999999997 110.476 -167.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.646 ' O ' HG23 ' A' ' 413' ' ' ILE . 14.3 mmt -118.55 91.08 40.96 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 108.932 -0.766 . . . . 0.14000000000000001 108.932 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.747 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 34.1 Cg_exo -59.2 89.79 0.07 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 123.367 2.711 . . . . 0.5 109.511 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 18.8 pt -91.6 -135.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.812 -0.631 . . . . 0.88 112.184 -170.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.449 ' H ' HG13 ' A' ' 413' ' ' ILE . 16.0 t70 -89.64 165.53 14.18 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.063 0.459 . . . . 2.4900000000000002 110.654 -164.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.18 -11.83 58.4 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 124.135 0.974 . . . . 1.9199999999999999 111.495 -165.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 30.6 p -68.18 -12.77 61.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 113.965 -1.471 . . . . 0.94999999999999996 111.777 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . 0.412 ' HA2' ' HB ' ' A' ' 130' ' ' 1RG . . . 123.82 -40.84 1.87 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.996 -0.621 . . . . 0.68000000000000005 113.133 168.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 419' ' ' GLY . 32.3 t -59.74 171.06 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 122.978 0.511 . . . . 0.75 111.763 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.626 ' HA2' HG12 ' A' ' 413' ' ' ILE . . . -175.81 122.58 0.87 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.039 -1.224 . . . . 0.20000000000000001 110.039 170.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.726 HG22 ' SD ' ' A' ' 450' ' ' MET . 2.4 mp -81.63 143.52 12.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 110.05 -0.352 . . . . 0.28999999999999998 110.05 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.676 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 33.4 p80 -160.32 161.84 33.36 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.298 -0.41 . . . . 0.089999999999999997 111.617 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.691 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -85.03 146.63 27.09 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.402 -0.962 . . . . 1.0700000000000001 108.402 173.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 445' ' ' THR . 37.7 t -133.15 96.32 3.73 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.788 0.804 . . . . 0.23000000000000001 110.074 -171.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . 0.423 ' HA ' ' HG3' ' A' ' 447' ' ' PRO . 8.0 t70 -82.04 -18.16 44.21 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.211 -1.359 . . . . 0.41999999999999998 109.551 -176.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.75 ' CZ3' HG23 ' A' ' 407' ' ' VAL . 11.7 p90 -86.22 -19.13 30.44 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 113.983 -1.462 . . . . 0.32000000000000001 110.915 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -103.89 113.47 65.37 Favored Pre-proline 0 CA--C 1.505 -0.778 0 CA-C-O 122.588 1.185 . . . . 1.74 109.998 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.461 ' HG2' ' OE1' ' A' ' 428' ' ' GLU . 38.6 Cg_endo -87.47 -9.11 6.0 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 124.231 3.288 . . . . 0.72999999999999998 112.779 -174.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.537 ' HG3' ' HD3' ' A' ' 437' ' ' ARG . 2.7 pm0 -111.6 152.2 27.88 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.242 1.02 . . . . 2.1600000000000001 113.291 176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.655 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.5 OUTLIER -163.07 132.02 4.03 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-N 112.608 -2.087 . . . . 0.33000000000000002 105.405 172.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 169.06 -158.61 31.28 Favored Glycine 0 C--N 1.283 -2.401 0 N-CA-C 110.373 -1.091 . . . . 0.17000000000000001 110.373 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.452 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -45.53 174.85 0.01 OUTLIER Glycine 0 CA--C 1.497 -1.045 0 C-N-CA 120.155 -1.022 . . . . 0.20999999999999999 111.493 167.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.541 ' HB2' ' CD ' ' A' ' 435' ' ' LYS . 8.9 p-10 -51.9 101.82 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 123.341 1.543 . . . . 1.8500000000000001 113.834 -154.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.745 ' HG ' ' HD2' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -95.87 -36.02 11.26 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 112.533 -2.122 . . . . 1.21 109.378 170.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.697 ' CH2' ' HE3' ' A' ' 435' ' ' LYS . 67.8 p-90 -54.75 -27.47 41.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.213 -0.903 . . . . 0.16 112.276 -170.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.697 ' HE3' ' CH2' ' A' ' 434' ' ' TRP . 0.0 OUTLIER -90.52 -35.37 15.11 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.468 0.651 . . . . 0.22 112.216 -177.343 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 1.8 p -90.4 -43.39 10.33 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.991 -1.004 . . . . 0.25 110.787 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.745 ' HD2' ' HG ' ' A' ' 433' ' ' LEU . 1.6 mtp180 -93.29 -17.77 23.23 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.536 -1.211 . . . . 1.8200000000000001 109.607 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 434' ' ' TRP . . . 53.67 49.82 56.28 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.765 -1.107 . . . . 0.23999999999999999 115.101 162.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 50.0 m -83.38 110.28 18.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.736 1.268 . . . . 1.01 111.31 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 37.33 -126.85 0.19 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.303 -1.317 . . . . 0.5 114.481 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . . . . . . . . . . . -128.28 -21.32 1.49 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.14 -0.552 . . . . 0.26000000000000001 113.029 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.555 ' HB3' HASB ' A' ' 130' ' ' 1RG . 29.2 p -102.11 -166.05 1.25 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.244 0.545 . . . . 0.34999999999999998 112.273 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.474 HG12 HG11 ' A' ' 347' ' ' VAL . 2.2 mp -96.62 131.15 44.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.314 -0.857 . . . . 0.12 110.619 -174.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.405 HD22 ' N ' ' A' ' 444' ' ' ASN . 0.9 OUTLIER -104.99 94.39 5.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.431 0.634 . . . . 0.62 110.252 -178.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.749 ' HA ' HG22 ' A' ' 368' ' ' ILE . 3.9 m -90.39 145.53 32.74 Favored Pre-proline 0 C--O 1.211 -0.969 0 CA-C-N 114.713 -1.131 . . . . 0.10000000000000001 112.85 -176.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.672 ' HD2' HG21 ' A' ' 366' ' ' THR . 75.8 Cg_exo -50.44 146.51 19.03 Favored 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 123.971 3.114 . . . . 0.23999999999999999 113.659 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.691 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 27.8 Cg_exo -67.3 -23.38 44.85 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.963 2.442 . . . . 0.31 112.364 -176.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.524 ' O ' ' HG2' ' A' ' 451' ' ' LYS . 34.1 p -80.64 -24.98 38.62 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.363 -0.835 . . . . 1.1000000000000001 112.079 -175.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.804 ' O ' HD21 ' A' ' 364' ' ' LEU . 32.8 m -99.38 -48.98 11.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.643 -0.708 . . . . 0.080000000000000002 112.864 -170.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.954 ' SD ' HD23 ' A' ' 453' ' ' LEU . 0.0 OUTLIER -66.95 -2.27 5.07 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.754 -0.779 . . . . 0.070000000000000007 110.349 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 448' ' ' SER . 41.4 pttt -80.81 -39.51 26.53 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.973 -1.121 . . . . 0.92000000000000004 107.973 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.512 ' N ' ' HG3' ' A' ' 451' ' ' LYS . 3.7 mm-40 -61.53 -46.35 90.31 Favored 'General case' 0 CA--C 1.472 -2.032 0 CA-C-N 112.499 -2.137 . . . . 0.25 106.356 -176.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.954 HD23 ' SD ' ' A' ' 450' ' ' MET . 3.6 tp -46.81 -67.49 0.28 Allowed 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 109.612 -3.449 . . . . 0.050000000000000003 112.66 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 387' ' ' LYS . 16.3 t80 -45.46 -23.96 0.27 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 124.008 0.817 . . . . 0.13 109.361 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.449 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -88.36 -26.09 29.03 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.925 -1.034 . . . . 0.13 111.845 -176.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.735 ' HE1' HD22 ' A' ' 364' ' ' LEU . 0.0 OUTLIER -102.45 -44.31 5.4 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 113.309 0.855 . . . . 0.059999999999999998 113.309 176.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 453' ' ' LEU . 0.5 OUTLIER -72.12 147.71 10.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 122.528 1.156 . . . . 0.080000000000000002 110.747 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.64 153.79 37.66 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-N 112.878 -1.965 . . . . 0.47999999999999998 107.943 -178.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 386' ' ' ASN . 42.4 mtmt -55.57 103.01 0.08 Allowed 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 121.783 0.801 . . . . 0.98999999999999999 110.122 173.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 128.58 -11.67 6.33 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 113.637 -1.619 . . . . 0.19 111.394 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.658 HG21 ' HB ' ' A' ' 457' ' ' VAL . 10.3 m -65.6 150.34 96.21 Favored Pre-proline 0 N--CA 1.44 -0.961 0 N-CA-C 108.443 -0.947 . . . . 0.13 108.443 171.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.574 ' HD3' ' CE ' ' A' ' 340' ' ' MET . 5.3 Cg_endo -93.51 163.55 2.37 Favored 'Trans proline' 0 N--CA 1.42 -2.852 0 C-N-CA 122.0 1.8 . . . . 0.17999999999999999 109.644 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.72 ' CG2' ' HB2' ' A' ' 382' ' ' PHE . 3.0 m -125.19 152.71 31.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 107.392 -1.336 . . . . 0.56999999999999995 107.392 170.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.762 HD13 ' CD2' ' A' ' 344' ' ' TYR . 5.1 mp -133.02 150.01 52.17 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 108.09 -1.078 . . . . 0.13 108.09 174.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 1.026 HG23 HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -140.23 138.57 37.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 103.879 -2.638 . . . . 0.10000000000000001 103.879 163.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.764 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 2.5 p90 . . . . . 0 C--O 1.247 0.956 0 O-C-N 123.768 0.668 . . . . 1.0900000000000001 110.719 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' 1RG . . . . . 0.736 ' HBD' ' O ' ' A' ' 130' ' ' 1RG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_